{
  "evaluation_metadata": {
    "evaluator_name": "LLM-as-Judge Evaluator (Model: claude-haiku-4-5)",
    "evaluator_model": "claude-haiku-4-5",
    "model_evaluated": "nemotron-nano-30b-reasoning",
    "experiment": "e6_semantic_retrieval",
    "pattern": "qualitative_2hop_cross_year",
    "total_questions_in_experiment": 1000
  },
  "evaluation_results": [
    {
      "question_id": 77,
      "question": "How did the gross benefit obligation and the actuarial losses for LMT's nonqualified defined benefit pension plans evolve between 2023 and 2024?",
      "original_answer": "In 2023, the gross benefit obligation for LMT's nonqualified defined benefit pension plans was $1.0 billion with actuarial losses totaling $347 million. By 2024, the gross benefit obligation decreased to $905 million, and the actuarial losses declined to $303 million. This indicates a reduction in both the liability and the associated actuarial losses over the period.",
      "llm_answer": "\nThe gross benefit obligation for LMT’s non‑qualified defined‑benefit pension plans fell from roughly **$1.0 billion at the end of 2023 to $905 million at the end of 2024**.  At the same time, the pretax actuarial losses that were recorded in accumulated other comprehensive loss declined from **$347 million in 2023 to $303 million in 2024**.  This reflects a modest reduction in both the overall obligation and the unrecognized actuarial losses over the one‑year period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All quantitative data matches the ground truth exactly: (1) Gross benefit obligation 2023: $1.0 billion ✓, (2) Gross benefit obligation 2024: $905 million ✓, (3) Actuarial losses 2023: $347 million ✓, (4) Actuarial losses 2024: $303 million ✓. The multi-hop synthesis is sound - the answer correctly identifies and compares both metrics across both years for LMT's nonqualified defined benefit pension plans. The LLM provides additional context by noting these are 'pretax actuarial losses...recorded in accumulated other comprehensive loss,' which adds helpful specificity without contradicting the ground truth. The reasoning is logical and the conclusion about 'modest reduction in both the overall obligation and the unrecognized actuarial losses' is appropriate and well-supported by the data. The only minor distinction from the ground truth is the LLM's slightly more detailed characterization of the losses (specifying they are pretax and recorded in AOCL), but this represents added value rather than any inaccuracy. All entities (LMT, nonqualified defined benefit pension plans, years 2023-2024) are correctly identified.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1210,
        "completion_tokens": 335,
        "total_tokens": 1545
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did General Motors' long-term rate of return assumptions on U.S. pension plan assets evolve between 2022 and 2024, and what does this indicate about the company's strategic asset mix adjustments?",
      "original_answer": "In 2022, General Motors reported that the weighted-average long-term rate of return on U.S. pension plan assets decreased from 5.6% at December 31, 2020, to 5.4% at December 31, 2021. By contrast, in 2024, the company indicated that the weighted-average long-term rate of return on U.S. pension plan assets increased from 6.3% at December 31, 2023, to 6.5% at December 31, 2024. This indicates a notable shift in the company's strategic asset mix, moving from a more conservative assumption in 2022 to a more optimistic projection in 2024, likely reflecting changes in capital market assumptions and investment strategies aimed at improving funded status.",
      "llm_answer": "\nGM lifted its weighted‑average long‑term return assumption on U.S. pension assets from roughly 5.4 % (the level used in the 2022 valuation) to 6.5 % by the end of 2024.  At the same time the plan’s strategic mix was re‑balanced: debt exposure fell from about 68 % of assets to ≈60 %, while allocations to private‑equity, real‑estate and other alternatives rose from roughly 23 % to ≈29 % of the portfolio.  This shift shows GM is deliberately reducing fixed‑income weighting and increasing higher‑return alternatives to improve the funded status of its pension plans.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) CRITICAL FACTUAL ERROR - The LLM states the 2022 valuation used 5.4%, but the ground truth clearly indicates 2022 reported 5.4% at December 31, 2021 (not 2022). The LLM conflates the 2022 filing's historical data with current year data. (2) ASSET MIX DATA NOT IN GROUND TRUTH - The LLM provides specific asset allocation percentages (debt 68%→60%, alternatives 23%→29%) that are NOT present in the original answer. This appears to be fabricated or from a different source not verified by the ground truth. (3) INCOMPLETE COMPARISON - The ground truth shows TWO separate time periods: 2022 filing (5.6%→5.4% for 2020-2021) and 2024 filing (6.3%→6.5% for 2023-2024). The LLM only addresses the 2024 endpoint (5.4%→6.5%) without properly contextualizing the 2022 data. (4) CORRECT ELEMENTS - The LLM correctly identifies the overall trend (increase from ~5.4% to 6.5%) and correctly interprets the strategic shift toward alternatives and away from fixed income. However, the asset allocation percentages are unverified and potentially incorrect. (5) MULTI-HOP REASONING - While the LLM attempts to synthesize asset mix changes with return assumptions, the asset mix data cannot be verified against the ground truth, making this synthesis unreliable. The core insight about strategic repositioning is sound but built on unverified data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 379,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has Chevron's relationship with PDC Energy evolved between 2023 and 2024, and what specific operational and financial impacts were attributed to this change?",
      "original_answer": "In 2023, Chevron acquired PDC Energy, and as a result, PDC was excluded from Chevron’s internal control assessment due to the business combination. By 2024, the integration had progressed to the point where Chevron reported a $2.2 billion increase in U.S. upstream earnings attributed to legacy PDC assets, and a 19% increase in net oil-equivalent production driven by the full-year contribution from PDC. This reflects a shift from acquisition to operational integration and performance contribution.",
      "llm_answer": "\nBetween 2023 and 2024 the relationship moved from a pending acquisition in 2023 to full integration of PDC Energy as a subsidiary of Chevron.  The combined assets added roughly 250,000 barrels‑per‑day of net oil‑equivalent production (a 19 % rise) and contributed about $2.2 billion of sales volume, which drove a $3.5 billion increase in U.S. upstream earnings and lifted overall net income, while also allowing Chevron to exclude PDC from its internal‑control assessments after the 2023 acquisition.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - CRITICAL ERROR: LLM states '$3.5 billion increase in U.S. upstream earnings' but ground truth clearly states '$2.2 billion increase in U.S. upstream earnings.' This is a significant factual error ($1.3 billion discrepancy). The 19% production increase and 250,000 barrels-per-day figures are correct. (2) MISCHARACTERIZATION OF SALES VOLUME: LLM states PDC 'contributed about $2.2 billion of sales volume' which conflates the earnings increase with sales volume - the ground truth indicates $2.2 billion was the earnings increase, not sales volume. This is a semantic/conceptual error. (3) MULTI-HOP REASONING: The LLM correctly synthesized the evolution from acquisition (2023) to integration (2024) and identified the internal control exclusion correctly. However, the core financial impact number is wrong. (4) COMPLETENESS: The answer addresses the relationship evolution and operational/financial impacts, but the primary financial metric is incorrect. (5) ENTITY ACCURACY: Companies and years are correct (Chevron, PDC Energy, 2023-2024). The production percentage (19%) is correct. The fundamental issue is the $3.5 billion vs. $2.2 billion error on earnings, which is the most critical financial metric in the answer. This single error significantly undermines the accuracy of the response despite getting other details right.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 385,
        "total_tokens": 1640
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did Southern Company's treatment and valuation of energy-related derivatives change between 2022 and 2024, particularly in terms of unrealized gains (losses) and their presentation in financial statements?",
      "original_answer": "In 2022, Southern Company reported the pre-tax effects of unrealized derivative gains (losses) from energy-related derivatives that were designated as regulatory hedging instruments and deferred, specifically as of December 31, 2021, and 2020. By 2024, the company shifted its disclosure focus to the fair value of energy-related derivatives, interest rate derivatives, and foreign currency derivatives, which were presented as either assets or liabilities in the balance sheets, typically under 'Other' or separately as 'Risk Management Activities'. This indicates a change in both the valuation approach and the presentation of these instruments in financial disclosures.",
      "llm_answer": "\nSouthern Company’s regulatory‑hedge unrealized gain on energy‑related derivatives rose sharply from about **$12 million in the 2021 comparative figures shown in the 2022 10‑K** to **$155 million in the 2024 balance‑sheet data (December 31 2023)**.  The 2024 filing now presents the gain (and the related liabilities) as separate **current and non‑current regulatory assets and liabilities**, net of offsetting amounts, whereas the 2022 filing aggregated the amounts in “Other regulatory assets/liabilities” without the detailed offset schedule.  As a result, the unrealized gains are recognized as regulatory assets/liabilities that flow into fuel expense or revenue through the rate‑recovery mechanism, rather than being recorded only in AOCI or as a single aggregate figure.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and unsupported claims that diverge substantially from the ground truth. CRITICAL ISSUES: (1) UNVERIFIED NUMBERS: The LLM cites specific dollar amounts ($12 million in 2021, $155 million in 2023) that are not mentioned in the ground truth answer. These numbers appear to be fabricated or hallucinated, as the ground truth explicitly does not provide specific quantitative values for unrealized gains/losses. (2) MISCHARACTERIZATION OF CHANGE: The ground truth indicates a shift from 'pre-tax effects of unrealized derivative gains (losses) from energy-related derivatives designated as regulatory hedging instruments and deferred' to 'fair value of energy-related derivatives presented as assets or liabilities in balance sheets.' The LLM incorrectly frames this as a change in how regulatory assets/liabilities are presented (current vs. non-current, offset schedules), which is not supported by the ground truth. (3) INCOMPLETE SYNTHESIS: The ground truth mentions THREE types of derivatives (energy-related, interest rate, and foreign currency), but the LLM focuses only on energy-related derivatives and ignores the broader scope of the change. (4) INCORRECT MECHANISM DESCRIPTION: The LLM's claim about 'fuel expense or revenue through the rate-recovery mechanism' and 'AOCI' treatment is not mentioned in the ground truth and appears to be unsupported speculation. (5) PRESENTATION CHANGE MISUNDERSTOOD: The ground truth indicates a shift from deferred regulatory hedging treatment to fair value presentation in balance sheets under 'Other' or 'Risk Management Activities.' The LLM's description of 'separate current and non-current regulatory assets and liabilities' with 'detailed offset schedules' is not corroborated. The LLM answer demonstrates poor multi-hop reasoning by introducing specific numbers without source verification and mischaracterizing the nature of the accounting change. While the answer attempts to address the question's core topic, it fails on factual accuracy and introduces unverified quantitative claims.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 561,
        "total_tokens": 1939
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Chevron's financial relationship with Tengizchevroil evolve between 2022 and 2024, particularly in terms of its investment carrying value and equity earnings?",
      "original_answer": "In 2022, Chevron disclosed that its carrying value of its investment in Tengizchevroil (TCO) was about $100 higher than its underlying equity in TCO's net assets, with a significant portion of the investment tied to a $4,500 loan to fund the FGP/WPMP development. By 2024, Chevron's financial stake in Tengizchevroil had grown substantially, with its investment and advances reaching $27,368 million in 2024, compared to $26,954 million in 2023. Additionally, Chevron's equity in earnings from TCO declined from $4,386 million in 2022 to $3,033 million in 2024, indicating a reduction in profitability from the venture over this period.",
      "llm_answer": "\nBetween 2022 and 2024 Chevron’s stake in Tengizchevroil expanded — the carrying value of the equity investment rose from roughly **$26.9 billion (2023)** to **$27.4 billion (2024)**, after having been about **$23 billion in 2022**.  At the same time, equity‑method earnings from TCO fell sharply, dropping from **≈ $4.4 billion in 2022** to **≈ $3.0 billion in 2024** (≈ $3.4 billion in 2023), reflecting lower net earnings from the partnership as oil‑price volatility and reduced production at the Tengiz and Korolev fields impacted the affiliate’s profitability.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of Chevron's Tengizchevroil relationship evolution but contains some quantitative discrepancies. CORRECT ELEMENTS: (1) The 2024 investment value of $27.4 billion (stated as $27,368M in ground truth) is accurate; (2) The 2023 value of $26.9 billion ($26,954M in ground truth) is accurate; (3) Equity earnings decline from ~$4.4B (2022) to ~$3.0B (2024) is correct; (4) The intermediate 2023 earnings figure of ~$3.4B is reasonable; (5) The explanation about oil-price volatility and production impacts is contextually appropriate. DISCREPANCIES: (1) The 2022 carrying value is stated as 'about $23 billion' in the LLM answer, but the ground truth indicates the carrying value was about $100 million higher than underlying equity in net assets with a $4,500M loan component - this doesn't clearly translate to $23B and appears to be an approximation without clear justification; (2) The ground truth emphasizes the $4,500M loan to fund FGP/WPMP development in 2022, which the LLM answer omits entirely; (3) The LLM answer provides additional context about production at Tengiz and Korolev fields that, while plausible, is not explicitly stated in the ground truth. MULTI-HOP REASONING: The LLM correctly synthesizes the investment growth trajectory (2022→2023→2024) and correlates it with declining earnings, demonstrating sound multi-hop reasoning. The comparison across three years is properly structured. SEMANTIC EQUIVALENCE: The core message matches - investment grew while earnings declined - though the 2022 baseline figure lacks precision. The answer appropriately addresses both components of the question (investment carrying value and equity earnings evolution).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 469,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did Walmart's ownership stake in Alert Innovation evolve between fiscal 2023 and fiscal 2024, and what specific transaction occurred to change its relationship with the entity?",
      "original_answer": "In fiscal 2023, Walmart completed a $0.4 billion acquisition of Alert Innovation, which was previously consolidated as a variable interest entity, resulting in Walmart becoming a 100% owner. However, by fiscal 2024, Walmart had subsequently sold and deconsolidated Alert Innovation, indicating a complete exit from the entity. This marks a full transformation from full ownership to no ownership within a single fiscal year.",
      "llm_answer": "\nBetween fiscal 2023 and fiscal 2024 Walmart’s stake in Alert Innovation moved from a variable‑interest position to 100 % ownership after it completed a $0.4 billion acquisition in fiscal 2023; by the end of fiscal 2024 the company continued to hold a full 100 % interest, with no further transaction altering that relationship during the year.",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERROR: The LLM answer fundamentally contradicts the ground truth on the key transaction that occurred between fiscal 2023 and fiscal 2024. (1) WHAT WAS CORRECT: The LLM correctly identifies that Walmart acquired Alert Innovation for $0.4 billion in fiscal 2023, moving from a variable interest entity position to 100% ownership. The quantitative accuracy of the $0.4 billion figure is correct. (2) WHAT WAS INCORRECT: The LLM states that 'by the end of fiscal 2024 the company continued to hold a full 100% interest, with no further transaction altering that relationship during the year.' This is factually wrong. According to the ground truth, Walmart SOLD and DECONSOLIDATED Alert Innovation in fiscal 2024, meaning it exited the entity completely (0% ownership). The LLM failed to identify this critical transaction. (3) MULTI-HOP REASONING FAILURE: The question specifically asks 'what specific transaction occurred to change its relationship with the entity?' The ground truth answer identifies the sale/deconsolidation in fiscal 2024 as the key transaction. The LLM completely missed this transaction and incorrectly stated there was 'no further transaction' during fiscal 2024. This represents a fundamental failure in multi-hop synthesis across the two fiscal years. (4) SEMANTIC MISMATCH: The ground truth describes 'a full transformation from full ownership to no ownership within a single fiscal year' - this is the core narrative. The LLM's narrative of continued 100% ownership is semantically opposite to the correct answer. The LLM essentially answered a different question about what happened in fiscal 2023 only, rather than addressing the evolution between fiscal 2023 and fiscal 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1200,
        "completion_tokens": 467,
        "total_tokens": 1667
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Starbucks' foreign currency - other derivative asset and liability positions change from fiscal year 2022 to 2023, and what does this indicate about the company's exposure management strategy?",
      "original_answer": "In fiscal year 2022, Starbucks reported a foreign currency - other derivative asset of $55.3 million in Accumulated Other Comprehensive Income (AOCI) with $32.5 million expected to be reclassified into earnings within 12 months. By fiscal year 2023, Starbucks had shifted its position significantly, reporting foreign currency - other derivative assets of $1.9 million in current assets and $1.7 million in long-term assets, while carrying derivative liabilities of $4.7 million in current liabilities and $4.1 million in long-term liabilities. This indicates a substantial reduction in overall foreign currency - other derivative exposure and a shift from unrealized gains in equity to more balanced short- and long-term asset and liability positions.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2023 the fair‑value of Starbucks’ “foreign‑currency‑other” derivatives fell sharply: the asset position dropped from about **$115 million** (comprised of $39.9 m + $33.5 m designated plus $34.3 m + $7.3 m non‑designated) to roughly **$5.5 million**, while the liability rose from about **$6 million** to **$11 million**.  \n\nThis contraction shows that the company deliberately pared back its foreign‑currency derivative book, indicating a shift toward a more streamlined exposure‑management approach—relying less on extensive derivative hedges and more on operational or natural hedges to mitigate foreign‑currency risk.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS - MAJOR FACTUAL INACCURACIES:\n\n1. QUANTITATIVE ACCURACY FAILURES:\n   - LLM claims FY2022 asset position was ~$115 million (comprised of $39.9M + $33.5M + $34.3M + $7.3M). Ground truth shows FY2022 had $55.3 million in AOCI derivative assets, NOT $115 million. This is a 108% overstatement.\n   - LLM claims FY2023 asset position was ~$5.5 million ($1.9M current + $1.7M long-term = $3.6M, not $5.5M). Ground truth shows $1.9M current + $1.7M long-term = $3.6M total assets.\n   - LLM states liability rose from ~$6 million to ~$11 million. Ground truth shows FY2023 had $4.7M current + $4.1M long-term = $8.8M total liabilities, not $11 million.\n   - The component breakdown provided by LLM ($39.9M + $33.5M + $34.3M + $7.3M) does not match ground truth data structure at all.\n\n2. STRUCTURAL MISUNDERSTANDING:\n   - Ground truth clearly distinguishes between FY2022 position (reported in AOCI with reclassification expectations) and FY2023 position (split between current/long-term assets and liabilities).\n   - LLM appears to have conflated or misread the data, presenting numbers that don't align with either year's actual reporting.\n   - The component breakdown methodology used by LLM is not supported by the ground truth.\n\n3. DIRECTIONAL ACCURACY:\n   - LLM correctly identifies a REDUCTION in overall exposure (asset decline, liability increase), which aligns with ground truth.\n   - LLM's interpretation about shift toward streamlined approach is reasonable but based on incorrect numbers.\n\n4. MISSING CONTEXT:\n   - LLM fails to mention the AOCI framework and reclassification expectations from FY2022.\n   - LLM doesn't capture the shift from equity-based unrealized gains to balanced asset/liability positions.\n\n5. CALCULATION VERIFICATION:\n   - Ground truth FY2023 total assets: $1.9M + $1.7M = $3.6M (LLM states ~$5.5M - INCORRECT)\n   - Ground truth FY2023 total liabilities: $4.7M + $4.1M = $8.8M (LLM states ~$11M - INCORRECT)\n   - All major numeric claims are materially wrong.\n\nCONCLUSION: While the LLM's qualitative interpretation about exposure management strategy reduction is directionally reasonable, the quantitative foundation is fundamentally flawed with numbers that are significantly off from ground truth. This is a critical failure for a financial analysis question where precision is paramount.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 629,
        "total_tokens": 1993
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did Medtronic's treatment of A Preferred Shares evolve between fiscal years 2022 and 2024, and what specific action was taken regarding these shares in 2022?",
      "original_answer": "In fiscal year 2022, Medtronic redeemed 1,872 A Preferred Shares for $0.075 million during the third quarter, and no A Preferred Shares were outstanding by April 29, 2022. By fiscal year 2024, no A Preferred Shares remained outstanding, indicating that the company did not reissue or reintroduce this class of shares after the redemption in 2022. This shows a discontinuation of the A Preferred Shares following their redemption.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2024 Medtronic went from having a small number of A Preferred Shares outstanding to none.  In the third quarter of fiscal 2022 the company redeemed the 1,872 A Preferred Shares that were still issued, paying $0.075 million and effectively retiring those shares; consequently, at the end of fiscal 2022 (and thereafter through fiscal 2024) no A Preferred Shares remained outstanding.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and addresses all key aspects of the question. Quantitative verification: (1) 1,872 A Preferred Shares redeemed - CORRECT, (2) $0.075 million redemption price - CORRECT, (3) Q3 fiscal 2022 timing - CORRECT, (4) No shares outstanding by end of FY2022 and through FY2024 - CORRECT. The answer correctly synthesizes the multi-hop information: it traces the evolution from FY2022 to FY2024, identifies the specific redemption action in Q3 FY2022, and confirms the discontinuation through FY2024. The reasoning is sound - the model properly explains that the redemption resulted in no outstanding shares thereafter. The only minor distinction from the ground truth is that the LLM uses slightly different phrasing ('went from having a small number...to none' vs the ground truth's more direct statement about 'no A Preferred Shares outstanding by April 29, 2022'), but this is semantically equivalent and actually provides helpful context about the transition. The answer demonstrates proper multi-hop synthesis across the fiscal years and correctly identifies all entities (Medtronic, A Preferred Shares, fiscal years 2022-2024). No calculation errors or factual inaccuracies detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1214,
        "completion_tokens": 343,
        "total_tokens": 1557
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Comcast's financial relationship with Atairos evolve between 2022 and 2023, particularly in terms of equity income (losses) driven by fair value adjustments on underlying investments?",
      "original_answer": "In 2022, Comcast's equity in net income (losses) from investees, particularly Atairos, showed a loss of $(434) million due to fair value adjustments on its underlying investments. In contrast, by 2023, Atairos generated income of $1.1 billion for Comcast, reflecting a significant turnaround. This change indicates a substantial improvement in the performance of Atairos's underlying investments over the period.",
      "llm_answer": "\nBetween 2022 and 2023 Comcast’s equity‑method earnings from its Atairos investment flipped from a **$(434 million) loss** in 2022 to a **$1.1 billion gain** in 2023.  The swing was driven by favorable fair‑value adjustments on Atairos’s underlying investments, turning what had been a net loss in 2022 into a sizable equity‑income gain in 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. All quantitative data is correct: the 2022 loss of $(434) million and the 2023 gain of $1.1 billion are both accurately stated with proper formatting. The multi-hop reasoning is sound—the answer correctly synthesizes information about Comcast's equity-method investment in Atairos across two fiscal years and properly attributes the swing to fair value adjustments on underlying investments. The answer uses semantically equivalent terminology ('equity-method earnings' vs 'equity in net income from investees', 'gain' vs 'income') that conveys the same meaning. The temporal comparison is clear and logical, showing the evolution from loss to gain. The only minor consideration is that the LLM uses slightly different phrasing ('flipped from...to', 'swing') compared to the ground truth's more straightforward presentation, but this represents stylistic variation rather than factual error. The answer fully addresses all aspects of the multi-part question regarding the financial relationship evolution, the specific metrics involved, and the drivers of change.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1200,
        "completion_tokens": 320,
        "total_tokens": 1521
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How has COP's natural gas reserves in the Asia Pacific/Middle East region evolved from 2023 to 2024, and what does this indicate about the company's strategic positioning in that geographic area?",
      "original_answer": "In 2023, COP reported 312 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region. By 2024, this figure slightly declined to 296 billion cubic feet. This minor decrease suggests limited growth or a strategic reallocation of resources in the region during that period.",
      "llm_answer": "\nFrom the end of 2023 to the end of 2024 the company’s reported natural‑gas reserves in the Asia‑Pacific/Middle‑East region slipped from roughly **305 billion cubic feet to 289 billion cubic feet** (about a 5 % decline). This reduction indicates that ConocoPhillips is **scaling back its proven gas base in that region**, shifting strategic focus and investment toward other areas such as North‑American onshore plays and LNG projects rather than expanding its reserve base in Asia‑Pacific/Middle‑East.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM provides significantly incorrect reserve figures. Ground truth shows 312 BCF (2023) declining to 296 BCF (2024), but the LLM reports 305 BCF (2023) declining to 289 BCF (2024). These are material discrepancies: the 2023 figure is off by 7 BCF (2.2% error) and the 2024 figure is off by 7 BCF (2.4% error). The calculated decline percentage is also wrong: LLM states ~5% decline, but the correct decline is (312-296)/312 = 5.1%, which is close but based on incorrect base numbers. QUANTITATIVE ACCURACY ASSESSMENT: Both the starting and ending reserve figures are factually incorrect, which is a fundamental failure for a financial question requiring precise data from SEC filings. QUALITATIVE REASONING: The LLM's interpretation that the decline indicates 'scaling back' and 'shifting strategic focus' is reasonable inference, though the ground truth answer is more cautious, describing it as 'limited growth or strategic reallocation.' The LLM adds specific detail about shifting toward North American onshore and LNG projects, which goes beyond the ground truth but cannot be verified as incorrect from the provided information. MULTI-HOP SYNTHESIS: The answer correctly identifies the company as ConocoPhillips (COP), correctly identifies the region (Asia Pacific/Middle East), and correctly identifies the metric (natural gas reserves in BCF). However, the failure to retrieve accurate reserve numbers from the source documents is a critical flaw. ENTITY ACCURACY: Company and region identification are correct; metric terminology is appropriate. OVERALL ASSESSMENT: While the reasoning structure and interpretation are reasonable, the fundamental quantitative errors make this answer significantly incorrect for a financial analysis question where precise numbers are essential.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1211,
        "completion_tokens": 496,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did the revenue performance of ENBREL in Canada evolve between 2022 and 2024, and what does this indicate about its market trajectory?",
      "original_answer": "In 2022, ENBREL in Canada generated $113 million in revenue, which declined to $47 million in 2023, and further dropped to $28 million in 2024. This indicates a consistent downward trend in revenue, suggesting a shrinking market presence or reduced demand for ENBREL in Canada over this period.",
      "llm_answer": "\nIn Canada, ENBREL sales fell sharply each year—from **$113 million in 2021 to $73 million in 2022 (‑35 %), $47 million in 2023 (‑36 % YoY), and $28 million in 2024 (‑40 % YoY)**.  This accelerating decline signals a continued erosion of the product’s Canadian market, driven by biosimilar competition, patent expirations and pricing pressure, indicating that ENBREL’s trajectory in Canada is decisively downward.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains a fundamental factual error regarding the starting year. The ground truth specifies revenue evolution between 2022-2024 ($113M in 2022 → $47M in 2023 → $28M in 2024), but the LLM introduces a 2021 data point ($113M in 2021) that is not in the original answer and shifts all subsequent years. This is a major error that misrepresents the time period being analyzed. VERIFICATION OF NUMBERS: (1) Ground truth 2022: $113M - LLM claims $113M in 2021 (WRONG YEAR); (2) Ground truth 2023: $47M - LLM correctly states $47M in 2023; (3) Ground truth 2024: $28M - LLM correctly states $28M in 2024. CALCULATION ERRORS: The LLM calculates a -35% decline from 2021 to 2022 ($113M to $73M), but the ground truth shows 2022 starting at $113M, not 2021. The percentage calculations themselves (-36% YoY for 2023, -40% YoY for 2024) are mathematically correct based on the numbers provided, but they're applied to an incorrect baseline year. MULTI-HOP REASONING: The LLM correctly synthesizes the downward trend and provides reasonable contextual explanation (biosimilar competition, patent expirations, pricing pressure), which aligns with the ground truth's conclusion about market trajectory. However, this qualitative reasoning cannot compensate for the quantitative errors. COMPLETENESS: The question asks about evolution between 2022-2024, and while the LLM addresses this period, it incorrectly adds 2021 data that wasn't requested and creates confusion about the baseline. The core conclusion about downward trajectory is correct, but the factual foundation is flawed. The answer demonstrates understanding of the market dynamics but fails on basic data accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1174,
        "completion_tokens": 468,
        "total_tokens": 1643
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has Qualcomm's approach to linking human capital advancements with executive compensation evolved from fiscal 2023 to fiscal 2024, and what specific performance modifier range was applied in fiscal 2024?",
      "original_answer": "In fiscal 2023, Qualcomm indicated that human capital advancements would be considered in determining executives' fiscal 2024 bonus. By fiscal 2024, this approach evolved into a more defined structure where progress toward human capital advancements served as a non-financial performance modifier that could adjust executives' bonus payouts by a multiplier ranging from 0.9 to 1.1. This represents a shift from a general consideration to a quantified performance modifier in executive compensation.",
      "llm_answer": "\nFrom fiscal 2023 to fiscal 2024 Qualcomm moved from a largely qualitative reference to human‑capital progress in its executive‑bonus discussion to a formal, quantitative performance modifier.  For fiscal 2024 the HR and Compensation Committee explicitly ties progress on human‑capital goals to a bonus‑adjustment multiplier of **0.9 to 1.1**, whereas in fiscal 2023 no such defined range was disclosed.  This evolution codifies human‑capital advancements as a direct, measurable factor that can raise or lower executive bonus payouts.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. Verification of key elements: (1) NUMERIC ACCURACY: The performance modifier range of 0.9 to 1.1 is correctly stated and matches the ground truth exactly. (2) TEMPORAL ACCURACY: The fiscal 2023 to fiscal 2024 evolution is correctly identified and properly contextualized. (3) CONCEPTUAL ACCURACY: The answer correctly captures the shift from qualitative consideration ('would be considered') to quantified performance modifier with defined range. (4) MULTI-HOP SYNTHESIS: The answer successfully synthesizes information across two fiscal years, comparing the approach in each period and identifying the evolution. (5) COMPLETENESS: All parts of the question are addressed - the evolution is explained, the specific range is provided, and the nature of the change (qualitative to quantitative) is clearly articulated. (6) WORDING: The LLM uses slightly different but semantically equivalent language ('formal, quantitative performance modifier' vs 'more defined structure where progress...served as a non-financial performance modifier'), which is appropriate and acceptable. The phrase 'codifies human-capital advancements as a direct, measurable factor' effectively conveys the same meaning as the ground truth's description of the shift. Minor note: The LLM adds the detail that 'no such defined range was disclosed' in fiscal 2023, which is a reasonable inference from the ground truth's statement that fiscal 2023 indicated human capital 'would be considered' without a specific range, though this is implicit rather than explicitly stated in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 444,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has the therapeutic scope of Breyanzi evolved between 2022 and 2024, based on the specific indications and approvals documented in those years?",
      "original_answer": "In 2022, Breyanzi was associated with trials for 3L+ Chronic Lymphocytic Leukemia (TRANSCEND-CLL-004) and 3L+ Follicular Lymphoma (TRANSCEND-FL), both with expected timing in 2023/24. By 2024, Breyanzi received FDA accelerated approvals for two distinct indications: relapsed or refractory Follicular Lymphoma (FL) after at least two prior lines of therapy (approved in May 2024), and relapsed or refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) after at least two prior lines of therapy, including a Bruton tyrosine kinase inhibitor and a B-cell lymphoma 2 inhibitor (approved in March 2024). This reflects a shift from being in late-stage trials to having concrete accelerated approvals in specific patient populations.",
      "llm_answer": "\nBetween 2022 and 2024 Breyanzi’s label expanded from the initial approvals for relapsed / refractory chronic‑lymphocytic leukemia/small‑lymphocyte lymphoma, follicular lymphoma and mantle‑cell lymphoma (2022 filing, p. 42) to multiple 2024 FDA accelerated approvals that require prior BTK‑inhibitor + BCL‑2‑inhibitor therapy and also add a Japan MHLW approval extending the follicular‑lymphoma indication to patients who have received only one prior line of treatment (2024 filings, pp. 44‑51). This widens both the disease spectrum and the line‑of‑therapy eligibility for the therapy.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) FACTUAL INACCURACY - The LLM claims Breyanzi had 'initial approvals for relapsed/refractory chronic-lymphocytic leukemia/small-lymphocyte lymphoma, follicular lymphoma and mantle-cell lymphoma (2022 filing)' in 2022. The ground truth explicitly states that in 2022, Breyanzi was only in TRIALS (TRANSCEND-CLL-004 and TRANSCEND-FL), NOT approved. The LLM incorrectly backdates approvals to 2022 that actually occurred in 2024. (2) MISSING KEY DETAILS - The LLM fails to mention the specific approval dates (March 2024 for CLL/SLL, May 2024 for FL) documented in the ground truth. (3) INCOMPLETE SYNTHESIS - While the LLM mentions Japan MHLW approval for 1L+ FL, the ground truth focuses on FDA accelerated approvals with specific prior therapy requirements (BTK inhibitor + BCL-2 inhibitor for CLL/SLL). The LLM conflates different regulatory approvals without clearly distinguishing FDA vs. Japan approvals. (4) INCORRECT CHARACTERIZATION - The LLM describes this as 'expansion from initial approvals' when the ground truth shows a transition from trials to first approvals. This is a fundamental misrepresentation of the therapeutic evolution. (5) MISSING CRITICAL CONTEXT - The ground truth emphasizes the shift from 'late-stage trials to concrete accelerated approvals in specific patient populations,' which the LLM does not adequately capture. The LLM's statement about 'widening disease spectrum' is partially correct but obscures the fact that 2022 had NO approvals, only trials. The answer demonstrates poor multi-hop synthesis and contains a critical factual error about the 2022 status of Breyanzi.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 448,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has the financial performance of Disney's Resorts and Vacations segment evolved from 2023 to 2024, and how does this compare to the overall revenue growth of the Parks & Experiences segment?",
      "original_answer": "The Resorts and Vacations segment saw an increase in revenue from $7,949 million in 2023 to $8,375 million in 2024, representing a 5% growth. This growth was slightly below the overall Parks & Experiences revenue growth of 5%, which increased from $32,549 million in 2023 to $34,151 million in 2024. The Resorts and Vacations segment remained a significant contributor to the overall Parks & Experiences division, maintaining a consistent proportion of total revenue despite the modest growth difference.",
      "llm_answer": "\nFrom fiscal 2023 to fiscal 2024, revenue in Disney’s **Resorts & Vacations** business rose to **$8.38 billion**, a **5 % increase** over the prior year, driven by higher average ticket prices for cruise sailings, modest gains in hotel room rates and occupancy, and slightly higher DVC unit sales, while a 1 % dip in DVC unit volume offset some growth. This 5 % rise is essentially in line with the **overall Parks & Experiences segment**, which grew **5 %** to **$34.15 billion** in the same period. Thus, the Resorts & Vacations sub‑segment is performing in step with the broader segment’s revenue expansion.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. Quantitative verification: Resorts & Vacations revenue of $8.38 billion (matches $8,375 million in ground truth with acceptable formatting variation), 5% growth rate (correct), Parks & Experiences total of $34.15 billion (matches $34,151 million, acceptable formatting), and 5% growth rate (correct). The calculation of growth rates is accurate: ($8,375M - $7,949M) / $7,949M = 5.36% ≈ 5%, and ($34,151M - $32,549M) / $32,549M = 4.92% ≈ 5%. Multi-hop synthesis is sound: the answer correctly identifies that both segments grew at approximately the same rate (5%), and appropriately contextualizes the Resorts & Vacations segment within the broader Parks & Experiences division. The LLM provides additional operational context (higher ticket prices for cruises, hotel room rates/occupancy gains, DVC unit sales, and a 1% dip in DVC volume) that enriches the answer without contradicting ground truth. The comparison is properly framed as 'in step with' or 'essentially in line with' the broader segment. Minor note: The ground truth states the overall Parks & Experiences growth was 5%, while precise calculation yields 4.92%, but both sources round to 5%, so this is not a discrepancy. The answer fully addresses all parts of the multi-part question: evolution from 2023 to 2024, comparison to overall segment growth, and contextual positioning. Wording differs from ground truth but semantic meaning is preserved and enhanced with operational drivers.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 417,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How has the structure and value of CVS's forward contracts associated with accelerated share repurchase (ASR) transactions evolved between 2023 and 2024?",
      "original_answer": "In 2023, CVS executed a $2.0 billion ASR with Citibank, N.A., which was accounted for as an initial treasury stock transaction of $1.6 billion and a forward contract of $0.4 billion. The forward contract was classified as an equity instrument and recorded within capital surplus, with the final 20% of shares received in February 2023. In 2024, CVS entered into a larger $3.0 billion ASR with Morgan Stanley, accounted for as an initial treasury stock transaction of $2.6 billion and a forward contract of $0.4 billion. The forward contract was similarly classified and recorded, but the remaining 15% of shares were received later, in March 2024. Despite the increase in the ASR size, the forward contract value remained constant at $0.4 billion, indicating a shift in the proportion of the ASR allocated to the forward contract component.",
      "llm_answer": "\nBetween 2023 and 2024 the company’s ASR‑related forward contracts grew in size and followed the same equity‑classification pattern. In 2023 the firm entered a $2.0 billion fixed‑dollar ASR with Citibank, recording an initial treasury‑stock purchase of roughly $1.6 billion and a forward contract of about $0.3 billion that was booked in capital surplus and later re‑classified to treasury stock when the remaining shares were received in February 2023. In 2024 the company executed a larger $3.0 billion ASR with Morgan Stanley, initially taking an $2.6 billion treasury‑stock position and a $0.4 billion forward contract—again classified as equity and subsequently re‑classified to treasury stock after the final share delivery in March 2024. Thus, the forward‑contract component expanded proportionally with the larger notional amount, but its accounting treatment (equity classification and later re‑classification) remained consistent.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates good understanding of the overall structure and evolution of CVS's ASR transactions, but contains a critical quantitative error that undermines accuracy. SPECIFIC ERRORS: (1) The 2023 forward contract value is stated as 'about $0.3 billion' when the ground truth clearly specifies $0.4 billion. This is a material factual error on a key metric. (2) The LLM states the forward contract 'expanded proportionally with the larger notional amount' but this is contradicted by the actual data: the ASR grew from $2.0B to $3.0B (50% increase) while the forward contract remained constant at $0.4B (0% increase). This represents a SHRINKING proportion, not expansion. CORRECT ELEMENTS: (1) Both ASR amounts are correct ($2.0B in 2023, $3.0B in 2024). (2) Both treasury stock amounts are correct ($1.6B and $2.6B respectively). (3) Counterparty names are correct (Citibank and Morgan Stanley). (4) Share delivery dates are correct (February 2023, March 2024). (5) The equity classification and subsequent reclassification to treasury stock is correctly described. (6) The overall narrative structure and accounting treatment consistency is well-articulated. MULTI-HOP REASONING: The LLM successfully synthesized information across two years and identified the key comparison point (forward contract value stability despite ASR growth), but drew an incorrect conclusion about proportional expansion. The reasoning framework is sound but the execution contains a logical error that contradicts the data presented. The quantitative error (0.3B vs 0.4B) is particularly problematic as it's a direct factual claim about a specific financial metric.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 454,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did Duke Energy's disclosure regarding the Master Retirement Trust's pension asset valuation methodology evolve from 2023 to 2024, particularly in terms of transparency around fair value categorization?",
      "original_answer": "In 2023, Duke Energy disclosed the allocation percentages of the Master Retirement Trust among its subsidiaries and noted that certain investments measured at fair value using the net asset value per share practical expedient were not categorized in the fair value hierarchy. In 2024, the company maintained the same allocation percentages but added a new disclosure element — a reconciliation of beginning and ending balances of the Master Retirement Trust's qualified pension and other post-retirement assets, specifically those valued using significant unobservable inputs (Level 3). This represents a significant increase in transparency regarding the fair value categorization of pension assets.",
      "llm_answer": "\nFrom 2023 to 2024 Duke Energy’s Master Retirement Trust disclosure became slightly more transparent about how its assets are valued under the fair‑value hierarchy.  In the 2023 table the fair‑value amounts were split as Level 1 $2,042 M, Level 2 $4,944 M, Level 3 $76 M and “Not Categorized” $179 M; by 2024 the same categories were $2,242 M (Level 1), $4,481 M (Level 2), $68 M (Level 3) and $178 M (Not Categorized).  The shift shows a modest increase in assets measured with observable market prices (Level 1) and a reduction in those relying on unobservable inputs (Level 2 and especially Level 3), accompanied by a concise reconciliation of the Level 3 balance, indicating clearer reporting of the valuation methodology.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its credibility. CRITICAL ISSUES: (1) The LLM provides specific dollar amounts ($2,042M Level 1, $4,944M Level 2, $76M Level 3, $179M Not Categorized for 2023, and corresponding 2024 figures) that are NOT mentioned in the ground truth answer. The ground truth makes no reference to these specific numerical values, suggesting the LLM either fabricated these numbers or drew them from unreliable sources. (2) The ground truth explicitly states that in 2023, certain investments 'were not categorized in the fair value hierarchy,' but the LLM's answer treats 'Not Categorized' as a standard reporting category with specific dollar amounts, which may misrepresent how Duke Energy actually disclosed this information. (3) The LLM's characterization of the evolution differs from ground truth: Ground truth emphasizes the addition of a NEW reconciliation disclosure for Level 3 assets in 2024 as the key transparency improvement. The LLM instead focuses on shifts in asset allocation between levels and describes a 'concise reconciliation' without clearly stating this was a NEW disclosure element added in 2024. (4) The LLM's interpretation that Level 1 increased and Level 3 decreased is presented as analytical insight, but without verification against actual filings, this appears speculative. (5) The ground truth notes 'maintained the same allocation percentages' between years, but the LLM's numbers show significant changes (Level 1: $2,042M to $2,242M, Level 2: $4,944M to $4,481M, Level 3: $76M to $68M), which contradicts the ground truth's statement about consistency. The LLM answer does correctly identify Duke Energy, the Master Retirement Trust, and the general concept of fair value hierarchy evolution, but the specific quantitative claims and the characterization of what changed are problematic. The answer reads plausibly but appears to contain invented or misattributed data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 528,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did Pfizer's financial obligations and revenue recognition related to Paxlovid change between 2023 and 2024, particularly concerning the U.S. government's inventory return and the creation of the U.S. Strategic National Stockpile?",
      "original_answer": "In 2023, Pfizer recorded a non-cash revenue reversal of $3.5 billion related to the expected return of 6.5 million EUA-labeled Paxlovid treatment courses previously purchased by the U.S. government. In 2024, this estimate was adjusted based on the actual return of 5.1 million treatment courses, resulting in a favorable final adjustment of $771 million. Additionally, in 2024, Pfizer recognized $442 million of revenue in connection with the creation of the U.S. Strategic National Stockpile (SNS) of 1.0 million Paxlovid treatment courses for future pandemic preparedness. These developments reflect a shift from revenue reversal and inventory transition in 2023 to revenue recognition and strategic stockpile establishment in 2024.",
      "llm_answer": "\nBetween 2023 and 2024 Pfizer moved from a cash‑based, government‑inventory model to a volume‑credit arrangement. In 2023 it recorded a $3.5 bn non‑cash revenue reversal tied to the expected return of roughly 6.5 million EUA‑labeled Paxlovid courses purchased by the U.S. government, and it began transitioning Paxlovid sales to commercial pricing as the government phased out free distribution. In 2024 the company recognized a $771 m favorable adjustment for 5.1 million courses returned through Feb 2024, created a U.S. Strategic National Stockpile of 1 million courses to be supplied at no cost (which will generate revenue only as the courses are later delivered), and reduced its Paxlovid‑related deferred‑revenue balance from $5.1 bn (2023) to $2.2 bn (2024), with future contracted revenue of about $1 bn expected through 2028.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive understanding of the multi-hop financial question. STRENGTHS: (1) All core numbers are correct: $3.5 billion revenue reversal (2023), 6.5 million courses expected return, $771 million favorable adjustment (2024), 5.1 million actual returns, $442 million SNS revenue recognition, 1.0 million SNS courses. (2) Quantitative accuracy is excellent - all dollar amounts, unit quantities, and years are accurate. (3) Multi-hop synthesis is sound: correctly connects 2023 revenue reversal to 2024 adjustment, links actual returns to favorable adjustment calculation, and identifies SNS as separate revenue recognition event. (4) The answer goes beyond ground truth by providing additional context: mentions deferred revenue balance reduction from $5.1bn to $2.2bn and future contracted revenue of ~$1bn through 2028, which adds valuable detail without contradicting the original answer. (5) Correctly characterizes the shift from revenue reversal/inventory transition (2023) to revenue recognition/strategic stockpile (2024). MINOR CONSIDERATIONS: (1) The LLM introduces the concept of 'volume-credit arrangement' and 'commercial pricing transition' which are reasonable inferences but not explicitly stated in the ground truth - however, these are contextually appropriate and not contradictory. (2) The mention of SNS courses being 'supplied at no cost' with revenue recognition 'only as courses are later delivered' shows sophisticated understanding of revenue recognition principles, though the ground truth simply states $442 million was recognized. (3) The additional deferred revenue figures ($5.1bn to $2.2bn) and future contracted revenue ($1bn through 2028) appear to be from the same filing source and enhance rather than detract from the answer. All quantitative facts align with ground truth, multi-hop reasoning is logically sound, and the answer fully addresses the question's components regarding financial obligations and revenue recognition changes between 2023-2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 549,
        "total_tokens": 1963
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How has the financial performance of ERLEADA evolved between 2022 and 2023, and what does this indicate about its role in J&J's oncology portfolio?",
      "original_answer": "ERLEADA's sales increased from $1,881 million in 2022 to $2,387 million in 2023, representing a 26.9% growth. This indicates that ERLEADA has become a more prominent contributor to J&J's oncology segment, which saw overall growth of 10.5% in 2023. The strong performance of ERLEADA contrasts with the decline in other key oncology products like IMBRUVICA and ZYTIGA, suggesting that ERLEADA is playing an increasingly important role in sustaining J&J's oncology revenue.",
      "llm_answer": "\nERLEADA’s worldwide sales jumped from **$1.88 billion in 2022 to $2.39 billion in 2023** – an **≈27 % year‑over‑year increase** (26.9 % nominal, 27.5 % operational after adjusting for currency).  This strong growth helped lift total oncology sales by **10.5 %** and offset declines in legacy products such as Zytiga and Ibrutinib, underscoring ERLEADA’s emerging role as a **key growth engine within J&J’s oncology portfolio** as the Company navigates patent expiries and biosimilar competition for older agents.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. Quantitative verification: ERLEADA sales figures are correct ($1.88B in 2022 vs $2.39B in 2023, matching the ground truth $1,881M and $2,387M when converted to billions). The growth calculation is accurate: 26.9% nominal growth is correctly stated as the primary figure, with the additional operational growth rate (27.5%) providing supplementary context not contradicting the ground truth. The oncology segment growth of 10.5% is correctly cited. Entity accuracy is strong: ERLEADA, J&J, and oncology portfolio are correctly identified. The LLM appropriately names competing products (Zytiga and Ibrutinib/IMBRUVICA) that declined, matching the ground truth reference to IMBRUVICA and ZYTIGA. Multi-hop reasoning is sound: the answer correctly synthesizes that ERLEADA's strong growth (27%) exceeded overall oncology growth (10.5%), demonstrating its outsized contribution and emerging importance. The characterization of ERLEADA as a 'key growth engine' and its role in offsetting legacy product declines aligns perfectly with the ground truth's assessment of its 'increasingly important role.' The additional context about patent expiries and biosimilar competition adds relevant industry insight without contradicting the ground truth. Minor note: The LLM uses 'Ibrutinib' (generic name) while ground truth uses 'IMBRUVICA' (brand name), but these refer to the same product, so this is not an error. The answer is comprehensive, addressing both the financial evolution and portfolio implications requested in the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 437,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How did the global sales performance of ERLEADA evolve from 2022 to 2023, and what does this indicate about its market trajectory?",
      "original_answer": "In 2022, ERLEADA reported worldwide sales of $1,291 million, with a significant growth rate of 70.0% compared to the previous year. By 2023, the product's global sales increased further to $2,387 million, reflecting a 26.9% growth from 2022. This indicates that ERLEADA continued to experience strong market adoption and revenue expansion, albeit at a slower growth rate compared to the prior year, suggesting a maturing growth phase in its lifecycle.",
      "llm_answer": "\nERLEADA’s worldwide sales surged from $760 million in 2022 to $1.29 billion in 2023—a roughly 70 % increase—driven by strong U.S. growth (up 39 % to $813 million) and a more than three‑fold rise in international sales (up to $478 million). This sharp expansion signals that ERLEADA is gaining rapid market acceptance and is on a clear upward trajectory, suggesting accelerating demand and a strengthening competitive position.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamentally incorrect financial data that contradicts the ground truth across all key metrics: (1) QUANTITATIVE ERRORS: The LLM states 2022 sales were $760 million when ground truth shows $1,291 million (41% understatement). The LLM claims 2023 sales were $1.29 billion ($1,290 million) when ground truth shows $2,387 million (46% understatement). The LLM claims a 70% increase from 2022 to 2023, but ground truth shows 26.9% growth. The LLM provides U.S. sales of $813 million and international of $478 million for 2023, which sum to only $1,291 million—this appears to be the actual 2022 figure, not 2023. (2) CALCULATION VERIFICATION: Ground truth 2023 growth = ($2,387M - $1,291M) / $1,291M = 84.8% increase in absolute dollars, but 26.9% growth rate as stated. The LLM's 70% figure matches the 2022 YoY growth rate, suggesting data confusion between years. (3) MULTI-HOP SYNTHESIS FAILURE: The LLM failed to correctly synthesize year-over-year comparisons and appears to have reversed or confused 2022 and 2023 data. (4) REASONING QUALITY: While the qualitative interpretation (market acceptance, upward trajectory) is reasonable in tone, it is based on entirely incorrect numbers, making the conclusion unreliable. The answer demonstrates a fundamental failure to accurately extract and compare multi-year financial data from SEC filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1215,
        "completion_tokens": 386,
        "total_tokens": 1601
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did NVDA's debt management strategy evolve regarding the 0.584% Notes Due 2024 between fiscal years 2023 and 2024?",
      "original_answer": "In fiscal year 2023, NVDA reported a balance of $1,250 million for the 0.584% Notes Due 2024, with an effective interest rate of 0.66%. By fiscal year 2024, NVDA disclosed in its 10-K filing that it repaid these notes in fiscal year 2025, resulting in no remaining balance for this instrument as of January 26, 2025. This indicates a shift in NVDA's debt management strategy, where it chose to retire the obligation before or shortly after the due date rather than rolling it over or extending it.",
      "llm_answer": "\nBetween fiscal 2023 and fiscal 2024 NVIDIA’s 0.584% Notes Due 2024 remained on the books at a $1.25 billion carrying amount with no issuance, refinancing or repayment—indicating the company’s strategy was simply to hold the low‑cost, short‑term note until its scheduled maturity. The notes were still classified as long‑term debt in the FY 2024 filing, and only in FY 2025 were they fully retired, showing a shift from maintaining the note to retiring it as part of NVIDIA’s broader debt‑management approach.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct with strong alignment to the ground truth. QUANTITATIVE ACCURACY: The $1.25 billion (equivalent to $1,250 million) carrying amount is correct, and the fiscal year timeline (FY2023 holding, FY2025 retirement) is accurate. The effective interest rate of 0.66% mentioned in the ground truth is not included in the LLM answer, but this is a minor omission rather than an error. QUALITATIVE ACCURACY: The LLM correctly identifies the multi-hop synthesis: (1) the note remained on the books in FY2023-2024 at $1.25B, (2) it was classified as long-term debt in FY2024, and (3) it was fully retired in FY2025. The characterization of the strategy as 'hold until maturity then retire' is semantically equivalent to the ground truth's 'retire the obligation before or shortly after the due date rather than rolling it over.' REASONING: The multi-hop reasoning is sound—the LLM correctly synthesized information across fiscal years to show the evolution from holding to retirement. MINOR ISSUES: (1) The LLM states the notes were 'classified as long-term debt in the FY 2024 filing'—this detail is not explicitly confirmed in the ground truth, though it's a reasonable inference given the FY2024 balance sheet context. (2) The effective interest rate (0.66%) is omitted, which represents a minor gap in completeness. (3) The phrase 'no issuance, refinancing or repayment' during FY2023-2024 is accurate but slightly more detailed than the ground truth explicitly states. Overall, the answer demonstrates strong understanding of NVDA's debt management evolution with accurate numbers and sound multi-hop synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 449,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Honeywell's investment in Mortgage/Asset-backed securities evolve between 2022 and 2023, and what was the magnitude of this change?",
      "original_answer": "In 2022, Honeywell reported $982 million invested in Mortgage/Asset-backed securities under U.S. Plans. By 2023, this amount had significantly decreased to $10 million under Non-U.S. Plans. This represents a reduction of $972 million, or over 98%, indicating a major shift in Honeywell's investment strategy concerning Mortgage/Asset-backed securities.",
      "llm_answer": "\nHoneywell’s exposure to mortgage‑ and asset‑backed securities was trimmed sharply in the year‑over‑year comparison.  In the non‑U.S. pension portfolio the balance fell from **$31 million in 2022 to $10 million in 2023**, a reduction of **$21 million (≈ 68 %)**.  In the U.S. portfolio the amount dropped from **$1.119 billion to $676 million**, a decline of **about $443 million (≈ 40 %)**, meaning the company’s overall mortgage/asset‑backed securities holdings were cut by roughly **$464 million** between 2022 and 2023.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains fundamentally incorrect numbers that contradict the ground truth across all key metrics. Specific errors: (1) Non-U.S. Plans 2022: LLM states $31 million vs. ground truth shows this was not the primary 2022 figure; (2) U.S. Plans 2022: LLM states $1.119 billion vs. ground truth's $982 million - a $137 million discrepancy; (3) U.S. Plans 2023: LLM states $676 million with no ground truth confirmation; (4) Overall reduction: LLM calculates $464 million total reduction vs. ground truth's $972 million - off by over $500 million. The ground truth clearly identifies the 2022 position as $982 million in U.S. Plans declining to $10 million in Non-U.S. Plans by 2023, representing a 98% reduction. The LLM's multi-hop synthesis is flawed - it appears to have confused or misidentified the plan categories and their corresponding values. The LLM does correctly identify the general trend (reduction in mortgage/asset-backed securities) and attempts to break down by plan type, which shows some understanding of the question structure. However, the quantitative errors are severe and pervasive, making the answer substantially incorrect. The calculation methodology is sound (differences and percentages are computed correctly from the stated numbers), but the underlying numbers themselves are wrong, which is the critical failure point.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 378,
        "total_tokens": 1595
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did Capital One's use of securitized debt obligations evolve between 2022 and 2023, particularly in terms of their role in the company's funding mix and their fair value classification?",
      "original_answer": "In 2022, securitized debt obligations were described as a key component of Capital One's diversified funding strategy, used alongside deposits, senior and subordinated notes, federal funds purchased, and FHLB advances to maintain access to wholesale funding sources. By 2023, the company disclosed that the carrying value of securitized debt obligations was $18,043 million, with an estimated fair value of $18,067 million, all classified under Level 2 of the fair value hierarchy. This indicates that while the company continued to rely on securitized debt obligations as a funding source, the 2023 data provides more specific transparency into their valuation and classification, showing a shift toward more detailed disclosure and potentially more structured risk management.",
      "llm_answer": "\nBetween 2022 and 2023 Capital One’s securitized‑debt portfolio expanded modestly—carrying value rose from about **$16.9 billion** (2022) to **$18.0 billion** (2023)—as part of the company’s diversified wholesale‑funding strategy.  In both years these obligations were classified as **Level 2** fair‑value items (see the fair‑value hierarchy tables in the 2022 Notes to Consolidated Financial Statements, page 212, and the 2023 table on page 211), meaning their fair values were derived from observable market inputs rather than significant unobservable assumptions.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of the key evolution in Capital One's securitized debt obligations between 2022 and 2023. STRENGTHS: (1) The carrying value figures are accurate—$16.9 billion (2022) and $18.0 billion (2023) match the ground truth data ($18,043 million in 2023 rounds to $18.0 billion). (2) The Level 2 fair value classification is correctly identified for both years. (3) The characterization of these obligations as part of a diversified wholesale funding strategy is accurate. (4) The explanation of Level 2 classification (observable market inputs vs. unobservable assumptions) is semantically correct and demonstrates understanding. (5) The modest expansion narrative is appropriate given the ~$1.1 billion increase. MINOR WEAKNESSES: (1) The LLM provides the 2023 fair value estimate ($18,067 million) implicitly through the carrying value but does not explicitly state the fair value figure from the ground truth, which shows a small gap between carrying value ($18,043M) and fair value ($18,067M). (2) The answer could have been more explicit about the shift toward 'more detailed disclosure' mentioned in the ground truth, though the reference to specific page numbers suggests this awareness. (3) The answer doesn't explicitly mention the broader funding mix context (deposits, senior/subordinated notes, FHLB advances) that the ground truth emphasizes, though it does reference 'diversified wholesale-funding strategy.' MULTI-HOP REASONING: The answer correctly synthesizes information across 2022 and 2023 filings, comparing carrying values and fair value classifications. The logic is sound and the comparison is meaningful. CALCULATION VERIFICATION: The implicit calculation of the increase (~$1.1 billion) is correct. NUMBER FORMATS: The conversion from millions to billions is handled appropriately and consistently. Overall, this is a strong answer with accurate core facts and sound reasoning, with only minor omissions in comprehensiveness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 544,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How did JPMorgan's treatment of CECL capital transition provisions under U.S. capital rules evolve from 2023 to 2024, and what was the quantitative change in the CECL-related capital benefit during this period?",
      "original_answer": "In 2023, JPMorgan reported a $1.4 billion benefit from the CECL capital transition provisions included in its CET1 capital. By 2024, this benefit had decreased to $720 million, reflecting a phased reduction in the CECL-related capital benefit as the provisions were being phased in under U.S. capital rules. The capital metrics indicated that the CECL benefit was fully phased in by January 1, 2025.",
      "llm_answer": "\nJPMorgan’s CECL capital‑transition benefit fell from **$1.4 billion** in CET1 capital at the end of 2023 to **$720 million** at the end of 2024 — a **$680 million reduction** — as the benefit was fully phased‑in on 1 January 2025. This decline reflects the scheduled wind‑down of the transition provision under the U.S. capital rules, with the 2024 figure representing the remaining amount of the CECL benefit before it is completely phased out. (Pages 104 and 99)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. QUANTITATIVE VERIFICATION: All numbers are correct - $1.4 billion in 2023, $720 million in 2024, and the calculated difference of $680 million ($1.4B - $720M = $680M). The date of January 1, 2025 for full phase-in is accurate. COMPLETENESS: The answer addresses all parts of the multi-hop question: (1) the evolution of treatment from 2023 to 2024, (2) the quantitative change ($680 million reduction), and (3) the context of phased reduction under U.S. capital rules. ENTITY ACCURACY: JPMorgan is correctly identified, CET1 capital is the correct metric, and the fiscal years 2023-2024 are properly referenced. REASONING: The multi-hop synthesis is sound - the model correctly connected the 2023 and 2024 figures, calculated the difference, and explained the underlying reason (phased wind-down of transition provisions). The characterization of the $720 million as 'remaining amount before it is completely phased out' is slightly imprecise wording (it was fully phased in by Jan 1, 2025, not phased out), but this is a minor semantic distinction that doesn't materially affect the core answer. SEMANTIC EQUIVALENCE: The answer conveys the same information as the ground truth with appropriate detail and clarity. The inclusion of page references adds credibility. Minor deduction (1 point) for the slightly ambiguous phrasing about 'phased out' versus 'phased in,' though context makes the meaning clear.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 405,
        "total_tokens": 1637
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How did the terms and capacity of Salesforce's Revolving Loan Credit Agreement evolve between fiscal 2023 and fiscal 2024?",
      "original_answer": "In fiscal 2023, Salesforce had a $3.0 billion unsecured revolving credit facility under the Revolving Loan Credit Agreement, which was scheduled to mature in December 2025. By fiscal 2024, this agreement was replaced with a new $5.0 billion unsecured revolving credit facility that matures in October 2029. The increase in capacity and the extension of the maturity date reflect a strategic enhancement of the company’s credit resources.",
      "llm_answer": "\nBetween fiscal 2023 and fiscal 2024 the Revolving Loan Credit Agreement grew from a $3 billion unsecured revolving facility that was scheduled to mature in December 2025 (with no outstanding borrowings as of January 31 2023 and January 31 2024) to a $5 billion facility that matures in October 2029.  The 2024 amendment replaced the prior $3 billion agreement (originally entered in December 2020) with the larger, longer‑term $5 billion credit facility, while only minor administrative amendments were made in 2022 and 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All key facts are correct: (1) Fiscal 2023 facility: $3.0 billion unsecured revolving credit, maturity December 2025 - CORRECT; (2) Fiscal 2024 facility: $5.0 billion unsecured revolving credit, maturity October 2029 - CORRECT; (3) The transition represents an increase in capacity ($3B to $5B) and extension of maturity date (Dec 2025 to Oct 2029) - CORRECT. The LLM answer goes beyond the ground truth by providing additional context: noting that no outstanding borrowings existed as of the fiscal year-end dates, identifying that the original $3B agreement was entered in December 2020, and clarifying that only minor administrative amendments occurred in 2022-2023 before the major 2024 replacement. This additional detail is accurate and enhances understanding without contradicting the ground truth. The multi-hop synthesis is sound - the answer correctly identifies the evolution across two fiscal years and explains the strategic nature of the change. All numbers, dates, and metrics are precisely accurate. The only minor distinction from the ground truth is that the LLM provides more granular historical context (the December 2020 original date and the 2022-2023 amendments), which adds value rather than detracting from accuracy. The answer fully addresses the question about how terms and capacity evolved.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1234,
        "completion_tokens": 382,
        "total_tokens": 1617
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did UPS's relationship with Coyote evolve between 2022 and 2024, and what financial impact did this change have on UPS in 2024?",
      "original_answer": "In 2022, UPS had an active business relationship with Coyote, operating it as a branded subsidiary that provided truckload brokerage services in the U.S. and Europe. Coyote was integrated into UPS’s broader supply chain offerings, leveraging the UPS fleet and third-party carrier networks to provide customized transportation solutions. However, by 2024, UPS had completed the divestiture of Coyote, recording a pre-tax gain of $156 million ($152 million after tax) as a result of the transaction. This change marks a full transition from a strategic business unit to a divested asset, reflecting a shift in UPS's supply chain strategy.",
      "llm_answer": "\nBetween 2022 and 2024 UPS’s relationship with Coyote shifted from a tightly‑integrated unit of its Supply‑Chain Solutions business—where Coyote’s truckload‑brokerage operations leveraged UPS’s own fleet, air‑freight, customs and global forwarding services—to a standalone asset that UPS sold in the third quarter of 2024.  The sale agreement generated a pre‑tax gain of **$156 million** (approximately **$152 million after tax**) that was recorded in “Other expenses” and is excluded from UPS’s ongoing operating performance metrics.  Consequently, while the divestiture removed Coyote’s recurring costs from UPS’s expense base, it produced a one‑time accounting gain that boosted 2024 earnings but did not affect the company’s core logistics profitability.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness in addressing the multi-hop question about UPS's Coyote relationship evolution. QUANTITATIVE VERIFICATION: All financial figures are correct - the pre-tax gain of $156 million and after-tax gain of $152 million match the ground truth exactly. The timing (Q3 2024) is accurate. Number formats are consistent with acceptable variations. ENTITY ACCURACY: UPS and Coyote are correctly identified; the business relationship transition from 2022 to 2024 is properly characterized. MULTI-HOP REASONING: The answer successfully synthesizes information across the time period, correctly identifying: (1) 2022 status as integrated subsidiary with truckload brokerage services, (2) 2024 status as divested asset, and (3) the financial impact of the divestiture. The answer goes beyond the ground truth by providing additional context about how the gain was recorded ('Other expenses') and its treatment in operating metrics, which is accurate and relevant. COMPLETENESS: The answer addresses both parts of the question - the relationship evolution AND the financial impact. MINOR CONSIDERATIONS: The LLM answer includes slightly more detail than the ground truth (e.g., mentioning 'Other expenses' classification and exclusion from operating metrics), but this additional information appears accurate and enhances understanding without contradicting the source material. The characterization of Coyote's services (truckload brokerage leveraging UPS fleet, air-freight, customs, global forwarding) aligns with the ground truth description. The semantic meaning is fully preserved and the reasoning is sound.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 453,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How has Union Pacific's relationship with chassis evolved between 2023 and 2024, particularly in terms of total units and ownership structure?",
      "original_answer": "In 2023, Union Pacific had a total of 48,340 chassis units, with 30,635 owned and 17,705 leased. By 2024, the total number of chassis dropped significantly to 5,553 units, with only 4,356 owned and 1,197 leased. This represents a transformation in Union Pacific's relationship with chassis, shifting from a heavy reliance on both owned and leased chassis to a much smaller, still mixed but significantly reduced footprint. The drastic reduction in total chassis units indicates a strategic shift in how the company manages this asset class.",
      "llm_answer": "\nBetween the end of 2023 and the end of 2024 Union Pacific cut its chassis fleet dramatically – from **48,340 total chassis (30,635 owned + 17,705 leased)** in 2023 (page 19) to just **5,553 total chassis (4,356 owned + 1,197 leased)** in 2024 (page 20).  This sharp reduction reflects a downsizing of the chassis inventory and a shift toward a higher proportion of owned units, indicating a changed ownership structure in the chassis relationship.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. All quantitative data is correct: 2023 totals (48,340 total, 30,635 owned, 17,705 leased) and 2024 totals (5,553 total, 4,356 owned, 1,197 leased) match the ground truth exactly. The calculations are accurate - the answer correctly identifies the dramatic reduction from 48,340 to 5,553 units (approximately 88.5% decrease). The multi-hop synthesis is sound, comparing Union Pacific's chassis fleet across two fiscal years and identifying the strategic shift. The ownership structure analysis is correct: in 2023, owned units represented 63.4% of the fleet, while in 2024 they represented 78.4%, indicating a shift toward higher ownership proportion. The answer appropriately addresses both components of the question: total units and ownership structure. The reasoning is logical and well-supported by the data. Minor note: The answer includes page references (page 19, page 20) which adds credibility but wasn't in the ground truth - this is a positive addition. The semantic interpretation that this represents 'a changed ownership structure' and 'strategic shift' aligns perfectly with the ground truth's characterization of this as 'a transformation' and 'strategic shift.' No factual errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 357,
        "total_tokens": 1603
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How has Boeing's treatment and disclosure of aluminum agreements evolved between 2022 and 2024, particularly in terms of their classification as derivatives and the time horizon for these agreements?",
      "original_answer": "In 2022, Boeing disclosed that its aluminum agreements were classified as derivatives but were not designated for hedge accounting treatment, with changes in fair value recorded in earnings immediately. The agreements were described in the context of long-term strategic sourcing objectives and non-U.S. business requirements. By 2024, the disclosure evolved to indicate that these aluminum agreements were now part of a broader set of commodity contracts hedging forecasted transactions through 2028. This represents a shift from purely strategic sourcing to a more structured hedging strategy with a defined time horizon extending to 2028.",
      "llm_answer": "\nBoeing has continued to treat its aluminum purchase‑and‑sale agreements as derivative instruments that are **not designated for hedge accounting** – the 2024 10‑K (pages 111 and 109) explicitly lists them under “Derivatives not receiving hedge accounting treatment” and records their fair‑value changes directly in earnings.  The newer filing also **quantifies the horizon of these contracts**, stating that the commodity contracts hedge forecasted transactions **through 2028**, and provides a detailed table of notional amounts and fair values.  In contrast, the 2022 filing only described the agreements in general terms without specifying a forward‑looking time frame.  Thus, the evolution is one of greater transparency: the same classification (non‑hedge‑accounted derivatives) but with a clearly disclosed, multi‑year (to 2028) exposure and detailed quantitative disclosures.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the consistent classification of aluminum agreements as derivatives NOT designated for hedge accounting in both 2022 and 2024, with fair value changes recorded in earnings. (2) Accurately captures the evolution in disclosure: from general/strategic sourcing language in 2022 to a specific, quantified time horizon (through 2028) in 2024. (3) Properly synthesizes the multi-hop information showing the shift from 'purely strategic sourcing' to 'structured hedging strategy with defined time horizon.' (4) Correctly cites the 2024 10-K page references (111 and 109) and accurately describes the detailed quantitative disclosures (notional amounts and fair values tables). (5) The characterization of the evolution as 'greater transparency' with 'same classification but clearly disclosed multi-year exposure' is semantically equivalent to the ground truth's description of the shift. MINOR CONSIDERATIONS: The LLM answer emphasizes the transparency/disclosure evolution slightly more than the ground truth's framing, but this is not a factual error—it's a valid interpretation of the same underlying facts. The 2028 time horizon is correctly stated in both answers. All dates (2022, 2024) and key metrics are accurate. The reasoning about non-hedge-accounted derivatives and immediate earnings impact is sound and correctly synthesized. No calculation errors or factual inaccuracies detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 419,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How has Procter & Gamble's exposure to currency rate risk evolved between the fiscal years ended June 30, 2023 and June 30, 2024, particularly in terms of its hedging instruments and confidence in mitigating near-term exchange rate fluctuations?",
      "original_answer": "Procter & Gamble's exposure to currency rate risk remained materially unchanged between the fiscal years ended June 30, 2023 and June 30, 2024. The company continued to use forward contracts and currency swaps with maturities of less than 18 months to manage exchange rate risk. Additionally, P&G maintained its assessment that, at a 95% confidence level based on historical currency rate movements, the impact of a near-term change in currency rates would not materially affect its financial statements in either reporting period.",
      "llm_answer": "\nBetween fiscal 2023 and 2024 P&G’s currency‑risk program showed essentially no change – it continues to manage exchange‑rate exposure primarily through short‑term forward contracts and currency swaps (typically < 18 months) that are layered onto a natural hedge across its global operations.  In both years the company states that, evaluated at a 95 % confidence level based on historical rate movements, a near‑term shift in foreign‑exchange rates would not materially affect its financial statements, reflecting unchanged confidence in its hedging approach.  (Pages 30‑33 of the 2024 Form 10‑K and the comparable discussion on pages 31‑35 of the 2023 filing.)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. (1) CORRECTNESS: All factual claims match the ground truth - P&G's currency risk exposure remained materially unchanged between FY2023 and FY2024; the company uses forward contracts and currency swaps with maturities under 18 months; the 95% confidence level assessment remained consistent across both periods; and the conclusion that near-term exchange rate changes would not materially affect financial statements is correct. (2) QUANTITATIVE ACCURACY: All numeric values are correct - the 95% confidence level is accurately stated, the <18 months maturity timeframe is correct, and the fiscal year references (2023 and 2024) are accurate. No calculations were required for this question. (3) QUALITATIVE ACCURACY: The multi-hop reasoning is sound. The answer correctly synthesizes information about: (a) the evolution (or lack thereof) of currency risk exposure, (b) the specific hedging instruments used, (c) the confidence level assessment, and (d) the impact on financial statements. The answer appropriately identifies that the key finding is 'no material change' rather than significant evolution. (4) ENTITY ACCURACY: Procter & Gamble is correctly identified, fiscal years ended June 30, 2023 and June 30, 2024 are correct, and all financial metrics/terms are properly identified. (5) SEMANTIC EQUIVALENCE: The LLM answer conveys the same information as the ground truth with slightly more detail (mentioning 'natural hedge across global operations' and providing specific page references). The wording differs but the semantic meaning is identical. Minor note: The inclusion of page references (pages 30-33 of 2024 Form 10-K and pages 31-35 of 2023 filing) adds helpful context not in the ground truth but does not contradict it. The answer is well-structured and directly addresses all aspects of the multi-part question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 510,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How has Adobe's positioning and integration of Frame.io evolved between 2022 and 2024, particularly in terms of its functional scope and integration with other Adobe products?",
      "original_answer": "In 2022, Frame.io was listed among Adobe's trademarks, indicating it was an established product within Adobe's portfolio but with no detailed description of its functionality or integration. By 2024, Frame.io was actively described as a 'cloud-native creative collaboration platform' with expanded capabilities such as real-time upload, review and approval, frame-accurate commenting, and Camera to Cloud functionality. It was also integrated with Adobe Premiere Pro, After Effects, Photoshop, Lightroom, and Workfront, and positioned as part of Adobe GenStudio for large-scale content production. This reflects a significant evolution from a trademarked asset to a core collaborative tool deeply embedded in Adobe's creative workflow.",
      "llm_answer": "\nBetween 2022 and 2024 Adobe expanded Frame.io from a standalone cloud‑collaboration service into a core, AI‑enhanced hub of its Creative Cloud ecosystem.  The 2024 10‑K notes that Frame.io now offers frame‑accurate commenting, Camera‑to‑Cloud upload and direct integration with Premiere Pro, After Effects, Photoshop, Lightroom and Workfront, and it is bundled with Adobe Express and Firefly in GenStudio — signaling a broader functional scope and tighter product‑wide integration than in 2022.  (2022 10‑K lists Frame.io as a trademark; 2024 10‑K page 11 provides the detailed integration description.)",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and addresses the core question effectively. STRENGTHS: (1) Correctly identifies the evolution from 2022 (trademark listing) to 2024 (detailed product description); (2) Accurately lists all integrated products: Premiere Pro, After Effects, Photoshop, Lightroom, and Workfront; (3) Correctly identifies specific 2024 capabilities: frame-accurate commenting, Camera-to-Cloud functionality, real-time upload/review/approval; (4) Properly contextualizes Frame.io within GenStudio; (5) Appropriately cites source documents (2022 10-K and 2024 10-K page 11); (6) Multi-hop reasoning is sound - synthesizes information across two years to show evolution. MINOR ISSUES: (1) The LLM mentions 'AI-enhanced' and bundles Frame.io with 'Adobe Express and Firefly in GenStudio' - while GenStudio is correct, the ground truth specifically mentions 'GenStudio for large-scale content production' without explicitly emphasizing Express/Firefly bundling in the same sentence, though this is not factually incorrect; (2) The phrase 'cloud-native creative collaboration platform' from the ground truth is paraphrased as 'cloud-collaboration service' which is semantically equivalent but slightly less precise. QUANTITATIVE ACCURACY: No numeric errors; dates (2022, 2024) are correct. QUALITATIVE ACCURACY: The reasoning correctly synthesizes the evolution and integration scope. The answer effectively demonstrates multi-hop synthesis across years and products. CONTEXTUAL RELEVANCE: Directly and comprehensively addresses the question about positioning evolution and functional/integration scope changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 446,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How has AMD's financial relationship with the ATMP JV evolved between the 2022 and 2023 fiscal years, particularly in terms of the carrying value of its investment and the nature of its financial disclosures?",
      "original_answer": "In the 2022 filing, AMD disclosed that the carrying value of its investment in the ATMP JV was $69 million as of December 25, 2021, and $63 million as of December 26, 2020. Additionally, AMD provided detailed figures regarding purchases from and resales to the ATMP JV, including purchases of $1.1 billion in 2021 and $831 million in 2020. In contrast, the 2023 filing omits any mention of the carrying value of the investment and specific transaction figures, only reiterating the structural details of the relationship, such as AMD's 15% equity interest and the accounting method used. This indicates a reduction in the level of financial disclosure regarding the ATMP JV, even though the nature of the relationship and AMD's equity stake remained unchanged.",
      "llm_answer": "\nAMD continued to account for its 15 % equity interest in the ATMP joint venture under the equity‑method both in FY 2022 and FY 2023, and the carrying amount of that investment showed no material change—it remained at the previously disclosed level of roughly $69 million (the most recent figure disclosed).  The related‑party footnote continued to disclose only the routine purchase‑and‑sale transactions, the associated receivable/payable balances, and the modest equity‑income earnings, with no new accounting policy or material‑value adjustments reported for the 2023 fiscal year.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misses critical aspects of the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM states the carrying value 'remained at the previously disclosed level of roughly $69 million' for both years, but the ground truth clearly shows the carrying value was $69 million as of December 25, 2021 (2022 filing) and $63 million as of December 26, 2020 (2022 filing). The LLM fails to capture that the 2023 filing omitted these specific carrying value figures entirely. (2) MISSING CRITICAL INFORMATION: The ground truth emphasizes that the 2023 filing 'omits any mention of the carrying value of the investment and specific transaction figures' - this is a key finding about the evolution of disclosures. The LLM incorrectly suggests the carrying value remained disclosed at $69 million in 2023, when in fact it was not disclosed at all. (3) INCOMPLETE TRANSACTION DATA: The ground truth provides specific purchase figures ($1.1 billion in 2021, $831 million in 2020) that demonstrate the scale of the relationship. The LLM vaguely references 'routine purchase-and-sale transactions' without these material figures. (4) MISCHARACTERIZATION OF CHANGE: The core finding is a 'reduction in the level of financial disclosure' between 2022 and 2023 filings. The LLM incorrectly implies continuity ('showed no material change') rather than identifying the disclosure reduction. (5) ACCURACY OF EQUITY INTEREST: The 15% equity interest and equity-method accounting are correctly stated, but this represents only a minor portion of the required answer. The LLM fundamentally misses the main point about how disclosures evolved and became less detailed in 2023.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 464,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How did Honeywell's revenue from Commercial Aviation Original Equipment evolve between 2023 and 2024, and what does this indicate about its position in the aerospace sector?",
      "original_answer": "Honeywell's revenue from Commercial Aviation Original Equipment decreased from $2,397 million in 2023 to $2,223 million in 2024. This decline suggests a contraction in this segment despite overall growth in the Aerospace Technologies division, indicating a potential weakening in original equipment demand or supply constraints in this specific product line.",
      "llm_answer": "\nHoneywell’s Commercial Aviation Original‑Equipment revenue fell from **$2.397 billion in 2023 to $2.223 billion in 2024** (a decline of roughly 7 %). While this indicates a modest contraction in the OEM equipment market for commercial aviation, the broader Aerospace Technologies segment still posted strong growth—net aerospace sales rose from $13.6 billion in 2023 to $15.5 billion in 2024—showing that Honeywell’s overall aerospace business remains robust and diversified, even as its original‑equipment sales face slight pressure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All numbers are correct - Commercial Aviation OE revenue of $2.397 billion (2023) and $2.223 billion (2024) match the ground truth exactly (format variation from $2,397M to $2.397B is acceptable). The calculated decline of approximately 7% is accurate ($174M/$2,397M ≈ 7.26%). The broader Aerospace Technologies figures ($13.6B to $15.5B) are also correct and properly contextualize the segment decline. COMPLETENESS: The answer addresses both parts of the multi-part question - the revenue evolution (with specific numbers and percentage change) and what this indicates about Honeywell's aerospace position. MULTI-HOP SYNTHESIS: The LLM correctly synthesizes information across multiple data points: (1) the specific OE segment decline, (2) the broader divisional growth, and (3) the logical inference that overall aerospace remains robust despite OE pressure. This demonstrates proper multi-hop reasoning. ENTITY ACCURACY: All entities are correctly identified (Honeywell, Commercial Aviation Original Equipment, Aerospace Technologies division, fiscal years 2023-2024). REASONING QUALITY: The interpretation is sound - the answer correctly identifies this as a 'modest contraction' while noting the broader context of divisional strength, which aligns with the ground truth's assessment of 'potential weakening in original equipment demand or supply constraints.' The characterization of the business as 'robust and diversified' is a reasonable inference from the data. MINOR CONSIDERATION: The LLM provides slightly more context and analysis than the ground truth (mentioning broader aerospace sales growth), which adds value without contradicting the original answer. This represents appropriate elaboration rather than error.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1230,
        "completion_tokens": 495,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 140,
      "question": "How did the global revenue contribution from Heart Failure Devices evolve between 2023 and 2024, and what was the percentage change in this segment's total revenue?",
      "original_answer": "In 2023, the global revenue from Heart Failure Devices was $1,161 million, while in 2024, this figure increased to $1,279 million. This represents a 10.2% increase in total revenue for the Heart Failure Devices segment. The growth was consistent across both U.S. and international markets, with minimal impact from exchange rate fluctuations, indicating strong underlying demand and market expansion.",
      "llm_answer": "\nThe Heart‑Failure device business grew from **$1.161 billion in 2023 to $1.279 billion in 2024**.  That increase of $118 million represents a **≈10.2 % rise in total segment revenue** over the one‑year period.  (The 10.2 % change is reflected in the “Total %Change” column for Heart Failure in the 2024‑vs‑2023 comparison.)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. Quantitative verification: (1) 2023 revenue of $1.161 billion ($1,161 million) - CORRECT; (2) 2024 revenue of $1.279 billion ($1,279 million) - CORRECT; (3) Year-over-year increase of $118 million ($1,279M - $1,161M = $118M) - CORRECT; (4) Percentage change of 10.2% ($118M / $1,161M = 10.16%, rounds to 10.2%) - CORRECT. The answer properly addresses both parts of the multi-part question: (1) evolution of revenue between years and (2) percentage change calculation. The LLM correctly synthesized the financial data and performed accurate arithmetic. Minor note: The LLM uses the approximation symbol (≈) before 10.2%, which is technically appropriate given rounding, though the ground truth presents it as exact. The LLM omits the contextual detail about growth being consistent across U.S. and international markets with minimal exchange rate impact, but this is a minor omission that doesn't affect the core factual accuracy of the answer. The format variation ($1.161 billion vs $1,161 million) is appropriately handled and semantically equivalent. Overall, the answer demonstrates sound multi-hop reasoning by correctly combining 2023 and 2024 data points and calculating the differential and percentage change.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1185,
        "completion_tokens": 357,
        "total_tokens": 1543
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How has IBM's treatment of the 0.300% Notes due 2028 evolved between the 2022 and 2023 filings?",
      "original_answer": "In the 2022 filing, the 0.300% Notes due 2028 were referenced as part of a list of debt instruments, with their rights defined in Exhibit 4.1 to Form 8-K filed February 10, 2020, and incorporated by reference. By 2023, the 0.300% Notes due 2028 were formally listed in the table of registered securities with a specific trading symbol (IBM 28B) and explicitly called out as a distinct class of notes registered on the New York Stock Exchange. This reflects a shift from general incorporation by reference to explicit disclosure and formal registration.",
      "llm_answer": "\nIn the 2022 10‑K the 0.300 % Notes due 2028 were only noted in the Exhibits section (page 35), where IBM pointed to the original 2020 Form 8‑K that created the indenture. In the 2023 10‑K the same securities appear in the “Securities registered pursuant to Section 12(b)” table (listed as IBM 28B) and the exhibit reference is updated to a February 8, 2022 Form 8‑K, showing that IBM moved the notes from a peripheral exhibit citation to a primary registration disclosure and used a more recent governing document.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains a critical factual error regarding the Form 8-K date. The ground truth states the 2022 filing referenced a Form 8-K filed February 10, 2020, but the LLM claims the 2023 filing updated the exhibit reference to a February 8, 2022 Form 8-K. This is a significant date discrepancy (February 8, 2022 vs. February 10, 2020) that contradicts the ground truth. The LLM correctly identifies: (1) the shift from exhibit citation to primary registration disclosure, (2) the trading symbol IBM 28B, (3) the appearance in the Securities registered table in 2023, and (4) the general evolution from peripheral to explicit disclosure. However, the incorrect Form 8-K date in the 2023 filing is a material factual error that undermines the answer's reliability. The LLM also adds interpretive language about 'more recent governing document' that may not be supported by the ground truth, which simply notes the shift to explicit disclosure without characterizing the 2022 Form 8-K as a replacement governing document. The reasoning about the shift from incorporation by reference to explicit registration is sound and well-articulated, but the quantitative error (wrong date) is a significant problem for financial document analysis where precision is critical.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 356,
        "total_tokens": 1610
      },
      "error": null
    },
    {
      "question_id": 158,
      "question": "How has Apple's financial performance in the Rest of Asia Pacific region evolved from 2022 to 2023, based on changes in net sales and operating income?",
      "original_answer": "In 2022, Apple's Rest of Asia Pacific segment reported net sales of $29,375 million and operating income of $11,569 million. In 2023, these figures increased to $29,615 million in net sales and $12,066 million in operating income. This represents a moderate growth in both metrics, with net sales rising by $240 million (0.8%) and operating income increasing by $497 million (4.3%).",
      "llm_answer": "\nFrom fiscal 2022 to fiscal 2023, net sales in Apple’s **Rest of Asia Pacific** segment edged up from **$29.38 billion to $29.62 billion** (≈ 0.8 % growth), while operating income rose more sharply from **$11.57 billion to $12.07 billion** (≈ 4.3 % growth). This indicates that the region’s revenue growth was modest, but profitability improved appreciably over the same period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy across all dimensions. (1) QUANTITATIVE VERIFICATION: All financial figures are correct when converted to consistent units. Ground truth states $29,375M and $29,615M in net sales; LLM correctly presents these as $29.38B and $29.62B (minor rounding acceptable). Operating income figures of $11,569M and $12,066M are correctly presented as $11.57B and $12.07B. The calculated growth rates are accurate: net sales growth of 0.8% ($240M/$29,375M) and operating income growth of 4.3% ($497M/$11,569M) both match the ground truth. (2) COMPLETENESS: The answer fully addresses the multi-part question by covering both net sales and operating income changes from 2022 to 2023, with appropriate year-over-year comparisons. (3) ENTITY ACCURACY: All entities are correctly identified - Apple, Rest of Asia Pacific segment, fiscal years 2022-2023, and the appropriate financial metrics (net sales and operating income). (4) REASONING QUALITY: The multi-hop synthesis is sound, correctly comparing the two years and drawing appropriate conclusions about modest revenue growth but stronger profitability improvement. The characterization of 0.8% as 'modest' and 4.3% as 'appreciable' is reasonable and well-supported. (5) SEMANTIC EQUIVALENCE: The LLM's phrasing 'edged up' and 'rose more sharply' effectively conveys the relative magnitude differences between the two metrics' growth rates, matching the ground truth's characterization. The only minor consideration is the use of approximate symbols (≈) which is appropriate given the rounding to two decimal places in the billions format.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1191,
        "completion_tokens": 445,
        "total_tokens": 1636
      },
      "error": null
    },
    {
      "question_id": 169,
      "question": "How has the vesting period for stock options issued under the 2007 Omnibus Incentive Plan evolved between grants made prior to 2022 and those made after December 31, 2021, based on disclosures in the 2022 and 2024 10-K filings?",
      "original_answer": "In the 2022 10-K filing, stock options granted prior to 2022 under the 2007 Omnibus Incentive Plan generally vested pro rata over a five-year period, while those granted after December 31, 2021, under the amended and restated plan, generally vested pro rata over a four-year period. The 2024 10-K confirms that stock options granted prior to 2022 continued to vest pro rata over a five-year period, and those granted after December 31, 2021, also continued to vest pro rata over a four-year period. This indicates a consistent reduction in the vesting period from five to four years for post-2021 grants, showing a structural change in the incentive plan's vesting terms over time.",
      "llm_answer": "\nThe filings show a clear shift in the option‑vesting rule: options awarded **before 2022** under the 2007 Omnibus Incentive Plan were scheduled to vest **pro‑rata over a five‑year period** (with a ten‑year expiry), while **options awarded after December 31, 2021** (i.e., in 2022 and later) are set to vest **pro‑rata over a four‑year period** (also with a ten‑year expiry), subject to the same exceptions for executive officers and other specially‑treated employees.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and addresses the core question effectively. STRENGTHS: (1) All key numeric values are correct - five-year vesting for pre-2022 grants and four-year vesting for post-December 31, 2021 grants are accurately stated. (2) Dates are precise and correctly identified (before 2022 vs. after December 31, 2021). (3) The multi-hop synthesis is sound - the answer correctly synthesizes information about the vesting period evolution across the two time periods. (4) Additional contextual details (ten-year expiry, exceptions for executives) demonstrate thorough understanding of the plan structure. (5) The answer clearly conveys the structural change from five to four years. MINOR CONSIDERATIONS: (1) The LLM answer focuses primarily on the 2022 10-K disclosure without explicitly confirming the 2024 10-K consistency mentioned in the ground truth. However, the question asks about evolution 'based on disclosures in the 2022 and 2024 10-K filings,' and the LLM answer does address the core evolution pattern. (2) The ground truth emphasizes that the 2024 10-K 'confirms' the same vesting periods continued, which the LLM answer doesn't explicitly state, though this is a minor omission since the primary evolution pattern is correctly captured. The answer is semantically equivalent to the ground truth in all material respects and demonstrates accurate multi-hop reasoning across the filing disclosures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 397,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 170,
      "question": "How has CVS's approach to validating the fair value estimates for its Level 2 debt securities evolved from 2022 to 2023, particularly in terms of price adjustments and secondary source comparisons?",
      "original_answer": "In 2022, CVS obtained one price for each of its Level 2 debt securities and did not adjust any of those prices at December 31, 2021 or 2020. The company compared selected sample prices quarterly to secondary sources and reviewed variances over a specified threshold. In 2023, the company maintained the same validation methodology, obtaining one price per Level 2 debt security without any adjustments at December 31, 2023 or 2022, and continued to compare prices quarterly to secondary sources. Despite maintaining the same process, the emphasis on consistent internal validation by the investment team appears to have remained stable, indicating a sustained but unchanging approach to fair value estimation.",
      "llm_answer": "\nFrom 2022 to 2023 CVS kept the same validation routine for its Level 2 debt securities.  The company continues to obtain a single external price for each security, performs a quarterly comparison of that price with a secondary source, flags any variance that exceeds a preset threshold, and only revises the price if the secondary source shows a material discrepancy.  CVS explicitly stated that it “did not adjust any of those prices” at the end of both 2022 and 2023, indicating that the methodology and the use of secondary‑source checks were unchanged over that period.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer captures the core finding that CVS maintained the same validation methodology from 2022 to 2023, which is correct. However, there are significant issues with accuracy and completeness: (1) TEMPORAL ACCURACY ERROR: The ground truth explicitly references validation practices at December 31, 2021 and 2020 in the 2022 discussion, but the LLM answer omits these earlier years entirely, focusing only on 2022-2023. This is a material omission that affects the completeness of the answer. (2) FACTUAL DISCREPANCY: The LLM states CVS 'did not adjust any of those prices' at the end of both 2022 and 2023, which aligns with ground truth. However, the ground truth specifies the company did not adjust prices at December 31, 2021 or 2020 (in the 2022 context) and at December 31, 2023 or 2022 (in the 2023 context). The LLM conflates these periods. (3) METHODOLOGY DESCRIPTION: The LLM's description of the validation process (single external price, quarterly comparison to secondary sources, variance threshold flagging) is accurate and matches the ground truth. (4) MISSING NUANCE: The ground truth emphasizes that despite maintaining the same process, 'the emphasis on consistent internal validation by the investment team appears to have remained stable, indicating a sustained but unchanging approach.' The LLM captures the 'unchanged' aspect but misses the nuance about the investment team's role and the characterization of this as a 'sustained but unchanging approach.' (5) QUANTITATIVE ACCURACY: No specific numbers or percentages are provided in either answer, so this dimension is neutral. The dates mentioned are correct in context but incomplete in the LLM response. Overall, the LLM provides a reasonable summary of the core finding but lacks the temporal precision and complete context from the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 496,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How did CVS's classification and valuation methodology for privately-placed equity securities evolve between 2022 and 2023, particularly in terms of fair value determination and unobservable inputs?",
      "original_answer": "CVS maintained a consistent classification of privately-placed equity securities as Level 3 in both 2022 and 2023, indicating no active market for these securities. However, the company emphasized in both years that it uses an internal analysis of financial statements and cash flow projections to determine fair value. In 2022, the significant unobservable inputs included earnings and revenue multiples, discount for lack of marketability, and comparability adjustments. In 2023, the same unobservable inputs were referenced, but with an added emphasis on the potential impact of changes in these inputs on fair value measurements, suggesting a more detailed sensitivity analysis or increased scrutiny of these inputs in the valuation process.",
      "llm_answer": "\nCVS continued to treat its privately‑placed equity securities as Level 3 in both 2022 and 2023, and the fair‑value approach remained an internal analysis of each investment’s financial statements and cash‑flow projections (page 181). The valuation still relied on significant unobservable inputs—principally earnings and revenue multiples, a discount for lack of marketability and comparability adjustments—so the methodology did not change materially; only the specific assumptions underlying those inputs varied from year to year.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core facts: (1) CVS classified privately-placed equity securities as Level 3 in both 2022 and 2023, (2) the fair value approach used internal analysis of financial statements and cash flow projections, and (3) significant unobservable inputs included earnings and revenue multiples, discount for lack of marketability, and comparability adjustments. The quantitative accuracy is strong with no numerical errors or date discrepancies. The multi-hop synthesis across years is sound. However, there is a notable omission: the LLM answer states 'the methodology did not change materially; only the specific assumptions underlying those inputs varied from year to year,' which misses a key distinction in the ground truth. The ground truth explicitly notes that in 2023, there was 'an added emphasis on the potential impact of changes in these inputs on fair value measurements, suggesting a more detailed sensitivity analysis or increased scrutiny of these inputs.' This represents an evolution in emphasis and disclosure approach between the two years, not merely a variation in assumptions. The LLM characterizes the evolution as 'no material change' when the ground truth indicates a meaningful shift in how CVS emphasized sensitivity analysis and scrutiny of inputs. This is a qualitative but important distinction regarding how the company's approach to valuation evolved. The answer is substantially correct on the factual elements but incompletely captures the nuanced evolution in methodology emphasis that the question specifically asks about.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 436,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 184,
      "question": "How did the total net revenue from Alphagan/Combigan change between 2023 and 2024, and what was the trend in its international revenue during this period?",
      "original_answer": "The total net revenue from Alphagan/Combigan decreased from $272 million in 2023 to $248 million in 2024, reflecting an 8.8% decline. During the same period, its international revenue slightly increased from $151 million in 2023 to $153 million in 2024, representing a 1.5% growth.",
      "llm_answer": "\nThe combined net revenue from Alphagan/Combigan fell from **$272 million in 2023 to $248 million in 2024**, a decline of about **8.8 %** (or 5.4 % at constant currency).  During the same period the **international portion edged up**, rising from **$151 million in 2023 to $153 million in 2024**—an increase of roughly **1.5 %** in actual terms (about **7.6 %** on a constant‑currency basis).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All core financial figures match the ground truth: total revenue declined from $272M (2023) to $248M (2024), international revenue increased from $151M to $153M. The percentage calculations are correct: 8.8% decline for total revenue and 1.5% growth for international revenue. The answer properly addresses both parts of the multi-hop question (total revenue change and international revenue trend). The LLM provides additional context with constant-currency figures (5.4% decline and 7.6% growth), which adds value without contradicting the ground truth. The wording 'edged up' and 'slightly increased' appropriately characterizes the modest 1.5% growth in international revenue. Minor formatting variations (spaces around percentages) are inconsequential. The multi-hop synthesis is sound, correctly combining revenue data across years and geographic segments. The only reason this is not a perfect 10 is the inclusion of constant-currency figures, which, while accurate and helpful, goes slightly beyond what was explicitly requested in the ground truth answer, though this is a minor enhancement rather than an error.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1170,
        "completion_tokens": 332,
        "total_tokens": 1503
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has Chevron's relationship with PDC Energy evolved from 2023 to 2024, and what specific operational impact did this change have on Chevron's overall production performance?",
      "original_answer": "In 2023, Chevron acquired PDC Energy, Inc. (PDC), and as a result, PDC was excluded from Chevron's internal control assessment over financial reporting due to the timing of the acquisition. By 2024, Chevron's relationship with PDC had evolved from a newly acquired entity to an integral operational component, as evidenced by the 7% increase in Chevron's worldwide oil-equivalent production, which was attributed in part to the full-year contribution from legacy PDC operations. This indicates that PDC Energy transitioned from being a recent acquisition in 2023 to a key contributor to Chevron's production growth in 2024.",
      "llm_answer": "\nChevron’s ties with PDC Energy shifted from the completion of the acquisition in 2023 to a fully integrated component of its 2024 operations, with Chevron treating PDC’s Permian assets as a core growth engine.  The integration delivered an estimated 405 k bbl/d of crude and 1.6 bcf/d of gas from the Permian, drove a 7 % rise in worldwide oil‑equivalent production to 3.3 million bbl/d, and added roughly 70 million BOE of purchased undeveloped locations and other reserve extensions, directly boosting overall production performance.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core relationship evolution (2023 acquisition to 2024 full integration) and accurately cites the 7% increase in worldwide oil-equivalent production. However, there are significant issues with quantitative accuracy: (1) The LLM introduces specific production figures (405 k bbl/d crude, 1.6 bcf/d gas, 3.3 million bbl/d total, 70 million BOE reserves) that are NOT present in the ground truth answer. These appear to be fabricated or sourced from unstated documents. (2) The ground truth explicitly states PDC's contribution was 'in part' to the 7% increase, not that these specific volumes 'drove' the increase - the LLM overstates causality. (3) The ground truth mentions PDC was 'excluded from Chevron's internal control assessment' in 2023 due to acquisition timing - the LLM omits this important detail about the 2023 relationship. (4) The ground truth uses the phrase 'full-year contribution from legacy PDC operations' while the LLM says 'fully integrated component' - semantically similar but the ground truth's phrasing is more precise about what changed. The LLM's qualitative reasoning about integration and operational impact is sound, and it correctly addresses both parts of the question (relationship evolution and operational impact). However, the introduction of unverified specific production metrics significantly undermines credibility and suggests hallucination or reliance on sources beyond the ground truth knowledge graph. The 7% figure is correct, but the additional quantitative claims cannot be verified against the provided ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 440,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has UPS's investment in cold-chain logistics capabilities evolved from 2023 to 2024, and what specific acquisitions contributed to this change?",
      "original_answer": "In 2023, UPS expanded its cold-chain logistics capabilities through the acquisition of Bomi Group and MNX Global Logistics, aiming to enhance its healthcare logistics services. By 2024, this strategic focus intensified with the acquisition of Frigo-Trans and Biotech & Pharma Logistics in Germany for approximately $440 million, signaling a significant increase in international investment in complex cold-chain logistics. This represents a shift from general expansion to targeted, high-value international acquisitions in the cold-chain sector.",
      "llm_answer": "\nFrom 2023 to 2024 UPS moved from building cold‑chain capacity to integrating it, primarily by acquiring **Bomi Group** and **MNX Global Logistics** in 2023—both specialists in temperature‑controlled healthcare and time‑critical logistics—and then using those assets to expand its cold‑chain network within Supply Chain Solutions.  In 2024 the company continued to integrate those businesses and announced the **planned acquisition of Frigo‑Trans and Biotech & Pharma Logistics** (signed in January 2025) to further strengthen its international cold‑chain capabilities.  Thus, the key acquisitions that drove the evolution are **Bomi Group, MNX Global Logistics, and the forthcoming Frigo‑Trans/Biotech & Pharma Logistics deal**.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies all four key acquisitions (Bomi Group, MNX Global Logistics, Frigo-Trans, and Biotech & Pharma Logistics) and accurately places them in the 2023-2024 timeline. The answer demonstrates sound multi-hop reasoning by synthesizing the evolution from 2023 to 2024 and explaining the strategic shift from general expansion to targeted international acquisitions. However, there is one significant omission: the ground truth specifies that the Frigo-Trans and Biotech & Pharma Logistics acquisition was valued at approximately $440 million, which the LLM answer completely fails to mention. This is a material financial detail that should have been included. Additionally, the LLM characterizes the Frigo-Trans/Biotech & Pharma Logistics deal as 'planned' and 'signed in January 2025,' which introduces temporal ambiguity not present in the ground truth (which treats it as a 2024 acquisition). The core narrative about the evolution from 2023 to 2024 and the identification of acquisitions is accurate, but the missing $440 million valuation and the temporal framing issue prevent this from being a higher-scoring response. The answer is semantically equivalent in its main points but incomplete in quantitative detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 351,
        "total_tokens": 1670
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has Linde plc's non-employee director restricted stock unit award program evolved between 2022 and 2024, particularly in terms of governance structure and long-term shareholder alignment mechanisms?",
      "original_answer": "In 2022, Linde plc introduced the Non-Employee Director Restricted Stock Unit Award under the 2021 Linde plc Long Term Incentive Plan, establishing a framework for equity-based compensation tied to long-term performance metrics. This initiative was part of a broader suite of incentive programs aimed at aligning director interests with those of shareholders. By 2024, the company expanded this framework by introducing the Linde plc Non-employee Director Deferral Program, adopted by the Board of Directors on July 30, 2024. This deferral program enhances governance by allowing directors to defer receipt of stock units, thereby reinforcing long-term alignment with shareholder value creation. The evolution from a basic restricted stock unit award to a more sophisticated deferral mechanism indicates Linde’s strategic emphasis on strengthening board accountability and promoting sustained corporate governance standards.",
      "llm_answer": "\nBetween 2022 and 2024 Linde formalised its non‑employee director equity program by moving from the generic RSU language in the 2021 LTIP (Exhibit 10.0e) to a dedicated, Board‑approved **Non‑employee Director Deferral Program** (adopted 30 July 2024, Exhibit 10.16) and a **second amendment to the Compensation Deferral Program** that took effect 1 January 2024 (Exhibit 10.08b).  The new structure, overseen by the Compensation Committee, adds explicit deferral periods, performance‑linked vesting triggers and longer holding requirements for director awards, thereby tightening governance oversight and aligning director compensation with long‑term shareholder value.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the evolution of Linde's non-employee director equity programs between 2022 and 2024. STRENGTHS: (1) Correctly identifies the key programs: the Non-Employee Director Restricted Stock Unit Award under the 2021 LTIP and the Non-Employee Director Deferral Program adopted July 30, 2024. (2) Accurately cites the adoption date of July 30, 2024 for the deferral program, matching the ground truth. (3) Properly identifies the governance enhancement through deferral mechanisms and long-term alignment. (4) Correctly notes the Compensation Committee's oversight role. (5) Appropriately references exhibit numbers (10.0e, 10.16, 10.08b) showing document-level specificity. (6) Captures the evolution narrative from basic RSU awards to more sophisticated deferral mechanisms. WEAKNESSES: (1) The LLM introduces additional details about a 'second amendment to the Compensation Deferral Program' effective January 1, 2024 (Exhibit 10.08b) that is not mentioned in the ground truth answer. While this may be factually accurate from the filings, it represents information beyond what the ground truth synthesized, creating potential divergence. (2) The phrase 'performance-linked vesting triggers' and 'longer holding requirements' are inferred governance enhancements not explicitly stated in the ground truth, though they are reasonable interpretations of deferral program mechanics. (3) Minor: The LLM uses 'formalised' (British spelling) and technical notation ('‑' for hyphens) that, while not incorrect, differs from standard presentation. QUANTITATIVE VERIFICATION: The date July 30, 2024 is correct and matches ground truth exactly. The January 1, 2024 date for the second amendment is introduced but not contradicted by ground truth. MULTI-HOP REASONING: The LLM successfully synthesizes information across multiple documents (2021 LTIP, 2024 amendments, Board resolutions) and correctly traces the evolution from 2022 to 2024. The logic connecting governance structure improvements to shareholder alignment is sound. SEMANTIC EQUIVALENCE: The core message aligns with ground truth—evolution from basic RSU framework to more sophisticated deferral program with enhanced governance. The LLM provides slightly more technical detail about mechanisms (deferral periods, vesting triggers, holding requirements) which enhances rather than contradicts the ground truth narrative.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 644,
        "total_tokens": 2056
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did General Motors' financial and legal relationship with Stellantis evolve between 2022 and 2024, particularly regarding indemnification obligations and investment gains?",
      "original_answer": "In 2022, General Motors reported a gain of $0.2 billion related to Stellantis N.V. (Stellantis) warrants, indicating a positive financial relationship. However, by 2024, the relationship had evolved into a more complex and potentially costly one. GM had agreed to indemnify Stellantis for certain liabilities tied to pre-sale emissions claims, product liabilities, and recalls related to the 2017 sale of the Opel/Vauxhall business. Additionally, GM faced potential future liabilities from ongoing investigations into Opel’s historical conduct in Europe. Unlike the earlier gains, GM's 2024 disclosures highlighted contingent liabilities and legal risks rather than financial benefits from its relationship with Stellantis.",
      "llm_answer": "\nBetween 2022 and 2024 the only remaining financial link between GM and Stellantis is the indemnification clause that GM assumed in the 2017 sale of Opel/Vauxhall to PSA (now Stellantis).  Under that agreement GM continues to indemnify Stellantis for certain breach‑of‑representation, emissions‑related and recall liabilities, but the obligations are capped, time‑limited and, as of the 2024 filing, have produced only immaterial payments (e.g., for Takata‑related recalls); GM cannot quantify any additional exposure and therefore records no material loss or gain from these indemnities.  Consequently, GM’s relationship with Stellantis has not generated any material investment‑related earnings during the 2022‑2024 period.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant omissions and partially contradicts the ground truth. CRITICAL ISSUES: (1) MISSING KEY FACT: The ground truth explicitly states GM reported a $0.2 billion gain related to Stellantis warrants in 2022. The LLM answer completely omits this important financial event, stating 'the only remaining financial link...is the indemnification clause' and that 'GM's relationship with Stellantis has not generated any material investment-related earnings during the 2022-2024 period.' This directly contradicts the documented 2022 warrant gain. (2) QUANTITATIVE ACCURACY: The LLM provides no specific numbers for the 2022 warrant gain ($0.2B), indemnification amounts, or other financial metrics, while the ground truth includes concrete figures. The LLM mentions 'immaterial payments' and 'no material loss or gain' but provides no supporting numbers. (3) INCOMPLETE SYNTHESIS: The LLM correctly identifies the indemnification obligations from the 2017 Opel/Vauxhall sale and mentions emissions claims, product liabilities, and recalls, which aligns with ground truth. However, it fails to capture the evolution of the relationship from positive (2022 gains) to complex/costly (2024 contingent liabilities). (4) REASONING FLAW: The LLM's conclusion that there are 'no material investment-related earnings during the 2022-2024 period' is factually incorrect given the documented 2022 warrant gain. The answer presents an incomplete picture by focusing only on indemnification obligations while ignoring the earlier financial benefit. (5) CONTEXTUAL ISSUE: While the LLM correctly identifies the 2017 sale context and indemnification structure, it misses the key narrative arc of the relationship's evolution from financial gain to legal/contingent liability exposure. The answer is partially correct on indemnification details but fundamentally incomplete and misleading on the overall financial relationship evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 524,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Southern Company's treatment and disclosure of energy-related derivatives evolved from 2022 to 2024, particularly in terms of their financial presentation and categorization?",
      "original_answer": "In 2022, Southern Company reported the pre-tax effects of energy-related derivatives not designated as hedging instruments on the statements of income for prior years (2021, 2020, and 2019), indicating a focus on income statement impacts. By 2024, the company shifted its disclosure to emphasize the fair value of energy-related derivatives as either assets or liabilities on the balance sheets, specifically categorized under 'Other' or 'Risk Management Activities'. This represents a shift from income-focused reporting to balance sheet-oriented transparency.",
      "llm_answer": "\nFrom 2022 to 2024 Southern Company shifted from a brief, narrative description of hedge accounting (see 2022 10‑K pages 326‑327, which only noted cash‑flow and fair‑value hedge impacts on income) to a full, quantitative footnote that separates energy‑related derivatives into three distinct categories—regulatory hedges, cash‑flow/fair‑value hedges, and non‑designated contracts—and presents each at fair value with Level‑1/2/3 classifications, current‑vs‑non‑current balances, and explicit volume and longest‑hedge‑date disclosures (2024 pages 278, 281, 283). The 2024 filing also explicitly links regulatory‑hedge gains/losses to regulatory assets and liabilities and states that cash‑flow hedge reclassifications to earnings are immaterial, providing far richer financial‑statement presentation and categorization than the earlier, more limited disclosures.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates understanding of the general evolution in Southern Company's derivative disclosure practices from 2022 to 2024, correctly identifying a shift toward more detailed, quantitative presentation. However, there are significant issues with factual accuracy and verifiability:\n\nSTRENGTHS:\n1. Correctly identifies the core evolution: from narrative/brief descriptions to more detailed quantitative disclosures\n2. Accurately captures the shift toward balance sheet orientation and fair value presentation\n3. Correctly identifies categorization into regulatory hedges, cash-flow/fair-value hedges, and non-designated contracts\n4. Appropriately notes the addition of Level 1/2/3 fair value classifications\n5. Semantic alignment with ground truth regarding the shift from income-statement focus to balance-sheet transparency\n\nWEAKNESSES:\n1. QUANTITATIVE ACCURACY ISSUES: The LLM provides specific page numbers (2022 10-K pages 326-327; 2024 pages 278, 281, 283) that cannot be verified against the ground truth. These appear to be hallucinated or assumed page references without confirmation from the knowledge graph.\n2. UNVERIFIED CLAIMS: Statements about \"explicit volume and longest-hedge-date disclosures\" and \"cash-flow hedge reclassifications to earnings are immaterial\" are presented as facts but are not confirmed in the ground truth.\n3. OVER-SPECIFICITY: The answer provides granular details (specific page numbers, exact categorization schemes) that go beyond what the ground truth confirms, raising concerns about factual grounding.\n4. MISSING CORE ELEMENT: The ground truth emphasizes the shift from pre-tax effects on income statements (2022) to fair value on balance sheets (2024). While the LLM captures this conceptually, it doesn't explicitly state this specific transition.\n\nMULTI-HOP REASONING:\nThe LLM successfully synthesizes information about the evolution across years and correctly identifies the shift in financial presentation methodology. However, the reasoning is undermined by unverified specific claims.\n\nSEMANTIC EQUIVALENCE:\nThe LLM answer is semantically aligned with the ground truth's core message about the shift from income-focused to balance-sheet-oriented reporting, though it adds details not confirmed by the knowledge graph.\n\nJUSTIFICATION FOR SCORES:\n- Correctness (6): Core concept correct but specific claims unverified; page numbers and detailed disclosures cannot be confirmed\n- Quantitative Accuracy (4): Page numbers and specific disclosure details are unverified; no actual financial figures provided for comparison\n- Qualitative Accuracy (7): Good understanding of the evolution and categorization changes, but some claims lack grounding\n- Contextual Relevance (8): Directly addresses the question about evolution of treatment and disclosure from 2022 to 2024",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 752,
        "total_tokens": 2117
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did GILD's strategic relationship with Arcus evolve between 2023 and 2024, particularly in terms of equity ownership and governance influence?",
      "original_answer": "In 2023, GILD owned approximately 19.9% of Arcus' issued and outstanding voting stock and had two designees on Arcus' board of directors. In January 2024, GILD made an additional $320 million equity investment in Arcus, increasing its ownership to 33%, and expanded its board representation to three designees. This represents a significant increase in both financial commitment and governance influence over Arcus within a year.",
      "llm_answer": "\nBetween the end of 2023 and January 2024 Gilead’s stake in Arcus Biosciences rose from roughly 19.9 % (about 14.8 million shares) to approximately 33 % after a $320 million equity investment, thereby deepening its economic exposure.  The amendment to the collaboration agreement also increased Gilead’s board representation at Arcus from two to three designees and kept in place the right to purchase up to 35 % of Arcus’s voting stock over the next five years, enhancing Gilead’s governance influence over the partnership.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. Quantitative verification: (1) 2023 ownership of 19.9% - CORRECT, (2) January 2024 investment of $320 million - CORRECT, (3) Resulting ownership of 33% - CORRECT, (4) Board representation increase from 2 to 3 designees - CORRECT. The answer correctly identifies all key entities (Gilead/GILD, Arcus Biosciences) and time periods (end of 2023 vs January 2024). Multi-hop synthesis is sound: the answer properly connects the equity investment amount to the ownership percentage change and links this to governance influence through board representation expansion. The LLM answer adds valuable context by mentioning the 14.8 million shares detail and the five-year purchase option right (up to 35% of voting stock), which provides additional relevant information beyond the ground truth without contradicting it. The semantic meaning is fully preserved - the answer conveys that GILD deepened both its financial commitment and governance influence. Minor note: The answer uses 'Gilead' instead of 'GILD' in some places, but this is a stylistic variation that doesn't affect accuracy. The phrase 'deepening its economic exposure' effectively captures the significance of the increased investment. All calculations are implicit and correct (19.9% to 33% represents the stated increase from the $320M investment).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 379,
        "total_tokens": 1617
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has the maturity date and borrowing capacity of the 2021 Multicurrency Credit Facility evolved between 2022 and 2023?",
      "original_answer": "In 2022, the 2021 Multicurrency Credit Facility had a maximum borrowing capacity of $6.0 billion with a maturity date of June 30, 2025. By 2023, the borrowing capacity remained at $6.0 billion, but the maturity date was extended to July 1, 2026. This reflects a one-year extension of the facility’s term without any increase in the total commitment amount, indicating a strategic move to maintain financial flexibility over a longer horizon.",
      "llm_answer": "\nThe 2021 Multicurrency Credit Facility’s maturity was extended – it moved from a June 30 2025 maturity (the date in effect through 2022 after the Dec 8 2021 amendment) to a July 1 2026 maturity following the June 29 2023 amendment.  At the same time the total commitment stayed at **$6.0 billion** (with a $3.5 billion multicurrency sub‑limit, $200 million letter‑of‑credit sub‑limit and $50 million swingline sub‑limit), so borrowing capacity remained $6 bn but the loan’s maturity was pushed out an additional year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All key facts are correct: (1) Maturity dates are accurate - June 30, 2025 in 2022 and July 1, 2026 in 2023, representing a one-year extension; (2) Borrowing capacity correctly stated as $6.0 billion in both years with no change; (3) Amendment dates provided (Dec 8, 2021 and June 29, 2023) add helpful context not in the ground truth but are factually relevant; (4) Sub-limits are correctly identified ($3.5B multicurrency, $200M letter-of-credit, $50M swingline), providing additional detail that enhances understanding. The multi-hop synthesis is sound - the answer correctly compares the facility across two years and identifies the key evolution (maturity extension without capacity increase). The reasoning is logical and the conclusion about maintaining financial flexibility is appropriate. The only minor distinction from the ground truth is the inclusion of additional sub-limit details and amendment dates, which represent value-added information rather than errors. The answer fully addresses both components of the question (maturity date evolution and borrowing capacity evolution) with perfect numerical accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 334,
        "total_tokens": 1568
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has Chevron's utilization of imported crude oil in U.S. refining operations evolved between 2023 and 2024, and what changes in refinery capacity utilization accompanied this trend?",
      "original_answer": "Chevron's reliance on imported crude oil in U.S. refining operations remained consistent at approximately 60% of refinery inputs in both 2023 and 2024. However, the utilization of U.S. refineries changed: in 2023, crude unit distillation capacity utilization averaged 90.8%, while in 2024 it decreased to 86.6%. This indicates that while the company's dependency on imported crude oil remained stable, the overall operational intensity of its U.S. refineries declined slightly in 2024.",
      "llm_answer": "\nChevron kept the share of imported crude in its U.S. refinery feedstock essentially unchanged – about 60 percent of the crude processed in both 2023 and 2024.  At the same time, overall refinery utilization slipped: U.S. crude‑unit capacity utilisation fell from roughly 90.8 percent in 2023 to 86.6 percent in 2024 (and total system utilisation dropped from 89.8 percent to 87.9 percent), reflecting a modest reduction in operating rates despite the steady imported‑crude mix.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. All key quantitative data points are correct: (1) imported crude oil share at ~60% in both 2023 and 2024 - matches ground truth exactly; (2) crude unit distillation capacity utilization at 90.8% in 2023 and 86.6% in 2024 - both figures correct; (3) the directional change (decline from 2023 to 2024) properly identified. The LLM answer goes beyond the ground truth by including additional relevant data on total system utilization (89.8% to 87.9%), which provides valuable context without contradicting the original answer. Multi-hop reasoning is sound: the answer correctly synthesizes the relationship between stable imported crude percentages and declining refinery utilization rates, drawing the logical conclusion that operational intensity decreased despite consistent import dependency. Entity identification is accurate (Chevron, U.S. refining operations, crude unit capacity, system utilization). The wording differs from ground truth but conveys identical semantic meaning - 'kept the share...essentially unchanged' = 'remained consistent,' 'slipped' = 'decreased,' 'modest reduction' = 'declined slightly.' The additional system utilization data enhances the answer without introducing errors. Minor deduction from perfect score only because the ground truth didn't mention total system utilization, though this addition is factually accurate and contextually valuable rather than problematic.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 406,
        "total_tokens": 1657
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did UPS's hedging position in British Pound Sterling evolve between 2023 and 2024, and what does this shift indicate about the company's currency risk management strategy?",
      "original_answer": "In 2023, UPS reported a British Pound Sterling (GBP) hedge position of 663 million units, which decreased to 536 million units in 2024. This represents a reduction of 127 million units, or approximately 19.15%. The decrease indicates a strategic move to reduce exposure to GBP, suggesting that UPS may have reassessed its currency risk related to the British Pound and opted for a more conservative hedging approach or a lower anticipated risk in that currency during the later year.",
      "llm_answer": "\nUPS reduced its explicit British‑Pound‑sterling hedge from **$856 million in 2022 to $663 million in 2023 and further to $536 million in 2024** (pages 130 & 137).  This downward trend shows the company is scaling back its GBP‑focused derivative coverage, indicating a strategic shift toward relying more on natural currency exposure management (e.g., revenue‑based hedges) and a reassessment of foreign‑exchange risk rather than maintaining large notional hedge positions.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides mostly accurate information with some important distinctions from the ground truth. CORRECT ELEMENTS: (1) The 2023 and 2024 figures are accurate (663M and 536M units respectively), matching the ground truth exactly. (2) The directional trend is correct - showing a decrease in GBP hedging position. (3) The interpretation about strategic shift toward natural hedging and reassessment of FX risk is reasonable and aligns with the ground truth's conclusion. (4) The page references (130 & 137) suggest proper sourcing. ISSUES: (1) The LLM introduces a 2022 figure ($856 million) that is not mentioned in the ground truth answer. While this may be factually correct from the filing, it goes beyond what was asked and what the ground truth established as the relevant comparison period (2023-2024). (2) The LLM uses dollar amounts ($663M, $536M) while the ground truth specifies these as 'units' (663 million units, 536 million units). This is a significant distinction - the ground truth treats these as notional units of currency, not dollar values. This could indicate the LLM may have misinterpreted the nature of the hedge position. (3) The LLM does not calculate or mention the 127 million unit reduction or the 19.15% decrease that the ground truth explicitly states. (4) The LLM's interpretation about 'natural currency exposure management' and 'revenue-based hedges' is speculative and not directly supported by the ground truth, though it represents reasonable inference. MULTI-HOP REASONING: The LLM successfully synthesizes information across multiple years and correctly identifies the strategic implication, though the unit vs. dollar distinction suggests potential confusion about the underlying data structure. The answer is contextually relevant and addresses the core question about how the hedging position evolved and what it indicates about strategy, but the unit/dollar confusion and omission of the calculated reduction metrics prevent a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 537,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has the fair value of money market investments held by Bank of America evolved between 2023 and 2024, and what does this shift indicate about the company's short-term investment strategy?",
      "original_answer": "The fair value of money market investments held by Bank of America increased from $1.2 billion at December 31, 2023, to $1.3 billion at December 31, 2024. This indicates a modest growth in the company's short-term investment holdings, suggesting a slight expansion in liquidity management or short-term capital deployment strategies over the year.",
      "llm_answer": "\nThe fair‑value of Bank of America’s money‑market holdings rose from **$868 million at the end of 2023 to $1.3 billion at the end of 2024** (≈ 50 % growth).  This increase reflects a deliberate shift toward a larger, more liquid cash‑equivalent position—likely to preserve liquidity, capture higher short‑term yields in a rising‑rate environment, and reduce exposure to longer‑duration interest‑rate risk in the bank’s short‑term investment strategy.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains a major factual error in the 2023 baseline figure. Ground truth states money market investments were $1.2 billion at December 31, 2023, but the LLM claims $868 million—a difference of $332 million or 27.7% below the correct value. This is a significant quantitative error that undermines the entire analysis. The 2024 figure of $1.3 billion is correct, matching ground truth. However, the calculated growth rate of ~50% is incorrect based on the wrong 2023 baseline ($868M to $1.3B = 49.8% growth). The correct growth rate should be approximately 8.3% ($1.2B to $1.3B). REASONING ISSUES: While the LLM provides plausible strategic interpretations (liquidity preservation, capturing higher yields, reducing interest-rate risk), these inferences are speculative and not grounded in the actual data. The qualitative analysis about the company's strategy is reasonable in tone but is built on an incorrect quantitative foundation. COMPLETENESS: The answer does address both parts of the question (evolution of fair value and strategic implications), but the factual inaccuracy severely compromises the response. The semantic interpretation about short-term investment strategy is contextually relevant but cannot be properly evaluated when based on incorrect numbers. VERIFICATION: Ground truth clearly states $1.2B (2023) and $1.3B (2024); LLM states $868M (2023) and $1.3B (2024). This is a fundamental data error, not a formatting or rounding difference.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1210,
        "completion_tokens": 412,
        "total_tokens": 1623
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has the maximum expected volume of natural gas subject to physical supply contracts with sell-back options changed across Southern Company's subsidiaries between 2022 and 2024?",
      "original_answer": "In 2022, the maximum expected volume of natural gas subject to such contracts was 26 million mmBtu for Southern Company as a whole, with individual volumes of 6 million mmBtu for Alabama Power, 8 million mmBtu for Georgia Power, 4 million mmBtu for Mississippi Power, and 8 million mmBtu for Southern Power. By 2024, this volume had decreased to 15 million mmBtu company-wide, with corresponding reductions in each subsidiary's volume: 4 million mmBtu for Alabama Power, 6 million mmBtu for Georgia Power, 2 million mmBtu for Mississippi Power, and 3 million mmBtu for Southern Power. This represents a consistent reduction across all entities.",
      "llm_answer": "\nThe “maximum expected volume” of natural‑gas supply contracts with a sell‑back feature fell sharply – from roughly **26 million mmBtu** in the 2022 filing (which reports the 2021 levels) to about **15 million mmBtu** in the 2024 filing.  Accordingly, each subsidiary’s share dropped from **6 mmBtu (Alabama Power), 8 mmBtu (Georgia Power), 4 mmBtu (Mississippi Power) and 8 mmBtu (Southern Power)** in 2022 to **4 mmBtu, 6 mmBtu, 2 mmBtu and 3 mmBtu**, respectively, in 2024.  (Pages 319 of SO_10k_2022.pdf and 281 of SO_10k_2024.pdf.)",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct with accurate financial figures and proper multi-hop synthesis across subsidiaries and years. STRENGTHS: (1) All key numbers are correct - 26 million mmBtu (2022) and 15 million mmBtu (2024) for company-wide totals; (2) All subsidiary-level figures match ground truth exactly: Alabama Power (6→4), Georgia Power (8→6), Mississippi Power (4→2), Southern Power (8→3); (3) Proper multi-hop synthesis across all four subsidiaries and both years; (4) Correctly identifies the consistent reduction pattern across all entities; (5) Provides source citations (page numbers from 10-K filings). MINOR ISSUES: (1) The phrase 'which reports the 2021 levels' in parentheses is somewhat ambiguous and potentially confusing - the 2022 filing reports 2022 data, not 2021 data. This parenthetical appears to introduce unnecessary confusion about what year the data represents; (2) Uses 'mmBtu' without 'million' prefix in the subsidiary figures (e.g., '6 mmBtu' instead of '6 million mmBtu'), though this is a minor formatting inconsistency since mmBtu already implies the unit. The ground truth uses 'million mmBtu' consistently. QUANTITATIVE VERIFICATION: All numbers verified as correct. The sum check: 2022 (6+8+4+8=26✓), 2024 (4+6+2+3=15✓). The answer correctly captures the magnitude of change and the direction of movement. MULTI-HOP REASONING: Successfully synthesizes information across multiple subsidiaries and two different years, properly comparing corresponding values. The conclusion about 'consistent reduction across all entities' is logically sound and supported by the data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 443,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has the integration and application of the Firefly Vector Model evolved across Adobe's product suite between 2023 and 2024?",
      "original_answer": "In 2023, the Firefly Vector Model was integrated into Adobe Express, enabling users to generate custom images and text effects from text prompts in over 100 languages. By 2024, the Firefly Vector Model had expanded its application beyond Adobe Express and was now also integrated into Adobe Illustrator, powering features like Generative Recolor, which allows users to create different color palettes using text prompts and apply them to vector graphics. This represents a significant expansion of the Firefly Vector Model’s functionality and reach within Adobe’s creative tools, moving from a single-app integration to becoming a core AI-driven feature across multiple professional-grade applications.",
      "llm_answer": "\nBetween 2023 and 2024 Adobe moved the Firefly Vector Model from a single experimental feature in Illustrator (2023 – Generative Recolor and text‑to‑vector generation) to a broadly embedded capability across the Creative Cloud suite.  In 2023 it appeared in Illustrator, Fresco and Adobe Express, delivering editable vectors with Content Credentials; by 2024 the model powered vector generation in additional apps (e.g., Acrobat, Stock, and the web‑based Firefly Editor), was packaged with enterprise‑focused Firefly Services and Custom Models (including indemnification), and was monetised through a paid Generative‑Credits subscription plan, markedly expanding both the breadth of integration and the commercial‑ready AI workflow.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and contradictions with the ground truth. Key issues: (1) MAJOR FACTUAL ERROR - The LLM claims Firefly Vector Model appeared in Illustrator in 2023, but the ground truth explicitly states it was integrated into Adobe Express in 2023, not Illustrator. (2) INCORRECT EXPANSION NARRATIVE - The ground truth shows expansion FROM Adobe Express (2023) TO Adobe Illustrator (2024), but the LLM reverses this and adds unsupported claims about Acrobat, Stock, and web-based Firefly Editor integration in 2024 with no corroboration in the ground truth. (3) UNSUPPORTED DETAILS - The LLM introduces claims about Content Credentials, Firefly Services, Custom Models, indemnification, and Generative-Credits subscription plans that are not mentioned in the ground truth and cannot be verified. (4) INCOMPLETE CORE FACTS - The LLM fails to mention the key 2024 feature (Generative Recolor in Illustrator) that is central to the ground truth's narrative of expansion. (5) MISCHARACTERIZATION - The LLM describes 2023 as 'experimental' and Illustrator as the starting point, contradicting the ground truth which identifies Adobe Express as the 2023 integration point. The LLM answer appears to conflate or invent product roadmap details rather than accurately synthesizing the documented evolution. While the answer addresses the general topic of Firefly Vector Model evolution, it fundamentally misrepresents the specific applications and timeline documented in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 417,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has the commercial significance of Biktarvy evolved for GILD from 2023 to 2024, and what implications does this have for the company's HIV business strategy?",
      "original_answer": "In 2023, Biktarvy was a major revenue driver for GILD, generating $11,850 million in total product sales globally, representing a growth from $10,390 million in 2022. By 2024, although Biktarvy remained central to GILD's HIV portfolio, the company highlighted increased risks around its reliance on HIV products, particularly those containing TAF like Biktarvy, due to potential shifts in treatment paradigms and growing generic competition. This indicates that while Biktarvy continued to be a key asset, GILD faced mounting pressure to diversify or innovate within its HIV pipeline to sustain revenue growth.",
      "llm_answer": "\nBiktarvy’s sales grew from $10.4 billion in fiscal 2023 ( $8.5 bn U.S., $1.1 bn Europe, $0.8 bn other – page 65, 2023 10‑K) to $11.9 billion in fiscal 2024 ( $9.7 bn U.S., $1.3 bn Europe, $0.9 bn other – page 21, 2024 10‑K), a roughly 14 % increase and now representing the bulk of Gilead’s HIV product revenue.  This continued expansion reinforces Gilead’s HIV‑focused strategy of protecting the franchise through price‑management and rebate‑optimization while investing in next‑generation HIV therapies to sustain long‑term growth amid pricing‑pressure and competition risks (pages 18, 69, 88).",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the key financial figures: Biktarvy sales of $10.4B in 2023 and $11.9B in 2024, matching the ground truth exactly. (2) The geographic breakdown is provided with reasonable detail ($8.5B U.S., $1.1B Europe, $0.8B other for 2023; $9.7B U.S., $1.3B Europe, $0.9B other for 2024). (3) The calculated growth rate of ~14% is mathematically accurate (11.9/10.4 = 1.144 or 14.4%). (4) The LLM correctly identifies Biktarvy as central to GILD's HIV portfolio. WEAKNESSES: (1) The LLM answer focuses heavily on GILD's strategic response (price management, rebate optimization, next-generation therapies) but FAILS to adequately address the critical risk factors highlighted in the ground truth - specifically the mounting pressure from generic competition and potential shifts in treatment paradigms that represent growing threats to Biktarvy's dominance. (2) The ground truth emphasizes that GILD faced 'mounting pressure to diversify or innovate' due to these risks, but the LLM frames the strategy more as proactive optimization rather than defensive necessity. (3) The LLM answer lacks discussion of the specific risks around TAF-containing products and generic competition that the ground truth identifies as key implications for strategy. (4) While the LLM provides page references, it doesn't synthesize the risk narrative that is central to understanding the 'implications' for HIV business strategy. CALCULATION VERIFICATION: 11.9/10.4 = 1.144 = 14.4% growth (LLM states ~14%, which is acceptable rounding). MULTI-HOP REASONING: The LLM successfully connects 2023 and 2024 data and links to strategic implications, but incompletely captures the risk-driven nature of those implications. The answer reads as more optimistic about the strategy than the ground truth suggests is warranted given the competitive pressures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 504,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did the status and financial structure of the Series 2018-1A Securities evolve between 2022 and 2023, particularly in terms of outstanding principal and interest rate?",
      "original_answer": "In 2022, the Series 2018-1A Securities had an aggregate principal amount of $500.0 million and an interest rate of 3.652%. By 2023, the outstanding principal had slightly decreased to $496.8 million, while the interest rate remained unchanged at 3.652%. This indicates a minor reduction in the principal amount over the year without any modification to the interest rate.",
      "llm_answer": "\nThe Series 2018‑1A Securities continued to carry a fixed interest rate of **3.652 %** and an anticipated repayment date of **15 March 2028**.  At the end of 2022 the outstanding principal was **$496.1 million**, and by the end of 2023 it had risen slightly to **$496.8 million**—a modest increase that reflects only minimal amortization and no change in the coupon.  (2023 10‑K, p. 108; 2022 10‑K, p. 117)",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual errors regarding the principal amounts. Ground truth states: 2022 = $500.0 million, 2023 = $496.8 million (a DECREASE). LLM states: 2022 = $496.1 million, 2023 = $496.8 million (an INCREASE). This is a fundamental error in both the 2022 baseline figure and the directional change. The 2022 figure is off by $3.9 million ($500.0M vs $496.1M), which is material. The LLM incorrectly characterizes the trend as a 'modest increase' when the ground truth shows a decrease of $3.2 million. CORRECT ELEMENTS: The interest rate of 3.652% is accurate, and the 2023 principal of $496.8 million is correct. The repayment date and page citations add contextual detail not in the ground truth but appear reasonable. MULTI-HOP REASONING: The LLM failed to correctly synthesize the year-over-year comparison, getting both the starting point and the direction of change wrong. This is a critical failure for a multi-hop financial question requiring accurate comparison across two fiscal years. The semantic framing of 'minimal amortization' is contradicted by the actual $3.2 million decrease, which while modest, is directionally opposite to what the LLM states.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1200,
        "completion_tokens": 346,
        "total_tokens": 1546
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did UPS's relationship with Coyote evolve from 2023 to 2024 in terms of financial impact and strategic direction?",
      "original_answer": "In 2023, UPS recorded a $111 million impairment charge related to the Coyote trade name due to declining market conditions and a strategic evaluation of the business. By 2024, this strategic evaluation culminated in the September 2024 divestiture of Coyote, which significantly impacted UPS's Supply Chain Solutions revenue, contributing to a decrease primarily driven by Coyote's exit. This marks a clear evolution from impairment and strategic review in 2023 to full divestiture in 2024.",
      "llm_answer": "\nFrom 2023 to 2024 UPS moved Coyote from a core, growth‑focused acquisition (bought in 2022) to a non‑strategic unit that was impairing and then sold.  In 2023 the company recorded a $111 million impairment to the Coyote trade‑name and $119 million of goodwill/asset write‑downs, while the business still contributed roughly $800 million of revenue and $950 million of operating expenses.  In September 2024 UPS divested Coyote, recognizing a $156 million gain on the sale and eliminating the $806 million of revenue and $949 million of expenses that had dragged down its Supply‑Chain Solutions segment, thereby reshaping the business toward higher‑margin logistics and forwarding operations.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy with excellent multi-hop synthesis across 2023-2024 events. STRENGTHS: (1) Correctly identifies the $111 million impairment charge in 2023 - matches ground truth exactly. (2) Accurately captures the September 2024 divestiture as the culmination of strategic review. (3) Provides additional context about the 2022 acquisition and the business's financial metrics ($800M revenue, ~$950M operating expenses in 2023; $806M revenue, $949M expenses in 2024). (4) Correctly identifies the $156 million gain on sale in 2024. (5) Excellent multi-hop reasoning showing the evolution from impairment → strategic review → divestiture. (6) Properly contextualizes impact on Supply Chain Solutions segment. MINOR ISSUES: (1) The LLM mentions '$119 million of goodwill/asset write-downs' in 2023 in addition to the $111 million impairment - this detail is not present in the ground truth answer, though it may be accurate from the actual filings. This represents additional detail beyond the ground truth rather than an error. (2) The revenue and expense figures provided ($800M/$950M for 2023 and $806M/$949M for 2024) are not explicitly mentioned in the ground truth answer, though they appear reasonable and consistent with the narrative. These additions enhance rather than contradict the answer. The LLM successfully synthesizes the strategic evolution and financial impact across both years, correctly identifying the key turning points and their implications for the Supply Chain Solutions segment. The answer is more comprehensive than the ground truth while remaining factually consistent with the core claims.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 453,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Linde plc's structure of Performance Share Unit Awards evolve between 2022 and 2024, particularly in terms of the performance metrics used for grants beginning in 2019?",
      "original_answer": "In 2022, Linde plc disclosed two forms of Performance Share Unit Awards under the Amended and Restated 2009 Praxair, Inc. Long Term Incentive Plan: one with Return on Capital performance metrics (Exhibit 10.11k) and another with Total Shareholder Return performance metrics (Exhibit 10.11l). By 2024, these same forms of Performance Share Unit Awards remained in place, as evidenced by Exhibits 10.10l and 10.10m, which correspond directly to the 2019 grants with the same performance metrics. This indicates that the company maintained the same dual structure for Performance Share Unit Awards tied to 2019 grants, without introducing new metrics or eliminating existing ones.",
      "llm_answer": "\nFrom 2019 onward Linde’s Performance Share Unit awards were tied to two distinct performance metrics—Return on Capital (ROC) for one tranche and Total Shareholder Return (TSR) for the other. Between 2022 and 2024 the company made only procedural updates (the 2020 amendment and the January 2024 third amendment to the 2009 Long‑Term Incentive Plan) that refined the award language but left the underlying ROC and TSR metrics unchanged.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies the two performance metrics (Return on Capital and Total Shareholder Return) and accurately states that these metrics remained unchanged between 2022 and 2024. The answer also correctly references the 2009 Long-Term Incentive Plan and mentions procedural amendments (2020 amendment and January 2024 third amendment). However, there are significant gaps in completeness and specificity compared to the ground truth: (1) The LLM answer fails to explicitly reference the specific exhibit numbers (10.11k, 10.11l for 2022 and 10.10l, 10.10m for 2024) that provide documentary evidence of the dual structure's continuity. (2) The answer does not clearly establish the direct correspondence between the 2022 exhibits and 2024 exhibits as showing the same forms of awards tied to 2019 grants. (3) While the LLM mentions 'procedural updates' and amendments, it does not clearly state that the same dual structure was maintained across both years without introducing new metrics or eliminating existing ones—a key finding in the ground truth. (4) The LLM's reference to 'from 2019 onward' is somewhat vague compared to the ground truth's explicit statement about 2019 grants and their continuation through 2024. The core factual content about the two metrics is accurate, but the answer lacks the documentary specificity and explicit structural continuity analysis that characterizes the ground truth answer. The multi-hop reasoning is partially sound but incomplete in synthesizing the exhibit-level evidence across the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 428,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has the regulatory status of Trodelvy evolved between 2023 and 2024, and what does this indicate about its development trajectory?",
      "original_answer": "In 2023, Trodelvy was indicated for the treatment of adult patients with unresectable locally advanced or metastatic triple-negative breast cancer, hormone receptor-positive/HER2-negative breast cancer, and urothelial cancer. By 2024, the FDA granted Trodelvy a Breakthrough Therapy designation for the treatment of extensive-stage small cell lung cancer in patients whose disease has progressed after platinum-based chemotherapy. This indicates a strategic expansion of Trodelvy’s development into new oncology indications with high unmet medical need.",
      "llm_answer": "\nBetween 2023 and 2024 the FDA moved Trodelvy from an accelerated‑approval setting into a broader, full approval for HR⁺/HER2⁻ metastatic breast cancer (including EC approval), and granted it a Breakthrough‑Therapy designation for extensive‑stage small‑cell lung cancer, while also extending its label in Europe. These regulatory advances reflect a clear development trajectory toward expanding Trodelvy’s indications and reinforcing confidence in its clinical benefit across multiple oncology markets.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant inaccuracies that contradict the ground truth. (1) INCORRECT CLAIM ABOUT HR+/HER2- APPROVAL: The LLM states Trodelvy moved from 'accelerated-approval setting into a broader, full approval for HR+/HER2- metastatic breast cancer' between 2023-2024. However, the ground truth indicates HR+/HER2- breast cancer was ALREADY an approved indication in 2023, not a new approval in 2024. This is a fundamental factual error. (2) CORRECT ELEMENT: The LLM correctly identifies the Breakthrough Therapy designation for extensive-stage small cell lung cancer as a 2024 development, which matches the ground truth. (3) UNSUPPORTED CLAIMS: The LLM mentions 'EC approval' and 'extending its label in Europe' which are not mentioned in the ground truth and cannot be verified from the provided information. These appear to be fabricated details. (4) INCOMPLETE BASELINE: The LLM fails to clearly establish what the 2023 regulatory status was (triple-negative breast cancer, HR+/HER2- breast cancer, and urothelial cancer indications), making the comparison less clear. (5) REASONING QUALITY: While the LLM correctly identifies the trajectory as expansion into new indications, the specific factual claims about which approvals occurred when are substantially incorrect. The core insight about development trajectory is sound, but the supporting details are wrong. The answer demonstrates partial understanding but fails on factual accuracy regarding the timing and nature of regulatory changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 422,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the role of the Vertex AI platform within Google Cloud evolved from 2023 to 2024, particularly in terms of its capabilities and integration with generative AI models?",
      "original_answer": "In 2023, the Vertex AI platform was described as a tool that allowed developers to train, tune, augment, and deploy applications using generative AI models and services such as Enterprise Search and Conversations. By 2024, the platform had evolved to specifically support Gemini and other leading generative AI models, offering developers the ability to train, tune, augment, test, and deploy applications with additional services like vector search, grounding, and distillation to improve model cost and quality. This reflects a shift toward more advanced and optimized generative AI integration.",
      "llm_answer": "\nBetween 2023 and 2024, Vertex AI transitioned from a nascent developer platform for generative AI to the core engine of Google Cloud’s AI suite, now tightly coupled with the Gemini family of multimodal models and enriched with pre‑packaged AI agents (e.g., Duet AI for Cloud) and services such as vector search, grounding and model distillation. This deeper integration gave customers a more seamless, end‑to‑end workflow for training, tuning, deploying and scaling generative‑AI applications, helping drive a 31 % year‑over‑year increase in Google Cloud revenue in 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general evolution of Vertex AI from 2023 to 2024 and correctly identifies key capabilities (vector search, grounding, distillation, Gemini integration). However, there are significant issues: (1) QUANTITATIVE ERROR: The LLM introduces a '31% year-over-year increase in Google Cloud revenue in 2024' statistic that is NOT present in the ground truth answer and cannot be verified from the provided context. This is a factual addition that may or may not be accurate but goes beyond the scope of the original answer. (2) COMPLETENESS: The ground truth specifically mentions 'Enterprise Search and Conversations' as 2023 services, while the LLM mentions 'Duet AI for Cloud' as a 2024 service. The LLM's mention of 'pre-packaged AI agents' is not explicitly in the ground truth. (3) SEMANTIC DIFFERENCES: The LLM characterizes 2023 Vertex AI as 'nascent' while the ground truth presents it as already functional with specific capabilities. The ground truth emphasizes the addition of 'test' capability in 2024, which the LLM omits. (4) MULTI-HOP REASONING: The LLM attempts to connect platform evolution to revenue impact, which is reasonable inference but introduces unverified quantitative claims. The core evolution narrative is sound but embellished with external claims. The answer demonstrates good understanding of the platform's trajectory but compromises accuracy by introducing unsourced statistics and slightly mischaracterizing the 2023 baseline.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 409,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the treatment and valuation of weather derivatives changed in SO's financial disclosures from 2022 to 2024, particularly in terms of the amounts considered immaterial and excluded from derivative valuations?",
      "original_answer": "In 2022, SO disclosed that the premium and intrinsic value associated with weather derivatives were immaterial for all periods presented, but did not specify exact amounts. By 2024, SO continued to exclude the premium and intrinsic value of weather derivatives as immaterial, but also provided more specific context by disclosing that cash collateral held in broker margin accounts was $17 million and $62 million at the end of 2024 and 2023, respectively. This suggests a more detailed and structured approach to derivative disclosures over time, even though the weather derivative component remained immaterial.",
      "llm_answer": "\nBoth the 2022 filing (p. 123) and the 2024 filing (p. 285) expressly state that the premium and intrinsic value of weather‑related derivatives are deemed immaterial and are therefore excluded from the recorded fair‑value of those derivatives. As a result, the balance‑sheet derivative amounts for 2022 and 2024 omit these insignificant items, showing no material change in the treatment or valuation of weather derivatives between the two years.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer has significant gaps and misses critical information from the ground truth. Strengths: (1) Correctly identifies that weather derivatives' premium and intrinsic value are deemed immaterial in both 2022 and 2024 filings; (2) Correctly notes these amounts are excluded from fair-value calculations; (3) Appropriately cites page numbers for both years. Critical Deficiencies: (1) MAJOR OMISSION - The LLM completely fails to mention the specific cash collateral amounts ($17 million for 2024 and $62 million for 2023) that the ground truth identifies as a key change in disclosure practices. This is a quantitative accuracy failure as these specific dollar amounts are material to answering the question about how treatment and valuation changed; (2) The LLM concludes 'no material change in the treatment or valuation' which contradicts the ground truth's finding that there was 'a more detailed and structured approach to derivative disclosures over time' with the addition of specific collateral amounts; (3) The LLM misses the evolution in disclosure detail - the ground truth explicitly notes that 2024 provided 'more specific context' compared to 2022's lack of 'exact amounts'; (4) The answer is incomplete regarding the multi-hop synthesis required - it should have identified and compared the specific quantitative changes in disclosure practices across the two years. The LLM's statement that there is 'no material change' is factually incorrect based on the ground truth's documentation of enhanced disclosure specificity. The quantitative accuracy score is low because the answer omits the specific dollar figures ($17M and $62M) that are central to demonstrating how disclosure practices evolved.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 469,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the regulatory and market positioning of Biktarvy evolved between 2023 and 2024 based on GILD's disclosures?",
      "original_answer": "In 2023, Biktarvy was listed with a U.S. patent expiration year of 2033, indicating long-term market exclusivity protection in the U.S. In 2024, Biktarvy received an expanded regulatory indication from the FDA to treat people with HIV who have suppressed viral loads with known or suspected M184V/I resistance, a common form of treatment resistance. Additionally, the FDA approved an updated label with data reinforcing Biktarvy's safety and efficacy for use in pregnant people with HIV-1. This represents a shift from primarily patent protection in 2023 to expanded therapeutic application and broader patient eligibility in 2024.",
      "llm_answer": "\nBased on Gilead’s 2024 filings, the FDA granted Biktarvy a new expanded indication—covering HIV‑infected patients with the M184V/I resistance mutation and pregnant women with suppressed viral load— and updated its label to reflect these uses, strengthening its therapeutic positioning.  At the same time, the company’s patent exclusivity for Biktarvy remains in force through 2033 (U.S. and EU), preserving market protection, although it cautions that pricing pressures from insurers, rebates and emerging competition could limit net price growth.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct on key facts but has some notable issues: (1) CORRECT ELEMENTS: Patent expiration year of 2033 is accurate; FDA expanded indication for M184V/I resistance is correct; FDA approval for pregnant women is correct; the characterization of the shift from patent protection to expanded therapeutic application is sound. (2) QUANTITATIVE ACCURACY: All dates and years are correct (2023, 2024, 2033). No calculation errors present. (3) QUALITATIVE ISSUES: The LLM answer adds information about EU patent protection through 2033 and mentions pricing pressures/rebates/competition, which are not in the ground truth. While this additional context may be accurate from the filings, it goes beyond what was specified in the original answer and could be seen as either helpful elaboration or scope creep. More critically, the LLM characterizes the pregnant women indication as 'pregnant women with suppressed viral load,' but the ground truth states it was for 'pregnant people with HIV-1' with data reinforcing safety and efficacy - the LLM's phrasing adds a qualifier ('suppressed viral load') that may not be accurate to the actual indication. (4) MULTI-HOP REASONING: The answer correctly synthesizes the evolution from 2023 to 2024, showing understanding that patent protection continued while therapeutic positioning expanded. However, the ground truth emphasizes the shift more clearly as 'from primarily patent protection in 2023 to expanded therapeutic application' whereas the LLM presents both elements as concurrent rather than showing the temporal evolution as clearly. (5) COMPLETENESS: The answer addresses the core question about regulatory and market positioning evolution, though the framing of the pregnant women indication may be slightly inaccurate. The addition of competitive/pricing context, while potentially relevant, wasn't in the ground truth specification.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 517,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did AMT's utilization of the 2021 Multicurrency Credit Facility change between 2022 and 2023, particularly in terms of borrowing amounts and facility amendments?",
      "original_answer": "In 2022, AMT made additional net borrowings of $850.0 million under the 2021 Multicurrency Credit Facility, which were used to repay existing indebtedness and for general corporate purposes. By 2023, the company borrowed an aggregate of $3.0 billion and repaid $6.1 billion under the same facility, including a significant repayment of 842.6 million EUR ($919.1 million). Additionally, the facility underwent amendments in 2023 that extended its maturity date to July 1, 2026, maintained a total commitment of $6.0 billion, and replaced the LIBOR pricing benchmark with SOFR. This reflects a significant transformation in the usage and structure of the facility.",
      "llm_answer": "\nBetween 2022 and 2023 the company moved from a net draw on the 2021 Multicurrency Credit Facility to a net repayment.  In 2022 it borrowed roughly $1.2 bn under the facility, whereas in 2023 it drew $3.0 bn but repaid $6.1 bn (including €842.6 m of revolving debt), leaving a net reduction of about $3.1 bn in outstanding borrowings.  The facility was also amended on June 29 2023 (page 52 of the 2023 10‑K) to extend its maturity to July 1 2026 and to replace LIBOR with SOFR, preserving the $6.0 bn commitment but changing its structure.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the overall narrative of the facility's transformation but contains a significant quantitative error that undermines accuracy. STRENGTHS: (1) Correctly identifies the shift from net borrowing in 2022 to net repayment in 2023; (2) Accurately states 2023 borrowings of $3.0 billion and repayments of $6.1 billion; (3) Correctly identifies the EUR repayment amount (€842.6 million); (4) Accurately reports the June 29, 2023 amendment date, July 1, 2026 maturity extension, $6.0 billion commitment preservation, and LIBOR-to-SOFR conversion; (5) Good synthesis of multi-hop information across years and amendments. CRITICAL ERROR: The LLM states '2022 it borrowed roughly $1.2 bn under the facility' but the ground truth specifies 'additional net borrowings of $850.0 million' in 2022. This is a material discrepancy ($1.2B vs $850M, or 41% overstatement). The LLM's calculation of 'net reduction of about $3.1 bn' ($3.0B drawn - $6.1B repaid = -$3.1B) is mathematically correct but based on incomplete 2022 context. MISSING DETAILS: The answer doesn't explicitly state that the $850.0 million in 2022 was used for 'repaying existing indebtedness and general corporate purposes,' though this is a minor omission. The answer appropriately cites page 52 of the 2023 10-K, demonstrating source awareness. The semantic understanding of the facility's evolution is sound, but the quantitative error in 2022 borrowing amounts is a significant factual mistake that prevents a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 414,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has the role of Google Ad Manager in Alphabet's advertising revenue recognition strategy evolved between 2023 and 2024, particularly in terms of its integration with revenue reporting models?",
      "original_answer": "In 2023, Google Ad Manager was directly tied to Alphabet's advertising revenue recognition on a gross basis, with the company reporting the full amount billed to customers as revenue for ads placed on Google Network properties. By 2024, the language around Google Ad Manager shifted, emphasizing a more nuanced control-based evaluation where Alphabet asserts its role as principal by controlling advertising inventory before transfer to customers, being primarily responsible to them, and having discretion over pricing. This reflects a strategic evolution from a transactional reporting model to a more control-driven justification for gross revenue recognition, reinforcing the centrality of Google Ad Manager in revenue operations.",
      "llm_answer": "\nBetween 2023 and 2024 Alphabet continued to treat Google Ad Manager as the platform through which advertisers buy inventory on Google Network properties and to record the resulting advertising revenue on a **gross basis when it is the principal** (i.e., before any payments to network partners are booked as cost of revenue).  However, the 2024 filing sharpened the integration of Ad Manager into the company’s revenue‑recognition model by explicitly tying Ad Manager transactions to the **multiple‑performance‑obligation allocation and variable‑consideration guidance**, thereby providing a clearer mapping of gross billings to revenue line items and a more explicit separation of those billings from partner payouts.  The underlying gross‑versus‑net policy did not change, but the 2024 disclosures show a more detailed, obligation‑based treatment of Ad Manager‑generated advertising revenue.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains partially correct information but diverges significantly from the ground truth in its characterization of the evolution. CORRECT ELEMENTS: (1) The answer correctly identifies that Google Ad Manager remained the platform for advertising revenue recognition across both years; (2) It correctly notes that Alphabet records revenue on a gross basis when acting as principal; (3) The mention of 2024 showing more detailed disclosures is directionally accurate. INCORRECT/PROBLEMATIC ELEMENTS: (1) The ground truth emphasizes a shift FROM a 'transactional reporting model' TO a 'control-driven justification,' but the LLM answer suggests the underlying policy 'did not change' and only the disclosure detail changed - this misses the strategic evolution in how Alphabet justifies its principal status; (2) The LLM introduces 'multiple-performance-obligation allocation and variable-consideration guidance' which is not mentioned in the ground truth and appears to be an inference not supported by the source material; (3) The ground truth specifically highlights that 2024 language shifted to emphasize 'control-based evaluation' with explicit mention of controlling inventory, being primarily responsible, and having pricing discretion - the LLM answer does not capture this control-based shift; (4) The LLM's framing of 'obligation-based treatment' is different from the ground truth's 'control-based evaluation' - these are distinct accounting concepts. MULTI-HOP REASONING: The LLM failed to properly synthesize the evolution narrative. The ground truth presents a clear strategic shift in justification methodology (transactional to control-based), while the LLM presents it as merely enhanced disclosure detail without substantive policy change. This represents a fundamental misunderstanding of the evolution described. QUANTITATIVE ACCURACY: No specific numbers were required in either answer, so this scores well. QUALITATIVE ACCURACY: The answer demonstrates partial understanding but misses the core evolution narrative and introduces unsupported technical accounting concepts.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 565,
        "total_tokens": 1984
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has UPS's financial exposure and strategic positioning regarding Roadie evolved between 2023 and 2024, particularly in terms of goodwill impairment and risk assessment?",
      "original_answer": "In 2023, UPS recorded a $56 million goodwill impairment charge related to Roadie, indicating financial concerns about its value. By 2024, although no further impairment was recorded, Roadie was identified among the reporting units with limited excess of fair value over carrying value, signaling ongoing financial risk. This evolution reflects a shift from active impairment to a cautious monitoring stance due to Roadie's continued sensitivity to cost of capital and performance forecasts.",
      "llm_answer": "\nBetween 2023 and 2024 UPS moved from recording a $56 million goodwill impairment on Roadie (and a full $61 million impairment on the related Delivery Solutions unit) to concluding in its 2024 annual test that Roadie’s fair value still exceeds its carrying value but only by a thin margin—placing it among three reporting units with “limited excess” and $1.1 billion of the company’s total goodwill.  Management now flags Roadie as a higher‑risk unit, noting that a modest 100‑basis‑point rise in the cost of capital or a 10 % dip in projected cash flows could trigger future impairment, so the company’s financial exposure to Roadie remains present but is being monitored more closely.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates good understanding of the overall narrative arc (2023 impairment to 2024 cautious monitoring) and correctly identifies the $56 million goodwill impairment in 2023. However, there are significant quantitative accuracy issues: (1) The LLM introduces a $61 million impairment on 'Delivery Solutions unit' which is not mentioned in the ground truth and appears to be unsupported information. (2) The LLM provides specific risk thresholds (100-basis-point rise in cost of capital, 10% dip in cash flows) and mentions '$1.1 billion of the company's total goodwill' and 'three reporting units with limited excess' - none of which appear in the ground truth answer. These appear to be hallucinated details that, while plausible-sounding, cannot be verified against the original answer. (3) The ground truth states Roadie was 'identified among the reporting units' (plural, unspecified number) with limited excess, but the LLM specifies 'three reporting units' without source verification. The qualitative reasoning is sound - the shift from active impairment to cautious monitoring is correctly characterized, and the multi-hop synthesis across 2023-2024 is logically structured. The answer is contextually relevant and addresses the question's core components. However, the introduction of unverified quantitative details (the $61M figure, specific risk thresholds, $1.1B goodwill amount) significantly undermines confidence in the response's factual accuracy, even though the core narrative appears correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 421,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has Linde's relationship with helium evolved from 2022 to 2024, and what quantitative impact did this change have on the company's sales and operating profit?",
      "original_answer": "In 2022, helium was a supply component for Linde, indicating a positive or neutral role in operations. By 2024, helium had a negative impact on performance, with a 2% underlying sales decrease in the 'Other' segment primarily due to lower volumes in global helium and Linde Advanced Materials Technology (LAMT). Additionally, operating profit in the 'Other' segment saw increased costs related to helium, partially offset by an insurance recovery for LAMT. This reflects a shift from helium being a supply input to a source of cost pressure.",
      "llm_answer": "\nLinde’s helium business has continued to shrink – the volume of helium sold fell enough that the “Other” segment’s sales were $32 million (about 2 %) lower in 2024 than in 2023, a trend that extends the decline seen in 2022.  At the same time, operating profit in that segment rose $19 million (≈ 44 %) in 2024 versus 2023, because insurance recoveries and other cost‑savings more than offset the higher helium‑related expenses, underscoring a modest profitability gain despite the ongoing sales reduction.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) QUANTITATIVE ERRORS: The LLM provides specific numbers ($32 million sales decrease, $19 million operating profit increase, 44% increase) that are NOT present in the ground truth. The ground truth only mentions '2% underlying sales decrease' without specifying absolute dollar amounts. The LLM appears to have fabricated specific dollar figures. (2) INCOMPLETE SYNTHESIS: The LLM correctly identifies the 2% sales decrease in the 'Other' segment and mentions helium volume decline, which aligns with ground truth. However, it adds unverified quantitative claims about operating profit rising $19 million (44%) - the ground truth states operating profit saw 'increased costs related to helium, partially offset by an insurance recovery' but does NOT provide these specific numbers or claim a net profit increase. (3) DIRECTIONAL CONTRADICTION: The ground truth indicates helium had a 'negative impact on performance' with 'increased costs' that were 'partially offset' by insurance recovery - suggesting net negative impact. The LLM claims 'modest profitability gain' which contradicts the ground truth's characterization of negative impact. (4) MISSING CONTEXT: The LLM fails to adequately capture the evolution from 2022 (helium as supply component) to 2024 (negative impact source), instead focusing primarily on 2023-2024 comparison. (5) LAMT REFERENCE: Ground truth mentions 'Linde Advanced Materials Technology (LAMT)' as part of the helium-related issues; LLM does not reference this. The answer demonstrates partial understanding of the helium decline but introduces fabricated financial metrics that significantly undermine credibility.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 457,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the total value of loans covered under long-term credit protection agreements with FNMA and FHLMC evolve from 2023 to 2024, and what does this indicate about the Corporation's credit risk exposure on residential mortgage loans?",
      "original_answer": "In 2023, the Corporation had $8.7 billion in loans covered under credit protection agreements with FNMA and FHLMC, which decreased to $8.0 billion in 2024. This indicates a reduction in the Corporation's reliance on full credit protection for residential mortgage loans that become severely delinquent. Since these agreements provide full credit protection and the Corporation does not record an allowance for credit losses on these loans, the decline suggests a potential decrease in the volume of high-risk residential mortgage loans in their portfolio.",
      "llm_answer": "\nThe amount of loans covered by the Corporation’s long‑term credit‑protection agreements with FNMA and FHLMC fell from **$8.7 billion at the end of 2023 to $8.0 billion at the end of 2024** – a decline of roughly $0.7 billion (about 8 %).  This reduction shows that fewer residential‑mortgage loans are now fully guaranteed by these government‑sponsored enterprises, meaning the Corporation’s direct credit‑risk exposure on the remaining unprotected residential‑mortgage portfolio is relatively larger, even though the overall protected exposure has shrunk.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the key financial figures ($8.7 billion in 2023, $8.0 billion in 2024) and accurately calculates the decline ($0.7 billion or approximately 8%). The numeric data and calculations are precise and match the ground truth. WEAKNESSES: The LLM's interpretation of what this decline indicates is problematic and contradicts the ground truth. The ground truth states the decline 'suggests a potential decrease in the volume of high-risk residential mortgage loans in their portfolio' and indicates 'a reduction in the Corporation's reliance on full credit protection.' However, the LLM states 'the Corporation's direct credit-risk exposure on the remaining unprotected residential-mortgage portfolio is relatively larger.' This is a significant interpretive error. The LLM correctly notes that fewer loans are fully guaranteed, but then incorrectly concludes this means greater direct credit risk exposure. The ground truth emphasizes that since these agreements provide full credit protection and no allowance for credit losses is recorded, the decline indicates fewer high-risk loans overall. The LLM's statement about 'relative' increase in unprotected exposure is misleading—the ground truth indicates an absolute reduction in high-risk loans, not just a shift in the composition. The LLM also fails to mention the key insight that no allowance for credit losses is recorded on these protected loans, which is important context for understanding the credit risk implications. The answer addresses the evolution of loan values but provides an incorrect or at least significantly different interpretation of what this indicates about credit risk exposure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 461,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has Adobe's strategic positioning of Adobe Firefly evolved between 2023 and 2024, particularly in terms of competitive differentiation and associated regulatory risks?",
      "original_answer": "In 2023, Adobe positioned Adobe Firefly as a competitive differentiator by emphasizing its generative AI capabilities that are natively integrated into Adobe products and designed to be safe for commercial use. By 2024, Adobe continued to highlight Firefly's AI innovations but introduced new concerns around regulatory risks, particularly referencing the EU AI Act adopted in 2024, which could impose compliance costs, delay development, or require changes to AI development practices. This reflects a shift from purely competitive emphasis to a more risk-aware strategic positioning of the product.",
      "llm_answer": "\nAdobe shifted Firefly from a set of generative‑AI features embedded in Photoshop, Illustrator and Premiere (introduced in fiscal 2023 with a monthly “Generative Credits” allocation) to a broader, standalone Firefly web app and deeper, native integration across the Creative Cloud, Document Cloud and Experience Cloud suites by fiscal 2024 [page 20; 21].  This expansion differentiates Adobe by offering a unified, commercially‑safe AI layer that can be accessed directly from Acrobat and other Adobe apps, while also exposing the company to heightened regulatory risk as it must navigate newly enacted AI‑specific rules such as the EU AI Act and other emerging global frameworks [page 36; 21].",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth on the core strategic evolution of Adobe Firefly between 2023 and 2024. STRENGTHS: (1) Correctly identifies the shift from embedded generative AI features in 2023 to broader integration across Creative Cloud, Document Cloud, and Experience Cloud by 2024; (2) Accurately captures the competitive differentiation angle (unified, commercially-safe AI layer); (3) Properly identifies the regulatory risk shift, specifically mentioning the EU AI Act as a newly enacted framework in 2024; (4) Demonstrates sound multi-hop reasoning by synthesizing product evolution with regulatory implications; (5) Appropriately references specific page numbers suggesting source documentation. MINOR WEAKNESSES: (1) The answer provides more granular product-level detail (Photoshop, Illustrator, Premiere, Acrobat, Generative Credits) than the ground truth, which is more strategic/high-level - this is additional context rather than an error; (2) The phrase 'fiscal 2023' and 'fiscal 2024' are used, which is appropriate for SEC filings but the ground truth uses calendar years '2023' and '2024' - this is a minor temporal framing difference, not a factual error; (3) The answer emphasizes 'commercially-safe' positioning which aligns with ground truth's 'safe for commercial use' language. VERIFICATION: The core claim about regulatory risk shift from competitive emphasis to risk-aware positioning is well-supported. The mention of EU AI Act as newly enacted in 2024 is factually correct. The product expansion narrative (from embedded to standalone/broader integration) is a reasonable interpretation of the strategic evolution. No quantitative errors detected. The multi-hop synthesis correctly connects product evolution to regulatory implications.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 489,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the financial performance and regulatory trajectory of Trodelvy evolve between 2023 and 2024?",
      "original_answer": "In 2023, Trodelvy generated total product sales of $1,063 million, reflecting a 56% increase compared to the previous year. By 2024, the regulatory landscape for Trodelvy advanced significantly with the FDA granting it a second Breakthrough Therapy designation, specifically for the treatment of adult patients with extensive-stage small cell lung cancer who have progressed after platinum-based chemotherapy. This indicates both strong financial growth and increased regulatory recognition of the drug's potential clinical impact.",
      "llm_answer": "\nBetween 2023 and 2024, Trodelvy’s product sales jumped 24 % to $1.3 billion, propelled by stronger demand across all geographies (U.S., Europe and other international markets).  At the same time, the FDA awarded Trodelvy a second Breakthrough‑Therapy designation—this time for extensive‑stage small‑cell lung cancer after platinum‑based chemotherapy—highlighting a continued upward regulatory trajectory for the asset.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR QUANTITATIVE ERRORS: (1) The LLM states 2024 sales were $1.3 billion with a 24% increase, but the ground truth shows 2023 sales were $1,063 million (56% increase from prior year). The LLM's numbers are internally inconsistent and factually incorrect. If 2023 was $1,063M and there was a 24% increase, 2024 would be ~$1,318M, but this contradicts the ground truth baseline. The ground truth does not provide 2024 sales figures, only 2023 data. (2) The LLM incorrectly invents 2024 sales data ($1.3B) that is not in the ground truth. (3) The LLM correctly identifies the FDA Breakthrough Therapy designation for extensive-stage small cell lung cancer after platinum-based chemotherapy as accurate. (4) MULTI-HOP REASONING: The LLM partially addresses the question by covering both financial performance and regulatory trajectory, but the financial data is fabricated/incorrect. The regulatory information is accurate. (5) The LLM adds unsupported detail about 'stronger demand across all geographies' which is not mentioned in the ground truth. CRITICAL ISSUE: The LLM appears to have confused or invented 2024 sales data when the ground truth only provides 2023 sales of $1,063M with 56% YoY growth. The question asks about evolution between 2023-2024, but the ground truth only provides 2023 financial data and 2024 regulatory news, not 2024 sales figures. The LLM's answer fundamentally misrepresents the available data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1226,
        "completion_tokens": 395,
        "total_tokens": 1622
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How has Chevron's financial involvement and strategic positioning in Angola LNG evolved from 2022 to 2024, based on specific disclosures regarding its equity investments and affiliate transactions?",
      "original_answer": "In 2022, Chevron reported improved income from equity affiliates, including upstream-related earnings from Angola LNG, which contributed to an overall increase in income from equity affiliates to $5,657 million. By 2024, Chevron's specific interest in Angola LNG Limited was disclosed as a 36.4% ownership stake, with Angola LNG Limited described as a key entity that processes and liquefies natural gas produced in Angola for delivery to international markets. This evolution reflects a continued strategic emphasis on LNG as part of Chevron’s broader upstream portfolio, with a clear quantification of its stake in 2024, suggesting a more defined and stable long-term positioning compared to the more general mention of earnings contribution in 2022.",
      "llm_answer": "\nChevron has held a steady 36.4 percent equity interest in Angola LNG Limited since at least 2022, but the size of that stake and the capital it is deploying have risen markedly.  In the 2024 filing the company reports an investment balance of roughly $2.3 billion in Angola LNG (up from about $2.2 billion in 2022) and discloses a $4.5 billion loan to fund the Wellhead‑Pressure‑Management and Future‑Growth projects, while also earmarking roughly $0.8 billion of African‑region capital for offshore gas development in Angola.  These disclosures show a deepening financial commitment—larger equity exposure, expanded loan facilities, and targeted development spending—that positions Angola LNG as a core strategic pillar of Chevron’s upstream growth and LNG expansion strategy through 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ISSUES IDENTIFIED: The LLM answer contains significant factual errors and unsupported claims that contradict the ground truth. (1) OWNERSHIP STAKE CLAIM: The LLM asserts Chevron held a 'steady 36.4 percent equity interest in Angola LNG Limited since at least 2022,' but the ground truth explicitly states the 36.4% stake was 'disclosed' in 2024, not confirmed as existing in 2022. This is a major factual error suggesting the LLM fabricated historical consistency. (2) INVESTMENT BALANCE FIGURES: The LLM provides specific numbers ($2.3 billion in 2024, $2.2 billion in 2022) that are NOT mentioned in the ground truth. These appear to be hallucinated figures without source verification. The ground truth makes no mention of these specific investment balance amounts. (3) LOAN FACILITY CLAIM: The LLM claims a '$4.5 billion loan to fund the Wellhead-Pressure-Management and Future-Growth projects' - this specific loan amount and project description are completely absent from the ground truth and appear fabricated. (4) CAPITAL ALLOCATION: The claim of '$0.8 billion of African-region capital for offshore gas development in Angola' is also unsupported by the ground truth. (5) MULTI-HOP SYNTHESIS: While the LLM attempts to synthesize 2022-2024 evolution, it does so by inventing data points rather than working from disclosed information. The ground truth shows 2022 had general 'improved income from equity affiliates' ($5,657 million total) without specific Angola LNG quantification, while 2024 provided the 36.4% stake disclosure. The LLM reversed this timeline by claiming the stake was known in 2022. (6) WHAT WAS CORRECT: The LLM correctly identifies Angola LNG as a strategic LNG asset and correctly notes the 36.4% ownership stake (though with wrong timing). The general theme of 'deepening financial commitment' aligns with the evolution narrative, but lacks factual grounding. The answer demonstrates reasonable business logic but fails the fundamental requirement of factual accuracy in a financial context where precision is critical.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 554,
        "total_tokens": 1952
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did the value and issuance activity of META's Fixed-Rate Senior Unsecured Notes evolve from 2023 to 2024?",
      "original_answer": "In 2023, META issued $8.46 billion of net proceeds from Fixed-Rate Senior Unsecured Notes in May. By the end of 2024, the total value of these Notes had increased to $29.0 billion, up from $18.50 billion at the end of 2023, with an additional $10.50 billion issued in August 2024. This reflects both continued reliance on this form of debt financing and a significant increase in the total outstanding amount over the two-year period.",
      "llm_answer": "\nFrom the end of 2023 to the end of 2024 Meta’s fixed‑rate senior unsecured notes grew sharply, with total outstanding principal rising from **$18.5 billion** (as of Dec 31 2023) to **$29.0 billion** (as of Dec 31 2024).  The increase was driven by a **$8.46 billion issuance in May 2023** and a subsequent **$10.5 billion issuance in August 2024**, which together lifted the note portfolio by roughly **$10.5 billion** in 2024 alone.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct with accurate financial figures and proper multi-hop synthesis. Verification of key numbers: (1) $18.5 billion at end of 2023 - CORRECT, (2) $29.0 billion at end of 2024 - CORRECT, (3) $8.46 billion issuance in May 2023 - CORRECT, (4) $10.5 billion issuance in August 2024 - CORRECT. The calculation of the net increase in 2024 ($29.0B - $18.5B = $10.5B) is accurate and properly attributed to the August 2024 issuance. The multi-hop reasoning correctly synthesizes information across two fiscal years and identifies both issuance events. Minor issue: The LLM states the May 2023 issuance 'lifted the note portfolio' when discussing 2024 activity, which could be slightly clearer - the May 2023 issuance contributed to the $18.5B balance at end of 2023, while the August 2024 issuance drove the 2024 increase. However, this is a minor wording/clarity issue rather than a factual error. The answer appropriately addresses the evolution question by showing both the beginning and ending balances, the issuance activity, and the overall trend. All entities (META, Fixed-Rate Senior Unsecured Notes) are correctly identified. The answer demonstrates sound understanding of the multi-hop synthesis required to connect 2023 issuance activity, 2023 year-end balance, 2024 issuance activity, and 2024 year-end balance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1207,
        "completion_tokens": 376,
        "total_tokens": 1584
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did LIN's financial exposure to helium as a raw material change from 2023, when it was categorized as a supply, to 2024, when it became a dependency, based on specific cost or sourcing disclosures?",
      "original_answer": "In 2023, LIN categorized helium as a supply, indicating it was a standard input with manageable sourcing dynamics, and reported helium costs at 4.2% of total raw material expenses. By 2024, the relationship shifted to 'depends_on,' signaling increased strategic importance, and helium costs rose to 6.8% of raw material expenses, reflecting a more critical role in operations and a corresponding increase in cost exposure.",
      "llm_answer": "\nIn the 2023 Form 10‑K (page 62) helium is listed only as part of the $614 million “Rawmaterials and supplies” inventory, presented as a routine purchased supply. The 2024 filing (page 62) still reports helium under the same line item, but the ending balance has fallen to $529 million and the accompanying disclosure notes that helium is now a “critical dependency” sourced from a limited number of vendors and has experienced a modest price increase, signalling a shift from a generic supply to a strategically important raw material.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and fails to address the core quantitative elements of the ground truth. Specific issues: (1) QUANTITATIVE ERRORS: The ground truth provides specific cost percentages (4.2% in 2023, 6.8% in 2024) that are completely absent from the LLM answer. The LLM instead references inventory line items ($614M and $529M) which are not mentioned in the ground truth and appear to be fabricated or misattributed data. These inventory figures are not the relevant metrics for answering the question about helium's financial exposure as a percentage of raw material costs. (2) MISSING KEY DATA: The LLM fails to cite the critical percentage metrics that form the backbone of the ground truth answer (4.2% → 6.8% increase in helium costs as a share of total raw material expenses). This is a fundamental omission that undermines the entire answer. (3) INCOMPLETE SYNTHESIS: While the LLM correctly identifies the conceptual shift from 'supply' to 'critical dependency,' it does not quantify this shift with the specific cost exposure data provided in the ground truth. The answer describes the relationship change qualitatively but lacks the quantitative evidence that demonstrates the magnitude of the financial exposure change. (4) SOURCING DISCLOSURE: The LLM mentions 'limited number of vendors' and 'modest price increase' but these are vague characterizations compared to the precise percentage-based cost exposure metrics in the ground truth. (5) PAGE REFERENCES: The LLM cites 'page 62' for both years, which may or may not be accurate, but this does not compensate for the missing quantitative data. The answer reads as if it may be referencing different sections of the filings than those containing the actual cost percentage disclosures. Overall, the LLM answer demonstrates a conceptual understanding of the shift but fails to provide the specific financial metrics that are central to answering this multi-hop question about helium's changing financial exposure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 541,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did PayPal's utilization of European customer balances for credit activities evolve between 2022 and 2023, and what was the percentage change in the amount approved for such activities?",
      "original_answer": "In 2022, PayPal had $3.8 billion approved to fund credit activities, representing approximately 37% of European customer balances available for corporate use. In 2023, the approved amount decreased to $3.0 billion, representing approximately 39% of European customer balances. This indicates a reduction in the absolute amount approved for credit activities, even though the percentage slightly increased, signaling a more conservative approach to utilizing customer balances for credit funding.",
      "llm_answer": "\nPayPal’s ability to earmark European customer balances for credit purposes fell in absolute terms: the amount of balances that management could designate for credit activities dropped from **$3.8 billion in 2022 to $3.0 billion in 2023**.  This represents a **≈21 % decrease** in the approved dollar amount ( ($3.0 bn – $3.8 bn) / $3.8 bn ≈ ‑0.21 ).  (The share of European customer balances that could be used actually rose slightly, from about 37 % to 39 % of the total, but the approved capital itself was lower.)  [Source: PYPL_10k_2023.pdf page 75]",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All key quantitative facts are correct: (1) 2022 approved amount: $3.8 billion ✓, (2) 2023 approved amount: $3.0 billion ✓, (3) 2022 percentage: ~37% ✓, (4) 2023 percentage: ~39% ✓. The percentage change calculation is accurate: ($3.0B - $3.8B) / $3.8B = -0.2105 or approximately -21% ✓. The LLM correctly synthesized the multi-hop information by: (a) identifying the evolution in absolute dollar amounts, (b) calculating the percentage change, (c) noting the counterintuitive finding that while absolute amounts decreased, the percentage of total balances slightly increased, and (d) interpreting this as a more conservative approach. The answer demonstrates sound reasoning by explaining the apparent contradiction between declining absolute amounts and rising percentages. The source citation (PYPL_10k_2023.pdf page 75) adds credibility. Minor consideration: The LLM uses the approximation symbol (≈) and decimal notation (-0.21) rather than percentage format, but this is a stylistic choice and mathematically equivalent to the ground truth's presentation. The answer is well-structured, clear, and directly addresses all components of the multi-part question regarding evolution, amounts, and percentage change.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 357,
        "total_tokens": 1630
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Starbucks' exposure to foreign currency - other instruments evolve between 2023 and 2024, particularly in terms of their fair value and the expected reclassification impact on earnings?",
      "original_answer": "In 2023, Starbucks reported a fair value of $1,164 million for foreign currency - other instruments, with a net gain of $39.6 million included in AOCI. By 2024, the fair value decreased to $920 million, and the net gain included in AOCI dropped to $11.5 million. Additionally, the amount expected to be reclassified from AOCI into earnings within 12 months declined from $55.3 million in 2023 to $9.5 million in 2024, indicating a reduced short-term earnings impact from these instruments.",
      "llm_answer": "\nBetween fiscal 2023 and 2024 the “foreign‑currency‑other” component of Starbucks’ AOCI fell sharply—from an unrealized gain of **$39.6 million** as of Oct 1 2023 to **$11.5 million** as of Sep 29 2024— and the amount projected to be re‑classified to earnings over the next 12 months dropped from **$39.6 million** to **$9.5 million**.  Consequently, the realized gain/(loss) on these derivatives that flowed into earnings was essentially flat (a **$0.1 million** gain in 2024 versus a **$3.6 million** loss in 2023), indicating that the company’s foreign‑currency exposure and the related earnings impact have both receded markedly.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) MAJOR FACTUAL ERROR: The LLM states the reclassification amount dropped from '$39.6 million to $9.5 million,' but the ground truth clearly shows it declined from $55.3 million in 2023 to $9.5 million in 2024. The $39.6 million figure is the AOCI net gain, not the reclassification amount. This is a fundamental confusion of two different metrics. (2) MISSING KEY DATA: The LLM completely omits the fair value figures ($1,164 million in 2023 and $920 million in 2024), which are explicitly requested in the question ('particularly in terms of their fair value'). This is a significant omission of core information. (3) ADDITIONAL UNSOURCED DATA: The LLM introduces realized gain/loss figures ($0.1 million gain in 2024 vs $3.6 million loss in 2023) that are not mentioned in the ground truth answer and cannot be verified. This represents speculation beyond the provided data. (4) CORRECT ELEMENTS: The AOCI net gain figures ($39.6M to $11.5M) are correctly stated, and the reclassification amount of $9.5 million for 2024 is correct. The overall narrative about declining exposure is directionally accurate. (5) MULTI-HOP SYNTHESIS: While the answer attempts to synthesize information across years and metrics, the critical error in conflating the $39.6 million AOCI gain with the $55.3 million reclassification amount demonstrates flawed reasoning. The answer fails to properly distinguish between different components of AOCI analysis. The response addresses the evolution between years but with significant factual errors that undermine credibility.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 435,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did the fair value of energy-related derivatives held by Alabama Power and Georgia Power evolve from 2022 to 2023, and what was the directional change in their asset versus liability positions?",
      "original_answer": "In 2022, Alabama Power reported energy-related derivatives with a fair value of $55 million in assets and $11 million in liabilities, while Georgia Power reported $75 million in assets and $8 million in liabilities. By 2023, Alabama Power's energy-related derivatives decreased to $15 million in assets but increased significantly to $110 million in liabilities. Similarly, Georgia Power's derivatives were valued at $13 million in assets and $124 million in liabilities in 2023. This indicates a substantial shift toward liability exposure for both entities over the period.",
      "llm_answer": "\nThe reported fair‑value of the energy‑related derivatives held by Alabama Power and Georgia Power was essentially flat from 2022 to 2023 (about $15 million of assets and roughly $110–$124 million of liabilities for the two utilities).  However, the accounting classification changed – in 2022 the derivatives were shown only as liabilities, while in 2023 they appear as both assets (positive $15 million for Alabama Power and $13 million for Georgia Power) and liabilities, indicating a directional shift from a net‑liability position to a mixed asset‑liability position (i.e., from liability to asset).",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains fundamental factual errors and misrepresents the data from the ground truth. Specific issues: (1) QUANTITATIVE ERRORS: The LLM claims derivatives were 'shown only as liabilities' in 2022, but the ground truth clearly shows Alabama Power had $55M in assets and $11M in liabilities in 2022, and Georgia Power had $75M in assets and $8M in liabilities in 2022. These are substantial asset positions, not 'only liabilities.' (2) MISCHARACTERIZATION OF CHANGE: The LLM incorrectly states the position changed 'from liability to asset' when in fact both companies had significant assets in 2022 and the actual change was a dramatic DECREASE in assets (Alabama: $55M→$15M, Georgia: $75M→$13M) combined with a massive INCREASE in liabilities (Alabama: $11M→$110M, Georgia: $8M→$124M). This is the opposite directional characterization. (3) INCOMPLETE SYNTHESIS: The LLM failed to properly synthesize the multi-hop data across both companies and both years. It should have clearly shown the 2022 baseline for both entities before describing the 2023 changes. (4) INCORRECT CONCLUSION: The statement that there was a shift 'from liability to asset' is factually wrong - the shift was from a net asset position to a net liability position for both utilities. The correct characterization is a 'substantial shift toward liability exposure' as stated in the ground truth. (5) VAGUE LANGUAGE: Phrases like 'essentially flat' and 'roughly $110-$124 million' obscure the significant changes that occurred. The answer demonstrates a fundamental misunderstanding of the data and fails to accurately answer the core question about how fair values evolved and the directional changes in asset versus liability positions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 470,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did the asset allocation strategy for the U.S. Retiree Health Care Plan evolve from 2022 to 2023, particularly in terms of the percentage distribution between fixed income securities and equity securities?",
      "original_answer": "In 2022, the U.S. Retiree Health Care Plan allocated 65% to fixed income securities and cash equivalents and 35% to equity securities. By 2023, the allocation to fixed income securities increased to 80%, while equity securities decreased to 20%. This represents a shift toward a more conservative investment strategy in 2023 compared to 2022.",
      "llm_answer": "\nFrom 2022 to 2023 the U.S. Retiree Health Care Plan shifted its asset mix toward a higher fixed‑income allocation and a lower equity allocation.  In 2022 the plan’s assets were roughly 65 % fixed‑income and 35 % equity, whereas by the end of 2023 they were about 80 % fixed‑income and 20 % equity—moving the portfolio into the plan’s target range of 65‑80 % fixed income and 15‑25 % equity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All quantitative data matches the ground truth exactly: 2022 allocation of 65% fixed income/35% equity and 2023 allocation of 80% fixed income/20% equity. The answer correctly identifies the shift toward a more conservative strategy. The LLM goes beyond the ground truth by adding valuable context about the plan's target range (65-80% fixed income and 15-25% equity), which demonstrates the allocation moved into the target range. This additional information is accurate and relevant, showing the plan was aligning with its strategic objectives. The multi-hop reasoning is sound—the answer synthesizes the year-over-year comparison correctly and explains the strategic implication. The wording is clear and professional. The only minor consideration is that the ground truth explicitly states this represents 'a shift toward a more conservative investment strategy,' while the LLM uses the phrase 'shifted its asset mix toward a higher fixed-income allocation and a lower equity allocation' which is semantically equivalent but slightly less explicit about the strategic characterization. However, this is a negligible difference. All entities (U.S. Retiree Health Care Plan, years 2022-2023, fixed income securities, equity securities) are correctly identified and synthesized.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1199,
        "completion_tokens": 372,
        "total_tokens": 1571
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How has the regulatory approval status of Trodelvy evolved between 2022 and 2023, and what new indications were granted in 2023?",
      "original_answer": "In 2022, Trodelvy was indicated for the treatment of adult patients with unresectable locally advanced or metastatic triple-negative breast cancer (TNBC) who have received two or more prior systemic therapies and for metastatic urothelial cancer after platinum-based chemotherapy and a PD-1/PD-L1 inhibitor. By 2023, Trodelvy received additional approvals: it was granted EC approval and FDA approval for the treatment of adult patients with unresectable or metastatic hormone receptor-positive, HER2-negative (HR+/HER2-) breast cancer who have received endocrine-based therapy and at least two additional systemic therapies in the metastatic setting. This represents a significant expansion of the drug’s therapeutic applications.",
      "llm_answer": "\nBetween 2022 and 2023 Trodelvy’s approvals remained accelerated for its original metastatic TNBC and urothelial‑cancer indications (granted under the accelerated‑approval pathway in 2022; see page 8), but in 2023 the FDA granted a new, non‑accelerated indication: full approval for adult patients with unresectable locally advanced or metastatic HR⁺/HER2‑ breast cancer who have previously received endocrine therapy and at least two systemic therapies (see page 39). Thus, while the drug kept its earlier accelerated approvals, the 2023 approval expanded its use to a distinct breast‑cancer population.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and addresses the core question well. STRENGTHS: (1) Correctly identifies the 2022 indications for TNBC and metastatic urothelial cancer; (2) Accurately describes the 2023 HR+/HER2- breast cancer approval with correct patient population details (unresectable/metastatic, prior endocrine therapy, at least two systemic therapies); (3) Properly distinguishes between accelerated approval pathway (2022) and full approval (2023); (4) Correctly synthesizes the multi-hop information showing regulatory evolution across years; (5) Appropriately notes this represents an expansion to a 'distinct breast-cancer population.' MINOR ISSUES: (1) The LLM mentions 'EC approval' in the original ground truth answer but the LLM answer does not explicitly mention EC (European Commission) approval - it focuses primarily on FDA approval. The ground truth states 'EC approval and FDA approval' for the 2023 HR+/HER2- indication, but the LLM only references FDA approval. This is a notable omission of a regulatory jurisdiction; (2) The LLM's phrasing 'non-accelerated indication: full approval' is slightly imprecise terminology - it should be clearer that this is a standard/regular approval rather than accelerated approval, though the meaning is conveyed. QUANTITATIVE ACCURACY: All dates (2022, 2023) and patient population criteria are correct. No calculations required. QUALITATIVE ACCURACY: The reasoning about regulatory pathway differences and therapeutic expansion is sound. The multi-hop synthesis correctly connects 2022 baseline approvals with 2023 new approvals. CONTEXTUAL RELEVANCE: Highly relevant to the question asked. The answer directly addresses how regulatory status evolved and what new indications were granted. The omission of EC approval prevents this from being a perfect 9-10 score, as the ground truth explicitly mentions both EC and FDA approvals for the 2023 indication.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 520,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Meta's disclosure regarding user perception as a risk factor evolve between 2023 and 2024, particularly in terms of the nature of risks highlighted and their potential impact on business operations?",
      "original_answer": "In 2023, Meta emphasized user perception risks related to privacy, safety, content quality, and regulatory changes, specifically noting concerns around decreased user sentiment and engagement due to data practices and content policies. In 2024, while user perception was still acknowledged, the focus shifted toward broader operational and financial risks, such as integration challenges from acquisitions, tax liabilities, and investor sentiment. The explicit mention of user perception as a direct risk factor was notably reduced in 2024, indicating a strategic shift in how Meta communicated its risk profile.",
      "llm_answer": "\nIn the 2023 10‑K the “user‑perception” risk was framed narrowly: if people no longer view Meta’s products as useful, reliable or trustworthy, the company could lose users, engagement and ultimately revenue. The 2024 filing keeps that core concern but expands it into a systemic exposure— inaccurate or poorly‑perceived metrics can damage Meta’s reputation, deter marketers and developers from allocating budget or resources, and intersect with broader operational risks such as scaling, international regulation and potential liability. Consequently, user perception in 2024 is presented not just as a threat to user growth but as a material risk that can affect advertising revenue, partner relationships and the overall financial condition of the business.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "ASSESSMENT: The LLM answer provides a plausible interpretation of how Meta's user perception risk disclosure evolved, but it diverges significantly from the ground truth in key ways. STRENGTHS: (1) No quantitative errors - no numbers, dates, or calculations to verify, and the answer appropriately avoids making false claims about specific metrics. (2) Correctly identifies both 2023 and 2024 as the comparison years. (3) Acknowledges that user perception remained a concern in both years. CRITICAL WEAKNESSES: (1) DIRECTIONAL CONTRADICTION: The ground truth states that 'explicit mention of user perception as a direct risk factor was notably reduced in 2024,' indicating a REDUCTION in emphasis. The LLM answer claims the 2024 filing 'expands it into a systemic exposure' and presents it as 'not just as a threat to user growth but as a material risk,' suggesting an EXPANSION or ELEVATION of the risk. This is the opposite direction from the ground truth. (2) MISSING KEY ELEMENTS: The ground truth specifically mentions that 2024 shifted focus toward 'integration challenges from acquisitions, tax liabilities, and investor sentiment' - none of these are mentioned in the LLM answer. (3) INCOMPLETE SYNTHESIS: The ground truth indicates a 'strategic shift in how Meta communicated its risk profile' with reduced explicit mention of user perception. The LLM answer instead describes an expansion and deepening of the user perception risk narrative, which contradicts this strategic shift. (4) REASONING QUALITY: While the LLM's logic about how expanded user perception risks could affect advertising revenue and partner relationships is internally coherent, it doesn't align with what the actual filings show regarding the evolution of Meta's risk disclosure strategy. The answer appears to be inferring a logical expansion rather than reporting what actually occurred in the filings. MULTI-HOP SYNTHESIS: The answer fails to properly synthesize the comparative analysis across the two years' filings, instead presenting a narrative that contradicts the ground truth's core finding about the reduction in explicit user perception risk emphasis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 576,
        "total_tokens": 1933
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How has the notional amount of Lockheed Martin's variable interest rate swaps evolved from 2021 to 2024, and what does this indicate about the company's interest rate risk management strategy?",
      "original_answer": "In 2021, the notional amount of Lockheed Martin's variable interest rate swaps was $500 million, while by 2024, it had increased to $1.3 billion. This indicates a significant shift in the company's interest rate risk management strategy, with a growing emphasis on converting fixed-rate borrowings to variable-rate borrowings, likely in response to changes in the interest rate environment and the company's borrowing profile over the period.",
      "llm_answer": "\nThe notional amount of Lockheed Martin’s outstanding variable‑interest‑rate swaps grew from **$0.5 billion at the end of 2021** (as reported in the 2022 filing) to **$1.3 billion at the end of 2024** (the 2024 filing notes the same $1.3 billion figure for both 2024 and 2023). This roughly 2½‑fold increase shows that the company has markedly expanded its use of variable‑rate swaps to hedge the interest‑rate exposure of its fixed‑rate debt and to stabilize cash‑flow earnings as rates rose, indicating a more aggressive and broader interest‑rate risk‑management strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All numbers are correct - $0.5 billion (2021) matches the ground truth's $500 million (same value, acceptable format variation), and $1.3 billion (2024) matches exactly. The calculation of the 2.6x increase (roughly 2½-fold) is mathematically accurate ($1.3B / $0.5B = 2.6x). The note about 2023 and 2024 both showing $1.3 billion is a helpful additional detail not contradicting the ground truth. ENTITY ACCURACY: Lockheed Martin correctly identified, years (2021-2024) correct, metric (variable interest rate swaps notional amount) correctly identified. MULTI-HOP REASONING: The answer successfully synthesizes the evolution of the swap amounts across the time period and connects this to strategic implications. The interpretation that this represents a shift toward converting fixed-rate to variable-rate borrowings aligns with the ground truth's characterization. The additional context about 'stabilize cash-flow earnings as rates rose' provides reasonable interpretation of the company's motivation, though this specific phrase isn't in the ground truth - it represents sound financial reasoning rather than an error. COMPLETENESS: The answer addresses both parts of the question - the evolution of notional amounts AND what it indicates about risk management strategy. MINOR CONSIDERATIONS: The LLM provides slightly more detailed interpretation (mentioning the 2023 figure, explaining the hedging rationale) which adds value without contradicting the ground truth. The characterization as 'more aggressive and broader' is a reasonable interpretation of the 2.6x increase, though the ground truth uses 'significant shift' - both convey similar meaning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 477,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did PayPal's approach to its Seller Protection Programs evolve between 2022 and 2023, particularly in terms of financial provisions for transaction losses?",
      "original_answer": "In 2022, PayPal acknowledged the risk of losses from its Seller Protection Programs and noted that historical loss rates ranged between 0.09% and 0.15% of TPV, with the potential for increased losses due to macroeconomic conditions such as the ongoing impacts of the COVID-19 pandemic. By 2023, PayPal provided more structured financial disclosures, showing that the allowance for transaction losses was $64 million (down from $66 million in 2022), indicating a slight decrease in expected losses. This shift reflects a more defined and quantified approach to managing seller protection risk in 2023 compared to the more qualitative risk assessment in 2022.",
      "llm_answer": "\nPayPal continued to record a specific allowance for the losses that arise from its Seller‑Protection programs, but the reserve was trimmed slightly—from **$66 million at the end of 2022 to $64 million at the end of 2023**—showing a modest reduction in the estimated transaction‑loss exposure.  At the same time the allowance for negative customer balances grew from **$212 million to $218 million**, reflecting the company’s ongoing adjustment of provisions as actual charge‑offs and recoveries changed.  (Pages 113 & 114).",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identified the key financial figures for the Seller Protection Programs allowance ($66M in 2022 declining to $64M in 2023), which matches the ground truth exactly. The directional assessment (slight decrease/modest reduction) is accurate. The LLM also provided additional context about negative customer balances ($212M to $218M), which adds relevant information about PayPal's broader financial provisions. WEAKNESSES: The LLM answer is incomplete in addressing the full scope of the question about how PayPal's 'approach' evolved. The ground truth emphasizes a critical distinction: in 2022, PayPal used qualitative risk assessment with historical loss rate ranges (0.09%-0.15% of TPV), while in 2023 it shifted to more structured/quantified financial disclosures. The LLM answer fails to capture this important methodological evolution - it only reports the numbers without explaining the shift from qualitative to quantified approaches. The LLM also omits the historical loss rate context (0.09%-0.15% of TPV) and the macroeconomic conditions (COVID-19 impacts) mentioned in the ground truth. MULTI-HOP REASONING: The LLM demonstrates basic synthesis by comparing 2022 and 2023 figures, but misses the deeper multi-hop reasoning about the evolution of PayPal's risk management approach and disclosure methodology. The answer is more of a numerical comparison than an explanation of how the approach evolved. CALCULATION VERIFICATION: The numbers are correct ($66M→$64M represents a $2M decrease), and the characterization as 'modest reduction' is appropriate. The additional data on negative customer balances appears accurate but wasn't part of the original question's focus.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 466,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Starbucks' derivative asset and liability positions in foreign currency - other change from fiscal year 2023 to fiscal year 2024, and what was the magnitude of this change on the balance sheet?",
      "original_answer": "In fiscal year 2023, Starbucks reported a derivative asset of $1,164 million under 'Foreign currency - other.' By fiscal year 2024, this amount significantly decreased to $1.9 million in derivative assets under the same category. Additionally, the derivative liability for 'Foreign currency - other' increased from $2.0 million in 2023 to $4.7 million in 2024. This indicates a major reduction in the company's foreign currency derivative assets and a moderate increase in liabilities tied to foreign currency over this period.",
      "llm_answer": "\nThe foreign‑currency‑other derivative asset fell from $54.9 million at the end of fiscal 2023 to $3.6 million at the end of fiscal 2024—a decline of $51.3 million—while the related derivative liability rose modestly from $2.3 million to $2.6 million (an increase of $0.3 million).  Thus the net balance‑sheet exposure to foreign‑currency‑other derivatives was reduced by roughly $51 million between the two fiscal years.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on all key numeric values. Ground truth shows: (1) Derivative assets in 'Foreign currency - other' decreased from $1,164 million (2023) to $1.9 million (2024), a decline of $1,162.1 million. The LLM reported $54.9 million declining to $3.6 million (a $51.3 million decline) - completely wrong numbers. (2) Derivative liabilities increased from $2.0 million (2023) to $4.7 million (2024), an increase of $2.7 million. The LLM reported $2.3 million to $2.6 million (a $0.3 million increase) - again, incorrect values. The LLM's calculation of the $51.3 million decline is mathematically correct given its stated numbers ($54.9M - $3.6M = $51.3M), but those underlying numbers are wrong. The magnitude of the actual change is vastly larger than reported - the asset position declined by over $1.16 billion, not $51 million. The LLM correctly identified the direction of changes (assets down, liabilities up) and appropriately addressed the question's structure about balance sheet impact, but the specific financial data is dramatically inaccurate. This represents a critical failure in extracting and reporting the correct figures from the source documents.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 338,
        "total_tokens": 1589
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did the financial impact of energy-related derivatives on natural gas cost and revenue hedging positions evolve from 2022 to 2023?",
      "original_answer": "In 2022, energy-related derivatives had a negative impact of $117 million on natural gas revenues and a $27 million negative impact on the cost of natural gas. In 2023, the impact shifted positively with a $59 million gain on the cost of natural gas, while the revenue impact remained neutral at $0. This indicates a transformation in the role and effectiveness of these derivatives in managing natural gas exposure.",
      "llm_answer": "\nIn 2022 the non‑designated energy derivatives produced a roughly **$117 million loss** on natural‑gas revenue hedging and a **$65 million loss** on the cost of natural gas, but by 2023 those positions flipped to a **$11 million loss** on revenue and a **$59 million gain** on cost—an improvement of about **$100 million** in the overall hedging result from 2022 to 2023.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "MAJOR QUANTITATIVE ERRORS: The LLM answer contains significant factual inaccuracies in the 2022 figures. Ground truth states: 2022 had a $117M negative impact on natural gas revenues (correct in LLM) and a $27M negative impact on cost of natural gas (LLM incorrectly states $65M loss). This is a critical error of $38M discrepancy. For 2023, the LLM states a $11M loss on revenue, but ground truth shows $0 (neutral impact) - another significant error. The 2023 cost of natural gas gain of $59M is correct. The LLM's calculation of a ~$100M improvement is therefore based on incorrect baseline numbers and is not verifiable from the ground truth data. REASONING ISSUES: While the LLM correctly identifies the general trend (derivatives flipping from negative to positive impact), the specific numbers used to support this conclusion are materially wrong. The multi-hop synthesis is attempted but undermined by factual errors in the underlying data points. COMPLETENESS: The answer addresses both years and both metrics (revenue and cost), but with incorrect values for 2022 cost impact and 2023 revenue impact. CONTEXTUAL RELEVANCE: The question is appropriately addressed in terms of structure and scope, but the execution fails due to numerical inaccuracy. The semantic intent of showing evolution/transformation is captured, but the specific financial impacts are misrepresented.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1193,
        "completion_tokens": 384,
        "total_tokens": 1578
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Walmart's treatment of its Deferred Compensation Matching Plan evolve between the 2023 and 2024 10-K filings, particularly in terms of its documentation status and effective date?",
      "original_answer": "In the 2023 10-K filing, the Deferred Compensation Matching Plan was newly introduced as 'Walmart Inc. Deferred Compensation Matching Plan, as amended and restated effective November 8, 2023.' By the 2024 10-K filing, the plan was no longer labeled as newly introduced but was instead referenced as being 'incorporated by reference' to the 2024 Annual Report on Form 10-K, indicating that it had become an established, ongoing plan. The effective date remained unchanged at November 8, 2023, suggesting no substantive changes to the plan’s implementation timeline, but its treatment shifted from being newly introduced to being formally integrated into the company's long-term compensation framework.",
      "llm_answer": "\nIn the 2023 Form 10‑K the Deferred Compensation Matching Plan was only referenced in its prior form (effective Nov 8 2022) and was not highlighted as a newly restated document. The 2024 filing revises the disclosure to note the plan as “amended and restated effective Nov 8 2023” and lists it as Exhibit 10.1, thereby documenting the amendment and moving the plan’s effective date forward to late 2023.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that directly contradict the ground truth. (1) CRITICAL DATE ERROR: The LLM states the prior form was 'effective Nov 8 2022' but the ground truth clearly indicates the effective date was November 8, 2023 in both filings - there is no 2022 date mentioned. This is a major quantitative error. (2) REVERSED NARRATIVE: The LLM claims the 2023 filing referenced the plan 'in its prior form' and was 'not highlighted as newly restated,' but the ground truth explicitly states the 2023 filing introduced it as 'newly introduced as Walmart Inc. Deferred Compensation Matching Plan, as amended and restated effective November 8, 2023.' The LLM has inverted the timeline. (3) DOCUMENTATION STATUS MISCHARACTERIZATION: The LLM suggests the 2024 filing 'revises the disclosure to note the plan as amended and restated effective Nov 8 2023' and lists it as Exhibit 10.1, but the ground truth indicates the 2024 filing references it as 'incorporated by reference' - not as a newly documented amendment. The LLM misidentifies how the plan was treated in 2024. (4) MISSING KEY INSIGHT: The LLM fails to capture the core evolution described in the ground truth - the shift from 'newly introduced' status in 2023 to 'incorporated by reference' in 2024, indicating integration into the company's established framework. (5) EFFECTIVE DATE CONSISTENCY: While the LLM correctly identifies that November 8, 2023 is the effective date in the 2024 filing, it incorrectly suggests this represents a 'forward' movement from 2022, when no 2022 date exists in the ground truth. The answer demonstrates fundamental misunderstanding of the filing progression and contains a critical date error that undermines all subsequent analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 477,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has the disclosure and treatment of LTIP Units evolved between 2023 and 2024, particularly in terms of their dilutive effect and accrual policy?",
      "original_answer": "In 2023, LTIP Units were described as potentially dilutive securities that are convertible into units and exchangeable for common stock, with no material dilutive effect reported for the years 2023, 2022, and 2021. The company stated it does not adjust net income attributable to common stockholders or weighted average shares outstanding due to no dilutive impact. In 2024, the disclosure simplified, stating that LTIP Units are potentially dilutive but again noting no material dilutive effect for the years 2024, 2023, and 2022. Additionally, the accrual policy remained consistent, stating that distributions are accrued when declared. The treatment of LTIP Units remained stable with no significant change in dilutive impact or accrual policy.",
      "llm_answer": "\nThe 2024 filing again describes LTIP units as “potentially dilutive securities” but, like the 2023 filing, explicitly states that they had **no material dilutive effect** for 2024, 2023 or 2022. Consequently, the company does **not adjust net income attributable to common stockholders or the weighted‑average share/unit count** for income allocable to those units, and it continues to **accrue dividends on the LTIP units when they are declared**—a policy that is unchanged between 2023 and 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. (1) CORRECTNESS: All factual claims are accurate - LTIP Units are correctly identified as potentially dilutive securities with no material dilutive effect for 2024, 2023, and 2022. The statement that the company does not adjust net income or weighted-average shares/units is correct. The accrual policy (distributions accrued when declared) is accurately stated. (2) QUANTITATIVE ACCURACY: No specific numbers or calculations are required for this question, but the years cited (2024, 2023, 2022) are all correct. The answer correctly identifies the temporal scope of the disclosure. (3) QUALITATIVE ACCURACY: The multi-hop reasoning is sound - the answer successfully synthesizes information about both the dilutive effect treatment AND the accrual policy across both 2023 and 2024 filings. The comparison between years is implicit and correct (no significant change). The answer properly identifies that the treatment remained 'stable' or 'unchanged,' which matches the ground truth statement that 'treatment remained stable with no significant change.' (4) SEMANTIC EQUIVALENCE: The LLM uses slightly different phrasing than the ground truth (e.g., 'accrue dividends on the LTIP units when they are declared' vs. 'distributions are accrued when declared'), but these are semantically equivalent. The use of 'dividends' vs. 'distributions' is a minor terminology variation that doesn't affect accuracy. (5) COMPLETENESS: The answer addresses all aspects of the question - disclosure evolution, dilutive effect, and accrual policy. The only minor observation is that the answer could have been slightly more explicit about the 2023 baseline for comparison, but this is a very minor point and doesn't detract from the overall quality. The answer is well-structured, clear, and factually sound.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 511,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has Meta's compliance approach to the EU-U.S. Data Privacy Framework (EU-U.S. DPF) evolved between 2023 and 2024, particularly in response to regulatory actions and decisions?",
      "original_answer": "In 2023, Meta was in the process of implementing steps to comply with corrective orders from the Irish Data Protection Commission (IDPC) following a EUR €1.2 billion fine and a directive to suspend unlawful data transfers to the U.S. under Standard Contractual Clauses (SCCs). At that time, the EU-U.S. DPF had just been finalized, and Meta viewed its implementation as a key milestone to address data transfer compliance. By 2024, Meta had implemented compliance measures with the corrective orders and was actively engaging with regulators on new compliance models, such as the 'subscription for no ads' alternative introduced in November 2023. In 2024, the European Commission opened formal proceedings into the compliance of this model with the Digital Markets Act (DMA), issuing preliminary findings in July 2024 that suggested non-compliance. This reflects a shift from foundational compliance with the EU-U.S. DPF framework to navigating more complex regulatory scrutiny around specific business models under evolving EU laws.",
      "llm_answer": "\nBetween 2023 and 2024 Meta shifted from merely adopting the new EU‑U.S Data Privacy Framework to actively reshaping how it transfers and uses European users’ data in response to regulator pressure.  After the Irish Data‑Protection Committee imposed a €1.2 bn fine and issued corrective orders (now under an interim stay), the European Commission opened formal DMA proceedings in March 2024 and, in July 2024, issued preliminary findings that Meta’s “subscription‑for‑no‑ads” model does not comply with the DMA’s consent requirements—prompting Meta to move behavioral advertising from “legitimate interests” to explicit consent and to offer a less‑personalized ad tier for users who remain on the free service.  These steps illustrate a clear evolution toward stricter consent‑based mechanisms, greater transparency, and structural changes to its ad‑targeting and data‑transfer practices to meet EU privacy and competition rules.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the €1.2 billion fine from the Irish Data Protection Commission. (2) Correctly dates the July 2024 preliminary findings from the European Commission regarding DMA non-compliance. (3) Accurately describes the 'subscription-for-no-ads' model as a key compliance response introduced in late 2023. (4) Properly synthesizes the evolution from foundational EU-U.S. DPF implementation to more complex regulatory scrutiny. (5) Correctly identifies the shift toward explicit consent mechanisms and less-personalized ad tiers. WEAKNESSES AND ERRORS: (1) The LLM states the European Commission opened 'formal DMA proceedings in March 2024,' but the ground truth only confirms July 2024 preliminary findings—the March 2024 date for formal proceedings initiation is not verified in the ground truth and appears to be an unsupported claim. (2) The LLM mentions corrective orders are 'under an interim stay,' which is not mentioned in the ground truth and may be inaccurate or speculative. (3) The ground truth emphasizes Meta's engagement with regulators on 'new compliance models' more broadly, while the LLM focuses heavily on the subscription model and consent mechanisms, potentially narrowing the scope. (4) The ground truth notes the directive to 'suspend unlawful data transfers to the U.S. under Standard Contractual Clauses (SCCs)' as a key 2023 context, which the LLM does not explicitly address. (5) The LLM's characterization of moving advertising from 'legitimate interests' to 'explicit consent' is a reasonable inference but not explicitly stated in the ground truth. MULTI-HOP REASONING: The LLM demonstrates sound multi-hop synthesis by connecting the 2023 fine/corrective orders to 2024 regulatory actions and business model changes. However, the introduction of unverified dates (March 2024) and the interim stay claim weaken the reasoning chain. QUANTITATIVE ACCURACY: The €1.2 billion figure is correct; the July 2024 date is correct. The March 2024 date for formal proceedings is questionable. OVERALL: The answer captures the essential evolution narrative but introduces factual claims not supported by the ground truth, particularly regarding timing and interim measures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1498,
        "completion_tokens": 595,
        "total_tokens": 2094
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has Linde's approach to green hydrogen production evolved between 2023 and 2024, particularly in terms of production methods and emphasis on renewable energy sources?",
      "original_answer": "In 2023, Linde described green hydrogen as being produced primarily through electrolysis using renewable energy or from steam methane reforming of biomethane, and it was presented as one of the company's clean energy offerings alongside blue hydrogen. By 2024, the company had expanded its description to emphasize green hydrogen as 'renewable hydrogen' produced by electrolysis using renewable energy and water as feedstock, and it was clearly differentiated from low-carbon (blue) hydrogen. Additionally, in 2024, Linde placed more emphasis on the carbon intensity metric to differentiate production methods, indicating a more refined and strategic framing of green hydrogen within the broader context of clean energy solutions.",
      "llm_answer": "\nBetween 2023 and 2024 Linde moved from a general description of “green” hydrogen as an emerging clean‑energy option to a concrete, renewable‑energy‑focused production strategy.  In the 2024 filing (pages 5‑6) the company details that green hydrogen is now produced *exclusively* by electrolysis powered by renewable electricity (wind, solar, hydro) and that it is expanding commercial‑scale electrolyzer projects and partnerships to secure dedicated renewable power, whereas the 2023 filing (page 4) only mentioned green hydrogen as one of several “clean‑energy” pathways without emphasizing the renewable‑energy source or the scale of deployment.  Consequently, Linde’s 2024 approach places a far greater emphasis on renewable‑energy‑driven electrolysis as the primary method for delivering green hydrogen.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "ASSESSMENT: The LLM answer contains both accurate and inaccurate elements when compared to the ground truth.\n\nCORRECT ELEMENTS:\n1. The LLM correctly identifies that Linde's approach evolved between 2023 and 2024\n2. The LLM correctly notes increased emphasis on renewable energy-driven electrolysis in 2024\n3. The LLM correctly identifies that 2024 shows more concrete/strategic framing compared to 2023\n4. The general direction of evolution (from general clean energy to renewable-focused) is accurate\n\nINCORRECT/PROBLEMATIC ELEMENTS:\n1. CRITICAL ERROR: The LLM states green hydrogen is produced \"exclusively\" by electrolysis in 2024. The ground truth explicitly states that in 2024, Linde described green hydrogen as produced \"by electrolysis using renewable energy and water as feedstock\" - but the ground truth for 2023 mentions \"steam methane reforming of biomethane\" as an alternative method. The LLM's claim of \"exclusively\" electrolysis is not supported and appears to overstate the exclusivity.\n2. MISSING KEY DETAIL: The LLM fails to mention that in 2023, green hydrogen could also be produced from \"steam methane reforming of biomethane\" - this is a significant omission that affects the completeness of the evolution narrative.\n3. MISSING METRIC: The ground truth emphasizes that in 2024, Linde placed \"more emphasis on the carbon intensity metric to differentiate production methods.\" The LLM answer completely omits this important strategic shift regarding carbon intensity metrics.\n4. UNSUPPORTED SPECIFICITY: The LLM cites specific page numbers (pages 5-6 for 2024, page 4 for 2023) and mentions \"commercial-scale electrolyzer projects and partnerships\" - these details cannot be verified against the ground truth and may be hallucinated.\n5. INCOMPLETE DIFFERENTIATION: The ground truth notes clear differentiation from \"low-carbon (blue) hydrogen\" in 2024, which the LLM mentions only tangentially.\n\nMULTI-HOP REASONING: The LLM attempts to synthesize the evolution across years but does so incompletely. It captures the renewable energy emphasis shift but misses the carbon intensity metric emphasis and oversimplifies the production method evolution.\n\nQUANTITATIVE ACCURACY: No specific numbers are provided in either answer, so this is not a primary concern. However, the LLM's claim of \"exclusive\" electrolysis production is a factual claim that appears incorrect.\n\nSEMANTIC EQUIVALENCE: While the LLM's general framing of increased renewable emphasis is semantically similar to the ground truth, the omission of biomethane reforming as a 2023 method and the complete absence of carbon intensity metrics represent significant semantic gaps.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 713,
        "total_tokens": 2103
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did Southern Company's relationship with Sequent evolve between 2022 and 2023, and what were the financial implications of this change?",
      "original_answer": "Southern Company's relationship with Sequent evolved from a business ownership relationship in 2022 to a completed divestiture in 2023. In 2022, Southern Company Gas completed the sale of Sequent to Williams Field Services Group for $159 million, recognizing a pre-tax gain of $121 million. Additionally, the sale resulted in $85 million of additional tax expense due to changes in state apportionment rates. By 2023, Sequent was no longer part of Southern Company's portfolio, and the financial impact of the sale was fully reflected in the company's financial statements, with the gain from the sale reported as a $121 million pre-tax benefit. This marked a complete transformation in the relationship, shifting from operational integration to full separation.",
      "llm_answer": "\nSouthern Company completed the sale of Sequent in July 2021, and by 2022 the wholesale‑gas services business—including Sequent—was removed from its segment reporting, leaving only the after‑tax gain of $92 million that had been recorded in 2021. In 2023 there were no further earnings or expenses from Sequent; the only financial impact was the residual tax effect of the transaction (an $85 million additional tax expense recognized in 2021 that continued to flow through subsequent periods).",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on multiple critical dimensions: (1) TIMING ERROR: The LLM states the sale was completed in July 2021, but the ground truth clearly indicates the sale occurred in 2022. This is a major factual error that undermines the entire answer. (2) FINANCIAL NUMBERS - CRITICAL ERRORS: The LLM reports an after-tax gain of $92 million, but the ground truth specifies a pre-tax gain of $121 million. These are different metrics and different amounts. The LLM also fails to mention the $159 million sale price. (3) TAX EXPENSE MISCHARACTERIZATION: The LLM states the $85 million additional tax expense was 'recognized in 2021 that continued to flow through subsequent periods,' but the ground truth indicates this was a 2022 event related to changes in state apportionment rates. (4) INCOMPLETE MULTI-HOP SYNTHESIS: The question asks about the evolution between 2022 and 2023. The ground truth shows: 2022 = sale completed with $121M pre-tax gain and $85M tax expense; 2023 = Sequent no longer in portfolio, financial impact fully reflected. The LLM fails to properly address the 2022-2023 evolution and instead focuses on 2021 events. (5) MISSING KEY INFORMATION: The LLM omits the $159 million sale price entirely, which is a crucial financial figure. (6) SEMANTIC CONFUSION: The LLM conflates pre-tax and after-tax gains, uses incorrect amounts, and misplaces events in time. The answer demonstrates a fundamental misunderstanding of when the transaction occurred and its financial implications.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 420,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has Walmart's relationship with the Allswell brand evolved between 2023 and 2024, and what does this indicate about its strategic positioning within the company's private brand portfolio?",
      "original_answer": "In 2023, Walmart introduced the Allswell brand as part of its private brand offerings, indicating its initial entry into the market. By 2024, the brand was not only retained but explicitly listed among other mature private brands like 'bettergoods,' 'Equate,' and 'Great Value,' suggesting that Allswell has transitioned from a newly introduced brand to a more established part of Walmart's private label strategy. This evolution indicates that Allswell has likely gained traction and is being positioned as a core component of Walmart’s private brand portfolio.",
      "llm_answer": "\nBetween fiscal 2023 and fiscal 2024 Walmart continued to list “Allswell” among its stable of private‑brand labels and highlighted it as part of the strategic merchandise units that underpin the company’s omni‑channel offering.  The filings show no shift away from the brand; instead, its inclusion alongside other private‑label lines (e.g., “Equate,” “Free Assembly”) underscores Walmart’s intent to leverage Allswell to broaden its differentiated, higher‑margin product assortment while reinforcing the value‑price promise that drives customer traffic.  This steady positioning reflects a deliberate strategy to deepen the role of private‑brand assets—like Allswell—within Walmart’s overall portfolio to enhance profitability and competitive differentiation.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core facts: (1) Allswell was introduced in 2023 as a new private brand, (2) it was retained and listed among other private brands in 2024, and (3) this indicates strategic positioning within Walmart's private brand portfolio. The answer demonstrates sound multi-hop reasoning by synthesizing information across fiscal years and connecting brand retention to strategic intent. However, there are some notable differences from the ground truth: (1) The LLM mentions 'Free Assembly' as a comparable brand, while the ground truth specifically lists 'bettergoods,' 'Equate,' and 'Great Value'—this is a minor discrepancy in the specific brands cited as examples, though the general concept of listing alongside other mature brands is correct. (2) The LLM adds interpretive language about 'higher-margin product assortment' and 'profitability and competitive differentiation' that goes beyond what the ground truth explicitly states, though this reasoning is plausible and not contradicted by the source material. (3) The ground truth uses the phrase 'transitioned from a newly introduced brand to a more established part,' while the LLM uses 'steady positioning' and 'deliberate strategy to deepen'—these are semantically similar but the LLM's language is slightly more interpretive. The quantitative accuracy is strong (no numerical errors), and the qualitative reasoning about strategic intent is sound, though the LLM adds some inferences beyond the ground truth's more conservative framing. The answer is contextually relevant and addresses the question comprehensively, but the inclusion of different brand examples and additional interpretive elements prevents a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 468,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has the strategic importance of Embedded Processing products evolved from 2022 to 2023 based on TXN's revenue composition and strategic emphasis?",
      "original_answer": "In 2022, Embedded Processing products were described as one of two core segments, positioned alongside Analog as a key part of the business, though no specific revenue figures were disclosed. By 2023, Embedded Processing remained a strategic focus area, and notably, it partially offset a decline in Analog revenue, contributing to a $17.52 billion total revenue. This indicates that while Embedded Processing maintained its strategic importance, it also played a more pronounced compensatory role in the revenue mix during a year of overall revenue decline.",
      "llm_answer": "\nFrom 2022 to 2023 the company’s total revenue fell 12.5 % to $17.5 billion, but the decline was “primarily due to lower revenue from Analog, partially offset by higher revenue from Embedded Processing.” This is the first explicit indication that Embedded Processing is now a growth‑offsetting segment, and the firm’s strategic narrative repeatedly stresses “designing and selling our products into the industrial and automotive markets, which we believe represent the best long‑term growth opportunities,” a focus that aligns directly with Embedded Processing’s role. Consequently, while Analog remains a core revenue source, Embedded Processing’s contribution has risen in strategic importance—it is now the primary engine propping up overall sales and a key pillar of the company’s long‑term growth plan.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy with minor issues. STRENGTHS: (1) Quantitative accuracy is excellent - the 12.5% revenue decline calculation is correct ($17.5B represents a decline from ~$20B in 2022), and the $17.5B figure matches the ground truth's $17.52B (acceptable rounding variation). (2) The core narrative is accurate: Embedded Processing did offset Analog's decline, and this represents a shift in strategic importance. (3) Multi-hop synthesis is sound - the answer correctly connects revenue composition data with strategic emphasis by citing the company's focus on industrial and automotive markets. (4) Entity identification is correct (TXN/Texas Instruments, Analog, Embedded Processing, 2022-2023 timeframe). WEAKNESSES: (1) The LLM characterizes Embedded Processing as 'now the primary engine propping up overall sales' which slightly overstates the case - the ground truth indicates it 'partially offset' the decline, not that it became the primary revenue engine. Analog remained a core revenue source. (2) The phrase 'growth-offsetting segment' is somewhat awkward phrasing, though semantically it captures the compensatory role. (3) Minor: The answer adds interpretive language about 'long-term growth plan' that goes slightly beyond what the ground truth explicitly states, though this is reasonable inference from strategic emphasis. The answer successfully addresses the evolution question by showing Embedded Processing moved from being 'one of two core segments' to playing a more pronounced compensatory/strategic role, which is the key insight. The quantitative data is accurate and the reasoning is sound.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 452,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How has Chevron's involvement in Angola LNG evolved from 2022 to 2024, and what does this indicate about its strategic positioning in the LNG market?",
      "original_answer": "In 2022, Chevron's involvement in Angola LNG was referenced in the context of its production volumes, indicating operational participation. By 2024, Chevron's stake in Angola LNG Limited was explicitly stated as a 36.4% interest, highlighting a more defined and structured investment approach. This evolution suggests a strategic shift toward securing a stable position in the LNG market through formalized equity stakes.",
      "llm_answer": "\nFrom 2022 through 2024 Chevron kept its 36.4 % stake in Angola LNG and directed roughly $0.8 billion of capital into offshore development and liquefaction projects in Angola, while still meeting long‑term delivery commitments for that gas.  The continued investment and the inclusion of Angola’s gas volumes in the company’s reserve and production outlooks show that Chevron is using Angola LNG as a core pillar of its LNG growth strategy—expanding lower‑carbon gas supplies to offset declining oil volumes and strengthen its position in the global LNG market.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ISSUES: (1) The LLM answer introduces a specific capital investment figure of '$0.8 billion' that is NOT present in the ground truth. This is a factual claim that cannot be verified against the original answer and represents potential hallucination. (2) The LLM claims Chevron 'kept its 36.4% stake...from 2022 through 2024' but the ground truth only explicitly states the 36.4% stake was mentioned in 2024, with 2022 described more vaguely as 'referenced in the context of production volumes.' The LLM is making an unsupported assumption about continuity of the stake across this period. (3) The LLM adds substantial strategic interpretation ('core pillar of LNG growth strategy,' 'expanding lower-carbon gas supplies to offset declining oil volumes') that goes beyond what the ground truth supports. While this reasoning may be sound, it exceeds the scope of verifiable information from the knowledge graph. CORRECT ELEMENTS: (1) The 36.4% stake figure is accurate. (2) The general characterization of Angola LNG as part of Chevron's LNG strategy is reasonable and aligns with the ground truth's mention of 'strategic shift toward securing a stable position in the LNG market.' (3) The multi-hop synthesis attempt is appropriate for the question structure. ASSESSMENT: The answer demonstrates understanding of the question's intent and provides relevant strategic context, but introduces unverified quantitative claims and makes assumptions about stake continuity that aren't explicitly supported by the ground truth. The $0.8 billion figure is particularly problematic as it's a specific number that cannot be confirmed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 447,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How has the financial contribution and production status of the CH-53K program evolved between 2021 and 2024, and what does this indicate about its role within Lockheed Martin's RMS division?",
      "original_answer": "In 2021, the CH-53K program contributed to a $540 million increase in RMS net sales, driven by higher production volume alongside the Black Hawk and CRH programs. Additionally, it contributed to a $140 million increase in operating profit due to higher risk retirements and production volume. By 2024, the CH-53K program was described as being in a 'production ramp-up' phase, contributing $1.1 billion to higher product sales within RMS, indicating a shift from early-stage production and risk retirement to a more mature, high-volume production phase. This evolution shows that the CH-53K has transitioned from a developing program with growing financial impact to a key growth driver within RMS.",
      "llm_answer": "\nFrom 2021 through 2024 the CH‑53K heavy‑lift helicopter was a clear growth driver for RMS: in 2021 it accounted for about $540 million of the $794 million (≈5 %) increase in RMS net sales and helped lift segment operating profit by $183 million (≈11 %) (pp. 45, 48); by 2024 RMS product sales had risen $1.1 billion, with the “higher production volume on the CH‑53K program” cited as a primary contributor to that gain and to the segment’s net‑sales rise to $17.26 billion (p. 34). This sustained contribution demonstrates that the CH‑53K is a cornerstone, high‑margin program that underpins revenue expansion and margin improvement within Lockheed Martin’s Rotary and Mission Systems division.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the CH-53K as a growth driver for RMS, accurately cites the 2021 contribution of $540 million to net sales increase, correctly notes the 2024 production ramp-up phase with $1.1 billion contribution, and properly synthesizes the evolution from developing to mature program. The answer appropriately references specific page numbers and demonstrates sound multi-hop reasoning across the 2021-2024 timeframe. The characterization of CH-53K as a 'cornerstone, high-margin program' aligns with the ground truth's assessment of it as a 'key growth driver.' CRITICAL ERRORS: (1) Operating profit discrepancy: LLM states CH-53K contributed to a '$183 million (≈11%)' increase in segment operating profit in 2021, but ground truth specifies '$140 million increase in operating profit.' This is a significant numerical error ($43 million difference, ~31% overstatement). (2) The LLM provides additional context about RMS net sales rising to $17.26 billion and calculates percentages (≈5%, ≈11%) that are not verified in the ground truth and may introduce unverified calculations. MINOR ISSUES: The LLM's characterization of the program as 'high-margin' is an inference not explicitly stated in the ground truth, though it's a reasonable interpretation. The answer is well-structured and contextually relevant but the operating profit number error is material and affects the quantitative accuracy score significantly. The core narrative about evolution from 2021 to 2024 is sound, but the specific financial metrics must be precise in financial analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 436,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did PayPal's use of macroeconomic factors in its loss curves for revolving consumer credit products evolve between 2022 and 2023?",
      "original_answer": "In 2022, PayPal applied macroeconomic factors such as forecasted trends in unemployment and benchmark credit card charge-off rates to its revolving consumer credit loss curves, using a single scenario deemed most appropriate for the economic conditions. By 2023, the company updated its expected credit loss models for revolving consumer receivables to include forecasted trends in household disposable income and retail e-commerce sales, replacing unemployment rates after the first quarter of 2023. This reflects a shift in the macroeconomic indicators used to inform loss curves for this segment.",
      "llm_answer": "\nBetween 2022 and 2023 PayPal extended the forecast horizon embedded in its revolving‑credit loss curves from roughly a **2‑year** period to **about 5 years 7 months** (the “reasonable and supportable” horizon for revolving products in 2023), and it broadened the macro‑economic inputs used.  In 2022 the models relied mainly on **unemployment trends and benchmark credit‑card charge‑off rates**, whereas the 2023 models added **household disposable‑income trends and retail‑e‑commerce sales** (with unemployment still considered through Q1 2023) while still drawing on a single external scenario.  This longer, more comprehensive macro‑economic framework was applied to the 2023 loss‑curve calculations, though the company noted the changes did not materially affect the 2023 provision.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core evolution in PayPal's macroeconomic factors between 2022 and 2023, capturing the shift from unemployment and credit card charge-off rates to household disposable income and retail e-commerce sales. The qualitative aspects of the answer are sound - the multi-hop reasoning correctly synthesizes the changes across years and identifies the key metrics involved.\n\nHowever, there are significant quantitative accuracy issues:\n\n1. FORECAST HORIZON CLAIMS: The LLM introduces specific quantitative claims about forecast horizons (\"2-year period\" in 2022 and \"about 5 years 7 months\" in 2023) that are NOT present in the ground truth answer. The ground truth makes no mention of these specific time periods. This represents an unsupported quantitative claim that cannot be verified against the original answer.\n\n2. MISSING VERIFICATION: The ground truth does not provide information about forecast horizon changes, so the LLM appears to have added information not in the source material or is conflating different aspects of the disclosure.\n\n3. CORRECT ELEMENTS: The LLM correctly identifies:\n   - 2022 used unemployment trends and benchmark credit card charge-off rates\n   - 2023 added household disposable income and retail e-commerce sales\n   - Unemployment was still considered through Q1 2023\n   - A single external scenario was used\n   - The changes did not materially affect the 2023 provision\n\n4. SEMANTIC ALIGNMENT: The core narrative about the evolution of macroeconomic factors is semantically equivalent to the ground truth, but the addition of unsupported quantitative claims about forecast horizons introduces factual uncertainty.\n\nThe answer demonstrates good qualitative reasoning and contextual relevance but fails on quantitative accuracy due to the introduction of specific time period claims that cannot be verified against the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 519,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did Starbucks' foreign currency debt-related gains or losses included in AOCI change from 2023 to 2024, and what does this indicate about the company's exposure to foreign currency fluctuations?",
      "original_answer": "In 2023, Starbucks reported a foreign currency debt-related loss of $6.3 million included in OCI before reclassifications, while in 2024, the company reported a gain of $135.2 million in AOCI related to foreign currency debt. This indicates a significant shift from a loss to a substantial gain, suggesting a reversal in the company's exposure to foreign currency fluctuations over this period.",
      "llm_answer": "\nThe foreign‑currency‑debt gains that were recorded in AOCI fell from **$140.2 million at the end of fiscal 2023** to **$135.2 million at the end of fiscal 2024** – a decline of roughly **$5 million**.  This reduction shows that the company’s hedges on its foreign‑currency‑denominated long‑term debt generated smaller unrealized gains, indicating either a modest decrease in foreign‑exchange exposure or less favorable foreign‑currency movements compared with the prior year.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that contradict the ground truth. (1) CRITICAL NUMBER ERROR: The LLM states the 2023 figure was $140.2 million, but the ground truth clearly indicates it was a LOSS of $6.3 million. This is a major discrepancy - the LLM appears to have confused the ending balance with the year-over-year change. (2) The LLM correctly identifies the 2024 figure as $135.2 million, which matches the ground truth. (3) CALCULATION ERROR: The LLM calculates a $5 million decline ($140.2M - $135.2M), but this calculation is based on the incorrect 2023 starting figure. The actual change from 2023 to 2024 is from a $6.3 million LOSS to a $135.2 million GAIN - a swing of approximately $141.5 million, not a $5 million decline. (4) INTERPRETATION ERROR: The ground truth emphasizes a 'significant shift from a loss to a substantial gain,' indicating a reversal in foreign currency exposure. The LLM instead describes a modest decline in unrealized gains, which is a fundamentally different and incorrect interpretation. (5) MULTI-HOP REASONING: The LLM failed to properly synthesize the year-over-year comparison. It appears to have misidentified what the 2023 figure represents (possibly confusing it with a balance sheet amount rather than the OCI/AOCI change). (6) The LLM's conclusion about 'less favorable foreign-currency movements' contradicts the ground truth's indication of a reversal from loss to gain. The answer demonstrates a critical misunderstanding of the underlying data and fails to address the key insight about the company's changing exposure to foreign currency fluctuations.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1230,
        "completion_tokens": 445,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did the fair value of energy-related derivatives for Alabama Power and Georgia Power change between 2022 and 2023, and what was the overall trend in their combined liabilities related to these derivatives?",
      "original_answer": "In 2022, Alabama Power reported a net liability of $144 million related to derivatives in non-designated hedging relationships, including energy-related derivatives. In 2023, Alabama Power had $15 million in assets and $110 million in liabilities related to energy-related derivatives, resulting in a net liability of $95 million. Georgia Power had $13 million in assets and $124 million in liabilities related to energy-related derivatives in 2023, yielding a net liability of $111 million. Therefore, the combined net liability for energy-related derivatives across both entities decreased from $255 million in 2022 to $206 million in 2023, indicating a reduction in exposure.",
      "llm_answer": "\nThe liability associated with energy‑related derivatives fell sharply for both utilities.  According to the fair‑value tables, Alabama Power’s derivative liability dropped from **$210 million in 2022 (page 280)** to **$110 million in 2023 (page 281)**, and Georgia Power’s liability fell from **$358 million to $124 million** over the same period.  Consequently, the combined liability of the two companies was **$568 million in 2022** and **$234 million in 2023**, showing a clear downward trend in their exposure to energy‑related derivatives.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors in nearly all numeric values and calculations. Detailed verification: (1) ALABAMA POWER: LLM claims $210M liability in 2022 and $110M in 2023. Ground truth shows 2022 net liability of $144M (not $210M) and 2023 net liability of $95M (not $110M). The LLM appears to have cited only the liability component without netting assets, which is methodologically incorrect for this analysis. (2) GEORGIA POWER: LLM claims $358M in 2022 and $124M in 2023. Ground truth shows no 2022 figure provided but 2023 net liability of $111M (not $124M as a net figure). The $124M cited appears to be the gross liability component only. (3) COMBINED TOTALS: LLM calculates $568M (2022) and $234M (2023). Ground truth shows $255M (2022) and $206M (2023). The LLM's combined figures are substantially overstated - off by $313M in 2022 and $28M in 2023. (4) METHODOLOGY ERROR: The LLM appears to have confused gross liability amounts with net liability positions. The ground truth properly nets assets against liabilities to determine net exposure, while the LLM seems to have used only liability figures. (5) TREND ANALYSIS: While both answers correctly identify a downward trend, the magnitude of the trend is misrepresented due to incorrect base numbers. The actual reduction was from $255M to $206M ($49M decrease), not from $568M to $234M ($334M decrease). The LLM's answer fails on quantitative accuracy due to fundamental errors in identifying and calculating the correct net liability positions for both companies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 426,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did Walmart's financial relationship with Alert Innovation evolve between fiscal 2023 and fiscal 2024, particularly in terms of acquisition and subsequent disposition activities?",
      "original_answer": "In fiscal 2023, Walmart completed a $0.4 billion acquisition of Alert Innovation, bringing its ownership to approximately 100%. However, in fiscal 2024, Walmart sold and deconsolidated the Alert Innovation entity, signaling a complete exit from the investment. This represents a full evolution from acquisition to divestiture within a one-year span.",
      "llm_answer": "\nBetween fiscal 2023 and fiscal 2024, Walmart moved from a partial‑ownership position to 100 % ownership of Alert Innovation—completing a $0.4 billion acquisition (and a concurrent buy‑out of Massmart’s non‑controlling interest) that was disclosed in the 2023 filing.  The 2024 filing notes no further purchase or sale of Alert Innovation; it simply reports the investment as a fully consolidated subsidiary, with the actual disposition later occurring in fiscal 2025 when the entity was sold and de‑consolidated.",
      "correctness_score": 4,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. CRITICAL ERRORS: (1) The LLM states the disposition occurred in fiscal 2025, but the ground truth explicitly states it occurred in fiscal 2024. This is a fundamental misunderstanding of the question's scope and the actual timeline. (2) The LLM claims the 2024 filing shows 'no further purchase or sale of Alert Innovation' and that it was 'simply reported as a fully consolidated subsidiary,' which directly contradicts the ground truth that states Walmart 'sold and deconsolidated the Alert Innovation entity' in fiscal 2024. CORRECT ELEMENTS: (1) The $0.4 billion acquisition amount is correct. (2) The achievement of 100% ownership is correct. (3) The mention of Massmart's non-controlling interest buy-out is a reasonable contextual detail. REASONING ISSUES: The LLM failed to properly synthesize the multi-hop information across fiscal years. The question specifically asks about the evolution 'between fiscal 2023 and fiscal 2024,' and the ground truth clearly indicates both the acquisition (fiscal 2023) and the complete exit/divestiture (fiscal 2024) occurred within this timeframe. The LLM's assertion that disposition occurred in fiscal 2025 represents a failure to answer the actual question asked. The quantitative accuracy score reflects that the dollar amount is correct, but the qualitative accuracy is low because the core narrative about when the disposition occurred is fundamentally wrong, making the entire answer misleading despite some correct individual facts.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 431,
        "total_tokens": 1655
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did the regulatory approval status of Trodelvy evolve between 2022 and 2023, and what does this indicate about Gilead's oncology strategy?",
      "original_answer": "In 2022, Trodelvy was part of Gilead's marketed product portfolio and contributed to growth in the oncology franchise, though no specific regulatory updates were mentioned. By 2023, Trodelvy received both FDA and EC approvals for the treatment of adult patients with unresectable locally advanced or metastatic HR+/HER2- breast cancer who had received prior endocrine-based therapy and at least two additional systemic therapies. This regulatory progress indicates a strategic focus by Gilead on expanding the therapeutic applications of Trodelvy and strengthening its position in the oncology market, particularly in breast cancer treatment.",
      "llm_answer": "\nBetween 2022 and 2023 Trodelvy’s FDA status evolved from an **accelerated‑approval** label (granted in 2022 for metastatic triple‑negative breast cancer and for metastatic urothelial cancer) to a **new full approval** in 2023 for unresectable locally advanced or metastatic HR⁺/HER2‑ breast cancer after prior endocrine therapy and systemic treatment.  This expansion into a distinct solid‑tumor indication reflects Gilead’s oncology strategy of **broadening Trodelvy’s target portfolio to capture additional high‑unmet‑need cancer markets**, thereby diversifying its oncology revenue stream and reinforcing its focus on antibody‑drug‑conjugate growth.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) FACTUAL ERRORS ON ACCELERATED APPROVAL: The LLM claims Trodelvy received accelerated approval in 2022 for metastatic triple-negative breast cancer (TNBC) and urothelial cancer. The ground truth does not mention these 2022 approvals - it only states Trodelvy was 'part of Gilead's marketed product portfolio' in 2022 with no specific regulatory updates mentioned. The LLM appears to have introduced information not supported by the ground truth. (2) APPROVAL TYPE CONFUSION: The LLM distinguishes between 'accelerated approval' (2022) and 'full approval' (2023), but the ground truth simply states that by 2023, Trodelvy received 'FDA and EC approvals' for HR+/HER2- breast cancer without specifying the approval pathway or contrasting it with prior approvals. (3) INDICATION ACCURACY: The LLM correctly identifies the 2023 approval for HR+/HER2- breast cancer with prior endocrine therapy and systemic treatments, which matches the ground truth. However, the claim about TNBC and urothelial cancer approvals in 2022 is not supported. (4) STRATEGIC INTERPRETATION: The LLM's interpretation about broadening Trodelvy's portfolio and ADC strategy is reasonable inference, but the ground truth more conservatively states it indicates 'expanding therapeutic applications' and 'strengthening position in oncology market, particularly in breast cancer treatment.' The LLM adds unsupported specificity about 'diversifying revenue stream' and 'ADC growth focus.' (5) MULTI-HOP REASONING: The LLM failed to properly synthesize the available information - it introduced claims about prior approvals that contradict the ground truth's statement that 'no specific regulatory updates were mentioned' for 2022. This is a critical factual error that undermines the entire answer's credibility.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 490,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How has Simon Property Group's financial relationship with ABG evolved between 2023 and 2024, particularly in terms of capital transactions and strategic positioning?",
      "original_answer": "In 2023, Simon Property Group (SPG) engaged in multiple capital transactions with ABG, including recognizing a non-cash pre-tax gain of $36.4 million from a dilution of ownership in ABG during the second quarter and an additional $145.8 million gain in the third quarter due to further dilution from SPARC Group issuing equity. Additionally, SPG had a long-standing strategic partnership with ABG dating back to 2021, involving licensing ventures such as Forever 21, Brooks Brothers, and Eddie Bauer, which resulted in significant gains. In 2024, SPG no longer reported active capital transactions with ABG, such as gains from dilution or new equity investments. Instead, the 2024 filing only referenced historical transactions, such as the 2021 sale of a portion of SPG’s ABG interest for a pre-tax gain of $18.8 million and the 2022 acquisition of Reebok assets alongside a strategic partnership. This indicates a shift from active financial engagement and restructuring with ABG in 2023 to a more stable, historically referenced relationship in 2024.",
      "llm_answer": "\nBetween 2023 and 2024 Simon Property Group’s stake in ABG moved from a series of dilutive capital events that produced recurring non‑cash gains to a complete exit.  In 2023 the company recorded multiple deemed‑disposal gains (e.g., $10.3 M in Q4‑23, $12.4 M in Q3‑23, $36.4 M in Q2‑23 and a $145.8 M gain from a SPARC equity issuance) as ABG’s capital transactions reduced its ownership to roughly 9‑10 % and generated deferred‑tax expenses.  In early 2024 it sold the remaining ABG interest for $1.2 billion cash, recognizing a $414.8 million pretax gain, thereby ending the partnership and reallocating the proceeds toward other growth initiatives such as the additional 4 % acquisition in TRG.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains multiple critical factual errors that fundamentally contradict the ground truth:\n\n1. MAJOR FACTUAL ERROR - Complete Exit Claim: The LLM states SPG sold its remaining ABG interest for $1.2 billion in early 2024 and ended the partnership. The ground truth explicitly states that in 2024, SPG 'no longer reported active capital transactions with ABG' and only 'referenced historical transactions.' There is NO mention of a $1.2 billion sale or complete exit in 2024 in the ground truth.\n\n2. QUANTITATIVE ERRORS - Gain Amounts: The LLM lists Q4-23 gain as $10.3M and Q3-23 as $12.4M. The ground truth only mentions Q2-23 ($36.4M) and Q3-23 ($145.8M from SPARC). The Q4-23 and Q3-23 figures cited by LLM are not in the ground truth and appear fabricated.\n\n3. MISSING KEY INFORMATION: The LLM completely omits the strategic partnership context (Forever 21, Brooks Brothers, Eddie Bauer licensing ventures) that was central to the 2023 relationship described in the ground truth.\n\n4. INCORRECT NARRATIVE: The LLM characterizes the evolution as moving to a 'complete exit' with a $414.8M gain and reallocation to TRG acquisition. None of these details appear in the ground truth, which describes a shift from 'active financial engagement' to a 'more stable, historically referenced relationship.'\n\n5. MULTI-HOP REASONING FAILURE: The LLM failed to correctly synthesize the 2023 vs 2024 comparison. The ground truth shows 2023 had active gains from dilution events, while 2024 only referenced historical transactions - not an exit.\n\n6. DEFERRED TAX MENTION: While the LLM mentions deferred-tax expenses, the ground truth does not discuss this, suggesting potential hallucination or confusion with other filings.\n\nThe answer is fundamentally incorrect on the core claim (complete exit in 2024) and contains multiple unsupported numerical claims.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 507,
        "total_tokens": 1949
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did Chevron's relationship with Chevron Phillips Chemical Company LLC evolve between 2022 and 2024, particularly in terms of financial reporting and investment value?",
      "original_answer": "In 2022, Chevron Phillips Chemical Company LLC was included in Chevron’s consolidated financial disclosures, specifically in Note 8 on page 70 of the 10-K filing, indicating it was a consolidated subsidiary. By 2024, the company was reported as an equity method investee under 'Downstream' in the Investments and Advances section, with a disclosed investment value of $8,571 million as of December 31, 2024, up from $7,765 million in 2023. This reflects a shift from full consolidation to an equity method investment, suggesting a structural or ownership change in Chevron’s relationship with the entity.",
      "llm_answer": "\nChevron’s equity investment in Chevron Phillips Chemical Company LLC grew from roughly **$7.8 billion at the end of 2023 to $8.6 billion at the end of 2024** (the balance was essentially unchanged between 2022 and 2023), as shown in Note 15 of the 2024 10‑K where the Downstream segment’s “Investments and Advances” line item lists $8,571 million for 2024 versus $7,765 million for 2023.  Consequently, equity‑method earnings from CPC rebounded to **$903 million in 2024** after falling to **$608 million in 2023** (and had been $867 million in 2022), with the investment and its earnings now reported as part of the Downstream segment’s assets and segment‑wide asset totals.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identified the key financial figures ($7,765 million in 2023 and $8,571 million in 2024) and accurately noted the growth in investment value. The equity method earnings figures ($903M in 2024, $608M in 2023, $867M in 2022) appear reasonable and add valuable context. The reference to Note 15 and the Downstream segment is appropriate. CRITICAL WEAKNESSES: (1) The LLM completely missed the most important aspect of the ground truth answer - the fundamental shift from CONSOLIDATED subsidiary status in 2022 to EQUITY METHOD investee by 2024. This is a major structural change in the relationship that the question specifically asks about ('how did the relationship evolve'). The ground truth explicitly states this shift was documented in Note 8 (2022) versus the Investments and Advances section (2024). (2) The LLM's statement that 'the balance was essentially unchanged between 2022 and 2023' is not supported by the ground truth, which does not provide 2022 investment value data for comparison in the same format. (3) The LLM failed to address the consolidation-to-equity-method transition, which is the core evolution of the relationship. QUANTITATIVE VERIFICATION: The 2023-2024 figures ($7,765M to $8,571M) are correct. The earnings figures cannot be fully verified from the ground truth provided but appear plausible. MULTI-HOP REASONING: The LLM provided financial data synthesis but failed to synthesize the structural/accounting change that is central to understanding the relationship evolution. The answer reads as a financial performance update rather than an explanation of how the relationship fundamentally changed. SEMANTIC ISSUE: The question asks about evolution 'particularly in terms of financial reporting and investment value' - the LLM addressed investment value but completely omitted the financial reporting change (consolidation vs. equity method), which is arguably the more significant evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 528,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did the status and financial impact of Meta's Facilities Consolidation Strategy evolve between the end of 2023 and the end of 2024?",
      "original_answer": "At the end of 2023, Meta had 'substantially completed' its facilities consolidation initiatives as part of the 2022 Restructuring, indicating the process was still ongoing. By the end of 2024, the company reported that it had 'completed the 2022 restructuring initiatives,' which included the facilities consolidation strategy, showing the process had reached full completion. Additionally, the 2024 disclosure included a financial summary of the 2022 Restructuring pre-tax charges across three years (2022–2024), indicating a retrospective quantification of the financial impact that was not explicitly detailed in 2023.",
      "llm_answer": "\nBy the end of 2024 Meta had essentially completed its 2022 facilities‑consolidation program—sub‑leasing or early‑terminating the targeted office buildings and finishing the related lease‑exit accounting—so the initiative was no longer an active restructuring effort.  In 2024 the company recorded a $5.19 billion pre‑tax charge for facilities consolidation (comprising $362 m of cost‑of‑revenue, $3.15 billion of R&D, $854 m of marketing and $828 m of G&A expenses), which reflects the final lease‑termination costs and remaining impairments, whereas at the end of 2023 it had only recognized $2.43 billion of impairment losses on impaired lease ROU assets and was still incurring exit‑cost charges.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides relevant qualitative information about the evolution of Meta's facilities consolidation strategy between 2023 and 2024, correctly capturing that the initiative moved from 'substantially completed' to 'completed' status. The answer appropriately describes the shift from an active restructuring effort to a concluded program, and correctly identifies the types of activities involved (sub-leasing, early termination, lease-exit accounting). However, there are significant quantitative accuracy issues that prevent a higher score: (1) The LLM provides specific 2024 charge figures ($5.19 billion total, with $362M cost-of-revenue, $3.15B R&D, $854M marketing, $828M G&A) that cannot be verified against the ground truth, which does not provide these specific breakdowns. (2) The LLM cites a $2.43 billion impairment loss figure for end of 2023 that is not mentioned in the ground truth. (3) The ground truth emphasizes that 2024 included 'a financial summary of the 2022 Restructuring pre-tax charges across three years (2022–2024)' but the LLM only discusses 2024 charges, missing the multi-year retrospective quantification aspect. (4) The LLM's specific numerical claims appear to be fabricated or from sources not in the ground truth, creating factual accuracy concerns. The qualitative reasoning about status progression is sound and well-articulated, and the answer is contextually relevant to the question asked. The core conceptual evolution (substantially completed → completed) is captured correctly, but the introduction of unverified specific financial figures significantly undermines the answer's reliability.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 450,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How has Lockheed Martin's involvement in hypersonics programs evolved from 2022 to 2024, particularly in terms of strategic focus and program status?",
      "original_answer": "In 2022, Lockheed Martin's involvement in hypersonics programs was described as a key growth area that was dependent on U.S. Government authorization and funding, indicating that the programs were still in a development phase with uncertain future funding. By 2024, the company was actively producing hypersonic strike weapons under multiple programs with the U.S. Air Force and Army, showing a shift from a funding-dependent future initiative to an active production program. This evolution reflects a significant advancement in the maturity and strategic importance of hypersonics within Lockheed Martin's portfolio.",
      "llm_answer": "\nFrom 2022 through 2024 Lockheed Martin shifted its hypersonics work from early‑stage technology maturation toward engineering‑manufacturing development and low‑rate production, concentrating on strike‑weapon systems for the U.S. Army and Navy (e.g., the ARRW/Conventional Prompt Strike and related Army hypersonic programs).  By 2024 the company reports that these efforts are in the advanced‑prototype/low‑rate‑initial‑production phase, with flight‑test milestones scheduled for the mid‑2020s and ongoing work to resolve supply‑chain and funding uncertainties.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures the general evolution of Lockheed Martin's hypersonics programs from 2022 to 2024, showing progression toward production. However, there are significant discrepancies with the ground truth:\n\n1. ENTITY ACCURACY ISSUES: The LLM mentions 'U.S. Army and Navy' while the ground truth specifies 'U.S. Air Force and Army.' This is a factual error in identifying the correct military branches involved. The mention of ARRW/Conventional Prompt Strike adds specificity not in the ground truth, which could be accurate but cannot be verified against the provided source.\n\n2. CHARACTERIZATION DIFFERENCES: The ground truth describes a shift from 'funding-dependent future initiative' to 'active production program,' emphasizing the maturity change. The LLM describes a more technical progression (early-stage technology maturation → engineering-manufacturing development → low-rate production) with additional details about flight-test milestones and supply-chain uncertainties. While this is more detailed, it introduces information not explicitly confirmed in the ground truth.\n\n3. COMPLETENESS: Both answers address the 2022-to-2024 evolution and strategic focus shift. The LLM provides more granular technical detail about development phases, but the ground truth emphasizes the shift from uncertain funding to active production as the key evolution.\n\n4. QUANTITATIVE ACCURACY: No specific numbers, dates, or dollar amounts are provided in either answer, so this dimension is neutral. However, the LLM's reference to 'mid-2020s' flight-test milestones is vague and cannot be verified.\n\n5. MULTI-HOP REASONING: Both answers correctly synthesize information across the 2022-2024 timeframe. The LLM's reasoning about development phases is logical but adds interpretive layers not in the ground truth.\n\n6. KEY DISCREPANCY: The mention of 'Navy' instead of 'Air Force' is a material factual error that reduces confidence in the answer's accuracy, suggesting potential hallucination or confusion about program details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 549,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did Southern Company's treatment and disclosure of energy-related derivatives evolve from 2022 to 2023, particularly in terms of their designation and financial impact?",
      "original_answer": "In 2022, Southern Company reported the pre-tax effects of unrealized derivative gains (losses) from energy-related derivatives that were designated as regulatory hedging instruments and deferred. By 2023, the company expanded its disclosure to include the pre-tax effects of energy-related derivatives not designated as hedging instruments on its statements of income, covering the years 2023, 2022, and 2021. This indicates a shift from focusing only on regulatory hedging instruments to providing a broader view of its energy-related derivative activities.",
      "llm_answer": "\nSouthern Company continued to separate its energy‑related derivatives into two groups: those that are formally designated as cash‑flow or fair‑value hedges and those that are not.  In the 2023 income statement the derivatives **not** designated as hedges generated a **$59 million pre‑tax gain**, reversing the **$76 million pre‑tax loss** recorded in 2022, while the designated hedge portfolio showed a modest contraction – the fair‑value hedge adjustment on long‑term debt fell from $282 million (2022) to $235 million (2023) and the net asset balance of designated cash‑flow/fair‑value hedges dropped from $141 million to $32 million, with liabilities rising to $659 million.  This shift reflects both a change in the realized financial impact of the non‑designated derivatives and a re‑balancing of the company’s designated hedge positions between 2022 and 2023.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides specific financial numbers and demonstrates understanding of the evolution of Southern Company's derivative treatment, but contains significant quantitative accuracy issues that undermine the response. STRENGTHS: (1) Correctly identifies the shift from regulatory hedging instruments to broader disclosure including non-designated derivatives; (2) Appropriately distinguishes between designated and non-designated derivatives; (3) Captures the conceptual evolution from 2022 to 2023; (4) Provides relevant context about fair-value hedge adjustments and asset/liability balancing. CRITICAL ISSUES: (1) The specific dollar amounts cited ($59M gain in 2023, $76M loss in 2022, $282M fair-value adjustment, $235M adjustment, $141M to $32M asset balance, $659M liabilities) cannot be verified against the ground truth, which does not provide these specific numbers. The ground truth only states that the company 'reported the pre-tax effects' and 'expanded its disclosure' without quantifying these effects; (2) The LLM introduces precise figures that may or may not be accurate - this is a major concern for financial data where precision is critical; (3) The ground truth emphasizes a shift in DISCLOSURE APPROACH (from regulatory hedging focus to broader view), while the LLM emphasizes FINANCIAL IMPACT CHANGES - these are related but distinct concepts. MULTI-HOP REASONING: The LLM correctly synthesizes information about how derivative treatment evolved across years, but the specific numbers provided create uncertainty about factual accuracy. The reasoning about re-balancing and portfolio shifts is sound IF the numbers are correct, but cannot be verified. RECOMMENDATION: Without access to the actual 10-K filings to verify the specific dollar amounts, the quantitative accuracy cannot be confirmed. The conceptual understanding is solid, but the introduction of unverified specific numbers significantly reduces confidence in the answer's correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 534,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did Gilead's intellectual property strategy regarding Truvada evolve between 2022 and 2023, particularly in terms of patent disclosures?",
      "original_answer": "In 2022, Gilead highlighted the October 2020 loss of exclusivity of Truvada in the United States as a transitory headwind, indicating that the product was no longer protected under patent, which likely affected revenue. In 2023, Gilead provided structured disclosures regarding the patent expiration dates of its principal products, including Truvada, focusing on the actual or estimated expiration dates in the U.S. and the EU. This represents a shift from acknowledging a past loss of exclusivity to proactively disclosing future intellectual property timelines for key products.",
      "llm_answer": "\nBetween 2022 and 2023 Gilead did not introduce any new patent‑term extensions or additional exclusivity for Truvada; the company’s 10‑K filings kept the same expiration profile—U.S. composition‑of‑matter protection and EU market‑exclusivity listed for 2030 (with only a six‑month pediatric extension for Veklury, not Truvada). The 2022 filing (page 6) disclosed the 2030 expiry and noted ongoing patent‑litigation settlements for TAF‑containing products, while the 2023 filing (page 6) retained the identical 2030 dates and offered no new disclosures or extensions for Truvada, indicating that the IP strategy for this product remained unchanged.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misses the core evolution described in the ground truth. Key issues: (1) FACTUAL ERRORS: The LLM claims both 2022 and 2023 filings listed 2030 expiration dates for Truvada, but the ground truth indicates the 2022 filing referenced the October 2020 loss of exclusivity (past event), not a 2030 date. The LLM conflates different products and timelines. (2) MISUNDERSTANDING OF EVOLUTION: The ground truth describes a strategic shift from acknowledging past loss of exclusivity (2022) to proactively disclosing future IP timelines (2023). The LLM incorrectly claims the strategy 'remained unchanged' and that there were 'no new disclosures,' which directly contradicts the ground truth's description of a shift in disclosure approach. (3) INCOMPLETE SYNTHESIS: The LLM fails to capture the multi-hop reasoning required: comparing how Gilead discussed Truvada's IP status differently across the two years. Instead, it focuses on patent extensions and litigation settlements that are not central to the question. (4) NUMERIC INACCURACY: The LLM references specific page numbers (page 6) and dates (2030) without verification against the actual ground truth data, and these appear to be incorrect or misapplied. (5) MISSING CONTEXT: The LLM does not address the key distinction between discussing a past loss of exclusivity versus proactively disclosing future expiration timelines, which is the essence of the 'evolution' the question asks about. The answer demonstrates a fundamental misunderstanding of what changed between 2022 and 2023 in Gilead's IP disclosure strategy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 445,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did SPG's use of the Supplemental Facility evolve between 2022 and 2024, particularly in terms of borrowing and repayment activities?",
      "original_answer": "In 2022, SPG borrowed $1.05 billion under the Supplemental Facility in January 2022, which was used to fund the early extinguishment of nine mortgages with a principal balance of $1.16 billion. This borrowing was repaid shortly after issuance. By 2024, SPG again utilized the Supplemental Facility, borrowing €750.0 million ($815.4 million U.S. dollar equivalent) in November 2023, which was repaid on November 17, 2023. Additionally, in 2024, SPG issued new senior unsecured notes to redeem other outstanding notes at maturity, indicating a shift in financing strategy. The evolution shows a continued reliance on the Supplemental Facility for short-term financing needs but with a more structured approach to repayment and refinancing.",
      "llm_answer": "\nBetween 2022 and 2024 the Supplemental Facility shifted from a source of new borrowing to a facility that was actively retired.  After drawing $1.05 billion in December 2021 and repaying it in January 2022, the company later used the proceeds of a €750 million bond issuance (November 2023) to settle the remaining €750 million of borrowings under the Supplemental Facility, leaving essentially no outstanding balance at year‑end 2024 while preserving the $3.5‑$4.5 billion capacity for future use.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains several significant factual errors that undermine its credibility:\n\n1. CRITICAL DATE ERROR: The LLM states the company 'drew $1.05 billion in December 2021 and repaid it in January 2022.' The ground truth clearly states this borrowing occurred in January 2022, not December 2021. This is a fundamental factual error.\n\n2. INCOMPLETE/INACCURATE 2022 INFORMATION: The ground truth specifies that the $1.05 billion borrowed in January 2022 was used to fund early extinguishment of nine mortgages with a principal balance of $1.16 billion. The LLM completely omits this critical context about the purpose and use of the borrowing.\n\n3. TIMING ERROR FOR 2023 BORROWING: The ground truth states the €750 million was borrowed in November 2023 AND repaid on November 17, 2023 (same month, very short-term). The LLM's phrasing 'used the proceeds of a €750 million bond issuance (November 2023) to settle the remaining €750 million of borrowings' is misleading and doesn't clearly convey that this was a short-term facility draw and repayment within the same month.\n\n4. UNSUPPORTED CLAIM: The LLM states the company 'later used the proceeds of a €750 million bond issuance...to settle the remaining €750 million of borrowings.' The ground truth does not indicate that a €750 million bond issuance was used to repay the Supplemental Facility borrowing. This appears to be an inference not supported by the source data.\n\n5. MISSING CONTEXT: The ground truth mentions that in 2024, SPG issued new senior unsecured notes to redeem other outstanding notes at maturity, indicating a shift in financing strategy. The LLM completely omits this important evolution in financing approach.\n\n6. SPECULATIVE INFORMATION: The LLM mentions '$3.5-$4.5 billion capacity for future use' which is not mentioned in the ground truth and appears to be unsupported speculation.\n\nThe LLM does correctly identify that the facility was used for short-term financing needs and that there was minimal outstanding balance by year-end 2024, but the numerous factual errors, date mistakes, and omissions of key details significantly undermine the answer's accuracy and reliability.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 583,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has the role of cash buffer needs in MetLife's capital management strategy evolved from 2022 to 2024, particularly in terms of liquidity levels and their impact on capital allocation decisions?",
      "original_answer": "In 2022, MetLife maintained a short-term liquidity position of $12.4 billion and a total liquid asset base of $223.0 billion, reflecting a strong buffer to meet business requirements under both normal and stress scenarios. The company emphasized its belief in having ample liquidity and highlighted active monitoring and adjustment of liquidity and capital plans. By 2024, the narrative shifted to a more cautious tone, noting that maintaining or increasing cash buffers could limit capital available for innovation, acquisitions, and shareholder returns. This indicates that while liquidity remained a strategic priority, the implications of holding larger cash buffers became more pronounced, potentially constraining other capital deployment opportunities.",
      "llm_answer": "\nBetween 2022 and 2024 MetLife moved from a peripheral reference to “cash‑buffer needs” in its capital‑risk discussion (2022 Capital Risks note) to an explicit strategic focus on preserving a sizable cash buffer that can constrain dividend and share‑repurchase decisions (2024 Capital Risks note).  The 2024 filing stresses that legal, regulatory and market pressures may require the company to grow that buffer, directly tying liquidity levels to capital‑allocation choices, whereas the 2022 discussion treated the buffer as just one of several factors that could limit returns.  As a result, MetLife now manages its capital more conservatively, using the buffer to safeguard against stress scenarios and to maintain flexibility in its capital plan.",
      "correctness_score": 6,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the evolution of MetLife's cash buffer strategy from 2022 to 2024, capturing the shift from peripheral treatment to explicit strategic focus. The qualitative assessment is sound - the answer accurately describes how the company moved from treating buffers as one of several factors to making them a primary constraint on capital allocation. The reasoning about regulatory pressures and stress scenario management is appropriate and well-articulated. CRITICAL WEAKNESSES: The LLM answer completely fails to include the specific quantitative data provided in the ground truth. The ground truth explicitly states: (1) 2022 short-term liquidity of $12.4 billion, (2) 2022 total liquid asset base of $223.0 billion. These are concrete, verifiable numbers that directly support the narrative about liquidity levels and their evolution. The LLM answer provides zero quantitative metrics, which is a significant omission for a question specifically asking about 'liquidity levels' and their 'impact on capital allocation decisions.' MULTI-HOP REASONING: The LLM answer demonstrates sound multi-hop reasoning by synthesizing information across 2022 and 2024 filings and connecting liquidity management to capital allocation constraints. However, this reasoning is incomplete without the supporting financial data. SEMANTIC EQUIVALENCE: While the LLM captures the directional shift and strategic implications correctly, the absence of quantitative support undermines the answer's credibility and completeness. A strong answer would have integrated both the qualitative narrative shift AND the specific liquidity figures. The question explicitly asks about 'liquidity levels' - this demands numerical specificity that the LLM answer lacks entirely.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 485,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Starbucks' exposure to 'Foreign currency - other' derivatives evolve between 2022 and 2023, particularly in terms of asset and liability classifications?",
      "original_answer": "In 2022, Starbucks reported 'Foreign currency - other' derivative liabilities of $0.3 million under accrued liabilities and no corresponding asset value. By 2023, the company had a derivative asset of $1.9 million under prepaid expenses and other current assets and a derivative liability of $4.7 million under accrued liabilities for the same category. This indicates a significant increase in exposure and a shift toward a more balanced treatment across asset and liability classifications.",
      "llm_answer": "\nBetween the fiscal year ended October 2, 2022 and the year ended October 1, 2023 the “foreign‑currency – other” derivatives moved from a net‑asset position to a net‑liability position.  In 2022 the derivatives were recorded almost entirely as assets – ≈ $73 million of derivative assets (prepaid expenses and long‑term assets) versus only about $6 million of liabilities – giving a net‑asset balance.  By the end of 2023 the asset portion had shrunk to roughly $3–4 million, while liabilities had risen to roughly $6–7 million (accrued and long‑term liabilities), so the classification on the balance sheet shifted from an asset to a liability.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contains dramatically wrong numbers that do not match the ground truth. Specific issues: (1) QUANTITATIVE ERRORS - The LLM claims 2022 had ~$73 million in derivative assets and ~$6 million in liabilities, but the ground truth shows $0 in assets and $0.3 million in liabilities for 'Foreign currency - other' derivatives. The LLM's numbers are off by orders of magnitude (73x for assets). For 2023, the LLM claims ~$3-4 million in assets and ~$6-7 million in liabilities, but ground truth shows $1.9 million in assets and $4.7 million in liabilities. While the 2023 liability figure is closer, the asset figure is still incorrect. (2) CLASSIFICATION ERRORS - The LLM incorrectly describes the 2022 position as 'net-asset' when it was actually net-liability ($0.3M liability with no assets). The LLM also mischaracterizes the shift as moving from 'asset to liability' when the correct characterization is that the company went from having only a small liability ($0.3M) to having both a meaningful asset ($1.9M) and a larger liability ($4.7M). (3) MULTI-HOP REASONING - The LLM failed to correctly synthesize the year-over-year comparison. The narrative about a shift from net-asset to net-liability position is completely fabricated and contradicts the actual data. (4) MISSING CONTEXT - The LLM failed to identify the specific balance sheet line items (prepaid expenses and other current assets for the asset; accrued liabilities for the liability) that are central to the question about 'asset and liability classifications.' The answer demonstrates a fundamental misunderstanding of the data and provides numbers that appear to be either from a different derivative category or entirely fabricated.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 475,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has The Coca-Cola Company's relationship with Coca-Cola FEMSA evolved from 2023 to 2024, particularly in terms of its strategic engagement and financial stake?",
      "original_answer": "In 2023, Coca-Cola FEMSA was one of The Coca-Cola Company's five largest independent bottling partners, operating in multiple countries including Mexico, Brazil, and Argentina, and collectively these top five bottlers accounted for 42% of Coca-Cola's worldwide unit case volume. By 2024, the relationship had evolved significantly, as Coca-Cola FEMSA transitioned from being a key bottler to becoming an equity method investee in which The Coca-Cola Company held a 28% ownership stake. This shift indicates a deeper financial commitment and alignment beyond the traditional bottler-concentrate supplier model.",
      "llm_answer": "\nBetween 2023 and 2024 the Company deepened its ties with Coca‑Cola FEMSA by extending long‑term, renewable Comprehensive Beverage Agreements that grant FEMSA exclusive territory rights and an incidence‑based pricing model, while simultaneously raising its equity exposure—holding a 28 % stake (carrying value $1.786 bn vs. fair value $4.544 bn) and generating $1.770 bn of equity income in 2024.  This dual evolution reflects a shift from a purely contractual bottling relationship to a strategic, equity‑based partnership with a substantially larger financial stake than in the prior year.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides relevant information about the evolution of the relationship but introduces unverified financial details not present in the ground truth. STRENGTHS: (1) Correctly identifies the 28% ownership stake held by Coca-Cola Company in Coca-Cola FEMSA; (2) Accurately characterizes the shift from traditional bottler relationship to equity-based partnership; (3) Properly describes the strategic deepening of ties through long-term agreements; (4) Correctly notes the transition to equity method investee status. WEAKNESSES: (1) Introduces specific financial figures ($1.786 bn carrying value, $4.544 bn fair value, $1.770 bn equity income in 2024) that are NOT present in the ground truth and cannot be verified against it; (2) Adds details about 'Comprehensive Beverage Agreements,' 'exclusive territory rights,' and 'incidence-based pricing model' that go beyond the ground truth scope; (3) The ground truth emphasizes FEMSA's prior status as 'one of five largest independent bottling partners' accounting for 42% of unit case volume—the LLM answer omits this important contextual detail about the baseline relationship in 2023. QUANTITATIVE ACCURACY ISSUE: While the 28% stake is correct, the introduction of unverified carrying values, fair values, and equity income figures without ground truth support creates uncertainty. These numbers may be accurate from actual filings, but they cannot be confirmed against the provided ground truth, which makes them problematic for evaluation purposes. The answer demonstrates good qualitative understanding of the relationship evolution but overextends beyond what can be verified in the ground truth provided.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 457,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has Intel's strategic positioning of FPGAs evolved between 2022 and 2024, particularly in terms of their role within adjacent products and their broader production focus?",
      "original_answer": "In 2022, Intel positioned FPGAs as part of its 'adjacent products' within the Client Computing Group (CCG), Data Center Group (DCG), and Internet of Things Group (IOTG), indicating a supporting role within comprehensive platform solutions. By 2024, FPGAs were explicitly listed under direct product definitions, signaling a shift toward a more central production focus. This reflects a transformation in the strategic importance of FPGAs, moving from a supplementary role to a core product offering.",
      "llm_answer": "\nBetween 2022 and 2024 Intel shifted FPGAs from a peripheral “adjacent‑product” offering into a core pillar of its platform strategy, embedding them in the Programmable Solutions Group and tying them to AI, networking and autonomous‑driving solutions across CCG, DCG and IOTG.  At the same time the company aligned FPGA production with its broader “shell‑ahead” manufacturing expansion— investing in EUV‑enabled process nodes, new wafer‑fab capacity in Ireland, Arizona and Ohio, and leveraging government incentives—so that FPGAs now sit alongside Intel’s core logic and foundry capacity as a strategic growth engine rather than an after‑thought.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) FACTUAL ERRORS - The LLM answer introduces significant unsupported claims not present in the ground truth: mentions of 'Programmable Solutions Group' (not verified in original answer), specific manufacturing details about EUV-enabled nodes, wafer-fab capacity in Ireland/Arizona/Ohio, and government incentives. These details are NOT in the ground truth and appear to be hallucinated. (2) INCOMPLETE CORE ANSWER - The LLM correctly identifies the shift from 'adjacent products' to core positioning, but adds substantial fabricated details about manufacturing strategy that cannot be verified against the knowledge graph. (3) ENTITY ACCURACY - While CCG, DCG, and IOTG are correctly mentioned, the introduction of 'Programmable Solutions Group' is not supported by the ground truth, which only mentions FPGAs being listed under 'direct product definitions' by 2024. (4) MULTI-HOP REASONING - The core multi-hop synthesis (2022 positioning vs 2024 positioning) is partially correct in concept but contaminated with unverified manufacturing claims. The ground truth focuses on organizational positioning and product categorization changes, not manufacturing expansion details. (5) SEMANTIC ISSUES - The phrase 'shell-ahead' manufacturing appears to be a misremembering or hallucination of 'IDM 2.0' or similar Intel strategy terms, but is not in the ground truth. The answer conflates product strategy evolution with manufacturing capacity expansion, which goes beyond what the ground truth supports. The core insight about moving from 'adjacent' to 'direct product' is correct, but the answer is significantly padded with unverifiable claims that reduce confidence in its accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 466,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did ConocoPhillips' financial activity related to the Lower 48 region evolve from 2022 to 2023, particularly in terms of asset acquisition and depreciation, depletion, and amortization expenses?",
      "original_answer": "In 2022, ConocoPhillips noted that purchases in the Lower 48 were driven by the Concho acquisition, indicating a strategic expansion in that region. The depreciation, depletion, amortization, and impairments expense for the Lower 48 was $4,854 million. In 2023, the company's expense for the same category in the Lower 48 increased to $5,729 million, showing a significant rise of $875 million. This increase suggests continued investment and asset utilization in the Lower 48 following the acquisition.",
      "llm_answer": "\nBetween 2022 and 2023 ConocoPhillips kept expanding its Lower 48 position by developing proved undeveloped reserves—page 165 notes roughly 399 MMBOE of extensions and discoveries in the Lower 48 and ≈ 65 % of 2021 PUD transfers came from that region—and by integrating prior acquisitions such as the Concho purchase (page 163).  Consequently, depreciation, depletion and amortization expense for the Lower 48 segment climbed to **$5.73 billion in 2023**, up from **$4.85 billion in 2022**, reflecting the larger capital base and higher production volumes associated with the added reserves.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. QUANTITATIVE VERIFICATION: All financial figures are correct - $5.73 billion (2023) and $4.85 billion (2022) match the ground truth values of $5,729 million and $4,854 million respectively (format variation is acceptable). The calculated increase of $875 million is implicit in the comparison and accurate. ENTITY ACCURACY: ConocoPhillips correctly identified, Lower 48 region properly specified, years 2022-2023 correct, and the Concho acquisition properly referenced. MULTI-HOP REASONING: The answer successfully synthesizes information across multiple dimensions: (1) asset acquisition activity (Concho acquisition, PUD transfers, extensions and discoveries), (2) depreciation/depletion/amortization expense evolution, and (3) the causal relationship between expanded asset base and increased expenses. The logic is sound - larger capital base and higher production volumes logically explain the expense increase. COMPLETENESS: The answer addresses all parts of the question regarding financial activity evolution, asset acquisition, and DD&A expenses. ADDITIONAL CONTEXT: The LLM provides supplementary relevant details (399 MMBOE of extensions/discoveries, 65% PUD transfer attribution) that enhance understanding without introducing errors. These details appear consistent with SEC filing disclosures and strengthen the answer's credibility. MINOR CONSIDERATION: The answer goes slightly beyond the ground truth by providing additional context about reserve development and PUD transfers, but this is additive rather than contradictory and demonstrates thorough document review. No factual errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 458,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Emerson's financial and strategic relationship with AspenTech evolve between 2022 and 2024, particularly in terms of ownership structure and financial impact on gross margins?",
      "original_answer": "In 2022, Emerson completed the acquisition of AspenTech, contributing approximately $6.0 billion in cash, paying $87.69 per share to Heritage AspenTech stockholders, and retaining $168 million in AspenTech's balance sheet. The acquisition positively impacted gross margins by 0.6 percentage points in 2023. By 2024, Emerson owned 55% of AspenTech on a fully diluted basis, and AspenTech continued to operate under its former name and ticker symbol 'AZPN.' The acquisition's financial impact persisted, contributing to a gross margin increase of 1.8 percentage points to 50.8% in 2024, despite a negative impact from acquisition-related inventory step-up amortization of $231 million, which reduced margins by 1.3 percentage points.",
      "llm_answer": "\nBetween 2022 and 2024 Emerson’s ownership in AspenTech moved from the 55 % stake it acquired in the May 2022 Heritage AspenTech transaction (recorded with a $5.9 bn non‑controlling interest) to a proposed full buy‑out of the remaining shares at $240 per share in October 2024.  The software business added roughly 0.6 percentage‑point to gross margin in 2023 and helped lift the overall margin from 45.7 % (2022) to 50.8 % (2024), although inventory‑step‑up amortization of $231 m (≈1.3 pts) weighed on 2024 margins; the pending acquisition would eliminate the non‑controlling interest and is expected to provide a more stable, higher‑margin contribution.  (Pages 54, 56 & 25)",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer addresses the evolution of Emerson's relationship with AspenTech between 2022-2024 and includes relevant financial metrics, but contains several significant quantitative discrepancies that reduce overall accuracy.\n\nCORRECT ELEMENTS:\n- Correctly identifies the May 2022 Heritage AspenTech transaction\n- Accurately states the 0.6 percentage-point gross margin contribution in 2023\n- Correctly cites the $231 million inventory step-up amortization and 1.3 percentage-point negative impact in 2024\n- Correctly identifies the 50.8% gross margin in 2024\n- Appropriately mentions the October 2024 proposed full buyout\n- Properly synthesizes multi-hop information across years and metrics\n\nSIGNIFICANT ERRORS:\n1. OWNERSHIP STRUCTURE DISCREPANCY: The LLM states Emerson \"moved from the 55% stake it acquired in the May 2022 Heritage AspenTech transaction\" but the ground truth indicates that by 2024, Emerson owned 55% on a fully diluted basis. The LLM's phrasing suggests 55% was the initial stake in 2022, which is misleading about the ownership evolution.\n\n2. CASH CONSIDERATION: The LLM states \"$5.9 bn non-controlling interest\" while the ground truth specifies \"approximately $6.0 billion in cash.\" This is a material difference ($100 million variance) and the LLM conflates the non-controlling interest accounting treatment with the actual cash paid.\n\n3. PRICE PER SHARE: The ground truth specifies $87.69 per share paid to Heritage AspenTech stockholders in 2022, which the LLM omits entirely. The LLM mentions the $240 per share October 2024 proposed buyout but doesn't provide the original 2022 price.\n\n4. RETAINED BALANCE SHEET AMOUNT: The ground truth mentions retaining $168 million in AspenTech's balance sheet, which the LLM completely omits.\n\n5. GROSS MARGIN PROGRESSION: The LLM states margins \"helped lift the overall margin from 45.7% (2022) to 50.8% (2024)\" but doesn't clearly articulate that the 1.8 percentage-point contribution in 2024 (as stated in ground truth) is the net positive impact after the $231M inventory step-up amortization.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across multiple years and connects ownership structure changes to financial impacts. The reasoning about how the pending acquisition would eliminate non-controlling interest is sound and adds relevant context.\n\nSEMANTIC ISSUES: The phrasing \"moved from the 55% stake it acquired\" is ambiguous and could be misinterpreted as the ownership percentage changing, when the ground truth suggests 55% was the position by 2024, not necessarily the initial position.\n\nOVERALL ASSESSMENT: The answer demonstrates good understanding of the multi-hop question and includes most key elements, but the quantitative inaccuracies (cash amount, missing price per share, missing retained balance sheet amount) and the ambiguous ownership structure description prevent this from being a high-quality response. The answer would benefit from more precise financial figures and clearer articulation of the ownership evolution timeline.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 809,
        "total_tokens": 2171
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has the treatment and availability of shares under the 2015 Director Stock Plan evolved between 2022 and 2024, particularly in terms of share recovery and issuance mechanics?",
      "original_answer": "In 2022, the 2015 Director Stock Plan specified that each share issued under the plan reduced the number of shares remaining for issuance by one, and shares recovered from expired, forfeited, or cash-settled awards were again available for issuance. By 2024, the plan had a total of 35,395,894 shares authorized for issuance as of January 1, 2015, with 37,608,213 shares recovered for issuance between 2015 and 2024. However, 42,343,146 shares were covered by new awards and reinvested dividends since 2015, leaving 30,660,961 shares available for future issuance. This reflects a net reduction in available shares over time despite ongoing share recovery, indicating a shift in the balance between new issuances and recovered shares.",
      "llm_answer": "\nBetween 2022 and 2024 the 2015 Director Stock Plan’s free‑share pool fell from about **34 million** shares (reported for 2022) to roughly **30.7 million** shares (reported for 2024).  This decline reflects the plan’s rule that shares recovered from expired, forfeited, cash‑settled or otherwise terminated awards are added back to the pool, but the pool is reduced only by the **net** shares actually delivered when options are exercised or tax‑withholding is satisfied; reinvested dividends or cash dividends do not lower the maximum issuance amount.  Consequently, while new shares continue to be authorized and recovered on a one‑for‑one basis, the net number of shares available for future grants has contracted modestly over the 2022‑2024 period.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant quantitative errors and incomplete synthesis of the ground truth information. SPECIFIC ISSUES: (1) QUANTITATIVE ERRORS: The LLM states 2022 shares were 'about 34 million' and 2024 shares were 'roughly 30.7 million.' The ground truth specifies 30,660,961 shares available for future issuance in 2024 (which rounds to ~30.7M, so this is correct), but provides no 2022 baseline figure for comparison. The LLM's claim of a 34M figure in 2022 cannot be verified against the ground truth and appears to be an unsupported assertion. (2) INCOMPLETE SYNTHESIS: The ground truth provides specific numbers: 35,395,894 shares authorized (as of Jan 1, 2015), 37,608,213 shares recovered (2015-2024), 42,343,146 shares covered by new awards and reinvested dividends, and 30,660,961 shares available. The LLM answer omits these specific figures entirely and instead provides only approximate ranges ('about 34 million,' 'roughly 30.7 million'). (3) MECHANICAL EXPLANATION ISSUES: The LLM's explanation of the mechanics (shares recovered added back, net shares delivered reduce pool, reinvested dividends don't lower maximum) is partially correct but oversimplified. The ground truth indicates that reinvested dividends ARE counted against the pool (they're part of the 42,343,146 shares covered by new awards and reinvested dividends), contradicting the LLM's statement that 'reinvested dividends do not lower the maximum issuance amount.' (4) MISSING KEY CONTEXT: The LLM fails to mention the critical distinction between total authorized shares (35.4M), recovered shares (37.6M), and shares used (42.3M), which together explain the net reduction in available shares. (5) REASONING QUALITY: While the LLM correctly identifies that available shares declined, it doesn't explain the underlying mechanics with the precision provided in the ground truth. The statement about 'net shares actually delivered' is vague and doesn't capture the full picture of how reinvested dividends factor into the calculation. STRENGTHS: The LLM correctly identifies the general trend (decline in available shares) and the approximate 2024 figure (30.7M). The overall direction of reasoning is sound. WEAKNESSES: Missing specific numbers, incorrect characterization of reinvested dividends treatment, unsupported 2022 baseline, and incomplete multi-hop synthesis of the five key metrics from the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 641,
        "total_tokens": 2021
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has Starbucks' relationship with the Global Coffee Alliance evolved from fiscal year 2022 to fiscal year 2023 in terms of strategic emphasis and revenue contribution?",
      "original_answer": "In fiscal year 2022, the Global Coffee Alliance contributed to the growth of the Channel Development segment, which saw a $250 million increase in revenue driven by product sales and royalty income from the alliance. By fiscal year 2023, the strategic emphasis on the Global Coffee Alliance had evolved, with Starbucks explicitly highlighting its licensing relationship with Nestlé under the alliance as a core channel for product distribution, indicating a deeper integration and ongoing importance to Starbucks' global licensing and product expansion strategy. This evolution reflects a shift from viewing the alliance primarily as a revenue driver to positioning it as a strategic enabler of global product reach and brand extension.",
      "llm_answer": "\nFrom fiscal 2022 to 2023 the Alliance remained a cornerstone of Starbucks’ Channel‑Development strategy, with revenue from the licensed Global Coffee Alliance continuing to generate a double‑digit lift in that segment’s sales.  Whereas the 2022 filing highlighted margin pressure from the North‑American Coffee Partnership joint venture, the 2023 filing shifts the emphasis toward expanding the Alliance‑based licensed model and leveraging Nestlé’s distribution to grow product sales and royalty income, positioning the partnership as a sustained growth engine rather than a marginal contributor.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ISSUES: (1) QUANTITATIVE ACCURACY - The LLM answer claims 'double-digit lift' in Channel Development segment sales but provides no specific numbers. The ground truth explicitly states a '$250 million increase in revenue' for FY2022. The LLM fails to cite this concrete figure, which is a significant omission for a financial question. (2) ENTITY CONFUSION - The LLM introduces 'North American Coffee Partnership joint venture' and discusses 'margin pressure' from it, which is NOT mentioned in the ground truth. This appears to be either fabricated or confused with different information not relevant to the Global Coffee Alliance evolution question. (3) PARTIAL CORRECTNESS - The LLM correctly identifies: (a) the shift from FY2022 to FY2023, (b) the Nestlé licensing relationship, (c) the evolution toward strategic positioning, (d) the focus on product distribution and royalty income. (4) MISSING KEY DETAIL - The ground truth emphasizes a shift 'from viewing the alliance primarily as a revenue driver to positioning it as a strategic enabler of global product reach and brand extension.' The LLM captures this conceptually ('sustained growth engine rather than marginal contributor') but misses the nuance about the strategic shift in emphasis. (5) MULTI-HOP REASONING - The LLM attempts to synthesize the evolution across years but introduces unsupported claims about margin pressure and North American partnerships that muddy the analysis. The core multi-hop synthesis (comparing FY2022 to FY2023 strategic positioning) is partially sound but contaminated with extraneous information. VERDICT: While the LLM captures the directional evolution and some key concepts, it fails on quantitative precision (missing the $250M figure), introduces potentially fabricated details about margin pressure, and doesn't fully articulate the strategic shift from revenue driver to strategic enabler.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 514,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has NEE's financial stake and involvement in the Mountain Valley Pipeline evolved between 2022 and 2023, and what does this indicate about its investment strategy?",
      "original_answer": "In 2022, NEE's equity method investments totaled $6,159 million, and the Mountain Valley Pipeline was listed among key equity method investees alongside NEP OpCo, Sabal Trail, and Silver State South Solar, with NEE's interest ranging from approximately 32% to 55%. By 2023, NEE's total equity method investments were $6,156 million, with its interest in the principal entities, including the Mountain Valley Pipeline, ranging from approximately 32.8% to 52.6%. The shift from a broader range (32%–55%) in 2022 to a narrower range (32.8%–52.6%) in 2023 suggests a slight adjustment in ownership stakes, potentially reflecting a more refined or strategic investment posture. Additionally, in 2023, the Mountain Valley Pipeline was specifically noted in the context of Nonrecurring Fair Value Measurements, indicating a possible revaluation or change in financial treatment.",
      "llm_answer": "\nBetween 2022 and 2023 NEE’s exposure to the Mountain Valley Pipeline was sharply reduced.  In 2022 the company recorded a $674 million impairment on its equity‑method investment in the pipeline, whereas in 2023 the related impairment fell to only $38 million, and the carrying value of the investment dropped from roughly $4.97 billion to $3.96 billion (see the 2022‑2023 equity‑method investment tables).  This pull‑back—accompanied by NEER’s large additions of wind and solar capacity—signals that NEE is de‑emphasizing high‑cost fossil‑fuel infrastructure and reallocating capital toward renewable generation and related growth projects.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations that fundamentally contradict the ground truth. (1) CRITICAL ERRORS: The LLM claims NEE's exposure to MVP was 'sharply reduced' and cites specific impairment figures ($674M in 2022, $38M in 2023) and carrying value changes ($4.97B to $3.96B). However, the ground truth shows that NEE's total equity method investments remained essentially flat between 2022 and 2023 ($6,159M to $6,156M), with MVP listed as one of several key investees. The ground truth makes NO mention of impairment charges of these magnitudes or carrying value figures for MVP specifically. (2) QUANTITATIVE ACCURACY FAILURE: The specific dollar amounts cited ($674M impairment, $38M impairment, $4.97B to $3.96B carrying values) cannot be verified against the ground truth and appear to be fabricated or misattributed. The ground truth discusses ownership percentage ranges (32%-55% in 2022, 32.8%-52.6% in 2023), not impairment amounts or carrying values. (3) MULTI-HOP REASONING FAILURE: The LLM incorrectly synthesized information, apparently confusing or inventing financial metrics not present in the source documents. The claim about 'NEER's large additions of wind and solar capacity' is not substantiated by the ground truth provided. (4) SEMANTIC MISMATCH: The ground truth indicates a 'slight adjustment in ownership stakes' and a 'more refined or strategic investment posture,' whereas the LLM claims a 'sharp reduction' in exposure and a 'pull-back' from fossil fuels. These are contradictory characterizations. (5) INVESTMENT STRATEGY INTERPRETATION: While the LLM's conclusion about de-emphasizing fossil fuels might be reasonable speculation, it is not supported by the actual data presented in the ground truth, which shows stable equity method investment levels and a narrowing (not elimination) of ownership ranges.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 508,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has Medtronic's InterStim Therapy product line evolved between 2022 and 2024 in terms of neurostimulator offerings and therapeutic indications?",
      "original_answer": "In 2022, InterStim therapy was described with a range of neurostimulators including InterStim II, InterStim Micro, and InterStim X, targeting symptoms of overactive bladder, urinary retention, and bowel incontinence. By 2024, the product line continued to include InterStim II and InterStim X, now specifically labeled as 'recharge-free' neurostimulators, and retained its focus on overactive bladder and urinary retention, but expanded its therapeutic scope to include 'chronic fecal incontinence.' This reflects a refinement in product positioning and a broadening of clinical applications over the two-year period.",
      "llm_answer": "\nBetween 2022 and 2024 Medtronic expanded the InterStim neurostimulation portfolio with newer platforms—InterStim II, the rechargeable InterStim Micro and the recharge‑free InterStim X—and added the closed‑loop Inceptiv SCS, which received U.S. FDA approval in April 2024 (pages 39, 47, 74). These devices now cover a broader range of therapeutic indications, including overactive bladder, urinary retention, bowel incontinence, chronic pain and diabetic peripheral neuropathy, while offering improved recharge options and adaptive programming (pages 48, 42).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) FACTUAL ERRORS - The LLM answer introduces products and information NOT in the ground truth. Specifically: (a) 'Inceptiv SCS' is mentioned as a closed-loop device with FDA approval in April 2024, but this is NOT mentioned in the original answer about InterStim evolution and appears to be a different product line (spinal cord stimulation, not bladder/bowel therapy); (b) 'InterStim Micro' is described as 'rechargeable' in the LLM answer, but the ground truth indicates InterStim Micro was present in 2022 but notably ABSENT from the 2024 product line description, suggesting it may have been discontinued or de-emphasized. (2) INCOMPLETE/INACCURATE PRODUCT EVOLUTION - The LLM answer fails to capture the key evolution: InterStim Micro disappeared from the 2024 lineup, and the 2024 products are specifically labeled as 'recharge-free' (InterStim II and InterStim X), not just 'rechargeable' options. (3) THERAPEUTIC INDICATIONS - The LLM answer adds 'chronic pain and diabetic peripheral neuropathy' which are NOT mentioned in the ground truth for InterStim therapy. These appear to be associated with SCS (spinal cord stimulation) products, not InterStim bladder/bowel devices. The ground truth specifically mentions the expansion to 'chronic fecal incontinence' (not just 'bowel incontinence'), which the LLM answer mentions but conflates with other unrelated indications. (4) MULTI-HOP REASONING FAILURE - The answer conflates InterStim (bladder/bowel neuromodulation) with SCS (spinal cord stimulation for pain), which are distinct product lines. This represents a fundamental synthesis error. (5) CORRECT ELEMENTS - The LLM correctly identifies InterStim II and InterStim X as part of the 2024 portfolio and correctly notes the 'recharge-free' positioning. The mention of 'overactive bladder' and 'urinary retention' is accurate. However, these correct elements are overwhelmed by the introduction of incorrect products and indications that don't belong to the InterStim therapy evolution being asked about.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 550,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Simon Property Group's financial stake and strategic relationship with Authentic Brands Group (ABG) evolve from 2022 to 2024?",
      "original_answer": "In 2022, Simon Property Group held a 1.37% interest in ABG and had merged Forever 21 operations into SPARC Group after increasing its stake to 50% alongside ABG. By 2024, Simon sold a portion of its ABG stake, realizing a pre-tax gain of $18.8 million, and later acquired additional interests in ABG for $100 million in cash, indicating a dynamic evolution in their financial relationship.",
      "llm_answer": "\nFrom 2022 through 2024 Simon Property Group’s exposure to Authentic Brands Group (ABG) shifted from a modest, passive minority position to an active, equity‑heavy partnership and then to a full exit.  In early 2021 SPG acquired additional licensing and operating interests in Forever 21 (bringing its stake to 50 %) and later, in December 2021, sold part of its ABG holding for $65.5 million while purchasing an extra $100 million of interests, raising its effective ownership to roughly 10 % – still a non‑controlling but strategically significant block.  Building on that relationship, in the first quarter of 2022 SPG entered a long‑term strategic partnership with ABG that made ABG the core U.S. licensee and operating partner for Reebok, and by 2024 SPG had grown its ABG equity to about 11 % before ultimately selling its remaining interest for $1.2 billion, realizing a $414.8 million pre‑tax gain and ending the strategic tie‑up.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains numerous significant factual errors and contradictions with the ground truth:\n\n1. QUANTITATIVE ERRORS (Critical):\n   - LLM claims SPG sold ABG holding for $65.5 million in December 2021 - NOT mentioned in ground truth\n   - LLM states SPG grew ABG equity to ~11% by 2024 - Ground truth shows SPG sold a portion and acquired additional interests for $100M, not growing to 11%\n   - LLM claims SPG sold remaining interest for $1.2 billion with $414.8M pre-tax gain - NOT in ground truth\n   - Ground truth shows: 1.37% interest in 2022, sale realizing $18.8M pre-tax gain, then acquisition of additional interests for $100M\n   - LLM's $1.2B sale and $414.8M gain are completely fabricated numbers not supported by ground truth\n\n2. TIMELINE ERRORS:\n   - LLM references events in \"early 2021\" and \"December 2021\" which are outside the 2022-2024 timeframe specified in the question\n   - Ground truth focuses on 2022-2024 evolution\n   - LLM's narrative structure suggests a \"full exit\" by 2024, contradicting ground truth which shows ongoing acquisition activity\n\n3. ENTITY/RELATIONSHIP ERRORS:\n   - LLM mentions Reebok partnership details not in ground truth\n   - LLM describes evolution as \"modest minority → active partnership → full exit\" but ground truth shows: minority stake → partial sale with gain → additional acquisition for $100M\n   - The characterization of a \"full exit\" is fundamentally incorrect\n\n4. MULTI-HOP REASONING FAILURE:\n   - LLM failed to correctly synthesize the actual financial transactions from ground truth\n   - The answer invents a narrative arc (exit story) that contradicts the actual evolution (stake adjustments with continued involvement)\n   - Core relationship evolution is misrepresented\n\n5. WHAT WAS CORRECT:\n   - Correctly identified Simon Property Group and Authentic Brands Group\n   - Correctly identified Forever 21 involvement\n   - General acknowledgment of evolving relationship (though details wrong)\n\nThe LLM answer appears to have hallucinated major financial figures ($1.2B sale, $414.8M gain) and mischaracterized the nature of SPG's relationship evolution with ABG.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 581,
        "total_tokens": 1910
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How has ConocoPhillips' investment activity in the Lower 48 region evolved from 2021 to 2023, particularly in terms of depreciation, depletion, and amortization expenses?",
      "original_answer": "ConocoPhillips' depreciation, depletion, and amortization (DD&A) expenses in the Lower 48 region increased from $4,067 million in 2021 to $5,729 million in 2023, indicating a significant rise in asset utilization or investment activity. This reflects a growing emphasis on the Lower 48 as a core operational area for the company.",
      "llm_answer": "\nFrom 2021 through 2023 the company’s depreciation, depletion and amortization (DD&A) charge for its Lower 48 operations rose sharply—from **$4.07 billion in 2021** to **$4.85 billion in 2022** and then to **$5.73 billion in 2023** (see page 133).  This upward trend reflects the higher capital base built after the 2021 Concho and Shell Permian acquisitions and the subsequent growth in proved reserves, which drives greater depletion, while the larger PP&E portfolio results in higher depreciation and amortization.  Consequently, ConocoPhillips’ investment activity in the Lower 48 has intensified, as evidenced by the rising DD&A expense over the three‑year period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. All quantitative data is correct: $4.07 billion (2021), $4.85 billion (2022), and $5.73 billion (2023) match the ground truth values of $4,067 million, $4,850 million, and $5,729 million respectively (format variations are acceptable). The answer correctly identifies the upward trend and provides superior context by including the 2022 intermediate year data, which the ground truth omitted. The multi-hop reasoning is sound: the LLM correctly synthesizes information about the Concho and Shell Permian acquisitions, their impact on the capital base, and how this drives higher DD&A expenses through both increased proved reserves (depletion) and larger PP&E portfolios (depreciation/amortization). The explanation of causality is logical and well-reasoned. The answer fully addresses the question's focus on investment activity evolution and DD&A expense trends. The only minor distinction is that the ground truth provides a more concise statement while the LLM offers richer contextual explanation, but this is a strength rather than a weakness. The reference to page 133 adds credibility. All entities (ConocoPhillips, Lower 48 region, DD&A metric, fiscal years) are correctly identified and synthesized.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 358,
        "total_tokens": 1613
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How has Verizon's (VZ) treatment and valuation approach for international bonds evolved from 2023 to 2024 based on their 10-K disclosures?",
      "original_answer": "In 2023, Verizon described that international bonds were valued using matrix prices with input from independent third-party valuation sources as part of the broader fixed income securities category. By 2024, international bonds were specifically itemized in a detailed table with a total value of $12 million, broken down into $10 million in Level 1 and $2 million in Level 2 inputs. This represents a shift from a general description in 2023 to a more transparent and segmented valuation approach in 2024, indicating a more refined disclosure strategy and possibly a more structured approach to valuing international bonds.",
      "llm_answer": "\nVerizon now manages the foreign‑currency risk of its international debt with fair‑value hedges using cross‑currency swaps, and the portions of those hedges that were previously excluded from hedge accounting (the time‑value and basis‑spread components) are amortized systematically into interest expense—$104 million will be amortized over the next 12 months (see page 86 of the 2023 10‑K and the updated disclosure on page 96 of the 2024 10‑K). The balance of excluded hedge components has fallen from $488 million in 2022 to $400 million in 2023, indicating that more of the fair‑value adjustment is being recognized in earnings rather than retained in other comprehensive income. As a result, exchange gains and losses on the hedged foreign‑currency debt are recorded directly in interest expense, reflecting a more integrated valuation approach for its international bonds.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 1,
      "detailed_feedback": "The LLM answer is fundamentally misaligned with the question and ground truth. CRITICAL ISSUES: (1) TOPIC MISMATCH: The question asks about the treatment and valuation approach for international bonds (fair value measurement, Level 1/2 inputs, disclosure changes). The LLM answer discusses hedge accounting for foreign-currency risk using cross-currency swaps and amortization of excluded hedge components—a completely different topic. (2) MISSING CORE INFORMATION: The ground truth identifies a specific evolution: 2023 showed general matrix pricing descriptions, while 2024 showed itemized tables with $12M total ($10M Level 1, $2M Level 2). The LLM answer provides none of this valuation hierarchy information. (3) INCORRECT NUMBERS: The LLM cites $104M amortization, $488M in 2022, and $400M in 2023—these relate to hedge accounting exclusions, not international bond valuation. These numbers don't appear in the ground truth answer and are contextually irrelevant. (4) WRONG DISCLOSURE FOCUS: The ground truth emphasizes transparency improvements in fair value measurement disclosures. The LLM focuses on interest expense accounting and comprehensive income treatment—different disclosure areas entirely. (5) FAILED MULTI-HOP SYNTHESIS: The question requires synthesizing 2023 vs 2024 10-K disclosures on international bond valuation. The LLM synthesized information about hedge accounting instead. (6) SEMANTIC DISCONNECT: 'Integrated valuation approach' in the LLM answer doesn't match the ground truth's 'refined disclosure strategy' and 'segmented valuation approach.' The LLM appears to have retrieved information from a different section of the 10-K filings entirely, possibly confusing international debt hedging with international bond fair value measurement.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 482,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Emerson's relationship with AspenTech evolve between 2022 and 2024, particularly in terms of financial stake and operational integration?",
      "original_answer": "In 2022, Emerson had a financial stake in AspenTech valued at $8,326 million, as shown in the balance sheet following acquisitions and currency adjustments. By 2024, Emerson's relationship had transformed significantly: it contributed the AspenTech Industrial Software Business along with $6.0 billion in cash to form 'New AspenTech,' retaining a 55% ownership stake in the newly structured company. This indicates a strategic restructuring rather than a simple financial investment, with increased operational integration and a formalized majority ownership.",
      "llm_answer": "\nBetween 2022 and 2024 Emerson moved from a minority holding to a controlling interest in AspenTech – it acquired roughly $6 billion of cash consideration that gave it a **55 % (fully‑diluted) stake** in the company (EMR_10‑K‑2024 p. 26).  As a result of that business combination, AspenTech’s goodwill and intangible assets (e.g., the $8.3 bn goodwill balance shown for AspenTech in EMR_10‑K‑2022 p. 61) were consolidated into Emerson’s balance sheet, and the combined “New AspenTech” continues to operate under its historic name while its financial results are now reported within Emerson’s Software & Control segment (EMR_10‑K‑2024 pp. 22‑23, 25).  This created both a significant equity stake for Emerson and full operational integration of AspenTech’s software business into Emerson’s portfolio.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains both correct and problematic elements. CORRECT ELEMENTS: (1) The 55% ownership stake in New AspenTech is accurate; (2) The $8.3 billion goodwill figure from 2022 is correctly cited; (3) The operational integration into the Software & Control segment is accurate; (4) The characterization of moving from minority to controlling interest is correct; (5) The reference to the $6 billion cash contribution is accurate. PROBLEMATIC ELEMENTS: (1) The LLM states Emerson 'acquired roughly $6 billion of cash consideration' which is misleading phrasing - the ground truth indicates Emerson CONTRIBUTED $6 billion in cash (along with the AspenTech Industrial Software Business) to form New AspenTech, not that it acquired cash; (2) The statement about 'minority holding to controlling interest' is somewhat imprecise - the ground truth indicates the 2022 stake was valued at $8.326 billion (a significant investment), not clearly characterized as 'minority' in the original answer; (3) The LLM's description of the transaction mechanics is somewhat confused - it presents the relationship as if Emerson acquired AspenTech when actually it was a restructuring where Emerson contributed assets to form a new entity. MULTI-HOP REASONING: The LLM successfully synthesizes information across multiple years and documents (2022 balance sheet data, 2024 restructuring details, segment reporting), demonstrating adequate multi-hop reasoning. However, the characterization of the transaction direction (acquisition vs. contribution) represents a meaningful misunderstanding of the operational integration mechanics. The answer captures the evolution in financial stake and operational integration but mischaracterizes the nature of the 2024 transaction.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 478,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Starbucks' position in interest rate swaps evolve between 2022 and 2023, particularly in terms of their classification and associated liabilities?",
      "original_answer": "In 2022, Starbucks had an interest rate swap classified as a long-term liability with a value of $34.0 million. By 2023, the company's interest rate swaps were categorized under both current and long-term liabilities, with $0.4 million listed under accrued liabilities (current) and $19.2 million under other long-term liabilities. This reflects a shift in the classification and a net decrease in the overall liability associated with interest rate swaps from $34.0 million in 2022 to $19.6 million in 2023.",
      "llm_answer": "\nBetween fiscal 2022 and 2023 Starbucks continued to treat its interest‑rate swaps as **designated fair‑value hedges of long‑term debt**.  In 2022 the swaps were recorded as a relatively small accrued‑liability of **$12 million** (shown under “Accrued liabilities”) and a **$(52.3 million)** cumulative fair‑value hedge adjustment that reduced the carrying amount of the hedged debt; by the end of 2023 the same swaps had moved to the **long‑term‑liability** line (≈ $41 million) and the cumulative hedge adjustment remained negative, reflecting ongoing fair‑value movements.  Consequently, earnings‑impact losses fell from **$65 million** in 2022 to **$18.7 million** in 2023, but the swaps stayed classified as fair‑value hedges with a larger, long‑term derivative liability on the balance sheet.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and contradicts the ground truth on multiple critical dimensions:\n\n1. QUANTITATIVE ACCURACY - MAJOR ERRORS:\n   - Ground truth: 2022 liability = $34.0 million (long-term only)\n   - LLM claims: 2022 = $12 million (accrued) + $(52.3 million) hedge adjustment\n   - Ground truth: 2023 liability = $19.6 million total ($0.4M current + $19.2M long-term)\n   - LLM claims: 2023 = ~$41 million (long-term)\n   - The LLM's numbers are substantially different from ground truth across both years\n   - The LLM introduces numbers ($12M, $52.3M, $41M, $65M, $18.7M) that do not match the ground truth figures\n\n2. CLASSIFICATION ACCURACY:\n   - Ground truth: 2022 = long-term liability only ($34.0M)\n   - LLM claims: 2022 = accrued liability ($12M) + hedge adjustment\n   - Ground truth: 2023 = split between current ($0.4M) and long-term ($19.2M)\n   - LLM claims: 2023 = moved to long-term (~$41M)\n   - The LLM's classification narrative contradicts the ground truth evolution\n\n3. MULTI-HOP REASONING:\n   - The LLM appears to have synthesized information about fair-value hedges and hedge accounting mechanics, but applied incorrect numbers\n   - The discussion of cumulative hedge adjustments and earnings impacts introduces concepts not verified in ground truth\n   - The reasoning about fair-value hedge treatment may be conceptually sound but is applied to wrong numerical values\n\n4. DIRECTIONAL ACCURACY:\n   - Ground truth shows: Net decrease from $34.0M (2022) to $19.6M (2023)\n   - LLM shows: Increase from $12M to ~$41M (contradicts the decrease)\n   - This is a fundamental directional error in the evolution narrative\n\n5. MISSING GROUND TRUTH ELEMENTS:\n   - LLM fails to mention the specific 2023 split: $0.4M current + $19.2M long-term\n   - LLM fails to capture the net decrease in total liability\n   - LLM introduces unverified earnings impact figures ($65M, $18.7M)\n\nThe answer demonstrates some understanding of interest rate swap accounting concepts but applies substantially incorrect financial figures throughout, making it factually unreliable for decision-making purposes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 577,
        "total_tokens": 1905
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did NextEra Energy Resources' financial commitment and involvement in the Mountain Valley Pipeline evolve from 2022 to 2023?",
      "original_answer": "In 2022, NextEra Energy Resources recorded an impairment charge of approximately $0.8 billion related to its equity method investment in the Mountain Valley Pipeline, which was fully written off due to the very low probability of pipeline completion. By 2023, despite the ongoing challenges, NEE's subsidiary NEER maintained a 32.8% equity investment in the joint venture and committed to a 20-year natural gas transportation agreement with an annual obligation of approximately $70 million, subject to the completion of construction.",
      "llm_answer": "\nIn 2022 NextEra Energy Resources recorded a $0.8 bn impairment charge (a $0.6 bn after‑tax write‑off) and eliminated its $0.6 bn equity‑method investment in the Mountain Valley Pipeline after a court vacatur made completion appear highly unlikely. By the end of 2023 the company still held a 32.8 % equity stake in the project through NEER and disclosed a planned $1.06 bn equity contribution for 2024, showing that although the investment had been largely written down, it remained on the books with ongoing capital‑expenditure commitments that are tied to the pipeline’s eventual construction.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general narrative of NextEra's evolving commitment to MVP but contains significant quantitative discrepancies and introduces unsupported information. CORRECT ELEMENTS: (1) 2022 impairment charge of $0.8 billion is accurate; (2) 32.8% equity stake in 2023 is correct; (3) General narrative about court vacatur and low completion probability is appropriate; (4) Recognition of ongoing capital commitments is relevant. CRITICAL ERRORS: (1) The LLM introduces a $1.06 billion equity contribution planned for 2024 that is NOT mentioned in the ground truth answer and cannot be verified from the provided context; (2) The ground truth specifies a 20-year natural gas transportation agreement with ~$70 million annual obligation, which the LLM completely omits - this is a key component of the 2023 commitment; (3) The LLM states the investment was 'largely written down' and 'on the books with ongoing capital-expenditure commitments' but doesn't clearly articulate the distinction between the impairment charge and the maintained equity stake. MULTI-HOP REASONING: The LLM attempts to synthesize 2022 and 2023 information but fails to include the critical 2023 commitment detail (the $70M annual transportation agreement obligation). The introduction of the $1.06B 2024 contribution appears to be fabricated or from an unreliable source. QUANTITATIVE ISSUES: While the $0.8B impairment and 32.8% stake are correct, the omission of the $70M annual obligation and introduction of the unverified $1.06B figure significantly undermines quantitative accuracy. The answer is partially correct but materially incomplete regarding 2023 commitments and contains potentially false information about 2024 plans.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 469,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How has The Coca-Cola Company's investment in equity and debt securities related to its captive insurance company reinsuring group annuity insurance contracts evolved between 2023 and 2024?",
      "original_answer": "In 2023, The Coca-Cola Company reported that its captive insurance company reinsuring group annuity insurance contracts held $1,643 million in equity and debt securities as part of its solvency capital funds. By 2024, this amount increased to $1,883 million, indicating a growth in the company's investment in these securities over the year.",
      "llm_answer": "\nBetween the end of 2023 and the end of 2024 the Company’s solvency‑capital portfolio that backs the captive insurance company’s group‑annuity reinsurance (the vehicle that funds European and Canadian pension‑plan obligations) expanded from **$1.643 billion** of combined equity and debt securities to **$1.883 billion**—an increase of roughly **$240 million (≈15 %)**.  This continues the upward trend seen in prior years (the balance was $1.378 billion at the end of 2022), reflecting the Company’s ongoing practice of investing a majority of the captive’s required capital in market‑able equity and debt securities that are recorded in “other non‑current assets” because they cannot be used to meet current insurance liabilities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. QUANTITATIVE VERIFICATION: All key numbers are correct - 2023: $1,643 million ($1.643 billion), 2024: $1,883 million ($1.883 billion), increase of $240 million. The percentage calculation (≈15%) is accurate: ($240M / $1,643M = 14.6%, rounds to ~15%). The additional 2022 comparison figure of $1,378 billion is also correct. ENTITY ACCURACY: Correctly identifies The Coca-Cola Company, the captive insurance company, group annuity reinsurance contracts, and the relevant time periods (2023-2024). MULTI-HOP REASONING: Excellent synthesis - the answer correctly connects the solvency-capital portfolio concept to the equity/debt securities holdings, explains the purpose (funding European and Canadian pension obligations), and notes the accounting treatment (recorded in 'other non-current assets'). COMPLETENESS: Addresses the core question about evolution between 2023-2024, provides the specific dollar amounts, calculates the change, and adds valuable context about the trend and investment strategy. MINOR CONSIDERATIONS: The answer goes beyond the ground truth by providing additional context (2022 comparison, accounting treatment, investment strategy rationale), which enhances rather than detracts from accuracy. The format variation ($1.643 billion vs $1,643 million) is semantically equivalent and acceptable. All calculations are mathematically sound and verifiable.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 397,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How has Intel's approach to the Intel 4 process node evolved from 2022 to 2024, particularly in terms of production status and strategic positioning within Intel's product roadmap?",
      "original_answer": "In 2022, Intel was incurring higher period charges related to the ramp-up of Intel 4, indicating early-stage production challenges and investment. By 2024, Intel 4 had transitioned to high-volume manufacturing in Ireland and became the process node for the high-volume Intel Core Ultra processor, marking its strategic importance in Intel's product roadmap. This evolution shows a shift from initial investment and production ramp-up in 2022 to full-scale production and product integration by 2024.",
      "llm_answer": "\nFrom 2022 through 2024 Intel moved Intel 4 from a design‑ready EUV node to a production‑ready platform: the Core Ultra processor became the first high‑volume client chip shipped on Intel 4 in 2023, and by the end of 2024 the company had transferred high‑volume manufacturing of Intel 4 to its Ireland fab, expanding capacity and positioning the node to carry an increasing share of its processor portfolio. Intel 4 now serves as the foundational technology for upcoming products and for the next‑generation Intel 3 and 18A nodes, underpinning Intel’s product roadmap and its broader foundry strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides a reasonable narrative of Intel 4's evolution but contains a significant factual error regarding timing. The ground truth states that Intel Core Ultra became the high-volume processor on Intel 4 by 2024, while the LLM claims this occurred in 2023. This is a material discrepancy in a key factual claim. The LLM correctly identifies: (1) the transition from design-ready to production-ready status, (2) the shift to high-volume manufacturing in Ireland, (3) Intel 4's strategic importance in the product roadmap, and (4) its role as foundational technology for Intel 3 and 18A nodes. However, the 2023 vs 2024 date error for Core Ultra's high-volume shipment is a quantitative accuracy issue that undermines the timeline narrative. The LLM also adds contextual information about foundry strategy that, while potentially accurate, goes beyond what the ground truth explicitly states. The answer demonstrates good qualitative reasoning about the evolution from ramp-up to full-scale production, but the date discrepancy and the claim about 2023 shipments (when ground truth indicates 2024 positioning) represent factual errors that prevent a higher score. The multi-hop synthesis is generally sound, but the temporal accuracy is compromised.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 354,
        "total_tokens": 1638
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Emerson's strategic relationship with AspenTech evolve between 2022 and 2024, particularly in terms of ownership structure and financial integration?",
      "original_answer": "In 2022, AspenTech was described as a strategic partner of Emerson, with no mention of ownership stakes or integration into Emerson's financials. By 2024, Emerson had merged its industrial software business with AspenTech, creating 'New AspenTech,' and retained a 55% ownership stake in the newly formed entity. This marked a significant shift from a partnership to a partially owned subsidiary structure. Additionally, AspenTech's financials were now integrated into Emerson's results, with the acquisition positively impacting gross margins by 0.6 percentage points in 2023 and influencing SG&A expenses in 2024 due to the deeper integration.",
      "llm_answer": "\nBetween 2022 and 2024 Emerson’s stake in AspenTech increased from the ~55 % fully‑diluted ownership it obtained in May 2022 (when it contributed two of its own software businesses and about $6 bn cash to form “New AspenTech”) to roughly 57 % by the end of 2024, and in November 2024 the company announced a proposal to buy the remaining shares at $240 per share—effectively moving toward full ownership.  The 2022 transaction integrated AspenTech’s industrial‑software portfolio into Emerson’s results (its software businesses added about 9.5 % of Emerson’s 2024 sales and lifted gross margin), and the 2024 acquisition plan would absorb the rest of AspenTech using cash on hand and committed credit facilities.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) CRITICAL ERROR - The LLM states the 2022 transaction occurred in 'May 2022' with Emerson obtaining '~55% fully-diluted ownership' by contributing 'two of its own software businesses and about $6 bn cash.' The ground truth indicates that in 2022, AspenTech was merely described as a 'strategic partner' with 'no mention of ownership stakes.' The major merger/integration transaction creating 'New AspenTech' with 55% ownership occurred by 2024, not 2022. (2) TIMELINE CONFUSION - The LLM conflates the 2022 and 2024 events, placing the merger transaction in 2022 when it should be 2024. (3) OWNERSHIP PROGRESSION ERROR - The LLM claims ownership increased from '~55%' to 'roughly 57%' between 2022-2024, but the ground truth shows the 55% stake was established by 2024 (not 2022), with no mention of a 57% intermediate position. (4) PARTIAL CREDIT - The LLM correctly identifies: the 55% ownership stake in the final entity, the November 2024 acquisition proposal at $240/share, the integration of software businesses into Emerson's financials, and the positive impact on gross margins. However, these correct elements are embedded within a fundamentally incorrect timeline and transaction structure. (5) MISSING CONTEXT - The LLM fails to clearly distinguish between the 2022 partnership status and the 2024 merger/integration event, which is the core evolution the question asks about. The answer suggests continuous ownership from 2022 onward rather than a shift from partnership to ownership in 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 440,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How has Intel's approach to the Intel 4 process node evolved from 2022 to 2024, particularly in terms of its manufacturing readiness and performance improvements?",
      "original_answer": "In 2022, Intel 4 was newly introduced as part of a restructured naming convention for manufacturing process nodes, signaling its position as a next-generation node following Intel 7. By 2024, Intel 4 had transitioned from a conceptual roadmap item to a fully realized product, with high-volume manufacturing ramped up in Ireland. Intel 4, as the company's first EUV lithography node, delivered a 20% performance-per-watt improvement over Intel 7 and was used in the production of the Intel Core Ultra processor, which began shipping in 2023. This represents a significant evolution from its initial naming in 2022 to full-scale production and performance quantification by 2024.",
      "llm_answer": "\nFrom 2022 to 2024 Intel moved Intel 4 from a roadmap announcement to a production‑ready EUV node: the first high‑volume client product (Core Ultra) shipped in 2023, and by the end of 2024 the company had ramped Intel 4 into high‑volume manufacturing in Ireland, where it is expected to represent an increasing share of processor output in 2025.  Compared with the prior Intel 7 node, Intel 4 delivers roughly 20 % higher performance‑per‑watt and greater density, and the experience gained has been used to accelerate the next‑generation Intel 3 and Intel 18A nodes while the earlier Intel 20A effort was cancelled.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive coverage of Intel 4's evolution from 2022 to 2024. STRENGTHS: (1) All key numeric values are correct - the 20% performance-per-watt improvement is accurately stated and matches ground truth; (2) Timeline is accurate - correctly identifies 2022 as introduction year, 2023 as Core Ultra shipping, and 2024 as high-volume manufacturing ramp in Ireland; (3) Technical details are precise - correctly identifies Intel 4 as first EUV lithography node, mentions density improvements, and accurately references Core Ultra processor; (4) Multi-hop synthesis is sound - successfully connects the evolution from roadmap announcement through production to performance quantification; (5) Additional context provided (Intel 3, Intel 18A acceleration, Intel 20A cancellation) adds relevant detail not contradicting ground truth. MINOR CONSIDERATIONS: (1) The LLM answer includes forward-looking statements about 2025 market share expectations that go slightly beyond the ground truth's 2024 endpoint, though this is reasonable extrapolation rather than factual error; (2) The phrase 'roughly 20%' vs ground truth's '20%' is semantically equivalent and appropriately cautious; (3) The answer mentions 'greater density' which is implied but not explicitly stated in ground truth - this is a reasonable inference from EUV node progression. VERIFICATION: All quantitative claims (20% improvement, 2023 shipping, 2024 Ireland ramp, EUV lithography) are factually correct. The multi-hop reasoning correctly synthesizes information about manufacturing readiness progression and performance improvements across the specified time period. No calculation errors or factual contradictions identified.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 475,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How has the role and positioning of InterStim Micro evolved within MDT's Pelvic Health therapies between 2022 and 2024?",
      "original_answer": "In 2022, InterStim Micro was listed as one of several neurostimulators within MDT's Pelvic Health product portfolio, which also included InterStim X and InterStim II, used to treat overactive bladder, urinary retention, and fecal incontinence. By 2024, InterStim Micro was specifically highlighted as the rechargeable neurostimulator option, differentiated from the recharge-free InterStim X and InterStim II. This indicates a more defined strategic positioning of InterStim Micro as the rechargeable variant within the broader InterStim therapy lineup, with an emphasis on its continued global growth and adoption.",
      "llm_answer": "\nBetween 2022 and 2024 Medtronic promoted the InterStim Micro from a niche, rechargeable neurostimulator for over‑active bladder and fecal incontinence to a central pillar of its Pelvic‑Health offering.  The device is now highlighted alongside the InterStim X and InterStim II in the company’s Neuroscience segment reporting and growth outlook, underscoring its expanded role as a flagship, integrated therapy for pelvic‑floor disorders.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "ANALYSIS: The LLM answer contains both accurate and inaccurate elements when compared to the ground truth.\n\nCORRECT ELEMENTS:\n- Correctly identifies InterStim Micro, InterStim X, and InterStim II as the three neurostimulator options\n- Correctly notes the time period (2022-2024)\n- Correctly identifies Medtronic/MDT as the company\n- Correctly mentions pelvic health/pelvic-floor disorders as the therapeutic area\n- Correctly identifies overactive bladder and fecal incontinence as indications\n- Correctly notes that InterStim Micro is rechargeable\n\nINCORRECT/PROBLEMATIC ELEMENTS:\n1. CHARACTERIZATION ERROR: The LLM describes InterStim Micro as being \"promoted from a niche, rechargeable neurostimulator\" to a \"central pillar\" and \"flagship, integrated therapy.\" The ground truth indicates a more modest evolution: InterStim Micro was already listed as one of several neurostimulators in 2022, and by 2024 it was \"specifically highlighted as the rechargeable neurostimulator option.\" This is a differentiation/clarification of positioning, not a promotion from niche to flagship status.\n\n2. OVERSTATED CLAIMS: The phrase \"central pillar of its Pelvic-Health offering\" and \"flagship, integrated therapy\" goes beyond what the ground truth supports. The ground truth states it was \"more defined strategic positioning\" with \"emphasis on its continued global growth and adoption\" - not that it became a central pillar or flagship product.\n\n3. MISSING CONTEXT: The LLM fails to mention that InterStim X and InterStim II are characterized as \"recharge-free\" options, which is the key differentiator that defines InterStim Micro's positioning (as the rechargeable alternative).\n\n4. UNSUPPORTED DETAIL: The reference to \"Neuroscience segment reporting and growth outlook\" appears to be an inference not explicitly stated in the ground truth.\n\nMULTI-HOP REASONING: The LLM attempted to synthesize information across the 2022-2024 period but misinterpreted the nature of the evolution, overstating the magnitude of the positioning change.\n\nQUANTITATIVE ACCURACY: No specific numbers, dates, or calculations were required or provided, so this scores well on what was presented.\n\nQUALITATIVE ACCURACY: The core reasoning is flawed because the LLM mischaracterized the evolution as a promotion to \"flagship\" status rather than a clarification of its specific role as the rechargeable option within the portfolio.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 649,
        "total_tokens": 1906
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has the disclosure around the dilutive effect of LTIP Units evolved from 2022 to 2024, particularly in terms of material impact across reporting periods?",
      "original_answer": "In 2022, the disclosure stated that LTIP units were exchangeable for common stock and that no securities had a material dilutive effect for the years ended December 31, 2021, 2020, and 2019. By 2024, the disclosure simplified to state that no securities had a material dilutive effect for the years ended December 31, 2024, 2023, and 2022, without explicitly referencing the exchangeability of LTIP units into common stock. This indicates a reduction in the level of detail provided about LTIP units' conversion features, while maintaining the same conclusion regarding dilution impact.",
      "llm_answer": "\nFrom 2022 through 2024 the filings repeatedly note that LTIP Units are “potentially dilutive” but explicitly state that “no securities had a material dilutive effect” for each of those years, and that the company does not adjust net income attributable to common stockholders or the weighted‑average share (or unit) counts for income allocable to limited partners/units because such an adjustment would have no dilutive impact. Consequently, the disclosure has remained consistent—LTIP Units are mentioned as a possible source of dilution, yet their actual dilutive influence is deemed immaterial across the 2022‑2024 reporting periods.",
      "correctness_score": 4,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ISSUES: (1) The LLM answer fundamentally mischaracterizes the evolution of disclosure. The ground truth explicitly states there was a REDUCTION in detail from 2022 to 2024 - specifically that 2022 explicitly referenced exchangeability of LTIP units into common stock, while 2024 removed this detail. The LLM claims disclosure 'remained consistent,' which directly contradicts the ground truth's core finding about evolution/change. (2) The LLM introduces language ('potentially dilutive,' adjustments to net income/weighted-average shares) that is not present in the ground truth answer and appears to be fabricated or from different source material. The ground truth makes no mention of these specific adjustment mechanisms. (3) MULTI-HOP REASONING FAILURE: The question asks specifically about HOW disclosure 'evolved' - implying change over time. The ground truth identifies a specific evolution (explicit exchangeability language in 2022 → simplified statement in 2024). The LLM fails to identify this evolution and instead claims consistency. (4) POSITIVE ELEMENTS: The LLM correctly identifies that LTIP units are mentioned across the period and that no material dilutive effect was found in all years mentioned. The years (2022-2024) are correct. (5) The LLM's statement about 'reduction in level of detail' aligns with ground truth, but this insight is buried and contradicted by the claim of consistency. VERDICT: While some individual facts are correct (years, no material dilution conclusion), the answer fundamentally fails to capture the key evolution in disclosure that the question and ground truth emphasize. The claim of consistency directly contradicts the ground truth's finding of reduced detail/simplified disclosure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 475,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has MetLife's approach to managing cash buffer needs in relation to stock repurchases evolved from 2022 to 2024, particularly in terms of remaining repurchase authorization and liquidity considerations?",
      "original_answer": "In 2022, MetLife had $1.5 billion remaining under its $3.0 billion common stock repurchase authorization as of December 31, 2021, indicating a significant but partially utilized capacity for returning capital to shareholders. By 2024, the company emphasized increased caution around cash buffer needs, noting that maintaining or increasing liquidity buffers could limit capital available for repurchases, acquisitions, and innovation. This reflects a shift from a more active repurchase posture in 2022 to a more conservative liquidity strategy in 2024, influenced by regulatory, market, and internal capital considerations.",
      "llm_answer": "\nFrom 2022 through 2024 MetLife has kept the board‑approved $3 billion repurchase ceiling, but the unused portion of that authority has been treated increasingly as part of a broader cash‑buffer strategy.  The 2022 filing noted roughly $1.5 billion of capacity remaining at the end of 2021, and the 2024 filing emphasizes that any additional cash reserves needed for liquidity or regulatory risk may further constrain the amount of stock that can be repurchased, effectively reducing the practical repurchase authorization available after 2022.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively captures the evolution of MetLife's repurchase strategy from 2022 to 2024. STRENGTHS: (1) Correctly identifies the $3 billion board-approved repurchase ceiling maintained throughout the period; (2) Accurately cites the $1.5 billion remaining capacity as of end of 2021 (reported in 2022 filing); (3) Properly synthesizes the shift from active repurchase posture to conservative liquidity strategy; (4) Correctly identifies the key constraint: increased cash buffer needs limiting practical repurchase authorization; (5) Accurately characterizes the multi-hop reasoning connecting regulatory/market considerations to capital allocation decisions. MINOR WEAKNESSES: (1) The phrase 'effectively reducing the practical repurchase authorization available after 2022' is slightly ambiguous - it could be clearer that this refers to the practical constraint rather than formal authorization reduction; (2) Could have been more explicit about the 'regulatory, market, and internal capital considerations' mentioned in ground truth, though these are implied; (3) The phrasing 'unused portion...treated increasingly as part of a broader cash-buffer strategy' is accurate but slightly less direct than ground truth's explicit statement about 'maintaining or increasing liquidity buffers could limit capital available for repurchases.' QUANTITATIVE VERIFICATION: All numbers are correct ($3B authorization, $1.5B remaining at end of 2021). MULTI-HOP SYNTHESIS: Successfully connects information across 2022 and 2024 filings to show evolution in approach. The answer demonstrates sound reasoning about how regulatory and market factors influenced capital allocation strategy over the period.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 475,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did Starbucks' foreign currency - other derivative asset and liability positions evolve from fiscal year 2022 to 2023, and what specific changes occurred in their balance sheet classifications?",
      "original_answer": "In fiscal year 2022, Starbucks reported foreign currency - other derivative assets of $103.9 million recognized in OCI before reclassifications and $22.0 million reclassified from AOCI to earnings. By fiscal year 2023, the foreign currency - other derivative assets on the balance sheet were reported as $1.9 million in prepaid expenses and other current assets and $1.7 million in other long-term assets as of October 1, 2023, while derivative liabilities were $4.7 million in accrued liabilities and $4.1 million in other long-term liabilities. This represents a significant reduction in asset positions compared to the prior year, with a shift in balance sheet classification.",
      "llm_answer": "\nFrom fiscal 2023 to fiscal 2024 the “foreign‑currency‑other” derivative fell sharply in size – the asset recorded in prepaid expenses and other current assets dropped from **$32.0 million (2023) to $1.9 million (2024)**, and the long‑term portion fell from **$22.9 million to $1.7 million**.  At the same time the liability grew from virtually none in 2023 to **$4.7 million in accrued liabilities and $4.1 million in other long‑term liabilities in 2024**.  Consequently, the derivatives moved from being reported solely as prepaid‑expense assets (and long‑term assets) in 2023 to being split between smaller prepaid‑expense assets and new liability classifications (accrued liabilities and other long‑term liabilities) on the 2024 balance sheet.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer is fundamentally incorrect on multiple dimensions: (1) WRONG TIME PERIOD: The question asks about FY2022 to FY2023, but the LLM discusses FY2023 to FY2024 instead. This is a complete misalignment with the question. (2) WRONG NUMBERS: The LLM cites $32.0 million and $22.9 million for 2023 positions, but the ground truth shows $1.9 million in current assets and $1.7 million in long-term assets for FY2023. These are dramatically different figures. (3) MISSING KEY DATA: The ground truth includes important FY2022 information ($103.9 million in OCI and $22.0 million reclassified from AOCI), which the LLM completely omits. (4) INCORRECT SYNTHESIS: The LLM fails to properly synthesize the year-over-year evolution from 2022 to 2023 as requested. Instead, it discusses a different period (2023-2024) with different numbers. (5) BALANCE SHEET CLASSIFICATION: While the LLM correctly identifies that liabilities emerged ($4.7M accrued, $4.1M long-term), it mischaracterizes the prior year asset positions and fails to explain the significant reduction from FY2022 levels. The answer demonstrates a fundamental failure to address the correct fiscal years and provides incorrect quantitative data that contradicts the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 354,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has Procter & Gamble's global cash management strategy evolved in relation to its restructuring activities and corporate-level financial performance between fiscal 2022 and fiscal 2024?",
      "original_answer": "In fiscal 2022, Procter & Gamble incurred restructuring costs within its historical range of $250 to $500 million before tax, with $147 million in restructuring accruals as of June 30, 2022. Corporate net earnings improved by $872 million to $485 million, partly due to tax benefits and lower restructuring charges. By fiscal 2024, restructuring costs increased significantly to $659 million before tax, including $216 million in non-cash foreign currency translation losses. Corporate net earnings decreased by $1.0 billion, largely due to the $1.4 billion impairment charge of the Gillette intangible asset and incremental restructuring charges. This indicates a shift toward more aggressive restructuring actions, particularly in Enterprise Markets like Nigeria, which impacted both cash flow and earnings. The global cash management strategy remained focused on liquidity and tax considerations, but faced increased pressure from these restructuring activities and impairment charges.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2024 P&G kept its cash‑management anchor on strong operating cash flow to fund dividends, share‑repurchases and strategic investments, but the way that cash was allocated changed. In 2022 the company executed a $10 bn repurchase program and supported a modest restructuring effort (≈ $250‑$500 m annual spend) with about 65 % of the $147 m accrued charges settled in cash. By 2024 it launched a broader portfolio‑rationalisation restructuring that generated $659 m of before‑tax charges—including $216 m of foreign‑currency translation losses—raising accrued restructuring liabilities to $166 m (≈ 64 % cash‑settled) while corporate‑level earnings turned negative, showing that cash was now being directed toward larger‑scale restructuring and impairment costs as part of the overall liquidity strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates good understanding of the overall narrative and multi-hop synthesis but contains several significant quantitative errors and omissions:\n\nCORRECT ELEMENTS:\n- Correctly identifies the shift from modest restructuring (~$250-500M) in 2022 to more aggressive restructuring ($659M) in 2024\n- Accurately cites the $216M foreign currency translation losses in 2024\n- Correctly notes the $147M restructuring accruals as of June 30, 2022\n- Properly synthesizes the connection between restructuring activities and cash allocation strategy\n- Appropriately contextualizes the shift toward larger-scale restructuring and impairment costs\n- Good narrative flow connecting cash management strategy evolution to restructuring activities\n\nINCORRECT/PROBLEMATIC ELEMENTS:\n1. QUANTITATIVE ERRORS:\n   - States accrued restructuring liabilities raised to $166M in 2024, but ground truth doesn't provide this specific figure for 2024 comparison\n   - Claims \"≈ 64% cash-settled\" for 2024 accruals, but this calculation cannot be verified from ground truth and appears inconsistent with the 65% figure cited for 2022\n   - The $10B repurchase program is mentioned but not verified in ground truth context\n\n2. MISSING KEY INFORMATION:\n   - Fails to mention the $872M improvement in corporate net earnings in fiscal 2022\n   - Omits the critical $1.4B Gillette intangible asset impairment charge in fiscal 2024\n   - Does not explicitly state that corporate net earnings decreased by $1.0B in 2024\n   - Missing specific mention of Enterprise Markets like Nigeria as a driver of restructuring\n   - Doesn't clearly articulate that corporate-level earnings turned negative (states \"turned negative\" but ground truth shows $485M in 2022 vs. negative in 2024)\n\n3. REASONING GAPS:\n   - While the multi-hop synthesis is generally sound, the answer doesn't fully explain the causal relationship between the Gillette impairment and the overall cash management strategy shift\n   - The connection between tax benefits mentioned in ground truth and cash management strategy is not addressed\n\nQUANTITATIVE ACCURACY: The core restructuring numbers ($250-500M, $659M, $216M, $147M) are correct, but the introduction of unverified figures ($166M accruals, 64% cash settlement rate) and missing key earnings figures ($872M improvement, $1.4B impairment, $1.0B decrease) reduces accuracy.\n\nQUALITATIVE ACCURACY: The reasoning about cash allocation strategy evolution and the shift toward more aggressive restructuring is sound and well-articulated, though incomplete in addressing all contributing factors.\n\nCONTEXTUAL RELEVANCE: The answer directly addresses the question about evolution of cash management strategy in relation to restructuring and financial performance, maintaining good relevance throughout.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1466,
        "completion_tokens": 745,
        "total_tokens": 2212
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has NVIDIA's positioning and application of Omniverse evolved between 2022 and 2023, particularly in terms of its integration with enterprise solutions and simulation technologies?",
      "original_answer": "In 2022, NVIDIA Omniverse was positioned primarily as a virtual world simulation and collaboration platform for 3D workflows, emphasizing its availability as a software subscription for enterprise use and free for individuals. It was highlighted in use cases such as virtual car showrooms, surgical training, and architectural walkthroughs, and was integrated with DRIVE Sim software for automotive simulation and validation. By 2023, Omniverse had evolved into a more robust development platform and operating system for building virtual world simulation applications. It was increasingly tied to industrial enterprises for digitalizing complex physical assets and processes, including digital twins of factories and real-time 3D product configurators. Additionally, it was more explicitly linked to NVIDIA's accelerated computing infrastructure both on-premises and in the cloud, indicating a broader integration with enterprise-grade simulation and AI workflows.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2023 NVIDIA moved Omniverse from a creator‑focused, subscription‑based 3‑D collaboration tool toward an enterprise‑grade, cloud‑native platform (e.g., NVIDIA Omniverse Cloud on Microsoft Azure) that serves as the backbone of the industrial “metaverse.”  In 2023 the company highlighted its tighter integration with the AI‑Enterprise software stack, DGX Cloud, and data‑center compute, positioning Omniverse as a scalable simulation engine for industrial use‑cases such as digital twins, automotive design and architectural walkthroughs, rather than just a graphics‑collaboration service.  This evolution reflects a strategic shift to embed Omniverse within enterprise AI and simulation workflows, offering managed, AI‑accelerated simulation services to large‑scale customers.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth on the core evolution of NVIDIA Omniverse between 2022 and 2023. STRENGTHS: (1) Correctly identifies the shift from creator-focused/subscription-based tool to enterprise-grade platform; (2) Accurately captures the integration with enterprise solutions (AI-Enterprise stack, DGX Cloud, data-center compute); (3) Properly synthesizes the evolution toward industrial applications including digital twins, automotive design, and architectural walkthroughs; (4) Correctly emphasizes the cloud-native positioning (Azure integration); (5) No quantitative errors or incorrect dates/metrics. MINOR GAPS: (1) The ground truth mentions specific 2022 use cases (virtual car showrooms, surgical training, DRIVE Sim integration) that the LLM answer doesn't explicitly reference, though it does mention automotive design and architectural walkthroughs; (2) The ground truth's mention of 'free for individuals' positioning in 2022 is not captured; (3) The ground truth's specific reference to 'real-time 3D product configurators' as a 2023 evolution is not mentioned. MULTI-HOP REASONING: The LLM successfully synthesizes information across the two fiscal years and correctly identifies the strategic shift toward enterprise AI/simulation workflows. The reasoning about embedding Omniverse within enterprise infrastructure is sound and well-supported. SEMANTIC EQUIVALENCE: The LLM's characterization of the evolution is semantically equivalent to the ground truth - both describe a shift from general-purpose collaboration to enterprise-focused simulation platform. The addition of specific cloud platform details (Azure) and AI-Enterprise stack integration adds valuable context not contradicting the ground truth. Overall, this is a high-quality answer with minor omissions of specific use cases and pricing models from 2022.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 508,
        "total_tokens": 1961
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did AMT's financial commitments related to communications sites evolve from 2023 to 2024, particularly in terms of anticipated spending and future obligations?",
      "original_answer": "In 2023, AMT anticipated spending approximately $450 million related to data center assets as part of its construction plans for 2,500 to 3,500 communications sites globally. By 2024, the company disclosed a much larger financial commitment, with an estimated undiscounted future cash outlay of $4.5 billion for asset retirement obligations tied to leased sites hosting communications infrastructure. This indicates a significant increase in long-term financial exposure related to communications sites, shifting from near-term capital allocation planning in 2023 to a more mature and substantial obligation structure in 2024.",
      "llm_answer": "\nFrom 2023 to 2024 AMT’s contractual cash needs for its communications sites grew materially: the 2024 “Material Cash Requirements” table projects $36.8 bn of debt maturities and $11.5 bn of operating‑lease payments through 2029—up from roughly $33 bn of debt and $10.8 bn of leases a year earlier—while the company raised its 2024 capital‑expenditure outlook to $1.55‑$1.66 bn (including about $450 m earmarked for data‑center assets), signaling higher spending on tower and infrastructure projects.  In addition, the estimated asset‑retirement obligation stands at $4.5 bn and restricted cash held for site‑related obligations increased to $108.6 m, underscoring the expanding scale of AMT’s future financial commitments to its communications sites.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "ASSESSMENT: The LLM answer contains both correct and incorrect information, with significant divergence from the ground truth on key points.\n\nCORRECT ELEMENTS:\n- The $4.5 billion asset retirement obligation figure is accurate and matches ground truth\n- The $450 million data center asset spending is correctly cited\n- The mention of restricted cash ($108.6M) adds relevant detail\n- The general direction of increasing financial commitments is correct\n\nINCORRECT/PROBLEMATIC ELEMENTS:\n1. SCOPE MISMATCH: The LLM answer focuses heavily on debt maturities ($36.8B), operating-lease payments ($11.5B), and capital expenditure guidance ($1.55-$1.66B) - these are broader corporate financial metrics, not specifically \"communications sites\" commitments as the question asks\n2. MISSING KEY COMPARISON: The ground truth specifically highlights the 2023 context ($450M anticipated spending for 2,500-3,500 communications sites) versus 2024 ($4.5B asset retirement obligations). The LLM answer mentions the $450M but doesn't establish the 2023 baseline for comparison\n3. MISCHARACTERIZATION: The LLM conflates general corporate cash requirements with communications-site-specific obligations. The question asks specifically about communications sites evolution, not overall debt and lease obligations\n4. INCOMPLETE SYNTHESIS: While the LLM mentions both years, it doesn't clearly articulate the shift from \"near-term capital allocation planning\" (2023) to \"mature obligation structure\" (2024) that the ground truth emphasizes\n\nQUANTITATIVE ACCURACY: Numbers cited ($4.5B, $450M, $108.6M) are correct, but the broader debt/lease figures ($36.8B, $11.5B, $1.55-$1.66B) are not directly relevant to the specific question about communications sites commitments\n\nQUALITATIVE ACCURACY: The reasoning conflates different types of financial obligations. The multi-hop synthesis is incomplete - it doesn't properly connect the 2023 capital planning context to the 2024 obligation structure\n\nCONTEXTUAL RELEVANCE: While the answer discusses AMT's financial evolution, it strays from the specific focus on communications sites commitments by introducing broader corporate financial metrics that aren't central to answering the question",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 598,
        "total_tokens": 1947
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How has ExxonMobil's characterization of asset divestitures in relation to strategic objectives evolved between 2023 and 2024, particularly in terms of the language used to describe the proceeds from these transactions?",
      "original_answer": "In 2023, ExxonMobil described proceeds from asset sales as part of 'sales of subsidiaries, property, plant and equipment, and sales and returns of investments,' emphasizing a disciplined review process to ensure assets align with strategic goals. By 2024, the company refined its language, referring more broadly to 'proceeds from asset sales and returns of investments,' maintaining the same strategic alignment rationale but streamlining the description. This evolution indicates a more consolidated framing of divestiture proceeds without specific mention of subsidiaries or equipment sales, suggesting a possible shift toward a more generalized narrative around asset management.",
      "llm_answer": "\nBetween 2023 and 2024 the wording shifted from a generic investor‑focused note—“proceeds associated with sales of subsidiaries… are useful for investors to consider when evaluating cash available for investment and financing”—to an explicit link to strategy: the 2024 MD&A says the company “employs a long‑standing and regular disciplined review process to ensure that assets are contributing to the Corporation’s strategic objectives” and that assets are divested when they “are no longer meeting these objectives or are worth considerably more to others.”  In other words, the 2023 discussion merely described the cash‑flow utility of asset‑sale proceeds, while the 2024 language frames those proceeds as part of a strategic‑objective‑driven review that underpins cost‑saving targets and long‑term earnings power.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ISSUES: The LLM answer fundamentally mischaracterizes the evolution described in the ground truth. The ground truth states that the 2024 language became MORE CONSOLIDATED/GENERALIZED (shifting from 'sales of subsidiaries, property, plant and equipment, and sales and returns of investments' to 'proceeds from asset sales and returns of investments'), while the LLM claims the opposite—that 2024 language became MORE EXPLICIT and STRATEGIC. This is a major factual error in the core claim. The LLM introduces concepts (cost-saving targets, long-term earnings power, investor-focused notes) that are not present in the ground truth answer and appear to be fabricated or misattributed. The LLM correctly identifies that both years reference strategic objectives and disciplined review processes, but misrepresents the nature of the linguistic evolution. The ground truth emphasizes STREAMLINING/CONSOLIDATION of terminology, while the LLM emphasizes STRATEGIC EMPHASIS—these are contradictory characterizations. The LLM does not accurately capture that the 2024 description removed specific mention of 'subsidiaries' and 'equipment' in favor of broader 'asset sales' language. While the LLM demonstrates some understanding of the strategic context, it fundamentally inverts the direction of change and introduces unsupported claims about the nature of the evolution. The answer fails the primary requirement of accurately describing how the characterization 'evolved.'",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 407,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How has Comcast's financial exposure to Universal Beijing Resort evolved from 2022 to 2023, based on the changes in consolidated asset and liability amounts?",
      "original_answer": "In 2022, Comcast's consolidated balance sheet included $9.7 billion in assets and $8.1 billion in liabilities related to Universal Beijing Resort. By 2023, these figures had decreased to $7.8 billion in assets and $7.2 billion in liabilities. This indicates a reduction in both the scale of assets and liabilities associated with the Universal Beijing Resort, suggesting either asset depreciation, debt repayment, or a strategic reduction in the resort's financial footprint within Comcast's consolidated statements.",
      "llm_answer": "\nComcast’s exposure to Universal Beijing Resort contracted in the 2022‑2023 period: the 2023 Form 10‑K reports $7.8 billion in related assets and $7.2 billion in related liabilities, down from $9.7 billion in assets and $8.1 billion in liabilities recorded in the prior year.  The roughly $1.9 billion drop in assets and $0.9 billion drop in liabilities reflects a smaller financial stake in the joint venture.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. (1) QUANTITATIVE VERIFICATION: All financial figures are correct - 2023 assets of $7.8B, 2023 liabilities of $7.2B, 2022 assets of $9.7B, and 2022 liabilities of $8.1B match the ground truth exactly. The calculated changes are also accurate: $9.7B - $7.8B = $1.9B asset decrease and $8.1B - $7.2B = $0.9B liability decrease. (2) COMPLETENESS: The answer addresses the core question about how financial exposure evolved from 2022 to 2023, providing both the absolute figures and the year-over-year changes. (3) ENTITY ACCURACY: Comcast and Universal Beijing Resort are correctly identified, years are correct (2022 and 2023), and financial metrics (assets and liabilities) are properly specified. (4) REASONING: The multi-hop synthesis is sound - the model correctly extracted data from two different years and compared them to characterize the trend. The interpretation that this reflects 'a smaller financial stake in the joint venture' is reasonable and aligns with the ground truth's suggestion of 'reduction in the resort's financial footprint.' (5) SEMANTIC EQUIVALENCE: The phrasing 'contracted,' 'down from,' and 'smaller financial stake' effectively conveys the same meaning as the ground truth's 'reduction' and 'decreased.' Minor note: The ground truth provides slightly more interpretive context (mentioning asset depreciation, debt repayment, or strategic reduction), while the LLM answer is more concise but still captures the essential finding. This is not a deficiency but rather a stylistic difference.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1234,
        "completion_tokens": 435,
        "total_tokens": 1670
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How has the nature of Customer Demand Volatility as a risk factor for Caterpillar evolved between 2023 and 2024, particularly in relation to its impact on financial performance and supply chain stability?",
      "original_answer": "In 2023, Customer Demand Volatility was described as being primarily driven by economic uncertainties, including the lingering effects of a global pandemic, which led to inflationary pressures, supply chain disruptions, and labor inefficiencies, all of which limited Caterpillar's ability to meet customer demand. By 2024, while the risk remained, the focus shifted slightly to include broader commodity price changes, material price increases, and significant disruptions to supply chains or shortages of labor and material as key contributors to financial performance risks. This evolution indicates a broadening of the risk profile to include more systemic supply-side challenges alongside demand volatility.",
      "llm_answer": "\nBetween the 2023 and 2024 filings, Caterpillar’s discussion of customer‑demand volatility shifted from a broad, cyclical macro‑economic risk to a more acute, multi‑factor exposure driven by inflation‑induced commodity price swings, tighter credit conditions and geopolitical supply‑chain disruptions.  This evolution means that demand fluctuations now have a tighter linkage to revenue and margin pressure, forcing the company to manage inventory and production more tightly and making supply‑chain stability a direct driver of financial performance.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the 2023-2024 timeframe and Caterpillar as the subject company. (2) The answer accurately captures that the risk evolved from pandemic-related disruptions in 2023 to broader systemic challenges in 2024. (3) The mention of commodity price changes, inflation, and supply chain disruptions aligns with the ground truth. (4) The LLM correctly notes the shift in focus and the connection to financial performance and supply chain stability. (5) No quantitative errors present (no specific numbers were claimed that could be wrong).\n\nWEAKNESSES: (1) The LLM introduces elements not explicitly mentioned in the ground truth, particularly 'tighter credit conditions' and 'geopolitical supply-chain disruptions' - while these may be reasonable inferences, they represent additions beyond what the ground truth specifies. (2) The ground truth emphasizes 'economic uncertainties' and 'lingering effects of global pandemic' as 2023 drivers, but the LLM characterizes this more vaguely as 'broad, cyclical macro-economic risk' without explicitly mentioning pandemic effects. (3) The ground truth specifically mentions 'labor inefficiencies' in 2023 and 'shortages of labor and material' in 2024, but the LLM only vaguely references 'tighter' management without capturing these specific labor-related aspects. (4) The LLM's characterization of the shift as moving from 'broad' to 'acute, multi-factor' is somewhat interpretive and not directly supported by the ground truth language. (5) The ground truth describes a 'broadening' of risk profile, while the LLM describes a shift from 'broad' to 'acute' - these are subtly different characterizations.\n\nMULTI-HOP REASONING: The LLM demonstrates sound multi-hop reasoning by connecting the evolution of risk factors to their impact on financial performance and supply chain management. However, it adds interpretive layers (credit conditions, geopolitical factors) not explicitly in the ground truth.\n\nSEMANTIC EQUIVALENCE: While the core message about evolution from pandemic-driven to broader systemic challenges is preserved, the LLM's specific framing introduces elements that diverge from the ground truth's more precise characterization.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 595,
        "total_tokens": 1925
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did the fair value and valuation methodology of Net derivative assets (liabilities) evolve from 2022 to 2024?",
      "original_answer": "In 2022, the fair value of Net derivative assets (liabilities) was $19 million as of December 31, 2021, with changes in value primarily tied to derivative activity such as issuances ($68 million), settlements ($-37 million), and transfers ($6 million). By 2024, the fair value had increased significantly to $58 million as of December 31, 2023. Additionally, the valuation methodology shifted from being primarily based on realized and unrealized gains/losses reported in net income to being assessed using discounted cash flows with a focus on observable inputs like swap rates (3-5%, weighted average of 4%). This indicates both a material increase in value and a methodological shift toward more transparent and observable valuation techniques.",
      "llm_answer": "\nBetween the end of 2022 and the end of 2024 the fair‑value of Capital One’s net derivative assets (liabilities) measured with Level‑3 inputs rose modestly—from roughly **$58 million** (the balance carried forward into 2023) to **$69 million** as of December 31 2024.  The valuation continued to be based on discounted‑cash‑flow models that use unobservable swap‑rate inputs (weighted‑average ≈ 4 %), and the increase reflects net settlements, purchases and a $(25) million unrealized loss recorded in earnings during 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that fundamentally misrepresent the evolution of net derivative assets from 2022 to 2024. Key issues: (1) WRONG STARTING POINT: The LLM states the 2022 value was '$58 million (the balance carried forward into 2023)' but the ground truth clearly shows the 2022 fair value was $19 million as of December 31, 2021. The $58 million figure is actually the 2024 value from the ground truth. (2) WRONG ENDING POINT: The LLM claims the 2024 value was $69 million, but the ground truth shows it was $58 million as of December 31, 2023. The LLM appears to have confused the time periods entirely. (3) INCOMPLETE EVOLUTION NARRATIVE: The ground truth describes a significant evolution showing derivative activity components (issuances of $68M, settlements of -$37M, transfers of $6M) and a methodological shift from realized/unrealized gains/losses to discounted cash flows with observable swap rate inputs. The LLM mentions discounted cash flow models but mischaracterizes the inputs as 'unobservable' when the ground truth indicates they are 'observable inputs like swap rates.' (4) MISSING CONTEXT: The LLM fails to capture the material increase in value and the shift in valuation methodology that represents the core evolution described in the ground truth. (5) COMPANY ATTRIBUTION: While the LLM mentions 'Capital One,' the ground truth does not specify the company, suggesting this may be an assumption not verified against the source material. The answer demonstrates fundamental misunderstanding of the multi-hop synthesis required, with inverted or confused time periods and values.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 447,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How has NVIDIA's GeForce NOW cloud gaming offering evolved from 2022 to 2023 in terms of its positioning within the company's broader GPU and cloud platform ecosystem?",
      "original_answer": "In 2022, GeForce NOW was positioned as a cloud platform enabling gamers to access interactive graphics applications from nearly any device, emphasizing its role in extending NVIDIA’s graphics leadership and ecosystem reach. It was mentioned alongside other cloud platforms like vGPU for enterprise use. By 2023, GeForce NOW was more specifically integrated into the broader NVIDIA accelerated computing platform narrative, and its positioning shifted to emphasize cloud gaming as part of a suite of GPU-driven services, including AI training platforms like NVIDIA DGX Cloud. This evolution reflects a more strategic alignment of GeForce NOW with NVIDIA’s expanding cloud infrastructure and software offerings, particularly in the context of gaming as a service.",
      "llm_answer": "\nBetween 2022 and 2023, GeForce NOW moved from a stand‑alone cloud‑gaming streamer for low‑end devices to an integral part of NVIDIA’s full‑stack, GPU‑accelerated cloud platform. It now runs on RTX 40‑series hardware and AI‑enhanced technologies such as DLSS 3.5 and the Avatar Cloud Engine, and is delivered through multiple cloud providers as an extension of NVIDIA’s broader GPU‑and‑AI cloud ecosystem.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and introduces unsupported claims not present in the ground truth. Key issues: (1) The claim about 'RTX 40-series hardware' is not mentioned in the original answer and appears to be fabricated technical detail not verified in SEC filings. (2) References to 'DLSS 3.5' and 'Avatar Cloud Engine' are specific product features not mentioned in the ground truth, suggesting the model hallucinated technical specifications. (3) The characterization of GeForce NOW as moving from 'stand-alone cloud-gaming streamer for low-end devices' contradicts the ground truth, which describes it as enabling access 'from nearly any device' in 2022 - not specifically low-end devices. (4) While the LLM correctly identifies the evolution toward integration with NVIDIA's broader GPU/cloud ecosystem, it does so by adding unverified technical details rather than accurately synthesizing the actual positioning shift described in the ground truth. (5) The ground truth emphasizes positioning within enterprise cloud platforms (vGPU) and AI services (DGX Cloud), but the LLM answer focuses on gaming-specific hardware/software features. (6) The multi-hop reasoning is weak because it introduces new entities (RTX 40-series, DLSS 3.5, Avatar Cloud Engine) not supported by the source material. The core insight about integration into NVIDIA's accelerated computing platform is present but overshadowed by unsupported technical claims that reduce credibility.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 412,
        "total_tokens": 1709
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did the revenue performance of Inlyta evolve between 2022 and 2023, and what factors influenced this change?",
      "original_answer": "In 2022, Inlyta had total global revenue of $1,003 million, while in 2023, its revenue increased to $1,036 million, representing a 3% growth. This growth was primarily driven by continued adoption of Inlyta in combination with immune checkpoint inhibitors for the first-line treatment of advanced renal cell carcinoma (RCC) in the U.S., and growth in emerging markets. However, this increase was partially offset by lower volumes and lower net prices in certain European markets.",
      "llm_answer": "\nInlyta’s worldwide sales rose modestly from about **$1.00 billion in 2022 to $1.04 billion in 2023** (≈ 3–5 % growth).  The increase was driven primarily by **strong uptake of Inlyta + immune‑checkpoint‑inhibitor combinations for first‑line renal‑cell carcinoma in the United States** and **continued expansion in emerging markets**, while price pressures in certain European markets and modest volume declines elsewhere limited upside.  Overall, the revenue gain reflects both the product’s deepening clinical adoption and the impact of pricing and competitive dynamics across regions.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy with minor quantitative imprecision. CORRECT ELEMENTS: (1) Revenue figures are appropriately rounded and semantically equivalent - '$1.00 billion' and '$1.04 billion' correctly represent the ground truth $1,003M and $1,036M respectively; (2) Growth percentage of '3-5%' is reasonable given the actual 3.3% growth ($33M/$1,003M), though the range is slightly broader than the precise 3% stated in ground truth; (3) All key drivers are correctly identified: first-line RCC treatment with immune checkpoint inhibitors in the U.S., emerging market growth, and European market headwinds; (4) Multi-hop synthesis is sound - the answer correctly combines revenue performance data with causal factors across geographic regions. MINOR ISSUES: (1) The growth range of '3-5%' is slightly imprecise - the actual growth is 3.3%, which rounds to 3%, not a 3-5% range. This represents a minor overstatement of uncertainty; (2) The phrase 'modest volume declines elsewhere' is slightly more general than the ground truth's specific reference to 'lower volumes and lower net prices in certain European markets,' though semantically similar. STRENGTHS: The answer effectively synthesizes multi-hop information (combining 2022 and 2023 data with geographic and therapeutic context), uses appropriate financial terminology, and provides balanced perspective on both growth drivers and limiting factors. The reasoning quality is high, correctly identifying the interplay between clinical adoption and pricing/competitive dynamics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 429,
        "total_tokens": 1687
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has the treatment and valuation of network location intangibles evolved from 2023 to 2024, particularly in terms of amortization assumptions and impairment review processes?",
      "original_answer": "In 2023, the company amortized network location intangibles on a straight-line basis over their estimated useful lives, with a weighted average amortization period of 15 years as of December 31, 2023. The focus was on the relationship between these intangibles and tower assets, particularly in terms of potential revenue growth from leasing excess capacity. By 2024, the company expanded its disclosures to include a more detailed impairment review process for network location intangibles, assessing impairment on an individual tower basis and identifying specific triggers such as lack of tenant leases or expenses exceeding revenues. Additionally, while amortization remained a key treatment, the company's broader discussion of asset retirement obligations in 2024, including a $470 million increase in liability due to revised settlement dates, indirectly impacts the valuation and useful life assumptions for these intangible assets.",
      "llm_answer": "\nFrom 2023 to 2024 the Company lengthened the estimated useful life of its tower assets (and the network‑location intangibles tied to them) from a 20‑year straight‑line schedule to about 30 years, which reduced the annual amortization/depreciation expense (e.g., a $730 million after‑tax decrease in 2024).  At the same time, the impairment process was sharpened: goodwill and intangible assets are now tested annually (and interim‑tested when triggers occur) using third‑party market data and discounted‑cash‑flow models on a tower‑by‑tower basis, leading to the $322 million India and $80 million Spain goodwill impairments in 2023 and no further impairments after the 2024 India divestiture.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not supported by the ground truth. Critical issues: (1) WRONG USEFUL LIFE CHANGE: The LLM claims the company lengthened useful lives from 20 years to 30 years, but the ground truth states the 2023 weighted average amortization period was 15 years - no mention of a 20-to-30 year shift. (2) UNSUPPORTED $730M FIGURE: The LLM cites a '$730 million after-tax decrease in 2024' from the useful life change, but this specific number does not appear in the ground truth and cannot be verified. (3) INCORRECT IMPAIRMENT AMOUNTS: The LLM references '$322 million India and $80 million Spain goodwill impairments in 2023' - these figures are not mentioned in the ground truth, which focuses on network location intangibles impairment review processes, not goodwill impairments. (4) MISSING KEY GROUND TRUTH ELEMENTS: The LLM fails to mention the 15-year weighted average amortization period from 2023, the relationship between network location intangibles and tower assets, the $470 million asset retirement obligation increase in 2024, or the specific impairment triggers (lack of tenant leases, expenses exceeding revenues). (5) SCOPE CONFUSION: The ground truth discusses network location intangibles specifically, while the LLM conflates this with broader tower asset depreciation and goodwill impairments. (6) PARTIAL ACCURACY: The LLM correctly identifies that impairment testing occurs on a tower-by-tower basis and mentions third-party market data and DCF models, which aligns with ground truth's 'individual tower basis' assessment. However, this partial correctness is overwhelmed by the numerous factual errors. The answer demonstrates a fundamental misunderstanding of the evolution from 2023 to 2024 and introduces unsupported financial figures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 495,
        "total_tokens": 1912
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has ExxonMobil's strategic emphasis on Guyana evolved between 2023 and 2024, particularly in terms of its upstream growth portfolio and production capacity?",
      "original_answer": "In 2023, ExxonMobil highlighted Guyana as a key component of its upstream growth portfolio, noting four additional discoveries on the Stabroek Block and the startup of the Prosperity FPSO vessel, which brought production to nearly 440 kbd in the fourth quarter. By 2024, Guyana was formally categorized under 'Advantaged Assets' within the updated earnings drivers, reflecting its strategic elevation alongside the Permian and LNG projects as a core contributor to earnings through volume/mix growth. This shift indicates a transition from a discovery and early production phase in 2023 to a more mature, financially impactful asset in 2024.",
      "llm_answer": "\nBetween 2023 and 2024 ExxonMobil moved from early‑stage exploration in Guyana’s Stabroek Block to actually bringing the resource on stream – the Payara development’s FPSO reached name‑plate capacity in January 2024 and gross production from the three operating vessels rose to nearly 440 kbd by year‑end.  Consequently, Guyana has become a central pillar of the company’s upstream growth portfolio, with plans for six FPSO vessels (including the upcoming Whiptail project) to expand capacity and to be treated as a core “advantaged asset,” shifting the strategic focus from discovery to sustained, high‑volume production.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general strategic evolution of Guyana from early production to mature asset status and correctly identifies the shift to 'advantaged asset' classification. However, there are significant factual errors that reduce accuracy: (1) The LLM incorrectly attributes the January 2024 nameplate capacity achievement to 'Payara development's FPSO' when the ground truth specifically references the 'Prosperity FPSO vessel' as the startup that brought production to nearly 440 kbd in Q4 2023. (2) The LLM states production 'rose to nearly 440 kbd by year-end' (2024), but the ground truth indicates this 440 kbd level was achieved in Q4 2023, not 2024. This is a critical temporal error. (3) The LLM mentions 'six FPSO vessels' and 'Whiptail project' which are not mentioned in the ground truth, introducing potentially inaccurate forward-looking details. (4) The production figure of 440 kbd is correct and properly formatted. (5) The core multi-hop reasoning is sound - the answer correctly synthesizes the transition from discovery/early production phase to mature 'advantaged asset' status. (6) The semantic understanding of the strategic shift is accurate. The answer demonstrates good qualitative reasoning about the strategic evolution but contains material factual errors regarding specific vessel names, timing of production milestones, and introduces unverified future capacity details that diverge from the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 401,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has the X1 platform's integration with third-party streaming services evolved between 2022 and 2023, and what does this evolution indicate about Comcast's strategy in reducing cord-cutting and increasing average revenue per user (ARPU)?",
      "original_answer": "In 2022, the X1 platform integrated third-party streaming services such as Disney+ and Netflix, and provided access to Peacock's premium tier, with Comcast earning commission revenue from the sale of these services. By 2023, the X1 platform continued to support third-party integrations but now included Xumo Play, NBC, and Sky as part of the NOW TV service, which was specifically marketed to residential broadband customers. This expansion indicates a strategic pivot toward enhancing the value of broadband subscriptions and bundling streaming access to retain customers and potentially increase ARPU through deeper content integration and commission-generating partnerships.",
      "llm_answer": "\nBetween 2022 and 2023 Comcast deepened the X1 platform’s native connectivity to third‑party streaming services—adding direct, voice‑controlled access to the ad‑supported tier of Peacock, launching the standalone NOW streaming offering in the United States, and expanding integration of other DTC apps such as Disney+ and Netflix through the Xumo Stream Box.  This broader, monetised integration turns X1 into a single‑pane‑of‑glass entertainment hub that keeps broadband and video subscribers inside the Comcast ecosystem, slowing cord‑cutting and generating additional ARPU from streaming‑related commissions and higher‑value bundled services.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures several correct elements but contains some inaccuracies and introduces unsupported details. CORRECT ELEMENTS: (1) The answer correctly identifies the evolution from 2022 to 2023, (2) Correctly mentions Disney+, Netflix, and Peacock as integrated services, (3) Correctly identifies NOW as a streaming offering launched/expanded in this period, (4) Correctly identifies the strategic goal of reducing cord-cutting and increasing ARPU through bundling and commissions. PROBLEMATIC ELEMENTS: (1) The LLM introduces 'Xumo Stream Box' which is not mentioned in the ground truth answer - this appears to be an unsupported detail that may conflate different products or services, (2) The LLM mentions 'ad-supported tier of Peacock' and 'voice-controlled access' which are not explicitly stated in the ground truth, (3) The ground truth specifically mentions 'Xumo Play, NBC, and Sky as part of the NOW TV service' but the LLM's phrasing about Xumo Stream Box and integration is less precise and potentially inaccurate, (4) The LLM states 'launching the standalone NOW streaming offering in the United States' but the ground truth indicates NOW TV was marketed to 'residential broadband customers' - the LLM's characterization is broader and less specific. MULTI-HOP REASONING: The LLM correctly synthesizes the strategic implications (reducing cord-cutting, increasing ARPU through commissions and bundling), which matches the ground truth's assessment. However, the specific product details and service integrations are not accurately represented. QUANTITATIVE ACCURACY: No specific numbers or dates are provided in either answer, so this dimension is neutral. The temporal comparison (2022 vs 2023) is correctly maintained. OVERALL ASSESSMENT: The answer demonstrates understanding of the strategic direction but introduces inaccuracies in specific product/service details that would be important for a precise evaluation of Comcast's strategy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 529,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has Caterpillar's relationship with FG Wilson evolved between 2023 and 2024 in terms of its distribution network coverage for electric power generation systems?",
      "original_answer": "In 2023, FG Wilson's electric power generation systems were distributed through a network of 110 distributors covering 109 countries. By 2024, this distribution network had slightly contracted to 108 distributors, now covering 158 countries. This indicates a minor reduction in the number of distributors but an expansion in the geographic reach of the network. The change suggests a strategic shift toward optimizing distributor efficiency while broadening market access.",
      "llm_answer": "\nCaterpillar still sells FG Wilson‑branded electric‑power generation systems through the same global network of **108 distributors covering 158 countries** in both the 2023 and 2024 filings (see CAT 10‑K 2023 p. 65 and CAT 10‑K 2024 p. 66).  No expansion or contraction of that distributor base is noted, indicating that the partnership and its coverage have remained essentially unchanged between the two years.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that directly contradict the ground truth. (1) QUANTITATIVE ACCURACY FAILURES: The LLM claims the distribution network was '108 distributors covering 158 countries' in BOTH 2023 and 2024, stating 'no expansion or contraction.' However, the ground truth clearly shows: 2023 had 110 distributors covering 109 countries; 2024 had 108 distributors covering 158 countries. The LLM got the 2024 numbers correct but completely missed the 2023 baseline, making the year-over-year comparison impossible to assess from their answer. (2) MULTI-HOP REASONING FAILURE: The question explicitly asks how the relationship 'evolved between 2023 and 2024' - this requires synthesizing data from two different years and comparing them. The LLM failed to do this synthesis, instead claiming both years had identical metrics. This is a fundamental failure of multi-hop reasoning. (3) INCOMPLETE ANALYSIS: The ground truth identifies a strategic shift (reduction in distributors from 110 to 108, but expansion in geographic coverage from 109 to 158 countries). The LLM completely missed this nuanced evolution and incorrectly concluded the partnership 'remained essentially unchanged.' (4) CITATION ISSUES: While the LLM provides page references, the actual data cited does not support the claim of no change between years. The answer demonstrates a failure to properly extract and compare year-over-year data from the filings. The only partially correct element is the 2024 figures (108 distributors, 158 countries), but this is insufficient given the core question requires year-over-year comparison.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1225,
        "completion_tokens": 446,
        "total_tokens": 1672
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Capital One's exposure to securitized debt obligations change between 2022 and 2024, particularly in terms of the carrying value and fair value of these obligations?",
      "original_answer": "In 2022, Capital One reported that the assets and liabilities of consolidated VIEs, including securitized debt obligations, were primarily composed of loan receivables and debt securities issued by the VIEs, with the liabilities reported under 'securitized debt obligations' on the consolidated balance sheets. By 2024, the carrying value of 'Securitized debt obligations' was $18,043 million, with a fair value of $18,067 million, all categorized under Level 2 of the fair value hierarchy. This indicates that Capital One maintained a significant exposure to securitized debt obligations, with a slight increase in fair value relative to carrying value, suggesting stable valuation and continued involvement in securitization activities.",
      "llm_answer": "\nCapital One’s securitized‑debt exposure was essentially flat from 2022 through 2024.  The carrying amount hovered around $18 billion (e.g., $18,043 million as of 31 Dec 2023 per page 220, with the 2022 filing showing a comparable $18 billion balance), and the estimated fair value was $18,067 million (Level 2) in 2023 and remained virtually unchanged in 2024.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant issues with temporal accuracy and incomplete information synthesis. CRITICAL ERRORS: (1) The LLM cites '$18,043 million as of 31 Dec 2023' but the ground truth explicitly states this figure is from 2024 ('By 2024, the carrying value of Securitized debt obligations was $18,043 million'). This is a major factual error regarding the year. (2) The LLM claims '2022 filing showing a comparable $18 billion balance' but provides no specific 2022 figure - the ground truth does not provide a 2022 carrying value number, only describing 2022 qualitatively. The LLM appears to have fabricated or assumed a 2022 comparison without evidence. (3) The LLM states fair value was '$18,067 million (Level 2) in 2023 and remained virtually unchanged in 2024' but the ground truth only provides the 2024 fair value of $18,067 million - there is no 2023 fair value figure mentioned in the ground truth. CORRECT ELEMENTS: The carrying value of $18,043 million and fair value of $18,067 million are correct numbers. The Level 2 fair value hierarchy classification is correct. The characterization of exposure as 'essentially flat' is reasonable given the minimal difference between carrying and fair value. MISSING INFORMATION: The answer fails to adequately address the 2022-to-2024 change because it lacks specific 2022 data and incorrectly dates the 2024 figures as 2023. The ground truth emphasizes 'slight increase in fair value relative to carrying value' and 'stable valuation' - the LLM captures the stability concept but misses the temporal specificity. The multi-hop reasoning is incomplete because the LLM did not properly synthesize the year-over-year comparison across the 2022-2024 period as requested.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 472,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has McDonald's use of line of credit agreements evolved between 2023 and 2024 in relation to its financing activities and cash flow management?",
      "original_answer": "In 2023, McDonald's cash used for financing activities totaled $4.4 billion, a decrease of $2.2 billion compared to 2022, primarily due to increased bond issuances. The company's cash and equivalents balance was $4.6 billion at the end of 2023, reflecting sufficient liquidity supported by cash from operations and access to commercial paper borrowings and line of credit agreements. In 2024, cash used for financing activities increased to $7.5 billion, a rise of $3.1 billion compared to 2023, driven by decreased bond issuances. The company's cash and equivalents balance dropped to $1.1 billion at year-end 2024, with the prior year's higher balance attributed to the timing of debt issuances that funded 2024's required cash outflows. The company continued to rely on its line of credit agreements and commercial paper to meet short-term funding needs. This indicates a shift from surplus liquidity and bond financing in 2023 to a more cash-constrained environment in 2024, with greater reliance on existing credit facilities.",
      "llm_answer": "\nBetween 2023 and 2024 McDonald’s replaced its prior $15 billion borrowing facility—originally authorized in December 2022 and with about $9.7 billion drawn as of 31 Dec 2023—by terminating that 2022 program and adopting a new, identical $15 billion line of credit that has no set expiration date (effective 1 Jan 2025).  The company continues to rely on this committed credit line (and its $4 billion commercial‑paper program) to meet short‑term financing needs, as evidenced by a rise in cash used for financing activities and a drop in bond issuances, using the credit facility to fund dividend payments, share repurchases and the accelerated restaurant‑development capital program.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies specific details about McDonald's line of credit evolution: (1) the $15 billion borrowing facility authorized in December 2022, (2) approximately $9.7 billion drawn as of Dec 31, 2023, (3) termination of the 2022 program and adoption of a new identical $15 billion facility effective January 1, 2025 with no set expiration date, and (4) the $4 billion commercial paper program. These specific structural details about the credit facilities are accurate and represent valuable information not explicitly in the ground truth. The answer correctly notes the shift toward greater reliance on credit facilities and decreased bond issuances.\n\nWEAKNESSES: The LLM answer fails to address critical quantitative metrics from the ground truth that directly answer the question about financing activities and cash flow management: (1) No mention of cash used for financing activities ($4.4B in 2023, $7.5B in 2024), (2) No discussion of cash and equivalents balances ($4.6B in 2023, $1.1B in 2024), (3) No comparison of the $2.2B decrease in 2023 vs. $3.1B increase in 2024, (4) No mention of bond issuances as a key driver of the financing activity changes. The ground truth explicitly states that increased bond issuances decreased cash used in 2023, while decreased bond issuances increased cash used in 2024—a critical multi-hop synthesis point.\n\nMULTI-HOP REASONING: The LLM answer provides structural details about credit facility changes but fails to synthesize the broader cash flow management evolution. The ground truth shows a clear narrative: 2023 had surplus liquidity from bond issuances ($4.6B cash), while 2024 faced cash constraints ($1.1B cash) requiring greater reliance on credit facilities. The LLM mentions the shift to credit reliance but doesn't quantify or contextualize it within the cash flow metrics.\n\nCOMPLETENESS: The question asks about evolution of line of credit use \"in relation to its financing activities and cash flow management.\" The LLM addresses credit facility structure but largely omits the financing activities and cash flow management components that form the core of the ground truth answer.\n\nNUMERIC VERIFICATION: The specific numbers provided ($15B facility, $9.7B drawn, $4B commercial paper) appear accurate based on typical SEC filing disclosures, but these are not contradicted by the ground truth—they simply represent a different level of detail about the credit facilities themselves rather than their impact on overall financing activities.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 674,
        "total_tokens": 2103
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has the role of the Worldwide Business Conduct Manual in reinforcing internal controls evolved between 2022 and 2024, and what does this indicate about Procter & Gamble's approach to governance?",
      "original_answer": "In 2022, the Worldwide Business Conduct Manual was described as reinforcing the company's commitment to conducting business with integrity and within the letter and spirit of the law, emphasizing its role in supporting internal controls through policies, segregation of duties, and employee development. In 2024, while the core description remained similar, the manual was more specifically tied to governance frameworks such as the oversight activities of the Global Leadership Council and the responsibilities of the Disclosure Committee in evaluating significant business activities. This indicates a shift toward emphasizing structured governance mechanisms alongside ethical conduct, suggesting a more integrated approach to internal control over time.",
      "llm_answer": "\nBetween 2022 and 2024 the Worldwide Business Conduct Manual shifted from being mentioned only as a general reinforcer of “strong internal controls” to a explicitly integrated element of Procter & Gamble’s control framework—management’s 2024 internal‑control report cites the Manual as the vehicle that embeds integrity‑driven policies, and the 2024 auditor’s testing specifically evaluates controls over high‑risk areas (e.g., impairment of the Gillette indefinite‑lived intangible asset) that are governed by the Manual. This evolution indicates that P&G has moved from a broad ethical statement to a formal, board‑oversighted control component that is self‑assessed, audited and tied to critical financial‑reporting judgments, reflecting a more rigorous and systematic approach to governance.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) FACTUAL ERRORS - The LLM answer introduces specific claims NOT present in the ground truth: mentions of 'Gillette indefinite-lived intangible asset impairment' testing, 'management's 2024 internal-control report,' and 'auditor's testing' of specific high-risk areas. These details are fabricated and not supported by the original answer. (2) QUANTITATIVE ACCURACY - No numbers are provided in either answer, so this is neutral, but the LLM adds unverifiable specifics about auditor testing and financial reporting judgments that cannot be confirmed. (3) MULTI-HOP REASONING - The ground truth correctly identifies a shift from general ethical commitment (2022) to structured governance mechanisms (2024), specifically mentioning Global Leadership Council oversight and Disclosure Committee responsibilities. The LLM answer acknowledges this shift but MISREPRESENTS the evidence by inventing specific audit procedures and financial statement impacts not mentioned in the ground truth. (4) SEMANTIC EQUIVALENCE - While the LLM captures the general concept of evolution toward more formal governance, it does so by fabricating supporting details rather than accurately synthesizing the actual information provided. The ground truth explicitly mentions 'Global Leadership Council' and 'Disclosure Committee' as key governance structures; the LLM omits these specific entities and instead invents audit testing details. (5) CORE PROBLEM - The LLM appears to have hallucinated specific audit procedures and financial reporting examples (Gillette impairment) that are not in the ground truth, which violates the fundamental requirement of factual accuracy in financial document analysis. This is particularly problematic for SEC filing evaluation where precision is critical.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 488,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Exxon's strategic positioning in Guyana evolved between 2023 and 2024, as reflected in its long-lived asset disclosures and earnings driver definitions?",
      "original_answer": "In 2023, Exxon disclosed $9,689 million in long-lived assets in Guyana, indicating it was already a significant contributor among non-U.S. assets. By 2024, Guyana was explicitly named as part of Exxon's 'Advantaged Assets' under the new 'Advantaged Volume Growth' earnings driver, which includes key growth projects like Guyana and LNG. This evolution shows that Guyana transitioned from being a quantitatively notable asset in 2023 to a strategically emphasized growth engine in 2024.",
      "llm_answer": "\nExxon’s long‑lived‑asset base in Guyana expanded sharply—​the company reported roughly **$9.7 bn of assets in Guyana at the end of 2023**, up from about **$6.8 bn in 2022** (XOM 10‑K 2024 p. 27; XOM 10‑K 2023 p. 115).  At the same time, the 2024 earnings‑driver framework explicitly places Guyana in the **“Advantaged Volume Growth”** category (alongside the Permian and LNG), underscoring that the offshore Guyana discoveries are now a core, high‑return pillar of Exxon’s upstream strategy and a primary driver of future earnings.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy with minor issues. STRENGTHS: (1) The $9.7 billion figure for 2023 Guyana long-lived assets is correct (matches ground truth's $9,689 million). (2) The identification of 'Advantaged Volume Growth' as the 2024 earnings driver category is accurate. (3) The multi-hop synthesis correctly connects the quantitative asset growth (2022-2023) with the strategic repositioning (2024 earnings driver framework). (4) The characterization of Guyana as a 'core, high-return pillar' and 'primary driver of future earnings' aligns with the ground truth's description of it as a 'strategically emphasized growth engine.' (5) The mention of Permian and LNG alongside Guyana in the earnings driver framework is contextually appropriate. MINOR ISSUES: (1) The LLM provides additional historical context ($6.8 billion in 2022) not explicitly mentioned in the ground truth, though this is not incorrect—it enhances the narrative of asset growth. (2) The ground truth emphasizes the 'transition' from quantitatively notable (2023) to strategically emphasized (2024), while the LLM frames it more as concurrent expansion and strategic emphasis. This is a subtle framing difference rather than a factual error. (3) The LLM does not explicitly state that Guyana was 'already a significant contributor among non-U.S. assets' in 2023, though this is implied. QUANTITATIVE VERIFICATION: $9.7 billion ≈ $9,689 million (acceptable format variation). The 2022 figure of $6.8 billion cannot be verified against the ground truth but is not contradicted. MULTI-HOP REASONING: The answer correctly synthesizes information across two dimensions: (1) long-lived asset disclosures (2023-2024 evolution) and (2) earnings driver definitions (2024 framework). The logical connection between asset growth and strategic emphasis is sound. OVERALL: The answer is substantially correct with accurate numbers, proper entity identification, and sound multi-hop reasoning. The minor framing differences and additional context do not detract from the core accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 554,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Capital One's reliance on securitized debt obligations as a funding source evolved from 2022 to 2024, based on the disclosed figures and descriptions?",
      "original_answer": "In 2022, Capital One identified securitized debt obligations as part of its diversified funding mix, which also included deposits, senior and subordinated notes, federal funds purchased, and FHLB advances. While no specific dollar value was disclosed in 2022, the company emphasized the strategic importance of securitized debt obligations in maintaining access to wholesale funding. By 2024, Capital One disclosed that its securitized debt obligations had a carrying value of $14,264 million and an estimated fair value of $14,335 million. This represents a concrete quantification of the instrument's role in the company's capital structure, showing an increased transparency and continued use of this funding source.",
      "llm_answer": "\nFrom 2022 to 2024 Capital One’s outstanding securitized‑debt balance grew sharply – the 2022 maturity schedule listed a total of roughly **$15 billion** of securitized obligations, while the 2024 balance‑sheet shows a **carrying value of about $18 billion** (up from ≈$14.3 billion in fair‑value terms).  This increase occurred even as the firm’s overall wholesale‑funding level stayed flat, so the proportion of securitized debt in Capital One’s funding mix rose by roughly 20 % over the period.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that fundamentally contradict the ground truth. (1) QUANTITATIVE ERRORS - CRITICAL: The LLM claims 2024 carrying value is 'about $18 billion' when the ground truth explicitly states it is $14,264 million ($14.264 billion). This is a major discrepancy of approximately $3.7 billion or 26% overstatement. The LLM also claims 2022 had 'roughly $15 billion' of securitized obligations, but the ground truth explicitly states 'no specific dollar value was disclosed in 2022.' The LLM fabricated a 2022 figure that doesn't exist in the source documents. (2) CALCULATION ERRORS: The LLM's claim of a '20% increase' in proportion is unsupported and appears to be based on the incorrect $18 billion figure. Using the correct 2024 figure of $14.264 billion would show a different trend entirely. (3) MULTI-HOP REASONING FAILURE: The LLM failed to correctly synthesize the available information. It invented data points (2022 securitized debt balance) that were not disclosed and misrepresented the 2024 figures. (4) SEMANTIC ISSUES: The LLM's narrative of 'sharp growth' contradicts the actual data showing securitized debt obligations at $14.264 billion in 2024, which is lower than the fabricated $15 billion 2022 figure the LLM created. The ground truth emphasizes increased transparency and continued use, not dramatic growth. The only correct element is that Capital One does use securitized debt obligations as a funding source, but the specific numbers, trends, and analysis are substantially incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 426,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has NVIDIA's Omniverse platform evolved in terms of its positioning and enterprise adoption between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, Omniverse was described as 'real-time 3D design collaboration and virtual world simulation software' aimed at empowering creators to collaborate across leading design applications. By fiscal year 2023, Omniverse had evolved into a more robust enterprise-focused development platform and operating system for building virtual world simulation applications. It was made available as a software subscription for enterprise use and offered free for individual users, with industrial enterprises adopting its 3D and simulation technologies to digitalize complex physical assets and environments, including digital twins of factories and real-time 3D product configurators. This indicates a strategic shift from a creative collaboration tool to a broader enterprise simulation and digital twin platform.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2023 NVIDIA moved Omniverse from a standalone, subscription‑based 3D‑collaboration platform (available to enterprises and free for individuals) toward a cloud‑native, AI‑accelerated offering—**Omniverse Cloud** on Microsoft Azure—positioning it as a core service for building industrial‑metaverse and digital‑twin workloads.  This shift was accompanied by a rapid rise in enterprise adoption, with large cloud providers now accounting for more than half of the Data‑Center revenue linked to Omniverse and the platform being cited as a key driver of AI‑inference and automotive‑data‑center demand.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and introduces information not supported by the ground truth. Key issues: (1) The ground truth makes no mention of 'Omniverse Cloud' on Microsoft Azure - this appears to be fabricated or confused with other offerings. (2) The claim about 'large cloud providers now accounting for more than half of the Data-Center revenue linked to Omniverse' is a specific quantitative claim not present in the ground truth and cannot be verified. (3) The LLM correctly identifies the shift from creative collaboration to enterprise focus, which aligns with ground truth. (4) The LLM correctly notes the subscription model for enterprises and free for individuals, matching ground truth. (5) However, the LLM introduces unsupported details about 'cloud-native, AI-accelerated offering' and specific revenue metrics that are not in the original answer. (6) The ground truth emphasizes digital twins, factory digitalization, and 3D product configurators - the LLM mentions digital twins but adds unverified claims about 'automotive-data-center demand' and 'AI-inference' as key drivers. (7) The multi-hop reasoning is partially sound in identifying evolution between years, but the synthesis introduces speculative or incorrect details. The answer demonstrates some understanding of Omniverse's evolution but significantly diverges from the ground truth by adding unsubstantiated claims about cloud partnerships, revenue metrics, and specific use cases not mentioned in the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 421,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Pfizer's financial relationship with Viatris evolved between 2022 and 2023, particularly in terms of net amounts due under their various agreements?",
      "original_answer": "In 2022, the net amounts due to Viatris under the agreements were $94 million as of December 31, 2022. By 2023, this amount had decreased to $33 million as of December 31, 2023. This indicates a significant reduction in the net financial obligations between the two companies over the period, suggesting a winding down or stabilization of transitional financial arrangements established post-separation.",
      "llm_answer": "\nBetween the end of 2022 and the end of 2023 the balance Pfizer owed under the post‑separation agreements with Viatris fell sharply — from **$94 million** (as reported in the 2022 filing, page 75) to **$33 million** (as reported in the 2023 filing, page 78).  This reduction reflects the ongoing wind‑down of the transitional services, manufacturing and other agreements that were established at the time of the Viatris separation, with the bulk of the $277 million payment that had been recorded as a payable in 2021 already settled.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. All key financial figures are correct: $94 million (Dec 31, 2022) and $33 million (Dec 31, 2023) match the ground truth exactly. The calculation of the reduction ($61 million decrease) is implicit and accurate. The answer correctly identifies the multi-hop relationship between Pfizer and Viatris, properly synthesizing information about the post-separation agreements and their evolution over the two-year period. The LLM provides additional context by referencing the $277 million payment recorded as payable in 2021, which adds depth without contradicting the ground truth. The reasoning is sound: the reduction reflects wind-down of transitional arrangements, which aligns with the ground truth's characterization of 'winding down or stabilization.' The page references (page 75 for 2022, page 78 for 2023) add specificity, though these cannot be verified against the ground truth provided. The semantic meaning is fully equivalent to the original answer - both convey that net amounts due decreased significantly from 2022 to 2023 due to settlement of post-separation obligations. Minor deduction from perfect score (9 vs 10) only because the additional context about the $277 million, while helpful, goes slightly beyond what was explicitly stated in the ground truth, though it does not contradict it.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 382,
        "total_tokens": 1618
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How has ExxonMobil's strategic emphasis on Guyana evolved between 2023 and 2024, and what specific changes in project activity or classification reflect this evolution?",
      "original_answer": "In 2023, ExxonMobil's operations in Guyana were characterized by active exploration and development, with 12.6 net exploratory and development wells completed, and key projects such as Payara, Yellowtail, and Uaru underway. By 2024, Guyana was formally classified as part of ExxonMobil's 'Advantaged Assets' under the 'Advantaged Volume Growth' earnings driver, signaling a strategic elevation of its importance alongside the Permian Basin and LNG. This reclassification reflects a shift from operational reporting to strategic prioritization, indicating increased emphasis on Guyana as a core growth asset.",
      "llm_answer": "\nBetween 2023 and 2024 ExxonMobil moved Guyana from being described only as a developing offshore resource in its “Other Americas” activities (2023 10‑K, pp. 19‑20 – net acreage ≈ 4.6 million offshore acres, 12.6 net exploratory/development wells, Payara development start‑up, Uaru project funded) to being explicitly classified as an **“Advantaged Asset”** in the 2024 earnings‑driver definitions (2024 10‑K, p. 37 – “Advantaged Assets (Advantaged growth projects) … Includes Permian, Guyana and LNG”).  This re‑classification signals that Guyana is now treated as a high‑return, low‑cost source of volume growth and is grouped with the Permian and LNG projects in the company’s strategic narrative.  The 2024 filing therefore reflects a strategic evolution: Guyana’s projects are no longer just “ongoing activities” but are positioned as core, advantaged growth drivers in ExxonMobil’s portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. QUANTITATIVE ACCURACY: All specific numbers are correct - 12.6 net exploratory/development wells (2023), 4.6 million offshore acres, and the page references (2023 10-K pp. 19-20, 2024 10-K p. 37) are accurate. The numeric data matches the ground truth precisely. ENTITY ACCURACY: All entities correctly identified - ExxonMobil, Guyana, Permian Basin, LNG, Payara, Uaru projects, and the specific classification terminology ('Advantaged Assets', 'Advantaged Volume Growth') are all accurate. MULTI-HOP REASONING: The answer successfully synthesizes information across two fiscal years (2023 and 2024) and multiple document sections, correctly identifying the reclassification from 'Other Americas' operational reporting to 'Advantaged Assets' strategic classification. The logical progression from operational description to strategic prioritization is sound. COMPLETENESS: The answer addresses both parts of the question - how the emphasis evolved (from developing offshore resource to advantaged asset) and what specific changes reflect this (reclassification, project grouping with Permian and LNG). SEMANTIC EQUIVALENCE: The LLM answer conveys the same core information as the ground truth with slightly more detailed documentation (specific page numbers, acreage figures) while maintaining factual accuracy. The characterization of the shift from 'operational reporting to strategic prioritization' is semantically equivalent to the ground truth's description of 'reclassification reflecting increased emphasis.' Minor note: The LLM provides additional context (acreage, specific page citations) that enhances rather than contradicts the ground truth. No calculation errors or factual inaccuracies detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 489,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the weighted-average interest rate and face value of senior notes with maturities greater than 10 years evolve from 2022 to 2023?",
      "original_answer": "In 2022, the weighted-average interest rate for senior notes with maturities greater than 10 years was 3.67%, with a face value of $54.536 billion. In 2023, the interest rate remained unchanged at 3.8%, but the face value slightly decreased to $53.4 billion. This indicates a slight reduction in long-term debt in this category, while the interest rate stayed stable.",
      "llm_answer": "\nFrom 2022 to 2023 the weighted‑average interest rate on Comcast’s senior notes that mature after 10 years stayed essentially flat at **3.8 %** in both years.  At the same time, the face‑value amount of those long‑dated notes edged up slightly from **$52.8 billion** (as of 2022) to **$53.4 billion** (as of 2023).",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its credibility. (1) CRITICAL ERRORS: The 2022 face value is stated as $52.8 billion in the LLM answer, but the ground truth shows $54.536 billion - a discrepancy of $1.736 billion (3.2% error). The 2022 interest rate is stated as 3.8% in the LLM answer, but ground truth shows 3.67% - a 0.13 percentage point error. The LLM claims the interest rate 'stayed essentially flat at 3.8% in both years,' but ground truth shows 3.67% in 2022 and 3.8% in 2023, representing a change of +0.13 percentage points, not stability. (2) CORRECT ELEMENTS: The 2023 face value of $53.4 billion is correct. The 2023 interest rate of 3.8% is correct. The general direction of face value change (slight increase from 2022 to 2023) is correct in the LLM answer, though based on incorrect 2022 baseline. (3) MULTI-HOP REASONING: The LLM correctly identified the need to compare two years and two metrics (interest rate and face value), but failed to accurately retrieve or synthesize the 2022 baseline data. The conclusion about 'essentially flat' interest rates is factually incorrect given the 0.13 percentage point increase. (4) SEMANTIC ISSUES: While the LLM appropriately addresses the question's structure (comparing 2022 to 2023 for both metrics), the fundamental numerical inaccuracies make the answer unreliable. The contextual relevance is good (addresses the right company, metrics, and time period), but quantitative accuracy is severely compromised by the incorrect 2022 baseline figures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1168,
        "completion_tokens": 425,
        "total_tokens": 1593
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the nuclear decommissioning trusts managed by Alabama Power and Georgia Power shift their domestic equity investment allocations and valuation methodologies between 2023 and 2024, particularly in terms of Level 1 and Level 2 input classifications?",
      "original_answer": "In 2023, Alabama Power reported $396 million in domestic equity investments under Level 1 inputs and $169 million under Level 2 inputs, totaling $565 million. Georgia Power reported $255 million in Level 1 and $1 million in Level 2, totaling $256 million. By 2024, Alabama Power’s domestic equity investments increased to $443 million in Level 1 and $208 million in Level 2, totaling $651 million. Georgia Power saw its Level 1 domestic equity investments rise to $321 million while Level 2 remained at $1 million, totaling $322 million. This indicates a strategic shift toward higher allocations in domestic equities, particularly through more actively traded (Level 1) instruments, which may reflect a more transparent or liquid investment approach in line with evolving trust management strategies.",
      "llm_answer": "\nBetween 2023 and 2024 the nuclear decommissioning trusts of Alabama Power and Georgia Power moved a larger share of their domestic‑equity holdings into Level 2 valuation, with Alabama Power’s Level 2 domestic‑equity balance increasing to $443 million (up from $396 million) and Georgia Power’s to $321 million (up from $255 million); Level 3 balances stayed essentially flat ($208 million and $1 million, respectively). This reflects a shift toward using observable market‑based inputs (Level 2) for valuation and a reduced reliance on Level 1 or Level 3 classifications.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamental and pervasive errors that completely misrepresent the ground truth data:\n\n(1) CRITICAL NUMBER TRANSPOSITION ERRORS:\n- Alabama Power Level 2: LLM states \"$443 million (up from $396 million)\" but ground truth shows Level 2 went from $169M (2023) to $208M (2024). The $443M figure is actually Alabama Power's 2024 Level 1 value, not Level 2.\n- Georgia Power Level 2: LLM states \"$321 million (up from $255 million)\" but ground truth shows Level 2 stayed at $1M in both years. The $321M figure is actually Georgia Power's 2024 Level 1 value, not Level 2.\n- The LLM has systematically confused Level 1 and Level 2 classifications, swapping the values entirely.\n\n(2) INVERTED INTERPRETATION:\n- Ground truth shows a shift TOWARD Level 1 (more liquid, actively traded instruments): Alabama Power Level 1 increased from $396M to $443M; Georgia Power Level 1 increased from $255M to $321M.\n- LLM incorrectly claims the shift was TOWARD Level 2 (observable market inputs), which is the opposite of what occurred.\n- LLM's statement about \"reduced reliance on Level 1\" directly contradicts the data showing Level 1 allocations increased significantly.\n\n(3) LEVEL 3 CONFUSION:\n- LLM mentions \"Level 3 balances stayed essentially flat ($208 million and $1 million)\" but these are actually the 2024 Level 2 values, not Level 3 values. The answer conflates Level 2 and Level 3 classifications.\n\n(4) MULTI-HOP SYNTHESIS FAILURE:\n- The answer fails to correctly synthesize data across both companies and both years.\n- The core narrative about valuation methodology shift is inverted and factually wrong.\n\n(5) SEMANTIC MISALIGNMENT:\n- While the answer attempts to address the question's structure, it fundamentally misrepresents what the data shows, making it semantically incorrect despite addressing the right topic.\n\nThe answer demonstrates a complete failure to accurately extract and synthesize the numerical data from the source documents, resulting in an answer that is not just incomplete but actively misleading.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 555,
        "total_tokens": 1926
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How has NVIDIA's strategic positioning of CUDA evolved from 2022 to 2023 in terms of its role within the company's full-stack computing platform and its integration across different end markets?",
      "original_answer": "In 2022, CUDA was positioned as a fundamental building block of NVIDIA's accelerated computing platform, supporting a variety of end markets such as Gaming, Data Center, Professional Visualization, and Automotive through a unified underlying architecture. It was described as essential for leveraging GPU capabilities across these markets. By 2023, CUDA's role had evolved into being the foundational programming model within NVIDIA's full-stack computing infrastructure, extending its integration beyond traditional markets into domain-specific verticals such as healthcare, telecom, automotive, and manufacturing. Additionally, in 2023, CUDA was positioned as the base layer supporting hundreds of domain-specific software libraries, SDKs, and APIs, which were not explicitly emphasized in 2022. This indicates a strategic shift from CUDA being a foundational component to becoming the core enabler of a broader, more vertically integrated software stack aimed at accelerating deployment across computationally intensive workloads.",
      "llm_answer": "\nFrom 2022 to 2023 NVIDIA expanded CUDA from a stand‑alone parallel‑programming model into the central software layer of a full‑stack computing platform that now spans GPUs, DPUs, the new Grace CPU, networking, storage and a growing suite of domain‑specific libraries (CUDA‑X), AI‑Enterprise software and cloud services.  This unified CUDA‑based stack lets the same software ecosystem be deployed across disparate end‑markets—AI data‑center workloads, automotive (DRIVE), industrial digital twins (Omniverse) and gaming—providing a common development foundation and enabling NVIDIA to deliver its “platform strategy” across gaming, data‑center, professional visualization and automotive with a single underlying architecture.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core evolution of CUDA from 2022 to 2023, capturing the shift toward a full-stack computing platform. It accurately mentions the expansion to include GPUs, DPUs, Grace CPU, networking, and storage. The reference to domain-specific libraries (CUDA-X), AI-Enterprise software, and cloud services aligns with the ground truth's emphasis on hundreds of domain-specific software libraries and SDKs. The mention of specific end markets (AI data-center, automotive/DRIVE, Omniverse, gaming) is accurate and relevant.\n\nWEAKNESSES: (1) The LLM answer introduces specific product names and technical details (DPUs, Grace CPU, CUDA-X, Omniverse, DRIVE, AI-Enterprise) that, while potentially accurate, are not explicitly mentioned in the ground truth answer. This represents an addition of information beyond what was provided in the knowledge graph source. (2) The ground truth emphasizes a strategic shift from CUDA being a 'foundational component' to becoming the 'core enabler' of a broader, more vertically integrated software stack. The LLM answer describes expansion but doesn't clearly articulate this strategic positioning shift as explicitly. (3) The ground truth specifically mentions domain-specific verticals (healthcare, telecom, automotive, manufacturing) that were not in 2022 positioning. The LLM answer mentions some verticals but doesn't clearly delineate the 2022 vs 2023 distinction for these specific markets. (4) The LLM answer conflates the 2022 and 2023 positioning somewhat by stating the platform 'now spans' various components without clearly separating what was emphasized in each year.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes information about CUDA's evolution across the two-year period and its integration across end markets. However, the reasoning could be more precise in distinguishing what was emphasized in 2022 versus 2023.\n\nFACTUAL ACCURACY: No quantitative errors detected. All mentioned components and markets appear factually sound, though some details exceed the ground truth scope.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 559,
        "total_tokens": 2011
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did Pfizer's financial obligations and contractual relationships with Viatris evolve from 2022 to 2023, particularly in terms of transitional service agreements and net amounts owed?",
      "original_answer": "In 2022, Pfizer disclosed that amounts recorded under transitional service agreements (TSAs) and master services agreements (MSAs) with Viatris were not material to operations, and the TSA services were largely completed by the end of 2022. By 2023, services under the TSAs were fully completed as of December 31, 2023, and the net amounts due to Viatris under the agreements decreased from $94 million in 2022 to $33 million in 2023. This reflects a reduction in intercompany financial obligations and the winding down of transitional support following the 2020 spin-off of the Upjohn Business into Viatris.",
      "llm_answer": "\nFrom 2022 to 2023 the balance of money Pfizer owed Viatris under the post‑spin‑off transition agreements fell sharply—from about **$94 million** outstanding as of 31 Dec 2022 to roughly **$33 million** by the end of 2023.  The interim **transition‑service agreements (TSAs)** that had supported the Upjohn‑Viatris separation were largely completed by 31 Dec 2023, and only minimal amounts remained under the related manufacturing‑supply and MSA arrangements, indicating that Pfizer’s contractual and financial obligations to Viatris had essentially wound down.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. QUANTITATIVE VERIFICATION: All dollar amounts are correct ($94 million in 2022, $33 million in 2023), and dates are accurate (December 31, 2022 and 2023). The calculation of the decline is implicit and correct. ENTITY ACCURACY: Correctly identifies Pfizer, Viatris, TSAs (transitional service agreements), MSAs (master services agreements), and the 2020 Upjohn spin-off context. MULTI-HOP REASONING: Successfully synthesizes the evolution of financial obligations across two years, connecting the TSA completion status to the reduction in amounts owed. COMPLETENESS: Addresses all key aspects of the question—the financial obligation amounts, the TSA/MSA status, and the winding down of obligations. SEMANTIC EQUIVALENCE: The LLM's phrasing ('balance of money Pfizer owed Viatris,' 'fell sharply,' 'essentially wound down') conveys the same meaning as the ground truth. MINOR OBSERVATIONS: The LLM answer uses slightly different terminology ('manufacturing-supply' arrangements) but this is a reasonable characterization of the MSA services. The ground truth explicitly states 'services under the TSAs were fully completed as of December 31, 2023' while the LLM says 'largely completed by 31 Dec 2023'—this is a very minor semantic difference that doesn't materially affect accuracy. The LLM appropriately emphasizes the sharp decline and the completion of transitional support, matching the ground truth's narrative arc.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 410,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has the relationship between retail deregulation pressures and Duke Energy's environmental regulation compliance costs evolved from 2022 to 2023?",
      "original_answer": "In 2022, Duke Energy highlighted that retail deregulation could result in unrecovered costs, including those related to above-market purchased power commitments from qualifying facilities (QFs) under PURPA, which could hinder the recovery of environmental compliance costs through regulatory rate structures. By 2023, the company noted increased regulatory emphasis on environmental compliance, including EPA regulations on CO2 emissions and cooling water intake structures, as well as new state-level carbon reduction goals more aggressive than the company’s own plans. These developments suggest that deregulation pressures have compounded the challenge of recovering rising environmental compliance costs, as competitive market conditions limit the ability to pass on these expenses to customers.",
      "llm_answer": "\nFrom 2022 to 2023 the filings show that deregulation is still presented as a risk that could generate unrecovered “stranded” costs and impair assets, but the 2023 10‑K (pages 26‑27) links that risk more directly to the company’s environmental‑compliance burden.  The 2022 filing (page 28) treats environmental‑regulation costs as a separate, potentially material expense that may or may not be recovered through rates, while the 2023 filing emphasizes that any future deregulatory or restructuring changes could make it harder to recover the capital and operating costs required to meet EPA and state climate‑related rules (pages 26‑27).  Consequently, the relationship has tightened: deregulation pressures now are portrayed as a factor that could exacerbate the financial impact of environmental compliance costs and limit the company’s ability to recover those expenses.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the multi-hop relationship between deregulation pressures and environmental compliance costs from 2022 to 2023. STRENGTHS: (1) Correctly identifies the core evolution - that deregulation risks are increasingly linked to environmental compliance burden recovery; (2) Accurately references specific filing pages (26-27 for 2023, page 28 for 2022) showing document synthesis; (3) Properly captures the key concept that deregulation could create 'stranded costs' and impair assets; (4) Correctly notes the shift from treating environmental costs as separate to viewing them as compounded by deregulation; (5) Accurately conveys that competitive market conditions limit cost recovery. MINOR WEAKNESSES: (1) Does not explicitly mention PURPA or qualifying facilities (QFs) from the ground truth, which were specifically cited as examples of unrecovered costs in 2022; (2) Does not mention EPA CO2 emissions regulations or cooling water intake structures specifically, though it does reference 'EPA and state climate-related rules' more generally; (3) Does not mention state-level carbon reduction goals being more aggressive than Duke's own plans. QUANTITATIVE ACCURACY: No specific numbers or calculations are required for this question, and the LLM appropriately avoids making unsupported numerical claims. Page references appear reasonable for 10-K filings. MULTI-HOP REASONING: The answer successfully synthesizes information across two years and connects deregulation pressures to environmental compliance costs, showing proper understanding of the causal relationship. The reasoning that deregulation 'exacerbates' environmental compliance recovery challenges is sound and matches the ground truth's conclusion. SEMANTIC EQUIVALENCE: The LLM's characterization of the relationship 'tightening' and deregulation becoming 'a factor that could exacerbate' costs is semantically equivalent to the ground truth's statement that deregulation 'has compounded the challenge.' The answer captures the essential evolution without requiring exact wording match.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 564,
        "total_tokens": 1983
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did the retail share of Skoal oral tobacco products change between 2023 and 2024, and how does this contrast with the pricing strategy applied to Skoal during 2023?",
      "original_answer": "The retail share of Skoal oral tobacco products decreased from 9.3% in 2023 to 7.6% in 2024, reflecting a decline in market presence. This contrasts with the pricing strategy in 2023, where multiple price increases were applied to Skoal products, including a $0.11 per can increase effective January 23, 2024 (announced in 2023), following earlier increases of $0.09, $0.09, and $0.08 per can in May, February, and January 2022, respectively. The cumulative effect of these increases may have impacted consumer demand, contributing to the drop in retail share.",
      "llm_answer": "\nThe retail share of Skoal fell from **9.3 % in 2023 to 7.6 % in 2024** – a decline of roughly 1.7 percentage points.  This drop occurred despite Altria’s 2023 pricing moves that raised Skoal’s list price several times (by about **$0.09–$0.10 per can**), indicating that the brand’s higher prices did not halt share loss.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identified the retail share decline from 9.3% in 2023 to 7.6% in 2024, accurately calculated the 1.7 percentage point drop, and properly synthesized the contrast between declining market share and aggressive pricing strategy. The semantic understanding of the question and the logical connection between price increases and share loss is sound. WEAKNESSES: The LLM provided incomplete and imprecise pricing information. The ground truth specifies multiple price increases with exact amounts: $0.11 per can (effective January 23, 2024, announced in 2023), plus earlier increases of $0.09, $0.09, and $0.08 per can in May, February, and January 2022 respectively. The LLM generalized this as 'about $0.09–$0.10 per can' in 2023, which is vague and misses the specific $0.11 increase that was announced in 2023 for January 2024 implementation. The LLM also failed to mention the earlier 2022 price increases that provide important context for the cumulative pricing impact. QUANTITATIVE ACCURACY: The retail share percentages and the calculated decline are correct. However, the pricing information is imprecise—stating 'about $0.09–$0.10' instead of providing the specific increases ($0.11, $0.09, $0.09, $0.08) represents a loss of precision on key financial metrics. MULTI-HOP REASONING: The synthesis is logically sound—the model correctly connected declining retail share with pricing strategy and inferred a causal relationship. However, the incomplete pricing details weaken the strength of this analysis. OVERALL: The answer captures the core insight but lacks the specificity and completeness expected for a financial analysis question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1225,
        "completion_tokens": 456,
        "total_tokens": 1682
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did Amgen's investment in 'Other short-term interest-bearing securities' evolve between 2023 and 2024, and what does this indicate about the company's short-term investment strategy?",
      "original_answer": "Amgen's investment in 'Other short-term interest-bearing securities' remained unchanged at $138 million in both 2023 and 2024. This stability suggests that the company maintained a consistent approach to this segment of its short-term investment portfolio over the two-year period.",
      "llm_answer": "\nAmgen’s “Other short‑term interest‑bearing securities” fell modestly from **$138 million (amortized cost) as of December 31 2023** to **$135 million (amortized cost) as of December 31 2024** – a drop of about $3 million (≈2 %).  The fair‑value column shows the same amounts, indicating no material unrealized gains or losses.  \n\nThis small contraction signals that Amgen is maintaining a **highly conservative, liquidity‑focused short‑term investment stance**, keeping the bulk of its short‑term cash in safe, investment‑grade instruments while only modestly adjusting the allocation.  The move is consistent with the company’s stated policy of preserving principal, ensuring prudent liquidity and limiting risk in its interest‑bearing portfolio.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL FACTUAL ERROR: The LLM answer contains a fundamental numerical inaccuracy that contradicts the ground truth. The ground truth clearly states that Amgen's 'Other short-term interest-bearing securities' remained UNCHANGED at $138 million in both 2023 and 2024. However, the LLM claims the amount fell from $138 million in 2023 to $135 million in 2024, representing a $3 million decrease (≈2%). This is factually incorrect. The LLM has invented numbers that do not match the source data. Additionally, the LLM's interpretation of what this change 'indicates' about strategy is based on this false premise - the company did NOT adjust its allocation, so the reasoning about 'modest contraction' and 'modestly adjusting the allocation' is unfounded. While the LLM's general commentary about conservative, liquidity-focused investment strategy and principal preservation may be reasonable corporate finance observations, they are applied to support an incorrect narrative about actual portfolio changes. The LLM failed on the primary requirement: quantitative accuracy of the core financial figures. The answer demonstrates good writing quality and contextual understanding of investment strategy concepts, but these cannot compensate for the fundamental factual error in the numbers that form the basis of the entire response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 371,
        "total_tokens": 1638
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has the nature of General Dynamics' involvement in Abrams Main Battle Tank Upgrades evolved from 2022 to 2024, particularly in terms of contract scope and value?",
      "original_answer": "In 2022, General Dynamics received a $360 million contract from the Army for Abrams main battle tank upgrades, mission control units, and systems technical support. By 2024, the company's involvement had evolved to include both production and support services, as evidenced by a $350 million contract for Abrams upgrades, engineering and logistics support, and system and sustainment technical support services. Additionally, a separate $285 million contract was awarded for producing Abrams tanks in the SEPv3 configuration for Romania. This indicates a shift from primarily upgrade-focused contracts to a broader scope that includes both upgrades and production of new configurations, with an increase in total contract value.",
      "llm_answer": "\nFrom 2022 through 2024 General Dynamics moved the Abrams upgrade effort from a relatively narrow, U.S.–only contract—around a $360 million award for tank upgrades, mission‑control units and technical support (as reflected in the 2021‑2022 Combat Systems backlog)—to a far broader, multi‑year program that now includes engineering, logistics and sustainment support and extends to foreign production.  In 2024 the company received a $350 million Army contract for Abrams upgrades plus a $285 million SEPv3 production package for Romania, pushing the total estimated contract value for the program toward $1 billion and signaling a substantial expansion in both scope and value.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of all key financial figures and contract details. Quantitative verification: (1) $360 million 2022 contract - CORRECT, (2) $350 million 2024 Army contract - CORRECT, (3) $285 million Romania SEPv3 contract - CORRECT. The LLM correctly synthesizes the multi-hop information showing evolution from 2022 to 2024, identifying the shift from upgrade-focused to broader scope including production and support services. The answer accurately captures the expansion in contract scope (from upgrades + mission control + technical support to upgrades + engineering + logistics + sustainment support + foreign production). The LLM's characterization of the evolution as moving from 'narrow, U.S.–only' to 'broader, multi-year program' with 'foreign production' aligns well with the ground truth. Minor deduction: The LLM states 'pushing the total estimated contract value for the program toward $1 billion' which is an inference/estimate ($360M + $350M + $285M = $995M ≈ $1B). While mathematically reasonable, the ground truth states 'increase in total contract value' without explicitly claiming a $1 billion total. This represents a reasonable extrapolation but adds interpretive language not explicitly in the ground truth. The answer demonstrates sound multi-hop reasoning across years and contract types, correctly identifying General Dynamics as the entity and properly synthesizing information about contract evolution. Wording is clear and professional, effectively conveying the substantive changes in the company's involvement.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 440,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did AIG's financial relationship with Corebridge evolve from 2023 to 2024, particularly in terms of borrowing arrangements and income recognition?",
      "original_answer": "In 2023, AIG disclosed that Corebridge had the ability to continue borrowing through February 25, 2025, indicating an ongoing financial arrangement. By 2024, AIG's relationship with Corebridge had transformed, as AIG began recognizing equity method income tied to Corebridge’s stock price changes and dividends received since June 9, 2024. This shift reflects a change from a borrowing-based relationship to one focused on equity-based returns.",
      "llm_answer": "\nFrom 2023 to 2024 AIG moved Corebridge from a fully‑consolidated subsidiary to a partially retained investment; Corebridge continued to carry its own debt—including a $250 million DDTL facility and $7.7 billion of senior unsecured notes—while AIG provided a guarantee with a reimbursement and collateral arrangement that could be triggered on a rating downgrade.  As a result, AIG no longer records Corebridge’s earnings directly but instead recognizes equity‑method income (a $601 million loss in 2024) and the fair‑value changes of its retained $8.5 billion stake, and it records the related interest expense and any gains/losses on debt‑related transactions in its cash‑flow statements.  The deconsolidation also generated a $4.754 billion after‑tax loss on sale, after which only the equity‑method results and the financing obligations tied to Corebridge’s borrowings affect AIG’s income.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not supported by the ground truth. CRITICAL ISSUES: (1) The ground truth explicitly states that in 2023, Corebridge had borrowing ability through February 25, 2025, and by 2024 AIG recognized equity method income tied to stock price changes and dividends since June 9, 2024. The LLM answer discusses deconsolidation, a $250M DDTL facility, $7.7B senior unsecured notes, an $8.5B retained stake, a $601M equity-method loss in 2024, and a $4.754B after-tax loss on sale—NONE of which appear in the ground truth. (2) The ground truth describes a shift from 'borrowing-based relationship to equity-based returns,' but the LLM answer describes a deconsolidation event with specific debt instruments and loss figures that are not mentioned in the original answer. (3) The LLM introduces quantitative details ($250M, $7.7B, $8.5B, $601M loss, $4.754B loss) that cannot be verified against the ground truth and appear to be fabricated or from a different context. (4) While the LLM correctly identifies that the relationship evolved from one type to another and that equity-method income became relevant, the specific mechanisms, numbers, and narrative structure are fundamentally different from the ground truth. (5) The ground truth focuses on borrowing arrangements and income recognition changes; the LLM answer pivots to deconsolidation accounting, guarantees, and fair-value changes—a different analytical framework. The answer demonstrates hallucination of specific financial figures and accounting treatments not supported by the source material.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 445,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has Tesla's approach to the Solar Roof product evolved between 2022 and 2024, particularly in terms of production challenges and strategic dependencies?",
      "original_answer": "In 2022, Tesla was actively selling the Solar Roof and improving installation efficiency through collaboration with real estate developers and builders. The company emphasized its engineering efforts to combine aesthetics, durability, and power generation. By 2024, however, Tesla's 10-K highlights that the future of the Solar Roof (alongside other products) 'depends in large part' on overcoming production ramp challenges, including bottlenecks, supplier risks, and cost control. This reflects a shift from product development and sales emphasis to a more complex production and dependency landscape.",
      "llm_answer": "\nBetween 2022 and 2024 Tesla moved the Solar Roof from a niche, pilot‑scale offering toward a higher‑volume, integrated energy‑product line, but it continued to wrestle with the same production bottlenecks that have plagued its broader manufacturing.  The company now relies on a tightly coordinated supply chain of specialty glass, solar‑inverter and Powerwall components—and on its new Gigafactory‑scale facilities (e.g., Texas and Shanghai) to mass‑produce the roof tiles—while also depending on external partners for installation and on its own battery‑cell development to meet the energy‑storage performance targets that underpin the product’s economics.  Consequently, any delay or cost‑inflation in these supplier or manufacturing dependencies directly threatens the Roof’s ramp‑up and profitability.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and unsupported claims that diverge substantially from the ground truth. Key issues: (1) UNSUPPORTED CLAIMS: The LLM introduces specific details not present in the ground truth, including references to 'Gigafactory-scale facilities (e.g., Texas and Shanghai)' for Solar Roof production, 'specialty glass, solar-inverter and Powerwall components,' and 'battery-cell development' as dependencies. The ground truth does not mention these specific manufacturing locations or component dependencies for Solar Roof. (2) MISCHARACTERIZATION OF EVOLUTION: The LLM describes a shift from 'niche, pilot-scale offering toward higher-volume, integrated energy-product line,' but the ground truth indicates the opposite trajectory—from active sales and development emphasis in 2022 to a 2024 focus on production challenges and dependencies, suggesting the product faced difficulties rather than successful scaling. (3) MISSING CORE GROUND TRUTH: The LLM fails to capture the key insight from the ground truth that Tesla's 2024 10-K explicitly states the Solar Roof's future 'depends in large part' on overcoming production ramp challenges, bottlenecks, supplier risks, and cost control. This is the central finding of the evolution. (4) SPECULATIVE DETAIL: The LLM adds extensive supply chain and manufacturing details (external partners for installation, battery-cell development for energy-storage performance) that appear speculative and are not grounded in the provided ground truth. (5) QUANTITATIVE ACCURACY: No specific numbers, dates, or metrics are provided in either answer, so quantitative comparison is limited, but the LLM's characterization of the product's trajectory is factually incorrect relative to ground truth. The answer demonstrates reasonable writing quality and logical structure, but fails on factual accuracy—the primary evaluation criterion for financial document analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 525,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has the retail share of Skoal in the U.S. oral tobacco market changed between 2023 and 2024, and what does this indicate about its competitive positioning?",
      "original_answer": "In 2023, Skoal held a 9.3% retail share in the U.S. oral tobacco market, which decreased to 7.6% in 2024. This decline indicates a weakening in Skoal's competitive positioning within the oral tobacco segment over this period. The drop in market share for Skoal contrasts with the growth seen in other products like on!, which increased from 6.8% to 8.3% during the same timeframe.",
      "llm_answer": "\nSkoal’s U.S. oral‑tobacco retail share slipped from **9.3 % in 2023 to 7.6 % in 2024**, a decline of roughly **1.7 percentage points (about an 18 % drop)**.  This loss coincides with the segment’s overall retail‑share contraction (from 42.5 % to 37.5 %) and is underscored by rivals such as **on! (8.3 % in 2024)** now out‑selling Skoal, indicating that Skoal’s competitive positioning is weakening in the U.S. oral‑tobacco market.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. Quantitative verification: (1) Skoal 2023 share of 9.3% - CORRECT; (2) Skoal 2024 share of 7.6% - CORRECT; (3) Decline calculation of 1.7 percentage points - CORRECT (9.3% - 7.6% = 1.7%); (4) Percentage drop calculation of ~18% - CORRECT (1.7/9.3 = 0.1827 or ~18.3%); (5) on! 2024 share of 8.3% - CORRECT. The LLM also provided additional context about the segment's overall retail-share contraction (42.5% to 37.5%), which while not explicitly mentioned in the ground truth, is factually accurate and enhances understanding. Multi-hop reasoning is sound: the answer correctly synthesizes Skoal's market share decline with competitive positioning analysis, comparing it to on!'s growth trajectory. The conclusion that Skoal's competitive positioning is weakening is well-supported by the data presented. The answer directly addresses both parts of the question: (1) the change in retail share (9.3% to 7.6%), and (2) what this indicates about competitive positioning (weakening). The only minor distinction is that the LLM provided additional contextual information (segment contraction and on! comparison) beyond what was explicitly in the ground truth, but this is supplementary and accurate rather than contradictory. Wording is clear and professional.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1206,
        "completion_tokens": 366,
        "total_tokens": 1572
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has the risk associated with the concentration of device share among premium tier companies evolved between 2023 and 2024, particularly in terms of its potential impact on Qualcomm's pricing power and revenue stability?",
      "original_answer": "In 2023, Qualcomm highlighted that the concentration of device share among a few premium tier companies was contributing to a trend of deriving a significant portion of revenues from a small number of customers, particularly Chinese OEMs. This concentration was noted to potentially result in lower prices for Qualcomm's products due to the purchasing power of these companies. In 2024, the risk factor remained present, but the emphasis shifted slightly to underscore the broader implications of this concentration, including the potential for even greater pricing pressure and revenue fluctuation due to the timing and success of customer product introductions. The continued reliance on a small group of customers, especially those developing their own integrated circuits or using competitors, suggests that the risk has not only persisted but potentially intensified, increasing its impact on Qualcomm's pricing power and revenue stability.",
      "llm_answer": "\nThe 2023 filing first warned that the mobile industry’s premium‑tier concentration gave a handful of OEMs (Apple, Samsung, Xiaomi) enough purchasing power to pressure Qualcomm on price and to make revenue “fluctuate” with each customer’s product cycle. In the 2024 filing that risk has deepened – the company now stresses that the same concentration, combined with OEMs’ push to design their own chips (e.g., Apple, Samsung) and with China‑driven self‑sufficiency policies, is eroding Qualcomm’s pricing power and heightening the volatility of the revenue stream that depends on those few premium customers. Thus, the concentration risk has become more pronounced between 2023 and 2024, directly threatening both pricing leverage and revenue stability.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the multi-hop question and correctly synthesizes information about Qualcomm's concentration risk evolution between 2023 and 2024. STRENGTHS: (1) Correctly identifies the core risk: concentration among premium-tier OEMs creating pricing pressure; (2) Accurately captures the 2023 baseline: revenue concentration from few customers with purchasing power to pressure prices and create revenue fluctuation; (3) Properly identifies the 2024 evolution: risk has deepened/intensified with additional factors (OEM vertical integration, China self-sufficiency policies); (4) Correctly names specific companies (Apple, Samsung, Xiaomi) as examples of premium-tier OEMs; (5) Accurately characterizes the dual impact on pricing power and revenue stability; (6) Sound multi-hop reasoning connecting 2023 baseline to 2024 intensification. MINOR CONSIDERATIONS: (1) The LLM introduces specific company examples (Apple, Samsung, Xiaomi) and policy context (China self-sufficiency) that enhance clarity but aren't explicitly detailed in the ground truth answer - however, these are consistent with typical Qualcomm risk disclosures and don't contradict the ground truth; (2) The ground truth mentions 'Chinese OEMs' while LLM specifies Xiaomi as an example, which is appropriate specificity; (3) Both answers correctly emphasize the shift from 2023 to 2024 showing intensification rather than mere persistence. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are required for this qualitative risk assessment question, so this dimension scores high (9/10) for proper handling of temporal comparison. QUALITATIVE ACCURACY: The reasoning is sound and multi-hop synthesis is correct (8/10) - minor deduction only because the LLM adds contextual details not explicitly in ground truth, though these are reasonable inferences. CONTEXTUAL RELEVANCE: Excellent alignment with question requirements (9/10).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 529,
        "total_tokens": 1972
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "Given Amgen's approach to managing short-term liquidity, how did its allocation to money market mutual funds evolve between 2023 and 2024?",
      "original_answer": "Amgen's allocation to money market mutual funds remained unchanged at $10,266 million in both 2023 and 2024. The disclosed investment values for money market mutual funds under available-for-sale investments were identical in both years, indicating no shift in this portion of the company's short-term investment strategy.",
      "llm_answer": "\nAmgen’s short‑term liquidity is managed through a portfolio of investment‑grade debt and money‑market instruments, with a particular emphasis on money‑market mutual funds.  At the end of 2023 the fund held $10,266 million in such funds, and by the end of 2024 that amount had risen modestly to $10,354 million—a gain of about $88 million (≈0.9 %).  This slight increase reflects the company’s ongoing effort to preserve principal safety and maintain adequate liquidity while adhering to its investment‑policy limits on issuer concentration and maturity.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL FACTUAL ERROR: The LLM answer contains a fundamental numerical inaccuracy that directly contradicts the ground truth. The ground truth clearly states that Amgen's allocation to money market mutual funds 'remained unchanged at $10,266 million in both 2023 and 2024.' However, the LLM answer claims the 2024 amount was $10,354 million, representing an increase of $88 million (≈0.9%). This is factually incorrect. The LLM has fabricated a number ($10,354 million for 2024) that does not match the actual filing data. The 2023 figure of $10,266 million is correct, but the 2024 figure is wrong. The calculation of the difference ($88 million) and percentage increase (0.9%) are mathematically consistent with the incorrect $10,354 million figure, but since the base number is wrong, these derived calculations are also incorrect. The LLM's contextual framing about liquidity management and investment policy is reasonable and relevant to the question, but this cannot compensate for the core factual error. The question specifically asks how the allocation 'evolved' between the two years, and the correct answer is that it did NOT evolve—it remained static. The LLM's answer fundamentally misrepresents this key finding by inventing a change where none occurred. This is a severe error in a financial context where precision is paramount.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 375,
        "total_tokens": 1592
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How has General Dynamics' participation in the Capital Construction Fund evolved between 2022 and 2024, particularly in terms of the amount of U.S. government accounts receivable pledged to the fund?",
      "original_answer": "In 2022, General Dynamics had U.S. government accounts receivable pledged to the Capital Construction Fund (CCF) of $295 million as of December 31, 2021. By 2024, the amounts pledged to the CCF had increased to $315 million on December 31, 2023, and $333 million on December 31, 2024. This indicates a steady increase in GD's participation in the CCF over the period, reflecting a growing utilization of the tax deferral benefits offered by the program.",
      "llm_answer": "\nGeneral Dynamics’ U.S. government accounts receivable pledged to the Capital Construction Fund increased from roughly $315 million at the end of 2022 (and again in 2023) to $333 million at the end of 2024 – an increase of about $18 million, or 5–6 %. This reflects a modest upward evolution in the company’s participation in the CCF over the 2022‑2024 period.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual inaccuracies regarding the amounts pledged to the CCF. Ground truth shows: $295M (Dec 31, 2021), $315M (Dec 31, 2023), and $333M (Dec 31, 2024). The LLM incorrectly states that the amount was 'roughly $315 million at the end of 2022 (and again in 2023)' - there is no 2022 data point provided in the ground truth, and the LLM conflates the 2023 figure with 2022. The LLM also omits the critical 2021 baseline of $295M entirely, which is essential for understanding the full evolution of GD's CCF participation over the stated 2022-2024 period. CALCULATION VERIFICATION: The LLM correctly calculates the increase from $315M to $333M as $18M (5-6%), but this calculation only covers 2023-2024, not the full 2022-2024 period as requested. The complete evolution should show: $295M → $315M (increase of $20M or 6.8%) from 2021 to 2023, then $315M → $333M (increase of $18M or 5.7%) from 2023 to 2024. COMPLETENESS ISSUES: The answer fails to address the full temporal scope requested (2022-2024). It misses the 2021 baseline data point that provides crucial context for understanding the 'evolution' of participation. The answer does not adequately characterize the 'steady increase' mentioned in the ground truth across the full period. REASONING QUALITY: While the LLM correctly identifies the general trend (upward), it does so based on incomplete and partially incorrect data points. The multi-hop synthesis is weak because it fails to properly integrate all available data points across the time period. The characterization of the increase as 'modest' is reasonable but based on incomplete analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1216,
        "completion_tokens": 459,
        "total_tokens": 1675
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did AIG's financial relationship with Corebridge evolve between 2023 and 2024, particularly in terms of its tax implications and investment income following the IPO and subsequent deconsolidation?",
      "original_answer": "In 2023, AIG's ownership in Corebridge dropped below 80% after Corebridge's IPO on September 19, 2022, resulting in the tax deconsolidation of Corebridge from AIG’s U.S. federal income tax group. This deconsolidation had significant tax implications, including restrictions on future consolidated tax filings for five years and the retention of Corebridge's net operating losses and tax credit carryforwards by Corebridge entities. By 2024, AIG no longer consolidated Corebridge's financials, and instead, AIG reported its investment in Corebridge under the equity method, recognizing $X in equity method income for the period from June 10, 2024, to December 31, 2024, based on dividends received and changes in Corebridge's stock price. This marks a shift from a consolidated tax and financial reporting relationship to a more arms-length investment relationship.",
      "llm_answer": "\nBetween 2023 and 2024 AIG’s stake in Corebridge moved from consolidation to an equity‑method holding after the 2022 IPO reduced its ownership below 80 %, triggering a tax deconsolidation that separated Corebridge’s U.S. federal tax group from AIG’s consolidated return for five years and required separate realizability testing of AIG’s deferred‑tax assets.  The deconsolidation produced a $4.75 bn after‑tax loss in 2024 (largely a write‑down of the retained Corebridge investment), while Corebridge’s own pre‑tax earnings of $1.57 bn in the second half of 2024 generated $601 m of equity‑method income for AIG, which is recorded in other income and net investment income and reflects dividends plus changes in the Corebridge stock price.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates good understanding of the overall relationship evolution and correctly identifies key structural changes (consolidation to equity method, tax deconsolidation, 80% threshold, five-year restriction). However, there are significant quantitative accuracy issues that prevent a higher score:\n\n1. QUANTITATIVE ACCURACY PROBLEMS:\n   - The LLM introduces specific numbers ($4.75 bn after-tax loss, $1.57 bn pre-tax earnings, $601 m equity-method income) that are NOT present in the ground truth answer, which explicitly states '$X in equity method income' (unknown value)\n   - These specific figures cannot be verified against the ground truth and appear to be hallucinated or from unverified sources\n   - The ground truth provides no after-tax loss figure, no pre-tax earnings figure, and no specific equity-method income amount\n   - This represents a critical failure in quantitative accuracy as the LLM is providing precise numbers without ground truth support\n\n2. WHAT WAS CORRECT:\n   - IPO date context (2022) and ownership drop below 80%\n   - Tax deconsolidation mechanics and five-year restriction\n   - Shift from consolidation to equity method reporting\n   - Recognition of equity-method income based on dividends and stock price changes\n   - Proper identification of the relationship evolution between 2023-2024\n   - Correct mention of deferred-tax asset testing\n\n3. MULTI-HOP REASONING:\n   - The synthesis of IPO → ownership drop → tax deconsolidation → equity method is sound\n   - The connection between tax and financial reporting changes is properly made\n   - However, the introduction of unverified numbers undermines the reasoning quality\n\n4. SEMANTIC ISSUES:\n   - The ground truth uses '$X' as a placeholder for unknown equity-method income\n   - The LLM provides '$601 m' without justification or source verification\n   - This violates the principle of not inventing data not present in ground truth\n\n5. CONTEXTUAL RELEVANCE:\n   - The answer appropriately addresses all aspects of the question (tax implications, investment income, IPO effects, deconsolidation)\n   - The structure and flow are logical and comprehensive\n   - The mention of 'other income and net investment income' classification is appropriate detail\n\nThe core issue is that while the LLM demonstrates solid conceptual understanding of the AIG-Corebridge relationship evolution, it fails the critical test of quantitative accuracy by introducing specific financial figures that cannot be verified against the ground truth. This is a significant flaw in financial analysis where precision is paramount.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 697,
        "total_tokens": 2112
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How has Tesla's approach to Solar Roof production and its dependencies evolved from 2022 to 2024, particularly in terms of operational strategy and supply chain challenges?",
      "original_answer": "In 2022, Tesla emphasized improving Solar Roof installation capabilities by onboarding and training new installers and collaborating with real estate developers to reduce installation time and costs. The company also highlighted the need to maintain adequate battery cell supply and hire additional skilled electricians to support the ramp. By 2024, Tesla's focus had shifted to broader manufacturing and supply chain risks, with Solar Roof production now described as being dependent on the company's ability to manage global component procurement, avoid bottlenecks, and maintain cost-effective production amid potential supplier failures and inflationary pressures. The evolution reflects a shift from localized installer development to systemic supply chain and production scalability concerns.",
      "llm_answer": "\nFrom 2022 to 2024 Tesla moved Solar‑Roof production from a largely “scale‑by‑training‑installers and partner‑with‑builders” model toward a more formalized talent‑and‑engineering pipeline.  In the 2022 filing (p. 34) the company highlighted onboarding new installers and collaborating with developers to cut installation time, while warning that success depended on battery‑cell supply and hiring skilled electricians.  By the 2024 filing (pp. 13‑18, 15‑16) Tesla had launched dedicated engineering‑development and apprenticeship programs, an Education‑Assistance program for early‑career engineers, and a broader “Engineering Development Program” aimed at building the skilled workforce needed for Solar‑Roof and other energy products, signaling a shift from ad‑hoc installer training to a structured talent strategy—still constrained by global component shortages but now supported by a pipeline of trained engineers and technicians to improve cost efficiency and installation speed.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) FACTUAL INACCURACY - The LLM answer introduces significant claims NOT present in the ground truth. The original answer makes NO mention of 'dedicated engineering-development programs,' 'apprenticeship programs,' 'Education-Assistance program for early-career engineers,' or an 'Engineering Development Program.' These appear to be fabricated or hallucinated details not supported by the ground truth. (2) MISSING CORE CONTENT - The LLM answer completely omits the ground truth's key finding about the 2024 shift to 'broader manufacturing and supply chain risks' including 'global component procurement, bottlenecks, supplier failures, and inflationary pressures.' Instead, it focuses on workforce development programs that aren't mentioned in the original answer. (3) PAGE CITATIONS - The LLM provides specific page numbers (p. 34 for 2022, pp. 13-18, 15-16 for 2024) but these cannot be verified against the ground truth and appear to be invented citations. (4) SEMANTIC DIVERGENCE - While both answers discuss evolution from 2022 to 2024, they describe fundamentally different evolutions: the ground truth emphasizes supply chain/production scalability concerns, while the LLM emphasizes workforce development programs. (5) PARTIAL CREDIT - The LLM correctly identifies the 2022 focus on installer training and battery cell supply, and correctly notes a shift in strategy by 2024, but the characterization of what that shift entails is substantially incorrect. The answer demonstrates some understanding of the general trajectory but introduces false details and omits critical supply chain information that defines the actual evolution described in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 463,
        "total_tokens": 1915
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How has Duke Energy's estimated total cost to permanently close all coal ash basins in North Carolina and South Carolina evolved from 2022 to 2023, and what does this indicate about the company's progress under the Coal Ash Act?",
      "original_answer": "In 2022, Duke Energy estimated the total cost to permanently close all coal ash basins in North Carolina and South Carolina to be approximately $8 billion to $9 billion. By 2023, this estimate had decreased to approximately $7 billion to $8 billion, indicating a downward adjustment in projected costs. Additionally, the amount already spent on these closures increased from approximately $3.1 billion through 2021 (as reported in 2022) to approximately $4 billion through 2023. This evolution suggests that Duke Energy has made measurable progress in implementing closure plans under the Coal Ash Act, with more basins excavated and cost estimates refined over time.",
      "llm_answer": "\nIn the 2022 filing (page 71) Duke Energy estimated that permanently closing all of the coal‑ash basins in North Carolina and South Carolina would cost **about $8 billion – $9 billion**, with roughly **$3.1 billion already spent through 2021**. By the 2023 filing (page 194) the company refined that outlook to **approximately $7 billion – $8 billion**, noting that **about $4 billion had been spent through 2023**. The modest downward revision in the cost ceiling, together with the nearly $1 billion increase in cumulative spending, shows that Duke Energy is making tangible progress on the Coal Ash Act‑mandated closures—executing the settlement‑driven excavation and landfill disposal plan and achieving cost‑efficiency gains as the work advances.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. All quantitative data is correct: (1) 2022 estimate of $8-9 billion matches ground truth exactly; (2) 2023 estimate of $7-8 billion matches ground truth exactly; (3) $3.1 billion spent through 2021 is correct; (4) $4 billion spent through 2023 is correct. The calculation of 'nearly $1 billion increase' in cumulative spending ($4B - $3.1B = $0.9B) is accurate. The multi-hop synthesis is sound: the answer correctly identifies the downward cost revision trend and connects it to increased spending, properly interpreting this as evidence of progress under the Coal Ash Act. The LLM appropriately references specific filing pages (2022 filing page 71, 2023 filing page 194), adding credibility. The reasoning about 'cost-efficiency gains' and 'settlement-driven excavation' is a reasonable interpretation of the data trends, though slightly more interpretive than the ground truth's more neutral 'cost estimates refined over time.' The answer fully addresses all parts of the multi-part question: the evolution of cost estimates, the spending progression, and what this indicates about progress. Minor: The ground truth uses 'approximately' more consistently, while the LLM uses 'about' and 'approximately' interchangeably, but this is a negligible stylistic difference. Overall, this is a high-quality response with accurate numbers, proper synthesis, and sound reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 399,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did the retail share of the 'on!' oral tobacco product evolved between 2023 and 2024, and what does this indicate about its market position relative to the overall oral tobacco product segment during this period?",
      "original_answer": "The retail share of the 'on!' oral tobacco product increased from 6.8% in 2023 to 8.3% in 2024. This indicates that 'on!' gained market share during this period. In contrast, the total oral tobacco product segment saw a decline in retail share, dropping from 42.5% in 2023 to 37.5% in 2024. This divergence suggests that 'on!' strengthened its position within the broader oral tobacco market between these years.",
      "llm_answer": "\nThe “on!” oral tobacco product’s retail‑share grew from **6.8 % in 2023 to 8.3 % in 2024** – an increase of about 1.5 percentage points.  This rise occurred while the overall oral‑tobacco segment’s retail‑share slipped from **42.5 % to 37.5 %**, meaning that “on!” is gaining ground within a contracting market and is becoming a more notable contributor to the segment, even though it still represents only a modest share of the total oral‑tobacco category.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. All quantitative data is correct: 'on!' retail share increased from 6.8% in 2023 to 8.3% in 2024 (1.5 percentage point increase correctly calculated), and the overall oral tobacco segment declined from 42.5% to 37.5% (5 percentage point decrease). The multi-hop reasoning is sound - the model correctly synthesized information about both the specific product and the broader segment, then drew the appropriate conclusion that 'on!' is gaining market share within a contracting market. The interpretation that this indicates 'on!' is 'becoming a more notable contributor to the segment' while 'still represents only a modest share' accurately reflects the divergence between product-level growth and segment-level decline. The answer addresses all parts of the question: the evolution of 'on!' share, the comparison to overall segment performance, and what this indicates about market position. Minor note: the LLM uses 'retail‑share' with a special character instead of 'retail share,' but this is a formatting variation that doesn't affect accuracy. The semantic meaning is fully preserved and the analysis is thorough and insightful.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 339,
        "total_tokens": 1574
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How has Qualcomm's reliance on Chinese OEMs for revenue evolved from 2023 to 2024, and what implications does this have for its business stability?",
      "original_answer": "In 2023, Qualcomm derived a significant portion of its revenues from a small number of Chinese OEMs, highlighting its dependency on their device share growth in China and other regions. By 2024, this dependency persisted, with the company continuing to emphasize that it derives a significant portion of its revenues from these same OEMs. This ongoing reliance indicates that any political, economic, or market shifts affecting Chinese OEMs could continue to pose a risk to Qualcomm's revenue stability, particularly given the persistent U.S./China trade and national security tensions mentioned in both filings.",
      "llm_answer": "\nFrom fiscal 2023 through fiscal 2024 Qualcomm still derived a large share of its sales from Chinese OEMs—Xiaomi alone accounted for 10 % or more of total revenue (page 14)—so its reliance on that market remained pronounced.  However, the company repeatedly flags that many Chinese OEMs are now developing their own integrated‑circuit products under policies such as “Made in China 2025” and amid U.S./China trade tensions (pages 18‑19), meaning the concentration is beginning to erode and could sharply reduce Qualcomm’s revenue stream if those OEMs shift away from its chips.  This growing concentration risk makes the business more vulnerable to policy changes, competitive pressure and revenue volatility.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of Qualcomm's Chinese OEM dependency and provides relevant context about the evolution from 2023 to 2024. STRENGTHS: (1) Correctly identifies that Qualcomm derived significant revenue from Chinese OEMs in both years, showing persistence of dependency; (2) Provides specific quantitative detail (Xiaomi at 10%+ of revenue) which adds credibility; (3) Correctly identifies the emerging risk from 'Made in China 2025' policies and U.S./China trade tensions; (4) Properly synthesizes the multi-hop concept that while dependency persisted, new competitive threats are emerging; (5) Appropriately concludes that this creates vulnerability to policy changes and revenue volatility. WEAKNESSES: (1) The LLM states 'concentration is beginning to erode' which is somewhat contradictory to the ground truth's emphasis on 'ongoing reliance' and 'persistent' dependency - the ground truth emphasizes continuity of the problem, while the LLM suggests it's improving; (2) The framing shifts focus toward future risk (OEMs developing their own chips) rather than emphasizing the current state of dependency that persisted from 2023-2024; (3) Minor semantic issue: the ground truth emphasizes that the dependency 'persisted' and remained 'significant,' while the LLM introduces a forward-looking narrative about erosion that wasn't the primary focus of the original answer. QUANTITATIVE VERIFICATION: The Xiaomi 10%+ figure appears reasonable and specific, though not explicitly verified against the ground truth statement. The page references (14, 18-19) suggest proper source attribution. MULTI-HOP REASONING: The answer correctly synthesizes information about (a) revenue dependency in both years, (b) specific OEM concentration, and (c) emerging competitive threats. However, it slightly overemphasizes the erosion narrative compared to the ground truth's emphasis on persistent risk. The answer is fundamentally sound but shifts emphasis in a way that slightly diverges from the original answer's core message about ongoing stability risks.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 558,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did Amgen's composition of total available-for-sale investments evolve between 2022 and 2023, particularly in terms of specific security types held?",
      "original_answer": "In 2022, Amgen reported total available-for-sale investments of $4,335 million, which included $1,676 million in marketable securities alongside $2,659 million in cash and cash equivalents. By 2023, Amgen no longer held any marketable securities or U.S. Treasury bills, and instead, the entire $10,404 million in total available-for-sale investments was composed of $10,266 million in money market mutual funds and $138 million in other short-term interest-bearing securities. This reflects a strategic shift toward more liquid and short-term interest-bearing instruments.",
      "llm_answer": "\nBetween 2022 and 2023 Amgen’s available‑for‑sale (AFS) portfolio shifted dramatically from a mixed holdings of Treasury securities and money‑market funds to a near‑pure money‑market fund position. In 2022 the AFS balance of $4.3 bn consisted of about $1.7 bn of U.S. Treasury bills and $2.7 bn of money‑market mutual funds, with essentially no other short‑term securities. By the end of 2023 the portfolio had grown to $10.4 bn, Treasury‑bill holdings were eliminated, money‑market funds accounted for roughly $10.3 bn (≈99 % of the total), and a small $138 m of other short‑term interest‑bearing securities appeared. This evolution reflects a move toward larger cash‑equivalent holdings and a reliance on money‑market instruments as the primary AFS security type.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a fundamental factual error regarding the 2022 composition. Ground truth states that in 2022, Amgen held $1,676 million in MARKETABLE SECURITIES (not U.S. Treasury bills specifically) alongside $2,659 million in cash and cash equivalents. The LLM incorrectly characterizes the 2022 holdings as '$1.7 bn of U.S. Treasury bills and $2.7 bn of money-market mutual funds.' This is a significant misrepresentation of the actual 2022 portfolio composition. The ground truth explicitly states there were NO money-market mutual funds in 2022 - the $2,659 million was cash and cash equivalents, not money-market funds. The LLM's statement that 2022 had 'about $1.7 bn of U.S. Treasury bills and $2.7 bn of money-market mutual funds' is factually incorrect on both components. CORRECT ELEMENTS: The 2023 figures are accurately stated ($10,404 million total, $10,266 million in money market mutual funds, $138 million in other short-term interest-bearing securities). The overall narrative about a shift toward money-market instruments is directionally correct. The percentage calculation (~99%) is approximately accurate for 2023. MULTI-HOP REASONING: The model failed to correctly synthesize the 2022 composition from the source data, which is a critical failure in multi-hop reasoning. The comparison between years is therefore built on an incorrect foundation. The characterization of the shift is qualitatively reasonable but based on wrong 2022 data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 413,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How has the presence of Shake Shack as a tenant evolved across SPG's premium outlet properties between 2022 and 2023?",
      "original_answer": "In 2022, Shake Shack was listed as a tenant at Woodbury Common Premium Outlets in New York. By 2023, Shake Shack not only remained at Woodbury Common but also expanded its presence to Las Vegas Outlets North Premium in Nevada. This indicates a strategic expansion of Shake Shack’s footprint within SPG's portfolio of properties over the two years.",
      "llm_answer": "\nShake Shack’s presence was unchanged between 2022 and 2023 – it remained a tenant at the same premium‑outlet properties (notably the Las Vegas Outlets and Woodbury Common Premium Outlets), with no new or removed locations across SPG’s premium‑outlet portfolio.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on the core factual claim. Ground truth states that Shake Shack EXPANDED its presence from 1 property in 2022 (Woodbury Common) to 2 properties in 2023 (Woodbury Common + Las Vegas Outlets North). The LLM claims the presence was 'unchanged' and that Shake Shack was at 'the same premium-outlet properties' in both years, which directly contradicts the ground truth. The LLM incorrectly suggests Shake Shack was already at Las Vegas Outlets in 2022, when it was only added in 2023. This is a critical multi-hop reasoning failure - the model failed to properly synthesize the temporal evolution of Shake Shack's footprint across the two years. The question specifically asks 'how has...evolved' (implying change), and the ground truth clearly shows expansion, but the LLM answer states 'unchanged.' The entity identification is partially correct (both properties are named correctly), but the temporal sequencing and the key insight about expansion is completely wrong. This represents a fundamental misunderstanding of the multi-hop question requiring comparison of tenant presence across two different years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1144,
        "completion_tokens": 326,
        "total_tokens": 1471
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did the classification of retirement annuity contracts within the fair value hierarchy evolve between 2022 and 2024, and what does this indicate about GD's valuation methodology for these assets?",
      "original_answer": "In 2022, retirement annuity contracts were part of Level 3 assets, indicating that their fair value was determined using unobservable inputs. By 2024, these contracts remained in Level 3, but the disclosure noted that investments valued using net asset value (NAV) as a practical expedient were now included in the tables for reconciliation to total plan assets, which was not explicitly stated in 2022. This suggests a refinement in disclosure practices rather than a change in hierarchy classification, indicating that while the valuation methodology remained complex and less observable, GD improved transparency in how these assets are reported.",
      "llm_answer": "\nBetween 2022 and 2024 the retirement‑annuity contracts stayed in **Level 3** of the fair‑value hierarchy, but their reported fair value fell from **$35 million (as of 31 Dec 2021)** to **$22 million (as of 31 Dec 2024)**.  This decline reflects a smaller portfolio and/or changes in the unobservable inputs used to value the contracts, showing that General Dynamics continues to apply internally‑derived, non‑market‑based assumptions for these assets, though the reduced balance and continued Level 3 classification indicate the company is refining its methodology—relying more on observable inputs where possible and treating the remaining exposure as a relatively immaterial, internally‑valued component.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its credibility. (1) QUANTITATIVE ACCURACY ISSUES: The LLM provides specific dollar amounts ($35 million as of Dec 31, 2021 and $22 million as of Dec 31, 2024) that are not verified in the ground truth and appear to be fabricated or incorrectly sourced. The ground truth makes no mention of these specific values. The LLM also cites a 2021 date when the question asks about 2022-2024 evolution, creating a temporal mismatch. (2) INCOMPLETE SYNTHESIS: The LLM fails to address the key disclosure refinement identified in the ground truth—that by 2024, investments valued using NAV as a practical expedient were now included in reconciliation tables, which was not explicitly stated in 2022. This is a critical distinction that the ground truth emphasizes as the main evolution. (3) MISCHARACTERIZATION OF CHANGE: The ground truth explicitly states this represents 'a refinement in disclosure practices rather than a change in hierarchy classification.' The LLM incorrectly suggests the decline in fair value and continued Level 3 classification indicate 'refining methodology' and 'relying more on observable inputs where possible'—this contradicts the ground truth's finding that the hierarchy classification remained unchanged and the change was primarily disclosure-related, not methodology-related. (4) REASONING FLAW: The LLM's logic that a declining balance indicates 'refining methodology' is speculative and not supported by the ground truth. The ground truth indicates the methodology remained complex and less observable (Level 3), with only disclosure transparency improving. (5) CORRECT ELEMENTS: The LLM correctly identifies that retirement annuity contracts remained in Level 3 and that GD uses unobservable inputs, but these correct elements are overshadowed by the fabricated numbers and misinterpretation of the primary finding about disclosure refinement versus methodology change.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 530,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did AIG's financial relationship with Corebridge evolve between 2023 and 2024, particularly in terms of potential equity dilution and income recognition?",
      "original_answer": "In 2023, AIG had a stake in Corebridge that included a potential equity dilution mechanism tied to Blackstone's right to exchange its ownership interest in Corebridge for AIG common shares, which would have introduced up to 24.1 million additional shares in 2022 (and 4.4 million in 2023) had the IPO not occurred before 2024. However, since the IPO occurred on September 19, 2022, this exchange right was terminated. By 2024, AIG's relationship with Corebridge had shifted from a stakeholding to an equity method investment, where AIG reported income based on dividends received and changes in Corebridge's stock price from June 9, 2024 onwards. This reflects a transformation from a potential equity dilution scenario to a post-divestiture equity income model.",
      "llm_answer": "\nBetween 2023 and 2024 AIG’s exposure to Corebridge shifted from a consolidated subsidiary to an equity‑method investment.  In 2023 AIG owned roughly 52 % of Corebridge (after the 2023 share‑repurchase and secondary‑offering activity disclosed in the Non‑controlling‑interest note), and its stake was only modestly adjusted by those transactions.  In the second quarter of 2024 AIG de‑consolidated Corebridge, recording a $4.8 bn after‑tax loss on the de‑consolidation (see the loss‑on‑deconsolidation table on page 110), and thereafter accounted for its remaining interest under the equity method, recognizing $601 m of equity‑method income—comprised of dividends received and the change in the fair value of its retained Corebridge shares— for the June‑December 2024 period (page 109).  The only dilutionary effect was the normal market‑driven fluctuation in Corebridge’s share count; there were no new issuances that materially diluted AIG’s ownership percentage.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misses critical elements of the ground truth answer. Key issues: (1) MAJOR ERROR - The LLM claims AIG owned 'roughly 52%' of Corebridge in 2023, but the ground truth indicates AIG had a stake with potential equity dilution mechanisms tied to Blackstone's exchange rights, not a 52% ownership stake. This is a fundamental mischaracterization of the relationship. (2) MISSING CRITICAL INFORMATION - The LLM completely omits the Blackstone exchange right mechanism that would have introduced 24.1 million shares in 2022 and 4.4 million in 2023, which was a key aspect of the financial relationship evolution. (3) INCORRECT TIMELINE - The ground truth emphasizes that the IPO occurred on September 19, 2022, which terminated the exchange right. The LLM does not mention this critical event or its significance. (4) PARTIAL ACCURACY - The LLM correctly identifies the shift from consolidated subsidiary to equity-method investment in Q2 2024 and mentions the $4.8 billion after-tax loss on de-consolidation and $601 million equity-method income, which are accurate details. However, these correct details do not compensate for the fundamental misunderstanding of the 2023 relationship structure. (5) INCOMPLETE SYNTHESIS - The question specifically asks about 'potential equity dilution' evolution, but the LLM dismisses this as 'normal market-driven fluctuation' and states 'there were no new issuances that materially diluted AIG's ownership percentage,' which contradicts the ground truth's emphasis on the Blackstone exchange right mechanism as a key feature of the 2023 relationship. The LLM answer addresses the 2024 portion reasonably well but fundamentally misrepresents the 2023 situation and fails to capture the critical evolution from a potential dilution scenario to post-divestiture equity income model.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 505,
        "total_tokens": 1940
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has Comcast's financial exposure to Universal Beijing Resort evolved from 2022 to 2024, based on its debt disclosures and consolidation treatment?",
      "original_answer": "In 2022, Comcast disclosed that Universal Beijing Resort had $3.6 billion in debt as of December 31, 2021, and $2.5 billion as of December 31, 2020. By 2024, Comcast clarified that Universal Beijing Resort had $3.4 billion in debt outstanding as of December 31, 2024, and $3.5 billion as of December 31, 2023. This indicates that the debt levels stabilized after earlier reductions, and Comcast now consolidates Universal Beijing Resort as a variable interest entity (VIE), with its assets and liabilities fully included in Comcast’s consolidated balance sheets at $7.3 billion in assets and $7.0 billion in liabilities as of 2024.",
      "llm_answer": "\nComcast’s recorded debt tied to Universal Beijing Resort slipped only slightly—from roughly $3.5 billion of outstanding debt (including a $3.1 billion term loan) as of the end of 2023 to about $3.4 billion (including a $3.0 billion term loan) by the end of 2024—reflecting scheduled repayments on the resort’s ¥29.7 billion (≈$4.2 bn) financing.  The resort continues to be fully consolidated as a variable‑interest entity, so Comcast’s financial exposure is now limited to its 30 % equity interest and the remaining debt of the VIE, which has been modestly reduced but remains on the consolidated balance sheet.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant quantitative errors and incomplete synthesis of the ground truth information. CRITICAL ISSUES: (1) MISSING 2022 DATA: The ground truth explicitly states 2022 disclosures showing $3.6B debt (Dec 31, 2021) and $2.5B debt (Dec 31, 2020). The LLM answer completely omits the 2022 baseline, failing to address the 'evolved from 2022 to 2024' requirement of the question. (2) INCORRECT DEBT FIGURES: The LLM states $3.5B for 2023 and $3.4B for 2024, which matches the ground truth. However, the LLM adds unsupported detail about a '$3.1 billion term loan' (2023) and '$3.0 billion term loan' (2024) that are not mentioned in the ground truth. These specific term loan figures cannot be verified and appear to be hallucinated. (3) MISSING CONSOLIDATION DETAILS: The ground truth provides specific consolidated balance sheet figures ($7.3B in assets and $7.0B in liabilities as of 2024), which the LLM answer completely omits. (4) EQUITY INTEREST CLAIM: The LLM states Comcast has a '30% equity interest,' but the ground truth indicates full consolidation as a VIE with no specific equity percentage mentioned. This appears to be an unsupported claim. (5) CURRENCY CONVERSION: The LLM mentions ¥29.7 billion (≈$4.2bn) financing, which is not in the ground truth and cannot be verified. (6) INCOMPLETE MULTI-HOP SYNTHESIS: The answer fails to synthesize the evolution from 2022 ($3.6B) through 2023 ($3.5B) to 2024 ($3.4B), missing the narrative of debt reduction and stabilization. POSITIVE ASPECTS: The answer correctly identifies VIE consolidation treatment and acknowledges the debt reduction trend. The 2023-2024 debt figures are accurate. However, the omission of 2022 baseline data, unsupported specific figures, and missing consolidated balance sheet details represent substantial gaps in addressing the multi-hop question about financial exposure evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 512,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has the structure of aircraft trade-in commitments changed between 2022 and 2023, particularly in terms of customer eligibility and risk exposure?",
      "original_answer": "In 2022, the Aerospace segment had outstanding options with 'some customers' to trade in aircraft as partial consideration for new aircraft purchases, indicating a broader or less-specific customer eligibility. By 2023, the eligibility was narrowed to 'some Gulfstream customers,' suggesting a more specific subset of customers was offered trade-in options. Additionally, while both years acknowledged the risk associated with adverse market changes affecting trade-in values, 2023 introduced a more specific framing by highlighting Gulfstream, a key business jet brand, which may indicate a strategic focus or increased risk concentration in that segment. Despite these structural changes, both years reported that the estimated change in fair market values from the commitment date was 'not material.'",
      "llm_answer": "\nBetween 2022 and 2023 the company’s aircraft‑trade‑in arrangements kept the same basic mechanics—options that let customers trade in an aircraft for a set fair‑market value (usually ≤ 45 days before delivery) or that guarantee a pre‑determined trade‑in price, with any shortfall treated as a revenue reduction—but the eligibility narrowed.  In the 2022 filing the commitments were described generally as “some customers” having such options, whereas the 2023 filing specifies that “some Gulfstream customers” hold the options, indicating a more limited pool of eligible customers.  The risk profile (exposure to adverse market‑value changes) remains, but the company continues to regard the potential financial impact as not material in either year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensiveness in addressing the multi-hop question about aircraft trade-in commitment structure changes between 2022 and 2023. STRENGTHS: (1) Correctly identifies the key structural change: narrowing of customer eligibility from 'some customers' (2022) to 'some Gulfstream customers' (2023), which matches the ground truth exactly. (2) Accurately describes the mechanics of the trade-in arrangements (options with fair-market value assessments, pre-determined pricing, shortfall treatment as revenue reduction, timing windows). (3) Correctly notes that risk exposure remains consistent across both years regarding adverse market-value changes. (4) Accurately states that the financial impact was assessed as 'not material' in both years. (5) Properly synthesizes multi-hop information by comparing 2022 and 2023 filings and identifying the strategic narrowing to Gulfstream. MINOR CONSIDERATIONS: The LLM answer provides slightly more operational detail about the mechanics (≤45 days before delivery, shortfall treatment) than the ground truth explicitly mentions, but this appears to be accurate supplementary information that enhances rather than contradicts the answer. The ground truth mentions 'may indicate a strategic focus or increased risk concentration' regarding Gulfstream, while the LLM answer presents this more factually without speculation, which is appropriate. No numeric errors, date errors, or calculation issues detected. The semantic meaning and factual content align well with the ground truth across all key points.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 437,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has Tesla's approach to the Tesla Semi evolved between 2022 and 2024, particularly in terms of its production status and strategic positioning within Tesla's product lineup?",
      "original_answer": "In 2022, Tesla had only announced the Tesla Semi as part of its planned electric vehicles, indicating it was in the conceptual and development phase. By 2024, Tesla had moved the Tesla Semi into 'pilot production' at its Nevada facility, signaling a significant advancement in its development and a step closer to commercialization. This evolution reflects Tesla's strategic shift from merely planning the vehicle to actively preparing it for market entry.",
      "llm_answer": "\nTesla first introduced the Semi in its 2022 business overview as a planned commercial‑vehicle model that would be built on a next‑generation platform and rely on the company’s new battery‑cell and autonomous‑driving technologies. By 2024 the Semi had progressed to pilot‑production status at the Nevada Gigafactory (as shown in the 2024 segment table), but full‑scale manufacturing was still limited; the truck is now positioned as part of Tesla’s strategy to expand into commercial‑vehicle sales, leverage its advancing battery and Full‑Self‑Driving capabilities, and support profitable growth across its broader product lineup.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive understanding of Tesla's Semi evolution. Strengths: (1) Correctly identifies 2022 as the announcement/planning phase and 2024 as pilot production phase, matching ground truth; (2) Accurately specifies Nevada Gigafactory as the production location; (3) Properly characterizes the progression from conceptual/development to pilot production; (4) Adds valuable context about the platform, battery technology, and autonomous driving integration without contradicting ground truth; (5) Explains strategic positioning within Tesla's broader product lineup and commercial vehicle expansion strategy. The answer goes beyond the ground truth by providing additional relevant details (next-generation platform, battery-cell technology, Full-Self-Driving capabilities, profitable growth strategy) that enhance understanding while remaining factually consistent. No numeric errors or calculation issues present. The multi-hop synthesis is sound - correctly connecting 2022 status, 2024 status, and strategic implications. Minor consideration: The phrase 'full-scale manufacturing was still limited' is slightly more cautious than the ground truth's 'step closer to commercialization,' but this represents appropriate nuance rather than error. The answer fully addresses all parts of the question regarding production status evolution and strategic positioning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 394,
        "total_tokens": 1673
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did the valuation allowance related to Altria's investment in Cronos evolve between 2022 and 2024, and what does this indicate about the company's expectations regarding the realizability of associated deferred tax assets?",
      "original_answer": "Between 2022 and 2024, the valuation allowance related to Altria's investment in Cronos increased from $379 million in 2022 to $402 million in 2024. This indicates that Altria continued to maintain significant uncertainty regarding the realizability of deferred tax assets associated with the Cronos investment, as the company still did not expect the temporary difference to reverse in the foreseeable future. The steady increase in the allowance suggests a cautious stance by Altria in recognizing the full value of these assets.",
      "llm_answer": "\nAltria’s valuation allowance for the deferred‑tax assets tied to its Cronos investment was $379 million at the end of 2022, edged up to $397 million in 2023 and to $402 million in 2024.  Although the overall valuation allowance was cut sharply—from $3.1 billion in 2022 to $2.26 billion in 2023 and to $0.67 billion in 2024—the Cronos‑related allowance stayed roughly stable, signalling that the company still harbors uncertainty about fully realizing those assets but now expects enough positive evidence to keep the allowance relatively small.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of the Cronos-related valuation allowance figures: $379 million (2022), $397 million (2023), and $402 million (2024). All numbers match the ground truth. The answer correctly identifies the multi-year evolution and provides additional context about the overall valuation allowance reduction ($3.1B to $2.26B to $0.67B), which adds valuable perspective not in the original answer but is factually accurate and relevant. The LLM's interpretation that the Cronos allowance 'stayed roughly stable' while the overall allowance declined sharply is a reasonable and insightful synthesis. However, there is a subtle interpretive difference: the ground truth emphasizes 'steady increase' and 'cautious stance,' while the LLM characterizes it as 'roughly stable' and suggests 'enough positive evidence' to keep it 'relatively small.' The LLM's framing of 'positive evidence' is slightly different from the ground truth's emphasis on 'continued uncertainty' and 'did not expect the temporary difference to reverse.' The LLM answer is more nuanced in suggesting a shift toward positive evidence, whereas the ground truth maintains a more consistently cautious tone. The $23M increase from 2022-2024 is modest relative to the overall allowance, supporting the 'roughly stable' characterization, though the ground truth's 'steady increase' is also accurate. The answer fully addresses the question's multi-part requirements: evolution of the allowance, what it indicates about expectations, and the company's stance. Multi-hop reasoning is sound—correctly synthesizing information about the specific Cronos allowance within the broader context of Altria's overall valuation allowance changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 478,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did the financial treatment and valuation impact of Amgen's investment in BeiGene evolve between 2023 and 2024?",
      "original_answer": "In 2023, Amgen changed the accounting method for its investment in BeiGene from the equity method to fair value, resulting in gains recognized in connection with this revaluation. By 2024, the investment contributed net unrealized losses within Amgen's Other income (expense), net, reflecting a shift from gains in 2023 to losses in 2024 due to market or valuation changes. This evolution shows a reversal in the financial benefit derived from the BeiGene investment over the two years.",
      "llm_answer": "\nBetween 2023 and 2024 Amgen’s accounting for its BeiGene stake changed from the equity‑method to fair‑value measurement, so that earnings now reflect the investment’s mark‑to‑market movements. In 2023 the fair‑value adjustment produced a **gain** that boosted “Other income (expense), net,” while in 2024 the same valuation approach resulted in **net unrealized losses** on the BeiGene equity, pulling that line item down sharply. Thus, the financial treatment shifted from recognizing gains to recognizing losses, directly affecting Amgen’s earnings volatility and the perceived value of the investment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness in addressing the multi-hop question about Amgen's BeiGene investment evolution. STRENGTHS: (1) Correctly identifies the accounting method change from equity method to fair value measurement in 2023. (2) Accurately characterizes the 2023 outcome as gains/positive impact on Other income (expense), net. (3) Accurately characterizes the 2024 outcome as net unrealized losses. (4) Properly synthesizes the reversal pattern between the two years. (5) Correctly identifies the financial line item affected (Other income (expense), net). (6) Appropriately explains the mark-to-market mechanism driving the changes. (7) No quantitative errors - no specific dollar amounts were required and none were provided incorrectly. MINOR CONSIDERATIONS: The LLM answer adds interpretive language about 'earnings volatility' and 'perceived value' which, while reasonable inferences, go slightly beyond what the ground truth explicitly states. However, these additions are logical extensions of the core facts and do not contradict the ground truth. The answer is semantically equivalent to the original, using slightly different phrasing ('mark-to-market movements' vs. the ground truth's more implicit reference to valuation changes) but conveying identical meaning. The multi-hop reasoning is sound - the answer correctly synthesizes information about the accounting change, its 2023 impact, its 2024 impact, and the overall evolution pattern. All entities (Amgen, BeiGene, years 2023-2024, accounting methods, financial line items) are correctly identified and contextualized.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 445,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has the positioning and market strategy for Disney+ Hotstar evolved between 2023 and 2024, particularly in terms of its regional branding and service structure?",
      "original_answer": "In 2023, Disney+ Hotstar was described as a DTC service primarily in India that offered general entertainment, family, and sports programming. It was positioned as a distinct regional brand within Disney’s broader Direct-to-Consumer portfolio. By 2024, while still branded as Disney+ Hotstar in India and Southeast Asia, the company had merged its previously separate Star+ and Disney+ services in Latin America into a single Disney+ product offering by the end of June 2024. This indicates a strategic shift toward consolidating regional streaming services under the Disney+ brand umbrella, streamlining offerings, and possibly enhancing content integration across markets.",
      "llm_answer": "\nBetween 2023 and 2024 Disney shifted from operating three separate SVOD brands—Disney+, Star+ and the region‑specific Disney+ Hotstar—to a more unified offering.  In 2023, Disney+ Hotstar was the distinct brand for India and certain Southeast Asian markets, while Star+ existed as a separate general‑entertainment tier in Latin America; by the end of June 2024 the company merged Star+ into a single Disney+ product (Combo+ was discontinued) and continued to operate only the localized Disney+ Hotstar brand in India/SE Asia, signalling a strategy of consolidating under the global Disney+ name while retaining a customized Hotstar service for those specific regions.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes the multi-hop information about Disney's streaming service evolution. STRENGTHS: (1) Correctly identifies the three separate SVOD brands in 2023 (Disney+, Star+, Disney+ Hotstar), (2) Accurately dates the merger completion to end of June 2024, (3) Properly describes the consolidation strategy of merging Star+ into Disney+ in Latin America, (4) Correctly notes that Disney+ Hotstar remained as the localized brand for India/SE Asia, (5) Adds relevant detail about Combo+ discontinuation which provides additional context about the restructuring. MINOR CONSIDERATIONS: (1) The LLM answer is slightly more detailed than the ground truth (mentions Combo+ discontinuation and explicitly states 'three separate SVOD brands'), but this additional detail is accurate and enhances understanding rather than contradicting the ground truth, (2) The phrasing 'signalling a strategy of consolidating under the global Disney+ name while retaining a customized Hotstar service' effectively captures the strategic shift described in the original answer. MULTI-HOP REASONING: The answer successfully synthesizes information across the 2023-2024 timeframe and correctly identifies the regional differences in strategy (consolidation in Latin America vs. retention of Hotstar branding in India/SE Asia). All dates, service names, and strategic positioning are accurate. The answer fully addresses the question about positioning and market strategy evolution, regional branding, and service structure changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 431,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did PayPal's approach to its Protection Programs evolve between 2023 and 2024, particularly in terms of risk exposure and loss recovery mechanisms?",
      "original_answer": "In 2023, PayPal disclosed that the costs associated with its protection programs were recorded in 'transaction and credit losses' during the period the payment transaction was completed, and it did not provide a separate service to customers under these programs. By 2024, PayPal introduced more detailed disclosures around its protection programs, highlighting that it incurs substantial losses from these programs due to customer disputes and faces challenges in recovering losses from merchants, especially in cases involving fraud or merchant insolvency. Additionally, PayPal noted that it may face increased exposure due to evolving fraud schemes and potential regulatory changes affecting chargeback requirements. This indicates a shift toward more explicit risk acknowledgment and a broader understanding of potential financial impact.",
      "llm_answer": "\nPayPal’s 2023 10‑K (Note 13) described its purchase‑seller protection programs and warned that it could be unable to recover losses when merchants become insolvent or when disputed transactions involve fraudulent merchants, noting that established allowances “may be insufficient to cover incurred losses.” The 2024 filing (page 24) repeats this language but sharpens the focus on the limited recovery outlook—stating that the company may not be able to fully recover losses from merchants who are unwilling or unable to pay, or when a transaction is deemed fraudulent—thereby signalling a more explicit acknowledgment of heightened risk exposure and a more conservative stance on loss‑recovery mechanisms.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the evolution of PayPal's protection program disclosures between 2023 and 2024, capturing the key shift toward more explicit risk acknowledgment. STRENGTHS: (1) Correctly references 2023 10-K Note 13 and 2024 filing (page 24), demonstrating proper document sourcing; (2) Accurately captures the core evolution: from general warnings about insufficient allowances to more explicit acknowledgment of recovery challenges; (3) Correctly identifies key risk factors: merchant insolvency, fraudulent merchants, and inability to recover losses; (4) Properly synthesizes the multi-hop comparison showing progression from general to more conservative stance; (5) Semantic equivalence is strong—'heightened risk exposure' and 'more conservative stance on loss-recovery mechanisms' align with ground truth's 'shift toward more explicit risk acknowledgment.' WEAKNESSES: (1) The LLM answer omits a specific detail from ground truth: that in 2023, costs were 'recorded in transaction and credit losses during the period the payment transaction was completed' and that PayPal 'did not provide a separate service to customers under these programs'—this is a material distinction about accounting treatment; (2) The LLM answer doesn't explicitly mention 'evolving fraud schemes and potential regulatory changes affecting chargeback requirements' noted in ground truth; (3) The answer doesn't clearly articulate that 2024 introduced 'more detailed disclosures' as a structural change in reporting approach. QUANTITATIVE ACCURACY: No specific numbers are provided in either answer, so this is not a differentiator. Both answers appropriately avoid false precision. MULTI-HOP REASONING: The LLM correctly synthesizes information across two fiscal years and two different document sections, properly comparing the evolution of disclosure language and risk framing. The logic is sound and the comparison is valid. OVERALL ASSESSMENT: The answer captures the essential evolution and demonstrates good document sourcing and comparative analysis, but misses some specific accounting and regulatory context details that were in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 578,
        "total_tokens": 1966
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has NextEra Energy's relationship with solar generation facilities evolved from 2022 to 2024, particularly in terms of ownership structure and financial exposure?",
      "original_answer": "In 2022, NextEra Energy Resources was actively divesting ownership stakes in solar generation facilities, including the sale of a 100% ownership interest in a 100 MW solar facility in Arizona and the sale of a 90% ownership interest in a portfolio that included four solar facilities. These transactions resulted in significant cash proceeds and the recognition of gains. By 2024, the company's relationship had transformed into a more complex structure involving equity stakes and consolidated variable interest entities (VIEs). For example, NextEra consolidated eight VIEs owning solar generation facilities with approximately 765 MW of capacity and held a 10% direct ownership interest in additional solar facilities. This shift indicates a strategic move from outright ownership and divestiture to a more diversified and financially leveraged stake through VIEs, with increased financial exposure through guarantees and credit support.",
      "llm_answer": "\nBetween 2022 and 2024 NEE transferred most of its solar portfolio into joint‑venture entities in which it sold Class B membership interests to third‑party investors, retained a controlling stake, and accounted for the investors’ share as noncontrolling interests using the HLBV method; the investors receive cash flows until a contractual “flip” date, after which earnings and tax benefits flow back to NEE. At the same time, NEE consolidated additional solar‑focused VIEs (≈10 GW of capacity), leaving the company exposed to debt guarantees, call‑price repurchase obligations on the sold interests, and the financial performance of those solar assets.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations compared to the ground truth. QUANTITATIVE ERRORS: (1) The LLM claims NEE consolidated 'approximately 10 GW of capacity' in solar VIEs, but the ground truth specifies 'approximately 765 MW of capacity' - this is a massive overstatement (10,000 MW vs 765 MW, roughly 13x too high). (2) The LLM does not mention the specific 2022 transactions (100% ownership in 100 MW Arizona facility, 90% ownership in four-facility portfolio) that are central to demonstrating the evolution from 2022 to 2024. STRUCTURAL/CONCEPTUAL ERRORS: (1) The LLM introduces a joint-venture structure with 'Class B membership interests,' 'HLBV method,' and 'flip dates' that are NOT mentioned in the ground truth. While these may be real financial structures, they are not supported by the provided knowledge graph and appear to be hallucinated details. (2) The ground truth clearly states the 2022 relationship involved 'active divesting' and 'sales,' while the LLM's narrative about joint ventures with retained controlling stakes and noncontrolling interests is a different structure not corroborated by the source material. MISSING ELEMENTS: (1) No mention of the specific 2022 divestiture transactions that are explicitly detailed in the ground truth. (2) The 10% direct ownership interest mentioned in ground truth is not addressed. PARTIAL CREDIT: The LLM correctly identifies (1) the shift toward VIE consolidation, (2) financial exposure through guarantees and obligations, and (3) the general evolution of the relationship. However, the magnitude of the quantitative error (765 MW vs 10 GW) and the introduction of unsupported structural details significantly undermine the answer's reliability. The answer demonstrates some understanding of the general direction of change but fails on factual accuracy and introduces potentially misleading information.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 516,
        "total_tokens": 1919
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did ACN's investment in Mutual Fund Debt Securities evolve from 2022 to 2023, and what was the change in valuation methodology as reflected in the fair value hierarchy levels?",
      "original_answer": "In 2022, ACN reported Mutual Fund Debt Securities valued at $379,989 with the entire amount categorized under Level 2 of the fair value hierarchy. In 2023, this investment decreased to $253,025, and the valuation remained entirely under Level 2. The decrease in value indicates a reduction in exposure to Mutual Fund Debt Securities over the year, while the valuation methodology remained consistent, relying on observable market data.",
      "llm_answer": "\nFrom fiscal 2022 to fiscal 2023 the amount of Mutual Fund Debt Securities held in ACN’s defined‑benefit pension plans fell sharply—from **$484.2 million (classified as Level 2)** as of August 31 2022 (page 89 of the 2022 10‑K) to **$189.3 million (also Level 2)** as of August 31 2023 (page 96 of the 2023 10‑K), a decline of roughly **$295 million (≈61 %)**.  The securities remained **classified as Level 2** in the fair‑value hierarchy, indicating that the valuation methodology—using observable market prices for similar instruments—did not change between the two years.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamentally incorrect numbers that do not match the ground truth data. Ground truth shows: 2022: $379,989 (Level 2), 2023: $253,025 (Level 2). LLM reports: 2022: $484.2 million, 2023: $189.3 million. These are off by approximately 1,000x in magnitude - the LLM appears to have confused thousands with millions or pulled data from a different line item entirely. The LLM's calculated decline of $295 million (61%) is mathematically consistent with its own incorrect numbers, but the base numbers are wrong. The only correct element is that both years remained Level 2 in the fair value hierarchy and the methodology remained consistent. The LLM correctly identified the company (ACN), the metric (Mutual Fund Debt Securities), the years (2022-2023), and the fair value hierarchy classification, but the core quantitative data - the actual dollar amounts - are dramatically incorrect. This is a complete failure on the primary metric of financial accuracy. The semantic understanding of the question is sound, but the execution is fatally flawed due to incorrect source data or calculation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 322,
        "total_tokens": 1582
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has Chevron's financial stake and involvement in Tengizchevroil evolved between 2022 and 2023?",
      "original_answer": "In 2022, Chevron's carrying value of its investment in Tengizchevroil was $23,727 million with a reported equity in earnings of $1,238 million. By 2023, Chevron disclosed that its carrying value was approximately $80 million higher than its underlying equity in Tengizchevroil's net assets, indicating a more complex valuation approach. Additionally, Chevron highlighted that it provided a loan of $4,500 million to Tengizchevroil to fund the Future Growth Project and Wellhead Pressure Management Project (FGP/WPMP). This shows a significant deepening of Chevron's financial involvement and strategic commitment to the partnership in 2023 compared to 2022.",
      "llm_answer": "\nChevron’s equity stake in Tengizchevroil (TCO) was essentially unchanged at a 50 % ownership level, but the carrying value of that investment rose from **$26.5 bn at the end of 2022 to $26.9 bn at the end of 2023** (CVX 10‑K 2023, p. 80/82).  At the same time, equity earnings from TCO jumped from **$2.8 bn in 2022 to $4.4 bn in 2023**, reflecting higher oil prices and production, and the investment includes a $4.5 bn loan to fund the FGP/WPMP project and a roughly $80 m valuation premium over underlying equity (CVX 10‑K 2023, p. 80/82).",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significantly incorrect financial figures that contradict the ground truth. (1) CARRYING VALUE ERROR: LLM states carrying value rose from $26.5 bn (2022) to $26.9 bn (2023), but ground truth shows $23,727 million ($23.727 bn) in 2022. The LLM's 2022 figure is off by approximately $2.8 billion (12% error). (2) EQUITY EARNINGS ERROR: LLM claims equity earnings jumped from $2.8 bn (2022) to $4.4 bn (2023), but ground truth shows $1,238 million ($1.238 bn) in 2022. The LLM's 2022 figure is off by approximately $1.56 billion (126% error). (3) CORRECT ELEMENTS: The LLM correctly identifies the 50% ownership stake, the $4.5 billion loan for FGP/WPMP, and the approximately $80 million valuation premium. (4) MULTI-HOP REASONING: While the LLM attempts to synthesize information across years and identify the evolution of Chevron's involvement, the fundamental numerical errors undermine the entire analysis. The comparison between 2022 and 2023 is based on incorrect baseline figures. (5) MISSING CONTEXT: The LLM does not adequately explain the shift in valuation methodology (carrying value vs. underlying equity) that the ground truth highlights as significant. The answer provides some relevant context about higher oil prices and production but misses the nuance about the more complex valuation approach in 2023. The quantitative accuracy is critically flawed with multiple large discrepancies in key financial metrics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 407,
        "total_tokens": 1695
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has Disney's relationship with ABC Network evolved between 2023 and 2024, particularly in terms of its strategic positioning within Disney's broader entertainment ecosystem?",
      "original_answer": "In 2023, ABC Network was positioned as a core component of Disney's 'Linear Networks' within the Entertainment segment, specifically highlighting its domestic footprint through eight owned ABC television stations and its role in content distribution. By 2024, ABC Network's role had evolved, with its programming becoming more integrated into Disney's direct-to-consumer platforms, such as Hulu and Disney+. Specifically, content from ABC Network was made available on Hulu's SVOD service one day after its linear airing. This shift indicates a strategic move toward digital integration and away from traditional linear distribution. Additionally, while ABC Network was still referenced in the context of affiliate fees in 2023, 2024 emphasized its contribution to streaming services rather than standalone linear revenue.",
      "llm_answer": "\nBetween fiscal 2023 and 2024 Disney tightened the link between its ABC broadcast network and the rest of its entertainment‑sports ecosystem, using ABC to air ESPN‑produced programming (“ESPN on ABC”) and to serve as the distribution outlet for new ESPN‑branded linear channels that will appear on the company’s upcoming direct‑to‑consumer platform (planned for launch in fall 2025). This reflects a strategic shift that positions ABC not only as a traditional broadcast outlet but also as a key conduit for Disney’s expanding sports‑focused DTC and streaming services, reinforcing the cohesion of Disney’s Entertainment, Sports and Experiences segments. (See Competition and Seasonality section, page 9.)",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer is largely incorrect and fails to address the ground truth. Critical issues: (1) WRONG FOCUS: The LLM discusses ESPN programming on ABC and a DTC sports platform launching in fall 2025, which is not mentioned in the ground truth. The ground truth specifically addresses ABC's integration with Hulu and Disney+ for content distribution one day after linear airing. (2) MISSING KEY FACTS: The LLM completely omits the core evolution described in the ground truth - the shift from traditional linear distribution to direct-to-consumer platforms (Hulu SVOD, Disney+). (3) INCORRECT EMPHASIS: The ground truth emphasizes ABC's eight owned television stations and the transition from affiliate fees to streaming contributions. The LLM focuses on sports content and ESPN integration, which is not part of the ground truth answer. (4) UNVERIFIED CLAIMS: The LLM mentions a DTC platform launching in fall 2025 and ESPN-branded linear channels - these specific details are not in the ground truth and appear to be either fabricated or from different source material. (5) MULTI-HOP REASONING FAILURE: The question asks about ABC's evolution in Disney's entertainment ecosystem between 2023-2024. The ground truth provides a clear 2023→2024 progression (linear networks → streaming integration). The LLM provides a different narrative entirely about sports integration. (6) SEMANTIC MISMATCH: While both answers discuss strategic positioning, they describe fundamentally different strategic shifts - the ground truth is about digital/streaming integration, the LLM is about sports content consolidation. The LLM answer appears to address a different aspect of Disney's strategy or potentially conflates ABC with ESPN operations.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 471,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has General Dynamics' positioning of the ASCOD vehicle within its Land Systems portfolio evolved between 2022 and 2023, and what does this indicate about potential shifts in production focus or investment allocation?",
      "original_answer": "In 2022, General Dynamics explicitly stated it was 'producing and upgrading' the ASCOD vehicle, indicating active development and enhancement of the platform. By 2023, the company's disclosure shifted to simply 'offering' the ASCOD, without specific mention of production or upgrades. This change in language suggests a potential shift in focus away from active investment or development of the ASCOD platform, possibly reallocating resources to other vehicle programs like the Piranha 5 and AJAX, which are explicitly called out in both years with continued production and international deployments.",
      "llm_answer": "\nBetween 2022 and 2023 General Dynamics moved the ASCOD from a peripheral “tracked‑vehicle option” to a central pillar of its Land Systems growth strategy.  The 2022 filing merely listed ASCOD as one of several ELS offerings (e.g., Spanish Pizarro, Austrian Ulan), whereas the 2023 filing highlighted that Land Systems is producing 399 ASCOD‑derived LAVs for Canada, fielding the Ajax family, and explicitly investing in robotic/autonomous extensions such as the MUTT and TRX built on the ASCOD chassis.  This shift signals that GD is reallocating production capacity and R&D spend toward ASCOD‑based platforms and related autonomous‑vehicle programs, indicating a strategic focus on expanding the ASCOD portfolio as a growth engine.",
      "correctness_score": 1,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is fundamentally contradictory to the ground truth and contains multiple critical errors: (1) DIRECTIONAL REVERSAL: The ground truth states ASCOD positioning DECLINED from 'producing and upgrading' (2022) to merely 'offering' (2023), indicating reduced investment. The LLM claims the opposite—that ASCOD moved to a 'central pillar' and that GD is 'reallocating production capacity and R&D spend toward ASCOD-based platforms.' This is a complete inversion of the actual trend. (2) UNSUPPORTED CLAIMS: The LLM cites '399 ASCOD-derived LAVs for Canada' and mentions MUTT and TRX autonomous programs, but the ground truth makes no mention of these specific numbers or programs. These appear to be fabricated details not present in the source material. (3) MISINTERPRETATION OF LANGUAGE SHIFT: The ground truth correctly identifies that the shift from 'producing and upgrading' to 'offering' signals reduced focus and potential resource reallocation to other programs (Piranha 5, AJAX). The LLM misreads this as evidence of increased strategic importance. (4) MISSING KEY INSIGHT: The ground truth explicitly notes that Piranha 5 and AJAX are called out in both years with continued production and international deployments, suggesting these are the actual focus areas. The LLM fails to recognize this comparative analysis. (5) LOGICAL INCONSISTENCY: If GD were truly investing heavily in ASCOD-based autonomous platforms, the 2023 filing would likely maintain or expand language about 'producing' and 'upgrading,' not reduce it to 'offering.' The LLM's conclusion contradicts basic business communication patterns. The answer demonstrates a fundamental failure to synthesize the multi-hop comparison between 2022 and 2023 filings and reaches conclusions opposite to what the evidence supports.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 490,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has PayPal's utilization of European customer balances for credit activities evolved between 2023 and 2024, and what does this shift indicate about the company's credit funding strategy?",
      "original_answer": "In 2023, PayPal had approved $3.0 billion of European customer balances for credit activities, representing approximately 39% of balances made available for corporate use. By 2024, the approved amount had decreased to $2.0 billion, or 26% of European customer balances. This indicates a strategic shift toward reducing reliance on customer balances for credit funding, potentially in favor of external financing sources, as evidenced by PayPal's multi-year agreement to sell consumer installment receivables, which saw $20.8 billion in loans sold in 2024 compared to $5.5 billion in 2023.",
      "llm_answer": "\nBetween 2023 and 2024 the amount of European customer balances that PayPal can designate for credit‑funding fell sharply—from **$3.0 billion (about 39 % of European balances) in 2023 to $2.0 billion (about 26 % of European balances) in 2024**.  This pull‑back signals that PayPal is moving away from relying primarily on internal European customer deposits to finance its credit products and is instead increasingly tapping external sources such as debt issuances, loan‑sale/ securitization agreements, and partnership funding to meet its credit‑funding needs.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies all key quantitative metrics: $3.0 billion (39%) in 2023 declining to $2.0 billion (26%) in 2024 for European customer balances approved for credit activities. The numerical accuracy is excellent with proper formatting and percentage calculations. The answer correctly interprets the strategic shift away from reliance on customer balances toward external financing sources. However, the answer is incomplete in one important respect: it fails to mention the specific evidence provided in the ground truth about PayPal's multi-year agreement to sell consumer installment receivables, which showed $20.8 billion in loans sold in 2024 versus $5.5 billion in 2023. This concrete example would have strengthened the answer by providing quantitative support for the claim about increased reliance on external sources. The LLM's general statement about 'debt issuances, loan-sale/securitization agreements, and partnership funding' is directionally correct but lacks the specific data point that would fully substantiate the strategic shift narrative. The reasoning is sound and the semantic interpretation of the shift is accurate, but the answer would have been stronger with the complete set of supporting evidence from the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 356,
        "total_tokens": 1654
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did the valuation and categorization of equity securities within NEE's Special Use Funds evolve between 2022 and 2024, and what does this indicate about changes in transparency or investment composition?",
      "original_answer": "In 2022, NEE's Special Use Funds reported equity securities at a carrying amount of $906 million (with an estimated fair value of $907 million) for NEE and $672 million (with an estimated fair value of $672 million) for FPL, without detailed categorization by valuation levels. By 2024, the equity securities in the Special Use Funds had grown significantly, with NEE holding $2,614 million in Level 1 equity securities and FPL holding $1,028 million in Level 1 equity securities, alongside more granular disclosures that included Level 2 and Level 3 valuations. This indicates a substantial increase in equity investments and a shift toward more transparent and detailed reporting of asset valuation methodologies.",
      "llm_answer": "\nBetween 2022 and the 2024 filing, the equity portion of NEE’s Special Use Funds shifted from a valuation base that was largely Level 2/Level 3 (i.e., internally‑priced or commingled funds with significant unobservable inputs) toward a portfolio that is now predominantly Level 1 (quoted market prices) with only a modest residual Level 3 exposure ($≈ $229 million for NEE and $≈ $204 million for FPL).  The 2024 tables show that equity securities are now classified as $2.6 billion Level 1 for NEE and $1.0 billion Level 1 for FPL, while Level 2 holdings have grown (e.g., $3.3 billion and $2.99 billion respectively) and Level 3 assets remain small, reflecting a move toward more observable market pricing and greater transparency in the funds’ composition.  This evolution also signals a strategic re‑allocation of the funds’ assets—adding more liquid equity and corporate‑bond exposures and reducing reliance on illiquid, internally‑valued holdings—while still retaining a minor Level 3 slice for niche or strategic investments.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM answer contains a fundamental factual error regarding the 2022 baseline. The ground truth states that in 2022, equity securities were reported at $906M (NEE) and $672M (FPL) WITHOUT detailed categorization by valuation levels (i.e., no Level 1/2/3 breakdown was provided). The LLM incorrectly claims the 2022 portfolio was 'largely Level 2/Level 3' with 'internally-priced or commingled funds,' which contradicts the ground truth that 2022 lacked this granular categorization entirely. This is a major mischaracterization of the baseline condition. (2) The LLM introduces unsupported numbers: it cites '$3.3 billion and $2.99 billion respectively' for Level 2 holdings in 2024, which are NOT mentioned in the ground truth answer. The ground truth only specifies Level 1 amounts ($2,614M NEE, $1,028M FPL) and Level 3 amounts (~$229M NEE, ~$204M FPL), but does NOT provide Level 2 figures. The LLM appears to have fabricated or misremembered these Level 2 values. (3) MULTI-HOP REASONING - The LLM's interpretation of the evolution is fundamentally flawed. The correct narrative is: 2022 had no valuation-level categorization → 2024 introduced detailed Level 1/2/3 categorization. This represents improved TRANSPARENCY/DISCLOSURE, not a portfolio shift from Level 2/3 to Level 1. The LLM conflates disclosure improvements with actual asset reallocation, which is a logical error. (4) SEMANTIC ISSUES - The LLM's framing of 'strategic re-allocation' and 'reducing reliance on illiquid holdings' is speculative and not supported by the ground truth, which simply notes 'a shift toward more transparent and detailed reporting.' The ground truth does not characterize the change as a strategic portfolio reallocation. (5) CORRECT ELEMENTS - The LLM does correctly identify the 2024 Level 1 amounts ($2.6B NEE, $1.0B FPL) and acknowledges increased transparency, but these correct elements are overshadowed by the fundamental misunderstanding of the 2022 baseline and the introduction of unsupported numbers.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 555,
        "total_tokens": 2007
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did the scope and utilization of Accenture's share purchase program evolve from fiscal 2022 to fiscal 2023, particularly in terms of shares acquired under the public program versus those acquired through employee-related transactions?",
      "original_answer": "In fiscal 2022, Accenture purchased 1,964,612 Class A ordinary shares under the publicly announced open-market share purchase program for an aggregate price of $576 million. Additionally, 97,251 shares were acquired through employee-related transactions, such as share withholding for payroll tax obligations, which do not affect the aggregate available authorization. In fiscal 2023, there is no mention of shares purchased under the public program, but the company continued acquiring shares through employee-related transactions under equity share plans. This indicates a shift where the public share purchase program saw reduced or no activity, while employee-related share acquisitions remained consistent.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2023 Accenture expanded the Board‑approved open‑market share purchase program, raising its authorization from roughly $3.1 bn to about $6 bn and using it to acquire roughly 13–14 million Class A shares—up from the ~2 million shares bought in the fourth quarter of FY 2022. In contrast, shares obtained through employee‑related mechanisms (payroll‑tax withholding, ESPP, etc.) remained minimal—about 2 million shares in FY 2023—and therefore did not constrain the program’s remaining capacity.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains multiple critical factual errors that fundamentally contradict the ground truth: (1) QUANTITATIVE ERRORS - The LLM claims 13-14 million shares were acquired in FY2023, but the ground truth explicitly states there is NO mention of shares purchased under the public program in FY2023. The LLM also claims ~2 million shares were bought in Q4 FY2022, but ground truth shows 1,964,612 shares for the entire FY2022. The authorization figures ($3.1bn to $6bn) are not mentioned in the ground truth and appear fabricated. (2) DIRECTIONAL MISREPRESENTATION - The LLM describes an 'expansion' and 'increased activity' in the public program from FY2022 to FY2023, when the ground truth explicitly indicates a 'shift' toward REDUCED or NO activity in the public program in FY2023. (3) EMPLOYEE TRANSACTIONS - The LLM claims ~2 million shares in FY2023 for employee-related transactions, but ground truth shows 97,251 shares in FY2022 and describes employee acquisitions as 'minimal' and 'consistent,' not reaching 2 million. (4) MULTI-HOP REASONING FAILURE - The LLM failed to correctly synthesize the comparison between fiscal years, arriving at the opposite conclusion (expansion vs. reduction). The answer demonstrates fundamental misunderstanding of the source material and provides numbers that cannot be verified against the ground truth. The only partially correct element is acknowledging that employee-related transactions remained separate from the public program authorization.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 414,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Chevron's financial reporting relationship with Chevron Phillips Chemical Company LLC evolve between 2022 and 2023, particularly in terms of its consolidation status and investment accounting approach?",
      "original_answer": "In 2022, Chevron Phillips Chemical Company LLC was consolidated into Chevron’s financial statements, as indicated by the inclusion of 'Note 8: Summarized Financial Data - Chevron Phillips Chemical Company LLC' among other consolidated subsidiaries. However, in 2023, Chevron explicitly stated that its investment in Chevron Phillips Chemical Company LLC was accounted for using the equity method, and it was no longer consolidated under Chevron U.S.A. Inc.'s financial data. This reflects a significant structural change where Chevron transitioned from consolidating the entity to reporting its investment under the equity method, altering how its financial performance is reflected in Chevron’s consolidated results.",
      "llm_answer": "\nBetween 2022 and 2023 Chevron continued to treat its 50 % stake in Chevron Phillips Chemical Company LLC as an equity‑method investment and did not consolidate CPChem into its consolidated financial statements.  The equity‑method accounting resulted in a decline in Chevron’s share of CPChem’s net income (from $1.66 bn in 2022 to $1.17 bn in 2023) while the carrying amount of the investment grew (CPChem’s net equity rose from $13.57 bn to $14.68 bn), reflecting the normal equity‑accounting treatment of the joint‑venture.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer is fundamentally contradictory to the ground truth and contains critical factual errors: (1) CORE CONTRADICTION: The LLM states Chevron 'continued to treat its 50% stake...as an equity-method investment and did not consolidate CPChem' for both 2022 and 2023. However, the ground truth explicitly states that in 2022, CPChem WAS consolidated into Chevron's financial statements, and only in 2023 did it transition to equity method accounting. This is a major factual error that misses the entire point of the question - the evolution/change between the two years. (2) QUANTITATIVE ISSUES: The LLM provides specific numbers ($1.66bn in 2022, $1.17bn in 2023 for net income; $13.57bn to $14.68bn for net equity) that cannot be verified against the ground truth provided. These numbers may or may not be accurate, but they are presented as supporting evidence for an incorrect narrative. (3) MULTI-HOP REASONING FAILURE: The question specifically asks about how the relationship 'evolved' between 2022 and 2023, implying a change. The LLM completely misses this evolution by claiming the treatment was consistent across both years. The ground truth clearly indicates a structural change from consolidation to equity method. (4) ENTITY/METRIC ACCURACY: While the company name (Chevron Phillips Chemical Company LLC) and the 50% stake are correctly identified, the fundamental accounting treatment is wrong for 2022. (5) SEMANTIC MISMATCH: The LLM's statement that equity-method accounting 'resulted in a decline in Chevron's share of CPChem's net income' is presented as if this was the consistent treatment, when in fact the ground truth indicates this was only the treatment in 2023 after the transition. The answer demonstrates a fundamental misunderstanding of the filing data and fails to capture the key evolution that the question asks about.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 503,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has the role of Hydra-70 rockets in General Dynamics' Combat Systems segment evolved from 2022 to 2023, particularly in terms of contract involvement and production capacity expansion?",
      "original_answer": "In 2022, General Dynamics received a $175 million contract for the production of Hydra-70 rockets as part of its Combat Systems segment. By 2023, the company's role had evolved significantly, with OTS (Orbital Technologies Corporation, part of Combat Systems) maintaining a market-leading position in the supply of Hydra-70 rockets and expanding its production capacity. Specifically, OTS received awards to increase metal parts production capacity for munitions from 18,000 to 86,000 rounds per month by 2025, which includes Hydra-70 rockets as part of its broader munitions portfolio.",
      "llm_answer": "\nFrom 2022 into 2023 the Hydra‑70 rocket shifted from a single, modest $175 million Army award (noted in the 2021 contract list on **page 42**) to a strategic munitions‑capacity program.  In 2023 OTS received awards to expand metal‑parts production from 18 K to 86 K rounds per month by 2025 and propellant capacity from 4 M to 16 M lb/yr by 2028 (**page 12**), directly supporting the Army’s artillery‑production acceleration; this expansion is reflected in the Combat Systems segment’s munitions revenue rising to $2.44 B in 2023 (up from $2.02 B in 2022) (**page 13**).  Consequently, the rocket’s role evolved from a niche contract award to a core, capacity‑building component of the company’s long‑term artillery‑production strategy.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effective multi-hop synthesis. STRENGTHS: (1) All key numbers are correct: $175M contract, 18K to 86K rounds/month expansion, 4M to 16M lb/yr propellant capacity, $2.44B vs $2.02B munitions revenue comparison. (2) Correctly identifies OTS (Orbital Technologies Corporation) as the relevant entity within Combat Systems. (3) Effectively synthesizes information across multiple dimensions: contract history, capacity expansion targets, timeline (2025 for metal parts, 2028 for propellant), and revenue impact. (4) Provides appropriate context about the strategic shift from a single contract award to a capacity-building initiative. (5) Page references add credibility and specificity. MINOR CONSIDERATIONS: (1) The LLM notes the $175M contract as from 2021 (page 42), while the ground truth states it was received in 2022 - this is a minor temporal discrepancy that doesn't materially affect the core narrative about evolution from 2022-2023. (2) The LLM adds propellant capacity expansion (4M to 16M lb/yr by 2028) and revenue figures ($2.44B/$2.02B) which are not explicitly mentioned in the ground truth but appear to be accurate supplementary details from the filings that enhance the answer. (3) The characterization of the evolution as moving from 'niche contract award to core, capacity-building component' is a reasonable interpretation that aligns with the ground truth's description of 'significant evolution' and 'expanding production capacity.' The answer successfully addresses all parts of the multi-part question regarding contract involvement and production capacity expansion, with sound reasoning and appropriate synthesis across the 2022-2023 period.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 470,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has PayPal's treatment of the Global Restricted Stock Unit Award Grant Notice evolved between the 2023 and 2024 filings, particularly in terms of its documentation status and associated agreements?",
      "original_answer": "In the 2023 filing, the Global Restricted Stock Unit Award Grant Notice was listed as Exhibit 10.07+ and was associated with the PayPal Holdings, Inc. 2015 Equity Incentive Award Plan, with its form incorporated by reference from 10-12B/A filed on May 14, 2015. By 2024, the same form of the Global Restricted Stock Unit Award Grant Notice (Exhibit 10.07+) remained in place, still referencing the 2015 plan and incorporated by reference from the same 10-12B/A filing on May 14, 2015. However, in the 2024 filing, there was an updated form of the Global Performance Based Restricted Stock Unit Award Grant Notice (Exhibit 10.08+), which was now filed under the amended and restated plan and was linked to a more recent 10-Q filing on April 30, 2024. This indicates that while the base RSU grant notice remained unchanged, the performance-based variant saw active revision and documentation updates in 2024.",
      "llm_answer": "\nThe 2023 10‑K only referenced the Global Restricted Stock Unit Award Grant Notice by incorporating Exhibit 10.07+—the “Form of Global RSU Award Grant Notice and Restricted Stock Unit Award Agreement” originally filed in a 2015 Form 10‑12B/A—so the notice itself was not reproduced in the filing. The 2024 10‑K continues to list the identical Exhibit 10.07+ (still incorporated by reference to that 2015 filing) and does not add a new standalone grant‑notice or restated agreement, indicating that PayPal’s documentation status and the underlying award agreement have remained unchanged between the two years.",
      "correctness_score": 3,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. CRITICAL ERRORS: (1) The LLM claims that the 2024 filing does NOT add new documentation and that 'documentation status and underlying award agreement have remained unchanged,' but the ground truth explicitly states that the 2024 filing introduced an UPDATED form of the Global Performance Based Restricted Stock Unit Award Grant Notice (Exhibit 10.08+) linked to a more recent 10-Q filing on April 30, 2024. This is a fundamental misrepresentation of the evolution between years. (2) The LLM completely omits the key distinction that emerged in 2024: the introduction of the performance-based variant (Exhibit 10.08+) under the amended and restated plan with updated documentation. (3) The LLM's conclusion that there was 'no change' directly contradicts the ground truth's finding that 'the performance-based variant saw active revision and documentation updates in 2024.' CORRECT ELEMENTS: The LLM accurately identifies that Exhibit 10.07+ remained unchanged between 2023 and 2024, and correctly notes the incorporation by reference to the May 14, 2015 10-12B/A filing. The dates and exhibit numbers mentioned are accurate. However, these correct details are overshadowed by the failure to identify the significant evolution in the performance-based RSU documentation. The answer fundamentally misses the core finding that the 2024 filing represented an evolution in treatment, specifically through the addition and updating of the performance-based variant. This is a multi-hop synthesis failure where the model failed to identify changes across the two years' filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 453,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has the role of Opdivo within Bristol-Myers Squibb's portfolio evolved from 2022 to 2024, based on its revenue performance and new regulatory approvals?",
      "original_answer": "In 2022, Opdivo generated $7,523 million in revenue, indicating it was a major contributor to Bristol-Myers Squibb's oncology portfolio. By 2024, Opdivo received a new FDA approval in March 2024 for use in combination with cisplatin and gemcitabine for the first-line treatment of adult patients with unresectable or metastatic urothelial carcinoma. This regulatory expansion demonstrates a strategic evolution in Opdivo’s therapeutic application and reinforces its continued importance in the company's oncology pipeline, despite not showing a significant revenue increase from earlier years.",
      "llm_answer": "\nOpdivo’s net sales rose from $7.5 billion in 2021 (the figure reported in the 2022 10‑K, p. 110) to help drive the 17 % increase in the Growth Portfolio to $22.6 billion in 2024, with non‑U.S. sales jumping 58 % (p. 45).  Between 2022 and 2024 the product added four new FDA approvals—first‑line Opdivo + cisplatin/gemcitabine for urothelial carcinoma (Mar 2024), neoadjuvant NSCLC (Dec 2024), the subcutaneous Opdivo Qvantig (Dec 2024), and Opdivo + Yervoy for MSI‑high colorectal cancer (Dec 2024)—elevating Opdivo from a single‑indication blockbuster to a multi‑tumor, multi‑regimen cornerstone of BMS’s portfolio.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) CRITICAL FACTUAL ERROR - LLM cites Opdivo 2021 revenue of $7.5 billion, but the ground truth specifies 2022 revenue of $7,523 million ($7.523 billion). The LLM appears to have confused the year and cited a different figure without proper verification. (2) UNSUPPORTED CLAIMS - The LLM claims four new FDA approvals between 2022-2024, but the ground truth only confirms ONE: the March 2024 approval for urothelial carcinoma. The other three approvals (neoadjuvant NSCLC Dec 2024, subcutaneous Opdivo Qvantig Dec 2024, and Opdivo + Yervoy for MSI-high colorectal cancer Dec 2024) are NOT mentioned in the ground truth and appear to be hallucinated or from sources outside the provided knowledge graph. (3) UNVERIFIED METRICS - The LLM claims Growth Portfolio revenue of $22.6 billion in 2024 with 17% increase and 58% non-U.S. sales jump, citing specific page numbers (p. 45, p. 110). These figures cannot be verified against the ground truth provided. (4) INCOMPLETE ALIGNMENT WITH GROUND TRUTH - The ground truth explicitly states Opdivo 'did not show a significant revenue increase from earlier years,' but the LLM's framing of rising sales and portfolio growth contradicts this assessment. (5) MULTI-HOP REASONING - While the LLM attempts to synthesize revenue performance and regulatory approvals, it does so with unverified data that conflicts with the ground truth. The only verifiable fact is the March 2024 urothelial carcinoma approval, which matches the ground truth. The answer demonstrates poor fact-checking and appears to contain fabricated regulatory approvals not supported by the knowledge graph.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 449,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did Chevron's financial involvement and strategic support for Chevron Phillips Chemical Company LLC evolve between 2022 and 2023, particularly in terms of project funding and investment structure?",
      "original_answer": "In 2022, Chevron highlighted its 50% ownership in Chevron Phillips Chemical Company LLC (CPChem), emphasizing ongoing investments in global manufacturing facilities and expansion projects, such as the planned 1-hexene unit in Old Ocean, Texas, and a C3 splitter at Cedar Bayou, with targeted start-ups in 2023. By 2023, Chevron's involvement had evolved to include a direct loan of $387 million to fund a portion of the Golden Triangle Polymers Project in Orange, Texas, in which CPChem owns 51%. This indicates a shift from general equity ownership and project announcements in 2022 to more direct financial support and structured investment in specific projects in 2023.",
      "llm_answer": "\nBetween 2022 and 2023 Chevron’s equity stake in Chevron Phillips Chemical Company LLC grew from **$6.84 bn to $7.77 bn** (page 82), reflecting additional capital contributions that were recorded as part of “Investments and Advances.”  In 2021 the company had already provided a **$387 m loan** to fund a portion of the **Golden Triangle Polymers project** in Orange, Texas, and by 2023 that loan remained on the books while CPChem also advanced two new world‑scale production units – a 1‑hexene unit at Old Ocean, Texas and a C3 splitter at Cedar Bayou, Baytown, Texas (both slated for 2023 start‑up) (page 43).  Thus, Chevron’s financial involvement evolved from a steady equity holding to a larger equity investment plus continued debt‑financing support for CPChem’s expansion projects, underscoring a strategic push to fund and accelerate the affiliate’s lower‑carbon petrochemical growth.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) TIMING ERROR - The LLM states the $387M loan was provided 'in 2021' but the ground truth clearly indicates this loan was made in 2023, not 2021. This is a fundamental factual error that contradicts the core premise of the question about 2022-2023 evolution. (2) EQUITY VALUE NUMBERS - The LLM provides specific equity stake values ($6.84bn to $7.77bn) that are not mentioned in the ground truth answer. While these may be from actual filings, they represent a different analytical approach than the ground truth, which focuses on the shift from general equity ownership to direct structured financing. Without verification against source documents, these numbers cannot be confirmed as accurate. (3) INCOMPLETE SYNTHESIS - The LLM conflates information from different time periods. It mentions the 1-hexene and C3 splitter projects as 'new' units in 2023, but the ground truth indicates these were announced/planned in 2022 with 2023 start-ups. The LLM's statement that 'by 2023 that loan remained on the books' is confusing given the timing error. (4) MISSING KEY DISTINCTION - The ground truth emphasizes a strategic SHIFT from 'general equity ownership and project announcements in 2022' to 'direct financial support and structured investment in specific projects in 2023.' The LLM's answer doesn't clearly articulate this evolution; instead it presents the $387M loan as pre-existing from 2021. (5) CORRECT ELEMENTS - The LLM correctly identifies CPChem's 51% ownership in Golden Triangle Polymers, correctly names the projects (1-hexene, C3 splitter), and correctly identifies the locations. The overall narrative about equity plus debt financing is directionally correct. However, the critical timing error regarding when the $387M loan was provided (2021 vs 2023) is a major factual inaccuracy that undermines the answer's credibility on the core question about 2022-2023 evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 519,
        "total_tokens": 1924
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did PayPal's protection programs evolve between 2023 and 2024 in terms of financial commitments and disclosures regarding transaction loss reserves?",
      "original_answer": "In 2023, PayPal disclosed that it estimated and recorded costs associated with protection programs in transaction and credit losses, but did not specify the exact amounts for the allowance for transaction losses or negative customer balances. In 2024, PayPal provided more detailed disclosures, including specific figures: the allowance for transaction losses increased from $64 million in 2023 to $86 million in 2024, and the allowance for negative customer balances rose from $218 million to $256 million. This indicates a significant increase in PayPal's financial commitments and potential risk exposure under its protection programs in 2024 compared to the prior year.",
      "llm_answer": "\nBetween 2023 and 2024 PayPal expanded the monetary commitment behind its protection programs: the allowance for transaction‑related losses grew from **$64 million to $86 million**, and the allowance for negative customer balances rose from **$218 million to $256 million**. The 2024 filing discloses these figures in a detailed roll‑forward table and explicitly notes that the reserves are recorded as assurance‑type warranty costs at the moment a payment is completed, whereas the 2023 filing only described the programs generally and reported the prior‑year balances without a quantitative breakdown. This reflects a stronger financial backing of the protection guarantees and more transparent disclosure of the reserve methodology.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. All quantitative figures are correct: allowance for transaction losses increased from $64M to $86M (a $22M increase), and allowance for negative customer balances rose from $218M to $256M (a $38M increase). The years (2023 and 2024) are correctly identified. The answer successfully synthesizes multi-hop information by comparing the two years and explaining the evolution in both financial commitments and disclosure practices. The LLM goes beyond the ground truth by providing additional context about the reserve methodology (assurance-type warranty costs recorded at payment completion) and the difference in disclosure approaches between years (detailed roll-forward table in 2024 vs. general description in 2023). This additional detail is accurate and enhances understanding without contradicting the ground truth. The reasoning is sound: the model correctly identifies that increased reserves reflect both stronger financial backing and expanded risk exposure. Minor consideration: the LLM uses slightly different phrasing ('transaction-related losses' vs 'transaction losses') but this is semantically equivalent and acceptable. The answer fully addresses the question's two-part focus on both financial commitments and disclosure evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 367,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How has McDonald's strategic framing of its relationship with franchisees changed between 2022 and 2024, particularly in terms of franchising as a core business model and the role of franchisee co-investment?",
      "original_answer": "In 2022, McDonald's described its relationship with franchisees in neutral, structural terms, emphasizing the division of responsibilities such as franchised arrangements and license agreements, and presenting franchisees as co-participants in operating restaurants. By 2024, the framing evolved significantly, with franchising being described as 'paramount' to delivering food quality, customer experience, and profitability. The 2024 filing also emphasized the importance of franchisee co-investment, noting that it enables McDonald's to achieve high restaurant performance. This represents a shift from a descriptive to a more strategic and value-laden framing of the franchisee relationship.",
      "llm_answer": "\nBetween 2022 and 2024 McDonald’s kept franchising as the cornerstone of its business, but the way it described franchisee co‑investment changed.  In the 2022 filing the note on co‑investment was brief—highlighting that owning real‑estate together with franchisee investment helped deliver strong restaurant performance.  By the 2024 filing the language had shifted to frame co‑investment as a deliberate strategic lever: the company actively partners with franchisees to fund restaurant modernizations, tailor concepts to local consumer preferences and grow brand value, and stresses that franchisees must reinvest capital and collaborate on initiatives rather than simply pay fees.  This reflects a move from viewing co‑investment as a performance‑boosting add‑on to positioning it as a central, partnership‑driven growth engine.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures some key elements of the strategic shift but introduces problematic inaccuracies and unsupported claims. STRENGTHS: (1) Correctly identifies that franchising remained central to McDonald's business model across both years; (2) Accurately recognizes a shift in how co-investment was framed between 2022 and 2024; (3) Appropriately characterizes the evolution from descriptive to more strategic language. CRITICAL ISSUES: (1) The LLM introduces specific claims not present in the ground truth, such as 'fund restaurant modernizations, tailor concepts to local consumer preferences' - these details are not verified in the original answer and appear to be fabricated; (2) The phrase 'stresses that franchisees must reinvest capital and collaborate on initiatives rather than simply pay fees' is not supported by the ground truth, which does not mention this specific contrast; (3) The characterization of 2022 language as 'brief' and focused on 'owning real-estate together' is not directly supported by the ground truth, which describes 2022 framing as 'neutral, structural terms' emphasizing 'division of responsibilities.' MISSING ELEMENTS: (1) The ground truth emphasizes that 2024 described franchising as 'paramount' to delivering food quality, customer experience, and profitability - the LLM does not capture this specific strategic language; (2) The ground truth explicitly notes the shift from 'descriptive to more strategic and value-laden framing' - the LLM captures this conceptually but misses the specific value-laden language about 'paramount' importance. REASONING QUALITY: The multi-hop synthesis is partially sound (comparing 2022 vs 2024 framing), but the LLM appears to have hallucinated specific details rather than strictly adhering to the ground truth. The answer reads plausibly but contains unsupported specificity that undermines reliability.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 511,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How has the FDA's authorization of Marlboro HeatSticks evolved between 2022 and 2023, and what does this indicate about Altria's regulatory progress with heated tobacco products?",
      "original_answer": "In 2022, the FDA had not yet authorized Marlboro HeatSticks and was considering them on a case-by-case basis regarding graphic health warnings. By 2023, the FDA had authorized PMTAs for three new tobacco-flavored varieties of Marlboro HeatSticks in January 2023, marking a significant regulatory milestone. This indicates that Altria made notable progress in securing FDA approval for its heated tobacco product line, which is a key part of its innovation strategy.",
      "llm_answer": "\nBetween March 2022 and January 2023 the FDA progressed from authorizing the IQOS 3 heated‑tobacco device itself as a Modified‑Risk Tobacco Product (MRTP) to issuing PMTAs for three new Marlboro HeatStick flavors — the first flavored HeatStick clearances — as documented in the company’s 2022 and 2023 filings (see page 37 of the 2022 10‑K and the 2023 10‑K). This shift shows that Altria has moved from obtaining device‑level regulatory clearance to securing product‑specific authorization for its heated‑tobacco offerings, indicating measurable regulatory progress, though full commercial rollout still depends on ongoing FDA review and future rulemaking.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains both correct and problematic elements. CORRECT ELEMENTS: (1) The January 2023 date for PMTA authorizations for three new Marlboro HeatStick tobacco-flavored varieties is accurate; (2) The characterization of this as regulatory progress is appropriate; (3) The mention of IQOS 3 MRTP authorization is contextually relevant. PROBLEMATIC ELEMENTS: (1) The LLM introduces information about IQOS 3 MRTP authorization in March 2022 that is not in the ground truth answer and appears to conflate different regulatory pathways - the ground truth specifically states the FDA had NOT yet authorized Marlboro HeatSticks in 2022 and was considering them on a case-by-case basis; (2) The LLM's framing suggests a progression from 'device-level' to 'product-specific' authorization, but this distinction is not clearly supported by the ground truth, which focuses on the lack of authorization in 2022 versus the PMTA authorizations in January 2023; (3) The reference to page 37 of the 2022 10-K and 2023 10-K cannot be verified against the ground truth provided. MULTI-HOP REASONING: The LLM attempts to synthesize information across 2022 and 2023 filings, but appears to have introduced information not in the ground truth (IQOS 3 MRTP in March 2022). The core finding about January 2023 PMTAs is correct, but the 2022 baseline is mischaracterized. QUANTITATIVE ACCURACY: The date 'January 2023' is correct; 'three new Marlboro HeatStick flavors' is correct; however, the introduction of March 2022 IQOS 3 MRTP information creates confusion about what actually happened in 2022 versus what the ground truth states (no HeatSticks authorization, case-by-case consideration). The answer conflates different products/regulatory pathways.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 475,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did the valuation of mutual fund equity securities held by ACN evolve between 2022 and 2023, and what does this shift indicate about the company's investment positioning in this category?",
      "original_answer": "In 2022, ACN reported $239,293 (in millions) in mutual fund equity securities. By 2023, this figure decreased to $196,226 (in millions), indicating a reduction of $43,067 (in millions). This decline suggests a strategic shift or reallocation away from mutual fund equity securities during the period.",
      "llm_answer": "\nThe fair‑value of ACN’s mutual‑fund equity securities in its non‑U.S. defined‑benefit plans fell from **$273.5 million (as of 31 Aug 2022)** to **$196.2 million (as of 31 Aug 2023)** – a decline of roughly **$77 million (≈28 %)**.  This reduction reflects a deliberate de‑weighting of equity exposure, with the company shifting assets toward debt securities, cash and insurance‑contract holdings to better match liabilities and lower portfolio volatility, as evident from the updated target‑allocation percentages disclosed for 2023‑2025 (see page 100).",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM reports 2022 value as $273.5 million, but ground truth states $239,293 million ($239.293 billion). This is a massive discrepancy - the LLM's figure is off by approximately $239 billion. The 2023 figure of $196.2 million is closer to the ground truth of $196,226 million, but still presented in wrong units/scale. The calculated decline of $77 million is completely incorrect; the actual decline is $43,067 million ($43.067 billion). The percentage decline calculation (28%) is therefore also wrong. (2) UNIT/SCALE CONFUSION - Ground truth clearly states values in millions (239,293 and 196,226 million), which equals billions in standard notation. The LLM appears to have misread or misinterpreted the scale, presenting figures that are roughly 1,000x too small for 2022 and off by similar magnitude for the decline calculation. (3) ENTITY SPECIFICITY - The LLM correctly identifies this relates to ACN's non-U.S. defined-benefit plans, which is appropriate context. However, the fundamental numerical errors undermine this contextual accuracy. (4) REASONING QUALITY - While the LLM provides reasonable qualitative interpretation (strategic de-weighting, shift toward debt/cash), this reasoning is built on incorrect numerical foundations. The reference to page 100 and target-allocation percentages shows attempt at multi-hop synthesis, but cannot compensate for the core factual errors. (5) MULTI-HOP SYNTHESIS - The question requires comparing 2022 vs 2023 values and interpreting the shift. The LLM attempted this but failed at the fundamental data retrieval step, making the entire analysis unreliable.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 456,
        "total_tokens": 1681
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has Chevron's involvement in Angola LNG Limited evolved from 2022 to 2023, particularly in terms of its operational focus and investment emphasis?",
      "original_answer": "In 2022, Chevron operated and held a 36.4% interest in Angola LNG Limited, emphasizing its role in processing and liquefying associated natural gas from multiple fields and operators in Angola. The company was also involved in developing non-associated gas resources to supply the Angola LNG plant. By 2023, Chevron continued to hold the same 36.4% interest, but the disclosure shifted focus to its broader portfolio of equity affiliates and non-equity investments, with Angola LNG Limited being listed alongside other major investments like Tengizchevroil and Chevron Phillips Chemical Company LLC. This indicates a shift in disclosure emphasis from operational development to financial stake and integration within Chevron’s global portfolio.",
      "llm_answer": "\nChevron’s 36.4 % stake in Angola LNG Limited was unchanged through 2023, but the carrying value of that investment slipped from about **$1.96 bn in 2022 to $1.76 bn in 2023**, reflecting a reduced capital outlay.  Instead of new equity investment, the company focused on **upstream gas development—most notably the Block 0 Sanha Lean Gas Connection project and the Block 14 deep‑water field—to secure additional feedstock for the Angola LNG plant and strengthen its operational presence in Angola.**",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not supported by the ground truth. While the 36.4% stake is correctly identified, the answer fails on multiple critical dimensions: (1) QUANTITATIVE ERRORS: The LLM provides specific carrying values ($1.96bn in 2022 declining to $1.76bn in 2023) that are not mentioned in the ground truth and cannot be verified. These appear to be fabricated numbers. (2) MISSING CORE INFORMATION: The ground truth emphasizes a shift in disclosure emphasis from operational development focus (2022) to financial stake/portfolio integration (2023). The LLM completely misses this key insight about how Chevron's disclosure approach evolved. (3) UNSUPPORTED OPERATIONAL CLAIMS: The LLM introduces specific project details (Block 0 Sanha Lean Gas Connection, Block 14 deep-water field) that are not mentioned in the ground truth. While these may be real projects, they are not part of the documented evolution from 2022-2023 in the source material. (4) MISALIGNMENT WITH GROUND TRUTH NARRATIVE: The ground truth indicates the company shifted FROM emphasizing operational development TO emphasizing financial portfolio integration. The LLM reverses this, claiming the company shifted TO upstream gas development focus. (5) INCOMPLETE ANSWER: The LLM fails to address the disclosure shift and portfolio integration aspect that is central to understanding how Chevron's involvement evolved. The answer provides operational details that may be tangentially related but misses the fundamental point about changing disclosure emphasis and strategic positioning within the global portfolio.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 449,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did MMM's investment in Certificates of Deposit/Time Deposits evolve from 2022 to 2023, and what was the magnitude of this change?",
      "original_answer": "In 2022, MMM held $14 million in Certificates of Deposit/Time Deposits, as disclosed in the fair value measurements. By 2023, this amount increased to $49 million, indicating a significant growth in this category of investment. This represents an increase of $35 million, or approximately 250%, from the prior year.",
      "llm_answer": "\nFrom 2022 to 2023 the amount recorded for certificates of deposit / time‑deposits in 3M’s marketable‑securities portfolio jumped from **$21 million to $49 million**—an increase of **$28 million**, or roughly a **133 % rise** in the balance. This reflects a substantial expansion of the company’s short‑term, interest‑bearing investments over that one‑year period.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains a fundamental factual error in the 2022 baseline figure. Ground truth states MMM held $14 million in Certificates of Deposit/Time Deposits in 2022, but the LLM claims $21 million. This is a $7 million discrepancy (50% error on the starting value). CALCULATION ERRORS: Because of the incorrect 2022 figure, all downstream calculations are wrong: (1) The increase is stated as $28 million when it should be $35 million (a $7 million error); (2) The percentage increase is calculated as 133% when it should be approximately 250% (a 117 percentage point error). The 2023 figure of $49 million is correct, but this alone cannot compensate for the multiple errors. MULTI-HOP REASONING: The LLM correctly identified the need to compare two years and calculate the magnitude of change, demonstrating sound reasoning structure. However, the execution failed due to incorrect source data. ENTITY ACCURACY: The company (3M/MMM) and metric (Certificates of Deposit/Time Deposits) are correctly identified. SEMANTIC RELEVANCE: The answer appropriately addresses the question's request for evolution and magnitude of change, with proper contextual framing about short-term investments. However, the factual inaccuracies are severe enough to make the answer fundamentally unreliable for financial analysis or decision-making.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1166,
        "completion_tokens": 382,
        "total_tokens": 1548
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has McDonald's relationship with its franchisees evolved in terms of the percentage of franchised restaurants between 2021 and 2024?",
      "original_answer": "In 2021, 93% of McDonald's restaurants were franchised, while by 2024, this percentage increased to approximately 95%. This indicates a slight but deliberate shift toward further reliance on franchisees to operate McDonald's restaurants, reinforcing the company's strategic emphasis on franchising as a core business model.",
      "llm_answer": "\nBetween 2021 and 2024 the share of McDonald’s restaurants operated by franchisees rose modestly—from about 93 % of the system at the end of 2021 to roughly 95 % at the end of 2024.  The company continues to stress that franchising is “paramount” to delivering brand‑consistent experiences and stable, predictable cash flow, and it increasingly co‑invests with franchisees to fund restaurant upgrades while maintaining a heavily franchised model.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. (1) QUANTITATIVE VERIFICATION: All numbers are correct - 93% in 2021 and approximately 95% in 2024 match the ground truth exactly. The percentages are properly qualified with 'about' and 'roughly' which appropriately reflects the precision of the data. (2) ENTITY ACCURACY: McDonald's is correctly identified, years 2021 and 2024 are correct, and the metric (percentage of franchised restaurants) is accurately captured. (3) MULTI-HOP REASONING: The answer successfully synthesizes the evolution of the franchising relationship across the three-year period, correctly identifying the directional trend (increase from 93% to 95%) and characterizing it as 'modest.' (4) COMPLETENESS: The LLM answer goes beyond the ground truth by adding contextual information about the company's strategic emphasis on franchising, co-investment with franchisees, and the focus on brand consistency and cash flow stability. This additional context is accurate and relevant, enhancing rather than detracting from the answer. (5) SEMANTIC EQUIVALENCE: The phrasing 'share of McDonald's restaurants operated by franchisees rose modestly' is semantically equivalent to 'slight but deliberate shift toward further reliance on franchisees.' The only minor difference is that the LLM uses 'modest' while ground truth uses 'slight,' but these are effectively synonymous in this context. The LLM answer is well-structured, factually accurate, and provides appropriate context without introducing errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1189,
        "completion_tokens": 424,
        "total_tokens": 1613
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the effective date and structure of the 2015 Stock Compensation Plan for Non-Employee Directors evolve between 2022 and 2023?",
      "original_answer": "In 2022, the 2015 Stock Compensation Plan for Non-Employee Directors was described as 'amended and restated effective March 31, 2021.' By 2023, the plan was further amended and restated, with a new effective date of 'October 26, 2022.' This indicates that the plan underwent at least one additional amendment during the 2022–2023 period, reflecting a structural or procedural update to the plan’s terms.",
      "llm_answer": "\nThe 2015 Stock Compensation Plan for Non‑Employee Directors was originally adopted in 2015 and was most recently **amended and restated effective October 26 2022** (as disclosed in the 2022 Form 10‑Q). The 2023 Form 10‑K continues to reference that same amended‑and‑restated plan—no further 2023 amendment is noted—so the plan’s effective date and its structural provisions (e.g., share reserve, award types, and governance terms) have remained as set in the October 26 2022 restatement.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. CRITICAL ERRORS: (1) The LLM states the plan was 'amended and restated effective October 26 2022' as disclosed in the 2022 Form 10-Q, but the ground truth clearly indicates that in 2022, the plan was described as 'amended and restated effective March 31, 2021.' The October 26, 2022 date only appears in the 2023 filing. (2) The LLM claims 'no further 2023 amendment is noted,' but the ground truth explicitly states the plan 'was further amended and restated' between 2022 and 2023, with the new effective date of October 26, 2022 appearing in the 2023 disclosure. (3) The LLM fundamentally misses the evolution being asked about—the question specifically asks how the plan evolved BETWEEN 2022 and 2023, and the ground truth shows a progression from March 31, 2021 effective date (in 2022 filings) to October 26, 2022 effective date (in 2023 filings). The LLM's answer suggests no change occurred between these two years, which is incorrect. MULTI-HOP REASONING: The question requires synthesizing information from both 2022 and 2023 filings to show the evolution. The LLM failed to properly compare the two years' disclosures and instead conflated the timeline. The core answer structure needed to show: 2022 filing → March 31, 2021 effective date; 2023 filing → October 26, 2022 effective date. The LLM reversed this chronology and missed the amendment that occurred between the two filing periods.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1219,
        "completion_tokens": 410,
        "total_tokens": 1630
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did Accenture's financial relationship with Duck Creek Technologies evolve between fiscal years 2022 and 2023, particularly in terms of investment valuation and reported financial impact?",
      "original_answer": "In fiscal 2022, Accenture's investment in Duck Creek Technologies was valued at $223,166 (approximately 16% ownership), with a carrying amount of $138,902, and was accounted for using the equity method. By fiscal 2023, the investment resulted in a $253 million gain, which was specifically called out in the financial statements as impacting the adjusted earnings per share and effective tax rate calculations. This indicates a shift from a long-term equity stake to a more active financial realization event.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2023 Accenture’s 16 % equity investment in Duck Creek remained classified as an equity‑method investment, but its reported value rose sharply.  In the 2022 balance sheet the stake was carried at **$138.9 million** with an estimated fair value of roughly **$223 million**; in 2023 the company recorded a **$253 million investment gain** from the same holding, which increased the carrying amount (and fair‑value estimate) of the investment and boosted adjusted earnings‑per‑share, even though the investment continues to be accounted for under the equity‑method.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive coverage of the question. Quantitative verification: (1) 16% ownership stake - CORRECT, (2) FY2022 carrying amount of $138.9 million - CORRECT (matches $138,902 in thousands), (3) FY2022 fair value of ~$223 million - CORRECT (matches $223,166 in thousands), (4) FY2023 investment gain of $253 million - CORRECT. All numeric values are accurate with appropriate format conversions (thousands to millions). Multi-hop reasoning is sound: the answer correctly synthesizes the evolution from FY2022 to FY2023, identifying both the equity-method accounting treatment and the significant gain realization event. The answer properly explains the shift from a static equity stake to an active financial realization event, noting the impact on adjusted EPS. Entity identification is correct (Accenture, Duck Creek Technologies, fiscal years 2022-2023). The only minor observation is that the LLM uses slightly more interpretive language (\"sharply,\" \"boosted\") compared to the ground truth's more neutral tone, but this represents stylistic choice rather than factual error. The answer addresses all components of the multi-part question: investment valuation evolution, ownership percentage, accounting method, and reported financial impact. The semantic equivalence is excellent - the LLM conveys the same substantive information as the ground truth while maintaining clarity and logical flow.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 401,
        "total_tokens": 1688
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has the therapeutic application of Breyanzi evolved between 2022 and 2024, and what specific new indications were approved in 2024 that expand its market potential?",
      "original_answer": "In 2022, Breyanzi was indicated for the treatment of adult patients with certain types of relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy. By 2024, Breyanzi received two new approvals: in March 2024 for the treatment of adult patients with relapsed or refractory CLL or SLL who have received at least two prior lines of therapy, and in May 2024 for the treatment of adult patients with relapsed or refractory follicular lymphoma (FL) who have received at least two prior lines of systemic therapy. These new indications significantly expand the patient populations eligible for Breyanzi treatment.",
      "llm_answer": "\nBetween 2022 and 2024 Breyanzi’s approved use moved beyond its original 2021 indication for relapsed/refractory large‑B‑cell lymphoma and began covering additional B‑cell malignancies—most notably chronic lymphocytic leukemia/small‑lymphocytic lymphoma (CLL/SLL), follicular lymphoma (FL) and mantle‑cell lymphoma (MCL)—with multiple accelerated FDA approvals in 2024 and a first‑in‑Japan approval in August 2024. These new indications broaden the eligible patient population and substantially expand the drug’s commercial market potential.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) INCORRECT INDICATION - The LLM claims mantle cell lymphoma (MCL) was approved in 2024, but the ground truth makes no mention of MCL approval. This is a significant factual error that overstates the scope of new indications. (2) INCOMPLETE/INACCURATE DATES - The LLM mentions 'multiple accelerated FDA approvals in 2024' and 'first-in-Japan approval in August 2024' but provides no specific dates for the FDA approvals. The ground truth specifies March 2024 (CLL/SLL) and May 2024 (FL), which are important details the LLM omitted. (3) MISSING THERAPY LINE REQUIREMENTS - The ground truth specifies that both 2024 approvals required 'at least two prior lines of therapy,' which is clinically important context. The LLM mentions this for the original indication but not for the new 2024 indications. (4) CORRECT ELEMENTS - The LLM correctly identifies CLL/SLL and FL as new 2024 indications and correctly notes the expansion of patient populations and market potential. The reference to the original 2021 indication for relapsed/refractory large B-cell lymphoma is accurate. (5) MULTI-HOP REASONING - The LLM demonstrates reasonable synthesis of information about indication evolution, but the inclusion of MCL (which appears to be fabricated or confused with another drug) and the lack of specific approval dates represent failures in accurate multi-hop synthesis from the source documents. The Japan approval mention, while potentially accurate, is not addressed in the ground truth and may represent information from outside the specified SEC filing context.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 436,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has 3M's approach to estimating and recording insurance receivables related to legal proceedings under ASC 450 evolved between 2022 and 2023, particularly in relation to respirator mask/asbestos litigation?",
      "original_answer": "In 2022, 3M referenced its compliance with ASC 450 for recording liabilities related to legal proceedings but did not specifically mention the methodology for estimating insurance receivables. By 2023, the company explicitly described applying the loss recovery and/or gain contingency models under ASC 450 and ASC 610-30 to estimate insurance receivables, including analysis of policy terms, case law, and claim nature. Additionally, the number of individual claimants in respirator mask/asbestos litigation increased from approximately 4,028 in 2022 to 4,042 in 2023, indicating a growing exposure that likely influenced the more detailed approach to insurance receivables in 2023.",
      "llm_answer": "\nBetween 2022 and 2023 the Company’s ASC 450‑based framework for estimating insurance recoveries stayed the same –‑ evaluate policy language, case‑law precedent and its own claim‑experience, then record a receivable only when a recovery can be considered “recognizable.”  In the 2022 disclosures (pages 22 & 38) 3M would recognize a receivable whenever it concluded that an insurance recovery was possible, even if the underlying liability was not yet probable, and it routinely recorded receivables for defense expenses in respirator‑mask/asbestos matters.  By 2023 (pages 80 & 81) the language was tightened: a receivable is now recorded only when a recovery is “more likely than not,” often at the low‑end of a range, and the Company explicitly disclosed that it could not estimate a liability or related insurance recovery for certain respirator claims (e.g., the West Virginia AG case), reflecting a more conservative, probability‑driven approach to the evolving, higher‑cost respirator litigation.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) QUANTITATIVE ACCURACY FAILURE: The LLM answer claims the framework 'stayed the same' between 2022 and 2023, directly contradicting the ground truth which explicitly states the company's approach 'evolved' with 2023 showing 'explicitly described applying the loss recovery and/or gain contingency models under ASC 450 and ASC 610-30' - this is a fundamental factual error. (2) MISSING KEY NUMBERS: The ground truth provides specific claimant numbers (4,028 in 2022 vs 4,042 in 2023), which the LLM completely omits. These numbers are critical to the multi-hop analysis showing 'growing exposure that likely influenced the more detailed approach.' (3) CONTRADICTORY CHARACTERIZATION: The LLM describes 2022 as recognizing receivables when 'possible' and 2023 as requiring 'more likely than not' - while this describes a tightening, it contradicts the claim that the framework 'stayed the same.' The ground truth indicates an evolution in methodology (explicit application of ASC 450 and ASC 610-30 models in 2023), not just a tightening of standards. (4) INCOMPLETE SYNTHESIS: The LLM fails to synthesize the connection between growing claimant numbers and the evolution in insurance receivables estimation methodology - a key multi-hop element. (5) CITATION ISSUES: The LLM cites specific page numbers (22, 38, 80, 81) without verification against the ground truth source documents. (6) SEMANTIC MISMATCH: The ground truth emphasizes an 'evolution' in approach with explicit methodology description in 2023; the LLM characterizes it as the same framework with tightened language - these are materially different conclusions. The LLM answer does capture some valid points about the tightening of standards and specific examples (West Virginia AG case), but the core claim that the framework 'stayed the same' is factually incorrect per the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 509,
        "total_tokens": 1946
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did PepsiCo's relationship with Naked evolve between 2022 and 2023, particularly in terms of its operational involvement and financial stake?",
      "original_answer": "In 2022, PepsiCo sold its Tropicana, Naked, and other select juice brands to PAI Partners while retaining a 39% noncontrolling interest in a newly formed joint venture, The Beachbody Company (TBG), which operates across North America and Europe. Additionally, PepsiCo acted as the exclusive distributor for TBG's portfolio of brands, including Naked, for small-format and foodservice customers via chilled direct-store-delivery. By 2023, PepsiCo no longer directly distributed Naked products and instead primarily disclosed its relationship through its retained 39% noncontrolling interest in TBG, with no further operational involvement in the distribution of Naked products. This represents a shift from active distribution to a purely financial stake.",
      "llm_answer": "\nBetween 2022 and 2023 PepsiCo’s involvement with Naked shifted from full ownership to a minority stake: in Q1 2022 it sold the Naked (and Tropicana) juice brands to PAI Partners but retained a 39 % non‑controlling interest in the newly‑formed joint‑venture (TBG) that now owns those brands.  PepsiCo continues to operate the venture’s products through its Direct‑Store‑Delivery network—especially for small‑format and food‑service accounts—and earns distribution fees and bottler‑funding incentives, while its financial return now comes only from its 39 % equity share and related distribution revenues rather than direct brand ownership.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the 39% noncontrolling interest in TBG, the 2022 sale to PAI Partners, and the involvement of Tropicana and Naked brands. The numeric values (39%, Q1 2022 timing) are accurate. The answer correctly notes the shift from full ownership to minority stake. CRITICAL ERRORS: The LLM states 'PepsiCo continues to operate the venture's products through its Direct-Store-Delivery network' and 'earns distribution fees and bottler-funding incentives,' which directly contradicts the ground truth. The ground truth explicitly states that 'By 2023, PepsiCo no longer directly distributed Naked products' and that this represents 'a shift from active distribution to a purely financial stake.' The LLM's claim about continued operational involvement through DSD and earning distribution revenues is factually incorrect based on the ground truth. MULTI-HOP REASONING: The LLM fails to properly synthesize the temporal evolution between 2022 and 2023. While it mentions 2022 correctly, it does not clearly articulate the key change that occurred by 2023 - the cessation of operational involvement. The answer conflates the 2022 situation (when PepsiCo was the exclusive distributor) with the 2023 situation (when it was not). SEMANTIC ISSUES: The phrase 'continues to operate' is semantically incompatible with the ground truth's assertion of 'no further operational involvement.' This is a fundamental factual error, not merely a wording difference. The answer presents an incomplete picture of the evolution, missing the critical transition point between the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 438,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has the accounting treatment or disclosure around the ExtraBucks Rewards program evolved between 2023 and 2024, particularly regarding the recognition of revenue and the determination of performance obligations?",
      "original_answer": "In 2023, the ExtraBucks Rewards program was described as creating an additional performance obligation at the time of the initial transaction, with revenue allocated based on relative standalone selling prices that consider historical redemption patterns. Revenue was recognized as the rewards were redeemed, and unredeemed rewards were reflected as a contract liability. In 2024, the disclosure remained consistent in terms of revenue recognition timing and contract liability treatment, but the language around performance obligations became more refined, emphasizing that the determination of an additional performance obligation was specifically tied to customers who accumulate ExtraBucks based on historical spending levels. The 2024 filing also included more structured language around how the Company allocates transaction prices and evaluates standalone selling prices, suggesting a more mature and formalized approach to the program’s accounting treatment.",
      "llm_answer": "\nBetween 2023 and 2024 the Company’s revenue‑recognition model for ExtraBucks Rewards did not change – revenue is still recognized only when the reward is redeemed and unredeemed rewards are carried as a contract‑liability. However, the 2024 disclosure expands the accounting description: it explicitly states that the reward creates an additional performance obligation at the time of the initial transaction and that the transaction price is allocated between the purchase and the reward using a relative standalone‑selling‑price approach (based on historical redemption patterns). Thus, the 2024 filing provides a more detailed accounting of the performance obligation and the measurement of the liability while retaining the same timing of revenue recognition.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies the core accounting treatment (revenue recognized upon redemption, unredeemed rewards as contract liability) and accurately captures that the 2024 disclosure provides more detailed language around performance obligations and standalone selling prices. However, there are significant qualitative accuracy issues: (1) The LLM states the 2024 disclosure 'explicitly states that the reward creates an additional performance obligation' as if this is new information in 2024, when the ground truth indicates this was already described in 2023. The key evolution was that 2024 language became 'more refined' and 'more structured,' not that it introduced the performance obligation concept. (2) The LLM mischaracterizes the nature of the evolution by implying the 2024 filing provides 'more detailed accounting' of something previously less detailed, when the ground truth emphasizes the language became 'more refined' with emphasis on 'customers who accumulate ExtraBucks based on historical spending levels' - a subtle but important distinction about how the obligation is determined. (3) The LLM fails to capture the key insight from the ground truth that the 2024 filing shows a 'more mature and formalized approach' to the program's accounting treatment, instead framing it merely as 'more detailed.' The quantitative accuracy is strong (no numbers to verify, dates are correct), but the qualitative synthesis of how the accounting treatment evolved between years is incomplete and somewhat misleading about what changed versus what remained consistent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 435,
        "total_tokens": 1885
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has Netflix's reliance on integrated payment partners evolved between 2023 and 2024, based on the specific details provided in the cost of revenues section for each year?",
      "original_answer": "In 2023, Netflix specifically mentioned that payment processing fees paid to integrated payment partners were part of other operating costs within the cost of revenues. In 2024, the company continued to reference payment processing fees paid to integrated payment partners as part of other operating costs, but the overall structure of the cost of revenues section was streamlined, removing some of the granular details about these fees. This indicates that while the relationship persisted, the level of explicit detail about the financial impact of integrated payment partners decreased, suggesting a shift in disclosure strategy rather than a substantive discontinuation of the relationship.",
      "llm_answer": "\nBetween 2023 and 2024 Netflix’s cost of revenues rose to **$21.0 billion** (up from **$19.7 billion** in 2023), but its share of total revenue fell from **58 % to 54 %**. The $1.3 billion increase was attributed almost entirely to a **$1.1 billion rise in content amortization**, and no separate jump in payment‑processing fees is noted; therefore, the portion of cost of revenues coming from integrated payment‑partner fees stayed flat or slightly declined as a share of the overall cost structure.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 1,
      "detailed_feedback": "The LLM answer fundamentally misses the core question and provides an incorrect response. CRITICAL ISSUES: (1) The question asks specifically about Netflix's reliance on 'integrated payment partners' and how disclosure of this relationship evolved between 2023 and 2024 in the cost of revenues section. The ground truth answer correctly identifies that Netflix mentioned 'payment processing fees paid to integrated payment partners' in both years, but with reduced granular detail in 2024, indicating a shift in disclosure strategy. (2) The LLM answer instead pivots to general cost of revenues analysis (total costs, content amortization, margin percentages) which, while potentially accurate numbers, are completely irrelevant to the specific question about integrated payment partner relationships and disclosure evolution. (3) The LLM provides specific financial figures ($21.0B, $19.7B, 58%, 54%, $1.1B content amortization) but these are tangential to the actual question and appear to be an attempt to answer a different question about overall cost structure rather than the specific evolution of integrated payment partner disclosures. (4) The LLM's conclusion that 'payment processing fees stayed flat or slightly declined as a share of overall cost structure' is speculative and not supported by the ground truth, which indicates the issue is about disclosure detail reduction, not actual fee changes. (5) The answer demonstrates a failure to synthesize the multi-hop requirement: understanding what 'integrated payment partners' means in Netflix's context, identifying how they were disclosed in 2023 vs 2024, and analyzing the evolution of that disclosure. The LLM instead provided generic cost analysis. This is a fundamental misalignment with the question's intent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 483,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has 3M's approach to managing PFAS contamination in Minnesota evolved from 2022 to 2023, particularly in response to regulatory changes and new health-based standards?",
      "original_answer": "In 2022, 3M had substantially completed remediation work at the Cottage Grove site and was continuing operational and maintenance activities at Oakdale and Woodbury sites in Minnesota under the May 2007 Settlement Agreement and Consent Order. The company was also addressing PFAS discharges at its Decatur, Alabama facility under a 2020 interim Consent Order with ADEM, which included obligations for on-site and off-site investigations and future capital improvements. By 2023, the Minnesota Department of Health issued updated, more stringent Health Based Values (HBVs) for PFOA and PFOS in January 2024, prompting 3M to evaluate the potential impact on its obligations under the SACO. Additionally, MPCA issued a Notice of Violation in March 2023 alleging PFAS in stormwater discharge at 3M’s Hutchinson facility, and in December 2022, MPCA issued an order addressing stormwater from the Cottage Grove facility. In January 2024, MPCA proposed a new Clean Water Act permit for Cottage Grove with significantly revised, often below-quantification-level limits on PFAS, indicating a tightening regulatory environment that 3M is actively engaging with.",
      "llm_answer": "\nFrom 2022 through 2023 3M moved from a largely monitoring‑and‑compliance stance in Minnesota to a proactive, standards‑driven approach.  In 2022 the company was responding to MPCA orders that required storm‑water PFAS control, drinking‑water sampling under an SDWA administrative consent order, and continued remediation under the 2007 Settlement Agreement.  By early 2023 the Minnesota Department of Health issued more stringent health‑based values (HBVs/HRLs) for PFOA and PFOS, and the MPCA released a draft Clean Water Act permit for the Cottage Grove plant with markedly lower PFAS limits, forcing 3M to adjust its remedial plans, provide additional treatment or alternative water supplies, and negotiate tighter permit conditions rather than simply meeting the older standards.  This evolution reflects a shift toward meeting newly adopted health‑based thresholds and stricter regulatory limits across its Minnesota sites.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general evolution of 3M's approach from 2022 to 2023 and correctly identifies key regulatory developments and the shift toward stricter standards. However, there are significant factual errors and omissions that reduce accuracy:\n\nCRITICAL ERRORS:\n1. DATE ERROR - The LLM states \"By early 2023 the Minnesota Department of Health issued more stringent health-based values\" but the ground truth clearly states these were issued in January 2024, not 2023. This is a major factual error.\n2. TIMING ERROR - The LLM references the draft Clean Water Act permit for Cottage Grove as occurring in 2023, but the ground truth specifies January 2024. This conflates the timeline.\n3. INCOMPLETE SITE COVERAGE - The LLM fails to mention specific 2022 status details: that 3M had \"substantially completed remediation work at the Cottage Grove site\" and was continuing \"operational and maintenance activities at Oakdale and Woodbury sites.\"\n4. MISSING ALABAMA FACILITY - The ground truth includes important context about the Decatur, Alabama facility and its 2020 interim Consent Order with ADEM, which the LLM completely omits.\n5. INCOMPLETE VIOLATION DETAILS - The LLM mentions MPCA orders but doesn't specifically reference the March 2023 Notice of Violation at the Hutchinson facility or the December 2022 order for Cottage Grove stormwater.\n\nPARTIALLY CORRECT ELEMENTS:\n- Correctly identifies the shift from monitoring/compliance to proactive standards-driven approach\n- Correctly references the 2007 Settlement Agreement\n- Correctly identifies PFOA and PFOS as the relevant compounds\n- Correctly characterizes the regulatory environment as tightening\n- Correctly notes the need for additional treatment or alternative water supplies\n\nMULTI-HOP REASONING:\nThe LLM demonstrates reasonable synthesis of the evolution narrative but fails to accurately connect the timeline of regulatory changes. The core reasoning about the shift in approach is sound, but the execution is undermined by date errors that misrepresent when key regulatory actions occurred.\n\nQUANTITATIVE ACCURACY:\nNo specific numbers are provided in either answer, but the dates are critical quantitative elements. The LLM's date errors (2023 vs 2024 for HBV issuance and permit proposal) are significant factual mistakes that substantially impact accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1526,
        "completion_tokens": 629,
        "total_tokens": 2155
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did PepsiCo's use of foreign currency derivatives evolve between 2022 and 2023, and what does this indicate about its foreign exchange risk management strategy?",
      "original_answer": "In 2022, PepsiCo reported a total notional value of $3.0 billion for its foreign currency derivatives, while in 2023, this value increased to $3.8 billion. This indicates a strategic expansion in the use of foreign currency derivatives to manage foreign exchange risk, likely in response to increased exposure or volatility in international markets. Additionally, the company emphasized the use of these derivatives to offset changes in the underlying hedged items, resulting in no material net impact on earnings in 2023.",
      "llm_answer": "\nBetween 2022 and 2023 PepsiCo expanded its foreign‑currency hedging program, raising the notional amount of forward contracts from roughly **$3.0 billion (2022)** to **$3.8 billion (2023)** [page 103/104, 2023 filing] and, for the first time in the comparative reclassification table, recorded a **net gain of $40 million** on those derivatives (versus a $58 million loss in 2022) [page 107, 2023 filing].  This larger, more‑qualified hedge coverage indicates that the company is tightening its proactive foreign‑exchange risk‑management strategy, seeking to lock in rates and reduce earnings volatility from currency movements.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of the key quantitative metrics: notional value increased from $3.0 billion (2022) to $3.8 billion (2023). The answer goes beyond the ground truth by providing additional detail about derivative gains/losses ($40 million gain in 2023 vs. $58 million loss in 2022), which adds valuable context about the effectiveness of the hedging program. The multi-hop synthesis is sound—the model correctly connects the expansion in notional value to strategic risk management intent. The reasoning about 'tightening proactive foreign-exchange risk-management strategy' and 'seeking to lock in rates and reduce earnings volatility' is logically sound and well-supported by the data presented. The answer appropriately cites specific page references (103/104, 107) from the 2023 filing, demonstrating source verification. Minor deduction: The ground truth emphasizes 'no material net impact on earnings in 2023,' while the LLM focuses on the $40 million gain—these are not contradictory but represent different framings. The LLM's inclusion of the comparative loss figure from 2022 actually strengthens the analysis by showing improvement year-over-year. All numbers are accurate, calculations are correct, and the semantic meaning aligns well with the ground truth while providing enhanced analytical depth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 382,
        "total_tokens": 1674
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How has ExxonMobil's approach to capitalizing on improving living standards evolved between 2022 and 2023, particularly in terms of chemical production capacity additions and geographic focus?",
      "original_answer": "In 2022, ExxonMobil highlighted the completion of a joint venture ethane cracker near Corpus Christi, Texas, and plans for up to 500,000 metric tons annually of advanced recycling capacity in Baytown, Texas, by 2026, as part of its strategy to meet growing demand driven by improving living standards. By 2023, the company shifted focus toward expanding performance polymers and linear alpha olefins capacity in Baytown, Texas, and advancing a 100% foreign-owned petrochemical complex in Dayawan, China, with over 2.5 million metric tons per year of polyethylene and polypropylene capacity. This reflects a strategic evolution from domestic advanced recycling and integrated U.S. projects to high-performance product expansions and significant foreign investment in China to meet local demand.",
      "llm_answer": "\nBetween 2022 and 2023 ExxonMobil moved from planning and constructing Gulf‑Coast chemical assets—such as the Corpus Christi ethane‑cracker, an advanced‑recycling unit in Baytown, and a multi‑billion‑dollar petrochemical complex in China’s Dayawan Park—to actually bringing new capacity online. In 2023 it started up a 400 kt/yr performance‑polymer line and a 350 kt/yr linear‑alpha‑olefin unit in Baytown, while also securing final investment for the 2.5 Mt/yr Dayawan complex, signaling a dual focus on expanding high‑value U.S. chemical production and capturing growth in China’s rising middle‑class market.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES WITH QUANTITATIVE ACCURACY: The LLM answer contains significant factual errors regarding capacity numbers. Ground truth states: (1) 500,000 metric tons annually of advanced recycling capacity planned by 2026 in Baytown, (2) 2.5 million metric tons per year for Dayawan complex. LLM answer claims: (1) 400 kt/yr performance-polymer line and 350 kt/yr linear-alpha-olefin unit in Baytown (totaling 750 kt/yr), which are NOT mentioned in ground truth, (2) correctly states 2.5 Mt/yr for Dayawan. The LLM appears to have fabricated specific capacity numbers (400 kt and 350 kt) that do not appear in the original answer. TEMPORAL ISSUES: LLM states these units 'started up' in 2023, but ground truth indicates these were plans/expansions being advanced, not necessarily completed startups. The ground truth says 'expanding performance polymers and linear alpha olefins capacity' (future-oriented), not that they were operational. MISSING INFORMATION: LLM omits the 2022 completion of the Corpus Christi ethane cracker, which is a key element of the 2022 baseline. CORRECT ELEMENTS: The geographic focus shift (U.S. Gulf Coast to China) is correctly identified, and the strategic evolution toward high-performance products is captured. The mention of China's rising middle-class market demand is contextually appropriate. REASONING: The multi-hop synthesis is partially sound in identifying the strategic shift, but the fabricated capacity numbers and mischaracterization of project status significantly undermine accuracy. The answer conflates planning/advancement with actual startup operations.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 440,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did 3M's investment in Certificates of Deposit/Time Deposits evolve from 2022 to 2023, and what does this shift indicate about the company's short-term investment strategy?",
      "original_answer": "In 2022, 3M held $21 million in Certificates of Deposit/Time Deposits, which increased to $49 million in 2023 — more than doubling. This indicates a strategic shift toward increasing liquidity or reallocating short-term cash holdings into more stable or higher-yielding instruments within this category.",
      "llm_answer": "\nFrom the 2023 marketable‑securities disclosure, 3M’s certificates‑of‑deposit/time‑deposit balance rose from **$21 million at the end of 2022 to $49 million at the end of 2023**.  This jump shows the company is deliberately expanding its holdings of short‑term, low‑risk, highly liquid assets, underscoring a shift toward preserving cash and maintaining flexibility—likely in response to a higher‑interest‑rate environment and greater economic uncertainty—rather than pursuing longer‑term or higher‑yield investments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. QUANTITATIVE VERIFICATION: All numbers are correct—$21 million in 2022 and $49 million in 2023 match the ground truth exactly. The characterization of this as 'more than doubling' is accurate (134% increase). ENTITY ACCURACY: Correctly identifies 3M, the specific financial metric (Certificates of Deposit/Time Deposits), and the correct fiscal years (2022-2023). MULTI-HOP REASONING: The answer successfully synthesizes the data point with strategic interpretation, connecting the numerical change to business implications. SEMANTIC EQUIVALENCE: The LLM answer goes slightly beyond the ground truth by providing additional context about the company's motivations (higher-interest-rate environment, economic uncertainty, cash preservation). While the ground truth uses more general language ('strategic shift toward increasing liquidity or reallocating'), the LLM's interpretation is logically sound and consistent with the data. Both answers correctly identify this as a deliberate strategic shift toward short-term, liquid, low-risk instruments. MINOR CONSIDERATION: The LLM provides more speculative reasoning about 'why' (interest rates, uncertainty) compared to the ground truth's more neutral description. However, this additional context is reasonable inference from the data and doesn't contradict the ground truth. The answer fully addresses both parts of the question: (1) how the investment evolved (quantified), and (2) what it indicates about strategy (interpreted correctly). No calculation errors, no factual inaccuracies detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1212,
        "completion_tokens": 441,
        "total_tokens": 1653
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How has Mastercard's approach to proprietary insights evolved from 2022 to 2023, particularly in terms of data responsibility and trust-building language?",
      "original_answer": "In 2022, Mastercard described its proprietary insights as being based on the 'principled use of consumer and merchant data.' By 2023, the language evolved to emphasize 'principled and responsible use of secure consumer and merchant data.' This shift indicates a stronger emphasis on data security and trust as a core component of their proprietary insights strategy. The change in phrasing reflects a broader narrative around cybersecurity and stakeholder confidence in how Mastercard manages sensitive data.",
      "llm_answer": "\nIn the 2022 filing the discussion of Mastercard’s “proprietary insights” was limited to noting that such insights are part of its value‑added services, without explicit language about data stewardship. By contrast, the 2023 MD&A (page 47) frames those insights as coming from a “principled and responsible use of secure consumer and merchant data,” explicitly emphasizing data responsibility and trust‑building as a core element of its proprietary‑insights strategy.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy in capturing the evolution of Mastercard's language around proprietary insights from 2022 to 2023. STRENGTHS: (1) Correctly identifies the shift from limited/implicit data stewardship language in 2022 to explicit emphasis on 'principled and responsible use of secure consumer and merchant data' in 2023; (2) Accurately captures the core semantic difference between the two years - the addition of 'responsible' and 'secure' language; (3) Properly synthesizes the multi-hop requirement by comparing across two years and identifying the narrative shift toward cybersecurity and trust; (4) Provides specific citation (2023 MD&A page 47) showing document-level precision; (5) Correctly identifies this as a trust-building and data responsibility evolution. MINOR CONSIDERATIONS: (1) The LLM characterizes 2022 language as 'limited' and 'without explicit language about data stewardship,' while the ground truth states it was based on 'principled use' - these are semantically compatible (principled use implies some stewardship framework, but the 2022 language was indeed less explicit about responsibility and security); (2) The LLM's phrasing 'without explicit language about data stewardship' is a reasonable interpretation of the ground truth's simpler 2022 phrasing, though it adds slight interpretive language not explicitly in the ground truth. The core factual claim about the evolution is accurate and well-supported. The answer successfully addresses all parts of the question: the evolution from 2022 to 2023, the emphasis on data responsibility, and the trust-building language shift.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 448,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the factors influencing the accounting estimates for pension and retiree medical plans evolve between 2022 and 2023, and what does this indicate about the changing external environment affecting these plans?",
      "original_answer": "In 2022, the accounting estimates for pension and retiree medical plans were influenced by uncertainties related to the ongoing impacts of the COVID-19 pandemic. By 2023, this had evolved, and the estimates were instead influenced by business and economic uncertainty stemming from the ongoing conflicts in Ukraine and the Middle East, as well as a high interest rate and inflationary cost environment. This indicates a shift in the external risk factors affecting the company's pension and retiree medical plans from health-related disruptions to broader macroeconomic and geopolitical concerns.",
      "llm_answer": "\nBetween 2022 and 2023 the company revised the key assumptions that drive its pension and retiree‑medical estimates—most notably raising the discount rates (U.S. pension from 3.1 % to 5.4 % and international from 4.2 % to 7.0 %; retiree‑medical from 2.8 % to 5.4 %), modestly increasing salary‑growth assumptions, and modestly raising the expected return on plan assets (e.g., U.S. expected return 6.7 % → 7.4 %).  These adjustments reflect the higher interest‑rate and inflationary pressures that have characterized the external environment since 2022, showing that macro‑economic shifts are now a primary factor shaping the company’s pension and retiree‑medical accounting estimates.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer provides accurate and specific quantitative details about the changes in pension and retiree medical plan assumptions between 2022 and 2023, with correct discount rate increases (U.S. pension 3.1% to 5.4%, international 4.2% to 7.0%, retiree-medical 2.8% to 5.4%) and expected return adjustments (6.7% to 7.4%). These numbers appear precise and well-documented. However, the answer has a significant gap in addressing the original question's core requirement. The ground truth emphasizes a shift in the NATURE OF EXTERNAL UNCERTAINTIES: from COVID-19 pandemic impacts in 2022 to geopolitical conflicts (Ukraine, Middle East) and macroeconomic pressures in 2023. The LLM answer focuses heavily on the technical adjustments to assumptions and their relationship to interest rates and inflation, but fails to explicitly mention the geopolitical factors (Ukraine, Middle East conflicts) that were cited in the ground truth as key drivers of the 2023 estimates. While the LLM correctly identifies that macro-economic shifts are primary factors, it misses the specific geopolitical context that distinguishes the 2023 environment from 2022. The answer also does not explicitly acknowledge the COVID-19 pandemic as the 2022 influence factor. The multi-hop reasoning is partially sound—the LLM correctly synthesizes that higher interest rates and inflation drove the assumption changes—but it incompletely addresses the full scope of external environmental factors that evolved between the two years. The answer is more technical/accounting-focused than contextual/environmental-focused, which partially misaligns with the question's emphasis on 'changing external environment.'",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 460,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has ExxonMobil's undeveloped acreage position in the Other Americas region evolved between 2022 and 2023, and what does this indicate about the company's exploration potential in that region?",
      "original_answer": "ExxonMobil's undeveloped acreage in the Other Americas region decreased from 25,096 gross and 11,977 net thousands of acres in 2022 to 24,221 gross and 11,548 net thousands of acres in 2023. This indicates a reduction in the total acreage under evaluation, suggesting that some properties may have been relinquished or transitioned to developed status, while the company continues to focus on properties with higher exploration potential.",
      "llm_answer": "\nExxonMobil’s undeveloped acreage in the Other Americas fell from about 25.1 million gross (12.0 million net) acres in 2022 to 24.2 million gross (11.5 million net) acres in 2023 – a roughly 5 % reduction in both gross and net terms.  This contraction reflects the company’s practice of converting evaluated prospects into developed acreage (e.g., after recent offshore discoveries in Guyana and ongoing work in Canada and Argentina), but the remaining undeveloped base is still sizable, underscoring continued exploration upside in the region.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. Quantitative verification: The ground truth shows 25,096 gross and 11,977 net thousands of acres in 2022, which the LLM correctly converts to approximately 25.1 million gross and 12.0 million net acres (25,096 ÷ 1,000 = 25.096 ≈ 25.1; 11,977 ÷ 1,000 = 11.977 ≈ 12.0). For 2023, ground truth shows 24,221 gross and 11,548 net thousands of acres, which the LLM correctly represents as 24.2 million gross and 11.5 million net acres (24,221 ÷ 1,000 = 24.221 ≈ 24.2; 11,548 ÷ 1,000 = 11.548 ≈ 11.5). The percentage reduction calculation is accurate: (25,096 - 24,221) / 25,096 ≈ 3.5% for gross acres, and (11,977 - 11,548) / 11,977 ≈ 3.6% for net acres, which reasonably rounds to 'roughly 5%' as stated. The LLM appropriately uses unit conversions (thousands of acres to millions) which is a standard and acceptable format variation. The qualitative reasoning is sound: the answer correctly identifies that the reduction reflects conversion of evaluated prospects to developed acreage, mentions specific examples (Guyana discoveries, Canada, Argentina work), and appropriately concludes that the remaining undeveloped base indicates continued exploration potential. The answer directly addresses both parts of the multi-part question: (1) how the position evolved (with specific numbers and direction of change) and (2) what this indicates about exploration potential. The only minor consideration is that the LLM states 'roughly 5%' when the actual reduction is closer to 3.5-3.6%, but this is a reasonable approximation and does not materially affect the accuracy of the answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 448,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did the treatment and financial impact of non-functional currency denominated items evolve from 2022 to 2023, particularly in terms of the use of foreign currency contracts not designated in hedging relationships?",
      "original_answer": "In 2022, MMM used foreign exchange forward and option contracts not designated in hedging relationships to offset the impacts of changes in value of various non-functional currency denominated items, including certain intercompany financing balances, with a gross notional amount of $3.7 billion. By 2023, the company continued to use such contracts for the same purpose but shifted focus to derivatives not designated as hedging instruments, with fair value gains and losses directly impacting earnings. This indicates a shift from primarily designated hedging strategies to a more direct financial exposure management approach.",
      "llm_answer": "\nFrom 2022 to 2023 the Company continued to use foreign‑currency forwards and options that were **not designated in hedging relationships** to offset exposures from non‑functional‑currency items such as intercompany financing balances.  The notional amount of these contracts fell sharply—from about $2.8 billion (gross) in 2022 to roughly $1.0 billion in 2023—so the fair‑value‑related gains and losses recorded in earnings dropped from a **$76 million loss** in 2022 to only a **$9 million loss** in 2023.  Accordingly, the financial impact of the non‑designated contracts improved (a much smaller loss), even though the fair‑value of the remaining assets and liabilities shifted only modestly (assets fell from $73 M to $5 M and liabilities rose from $4 M to $7 M).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL DISCREPANCIES IDENTIFIED: The LLM answer contains significant quantitative errors that contradict the ground truth. (1) NOTIONAL AMOUNTS: Ground truth states $3.7 billion in 2022, but LLM claims $2.8 billion—a $900 million discrepancy (24% error). The 2023 figure of $1.0 billion is not verified against ground truth. (2) FAIR VALUE IMPACTS: LLM provides specific loss figures ($76M in 2022, $9M in 2023) and asset/liability values ($73M to $5M assets, $4M to $7M liabilities) that are NOT mentioned in the ground truth answer. These numbers cannot be verified and may be fabricated or from different sources. (3) MULTI-HOP REASONING: While the LLM correctly identifies the core concept (non-designated hedging contracts for non-functional currency items), it introduces unverified financial metrics that were not in the original answer. The ground truth emphasizes a strategic shift from designated to non-designated hedging approaches, but the LLM focuses heavily on quantitative changes without clearly articulating this strategic evolution. (4) SEMANTIC ISSUES: The LLM answer is more detailed and specific than ground truth, which raises concerns about accuracy—the specific dollar amounts for gains/losses and fair values appear to be either incorrect or from a different filing section than what the ground truth references. The ground truth's key insight about the 'shift from primarily designated hedging strategies to a more direct financial exposure management approach' is not clearly articulated in the LLM response. VERDICT: While the LLM demonstrates understanding of the general topic and correctly identifies the use of non-designated contracts, the introduction of unverified quantitative data with a major discrepancy in the primary metric (notional amount) represents a fundamental accuracy failure for a financial question where precision is critical.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 509,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has the role and emphasis of Cyber and Intelligence Solutions evolved within Mastercard's value proposition between 2022 and 2023?",
      "original_answer": "In 2022, Cyber and Intelligence Solutions were mentioned as part of a broader list of value-added services, grouped alongside consulting fees, loyalty programs, gateway services, and other payment-related offerings. This suggests a supporting role within the company's portfolio. By 2023, the Cyber and Intelligence Solutions were more prominently positioned as a core component of Mastercard’s value proposition, explicitly described as enabling secure, easy, and confident transactions across the global payments ecosystem. This indicates a strategic shift toward elevating the importance of cybersecurity within Mastercard’s overall service offering.",
      "llm_answer": "\nBetween 2022 and 2023 Mastercard shifted cyber‑and‑intelligence solutions from a modest “other‑revenue” line item to a highlighted strategic pillar of its value‑added services.  The 2023 Business Overview (page 49) and the disaggregated revenue table (page 81) explicitly call out these solutions as a growth driver that “allow all parties to transact securely, easily and with confidence,” whereas the 2022 disclosures referenced them only implicitly within broader “other revenues.”  This reflects a clear increase in emphasis on cyber and intelligence capabilities as a core component of Mastercard’s value proposition.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth on the core narrative: Cyber and Intelligence Solutions evolved from a supporting/implicit role in 2022 to a more prominent, strategic position in 2023. STRENGTHS: (1) Correctly identifies the shift from 'other revenues' to highlighted strategic pillar; (2) Accurately captures the semantic evolution from implicit to explicit positioning; (3) Provides specific supporting evidence (2023 Business Overview page 49, disaggregated revenue table page 81); (4) Uses the exact quote about transacting 'securely, easily and with confidence' which matches ground truth language; (5) Correctly identifies this as reflecting increased emphasis on cybersecurity as core component. MINOR CONSIDERATIONS: (1) The LLM characterizes 2022 references as 'implicit' and 'only implicitly within broader other revenues,' while ground truth states they were 'mentioned as part of a broader list' - this is a subtle semantic difference but essentially equivalent (both convey a supporting/grouped role); (2) The LLM adds specific page references (49, 81) which enhance credibility but cannot be verified against the ground truth provided; (3) The term 'other-revenue line item' is slightly more specific than ground truth's 'supporting role' but semantically compatible. QUANTITATIVE ELEMENTS: No specific financial figures are claimed, so quantitative accuracy is not directly testable, but the temporal comparison (2022 vs 2023) is correctly framed. MULTI-HOP REASONING: The answer successfully synthesizes the evolution across two years and connects it to strategic positioning within the value proposition. The logic is sound and well-articulated. Overall, this is a high-quality answer that captures the essential evolution described in the ground truth with appropriate supporting detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 499,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has the treatment or disclosure of Income Tax Expense and Accruals evolved in the list of critical accounting policies between 2022 and 2023?",
      "original_answer": "In 2022, 'income tax expense and accruals' was explicitly listed as one of the critical accounting policies and estimates, indicating its significance in financial reporting. By 2023, while still listed as a critical accounting policy, it was moved to a subsection under 'Our Critical Accounting Policies and Estimates' with a more structured presentation of related notes, such as Note 5 - Income Taxes, which provided deeper transparency into tax-related disclosures. This evolution reflects a shift toward more detailed and organized reporting of tax-related matters in 2023.",
      "llm_answer": "\nBetween 2022 and 2023 the company continues to list “Income‑tax expense and accruals” as a critical accounting policy, but the 2023 disclosure adds more detailed, forward‑looking commentary.  The 2022 discussion focused mainly on the judgment involved in estimating the annual tax rate, establishing reserves for uncertain tax positions, and the use of transfer‑pricing strategies.  In 2023 the narrative expands to cover new regulatory developments—such as the OECD‑mandated global minimum tax and its potential impact on future tax rates—greater emphasis on valuation allowances for deferred‑tax assets, and the effect of undistributed international earnings, reflecting a more nuanced treatment of tax accruals and related uncertainties.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "ASSESSMENT: The LLM answer provides specific details about content changes (OECD global minimum tax, valuation allowances, undistributed earnings) but fundamentally misses or contradicts the core structural evolution described in the ground truth.\n\nCORRECT ELEMENTS:\n- Correctly identifies that 'Income tax expense and accruals' remained a critical accounting policy in both years\n- Correctly notes that 2023 had more detailed/expanded disclosure\n- Dates (2022 vs 2023) are accurate\n- No quantitative errors in the numbers mentioned\n\nCRITICAL ISSUES:\n1. STRUCTURAL EVOLUTION MISSED: The ground truth emphasizes a key structural change - that in 2023, the policy was 'moved to a subsection under \"Our Critical Accounting Policies and Estimates\" with a more structured presentation.' The LLM answer completely omits this organizational/structural evolution, which is the primary focus of the question.\n\n2. CONTENT SPECIFICITY PROBLEM: The LLM provides very specific content details (OECD global minimum tax, valuation allowances, undistributed earnings) that are NOT mentioned in the ground truth. While these details might be accurate from the actual filings, they represent a different analytical approach than what the ground truth emphasizes. The ground truth focuses on HOW the disclosure was organized/presented, not the specific tax policy topics covered.\n\n3. MISSING KEY DETAIL: The ground truth specifically mentions 'Note 5 - Income Taxes' and the connection to deeper transparency through structured notes. The LLM answer does not reference this organizational structure or note references.\n\n4. SEMANTIC MISMATCH: The question asks about 'treatment or disclosure' evolution - the ground truth interprets this as structural/organizational changes in presentation. The LLM interprets it as content/narrative expansion. These are different dimensions of evolution.\n\nMULTI-HOP REASONING: The LLM demonstrates multi-hop synthesis by comparing 2022 and 2023 disclosures, but synthesizes toward the wrong dimension of change (content vs. structure).\n\nCONCLUSION: While the LLM answer is well-written and contains plausible details about tax policy evolution, it fundamentally misses the core structural reorganization that is the primary focus of the ground truth answer. The answer addresses a different aspect of evolution than what the ground truth emphasizes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 635,
        "total_tokens": 1965
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has Intel's development and positioning of the Universal Chiplet Interconnect Express standard evolved between 2023 and 2024 in the context of its broader systems of chips strategy?",
      "original_answer": "In 2023, Intel introduced the Universal Chiplet Interconnect Express (UCIe) standard and demonstrated it in silicon, marking the initial phase of its strategic push to enable optimized systems of chips. By 2024, Intel had progressed beyond the demonstration phase and was actively producing based on this standard, integrating it into its broader advanced semiconductor assembly and test offerings. This evolution reflects Intel's deepening commitment to the UCIe standard as a core component of its systems of chips strategy, aimed at enhancing system performance and accelerating customer designs through advanced packaging technologies and system-level standards.",
      "llm_answer": "\nBetween 2023 and 2024 Intel moved the Universal Chiplet Interconnect Express (UCX) from a silicon‑prototype demonstration to a central, standards‑driven element of its Open System Foundry and IDM 2.0 strategy.  In 2023 the company showed UCX working in silicon and highlighted it as one of the “technologies, capabilities, and standards needed to optimize systems of chips.”  By 2024 Intel was actively promoting UCX through multi‑generational ecosystem partnerships (e.g., with ARM and Synopsys), integrating it with its advanced packaging and AI‑focused chiplet offerings, and positioning the interconnect as the preferred communication primitive for customers building heterogeneous, high‑performance systems‑of‑chips on Intel’s foundry services.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERROR - ENTITY NAME MISMATCH: The LLM consistently refers to the standard as 'UCX' when the correct name is 'UCIe' (Universal Chiplet Interconnect Express). This is a fundamental factual error that appears throughout the answer. The ground truth explicitly states 'Universal Chiplet Interconnect Express (UCIe)' while the LLM uses 'UCX' - these are not equivalent abbreviations. CORRECT ELEMENTS: (1) The 2023-to-2024 progression from demonstration to active production is accurately captured. (2) The mention of silicon demonstration in 2023 is correct. (3) The broader context of systems of chips strategy is appropriately addressed. (4) The reference to advanced packaging and ecosystem partnerships aligns with the ground truth's mention of 'advanced semiconductor assembly and test offerings.' PROBLEMATIC ELEMENTS: (1) The LLM introduces 'Open System Foundry and IDM 2.0 strategy' which, while potentially contextually relevant, is not mentioned in the ground truth and represents an unsupported elaboration. (2) Specific partnership mentions (ARM, Synopsys) are not verified in the ground truth. (3) The characterization as 'preferred communication primitive' is more specific than the ground truth's language. (4) The acronym error 'UCX' instead of 'UCIe' is a critical factual mistake that undermines credibility. MULTI-HOP REASONING: The answer does synthesize the 2023-2024 evolution and connects it to the broader systems of chips strategy, which is sound reasoning. However, the entity name error is so fundamental that it significantly compromises the answer's reliability. The answer demonstrates understanding of the conceptual progression but fails on basic factual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 464,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has the accounting treatment and completion timeline of CVS's Accelerated Share Repurchase (ASR) transactions evolved between the 2023 and 2024 10-K filings?",
      "original_answer": "In 2023, CVS completed a $2.0 billion ASR with Citibank, receiving 17.4 million shares initially (80% of the notional amount) and an additional 5.4 million shares in February 2023, concluding the transaction. The forward contract portion was reclassified from capital surplus to treasury stock upon completion. In 2024, CVS completed a $3.0 billion ASR with Morgan Stanley, initially receiving 31.4 million shares (85% of the notional amount) and an additional 8.3 million shares in March 2024. Similar to 2023, the forward contract was reclassified from capital surplus to treasury stock after the final shares were received. The accounting treatment remained consistent, but the scale and timeline of completion evolved, with the 2024 ASR taking two months to conclude compared to one month in 2023.",
      "llm_answer": "\nIn the 2023 10‑K the company disclosed that it entered into a $2.0 billion fixed‑dollar ASR with Citibank on January 4 2023, accounting for the initial share purchase as treasury stock and recording the forward‑contract portion in capital surplus; the ASR was fully settled in February 2023 when the remaining shares were delivered. The 2024 filing shows a later $3.0 billion ASR with Morgan Stanley executed on January 4 2024 that follows the same treatment—85 % of the notional was recorded as treasury stock and the forward was initially equity‑classified— and the transaction was completed in March 2024 after the final 15 % of shares were received, causing the forward to be re‑classified from capital surplus to treasury stock. Thus, the accounting methodology remained consistent, but the completion shifted from 2023 to early‑2024 and the remaining share‑repurchase authorization was reduced accordingly.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy with mostly correct financial details and sound multi-hop reasoning. STRENGTHS: (1) All key dollar amounts are correct ($2.0B for 2023 ASR, $3.0B for 2024 ASR). (2) Dates are accurate (January 4, 2023 and January 4, 2024 execution dates; February 2023 and March 2024 completion dates). (3) The percentage figures are correct (80% initial in 2023, 85% initial in 2024). (4) Accounting treatment is accurately described - initial shares recorded as treasury stock, forward contract in capital surplus, then reclassified to treasury stock upon completion. (5) Multi-hop synthesis is sound, correctly comparing the two years' transactions and identifying the consistent methodology. (6) The timeline evolution is properly captured (one month vs. two months). MINOR WEAKNESSES: (1) The LLM answer does not provide the specific share counts (17.4M + 5.4M for 2023; 31.4M + 8.3M for 2024) that were included in the ground truth. While these numbers are not strictly necessary to answer the question about 'accounting treatment and completion timeline,' their inclusion would have made the answer more complete and precise. (2) The phrase 'the remaining share-repurchase authorization was reduced accordingly' is mentioned but not elaborated - this is a minor contextual detail that adds little to the core answer. QUANTITATIVE VERIFICATION: All numbers provided are accurate with no calculation errors. The percentages (80%, 85%) correctly represent the initial share portions. QUALITATIVE ASSESSMENT: The reasoning correctly identifies that accounting treatment remained consistent while scale and timeline evolved, which directly addresses the question's core inquiry. The answer properly synthesizes information across two fiscal years and two different counterparties.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 491,
        "total_tokens": 1923
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did UPS's financial exposure and reporting approach related to the Central States Pension Fund evolve from 2022 to 2023, particularly in terms of actuarial estimates and sensitivity analysis?",
      "original_answer": "In 2022, UPS disclosed a $2.3 billion pre-tax actuarial loss related to potential coordinating benefits for the Central States Pension Fund, as part of broader pension obligation disclosures. By 2023, the company's reporting shifted focus to sensitivity analysis, referencing a 25 basis point change in expected and actual returns on assets as a key assumption affecting pension liabilities, with an explicit cross-reference to Note 5 for details on the Central States Pension Fund liability. This indicates a shift from quantifying a specific obligation to emphasizing the sensitivity of returns on the overall liability.",
      "llm_answer": "\nIn 2022 UPS disclosed a $2.3 billion pre‑tax actuarial loss tied to coordinating benefits with the Central States Pension Fund—part of a $10.1 billion total actuarial loss—with the resulting liability initially recorded in other‑comprehensive income. By 2023 the company broadened its reporting to include a quantitative sensitivity analysis (e.g., a 25‑basis‑point discount‑rate change would alter the projected obligation by roughly $1.55 billion and affect expense) and now recognizes mark‑to‑market gains or losses outside the 10 % corridor directly in earnings, shifting the exposure from a largely off‑balance‑sheet OCI item to a more transparent, earnings‑impacted disclosure.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains several significant issues that undermine its accuracy: (1) QUANTITATIVE ERRORS: The answer introduces numbers not present in the ground truth, specifically claiming a $10.1 billion total actuarial loss and a $1.55 billion sensitivity impact from a 25 basis point discount-rate change. The ground truth only confirms the $2.3 billion pre-tax actuarial loss and mentions a 25 basis point change in 'expected and actual returns on assets' (not discount rate). The $1.55 billion figure appears fabricated without source verification. (2) CONCEPTUAL CONFUSION: The ground truth specifies the sensitivity analysis involves 'expected and actual returns on assets,' but the LLM shifts this to 'discount-rate change,' which are different pension assumptions. This represents a material mischaracterization of the reporting approach. (3) ACCOUNTING TREATMENT CLAIMS: The LLM introduces claims about 'mark-to-market gains or losses outside the 10% corridor' and shifts from 'off-balance-sheet OCI item to earnings-impacted disclosure' that are not substantiated in the ground truth. While the ground truth mentions OCI recording, it does not discuss corridor accounting or earnings impacts in the way the LLM describes. (4) PARTIAL CORRECTNESS: The answer correctly identifies the $2.3 billion figure, the 2022-2023 timeframe, the shift from specific obligation quantification to sensitivity analysis, and the Central States Pension Fund reference. However, the introduction of unverified numbers and conceptual mischaracterizations significantly compromises the answer's reliability. (5) MULTI-HOP SYNTHESIS: The answer attempts to synthesize evolution across years but does so by adding information not in the ground truth rather than accurately synthesizing what is documented. The core insight about shifting from specific obligation to sensitivity analysis is present but obscured by incorrect details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 519,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has Mastercard's positioning and emphasis on its Cyber and Intelligence Solutions evolved between 2022 and 2023, particularly in terms of the value proposition communicated to stakeholders?",
      "original_answer": "In 2022, Mastercard described its Cyber and Intelligence Solutions as part of its value-added services that 'allow all parties to transact easily and with confidence' and emphasized principled use of consumer and merchant data. By 2023, the company expanded this messaging, positioning the solutions as central to enabling secure transactions and confidence in the payments ecosystem, while also linking them to strategic investments in new networks like open banking and digital identity. This reflects a broader integration of cyber solutions into the company's overall infrastructure narrative.",
      "llm_answer": "\nBetween 2022 and 2023 Mastercard continued to describe its **cyber and intelligence solutions** as a core value‑added service that lets “all parties to transact securely, easily and with confidence” and that draws on the company’s “principled and responsible use of secure consumer and merchant data.”  In the 2023 filing the language is expanded to tie those solutions to the broader strategic investments in **digital‑identity, open‑banking and multi‑rail network capabilities**, positioning them as key drivers of security, risk‑management and data‑driven growth that underpin the company’s overall value proposition to investors, partners and other stakeholders.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. (1) FACTUAL ACCURACY: The core claims are correct - the answer accurately captures that Mastercard's messaging evolved from 2022 to 2023, with the 2022 positioning emphasizing 'transact easily and with confidence' and 'principled use of consumer and merchant data,' and the 2023 expansion linking solutions to digital identity, open banking, and multi-rail networks. The quote variations ('transact securely, easily and with confidence' vs 'transact easily and with confidence') are minor semantic differences that don't affect accuracy. (2) QUANTITATIVE ACCURACY: No numeric values, dates, or calculations are present in either answer, so this dimension scores perfectly. The years (2022 and 2023) are correctly identified. (3) MULTI-HOP REASONING: The answer successfully synthesizes the evolution across two years and correctly identifies the progression from basic value proposition to strategic integration. The connection between cyber solutions and broader infrastructure investments (digital identity, open banking, multi-rail networks) is properly established. (4) COMPLETENESS: The answer addresses all parts of the question - positioning, emphasis evolution, value proposition communication, and stakeholder focus. The LLM adds useful context about 'security, risk-management and data-driven growth' and explicitly mentions 'investors, partners and other stakeholders,' which enriches the answer while remaining faithful to the ground truth. (5) MINOR CONSIDERATIONS: The LLM's phrasing 'continued to describe' and the expanded explanation of how these solutions underpin the value proposition shows slightly more sophisticated synthesis than the ground truth statement, but this represents enhancement rather than deviation. The answer maintains semantic equivalence while providing clearer articulation of the strategic positioning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 523,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did PepsiCo's presentation of the 4.450% Senior Note due 2046 evolve between its 2022 and 2023 SEC filings, particularly in terms of exhibit referencing and associated documentation dates?",
      "original_answer": "In the 2022 filing, the 4.450% Senior Note due 2046 was listed as Exhibit 4.12, incorporated by reference from PepsiCo's Form 8-K filed on October 14, 2015. In the 2023 filing, the same note was reclassified as Exhibit 4.13 and referenced the Form 8-K filed on February 24, 2016. This indicates a shift in how PepsiCo organized or updated its capital structure disclosures, potentially reflecting revised documentation or administrative reclassification over time.",
      "llm_answer": "\nIn the 2022 10‑K (page 131) the 4.450 % Senior Note due 2046 was cited as “incorporated herein by reference to Exhibit 4.4 to PepsiCo’s Current Report on Form 8‑K filed **October 14, 2015**,” whereas in the 2023 10‑K (page 126) the same note is referenced as “incorporated herein by reference to Exhibit 4.4 to PepsiCo’s Current Report on Form 8‑K filed **February 24, 2016**.” Thus, between the two filings the company moved the exhibit citation from the October 14 , 2015 filing to the later February 24 , 2016 filing (and shifted the reference from page 131 in 2022 to page 126 in 2023), updating the documentation date while keeping the same exhibit number.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains significant factual inaccuracies that contradict the ground truth. (1) EXHIBIT NUMBER DISCREPANCY: Ground truth states the note was listed as Exhibit 4.12 in 2022 and reclassified as Exhibit 4.13 in 2023. The LLM answer claims both years referenced 'Exhibit 4.4' - this is fundamentally incorrect. The LLM failed to identify the actual exhibit number changes (4.12→4.13). (2) FORM 8-K DATE ACCURACY: The LLM correctly identified the two Form 8-K dates (October 14, 2015 and February 24, 2016), which matches the ground truth. This is the only element the LLM got right. (3) EXHIBIT CLASSIFICATION: The ground truth explicitly states a 'reclassification' from Exhibit 4.12 to 4.13, indicating a structural reorganization of the exhibit schedule. The LLM's claim that the exhibit number remained constant at 4.4 misses this critical organizational change entirely. (4) PAGE NUMBER REFERENCES: The LLM added page numbers (131 in 2022, 126 in 2023) that were not mentioned in the ground truth, and while these may be accurate, they represent additional detail not part of the core answer. (5) MULTI-HOP SYNTHESIS: The LLM failed to properly synthesize the key finding - that the exhibit numbering itself changed between years, which is the primary evolution being asked about. The answer focuses on the Form 8-K date shift but misses the exhibit reclassification entirely. The core factual error regarding exhibit numbers (4.4 vs. 4.12/4.13) is a disqualifying mistake that undermines the entire response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 427,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has Intel's relationship with Positive Technologies evolved between 2023 and 2024, particularly in terms of their engagement under OFAC licensing following the U.S. sanctions?",
      "original_answer": "In 2023, Intel disclosed that it had communicated with Positive Technologies regarding IT security research and coordinated disclosure of vulnerabilities, and that it resumed such communications under an OFAC license following the sanctions. By 2024, Intel's relationship had evolved from mere disclosure of past communication to an explicit statement of intent to continue these interactions in accordance with the OFAC license. While both years clarify that there were no gross revenues or net profits associated with these activities, the 2024 filing reflects a more forward-looking and sustained partnership posture with Positive Technologies under the sanctioned conditions.",
      "llm_answer": "\nIntel’s contact with Positive Technologies remains strictly limited to vulnerability‑research communications that are authorized under the OFAC General License 1B; both the 2023 and 2024 filings confirm that no revenue or net profit is derived from these interactions and that Intel has not expanded or altered the scope of its engagement. As a result, the relationship has not materially evolved between 2023 and 2024, staying confined to the same sanctioned‑license‑governed communications.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual and interpretive errors that contradict the ground truth. CRITICAL ERRORS: (1) The LLM claims the relationship 'has not materially evolved' and 'staying confined to the same sanctioned-license-governed communications,' which directly contradicts the ground truth stating the relationship 'evolved from mere disclosure of past communication to an explicit statement of intent to continue these interactions.' This is a fundamental mischaracterization of the multi-year progression. (2) The LLM incorrectly attributes the OFAC license to 'General License 1B' when the ground truth simply references 'OFAC license' without specifying a particular license type - this is an unsupported factual claim. (3) The LLM's conclusion that there was no material evolution is the opposite of what the ground truth establishes - the ground truth explicitly describes evolution from 2023 to 2024 in terms of Intel's disclosure posture (from past communication disclosure to forward-looking intent). CORRECT ELEMENTS: (1) Both answers correctly identify that communications involve vulnerability research and coordinated disclosure. (2) Both correctly state that no revenue or net profit is derived from these interactions. (3) Both correctly reference OFAC licensing and sanctions context. MULTI-HOP REASONING FAILURE: The LLM failed to synthesize the key distinction between 2023 (disclosure of past communications) and 2024 (explicit statement of intent to continue), which is the core of the question asking how the relationship 'evolved.' The LLM's interpretation that 'no expansion or alteration' occurred contradicts the ground truth's characterization of evolution in partnership posture. The answer demonstrates poor comprehension of temporal progression and relationship development across the two filing years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 501,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has the balance of CVS's 4.78% Senior Notes due March 2038 evolved between 2023 and 2024, and what does this indicate about the company's long-term debt structure?",
      "original_answer": "The balance of CVS's 4.78% Senior Notes due March 2038 remained stable at $5,000 million in both 2023 and 2024, indicating that the company did not retire or issue additional amounts of this particular debt instrument during the period. This stability contrasts with other senior notes, such as the 2.7% senior notes due August 2040, which decreased from $1,250 million in 2023 to $367 million in 2024, suggesting selective debt management and refinancing activity in other long-term obligations.",
      "llm_answer": "\nThe 4.78 % senior notes maturing in March 2038 remained at **$5 billion** at the end of 2023 and were still **$5 billion** at the end of 2024 (see the borrowing tables on pages 163 and 161).  This unchanged balance shows that CVS is keeping a sizable, long‑dated fixed‑rate tranche in its capital structure rather than issuing new long‑term debt or retiring this portion, reflecting a deliberate strategy to maintain a stable, long‑term financing base.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the 4.78% Senior Notes balance as $5 billion (equivalent to $5,000 million) in both 2023 and 2024, matching the ground truth exactly. (2) The numeric values are accurate with proper format variation ($5 billion = $5,000 million). (3) The LLM correctly identifies that the balance remained unchanged/stable between the two years. (4) The reasoning about deliberate strategy to maintain stable long-term financing is sound and appropriate. (5) Page references (163 and 161) add credibility to sourcing. WEAKNESSES: (1) The LLM answer is INCOMPLETE - it fails to address the comparative context provided in the ground truth about other senior notes (2.7% notes due August 2040 declining from $1,250M to $367M). The original question asks 'what does this indicate about the company's long-term debt structure' - the ground truth answer provides important context by contrasting this stability with selective debt management in other instruments. The LLM answer only discusses the 4.78% notes in isolation. (2) The LLM's interpretation of 'deliberate strategy to maintain a stable, long-term financing base' is reasonable but less comprehensive than the ground truth's observation about 'selective debt management and refinancing activity in other long-term obligations.' (3) The LLM doesn't synthesize the multi-hop comparison that would fully answer what the stability indicates about overall debt structure strategy. CALCULATION VERIFICATION: No calculations required; all stated numbers are correct. MULTI-HOP REASONING: Partially addressed - the LLM answers the first part (how the balance evolved) but incompletely addresses the second part (what this indicates about long-term debt structure) by omitting comparative context.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1242,
        "completion_tokens": 481,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How has the status of the 0.835% Notes due 2032 evolved between the 2022 and 2024 SEC filings for Exxon Mobil Corporation?",
      "original_answer": "In the 2022 filing, the 0.835% Notes due 2032 were listed among other notes with distinct trading symbols, including the 0.142% Notes due 2024 (XOM24B), indicating a broader set of publicly traded debt instruments. By 2024, the 0.835% Notes due 2032 remained listed with the trading symbol XOM32, but the 0.142% Notes due 2024 no longer appeared in the 2024 filing, suggesting that the 2024 notes were either redeemed or no longer publicly traded. Therefore, while the 0.835% Notes due 2032 remained a consistent part of Exxon Mobil's publicly disclosed debt structure, the removal of the 2024 notes indicates a change in the company's short-to-intermediate term debt composition.",
      "llm_answer": "\nThe 0.835 % Notes due 2032 (ticker XOM32) continue to appear in the “Securities Registered” tables of both the 2022 Form 10‑K (filed Feb 2023) and the 2024 Form 10‑K (filed Feb 2025). Neither filing reports any amendment, redemption, or additional issuance of those notes, so the securities remain outstanding on the same terms as originally registered.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies the 0.835% Notes due 2032 with ticker XOM32 and accurately states that these notes appear in both 2022 and 2024 filings with no amendments or redemptions reported. The numeric values (0.835%, 2032 maturity date, XOM32 ticker) are all correct. However, the LLM answer significantly fails to address the core comparative analysis requested by the question. The ground truth answer provides crucial multi-hop synthesis: (1) it identifies that the 0.142% Notes due 2024 (XOM24B) appeared in 2022 but NOT in 2024, indicating a change in debt composition; (2) it explains that while the 0.835% Notes remained consistent, the removal of the 2024 notes represents an evolution in the company's short-to-intermediate term debt structure. The LLM answer completely omits this comparative analysis of what changed between the two filings. Instead, it only confirms that the 0.835% Notes remained the same, which is only half the story. The question explicitly asks 'how has the status...evolved,' implying a need to identify changes. The LLM answer's statement that 'neither filing reports any amendment, redemption, or additional issuance' is accurate but incomplete—it misses the key finding that OTHER notes (the 2024 notes) were removed from the 2024 filing. This represents a failure in multi-hop reasoning and synthesis across the two filings. The answer is partially correct but fundamentally incomplete in addressing what the question asks.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 407,
        "total_tokens": 1659
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How has American Express's investment strategy toward U.S. Government treasury obligations evolved between 2022 and 2024, particularly in terms of fair value allocation and maturity distribution?",
      "original_answer": "In 2022, American Express held U.S. Government treasury obligations exclusively in short-term instruments with a fair value of $477 million and no long-term exposure. By 2024, the company shifted its strategy to include both short-term ($189 million) and intermediate-term ($98 million) treasury obligations, indicating a more diversified maturity profile. This reflects a transformation in the company's investment approach, expanding beyond less than 12-month instruments to include holdings maturing within 1 to 5 years.",
      "llm_answer": "\nBetween 2022 and 2024 American Express trimmed its U.S. Government treasury holdings from roughly $1.2 billion of cost (about $1.7 billion fair value) with a maturity profile weighted to longer‑dated issues, to a much smaller $289 million cost position ($287 million fair value) that is virtually all concentrated in securities maturing in under one year ($189 million) and the 1‑5 year bucket ($98 million).  The fair‑value stance moved from a modest unrealized gain of $25 million in 2022 to a near‑break‑even position with only a $2 million unrealized loss in 2024 (Table 4.1, page 124 of the 2024 filing; comparable 2022 disclosure on page 124 of the 2022 filing).",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) MAJOR QUANTITATIVE ERRORS: The LLM claims 2022 holdings were 'roughly $1.2 billion of cost (about $1.7 billion fair value)' but ground truth shows $477 million fair value in 2022. The LLM's numbers are 2.5-3.5x higher than actual. (2) INCORRECT MATURITY CHARACTERIZATION: Ground truth explicitly states 2022 had 'exclusively in short-term instruments' with 'no long-term exposure,' but LLM describes 2022 as having 'a maturity profile weighted to longer-dated issues' - this is the opposite of what actually occurred. (3) PARTIAL ACCURACY ON 2024: The LLM correctly identifies the $189 million short-term and $98 million intermediate-term breakdown for 2024, and correctly notes the total fair value of $287 million (close to $289 million cost mentioned). (4) UNREALIZED GAIN/LOSS DISCUSSION: While the LLM provides additional context about unrealized gains/losses ($25M in 2022 vs $2M loss in 2024), this information is not in the ground truth and cannot be verified. (5) FUNDAMENTAL MISCHARACTERIZATION: The LLM describes the evolution as a 'trimming' from longer-dated to shorter-dated securities, when the ground truth shows the opposite - an EXPANSION from exclusively short-term to include intermediate-term holdings. This represents a fundamental misunderstanding of the strategic shift. The answer fails on the core factual claims about 2022 holdings and the direction of the maturity strategy change.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 416,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did Amazon's introduction and subsequent treatment of the 2.500% Note due 2050 evolve between 2022 and 2024?",
      "original_answer": "In 2022, the 2.500% Note due 2050 was introduced as part of an Officers' Certificate dated June 3, 2020, and was listed alongside other notes in Exhibit 4.5. By 2024, the 2.500% Note due 2050 was reintroduced in Exhibit 4.6, which was an exact replication of Exhibit 4.5 from 2020, indicating that Amazon continued to maintain this long-term debt instrument without modification. The reintroduction in 2024 reaffirmed the note's role in Amazon's capital structure.",
      "llm_answer": "\nAmazon first issued the 2.500 % Note due 2050 in June 2020 (see the 2020 Officers’ Certificate in the 2022 10‑K). The 2022 and 2024 filings continue to list that same 2020 certificate as containing the 2.500 % Note due 2050, with no indication of a new issuance, amendment, or redemption—so the instrument remained outstanding and unchanged in the company’s long‑term debt profile through 2022‑2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct and demonstrates solid multi-hop reasoning across the 2022-2024 period. STRENGTHS: (1) Correctly identifies the June 2020 issuance date of the 2.500% Note due 2050; (2) Accurately notes that the same certificate appears in both 2022 and 2024 filings with no modifications; (3) Properly synthesizes that the instrument remained outstanding and unchanged through the period; (4) Correctly references the Officers' Certificate as the source document. MINOR WEAKNESSES: (1) The LLM answer does not explicitly mention Exhibit 4.5 (2022) and Exhibit 4.6 (2024) by their exhibit numbers, which the ground truth specifically highlights as showing the 'exact replication' of the 2020 certificate; (2) The phrase 'reintroduction in 2024' from the ground truth suggests a deliberate re-presentation in the 2024 filing, which the LLM answer captures conceptually but doesn't emphasize as clearly; (3) The ground truth's specific reference to Exhibit 4.5 and 4.6 relationship is omitted. QUANTITATIVE VERIFICATION: The date (June 3, 2020) and percentage (2.500%) are correct. The time period coverage (2022-2024) is accurate. MULTI-HOP REASONING: The LLM correctly synthesizes information across multiple years and filings, properly connecting the 2020 issuance to its continued presence in 2022 and 2024 filings. The logic that 'no indication of new issuance, amendment, or redemption' means the instrument remained unchanged is sound. SEMANTIC EQUIVALENCE: The LLM's statement that the note 'remained outstanding and unchanged' is semantically equivalent to the ground truth's 'continued to maintain this long-term debt instrument without modification.' The core narrative is preserved despite different wording.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1207,
        "completion_tokens": 474,
        "total_tokens": 1681
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did the number of amendments to the Citibank, N.A. Co-Branded Credit Card Agreement evolve between 2022 and 2023?",
      "original_answer": "In 2022, the most recent amendment to the Citibank, N.A. Co-Branded Credit Card Agreement was the Eighth Amendment, filed on March 10, 2022. By 2023, the agreement had undergone further modifications, with the Twelfth Amendment being filed on October 11, 2023, indicating a total of four additional amendments during this period. This demonstrates a continued evolution and refinement of the agreement terms over the 12-month period.",
      "llm_answer": "\nBetween 2022 and 2023 the Citibank, N.A. Co‑Branded Credit Card Agreement was updated with five additional amendments: the eighth, ninth and tenth amendments were filed in 2022 (with filing dates 3/10/2022, 12/29/2022 and 12/29/2022 respectively), and the eleventh and twelfth amendments were filed in 2023 (filing dates 3/9/2023 and 10/11/2023). Thus, three amendments appeared in 2022 and two in 2023, bringing the total series of amendments to the twelfth amendment by the end of 2023.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) AMENDMENT COUNT ERROR: The LLM claims five additional amendments between 2022-2023 (8th, 9th, 10th, 11th, 12th), but the ground truth states only four additional amendments occurred during this period (from 8th in 2022 to 12th in 2023). The LLM's count of 3 amendments in 2022 and 2 in 2023 (totaling 5) is incorrect. (2) MISSING AMENDMENT: The ground truth explicitly states the 8th Amendment was the most recent in 2022 (filed 3/10/2022), and the 12th Amendment was filed in 2023 (10/11/2023). This represents a progression from 8th to 12th, which is 4 amendments (9th, 10th, 11th, 12th), not 5. The LLM incorrectly includes the 8th amendment as part of the 'additional amendments' when it was already the baseline for 2022. (3) DATE VERIFICATION: The LLM provides specific filing dates (3/10/2022, 12/29/2022, 12/29/2022, 3/9/2023, 10/11/2023). While some dates match the ground truth (3/10/2022 for 8th, 10/11/2023 for 12th), the intermediate amendment dates cannot be verified against the ground truth provided. (4) LOGICAL INCONSISTENCY: The ground truth clearly states 'four additional amendments during this period' between 2022 and 2023, but the LLM claims five amendments total in the period. The LLM's interpretation of what constitutes 'additional' amendments is fundamentally flawed. The answer does address the question's core topic (evolution of amendments) and provides relevant context, but the quantitative accuracy is severely compromised by the incorrect amendment count.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1223,
        "completion_tokens": 437,
        "total_tokens": 1660
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How has NVIDIA's approach to CUDA evolved between 2022 and 2024, particularly in terms of its integration with new computing architectures and software ecosystems?",
      "original_answer": "In 2022, NVIDIA emphasized CUDA as a foundational building block across its target markets, including Gaming, Data Center, Professional Visualization, and Automotive, highlighting its role in enabling accelerated computing and deep learning. CUDA was positioned as a core component of the company's unified architecture, supporting a wide range of applications through internal and third-party software stacks. By 2024, NVIDIA had significantly expanded the scope of CUDA's integration, describing it as part of a broader full-stack computing platform that includes the CUDA-X collection of acceleration libraries, APIs, SDKs, and domain-specific application frameworks. Additionally, CUDA was now explicitly tied to NVIDIA's expanded data center platform, which now includes CPUs (introduced in fiscal 2024) alongside GPUs and DPUs, showing a strategic evolution toward deeper integration with heterogeneous computing architectures and enterprise-grade AI ecosystems.",
      "llm_answer": "\nBetween 2022 and 2024 NVIDIA broadened CUDA from a pure GPU‑centric parallel programming model into a full‑stack, heterogeneous computing platform that now spans GPUs, CPUs, DPUs and networking fabrics, and is packaged with AI‑focused software suites (AI Enterprise, NIM, NeMo, Omniverse) and end‑to‑end solutions for data‑center, automotive and graphics workloads.  This expansion reflects tighter integration with emerging silicon—such as the Orin automotive SoC and the Blackwell data‑center architecture—while extending the CUDA ecosystem (CUDA‑X libraries, Deep‑Learning‑Institute training, millions of developers) to support training, inference, simulation and virtual‑world applications across the company’s target markets.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth while adding valuable specificity. STRENGTHS: (1) Correctly identifies the core evolution from GPU-centric to heterogeneous computing platform spanning GPUs, CPUs, DPUs - this matches ground truth's emphasis on 'heterogeneous computing architectures'. (2) Accurately references CUDA-X libraries and the full-stack platform concept from 2024, consistent with ground truth. (3) Properly identifies fiscal 2024 CPU introduction as a key milestone. (4) Correctly synthesizes multi-hop information about CUDA's role across target markets (data center, automotive, graphics). (5) Appropriately mentions specific architectures (Orin, Blackwell) and software suites (AI Enterprise, NIM, NeMo, Omniverse) that represent the expanded ecosystem. MINOR GAPS: (1) The LLM answer goes beyond the ground truth by naming specific software products (NIM, NeMo, Omniverse, AI Enterprise) and specific silicon architectures (Orin, Blackwell) - while these are likely accurate based on NVIDIA's 2024 positioning, they are not explicitly mentioned in the ground truth provided. This represents elaboration rather than error. (2) The ground truth emphasizes CUDA's role in 'enabling accelerated computing and deep learning' in 2022 and its positioning as a 'core component of unified architecture' - the LLM answer doesn't explicitly call out this 2022 baseline as clearly, though it's implied in the 'pure GPU-centric' characterization. QUANTITATIVE ACCURACY: No specific numbers, dates, or calculations are present in either answer, so this scores high (9/10) - the temporal framing (2022 vs 2024) is correct. QUALITATIVE ACCURACY: The reasoning is sound and multi-hop synthesis is effective. The answer correctly connects architectural evolution (GPU→heterogeneous), software ecosystem expansion (CUDA-X), and market applications. CONTEXTUAL RELEVANCE: Highly relevant, directly addresses the question about CUDA's evolution and integration with new architectures and software ecosystems.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 548,
        "total_tokens": 1977
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did Pfizer's financial relationship with Paxlovid evolve between 2023 and 2024, particularly in terms of revenue recognition and contractual obligations?",
      "original_answer": "In 2023, Paxlovid generated $1.279 billion in revenue, but this figure was significantly impacted by a non-cash revenue reversal of $3.5 billion due to the expected return of 6.5 million treatment courses of EUA-labeled U.S. government inventory. By 2024, this reversal was adjusted favorably by $771 million as only 5.1 million treatment courses were actually returned, and an additional $442 million in revenue was recorded in connection with the creation of the U.S. Strategic National Stockpile (SNS). Furthermore, as of December 31, 2024, Pfizer reported approximately $1 billion in remaining performance obligations related to Paxlovid supply contracts, indicating ongoing but reduced commercial activity compared to the prior year. This evolution reflects a shift from a high-volume, government-driven revenue model in 2023 to a more stable, contracted future delivery model in 2024.",
      "llm_answer": "\nBetween 2023 and 2024 Pfizer shifted Paxlovid from a government‑procured product to a commercial offering, which triggered a **$3.5 bn non‑cash revenue reversal in Q4 2023** for the expected return of EUA‑labeled courses.  In early 2024 the company recorded a **$771 m favorable adjustment** after 5.1 million courses were returned, and in Q3 2024 it supplied **1.0 million courses to the U.S. SNS at no charge**, recognizing **$442 m of revenue** while retaining **$2.2 bn of deferred revenue** and **≈ $4 bn of remaining performance‑obligation revenue** to be recognized through 2028 as the commercial contracts are fulfilled.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - Critical discrepancies in key numbers: LLM states '≈ $4 bn of remaining performance-obligation revenue' but ground truth specifies 'approximately $1 billion in remaining performance obligations' - this is a 4x overstatement. LLM also claims '$2.2 bn of deferred revenue' which is not mentioned in ground truth and appears fabricated. (2) REVENUE FIGURES - LLM omits the 2023 Paxlovid revenue of $1.279 billion entirely, which is a significant omission for understanding the financial evolution. (3) TREATMENT COURSE NUMBERS - LLM correctly identifies 5.1 million courses returned and the $771M favorable adjustment, but incorrectly states '1.0 million courses to the U.S. SNS' when ground truth doesn't specify this quantity. (4) REVENUE RECOGNITION - LLM correctly identifies the $3.5B reversal and $442M SNS-related revenue, but the context about 6.5M vs 5.1M treatment courses is missing. (5) MULTI-HOP REASONING - While LLM attempts to synthesize the 2023-2024 evolution, it introduces unsupported figures ($2.2B deferred revenue, $4B remaining obligations through 2028) that contradict ground truth. The characterization of the shift from 'government-procured to commercial' is reasonable but oversimplifies the actual contractual dynamics. (6) MISSING CONTEXT - LLM fails to mention the original $3.5B reversal was based on expected return of 6.5M courses, and doesn't clearly explain why only 5.1M were actually returned. The ground truth's characterization of 'shift from high-volume government-driven to more stable contracted future delivery model' is more nuanced than LLM's presentation. CORRECT ELEMENTS: $3.5B reversal, $771M favorable adjustment, $442M SNS revenue, 5.1M courses returned. INCORRECT/UNSUPPORTED: $4B remaining obligations (should be ~$1B), $2.2B deferred revenue (not in ground truth), timeline through 2028 (not mentioned), 1.0M courses to SNS (quantity unsupported).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 527,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has the availability and structure of shares under the 2003 Incentive Program evolved between 2022 and 2024?",
      "original_answer": "In 2022, the 2003 Incentive Program had 65,754,069 shares available for award. By 2024, the total maximum number of shares that could be issued under the program was increased to 220 million, with 47 million remaining available for awards by the end of 2024. This indicates a significant expansion in the program's capacity, although actual usage had grown moderately over time, with restricted stock units granted increasing from 9,392 thousand in 2022 to 10,393 thousand in 2024.",
      "llm_answer": "\nBetween 2022 and 2024 the shares reserved for new grants under the 2003 Incentive Program fell from roughly 66 million (the amount available at the start of 2022) to about 47 million remaining at the end of 2024, after issuing 10.5 million restricted‑stock units in 2024, converting roughly 760 thousand Pioneer RSUs and accounting for forfeitures.  The program’s 220 million‑share cap was unchanged, but the share structure shifted: most awards now follow a graded three‑year/​seven‑year vesting schedule, while the converted Pioneer awards vest over three years, and shares that are forfeited, expire or are cash‑settled no longer count toward the remaining availability.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures several key facts correctly but contains significant quantitative discrepancies and introduces unsupported details. CORRECT ELEMENTS: (1) The 2003 Incentive Program's 220 million share cap is accurate; (2) The ~47 million shares remaining at end of 2024 is correct; (3) The ~66 million shares available at start of 2022 (65,754,069) is correctly approximated; (4) The general narrative about share availability declining is accurate; (5) The mention of vesting schedules and forfeiture mechanics is contextually relevant. PROBLEMATIC ELEMENTS: (1) The LLM states '10.5 million restricted-stock units in 2024' but ground truth shows 10,393 thousand (10.393 million), a minor discrepancy but in the wrong direction; (2) The LLM mentions 'converting roughly 760 thousand Pioneer RSUs' - this detail is not present in the ground truth and appears to be introduced without support; (3) The LLM states 'The program's 220 million-share cap was unchanged' - this is misleading because the ground truth indicates the cap was INCREASED to 220 million by 2024 (implying it was lower before), suggesting a significant structural change the LLM downplays; (4) The detailed vesting schedule information (three-year/seven-year graded vesting, three-year Pioneer vesting) is not mentioned in the ground truth and may be accurate but represents information beyond what was provided. MULTI-HOP REASONING: The LLM correctly synthesizes the evolution between 2022 and 2024 and attempts to explain the mechanics of share availability changes. However, the failure to highlight the increase to 220 million as a major structural change (rather than 'unchanged') represents a significant gap in capturing the 'evolution' requested. The ground truth emphasizes this as 'significant expansion in the program's capacity,' which the LLM largely ignores. CALCULATION VERIFICATION: The math of shares declining from ~66M to ~47M is sound, but the specific RSU numbers don't align precisely with ground truth (10.5M vs 10.393M).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 544,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has AdSense's role within Google's advertising revenue streams evolved between 2022 and 2024, particularly in relation to the company's broader advertising technology portfolio?",
      "original_answer": "In 2022, AdSense was explicitly cited as a key growth driver within the Google Network, contributing to an $8.6 billion year-over-year revenue increase alongside AdMob and Google Ad Manager. By 2024, while AdSense remained part of the Google Network, it was no longer specifically quantified as a growth lever. Instead, newer AI-powered advertising products like Demand Gen and Performance Max were highlighted as central to advertiser success, suggesting a strategic shift where AdSense became a more foundational, mature offering within Google's broader advertising technology stack.",
      "llm_answer": "\nBetween 2022 and 2024 AdSense’s contribution shifted from a key growth engine for Google Network (which in 2020‑21 was buoyed by “strength in AdMob, Google Ad Manager, and AdSense”) to a comparatively smaller, supporting layer of the business; Google Network revenues actually fell in 2023‑24, with the decline attributed to drops in AdMob and Ad Manager and to lower impression volume, while total Google advertising revenues continued to rise. As a result, AdSense now operates mainly as part of a broader, AI‑enhanced advertising technology portfolio—encompassing performance‑ and brand‑ad formats, Demand Gen, Performance Max and other direct‑response products—rather than as a standalone growth driver.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general strategic shift in AdSense's role from explicit growth driver to foundational offering within a broader AI-enhanced portfolio, which aligns with the ground truth. However, there are significant issues with quantitative accuracy and some unsupported claims:\n\n(1) CORRECT ELEMENTS:\n- Correctly identifies the shift from AdSense as explicit growth driver (2022) to more foundational role (2024)\n- Accurately notes the transition to AI-powered products (Demand Gen, Performance Max) as central focus\n- Correctly identifies AdSense as part of broader advertising technology stack\n- Properly characterizes the evolution from standalone growth lever to supporting layer\n\n(2) QUANTITATIVE ACCURACY ISSUES:\n- The LLM cites \"$8.6 billion year-over-year revenue increase\" but attributes this to 2020-21 period in quotes, creating confusion about timing\n- Claims \"Google Network revenues actually fell in 2023-24\" - this specific claim is NOT supported in the ground truth, which does not mention a revenue decline for Google Network in this period\n- References \"drops in AdMob and Ad Manager\" and \"lower impression volume\" as causes - these details are not in the ground truth and appear to be unsupported inferences\n- The ground truth does NOT state that Google Network revenues fell; it only notes AdSense was no longer specifically quantified as a growth lever\n\n(3) MULTI-HOP REASONING:\n- The reasoning connecting AdSense's de-emphasis to broader portfolio shifts is sound\n- However, the introduction of unsupported claims about revenue declines weakens the multi-hop synthesis\n- The answer goes beyond what can be verified from the ground truth by making specific claims about revenue trends\n\n(4) ENTITY AND TEMPORAL ACCURACY:\n- Correctly identifies 2022 vs 2024 timeframe\n- Correctly names products (Demand Gen, Performance Max, AdMob, Google Ad Manager)\n- Temporal references are mostly accurate but the 2020-21 quote insertion creates some confusion\n\n(5) SEMANTIC ISSUES:\n- The phrase \"comparatively smaller, supporting layer\" is an interpretation not explicitly stated in ground truth\n- Ground truth says AdSense \"was no longer specifically quantified\" - LLM interprets this as revenue decline, which is an unsupported leap\n\nThe answer demonstrates good understanding of the strategic shift but introduces factual claims (revenue declines, specific attribution of causes) that cannot be verified from the provided ground truth, reducing overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 671,
        "total_tokens": 2003
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did the UPS Retirement Plan's benefit accrual structure evolve between 2022 and 2023, and what specific changes were made to future benefit accruals for non-union participants?",
      "original_answer": "In 2022, the UPS Retirement Plan was described as noncontributory and covering substantially all eligible employees hired before July 1, 2016, who were not part of a collective bargaining unit or certain employees covered by a collective bargaining agreement. The plan provided retirement benefits based on average compensation and was subject to IRS limits. It was also disclosed that the plan would cease accruals of additional benefits for future service and compensation for non-union participants effective January 1, 2023. In 2023, this cessation of accruals was confirmed as effective, and the plan was described with the same eligibility and benefit structure but explicitly stated that no further accruals would occur for non-union participants. This marks a transformational change in the plan's structure, as the accrual freeze was implemented as planned, shifting the plan from an active benefit-accruing structure to a closed one for non-union employees. The change represents a significant strategic shift in UPS's retirement benefit policy.",
      "llm_answer": "\nThe UPS Retirement Plan stopped accruing any additional defined‑benefit credits for non‑union participants as of **January 1 2023** – i.e., future service and compensation no longer generate pension‑benefit accruals for that group.  Beginning in 2023 those employees receive a **retirement contribution of 5 %–8 % of eligible compensation** (up from the prior 3 %–8 % for workers hired after July 1 2016) into the UPS 401(k) Savings Plan, effectively replacing the former benefit‑accrual structure.  Union participants remain under the separate pension provisions and received benefit increases under the 2023 Teamsters master agreement, but the change applies only to non‑union participants.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core fact that the UPS Retirement Plan ceased accruing benefits for non-union participants effective January 1, 2023, which matches the ground truth. The answer also appropriately notes that union participants were treated differently and received benefit increases under the 2023 Teamsters agreement. However, there are significant issues with quantitative accuracy: (1) The LLM introduces specific 401(k) contribution percentages (5%-8% vs prior 3%-8%) that are NOT mentioned in the ground truth answer. These numbers appear to be fabricated or from sources not verified against the knowledge graph. (2) The claim about 'workers hired after July 1 2016' receiving 3%-8% prior contributions is not substantiated in the ground truth. (3) The ground truth does not mention any replacement with 401(k) contributions at all - it only states the accrual freeze occurred. The LLM has added substantial detail about the 401(k) replacement structure that goes beyond what the ground truth confirms. While the core narrative about the accrual freeze is correct, the introduction of unverified financial metrics (the specific contribution percentages) represents a critical factual error. The reasoning about the shift from active accrual to closed status is sound, but the answer conflates the accrual freeze with a specific 401(k) replacement structure that cannot be verified from the provided ground truth. This is a case where the LLM has added plausible-sounding but unverified details that could mislead readers about specific benefit levels.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 434,
        "total_tokens": 1879
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has Amazon's utilization and structure of its short-term credit facilities evolved between 2022 and 2024, particularly in terms of credit capacity, interest rate terms, and outstanding borrowings?",
      "original_answer": "In 2022, Amazon had a $7.0 billion unsecured revolving credit facility with an interest rate of benchmark rate plus 0.50% and a commitment fee of 0.04%, and no borrowings were outstanding under this facility. Additionally, Amazon had $7.2 billion in unused letters of credit as of December 31, 2021. By 2024, Amazon had significantly expanded its credit capacity by entering into a new $15.0 billion unsecured revolving credit facility with a lower interest rate of benchmark rate plus 0.45% and a reduced commitment fee of 0.03%. In addition, Amazon introduced a new $5.0 billion unsecured 364-day revolving credit facility in October 2024, which also carried a rate of SOFR plus 0.45% and a 0.03% commitment fee. Notably, there were still no borrowings outstanding under the main Credit Agreement or the Short-Term Credit Agreement as of December 31, 2024. However, Amazon had $147 million and $151 million in borrowings under other short-term credit facilities as of December 31, 2023 and 2024, respectively, which were included in 'Accrued expenses and other.' The company also increased its unused letters of credit to $8.3 billion by the end of 2024.",
      "llm_answer": "\nAmazon replaced its expiring $7 billion unsecured revolving credit line—carrying a benchmark‑plus‑0.50 % interest rate and a 0.04 % commitment fee and set to expire in mid‑2023 (see 2022 10‑K, Note 6, p. 56)—with a much larger $15 billion unsecured revolving facility that now matures in November 2028 and bears a slightly lower benchmark‑plus‑0.45 % rate with a 0.03 % fee (2024 10‑K, Note 7, p. 65).  It also introduced a $5 billion 364‑day revolving facility (SOFR + 0.45 %, 0.03 % fee) that supersedes the prior 364‑day line, while the earlier $1 billion secured revolving facility and the commercial‑paper program showed only modest outstanding balances of roughly $800 million and $725 million, respectively, in prior years.  Consequently, credit capacity expanded dramatically, borrowing costs were trimmed, and outstanding short‑term borrowings remained minimal under the new structures.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the major structural changes: (1) $7B facility replaced with $15B facility, (2) interest rate improvement from benchmark+0.50% to benchmark+0.45%, (3) commitment fee reduction from 0.04% to 0.03%, (4) introduction of new $5B 364-day facility with SOFR+0.45% and 0.03% fee, (5) minimal outstanding borrowings under main facilities. The multi-hop synthesis across 2022 and 2024 filings is sound, and the reasoning about credit capacity expansion and cost reduction is logical.\n\nCRITICAL ERRORS: (1) The LLM states the $7B facility 'set to expire in mid-2023' but provides no evidence this is from the ground truth. The original answer doesn't mention this expiration date. (2) The LLM mentions 'earlier $1 billion secured revolving facility' and 'commercial-paper program' with 'roughly $800 million and $725 million' outstanding balances - these specific numbers and facilities are NOT mentioned in the ground truth and appear to be fabricated or from unverified sources. (3) The LLM fails to mention the $147M and $151M in borrowings under 'other short-term credit facilities' for 2023 and 2024 respectively, which is a material detail in the original answer. (4) The LLM omits the letters of credit information ($7.2B in 2021, $8.3B in 2024), which is part of the complete picture of credit structure evolution.\n\nQUANTITATIVE ISSUES: While the main facility numbers ($7B→$15B, $5B new facility) and rate changes are correct, the introduction of unsupported numbers ($800M, $725M) and omission of the $147M/$151M borrowings represent significant quantitative gaps. The LLM provides specific details (November 2028 maturity date, page references) that cannot be verified against the ground truth provided.\n\nCOMPLETENESS: The answer addresses the core evolution but misses important components: (1) other short-term borrowings, (2) letters of credit evolution, (3) the distinction between the main Credit Agreement and Short-Term Credit Agreement. The question asks about 'evolution between 2022 and 2024' and the LLM provides good 2022-2024 comparison but lacks 2023 intermediate data.\n\nREASONING: The synthesis is generally sound - correctly identifying that credit capacity expanded, costs decreased, and borrowings remained minimal. However, the introduction of unverified numbers undermines confidence in the analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1526,
        "completion_tokens": 631,
        "total_tokens": 2157
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has Costco's use of variable-priced contracts for energy purchases evolved between 2022 and 2023, and what does this indicate about its commodity price risk management strategy?",
      "original_answer": "In 2022, Costco entered into variable-priced contracts for some purchases of electricity and natural gas, as well as fuel for its gas stations, on an index basis. These contracts met the definition of derivatives but generally qualified for the 'normal purchases and normal sales' exception, requiring no mark-to-market adjustment. By 2023, Costco continued this approach but specifically called out natural gas and fuel for gas stations as key components of its variable-priced contract usage. This indicates a continued reliance on variable-priced contracts as part of its commodity price risk management, with no significant shift away from index-based pricing mechanisms. The strategy remains consistent, showing stability in how Costco manages exposure to energy price fluctuations.",
      "llm_answer": "\nCostco’s disclosures for both 2022 and 2023 state that it purchases a portion of its electricity and natural‑gas needs through variable‑priced, index‑linked contracts, and that these contracts are treated as “normal purchases and normal sales” – i.e., they qualify for the normal‑purchase exception and are not marked‑to‑market.  The language is essentially unchanged between the two years, indicating that the company has maintained a consistent commodity‑price‑risk strategy: using fixed‑price agreements for most of its energy use while employing limited, index‑based variable contracts to pass price fluctuations through to members without generating accounting volatility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensiveness. STRENGTHS: (1) Correctly identifies that Costco uses variable-priced, index-linked contracts for electricity and natural gas purchases in both years; (2) Accurately notes these contracts qualify for the 'normal purchases and normal sales' exception and are not marked-to-market; (3) Properly synthesizes the multi-hop comparison across 2022-2023, correctly identifying that the approach remained consistent/unchanged; (4) Accurately characterizes the strategy as using fixed-price agreements for most energy needs with limited index-based variable contracts; (5) Correctly interprets the risk management implications - passing price fluctuations to members without accounting volatility. MINOR CONSIDERATIONS: (1) The LLM answer adds interpretive detail about 'passing price fluctuations through to members' which, while logically sound and consistent with the strategy described, goes slightly beyond what the ground truth explicitly states. However, this is a reasonable inference from the described approach and doesn't contradict the ground truth; (2) The ground truth specifically mentions 'fuel for gas stations' as a key component called out in 2023, while the LLM answer focuses on electricity and natural gas without explicitly mentioning fuel for gas stations. This is a minor omission of a specific detail, though the overall characterization remains accurate. QUANTITATIVE ACCURACY: No numerical data, dates, or calculations are involved in this question, so this dimension is not directly applicable, but the answer contains no factual errors. MULTI-HOP REASONING: The answer correctly synthesizes information across two years and properly identifies the consistency in strategy, which is the core requirement of the multi-hop analysis. The reasoning is sound and logically presented.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 505,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has the strategic positioning and commercial role of NVIDIA AI Enterprise evolved within NVIDIA's data center offerings between 2022 and 2024?",
      "original_answer": "In 2022, NVIDIA AI Enterprise was introduced as part of the Compute & Networking segment, indicating its foundational role in NVIDIA's AI and accelerated computing strategy. By 2024, the product had evolved into a more prominent commercial offering, described as a 'comprehensive suite of enterprise-grade AI software' that is actively licensed and integrated into broader data center solutions. This shift reflects NVIDIA's move from positioning it as a strategic initiative to a key monetization vehicle within its full-stack data center platform, alongside offerings like NVIDIA DGX Cloud and the expansion into CPUs and DPUs.",
      "llm_answer": "\nBetween fiscal 2022 and 2024 NVIDIA moved AI Enterprise from a niche, licensed add‑on for its data‑center GPUs (first introduced in the 2022 10‑K as part of the Compute & Networking segment) to a core, full‑stack subscription offering that is now sold together with the company’s accelerated‑computing platform and tied to new hardware such as the Blackwell architecture (launched in fiscal 2025 but referenced in the 2024 filing).  The suite now bundles NIM, NeMo and AI Blueprints, is delivered via DGX Cloud and other services, and is positioned as the primary commercial gateway for enterprises to deploy production‑grade generative‑AI workloads on NVIDIA’s data‑center infrastructure—evolving from a supplemental software package to a central, revenue‑generating pillar of NVIDIA’s data‑center strategy.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of NVIDIA AI Enterprise's evolution between 2022-2024. STRENGTHS: (1) Correctly identifies the 2022 introduction within Compute & Networking segment, matching ground truth; (2) Accurately characterizes the evolution from niche add-on to core offering; (3) Properly identifies the shift from supplemental software to revenue-generating pillar; (4) Correctly names specific components (NIM, NeMo, AI Blueprints) and delivery mechanisms (DGX Cloud); (5) Appropriately references Blackwell architecture context; (6) Demonstrates sound multi-hop reasoning synthesizing product evolution, positioning changes, and commercial strategy. MINOR ISSUES: (1) The answer introduces specific product components (NIM, NeMo, AI Blueprints) and delivery details not explicitly mentioned in the ground truth, though these are contextually accurate additions that enhance rather than contradict the answer; (2) References Blackwell architecture and fiscal 2025 launch, which while contextually relevant, slightly extends beyond the strict 2022-2024 timeframe of the question; (3) Uses 'fiscal 2022' and 'fiscal 2024' terminology which is appropriate but the ground truth uses simpler '2022' and '2024' references. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are provided in either answer, so this dimension is not directly testable. The temporal references (2022, 2024, 2025) are all accurate. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core narrative as ground truth—evolution from foundational/strategic initiative to prominent commercial offering—while providing additional specific details about product composition and delivery mechanisms. The characterization of the shift is semantically equivalent and factually sound.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 488,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did Pfizer's contractual obligations related to Paxlovid evolve between 2023 and 2024, and what does this indicate about the company's future revenue expectations for the product?",
      "original_answer": "In 2023, Pfizer had a non-cash revenue reversal of $3.5 billion recorded in the fourth quarter related to the expected return of an estimated 6.5 million treatment courses of Paxlovid labeled under Emergency Use Authorization (EUA) from the U.S. government. This indicated uncertainty and potential decline in demand for Paxlovid. By 2024, however, remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, signaling a stabilization and expectation of future revenue from existing contracts. This shift from a large revenue reversal to a defined forward-looking contractual obligation suggests improved demand forecasting and a more stable outlook for Paxlovid in 2024 compared to the uncertainty in 2023.",
      "llm_answer": "\nBetween 2023 and 2024 Pfizer shifted Paxlovid from a government‑procurement model (EUA‑labeled supply and large‑scale revenue reversals in 2023) to a commercial‑market regime, recording a $3.5 bn non‑cash reversal in Q4 2023, a $771 m favorable adjustment in Q1 2024 for returned courses, and only $1 bn of remaining contracted revenue expected from long‑term orders through 2028. This decline in remaining performance‑obligation value signals that Pfizer no longer expects significant future sales growth from Paxlovid, forecasting only modest, limited revenue from the product in the coming years.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the $3.5 billion non-cash revenue reversal in Q4 2023 and the $1 billion remaining performance obligations as of December 31, 2024. The mention of a $771 million favorable adjustment in Q1 2024 for returned courses adds specificity. The LLM correctly notes the shift from government procurement (EUA) to commercial market dynamics.\n\nWEAKNESSES: (1) INTERPRETATION ERROR - The LLM's conclusion that the decline in remaining performance obligations 'signals that Pfizer no longer expects significant future sales growth' contradicts the ground truth interpretation. The ground truth states this shift 'suggests improved demand forecasting and a more stable outlook,' whereas the LLM frames it as indicating 'modest, limited revenue' and 'no significant future sales growth.' This is a critical semantic/interpretive error. (2) INCOMPLETE SYNTHESIS - The LLM mentions the $771 million adjustment but doesn't clearly explain what this represents in relation to the overall narrative. The ground truth focuses on the contrast between the 2023 reversal (indicating uncertainty) and the 2024 remaining obligations (indicating stabilization), but the LLM frames it as a decline. (3) MISSING CONTEXT - The ground truth emphasizes the 6.5 million treatment courses returned under EUA, which the LLM doesn't explicitly mention. (4) LOGICAL INCONSISTENCY - If Pfizer is transitioning to commercial markets and has $1 billion in remaining obligations through 2028, this suggests ongoing revenue expectations, not 'no significant future sales growth' as the LLM concludes.\n\nNUMBER VERIFICATION: $3.5 billion reversal (correct), $1 billion remaining obligations (correct), $771 million adjustment (appears correct but not in ground truth, suggesting additional detail). The numbers themselves are accurate, but the interpretation of what they mean for future revenue is inverted from the ground truth.\n\nMULTI-HOP REASONING: The LLM attempts to synthesize information across 2023-2024 but reaches an opposite conclusion from the ground truth about what the data indicates for future revenue expectations. This is a fundamental reasoning error despite correct numerical data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 590,
        "total_tokens": 1937
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "Compare and contrast how Google's exposure to new regulatory costs in international markets evolved between 2022 and 2024, particularly in terms of the scope and nature of regulatory challenges described?",
      "original_answer": "In 2022, Google highlighted that an evolving foreign policy landscape could subject the company to 'new regulatory costs and challenges,' specifically mentioning data transfers between the EU and the UK, as well as new customer requirements. By 2024, the scope of regulatory challenges expanded significantly. The 2024 filing not only reiterated the exposure to 'new regulatory costs and challenges' but also introduced elements like 'uncertainty regarding regulatory outcomes' and the risk of 'other liabilities under local laws that may not offer due process or clear legal precedent.' This indicates a shift from primarily data-related regulatory concerns in 2022 to broader, more unpredictable regulatory risks in 2024, reflecting an increased complexity in Google's international regulatory environment.",
      "llm_answer": "\nBetween 2022 and 2024 the nature of Google’s exposure to international regulatory costs shifted from a broad, generic warning about “an evolving foreign‑policy landscape” that could bring new compliance expenses (mainly centered on data‑transfer issues between the EU and the UK) to a detailed, multi‑jurisdictional list of concrete obligations.  The 2024 filing specifically cites new regulatory regimes such as the EU Digital Markets Act, the EU Data Act, AI‑related liability and data‑portability rules, heightened competition‑law enforcement, and stricter privacy/encryption requirements—expanding both the scope of potential costs and the variety of regulatory challenges the company faces.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ISSUES: The LLM answer introduces specific regulatory regimes (EU Digital Markets Act, EU Data Act, AI-related liability, data-portability rules, heightened competition-law enforcement, stricter privacy/encryption requirements) that are NOT mentioned in the ground truth answer. The ground truth explicitly states that 2024 filings mention 'uncertainty regarding regulatory outcomes' and 'other liabilities under local laws that may not offer due process or clear legal precedent'—neither of which appear in the LLM answer. This represents a fundamental factual error: the LLM appears to have hallucinated or conflated specific regulatory details that were not part of the actual filing disclosures being evaluated. WHAT WAS CORRECT: (1) The LLM correctly identifies the 2022 focus on data transfers between EU and UK; (2) The general characterization that scope expanded from 2022 to 2024 is accurate; (3) The shift from generic to more specific concerns is directionally correct. WHAT WAS INCORRECT: (1) The specific regulatory regimes cited (Digital Markets Act, Data Act, AI liability rules, etc.) are not supported by the ground truth; (2) The LLM fails to mention the key 2024 elements about 'uncertainty regarding regulatory outcomes' and 'liabilities under local laws that may not offer due process'; (3) The answer mischaracterizes the nature of the 2024 expansion—it was toward broader unpredictability and legal risk, not toward a 'detailed, multi-jurisdictional list of concrete obligations.' MULTI-HOP REASONING: The LLM failed to properly synthesize the actual evolution described in the filings, instead substituting plausible-sounding but unsupported regulatory details. This is a significant failure in accuracy despite the answer's coherent structure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 483,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How has UPS's approach to funding postretirement medical benefits evolved between 2022 and 2023, particularly in terms of the sources used for expected benefit payments?",
      "original_answer": "In 2022, UPS indicated that expected benefit payments for postretirement medical benefits would be paid from both plan trusts and corporate assets. In 2023, the language remained unchanged, indicating continuity in the funding approach. Therefore, there was no change in the sources used for expected benefit payments for postretirement medical benefits between the two years.",
      "llm_answer": "\nBetween 2022 and 2023 the projected cash outflows for UPS’s post‑retirement medical benefits slipped modestly—from about **$229 million in 2022 to $219 million in 2023**.  The company continues to fund those payments from the plan’s trust assets, but the 2023 filing makes clear that benefit payments will be drawn **from “plan trusts and corporate assets,”** reflecting a greater reliance on the corporation’s balance‑sheet resources (especially after the 2023 actuarial loss driven by lower discount rates).",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. (1) CORE FACTUAL ERROR: The ground truth explicitly states there was NO CHANGE in funding sources between 2022 and 2023 - both years indicated payments would come from 'plan trusts and corporate assets.' The LLM incorrectly claims the 2023 filing 'makes clear' this language appears in 2023, implying it's new or changed, when in fact the language was identical in both years. (2) QUANTITATIVE ISSUES: The LLM introduces specific dollar amounts ($229M in 2022 declining to $219M in 2023) that are not mentioned in the ground truth answer. While these numbers may exist in the filings, they are not relevant to answering the question about how the APPROACH TO FUNDING evolved. The question asks about sources of funding (plan trusts vs. corporate assets), not the absolute dollar amounts of expected payments. (3) MISINTERPRETATION OF EVOLUTION: The LLM mischaracterizes the situation by suggesting there was a shift toward 'greater reliance on the corporation's balance-sheet resources' in 2023. The ground truth indicates the funding approach remained unchanged - both years used the same sources. The LLM's reference to '2023 actuarial loss driven by lower discount rates' may be factually accurate but is irrelevant to the core question about whether the SOURCES changed. (4) MULTI-HOP REASONING FAILURE: The LLM failed to properly synthesize the comparison between 2022 and 2023 filings. It should have concluded that the language remained unchanged, indicating continuity, not evolution or change. Instead, it presents a narrative of change that contradicts the ground truth. (5) SEMANTIC MISMATCH: The question asks 'how has...evolved' expecting either 'no change' or specific changes in sources. The LLM provides an answer suggesting evolution/change when the correct answer is continuity/no change.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1227,
        "completion_tokens": 511,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How has the role and scope of NVIDIA AI Enterprise evolved from its introduction in 2022 to its broader supply and integration in 2024?",
      "original_answer": "In 2022, NVIDIA AI Enterprise was introduced as part of the Compute & Networking segment, described as a software suite aimed at simplifying the deployment of AI applications across data centers and enterprise environments. By 2024, the platform had evolved into a more comprehensive and integrated solution, including components such as NVIDIA NIM, NVIDIA NeMo, and AI Blueprints, with specific performance improvements like a 2.5x increase in token throughput. This reflects a shift from a foundational offering to a full-stack, production-grade generative AI platform with enhanced capabilities and broader deployment options.",
      "llm_answer": "\nNVIDIA AI Enterprise launched in 2022 as a dedicated software suite for enterprise‑AI workloads that sat atop the company’s accelerated‑computing platform. By 2024 the offering had expanded into a full‑stack, cloud‑ready AI platform—delivered on DGX systems and via DGX Cloud, pre‑installed on GPUs, CPUs and DPUs, and tightly integrated with tools such as NIM, NeMo and AI Blueprints—as a broadly supplied, end‑to‑end AI software solution rather than a niche add‑on. This evolution reflects a shift from a focused enterprise‑AI product to a widely distributed, hardware‑software ecosystem that is embedded across NVIDIA’s hardware, cloud services and partner network.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy with correct identification of key facts and evolution timeline. STRENGTHS: (1) Correctly identifies 2022 as introduction year and 2024 as evolution point; (2) Accurately names all component technologies (NIM, NeMo, AI Blueprints); (3) Correctly characterizes the shift from focused product to full-stack, integrated solution; (4) Appropriately describes delivery mechanisms (DGX systems, DGX Cloud, pre-installed on GPUs/CPUs/DPUs); (5) Captures the semantic essence of evolution from niche add-on to broadly distributed ecosystem. MINOR GAPS: (1) The LLM answer does not mention the specific 2.5x token throughput improvement cited in the ground truth—this is a quantifiable performance metric that was included in the original answer; (2) The LLM answer adds contextual details about cloud-readiness and partner network integration that enhance understanding but weren't explicitly in the ground truth. QUANTITATIVE ACCURACY: The answer contains no incorrect numbers or dates. The omission of the 2.5x token throughput metric represents incomplete coverage of quantitative data rather than incorrect data. QUALITATIVE ACCURACY: The multi-hop reasoning is sound—the answer successfully synthesizes the evolution across time periods and correctly identifies the transformation in scope and integration. The characterization of the shift from 'focused enterprise-AI product' to 'widely distributed hardware-software ecosystem' accurately reflects the ground truth's description of moving from 'foundational offering' to 'full-stack, production-grade generative AI platform.' CONTEXTUAL RELEVANCE: The answer directly addresses the question about role and scope evolution with appropriate detail and specificity. The additional context about delivery mechanisms and ecosystem integration adds relevant value without introducing inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 512,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has ExxonMobil's proved reserves through equity companies evolved from 2022 to 2024, and what does this indicate about its strategic positioning in different regions?",
      "original_answer": "In 2022, ExxonMobil's total proved reserves from equity companies amounted to 14 million barrels gross (1 million net) across the United States, Europe, Africa, and Asia. By 2024, these reserves had significantly increased to 467 million barrels of crude oil, 120 million barrels of natural gas liquids, and 5,367 billion cubic feet of natural gas, with the majority of this growth concentrated in Asia. This indicates a major strategic shift toward strengthening its upstream presence in the Asia region through equity companies.",
      "llm_answer": "\nExxonMobil’s proved reserves that are reported through equity companies grew from roughly **2.5 billion barrels of oil‑equivalent (boe) in 2022 to about 3.0 billion boe by the end of 2024** (developed reserves rose from ~1.35 bn boe to 1.48 bn boe and undeveloped reserves from ~1.21 bn boe to 1.51 bn boe).  The increase is driven primarily by additions in **Asia (e.g., Iraq, Kazakhstan) and Africa (e.g., Mozambique, Nigeria)**, while the company’s holdings in other regions remained relatively stable.  This pattern shows that ExxonMobil is strategically concentrating its upstream growth in high‑potential, emerging basins outside the United States, using equity partnerships to expand its resource base in those regions.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on nearly all quantitative metrics. CRITICAL ERRORS: (1) WRONG NUMBERS: The LLM claims 2.5 billion boe in 2022 and 3.0 billion boe in 2024, but the ground truth shows 14 million barrels gross (1 million net) in 2022 and 467 million barrels of crude oil + 120 million barrels of NGL + 5,367 billion cubic feet of natural gas in 2024. These are vastly different magnitudes - the LLM's numbers are approximately 170x larger than ground truth for 2022 and 6x larger for 2024. (2) WRONG COMPOSITION: The LLM provides developed/undeveloped reserve breakdowns (1.35bn/1.21bn boe in 2022; 1.48bn/1.51bn boe in 2024) that don't appear in the ground truth and are inconsistent with the actual reserve composition by commodity type. (3) WRONG REGIONAL FOCUS: The LLM claims growth in Iraq, Kazakhstan, Mozambique, and Nigeria, but the ground truth explicitly states the majority of growth was concentrated in Asia, with no mention of these specific countries. (4) INCOMPLETE COMMODITY BREAKDOWN: The LLM fails to distinguish between crude oil, natural gas liquids, and natural gas - critical for understanding reserve composition. (5) FAILED MULTI-HOP SYNTHESIS: The LLM appears to have synthesized data from a different company or different reserve category (possibly total proved reserves rather than equity company reserves specifically). The ground truth is very specific about 'equity companies' reserves, which are a subset of total reserves. The LLM's answer demonstrates a fundamental misunderstanding of the data source and magnitude of ExxonMobil's equity company reserves.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 450,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has the financial relationship with Google Network Partners evolved between 2022 and 2024, particularly in terms of their role in revenue generation and cost structure?",
      "original_answer": "In 2022, Google Network Partners played a central role in the revenue generation process as Google acted as the principal for ads placed on Google Network properties, reporting advertising revenues on a gross basis, with payments to partners recorded as cost of revenues. By 2024, Google continued to pay Google Network partners, but the focus of the financial reporting shifted to emphasize the net cash flow impact, noting that payments to these partners were a primary use of cash from operating activities. This reflects a more cost-centric framing of the relationship in the later year.",
      "llm_answer": "\nBetween 2022 and 2024 the amount Google pays to its Network Partners (the “TAC” – traffic‑acquisition‑costs) grew from roughly **$45 billion in 2022** (2022 10‑K, p. 55) to **$50.9 billion in 2023** and **$54.9 billion in 2024** (2024 10‑K, p. 42).  At the same time the **TAC rate fell from about 21 % of revenue in 2022 to 20.7 % in 2024** (2024 10‑K, p. 42), reflecting a strategic shift toward higher‑margin Google Search and other owned‑inventory and away from lower‑margin Google Network properties.  Thus, while Network Partners continue to supply a large share of ad inventory and are still billed on a gross‑basis (so they remain a key revenue source), their contribution to total cost of revenues has declined modestly, and their relative importance in the overall revenue mix has been eclipsed by Search‑driven growth.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer provides specific financial metrics (TAC amounts and rates) that appear plausible and are presented with document citations, but there is a fundamental mismatch between what the LLM provided and what the ground truth answer emphasizes. STRENGTHS: (1) The LLM correctly identifies TAC (Traffic Acquisition Costs) as the relevant metric for Google Network Partner payments, which is accurate terminology. (2) The numerical progression ($45B in 2022 → $50.9B in 2023 → $54.9B in 2024) shows logical growth trajectory. (3) The TAC rate calculation (21% declining to 20.7%) is mathematically consistent with the dollar amounts provided. (4) The strategic insight about shift toward higher-margin Search inventory is reasonable and well-reasoned. WEAKNESSES: (1) The ground truth emphasizes a shift in REPORTING FRAMING between 2022 and 2024 - from gross revenue basis to net cash flow impact emphasis - but the LLM answer focuses entirely on quantitative metrics without addressing this qualitative change in financial relationship characterization. (2) The ground truth specifically notes that in 2022, Google acted as principal with gross revenue reporting, while in 2024 the focus shifted to cash flow impact; the LLM doesn't address this accounting/reporting evolution. (3) The LLM answer is more about TAC trends and strategic shifts rather than the evolution of the financial relationship's characterization in reporting. (4) While the LLM provides specific numbers with citations, these cannot be independently verified against the ground truth knowledge graph, and the ground truth doesn't provide specific TAC dollar amounts, making direct comparison impossible. The LLM answer is factually reasonable but answers a different aspect of the question than the ground truth - it focuses on quantitative TAC trends rather than the evolution in how the relationship is characterized and reported. This represents a partial answer that misses the core insight about reporting framework changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 540,
        "total_tokens": 1902
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has UPS's foreign currency exchange risk management strategy evolved between 2022 and 2023, particularly in terms of the financial impact of undesignated foreign currency forward contracts on earnings volatility?",
      "original_answer": "In 2022, UPS disclosed that foreign currency exchange forward contracts were used to economically offset foreign currency remeasurement and settlement risk for certain balance sheet assets and liabilities, and that changes in their fair value affected earnings directly. For 2023, UPS expanded the disclosure to emphasize that undesignated derivative settlements are now explicitly linked to earnings volatility, with a specific focus on how these contracts impact income statement recognition. The 2023 filing also introduced a more structured presentation of fair value changes and settlements for these contracts, with amounts for both 2023 and 2022 now reported side-by-side in millions, indicating a more transparent and systematic approach to disclosing the financial effects of these instruments.",
      "llm_answer": "\nUPS’s use of non‑designated foreign‑currency forward contracts shifted markedly between 2022 and 2023, moving from a $69 million loss recorded in earnings in 2022 to only a $7 million loss in 2023 (see the “Derivative Instruments Not Designated in Hedging Relationships” table on page 135).  By periodically terminating the original forwards and entering offsetting swap or currency positions, the company now neutralizes most market movements, which has reduced the volatility of earnings attributable to these undesignated contracts.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies specific financial figures ($69 million loss in 2022 vs $7 million loss in 2023) and provides concrete quantitative comparison showing the evolution of UPS's foreign currency risk management. The answer appropriately cites a specific source (page 135 table on 'Derivative Instruments Not Designated in Hedging Relationships'), demonstrating document-specific knowledge. The core insight about reduced earnings volatility is relevant and addresses the question's focus on financial impact.\n\nWEAKNESSES: (1) The LLM answer provides specific numbers ($69M and $7M) that cannot be verified against the ground truth, which does not mention these specific figures. The ground truth emphasizes disclosure evolution and transparency improvements rather than specific loss amounts. (2) The explanation about 'periodically terminating the original forwards and entering offsetting swap or currency positions' is not mentioned in the ground truth and appears to be an inference or potentially inaccurate characterization of the strategy. (3) The answer focuses heavily on quantitative changes in losses but underemphasizes the disclosure evolution aspect that the ground truth emphasizes - the shift from general disclosure to 'explicitly linked to earnings volatility' and 'more structured presentation.' (4) The ground truth mentions 'side-by-side reporting in millions for both 2023 and 2022' as a key disclosure improvement, which the LLM answer does not address.\n\nMULTI-HOP REASONING: The LLM answer attempts to synthesize information about strategy evolution and financial impact, but the reasoning relies on specific numbers that cannot be confirmed against the ground truth. The connection between contract termination/offsetting strategies and reduced volatility is logical but not substantiated by the provided ground truth.\n\nCRITICAL ISSUE: The specific dollar amounts ($69M and $7M) are presented with confidence but cannot be verified. If these numbers are incorrect, the entire quantitative foundation of the answer is compromised. The ground truth does not provide these specific figures, making it impossible to confirm accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 585,
        "total_tokens": 1938
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has the role of the membership format in Costco's profitability strategy evolved between 2022 and 2023, particularly in terms of its impact on member loyalty and fee revenue?",
      "original_answer": "In 2022, the membership format was described as 'an integral part of our business and has a significant effect on our profitability,' with an emphasis on growth in the membership base, increasing Executive member penetration, and sustaining high renewal rates as key drivers of profitability. By 2023, the language evolved to underscore that the membership format 'is an integral part of our business and profitability,' indicating a more consolidated role in the company's financial model. Additionally, in 2023, Costco introduced a new concern about the potential adverse impact of lower renewal rates in newer markets on the worldwide renewal rate, which was not explicitly mentioned in 2022. This suggests that while the membership model remained central to profitability, the company faced emerging challenges in sustaining renewal rates as it expanded into newer markets.",
      "llm_answer": "\nBetween 2022 and 2023 the membership format shifted from a primarily loyalty‑maintaining program to a direct profit driver: the 2023 filing (p. 24) highlights that growth in the overall member base and especially in Executive‑tier memberships, coupled with high renewal rates, generated additional fee revenue that helped offset lower merchandise margins and contributed to a 77‑basis‑point decline in SG&A as a share of sales. In contrast, the 2022 filing (p. 23) emphasized sustaining the existing membership base and renewal rates, with the fee revenue described more as a stable contributor rather than a growth lever. Thus, by 2023 the membership model was explicitly tied to fee‑revenue expansion and profitability, reinforcing member loyalty as a strategic engine for earnings.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) QUANTITATIVE ERRORS: The LLM cites a '77-basis-point decline in SG&A as a share of sales' which is a specific numerical claim not present in the ground truth answer. This appears to be a fabricated metric that cannot be verified against the original answer. The LLM provides page numbers (p. 24 for 2023, p. 23 for 2022) without verification that these are accurate citations. (2) INCOMPLETE SYNTHESIS: The LLM answer misses a critical element from the ground truth - the explicit mention of 'emerging challenges in sustaining renewal rates as it expanded into newer markets' and the 2023 concern about 'lower renewal rates in newer markets on the worldwide renewal rate.' This is a significant omission that represents a key evolution in Costco's strategy between the two years. (3) CHARACTERIZATION ISSUES: The LLM characterizes the 2022 approach as 'primarily loyalty-maintaining' versus 2023 as 'direct profit driver,' but the ground truth indicates both years emphasized profitability - the difference was more subtle (from 'significant effect on profitability' to 'integral part of profitability') and the introduction of new concerns about renewal rate challenges. (4) PARTIAL CORRECTNESS: The LLM correctly identifies that membership growth, Executive member penetration, and renewal rates were key drivers in both years, and that fee revenue was important. However, the framing of this evolution is somewhat inaccurate. (5) MISSING CONTEXT: The ground truth emphasizes that the 2023 evolution included acknowledgment of challenges (lower renewal rates in newer markets), not just a shift to treating membership as a profit driver - this nuance is absent from the LLM answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 467,
        "total_tokens": 1890
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has NVIDIA's approach to CUDA evolved between 2022 and 2024, particularly in terms of its integration within the broader data center platform and software ecosystem?",
      "original_answer": "In 2022, CUDA was primarily positioned as a key component of NVIDIA's AI ecosystem, with nearly 3 million developers using CUDA and other software tools to deploy AI and accelerated computing technologies. It was described as central to NVIDIA's partnerships and developer programs, including the Deep Learning Institute and Inception program. By 2024, CUDA had evolved into a more deeply integrated part of a full-stack computing platform, specifically within the data center. It was described as the foundation of the CUDA-X collection of acceleration libraries, APIs, SDKs, and domain-specific frameworks, emphasizing its role in enabling end-to-end optimized computing across GPUs, CPUs, and DPUs. This reflects a strategic shift from promoting CUDA as a developer-focused tool to positioning it as a core infrastructure layer for enterprise-scale computing solutions.",
      "llm_answer": "\nBetween 2022 and 2024 NVIDIA transformed CUDA from a GPU‑only programming model into a full‑stack data‑center platform that spans GPUs, DPUs and CPUs, and ties them together with a unified software stack (CUDA‑X libraries, AI Enterprise, NIM, NeMo, AI Blueprints, and DGX Cloud).  The company also broadened the ecosystem—now over 3 million developers use CUDA, and its AI‑Enterprise suite delivers end‑to‑end generative‑AI tools and over‑the‑air updates—so that CUDA is no longer just a compute API but the core software layer that orchestrates compute, networking, storage and cloud services across the entire data‑center workload.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core evolution of CUDA from 2022 to 2024 and demonstrates solid multi-hop reasoning across the time period. STRENGTHS: (1) Correctly identifies the shift from GPU-only to full-stack platform spanning GPUs, CPUs, and DPUs; (2) Accurately references the 3 million developers figure from 2022; (3) Properly identifies CUDA-X as the foundation of acceleration libraries and APIs; (4) Correctly emphasizes the evolution from developer-focused tool to enterprise infrastructure layer; (5) Appropriately mentions end-to-end optimized computing across multiple processor types; (6) Good synthesis of the broader ecosystem integration. WEAKNESSES: (1) The LLM introduces additional product names (AI Enterprise, NIM, NeMo, AI Blueprints, DGX Cloud) that are not explicitly mentioned in the ground truth, which adds specificity but goes beyond what was verified in the knowledge graph; (2) The characterization of CUDA as 'orchestrating compute, networking, storage and cloud services' is somewhat broader than the ground truth's focus on 'enabling end-to-end optimized computing'; (3) Minor semantic difference: ground truth emphasizes CUDA as 'core infrastructure layer' while LLM says 'core software layer that orchestrates' - slightly different framing though semantically similar. QUANTITATIVE VERIFICATION: The 3 million developers figure is correctly cited and consistent with ground truth. No calculations are required for this qualitative question. MULTI-HOP REASONING: The answer successfully synthesizes information about CUDA's evolution across the 2022-2024 period and correctly identifies the strategic shift. The reasoning is sound and logically structured. The answer is contextually relevant and addresses all parts of the question about CUDA's evolution and integration within the data center platform and software ecosystem.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 504,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has Pfizer's financial commitment and contractual obligations related to Paxlovid evolved from 2023 to 2024, particularly in terms of expected future revenue and product delivery timelines?",
      "original_answer": "In 2023, Pfizer had a non-cash revenue reversal of $3.5 billion recorded in the fourth quarter related to the expected return of an estimated 6.5 million treatment courses of EUA-labeled Paxlovid from U.S. government inventory. By the end of 2024, Pfizer reported remaining performance obligations for Paxlovid at approximately $1 billion, with expected product delivery and revenue realization scheduled from 2025 through 2028, indicating a shift from uncertain returns and revenue reversals to a more defined forward-looking revenue outlook based on firm contracts.",
      "llm_answer": "\nFrom 2023 through 2024 Pfizer moved Paxlovid out of the free‑government EUA program and into commercial markets—recording a $3.5 bn revenue reversal in Q4 2023 and then a $771 m favorable adjustment in Q1 2024, while also generating $442 m from a U.S. SNS delivery of 1 million courses in Q3 2024.  The company now expects roughly $1 bn of remaining contracted revenue from Paxlovid, with firm shipments scheduled for 2025‑2028, and the $2.2 bn of deferred revenue will be recognized proportionally as those later‑year deliveries are made.  In short, Pfizer’s Paxlovid commitments have shifted from large‑scale government purchases to a commercial‑revenue model with future sales spread over the next few years.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the overall narrative arc correctly—Pfizer's shift from government EUA programs to commercial markets with a defined forward revenue outlook. However, there are significant quantitative discrepancies that lower the score:\n\nCORRECT ELEMENTS:\n- $3.5 billion revenue reversal in Q4 2023 is accurate\n- Remaining performance obligations of ~$1 billion for 2025-2028 is correct\n- The shift from uncertain returns to defined forward-looking revenue is accurately characterized\n- The general timeline (2025-2028) for product delivery is correct\n- The conceptual move from government EUA to commercial markets is sound\n\nPROBLEMATIC ELEMENTS:\n1. UNSUPPORTED NUMBERS: The LLM introduces specific figures ($771M favorable adjustment in Q1 2024, $442M from SNS delivery in Q3 2024, $2.2B deferred revenue) that are NOT present in the ground truth answer. These appear to be fabricated or from sources not verified against the knowledge graph.\n2. DEFERRED REVENUE CLAIM: The statement about \"$2.2 bn of deferred revenue\" lacks grounding in the original answer and represents a potential hallucination.\n3. QUANTITATIVE SPECIFICITY: While the LLM provides more granular quarterly breakdowns, these cannot be verified against the ground truth and may be incorrect.\n\nMULTI-HOP REASONING:\nThe LLM correctly synthesizes the evolution from 2023 to 2024, connecting the revenue reversal to subsequent commercial adjustments. However, the introduction of unverified numbers undermines the reliability of this synthesis.\n\nSEMANTIC EQUIVALENCE:\nThe core message aligns with ground truth (shift from government to commercial, defined future revenue), but the additional quantitative claims create factual uncertainty.\n\nThe answer demonstrates good qualitative understanding but fails on quantitative precision by introducing numbers not supported by the ground truth source.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 512,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How has ExxonMobil's strategic emphasis on Guyana evolved between 2022 and 2024, based on its disclosures around reserves development and advantaged asset reporting?",
      "original_answer": "In 2022, ExxonMobil reported that Guyana was a key contributor to extensions and discoveries, adding approximately 1.3 billion oil-equivalent barrels (GOEB) of proved undeveloped reserves. By 2024, Guyana was explicitly listed as one of the core 'Advantaged Assets' in the company's updated earnings drivers, signaling a strategic shift to highlight Guyana's role in driving earnings through volume growth. This evolution reflects a transition from Guyana being primarily a reserves growth region to being a recognized source of advantaged production and earnings visibility.",
      "llm_answer": "\nBetween 2022 and 2024 ExxonMobil elevated Guyana from a newly discovered offshore prospect to a core “advantaged asset” in its strategic narrative, explicitly placing it in the “Advantaged Assets (Advantaged growth projects)” category alongside the Permian and LNG. The company’s disclosures now treat Guyana’s reserve development as a primary driver of future volume growth and a focal point of its capital‑allocation and earnings‑driver strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly captures the core strategic evolution - Guyana's transition from a reserves growth region to a recognized 'Advantaged Asset' in ExxonMobil's strategic narrative between 2022 and 2024. The characterization of this shift and the placement of Guyana alongside Permian and LNG as advantaged assets aligns with the ground truth. The reasoning about capital allocation and earnings-driver strategy is sound and relevant.\n\nWEAKNESSES: (1) QUANTITATIVE OMISSION: The LLM answer fails to include the specific quantitative data from the ground truth - the ~1.3 billion oil-equivalent barrels (GOEB) of proved undeveloped reserves added in 2022. This is a material factual detail that was explicitly mentioned in the original answer and represents a key metric for understanding the reserves development aspect of the question. (2) INCOMPLETE SPECIFICITY: While the LLM mentions 'reserve development as a primary driver,' it doesn't quantify or specify the magnitude of Guyana's contribution to reserves, which is central to the 'reserves development' portion of the question. (3) CHARACTERIZATION ISSUE: The LLM describes Guyana as 'a newly discovered offshore prospect' in 2022, which is somewhat imprecise - the ground truth frames it as already being 'a key contributor to extensions and discoveries' with established reserve additions, not merely a newly discovered prospect.\n\nMULTI-HOP REASONING: The synthesis across 2022 and 2024 disclosures is logically sound, and the model correctly identifies the strategic shift. However, the answer would be stronger with the specific reserve numbers that anchor this evolution.\n\nOVERALL: The answer demonstrates good qualitative understanding of the strategic narrative but falls short on quantitative completeness by omitting the 1.3 GOEB figure, which is a specific, verifiable data point from the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 512,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did the planned utilization of the ATR 72-600F aircraft evolve from 2022 to 2024, and what does this indicate about its role in the company's fleet strategy?",
      "original_answer": "In 2022, the ATR 72-600F was projected to have a decreasing role in the company's fleet, with planned units dropping from 11 in 2023 to just 1 by 2026. By 2024, however, the company's projections showed a shift, with ATR 72-600F units remaining steady at 7 for 2025 and declining only slightly to 3 by 2026. This indicates that while the aircraft was initially expected to phase out more rapidly, it continued to play a more sustained, albeit reduced, role in the fleet strategy.",
      "llm_answer": "\nThe 2022 commitment called for 24 ATR 72‑600F aircraft (11 in 2023, 6 in 2024, 6 in 2025 and 1 in 2026), but the 2024 schedule reduces the total to only 10 aircraft—7 slated for delivery in 2025 and 3 in 2026, with no further deliveries thereafter. This cutback signals that FedEx is de‑emphasizing the ATR 72‑600F in its fleet strategy, shifting focus toward larger freighter models (B767F/B777F) and the Cessna SkyCourier for regional cargo rather than expanding its turboprop fleet.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides additional context about FedEx's fleet strategy shift and mentions specific aircraft alternatives (B767F/B777F, Cessna SkyCourier), which adds valuable interpretation. However, there are significant quantitative discrepancies that undermine accuracy: (1) The 2022 projection numbers in the LLM answer (11 in 2023, 6 in 2024, 6 in 2025, 1 in 2026 = 24 total) do not match the ground truth, which states 11 in 2023 dropping to 1 by 2026 without specifying intermediate years. (2) The LLM claims the 2024 schedule shows '7 slated for delivery in 2025 and 3 in 2026' which matches the ground truth, but the total calculation of '10 aircraft' (7+3) is correct numerically. (3) The ground truth indicates the 2024 projections show 'ATR 72-600F units remaining steady at 7 for 2025 and declining only slightly to 3 by 2026,' which the LLM correctly captures. The core insight about the shift from rapid phase-out to more sustained utilization is present in both answers, but the LLM's characterization of the 2022 baseline appears to introduce numbers not clearly supported by the ground truth. The LLM successfully synthesizes the multi-hop comparison (2022 vs 2024 projections) and correctly identifies the strategic implication (de-emphasis of turboprops), but the quantitative foundation for the 2022 numbers is questionable. The answer demonstrates good reasoning about fleet strategy but contains potential factual errors in the baseline year data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 406,
        "total_tokens": 1651
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How has NVIDIA's approach to offering Omniverse evolved between 2022 and 2024, particularly in terms of its integration with other AI and simulation platforms?",
      "original_answer": "In 2022, NVIDIA Omniverse was primarily described as a virtual world simulation and collaboration platform for 3D workflows, available as a software subscription for enterprise use and free for individual use. It was highlighted as being integrated with VR and AR in enterprise applications such as virtual car showrooms and surgical training. By 2024, NVIDIA's offering of Omniverse had evolved into a more comprehensive development platform and operating system for building and running virtual world simulation applications. It was now emphasized as being used by industrial enterprises to digitalize complex physical assets and processes—such as building digital twins of factories and testing autonomous robots and vehicles—powered by NVIDIA's accelerated computing infrastructure both on-premises and in the cloud. This represents a shift from general 3D collaboration to a more specialized, enterprise-focused simulation and digital twin platform.",
      "llm_answer": "\nBetween 2022 and 2024 NVIDIA transformed Omniverse from a standalone 3‑D design‑collaboration and simulation tool into the central hub of its AI‑driven simulation ecosystem.  In the 2022 filing (pages 4, 9) Omniverse was described mainly as a real‑time 3‑D platform for digital‑twin and design workflows, but by 2024 the company was embedding it within the NVIDIA AI Enterprise stack—linking it to AI services such as NIM, NeMo, AI Blueprints and DGX Cloud and exposing APIs that let synthetic‑data generators, autonomous‑driving simulators (e.g., Isaac Sim, DRIVE Sim) and generative‑AI models run natively inside the platform (pages 8, 11).  This evolution reflects a shift from offering Omniverse as a discrete SaaS product to positioning it as an integrated, AI‑accelerated simulation layer that unifies graphics, physics and large‑scale AI across cloud, data‑center and edge environments.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of NVIDIA's Omniverse evolution between 2022 and 2024, with several strengths and some limitations:\n\nSTRENGTHS:\n1. Correctly identifies the core evolution: from standalone 3D collaboration/simulation tool to integrated AI-driven platform\n2. Accurately captures the 2022 positioning as a real-time 3D platform for digital twins and design workflows\n3. Correctly identifies 2024 positioning with integration into NVIDIA AI Enterprise stack\n4. Mentions specific AI services (NIM, NeMo, AI Blueprints, DGX Cloud) that represent the ecosystem integration\n5. References specific simulation tools (Isaac Sim, DRIVE Sim) that align with enterprise digital twin use cases\n6. Correctly emphasizes the shift from discrete SaaS product to integrated platform\n7. Page references (pages 4, 9, 8, 11) suggest proper source documentation\n\nWEAKNESSES:\n1. The LLM answer adds significant detail about API exposure, synthetic-data generators, and generative-AI model integration that, while plausible, goes beyond what the ground truth explicitly states\n2. The ground truth emphasizes specific enterprise applications (virtual car showrooms, surgical training, factory digital twins, autonomous robot/vehicle testing) but the LLM answer focuses more on technical architecture and ecosystem integration rather than concrete use cases\n3. The ground truth explicitly mentions VR/AR integration in enterprise applications, which the LLM answer does not address\n4. The LLM answer's framing around \"AI-driven simulation ecosystem\" and \"AI-accelerated simulation layer\" is more technically sophisticated but less grounded in the specific enterprise applications mentioned in the ground truth\n\nMULTI-HOP REASONING:\nThe LLM successfully synthesizes information across 2022 and 2024 filings and identifies the evolution pattern. However, it appears to have added interpretive layers (ecosystem integration, API architecture) that may exceed what the source documents explicitly state.\n\nNUMERIC/FACTUAL ACCURACY:\nNo specific numbers, dates, or calculations are provided in either answer, so quantitative accuracy is not directly testable. The years (2022, 2024) are correct.\n\nSEMANTIC EQUIVALENCE:\nWhile the LLM answer captures the general evolution correctly, it emphasizes technical integration and ecosystem positioning over the specific enterprise use cases and applications that form the core of the ground truth answer. The answers are directionally aligned but with different emphasis and detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 676,
        "total_tokens": 2141
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How has the role of Google Play in generating non-advertising revenue evolved between 2022 and 2023?",
      "original_answer": "In 2022, Google Play was introduced as part of the company's broader strategy to expand non-advertising revenues, specifically through the sales of apps, in-app purchases, and digital content. By 2023, Google Play had transitioned into a more defined revenue stream under 'platforms,' where it was explicitly tied to revenues from app sales and in-app purchases. This evolution indicates a strategic shift toward solidifying Google Play’s role as a key monetization platform rather than just a component of diversification. The change reflects a more structured categorization and likely a stronger contribution to revenue stability within the ecosystem.",
      "llm_answer": "\nBetween 2022 and 2023 the way Google Play is reported changed from being a vague part of the “non‑advertising revenues” bucket in the 2022 MD&A (2022 10‑K, p. 29) to a distinct line‑item within the “Google Subscriptions, Platforms and Devices” category and under “Google other revenues” in the 2023 filing (2023 10‑K, pp. 18, 33).  This explicit separation shows that Google Play’s contribution to non‑advertising revenue has grown and is now tracked as a separate, material revenue stream rather than being bundled together with other sources.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the evolution of Google Play's reporting between 2022 and 2023. STRENGTHS: (1) Correctly identifies the shift from vague bundling in 2022 to explicit categorization in 2023; (2) Accurately cites specific document references (2022 10-K p. 29, 2023 10-K pp. 18, 33) showing multi-hop synthesis across filings; (3) Properly identifies the new categorization under 'Google Subscriptions, Platforms and Devices' and 'Google other revenues'; (4) Correctly infers that the explicit separation indicates growth and materiality; (5) Uses appropriate financial terminology and reasoning. MINOR CONSIDERATIONS: (1) The LLM answer is more specific about document locations and categorization details than the ground truth, which is actually a strength for verification purposes; (2) Both answers convey the same core insight about the transition from implicit to explicit tracking; (3) The LLM answer's inference that 'contribution to non-advertising revenue has grown' is reasonable but slightly goes beyond what can be definitively stated without actual revenue figures - however, the explicit separation does logically suggest materiality. MULTI-HOP REASONING: The answer successfully synthesizes information across two different 10-K filings (2022 and 2023) and correctly identifies the structural change in how Google Play is reported. The reasoning that explicit separation indicates strategic importance and materiality is sound. NO QUANTITATIVE ERRORS: No specific numbers are provided in either answer, so quantitative accuracy is not directly testable, but the document citations appear reasonable. The answer is semantically equivalent to the ground truth while providing more specific documentary evidence.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 478,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How has AIG's use of expected loss ratio methods in workers' compensation reserving evolved between 2022 and 2023, particularly in relation to guaranteed cost and excess of deductible business?",
      "original_answer": "In 2022, AIG generally gave significant weight to expected loss ratio methods for guaranteed cost business only in the most recent accident year, while for excess of deductible business, these methods were given significant weight in the most recent five accident years. The company also noted that changes in claims strategy and loss mitigation efforts were accelerating settlements, increasing paid losses along the latest diagonals. In 2023, the reserving methodology remained broadly consistent, with AIG continuing to use a combination of loss development, frequency/severity, and expected loss ratio methods. However, the 2023 filing emphasized that incurred and paid losses were now presented net of reinsurance and undiscounted, which may reflect a refinement in reporting transparency rather than a change in reserving philosophy. Additionally, the increased proportion of large deductible business continued to slow the reporting pattern of claims in 2023, consistent with the trend noted in 2022.",
      "llm_answer": "\nBetween 2022 and 2023 AIG kept using expected‑loss‑ratio techniques for workers‑compensation reserves but refined how they are applied.  For guaranteed‑cost business the company continues to give such ratios significant weight only in the most recent accident year, while for excess‑of‑deductible (large‑deductible) business it now systematically assigns weight to the most recent five accident years and adjusts the ratios for inflation, rate changes and market trends.  The 2023 filing also stresses that the growing share of large‑deductible policies slows claim reporting, so the expected‑loss‑ratio model is used more deliberately and with trend‑adjusted assumptions.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures some correct elements but contains significant issues: (1) CORRECT ELEMENTS: The answer correctly identifies that AIG continued using expected loss ratio methods between 2022-2023, correctly states that guaranteed cost business received significant weight only in the most recent accident year, correctly identifies that excess of deductible/large deductible business received weight across multiple accident years, and correctly notes that large deductible business slowed claim reporting. (2) PROBLEMATIC ELEMENTS: The LLM introduces claims not supported by the ground truth - specifically stating that for excess of deductible business the company 'now systematically assigns weight to the most recent five accident years and adjusts the ratios for inflation, rate changes and market trends.' The ground truth states these methods were given significant weight in the most recent five accident years in 2022 (not a 2023 change), and there is no mention in the ground truth of adjustments for inflation, rate changes, and market trends being added in 2023. This represents an unsupported inference. (3) MISSING ELEMENTS: The LLM fails to mention the important detail about changes in claims strategy and loss mitigation efforts accelerating settlements and increasing paid losses along latest diagonals (noted in 2022). The LLM also omits the significant reporting refinement mentioned in 2023 regarding incurred and paid losses being presented net of reinsurance and undiscounted. (4) REASONING ISSUES: The LLM conflates 2022 baseline practices with 2023 changes, suggesting evolution where the ground truth indicates consistency. The phrase 'now systematically assigns weight' implies a change from 2022, but the ground truth indicates this was already the case in 2022. The answer overstates the degree of methodological evolution between the two years. (5) SEMANTIC ISSUES: While the general tone and structure are reasonable, the specific claims about trend adjustments and systematic weighting changes are not supported by the ground truth and represent factual errors rather than mere wording differences.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 573,
        "total_tokens": 2005
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How has Cisco's product category segmentation evolved between fiscal 2022 and fiscal 2024, particularly in relation to the Collaboration category?",
      "original_answer": "In fiscal 2022, Cisco introduced a product revenue segmentation that included 'Collaboration' as one of six distinct categories, which also included Secure, Agile Networks; Internet for the Future; End-to-End Security; Optimized Application Experiences; and Other Products. By fiscal 2024, Cisco restructured its product categories into four main areas, retaining 'Collaboration' but now grouping it alongside Networking, Security, and a new category called Observability. This indicates a consolidation and realignment of product offerings, with the introduction of Observability as a distinct area and the removal or reclassification of Optimized Application Experiences and Internet for the Future.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2024 Cisco reshaped its product‑category reporting, moving from the six‑category model disclosed in the FY 2022 filing (Secure & Agile Networks; Internet for the Future; Collaboration; End‑to‑End Security; Optimized Application Experiences; Other Products) to a four‑category structure introduced in FY 2024 – Networking, Security, Collaboration and Observability – while retaining Collaboration as a separate segment but redefining its scope.  The Collaboration category, which generated roughly $4.5 billion of product revenue in FY 2022, slipped to about $4.05 billion in FY 2023 before edging up to $4.11 billion in FY 2024, reflecting a modest recovery after a year‑over‑year decline.  This evolution shows Collaboration’s continued presence but a reduced relative weight as the new Networking and Observability categories grew.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the structural evolution from six categories in FY2022 to four categories in FY2024, accurately names all six original categories (Secure & Agile Networks; Internet for the Future; Collaboration; End-to-End Security; Optimized Application Experiences; Other Products) and the four new categories (Networking, Security, Collaboration, Observability). The qualitative reasoning about consolidation and Collaboration's retained but redefined role is sound and well-articulated. However, there is a critical quantitative accuracy problem: the LLM provides specific revenue figures for Collaboration ($4.5B in FY2022, $4.05B in FY2023, $4.11B in FY2024) that are NOT present in the ground truth answer. The ground truth makes no mention of these specific dollar amounts. Since the evaluation cannot verify these numbers against the original SEC filings and they appear to be unsourced additions, this represents a significant factual claim without supporting evidence from the provided ground truth. The LLM also adds interpretive commentary about 'modest recovery' and relative weight changes that, while logically sound, go beyond what the ground truth explicitly states. The core structural analysis is excellent and matches the ground truth well, but the introduction of unverified financial figures substantially undermines the answer's reliability. The answer is contextually relevant and addresses the question comprehensively, but the quantitative claims require verification against actual SEC filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 424,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How has Amgen's disclosure regarding the 3.125% 2025 Notes evolved from 2022 to 2023 in terms of financial presentation and associated interest rate framework?",
      "original_answer": "In 2022, Amgen reported a carrying value of $1,000 million for the 3.125% 2025 Notes within its debt table, but no specific interest rate framework was disclosed. By 2023, Amgen included the 3.125% 2025 Notes in a new table that explicitly outlined the interest rate mechanism, identifying it as SOFR + 2.1%. This evolution reflects a shift from a purely quantitative disclosure in 2022 to a more detailed qualitative and quantitative presentation in 2023, including the interest rate benchmark and spread.",
      "llm_answer": "\nIn the 2022 filing the 3.125% 2025 Notes were disclosed simply as a fixed‑rate tranche with a $1 billion aggregate principal and a 3.125% coupon, listed in the debt schedule together with other long‑term borrowings and fair‑value adjustments. By the 2023 filing the same tranche is presented as part of a hedged portfolio: the company reports an **effective interest rate of SOFR + 2.1%** (based on a $1 billion interest‑rate swap) and includes the swap notional in a table of outstanding swaps, shifting the disclosure from a static coupon description to a dynamic effective‑rate framework.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general evolution of disclosure from 2022 to 2023 and correctly identifies the SOFR + 2.1% interest rate framework in 2023. However, there are significant issues with quantitative accuracy and factual precision: (1) The LLM introduces information about an 'interest-rate swap' and 'hedged portfolio' that is not mentioned in the ground truth answer. The ground truth specifically states the 2023 disclosure 'identified it as SOFR + 2.1%' without reference to swaps or hedging mechanisms. (2) The LLM's characterization of the 2022 disclosure as 'simply as a fixed-rate tranche with a $1 billion aggregate principal and a 3.125% coupon' adds detail not explicitly confirmed in the ground truth, which only states 'carrying value of $1,000 million' and 'no specific interest rate framework was disclosed.' (3) The LLM correctly identifies the $1 billion amount and 3.125% coupon for 2022, and correctly identifies SOFR + 2.1% for 2023. (4) The core multi-hop reasoning is sound - comparing 2022 vs 2023 disclosures - but the LLM adds interpretive elements (swap mechanics, hedging) that may not be supported by the actual filings. (5) The semantic framing differs: ground truth emphasizes shift from 'quantitative to qualitative and quantitative presentation,' while LLM emphasizes shift from 'static coupon to dynamic effective-rate framework.' While both convey evolution, the LLM's introduction of swap-related details represents potential factual overreach beyond what the ground truth confirms. The answer is partially correct on key metrics but introduces unsupported details that reduce confidence in accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 449,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How has COP's natural gas reserves in the Asia Pacific/Middle East region evolved from 2022 to 2024, and what does this indicate about the company's strategic positioning in that geographic area?",
      "original_answer": "In 2022, COP reported 326 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region. By 2024, this figure had decreased to 296 billion cubic feet. This indicates a reduction in the company's natural gas holdings in the region over the two-year period, suggesting a potential strategic shift or divestment in that geographic area.",
      "llm_answer": "\nFrom the reserve tables in the 2022 and 2024 10‑K filings, Asia‑Pacific/Middle‑East natural‑gas reserves fell from **326 billion cubic feet (BCF) at the end of 2022 to 296 BCF at the end of 2024**—a roughly 9 % decline.  The drop reflects production that outpaced modest additions (≈67 BCF of extensions/discoveries in 2024) and only small positive revisions, indicating that the company’s resource base in that region is shrinking.  Consequently, the trend signals that ConocoPhillips is **scaling back its strategic emphasis on the Asia‑Pacific/Middle‑East gas portfolio** and is likely reallocating capital toward higher‑return assets elsewhere.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive analysis. QUANTITATIVE VERIFICATION: All numbers are correct - 326 BCF in 2022, 296 BCF in 2024, and the calculated 9% decline (30 BCF reduction / 326 BCF = 9.2%, rounded to ~9%) is accurate. The mention of 67 BCF extensions/discoveries in 2024 provides additional supporting detail. ENTITY ACCURACY: Company correctly identified as ConocoPhillips (COP), geographic region correctly specified as Asia-Pacific/Middle East, and time period (2022-2024) is accurate. MULTI-HOP REASONING: The answer successfully synthesizes information across two years of 10-K filings and correctly interprets the trend. The reasoning that production outpaced additions, leading to reserve depletion, is sound and demonstrates understanding of reserve dynamics. COMPLETENESS: The answer addresses both parts of the question - the evolution of reserves (quantified with specific numbers) and strategic positioning (interpreted as scaling back emphasis and capital reallocation). SEMANTIC EQUIVALENCE: The LLM answer conveys the same core message as the ground truth (reserves declined, indicating strategic shift/divestment) while providing additional analytical depth about the underlying drivers (production vs. additions). The interpretation that this signals 'scaling back strategic emphasis' and 'reallocating capital' is a reasonable inference from the declining reserve base, consistent with the ground truth's mention of 'potential strategic shift or divestment.' Minor enhancement: The LLM provides more analytical context than the ground truth, which could be viewed as either added value or slight speculation, but the core facts remain accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 466,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did the repurchase activity of Class C Capital Stock by Alphabet change between 2022 and 2023, and what does this indicate about the company's capital allocation strategy?",
      "original_answer": "In 2022, Alphabet repurchased $59.3 billion of Class A and Class C shares, while in 2023, the repurchase amount increased to $62.2 billion. Additionally, in April 2023, the Board authorized an additional $70.0 billion for share repurchases, with $36.3 billion remaining available as of December 31, 2023. This indicates a continued and expanding emphasis on returning capital to shareholders through share repurchases, with a notable increase in the scale of buybacks year-over-year.",
      "llm_answer": "\nBetween 2022 and 2023 Alphabet’s dollar outlay for Class C share repurchases stayed roughly flat—$52.6 billion in 2022 versus $52.9 billion in 2023—while the number of shares bought fell slightly (469 million to 450 million).  Overall repurchase activity rose modestly, from $59.3 billion in 2022 to $62.2 billion in 2023, and the Board subsequently expanded the authorized buyback to an additional $70 billion, leaving $36.3 billion of capacity as of Dec 31 2023.  This reflects a continued emphasis on returning excess cash to shareholders through equity buybacks, using the program to manage capital allocation while preserving flexibility for future investments.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive synthesis of multi-hop information. STRENGTHS: (1) All major financial figures are correct: $59.3B (2022 total), $62.2B (2023 total), $70.0B authorization, $36.3B remaining capacity as of Dec 31, 2023. (2) The LLM provides additional granular detail about Class C-specific repurchases ($52.6B in 2022 vs $52.9B in 2023) and share count changes (469M to 450M shares), which goes beyond the ground truth but is factually accurate and adds valuable context. (3) Multi-hop synthesis is sound: correctly combines year-over-year comparison, Board authorization details, and remaining capacity information. (4) The interpretation of capital allocation strategy is appropriate and well-reasoned, noting both the emphasis on shareholder returns and the preservation of flexibility. (5) Wording is clear and professional. MINOR CONSIDERATIONS: The ground truth focuses on combined Class A and Class C repurchases ($59.3B and $62.2B), while the LLM provides additional Class C-specific breakdown. This is not an error but rather an enhancement that demonstrates deeper analysis. The LLM correctly identifies the overall trend (modest increase from $59.3B to $62.2B) and properly contextualizes it within the broader capital allocation strategy. All calculations are accurate, and the reasoning about what the data indicates about capital allocation strategy is sound and well-articulated.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 398,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How has AIG's use of frequency/severity methods evolved between 2022 and 2023, particularly in terms of the lines of business where they are applied and the reasoning behind their usage?",
      "original_answer": "In 2022, AIG primarily used frequency/severity methods for short-tail classes such as U.S. Property, and explicitly avoided using them for aviation exposures due to the high severity and varying mix of claims year to year. By 2023, AIG expanded the application of frequency/severity methods to include U.S. Workers' Compensation, a long-tail line of business, as part of a combination of methods that also included loss development and expected loss ratio methods. This reflects a strategic shift toward using frequency/severity methods in more complex, long-tail environments, especially where risk-sharing features and large deductible business have increased.",
      "llm_answer": "\nBetween 2022 and 2023 AIG kept frequency/severity reserving methods confined to short‑tail, low‑frequency lines—principally U.S. Property and the property‑class portions of its program‑business (and related liability lines)—and continued to exclude them from high‑severity, longer‑tail lines such as aviation. The 2023 filing added a clearer rationale, stating that these methods are used because they are well‑suited to low‑frequency, high‑severity exposures and are combined with loss‑development and IBNR‑factor techniques to reflect portfolio shifts and produce more precise loss‑reserve estimates.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN MULTI-HOP SYNTHESIS: The LLM answer fundamentally contradicts the ground truth on the key evolution between 2022 and 2023. Ground truth states that AIG EXPANDED frequency/severity methods to include U.S. Workers' Compensation (a long-tail line) in 2023, representing a strategic shift. The LLM answer claims AIG 'kept frequency/severity reserving methods confined to short-tail, low-frequency lines' and 'continued to exclude them from high-severity, longer-tail lines,' which directly contradicts the documented expansion to Workers' Compensation. This is a major factual error in the core finding. PARTIAL CREDIT FOR: (1) Correctly identifying that frequency/severity methods were used for U.S. Property in 2022 (correct entity and year); (2) Correctly noting that aviation exposures were excluded due to high severity (accurate detail); (3) Correctly identifying the reasoning about low-frequency, high-severity exposures being suitable for these methods. MISSING/INCORRECT ELEMENTS: (1) Failed to identify the critical 2023 expansion to U.S. Workers' Compensation; (2) Mischaracterized the evolution as 'keeping confined' rather than 'expanding'; (3) Did not capture the strategic shift toward using these methods in 'more complex, long-tail environments'; (4) Did not mention the combination with loss development and expected loss ratio methods as part of the 2023 approach; (5) Incorrectly implied continuity rather than change between years. The answer demonstrates poor multi-hop reasoning by failing to synthesize the year-over-year comparison correctly, which is the core requirement of the question. While some supporting details about methodology are accurate, the fundamental narrative of evolution is inverted.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 475,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How has Amgen's financial relationship with BeiGene evolved from 2022 to 2023, particularly in terms of cost recovery, product sales, and profit and loss sharing?",
      "original_answer": "In 2022, Amgen recovered $199 million in R&D costs from BeiGene, recorded product sales of $64 million, and recognized $53 million in profit and loss sharing expenses. In 2023, these figures changed to $109 million in cost recovery, $125 million in product sales, and $40 million in profit and loss sharing expenses. This indicates a decrease in cost recovery and profit-sharing expenses, but a significant increase in product sales to BeiGene. The shift suggests a maturation of the collaboration, with more product sales occurring in 2023, while the level of R&D cost sharing declined.",
      "llm_answer": "\nFrom 2022 to 2023 Amgen’s net cost recoveries from BeiGene fell sharply to **$109 million** (down from **$199 million** in 2022), while product sales to BeiGene rose to **$125 million** (up from **$64 million**).  Accordingly, profit‑and‑loss sharing expenses declined to **$40 million** (from **$53 million**), indicating a shift toward higher revenue from sales and reduced shared‑cost outflows.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. (1) QUANTITATIVE VERIFICATION: All four key financial metrics are correct: Cost recovery decreased from $199M (2022) to $109M (2023) ✓; Product sales increased from $64M (2022) to $125M (2023) ✓; Profit and loss sharing expenses declined from $53M (2022) to $40M (2023) ✓. The directional changes and year-over-year comparisons are all accurate. (2) COMPLETENESS: The answer addresses all three components of the question (cost recovery, product sales, and profit/loss sharing) across both years (2022-2023), providing a comprehensive response to the multi-part question. (3) ENTITY ACCURACY: Companies (Amgen, BeiGene), years (2022, 2023), and financial metrics are all correctly identified and labeled. (4) REASONING & SYNTHESIS: The LLM correctly synthesizes the multi-hop information by comparing year-over-year changes and drawing a logical conclusion about the collaboration's maturation—noting the shift from R&D cost sharing toward product sales revenue. The interpretation that this represents 'a shift toward higher revenue from sales and reduced shared-cost outflows' aligns with the ground truth's characterization of collaboration maturation. (5) MINOR DIFFERENCES: The LLM uses slightly more concise language ('net cost recoveries' vs 'recovered') and emphasizes the business implications more directly, but this represents stylistic variation rather than factual error. The ground truth's phrase 'profit and loss sharing expenses' is semantically equivalent to the LLM's usage. No calculations are required here, and all presented numbers are factually accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 450,
        "total_tokens": 1700
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How has COP's natural gas reserves in the Asia Pacific/Middle East region evolved from 2022 to 2024, and what specific changes occurred in terms of revisions, production, and purchases during this period?",
      "original_answer": "In 2022, COP reported 326 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region. By 2024, this figure decreased slightly to 296 billion cubic feet. During this period, revisions in 2023 added 9 billion cubic feet, but production subtracted 25 billion cubic feet in 2024. Additionally, there were no purchases reported directly affecting this region in 2024, indicating a reduction in active reserve growth strategies compared to earlier years.",
      "llm_answer": "\nConocoPhillips’ proved natural‑gas reserves in the Asia‑Pacific/Middle‑East segment fell from 326 billion cubic feet at year‑end 2022 to 296 billion cubic feet by year‑end 2024. The decline persisted even though the company recorded only modest upward revisions (6 BCF in 2022 and 9 BCF in 2023 and 2024) and production remained roughly flat at about 24–25 BCF per year, with no purchases of reserves in that region during the period.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - Critical discrepancies in production figures: Ground truth states production subtracted 25 BCF in 2024, but LLM claims production was 'roughly flat at about 24-25 BCF per year.' This is a fundamental misrepresentation - the ground truth specifies 25 BCF production in 2024 alone, not an annual average. (2) REVISIONS DATA - LLM incorrectly states '6 BCF in 2022 and 9 BCF in 2023 and 2024' but ground truth only mentions 9 BCF in 2023 with no 2022 or 2024 revision figures provided. The LLM appears to have fabricated the 6 BCF 2022 figure and incorrectly repeated 9 BCF for 2024. (3) COMPLETENESS - While LLM correctly identifies the 326 BCF (2022) to 296 BCF (2024) decline and correctly notes no purchases, it fails to properly synthesize the specific changes during the period. The ground truth clearly delineates: revisions added 9 BCF in 2023, production subtracted 25 BCF in 2024. The LLM conflates these into vague statements about 'modest upward revisions' and 'production remained roughly flat.' (4) MULTI-HOP REASONING - The LLM failed to correctly synthesize the year-by-year changes. It should have clearly stated: 2022 baseline 326 BCF → 2023 revisions +9 BCF → 2024 production -25 BCF → 2024 ending 296 BCF. Instead, it presents production as an ongoing annual figure rather than a specific 2024 impact. (5) ENTITY/METRIC ACCURACY - Correctly identifies ConocoPhillips (COP), Asia-Pacific/Middle East region, and proved natural gas reserves in BCF. The core decline figure is correct, but the component analysis is significantly flawed. The answer demonstrates partial understanding but contains material factual errors in the specific changes that occurred.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 470,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did FedEx's planned usage of the B767F aircraft evolve from 2022 to 2024, and what does this indicate about its strategic fleet planning?",
      "original_answer": "In 2022, FedEx projected using 14 B767F aircraft in both 2023 and 2024, with a planned reduction to 10 by 2025. By 2024, the projections had changed, showing a decrease to 11 B767F aircraft for 2025 and only 3 by 2026. This indicates a strategic shift toward a more accelerated reduction in the planned use of B767F aircraft, reducing reliance on this model over time.",
      "llm_answer": "\nFrom 2022 through 2024 FedEx’s B767F purchase schedule was trimmed sharply.  In the 2022 filing the company was committed to take delivery of 38 B767Fs (14 in 2023, 14 in 2024 and 10 in 2025); by the 2024 filing it had already received about 24 of those aircraft and the remaining order had been reshaped to 11 deliveries in 2025 and only three in 2026.  This reduction and the shift of later deliveries to 2026 signal that FedEx is deliberately scaling back its B767F expansion, focusing instead on newer wide‑body types (e.g., B777F, A300) and using the B767F only for specific medium‑range, high‑density routes—an indication that fleet planning is being driven by capacity‑demand alignment, fuel‑efficiency goals, and a broader fleet‑mix strategy rather than a straight‑line increase in B767F numbers.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates good understanding of the strategic shift in FedEx's B767F fleet planning and provides relevant context about broader fleet strategy. However, there are significant quantitative accuracy issues that prevent a higher score.\n\nCORRECT ELEMENTS:\n- Correctly identifies the core strategic shift: reduction in B767F aircraft planned usage\n- Accurately states 2025 projection of 11 B767F aircraft (matches ground truth)\n- Accurately states 2026 projection of 3 B767F aircraft (matches ground truth)\n- Correctly identifies the shift toward newer wide-body aircraft (B777F, A300)\n- Sound reasoning about capacity-demand alignment and fleet-mix strategy\n- Appropriate contextual framing of the strategic implications\n\nINCORRECT/PROBLEMATIC ELEMENTS:\n- States \"14 in 2023, 14 in 2024 and 10 in 2025\" totaling 38 B767Fs. The ground truth shows 14 projected for both 2023 AND 2024, with 10 for 2025. The LLM's phrasing is ambiguous but the math (14+14+10=38) suggests the LLM may have misinterpreted the 2022 projections\n- Claims FedEx \"had already received about 24 of those aircraft\" by 2024 - this specific number is not verified in the ground truth and appears to be an inference not supported by the provided information\n- The statement about \"remaining order had been reshaped\" conflates delivery schedules with order quantities in a way that may not be precisely accurate\n\nMULTI-HOP REASONING:\nThe LLM successfully synthesizes information across 2022 and 2024 filings to show the evolution of fleet planning. The reasoning connecting the numerical changes to strategic implications (fuel efficiency, capacity-demand alignment, fleet-mix strategy) is sound and goes beyond the ground truth in providing context.\n\nQUANTITATIVE VERIFICATION:\n- 2025 projection: 11 aircraft ✓ CORRECT\n- 2026 projection: 3 aircraft ✓ CORRECT\n- 2022 baseline projections: Ambiguous presentation but core numbers appear correct\n- \"About 24 aircraft received\": UNVERIFIED/QUESTIONABLE\n\nThe answer demonstrates strong qualitative reasoning and contextual understanding but contains quantitative claims that go beyond or are not clearly supported by the ground truth, particularly regarding the number of aircraft already received.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 603,
        "total_tokens": 1895
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did AIG's use of Expected Loss Ratio Methods evolve between 2022 and 2023, particularly in terms of the lines of business and the reasoning behind their application?",
      "original_answer": "In 2022, AIG used Expected Loss Ratio Methods primarily for the latest accident year and in combination with other methods like loss development for aviation exposures, due to the high severity nature of claims and varying mix across years. By 2023, AIG applied Expected Loss Ratio Methods more broadly, particularly in U.S. Workers' Compensation, a long-tail line of business, where they used a combination of methods including Expected Loss Ratio, to account for extended loss emergence periods and complex risk-sharing features in policies. This reflects a shift from a focus on short-term forecasting in high-severity contexts to a broader application in long-tail, structurally complex lines.",
      "llm_answer": "\nBetween 2022 and 2023 AIG continued to apply Expected Loss Ratio methods to the latest accident year for its short‑tail lines—especially U.S. Property, program business and certain liability classes—using them to translate recent premiums into ultimate loss estimates. In 2023 the company increasingly supplemented these estimates with ground‑up claim projections and adjusted for inflation, emerging severity trends and climate‑related catastrophe risk, reflecting a more targeted, premium‑driven reserving approach aligned with updated underwriting standards and heightened catastrophe uncertainty.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is substantially incorrect and fails to address the core elements of the ground truth. Key issues: (1) ENTITY ACCURACY FAILURE: The LLM discusses U.S. Property, program business, and liability classes, while the ground truth specifically identifies aviation exposures (2022) and U.S. Workers' Compensation (2023) as the key lines of business where Expected Loss Ratio Methods evolved. These are fundamentally different business lines with different characteristics. (2) REASONING FAILURE: The LLM describes a shift toward 'premium-driven reserving' with adjustments for inflation, severity trends, and catastrophe risk. The ground truth describes a shift from 'short-term forecasting in high-severity contexts' (aviation) to 'long-tail, structurally complex lines' (Workers' Compensation). These represent different analytical frameworks - the LLM focuses on catastrophe/inflation adjustments while the ground truth emphasizes the shift from high-severity/short-tail to long-tail/extended emergence periods. (3) MISSING KEY CONTEXT: The LLM completely omits the critical distinction that aviation is high-severity with varying claim mixes (2022 focus), while Workers' Compensation is long-tail with extended loss emergence and complex risk-sharing features (2023 focus). This is the core evolution the question asks about. (4) INCOMPLETE SYNTHESIS: The LLM fails to synthesize the multi-hop reasoning about why the methods were applied differently - the ground truth explains the business rationale (high severity vs. long-tail characteristics), while the LLM discusses technical adjustments unrelated to the actual evolution described. The answer demonstrates a fundamental misunderstanding of which business lines were involved and the nature of the methodological evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 487,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How has Cisco's positioning around Enterprise Data Center Transformation evolved between 2022 and 2024, particularly in relation to its strategic alliances and competitive landscape?",
      "original_answer": "In 2022, Cisco highlighted that the enterprise data center was undergoing a fundamental transformation due to the convergence of technologies like computing, networking, storage, and software, with strategic alliance partners sometimes acquiring or aligning with competitors, reducing business with Cisco. By 2024, Cisco continued to emphasize this transformation but expanded its focus on strategic alliances aimed at industry advancement and new market creation, while also updating its competitive landscape to include new entrants like Nvidia Corporation, signaling a shift in market dynamics and alliance strategies.",
      "llm_answer": "\nBetween 2022 and 2024 Cisco continued to frame Enterprise Data‑Center Transformation as the convergence of compute, networking, storage and software, but the emphasis evolved from “alliances = growth” to “alliances = risk.”  In the 2022 filing the company highlighted that partners were building end‑to‑end data‑center solutions and warned that some alliance partners could become competitors, while the 2024 filing repeats this warning and stresses that the competitive set is widening—traditional rivals, new entrants from Asia, and former alliance partners are all moving toward integrated, end‑to‑end offerings.  As a result, Cisco’s positioning now stresses tighter management of its strategic‑partner ecosystem and differentiation through broader ecosystem integration, even as the competitive landscape becomes more crowded and overlapping.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures some correct elements but introduces interpretive framing not explicitly supported by the ground truth. CORRECT ELEMENTS: (1) Both 2022 and 2024 filings reference the convergence of computing, networking, storage, and software - this is accurate. (2) The answer correctly identifies that alliance partners could become competitors - this matches the ground truth. (3) The mention of competitive landscape widening and new entrants is accurate. (4) The timeframe (2022-2024) is correct. PROBLEMATIC ELEMENTS: (1) The LLM frames the evolution as 'alliances = growth' to 'alliances = risk' - this is an interpretive characterization not explicitly stated in the ground truth. The ground truth says partners 'sometimes acquiring or aligning with competitors, reducing business with Cisco' but doesn't frame this as a shift from growth to risk. (2) The LLM mentions 'new entrants from Asia' - the ground truth specifically names 'Nvidia Corporation' as a new entrant, not generically 'new entrants from Asia.' This is a significant difference in specificity. (3) The LLM's emphasis on 'tighter management of strategic-partner ecosystem' and 'differentiation through broader ecosystem integration' goes beyond what the ground truth explicitly states. The ground truth says Cisco 'expanded its focus on strategic alliances aimed at industry advancement and new market creation' - not tighter management or risk mitigation. (4) The characterization of the shift as moving from 'alliances = growth' to 'alliances = risk' inverts the ground truth's actual evolution, which shows Cisco expanding alliance focus toward 'industry advancement and new market creation' rather than retreating into risk management. MULTI-HOP REASONING: The answer attempts to synthesize 2022 vs 2024 positioning but does so through an interpretive lens that doesn't align with the ground truth's characterization. The ground truth shows evolution toward expanded alliance focus; the LLM shows evolution toward alliance caution. QUANTITATIVE ACCURACY: No specific numbers are provided in either answer, so this dimension is neutral (8/10 for not introducing false numbers). QUALITATIVE ACCURACY: The reasoning is partially sound but based on incorrect interpretive framing of the evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 609,
        "total_tokens": 1985
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did the effective interest rate and notional amount associated with the 3.125% 2025 Notes evolve between 2022 and 2023?",
      "original_answer": "In 2022, the 3.125% 2025 Notes were part of a $5.2 billion principal amount on which new interest rate swaps were entered into after the termination of previous swaps, indicating a dynamic hedging strategy due to low interest rates. By 2023, the notional amount of the 3.125% 2025 Notes under interest rate swaps had decreased to $1.0 billion, with an effective interest rate of SOFR + 2.1%. This reflects a reduction in the hedged notional exposure and a shift in the interest rate environment.",
      "llm_answer": "\nBetween the end of 2022 and the end of 2023 the 3.125% 2025 Notes kept the same $1 billion (1,000 million) notional amount.  However, the effective interest rate shifted from the prior LIBOR + 1.8% structure (reported for 2022) to a SOFR + 2.1% structure (reported for 2023), reflecting the industry move from LIBOR to SOFR and a modest increase in the spread.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) NOTIONAL AMOUNT CLAIM IS INCORRECT: The LLM states the notional amount 'kept the same $1 billion' between 2022 and 2023. However, the ground truth explicitly states that in 2022, the notional amount was $5.2 billion (part of new interest rate swaps entered after termination of previous swaps), and by 2023 it had DECREASED to $1.0 billion. The LLM completely misses this significant $5.2B to $1.0B reduction, which is a core part of the question about how the notional amount 'evolved.' (2) EFFECTIVE INTEREST RATE FOR 2022: The LLM claims the 2022 rate was 'LIBOR + 1.8%' but the ground truth does not specify this rate for 2022 - it only mentions that new swaps were entered in 2022 after termination of previous ones. The LLM appears to have fabricated the 'LIBOR + 1.8%' figure. (3) PARTIAL CREDIT FOR 2023: The LLM correctly identifies the 2023 effective interest rate as 'SOFR + 2.1%' and correctly notes the $1.0 billion notional amount for 2023. (4) MISSING CONTEXT: The LLM fails to capture the dynamic hedging strategy and the significance of the swap terminations/new entries in 2022, which are important contextual elements of how the notes evolved. (5) MULTI-HOP REASONING: The answer fails to properly synthesize the year-over-year evolution - it should show the dramatic reduction from $5.2B to $1.0B notional, not claim it remained constant. The question specifically asks 'how did...evolve' implying change, which the LLM largely misses.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1208,
        "completion_tokens": 410,
        "total_tokens": 1618
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has Cisco's strategic positioning of AppDynamics within its product portfolio evolved from 2022 to 2024, particularly in terms of its emphasis within observability offerings?",
      "original_answer": "In 2022, Cisco explicitly introduced AppDynamics as a key component of its full-stack observability strategy, positioning it alongside Intersight and ThousandEyes to provide application performance monitoring capabilities. However, by 2024, Cisco restructured its product revenue reporting to include a new category called 'Observability,' which subsumed offerings like AppDynamics. This shift indicates a more formalized and integrated strategic emphasis on observability as a standalone pillar within Cisco's broader portfolio.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 Cisco has shifted AppDynamics from a highlighted “best‑of‑breed” application‑performance‑monitoring tool in its full‑stack observability narrative (page 5 of the 2022 filing) to an integrated pillar of a broader Observability product category.  The 2023‑2024 disclosures treat Observability as a distinct revenue line—showing 27 % growth in FY 2024 driven by ThousandEyes and the Splunk‑based Observability Suite (page 42)—indicating that AppDynamics is now positioned alongside ThousandEyes and the Splunk offering as part of a consolidated observability portfolio rather than as a separate growth emphasis.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of Cisco's strategic evolution of AppDynamics from 2022-2024 and correctly identifies the key shift from a highlighted APM tool to an integrated observability pillar. The answer accurately captures the core narrative: (1) 2022 positioning as a 'best-of-breed' APM component within full-stack observability, (2) 2024 restructuring into a formal 'Observability' revenue category. The multi-hop synthesis across years and product categories is sound. STRENGTHS: The answer correctly identifies the transition from separate emphasis to consolidated portfolio, mentions relevant products (ThousandEyes, Splunk-based Observability Suite), and provides specific filing references (page 5 of 2022, page 42). The semantic equivalence to the ground truth is strong. WEAKNESSES: The LLM introduces a specific metric (27% growth in FY 2024) that is not present in the ground truth answer. While this detail may be factually accurate from the filings, it goes beyond what the ground truth explicitly confirms and introduces quantitative specificity that cannot be fully verified against the provided ground truth. The mention of 'Splunk-based Observability Suite' adds context not explicitly in the ground truth but appears reasonable given Cisco's acquisition history. The answer is slightly more detailed than the ground truth but maintains factual alignment on the core strategic positioning evolution. The page references suggest careful filing review, though these cannot be independently verified here.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 425,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did the effective interest rate and notional amount associated with the 4.663% 2051 Notes evolve from 2022 to 2023?",
      "original_answer": "In 2022, the 4.663% 2051 Notes were part of a $5.2 billion principal amount of notes that were hedged using interest rate swaps, with the swaps terminated and replaced at then-current interest rates. In 2023, the notional amount of the 4.663% 2051 Notes was $1.5 billion, and the effective interest rate was SOFR + 4.3%. This indicates a continuation of the hedging strategy but with updated interest rate terms and a more specific disclosure of the notional amount and rate for the 2051 Notes.",
      "llm_answer": "\nFrom 2022 to 2023 the 4.663 % 2051 Notes kept the same outstanding notional amount of **$1.5 billion**.  However, the effective interest rate on that tranche shifted from the prior LIBOR‑plus‑4.1 % structure (which translated to roughly 5.6 % in 2022) to a SOFR‑plus‑4.3 % structure in 2023 (approximately 5.8‑6 % depending on the prevailing SOFR).  In other words, the notional stayed flat at $1.5 bn while the benchmark‑based effective rate increased slightly.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains both correct and problematic elements. CORRECT: (1) The notional amount of $1.5 billion for 2023 is accurate; (2) The 2023 effective rate of SOFR + 4.3% is correct; (3) The general characterization of a shift from LIBOR-based to SOFR-based pricing is reasonable. PROBLEMATIC: (1) The LLM claims the notional amount 'kept the same' at $1.5 billion from 2022 to 2023, but the ground truth indicates that in 2022, the 4.663% 2051 Notes were part of a $5.2 billion principal amount of notes (not specifically $1.5 billion for just this tranche in 2022). The LLM's assertion that the notional 'stayed flat at $1.5 bn' is not supported by the ground truth, which does not confirm the 2022 notional was $1.5 billion; (2) The LLM introduces a LIBOR-plus-4.1% structure for 2022 that is not mentioned in the ground truth, which only references that swaps were 'terminated and replaced at then-current interest rates' without specifying the exact prior rate; (3) The LLM provides estimated percentage ranges (5.6% in 2022, 5.8-6% in 2023) that are not in the ground truth and represent unsupported calculations; (4) The ground truth emphasizes the hedging strategy continuation and updated disclosure, while the LLM focuses more on rate mechanics. The answer demonstrates partial understanding but makes unsupported claims about 2022 rates and assumes the notional remained constant without proper evidence from the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 399,
        "total_tokens": 1632
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How has AIG's use of expected loss ratio methods evolved between 2022 and 2023, particularly in terms of the lines of business and segmentation criteria applied?",
      "original_answer": "In 2022, AIG referenced the use of expected loss ratio methods in a general sensitivity analysis related to loss reserve assumptions, without specifying detailed segmentation or particular lines of business. By 2023, AIG explicitly applied expected loss ratio methods to U.S. Workers' Compensation, a long-tail line of business, and introduced more granular segmentation criteria such as risk-sharing features, state and industry subsets, deductible size, and claim handling entities. This indicates a more structured and detailed application of the method in 2023 compared to 2022.",
      "llm_answer": "\nBetween 2022 and 2023 AIG moved from a more general use of expected‑loss‑ratio estimates—applying a premium‑percentage to short‑tail lines and projecting ultimate loss ratios for long‑tail lines with only modest trend adjustments—to a more structured, segmentation‑driven approach.  In 2023 the company gave the expected‑loss‑ratio method explicit weight for business written in excess of a deductible, using the five most recent accident years and adjusting the ratios for loss‑cost trends, rate changes and reinsurance (including ADC) impacts, and it segmented reserves by profit‑center‑coded lines of business (e.g., Excess Casualty, Financial Lines, Workers’ Compensation, etc.) rather than by the broader short‑/long‑tail categories used previously.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures some key evolution points but contains significant discrepancies with the ground truth. CORRECT ELEMENTS: (1) The answer correctly identifies that AIG moved from a general/less structured approach in 2022 to a more segmented approach in 2023; (2) Correctly identifies Workers' Compensation as a specific line of business mentioned in 2023; (3) Correctly notes the introduction of more granular segmentation criteria in 2023. PROBLEMATIC ELEMENTS: (1) The LLM introduces specific methodological details (premium-percentage for short-tail lines, five most recent accident years, ADC impacts, profit-center-coded lines) that are NOT mentioned in the ground truth answer. While these may be accurate from the source documents, they represent a significant expansion beyond what the ground truth specifies; (2) The ground truth explicitly states that 2022 used 'general sensitivity analysis related to loss reserve assumptions, without specifying detailed segmentation or particular lines of business,' but the LLM characterizes 2022 as applying 'premium-percentage to short-tail lines and projecting ultimate loss ratios for long-tail lines' - this is more specific than the ground truth indicates; (3) The ground truth mentions specific 2023 segmentation criteria (risk-sharing features, state and industry subsets, deductible size, claim handling entities) but the LLM answer mentions different criteria (profit-center-coded lines, Excess Casualty, Financial Lines, etc.). The LLM does mention 'business written in excess of a deductible' which aligns with 'deductible size' but omits the other specific segmentation criteria mentioned in ground truth; (4) The LLM introduces 'loss-cost trends, rate changes and reinsurance' adjustments which are not explicitly mentioned in the ground truth. MULTI-HOP REASONING: The answer does synthesize the evolution between years, but the synthesis appears to add details not present in the ground truth rather than accurately reflecting the documented evolution. The core insight about increased structure and segmentation is correct, but the specific implementation details diverge significantly from the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 584,
        "total_tokens": 1922
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did PepsiCo's engagement with the 2.850% Senior Notes due 2026 evolve between 2023 and 2024, particularly in terms of its broader debt issuance strategy as reflected in the additional notes introduced in 2024?",
      "original_answer": "In 2023, PepsiCo referenced the 2.850% Senior Notes due 2026 as part of a broader set of debt instruments, including other senior notes with varying interest rates and maturity dates. By 2024, the company introduced a significantly expanded range of senior notes, including higher-yielding instruments such as the 7.00% Senior Notes due 2029 and the 5.50% Senior Notes due 2035, indicating a more diversified and long-term debt issuance strategy. This evolution suggests that PepsiCo not only maintained its commitment to the 2.850% Senior Notes due 2026 but also broadened its capital structure by incorporating a wider spectrum of debt instruments with different risk-return profiles.",
      "llm_answer": "\nBetween 2023 and 2024 PepsiCo kept its original 2.850 % Senior Notes due 2026—first issued in 2016 and re‑authorized in the 2024 Board resolutions (page 129 of the 2024 10‑K).  At the same time the company broadened its issuance program, authorizing a suite of new unsecured senior notes in 2024 (e.g., a 5.125 % note due 2026, a floating‑rate note due 2026, and several longer‑dated fixed‑rate issues from 2028‑2034).  This reflects a staggered‑maturity strategy that diversifies funding sources, extends the average debt profile, and takes advantage of favorable market conditions while retaining the existing 2.850 % 2026 tranche as part of the laddered structure.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates good understanding of the overall narrative about PepsiCo's debt strategy evolution, but contains several problematic elements: (1) QUANTITATIVE ISSUES: The LLM introduces specific note details (5.125% note due 2026, floating-rate note due 2026, notes from 2028-2034) that are NOT mentioned in the ground truth answer. The ground truth specifically references 7.00% Senior Notes due 2029 and 5.50% Senior Notes due 2035 as examples of the new instruments introduced in 2024, but the LLM provides different percentages and maturity dates. This is a significant factual discrepancy. (2) CITATION ACCURACY: The LLM cites 'page 129 of the 2024 10-K' and mentions 'Board resolutions' - these specific references cannot be verified against the ground truth and may be hallucinated details. (3) CORRECT ELEMENTS: The LLM correctly identifies that the 2.850% Senior Notes due 2026 were maintained from 2023 to 2024, correctly characterizes the strategy as diversified/laddered, and accurately conveys the concept of extending the debt maturity profile. (4) MULTI-HOP REASONING: The reasoning about staggered-maturity strategy and diversification is sound and well-articulated, showing good synthesis of the evolution concept. (5) SEMANTIC ALIGNMENT: While the overall narrative matches the ground truth's intent (maintaining existing notes while broadening the debt program), the specific new instruments cited are materially different from those in the ground truth, which undermines factual accuracy. The answer reads plausibly but introduces unverified specific details that contradict the ground truth's examples.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 448,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How has Cisco's exposure to channel partner financing guarantees evolved between fiscal years 2022 and 2024, and what does this indicate about the company's financial risk management strategy?",
      "original_answer": "In fiscal year 2022, Cisco disclosed that the volume of channel partner financing was $27.9 billion, with a balance of financing subject to guarantees amounting to $1.4 billion as of July 30, 2022. By fiscal year 2024, while the company continued to provide financing guarantees, the specific volume of channel partner financing and the balance subject to guarantees were no longer explicitly quantified in the disclosures. This shift indicates a potential strategic move toward reducing transparency around these financial commitments, which may reflect a broader risk management approach to limit visibility into contingent liabilities. However, the absence of updated figures prevents definitive conclusions about the actual change in exposure.",
      "llm_answer": "\nCisco’s guarantee liability fell from roughly **$1.4 billion at the end of fiscal 2022 to $1.7 billion in fiscal 2023, then declined to about $1.2 billion by the end of fiscal 2024**.  The reduction reflects a deliberate pull‑back from extensive third‑party financing guarantees, shifting most of the credit risk to external lenders and tightening underwriting standards.  This trend demonstrates Cisco’s effort to **lower contingent cash‑outflows and preserve balance‑sheet strength**, using guarantees only where they provide clear strategic benefit rather than as a broad financing tool.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer provides specific numerical claims that directly contradict the ground truth and cannot be verified. (1) QUANTITATIVE ACCURACY FAILURE: The LLM states guarantee liability was '$1.4 billion at end of fiscal 2022' (correct), but then claims it rose to '$1.7 billion in fiscal 2023' and fell to '$1.2 billion by end of fiscal 2024.' The ground truth explicitly states that by fiscal 2024, 'the specific volume of channel partner financing and the balance subject to guarantees were no longer explicitly quantified in the disclosures.' The LLM has fabricated specific numbers for fiscal 2023 and 2024 that do not exist in the source documents. (2) MULTI-HOP REASONING FAILURE: The LLM incorrectly synthesized information by inventing data points. The ground truth indicates a shift toward REDUCED TRANSPARENCY (numbers no longer disclosed), not a documented decline in actual exposure. The LLM misinterpreted this as evidence of actual reduction in guarantees. (3) SEMANTIC MISALIGNMENT: The ground truth emphasizes that 'the absence of updated figures prevents definitive conclusions about the actual change in exposure,' yet the LLM confidently asserts a specific downward trend with precise dollar amounts. This is fundamentally contradictory. (4) ENTITY/METRIC ACCURACY: While Cisco and the fiscal years are correct, the financial metrics presented are fabricated. The LLM conflates the absence of disclosure with evidence of declining exposure—a critical logical error. (5) RISK MANAGEMENT INTERPRETATION: The ground truth suggests reduced transparency may indicate a strategic move to limit visibility into contingent liabilities, while the LLM interprets it as evidence of actual risk reduction. These are opposite conclusions. The answer demonstrates confident but factually incorrect synthesis that would mislead users about Cisco's actual financial position and risk management strategy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 520,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How has the status and interest rate structure of the 2.45% 2030 Notes evolved between 2022 and 2023?",
      "original_answer": "In 2022, Amgen disclosed that it had entered into interest rate swap contracts with an aggregate notional amount of $1.0 billion with respect to the 2.45% 2030 Notes, effectively converting the fixed-rate interest to a floating LIBOR-based coupon. By 2023, the 2.45% 2030 Notes remained outstanding with a notional amount of $1.0 billion, but the interest rate structure had transitioned from LIBOR to SOFR, now stated as SOFR + 1.3%. This reflects a continuation of the note's existence but with a modified floating-rate benchmark.",
      "llm_answer": "\nBetween 2022 and 2023 the 2.45 % 2030 Notes remained outstanding with a $1.25 billion principal amount on the balance sheet (see page 130).  The fixed‑coupon notes were hedged with interest‑rate swaps that convert the 2.45 % coupon into a floating SOFR‑plus‑1.3 % rate; this swap structure, originally entered in 2021, was still in place at year‑end 2023, as shown by the $1 billion notional and “SOFR + 1.3 %” effective rate listed for the 2030 Notes (page 144).  No redemption or new issuance of the 2030 Notes occurred during 2022‑2023, so the only evolution was the continued use of the same swap‑based floating‑rate structure.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS: (1) PRINCIPAL AMOUNT DISCREPANCY: LLM states $1.25 billion principal amount on balance sheet, but ground truth indicates $1.0 billion notional amount for the swap contracts. This is a significant quantitative error - the LLM introduced a number not supported by ground truth. (2) SWAP ORIGINATION DATE: LLM claims swaps were 'originally entered in 2021,' but ground truth states they were entered in 2022. This is a factual error on timing. (3) LIBOR-TO-SOFR TRANSITION: Ground truth explicitly states the transition FROM LIBOR (in 2022) TO SOFR (in 2023), showing evolution over the period. LLM mentions SOFR + 1.3% but doesn't clearly articulate this transition as the key evolution between years - it presents the 2023 state but obscures the 2022 baseline. CORRECT ELEMENTS: (1) The $1.0 billion notional amount for swaps is correct. (2) SOFR + 1.3% rate in 2023 is correct. (3) Recognition that notes remained outstanding is correct. (4) The hedging structure concept is correct. MULTI-HOP REASONING: The LLM failed to properly synthesize the year-over-year evolution. The ground truth clearly shows a LIBOR baseline in 2022 transitioning to SOFR in 2023 - this is the core 'evolution' the question asks about. The LLM's answer suggests the swap structure was static ('same swap-based floating-rate structure'), which contradicts the documented transition from LIBOR to SOFR. The introduction of the $1.25 billion figure without ground truth support is particularly problematic for a financial question requiring precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 425,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How has FedEx's relationship with Pass-Through Certificates evolved between 2022 and 2023, particularly regarding its financial guarantees and obligations?",
      "original_answer": "In 2022, FedEx Express had issued $970 million of Pass-Through Certificates, Series 2020-1AA, which were fully and unconditionally guaranteed by FedEx. These certificates were secured by 19 Boeing aircraft with a net book value of $1.8 billion. However, in 2023, FedEx clarified that pass-through certificates associated with leveraged operating leases were not direct obligations of, nor guaranteed by, FedEx or FedEx Express. This indicates a shift from direct financial guarantees in 2022 to a position of no direct financial obligation in 2023.",
      "llm_answer": "\nBetween 2022 and 2023 FedEx’s exposure to the pass‑through trusts shifted from a direct, unconditional guarantee to a more arms‑length lease‑based structure. In the 2022 filing the $970 million of Series 2020‑1AA certificates were described as “fully and unconditionally guaranteed by FedEx,” with FedEx Express using the proceeds for general corporate purposes. By the 2023 filing the same certificates are noted only as “leveraged operating leases” where the pass‑through trusts—not FedEx or FedEx Express—are the obligors, and FedEx’s maximum exposure is limited to the future minimum lease payments disclosed in the lease‑payment schedule. Consequently, the financial guarantees and obligations that once backed the certificates were removed, leaving the trusts to bear the payment risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive understanding of FedEx's evolving relationship with Pass-Through Certificates. QUANTITATIVE ACCURACY: All numbers are correct - $970 million Series 2020-1AA certificates, $1.8 billion net book value of Boeing aircraft (mentioned in ground truth, appropriately not repeated in LLM answer as it focuses on the guarantee shift). The dates (2022 vs 2023) are correctly identified. ENTITY ACCURACY: FedEx, FedEx Express, and the specific certificate series are all correctly identified. MULTI-HOP REASONING: The LLM successfully synthesizes the key evolution: (1) 2022 position - direct, unconditional guarantee by FedEx, (2) 2023 position - no direct obligation or guarantee, with trusts as obligors and FedEx's exposure limited to lease payments. This correctly captures the shift from direct financial guarantees to an arms-length lease structure. COMPLETENESS: The answer addresses all aspects of the question - the relationship evolution, financial guarantees, and obligations across both years. The LLM provides additional helpful context about how proceeds were used and the mechanism of exposure limitation through lease payments. SEMANTIC EQUIVALENCE: The LLM's characterization of the shift from 'direct, unconditional guarantee' to 'leveraged operating leases' with 'trusts as obligors' precisely matches the ground truth's description of moving from 'fully and unconditionally guaranteed' to 'not direct obligations of, nor guaranteed by, FedEx.' Minor note: The LLM answer is slightly more detailed and explanatory than the ground truth, but this adds value without introducing inaccuracies. The reasoning is sound and the synthesis across the two years is logical and well-articulated.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 478,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did Mastercard's use of risk mitigation arrangements to manage gross settlement exposure evolve from 2023 to 2024, and what does this indicate about the company's risk management strategy?",
      "original_answer": "In 2023, Mastercard had $75,023 million in gross settlement exposure, with $12,167 million covered by risk mitigation arrangements. By 2024, gross settlement exposure increased to $78,385 million, and the company applied $13,466 million in risk mitigation arrangements, reflecting an increase in both total exposure and the amount mitigated. This indicates that Mastercard's risk management strategy became more robust over time, as it increased its use of mitigation tools in response to growing settlement exposure.",
      "llm_answer": "\nFrom 2023 to 2024 Mastercard’s gross settlement exposure grew modestly—from about **$75 bn to $78.4 bn**—and the company applied a larger amount of risk‑mitigation collateral and guarantees—**$12.2 bn to $13.5 bn**—to offset that exposure.  Consequently, net settlement exposure rose only slightly, from **$62.9 bn to $64.9 bn**, reflecting a deliberate scaling of mitigation measures in step with higher transaction volumes and a continuous refinement of its risk‑assessment methodology.  This shows that Mastercard’s risk‑management strategy is proactive and data‑driven: it expands collateral and credit‑enhancement requirements as exposure rises, while regularly reviewing and updating its risk standards to keep potential losses low.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All key numbers are correct - gross settlement exposure 2023: $75,023M (LLM: ~$75bn ✓), 2024: $78,385M (LLM: $78.4bn ✓); risk mitigation arrangements 2023: $12,167M (LLM: $12.2bn ✓), 2024: $13,466M (LLM: $13.5bn ✓). The net settlement exposure calculations are also accurate: 2023 net = $75,023M - $12,167M = $62,856M (LLM states $62.9bn, which is a reasonable rounding), 2024 net = $78,385M - $13,466M = $64,919M (LLM states $64.9bn ✓). Number format variations ($75,023M vs $75bn) are appropriately handled. MULTI-HOP REASONING: The answer correctly synthesizes information across both years, comparing the evolution of gross exposure, mitigation amounts, and net exposure. The logical progression from 2023 to 2024 is sound. ENTITY ACCURACY: Mastercard correctly identified, years correctly specified (2023-2024), financial metrics properly labeled. QUALITATIVE ASSESSMENT: The interpretation that Mastercard's strategy became 'more robust' and 'proactive and data-driven' aligns well with the ground truth's characterization. The answer adds valuable context about transaction volumes and risk-assessment methodology refinement, which is reasonable inference from the data pattern. MINOR CONSIDERATIONS: The net settlement exposure figure for 2023 shows slight rounding ($62.9bn vs calculated $62.856bn), but this is within acceptable tolerance for billion-dollar figures. The answer goes slightly beyond the ground truth by discussing 'collateral and credit-enhancement requirements' and 'risk standards,' but these are reasonable elaborations consistent with the data pattern and don't contradict the source material. Overall, the answer demonstrates comprehensive understanding of the multi-hop question and provides accurate, well-reasoned synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 502,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did Nike's liabilities related to foreign exchange forwards and options designated as hedging instruments change between 2022 and 2024, and what does this indicate about the company's exposure or strategy?",
      "original_answer": "In 2022, Nike reported $37 million in liabilities for foreign exchange forwards and options designated as hedging instruments under accrued liabilities, and $11 million under deferred income taxes and other liabilities, totaling $48 million. By 2024, the liability under accrued liabilities for the same category increased to $110 million, while the amount under deferred income taxes and other liabilities decreased to $5 million, resulting in a total of $115 million. This represents a significant increase in total liabilities for designated hedging instruments related to foreign exchange forwards and options, indicating a potential increase in Nike's foreign exchange risk exposure or a strategic shift in hedging activity.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2024 the liability for foreign‑exchange forwards and options that are designated as hedging instruments rose from roughly **$48 million** (reported in the 2022 balance sheet) to about **$146 million** in 2024 – an increase of roughly **$98 million**.  This jump shows that Nike deliberately expanded its hedge book, locking in exchange rates for a larger share of its cross‑border sales and cost structure, indicating a proactive strategy to manage heightened foreign‑currency volatility and protect earnings.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains a major factual error in the 2024 liability figure. Ground truth states the 2024 total liability is $115 million ($110M in accrued liabilities + $5M in deferred income taxes), but the LLM claims it is approximately $146 million. This is a $31 million discrepancy (27% error). The 2022 figure of $48 million is correct ($37M + $11M), and the calculation of the increase from $48M to $115M would be $67 million, not the $98 million stated. The LLM's claimed increase of $98 million is mathematically inconsistent with the stated 2024 figure of $146 million (which would only represent a $98M increase if 2022 was $48M, but $146M - $48M = $98M, yet the ground truth shows $115M, not $146M). MULTI-HOP REASONING: The LLM correctly identifies this as a multi-year comparison and attempts to synthesize the change, but the fundamental numbers are wrong, undermining the entire analysis. ENTITY ACCURACY: Nike and the correct fiscal years (2022, 2024) are identified correctly. The metric (foreign exchange forwards and options designated as hedging instruments) is correctly identified. QUALITATIVE ASSESSMENT: While the LLM's interpretation about Nike's hedging strategy and foreign exchange risk management is reasonable and contextually appropriate, it is built on incorrect numerical foundations. The reasoning about deliberate expansion of the hedge book and protection against currency volatility is logical but cannot be validated given the incorrect baseline numbers. MISSING DETAIL: The LLM fails to break down the liability components (accrued liabilities vs. deferred income taxes), which is important context provided in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 465,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did the representation of Bounty within P&G's Baby, Feminine & Family Care segment evolve between the 2022 and 2023 10-K filings, and what does this suggest about its brand visibility?",
      "original_answer": "In the 2022 10-K filing, Bounty was mentioned as part of P&G's Family Care business within the Baby, Feminine & Family Care segment, but it was not explicitly listed among the key brands. In contrast, the 2023 10-K filing explicitly included Bounty among the major brands under the Family Care category. This change suggests an increase in Bounty's brand visibility within P&G's portfolio, though the filings do not provide specific market share or sales figures to quantify this shift. The explicit mention in 2023 indicates a possible strategic move to highlight Bounty's role, though no direct strategic intent is stated in the evidence provided.",
      "llm_answer": "\nIn the 2022 filing Bounty is listed explicitly as a major brand within the Baby, Feminine & Family Care segment, highlighting its prominence in P&G’s brand portfolio. By the 2023 filing the brand is no longer presented as a stand‑alone marquee—its mention is folded under broader brand groupings and its standalone emphasis is removed—signaling a deliberate reduction in the brand’s visibility and strategic focus.",
      "correctness_score": 1,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 1,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and directly contradicts the ground truth. The ground truth states that in 2022, Bounty was NOT explicitly listed among key brands, but in 2023 it WAS explicitly included—representing an INCREASE in visibility. The LLM answer reverses this entirely, claiming Bounty was 'listed explicitly as a major brand' in 2022 and then 'no longer presented as a stand-alone marquee' in 2023, suggesting a DECREASE in visibility. This is the opposite of what actually occurred. The LLM has inverted the directional change of Bounty's representation. While the LLM correctly identifies the years (2022 vs 2023) and the segment (Baby, Feminine & Family Care), it completely mischaracterizes the evolution of Bounty's brand visibility. The ground truth explicitly notes that 2023 showed increased visibility through explicit mention, while 2022 did not feature Bounty prominently. The LLM's conclusion about 'deliberate reduction in the brand's visibility' is factually incorrect based on the filing evidence. This is a critical error in multi-hop reasoning that fundamentally undermines the answer's validity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 323,
        "total_tokens": 1599
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How has Oracle's approach to its hardware business, particularly Oracle Engineered Systems, evolved between fiscal 2022 and fiscal 2023 in terms of revenue recognition and strategic emphasis?",
      "original_answer": "In fiscal 2022, Oracle's hardware business, which includes Oracle Engineered Systems, was described in terms of its contractual activities and revenue recognition, with an emphasis on the timing of revenue recognition for cloud and license contracts. By fiscal 2023, Oracle introduced a more detailed explanation of how hardware and related software are treated as a combined performance obligation, with revenue recognized at the point in time of delivery and ownership transfer. Additionally, in 2023, Oracle emphasized ongoing R&D investments to improve and develop new hardware products and services, which was not explicitly mentioned in 2022. This indicates a shift toward a more strategic focus on innovation and integration of hardware and software components within the hardware business.",
      "llm_answer": "\nOracle continues to recognize hardware product revenue at the moment the Engineered System and its software are delivered, and to recognize hardware‑support revenue ratably over the support term in both the 2022 and 2023 filings.  However, the 2023 filing stresses that hardware now makes up only about 6 % of total revenue and carries lower operating margins, highlighting its volatility, dependence on indirect channels and the need for ongoing R&D investment, whereas the 2022 filing presented hardware as a slightly larger, growing segment ($3.18 B in fiscal 2022) but still emphasized its low‑margin, indirect‑channel nature.  Consequently, the strategic emphasis shifted from a modest growth narrative to a clearer focus on hardware’s small, low‑margin, unpredictable role within the broader cloud‑centric business.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer addresses the core question about Oracle's hardware business evolution between fiscal 2022 and 2023, but contains significant quantitative inaccuracies and some unsupported claims. STRENGTHS: (1) Correctly identifies that revenue recognition methodology remained consistent (point-in-time for hardware delivery, ratably for support) across both years; (2) Appropriately captures the shift in strategic emphasis from growth narrative to focus on hardware's limited role; (3) Correctly notes the low-margin, indirect-channel nature of hardware business; (4) Properly synthesizes multi-hop information about strategic positioning. WEAKNESSES: (1) CRITICAL - States hardware is '6% of total revenue' in 2023 without source verification; this specific percentage is not confirmed in the ground truth; (2) CRITICAL - Cites '$3.18B in fiscal 2022' as hardware revenue without verification against actual filing data; this specific number cannot be confirmed; (3) The ground truth emphasizes 'more detailed explanation of hardware and software as combined performance obligation' and 'ongoing R&D investments' as key 2023 changes, but the LLM answer downplays these aspects in favor of margin/channel discussion; (4) The LLM answer introduces quantitative claims (6%, $3.18B) that go beyond what the ground truth explicitly states, suggesting potential hallucination of specific metrics. MULTI-HOP REASONING: The answer does synthesize information across two fiscal years and compares strategic positioning, which is appropriate. However, the introduction of unverified specific percentages and dollar amounts undermines the credibility of the synthesis. The answer would be stronger if it stuck to the documented shifts in revenue recognition presentation and R&D emphasis rather than introducing specific financial metrics that cannot be verified against the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 509,
        "total_tokens": 1925
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did the sales performance of the product ERLEADA evolve between 2022 and 2023, and what does this indicate about its market trajectory?",
      "original_answer": "In 2022, ERLEADA generated $1,881 million in sales, and by 2023, its sales increased to $2,387 million, representing a 26.9% growth. This indicates a strong upward trajectory for ERLEADA in the market, suggesting increased adoption or improved commercial performance over the period.",
      "llm_answer": "\nERLEADA’s sales jumped from roughly **$1.88 billion in 2022 to $2.39 billion in 2023**, a **≈27 % increase** (as shown in the 2023 vs. 2022 oncology sales table on page 31). This growth, driven by continued share gains and broader market adoption in metastatic castration‑resistant prostate cancer, signals a **strong, upward market trajectory** for the product.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. Quantitative verification: 2022 sales of $1.88 billion (vs. ground truth $1,881 million - correct, format variation acceptable), 2023 sales of $2.39 billion (vs. ground truth $2,387 million - correct, format variation acceptable), and growth rate of ≈27% (vs. ground truth 26.9% - appropriately rounded, calculation verified: ($2,387-$1,881)/$1,881 = 26.9%). The LLM correctly identified the product (ERLEADA), the time period (2022-2023), and the financial metrics. Multi-hop reasoning is sound: the answer synthesizes the sales figures across two years and correctly interprets the growth rate as indicating market trajectory. The LLM provides additional context about market drivers (share gains, broader adoption in metastatic castration-resistant prostate cancer) which, while not explicitly in the ground truth, represents reasonable inference from the data and enhances the answer without introducing factual errors. The conclusion about 'strong, upward market trajectory' directly matches the ground truth assessment. Minor deduction (1 point) only because the percentage is rounded to ≈27% rather than stated as 26.9%, though this is a reasonable approximation and not a material error. The answer fully addresses both parts of the question: sales evolution (with specific numbers and growth rate) and market trajectory implications.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1159,
        "completion_tokens": 391,
        "total_tokens": 1551
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How has the nature of CMCSA's relationship with local broadcast television stations evolved from 2023 to 2024, particularly in terms of competitive positioning and dependency for content distribution?",
      "original_answer": "In 2023, CMCSA's Media segment directly competed with local broadcast television stations for viewers' attention and advertising revenue. By 2024, the relationship shifted to a more interdependent one, where CMCSA's linear television networks became reliant on local broadcast television stations for retransmission consent, which is necessary for distributing broadcast network programming to video service customers. This marks a shift from competition to dependency, reflecting a strategic and operational evolution in how CMCSA interacts with local broadcast stations.",
      "llm_answer": "\nFrom 2023 to 2024 the relationship shifted from a relatively straightforward affiliation model to one that is increasingly driven by negotiated retransmission‑consent fees and higher leverage points for local stations.  The 2023 filing describes the need to secure affiliations with independent broadcast stations, while the 2024 filing emphasizes that programming costs now include payments to those stations for consent to carry their signals and that industry consolidation is intensifying their demands—making Comcast’s distribution of broadcast network content more competitive and more dependent on each station’s pricing and carriage terms.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures some key elements of the relationship evolution but introduces interpretations not clearly supported by the ground truth and misses the core shift described. STRENGTHS: (1) Correctly identifies the shift from 2023 to 2024; (2) Accurately mentions retransmission consent as a key mechanism; (3) Recognizes increased dependency and negotiated terms; (4) No quantitative errors or incorrect numbers/dates. WEAKNESSES: (1) The ground truth emphasizes a shift from COMPETITION to DEPENDENCY, but the LLM answer frames it as 'affiliation model' to 'retransmission-consent fees' - this is a different framing that doesn't clearly capture the competitive-to-dependent shift; (2) The LLM introduces concepts like 'industry consolidation intensifying demands' and 'higher leverage points for local stations' that are not explicitly stated in the ground truth; (3) The phrase 'more competitive and more dependent' is somewhat contradictory and doesn't cleanly convey the ground truth's clearer narrative of shifting FROM competition TO dependency; (4) The LLM answer adds interpretive layers ('affiliation model,' 'pricing and carriage terms,' 'industry consolidation') that go beyond what the ground truth establishes, potentially conflating different aspects. MULTI-HOP REASONING: The LLM does attempt to synthesize across 2023 and 2024 filings, but the synthesis appears to introduce assumptions not grounded in the provided ground truth. The core insight - that CMCSA moved from competing with local broadcast stations to becoming dependent on them for retransmission consent - is partially captured but obscured by additional framing. The answer would benefit from more directly stating the competition-to-dependency shift as the primary evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 480,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did the value of Held-to-Maturity (HTM) securities held by MA evolve between 2023 and 2024, and what does this shift indicate about the company's investment strategy?",
      "original_answer": "In 2023, MA held $306 million in HTM securities, but by 2024, this amount dropped significantly to $38 million. This indicates a major shift in MA's investment strategy, with a sharp reduction in long-term held securities, likely reflecting a move toward more liquid or short-term investment positions.",
      "llm_answer": "\nThe Company’s held‑to‑maturity portfolio fell dramatically — from **$306 million at the end of 2023** to only **$38 million at the end of 2024** (a decline of roughly 87 %).  This sharp reduction shows that Mastercard is deliberately shrinking its short‑term, low‑yield time‑deposit holdings and reallocating the cash to more flexible, higher‑return assets such as available‑for‑sale securities and equity investments, reflecting a strategic shift toward greater liquidity and potentially better risk‑adjusted returns in the current interest‑rate environment.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) All core numbers are factually correct: $306 million in 2023 and $38 million in 2024 are accurate. (2) The percentage calculation of ~87% decline is mathematically correct ((306-38)/306 = 0.876 or 87.6%). (3) The company identification (Mastercard/MA) is correct. (4) The temporal framing (end of 2023 to end of 2024) is accurate. (5) The answer correctly identifies this as a significant strategic shift. WEAKNESSES: (1) The LLM introduces interpretive details not present in the ground truth, specifically claiming the reduction reflects a move away from 'short-term, low-yield time-deposit holdings' and toward 'available-for-sale securities and equity investments.' The ground truth only states the shift indicates 'a move toward more liquid or short-term investment positions' without specifying the destination asset classes. (2) The LLM adds context about 'current interest-rate environment' which, while plausible, is not supported by the ground truth answer. (3) The characterization of HTM securities as 'short-term' is potentially misleading since HTM securities are typically longer-term by definition, though the LLM may be referring to the composition of MA's specific HTM portfolio. MULTI-HOP REASONING: The answer correctly synthesizes the comparison between two years and draws a logical conclusion about strategic shift, which matches the ground truth's inference. However, the additional interpretive layer about specific asset reallocation goes beyond what can be verified from the provided ground truth. OVERALL ASSESSMENT: The factual foundation is solid with correct numbers and calculations, but the answer adds speculative interpretation about investment destinations and market conditions that exceed the scope of the ground truth answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1221,
        "completion_tokens": 483,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How has the positioning of the Always brand within Procter & Gamble's Baby, Feminine & Family Care segment evolved between 2022 and 2023, particularly in terms of its product categorization and associated sub-categories?",
      "original_answer": "In 2022, Always was categorized under Feminine Care within the Baby, Feminine & Family Care segment, which included sub-categories like Adult Incontinence and Feminine Care. By 2023, the brand remained part of the same reportable segment but was more specifically aligned with 'Menstrual Care' under the updated Feminine Care sub-category, reflecting a more targeted positioning. This evolution indicates a strategic shift in how Always is being categorized to emphasize its core focus area.",
      "llm_answer": "\nBetween 2022 and 2023 the Always brand did **not** move to a different segment or product group – it remained classified under **Feminine Care**, the sub‑category that covers both **menstrual care** (e.g., Tampax) and **adult incontinence** (Always Discreet).  The 2023 filing lists Always alongside Always Discreet and Tampax within the “Feminine Care (Adult Incontinence, Menstrual Care)” grouping, and the segment’s flat net sales with a 13 % rise in earnings indicate that the brand’s positioning stayed the same but shifted toward higher‑margin, premium offerings rather than a change in categorisation.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) CORE CLAIM ERROR: The LLM states Always 'did NOT move to a different segment or product group' and 'remained classified under Feminine Care,' but the ground truth explicitly states that by 2023, Always was 'more specifically aligned with Menstrual Care under the updated Feminine Care sub-category,' indicating a strategic shift in categorization. This is a fundamental misunderstanding of the evolution being asked about. (2) CATEGORIZATION MISREPRESENTATION: The LLM conflates the 2023 structure by listing 'Feminine Care (Adult Incontinence, Menstrual Care)' as if this represents no change, when the ground truth indicates Always moved from a broader Feminine Care category to a more specific 'Menstrual Care' positioning within that category. (3) UNSUPPORTED CLAIMS: The LLM introduces claims about 'higher-margin, premium offerings' and cites specific metrics ('13% rise in earnings,' 'segment's flat net sales') that are not mentioned in the ground truth and appear to be fabricated or misremembered. These numbers cannot be verified and are presented without source attribution. (4) INCOMPLETE ANALYSIS: The LLM fails to capture the strategic shift in positioning that the ground truth emphasizes - the evolution from a broader categorization to a more targeted, specific alignment with Menstrual Care. (5) LOGICAL INCONSISTENCY: The LLM's statement that positioning 'stayed the same but shifted toward higher-margin, premium offerings' is contradictory and doesn't align with the ground truth's description of a strategic categorization change. The answer fundamentally misses the core point of the question about how Always's positioning evolved in terms of product categorization.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 487,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How has Oracle's positioning and financial contribution of Oracle Engineered Systems evolved between 2022 and 2023, particularly in terms of revenue recognition and strategic emphasis?",
      "original_answer": "In 2022, Oracle Engineered Systems were disclosed as part of hardware revenues, but no specific percentage of total revenue was provided. Revenue recognition for hardware products, including Engineered Systems, was described as occurring at the point in time when the product and related software were delivered. By 2023, Oracle explicitly stated that the hardware business, which includes Engineered Systems, represented 6% of total revenues in both fiscal 2023 and fiscal 2024, indicating a clearer and more consistent measurement of the product line's contribution. Additionally, in 2023, Oracle emphasized ongoing R&D investments to improve hardware offerings and introduced more detailed factors affecting hardware revenue predictability, such as manufacturing partner performance and competitive positioning against cloud infrastructure offerings. This reflects both quantitative and strategic evolution in how Oracle presents and manages the Engineered Systems product line.",
      "llm_answer": "\nBetween fiscal 2022 and 2023 Oracle’s Engineered‑Systems hardware remained a modest, roughly 6 %‑of‑total‑revenue line item, and its revenue is recognized at the point in time when the hardware (and any bundled software) is delivered and ownership transfers to the customer.  The company continues to treat hardware support contracts as a percentage‑of‑net‑hardware‑fee that is then recognized ratably over the support term, but it explicitly notes that the hardware business carries lower operating margins than its cloud‑and‑license operations and that its future investments will be directed toward “developing, marketing, selling and delivering our cloud‑based offerings.”  Consequently, while the recognition timing has not changed, the strategic emphasis has shifted away from growing the hardware segment toward expanding cloud services, with hardware now serving mainly as a complementary, low‑margin complement to the broader cloud‑and‑license strategy.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "MAJOR ISSUES: (1) QUANTITATIVE ERROR - The LLM states hardware was 'roughly 6% of total revenue' in both 2022 and 2023, but the ground truth explicitly states that in 2022, 'no specific percentage of total revenue was provided.' The 6% figure only appears in 2023 and 2024 disclosures. This is a critical factual error that contradicts the core finding about evolution between the two years. (2) INCOMPLETE SYNTHESIS - The LLM fails to capture the key evolution: the shift from NO DISCLOSED PERCENTAGE in 2022 to an EXPLICIT 6% disclosure in 2023. This is the central point of the ground truth answer about how Oracle's positioning evolved. (3) MISSING STRATEGIC CONTEXT - While the LLM mentions strategic shift toward cloud, it doesn't adequately capture that the 2023 evolution included 'more detailed factors affecting hardware revenue predictability' and 'ongoing R&D investments to improve hardware offerings,' which represent a more nuanced strategic emphasis than simply de-emphasizing hardware. (4) PARTIALLY CORRECT ELEMENTS - The LLM correctly identifies: revenue recognition timing (point of delivery), support contract treatment, lower operating margins, and strategic shift toward cloud. However, these correct elements don't compensate for the fundamental error about the 6% figure applying to 2022. (5) REASONING FLAW - The LLM's statement that hardware 'remained a modest, roughly 6%-of-total-revenue line item' between 2022-2023 suggests continuity when the ground truth emphasizes a change in disclosure and measurement clarity. The multi-hop reasoning fails to properly synthesize the evolution aspect of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1495,
        "completion_tokens": 448,
        "total_tokens": 1943
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How has Comcast's relationship with representation firms evolved in terms of advertising sales strategy between 2023 and 2024?",
      "original_answer": "In 2023, Comcast worked with representation firms as an extension of its sales force to sell a portion of the advertising units allocated to them, recording revenue net of agency commissions. By 2024, Comcast had evolved this relationship into formal representation agreements under which they sell advertising on behalf of third parties, indicating a deeper strategic alignment and expanded role for these firms. This reflects a shift from a co-selling model to a more formalized representation structure.",
      "llm_answer": "\nComcast’s advertising‑sales model with representation firms has stayed essentially unchanged from 2023 to 2024: the company still treats these firms as an extension of its own sales force, selling a portion of the advertising inventory that is allocated to it and recording the net amount after agency commissions.  Both the 2023 and 2024 Form 10‑K filings describe the same practice—recognizing advertising revenue on a gross basis and then offsetting the fees paid to representation firms in other operating expenses—indicating no substantive shift in strategy, only a consistent continuation of the approach.",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in its core claim. The ground truth explicitly states that Comcast's relationship with representation firms EVOLVED between 2023 and 2024, shifting from a co-selling model (where firms sold allocated units as an extension of sales force) to a formalized representation structure (where firms sell advertising on behalf of third parties). The LLM answer directly contradicts this by claiming the relationship 'stayed essentially unchanged' and that there was 'no substantive shift in strategy, only a consistent continuation.' This is a critical factual error that misses the entire premise of the question. The LLM correctly identifies that both years involved representation firms and revenue recognition practices, but completely fails to recognize the strategic evolution that occurred. The LLM's assertion that both filings 'describe the same practice' contradicts the ground truth's clear distinction between the two models. While the LLM demonstrates some understanding of the accounting mechanics (gross basis, agency commissions, other operating expenses), it fundamentally misinterprets the nature of the relationship change. The multi-hop reasoning required here was to synthesize the differences between 2023 and 2024 approaches, which the LLM failed to do. This represents a major comprehension failure on a question specifically asking about evolution/change over time.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 395,
        "total_tokens": 1669
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How has Oracle's approach to its industry-specific hardware offerings evolved between fiscal 2022 and fiscal 2023, particularly in terms of revenue recognition and strategic emphasis?",
      "original_answer": "In fiscal 2022, Oracle described its hardware business as including industry-specific hardware and recognized hardware revenues at the point in time when products and related software were delivered to customers. By fiscal 2023, Oracle introduced a more detailed explanation of revenue recognition for hardware, stating that revenues for combined performance obligations (hardware plus related software) are generally recognized at the point in time of delivery and ownership transfer. Additionally, in 2023, Oracle emphasized ongoing investments in R&D to improve existing hardware offerings and develop new products, signaling a more strategic focus on innovation in this area compared to 2022, where the description was more general and focused on the breadth of offerings.",
      "llm_answer": "\nOracle’s accounting for its industry‑specific hardware remained the same: product sales are recognized at the point in time when the hardware (and its embedded software) is delivered, while hardware‑support fees are recorded ratably over the contractual term.  The 2023 filing shows the same revenue‑recognition pattern as 2022, but the company’s strategic focus on hardware was unchanged – it still describes hardware as a modest (~6 % of total revenue) yet strategically important component of its broader cloud‑and‑infrastructure portfolio, emphasizing continued R&D investment and the need to manage volatile quarterly sales and lower margins relative to its cloud and license businesses.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misses the core evolution described in the ground truth. Key issues: (1) INCORRECT CORE CLAIM: The LLM states 'Oracle's accounting for its industry-specific hardware remained the same' between 2022 and 2023, directly contradicting the ground truth which explicitly states Oracle 'introduced a more detailed explanation of revenue recognition for hardware' in 2023, moving from a general description to specific mention of 'combined performance obligations (hardware plus related software).' This is a fundamental misunderstanding of the question's focus on evolution/change. (2) UNSUPPORTED QUANTITATIVE CLAIM: The LLM introduces a specific metric (~6% of total revenue) that does not appear in the ground truth and cannot be verified. This is a fabricated number that undermines credibility. (3) MISSING KEY EVOLUTION: The ground truth emphasizes that 2023 showed 'ongoing investments in R&D to improve existing hardware offerings and develop new products, signaling a more strategic focus on innovation' compared to 2022's 'more general' description. The LLM mentions R&D investment but frames it as 'unchanged' rather than highlighting the shift in strategic emphasis. (4) MISCHARACTERIZATION: The LLM describes hardware as 'modest (~6% of total revenue) yet strategically important' - while the characterization of strategic importance aligns with ground truth, the specific percentage is unsubstantiated and the overall framing suggests continuity rather than evolution. (5) INCOMPLETE SYNTHESIS: The question specifically asks about evolution 'particularly in terms of revenue recognition and strategic emphasis.' The LLM addresses revenue recognition only superficially and misses the key distinction that 2023 provided MORE DETAILED explanation of combined performance obligations. The strategic emphasis evolution (from general to innovation-focused R&D) is mentioned but downplayed as 'unchanged.' The answer fails the multi-hop reasoning requirement by not properly synthesizing the differences between the two fiscal years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 561,
        "total_tokens": 1938
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did the sales performance of IMBRUVICA (ibrutinib) evolve between 2022 and 2023, and what factors contributed to this change?",
      "original_answer": "IMBRUVICA sales decreased from $3.784 billion in 2022 to $3.264 billion in 2023, a decline of 13.7%. In 2022, the growth of IMBRUVICA was already being offset by competitive pressures from novel oral agents and market dynamics related to the pandemic, such as delays in new patient starts. By 2023, this downward trend continued, with the product experiencing a significant drop in sales, reflecting sustained competitive pressures and likely increased market saturation or treatment shifts in the oncology space.",
      "llm_answer": "\nIMBRUVICA (ibrutinib) sales fell sharply – from roughly **$3.78 billion in fiscal 2022 to about $3.26 billion in fiscal 2023**, a decline of **≈13–14 %**.  The drop was attributed to **global competitive pressures on the BTK‑inhibitor franchise**, including newer oral agents and pricing pressure that eroded market share, even as the company’s overall oncology portfolio grew modestly thanks to other products such as DARZALEX, CARVYKTI and ERLEADA.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy on the core quantitative metrics and provides relevant context about competitive pressures. Verification of key numbers: (1) 2022 sales of $3.78B vs. ground truth $3.784B - essentially correct with minor rounding; (2) 2023 sales of $3.26B vs. ground truth $3.264B - essentially correct with minor rounding; (3) Percentage decline of 13-14% vs. ground truth 13.7% - accurate (calculation: ($3.784B - $3.264B)/$3.784B = 13.7%, and LLM's range of 13-14% captures this). The LLM correctly identifies the multi-hop synthesis: sales decline + competitive pressures from novel oral BTK inhibitors + market dynamics. The answer appropriately contextualizes the decline within the broader oncology portfolio performance. Minor differences from ground truth: (1) The LLM mentions specific competing products (DARZALEX, CARVYKTI, ERLEADA) and notes the overall oncology portfolio grew modestly - this adds relevant context not explicitly in the ground truth but is factually appropriate; (2) The ground truth mentions 'pandemic-related delays in new patient starts' as a 2022 factor, which the LLM does not explicitly reference, though this is a relatively minor omission; (3) The LLM uses 'fiscal 2022' and 'fiscal 2023' terminology which is appropriate for SEC filings. The reasoning is sound - correctly synthesizing that competitive pressures from novel oral agents and market saturation drove the decline. The answer is well-structured and directly addresses both parts of the question (performance evolution and contributing factors). The only minor gap is not explicitly mentioning pandemic-related factors from 2022, but the core answer is substantively correct and comprehensive.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 469,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has Comcast's involvement with Universal Beijing Resort evolved from 2023 to 2024 in terms of debt levels, ownership structure, and financial risk exposure?",
      "original_answer": "In 2023, Universal Beijing Resort had $3.5 billion of debt outstanding, including a $3.1 billion term loan, and was consolidated by Comcast, which owns a 30% interest. By 2024, the debt level slightly decreased to $3.4 billion, with the term loan principal reducing to $3.0 billion. Comcast continues to consolidate Universal Beijing Resort as a VIE, maintaining its 30% ownership stake. The maximum financial risk exposure for Comcast remains limited to its 30% equity interest, indicating a stable risk profile despite the slight reduction in debt. This evolution reflects a minor decrease in leverage but no change in ownership or governance structure.",
      "llm_answer": "\nFrom 2023 to 2024 Comcast’s stake in Universal Beijing Resort remained at 30 percent and the resort continued to be consolidated as a variable‑interest entity because Comcast controls the activities that most affect its economic performance.  The resort’s outstanding debt fell slightly, from about $3.5 billion (including a $3.1 billion term loan) at the end of 2023 to roughly $3.4 billion (with a $3.0 billion term loan) by the end of 2024, and there were no new liquidity guarantees or other financial commitments linking Comcast to the debt.  Consequently, Comcast’s financial risk exposure stayed limited to its 30 percent equity interest (and any remaining unfunded capital commitments), with no additional guarantees or contingent liabilities introduced between the two years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. All quantitative data is correct: 30% ownership stake maintained, debt declining from $3.5B to $3.4B, term loan reducing from $3.1B to $3.0B. The multi-hop synthesis is sound, correctly connecting ownership structure, debt levels, consolidation status (VIE), and financial risk exposure across both years. The answer properly addresses all three dimensions of the question (debt levels, ownership structure, financial risk exposure) and accurately conveys that there was no change in governance/ownership while debt slightly decreased. The LLM adds valuable context about the absence of new liquidity guarantees or contingent liabilities, which enhances understanding of the stable risk profile. The reasoning about VIE consolidation and how Comcast's risk is limited to its 30% equity interest is logically sound and semantically equivalent to the ground truth. Minor point: the LLM mentions 'unfunded capital commitments' which is a reasonable elaboration not contradicting the ground truth, though not explicitly stated in the original answer. Overall, this is a comprehensive, accurate response that successfully synthesizes multi-year financial information.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 346,
        "total_tokens": 1709
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How did the financial commitment related to future lease payments for build-to-suit facilities and equipment evolve from 2022 to 2023, and what does this indicate about FedEx's leasing strategy?",
      "original_answer": "In 2022, FedEx disclosed future undiscounted payments of approximately $3.4 billion for build-to-suit facilities that had not yet commenced, with expected commencement dates from 2023 to 2024. By 2023, the company reported a significant reduction in these future commitments, with undiscounted payments dropping to approximately $0.9 billion for build-to-suit facilities and equipment, with commencement dates expected from 2025 to 2027. This indicates a strategic shift toward fewer long-term build-to-suit lease commitments and a more extended timeline for asset utilization.",
      "llm_answer": "\nIn the 2022 disclosure (page 58) FedEx noted that it had signed additional build‑to‑suit leases with undiscounted future payments of roughly **$3.4 billion**, most slated to commence in 2023‑2024. By the 2023‑2024 footnote (page 98) the remaining undiscounted commitment for those build‑to‑suit facilities and equipment had fallen to about **$0.9 billion**, with commencement now pushed to 2025‑2027. This decline indicates that many of the planned off‑balance‑sheet projects either came online or were cancelled, and FedEx is scaling back its large‑scale build‑to‑suit expansion in favor of more controlled, longer‑term lease arrangements.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive understanding of FedEx's leasing strategy evolution. QUANTITATIVE VERIFICATION: All key numbers are correct - $3.4 billion in 2022 undiscounted future payments for build-to-suit facilities, declining to $0.9 billion by 2023. The timeline shifts are accurately captured (2023-2024 commencement dates in 2022 disclosure vs. 2025-2027 in 2023 disclosure). COMPLETENESS: The answer addresses all components of the multi-part question: (1) the financial commitment amounts, (2) the evolution from 2022 to 2023, and (3) what this indicates about FedEx's leasing strategy. MULTI-HOP SYNTHESIS: The LLM correctly synthesized information across two different fiscal year disclosures and identified the strategic implications. The reasoning that 'many of the planned off-balance-sheet projects either came online or were cancelled' is a logical inference from the data reduction. ENTITY ACCURACY: FedEx is correctly identified, fiscal years are accurate, and the financial metrics (undiscounted future payments for build-to-suit facilities and equipment) are properly characterized. SEMANTIC EQUIVALENCE: The LLM's interpretation that this represents 'a strategic shift toward fewer long-term build-to-suit lease commitments and a more extended timeline' aligns well with the ground truth's characterization of 'a strategic shift toward fewer long-term build-to-suit lease commitments and a more extended timeline for asset utilization.' The additional context about 'more controlled, longer-term lease arrangements' adds reasonable interpretive value without contradicting the ground truth. Minor note: The LLM references specific page numbers (58, 98) which adds helpful sourcing detail, though these weren't in the original answer. No factual errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 492,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has Mastercard's relationship with Dynamic Yield LTD evolved between 2023 and 2024, and what does this indicate about the company's strategic focus during this period?",
      "original_answer": "In 2023, Mastercard disclosed that it had acquired Dynamic Yield LTD in April 2022 for $325 million, with $200 million of goodwill attributed to synergies expected after the acquisition. By 2024, the relationship is described as stable, with no new investments or acquisitions involving Dynamic Yield reported during the year. This indicates that the integration of Dynamic Yield was largely completed by 2023, and Mastercard shifted focus to newer acquisitions like Recorded Future in 2024, signaling a strategic pivot toward cybersecurity and threat intelligence.",
      "llm_answer": "\nBetween 2023 and 2024 Mastercard did not make any additional investment in or acquire more of Dynamic Yield LTD – the company’s 2022 purchase remained the only exposure – and the business was fully integrated into Mastercard’s “value‑added services and solutions” portfolio.  The continued contribution of Dynamic Yield’s technology helped lift revenue from value‑added services to $9.274 bn in 2023 (up from $7.879 bn in 2022), underscoring Mastercard’s strategic shift toward data‑driven, cybersecurity and intelligence‑focused offerings rather than pure payment‑network fees.  This reflects a broader strategic focus on expanding high‑margin, analytics‑rich services that can be sold alongside its core payment‑network platform.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core relationship evolution (no new investments in Dynamic Yield between 2023-2024, integration completed, strategic shift toward newer acquisitions like Recorded Future). However, there are significant quantitative accuracy issues: (1) The LLM cites revenue figures for 'value-added services' ($9.274 bn in 2023, $7.879 bn in 2022) that are NOT verified in the ground truth and appear to be unsourced claims. The ground truth does not mention these specific revenue figures. (2) The LLM does not cite the original $325 million acquisition price or the $200 million goodwill figure mentioned in the ground truth, which are key factual details about the relationship. (3) The LLM correctly infers the strategic pivot but attributes it to 'data-driven, cybersecurity and intelligence-focused offerings' when the ground truth specifically mentions the pivot to 'cybersecurity and threat intelligence' via Recorded Future acquisition. The qualitative reasoning about integration completion and strategic focus is sound, but the introduction of unverified financial metrics significantly undermines credibility. The answer demonstrates good understanding of the multi-hop synthesis (2023 status → 2024 status → strategic implications) but fails on factual precision regarding specific numbers. The contextual relevance is strong as it addresses the evolution question and strategic implications, but the unsourced revenue data is a critical flaw.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 409,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has the Severance Plan for Senior Officers at Lowe's evolved between 2022 and 2024, particularly in terms of the most recent amendment dates and associated filings?",
      "original_answer": "In 2022, the Severance Plan for Senior Officers was described as 'amended and restated May 29, 2020' and was filed on August 26, 2020 (Exhibit 10.29). By 2024, the plan had been further amended and restated on May 26, 2022, with the updated version filed on November 27, 2024 (Exhibit 10.28). This indicates that Lowe's updated its Severance Plan for Senior Officers at least once between 2022 and 2024, with the most recent amendment occurring in mid-2022 and formally disclosed in late 2024.",
      "llm_answer": "\nThe Senior Officer Severance Plan was most recently restated on **May 26 2022** (Exhibit 10.28), filed as an exhibit to a **Form 10‑Q** (filed November 27 2024). The only prior amendment was a **May 29 2020** restatement (Exhibit 10.29) that appeared in a Form 10‑Q filed on **August 26 2020**; no further amendments have been disclosed through 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. All key dates and exhibit numbers are correct: May 26, 2022 amendment (Exhibit 10.28), November 27, 2024 filing date, May 29, 2020 prior amendment (Exhibit 10.29), and August 26, 2020 prior filing date. The answer correctly identifies the filing forms (Form 10-Q) and accurately synthesizes the multi-hop information about the plan's evolution between 2022 and 2024. The statement that 'no further amendments have been disclosed through 2024' is consistent with the ground truth, which indicates the May 26, 2022 amendment was 'the most recent' as of 2024. The answer demonstrates sound multi-hop reasoning by connecting amendment dates, exhibit numbers, and filing dates across the two time periods. Minor consideration: The LLM uses slightly different phrasing ('The only prior amendment was...') compared to the ground truth's 'at least once between 2022 and 2024,' but this is semantically equivalent and actually more precise. The answer is complete, addresses all aspects of the question about evolution and amendment dates, and maintains factual accuracy throughout.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1216,
        "completion_tokens": 321,
        "total_tokens": 1537
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did the fair value of Netflix's 6.375% Senior Notes change between December 31, 2021, and December 31, 2023, and what does this evolution indicate about market perceptions of the company's debt over this period?",
      "original_answer": "The fair value of Netflix's 6.375% Senior Notes increased from $999 million as of December 31, 2021, to $872 million as of December 31, 2023. This indicates a decrease in the fair value of the notes over the two-year period, suggesting a potential decline in market confidence or an increase in required yields for this debt instrument.",
      "llm_answer": "\nThe 6.375 % Senior Notes were quoted at a fair value of **$830 million on December 31 2021** and rose to **$872 million on December 31 2023**—an increase of about **$42 million (≈5 %)**, moving the bonds slightly above their $800 million par amount.  \nThis upward movement in market‑derived fair value indicates that investors grew more confident in Netflix’s debt, pricing the notes at a premium and signaling a perceived improvement in the company’s creditworthiness and financial outlook over the two‑year period.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamental factual inaccuracies that completely contradict the ground truth: (1) WRONG STARTING VALUE: LLM states $830 million on December 31, 2021, but ground truth shows $999 million - a $169 million error. (2) CORRECT ENDING VALUE: LLM correctly identifies $872 million on December 31, 2023. (3) WRONG DIRECTION OF CHANGE: LLM claims an increase of $42 million and interprets this as improved market confidence. However, the ground truth shows a DECREASE from $999M to $872M (a $127 million decline), indicating declining market confidence - the exact opposite conclusion. (4) CALCULATION ERROR: Even using LLM's own numbers ($830M to $872M), the increase would be $42M, which is correct arithmetic, but this is based on the wrong starting value. (5) MISINTERPRETATION: The LLM's conclusion that 'investors grew more confident in Netflix's debt' is directly contradicted by the actual data showing fair value declining from $999M to $872M. The correct interpretation is that market confidence declined or required yields increased. (6) PAR VALUE REFERENCE: LLM mentions $800 million par amount, which is not verified in the ground truth and appears to be an assumption. The ground truth clearly establishes the actual fair values at both dates. This is a multi-hop question requiring accurate synthesis of two specific data points and correct interpretation of their relationship. The LLM failed on both the data accuracy and the analytical conclusion.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1230,
        "completion_tokens": 413,
        "total_tokens": 1644
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did the sales performance of IMBRUVICA evolve between 2022 and 2023, and what does this indicate about its market position in the oncology segment?",
      "original_answer": "IMBRUVICA's sales decreased from $4,369 million in 2022 to $3,264 million in 2023, representing a decline of 25.2%. This indicates a weakening market position for IMBRUVICA within the oncology segment, especially as other products like DARZALEX and ERLEADA experienced significant growth during the same period.",
      "llm_answer": "\nIMBRUVICA’s worldwide sales fell from **$3.78 billion in 2022 to $3.26 billion in 2023**, a decline of roughly **13–14 %**.  The drop is attributed in the filing to “global competitive pressures,” reflecting loss of market share as newer oncology therapies and biosimilar/next‑generation BTK inhibitors erode its dominance.  Consequently, while the overall oncology segment grew double‑digit (10.5 % to $17.7 billion), IMBRUVICA’s performance indicates that its once‑leading market position is now being challenged and is no longer a primary growth driver for the company.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual errors that fundamentally undermine its credibility. (1) SALES FIGURES ARE WRONG: Ground truth shows IMBRUVICA sales of $4,369 million (2022) and $3,264 million (2023). The LLM states $3.78 billion (2022) and $3.26 billion (2023). Converting: $3.78B = $3,780M and $3.26B = $3,260M. The 2022 figure is off by $589 million ($4,369M vs $3,780M = 13.5% understatement). The 2023 figure is approximately correct ($3,264M vs $3,260M is negligible). (2) PERCENTAGE DECLINE IS WRONG: Ground truth shows a 25.2% decline. The LLM calculates 13-14% decline, which is mathematically incorrect even using their own stated figures: ($3.78B - $3.26B) / $3.78B = $0.52B / $3.78B = 13.8%. However, using correct figures: ($4,369M - $3,264M) / $4,369M = $1,105M / $4,369M = 25.3%, confirming the ground truth. The LLM's percentage is off by approximately 11 percentage points. (3) MULTI-HOP REASONING: The LLM correctly identifies the decline and attributes it to competitive pressures, which aligns with the ground truth's mention of weakening market position. The reference to other products (DARZALEX, ERLEADA growth) is mentioned in ground truth but not in LLM answer, representing a minor omission. The LLM adds context about oncology segment growth (10.5% to $17.7B) which is reasonable contextual information but not verified against ground truth. (4) ENTITY AND METRIC ACCURACY: IMBRUVICA is correctly identified. Years (2022, 2023) are correct. The oncology segment context is appropriate. (5) SEMANTIC EQUIVALENCE: While the LLM correctly conveys that IMBRUVICA's market position weakened, the fundamental numerical errors (wrong 2022 baseline, wrong decline percentage) make this answer factually incorrect despite reasonable qualitative reasoning about competitive pressures and market dynamics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1222,
        "completion_tokens": 506,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did LOW's inventory shrink reserve and LCNRV reserve evolve between 2022 and 2024, and what were the implications for net earnings?",
      "original_answer": "Between 2022 and 2024, LOW's inventory shrink reserve increased from $414 million to $427 million, while the LCNRV reserve increased from $168 million to $222 million. In 2024, a 10% change in either the amount of inventory subject to markdown or the weighted average estimated loss rate used in the LCNRV reserve calculation would have affected net earnings by approximately $17 million, and a 10% change in the estimated shrinkage rate would have impacted net earnings by approximately $32 million. These changes indicate a growing need for reserves, particularly for shrinkage, and highlight the increasing sensitivity of net earnings to inventory valuation assumptions.",
      "llm_answer": "\nThe LCNRV (lower‑of‑cost‑or‑net‑realizable‑value) reserve grew from about **$168 million at the end of fiscal 2021** (the figure disclosed in the 2022 filing) to roughly **$222 million at the end of fiscal 2024**, while the inventory‑shrink reserve rose from roughly **$414 million to $427 million** over the same period.  Because these reserves are recorded as additional cost of sales, the higher balances added non‑cash expense that reduced net earnings; the company estimates that a 10 % change in either reserve would shift net income by roughly **$13–$17 million**, implying that the reserve increases between 2022 and 2024 subtracted several tens of millions of dollars from earnings.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identified the directional trends for both reserves (shrink reserve increasing from $414M to $427M, LCNRV reserve increasing from $168M to $222M). The answer appropriately explains the mechanism (reserves recorded as cost of sales reducing net earnings) and correctly identifies the sensitivity analysis framework (10% changes affecting earnings). The semantic understanding of the question and multi-hop synthesis is sound.\n\nWEAKNESSES: (1) CRITICAL QUANTITATIVE ERROR: The LLM states the 10% change impact as '$13-$17 million' when the ground truth specifies two separate impacts: approximately $17 million for LCNRV and approximately $32 million for shrinkage. This is a significant misrepresentation of the sensitivity analysis. (2) TEMPORAL CONFUSION: The LLM references 'fiscal 2021' for the 2022 filing baseline, which is imprecise language. While technically the 2022 10-K would report 2021 year-end figures, the question asks about 2022-2024 evolution, and the ground truth clearly states the starting point as 2022 (not 2021). (3) INCOMPLETE SENSITIVITY ANALYSIS: The ground truth provides two distinct sensitivity metrics ($17M for LCNRV, $32M for shrinkage), but the LLM conflates these into a single '$13-17M' range, losing critical information about the differential impact of each reserve type. (4) VAGUE CONCLUSION: The phrase 'subtracted several tens of millions of dollars from earnings' is imprecise compared to the ground truth's more specific quantification.\n\nCALCULATION VERIFICATION: The reserve changes are correct ($414M→$427M = $13M increase; $168M→$222M = $54M increase). However, the sensitivity analysis numbers are materially wrong. The ground truth specifies $17M (LCNRV) and $32M (shrinkage), totaling $49M in combined sensitivity, not the $13-17M range stated.\n\nMULTI-HOP REASONING: The LLM demonstrates understanding of how to connect reserve balances to earnings impact through the cost-of-sales mechanism, but fails to properly synthesize the two separate sensitivity metrics provided in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 558,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did Qulipta's status and financial contribution evolve from 2022 to 2023, particularly in terms of its development and commercialization progress?",
      "original_answer": "In 2022, Qulipta was among the products that contributed to the reclassification of $1.0 billion of indefinite-lived research and development intangible assets to developed product rights upon receiving regulatory approvals. By 2023, Qulipta had transitioned from development to commercialization, generating $405 million in revenue in the United States and $3 million internationally, indicating a significant shift from a developmental asset to a revenue-generating product.",
      "llm_answer": "\nQulipta moved from essentially no sales in 2021 to $158 million of U.S. revenue in 2022 and $405 million in 2023 – a >150 % increase – showing that the drug progressed from its 2021 regulatory approval to full commercial launch and is now a growing contributor to AbbVie’s “other” net‑revenue segment.  The 2021 re‑classification of $1 billion of indefinite‑lived IPR&D to definite‑lived developed‑product rights for Qulipta (see Note 100) confirms that its development was completed and the asset began amortizing, and the steep revenue jump reported in 2023 (page 98) reflects the successful commercialization and expanding market uptake of the product.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM claims Qulipta generated '$158 million of U.S. revenue in 2022' but the ground truth makes NO mention of 2022 revenue for Qulipta. The ground truth only states that in 2022, Qulipta was reclassified from indefinite-lived R&D to developed product rights (a balance sheet reclassification), and that by 2023 it generated $405M US + $3M international revenue. The $158M 2022 figure appears to be fabricated or confused with another product/year. (2) The LLM incorrectly references a '2021 regulatory approval' and '2021 re-classification' - the ground truth states the reclassification occurred in 2022, not 2021. This is a critical dating error. (3) The LLM's calculation of '>150% increase' from $158M to $405M is mathematically correct (156% increase), but is based on the false premise that $158M was the 2022 figure. (4) WHAT WAS CORRECT: The LLM correctly identifies the $405M US revenue in 2023, correctly notes the transition from development to commercialization, correctly references the $1 billion reclassification of indefinite-lived IPR&D to developed product rights, and correctly understands that this reclassification indicates completion of development and beginning of amortization. (5) MULTI-HOP REASONING: The LLM demonstrates understanding of the connection between asset reclassification and revenue generation, but this reasoning is undermined by the factual errors about 2022 revenue and timing. The answer conflates or invents a 2022 revenue figure that doesn't appear in the ground truth, which is a fundamental error in a financial analysis context where precision is critical.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 454,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How has Honeywell's financial dependency on the Resideo subsidiary for environmental liabilities evolved between 2022 and 2023, and what does this indicate about the company's risk exposure?",
      "original_answer": "Honeywell's financial dependency on the Resideo subsidiary for environmental liabilities remained consistent between 2022 and 2023, with Resideo's subsidiary still obligated to pay 90% of Honeywell's annual net spending on environmental matters at specified sites, up to a maximum of $140 million per year. This ongoing arrangement indicates that Honeywell continues to rely on Resideo's payments to offset a significant portion of its environmental costs, suggesting that the risk mitigation strategy through this indemnification agreement has not changed over the two years.",
      "llm_answer": "\nBetween 2022 and 2023 the amount Honeywell can recover from Resideo under the indemnification‑reimbursement agreement grew—recorded receivables rose from $157 million to $187 million, and the total outstanding receivable (short‑ plus long‑term) increased from roughly $614 million to $661 million—while cash collections stayed at the $140 million annual cap. This shows that Honeywell is increasingly dependent on Resideo to offset its environmental spending, but the cap and the 2043 termination date mean that any future environmental liabilities that exceed the capped reimbursements or that arise after the agreement ends could expose Honeywell to additional cash‑flow risk.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misinterprets the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM cites specific receivable amounts ($157M to $187M, $614M to $661M) that are not mentioned in the ground truth and appear to be fabricated or from unreliable sources. The ground truth does not provide these specific numbers. (2) MISINTERPRETATION OF CORE FACT: The ground truth explicitly states that Honeywell's financial dependency 'remained consistent' between 2022 and 2023, with the 90% obligation and $140M annual cap unchanged. The LLM incorrectly claims dependency 'grew' based on unverified receivable figures. (3) MISSING KEY INFORMATION: The LLM fails to mention the critical 90% obligation that Resideo's subsidiary must pay, which is central to understanding the arrangement. The ground truth emphasizes this percentage as a key metric. (4) PARTIAL ACCURACY: The LLM correctly identifies the $140M annual cap and mentions the 2043 termination date (though not explicitly in ground truth, this is a reasonable inference about risk exposure). The discussion of future liability exposure after agreement termination is a reasonable analytical point but goes beyond what the ground truth establishes. (5) MULTI-HOP REASONING: The LLM fails to properly synthesize the comparison between 2022 and 2023, instead presenting unverified numbers rather than the ground truth's finding of consistency. The conclusion about 'increasing dependency' contradicts the ground truth's 'remained consistent' finding. The answer demonstrates poor fact-checking and introduces unsupported quantitative claims that undermine credibility.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 453,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How has Target's definition or treatment of 'original maturity' for cash equivalents evolved between 2022 and 2024, and what does this indicate about potential changes in their cash management strategy?",
      "original_answer": "In 2022, Target defined cash equivalents as highly liquid investments with an original maturity of three months or less, with no additional context or clarification. By 2024, the company maintained the same three-month threshold for original maturity but added a broader discussion around fair value measurements for other short-term assets and liabilities, suggesting a more comprehensive approach to short-term financial instruments. This evolution indicates a potential refinement in how Target evaluates and manages its cash and near-cash assets within a broader financial framework.",
      "llm_answer": "\nTarget’s 2022 and 2024 10‑K filings use the same wording for cash equivalents – “highly liquid investments with an original maturity of **three months or less from the time of purchase**” – and no alternate definition is introduced in the intervening years.  Consequently, there has been no material evolution in how Target classifies the “original maturity” of its cash‑equivalent holdings; the company continues to treat only instruments that mature within three months as cash equivalents.  The modest changes observed in the composition of those equivalents (e.g., a slight shift toward shorter‑dated short‑term investments and a lower overall cash‑equivalent balance) reflect routine liquidity‑management adjustments, but the underlying cash‑management strategy—maintaining a large, highly liquid buffer of short‑term assets—remains consistent.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies that Target maintained the same three-month threshold for original maturity between 2022 and 2024, which aligns with the ground truth. The specific wording quoted ('three months or less from the time of purchase') appears accurate and the numeric threshold is correct. However, there are significant issues with the overall assessment: (1) The LLM concludes there was 'no material evolution' in how Target classifies original maturity, which directly contradicts the ground truth's statement that the company 'added a broader discussion around fair value measurements for other short-term assets and liabilities, suggesting a more comprehensive approach.' (2) The LLM introduces unsupported claims about 'a slight shift toward shorter-dated short-term investments and a lower overall cash-equivalent balance' without providing specific numbers or evidence from the filings. (3) The ground truth indicates a refinement in how Target evaluates and manages cash within a broader financial framework, but the LLM dismisses this as merely 'routine liquidity-management adjustments.' (4) The LLM's characterization of the evolution as 'modest changes' and 'no material evolution' misses the key point that the ground truth identifies: the addition of broader discussion around fair value measurements represents a meaningful refinement in their approach, even if the three-month threshold remained constant. The LLM correctly identifies the core definition but fails to recognize and properly characterize the evolution in the broader context of cash management strategy that the ground truth emphasizes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 447,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did the valuation and classification of NVDA's 3.50% Notes Due 2040 evolve between 2023 and 2024, and what does this indicate about the company's long-term debt strategy?",
      "original_answer": "In 2023, the 3.50% Notes Due 2040 were listed under liabilities with a carrying value of $851 million as of January 28, 2024, and were categorized as Level 2 in the pricing hierarchy. By 2024, the valuation of the same notes increased to $1,000 million as of January 26, 2025, with a more detailed breakdown including an effective interest rate of 3.54% and a remaining term of 15.2 years. This indicates a strategic emphasis on long-term financing with stable interest rate structures.",
      "llm_answer": "\nThe $1 billion 3.50% Notes Due 2040 continued to be reported as an **unsecured senior long‑term obligation** (classified as Level 2 in the fair‑value hierarchy) in both fiscal 2023 and 2024.  Its **carrying amount remained $1 billion**, but the disclosed fair value slipped from **$870 million (Jan 29 2023)** to **$851 million (Jan 28 2024)**, reflecting the modest decline in market price as interest rates rose.  This stable, multi‑decade issuance shows NVIDIA’s strategy of financing growth with low‑coupon, long‑dated senior debt while managing interest‑rate exposure.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant numerical inaccuracies that contradict the ground truth. (1) CARRYING VALUE ERROR: Ground truth states carrying value was $851 million as of Jan 28, 2024, but LLM claims it 'remained $1 billion' in both years. This is a critical error - the carrying value did NOT remain constant. (2) FAIR VALUE DIRECTION ERROR: LLM states fair value 'slipped from $870 million (Jan 29 2023) to $851 million (Jan 28 2024)' - this is backwards. Ground truth indicates the valuation INCREASED from $851 million (2023) to $1,000 million (2024), not decreased. The LLM has inverted the valuation trend. (3) DATE CONFUSION: LLM references Jan 29, 2023 and Jan 28, 2024, but ground truth specifies Jan 28, 2024 for the 2023 fiscal year data and Jan 26, 2025 for 2024 data. (4) MISSING KEY DETAILS: Ground truth includes effective interest rate (3.54%) and remaining term (15.2 years) for 2024, which LLM omits. (5) REASONING FLAW: LLM's explanation that fair value declined due to rising interest rates contradicts the actual data showing valuation increased. The multi-hop synthesis is fundamentally flawed - the LLM failed to correctly identify the evolution of valuation between the two years, which is the core of the question. While the LLM correctly identifies the notes as unsecured senior long-term debt and Level 2 classification, the quantitative errors are severe enough to make the answer substantially incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 404,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did the financial performance of Venclexta evolve between 2022 and 2023, particularly in terms of total global revenue and the growth rate?",
      "original_answer": "In 2022, Venclexta generated a total global revenue of $2,009 million, with a growth rate of 10.4%. In 2023, the total global revenue from Venclexta increased to $2,288 million, representing a growth rate of 13.9%. This indicates an upward trend in both absolute revenue and growth rate year-over-year.",
      "llm_answer": "\nVenclexta’s global net sales rose from **$2.009 billion in 2022 to $2.288 billion in 2023**, an increase of **13.9 %** at actual currency rates (roughly **15 %** on a constant‑currency basis). The growth was broad‑based, with double‑digit gains in both U.S. and international markets.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identified the revenue figures ($2.009 billion in 2022 and $2.288 billion in 2023), properly converted them from millions to billions, and accurately stated the 13.9% growth rate for 2023. The answer appropriately addresses the question about financial evolution between the two years and provides additional context about broad-based growth across markets. CRITICAL ISSUE: The LLM answer is incomplete regarding the 2022 growth rate. The ground truth specifies that 2022 had a 10.4% growth rate, which is a key part of the question asking about 'growth rate' evolution. The LLM only mentions the 13.9% growth rate (for 2023) but fails to provide the 2022 growth rate of 10.4%, which is essential for demonstrating the 'upward trend in both absolute revenue and growth rate year-over-year' as stated in the ground truth. CALCULATION VERIFICATION: The revenue increase from $2.009B to $2.288B is correct ($279M increase). The 13.9% growth rate for 2023 is accurate. However, without the 2022 growth rate, the answer cannot fully demonstrate the evolution of growth rates between the two years. MULTI-HOP REASONING: The answer successfully synthesizes revenue data across two years but fails to complete the full multi-hop requirement by omitting the 2022 growth rate metric. The additional context about constant-currency basis (15%) and geographic performance is helpful but not part of the ground truth answer. SEMANTIC EQUIVALENCE: The core revenue numbers and 2023 growth rate are semantically equivalent to the ground truth, but the omission of the 2022 growth rate represents a significant gap in answering the complete question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1146,
        "completion_tokens": 454,
        "total_tokens": 1600
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How has Netflix's approach to executive severance and retention incentives evolved between the 2022 and 2023 SEC filings, particularly in terms of plan amendments and their effective dates?",
      "original_answer": "In 2022, the filing referenced the 'Amended and Restated Executive Severance and Retention Incentive Plan' with a filing date of September 10, 2021, indicating that the plan had undergone revisions by that date. By 2023, the filing showed further evolution, introducing the 'Executive Severance and Retention Incentive Plan as Amended and Restated effective January 1, 2024,' with a filing date of December 8, 2023. This demonstrates Netflix’s ongoing adjustments to executive compensation frameworks, with a forward-looking amendment effective in 2024.",
      "llm_answer": "\nBetween the 2022 and 2023 filings Netflix replaced its prior “Executive Severance and Retention Incentive Plan”—which had been adopted and filed as an amended‑and‑restated plan effective September 10 2021 in the 2022 Form 10‑K—with a newly amended and restated version that will become effective on January 1 2024 (Exhibit 10.16 in the 2023 filing) and, at the same time, introduced a separate “Executive Officer Severance Plan” that took effect on December 8 2023 (Exhibit 10.15). These moves signal a deliberate update to the company’s executive‑compensation framework, adjusting severance and retention triggers and shifting the operative dates of the plans.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains both accurate and problematic elements. CORRECT ELEMENTS: (1) The 2022 filing reference to 'Amended and Restated Executive Severance and Retention Incentive Plan' with September 10, 2021 date is accurate. (2) The 2023 filing reference to a plan effective January 1, 2024 is correct. (3) The December 8, 2023 filing date is accurate. (4) The general characterization of Netflix's ongoing adjustments to executive compensation is appropriate. PROBLEMATIC ELEMENTS: (1) The LLM introduces a separate 'Executive Officer Severance Plan' effective December 8, 2023 (Exhibit 10.15) that is NOT mentioned in the ground truth answer. This appears to be additional information not in the original answer, which could represent either an error (fabrication) or legitimate additional detail from the filings. However, since the ground truth specifically states the evolution was between the 'Amended and Restated Executive Severance and Retention Incentive Plan' (2022) and the 'Executive Severance and Retention Incentive Plan as Amended and Restated effective January 1, 2024' (2023), the introduction of a third separate plan suggests the LLM may have misinterpreted the filing structure or added information not supported by the ground truth. (2) The characterization of December 8, 2023 as an 'operative date' for a separate plan conflicts with the ground truth's focus on the January 1, 2024 effective date as the key evolution point. MULTI-HOP REASONING: The LLM correctly synthesizes information across 2022 and 2023 filings and identifies the temporal evolution. However, the introduction of the separate 'Executive Officer Severance Plan' creates ambiguity about whether the LLM accurately understood the filing structure. The ground truth presents a cleaner narrative of plan evolution (one plan amended twice), while the LLM presents a more complex structure (replacement plus new separate plan). QUANTITATIVE ACCURACY: Dates are correct (September 10, 2021; January 1, 2024; December 8, 2023), but the interpretation of what these dates represent differs from ground truth. The answer is partially correct but introduces elements not confirmed by the ground truth, reducing confidence in the overall accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 597,
        "total_tokens": 1912
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Lowe's documentation and structure of its Benefit Restoration Plan evolve from 2022 to 2024, and what does this indicate about the company's approach to employee retirement benefits?",
      "original_answer": "In 2022, Lowe's maintained the Benefit Restoration Plan as part of its defined contribution retirement offerings, supplementing benefits under the 401(k) Plan for employees affected by IRS limitations. The plan included both employee salary deferrals and employer contributions in the form of a Company Match. By 2024, the company formally introduced an updated and restated version of the Benefit Restoration Plan, effective January 1, 2025, as evidenced by the new exhibit filing (10.3) in the 2024 10-K. This indicates a deliberate effort to formalize and likely enhance the structure of the plan, signaling a more strategic and forward-looking approach to managing executive and high-earner compensation through improved documentation and alignment with long-term benefit policies.",
      "llm_answer": "\nFrom the 2022 filing (see NOTE 12 in the 2022 10‑K, pages 67‑71) the Benefit Restoration Plan was presented only as a supplemental defined‑contribution arrangement that provides matching contributions to employees whose 401(k) benefits are limited by IRS caps.  In the 2024 filing the plan was formally amended and restated, effective January 1 2025, and appears as Exhibit 10.3 in the 2024 10‑K (page 78), with revised eligibility language, updated matching formulas and integration with the newly restated 401(k) and cash‑deferral amendments.  This evolution shows that Lowe’s is actively refining and modernizing its retirement‑benefit structure to remain competitive, comply with regulatory changes, and clarify how supplemental benefits are administered.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness in addressing the multi-hop question about Lowe's Benefit Restoration Plan evolution from 2022 to 2024. STRENGTHS: (1) Correctly identifies the 2022 plan as a supplemental defined-contribution arrangement with matching contributions for employees affected by IRS limitations - matches ground truth characterization. (2) Accurately cites the 2024 amendment and restatement effective January 1, 2025, with proper exhibit reference (10.3 in 2024 10-K). (3) Provides specific sourcing (NOTE 12 in 2022 10-K, pages 67-71; Exhibit 10.3 in 2024 10-K, page 78) that demonstrates document-level verification. (4) Correctly synthesizes the multi-hop comparison: 2022 structure → 2024 formalization. (5) Appropriately interprets the evolution as indicating strategic refinement and modernization of retirement benefits. (6) Adds relevant context about regulatory compliance and competitive positioning that aligns with the ground truth's characterization of 'deliberate effort to formalize and enhance.' MINOR CONSIDERATIONS: The LLM answer includes slightly more operational detail (revised eligibility language, updated matching formulas, integration with 401(k) amendments) compared to the ground truth, but this represents appropriate elaboration rather than error. The semantic meaning is fully aligned - both answers convey that Lowe's moved from a basic supplemental arrangement to a more formally documented and strategically managed plan. No quantitative errors detected. All dates, exhibit numbers, and plan characteristics are accurate. The reasoning correctly synthesizes information across multiple filing years and documents.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 461,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did NVDA's financial obligations related to the 0.584% Notes Due 2024 evolve between fiscal years 2023 and 2024?",
      "original_answer": "In fiscal year 2023, NVDA reported a liability of $1,185 million for the 0.584% Notes Due 2024. By fiscal year 2024, this obligation was fully repaid, as stated in the 2024 10-K filing. This indicates a complete resolution of this specific debt obligation over the two-year period.",
      "llm_answer": "\nBetween the end of fiscal 2023 (January 28 2024) and the end of fiscal 2024 (January 26 2025), NVIDIA’s 0.584 % Notes Due 2024 fell from **$1.25 billion**—recorded as a short‑term liability of $1,250 million on page 72 of the 2023 10‑K—to **$0**—the same line shows “$‑” on page 72 of the 2024 10‑K, indicating the notes were fully retired (the company repurchased/repaid them in fiscal 2025). Thus the obligation evolved from a $1.25 bn short‑term debt to no outstanding balance.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL DISCREPANCY IN KEY NUMBERS: The LLM reports the FY2023 liability as $1,250 million ($1.25 billion), but the ground truth states it was $1,185 million. This is a material difference of $65 million (5.5% variance). The LLM's number is factually incorrect. CORRECT ELEMENTS: (1) The obligation was fully repaid/retired by FY2024, which matches ground truth; (2) The FY2024 balance is correctly stated as $0; (3) The general narrative of debt resolution is correct; (4) The fiscal year dates are accurate (Jan 28, 2024 for FY2023 end; Jan 26, 2025 for FY2024 end). REASONING ISSUES: The LLM states the notes were 'repurchased/repaid in fiscal 2025,' which is imprecise. The ground truth indicates the obligation was 'fully repaid' by FY2024 (which ended Jan 26, 2025), so technically the repayment occurred during FY2024, not in a separate 'fiscal 2025.' This is a minor semantic issue but adds confusion. MULTI-HOP SYNTHESIS: The answer correctly synthesizes the evolution across two fiscal years and identifies the complete resolution, which is appropriate for the multi-hop nature of the question. However, the foundational number error undermines the entire quantitative analysis. The $65 million discrepancy is not a rounding or formatting variation—it represents a factual error in reading/reporting the filing data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1183,
        "completion_tokens": 370,
        "total_tokens": 1553
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did the global revenue performance of Mavyret evolve between 2022 and 2023, and what were the trends in its United States and international markets during this period?",
      "original_answer": "In 2022, Mavyret generated total global revenue of $1,541 million, with $755 million from the United States and $786 million from international markets. By 2023, total revenue from Mavyret decreased to $1,430 million, driven by a decline in both U.S. and international markets. Specifically, U.S. revenue dropped to $659 million, a decrease of 12.7%, while international revenue slightly declined to $771 million, a marginal decrease of 1.9%. This indicates a contraction in Mavyret's market performance across both regions, with a more pronounced decline in the U.S. market.",
      "llm_answer": "\nMavyret’s worldwide net sales fell 12.7 % from 2022 to 2023, dropping from **$1.54 billion** to **$1.43 billion**. The decline was led by the U.S. market, where revenue slipped 12.7 % (from $755 M to $659 M), while international sales also fell modestly 1.9 % (from $786 M to $771 M).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. Verification of key metrics: (1) Global revenue 2022: $1.54B (stated) vs $1,541M (ground truth) - correct, acceptable format variation; (2) Global revenue 2023: $1.43B (stated) vs $1,430M (ground truth) - correct, acceptable format variation; (3) U.S. revenue 2022: $755M - correct; (4) U.S. revenue 2023: $659M - correct; (5) International revenue 2022: $786M - correct; (6) International revenue 2023: $771M - correct; (7) U.S. decline percentage: 12.7% - correct (($755M-$659M)/$755M = 12.7%); (8) International decline percentage: 1.9% - correct (($786M-$771M)/$786M = 1.9%); (9) Overall global decline: 12.7% stated - correct (($1,541M-$1,430M)/$1,541M = 7.2%, but the LLM states 12.7% which matches the U.S. decline rate, not the global rate). Minor issue: The LLM states worldwide decline as 12.7%, but the actual global decline is approximately 7.2%. However, the LLM correctly identifies that the U.S. market experienced a 12.7% decline. The answer comprehensively addresses all parts of the question: global revenue evolution, U.S. market trends, and international market trends. Multi-hop synthesis is sound - correctly combining data from multiple geographic segments across two years. The reasoning that U.S. decline was more pronounced than international decline is accurate and well-supported by the data presented.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1221,
        "completion_tokens": 385,
        "total_tokens": 1606
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Netflix's compliance with covenant limitations related to its Senior Notes evolve between 2022 and 2024, particularly in terms of repayment obligations and the scope of restrictions?",
      "original_answer": "In 2022, Netflix was in compliance with all covenant limitations tied to its Senior Notes, which included restrictions on creating liens, entering into sale and lease-back transactions, incurring additional indebtedness by certain subsidiaries, and merging or transferring substantial assets. These notes included various euro-denominated tranches with principal amounts totaling €5,170 million. By 2024, Netflix remained in compliance with these covenants, but the scope of limitations had slightly evolved—specifically, certain Senior Notes no longer referenced restrictions on sale and lease-back transactions, suggesting a narrowing of covenant scope for some notes. Additionally, in 2024, Netflix repaid $400 million of its 5.750% Senior Notes upon maturity, indicating active debt management and a shift in its debt composition.",
      "llm_answer": "\nNetflix continued to meet the same covenant package that governs its senior unsecured notes – the language restricting additional indebtedness, mergers, sale‑lease‑back transactions and the creation of liens was materially identical in the 2022 and 2024 filings, and the company affirmed compliance as of 31 Dec 2023 and 31 Dec 2024 【54】【56】.  The only evolution was the repayment at maturity in 2024 of the $400 million 5.750 % senior note, which removed that $400 million from short‑term debt, while the scope of the covenants themselves did not change.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the $400 million 5.750% Senior Notes repayment in 2024 as a key evolution. (2) The company name (Netflix) and years (2022, 2024) are correct. (3) The LLM correctly notes compliance with covenants in both periods. (4) The specific covenant types mentioned (liens, mergers, indebtedness restrictions) are accurate. (5) The $400 million figure is correct.\n\nWEAKNESSES: (1) CRITICAL OMISSION: The ground truth specifically mentions €5,170 million in euro-denominated tranches as part of the Senior Notes structure in 2022. The LLM completely omits this important quantitative detail about the debt composition. (2) COVENANT SCOPE EVOLUTION MISCHARACTERIZED: The ground truth states that 'certain Senior Notes no longer referenced restrictions on sale and lease-back transactions' by 2024, indicating a narrowing of covenant scope for some notes. The LLM contradicts this by stating 'the scope of the covenants themselves did not change' and that 'the language restricting...sale‑lease‑back transactions...was materially identical.' This is a direct factual contradiction with the ground truth's assertion of evolved scope. (3) INCOMPLETE SYNTHESIS: The LLM fails to capture the nuanced evolution described in the ground truth—that while overall compliance continued, the covenant scope for certain notes narrowed (removal of sale-leaseback restrictions for some notes). (4) MULTI-HOP REASONING: The LLM's synthesis is incomplete because it misses the distinction between 'overall compliance maintained' and 'scope of restrictions evolved for certain notes.'\n\nCALCULATION/NUMBER VERIFICATION: The $400 million figure is correct. However, the absence of the €5,170 million figure represents a significant omission of quantitative information about the debt structure.\n\nMULTI-HOP ASSESSMENT: The question asks about evolution 'particularly in terms of repayment obligations and the scope of restrictions.' The LLM addresses repayment obligations (the $400M maturity) but fails to properly address the scope evolution, instead claiming no change when the ground truth indicates narrowing of restrictions for certain notes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 580,
        "total_tokens": 1938
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Honeywell's approach to the Safety and Retail product line evolve between 2022 and 2023, and what structural change was introduced in 2023 that reflects this evolution?",
      "original_answer": "In 2022, Honeywell reported the Safety and Retail business unit as a standalone component under the Safety and Productivity Solutions segment, generating $2,387 million in revenue. By 2023, the company had realigned its organizational structure, merging the Safety and Retail unit with the Advanced Sensing Technologies unit to form a new business unit called Sensing and Safety Technologies. This structural change, introduced in July 2022 but reported in the 2023 filing, reflects a strategic shift toward integrating sensing capabilities with safety solutions to enhance technological offerings and streamline operations.",
      "llm_answer": "\nBetween 2022 and 2023 Honeywell moved its Safety and Retail offering out of a stand‑alone “Safety and Retail” unit and began bundling it with its Advanced Sensing Technologies business to deliver a more integrated safety‑and‑sensing portfolio. In 2023 the company formalized this shift by realigning the Safety and Retail business unit with Advanced Sensing Technologies, renaming the combined unit “Sensing and Safety Technologies,” and recasting prior‑period results to reflect the new reporting structure.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the core structural evolution: Safety and Retail was merged with Advanced Sensing Technologies to form Sensing and Safety Technologies in 2023. The qualitative reasoning about the strategic shift toward integration is sound and well-articulated. However, there is a significant quantitative omission: the ground truth specifies that Safety and Retail generated $2,387 million in revenue in 2022, which the LLM answer completely omits. This is a material financial metric that directly addresses the 'how did the approach evolve' aspect of the question. Additionally, the ground truth notes the structural change was 'introduced in July 2022 but reported in the 2023 filing,' which adds important temporal context that the LLM answer does not capture (it only states the formalization occurred in 2023). The LLM correctly identifies: (1) the standalone status in 2022, (2) the merger with Advanced Sensing Technologies, (3) the new unit name 'Sensing and Safety Technologies,' and (4) the restatement of prior-period results. The multi-hop synthesis is sound—the answer successfully connects the 2022 baseline with the 2023 structural change. The main weaknesses are the missing revenue figure and the incomplete temporal explanation of when the change was actually introduced versus when it was reported.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 374,
        "total_tokens": 1664
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How has the status and role of Class B-2 Common Stock evolved between 2023 and 2024, particularly in terms of its convertibility and impact on corporate governance?",
      "original_answer": "In 2023, Class B-2 Common Stock was described as part of a structure that would become convertible into Class A Common Stock, with potential dilutive effects on voting power and market price. It also played a role in approving significant corporate actions, indicating a governance influence. By 2024, no shares of Class B-2 Common Stock were outstanding prior to the Class B-1 Common Stock exchange offer, suggesting a strategic shift in equity structure. This indicates a transformation in the role of Class B-2 Common Stock, moving from an active governance and conversion position to a non-outstanding status, reducing its influence on corporate decisions.",
      "llm_answer": "\nBetween 2023 and 2024 Visa created Class B‑2 common stock for the first time by exchanging tendered Class B‑1 shares in its May 2024 exchange offer; the new B‑2 shares remain subject to the same transfer restriction that makes them non‑convertible and non‑voting until all U.S. covered litigation is finally resolved, and their conversion‑rate adjustments are double those of the existing B‑1 shares. Consequently, once the restriction lifts the B‑2 shares can be converted into Class A common stock (or, after a later date, into Series A preferred stock), diluting existing Class A shareholders and giving the B‑series holders limited but strategically important voting power on matters that require the affirmative vote of the B‑classes, such as major mergers or exits from Visa’s core payments business.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations that contradict the ground truth. Key issues: (1) MAJOR ERROR - The LLM claims Class B-2 stock was 'created for the first time' in May 2024 through an exchange offer, but the ground truth explicitly states Class B-2 existed in 2023 and describes its evolution between 2023-2024. The LLM fundamentally misunderstands the timeline. (2) CONTRADICTORY CHARACTERIZATION - The ground truth states that by 2024 'no shares of Class B-2 Common Stock were outstanding prior to the Class B-1 Common Stock exchange offer,' indicating B-2 shares were eliminated or converted. The LLM claims B-2 shares were created in 2024, which is the opposite of what occurred. (3) INCOMPLETE SYNTHESIS - The ground truth emphasizes the transformation from 'active governance and conversion position to a non-outstanding status,' showing a reduction in influence. The LLM instead describes B-2 as newly created with future conversion potential and 'strategically important voting power,' which misses the actual evolution. (4) GOVERNANCE ROLE MISCHARACTERIZATION - While the LLM correctly notes voting restrictions and conversion mechanics, it fails to capture that the key evolution was B-2 moving from outstanding to non-outstanding status, fundamentally changing its governance role. (5) MISSING CONTEXT - The ground truth emphasizes the 'strategic shift in equity structure' and reduction of B-2's influence; the LLM focuses on technical features of newly created shares rather than the actual evolution described in the ground truth. The answer demonstrates a fundamental misunderstanding of the multi-hop question about how the status evolved between the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 468,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How has The Home Depot's approach to enhancing the ease of shopping experience evolved between 2023 and 2024, particularly in terms of digital and in-store capabilities?",
      "original_answer": "In 2023, The Home Depot focused on improving the ease of shopping experience by investing in mobile app-enabled store navigation, electronic shelf labels, reconfigured service desks, and enhanced self-checkout options. These efforts were aimed at improving store navigation, convenience, and checkout speed. By 2024, the company expanded its focus to include more personalized digital experiences, such as customer product review summaries and enhanced product content, while continuing to invest in digital platforms to improve navigation and 'shopability.' The 2024 strategy placed greater emphasis on leveraging customer data to meet personalized expectations, indicating a shift toward deeper integration of data-driven insights into the shopping journey.",
      "llm_answer": "\nBetween fiscal 2023 and 2024 Home Depot moved from initial store‑level upgrades—such as refreshed layouts, electronic shelf‑labels, expanded self‑checkout and curb‑side pickup—to a systematic, omnichannel “interconnected shopping” strategy.  In 2024 the retailer deepened its digital investments by enhancing mobile‑first navigation, boosting the “shopability” of product pages with richer content and AI‑driven personalization, and scaling same‑day delivery and curb‑side options, while continuing to refine in‑store tools (e.g., way‑finding signage, self‑service lockers, associate‑enabled mobile maps) to make the entire journey—from inspiration to post‑purchase support—seamless across stores, online and on‑the‑job sites.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the evolution from 2023 to 2024 and mentions several accurate elements: electronic shelf labels, self-checkout expansion, mobile app/navigation improvements, enhanced product content, and personalization. The answer appropriately captures the shift toward omnichannel and data-driven approaches. No quantitative errors are present (no specific numbers were claimed). WEAKNESSES: (1) The LLM introduces concepts not explicitly mentioned in the ground truth, such as 'interconnected shopping strategy,' same-day delivery scaling, curb-side pickup, self-service lockers, and associate-enabled mobile maps. While these may be reasonable inferences about Home Depot's operations, they are not validated by the ground truth provided. (2) The ground truth specifically mentions 'mobile app-enabled store navigation' and 'reconfigured service desks' in 2023, but the LLM answer omits the service desk reconfiguration detail. (3) The ground truth emphasizes 'customer product review summaries' as a specific 2024 enhancement, which the LLM answer does not explicitly mention. (4) The ground truth's key insight about 'leveraging customer data to meet personalized expectations' and the 'shift toward deeper integration of data-driven insights' is present but less emphasized in the LLM answer. MULTI-HOP REASONING: The LLM successfully synthesizes the 2023-to-2024 evolution and correctly identifies the progression from basic store upgrades to more sophisticated digital integration. However, the addition of unvalidated details (same-day delivery, curb-side pickup, self-service lockers) suggests the model may have hallucinated or drawn from general knowledge rather than strictly adhering to the ground truth. SEMANTIC EQUIVALENCE: The core message aligns—evolution toward personalized, omnichannel experiences—but the specific details diverge in ways that reduce confidence in factual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 523,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How has the structure of the Target Corporation Long-Term Incentive Plan evolved from 2022 to 2024, particularly in terms of the specific forms of equity awards included under the plan?",
      "original_answer": "In 2022, the Long-Term Incentive Plan included forms such as Non-Qualified Stock Options, Restricted Stock Units, Performance-Based Restricted Stock Units, Performance Share Units, Price-Vested Stock Options, Non-Employee Director Non-Qualified Stock Options, and Non-Employee Director Restricted Stock Units. By 2024, the plan introduced new forms of equity awards, including the Cliff-Vested Restricted Stock Unit Agreement and the Performance Award Performance Share Unit Agreement, indicating an expansion in the types of equity compensation vehicles available under the plan.",
      "llm_answer": "\nFrom 2022 to 2024 the LTIP stayed under the 2020 plan but became more granular: the 2022 filing (Exhibit 10.4 * and related ** exhibits on page 68 of the 2022 10‑K) listed separate “Cliff‑Vested Restricted Stock Unit Agreement” and “Performance Award Performance Share Unit Agreement,” while the 2024 filing (Exhibit 10.4 * and ** exhibits on page 73 of the 2024 10‑K) retained those categories and added a dedicated “Target Corporation Officer EDCP (2025 Plan Statement)” as a new long‑term incentive vehicle.  Consequently, the plan evolved from a generic RSU/performance‑unit mix to a structured set of award types with distinct cliff‑vesting and performance‑award mechanics, plus an officer‑specific deferred compensation component.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and contradicts the ground truth in critical ways: (1) MAJOR ERROR - The LLM claims the 2022 filing listed 'Cliff-Vested Restricted Stock Unit Agreement' and 'Performance Award Performance Share Unit Agreement,' but the ground truth explicitly states these were NEW forms introduced BY 2024, not present in 2022. The 2022 plan included different forms: Non-Qualified Stock Options, Restricted Stock Units, Performance-Based Restricted Stock Units, Performance Share Units, Price-Vested Stock Options, Non-Employee Director Non-Qualified Stock Options, and Non-Employee Director Restricted Stock Units. (2) INCOMPLETE/INACCURATE - The LLM fails to list the specific 2022 award forms that were actually part of the plan, missing critical details about the baseline structure. (3) SPECULATIVE ADDITION - The LLM introduces a 'Target Corporation Officer EDCP (2025 Plan Statement)' as a new 2024 component, which is not mentioned in the ground truth and appears to be fabricated or misinterpreted. (4) MISCHARACTERIZATION - The LLM incorrectly frames the evolution as adding cliff-vesting and performance-award mechanics in 2024, when these were actually new additions to the existing 2022 structure. (5) PAGE REFERENCES - The LLM provides specific page numbers (68 for 2022, 73 for 2024) without verification, and the claim that both years listed the same award forms contradicts the ground truth about evolution. The core narrative of the answer is inverted: the ground truth shows expansion FROM a baseline set of awards TO a broader set including new cliff-vested and performance award forms, but the LLM suggests these forms existed in 2022. This represents a fundamental misunderstanding of the multi-hop synthesis required.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 483,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Qulipta's commercial performance evolve from its FDA approval in 2021 through 2023, based on AbbVie's financial disclosures?",
      "original_answer": "Qulipta was approved by the FDA in September 2021 for the preventive treatment of episodic migraine in adults, marking its entry into the market. By 2023, Qulipta had generated $405 million in U.S. revenue and $3 million internationally, totaling $408 million. This indicates a significant commercial trajectory following its approval, especially considering it had no revenue in 2021 and only $158 million in U.S. revenue in 2022. The product demonstrated strong growth, suggesting robust market adoption and positioning within AbbVie's portfolio.",
      "llm_answer": "\nQulipta generated virtually no sales immediately after its September 2021 FDA approval, posting $158 million of U.S. revenue (with only modest international sales) in 2022.  In 2023 the product’s U.S. sales more than doubled to $405 million and added roughly $3 million abroad, driving total worldwide revenue up by over 100 % year‑over‑year and signalling accelerating market uptake through 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. All quantitative data is correct: FDA approval in September 2021, $158 million U.S. revenue in 2022, $405 million U.S. revenue in 2023, and $3 million international revenue in 2023. The calculation of 'more than doubled' (405/158 = 2.56x) and 'over 100% year-over-year growth' is accurate. The answer correctly synthesizes the multi-hop information across years and geographic regions from AbbVie's disclosures. The characterization of 'virtually no sales immediately after approval' in 2021 aligns with the ground truth's statement of 'no revenue in 2021.' The reasoning about market adoption and commercial trajectory is sound and well-supported by the data. The only minor distinction is that the LLM uses slightly different phrasing ('roughly $3 million abroad' vs. '$3 million internationally'), but this is semantically equivalent and represents the same factual information. The answer effectively addresses all aspects of the question regarding Qulipta's commercial evolution from 2021 through 2023.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 307,
        "total_tokens": 1540
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How has Netflix's treatment and disclosure of the 2020 Stock Plan evolved between the 2022 and 2024 SEC filings, particularly in terms of its structural description and associated equity compensation activities?",
      "original_answer": "In 2022, the 2020 Stock Plan was referenced primarily through its inclusion in the exhibit list as a filed document (Def 14A, filed April 22, 2020), with no detailed description of its provisions or activities. In contrast, by 2024, the 2020 Stock Plan was not only explicitly described in detail but also linked to specific equity compensation activities, including the granting of incentive stock options, nonstatutory stock options, and restricted stock units (RSUs) with defined vesting schedules and performance-based criteria. This represents a significant shift from mere documentation to a more comprehensive disclosure of the plan's operational role in equity compensation.",
      "llm_answer": "\nBetween the 2022 and 2024 filings Netflix retained the same high‑level description of the 2020 Stock Plan but markedly deepened its quantitative disclosures.  The 2024 filing adds a full‑year stock‑option activity table that shows balances, grants, exercises, expirations and vested/exercisable amounts through 2024, includes a separate RSU/PSU schedule with unvested share counts and grant‑date fair values, reports $46 million of unrecognized compensation cost, and notes the recent $10 billion and $15 billion share‑repurchase authorizations.  These updates provide far more granular, forward‑looking detail on the plan’s structure and the company’s equity‑compensation activity.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misalignment with the ground truth. MAJOR ISSUES: (1) The LLM claims the 2024 filing adds 'a full-year stock-option activity table' with specific metrics, but the ground truth makes no mention of such detailed tables being added in 2024. (2) The LLM references specific dollar amounts ($46 million unrecognized compensation cost, $10 billion and $15 billion share-repurchase authorizations) that are not mentioned in the ground truth and cannot be verified as accurate from the provided context. (3) The LLM's core characterization is fundamentally different from ground truth: it claims Netflix 'retained the same high-level description' but 'deepened quantitative disclosures,' whereas the ground truth states the opposite - that in 2022 there was minimal disclosure (just exhibit listing) and by 2024 there was a shift to 'explicit detailed description' linked to specific equity compensation activities. (4) The LLM focuses heavily on quantitative tables and metrics that are not mentioned in the ground truth's description of the evolution. (5) The ground truth emphasizes a qualitative shift from 'mere documentation to comprehensive disclosure of the plan's operational role,' while the LLM emphasizes quantitative deepening of already-existing descriptions. CORRECT ELEMENTS: The LLM correctly identifies that the 2024 filing involves RSUs/PSUs and mentions vesting/performance criteria, which aligns with ground truth. However, the overall narrative and specific claims about tables, dollar amounts, and the nature of the evolution are either unsupported or contradictory to the ground truth. The answer demonstrates a fundamental misunderstanding of the actual evolution described in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 480,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did the company's approach to aluminum purchase agreements evolve between 2022 and 2023, particularly in terms of their classification and strategic use of derivative instruments?",
      "original_answer": "In 2022, the company described its aluminum purchase agreements as derivative instruments entered into for long-term strategic sourcing objectives and non-U.S. business requirements. By 2023, the company continued to use these agreements but provided additional clarity that the quantities of aluminum in these contracts offset each other and are priced at prevailing market prices. This evolution indicates a more refined strategy around market pricing alignment and potentially reduced exposure through offsetting positions.",
      "llm_answer": "\nBetween 2022 and 2023 the company kept its aluminum purchase agreements classified as **derivatives that do not receive hedge accounting treatment** – they are still recorded as “commodity contracts” in the “Derivatives not receiving hedge accounting treatment” table (page 103).  However, the **notional amount of those aluminum contracts fell dramatically**, from **$412 million in 2022 to $115 million in 2023** (page 103), indicating a more selective, strategic use of the instruments to support long‑term sourcing for its non‑U.S. operations rather than broad price‑risk hedging.  The company continues to disclose the fair‑value of these contracts in its Consolidated Statements of Financial Position (page 104) and notes that they are used to address long‑term sourcing objectives and non‑U.S. business requirements (page 103).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and provides more detailed information than the ground truth. Strengths: (1) Correctly identifies the classification as derivatives not receiving hedge accounting treatment, which is accurate and more specific than the ground truth. (2) Provides specific notional amounts ($412M in 2022 vs $115M in 2023) with page references, demonstrating concrete sourcing from the filings. (3) Correctly notes the dramatic decline in notional amounts, indicating a more selective strategic approach. (4) Accurately references disclosure locations (pages 103-104) and mentions Consolidated Statements of Financial Position. (5) Correctly identifies the long-term sourcing objectives and non-U.S. business requirements language. Minor considerations: (1) The ground truth mentions 'additional clarity that quantities offset each other and are priced at prevailing market prices' in 2023, which the LLM answer does not explicitly address. However, the LLM answer does note the strategic shift toward 'more selective, strategic use' which captures the essence of this evolution. (2) The LLM answer focuses more on the notional amount reduction as the key evolution metric, while the ground truth emphasizes the clarification about offsetting positions and market pricing. Both interpretations are valid ways to characterize the evolution. (3) The quantitative data provided (specific dollar amounts and page numbers) adds credibility and specificity beyond the ground truth. The answer demonstrates strong multi-hop reasoning by synthesizing classification information, notional amounts, and strategic intent across the two years. The semantic meaning aligns well with the ground truth's core message about evolution toward more refined/selective strategy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 483,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How has the disclosure or treatment of the Directors' Code of Conduct evolved between 2023 and 2024, particularly in terms of its accessibility and scope?",
      "original_answer": "In 2023, the Directors' Code of Conduct was explicitly referenced and posted on the company's website at a specific URL: https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/inv relations/directors-code-of-conduct.pdf. In 2024, the URL for the Directors' Code of Conduct changed to https://www.bny.com/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-ofconduct.pdf, indicating a shift in how the document is categorized or accessed. Additionally, in 2024, the company introduced a new section titled 'INSIDER TRADING POLICIES AND PROCEDURES,' which was not present in 2023, suggesting an expanded focus on compliance mechanisms beyond the Code itself. These changes reflect a transformation in the presentation and accessibility of the Directors' Code of Conduct, as well as an increased emphasis on insider trading compliance.",
      "llm_answer": "\nThe 2024 filing updates the public posting link for the Directors’ Code of Conduct—from an “inv relations” folder to the more prominent “investor‑relations” directory—while retaining the same language that the code applies to all directors. It also re‑emphasizes the company’s intent to post any future amendments or waivers of the Directors’ Code on its website, reinforcing a clearer, more transparent disclosure practice, though the substantive scope of the code remains unchanged.",
      "correctness_score": 5,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies the URL change from 'inv relations' to 'investor-relations' folder structure, which aligns with the ground truth. However, the answer has significant omissions and misses critical information: (1) The LLM fails to mention the specific URLs themselves, which are key details in the ground truth answer. (2) Most critically, the LLM completely omits the introduction of the new 'INSIDER TRADING POLICIES AND PROCEDURES' section in 2024, which the ground truth identifies as a major evolution and expanded focus on compliance mechanisms. This is a substantial gap since the question specifically asks about evolution in scope, and the new insider trading section represents a clear expansion of scope. (3) The LLM's characterization that 'the substantive scope of the code remains unchanged' directly contradicts the ground truth's finding that there was an 'expanded focus on compliance mechanisms beyond the Code itself.' (4) While the LLM correctly notes the URL reorganization and mentions reinforced transparency practices, it fails to capture the full picture of how the disclosure evolved. The answer addresses only partial aspects of the evolution (URL accessibility) while missing the scope expansion (new insider trading section). The quantitative accuracy is reasonable for the URL details mentioned, but the qualitative accuracy suffers from incomplete synthesis of the multi-hop information required to fully answer the question about evolution in both accessibility AND scope.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 419,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How has the structure and value of HD's 4.95% Senior Notes evolved between 2023 and 2024, and what does this indicate about the company's long-term debt strategy?",
      "original_answer": "In 2023, HD issued $750 million of 4.95% senior notes due September 30, 2026, at a discount of $1.6 million. By 2024, the carrying amount of these 4.95% senior notes due September 2026 was $747 million as of February 2, 2025, and the company also reported $980 million in 4.95% senior notes due September 2052. This indicates that while the original 2026 notes remained outstanding with only a slight reduction in carrying value, HD expanded its 4.95% senior note structure to a much longer maturity in 2052, suggesting a strategy of extending debt maturities and potentially locking in fixed interest rates over a longer horizon.",
      "llm_answer": "\nBetween the end of fiscal 2023 and the end of fiscal 2024 the existing 4.95 % senior notes due September 2026 grew only modestly – their carrying amount rose from $745 million to $747 million – while a new $1.75 billion series of 4.95 % notes maturing in June 2034 was issued in June 2024 (discount of $16.7 million).  This adds a longer‑dated, fixed‑rate tranche to the debt profile and signals Home Depot’s strategy of extending maturity, diversifying funding sources and locking in low‑cost long‑term financing to support growth initiatives such as the SRS acquisition while keeping overall leverage in check.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant discrepancies with the ground truth. (1) WRONG MATURITY DATES: The LLM claims a new $1.75 billion series of 4.95% notes was issued maturing in June 2034, but the ground truth indicates $980 million in 4.95% senior notes due September 2052 - completely different maturity date and amount. (2) WRONG CARRYING VALUE: The LLM states the 2026 notes' carrying amount rose from $745 million to $747 million, but ground truth shows $750 million issued at $1.6 million discount (implying ~$748.4 million initial carrying value) and $747 million by 2024 - a slight decrease, not an increase. (3) MISSING KEY INFORMATION: The ground truth explicitly mentions the $980 million 2052 notes, which represents a major debt issuance extending maturity to 2052 (30+ years), but the LLM completely misses this and instead references a non-existent 2034 maturity. (4) INCORRECT DISCOUNT: The LLM cites a $16.7 million discount for the alleged 2034 notes, but ground truth shows $1.6 million discount for the 2026 notes. (5) MULTI-HOP SYNTHESIS FAILURE: The LLM failed to correctly synthesize the evolution of HD's debt structure across 2023-2024. While the LLM correctly identifies the strategic intent (extending maturity, locking in rates), it does so based on incorrect debt instruments. The reference to 'SRS acquisition' adds context not in the ground truth but doesn't compensate for the fundamental factual errors. The answer demonstrates a fundamental misunderstanding of which debt instruments were actually issued and their key terms.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 434,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Intel's financial treatment and valuation of its investment in Beijing Unisoc Technology Ltd. evolve between 2021 and 2023, particularly in terms of observable price adjustments and net book value?",
      "original_answer": "In 2021, Intel recognized $471 million in observable price adjustments in its investment in Beijing Unisoc Technology Ltd. By the end of 2023, Intel was accounting for its interest in Unisoc as a non-marketable equity security, with a net book value of $1.1 billion as of December 30, 2023 (the same as December 31, 2022). This indicates that while Intel continued to hold the investment without marketability, the valuation remained stable over the two-year period despite the earlier price adjustment.",
      "llm_answer": "\nBetween 2021 and 2023 Intel recorded a one‑time $471 million observable‑price adjustment to the carrying amount of its equity stake in Beijing Unisoc Technology Ltd. in the first quarter of 2021, and by the end of 2022 the investment’s net book value had risen to $1.1 billion (the same figure reported as of December 30 2023).  Subsequent observable‑price adjustments for the broader non‑marketable equity portfolio fell sharply—from $750 million in 2021 to $17 million in 2023—so after the 2021 bump the Unisoc stake was carried at roughly $1.1 billion with only immaterial further re‑valuations.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key financial facts about Intel's Unisoc investment: (1) the $471 million observable price adjustment in Q1 2021 is accurate, (2) the $1.1 billion net book value figure is correct, and (3) the stability of valuation between 2022 and 2023 is properly noted. The answer demonstrates good multi-hop synthesis by connecting the 2021 adjustment to the subsequent stable valuation through 2023.\n\nHowever, there are some issues: (1) The LLM introduces information about broader non-marketable equity portfolio adjustments ($750 million in 2021 declining to $17 million in 2023) that, while potentially accurate, goes beyond what the ground truth specifies and adds complexity not directly requested. This represents scope creep rather than error. (2) The phrasing 'by the end of 2022 the investment's net book value had risen to $1.1 billion' could be slightly misleading—the ground truth indicates the $1.1 billion figure was the same at both December 31, 2022 and December 30, 2023, suggesting it was stable rather than having 'risen' to that level by 2022. (3) The statement about 'immaterial further re-valuations' after 2021 is a reasonable inference but not explicitly stated in the ground truth.\n\nQuantitative accuracy is strong: all dollar amounts ($471M, $1.1B, $750M, $17M) and the key dates (Q1 2021, 2022, 2023) are correct. The multi-hop reasoning connecting the 2021 adjustment to the 2023 valuation is sound. The answer appropriately addresses the evolution of Intel's financial treatment and valuation as requested, though it adds contextual information about the broader portfolio that, while not incorrect, extends beyond the specific Unisoc investment focus of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 471,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did AbbVie's engagement with Qulipta evolve from 2022 to 2023, particularly in terms of its regulatory and commercial development status?",
      "original_answer": "In 2022, Qulipta was part of a group of products that received regulatory approvals, leading to the reclassification of $1.0 billion of indefinite-lived research and development intangible assets to developed product rights. By 2023, AbbVie had introduced Qulipta with specific regulatory milestones: it received FDA approval in April 2023 for the preventive treatment of chronic migraine in adults and EC approval in August 2023 for the preventive treatment of migraine in adults with four or more migraine days per month. This evolution reflects a shift from asset reclassification to active regulatory and commercial advancement.",
      "llm_answer": "\nFrom 2022 into 2023 AbbVie moved Qulipta from a newly‑launched acute‑migraine option toward its first preventive indication.  In April 2023 the FDA approved Qulipta for the preventive treatment of chronic migraine in adults, and in August 2023 the European Commission followed with approval of Aquipta (Qulipta) for the same preventive use, allowing the company to begin commercial rollout of the preventive indication in both the United States and the EU.  This regulatory expansion marked the key evolution of Qulipta’s commercial development between the two years.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the key regulatory milestones - FDA approval in April 2023 and EC approval in August 2023 for preventive treatment of chronic migraine. The dates are accurate. The answer correctly captures the evolution from 2022 to 2023 and the shift toward preventive indication development.\n\nWEAKNESSES: (1) CRITICAL OMISSION: The ground truth specifically mentions that in 2022, Qulipta was part of a group receiving regulatory approvals that led to reclassification of $1.0 billion of indefinite-lived R&D intangible assets to developed product rights. This is a significant financial/accounting detail that the LLM completely omits. (2) CHARACTERIZATION ERROR: The LLM states Qulipta moved from 'a newly-launched acute-migraine option' but the ground truth does not characterize it as an acute-migraine treatment - it focuses on the preventive indication evolution. This mischaracterizes the product's prior status. (3) MINOR NAMING INCONSISTENCY: The LLM writes 'Aquipta (Qulipta)' when referring to the EC approval, but the ground truth simply calls it 'Qulipta' - this appears to be a transcription error or confusion. (4) INCOMPLETE SYNTHESIS: The answer fails to address the 2022 asset reclassification aspect, which is a key part of how AbbVie's engagement with Qulipta evolved during this period. The ground truth emphasizes both the accounting/asset reclassification in 2022 AND the regulatory approvals in 2023 as components of the evolution.\n\nQUANTITATIVE ACCURACY: Dates are correct (April 2023, August 2023), but the $1.0 billion asset reclassification figure from 2022 is completely missing.\n\nQUALITATIVE ACCURACY: The regulatory timeline is accurate, but the characterization of prior status and the omission of the asset reclassification represent significant gaps in understanding the full evolution of AbbVie's engagement with Qulipta.\n\nCONTEXTUAL RELEVANCE: The answer addresses the regulatory and commercial development aspects but misses the financial/accounting dimension that was part of the original answer's explanation of how engagement evolved.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 566,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How has Boeing's framing and strategic emphasis on 'upgrades and conversions' within the Global Services segment evolved between 2022 and 2023, based on the language used in the 10-K filings?",
      "original_answer": "In 2022, 'upgrades and conversions' were listed as part of a broader set of services under the Global Services segment, grouped alongside supply chain logistics, engineering, maintenance, spare parts, training systems, technical documents, and digital services. The description was general and lacked strategic framing. In 2023, while the service was still included, the context shifted subtly: it was now positioned within a more structured narrative that emphasized the full spectrum of sustaining aerospace platforms and systems, indicating a more integrated and strategic role within the segment. This evolution suggests a more deliberate positioning of 'upgrades and conversions' as a core capability rather than a general service offering.",
      "llm_answer": "\nBoeing’s 2022 Form 10‑K (page 5) and the 2023 Form 10‑K (page 3) both describe the Global Services segment with virtually the same wording – “upgrades and conversions” are listed together with maintenance, spare parts, training and digital analytics as a core offering for sustaining commercial and defense aircraft. The 2023 filing does not add new language or shift the strategic emphasis; it simply reiterates the same framing, underscoring that upgrades and conversions remain a key, recurring‑revenue driver within Global Services.",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in its core claim and directly contradicts the ground truth. CRITICAL ERROR: The LLM states that 'The 2023 filing does not add new language or shift the strategic emphasis; it simply reiterates the same framing,' which is the opposite of what the ground truth indicates. The ground truth explicitly states that 'the context shifted subtly' in 2023, with 'upgrades and conversions' being 'positioned within a more structured narrative that emphasized the full spectrum of sustaining aerospace platforms and systems,' representing 'a more integrated and strategic role within the segment' and 'a more deliberate positioning.' The LLM's claim of 'virtually the same wording' and 'no shift' directly contradicts the ground truth's assertion of an evolution in framing and strategic emphasis. QUANTITATIVE ACCURACY: The LLM correctly identifies the relevant 10-K filings (2022 and 2023) and references page numbers, though these cannot be independently verified. No numerical errors are present. QUALITATIVE ACCURACY: The LLM fails to recognize or articulate the subtle but important shift in strategic positioning that occurred between 2022 and 2023. It misses the key insight that 'upgrades and conversions' moved from being listed as part of a 'broader set of services' with 'general framing' to being positioned within a 'more structured narrative' emphasizing integration and strategic capability. The LLM's conclusion that the filings use 'virtually the same wording' is unsupported by the ground truth. CONTEXTUAL RELEVANCE: The answer addresses the right companies and years but fundamentally misses the evolution in framing that is the core of the question. The question specifically asks about how the framing 'evolved,' and the LLM incorrectly concludes there was no meaningful evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 498,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Intel's financial relationship with Beijing Unisoc Technology Ltd. evolve between 2021 and 2023, particularly in terms of the valuation and recognition of this investment?",
      "original_answer": "Intel's financial relationship with Beijing Unisoc Technology Ltd. remained consistent in terms of total net book value, which stayed at $1.1 billion as of both December 25, 2021 (from the 2022 filing) and December 30, 2023 (from the 2023 filing). However, in 2021, Intel recognized $471 million in observable price adjustments related to its investment in Unisoc, indicating a revaluation event during that year. This type of valuation adjustment was not explicitly mentioned in the 2023 filing, suggesting a stabilization of the investment's value over time or a lack of significant observable price changes in 2023 compared to 2021.",
      "llm_answer": "\nIntel classifies its stake in Beijing Unisoc Technology Ltd. as a non‑marketable equity security and adjusts its carrying amount only for observable price changes and impairment testing.  In 2021 the company recorded $471 million of observable‑price adjustments, bringing the investment’s net book value to $1.1 billion—a level that remained unchanged through 2022 and 2023, even though only $299 million and $17 million of additional observable adjustments were recognized in 2022 and 2023, respectively, and a $214 million impairment was taken in 2023, leaving the carrying amount at $1.1 billion as of Dec 30 2023.  (INTC 10‑K 2023 pages 58, 96; INTC 10‑K 2022 page 96).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and provides substantially more detail than the ground truth while remaining factually correct. Verification of key claims: (1) Net book value of $1.1 billion as of Dec 25, 2021 and Dec 30, 2023 - CORRECT, matches ground truth exactly. (2) $471 million observable price adjustments in 2021 - CORRECT, matches ground truth. (3) Additional observable adjustments of $299 million in 2022 and $17 million in 2023 - These figures are NOT mentioned in the ground truth but appear to be accurate supplementary details from the 10-K filings. (4) $214 million impairment in 2023 - This is a significant additional detail not in the ground truth. The LLM correctly notes this impairment was taken in 2023 while the carrying amount remained at $1.1 billion, which is mathematically consistent (the impairment would have offset other adjustments). (5) Classification as non-marketable equity security - Correct and provides helpful context. (6) Multi-hop synthesis: The LLM successfully synthesizes information across 2021-2023, comparing valuations and adjustments across years, which directly addresses the question about how the relationship 'evolved.' The answer goes beyond the ground truth by providing year-by-year observable adjustments and explaining the mechanism by which the carrying amount remained stable despite an impairment charge. The citation references (INTC 10-K 2023 pages 58, 96; INTC 10-K 2022 page 96) add credibility. Minor consideration: The ground truth states that 'valuation adjustment was not explicitly mentioned in the 2023 filing,' but the LLM provides specific 2023 figures ($17 million adjustments, $214 million impairment), which appears to be more complete information rather than contradictory. The LLM's answer is more comprehensive and detailed while maintaining factual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 500,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How has the role of Self-Service Lockers evolved within Home Depot's interconnected shopping experience between 2023 and 2024?",
      "original_answer": "In 2023, Self-Service Lockers were described as part of Home Depot's investments to improve the customer shopping experience, specifically to enable convenient online order pickup options alongside other features like wayfinding signage and electronic shelf labels. By 2024, Self-Service Lockers were positioned more strategically as part of the company's broader fulfillment network, specifically referenced in the context of leveraging stores as 'convenient customer pickup, return, and delivery fulfillment locations' under interconnected retail programs such as BOSS, BOPIS, BODFS, and BORIS. Additionally, in 2024, approximately 50% of U.S. online orders were fulfilled through a store, highlighting a more integrated and operationally significant role for Self-Service Lockers in the fulfillment process. This reflects a shift from a convenience-focused feature to a core component of the omnichannel delivery strategy.",
      "llm_answer": "\nBetween fiscal 2023 and 2024 Home Depot deepened the integration of self‑service lockers into its omnichannel journey, using them as a core node for online‑order storage and curb‑side pickup and expanding their presence in newly opened and remodeled stores. The lockers now work hand‑in‑hand with the mobile‑app navigation and real‑time inventory tools that guide customers to items, enabling faster, guaranteed pickup options and reinforcing the retailer’s “interconnected shopping experience” that blends digital convenience with the physical store environment.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "ASSESSMENT: The LLM answer captures some directional accuracy about Self-Service Lockers' evolution but contains significant omissions and lacks critical quantitative evidence from the ground truth.\n\nCORRECT ELEMENTS:\n- Correctly identifies the shift from convenience-focused to core omnichannel component\n- Accurately describes integration with mobile app and inventory tools\n- Properly characterizes the 'interconnected shopping experience' concept\n- Correctly notes expansion in newly opened/remodeled stores\n- Appropriately describes curb-side pickup functionality\n\nCRITICAL OMISSIONS:\n- MISSING KEY QUANTITATIVE DATA: The ground truth explicitly states 'approximately 50% of U.S. online orders were fulfilled through a store' in 2024 - this is a major metric demonstrating the strategic importance of Self-Service Lockers and is completely absent from LLM answer\n- MISSING SPECIFIC PROGRAMS: Ground truth references BOSS, BOPIS, BODFS, and BORIS as specific interconnected retail programs - LLM answer does not mention these programs at all\n- INCOMPLETE 2023 CONTEXT: Ground truth notes 2023 positioning included 'wayfinding signage and electronic shelf labels' alongside lockers - LLM answer doesn't establish this baseline\n- MISSING FULFILLMENT NETWORK CONTEXT: Ground truth emphasizes stores as 'convenient customer pickup, return, and delivery fulfillment locations' - LLM answer focuses mainly on pickup\n\nQUANTITATIVE ACCURACY ISSUES:\n- No quantitative data provided (0/1 metrics from ground truth included)\n- The 50% fulfillment statistic is a critical omission that significantly weakens the answer's credibility\n\nQUALITATIVE REASONING:\n- Multi-hop synthesis is partially successful but incomplete\n- Correctly identifies evolution trajectory but lacks supporting evidence\n- Does not adequately synthesize the operational significance demonstrated by the 50% fulfillment metric\n\nCONTEXTUAL RELEVANCE:\n- Addresses the core question about evolution between 2023-2024\n- Appropriately frames the shift in strategic importance\n- However, lacks the depth of interconnected retail context that would fully answer the question\n\nJUSTIFICATION: While the LLM answer demonstrates understanding of the general evolution and uses appropriate terminology, it fails to include critical quantitative evidence (50% fulfillment metric) and specific program names (BOSS, BOPIS, BODFS, BORIS) that are central to the ground truth answer. This represents a significant gap in completeness for a multi-hop financial/operational question requiring synthesis of specific filing data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 688,
        "total_tokens": 2056
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How has the level of detail and specificity in Costco's disclosure regarding the estimation methods for Insurance/Self-insurance Liabilities evolved from 2023 to 2024?",
      "original_answer": "In 2023, Costco provided a general description of its self-insurance practices and risk management mechanisms, including the use of a captive insurance subsidiary and a reinsurance program, but did not specify the factors used in estimating liabilities. In 2024, the company significantly expanded its disclosure, detailing that liabilities are estimated using historical claims experience, demographic factors, severity factors, and other actuarial assumptions. Additionally, 2024's disclosure included a discussion of the unpredictability of claim costs and the potential for significant differences between actual and recorded liabilities, which was not present in 2023. This represents a meaningful increase in transparency and specificity.",
      "llm_answer": "\nThe 2023 filing (page 46) only brief‑ly noted that retained‑risk insurance liabilities “are not discounted and are estimated using historical claims experience, demographic factors, severity factors, and other actuarial assumptions,” without elaborating on the drivers of those assumptions or the potential impact of external factors. In contrast, the 2024 filing (page 31) expands the description: it explicitly states that the estimates rely on historical claims data, demographic and severity factors, and other actuarial inputs, and it highlights that claim costs can fluctuate due to inflation, regulatory or legal changes, and unforeseen developments, while also noting that historical adjustments have been immaterial. This added detail provides a clearer, more specific picture of how Costco develops its insurance/self‑insurance liability estimates.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a fundamental factual error that directly contradicts the ground truth. The ground truth explicitly states that in 2023, Costco 'did not specify the factors used in estimating liabilities' and only provided 'a general description.' However, the LLM claims that the 2023 filing (page 46) 'briefly noted that retained-risk insurance liabilities are not discounted and are estimated using historical claims experience, demographic factors, severity factors, and other actuarial assumptions.' This is a direct contradiction - the LLM is attributing 2024-level specificity to the 2023 filing. The core finding of the ground truth is that there was a MEANINGFUL INCREASE in transparency from 2023 to 2024, with 2024 introducing the specific estimation factors. The LLM's answer undermines this key distinction by suggesting these details were already present in 2023. Additionally, the LLM provides specific page numbers (page 46 for 2023, page 31 for 2024) that cannot be verified against the ground truth and may be inaccurate. The LLM does correctly identify that 2024 added discussion of unpredictability and external factors (inflation, regulatory changes), which aligns with ground truth. However, the mischaracterization of 2023 disclosure is a major error that affects the entire premise of the answer. The answer fails to properly capture the evolution from general description (2023) to specific methodological details (2024).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 409,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did the financial impact of the Aldevron acquisition on inventory-related costs evolve from 2022 to 2023?",
      "original_answer": "In 2022, the Aldevron acquisition contributed to a $59 million increase in cost of sales due to fair value adjustments to inventory. By 2023, this specific acquisition-related cost associated with Aldevron was no longer present; instead, a new $87 million charge emerged in the second quarter, primarily related to excess inventory in the Biotechnology segment due to reduced demand. This indicates a shift from acquisition-driven inventory adjustments to operational inventory challenges.",
      "llm_answer": "\nThe inventory‑related cost impact of the Aldevron acquisition fell to $0 in 2022—after the one‑time $59 million fair‑value inventory uplift that was recorded in 2021—so there was no recurring charge that year. In 2023 the company reversed course and booked an $87 million write‑down of excess inventory in the Biotechnology segment, creating a new, larger inventory‑related cost headwind compared with the prior year.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. (1) CRITICAL ERROR - Timeline Misplacement: The LLM claims the $59 million fair-value inventory uplift occurred in 2021, but the ground truth explicitly states it occurred in 2022. The LLM then incorrectly states there was $0 impact in 2022, which directly contradicts the ground truth that shows the $59 million charge was recorded in 2022. (2) QUANTITATIVE ACCURACY ISSUES: While the $59 million and $87 million figures are correct, they are attributed to the wrong years and contexts. The LLM misplaces the $59 million charge to 2021 instead of 2022, fundamentally altering the answer to the question about 2022-2023 evolution. (3) INCOMPLETE SYNTHESIS: The question specifically asks about the evolution FROM 2022 TO 2023. The ground truth shows: 2022 had $59M acquisition-related cost, 2023 had $87M operational inventory charge. The LLM's answer suggests 2022 had $0 impact and 2023 had $87M, which misses the key comparison point. (4) CONTEXTUAL MISUNDERSTANDING: The LLM correctly identifies that 2023's charge was related to excess inventory in the Biotechnology segment due to reduced demand (operational, not acquisition-related), but fails to properly establish that 2022's $59M was the acquisition-related impact being compared. (5) REASONING FLAW: The LLM's statement that the company 'reversed course' in 2023 is misleading because it suggests a change in strategy, when the ground truth indicates a shift from acquisition-driven adjustments to operational challenges - a different phenomenon. The answer demonstrates partial understanding of the inventory dynamics but fails on the critical factual accuracy of which year contained which charge.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 475,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How has the treatment and recognition of shop card liabilities evolved between 2023 and 2024, and what does this indicate about Costco's approach to unclaimed balances?",
      "original_answer": "In both 2023 and 2024, Costco recognized revenue from shop cards upon redemption and accounted for outstanding balances as a liability, net of estimated breakage based on redemption data. However, the specific mention of 'estimated breakage' and the methodology tied to redemption data became more emphasized in 2024, indicating a more refined or formalized approach to tracking and accounting for unclaimed shop card balances. This evolution suggests Costco improved its estimation techniques for unclaimed balances, aligning its liability reporting more closely with actual redemption behavior over time.",
      "llm_answer": "\nBoth the 2023 filing (page 47) and the 2024 filing (page 48) state that Costco records shop‑card revenue only when the card is redeemed and that the unredeemed balance is carried as a “shop‑card liability,” net of an estimated breakage amount that is based on historical redemption data. The 2024 text adds a clearer description of the breakage estimation and notes that the liability is presented in “other current liabilities,” but the underlying accounting treatment is unchanged. This consistent policy shows Costco’s conservative approach to unclaimed balances—recognizing revenue only upon use and reserving for the portion that is expected to remain unredeemed.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and well-reasoned. STRENGTHS: (1) Correctly identifies that both 2023 and 2024 filings recognize shop card revenue upon redemption only; (2) Accurately states that unredeemed balances are carried as liabilities net of estimated breakage; (3) Correctly notes that breakage estimation is based on historical redemption data; (4) Properly identifies the page references (47 and 48) for the respective filings; (5) Accurately characterizes the accounting treatment as unchanged between years; (6) Correctly identifies the presentation location as 'other current liabilities' in 2024; (7) Demonstrates sound multi-hop reasoning by synthesizing information across both years and drawing appropriate conclusions about Costco's conservative approach. MINOR WEAKNESSES: (1) The LLM states the 2024 text 'adds a clearer description' of breakage estimation, which is accurate but could be more explicitly tied to the 'more emphasized' or 'more refined/formalized approach' language in the ground truth; (2) The answer characterizes the approach as 'unchanged' which is technically correct but slightly downplays the evolution aspect mentioned in the ground truth regarding 'more emphasized' methodology in 2024. The ground truth emphasizes that the methodology became 'more emphasized' and suggests 'improved estimation techniques,' while the LLM focuses more on consistency. However, both interpretations are defensible from the source material. QUANTITATIVE ACCURACY: No specific numbers or calculations are required for this question, so this dimension is not heavily tested. The page references (47, 48) appear reasonable for 10-K filings. MULTI-HOP REASONING: The answer successfully synthesizes information across 2023 and 2024 filings and draws appropriate conclusions about Costco's approach to unclaimed balances. The reasoning is sound and logically structured.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 514,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How has Intel's Foundry Services offering evolved from 2022 to 2023 in terms of strategic partnerships and customer engagement, based on the specific initiatives and agreements mentioned in those years?",
      "original_answer": "In 2022, Intel introduced its Foundry Services as part of the IDM 2.0 strategy, emphasizing plans to build a world-class foundry business with differentiated offerings, including leading-edge packaging and process technology, committed capacity in the US and Europe, and a strong IP portfolio. By 2023, Intel had significantly advanced this offering by securing four design wins on Intel 18A, including a major high-performance computing customer, and five new design wins in advanced packaging, particularly for AI-related designs. Additionally, Intel expanded its IFS Accelerator Ecosystem Alliance program to over 40 strategic agreements and entered into multigenerational agreements with ARM and Synopsys to enable optimized SoC design on Intel 18A. These developments indicate a shift from strategic intent in 2022 to concrete customer engagements and ecosystem partnerships in 2023.",
      "llm_answer": "\nFrom 2022 to 2023 Intel moved the IDM 2.0 foundry concept into a commercial reality: it announced the ARM‑ and Synopsys‑based design‑win framework in 2022 and, by 2023, the IFS Accelerator ecosystem had doubled to > 40 partners, secured multiple design wins on the advanced 18A node, and signed a commercial foundry agreement with Tower for capacity in New Mexico (plus expanded RAMP‑C ties with Nvidia, IBM, Microsoft, Boeing, Northrop Grumman). These partnerships and the resulting design‑win momentum drove a $483 million rise in foundry‑related revenue and positioned Intel’s advanced packaging and AI‑PC capabilities as the primary customer‑engagement differentiators.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains several significant factual errors and unsupported claims that substantially diverge from the ground truth:\n\n1. MAJOR FACTUAL ERRORS:\n   - Claims ARM and Synopsys agreements were announced in 2022, but ground truth states these were 2023 developments (multigenerational agreements with ARM and Synopsys entered in 2023)\n   - Mentions a 'commercial foundry agreement with Tower for capacity in New Mexico' - this is not mentioned in the ground truth at all and appears to be fabricated\n   - References 'expanded RAMP-C ties with Nvidia, IBM, Microsoft, Boeing, Northrop Grumman' - these specific partnerships are not mentioned in the ground truth\n   - Claims a '$483 million rise in foundry-related revenue' - this specific figure is not supported by the ground truth and appears to be invented\n\n2. PARTIALLY CORRECT ELEMENTS:\n   - Correctly identifies the shift from 2022 strategic intent to 2023 concrete engagements\n   - Correctly mentions the IFS Accelerator ecosystem expanding to >40 partners\n   - Correctly references design wins on Intel 18A node\n   - Correctly identifies advanced packaging and AI capabilities as differentiators\n\n3. MISSING INFORMATION:\n   - Fails to mention the four specific design wins on Intel 18A (including major HPC customer)\n   - Fails to mention five new design wins in advanced packaging for AI-related designs\n   - Does not properly characterize the 2022 foundry strategy components (leading-edge packaging, committed US/Europe capacity, IP portfolio)\n\n4. MULTI-HOP REASONING:\n   The answer attempts to synthesize evolution across years but introduces unsupported claims that break the chain of reasoning. The fabricated Tower agreement and RAMP-C partnerships, along with the unsubstantiated revenue figure, undermine the credibility of the entire response.\n\n5. QUANTITATIVE ACCURACY:\n   The $483 million figure is not verifiable from the ground truth and appears to be hallucinated. The >40 partners figure is correct but insufficient to offset the other numerical inaccuracies.\n\nThe answer demonstrates partial understanding of the question's intent but fails on factual accuracy due to multiple invented details and chronological misplacement of key agreements.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 601,
        "total_tokens": 2006
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did the financial impact of DHR's relationship with Aldevron evolve between 2022 and 2023, particularly in terms of goodwill and net cash consideration?",
      "original_answer": "In 2022, DHR preliminarily recorded approximately $6.1 billion of goodwill related to the Aldevron Acquisition. By 2023, the net cash consideration for Aldevron increased to $9.561 billion, indicating a more detailed or revised financial assessment of the acquisition. This evolution shows a significant increase in the financial commitment to the Aldevron relationship, particularly in terms of cash outlay, beyond the initial goodwill estimate provided in 2022.",
      "llm_answer": "\nDuring 2022‑2023 Danaher recorded no new goodwill from Aldevron – the roughly $6.1 billion of goodwill recognized at the 2021 acquisition remained unchanged – and it did not make any additional cash payments beyond the original $9.6 billion cash purchase price (net of non‑cash consideration of about $9.5 billion) that was funded in 2021.  Only minor measurement‑period adjustments were made, which did not materially affect the goodwill balance or require further cash outflows.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on multiple critical points: (1) GOODWILL CLAIM: The LLM states 'Danaher recorded no new goodwill from Aldevron' and that the $6.1B 'remained unchanged,' but the ground truth explicitly states that by 2023, the financial assessment evolved, implying changes occurred. The LLM's assertion of no change is contradicted by the ground truth's emphasis on 'evolution' between 2022 and 2023. (2) NET CASH CONSIDERATION: The LLM conflates the original 2021 purchase price ($9.6B) with the 2023 figure, stating 'it did not make any additional cash payments beyond the original $9.6 billion.' However, the ground truth clearly indicates the net cash consideration 'increased to $9.561 billion' by 2023, suggesting a revised or more detailed assessment. The LLM's claim that this was the 'original' 2021 price misses the key point that the ground truth presents this as a 2023 figure representing an evolution. (3) MEASUREMENT PERIOD ADJUSTMENTS: The LLM claims 'only minor measurement-period adjustments were made,' but the ground truth emphasizes a 'significant increase in the financial commitment,' which contradicts the characterization as 'minor.' (4) MULTI-HOP REASONING: The LLM failed to properly synthesize the evolution of the relationship between 2022 and 2023. The ground truth shows a progression from $6.1B goodwill (2022) to $9.561B net cash consideration (2023), indicating a material change in financial assessment. The LLM incorrectly treats these as static figures from 2021. (5) TEMPORAL ACCURACY: The LLM anchors all figures to 2021, missing the critical 2022-2023 evolution that is the core of the question. The ground truth explicitly compares 2022 and 2023 figures, showing change over time, which the LLM denies occurred.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 492,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has the maturity date of the AT&T Inc. 1.800% Global Notes changed between the 2022 and 2024 SEC filings, and what does this indicate about the company's debt structure evolution?",
      "original_answer": "In the 2022 SEC filing, the AT&T Inc. 1.800% Global Notes were due on September 5, 2026. In the 2024 filing, the same class of notes is listed with a maturity date of September 14, 2039. This indicates a significant shift in the company's debt structure, extending the maturity of this particular note by over 13 years.",
      "llm_answer": "\nThe 1.800 % Global Notes are listed as maturing on **September 14, 2039** in both the 2022 and the 2024 Form 10‑K filings, so the maturity date has not changed between the two filings. This continuity indicates that AT&T is keeping a long‑dated, low‑coupon debt tranche on its balance sheet and has not needed to refinance or extend this portion of its obligations, reflecting a stable, long‑term debt structure with limited near‑term refinancing pressure.",
      "correctness_score": 1,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on the core factual claim. According to the ground truth, the maturity date of AT&T's 1.800% Global Notes changed from September 5, 2026 (in 2022 filing) to September 14, 2039 (in 2024 filing). The LLM incorrectly states that the maturity date was September 14, 2039 in BOTH the 2022 and 2024 filings, claiming 'the maturity date has not changed.' This is a critical factual error that directly contradicts the ground truth. The LLM's reasoning about debt structure stability is based on this false premise. The question specifically asks about how the maturity date 'changed' between filings, and the ground truth clearly documents a 13+ year extension (from 2026 to 2039). The LLM's answer demonstrates a failure in multi-hop synthesis - it should have identified different maturity dates across the two filing years but instead reported identical dates. The quantitative accuracy is severely compromised by the incorrect dates (2026 vs 2039 discrepancy). The qualitative reasoning, while logically structured, is built on false information and therefore invalid. The answer fails to address the actual change in debt structure that occurred.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1203,
        "completion_tokens": 335,
        "total_tokens": 1538
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has Target's compliance with its debt leverage covenant evolved between 2023 and 2024, and what changes in credit facility structure may have influenced this compliance?",
      "original_answer": "In 2023, Target stated that it was, and expected to remain, in compliance with its debt leverage covenant, which was part of a $1.0 billion 364-day credit facility that would expire in October 2024, along with a $3.0 billion five-year facility expiring in October 2028. By 2024, Target had renewed its 364-day credit facility, extending its expiration to October 2025, while maintaining the same $3.0 billion five-year facility. The company continued to assert compliance with the debt leverage covenant. The renewal of the 364-day facility likely provided continued flexibility, supporting Target’s ability to remain compliant with the covenant.",
      "llm_answer": "\nTarget continued to satisfy its debt‑leverage covenant in both fiscal years, with the leverage metric actually improving modestly from 2023 to 2024 even though total long‑term debt rose slightly (from $13.467 billion to $14.151 billion, page 50).  The company’s credit‑facility overhaul—terminating the prior $1 billion 364‑day revolving line and replacing it with a new $1 billion 364‑day facility and a $3 billion, five‑year revolving facility that now runs to October 2028 ( page 35 – financing discussion) —provided a larger, longer‑term liquidity backstop and eliminated near‑term maturities, giving Target greater flexibility to meet the covenant while maintaining strong cash positions.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer addresses the core question about covenant compliance and credit facility changes, but contains significant factual errors that undermine its accuracy. CORRECT ELEMENTS: (1) Target remained in compliance with debt leverage covenant in both years - correct; (2) Long-term debt figures ($13.467B to $14.151B) - these appear reasonable and are cited with page references; (3) General narrative about credit facility renewal and flexibility - conceptually sound; (4) Identification of the $3B five-year facility expiring October 2028 - correct. CRITICAL ERRORS: (1) The LLM states Target 'terminated the prior $1 billion 364-day revolving line and replacing it with a new $1 billion 364-day facility' - this is confusing and potentially inaccurate. The ground truth indicates Target had a $1.0B 364-day facility expiring October 2024 in 2023, which was then RENEWED (not terminated and replaced) to October 2025 in 2024. The LLM's language suggests termination followed by replacement, which mischaracterizes the renewal process. (2) The LLM claims the company's actions 'eliminated near-term maturities' but the ground truth shows the 364-day facility was simply renewed/extended, not eliminated. (3) The LLM's statement about 'terminating the prior $1 billion 364-day revolving line and replacing it with a new $1 billion 364-day facility and a $3 billion, five-year revolving facility' conflates two separate facilities and misrepresents the structural changes. The ground truth clearly indicates both facilities existed in 2023 ($1B 364-day + $3B five-year), and in 2024 the 364-day was renewed while the five-year remained. MULTI-HOP REASONING: The LLM attempts to synthesize covenant compliance with facility structure changes, but the synthesis is based on partially incorrect characterizations of the facility changes. The reasoning about flexibility and liquidity backstop is sound in principle but built on a flawed foundation. QUANTITATIVE ISSUES: While debt figures are provided with citations, the characterization of facility changes contains structural inaccuracies that affect the quantitative narrative. The answer would benefit from clearer distinction between the two facilities and accurate description of renewal vs. replacement.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 604,
        "total_tokens": 1946
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has Intel's approach to expanding digital readiness for global populations evolved from 2022 to 2023, particularly in relation to its RISE strategy and external collaboration initiatives?",
      "original_answer": "In 2022, Intel committed to expanding digital readiness through its RISE strategy, focusing on collaborative initiatives with other technology companies via the Alliance for Global Inclusion to create an Inclusion Index with unified goals and metrics. By 2023, this effort had matured into the publication of the third global inclusion index survey, which transitioned into an index system where organizations scoring 50% or higher were formally recognized. Intel was among the 18 recognized organizations out of 27 respondents, indicating a more structured and outcome-focused approach to digital readiness and inclusion. This evolution reflects a shift from establishing collaborative frameworks to measuring and recognizing performance against defined benchmarks.",
      "llm_answer": "\nFrom 2022 to 2023 Intel shifted from launching the Alliance for Global Inclusion and developing its Inclusion Index (2022) to actively participating in the third‑annual global inclusion‑index survey, earning a spot on the index and using the RISE framework to broaden external partnerships that accelerate digital‑readiness initiatives for millions of people.  The company deepened collaboration by reporting progress in its Corporate‑Responsibility Report, linking diversity‑and‑inclusion metrics to executive compensation, and scaling joint programs with other technology firms to expand inclusive, technology‑driven access worldwide.  (Pages 15 (2022) & 18 (2023)).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core evolution of Intel's approach from 2022 to 2023 and correctly identifies key elements: the Alliance for Global Inclusion, the Inclusion Index, RISE strategy, and the third-annual survey. However, there are notable differences from the ground truth:\n\nSTRENGTHS:\n- Correctly identifies the shift from framework establishment (2022) to active participation and measurement (2023)\n- Accurately references the third global inclusion index survey\n- Properly connects RISE strategy to digital readiness initiatives\n- Mentions external collaboration and scaling of joint programs\n- Correctly identifies the progression from 2022 to 2023\n\nWEAKNESSES:\n- Missing specific quantitative data: Ground truth specifies \"18 recognized organizations out of 27 respondents\" and the \"50% or higher\" scoring threshold. The LLM answer mentions earning \"a spot on the index\" but doesn't provide these concrete metrics.\n- The LLM answer adds information not in the ground truth (linking diversity-and-inclusion metrics to executive compensation, reporting in Corporate Responsibility Report) which, while potentially accurate, goes beyond what was verified in the knowledge graph\n- Less precise on the structural evolution: Ground truth emphasizes the shift to \"a more structured and outcome-focused approach\" with \"formal recognition\" of performers, while LLM answer is more general about \"deepening collaboration\"\n- The page references (Pages 15 (2022) & 18 (2023)) are provided but cannot be verified against the ground truth\n\nMULTI-HOP REASONING:\nThe LLM correctly synthesizes information across 2022-2023 and connects RISE strategy to digital readiness initiatives. The reasoning is sound but less precise than the ground truth's emphasis on the transition from collaborative framework-building to performance measurement and recognition.\n\nQUANTITATIVE ACCURACY:\nThe LLM answer lacks the specific numbers (18 out of 27, 50% threshold) that are central to demonstrating the evolution. This is a notable omission for a question about how an approach \"evolved.\"\n\nOVERALL:\nThe answer demonstrates good understanding of the general trajectory but lacks the specific quantitative details and precise characterization of the structural shift that define the ground truth answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 619,
        "total_tokens": 1989
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Emerson's relationship with Micromine evolve between 2023 and 2024, and what financial implications were associated with this change?",
      "original_answer": "In 2023, Emerson (via its AspenTech subsidiary) entered into an agreement to acquire Micromine for AU$900 (approximately $623 USD), but later terminated the agreement due to uncertainty around Russian regulatory approval. This led to a mark-to-market gain of $24 in 2023 related to foreign currency forward contracts tied to the Micromine acquisition. By 2024, AspenTech had terminated all outstanding foreign currency forward contracts associated with the Micromine deal. The termination of the Micromine acquisition represented a shift from a strategic expansion effort in 2023 to a full withdrawal from the transaction, with no further financial commitments or exposures to Micromine reported in 2024.",
      "llm_answer": "\nBetween early 2023 and mid‑2023 Emerson (AspenTech) moved from actively pursuing the purchase of Micromine—using foreign‑currency forwards to hedge the deal—to terminating that agreement on August 1 2023 after the Russian‑regulatory approval proved uncertain. The termination ended any planned acquisition, eliminated the associated integration‑related expenses, and resulted in a modest $24 million mark‑to‑market gain on the unwound derivatives that was recorded in 2023; thereafter no further Micromine‑related financial activity or costs appeared in the 2024 results.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key events and financial figures. Strengths: (1) Correctly identifies Emerson/AspenTech as the acquiring entity; (2) Accurately states the termination date of August 1, 2023; (3) Correctly cites the $24 million mark-to-market gain on foreign currency derivatives in 2023; (4) Properly notes the termination of the acquisition agreement due to Russian regulatory uncertainty; (5) Accurately reflects that no further Micromine activity appeared in 2024. Minor weaknesses: (1) The original answer specifies the acquisition price as AU$900 million (approximately $623 USD), which the LLM answer omits entirely—this is a notable omission of specific financial detail; (2) The LLM answer states the mark-to-market gain was '$24 million' while the ground truth states '$24' (likely in millions based on context), creating minor ambiguity in the LLM's presentation, though the magnitude appears correct; (3) The LLM answer could have been more explicit about the 2024 termination of all outstanding foreign currency forward contracts, though it does mention 'unwound derivatives.' The multi-hop reasoning is sound—the answer correctly synthesizes the evolution from 2023 acquisition pursuit to 2024 withdrawal, and properly connects the financial implications (derivative gains, elimination of integration costs) to the strategic shift. The answer is well-structured and addresses both the relationship evolution and financial implications as requested. The omission of the AU$900 million acquisition price is the primary gap, though this doesn't fundamentally undermine the core narrative.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 455,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did the availability of shares under The Home Depot's U.S. Employee Stock Purchase Plan (ESPP) and the average purchase price of shares during the fiscal year change from 2022 to 2023?",
      "original_answer": "In 2022, there were approximately 17 million shares available under the U.S. ESPP, and associates purchased approximately one million shares at an average price of $305.14. In 2023, the number of shares available under the U.S. ESPP decreased to 15 million, and associates again purchased approximately one million shares, but at a lower average price of $277.19. This indicates a reduction in share availability and a notable decrease in the average purchase price during the fiscal year.",
      "llm_answer": "\nThe U.S. ESPP had roughly 17 million shares available at the start of fiscal 2022, but only about 15 million shares were available at the start of fiscal 2023.  At the same time, the average price paid for shares under the plan fell from approximately $305 per share in fiscal 2022 to about $277 per share in fiscal 2023.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct with accurate financial data and proper multi-hop synthesis. Strengths: (1) All key numbers are accurate - 17 million shares in 2022, 15 million in 2023, average prices of $305 and $277 respectively are all correct (minor rounding from $305.14 to $305 and $277.19 to $277 is acceptable). (2) The answer correctly identifies the change in share availability (decrease from 17M to 15M) and the change in average purchase price (decrease from ~$305 to ~$277). (3) Multi-hop reasoning is sound - the answer synthesizes information across two fiscal years and compares both metrics appropriately. (4) Entity identification is correct (Home Depot's U.S. ESPP, fiscal years 2022-2023). Minor weakness: (1) The LLM answer does not explicitly mention that associates purchased approximately one million shares in both years - this detail is present in the ground truth but omitted from the LLM response. This is a minor omission that doesn't affect the core answer to the question about availability and average price changes. (2) The LLM uses slightly more casual language ('roughly,' 'about') compared to the ground truth's more precise phrasing, though this is acceptable for semantic equivalence. Overall, the answer correctly addresses all main components of the multi-part question with accurate numbers and sound reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1213,
        "completion_tokens": 379,
        "total_tokens": 1592
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How has the pattern of impairment triggers and associated charges across DHR's business segments evolved between the 2022 and 2023 filings, and what does this indicate about shifting risks in its intangible asset portfolio?",
      "original_answer": "In the 2022 filing, DHR reported impairment triggers only in the Diagnostics segment during the first quarter of 2021, resulting in a $10 million impairment charge. In contrast, the 2023 filing identified impairment triggers in multiple segments: the Biotechnology segment in the second quarter of 2023, the Diagnostics and Biotechnology segments in the fourth quarter of 2023, and again in the Diagnostics segment in the first quarter of 2021 (which was included for comparative purposes). The impairment charges increased significantly, from $10 million in 2021 (reported in the 2022 filing) to $77 million in 2023 (reported in the 2023 filing). This indicates a notable expansion in both the scope and magnitude of impairment activity, particularly affecting the Biotechnology segment in 2023, which was not previously a focus of impairment events. This evolution suggests growing risks in DHR’s intangible asset portfolio, especially in its Biotechnology segment.",
      "llm_answer": "\nIn 2022 DHR recorded **no impairment charges** for intangible assets, but in 2023 it identified impairment triggers in the second quarter (Biotechnology) and fourth quarter (Biotechnology and Diagnostics), resulting in **$77 million of impairment charges** (up from $10 million in 2021 and none in 2022). This shift shows that the company is increasingly exposing its acquired technology and customer‑related intangibles—particularly in the high‑growth, volatile biotech and diagnostics segments—to potential write‑downs, signaling heightened risk and possible overvaluation in its intangible‑asset portfolio.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its credibility despite capturing some correct elements. CRITICAL ERRORS: (1) The LLM states '2022 DHR recorded no impairment charges' - this is incorrect. The ground truth clearly indicates the 2022 filing reported a $10 million impairment charge in the Diagnostics segment during Q1 2021. (2) The LLM omits the Q1 2021 impairment trigger in the Diagnostics segment that was reported in the 2023 filing for comparative purposes, failing to capture the complete pattern evolution. CORRECT ELEMENTS: (1) The $77 million impairment charge in 2023 is accurate. (2) The identification of Q2 2023 Biotechnology and Q4 2023 Biotechnology and Diagnostics triggers is correct. (3) The characterization of increased risk and potential overvaluation in the intangible asset portfolio is appropriate. (4) The focus on the Biotechnology segment as a new area of concern is valid. MULTI-HOP REASONING: The LLM partially synthesizes the evolution across filings but fails to properly compare the 2022 and 2023 filings' reporting of the same Q1 2021 event. The comparison structure is flawed - it should show how the 2023 filing expanded the narrative of impairment activity beyond what was reported in 2022. QUANTITATIVE ISSUES: While the $77 million and $10 million figures are correct, the statement about '2022 recorded no impairment charges' is factually wrong and represents a fundamental misreading of the ground truth. The answer conflates 'charges in 2022' with 'charges reported in the 2022 filing,' missing that the 2022 filing reported 2021 charges. COMPLETENESS: The answer addresses the pattern evolution and risk implications but incompletely captures the full scope of impairment triggers across both filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 483,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did the value of outstanding letters of credit related to trade contracts change between 2022 and 2023, and what does this indicate about the company's involvement in business transactions tied to trade contracts?",
      "original_answer": "The value of outstanding letters of credit related to trade contracts increased from $362 million in 2022 to $598 million in 2023. This significant increase indicates a growing involvement or expansion in business activities tied to trade contracts during this period.",
      "llm_answer": "\nThe company’s outstanding letters of credit that are tied to trade contracts grew from **$362 million at the end of fiscal 2022** to **$598 million at the end of fiscal 2023**—an increase of about **$236 million (≈ 65 %)**.  \nThis jump shows that the firm’s commitments related to trade‑contract transactions expanded markedly, indicating a larger role for the company in business dealings that require such credit guarantees.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. (1) QUANTITATIVE VERIFICATION: All numbers are correct - $362 million (2022), $598 million (2023), and the calculated increase of $236 million. The percentage calculation of approximately 65% is accurate (236/362 = 0.6519 or ~65.2%). (2) COMPLETENESS: The answer addresses both parts of the multi-part question: (a) the change in value between years, and (b) what this indicates about the company's involvement in trade contracts. (3) ENTITY ACCURACY: Correctly identifies the metric (outstanding letters of credit related to trade contracts), the fiscal years (2022 and 2023), and maintains proper temporal context. (4) REASONING: The multi-hop synthesis is sound - the model correctly extracted the two data points from different fiscal years and synthesized them to draw a logical conclusion about expanded business involvement. The interpretation that the increase indicates 'growing involvement or expansion' and 'larger role' in trade-contract transactions is semantically equivalent to the ground truth statement. (5) WORDING: The LLM uses slightly more detailed language ('commitments related to trade-contract transactions expanded markedly') compared to the ground truth's simpler phrasing ('growing involvement or expansion'), but this represents appropriate elaboration rather than deviation. Minor note: The LLM specifies 'fiscal 2022' and 'fiscal 2023' which adds helpful context, though the ground truth simply states '2022' and '2023'. This is a positive addition. No calculation errors, no factual inaccuracies detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1191,
        "completion_tokens": 437,
        "total_tokens": 1628
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How has the status of the 0.300% Notes due 2028 evolved between the 2023 and 2024 SEC filings, and what does this indicate about IBM's financial instruments disclosures?",
      "original_answer": "In the 2023 filing, the 0.300% Notes due 2028 were disclosed as part of IBM's instruments defining the rights of holders, with specific reference to Exhibit 4.1, filed on February 10, 2020. In the 2024 filing, the 0.300% Notes due 2028 are listed as actively issued financial instruments under the trading symbol IBM28B, registered on the New York Stock Exchange. This indicates a shift from merely disclosing the existence of the instrument in 2023 to formally recognizing it as an actively traded financial instrument in 2024, suggesting increased market engagement or liquidity for this instrument.",
      "llm_answer": "\nIn the 2023 filing the 0.300 % Notes due 2028 were only referenced generically in the “Exhibits defining the rights of holders” table, without a separate line in the securities‑registration table. By the 2024 filing the same notes appear as a distinct registered security (listed as IBM28B with its ticker and exchange) in the “Securities registered pursuant to Section 12(b)” table. This evolution shows that IBM now provides explicit, stand‑alone disclosure of the 0.300 % Notes due 2028 in its periodic reports, enhancing the transparency of its financial‑instrument disclosures.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and understanding of the multi-hop question about the evolution of IBM's 0.300% Notes due 2028 between 2023 and 2024 filings. STRENGTHS: (1) All numeric values are correct - the 0.300% interest rate is accurate, the 2028 maturity date is correct, and the ticker symbol IBM28B is properly identified. (2) The multi-hop synthesis is sound - the answer correctly traces the instrument's status across two filing years and identifies the key difference in disclosure treatment. (3) Entity identification is accurate - IBM is correctly identified, the specific note instrument is properly referenced, and the regulatory context (Section 12(b) registration) is correctly cited. (4) The reasoning about the shift from generic reference to explicit stand-alone disclosure is logically sound and matches the ground truth's characterization of increased market engagement/transparency. (5) The answer appropriately addresses both parts of the question: how the status evolved AND what it indicates about IBM's disclosures. MINOR CONSIDERATIONS: (1) The LLM answer uses slightly different framing than the ground truth - it emphasizes 'transparency enhancement' while ground truth emphasizes 'market engagement or liquidity' - but both interpretations are semantically valid and complementary. (2) The LLM answer doesn't explicitly mention the Exhibit 4.1 reference from February 10, 2020, though this is a minor detail that doesn't affect the core answer's correctness. (3) The characterization of the shift as moving from 'generic reference' to 'distinct registered security' is accurate and perhaps even more precise than the ground truth's wording. The answer successfully demonstrates understanding of SEC filing structures and the significance of explicit registration in periodic reports.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 496,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How has IBM's treatment of the 1.750% Notes due 2031 evolved between 2023 and 2024, particularly in terms of disclosure and registration on stock exchanges?",
      "original_answer": "In 2023, IBM disclosed the 1.750% Notes due 2031 in its 10-K filing, indicating that the instrument defining the rights of the holders was incorporated by reference as part of an exhibit filed on January 30, 2019. By 2024, the 1.750% Notes due 2031 were not only still referenced but also explicitly registered under a trading symbol (IBM31) on the New York Stock Exchange, reflecting a shift from mere disclosure to formal recognition and active listing on a financial market platform.",
      "llm_answer": "\nBetween 2023 and 2024 IBM moved from merely referencing the 1.750 % Notes due 2031 in the “Instruments defining the rights” paragraph of a 2019 Form 8‑K (as seen in the 2023 filing) to giving the securities an explicit entry in the 2024 Form 10‑K registration table. In the 2024 filing the notes are listed with the ticker **IBM31** and confirmed as registered on the New York Stock Exchange, showing a clear, standalone disclosure of their registration and exchange listing that was absent in the prior year’s filing.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy in capturing the evolution of IBM's treatment of the 1.750% Notes due 2031 between 2023 and 2024. STRENGTHS: (1) All key facts are correct - the notes are accurately identified with the correct interest rate and maturity year (2031); (2) The ticker symbol IBM31 is correctly stated; (3) The NYSE listing is correctly identified; (4) The temporal progression is accurately captured - from 2023 disclosure via incorporated reference to 2024 explicit registration table entry; (5) The semantic distinction between 'mere disclosure' and 'formal recognition/active listing' is well-articulated and matches the ground truth's intent; (6) Multi-hop synthesis is sound - the answer correctly connects the 2019 Form 8-K reference, 2023 disclosure practices, and 2024 registration table changes. MINOR CONSIDERATIONS: (1) The LLM mentions 'Form 8-K' specifically while the ground truth says 'instrument defining the rights...incorporated by reference as part of an exhibit filed on January 30, 2019' - this is a reasonable inference but adds slight specificity not explicitly confirmed in the ground truth statement; (2) The phrase 'registration table' in the 2024 filing is the LLM's characterization, which is semantically accurate but uses slightly different terminology than the ground truth's 'explicitly registered under a trading symbol'; (3) The answer could have mentioned the January 30, 2019 date more explicitly, though this is a minor omission. QUANTITATIVE VERIFICATION: All dates (2023, 2024, 2019), the interest rate (1.750%), maturity year (2031), and ticker (IBM31) are accurate. No calculations are required for this question. The answer successfully demonstrates the evolution from disclosure to formal registration without factual errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 487,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did Eli Lilly's financial relationship with Zyprexa evolve between 2023 and 2024, particularly in terms of revenue recognition and business model approach?",
      "original_answer": "In 2023, Eli Lilly generated $1.45 billion from the sale of the rights for the olanzapine portfolio, including Zyprexa, outside the U.S., indicating a direct revenue stream from product sales. By 2024, the company no longer reported Zyprexa as part of product sales; instead, revenue from the 2023 sale of rights was included in collaboration and other arrangements revenue, signaling a shift from direct product sales to revenue recognition through licensing and collaboration agreements. This change reflects a transformation in the financial relationship from active product sales to post-sale royalty or profit-sharing arrangements.",
      "llm_answer": "\nBetween 2023 and 2024 Eli Lilly essentially exited the traditional product‑sale model for Zyprexa.  In 2023 the company sold the worldwide rights to the olanzapine portfolio (which includes Zyprexa) and recorded a one‑time net gain of $1.45 billion on that transaction (page 75), recognizing revenue from the upfront sale and from the $579 million gain on the Baqsimi rights sale (page 75).  Thereafter, any remaining Zyprexa‑related cash flows are generated only through a supply agreement in which Lilly manufactures the product for the new owner and recognizes revenue over time as the product is produced, rather than through direct product sales or upfront licensing fees (pages 47 and 75).  This shift reflects a move from recognizing Zyprexa as a conventional product revenue stream to a collaboration/licensing model with deferred, performance‑based revenue recognition.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general narrative of Eli Lilly's shift from direct product sales to a licensing/collaboration model for Zyprexa between 2023 and 2024, which aligns with the ground truth. However, there are significant quantitative accuracy issues:\n\n1. QUANTITATIVE ERRORS:\n   - The LLM states a \"one-time net gain of $1.45 billion\" from the olanzapine portfolio sale, but the ground truth specifies this as revenue from the sale of rights, not a net gain figure. The LLM conflates the $1.45 billion with a separate $579 million Baqsimi gain, which appears to be mixing different transactions.\n   - The LLM introduces a $579 million figure for Baqsimi rights sale that is not mentioned in the ground truth answer, creating potential confusion about what comprises the $1.45 billion.\n   - The ground truth clearly states the $1.45 billion was generated from the sale of rights for the olanzapine portfolio outside the U.S., but the LLM says \"worldwide rights,\" which is a material difference in scope.\n\n2. REVENUE RECOGNITION ACCURACY:\n   - The LLM correctly identifies the shift from direct product sales to collaboration/licensing arrangements.\n   - The LLM adds detail about a \"supply agreement\" where Lilly manufactures for the new owner with performance-based revenue recognition, which is a reasonable inference but goes beyond what the ground truth explicitly states.\n   - The ground truth focuses on the shift to \"collaboration and other arrangements revenue,\" while the LLM provides more operational detail about the supply agreement mechanism.\n\n3. MULTI-HOP REASONING:\n   - The LLM successfully synthesizes the 2023-to-2024 transition and identifies the business model shift.\n   - However, the introduction of the Baqsimi transaction alongside the olanzapine sale creates ambiguity about whether these are separate or related transactions.\n\n4. SEMANTIC EQUIVALENCE:\n   - The core message about transitioning from product sales to licensing/collaboration is semantically equivalent to the ground truth.\n   - The characterization of revenue recognition changes is directionally correct.\n\n5. SPECIFIC ISSUES:\n   - \"Worldwide rights\" vs. \"outside the U.S.\" is a factual discrepancy that could be material.\n   - The mixing of the $1.45 billion olanzapine sale with the $579 million Baqsimi sale without clear delineation creates confusion.\n   - The ground truth does not mention a supply agreement explicitly, so while this may be accurate, it represents information not in the ground truth answer.\n\nThe answer demonstrates good understanding of the business model transition but contains quantitative inaccuracies and scope ambiguities that prevent a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 718,
        "total_tokens": 2100
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did the treatment and financial impact of the Mobility Preferred Interests evolve from 2023 to 2024, particularly in terms of redemption obligations and their effect on earnings per share calculations?",
      "original_answer": "In 2023, AT&T reclassified the Mobility Preferred Interests from equity to a liability due to the certainty of redemption, recording $2,670 in current liabilities and $2,670 in noncurrent liabilities. The company ultimately repurchased all remaining interests in April 2023 for $5,414, including accrued distributions. By 2024, the Mobility Preferred Interests were fully retired, and the focus shifted to their impact on earnings per share calculations, where under ASU 2020-06, the ability to settle these interests in stock was reflected in the diluted earnings per share computation for periods prior to the repurchase. This indicates a shift from active financial obligations to retrospective accounting treatment.",
      "llm_answer": "\nBy the end of 2023 AT&T had repurchased all of its Mobility Preferred Interests, eliminating any remaining redemption obligations; therefore, from 2024 onward these interests no longer appear as dilutive securities and have no effect on diluted earnings‑per‑share calculations. Before the repurchase, the interests were redeemable at the holder’s option at a price based on market value plus accrued distributions (payable in cash, AT&T stock, or a mix), and their potential settlement in stock was reflected in diluted EPS for 2023 but not for 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains both correct and incorrect elements. CORRECT ELEMENTS: (1) The repurchase occurred in April 2023 (implied by 'end of 2023' statement, though less precise than ground truth's specific date); (2) All remaining interests were repurchased; (3) The interests were fully retired by 2024; (4) The accounting treatment shifted from active obligations to retrospective EPS treatment; (5) The interests could be settled in cash, stock, or a mix. CRITICAL ERRORS: (1) MISSING KEY FINANCIAL DATA: The LLM completely omits the specific dollar amounts ($2,670 current liabilities, $2,670 noncurrent liabilities, $5,414 repurchase price) that are central to understanding the 'financial impact' explicitly requested in the question; (2) INCOMPLETE 2023 TREATMENT: The ground truth shows AT&T reclassified these interests from equity to liability in 2023 due to redemption certainty - this important accounting reclassification is not mentioned; (3) INACCURATE EPS STATEMENT: The LLM states the interests 'have no effect on diluted earnings-per-share calculations' for 2024, but the ground truth indicates they were 'reflected in the diluted earnings per share computation for periods prior to the repurchase' - meaning they DID affect 2023 EPS calculations, and the LLM's phrasing about 2024 is correct but incomplete regarding the retrospective impact. MULTI-HOP REASONING: The LLM successfully synthesizes the evolution from 2023 to 2024 and correctly identifies the shift from active obligations to retrospective treatment, but fails to fully capture the financial magnitude of the transaction. The answer addresses the question's structure but lacks the quantitative specificity needed to fully answer 'financial impact.' The omission of the $5,414 repurchase amount and liability classifications significantly weakens the response's ability to demonstrate understanding of the financial evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 516,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How has IBM's treatment and disclosure of the 0.875% Notes due 2030 evolved between 2023 and 2024, particularly in terms of its listing and registration status?",
      "original_answer": "In 2023, the 0.875% Notes due 2030 were disclosed as part of a list of instruments incorporated by reference to Exhibit 4.1 to Form 8-K filed on February 8, 2022. By 2024, the 0.875% Notes due 2030 were explicitly listed in the table of registered securities with a trading symbol (IBM30A) and registered on the New York Stock Exchange. This indicates a shift from a referenced disclosure to a fully listed and registered financial instrument.",
      "llm_answer": "\nBetween 2023 and 2024 IBM moved from merely referencing the 0.875 % Notes due 2030 in the 2023 filing (where they were only incorporated by reference to a 2022 Form 8‑K describing the indenture) to explicitly listing and registering them in the 2024 Form 10‑K.  The 2024 cover page now shows the notes as “0.875 % Notes due 2030 – IBM30A – New York Stock Exchange,” and they appear in the “Securities registered pursuant to Section 12(b)” table, confirming that the issue is formally listed on the NYSE and registered for public trading.  This represents a shift from a passive disclosure to a full, listed‑security disclosure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All key facts are correct: (1) The 0.875% Notes due 2030 are correctly identified with the exact percentage; (2) The trading symbol IBM30A is correctly stated; (3) The NYSE listing is correctly identified; (4) The 2023-2024 timeframe is correctly addressed; (5) The shift from referenced disclosure (via 2022 Form 8-K incorporation by reference) to explicit listing in the 2024 Form 10-K is accurately described. The multi-hop reasoning is sound - the answer correctly synthesizes information about how the disclosure evolved across years and filing types. The characterization of the shift from 'passive disclosure' to 'full, listed-security disclosure' is semantically equivalent to the ground truth's description of moving from 'referenced disclosure to a fully listed and registered financial instrument.' The answer provides additional helpful context by specifying the exact format shown on the 2024 cover page ('0.875% Notes due 2030 – IBM30A – New York Stock Exchange') and mentions the 'Securities registered pursuant to Section 12(b)' table, which adds relevant detail. No numerical errors, calculation errors, or factual inaccuracies are present. The only minor consideration is that the answer could have explicitly mentioned the February 8, 2022 Form 8-K date, though this is not essential to answering the core question about the evolution between 2023 and 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 396,
        "total_tokens": 1668
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did the structure and distribution terms of the Telco Preferred Interests evolve from 2023 to 2024, and what does this indicate about AT&T's approach to financing through preferred equity instruments?",
      "original_answer": "In 2023, the Telco Preferred Interests consisted of $2,000 of Class A-1 preferred interests issued in September 2020, paying a 4.25% annual distribution, and $5,250 of Class A-2 and A-3 preferred interests issued in April 2023, paying a 6.85% annual distribution. By 2024, the total Telco Preferred Interests had grown to $7,250, with the Class A-1 preferred interests still at 4.25% and the Class A-2 and A-3 interests remaining at 6.85%, both subject to reset every seven years. Additionally, in 2024, AT&T clarified that failure to pay distributions would not restrict cash movements or its ability to pay dividends or repurchase shares. The structure remained consistent in terms of redemption rights and noncontrolling interest classification, but the expansion of the instrument in 2024 suggests a continued reliance on preferred equity as a financing strategy.",
      "llm_answer": "\nFrom 2023 to 2024 AT&T kept the same basic structure for its Telco LLC preferred interests—cumulative, non‑convertible units with a 4.25 % annual distribution for Class A‑1 and a 6.85 % distribution for Classes A‑2/A‑3, each reset on a seven‑year schedule and callable after seven years.  The 2024 filing (pages 85 & 91) merely added clearer language about redemption‑upon‑default and call rights, but did not change the underlying distribution terms.  This demonstrates that AT&T is relying on preferred equity as a flexible, low‑leverage financing tool that can be retired on demand while preserving cash for other strategic uses.",
      "correctness_score": 5,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the distribution rates (4.25% for Class A-1, 6.85% for Classes A-2/A-3) and the seven-year reset schedule. The characterization of preferred equity as a flexible financing tool is reasonable. CRITICAL WEAKNESSES: (1) The LLM completely omits the specific dollar amounts ($2,000 for Class A-1 in 2023, $5,250 for Class A-2/A-3 in 2023, growing to $7,250 total in 2024), which are central quantitative facts in the ground truth answer. (2) The LLM fails to address the key structural evolution from 2023 to 2024—the growth from $7,250 to $7,250 (no change stated, but the ground truth indicates this was the 2024 total). (3) The LLM misses the important 2024 clarification about failure to pay distributions NOT restricting cash movements or dividend/share repurchase ability—a significant governance change that directly addresses AT&T's financing approach. (4) The LLM vaguely references 'clearer language about redemption-upon-default and call rights' without substantive detail, whereas the ground truth specifies the actual policy change regarding distribution payment restrictions. (5) The multi-hop synthesis is incomplete—the question asks how the structure 'evolved' from 2023 to 2024, but the LLM suggests minimal change ('kept the same basic structure') while omitting the actual quantitative growth and the important governance clarification. The LLM's conclusion about AT&T's financing strategy is somewhat supported but lacks the specific evidence from the 2024 clarification about non-restriction of cash movements. The answer reads as partially informed but significantly incomplete on the quantitative and governance dimensions that are central to understanding the evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 471,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How has Capital One's involvement in multifamily commercial real estate loans evolved between 2022 and 2023, particularly in terms of risk exposure under loss sharing agreements with government-sponsored enterprises?",
      "original_answer": "In 2022, Capital One originated multifamily commercial real estate loans with the intent to sell them to GSEs, entering into loss sharing agreements, which resulted in a liability of $82 million. By 2023, the company continued this practice but the liability recognized on the consolidated balance sheets for these loss sharing agreements increased to $137 million, indicating a significant increase in risk exposure. This evolution reflects a growing involvement in these types of loans and a corresponding rise in the financial obligations tied to their loss sharing agreements.",
      "llm_answer": "\nCapital One continued to originate multifamily commercial‑real‑estate loans that it sells to government‑sponsored enterprises and to enter into loss‑sharing agreements with those GSEs.  The 2023 10‑K (Note 18) shows the liability recorded for those loss‑sharing arrangements rising from **$82 million at the end of 2022 to $137 million at the end of 2023**, a result of both a larger volume of originations and the firm’s election to record new agreements at fair value, which now pushes unrealized gains and losses into earnings.  Consequently, while the credit risk is still mitigated by the GSEs, the firm’s exposure to potential losses under the loss‑sharing arrangements has increased materially between 2022 and 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. QUANTITATIVE VERIFICATION: All numbers are correct - $82 million liability at end of 2022 and $137 million at end of 2023 match the ground truth exactly. The calculation of the increase ($55 million) is implicit and correct. COMPLETENESS: The answer addresses all aspects of the question: (1) Capital One's involvement in multifamily CRE loans, (2) the evolution between 2022-2023, (3) risk exposure under loss sharing agreements with GSEs. ENTITY ACCURACY: Company (Capital One), metric (loss sharing agreement liability), years (2022-2023), and GSE references are all correct. MULTI-HOP REASONING: The answer correctly synthesizes information showing the progression of liability amounts and explains the drivers (larger volume of originations and fair value accounting election). ADDITIONAL INSIGHTS: The LLM answer goes beyond the ground truth by providing valuable context about the accounting treatment change (fair value recording pushing unrealized gains/losses into earnings) and clarifying that credit risk remains mitigated by GSEs while exposure to potential losses increased. This additional detail is accurate and enhances understanding without contradicting the ground truth. MINOR CONSIDERATION: The ground truth uses simpler language ('growing involvement' and 'rise in financial obligations'), while the LLM provides more technical accounting detail. This represents an enhancement rather than an error. The answer is semantically equivalent to and more detailed than the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 428,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did Amazon's co-branded credit card programs shift in strategic significance and associated regulatory risks from 2022 to 2023, particularly in terms of new compliance obligations and their potential impact on operating results?",
      "original_answer": "In 2022, Amazon introduced co-branded credit card programs as part of its payment offerings, highlighting the risk that renewal on less favorable terms or termination could adversely affect operating results. The regulatory risks at that time included compliance with payment card association rules such as data security and certification requirements. By 2023, Amazon expanded its offerings and emphasized additional compliance obligations, including data localization rules, which were not mentioned in 2022. This indicates that the co-branded credit card programs became subject to a broader set of regulatory risks, particularly in international jurisdictions, which could increase compliance costs and operational complexity. The potential impact on operating results grew as Amazon now faced risks not only from traditional payment regulations but also from evolving data governance laws, particularly regarding cross-border data transfers tied to these credit card programs.",
      "llm_answer": "\nIn 2022 Amazon treated its co‑branded credit‑card programs as a modest ancillary revenue source, warning only that renewal on less‑favorable terms or termination could adversely affect operating results and that the main compliance concerns were standard payment‑card rules, interchange fees and reliance on third‑party processors. By 2023 the disclosures emphasized that the programs now sit under heightened regulatory scrutiny—new authentication and data‑security mandates, expanded consumer‑protection and antitrust investigations, and broader “gatekeeper” obligations—creating additional compliance costs and the risk of curtailed or renegotiated agreements that could materially dent operating results.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ISSUES: The LLM answer introduces significant factual errors and unsupported claims not present in the ground truth. Specifically: (1) The LLM claims 2023 disclosures mentioned 'expanded consumer-protection and antitrust investigations' and 'gatekeeper obligations'—these are NOT mentioned in the original answer and appear to be fabricated details not supported by the knowledge graph. (2) The LLM characterizes the 2022 programs as 'modest ancillary revenue source' with concerns about 'interchange fees and reliance on third-party processors'—the ground truth makes no such characterization about revenue significance or mentions interchange fees. (3) The LLM mentions 'new authentication and data-security mandates' in 2023, but the ground truth specifically identifies 'data localization rules' as the new 2023 compliance obligation, which is a distinct regulatory concern. CORRECT ELEMENTS: (1) Both answers correctly identify that 2022 involved basic payment card compliance risks. (2) Both correctly note that 2023 brought expanded regulatory obligations. (3) Both correctly identify potential adverse impact on operating results. (4) The general trajectory of increased regulatory complexity is accurate. MULTI-HOP REASONING: The LLM failed to properly synthesize the specific regulatory evolution from the knowledge graph. Instead of accurately tracking the shift from payment card association rules (2022) to data localization rules (2023), the LLM introduced unsubstantiated regulatory concerns (antitrust, gatekeeper obligations, authentication mandates) that appear to be hallucinations. The answer demonstrates poor fidelity to the source material and introduces false specificity that undermines credibility. The core insight about increased regulatory burden is present but the specific regulatory mechanisms are incorrectly identified.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 504,
        "total_tokens": 1948
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How has PM's financial relationship with RBH evolved between 2022 and 2024, particularly regarding the consolidation status and valuation considerations of RBH within PM's financial statements?",
      "original_answer": "In 2022, RBH was deconsolidated from PM's financial statements due to CCAA proceedings initiated in 2019, with its financial results excluded since that time. Additionally, PM faced potential material impacts from unresolved Canadian tobacco litigation, including a CAD 3.1 billion allocation of compensatory damages against RBH. By 2024, PM's relationship with RBH had evolved into holding an equity investment, which required impairment analysis. The audit process emphasized significant judgment around the fair value estimate of the investment, including assumptions on discount rates, sales volumes, operating margins, and the tax treatment of a potential global settlement. This reflects a shift from a deconsolidated subsidiary to a valued equity stake requiring ongoing impairment evaluation.",
      "llm_answer": "\nBetween 2022 and 2024 PMI continues to treat RBH as an **equity‑method investment** rather than a consolidated subsidiary – RBH was de‑consolidated from PMI’s financial statements in March 2019 (and remains excluded in the 2024 balance sheet).  The only financial link is the 23 % equity stake and the related foreign‑currency translation adjustments (≈ $1.6 bn of cumulative translation losses recorded in OCI as of 2024), which are reflected in PMI’s accumulated other‑comprehensive‑losses.  Because the investment is not consolidated, PMI must test it for impairment using significant judgments—discount rates, projected sales volumes and operating margins for RBH’s combustible‑tobacco business, and the deductibility of settlement payments—procedures that auditors highlighted as a critical audit matter in 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the core evolution of PM's relationship with RBH from deconsolidated subsidiary to equity-method investment. The deconsolidation date (March 2019) is accurate. The mention of impairment testing with significant judgments (discount rates, sales volumes, operating margins) aligns with ground truth. The reference to critical audit matters in 2024 is appropriate. The 23% equity stake is mentioned correctly.\n\nWEAKNESSES AND ERRORS: (1) CRITICAL OMISSION: The LLM completely fails to mention the CAD 3.1 billion allocation of compensatory damages against RBH from Canadian tobacco litigation - a material financial impact explicitly highlighted in the ground truth as a key aspect of PM's relationship with RBH. This is a significant omission for a question about financial relationship evolution. (2) QUANTITATIVE ISSUE: The LLM cites \"≈ $1.6 bn of cumulative translation losses\" in OCI but this specific number cannot be verified against the ground truth provided, and the ground truth does not mention this figure. While the concept of foreign-currency translation adjustments is relevant, introducing an unverified specific dollar amount is problematic. (3) TERMINOLOGY: The LLM uses \"equity-method investment\" while the ground truth uses \"equity investment\" - these are subtly different accounting treatments. Equity-method investment implies the equity method of accounting (typically for 20-50% ownership with significant influence), while the ground truth simply refers to it as an equity investment requiring impairment analysis. This distinction matters for accounting precision. (4) INCOMPLETE SYNTHESIS: The answer addresses the consolidation status change and impairment considerations but misses the litigation damages aspect entirely, which is a material component of how PM's financial relationship with RBH evolved.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information about the deconsolidation, equity stake, and impairment testing requirements. However, it fails to synthesize the complete picture by omitting the litigation damages component, which is essential to understanding the full evolution of the financial relationship.\n\nNUMBER VERIFICATION: The 23% equity stake appears correct. The $1.6 billion figure for cumulative translation losses is not verified in the ground truth and may be inaccurate or from a different context. The CAD 3.1 billion damages figure is completely absent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 657,
        "total_tokens": 2073
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did the financial performance and strategic positioning of Baqsimi evolve between 2023 and 2024, particularly in terms of revenue contribution and its role within LLY's product portfolio?",
      "original_answer": "In 2023, Baqsimi contributed $677.6 million in total revenue, with $645.7 million from the U.S. and $31.9 million from outside the U.S., indicating it was still a growing product within LLY's portfolio. By 2024, Baqsimi was no longer reported as a direct revenue contributor through product sales; instead, it was disclosed as part of a collaboration and other arrangements, specifically under the 2023 sale of rights. This shift suggests that LLY transitioned Baqsimi from an internally commercialized product to a divested asset, impacting its strategic focus and revenue model. The absence of Baqsimi from direct product revenue in 2024 reflects a significant change in its role and contribution to LLY's financials.",
      "llm_answer": "\nBetween 2023 and 2024 Baqsimi’s direct product sales collapsed – the company recorded $677.6 million of total Baqsimi revenue in 2023 (up from $139.3 million in 2022) but, after selling the rights to Amphastar in June 2023, essentially no product‑sale revenue appears in 2024.  Instead, LLY now earns only royalty and contingent milestone payments (up to $450 million) and recognizes a small, over‑time net‑product revenue stream from the supply agreement under which it manufactures the drug for Amphastar.  This shift re‑positions Baqsimi from a core revenue‑generating product to a licensing asset that contributes only modest, future‑oriented income to LLY’s portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive understanding of Baqsimi's evolution. STRENGTHS: (1) All key numbers are correct: $677.6M total 2023 revenue is accurate, $645.7M U.S. and $31.9M international breakdown is implicit in the answer's focus on total revenue, and the $139.3M 2022 comparison figure is accurate. (2) The June 2023 sale to Amphastar is correctly identified as the pivotal transaction. (3) The multi-hop reasoning is sound: the answer correctly synthesizes that Baqsimi transitioned from direct product sales to a licensing/royalty model, with contingent milestone payments up to $450M and ongoing supply agreement revenue. (4) The characterization of the shift from 'core revenue-generating product' to 'licensing asset' accurately reflects the strategic repositioning described in the ground truth. (5) The answer correctly identifies that 2024 shows no direct product revenue from Baqsimi, consistent with the ground truth statement that it 'was no longer reported as a direct revenue contributor through product sales.' MINOR CONSIDERATIONS: The LLM answer provides additional context (Amphastar as the buyer, specific payment structures) that goes beyond the ground truth but is factually accurate and enhances understanding. The answer's characterization of 'direct product sales collapsed' is semantically equivalent to the ground truth's 'absence of Baqsimi from direct product revenue in 2024.' The supply agreement revenue stream mentioned is consistent with the ground truth's reference to 'collaboration and other arrangements.' No calculation errors detected. All entities (LLY, Baqsimi, Amphastar) correctly identified. The answer fully addresses both components of the question: financial performance (revenue decline) and strategic positioning (shift from product to licensing asset).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 500,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How has the composition of Union Pacific's Total Highway Revenue Equipment changed from 2022 to 2024, particularly in terms of the ratio of owned versus leased containers and chassis?",
      "original_answer": "In 2022, Union Pacific owned 78,837 units and leased 16,004 units of Total Highway Revenue Equipment, with containers making up the majority of owned assets and chassis being heavily leased. By 2024, the company significantly reduced both owned and leased equipment, with owned units dropping to 50,731 and leased units to 1,485. The most notable change was in leased containers, which fell from 1,856 in 2022 to just 288 in 2024, and owned chassis decreased from 29,875 to 4,356. This indicates a strategic shift toward owning fewer assets and leasing even fewer, especially in chassis.",
      "llm_answer": "\nFrom 2022 (which is reflected in the 2021 baseline figures) through 2024, Union Pacific moved sharply toward greater ownership of its highway‑revenue equipment.  Owned containers rose from roughly 96 % of the fleet in 2021 to about 99 % in 2024 (leased containers fell from 1,856 to 288), and owned chassis increased from roughly 68 % to 78 % of the chassis fleet (leased chassis dropped from 14,148 to 1,197).  Consequently, the proportion of equipment that is owned has expanded markedly, while the leased share has contracted over the 2022‑2024 period.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: The LLM answer contains significant factual inaccuracies that contradict the ground truth:\n\n1. QUANTITATIVE ACCURACY FAILURES:\n   - Ground truth: Owned units 2022=78,837; 2024=50,731 (DECREASE)\n   - LLM claims: Owned containers/chassis INCREASED from 2021 to 2024\n   - Ground truth: Leased chassis 2022=14,148; 2024=1,485\n   - LLM states: Leased chassis dropped to 1,197 (WRONG NUMBER)\n   - Ground truth: Leased containers 2022=1,856; 2024=288 (CORRECT in LLM)\n   - Ground truth: Owned chassis 2022=29,875; 2024=4,356\n   - LLM provides no owned chassis numbers for 2022/2024\n\n2. DIRECTIONAL ERROR - CRITICAL:\n   - LLM claims ownership INCREASED (\"moved sharply toward greater ownership\")\n   - Ground truth shows DRAMATIC DECREASE in both owned (78,837→50,731) and leased (16,004→1,485) equipment\n   - This is a fundamental misinterpretation of the data trend\n\n3. PERCENTAGE CALCULATIONS:\n   - LLM states owned containers went from ~96% to ~99%\n   - LLM states owned chassis went from ~68% to ~78%\n   - These percentages cannot be verified against provided ground truth numbers and appear inconsistent with the actual reduction in total equipment\n\n4. BASELINE YEAR CONFUSION:\n   - LLM references \"2021 baseline figures\" when question asks about 2022-2024\n   - Ground truth provides 2022 and 2024 data, not 2021\n   - This temporal misalignment suggests data source confusion\n\n5. MISSING KEY INFORMATION:\n   - LLM fails to mention the dramatic overall reduction in total equipment (from 94,841 to 52,216 units)\n   - Does not address the strategic shift toward fewer assets overall\n   - Misses the context that leased equipment contracted far more severely than owned\n\n6. SEMANTIC CONTRADICTION:\n   - LLM's conclusion (\"proportion of equipment that is owned has expanded\") contradicts the ground truth narrative of \"strategic shift toward owning fewer assets and leasing even fewer\"\n   - The actual story is about REDUCTION in both categories, not expansion of ownership proportion\n\nThe LLM answer fundamentally misrepresents the composition changes, getting the directional trend wrong and providing incorrect specific numbers for leased chassis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 591,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did Capital One's use of securitized debt obligations evolve between 2022 and 2023, particularly in terms of their role within the company's overall funding structure?",
      "original_answer": "In 2022, securitized debt obligations were explicitly described as one of the company's key funding sources alongside deposits, senior and subordinated notes, federal funds purchased, and FHLB advances. By 2023, while still present in the funding structure at $18.043 billion in carrying value, securitized debt obligations were categorized under Level 2 in the fair value hierarchy, indicating a shift toward more standardized valuation methods. This evolution suggests a more structured and possibly less volatile role for securitized debt obligations in Capital One's funding strategy.",
      "llm_answer": "\nBetween the end of 2021 and the end of 2023 Capital One’s outstanding securitized‑debt balance grew from about **$15 billion** (Table 6, 2022 10‑K, p. 67) to roughly **$18 billion** (Note 16, 2023 10‑K, p. 212), an increase driven by net issuances in its credit‑card and auto‑loan securitization programs.  This expansion lifted the share of securitized obligations within the firm’s total funding to roughly **4–5 %** of the capital structure, preserving their role as a supplemental, asset‑backed source of liquidity that complements deposits and unsecured debt in funding the loan portfolio.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer provides relevant information about Capital One's securitized debt evolution but has significant issues with the time period and some quantitative details. STRENGTHS: (1) Correctly identifies the growth in securitized debt from approximately $15B to $18B, matching the ground truth figure of $18.043B for 2023; (2) Appropriately characterizes securitized obligations as supplemental, asset-backed funding sources; (3) Correctly identifies credit-card and auto-loan securitization programs as drivers; (4) Reasonably estimates the 4-5% share of total funding structure. CRITICAL ISSUES: (1) TIME PERIOD MISMATCH: The question asks about 2022-2023 evolution, but the LLM answer compares 2021-2023 ('end of 2021' to 'end of 2023'), which is a different comparison period than requested. The ground truth specifically addresses 2022 vs 2023 characterization; (2) MISSING KEY INSIGHT: The ground truth emphasizes the shift in fair value hierarchy classification (Level 2 in 2023) and the change in how securitized debt was described/categorized, which the LLM answer completely omits. This is a material difference in how the evolution is characterized; (3) INCOMPLETE SYNTHESIS: The LLM answer focuses on quantitative growth but misses the qualitative shift in valuation methodology and structural role that the ground truth highlights. QUANTITATIVE VERIFICATION: The $15B and $18B figures appear reasonable based on the ground truth's $18.043B for 2023, though the 2021 baseline is not explicitly confirmed in the ground truth. The 4-5% estimate is reasonable but not explicitly verified. REASONING: The multi-hop synthesis is partially sound (connecting growth to securitization programs to funding role) but incomplete because it doesn't address the fair value hierarchy shift or the change in how the obligations were categorized between years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 503,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did the nature of LLY's revenue from Zyprexa evolve between 2023 and 2024, particularly in terms of the source and recognition method of that revenue?",
      "original_answer": "In 2023, Zyprexa revenue was primarily derived from the sale of the rights for the olanzapine portfolio. By 2024, the revenue associated with Zyprexa was recognized as part of collaboration and other arrangements, specifically stemming from the 2023 sale of rights for the olanzapine portfolio, and was included in collaboration revenue rather than product sales. This reflects a shift in how Zyprexa-related revenue was categorized and recognized in 2024 compared to 2023.",
      "llm_answer": "\nIn 2023 LLY still reported Zyprexa as ordinary product sales—$79.4 million in the United States and $1.62 billion outside the United States—recognized at the point of shipment, but a sizable share of that year’s Zyprexa‑related revenue came from a one‑time gain on the sale of the olanzapine portfolio rights, which was recorded as collaboration and other revenue and recognized up front. By 2024 the company no longer records Zyprexa product sales; any remaining Zyprexa‑related income consists only of future milestone or royalty payments that will be recognized as they are earned, marking a shift from recurring product revenue to a one‑off gain and potential deferred royalty income.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces unsupported quantitative claims. Critical issues: (1) QUANTITATIVE ERRORS: The LLM provides specific dollar amounts ($79.4 million US, $1.62 billion outside US) that are NOT present in the ground truth answer. The ground truth makes no mention of these specific figures, and introducing unverified numbers is a serious error in financial reporting. (2) MISCHARACTERIZATION OF 2023 REVENUE: The ground truth states that in 2023, Zyprexa revenue was 'primarily derived from the sale of the rights for the olanzapine portfolio,' suggesting this was the main revenue source. The LLM incorrectly separates this into 'ordinary product sales' plus 'a one-time gain,' which contradicts the ground truth's characterization that the primary source was the rights sale itself. (3) INCOMPLETE SYNTHESIS: The ground truth clearly states that in 2024, revenue was 'recognized as part of collaboration and other arrangements' and 'included in collaboration revenue rather than product sales.' The LLM's claim about 'future milestone or royalty payments' goes beyond what the ground truth establishes and appears to be speculation. (4) RECOGNITION METHOD CONFUSION: While the LLM attempts to address recognition methods, it conflates product sales recognition with the rights sale treatment in a way that doesn't align with the ground truth's clearer distinction between 2023 (rights sale as primary source) and 2024 (collaboration revenue categorization). (5) MULTI-HOP REASONING: The LLM fails to properly synthesize the key insight from the ground truth: the shift is fundamentally about how the SAME underlying transaction (the 2023 rights sale) was categorized differently in financial reporting between 2023 and 2024, not about a transition from product sales to royalties. The answer demonstrates partial understanding of the evolution but introduces unsupported details and misses the core point about revenue categorization changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 536,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How has the valuation methodology and classification of Federal Government Securities in the pension plan evolved from 2022 to 2024?",
      "original_answer": "In 2022, Federal Government Securities were valued under the 'Significant Other Observable Inputs (Level 2)' category and totaled $742 million. By 2024, the company clarified that these securities are valued using a bid evaluation process with bid data from independent pricing sources and are explicitly classified as Level 2 investments. This reflects a continuation in classification but adds specificity in methodology explanation.",
      "llm_answer": "\nBoth the 2022 filing (pages 72‑74) and the 2024 filing (page 56) classify Federal Government Securities as Level 2 investments and describe them as being valued through a bid‑evaluation process that uses independent pricing data. Thus, the valuation methodology and classification of these securities have remained unchanged from 2022 through 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies that Federal Government Securities are classified as Level 2 investments in both 2022 and 2024, and accurately describes the valuation methodology using bid-evaluation processes with independent pricing data. However, there is a critical omission: the ground truth specifies that Federal Government Securities totaled $742 million in 2022, which the LLM answer completely fails to mention. This is a significant quantitative gap. The LLM's conclusion that the methodology and classification 'remained unchanged' is semantically reasonable and supported by the evidence, but the answer is incomplete because it doesn't provide the specific dollar amount for 2022. The LLM correctly synthesizes information across the two filing years and accurately identifies the page references (pages 72-74 for 2022, page 56 for 2024). The reasoning about continuity in classification is sound. However, for a question asking how something 'evolved,' providing only the 2022 dollar amount without any 2024 comparison figure makes the answer incomplete in addressing the full scope of the question. The LLM should have either provided both years' valuations or explicitly noted that the 2024 filing did not provide a comparable dollar amount. The omission of the $742 million figure is a material factual gap that prevents this from being a fully correct answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1192,
        "completion_tokens": 384,
        "total_tokens": 1577
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did Capital One's credit score data utilization for product segmentation decisions evolve from 2022 to 2023, and what does this indicate about their credit risk modeling strategy?",
      "original_answer": "In 2022, Capital One used credit score data for product segmentation decisions based on historical credit score distributions from 2020 to 2021, as shown in Table 21. In 2023, the company updated its data to reflect credit score distributions from 2022 to 2023 in the same table. This shift indicates a more current and dynamic credit risk modeling strategy, with product segmentation decisions being informed by the most recent borrower behavior and risk profiles, suggesting a proactive approach to managing credit risk in evolving economic conditions.",
      "llm_answer": "\nFrom 2022 to 2023 Capital One shifted from a general reference to using borrower credit scores for “product segmentation decisions” to an explicit, data‑driven practice that leverages detailed FICO‑score distributions (e.g., Table 21) to shape product offerings and risk‑based pricing. This evolution shows that credit scores have become a core input in the firm’s credit‑risk models, allowing it to segment customers more precisely and tailor pricing and product terms to observed credit‑quality tiers.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ISSUES: (1) The LLM answer fails to specify the actual credit score data periods that changed between years. Ground truth explicitly states: 2022 used 2020-2021 distributions, while 2023 used 2022-2023 distributions. The LLM mentions 'Table 21' and FICO-score distributions but does NOT identify these specific time periods, which is a key factual element of the evolution. (2) The LLM answer is vague about what 'shifted' - it says Capital One moved from 'general reference' to 'explicit, data-driven practice,' but this characterization is not supported by the ground truth, which shows both years used Table 21 data, just with different underlying periods. (3) QUANTITATIVE ACCURACY: The LLM provides no specific numbers, percentages, or data ranges from Table 21, making it impossible to verify quantitative claims. The ground truth references specific distributions but the LLM does not cite them. (4) MULTI-HOP REASONING: The LLM correctly identifies that credit scores became a 'core input' and enabled 'more precise segmentation,' which aligns with the ground truth's conclusion about 'more current and dynamic' strategy. However, the reasoning path is incomplete - it doesn't explain HOW the shift from 2020-2021 data to 2022-2023 data demonstrates this evolution. (5) SEMANTIC ISSUES: The LLM's framing of a shift from 'general reference' to 'explicit, data-driven practice' misrepresents the actual evolution, which was about updating the reference periods to more current data, not about adopting a new methodology. (6) POSITIVE: The LLM correctly identifies Capital One, correctly references Table 21, and correctly concludes that the strategy became more dynamic/proactive. The answer demonstrates understanding of the general concept but lacks the specific factual details that define the evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 494,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How has Amazon's strategic positioning of AWS evolved from 2022 to 2023 in terms of its role within the company's broader business segments and investment priorities?",
      "original_answer": "In 2022, AWS was positioned primarily as a key area of investment within Amazon's broader technology and content spending, with an emphasis on supporting geographic expansion, new product categories, and internal operational efficiencies. The document highlighted that Amazon was investing in AWS alongside initiatives to build and deploy innovative software and electronic devices, indicating a strategic alignment with internal growth and infrastructure enhancement. By 2023, AWS had evolved into one of Amazon's three core business segments—alongside North America and International—reflecting its elevated strategic importance. The 2023 filing explicitly states that AWS serves developers and enterprises by offering a broad set of on-demand technology services, including compute, storage, database, analytics, and machine learning, and is now a distinct and central pillar of Amazon’s business model. This shift demonstrates a transformation in AWS's role from a strategic investment area to a standalone, mission-critical business segment.",
      "llm_answer": "\nFrom 2022 to 2023 AWS remained a distinct segment, but its strategic emphasis shifted from simply expanding its cloud‑service portfolio to positioning AWS as a core, long‑term profit engine that underpins Amazon’s overall growth.  This evolution is reflected in higher capital spending on AWS‑related infrastructure (e.g., data‑center expansion, satellite and autonomous‑vehicle projects) and in the company’s explicit focus on leveraging AWS to drive operating‑income and free‑cash‑flow growth across its North America, International and AWS segments.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "ASSESSMENT: The LLM answer contains significant factual errors and unsupported claims that contradict the ground truth.\n\nCORRECT ELEMENTS:\n- Correctly identifies AWS as a distinct segment in both 2022 and 2023\n- Appropriately characterizes the evolution toward AWS as a profit engine\n- Correctly mentions the three core business segments (North America, International, AWS)\n- Captures the general theme of AWS's elevated strategic importance\n\nMAJOR ERRORS AND UNSUPPORTED CLAIMS:\n1. QUANTITATIVE INACCURACY: The LLM claims \"higher capital spending on AWS-related infrastructure\" but provides NO specific numbers, dates, or comparative data. The ground truth does not mention increased capital spending or provide metrics to support this claim. This is a factual assertion without evidence.\n\n2. UNSUPPORTED CLAIMS: The LLM references \"satellite and autonomous-vehicle projects\" as AWS-related infrastructure investments. The ground truth makes NO mention of these projects in connection with AWS strategic positioning. This appears to be fabricated or confused information.\n\n3. INCOMPLETE SYNTHESIS: The ground truth emphasizes AWS's evolution from \"a strategic investment area\" (2022) to \"a standalone, mission-critical business segment\" (2023). The LLM captures the profit-engine aspect but misses the critical distinction about AWS's structural repositioning within the company's organizational framework.\n\n4. MISSING KEY CONTEXT: The ground truth explicitly states that in 2022, AWS was positioned \"within Amazon's broader technology and content spending\" alongside other initiatives. The LLM fails to capture this 2022 positioning context, instead jumping directly to profit-engine language without establishing the baseline.\n\n5. VAGUE LANGUAGE: The LLM uses phrases like \"higher capital spending\" and \"explicit focus\" without citing specific evidence, dates, or metrics from the filings.\n\nMULTI-HOP REASONING: The LLM attempts to synthesize information across years but does so with unsupported claims rather than grounded facts from the filings. The reasoning about profit engines and cash-flow growth is plausible but not substantiated by the ground truth.\n\nSCORING JUSTIFICATION:\n- Correctness (5): Core structure correct (AWS as segment), but multiple unsupported claims and missing key contextual details significantly undermine accuracy\n- Quantitative Accuracy (3): No specific numbers provided; claims about \"higher capital spending\" are unsubstantiated and potentially inaccurate\n- Qualitative Accuracy (6): Captures general evolution theme but misses structural repositioning details and includes unsupported claims about satellite/autonomous vehicle projects\n- Contextual Relevance (7): Addresses the question's timeframe and segments, but lacks grounding in actual filing evidence",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 748,
        "total_tokens": 2153
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How has Philip Morris International's financial relationship with Rothmans, Benson & Hedges Inc. (RBH) evolved between 2022 and 2024, particularly in terms of its accounting treatment and potential financial exposure?",
      "original_answer": "In 2022, RBH was deconsolidated from Philip Morris International’s financial statements due to its CCAA restructuring, and its financial results were no longer included in PMI’s consolidated financials. At that time, there was a comprehensive stay of Canadian tobacco litigation until March 31, 2022, and no loss accruals were made due to the inability to estimate potential losses. By 2024, PMI’s relationship with RBH had shifted from deconsolidation to an equity investment model. A proposed settlement of CAD 32.5 billion in the Canadian tobacco litigation emerged, prompting PMI to assess its investment in RBH for impairment. As a result, PMI recorded a non-cash impairment charge of $2,316 million in 2024, reflecting a decline in the estimated fair value of its investment. This marks a significant evolution from a deconsolidated entity with uncertain liabilities to a recognized equity investment with a quantified impairment.",
      "llm_answer": "\nBetween 2022 and 2024 PMI’s stake in Rothmans, Benson & Hedges has remained an equity investment that is now accounted for under the equity‑method (page 31) and is hedged for foreign‑exchange and interest‑rate risk, with the resulting gains/losses recorded in other‑comprehensive income (page 110).  In 2024 the company performed a quantitative fair‑value test after the CCAA‑related settlement proposal raised doubts about the allocation of a CAD 32.5 bn global settlement, and it recorded a $2.3 bn non‑cash impairment charge because the investment’s fair value had fallen below its carrying amount (page 31).  As a result, PMI’s exposure to RBH has shifted from a passive, de‑consolidated holding to a potentially material loss that could grow if the settlement or related litigation outcomes change.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the CAD 32.5 billion settlement amount and the $2.3 billion impairment charge (matching the ground truth's $2,316 million when rounded). (2) Correctly notes the shift to equity-method accounting and the 2024 impairment assessment. (3) Accurately references the CCAA restructuring context. (4) Properly identifies the non-cash nature of the impairment charge. WEAKNESSES: (1) CRITICAL OMISSION - The LLM completely fails to address the 2022 deconsolidation status, which is a key part of the 'evolution' between 2022 and 2024. The ground truth explicitly states RBH was deconsolidated in 2022 due to CCAA restructuring, but the LLM states the stake 'has remained an equity investment' - this is factually incorrect for the 2022 baseline. The evolution FROM deconsolidation TO equity investment is the core narrative. (2) The statement that RBH 'has remained an equity investment' contradicts the ground truth that it was deconsolidated in 2022 and only later became an equity investment. (3) Missing the detail about the comprehensive stay of Canadian tobacco litigation until March 31, 2022, and the inability to estimate losses in 2022. (4) The characterization of the current holding as 'passive' is somewhat contradicted by the material $2.3B impairment, though this is a minor semantic issue. QUANTITATIVE VERIFICATION: The $2.3 billion figure is acceptable (ground truth: $2,316 million; difference is rounding). CAD 32.5 billion settlement amount is correct. MULTI-HOP REASONING: The LLM fails to properly synthesize the temporal evolution - it should clearly distinguish between 2022 status (deconsolidated) and 2024 status (equity investment with impairment). The answer reads as if the equity-method treatment was continuous, which is incorrect. This is a significant failure in multi-hop reasoning across the 2022-2024 period.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 509,
        "total_tokens": 1961
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How has the commercial significance of Biktarvy evolved for GILD from 2022 to 2024, considering both its revenue contribution and associated product risks?",
      "original_answer": "In 2022, Biktarvy was a major revenue driver for GILD, generating $8,624 million in total product sales globally, indicating its strong market position in the HIV treatment segment. By 2024, while specific revenue figures are not provided, the company's risk disclosures highlight Biktarvy's ongoing importance but also emphasize heightened risks related to the HIV product class, particularly concerning the reliance on TAF-based therapies and potential shifts in treatment paradigms. This evolution suggests that although Biktarvy remains central to GILD's revenue, its commercial outlook has become more vulnerable to competitive and regulatory pressures.",
      "llm_answer": "\nBetween 2022 and 2024 Biktarvy continued to be Gilead’s largest HIV revenue driver—its product‑sales figure fell only modestly (from roughly $8.6 billion in 2021 to the low‑$8 billion range in the subsequent two years)—but its relative commercial weight has been eroding as newer HIV regimens and generic versions have gained market share.  At the same time, the product’s risk profile has intensified: pricing pressure from state affordability reviews and EU reimbursement assessments, ongoing litigation over kidney‑bone injuries, and the potential impact of 340B/Medicaid rebate changes and Medicaid‑rebate calculations have increased the uncertainty around its future sales trajectory.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ISSUES: (1) QUANTITATIVE ACCURACY - The LLM provides a 2021 revenue figure ($8.6 billion) that is NOT in the ground truth or question scope. The ground truth explicitly states 2022 Biktarvy revenue was $8,624 million ($8.624 billion), but the LLM cites 2021 as the baseline and claims 'low-$8 billion range in the subsequent two years' without providing specific 2022-2024 figures. This is a significant factual error - the LLM is using wrong baseline year and making unsupported claims about 2023-2024 revenue trends. (2) INCOMPLETENESS ON CORE DATA - The ground truth notes 'specific revenue figures are not provided' for 2024, which the LLM should acknowledge rather than imply revenue stayed in 'low-$8 billion range.' The LLM makes a comparative claim without proper sourcing. (3) RISK PROFILE ACCURACY - The LLM adds specific risk details (pricing pressure from state affordability reviews, EU reimbursement, kidney-bone injury litigation, 340B/Medicaid rebate changes) that are NOT mentioned in the ground truth. While these may be real risks from filings, they represent information beyond what the ground truth synthesized, making it unclear if these are accurate to the actual 10-K disclosures. (4) POSITIVE ASPECTS - The LLM correctly identifies Biktarvy as a major/largest HIV revenue driver, correctly notes erosion of relative commercial weight, and appropriately emphasizes heightened risk profile. The semantic understanding of the evolution is sound. (5) MULTI-HOP REASONING - The LLM attempts to synthesize revenue trends with risk evolution, which is appropriate, but the factual foundation is weak due to the 2021 baseline error and unsupported revenue claims for 2023-2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 464,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How has Union Pacific Railroad's financial stake and operational relationship with TTX evolved from 2022 to 2024, particularly in terms of investment value and car hire expenses?",
      "original_answer": "Union Pacific Railroad's financial stake in TTX increased from $1.6 billion in 2021 (referenced in the 2022 filing) to $1.9 billion in 2024. Additionally, UPRR's car hire expenses rose from $375 million in 2021 to $432 million in 2024. These increases indicate a growing financial and operational involvement with TTX over the period.",
      "llm_answer": "\nUnion Pacific’s equity investment in TTX grew markedly from about **$1.6 billion** (recorded as of 2021) to **$1.9 billion** by the end of 2024, reflecting its 37 % economic interest and subsequent capital additions under the equity‑method accounting.  At the same time, car‑hire expenses paid to TTX rose from **$402 million in 2022** to **$432 million in 2024** (up from $399 million in 2023), indicating higher utilization of TTX rail cars and a larger expense footprint over the period.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identified the equity investment values ($1.6B in 2021 to $1.9B in 2024) and the overall trend of increasing financial involvement. The answer appropriately addresses both investment value and car hire expenses, demonstrating multi-hop synthesis. The contextual framing about equity-method accounting and the 37% economic interest adds relevant detail. CRITICAL ERRORS: The car hire expense figures contain a significant discrepancy. The ground truth states car hire expenses rose from $375 million in 2021 to $432 million in 2024. However, the LLM reports $402 million in 2022 as the starting point, which differs from the ground truth baseline of $375 million in 2021. More problematically, the LLM provides intermediate year data ($399 million in 2023) that cannot be verified against the ground truth, which only provides 2021 and 2024 figures. This represents either fabricated data or reliance on sources not in the ground truth. QUANTITATIVE ACCURACY ISSUES: While the 2024 figure of $432 million is correct, the 2022 figure of $402 million is not confirmed in the ground truth, and the 2023 figure of $399 million appears to be unsupported. The ground truth explicitly states the comparison should be from 2021 ($375M) to 2024 ($432M), not from 2022 onwards. REASONING: The multi-hop synthesis is sound in structure (combining investment and expense trends), but the incomplete/incorrect intermediate data undermines confidence in the analysis. The LLM should have stuck to the documented 2021-2024 comparison rather than introducing unverified intermediate years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1214,
        "completion_tokens": 439,
        "total_tokens": 1653
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did Tesla's approach to scaling Solar Roof production change from 2022 to 2023, particularly regarding installer training initiatives and supply chain risk management?",
      "original_answer": "In 2022, Tesla emphasized expanding Solar Roof production by on-boarding and training new installers, collaborating with real estate developers, and reducing installation time and costs. The company also highlighted its need to hire additional personnel, particularly skilled electricians, to support the ramp. By 2023, Tesla's focus had shifted toward addressing broader supply chain risks and production ramp challenges, with language indicating that Solar Roof production now depended more on managing supplier reliability, global component constraints, and cost-effective manufacturing processes. The 2023 filing also noted that delays in production ramps could harm the business, signaling a shift from installer-focused growth to a more risk-averse strategy centered on supply chain resilience.",
      "llm_answer": "\nIn the 2023 filing Tesla explicitly “on‑boards and trains new installers” and partners with developers to accelerate Solar Roof installations, a focus that was only a brief mention in the 2022 document. At the same time, the 2023 filing expands its supply‑chain risk discussion—warning of component shortages, single‑source dependencies and the need to secure alternate sources and maintain battery‑cell supply—showing a more detailed risk‑management approach than in 2022.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IN CORE CLAIM: The LLM answer fundamentally reverses the ground truth narrative. The LLM states that installer training and developer partnerships were 'only a brief mention in the 2022 document' and became a focus in 2023, when the ground truth explicitly states the opposite: 2022 emphasized installer training and developer collaboration, while 2023 shifted focus to supply chain risks. This is a major factual inversion that contradicts the core premise of the question about how the approach 'changed from 2022 to 2023.' The LLM correctly identifies that 2023 expanded supply chain risk discussion (component shortages, single-source dependencies), which aligns with ground truth. However, the directional claim about installer training is backwards. The LLM also misses key 2022 details: the emphasis on hiring skilled electricians, reducing installation time/costs, and the specific focus on on-boarding new installers as a primary growth strategy in that year. The LLM's characterization of the shift from 'installer-focused growth to risk-averse strategy centered on supply chain resilience' is absent. While no specific numbers are provided in either answer (so quantitative accuracy is neutral), the qualitative reasoning about the strategic shift is fundamentally flawed due to the reversed timeline of priorities. The answer demonstrates partial understanding of supply chain risk evolution but fails on the primary comparative analysis requested.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 408,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How has The Coca-Cola Company's relationship with fountain retailers evolved between 2022 and 2023, particularly regarding the manufacturing and distribution of fountain syrups in the United States?",
      "original_answer": "In 2022, The Coca-Cola Company stated that U.S. bottlers were generally not authorized to manufacture fountain syrups, and instead, the Company itself manufactured and sold fountain syrups directly to authorized fountain wholesalers (including some bottlers) and certain fountain retailers. By 2023, the Company clarified that it continues to manufacture fountain syrups in the U.S., but now explicitly states that it sells these syrups to both fountain retailers and authorized fountain wholesalers or bottling partners who then distribute them to fountain retailers. This indicates a more explicit acknowledgment of a tiered distribution model involving bottling partners in 2023, suggesting a potential expansion of their distribution network or clarification of roles.",
      "llm_answer": "\nBetween 2022 and 2023 the Company’s model for U.S. fountain syrups was unchanged – it continues to **manufacture the syrups itself and sell them directly to authorized fountain wholesalers (and, where allowed, directly to fountain retailers)**, while U.S. bottlers remain prohibited from producing fountain syrups.  The firm still supports these retailers with promotional and marketing programs, but the underlying manufacturing‑and‑distribution chain has not shifted in the last two years.",
      "correctness_score": 4,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains a critical factual error regarding the evolution of the relationship between 2022 and 2023. The ground truth explicitly states that there WAS a change: in 2022, Coca-Cola sold fountain syrups to 'authorized fountain wholesalers (including some bottlers) and certain fountain retailers,' while in 2023, the company 'explicitly states that it sells these syrups to both fountain retailers and authorized fountain wholesalers or bottling partners.' The key difference is that 2023 shows more explicit acknowledgment of a tiered distribution model involving bottling partners, suggesting expansion or clarification of roles. The LLM incorrectly claims 'the model for U.S. fountain syrups was unchanged' and states the relationship 'has not shifted in the last two years.' This directly contradicts the ground truth's assertion of evolution in how the company describes its distribution network. The LLM correctly identifies that: (1) Coca-Cola manufactures fountain syrups itself, (2) U.S. bottlers are not authorized to manufacture them, (3) the company sells to authorized fountain wholesalers and fountain retailers. However, it fails to recognize the important distinction that 2023 brought more explicit acknowledgment of bottling partners in the distribution chain. The quantitative accuracy is high (no numbers to verify, dates are correct), but the qualitative accuracy is low because the core claim about whether the relationship evolved is factually incorrect. The answer misses the nuanced but important change in how Coca-Cola described its distribution model between these two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 443,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How has IBM's treatment and disclosure of the 0.950% Notes due 2025 evolved from 2022 to 2024, particularly in terms of its financial instrument classification and registration details?",
      "original_answer": "In 2022, the 0.950% Notes due 2025 were disclosed as part of IBM's exhibits in Form 8-K filings, specifically referenced under Exhibit 4.1 filed on May 22, 2017. By 2024, the 0.950% Notes due 2025 were not only still present but were actively listed as a financial instrument with a trading symbol 'IBM25B' on the New York Stock Exchange. This evolution indicates a shift from merely disclosing the instrument to formally registering and listing it for trading.",
      "llm_answer": "\nIBM has continued to treat the 0.950 % Notes due 2025 as senior unsecured **notes**—the same classification used in 2022.  In the 2024 10‑K the instrument is now set out explicitly in the “Securities Registered Pursuant to Section 12(b)” table (ticker IBM25B, NYSE) and the filing reiterates that the governing rights are those contained in the 2017 Form 8‑K (Exhibit 4.1), confirming the same registration under the 1933 Act.  Thus, while the 2024 filing presents the registration details in a more prominent, dedicated line, there has been no change in the notes’ financial‑instrument classification or registration status from 2022 to 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains both accurate and problematic elements. CORRECT ELEMENTS: (1) The 0.950% Notes due 2025 percentage is accurate; (2) The trading symbol 'IBM25B' on NYSE is correct; (3) The reference to Exhibit 4.1 from the 2017 Form 8-K is accurate; (4) The classification as senior unsecured notes is correct; (5) The mention of Section 12(b) registration is appropriate. PROBLEMATIC ELEMENTS: (1) The LLM claims there was 'no change in the notes' financial-instrument classification or registration status from 2022 to 2024,' which directly contradicts the ground truth. The ground truth explicitly states an 'evolution' and 'shift from merely disclosing the instrument to formally registering and listing it for trading.' (2) The LLM's conclusion that the notes were already registered in 2022 and merely presented more prominently in 2024 misses the key evolution described in the ground truth—the shift from exhibit disclosure to active listing with a trading symbol. (3) The LLM fails to capture the substantive change: in 2022 the notes were disclosed as exhibits in Form 8-K filings, but by 2024 they were actively listed for trading on NYSE with a specific ticker symbol, representing a meaningful evolution in their treatment and disclosure. MULTI-HOP REASONING: The LLM correctly synthesized information about the instrument's classification and registration details but failed to properly compare the 2022 vs. 2024 treatment to identify the evolution. The answer reads as if the notes had the same status throughout, when the ground truth indicates a clear progression from disclosure to active listing. QUANTITATIVE ACCURACY is high (dates, percentages, ticker symbol all correct), but QUALITATIVE ACCURACY is lower because the core analytical conclusion about evolution/change is incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 491,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How has GILD's strategic positioning of Biktarvy evolved from 2022 to 2024, particularly in terms of its financial risk exposure and competitive differentiation within the HIV treatment market?",
      "original_answer": "In 2022, Biktarvy was listed among GILD’s key marketed products, indicating its central role in the company's HIV portfolio and suggesting strong commercial positioning. By 2024, the company highlighted increasing financial risk tied to its reliance on nucleoside-based therapies like Biktarvy, particularly due to the potential shift in HIV treatment paradigms away from TAF-based regimens. This evolution reflects a growing concern over Biktarvy’s long-term competitive differentiation and its ability to sustain revenue, especially in the face of rising generic competition and changing therapeutic preferences.",
      "llm_answer": "\nSince the February 2022 settlement (see GILD 10‑K 2022 p. 94), Gilead has turned Biktarvy from a litigation‑heavy asset into a revenue‑generating product that now carries a contractual 3 % royalty to ViiV on U.S. sales through Oct 5 2027, while the one‑time $1.25 bn payment was recorded as a charge to cost of goods sold (p. 63).  This creates a predictable but ongoing financial exposure, even as the company leans on Biktarvy’s single‑tablet, once‑daily regimen and favorable resistance/safety profile to preserve its market‑share advantage over generic TAF rivals and other integrase‑based regimens, though it must navigate rising pricing pressures from Medicaid rebates, 340B caps and state affordability reviews that could compress margins (pp. 18, 21).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer provides specific financial details (3% royalty, $1.25bn payment, Oct 5 2027 date) and discusses competitive positioning, but has significant issues: (1) QUANTITATIVE ACCURACY: The specific numbers cited (3% royalty, $1.25bn payment, Oct 5 2027 date) cannot be verified against the ground truth provided, and the answer appears to reference specific page numbers that suggest these are from actual 10-K filings. However, the ground truth does not mention these specific figures, raising questions about accuracy. The answer focuses heavily on post-2022 settlement details rather than the 2022-2024 evolution requested. (2) COMPLETENESS: The question asks about evolution FROM 2022 TO 2024, but the LLM answer is heavily weighted toward 2022 settlement details and does not clearly articulate the 2024 positioning or how the strategic positioning changed over this period. The ground truth explicitly mentions 2024 concerns about TAF-based therapy shifts and generic competition, which the LLM answer only partially addresses. (3) ENTITY ACCURACY: Correctly identifies GILD and Biktarvy, mentions ViiV appropriately. (4) REASONING: The multi-hop synthesis is incomplete. The answer discusses financial risk (royalty obligations, pricing pressures) but does not adequately synthesize the evolution of competitive differentiation from 2022 to 2024 as requested. The ground truth emphasizes a shift in concern about long-term competitive positioning and paradigm shifts in HIV treatment, which the LLM answer mentions only tangentially. (5) SEMANTIC EQUIVALENCE: While the answer discusses competitive positioning and financial risk, it frames these primarily through the lens of the 2022 settlement rather than the 2022-2024 evolution. The ground truth's emphasis on growing concerns about TAF-based therapy shifts and generic competition by 2024 is not adequately captured. The answer provides operational/contractual details but misses the strategic evolution narrative that the ground truth emphasizes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 543,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did Lockheed Martin's approach to defined contribution retirement savings plans evolve between 2022 and 2023, particularly in terms of pension obligation transfers and associated financial impacts?",
      "original_answer": "In 2022, Lockheed Martin transferred $4.3 billion of gross defined benefit pension obligations through group annuity contracts, recognizing a noncash pension settlement charge of $1.5 billion. In 2023, instead of another annuity purchase, the company made $414 million in settlement payments to approximately 6,500 former employees who had not yet started receiving benefits. This shift indicates a strategic evolution from transferring large blocks of pension obligations to insurers (as in 2022) to directly settling smaller portions of obligations with individual participants in 2023.",
      "llm_answer": "\nBetween 2022 and 2023 Lockheed Martin kept the structure of its defined‑contribution retirement savings plan unchanged, modestly raising employer contributions to **$1.2 billion in 2023** (up from **$1.1 billion in 2022**) — as disclosed in the 2023 Form 10‑K (pages 61, 82, 89).  The company continued to shrink its defined‑benefit obligations through earlier annuity transfers (2021‑2022) and, in Q4 2023, executed a voluntary settlement that generated **$414 million of settlement payments**, reducing the remaining defined‑benefit liability but having no direct impact on the defined‑contribution plan beyond the modest contribution increase.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misses the core evolution described in the ground truth. CRITICAL ERRORS: (1) The LLM focuses on defined-contribution plan changes ($1.2B vs $1.1B contributions) when the question specifically asks about defined-benefit pension obligation transfers and their evolution. (2) The LLM mentions 'earlier annuity transfers (2021-2022)' but fails to identify the specific 2022 transaction: $4.3 billion in gross defined benefit pension obligations transferred via group annuity contracts with a $1.5 billion noncash settlement charge. (3) While the LLM correctly identifies the 2023 settlement payment of $414 million to approximately 6,500 former employees, it mischaracterizes this as 'Q4 2023' without confirming timing and downplays its significance. (4) The LLM incorrectly states the settlement 'having no direct impact on the defined-contribution plan' - the question asks about the evolution of the company's approach to retirement savings, which includes both DB and DC components. MULTI-HOP REASONING FAILURE: The question requires synthesizing information about how the company's strategy evolved from 2022 to 2023 in pension obligation management. The ground truth shows a clear strategic shift from large-scale annuity purchases ($4.3B in 2022) to direct participant settlements ($414M in 2023). The LLM fails to capture this strategic evolution and instead focuses on minor DC contribution increases that are tangential to the main question. QUANTITATIVE ISSUES: While the $414 million figure is correct, the LLM omits the critical 2022 figures ($4.3B transfer, $1.5B settlement charge) entirely. The contribution figures ($1.2B, $1.1B) appear to be correct but are not the primary focus of the question about pension obligation transfers. The answer demonstrates a fundamental misunderstanding of what the question is asking - it's about defined-benefit pension strategy evolution, not defined-contribution plan structure changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 537,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How has the composition of IBM's debt instruments maturing in 2025 evolved between 2022 and 2024, particularly regarding the 2.875% Notes due 2025?",
      "original_answer": "In 2022, IBM listed the 2.875% Notes due 2025 (IBM 25A) among other Notes due in 2025, including the 0.950% Notes due 2025 (IBM 25B) and the 0.875% Notes due 2025 (IBM 25C). By 2024, the 2.875% Notes due 2025 (IBM25A) remained, but the 0.875% Notes due 2025 (IBM 25C) were no longer listed, indicating a shift in the debt composition for that year. The 2.875% Notes due 2025 continued to be a key part of IBM's debt structure in 2024, suggesting a strategic decision to maintain this specific financial instrument while retiring or restructuring others.",
      "llm_answer": "\nBetween 2022 and 2024 the only IBM securities that mature in 2025 are the **2.875 % Notes due 2025 (ticker IBM25A)** and the **7.00 % Debentures due 2025 (ticker IBM25)** – both appear in the “Securities registered pursuant to Section 12(b)” tables of the 2021, 2022 and 2024 Form 10‑K filings.  The 2.875 % Notes have kept the same coupon and maturity date throughout, but their share of the 2025‑maturity bucket has slipped slightly as IBM increased the outstanding amount of the 7.00 % Debentures and issued newer tranches of debt, so by the 2024 filing the 7.00 % Debentures make up the larger portion of IBM’s 2025‑maturing obligations.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not supported by the ground truth. Key issues: (1) MAJOR ERROR - The LLM identifies '7.00% Debentures due 2025 (ticker IBM25)' as a security maturing in 2025 that appears in 2021, 2022, and 2024 filings. The ground truth makes no mention of this security and instead references '0.950% Notes due 2025 (IBM 25B)' and '0.875% Notes due 2025 (IBM 25C)' as other 2025-maturing instruments in 2022. (2) INCOMPLETE - The LLM fails to mention the 0.950% Notes due 2025 and 0.875% Notes due 2025 that were present in 2022 according to ground truth. (3) CONTRADICTORY CLAIM - The LLM states the 2.875% Notes 'kept the same coupon and maturity date throughout' and claims they appear in 2021, 2022, and 2024 filings, but provides no evidence of composition changes between these years. (4) UNSUPPORTED ASSERTION - The claim that '7.00% Debentures make up the larger portion of IBM's 2025-maturing obligations' by 2024 is not substantiated by the ground truth, which focuses on the presence/absence of specific note tranches. (5) MISSING KEY FINDING - The ground truth's central observation that the 0.875% Notes due 2025 were no longer listed by 2024 is completely absent from the LLM answer. The LLM appears to have fabricated security identifiers and mischaracterized the composition changes. While the 2.875% Notes identification is correct, the overall narrative about debt composition evolution is fundamentally inaccurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 413,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How has the strategic importance and risk profile of Biktarvy within Gilead's HIV portfolio evolved from 2022 to 2024, particularly in light of competitive pressures and changes in the treatment paradigm?",
      "original_answer": "In 2022, Biktarvy was positioned as a key growth driver for Gilead, with the company noting its 'continued growth in all geographies' and attributing part of the 11% revenue increase to its performance. By 2024, however, the strategic importance of Biktarvy appears more precarious. The 2024 10-K highlights increased risks around Gilead's HIV franchise, noting that 'many of our HIV products contain TAF' and that any shift away from nucleoside-based therapies could materially impact sales. This suggests that while Biktarvy was a growth asset in 2022, by 2024 it was increasingly seen as vulnerable to paradigm shifts in HIV treatment, representing a change in both strategic positioning and risk exposure.",
      "llm_answer": "\nBetween 2022 and 2024 Biktarvy continued to be Gilead’s primary HIV revenue generator—its “continued growth … in all geographies” was cited as a key driver of total sales in the 2022 filing (p. 45 of GILD_10K_2022.pdf).  However, the 2024 risk‑factor discussion (pp. 18‑19 of GILD_10K_2024.pdf) stresses that sales of HIV products are now vulnerable to market‑share gains by competitive regimens, generic entry, and potential shifts away from TAF‑based nucleoside therapies, while state‑level pricing reforms and affordability reviews (p. 21) add further pricing pressure.  Consequently, Biktarvy’s strategic importance has remained high but its risk profile has shifted from a growth engine to a product exposed to competitive, pricing and paradigm‑change risks.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across multiple dimensions. STRENGTHS: (1) Correctly identifies the 2022 positioning of Biktarvy as a growth driver with 'continued growth in all geographies' citation; (2) Accurately captures the 2024 risk profile shift, specifically mentioning TAF-based nucleoside therapy vulnerability; (3) Properly synthesizes multi-hop information across 2022 and 2024 filings; (4) Correctly identifies competitive pressures, generic entry risks, and pricing pressures as new risk factors; (5) Appropriately cites specific page numbers from both 10-K filings, demonstrating document-level accuracy; (6) The characterization of the shift from 'growth engine to a product exposed to competitive, pricing and paradigm-change risks' is semantically equivalent to the ground truth's assessment of increased vulnerability. MINOR CONSIDERATIONS: (1) The LLM answer provides slightly more granular detail on specific risk factors (state-level pricing reforms, affordability reviews) than the ground truth explicitly mentions, though these are consistent with the 2024 10-K discussion; (2) The LLM answer does not explicitly quantify the 11% revenue increase mentioned in the ground truth for 2022, though this is a minor omission that doesn't affect the core narrative; (3) The answer is more comprehensive than the ground truth in some respects, adding context about generic entry and state-level pricing that enriches the analysis. QUANTITATIVE ACCURACY: No specific numbers are disputed; the page references appear reasonable for 10-K documents. QUALITATIVE ACCURACY: The multi-hop reasoning correctly synthesizes information from 2022 and 2024 filings to show the evolution of Biktarvy's strategic positioning. The logic is sound and the conclusions are well-supported. CONTEXTUAL RELEVANCE: The answer directly addresses all aspects of the question regarding strategic importance, risk profile evolution, competitive pressures, and treatment paradigm changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 542,
        "total_tokens": 1924
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did the balance of the U.S. litigation escrow account evolve between the end of fiscal year 2022 and the end of fiscal year 2023, and what were the specific deposit contributions during each period?",
      "original_answer": "The balance of the U.S. litigation escrow account increased significantly from $1,449 million at the end of fiscal year 2022 to $3,089 million at the end of fiscal year 2023. During this time, deposits into the account rose from $1,000 million in fiscal year 2022 to $1,500 million in fiscal year 2023.",
      "llm_answer": "\nThe U.S. litigation escrow balance rose from $1.449 billion at the close of fiscal 2022 to $1.764 billion at the close of fiscal 2023. Deposits of $1.5 billion were added in fiscal 2022 and $1.0 billion in fiscal 2023 (offset by $685 million of payments in 2023, producing a net $315 million increase).",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains fundamental and pervasive factual errors that make it largely incorrect. (1) CRITICAL ERRORS - Balance figures are completely wrong: LLM states $1.449B→$1.764B, but ground truth shows $1,449M→$3,089M (approximately $1.45B→$3.09B). The ending balance is off by $1.325 billion (43% error). (2) DEPOSIT AMOUNTS REVERSED - LLM reverses the deposit sequence: claims $1.5B in 2022 and $1.0B in 2023, but ground truth shows $1.0B in 2022 and $1.5B in 2023. This is a fundamental factual error in the core data requested. (3) CALCULATION ISSUES - LLM introduces payment information ($685M in 2023) and net increase calculations ($315M) that are not mentioned in the ground truth answer. While this additional detail might seem analytical, it contradicts the ground truth data and suggests the LLM is fabricating supporting calculations. The math doesn't reconcile with the stated balances anyway: if starting at $1.449B, adding $1.5B, and subtracting $685M would yield ~$2.264B, not $1.764B. (4) MULTI-HOP SYNTHESIS - The question requires tracking two data points across two fiscal years (balance evolution and deposit contributions). The LLM failed to correctly synthesize either metric. (5) SEMANTIC EQUIVALENCE - While the LLM correctly uses billion/million format variations, this cannot offset the magnitude of numerical errors. The answer is factually incorrect on all primary metrics requested.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1165,
        "completion_tokens": 393,
        "total_tokens": 1558
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How has the role of fountain syrups in Coca-Cola's North America operating segment evolved between 2022 and 2023, particularly regarding the company's manufacturing and distribution responsibilities?",
      "original_answer": "In 2022, Coca-Cola explicitly stated that it manufactured fountain syrups in the United States and sold them directly to fountain retailers or to authorized fountain wholesalers or bottling partners for further distribution. By 2023, the company's description shifted: while it still referenced selling fountain syrups in the North America segment, it also indicated that outside the U.S., bottling partners were authorized to manufacture fountain syrups using company concentrates. This suggests a nuanced evolution where Coca-Cola may be emphasizing a more decentralized, authorization-based model, particularly outside the U.S., while maintaining direct control within the U.S. There is no explicit mention of a change in manufacturing responsibilities within North America itself, indicating operational continuity there.",
      "llm_answer": "\nBetween 2022 and 2023 Coca‑Cola kept its U.S. manufacturing of fountain‑syrup concentrates unchanged, but the way those syrups reach the end‑user shifted.  The 2023 MD&A (page 16) reports that fountain‑syrup sales are now counted only within the North America operating segment and that bottling partners and authorized wholesalers handle the downstream distribution to fountain retailers—reflecting the company’s broader refranchising/​network‑ed strategy that moves distribution responsibility out of Coca‑Cola’s direct operations and onto its bottling partners.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations that diverge substantially from the ground truth. Key issues: (1) INCORRECT CLAIM ABOUT CONCENTRATES: The LLM states Coca-Cola 'kept its U.S. manufacturing of fountain-syrup concentrates unchanged,' but the ground truth explicitly states Coca-Cola manufactured 'fountain syrups' (not concentrates) in the U.S. in 2022. This is a material distinction—the company makes finished syrups for fountains, not concentrates. (2) MISCHARACTERIZATION OF 2023 CHANGE: The LLM claims the 'way those syrups reach the end-user shifted' and attributes this to a 'refranchising/networked strategy,' but the ground truth indicates NO explicit change in manufacturing responsibilities within North America itself, only 'operational continuity.' The LLM invents a narrative of shifting distribution responsibility that isn't supported by the ground truth. (3) INCOMPLETE SYNTHESIS: The ground truth notes a nuanced evolution where bottling partners were authorized to manufacture fountain syrups OUTSIDE the U.S. using company concentrates—a key distinction the LLM misses entirely. The LLM conflates U.S. operations with international operations. (4) UNSUPPORTED INTERPRETATION: The LLM's claim about 'refranchising/networked strategy' moving distribution responsibility is not mentioned in the ground truth and appears to be an inference not grounded in the actual filing data. (5) CITATION ISSUE: The LLM references 'page 16' of 2023 MD&A but provides no verification this supports the claims made. The ground truth is more cautious, noting 'no explicit mention of a change' in North America manufacturing. The LLM answer fundamentally misrepresents the evolution as a shift in distribution when the ground truth emphasizes continuity in North America with potential decentralization outside the U.S.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 503,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How has the composition of IBM's debt instruments maturing in 2025 evolved between 2022 and 2024, particularly regarding the 0.950% Notes due 2025?",
      "original_answer": "In 2022, IBM had three sets of notes maturing in 2025: the 2.875% Notes due 2025 (IBM 25A), the 0.950% Notes due 2025 (IBM 25B), and the 0.875% Notes due 2025 (IBM 25C). By 2024, the 0.875% Notes due 2025 were no longer listed, leaving only the 2.875% Notes due 2025 (IBM 25A) and the 0.950% Notes due 2025 (IBM 25B). This indicates a reduction in the diversity of interest rate profiles for debt maturing in 2025, with the removal of the 0.875% instrument.",
      "llm_answer": "\nBetween 2022 and 2024 IBM’s debt maturing in 2025 moved from three separate note series—2.875 % Notes due 2025 (IBM 25A), 0.950 % Notes due 2025 (IBM 25B) and 0.875 % Notes due 2025 (IBM 25C)—to a reduced set that retained only the 2.875 % Notes and the 0.950 % Notes, while the 0.875 % issue was retired and a 7 % Debenture due 2025 (IBM 25) was added. The 0.950 % Notes due 2025 have remained outstanding with the same coupon and maturity terms, but they now constitute a larger proportion of IBM’s 2025 maturities because the lower‑coupon 0.875 % Notes have been removed from the schedule.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERROR: The LLM answer introduces a factually incorrect element that contradicts the ground truth. The original answer clearly states that by 2024, only the 2.875% Notes due 2025 (IBM 25A) and the 0.950% Notes due 2025 (IBM 25B) remained after the 0.875% Notes were removed. However, the LLM answer claims that 'a 7% Debenture due 2025 (IBM 25) was added' in 2024. This new instrument is NOT mentioned in the ground truth and represents a factual hallucination. The ground truth makes no reference to any 7% Debenture being added to the 2025 maturity schedule. This is a significant error that undermines the accuracy of the response. CORRECT ELEMENTS: The LLM correctly identifies the three note series in 2022 (2.875%, 0.950%, and 0.875%), correctly notes that the 0.875% Notes were removed, and correctly identifies that the 0.950% Notes remained outstanding with the same terms. The observation that the 0.950% Notes now constitute a larger proportion is a reasonable inference. QUANTITATIVE ACCURACY: While the percentages and note designations are correct for what actually existed, the introduction of the non-existent 7% Debenture is a major quantitative/factual error. MULTI-HOP REASONING: The synthesis of information across 2022 and 2024 is partially sound, but the addition of false information breaks the logical chain. The answer demonstrates understanding of the composition change but fails on factual verification. RECOMMENDATION: This answer would receive a low score due to the introduction of false information, despite getting several core facts correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 434,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How has Disney's strategic approach to cruise ships evolved between 2022 and 2024 based on disclosures in their 10-K filings?",
      "original_answer": "In 2022, Disney mentioned cruise ships as part of its broader travel and resort experiences, indicating that their success depended on consumer demand for out-of-home entertainment and travel. By 2024, Disney had elevated its approach, explicitly stating plans to 'expand investment in our Experiences segment' and 'additional expansion of our fleet of cruise ships.' This evolution reflects a shift from general dependence on consumer demand to an active investment and growth strategy in cruise ship operations. The 2024 filing also notes that new offerings, such as additional cruise ships, come with increased costs and uncertain returns, signaling a more capital-intensive and strategic focus compared to the more passive mention in 2022.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2024 Disney moved from merely noting “additional cruise ships” as part of a broader investment in its Experiences business to a explicit, multi‑year expansion plan.  In the 2022 filing the company referenced cruise‑ship investments only as an ancillary growth area, but the 2024 filing announces concrete plans to “expand our fleet of cruise ships,” signaling a strategic shift toward using the cruise line as a primary driver of revenue and brand‑experience growth and allocating additional capital and resources to accelerate that expansion.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of Disney's strategic evolution in cruise ship operations between 2022 and 2024. STRENGTHS: (1) Correctly identifies the temporal shift from 2022 to 2024; (2) Accurately captures the evolution from passive/ancillary mention to active strategic expansion; (3) Properly synthesizes the multi-hop information showing progression in Disney's approach; (4) Uses appropriate language ('ancillary growth area' vs 'primary driver') to convey the strategic shift; (5) No quantitative errors or incorrect numbers/dates. MINOR WEAKNESSES: (1) The LLM answer states cruise ships were mentioned as 'ancillary' in 2022, while the ground truth indicates they were mentioned as 'part of broader travel and resort experiences' - this is a subtle semantic difference but the LLM's characterization is reasonable interpretation; (2) The ground truth explicitly mentions 'increased costs and uncertain returns' as a key differentiator in the 2024 approach, which the LLM answer omits - this is a notable detail about the capital-intensive nature and risk profile that adds important context; (3) The ground truth emphasizes the shift from 'general dependence on consumer demand' to 'active investment and growth strategy,' while the LLM focuses more on the revenue/brand-experience driver aspect. The LLM answer is factually sound and captures the core evolution, but misses one important nuance about the increased costs and uncertain returns mentioned in 2024 filings. The multi-hop reasoning is sound - correctly synthesizing information across two different fiscal years to show strategic progression.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 447,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did Lockheed Martin's approach to pension risk transfer transactions evolve from 2022 to 2023, particularly in terms of financial impact and strategic intent?",
      "original_answer": "In 2022, Lockheed Martin detailed a specific pension risk transfer transaction from August 3, 2021, where $4.9 billion of gross defined benefit pension obligations were transferred via group annuity contracts (GACs), resulting in a noncash pension settlement charge of $1.7 billion. The company also noted that since December 2018, it had transferred approximately $11.6 billion in pension obligations, eliminating volatility for around 95,000 retirees. By 2023, the company reiterated its strategic intent to continue evaluating such transactions but shifted focus toward the broader financial and risk implications, including potential future contributions to the pension trust and the possibility of additional noncash settlement charges. The 2023 filing also introduced a nuanced risk: while most GACs relieve Lockheed of pension obligations, some could leave the company liable if the insurer defaults. This reflects a more cautious framing of pension risk transfer, acknowledging residual liability exposure not emphasized in 2022.",
      "llm_answer": "\nFrom 2022 through 2023 Lockheed Martin moved from the one‑off August 2021 $4.9 bn group‑annuity purchase— which generated a $1.7 bn non‑cash settlement charge— to an ongoing program of buying GACs that has now transferred roughly $11.6 bn of pension obligations for about 95 k retirees and eliminated the $69 m annual PBGC premium.  The company continues to evaluate additional risk‑transfer transactions, but it now warns that future deals may require extra contributions to the pension trust and could produce material non‑cash settlement charges, even though it made no contributions to its qualified defined‑benefit plans in 2023 and does not plan any for 2024.  The strategic intent remains to curb pension‑related earnings volatility and reduce long‑term liability exposure, while accepting the risk that insurance‑reimbursement structures could expose the firm to default risk.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of Lockheed Martin's pension risk transfer evolution from 2022 to 2023, with mostly accurate financial data and sound multi-hop reasoning. STRENGTHS: (1) All key numbers are correct: $4.9 billion transaction, $1.7 billion noncash settlement charge, $11.6 billion cumulative obligations transferred, ~95,000 retirees. (2) Correctly identifies the August 2021 transaction date and its characterization as a one-off event. (3) Accurately captures the strategic shift from 2022 to 2023: from reporting a specific transaction to evaluating ongoing programs. (4) Properly synthesizes the evolution in risk framing, noting the introduction of insurer default risk concerns in 2023. (5) Correctly identifies the strategic intent to reduce earnings volatility and long-term liability exposure. (6) Accurately notes the absence of pension contributions in 2023 and no planned contributions for 2024. WEAKNESSES: (1) The mention of '$69 m annual PBGC premium' elimination is not explicitly verified in the ground truth and appears to be an inference or additional detail not confirmed in the original answer. This is a minor addition that doesn't contradict the ground truth but adds information not explicitly stated. (2) The phrasing 'insurance-reimbursement structures' is slightly different from the ground truth's 'insurer defaults' framing, though semantically similar. (3) The answer could have been more explicit about the 'more cautious framing' shift between years, though this is implied. MULTI-HOP REASONING: The answer correctly synthesizes information across 2022 and 2023 filings, comparing transaction details, cumulative impacts, and strategic intent evolution. The reasoning chain is logical and well-structured. QUANTITATIVE VERIFICATION: All primary numbers check out correctly. The $69M PBGC premium detail is the only unverified element. SEMANTIC EQUIVALENCE: The answer conveys the same essential information as the ground truth, with appropriate flexibility in wording while maintaining factual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1484,
        "completion_tokens": 555,
        "total_tokens": 2040
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How has Tesla's relationship with its financing partners evolved between 2022 and 2023, particularly in terms of accounts receivable management and leasing program risks?",
      "original_answer": "In 2022, Tesla disclosed that accounts receivable from financing partners could take up to approximately two weeks to settle based on contractual payment terms, directly impacting the company's short-term liquidity and balance sheet fluctuations. By 2023, Tesla highlighted increased complexity and risk in managing its financing programs, noting that its leasing business depends on securing adequate financing or partners, and that residual value risks from leased vehicles could negatively affect profitability. This indicates a shift from a focus on operational cash flow timing in 2022 to a broader concern over credit, compliance, and residual value risks in 2023 as the leasing program scaled.",
      "llm_answer": "\nBetween 2022 and 2023 Tesla’s disclosures show a shift from a relatively passive description of receivables—highlighting that amounts from financing partners can swing by roughly two weeks and require an allowance for doubtful accounts—to a more robust focus on the **credit and residual‑value risks of its leasing and financing programs**.  In the 2023 filing the company explicitly warns that lease profitability depends on accurate residual‑value forecasts, tighter credit oversight, and the ability to secure or maintain external financing; any shortfall in these areas could limit vehicle deliveries and increase exposure to credit losses.  Thus, the relationship with financing partners has become **more strategically managed but also more exposed to residual‑value and financing‑risk considerations**.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across multiple dimensions. STRENGTHS: (1) Correctly identifies the temporal shift from 2022 to 2023 in Tesla's disclosures; (2) Accurately captures the evolution from focus on operational cash flow timing (two-week settlement period) to broader risk management concerns; (3) Properly synthesizes the multi-hop relationship between accounts receivable management, leasing programs, and residual value risks; (4) Correctly identifies key risk factors mentioned in 2023 filings (residual value forecasts, credit oversight, external financing needs); (5) Uses appropriate financial terminology and demonstrates sound reasoning about the strategic implications. MINOR AREAS FOR IMPROVEMENT: (1) The phrase 'roughly two weeks' in the LLM answer is slightly less precise than the ground truth's 'approximately two weeks,' though this is semantically equivalent; (2) The LLM answer could have been more explicit about the direct impact on 'short-term liquidity and balance sheet fluctuations' mentioned in the ground truth, though it does reference 'financing-risk considerations'; (3) The LLM's characterization of 2022 disclosures as 'relatively passive' is interpretive language not explicitly in the ground truth, though it's a reasonable characterization. QUANTITATIVE VERIFICATION: No specific dollar amounts or percentages are provided in either answer, so quantitative accuracy is assessed on the basis of temporal references (2022, 2023) which are correct. MULTI-HOP REASONING: The answer successfully synthesizes information across multiple filing years and connects accounts receivable management to leasing program risks to residual value concerns—demonstrating proper multi-hop synthesis. The logical progression from operational timing concerns to strategic risk management is sound and well-articulated.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 508,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "What changes occurred in Coca-Cola's fountain syrup distribution strategy between 2022 and 2023, and how did the roles of bottlers and fountain wholesalers evolve during this period?",
      "original_answer": "In 2022, Coca-Cola manufactured and sold fountain syrups directly to authorized fountain wholesalers (including certain authorized bottlers), who then sold or delivered the syrups to retailers. Bottlers in the U.S. were generally not authorized to manufacture fountain syrups. By 2023, the strategy evolved such that outside the United States, bottlers were typically authorized to manufacture fountain syrups using Coca-Cola concentrates, which they could sell to fountain retailers or authorized fountain wholesalers. This represents a shift from a more centralized syrup distribution model to a more integrated one, where bottlers play a more active role in the fountain syrup supply chain, particularly in international markets.",
      "llm_answer": "\nBetween 2022 and 2023 Coca‑Cola altered its fountain‑syrup model: in 2022 the syrup was sold to bottling partners (who were not authorized to manufacture it in the U.S.) and then passed to authorized fountain‑wholesalers for retail distribution, whereas by 2023 the Company itself manufactures the syrups and sells them directly to fountain‑retailers and authorized fountain‑wholesalers, with bottlers now limited to handling only the distribution of finished beverages. Thus, bottlers’ role shrank to downstream finished‑product distribution, while fountain‑wholesalers assumed a broader supply‑chain and distribution function for the syrups. (See KO_10k_2022.pdf pp. 8, 9, 10; KO_10k_2023.pdf p. 122.)",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS IN CORE FACTS: The LLM answer fundamentally misrepresents the 2022-2023 strategy shift. The ground truth states that in 2022, Coca-Cola sold fountain syrups directly to authorized fountain wholesalers (not bottlers as primary recipients), and by 2023, bottlers outside the U.S. became authorized to manufacture fountain syrups using Coca-Cola concentrates. The LLM answer incorrectly claims: (1) In 2022, syrup was 'sold to bottling partners' - this is backwards; bottlers were NOT authorized to manufacture fountain syrups in the U.S. in 2022. (2) By 2023, 'the Company itself manufactures the syrups and sells them directly to fountain-retailers' - this contradicts the ground truth which states bottlers outside the U.S. became authorized to manufacture syrups in 2023. (3) The LLM claims 'bottlers' role shrank to downstream finished-product distribution' - this is the opposite of what occurred; bottlers' role EXPANDED to include fountain syrup manufacturing outside the U.S. The LLM has inverted the direction of change. The answer demonstrates a fundamental misunderstanding of the multi-hop synthesis required: comparing 2022 bottler restrictions vs. 2023 bottler authorizations. While the LLM correctly identifies the years (2022, 2023) and companies (Coca-Cola, bottlers, fountain wholesalers), it completely reverses the nature of the strategic evolution. The reasoning is logically structured but factually incorrect at every substantive point. This is a major failure in multi-hop reasoning across the two filing years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 426,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How has AMD's financial relationship with the ATMP JV evolved between 2023 and 2024, particularly in terms of receivables and new investment activities?",
      "original_answer": "In 2023, AMD had receivables from the ATMP JV of $9 million, and there was no mention of any direct investment or loan made by AMD to the JV. By 2024, AMD's receivables from the ATMP JV increased to $12 million, and the company entered into a new $100 million one-year term loan agreement with one of the ATMP JVs to support its general corporate purposes. This marks a significant shift from a purely transactional relationship in 2023 to a more financially integrated one in 2024, where AMD is not only a customer but also a creditor and strategic supporter of the JV.",
      "llm_answer": "\nBetween fiscal 2023 and 2024 AMD’s financial exposure to the ATMP joint venture grew noticeably: payables to the JV increased from **$363 million** (as of Dec 30 2023) to **$476 million** (as of Dec 28 2024), and receivables from the JV rose from **$9 million** to **$12 million** over the same period.  In addition, AMD made a **$17 million equity contribution** to the ATMP JV in August 2024, which lifted the carrying value of its 15 % equity interest from roughly **$99 million** at the end of 2023 to about **$149 million** by the end of 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and addresses different aspects of AMD's ATMP JV relationship than the ground truth. Key issues: (1) PAYABLES vs RECEIVABLES CONFUSION: The LLM discusses payables ($363M to $476M) which are NOT mentioned in the ground truth answer. The ground truth specifically addresses receivables ($9M to $12M), which the LLM does mention correctly. However, the LLM's focus on payables suggests it may have confused the direction of cash flow or reported different metrics entirely. (2) INVESTMENT DISCREPANCY: The ground truth states AMD entered into a $100 million one-year term loan agreement in 2024. The LLM instead reports a $17 million equity contribution in August 2024. These are fundamentally different financial instruments (loan vs equity) and different amounts. The LLM's equity contribution figure does not appear in the ground truth at all. (3) EQUITY INTEREST VALUATION: The LLM provides carrying value figures ($99M to $149M) and a 15% equity interest percentage that are not mentioned in the ground truth. While these could be supplementary details from the filings, they represent a different analytical focus than the ground truth's emphasis on the loan agreement. (4) MULTI-HOP SYNTHESIS: The ground truth emphasizes the shift from transactional to financially integrated relationship, highlighting the new loan as a strategic development. The LLM's answer, while discussing financial evolution, focuses on different metrics (payables, equity contribution) that don't align with the ground truth's narrative. (5) RECEIVABLES ACCURACY: The LLM correctly identifies the receivables increase from $9M to $12M, which matches the ground truth exactly. This is the only fully accurate element. The answer demonstrates partial understanding of the relationship evolution but introduces incorrect or misaligned financial data that contradicts the ground truth's core findings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 521,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Lockheed Martin's approach to managing its nonqualified defined benefit pension plans evolve between 2022 and 2023, particularly in terms of pension obligation settlements and associated financial impacts?",
      "original_answer": "In 2022, Lockheed Martin purchased group annuity contracts to transfer $4.3 billion of gross defined benefit pension obligations and recognized a noncash pension settlement charge of $1.5 billion. In 2023, the company continued its strategy of reducing pension liabilities by making voluntary settlement payments of $414 million to approximately 6,500 former employees, significantly smaller in scale compared to the 2022 transaction. This indicates a shift from large-scale pension obligation transfers to a more targeted approach involving smaller settlements with former employees who had not yet started receiving benefits.",
      "llm_answer": "\nLockheed Martin’s strategy for its non‑qualified defined‑benefit pension plans moved from the large, bulk‑annuity de‑risking transactions of 2021‑2022—​which generated non‑cash settlement charges of $1.7 bn (2021) and $1.5 bn (2022) for the transfers of $4.9 bn and $4.3 bn of obligations—​to a more targeted, incremental approach in 2023.  In the fourth quarter of 2023 the company offered a voluntary settlement to former retirees, paying $414 million to about 6,500 participants and thereby reducing the accrued benefit obligation and the AOCL balance, but it did not record a comparable large settlement charge.  This reflects a shift toward smaller, selective settlements to manage pension‑related volatility while continuing to use annuity purchases and plan terminations to off‑load non‑qualified pension liabilities.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual inaccuracies that undermine its credibility. Most notably: (1) The LLM references a 2021 settlement charge of $1.7 billion and obligation transfer of $4.9 billion, which are NOT mentioned in the ground truth and appear to be fabricated or confused with other years. The ground truth only addresses 2022 and 2023. (2) The LLM states the 2022 settlement charge was $1.5 billion for transferring $4.3 billion in obligations—these numbers ARE correct and match the ground truth. However, the inclusion of unverified 2021 data is problematic. (3) The 2023 voluntary settlement payment of $414 million to approximately 6,500 former employees is correctly stated. QUALITATIVE ASSESSMENT: The LLM correctly identifies the strategic shift from large-scale bulk annuity transactions to smaller, targeted settlements. The characterization of the approach as moving from 'large, bulk-annuity de-risking' to 'more targeted, incremental approach' accurately reflects the evolution described in the ground truth. The mention of reducing AOCL balance and not recording comparable large settlement charges in 2023 adds relevant context. MULTI-HOP REASONING: The answer demonstrates sound reasoning in synthesizing the 2022 vs. 2023 comparison and identifying the strategic evolution. However, the introduction of unverified 2021 data suggests either hallucination or confusion about the scope of the question, which specifically asked about 2022-2023 evolution. SEMANTIC EQUIVALENCE: The core message about shifting from bulk transfers to targeted settlements is semantically equivalent to the ground truth. The terminology used ('de-risking,' 'off-load,' 'manage pension-related volatility') is appropriate and adds nuance. MAIN ISSUE: The inclusion of 2021 data that cannot be verified against the ground truth is a significant accuracy problem. The answer should have focused exclusively on the 2022-2023 comparison as specified in the question. This represents either fabrication or confusion about the temporal scope.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 560,
        "total_tokens": 1940
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did AMD's financial relationship with the ATMP JV evolve between 2023 and 2024, particularly in terms of its investment and equity income?",
      "original_answer": "In 2023, AMD recorded $16 million in equity income from the ATMP JV and had a carrying value of $99 million as of the end of the year. In 2024, AMD contributed an additional $17 million to the JV, increasing its investment's carrying value to $149 million by the end of the year. Equity income also rose to $33 million. This indicates a significant increase in both AMD's investment stake and the returns it received from the ATMP JV.",
      "llm_answer": "\nBetween the end of 2023 and the end of 2024 AMD’s equity interest in the ATMP joint venture expanded – the carrying value of its investment rose from roughly **$99 million** (as of Dec 30 2023) to **about $149 million** (as of Dec 28 2024) after the company contributed an additional **$17 million** of equity on Aug 8 2024, and the equity‑method income it recorded jumped from **$16 million** in 2023 to **$33 million** in 2024.  At the same time, purchases from the ATMP JV grew to **$1.7 billion** in 2024 (up from $1.7 billion in 2023) and payables to the JV increased to **$476 million**, while resales also rose, indicating a deepening financial relationship.  (Pages 75, 78, 80, 78‑ATMP section).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core financial metrics requested: carrying value increase from $99M to $149M, the $17M contribution, and equity income rise from $16M to $33M. The dates and entities are accurate. However, there is a critical quantitative error: the LLM states 'purchases from the ATMP JV grew to $1.7 billion in 2024 (up from $1.7 billion in 2023)' - this is internally contradictory and factually problematic. If purchases were $1.7B in both years, they did not 'grow' - this represents either a data error or a misstatement. The ground truth answer does not mention these purchase figures, suggesting the LLM may have added information not in the original answer, or the figures may be incorrect. Additionally, the mention of '$476 million' in payables and 'resales' information goes beyond the ground truth answer, which focused specifically on investment carrying value, contributions, and equity income. While this additional context could be relevant to 'deepening financial relationship,' it introduces unverified information. The multi-hop reasoning is sound in connecting the investment increase and equity income growth to show an evolving relationship, but the quantitative accuracy is compromised by the contradictory growth statement and potentially unverified additional metrics. The answer demonstrates good understanding of the core question but includes problematic or unverified supplementary information.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 400,
        "total_tokens": 1684
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Johnson & Johnson's financial stake and ownership relationship with Kenvue evolve between 2023 and 2024, particularly in terms of retained equity and associated gains or losses?",
      "original_answer": "In 2023, Johnson & Johnson retained a 9.5% ownership stake in Kenvue valued at $4.3 billion following the exchange offer, which resulted in a non-cash gain of $21.0 billion, including a $2.8 billion gain on the retained shares. By the end of 2024, the company completed a Debt-for-Equity Exchange of its remaining 182,329,550 shares of Kenvue Common Stock, thereby eliminating its ownership stake and incurring a loss of approximately $0.4 billion in the process. This marks a full exit from Kenvue after initially reducing its stake significantly in 2023.",
      "llm_answer": "\nBetween July 2023 (when the IPO left J&J with ~89.6 % of Kenvue) and the August 2023 exchange offer, J&J sold an additional 80.1 % of Kenvue, retaining only about 9.5 % of the outstanding shares; the stake was recorded at a fair‑market value of $4.3 billion and generated a one‑time, tax‑free gain of roughly **$2.8 billion** on the retained shares, which was reported in discontinued‑operations earnings.  In May 2024 J&J completed a debt‑for‑equity swap that exchanged the remaining 182 million Kenvue shares for commercial‑paper debt, eliminating any equity holding and resulting in a **$0.4 billion loss** recorded in “Other (income) expense.”  Thus, J&J’s ownership fell from a controlling stake to a small minority and then to zero, with a substantial gain in 2023 followed by a modest loss in 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive coverage of J&J's evolving relationship with Kenvue between 2023 and 2024. STRENGTHS: (1) All key numeric values are correct: 9.5% retained stake, $4.3 billion valuation, $2.8 billion gain on retained shares in 2023, 182 million shares exchanged in May 2024, and $0.4 billion loss in 2024. (2) Dates are accurate: July 2023 IPO, August 2023 exchange offer, May 2024 debt-for-equity swap. (3) The multi-hop synthesis is sound, correctly tracing the ownership evolution from ~89.6% (post-IPO) to 9.5% (post-exchange offer) to 0% (post-2024 swap). (4) Financial metrics are properly identified and contextualized: the $2.8 billion gain is correctly attributed to retained shares and reported in discontinued operations; the $0.4 billion loss is correctly placed in 'Other (income) expense.' (5) The answer provides excellent narrative flow showing the complete exit trajectory. MINOR OBSERVATIONS: (1) The original answer mentions a total non-cash gain of $21.0 billion (including the $2.8 billion on retained shares), while the LLM answer focuses on the $2.8 billion gain on retained shares specifically. However, the question asks about 'gains or losses' and the LLM correctly identifies the material gains/losses from J&J's perspective on the retained stake and subsequent exit. The $21.0 billion figure appears to include broader transaction gains beyond just the retained equity position. (2) The LLM provides additional helpful context (IPO timeline, exchange offer details, accounting treatment) that enhances understanding without introducing errors. CALCULATION VERIFICATION: All numbers check out—no arithmetic errors detected. The characterization of the 2023 transaction as generating a 'one-time, tax-free gain' and the 2024 transaction as resulting in a loss are both accurate. The answer correctly synthesizes information across two fiscal years and multiple transaction types.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 527,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How did AT&T's financial guarantee relationship with Southwestern Bell Telephone Co. evolve between 2022 and 2023, particularly in terms of its inclusion in guarantee agreements?",
      "original_answer": "AT&T's financial guarantee relationship with Southwestern Bell Telephone Co. remained consistent between 2022 and 2023, with the company continuing to guarantee certain obligations of Southwestern Bell Telephone Co. in both years. In 2022, the guarantee was listed in Exhibit 4-c, which included multiple entities such as Southwestern Bell Telephone Company. In 2023, the guarantee was again referenced in Exhibit 4-c, maintaining the same inclusion of Southwestern Bell Telephone Co. within the list of guaranteed entities. This indicates no change in the nature or scope of the guarantee.",
      "llm_answer": "\nBetween 2022 and 2023 the company continued to disclose the same guaranty of Southwestern Bell Telephone Co. in its SEC filings—both the 2022 Form 10‑K (page 141, 4‑b) and the 2023 Form 10‑K (page 102, 4‑b) list “Guaranty of certain obligations of Pacific Bell Telephone Co. and Southwestern Bell Telephone Co.” as an exhibit. No amendment, removal, or new inclusion of the Southwestern Bell guarantee was reported; the reference remained unchanged, indicating that the financial guarantee relationship stayed exactly as previously disclosed.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) EXHIBIT LOCATION MISMATCH: The LLM claims the guarantee is in Exhibit 4-b for both 2022 and 2023, but the ground truth explicitly states it is in Exhibit 4-c for both years. This is a factual error on a key detail. (2) ADDITIONAL ENTITY INTRODUCED: The LLM mentions 'Pacific Bell Telephone Co.' as part of the guarantee, which is not mentioned in the ground truth answer. While this may be accurate from the actual filings, it introduces information not present in the ground truth and potentially confuses the focus of the question on Southwestern Bell Telephone Co. specifically. (3) PAGE NUMBERS: The LLM provides specific page numbers (141 for 2022, 102 for 2023) that cannot be verified against the ground truth, which does not include page references. These specific citations may be incorrect. (4) CORE CONCLUSION CORRECT: The LLM correctly identifies that the guarantee relationship remained unchanged/consistent between 2022 and 2023, which matches the ground truth's conclusion. (5) MULTI-HOP REASONING: The answer does attempt to synthesize information across two years and two filings, but the exhibit designation error undermines the credibility of the synthesis. The fundamental claim about consistency is correct, but the supporting details contain significant inaccuracies that would mislead someone trying to locate the actual exhibits in the filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 389,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How has Lockheed Martin's involvement in hypersonics programs evolved from 2022 to 2023, particularly in terms of strategic positioning and program development responsibilities?",
      "original_answer": "In 2022, Lockheed Martin's involvement in hypersonics programs was described as a growth area that was dependent on U.S. Government authorization and funding, and was listed among other key development areas like classified programs and next-generation franchise programs. By 2023, the company's role had evolved significantly, with hypersonics programs now explicitly listed among major programs under the Space segment, indicating a more concrete and active role in designing, developing, and building hypersonic strike weapons for the U.S. Army and Navy. This reflects a shift from a potential growth area to a clearly defined and active program portfolio.",
      "llm_answer": "\nFrom 2022 to 2023 Lockheed Martin moved hypersonics from a niche Skunk Works/R&D effort into a cross‑segment, strategically prioritized program.  The 2022 filings (pages 15 & 41) note hypersonic work only within the Advanced Development Programs, but the 2023 disclosures (pages 4‑6) assign program‑development and management duties to Aeronautics, Space and Rotary & Mission Systems, stress the transition from undefinitized contract actions to funded contracts, and highlight multiple U.S. Army and Navy hypersonic strike‑weapon initiatives.  This reflects a deliberate repositioning to treat hypersonics as a core growth area with expanded program responsibilities and tighter focus on delivery, cost control, and integration with other advanced weapons systems.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of Lockheed Martin's hypersonics program evolution from 2022 to 2023. STRENGTHS: (1) Correctly identifies the core shift from a growth area/potential initiative in 2022 to an active, strategically prioritized program in 2023; (2) Accurately captures the multi-segment involvement (Aeronautics, Space, Rotary & Mission Systems) in 2023; (3) Properly synthesizes the transition from undefinitized to funded contracts; (4) Correctly identifies U.S. Army and Navy as key customers; (5) Appropriately characterizes the repositioning as moving from R&D/Skunk Works to core growth area with defined responsibilities. MINOR ISSUES: (1) The LLM provides specific page references (pages 15 & 41 for 2022; pages 4-6 for 2023) that cannot be verified against the ground truth knowledge graph, though this level of citation detail doesn't contradict the core facts; (2) The phrase 'niche Skunk Works/R&D effort' in 2022 is a reasonable inference but slightly more specific than the ground truth's 'growth area dependent on authorization and funding'; (3) The mention of 'undefinitized contract actions' is a reasonable technical detail that aligns with the transition narrative but isn't explicitly confirmed in the ground truth. MULTI-HOP REASONING: The answer successfully synthesizes information across two fiscal years and multiple business segments, correctly identifying the progression and its strategic implications. The reasoning about moving from potential to active program portfolio is sound and matches the ground truth's core message. SEMANTIC EQUIVALENCE: The LLM's characterization of the evolution is semantically equivalent to the ground truth - both describe a shift from a dependent/potential area to an active, defined program with concrete responsibilities. No quantitative errors detected (no specific dollar amounts or percentages provided to verify).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 516,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How did the balance of the U.S. litigation escrow account evolve from fiscal year 2022 to fiscal year 2023, and what were the respective amounts deposited into the account during those years?",
      "original_answer": "The balance of the U.S. litigation escrow account increased significantly from $1.4 billion as of September 30, 2022, to $3.089 billion as of September 30, 2023. During fiscal year 2022, $850 million was deposited into the account, while in fiscal year 2023, $1.0 billion was deposited.",
      "llm_answer": "\nThe U.S. litigation‑escrow account grew from about **$1.4 billion at the close of fiscal 2022** to **$1.764 billion at the close of fiscal 2023**.  During fiscal 2022 the company deposited **$850 million** into the escrow, and in fiscal 2023 it added a further **$1.0 billion** (net of interest and payments to opt‑out merchants), which together produced the higher year‑end balance.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains a major factual error regarding the fiscal year 2023 ending balance. Ground truth states the balance was $3.089 billion as of September 30, 2023, but the LLM claims it was $1.764 billion - a difference of $1.325 billion (43% understatement). This is a fundamental factual error that undermines the entire answer. CORRECT ELEMENTS: (1) Opening balance of $1.4 billion for FY2022 is correct, (2) FY2022 deposit of $850 million is correct, (3) FY2023 deposit of $1.0 billion is correct, (4) The reasoning about deposits contributing to balance growth is sound. INCORRECT ELEMENTS: (1) The closing balance for FY2023 of $1.764 billion is significantly wrong - should be $3.089 billion, (2) The parenthetical explanation about 'net of interest and payments to opt-out merchants' appears to be an attempt to rationalize the incorrect number rather than reflecting actual ground truth. MULTI-HOP SYNTHESIS: The model correctly identified that deposits flow into the account and affect the balance, but failed to accurately report the actual ending balance figure. The question asks for 'how the balance evolved' - the LLM provided an incorrect evolution trajectory. CALCULATION VERIFICATION: If we add the opening balance ($1.4B) + FY2023 deposit ($1.0B) = $2.4B minimum, yet the LLM reports $1.764B, which is mathematically inconsistent with the deposits claimed. The ground truth shows $3.089B, which accounts for the opening balance, deposits, and interest/other adjustments. The LLM's number cannot be reconciled with the data provided.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1178,
        "completion_tokens": 437,
        "total_tokens": 1616
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How has the role and positioning of Outdoor Garden within HD's product strategy evolved from 2022 to 2024, based on its classification and performance metrics?",
      "original_answer": "In 2022, Outdoor Garden was disclosed as a distinct product line with $10,317 million in net sales, accounting for 6.8% of total net sales, indicating its importance as a standalone category. By 2024, Outdoor Garden was grouped under the broader 'Hardlines' merchandising department, suggesting a strategic integration into a larger product segment. This shift reflects a change in how HD positions Outdoor Garden within its overall product portfolio, moving from a separate focus area to a component of a consolidated category.",
      "llm_answer": "\nOutdoor Garden has continued to be listed under the **Hardlines** merchandising group within HD’s **Primary segment** in both the 2022 and 2024 filings.  Its sales contribution has remained modest but steady—about 6–7 % of total net sales (≈ $48 billion of Hardlines sales in fiscal 2024)—indicating that the category’s absolute size is unchanged, while the company has increasingly highlighted it as a key growth lever in its outdoor‑living portfolio.  Consequently, from 2022 to 2024 Outdoor Garden’s role evolved from a peripheral line item to a deliberately emphasized component of HD’s Hardlines strategy.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains multiple critical factual errors that directly contradict the ground truth:\n\n1. MAJOR FACTUAL ERROR - Classification in 2022: The LLM claims Outdoor Garden was listed under Hardlines in 2022, but the ground truth explicitly states it was 'disclosed as a distinct product line' in 2022, NOT grouped under Hardlines. This is a fundamental misunderstanding of the core evolution being asked about.\n\n2. QUANTITATIVE ERRORS:\n   - The LLM states Outdoor Garden was '6-7% of total net sales' in both years. The ground truth specifies 6.8% in 2022 with $10,317 million in net sales. The LLM's percentage is approximately correct for 2022 but the claim that it remained unchanged is unsupported.\n   - The LLM references '$48 billion of Hardlines sales in fiscal 2024' which appears to be a total Hardlines figure, not Outdoor Garden's contribution. This conflates different metrics.\n   - The LLM fails to provide the actual 2024 Outdoor Garden sales figure, making it impossible to verify the claimed 'unchanged' positioning.\n\n3. CORE NARRATIVE FAILURE: The ground truth describes a strategic SHIFT from 2022 (distinct product line) to 2024 (grouped under Hardlines). The LLM incorrectly claims Outdoor Garden was 'listed under Hardlines' in BOTH years, completely missing the evolution that is the central point of the question.\n\n4. UNSUPPORTED CLAIMS: The LLM's assertion that the company 'increasingly highlighted it as a key growth lever' is not supported by the ground truth, which focuses on the reclassification/regrouping rather than increased emphasis.\n\n5. MULTI-HOP REASONING: The LLM failed to correctly synthesize the temporal evolution across the 2022-2024 period, which is the essential multi-hop requirement of this question.\n\nThe answer demonstrates a fundamental misreading of the source material and provides an incorrect narrative that contradicts the ground truth on the key factual claim about how Outdoor Garden's classification changed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 536,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How has AMD maintained its emphasis on an engaging and open environment as its global workforce expanded from 2023 to 2024, and what does this suggest about its talent retention strategy in a competitive semiconductor industry landscape?",
      "original_answer": "In 2023, AMD reported having approximately 26,000 employees and emphasized being at its best when 'our culture of innovation, creative minds and people from all kinds of backgrounds work together in an engaging and open environment.' By 2024, AMD’s global workforce grew to approximately 28,000 employees, and the company reiterated the same language, stating it is 'at our best when our culture of innovation, creative minds and people from all kinds of backgrounds work together in an engaging and open environment.' Despite a 7.7% increase in workforce size, AMD maintained identical messaging around its cultural values. This suggests that AMD is intentionally preserving its inclusive and innovative culture as a strategic element to retain top talent in the highly competitive semiconductor industry, where attracting skilled professionals is critical.",
      "llm_answer": "\nAMD has kept its “engaging and open” culture as it grew from roughly 26 K employees in 2023 to about 28 K in 2024 by ‑ ‑ running an annual global‑workforce survey that repeatedly places its culture in the top‑tier of tech firms, ‑ ‑ expanding inclusive programs such as Employee Resource Groups (with > 85 % of new hires joining an ERG), mentorship and leadership‑development tracks, and flexible hybrid/remote work options, ‑ ‑ and ‑ ‑ pairing these cultural investments with a “total‑rewards” model that offers competitive salaries, performance‑based incentives, inclusive benefits (e.g., parental‑leave, adoption assistance) and clear pathways for advancement.  \n\nTogether, these actions show that AMD’s talent‑retention strategy hinges on ‑ ‑ cultivating an inclusive, high‑engagement environment and ‑ ‑ linking employee growth and rewards to the company’s mission, helping it attract and keep top engineers amid intense competition in the semiconductor industry.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ISSUES: The LLM answer contains substantial factual inaccuracies and unsupported claims that are NOT present in the ground truth. (1) QUANTITATIVE ACCURACY: The employee counts (26K in 2023, 28K in 2024) are correct and match ground truth. However, the LLM introduces specific claims with no basis in the original answer: '85% of new hires joining an ERG' - this statistic is NOT mentioned in ground truth and appears fabricated. (2) UNSUPPORTED CLAIMS: The LLM extensively elaborates on programs and initiatives (annual global workforce surveys, Employee Resource Groups, mentorship tracks, flexible work options, total-rewards model, parental leave, adoption assistance) that are NOT mentioned in the ground truth. The ground truth explicitly states AMD 'reiterated the same language' about culture but does NOT provide details about specific HR programs or benefits. The LLM appears to have hallucinated these details. (3) MULTI-HOP REASONING: While the LLM correctly identifies the workforce growth and cultural emphasis, it fails to accurately represent what the ground truth actually says. The ground truth's key insight is that AMD maintained IDENTICAL messaging despite 7.7% workforce growth - suggesting intentional cultural preservation. The LLM shifts focus to specific programs not mentioned in source material. (4) SEMANTIC DIVERGENCE: The ground truth emphasizes AMD's consistency in messaging as a strategic choice. The LLM reframes this as evidence of specific programs and benefits that are not documented in the ground truth. This represents a fundamental misalignment with the actual evidence. (5) FACTUAL INTEGRITY: The introduction of specific percentages (85%), program names, and benefit details without source attribution violates the requirement to base answers on provided ground truth. The answer reads plausibly but is largely unsupported by the original answer provided.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1479,
        "completion_tokens": 516,
        "total_tokens": 1995
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did AT&T's relationship with The Ohio Bell Telephone Company evolve between 2022 and 2023, particularly in terms of its guarantee obligations?",
      "original_answer": "In 2022, AT&T had a guarantee obligation covering The Ohio Bell Telephone Company as part of a broader list of subsidiaries under Exhibit 4-c, which was originally filed in 2011. In 2023, although the structure of the guarantee remained similar, the exhibit reference was updated to reflect current documentation practices, indicating a continuation of the guarantee without any explicit discontinuation or expansion. This suggests that the nature of the relationship remained stable, but documentation was maintained in line with current reporting standards.",
      "llm_answer": "\nBetween 2022 and 2023 AT&T continued to provide a guaranty for The Ohio Bell Telephone Company’s obligations, as reflected in Exhibit 4‑c of both the 2022 and 2023 Form 10‑K filings. The company did not modify or terminate that guaranty during the period, so its guarantee obligation to Ohio Bell remained unchanged.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core facts: (1) AT&T maintained a guarantee obligation for The Ohio Bell Telephone Company, (2) this guarantee was reflected in Exhibit 4-c of both 2022 and 2023 10-K filings, and (3) the guarantee was not modified or terminated between these years. The dates and entities are accurate. However, the LLM answer lacks some contextual depth present in the ground truth. Specifically: (1) The ground truth mentions the guarantee was 'originally filed in 2011' and was part of 'a broader list of subsidiaries,' providing historical context that the LLM omits. (2) The ground truth notes that 'the exhibit reference was updated to reflect current documentation practices,' suggesting a procedural/administrative evolution in how the guarantee was documented, whereas the LLM simply states it 'remained unchanged.' (3) The ground truth explicitly characterizes the relationship as 'stable' with documentation 'maintained in line with current reporting standards,' which is a more nuanced assessment than the LLM's simpler statement that the guarantee was 'unchanged.' The LLM's answer is factually sound and addresses the main question adequately, but it misses the subtle distinction between the guarantee obligation itself remaining stable versus the documentation/exhibit structure being updated for current practices. This is a minor but meaningful omission in capturing the full evolution of the relationship.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1219,
        "completion_tokens": 401,
        "total_tokens": 1620
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did the financial impact of GE's relationship with AerCap evolve between 2023 and 2024, particularly in terms of gains on retained and sold ownership interests?",
      "original_answer": "In 2023, GE reported a $5.7 billion increase in corporate operating profit due to higher gains on retained and sold ownership interests, primarily driven by its AerCap and GE HealthCare investments. However, in 2024, the gains on retained and sold ownership interests decreased by $5.2 billion compared to 2023, again primarily related to AerCap and GE HealthCare. This indicates a significant reduction in the value or realization of these investments year-over-year.",
      "llm_answer": "\nIn 2023 GE recorded about **$5.78 billion** of gains on retained and sold ownership interests, a substantial portion of which came from the disposal of its AerCap stake. By 2024 those gains had **fallen by roughly $5.2 billion**, leaving only a modest residual gain, because the AerCap position had been largely monetized and no comparable large‑scale disposals occurred in 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the core financial evolution but contains some interpretive issues. CORRECT ELEMENTS: (1) The 2023 gains figure of ~$5.78 billion is accurate (ground truth states $5.7 billion, minor rounding variation acceptable). (2) The $5.2 billion decrease from 2023 to 2024 is correctly stated. (3) AerCap is correctly identified as a primary driver. (4) The year-over-year comparison is properly synthesized. ISSUES: (1) The LLM characterizes the 2024 gains as 'only a modest residual gain,' but the ground truth states gains 'decreased by $5.2 billion compared to 2023' without specifying the absolute 2024 amount as 'modest' - this is an interpretive addition not directly supported by the ground truth. (2) The explanation that 'the AerCap position had been largely monetized and no comparable large-scale disposals occurred in 2024' is reasonable inference but goes beyond what the ground truth explicitly states. The ground truth mentions both AerCap AND GE HealthCare as drivers in both years, while the LLM focuses primarily on AerCap. (3) The LLM doesn't explicitly mention GE HealthCare's contribution, which the ground truth identifies as a co-driver alongside AerCap. MULTI-HOP REASONING: The answer correctly synthesizes the 2023-2024 comparison and identifies the relationship evolution, though it adds interpretive context about monetization that isn't explicitly in the ground truth. QUANTITATIVE VERIFICATION: $5.78B ≈ $5.7B (acceptable), $5.2B decrease is exact match. The math is sound but the characterization of 2024 results as 'modest' is somewhat speculative.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1216,
        "completion_tokens": 444,
        "total_tokens": 1661
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How has Home Depot's strategic use of HD Supply evolved between 2022 and 2024, particularly in relation to its focus on professional customers and MRO services?",
      "original_answer": "In 2022, Home Depot highlighted the integration risks and challenges associated with its acquisition of HD Supply in 2020, noting that achieving synergies and benefits was subject to significant uncertainty and complexity. By 2024, HD Supply had become a core component of Home Depot’s strategy to serve professional customers, specifically through its MRO offerings to multifamily, hospitality, healthcare, and government housing facilities. The 2024 filing explicitly references HD Supply as a key contributor to Pro-focused growth initiatives, indicating a shift from post-acquisition integration concerns to a more mature and strategic role in supporting Home Depot's professional customer segment.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2024 Home Depot moved HD Supply from a peripheral distribution unit into the core of its professional‑customer strategy.  In 2022 the subsidiary was already delivering MRO products and value‑added services to multifamily, hospitality, healthcare and government‑housing accounts, but by 2024 the company had acquired SRS and was investing heavily in differentiated online tools, a dedicated Pro sales force, expanded trade‑credit (e.g., the Pro House Account program) and enhanced fulfillment options—all built around HD Supply’s MRO portfolio—to meet the increasingly complex purchase needs of Pros.  Consequently, HD Supply’s role evolved from simply supplying MRO items to becoming a strategic growth engine that deepens Home Depot’s focus on professional customers and their MRO service requirements.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) FACTUAL ERROR - The LLM claims HD Supply was 'already delivering MRO products and value-added services to multifamily, hospitality, healthcare and government-housing accounts' in 2022. The ground truth explicitly states that in 2022, Home Depot 'highlighted the integration risks and challenges' with 'significant uncertainty and complexity' - indicating HD Supply was still in post-acquisition integration phase, NOT yet a mature strategic component. The LLM conflates the 2024 mature state with 2022 conditions. (2) UNSUPPORTED CLAIMS - The LLM introduces specific initiatives (SRS acquisition, Pro House Account program, dedicated Pro sales force, online tools) that are NOT mentioned in the ground truth. While these may be factually accurate from filings, they represent information beyond what the knowledge graph provided and cannot be verified against the original answer. (3) TEMPORAL MISCHARACTERIZATION - The ground truth emphasizes a SHIFT from 'post-acquisition integration concerns' (2022) to 'mature and strategic role' (2024). The LLM obscures this critical evolution by suggesting HD Supply was already strategically mature in 2022. (4) CORRECT ELEMENTS - The LLM correctly identifies: the timeframe (2022-2024), the focus on professional customers, the MRO services, and the target customer segments (multifamily, hospitality, healthcare, government housing). The overall narrative of evolution toward strategic importance is directionally correct. (5) REASONING QUALITY - While the LLM's reasoning about strategic evolution is logical, it fails to capture the ground truth's key distinction: the 2022 state was characterized by integration challenges and uncertainty, not by already-functioning strategic operations. This is a fundamental misrepresentation of the 2022 baseline.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 495,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How has AMD's reliance on cross-licensing agreements evolved between 2023 and 2024, particularly in terms of patent portfolio size and its implications for technology exchange?",
      "original_answer": "In 2023, AMD reported having approximately 18,500 patent matters worldwide, including 12,800 issued patents and 5,600 pending applications. In 2024, this portfolio grew slightly to approximately 18,800 patent matters, with 13,200 issued patents and 5,600 pending applications. This increase in issued patents indicates a strengthening of AMD's intellectual property position, which likely enhances its leverage in cross-licensing agreements. AMD continues to emphasize that these agreements are critical for transferring and receiving technology and intellectual property rights, suggesting that the company's reliance on such agreements remains strong and possibly more strategically advantageous in 2024 due to the expanded patent portfolio.",
      "llm_answer": "\nBetween 2023 and 2024 AMD’s patent portfolio stayed essentially flat – it still holds roughly 7,500 U.S. patents and about 18.5 – 18.8 k worldwide patent matters (≈13 k issued, 5–6 k pending) – and it continues to depend on cross‑licensing and technology‑exchange deals to share and acquire patent rights.  The modest increase in worldwide filings shows a steady, not aggressive, expansion of its IP estate, which allows AMD to secure needed technologies (e.g., from Intel, Nvidia, ARM partners) while limiting litigation risk in a market dominated by strong competitors.  Consequently, AMD’s reliance on these agreements remains a core part of its strategy for technology exchange, but the evolution is limited to incremental growth rather than a dramatic shift.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer demonstrates substantial accuracy with some notable strengths and minor weaknesses: (1) CORRECT ELEMENTS: The LLM accurately captures the overall patent portfolio size (18.5-18.8k worldwide patent matters), the approximate split between issued patents (~13k) and pending applications (5-6k), and correctly identifies that the portfolio remained relatively flat between 2023 and 2024. The characterization of AMD's reliance on cross-licensing agreements as a core strategy is accurate. (2) QUANTITATIVE ACCURACY: The numbers provided are generally correct and align with ground truth. The LLM mentions '7,500 U.S. patents' which is not contradicted by the ground truth (which focuses on worldwide figures). The worldwide figures of 18.5-18.8k, 13k issued, and 5-6k pending all match the ground truth data. (3) MINOR DISCREPANCIES: The ground truth specifies more precise 2023 vs 2024 comparisons (18,500 to 18,800 total; 12,800 to 13,200 issued patents), while the LLM presents these as ranges rather than specific year-over-year changes. This is a minor presentation difference rather than an error. (4) QUALITATIVE REASONING: The LLM provides sound multi-hop reasoning by connecting patent portfolio growth to cross-licensing leverage and competitive positioning. However, the ground truth explicitly states the increase 'likely enhances its leverage in cross-licensing agreements' and notes the portfolio 'strengthening,' while the LLM characterizes the growth as 'modest' and 'incremental' rather than emphasizing the strengthening effect. (5) SYNTHESIS QUALITY: The LLM appropriately synthesizes information about patent portfolio evolution and its implications for technology exchange, though it adds speculative elements (e.g., 'from Intel, Nvidia, ARM partners') not present in the ground truth. (6) COMPLETENESS: The answer addresses both components of the question (portfolio size evolution and implications for technology exchange), though the ground truth more explicitly emphasizes the strategic advantage gained from the portfolio expansion.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 556,
        "total_tokens": 1940
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Johnson & Johnson's financial stake and strategic relationship with Kenvue evolve from 2023 to 2024, particularly regarding the retention and subsequent disposal of Kenvue shares?",
      "original_answer": "In 2023, Johnson & Johnson retained a 9.5% stake in Kenvue valued at $4.3 billion after completing the exchange offer in August. This stake was recorded in other assets and experienced a $0.4 billion expense by year-end due to subsequent changes. By 2024, the company completed a debt-for-equity exchange in May, using its remaining 182,329,550 shares of Kenvue Common Stock to satisfy $3.6 billion of commercial paper. This resulted in a $0.4 billion loss and marked the complete exit from Kenvue, ending any financial stake in the company.",
      "llm_answer": "\nAfter Kenvue’s May 2023 IPO, J&J owned roughly 89.6 % of the new company, but the August 23 2023 exchange offer reduced that exposure to about 9.5 % – a stake that remained on the balance sheet as an equity investment without a readily determinable market value and was reflected in other assets through the end of 2023. In the second quarter of 2024 J&J completed a debt‑for‑equity swap, exchanging the remaining 182 million Kenvue shares for commercial paper, thereby fully disposing of its Kenvue holdings and recording a ≈ $0.4 billion loss in other (income) expense.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a significant factual error regarding the timing of Kenvue's IPO and the exchange offer. According to the ground truth, the exchange offer was completed in August 2023, and J&J retained a 9.5% stake valued at $4.3 billion at that time. However, the LLM states 'After Kenvue's May 2023 IPO' - this is incorrect. Kenvue's IPO occurred in August 2023, not May 2023. The LLM correctly identifies: (1) the 89.6% initial ownership, (2) the reduction to 9.5% after the August 2023 exchange offer, (3) the classification as other assets, (4) the May 2024 debt-for-equity swap, (5) the 182 million shares exchanged, (6) the $3.6 billion commercial paper satisfaction (implied by the ~$0.4 billion loss), and (7) the complete exit from Kenvue. The LLM also correctly notes the $0.4 billion loss recorded. However, the answer omits the $4.3 billion valuation of the 9.5% stake in 2023 and the $0.4 billion expense by year-end 2023 mentioned in the ground truth. The multi-hop reasoning is sound - the answer correctly synthesizes the evolution from 2023 to 2024 and explains the strategic relationship changes. The core narrative is accurate despite the IPO date error and missing valuation details. The quantitative accuracy is reduced due to the IPO date error and missing the $4.3 billion valuation figure, though the key transaction amounts are correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 381,
        "total_tokens": 1670
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How has AT&T's relationship with Indiana Bell Telephone Co. Inc. evolved between 2022 and 2023 in terms of its inclusion in guarantee disclosures?",
      "original_answer": "In 2022, Indiana Bell Telephone Co. Inc. was listed among the entities whose obligations were guaranteed by AT&T under Exhibit 4-d. In 2023, the company continued to reference the same guarantee for Indiana Bell Telephone Co. Inc. under Exhibit 4-d, indicating that the guarantee remained in place without any modification or removal. Therefore, there was no change in the nature or status of the guarantee relationship between the two entities from 2022 to 2023.",
      "llm_answer": "\nBetween the 2022 and 2023 filings, Indiana Bell Telephone Co. Inc. remained listed in the “4‑c Guaranty of certain obligations” exhibit in AT&T’s Form 10‑K.  The company continues to be included as a guarantor in the same capacity in both years, showing that its presence in AT&T’s guarantee disclosures has not changed from 2022 to 2023.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERROR - EXHIBIT REFERENCE MISMATCH: The LLM answer states Indiana Bell Telephone Co. Inc. was listed in 'Exhibit 4-c Guaranty of certain obligations' in both 2022 and 2023. However, the ground truth explicitly states the guarantee was referenced under 'Exhibit 4-d' in both years. This is a significant factual error regarding the specific exhibit designation. The LLM appears to have confused or misidentified the exhibit number, which is a key detail in guarantee disclosures. CORRECT ELEMENTS: (1) The core conclusion that the guarantee remained unchanged between 2022 and 2023 is correct. (2) The identification of Indiana Bell Telephone Co. Inc. as the entity in question is correct. (3) The years (2022 and 2023) are correctly identified. (4) The characterization that there was no change in the guarantee relationship is semantically equivalent to the ground truth. INCORRECT ELEMENTS: (1) Exhibit 4-c vs. Exhibit 4-d - this is a material factual error in SEC filing references. (2) The LLM states the company 'continues to be included as a guarantor' which mischaracterizes the relationship - AT&T is the guarantor of Indiana Bell's obligations, not the other way around. This represents a reversal of the guarantee relationship. MULTI-HOP REASONING: The answer does attempt to synthesize information across two years and compare the status, which is appropriate for the question. However, the fundamental errors in exhibit identification and guarantee direction undermine the quality of this synthesis. The answer demonstrates partial understanding but contains material inaccuracies that would mislead someone relying on this information for compliance or research purposes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1200,
        "completion_tokens": 462,
        "total_tokens": 1662
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did GE's financial relationship with AerCap evolve from 2023 to 2024, particularly in terms of cash involvement and investment gains?",
      "original_answer": "In 2023, GE had a continuing financial involvement with AerCap through a note receivable, product leases, and transition services, which included a net cash payment of $203 million to AerCap. By 2024, GE no longer had continuing operational involvement but instead held an investment stake in AerCap. This shift resulted in a significant financial impact, as GE reported a decrease in gains on retained and sold ownership interests by $5.2 billion, largely attributed to its AerCap and GE HealthCare investments. This indicates a strategic and financial transition from operational collaboration to investment-based returns.",
      "llm_answer": "\nIn 2023 GE paid a net $203 million cash to AerCap (page 51) and held an equity stake that collapsed from about $7.4 billion (2022) to less than $1 billion by year‑end 2023 (pages 52‑57), reflecting a large unrealized loss and the subsequent sale of the remaining shares. By the end of 2024 GE’s exposure had been reduced to a small note‑receivable with essentially no equity position, so cash outflows and investment gains from AerCap are now negligible.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and omissions that undermine its accuracy:\n\n1. QUANTITATIVE ACCURACY ISSUES:\n   - The LLM correctly identifies the $203 million net cash payment to AerCap in 2023, which matches the ground truth.\n   - However, the LLM introduces unsupported claims about equity stake values ($7.4 billion in 2022 declining to less than $1 billion by end-2023) that are not mentioned in the ground truth and appear to be fabricated or confused with other data.\n   - The LLM fails to mention the critical $5.2 billion decrease in gains on retained and sold ownership interests, which is a key quantitative finding in the ground truth.\n   - The claim about 2024 exposure being \"negligible\" contradicts the ground truth, which indicates GE held an investment stake in AerCap in 2024.\n\n2. COMPLETENESS ISSUES:\n   - The LLM answer misses the most important financial metric: the $5.2 billion decrease in gains on retained and sold ownership interests from 2023 to 2024.\n   - The ground truth emphasizes a strategic transition from operational involvement (note receivable, product leases, transition services) to investment-based returns, but the LLM reverses this narrative, suggesting GE moved away from equity exposure.\n   - The LLM incorrectly suggests GE sold remaining shares and reduced exposure to \"negligible\" levels by 2024, when the ground truth indicates GE held an investment stake in 2024.\n\n3. ENTITY AND REASONING ACCURACY:\n   - The LLM correctly identifies GE and AerCap as the relevant entities.\n   - The multi-hop reasoning is flawed: the LLM attempts to trace the evolution but arrives at incorrect conclusions about the direction and nature of the relationship change.\n   - The LLM's characterization of the 2024 position as having \"essentially no equity position\" contradicts the ground truth's statement that GE \"held an investment stake in AerCap.\"\n\n4. SEMANTIC EQUIVALENCE:\n   - The LLM's narrative fundamentally misrepresents the nature of the transition. The ground truth describes a shift from operational collaboration to investment-based returns, while the LLM describes a complete exit from AerCap exposure.\n   - This is not merely a wording difference but a substantive mischaracterization of the financial relationship.\n\n5. CRITICAL OMISSIONS:\n   - No mention of the $5.2 billion decrease in gains (the most significant financial metric)\n   - No mention of the transition from operational involvement to investment stake\n   - Incorrect characterization of 2024 position\n\nThe answer demonstrates partial understanding of the 2023 cash flows but fundamentally misrepresents the 2024 position and omits the most material financial impact.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 721,
        "total_tokens": 1989
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How has The Home Depot's approach to store appearance and its role in competition evolved from 2022 to 2024, particularly in relation to customer experience and digital integration?",
      "original_answer": "In 2022, The Home Depot emphasized store appearance as a competitive factor alongside customer experience, price, and product availability. The company highlighted the importance of store location, appearance, and ease of shopping experience in both brick-and-mortar and online contexts. By 2024, the company expanded its focus, integrating store appearance into a broader 'interconnected shopping experience' that linked physical stores, digital platforms, and on-site services. The 2024 report specifically noted investments in digital platforms to enhance the presentation and ease of navigation for users, reflecting a shift toward digital integration as a core component of store and shopping experience competitiveness. This evolution shows a strategic shift from physical store aesthetics alone to a more holistic, digitally-enhanced customer experience.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 Home Depot moved its store‑appearance strategy from isolated physical upgrades (e.g., new signage, self‑checkout lanes, way‑finding refreshes) to a deliberately integrated omnichannel hub.  In 2022 the company highlighted investments in “store experience” and “interconnected shopping” that tied in‑store layout to online ordering, curb‑side pickup and mobile navigation, and by 2024 it was explicitly positioning each store as the center of a “frictionless interconnected experience” that blends digital tools (enhanced mobile apps, shoppable product pages, real‑time inventory) with the physical environment to meet customers’ expectations for speed, convenience and personalization—thereby using store appearance not just as a backdrop but as a competitive differentiator that reinforces its digital‑first customer experience.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core evolution from 2022 to 2024, capturing the shift from isolated physical store improvements to integrated omnichannel experiences. The answer accurately reflects the ground truth's main thesis about digital integration becoming central to store competitiveness. Specific details like 'curb-side pickup,' 'mobile apps,' 'real-time inventory,' and 'shoppable product pages' are reasonable elaborations consistent with typical retail digital strategies. The temporal framing (fiscal 2022 through 2024) is correct.\n\nWEAKNESSES: (1) The LLM introduces specific examples ('new signage, self-checkout lanes, way-finding refreshes') that are not explicitly mentioned in the ground truth, which could be fabricated details. (2) The phrase 'In 2022 the company highlighted investments in \"store experience\" and \"interconnected shopping\"' appears to conflate 2022 and 2024 messaging - the ground truth indicates 'interconnected shopping' was emphasized more prominently by 2024, not 2022. (3) The LLM's claim that 2022 focused on 'isolated physical upgrades' is an inference not directly supported by the ground truth, which states 2022 emphasized store appearance 'alongside' other factors but doesn't characterize them as 'isolated.' (4) The phrase 'explicitly positioning each store as the center of a \"frictionless interconnected experience\"' uses quotation marks suggesting direct citation, but this exact phrasing doesn't appear in the provided ground truth.\n\nMULTI-HOP REASONING: The answer successfully synthesizes the evolution across years and connects store appearance to digital integration, which is the core multi-hop requirement. However, the temporal attribution of specific messaging (what was emphasized in 2022 vs 2024) appears slightly misaligned with the ground truth's clearer delineation.\n\nFACTUAL ACCURACY: No quantitative errors (no numbers to verify). The qualitative claims are mostly aligned but contain some unsupported elaborations and potential temporal misattribution that reduce confidence in the answer's fidelity to the actual filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 570,
        "total_tokens": 2011
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How has AMD's financial relationship with the ATMP JV evolved between 2023 and 2024, particularly in terms of resales and new financial arrangements?",
      "original_answer": "In 2023, AMD's resales to the ATMP JV amounted to $14 million, with no mention of direct financial arrangements such as loans. By 2024, AMD's resales to the ATMP JV increased significantly to $121 million. Additionally, in October 2024, AMD entered into a one-year $100 million term loan agreement with one of the ATMP JVs to support the joint venture's general corporate purposes. This indicates a notable deepening of the financial relationship, moving beyond operational services to include direct financial support.",
      "llm_answer": "\nBetween fiscal 2023 and 2024 AMD’s dealings with the ATMP joint venture intensified: purchases of inventory remained roughly $1.7 billion, but resales to the JV surged from $14 million to $121 million, and payables to the JV rose from $363 million to $476 million.  In October 2024 AMD also entered a one‑year, $100 million term loan with one of the JVs (secured by the JV’s receivable from AMD) and increased its equity investment in the JV to about $149 million, underscoring a new, larger financial linkage.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the core evolution of AMD's relationship with ATMP JV, including: (1) resales increase from $14M to $121M (correct), (2) October 2024 $100M term loan agreement (correct), and (3) the characterization of deepening financial relationship (correct). The answer appropriately synthesizes multi-hop information across years and financial arrangements.\n\nWEAKNESSES - QUANTITATIVE ISSUES: The LLM introduces several numbers NOT in the ground truth answer: (1) \"purchases of inventory remained roughly $1.7 billion\" - not mentioned in original answer, (2) \"payables to the JV rose from $363 million to $476 million\" - not mentioned in original answer, (3) \"increased its equity investment in the JV to about $149 million\" - not mentioned in original answer. While these may be factually accurate from the 10-K filings, they represent SCOPE CREEP beyond what the ground truth identifies as the key evolution points.\n\nCRITICAL ISSUE: The LLM adds the detail that the term loan is \"secured by the JV's receivable from AMD\" - this specific detail about security is not in the ground truth answer. Additionally, the mention of equity investment increase to $149M is not in the ground truth.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes information across 2023-2024 and identifies the progression from operational resales to direct financial support (loan). The reasoning is sound.\n\nSEMANTIC EQUIVALENCE: The core message matches - resales increased significantly and a new $100M loan was added. However, the introduction of additional financial metrics (payables, equity investment, inventory purchases) that weren't highlighted in the ground truth suggests either: (a) the LLM is providing additional context not requested, or (b) the LLM may be confusing related but distinct financial metrics.\n\nVERIFICATION: The two core facts that can be verified against ground truth are correct: $14M→$121M resales and $100M October 2024 loan. The additional numbers cannot be verified against the provided ground truth but may be accurate from source documents.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 565,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How has Johnson & Johnson's approach to privacy compliance programs evolved between 2023 and 2024, particularly in response to new privacy laws and international data flow regulations?",
      "original_answer": "In 2023, Johnson & Johnson had established privacy compliance programs and controls that its global businesses were required to follow, with an emphasis on addressing new privacy laws expected in 'other territories' and increasing enforcement by governmental authorities, especially concerning data localization and international data flows. By 2024, the company maintained these privacy compliance programs but expanded its focus to include evolving technology and data-driven initiatives across the company, involving multiple vendors and third parties. The 2024 disclosure also specifically notes the expectation of new privacy laws 'globally' (not just in other territories) and highlights legislative actions imposing limitations on the use, sharing, and cross-border flows of personal data. This indicates a broadening of the company's compliance focus and a more anticipatory posture toward global regulatory changes.",
      "llm_answer": "\nBetween 2023 and 2024 J&J tightened its privacy‑compliance framework in direct response to a wave of new global privacy statutes and heightened enforcement of data‑localisation and cross‑border‑flow rules.  The company expanded its privacy‑compliance program and controls to cover the “broad compliance obligations” of emerging laws, added stricter monitoring of international data transfers, integrated privacy oversight into its cybersecurity governance (with quarterly CISO updates to the Regulatory Compliance & Sustainability Committee), and broadened mandatory data‑privacy training and third‑party risk assessments to mitigate the increased regulatory and reputational risks associated with cross‑border data flows.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and unsupported claims that diverge substantially from the ground truth. Specific issues: (1) UNSUPPORTED CLAIMS: The LLM introduces specific details not present in the ground truth, including 'quarterly CISO updates to the Regulatory Compliance & Sustainability Committee,' 'stricter monitoring of international data transfers,' 'integrated privacy oversight into its cybersecurity governance,' and 'broadened mandatory data-privacy training.' These specific governance mechanisms and implementation details are not mentioned in the original answer and appear to be fabricated or hallucinated. (2) MISCHARACTERIZATION OF EVOLUTION: The ground truth indicates J&J 'maintained' privacy compliance programs while expanding focus, not that it 'tightened' its framework. The LLM's framing of a dramatic overhaul ('tightened,' 'stricter,' 'integrated') overstates the actual evolution described in the source material. (3) MISSING KEY DISTINCTION: The ground truth specifically highlights the shift from addressing privacy laws in 'other territories' (2023) to 'globally' (2024), which is a crucial semantic distinction showing broadening scope. The LLM answer mentions 'global privacy statutes' but misses this important evolution in geographic scope. (4) QUANTITATIVE ACCURACY: No specific numbers, dates, or metrics are provided in either answer, so quantitative comparison is limited. However, the LLM's introduction of specific governance details (quarterly updates, specific committee names) without ground truth support is problematic. (5) MULTI-HOP REASONING: While the LLM attempts to synthesize information about regulatory evolution and company response, it does so by adding unsupported details rather than accurately synthesizing the actual ground truth information. The answer reads as plausible but factually unreliable. The core accurate elements (global privacy laws, data flow regulations, vendor/third-party involvement) are present but overshadowed by fabricated specifics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 550,
        "total_tokens": 1971
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has GE's financial exposure to Bank BPH evolved between 2023 and 2024, particularly in terms of estimated borrower litigation losses and related valuation allowances?",
      "original_answer": "In 2023, GE reported $2,669 million in total estimated losses related to borrower litigation for Bank BPH's foreign currency-denominated mortgage portfolio, with $1,712 million in valuation allowances against financing receivables held for sale and $957 million in other liabilities. By 2024, this total estimated loss decreased to $2,461 million, with $1,517 million in valuation allowances and $944 million in other liabilities. Additionally, the valuation allowance fully offset the financing receivables balance by the end of 2024, indicating a strategic shift in how GE managed its exposure to Bank BPH through a settlement program. This represents a reduction in GE's financial exposure to Bank BPH litigation risks over the period.",
      "llm_answer": "\nBetween 2023 and 2024 the estimated borrower‑litigation losses tied to GE’s Bank BPH mortgage portfolio fell from **$2.669 billion to $2.461 billion** – a reduction of about **$0.21 billion**.  In the 2024 filing the valuation allowance completely offsets the remaining financing‑receivable balance, whereas in 2023 it only partially covered the exposure, signalling that GE’s financial risk to Bank BPH has been markedly diminished and essentially neutralized.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the main trend (decrease from $2.669B to $2.461B) and the key insight about the valuation allowance offsetting the financing receivables balance in 2024. However, there are significant omissions in quantitative detail. The LLM provides only the total figures and the overall reduction ($0.21B), but fails to break down the component changes: (1) Valuation allowances decreased from $1,712M to $1,517M (a $195M reduction), and (2) Other liabilities decreased from $957M to $944M (a $13M reduction). These component details are important for understanding how the exposure evolved across different liability categories. The calculation of the $0.21B reduction is correct ($2,669M - $2,461M = $208M, which rounds to $0.21B). The qualitative assessment about the strategic shift and risk neutralization is sound and well-reasoned. The LLM correctly synthesizes the multi-hop information about the settlement program's impact. However, the answer is incomplete because it omits the specific breakdown of valuation allowances and other liabilities for both years, which are material details for understanding the full evolution of GE's exposure. The answer demonstrates good understanding of the overall narrative but lacks the granular financial detail that would make it fully comprehensive.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 369,
        "total_tokens": 1675
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has HD's treatment and positioning of the Indoor Garden product line evolved from 2022 to 2024, given its financial performance in 2022 and its merchandising department categorization in 2024?",
      "original_answer": "In 2022, HD's Indoor Garden product line generated $15,546 million in net sales, accounting for 10.3% of total revenue, indicating its significance as a standalone category. By 2024, the Indoor Garden product line was grouped under the 'Hardlines' merchandising department, suggesting a strategic shift to integrate it with related product lines rather than treating it as a distinct category. This reclassification implies a change in how HD is organizing and potentially promoting the product line within its broader offerings.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 the Indoor Garden line has remained positioned inside the **Hardlines merchandising department** (it is listed alongside Hardware, Outdoor Garden and Tools both in the 2022 filing and in the 2024 “Major Product Line | Merchandising Departments” table).  In 2022 the segment generated roughly **$15.5 billion in net sales—about 10 % of total company sales**—and continued to be a key growth driver, contributing a comparable share of the $48.6 billion Hardlines sales reported for fiscal 2024.  Thus, while the company has realigned other departmental groupings, it has kept Indoor Garden within Hardlines and maintained its importance as a core, high‑visibility product line.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a fundamental factual error that directly contradicts the ground truth. The ground truth explicitly states that 'By 2024, the Indoor Garden product line was grouped under the Hardlines merchandising department, suggesting a strategic shift' - implying this was a CHANGE from 2022. However, the LLM claims Indoor Garden 'has remained positioned inside the Hardlines merchandising department' and was 'listed alongside Hardware, Outdoor Garden and Tools both in the 2022 filing and in the 2024 filing.' This is incorrect. The ground truth indicates Indoor Garden was a STANDALONE CATEGORY in 2022 (generating $15,546 million or 10.3% of total revenue as a distinct line), and only by 2024 was it reclassified into Hardlines. The LLM's assertion that it was already in Hardlines in 2022 misses the entire point of the question - the evolution/change in treatment. QUANTITATIVE ISSUES: The LLM rounds $15,546 million to '$15.5 billion' (acceptable format variation) and 10.3% to 'about 10%' (acceptable rounding), so these are technically correct. However, the LLM's statement that Indoor Garden 'continued to be a key growth driver, contributing a comparable share of the $48.6 billion Hardlines sales' is vague and doesn't clearly establish whether the product line's importance changed. MULTI-HOP REASONING FAILURE: The question asks how treatment and positioning 'evolved' from 2022 to 2024. The LLM failed to identify the key evolution: from standalone category status to integration within Hardlines. Instead, it incorrectly claims continuity. This represents a fundamental failure in multi-hop synthesis across the two time periods. The LLM appears to have conflated or misread the filing data, claiming the categorization was consistent when the ground truth shows a strategic reclassification occurred.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 503,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has Colgate-Palmolive's use of sourcing strategies to manage cost volatility evolved from 2022 to 2024, particularly in relation to commodity price fluctuations?",
      "original_answer": "In 2022, Colgate-Palmolive utilized sourcing strategies as part of a broader risk management framework to manage volatility in foreign exchange, interest rates, and commodity prices, specifically mentioning the use of derivative instruments and local currency borrowings. By 2024, the company continued to rely on sourcing strategies but placed greater emphasis on managing raw material cost volatility, including commodities like resins, essential oils, and soybeans, while also incorporating more proactive cost containment and productivity initiatives. The 2024 disclosure highlights increased exposure to geopolitical and climatic disruptions, indicating a shift toward more defensive sourcing and cost management tactics in response to external pressures.",
      "llm_answer": "\nFrom 2022 through 2024 Colgate‑Palmolive has kept its core practice of using sourcing strategies—diversified supplier base, productivity initiatives and limited commodity‑hedging contracts—to blunt raw‑material price swings.  However, the 2024 disclosures show an evolution toward pairing those sourcing actions with more aggressive price‑adjustment and cost‑efficiency programs, explicitly linking sourcing and productivity measures to offset inflationary commodity costs while still relying on limited futures/forward contracts for targeted hedging.  In short, the company’s sourcing‑based risk‑management has broadened from pure cost‑containment to a combined approach of sourcing, productivity and selective hedging, with pricing actions now playing a larger role in managing commodity‑price volatility.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of Colgate-Palmolive's sourcing strategy evolution from 2022 to 2024, with accurate identification of key elements and sound multi-hop reasoning. STRENGTHS: (1) Correctly identifies the core sourcing strategies (diversified supplier base, productivity initiatives, hedging contracts) mentioned in both years; (2) Accurately captures the evolution toward more aggressive cost-efficiency and pricing actions by 2024; (3) Properly synthesizes the shift from pure cost-containment to a combined approach; (4) No quantitative errors or incorrect dates/metrics; (5) Correctly references specific commodities and hedging instruments. WEAKNESSES: (1) The LLM answer does not explicitly mention the increased exposure to geopolitical and climatic disruptions highlighted in the 2024 ground truth disclosure—this represents a notable omission of a key contextual element that characterizes the 'shift toward more defensive sourcing and cost management tactics'; (2) While the LLM mentions 'limited futures/forward contracts,' the ground truth emphasizes 'derivative instruments' more broadly in 2022, though this is a minor semantic difference; (3) The LLM's framing of 'aggressive price-adjustment' programs is somewhat different from the ground truth's emphasis on 'more proactive cost containment and productivity initiatives,' though both convey similar strategic intent. MULTI-HOP REASONING: The answer successfully synthesizes information across 2022 and 2024 disclosures, correctly identifying the temporal evolution and the relationship between sourcing, productivity, and pricing strategies. The reasoning is logical and well-structured. OVERALL: The answer is substantially correct and addresses the core question effectively, but the omission of geopolitical/climatic disruption context and the slightly different framing of strategic emphasis prevent a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 518,
        "total_tokens": 1915
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did the sales performance of TREMFYA evolve between 2023 and 2024, and what factors contributed to this change?",
      "original_answer": "In 2023, TREMFYA (guselkumab) experienced growth driven by market expansion, continued strength in PsO/PsA (Psoriasis and Psoriatic Arthritis), and favorable patient mix. By 2024, TREMFYA achieved sales of $3,670 million, an increase of 16.6% compared to $3,147 million in 2023. The growth in 2024 was attributed to an 18.1% change from operations, despite a negative currency impact of 1.5%. This indicates that TREMFYA not only maintained its market position but also expanded further in its therapeutic areas during this period.",
      "llm_answer": "\nTREMFYA sales rose sharply from about **$3.1 billion in fiscal 2023 to roughly $3.7 billion in fiscal 2024** (a ~16–18 % increase, with the operational growth rate cited at 18.1 % and total change at 16.6 %).  This growth was driven primarily by **expanding market adoption in psoriasis and psoriatic arthritis, favorable patient‑mix trends, and continued uptake across additional therapeutic indications**, while modest currency headwinds slightly tempered the headline rise.  The stronger performance reflects the drug’s expanding commercial footprint and the company’s ability to capitalize on growing demand for biologics in the immunology portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All key numbers are correct - 2023 sales of $3,147M (stated as ~$3.1B), 2024 sales of $3,670M (stated as ~$3.7B), total growth of 16.6%, operational growth of 18.1%, and currency impact of -1.5%. The percentage ranges cited (16-18%) appropriately bracket the exact 16.6% figure. COMPLETENESS: The answer addresses both parts of the multi-part question - it describes the sales evolution (the numbers and direction) and identifies contributing factors (market expansion, PsO/PsA strength, favorable patient mix, currency headwinds). ENTITY ACCURACY: TREMFYA is correctly identified with its generic name (guselkumab), fiscal years are correct (2023 vs 2024), and therapeutic areas (psoriasis and psoriatic arthritis) are accurately referenced. MULTI-HOP REASONING: The answer correctly synthesizes the relationship between operational growth (18.1%), currency impact (-1.5%), and total reported growth (16.6%), demonstrating sound understanding of how these components interact. The explanation that currency headwinds 'tempered' the headline rise correctly reflects the negative 1.5% currency impact. WORDING: The LLM uses slightly different phrasing than the ground truth (e.g., 'expanding market adoption' vs 'market expansion,' 'additional therapeutic indications' vs the more specific PsO/PsA focus) but maintains semantic equivalence and adds relevant context about the immunology portfolio. Minor note: The LLM mentions 'additional therapeutic indications' which is a reasonable inference but not explicitly stated in the ground truth, though this represents appropriate contextual elaboration rather than error.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 467,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did the structural change in Disney's relationship with A&E from 2022 to 2023 affect its reporting of subscriber numbers and financial stake in the partnership?",
      "original_answer": "In 2022, Disney reported A&E as a partner with 69 million domestic subscribers, indicating a collaborative but arms-length relationship. By 2023, Disney's relationship with A&E had evolved into a 50% equity stake, with A+E now classified as a significant equity investment. The 2023 report noted that A+E's channels, including A&E, had 58 million domestic subscribers. This shift from a partnership to a joint ownership model altered how Disney reported both subscriber data and financial performance, moving from simple subscriber counts in 2022 to including A+E’s financial results under 'Equity in the income of investees' in 2023.",
      "llm_answer": "\nThe 2023 filing no longer includes the detailed subscriber‑count tables for A+E that were disclosed in the 2022 filing; instead it only states that Disney holds a 50 % equity interest in A+E and describes the joint‑venture’s channel portfolio, removing the separate subscriber‑level metrics that had been reported in 2022. This reflects a structural shift in how Disney reports its partnership with A+E—from presenting granular audience numbers as part of its segment disclosures to treating the investment simply as a 50 % equity method holding without separate subscriber reporting.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the structural shift from partnership to 50% equity stake and accurately describes the change in reporting methodology (from granular subscriber metrics to equity method accounting). However, it has significant quantitative gaps: (1) The LLM fails to mention the specific subscriber numbers that are central to the ground truth answer—69 million domestic subscribers in 2022 and 58 million in 2023. These are critical data points that directly answer the question about how the structural change 'affected its reporting of subscriber numbers.' (2) The LLM does not explicitly state that A+E's financial results moved to 'Equity in the income of investees' accounting treatment, though it implies this through 'equity method holding.' (3) The LLM correctly identifies the 50% equity stake and the shift away from detailed subscriber-count tables, which are accurate. The reasoning about the structural change is sound and the multi-hop synthesis is logical—connecting the ownership change to the reporting methodology change. However, the answer is incomplete because it omits the specific subscriber count data that the ground truth emphasizes as a key impact of the structural change. The answer addresses the 'how it affected reporting' aspect but incompletely addresses the 'subscriber numbers' aspect of the question. The contextual relevance is good as it directly addresses the reporting change, but the quantitative accuracy suffers from missing the specific subscriber figures that are essential to fully answering the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 432,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did the financial impact of GE's relationship with AerCap evolve between 2023 and 2024, particularly in terms of realized and unrealized gains or losses?",
      "original_answer": "In 2023, GE reported an unrealized gain of $129 million from its investment in and note with AerCap. However, in 2024, the relationship had evolved such that GE recognized a significant decrease in gains on retained and sold ownership interests, which dropped by $5.2 billion compared to 2023, with AerCap being one of the primary contributors to this decline. This indicates a negative shift in the financial performance of the AerCap investment from a gain in 2023 to a loss or significantly reduced gain in 2024.",
      "llm_answer": "\nBetween 2022 and 2023 the AerCap exposure shifted dramatically: the company recorded a **$129 million net gain** (realized + unrealized) on its AerCap investment in 2023, after posting a **$865 million loss** in 2022, reflecting the sale of nearly all AerCap shares and the move to a residual senior‑note position. Because the remaining AerCap holding is now limited to that senior note, **2024 shows essentially no material realized or unrealized gains or losses** from the relationship.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ISSUES: (1) TIME PERIOD MISMATCH: The question explicitly asks about 2023-2024 evolution, but the LLM answer focuses on 2022-2023 comparison, which is NOT what was asked. This is a fundamental misalignment with the question. (2) INCOMPLETE 2024 DATA: The ground truth states that in 2024, GE recognized a significant decrease in gains on retained and sold ownership interests, with a $5.2 billion drop compared to 2023, and AerCap was a primary contributor. The LLM answer claims '2024 shows essentially no material realized or unrealized gains or losses,' which contradicts the ground truth's indication of significant losses/decreased gains in 2024. (3) CORRECT 2023 NUMBER: The LLM correctly identifies the $129 million net gain in 2023, which matches the ground truth's unrealized gain figure. (4) EXTRANEOUS 2022 DATA: The $865 million loss in 2022 is not part of the ground truth answer and represents information outside the requested 2023-2024 timeframe. (5) MISSING KEY SYNTHESIS: The LLM fails to synthesize the critical 2024 information about the $5.2 billion decline in gains on retained and sold ownership interests with AerCap as a primary driver. The answer incorrectly suggests minimal impact in 2024 when the ground truth indicates substantial negative impact. (6) REASONING QUALITY: While the explanation about the shift from equity holdings to senior note position is contextually reasonable, it leads to an incorrect conclusion about 2024 financial impact. The multi-hop reasoning fails because it doesn't properly connect the 2024 data points from the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 437,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How has Mastercard's multi-layered security approach evolved between 2022 and 2024, particularly in terms of addressing risks associated with third-party service providers, and what does this evolution indicate about the company's strategic response to emerging cybersecurity threats?",
      "original_answer": "In 2022, Mastercard's multi-layered security approach included a robust program to protect its network from cyber and information security threats, with multiple layers of protection and third-party assessments. However, there was no explicit mention of addressing risks related to third-party service providers. By 2024, Mastercard explicitly integrated third-party provider risk management into its security framework, noting that it works with experts across the organization and through public-private partnerships to monitor and respond to threats associated with the use of services provided by third-party providers. This indicates a strategic shift toward strengthening the ecosystem-wide resilience of its security architecture, particularly in response to the growing complexity and interconnectedness of the payments landscape.",
      "llm_answer": "\nMastercard’s security model moved from a broad, internally‑focused, multi‑layered defense (2022) to a tightly‑controlled ecosystem approach that explicitly evaluates, onboards and continuously monitors third‑party providers, and that embeds security into external platforms through token‑based services, virtual‑card‑in‑digital‑wallet integration and the Alias‑Based Remittances/Payouts framework (2024).  This shift shows the company’s strategic response to rising cyber risk is to harden the supply‑chain and partner layer—using standardized risk‑assessment processes, advanced authentication (tokenization, passkeys) and seamless, secure connectivity with external fintechs and government disbursement systems—to stay ahead of threats that increasingly originate outside its core network.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ISSUES: (1) The LLM answer introduces specific technical mechanisms (tokenization, passkeys, Alias-Based Remittances/Payouts framework, virtual-card-in-digital-wallet) that are NOT mentioned in the ground truth. These appear to be fabricated details not supported by the knowledge graph. (2) The ground truth explicitly states there was 'no explicit mention of addressing risks related to third-party service providers' in 2022, but the LLM characterizes 2022 as 'internally-focused' without this nuance. (3) The LLM's description of 2024 as involving 'tightly-controlled ecosystem approach that explicitly evaluates, onboards and continuously monitors third-party providers' goes beyond what the ground truth states. The ground truth says Mastercard 'works with experts...to monitor and respond to threats associated with the use of services provided by third-party providers'—a more modest claim than the LLM's detailed governance framework. (4) POSITIVE: The LLM correctly identifies the core evolution from internal focus to third-party risk integration, and correctly identifies the strategic shift toward ecosystem-wide resilience. (5) POSITIVE: No quantitative errors (no specific numbers were claimed). (6) The LLM's reasoning about supply-chain hardening and partner-layer security is logical but represents speculation beyond the ground truth. The answer conflates general security best practices with specific Mastercard initiatives not documented in the knowledge graph. This is a case where the LLM has added plausible-sounding but unsupported technical details that undermine factual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 443,
        "total_tokens": 1885
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How has Target Corporation's compliance with its debt leverage covenant evolved between 2022 and 2023, particularly in light of changes to its credit facilities?",
      "original_answer": "In 2022, Target Corporation stated that it was in compliance with its debt leverage covenant and expected to remain so, with a $3.0 billion unsecured revolving credit facility set to expire in October 2026. By 2023, Target had obtained a new $1.0 billion 364-day unsecured revolving credit facility (expiring in October 2024) and extended the expiration of its five-year $3.0 billion facility to October 2028. Despite these structural changes to its credit facilities, Target continued to assert compliance with the debt leverage covenant in 2023, indicating consistent adherence to regulatory requirements even as its financing arrangements evolved.",
      "llm_answer": "\nTarget continued to satisfy its debt‑leverage covenant after reshaping its revolving‑credit structure between 2022 and 2023—terminating the prior $2.5 bn 364‑day facility and entering a new $1 bn 364‑day facility while extending its $3 bn five‑year revolving facility to an October 2028 maturity (Financing section, page 33). The company reported that it remained “in compliance with these covenants” and had no outstanding balances under either facility during 2023 or 2022, indicating that the covenant did not become a constraint despite the credit‑facility changes.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains a significant factual error regarding the prior 364-day facility. The LLM states Target terminated a '$2.5 bn 364-day facility' but the ground truth indicates the prior facility was $3.0 billion (not $2.5 billion). This is a material misstatement of a key financial figure. The LLM correctly identifies: (1) the new $1.0 billion 364-day facility, (2) the extension of the $3.0 billion five-year facility to October 2028, and (3) compliance with debt leverage covenants in both years. However, the $2.5 billion figure is factually incorrect and represents a 17% error in the stated facility size. MULTI-HOP REASONING: The LLM appropriately synthesizes information about covenant compliance across 2022-2023 and connects it to credit facility changes, demonstrating sound multi-hop reasoning. The conclusion that the covenant 'did not become a constraint' is a reasonable inference supported by the compliance statements. COMPLETENESS: The answer addresses the evolution of compliance and credit facility changes, though it omits the specific mention that the original $3.0 billion facility was set to expire in October 2026 before being extended. SEMANTIC ISSUES: The phrasing 'terminating the prior $2.5 bn 364-day facility' is imprecise—the ground truth doesn't explicitly state termination of a prior 364-day facility, only that a new one was obtained. The answer's assertion about 'no outstanding balances' adds detail not explicitly confirmed in the ground truth provided. The quantitative error ($2.5B vs $3.0B) is the primary driver of the low correctness score, as financial accuracy is critical in this domain.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 459,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How has the nature of the risks associated with Salesforce's AI offerings, including generative AI such as Agentforce, evolved from 2023 to 2024?",
      "original_answer": "In 2023, Salesforce's primary risk related to third-party integrations and applications centered on potential claims or liabilities stemming from customer expectations for warranties, despite the company not developing or selling these third-party offerings. By 2024, the risk profile expanded significantly with the increased integration of AI into Salesforce's offerings, particularly generative and agentic AI like Agentforce. The 2024 disclosures highlight new risks such as ethical concerns, regulatory scrutiny, and potential legal liabilities from AI-generated content that may be inaccurate, biased, or infringe on copyright. Additionally, the company now anticipates increased costs related to AI governance, compliance, and testing, which were not specifically tied to AI in 2023.",
      "llm_answer": "\nIn the 2023 filing the company only warned in general terms that “social and ethical issues, including the use or capabilities of AI,” could cause reputational harm and liability. By the 2024 filing the risk discussion is far more specific: it calls out generative and agentic AI products such as Agentforce, highlights emerging ethical dilemmas, heightened regulatory scrutiny (e.g., the EU AI Act and DSA), and concrete dangers around accuracy, bias, privacy, security and data provenance that could generate liability and require substantial governance investment. Consequently, the nature of the AI‑related risks has evolved from a broad caution to a detailed, AI‑specific exposure that includes regulatory, reputational and financial consequences.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. STRENGTHS: (1) Correctly identifies the evolution of Salesforce's AI risk disclosures from 2023 to 2024, capturing the shift from general warnings to specific, detailed risk articulation. (2) Accurately names specific products (Agentforce) and regulatory frameworks (EU AI Act, DSA) that appear in 2024 disclosures. (3) Properly synthesizes the multi-hop comparison: 2023 risks (third-party integrations, general AI concerns) vs. 2024 risks (generative/agentic AI, ethical concerns, regulatory scrutiny, accuracy/bias/copyright issues, governance costs). (4) Correctly characterizes the nature of the evolution as moving from 'broad caution' to 'detailed, AI-specific exposure.' (5) No quantitative errors or date misstatements. (6) The reasoning about increased governance investment aligns with ground truth mention of 'increased costs related to AI governance, compliance, and testing.' MINOR CONSIDERATIONS: The LLM answer is slightly more concise than the ground truth but captures all essential elements. The mention of specific regulatory frameworks (EU AI Act, DSA) adds helpful context not explicitly in the ground truth summary but consistent with 2024 AI risk disclosures. The characterization of risks as 'regulatory, reputational and financial consequences' effectively summarizes the expanded risk profile. No factual inaccuracies detected. The answer demonstrates sound multi-hop reasoning by correctly synthesizing information across two fiscal years and multiple risk categories.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 436,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How has Lowe's delivery capability for parcel-eligible items evolved between fiscal years 2023 and 2024, and what specific improvements were made?",
      "original_answer": "In fiscal year 2023, most parcel-eligible items could be delivered within two business days at standard shipping rates. By fiscal year 2024, Lowe's improved this capability, enabling delivery of most parcel-eligible items within two business days or less. Additionally, in 2024, Lowe's expanded its delivery capabilities to include next-day delivery for major appliances in nearly every zip code in the United States. This represents a refinement and expansion of their delivery speed and geographic coverage.",
      "llm_answer": "\nBetween fiscal 2023 and 2024 Lowe’s shortened the standard shipping window for most parcel‑eligible items to two business days or less and broadened same‑day delivery through a nationwide gig‑worker network, while also enabling next‑day delivery of major appliances in almost every ZIP code; it further accelerated these gains by completing the market‑based delivery model rollout, which added new geographic areas and extra capacity for big‑and‑bulky products and improved overall network flow management.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains a mix of correct and incorrect information. CORRECT ELEMENTS: (1) The two business days or less delivery window for parcel-eligible items in 2024 is accurate; (2) Next-day delivery for major appliances in nearly every/almost every ZIP code is correct. INCORRECT/UNSUPPORTED ELEMENTS: (1) The claim about 'broadened same-day delivery through a nationwide gig-worker network' is not mentioned in the ground truth and appears to be fabricated or confused with other delivery services; (2) The reference to 'completing the market-based delivery model rollout' is not in the ground truth; (3) Claims about 'new geographic areas and extra capacity for big-and-bulky products' and 'improved overall network flow management' are not supported by the ground truth. MULTI-HOP REASONING: The LLM failed to properly synthesize the evolution between 2023 and 2024. The ground truth shows a clear progression: FY2023 had two business day delivery, FY2024 refined this to 'two business days or less' AND added next-day appliance delivery. The LLM conflates these improvements with unsubstantiated claims about same-day delivery and market-based rollouts. COMPLETENESS: While the LLM addresses the main improvements (two business days or less, next-day appliances), it adds significant unsupported details that dilute the accuracy of the response. The answer appears to confuse or conflate different delivery initiatives that are not mentioned in the ground truth. This represents a significant factual accuracy problem despite capturing some core elements correctly.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 432,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How has the financial impact of the Dermstore LLC sale evolved from 2022 to 2023 in terms of Target's consolidated revenues and operating income?",
      "original_answer": "The financial impact of the Dermstore LLC sale remained minimal in both years, as Dermstore represented less than 1 percent of Target's consolidated revenues, operating income, and net assets in both 2022 and 2023. The sale, which occurred in February 2021, resulted in a $335 million pretax gain included in Net Other (Income)/Expense, and no significant post-sale financial contribution or change was observed in either year.",
      "llm_answer": "\nThe February 2021 sale of Dermstore produced a one‑time $335 million pretax gain that was recorded in 2021’s net‑other‑income; Dermstore represented less than 1 % of Target’s consolidated revenue and operating income, so its impact is essentially immaterial in the subsequent years. As a result, the revenue trends (a 1.7 % decline to $105.8 billion in 2023) and the operating‑income swing (up 48 % to $5.7 billion in 2023) are driven by the broader business performance rather than by the Dermstore transaction.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct with strong quantitative accuracy. Key strengths: (1) Correctly identifies the $335 million pretax gain from the February 2021 sale; (2) Accurately states Dermstore represented less than 1% of consolidated revenues and operating income; (3) Correctly notes the gain was recorded in Net Other (Income)/Expense; (4) Properly characterizes the impact as immaterial in subsequent years (2022-2023); (5) Provides accurate 2023 revenue figure ($105.8 billion) and operating income percentage increase (48% to $5.7 billion). The multi-hop reasoning is sound—the answer correctly synthesizes that the sale's impact evolved from a one-time 2021 gain to minimal ongoing impact in 2022-2023, and appropriately contextualizes that broader business performance drives the trends rather than the Dermstore transaction. Minor weakness: The answer could have been more explicit about comparing the 2022 and 2023 periods directly (the question asks 'how has...evolved from 2022 to 2023'), though the answer does address this by noting 'no significant post-sale financial contribution or change was observed in either year' implicitly. The answer goes slightly beyond the ground truth by providing additional context about 2023 revenue and operating income trends, which adds value but wasn't explicitly required. All numeric values are accurate and properly formatted.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1234,
        "completion_tokens": 386,
        "total_tokens": 1621
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How has the strategic positioning of Data Cloud evolved between 2023 and 2024, particularly in terms of its role within Salesforce's broader service offerings and competitive landscape?",
      "original_answer": "In 2023, Data Cloud was described as a 'hyperscale, trusted data engine native to Salesforce' that unified enterprise data to deliver a 360-degree view of customers, emphasizing its integration across Salesforce's offerings like Marketing and Analytics. By 2024, Data Cloud was positioned within a broader context of competitive risk, with the filing noting that markets for offerings like Data Cloud are 'relatively new and uncertain,' and that Salesforce faces increasing competition as AI and data platforms evolve. Additionally, in 2024, Salesforce acknowledged limited experience in pricing consumption-based models like that of Data Cloud, signaling a shift from product-centric messaging to one that includes strategic risk and monetization challenges.",
      "llm_answer": "\nBetween fiscal 2023 and 2024 Salesforce transformed Data Cloud from a back‑end data‑unification engine that simply fed the Customer 360 view into a flagship, monetizable platform that underpins new consumption‑based offerings (e.g., Agentforce and industry‑specific clouds) and drives AI‑powered automation across Sales, Service, Marketing and Commerce. This evolution makes Data Cloud a central growth lever in Salesforce’s broader service portfolio, even as the company faces intensified competition from other data‑ and AI‑focused vendors and must carefully manage pricing, regulatory and adoption risks.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "ASSESSMENT: The LLM answer captures some correct elements but introduces unsupported claims and mischaracterizes the ground truth positioning.\n\nCORRECT ELEMENTS:\n- Correctly identifies the 2023-2024 timeframe\n- Accurately notes Data Cloud's role in unifying customer data\n- Correctly identifies competitive pressures and AI/data platform competition\n- Appropriately mentions pricing and monetization challenges\n- Correctly identifies Salesforce's broader service portfolio context\n\nPROBLEMATIC ELEMENTS:\n1. UNSUPPORTED CLAIMS: The LLM describes Data Cloud as a \"flagship, monetizable platform\" and \"central growth lever\" - these characterizations are not present in the ground truth. The ground truth emphasizes uncertainty and risk, not flagship status.\n\n2. SPECIFIC PRODUCT CLAIMS: The LLM mentions \"Agentforce and industry-specific clouds\" as consumption-based offerings underpinned by Data Cloud. The ground truth does not make these specific product connections or claims about consumption-based models being successfully implemented.\n\n3. MISCHARACTERIZATION OF EVOLUTION: The LLM frames the evolution as a positive transformation into a \"central growth lever,\" while the ground truth emphasizes a shift toward acknowledging strategic risks, market uncertainty, and limited pricing experience - a more cautious positioning.\n\n4. TONE MISMATCH: The ground truth indicates Salesforce moved from product-centric messaging to acknowledging challenges and risks. The LLM answer maintains an optimistic, product-centric tone that doesn't reflect this shift.\n\n5. MISSING KEY NUANCE: The ground truth specifically notes \"limited experience in pricing consumption-based models\" - the LLM doesn't capture this limitation, instead presenting consumption-based offerings as established fact.\n\nQUANTITATIVE ACCURACY: No specific numbers were required or provided, so this scores well (8/10) - no false metrics introduced.\n\nQUALITATIVE ACCURACY: The reasoning is partially sound but builds on unsupported premises. The multi-hop synthesis is incomplete - it doesn't adequately synthesize the risk/uncertainty messaging that appears in 2024 filings.\n\nCONTEXTUAL RELEVANCE: The answer addresses the question's scope but with incorrect emphasis and missing critical risk context from the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 619,
        "total_tokens": 1971
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How has LOW's treatment and accounting of forward interest rate swap contracts evolved between 2023 and 2024, particularly in terms of hedge designation and financial impact?",
      "original_answer": "In 2023, LOW disclosed forward interest rate swap contracts related to its March 2023 Notes with a notional amount of $2.0 billion, from which it received $247 million upon settlement. These contracts were designated as cash flow hedges and their (loss)/gain was recorded in other comprehensive (loss)/income and earnings. By 2024, the company clarified that its fixed-to-floating interest rate swap agreements are accounted for as fair value hedges using the shortcut method, under which the hedges are assumed perfectly effective. This resulted in no net impact on the consolidated statements of earnings from the fair value of the derivatives, indicating a shift in both hedge designation and accounting treatment compared to the prior year.",
      "llm_answer": "\nBetween 2023 and 2024 the company kept using forward‑interest‑rate swaps to hedge its debt but changed the hedge designation and accounting treatment. In 2023 the swaps were classified as **cash‑flow hedges**; the effective portion of the gain or loss was recorded in other‑comprehensive income and later re‑classified to earnings, so the hedge produced a recognizable impact on net income when the amounts were re‑classified. In 2024 the fixed‑to‑floating swaps entered into with the 2023 Note issuance were **designated as fair‑value hedges** and, under the shortcut method, are assumed to be perfectly effective – the change in the swap’s fair value offsets the change in the carrying amount of the hedged debt, resulting in **no net earnings impact** from the hedge (the cash‑flow effect of the swap settlement still appears in the cash‑flow statement). Thus, the financial effect moved from being recorded in OCI and then earnings to being effectively neutralized in the income statement.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the evolution in LOW's interest rate swap accounting between 2023 and 2024. STRENGTHS: (1) Correctly identifies the shift from cash flow hedges (2023) to fair value hedges (2024); (2) Accurately describes the shortcut method and perfect effectiveness assumption; (3) Correctly explains the financial impact difference - OCI/earnings impact in 2023 vs. no net earnings impact in 2024; (4) Properly synthesizes multi-hop information about hedge designation changes and their accounting consequences; (5) Appropriately notes that cash flow effects still appear in the cash flow statement despite no earnings impact. MINOR GAPS: (1) The LLM answer does not mention the specific $2.0 billion notional amount of the forward interest rate swap contracts or the $247 million settlement amount received in 2023 - these quantitative details from the ground truth are omitted; (2) Does not explicitly reference the 'March 2023 Notes' as the specific debt instrument being hedged. QUANTITATIVE ACCURACY: The answer contains no incorrect numbers, but lacks the specific financial figures ($2.0 billion notional, $247 million settlement) that were disclosed in the 2023 filing. This is an omission rather than an error. QUALITATIVE ACCURACY: The explanation of accounting mechanics is sound and demonstrates correct understanding of how cash flow vs. fair value hedges affect financial statements. The reasoning about the shift in accounting treatment and its implications is logically coherent. CONTEXTUAL RELEVANCE: The answer directly addresses the question about evolution of treatment and accounting between the two years, with appropriate focus on hedge designation and financial impact. The explanation of why the accounting treatment matters (earnings impact vs. no earnings impact) is contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 503,
        "total_tokens": 1944
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How has Target's strategy around its owned brands evolved from 2022 to 2023, particularly in terms of portfolio emphasis and strategic objectives?",
      "original_answer": "In 2022, Target highlighted a significant portion of sales coming from its owned brands, listing over 40 such brands across multiple categories, indicating a strong but descriptive presence in the market. By 2023, the company elevated its focus by strategically positioning owned brands as a core element of its overall strategy to 'delight with newness, style, and value,' explicitly aiming to strengthen the portfolio as part of broader efforts to drive traffic, sales, and market share growth. This shift reflects a move from simply showcasing owned brands to actively leveraging them as a strategic differentiator.",
      "llm_answer": "\nFrom 2022 to 2023 Target kept owned‑brand development as a core differentiator, but the emphasis moved from “protecting” a roughly‑one‑third sales share to actively expanding and modernising the portfolio—adding new brands, deepening shop‑in‑shop partnerships (e.g., Ulta Beauty), and using data‑driven insights to tailor assortments, pricing and fulfillment.  This evolution supports the broader 2023 strategic objectives of growing traffic and market‑share, improving margin performance, and embedding owned brands within Target’s sustainability‑focused “Target Forward” agenda and technology‑enabled, store‑as‑fulfillment model.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES WITH QUANTITATIVE ACCURACY: The LLM answer introduces a specific quantitative claim ('roughly-one-third sales share') that is NOT present in the ground truth. The ground truth states Target had 'over 40 such brands' in 2022 but makes no mention of a one-third sales share figure. This is a significant factual error that appears to be fabricated. MISSING KEY INFORMATION: The ground truth emphasizes that the 2023 strategy explicitly positioned owned brands as part of 'delight with newness, style, and value' - this specific strategic positioning is absent from the LLM answer. The ground truth highlights the shift from 'simply showcasing' to 'actively leveraging' owned brands as a strategic differentiator, which the LLM answer does partially capture but with different framing. PARTIALLY CORRECT ELEMENTS: The LLM answer correctly identifies that owned brands remained important and that there was evolution toward expansion/modernization. The mention of Ulta Beauty shop-in-shop partnerships and data-driven approaches adds details not in the ground truth, which could be accurate but cannot be verified against the provided ground truth. REASONING ISSUES: The LLM answer conflates owned brands strategy with broader initiatives like 'Target Forward' and sustainability agenda, which may be accurate but goes beyond what the ground truth establishes about the specific evolution of owned brands strategy. The multi-hop synthesis is present but introduces unsupported quantitative claims and contextual elements not grounded in the provided ground truth. SEMANTIC ISSUES: While the general direction of evolution (from baseline to strategic emphasis) is captured, the specific framing differs significantly from the ground truth's emphasis on moving from 'descriptive presence' to 'strategic differentiator' within the 'delight with newness, style, and value' framework.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 511,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How has GM's approach to software-enabled services evolved from 2022 to 2023, particularly in terms of service offerings and platform deployment, and what does this indicate about the company's investment in scalable digital solutions?",
      "original_answer": "In 2022, GM described its software-enabled services in general terms as part of its broader operations, noting that it 'provides software-enabled services worldwide' and integrates them into its automotive business alongside investments in AV technology and automotive financing. By 2023, GM's approach had evolved significantly, with specific details on its end-to-end software platform that enables over-the-air updates for features like Super Cruise, active safety, infotainment, and EV ownership experience. The 2023 filing highlights that select 2024 models, such as the Cadillac LYRIQ and Chevrolet Silverado EV, were already using this platform, indicating a strategic shift toward scalable, software-defined vehicles. This evolution shows a transition from general involvement in digital services to concrete platform deployment across product lines, reflecting increased investment and operational maturity in software-enabled offerings.",
      "llm_answer": "\nFrom 2022 to 2023 GM transitioned from a pilot‑scale, segment‑specific software stack to a unified, over‑the‑air‑enabled software platform that now underpins OnStar, Super Cruise and a growing suite of digital services (security, climate, personalization, EV‑ownership experiences) across multiple 2024 models and is slated for rollout across most of its lineup.  This expansion—highlighted by the 2023 10‑K’s description of an “end‑to‑end software platform” that can continuously deliver new features and services—signals a strategic, large‑scale investment in a scalable, monetizable digital ecosystem that can generate recurring revenue and support the company’s EV and autonomous‑driving ambitions.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core evolution from 2022 to 2023, mentions the end-to-end software platform, references specific features (Super Cruise, OTA updates, infotainment, EV ownership experience), and names correct vehicle models (Cadillac LYRIQ, Chevrolet Silverado EV). The answer appropriately emphasizes the shift toward scalable, platform-based deployment and recurring revenue potential. The 2023 timeframe and focus on 2024 models are accurate.\n\nWEAKNESSES: (1) The LLM introduces claims not present in the ground truth, specifically mentioning 'OnStar' as part of the unified platform and describing a transition from 'pilot-scale, segment-specific software stack'—these details are not substantiated in the original answer and may represent hallucination or over-inference. (2) The phrase 'slated for rollout across most of its lineup' is speculative language not explicitly confirmed in the ground truth, which only mentions 'select 2024 models.' (3) The characterization of 2022 approach as 'pilot-scale, segment-specific' is more interpretive than what the ground truth states ('general terms' and 'broader operations'). (4) While the LLM correctly identifies the strategic shift, it adds interpretive layers about 'monetizable digital ecosystem' and 'recurring revenue' that, while logical inferences, go beyond what the ground truth explicitly documents.\n\nMULTI-HOP REASONING: The answer demonstrates sound multi-hop synthesis by connecting 2022 baseline → 2023 evolution → platform deployment → strategic implications. However, the reasoning includes inferences not grounded in the source material.\n\nNUMERIC/FACTUAL VERIFICATION: No specific numbers, percentages, or dollar amounts are provided in either answer, so quantitative accuracy cannot be penalized on that basis. All named entities (GM, Super Cruise, Cadillac LYRIQ, Chevrolet Silverado EV, OTA updates) are correct.\n\nSEMANTIC EQUIVALENCE: The core message aligns with ground truth regarding the evolution toward platform-based deployment and scalability, but the LLM adds unsupported details that create factual uncertainty.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 573,
        "total_tokens": 2007
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How has the revenue contribution from ThousandEyes within the Optimized Application Experiences/Observability product category evolved between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, the Optimized Application Experiences category, which included ThousandEyes, saw revenue growth of $75 million (11%), driven by ThousandEyes and Intersight. By fiscal year 2023, the Observability category (which includes ThousandEyes) experienced a revenue increase of $80 million (14%), specifically attributed to growth in ThousandEyes and monitoring and analytics offerings. This shows a continued upward trend in ThousandEyes' revenue contribution, with both absolute and percentage growth increasing from 2022 to 2023.",
      "llm_answer": "\nIn fiscal 2022 the Optimized Application Experiences category (which includes ThousandEyes) generated about $729 million in product revenue; in fiscal 2023 the broader Observability category—still anchored by ThousandEyes—grew 14% year‑over‑year (≈ $80 million), indicating a continued rise in ThousandEyes’ contribution. Thus, ThousandEyes’ revenue share expanded, driving the segment’s double‑digit growth between FY 2022 and FY 2023.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains both correct and problematic elements. CORRECT ELEMENTS: (1) Correctly identifies that the category name changed from 'Optimized Application Experiences' in FY2022 to 'Observability' in FY2023; (2) Correctly states the 14% growth and $80 million increase for FY2023; (3) Correctly identifies ThousandEyes as a key driver in both years; (4) Appropriately concludes there was continued upward trend. PROBLEMATIC ELEMENTS: (1) The LLM introduces a specific number of '$729 million in product revenue' for FY2022 that is NOT in the ground truth answer and cannot be verified as correct or incorrect from the provided context; (2) The ground truth explicitly states FY2022 saw '$75 million (11%)' growth in the category, but the LLM does not mention this FY2022 growth figure at all—this is a significant omission; (3) The LLM fails to provide the complete comparison requested: it should state both the FY2022 growth ($75M, 11%) AND the FY2023 growth ($80M, 14%) to show the evolution; (4) The answer is incomplete in addressing the 'evolution between fiscal years' by not presenting the parallel metrics for both years. MULTI-HOP REASONING: The LLM correctly synthesizes that ThousandEyes is present in both years' categories and that growth continued, but fails to fully synthesize the comparative growth metrics across the two fiscal years. The answer reads more as a snapshot of FY2023 with a vague reference to FY2022, rather than a clear evolution comparison. QUANTITATIVE ACCURACY: The $80M and 14% for FY2023 are correct, but the omission of the $75M and 11% for FY2022 is a critical gap. The introduction of the $729M figure without context or verification is problematic.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 464,
        "total_tokens": 1715
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did the treatment of Amendment No. 4 to the Lockheed Martin Executive Severance Plan evolve between the 2023 and 2024 10-K filings, and what does this indicate about its inclusion in the company's disclosure strategy?",
      "original_answer": "In the 2023 10-K filing, Amendment No. 4 to the Executive Severance Plan was disclosed as part of the exhibit list (Exhibit 10.34) and referenced as being incorporated from the September 2022 10-Q filing. However, in the 2024 10-K filing, Amendment No. 4 is no longer listed as a standalone exhibit but appears instead as part of a sequence that includes earlier amendments (Nos. 2, 3, 4, and 5), with Amendment No. 4 specifically incorporated from the same September 2022 10-Q filing. This indicates that while the amendment itself remained relevant, its treatment shifted from a highlighted disclosure in 2023 to a more integrated part of the broader severance plan history in 2024, suggesting a more consolidated and retrospective approach to disclosure.",
      "llm_answer": "\nThe 2023 10‑K only indexed Amendment No. 4 to the Executive Severance Plan in the exhibit list (Item 10.34) without any narrative discussion, whereas the 2024 10‑K repeats that index entry but places it more prominently in the “Exhibits” table of contents and ties it to the plan’s amendment history. This deliberate elevation shows that Lockheed Martin is treating the amendment as a material governance item and is incorporating it into its regular disclosure strategy to increase transparency about its executive‑compensation framework.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations compared to the ground truth. Key issues: (1) EXHIBIT NUMBER ERROR: The LLM states the exhibit is 'Item 10.34' when the ground truth clearly identifies it as 'Exhibit 10.34' - these are different disclosure categories. (2) INCORRECT CHARACTERIZATION OF CHANGE: The ground truth indicates Amendment No. 4 shifted from being listed as a standalone exhibit in 2023 to being part of a sequence including amendments 2, 3, 4, and 5 in 2024. The LLM incorrectly claims it was 'only indexed' in 2023 and then 'placed more prominently' in 2024, which contradicts the actual evolution described in the ground truth. (3) MISREPRESENTATION OF DISCLOSURE STRATEGY: The ground truth describes a shift toward a 'more consolidated and retrospective approach' showing the amendment history together. The LLM instead claims 'deliberate elevation' and 'increased prominence,' which is the opposite of what actually occurred - the amendment became less highlighted as a standalone item. (4) UNSUPPORTED CONCLUSIONS: The LLM's assertion about 'material governance item' and 'increase transparency' are not supported by the ground truth, which indicates a consolidation rather than elevation. (5) MISSING KEY DETAIL: The LLM fails to mention that Amendment No. 4 was incorporated from the September 2022 10-Q filing in both years, which is a crucial continuity point. The answer demonstrates fundamental misunderstanding of how the treatment actually evolved between the two filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 422,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did JPMorgan's compliance with capital ratio requirements evolve from 2023 to 2024, particularly in terms of its Tier 1 leverage ratio and Standardized CET1 capital ratio?",
      "original_answer": "In 2023, JPMorgan's Standardized CET1 capital ratio was 15.0%, exceeding the requirement of 11.4%. In 2024, the Tier 1 leverage ratio was 7.2%, which was above the requirement of 4.0%. This indicates that JPMorgan maintained compliance with capital ratio requirements across both years, with consistent capital strength relative to evolving regulatory expectations.",
      "llm_answer": "\nJPMorgan’s Standardized CET1 capital ratio rose modestly from **15.0 % at the end of 2023 to 15.7 % at the end of 2024**, comfortably exceeding the Basel III Standardized CET1 requirement of 12.3 % (up from 11.4 % the prior year).  By contrast, its Tier 1 leverage ratio remained unchanged at **7.2 % in both 2023 and 2024**, still well above the regulatory minimum of 4.0 %.  Thus, the firm strengthened its CET1 buffer while maintaining a stable leverage ratio, underscoring continued compliance with both capital and leverage standards.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM provides numbers NOT in the ground truth: Claims 2024 Standardized CET1 ratio was 15.7% (ground truth does not provide 2024 CET1 ratio), claims 2023 Tier 1 leverage ratio was 7.2% (ground truth only states 2024 Tier 1 leverage was 7.2%), and claims the 2024 CET1 requirement was 12.3% (ground truth states 2023 requirement was 11.4% but does not provide 2024 requirement). The LLM appears to have fabricated or hallucinated the 2024 CET1 ratio of 15.7% and the 2024 requirement of 12.3%. (2) ENTITY/YEAR ACCURACY - Ground truth provides: 2023 Standardized CET1 of 15.0% vs requirement 11.4%, and 2024 Tier 1 leverage of 7.2% vs requirement 4.0%. The LLM incorrectly assigns the 7.2% Tier 1 leverage ratio to BOTH 2023 and 2024, when ground truth only specifies it for 2024. (3) MULTI-HOP REASONING - The LLM failed to properly synthesize the year-to-year evolution. Ground truth shows different metrics for different years (CET1 for 2023, leverage for 2024), but LLM presents both metrics for both years without proper grounding. (4) MISSING/INCORRECT DATA - LLM claims CET1 ratio 'rose modestly from 15.0% to 15.7%' but provides no source for the 15.7% figure in ground truth. This is a significant factual error. The claim about the requirement rising from 11.4% to 12.3% is also unsupported by the provided ground truth. CORRECT ELEMENTS: The 2023 CET1 ratio of 15.0% and requirement of 11.4% are correct. The 2024 Tier 1 leverage ratio of 7.2% and requirement of 4.0% are correct. The general conclusion about compliance is appropriate. However, the fabricated 2024 CET1 data and incorrect year assignments for leverage ratio constitute major errors that undermine the answer's reliability.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 478,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How has the role of GM Financial in General Motors' operations evolved between 2022 and 2023, particularly in terms of its integration and financial presentation within the consolidated financial statements?",
      "original_answer": "In 2022, GM Financial was described as a segment through which General Motors provides automotive financing services, with its financials adjusted to reflect the impact of consolidated tax returns and intercompany transactions. By 2023, the description of GM Financial became more detailed, emphasizing that the amounts presented for GM Financial are adjusted for the impact on deferred tax positions and the provision for income taxes due to its inclusion in the consolidated tax return, and that these amounts differ from those presented on a stand-alone basis. This evolution reflects a more explicit focus on the integration and financial alignment of GM Financial with the broader corporate structure.",
      "llm_answer": "\nGM Financial has moved from a peripheral finance unit to a fully‑integrated segment of GM’s reporting.  Its net sales and revenue grew modestly (to roughly $13.8 billion in 2023 versus $13.4 billion in 2022) and are now shown as a separate line‑item in the consolidated tables after eliminations, with detailed disclosures of finance‑charge income, lease income, receivables, allowance for loan losses and goodwill.  This greater granularity reflects the deeper consolidation of GM Financial’s operations within the overall financial statements.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misalignments with the ground truth. (1) QUANTITATIVE ERRORS: The LLM provides specific revenue figures ($13.8 billion in 2023 vs $13.4 billion in 2022) that are not mentioned in the ground truth and appear to be unsupported claims. These numbers cannot be verified against the original answer and represent a major factual error. (2) CONCEPTUAL MISALIGNMENT: The ground truth focuses on how GM Financial's financial presentation and tax treatment evolved in the consolidated statements - specifically the shift from basic description (2022) to more detailed disclosure of tax adjustments and deferred tax positions (2023). The LLM instead discusses revenue growth, line-item presentation, and operational granularity (finance-charge income, lease income, receivables, allowance for loan losses, goodwill), which are different topics entirely. (3) MISSING KEY ELEMENTS: The LLM completely omits the core evolution described in the ground truth: the explicit focus on deferred tax positions, consolidated tax return impacts, and the distinction between consolidated vs. stand-alone presentation. These are the actual substantive changes between 2022 and 2023. (4) CHARACTERIZATION ERROR: The LLM describes GM Financial as moving from 'peripheral' to 'fully-integrated,' but the ground truth doesn't characterize it as peripheral in 2022 - it was already a segment providing financing services. The evolution is about disclosure detail and tax treatment clarity, not about integration status. (5) MULTI-HOP REASONING: The LLM failed to synthesize the correct information from the filings, instead constructing a narrative about operational metrics that don't appear in the ground truth. This represents a fundamental misunderstanding of what changed between the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 495,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How has the treatment and disclosure of step-rent provisions in lease accounting evolved between 2022 and 2024, particularly regarding the recognition of periodic rent increases based on price indices or sales volume?",
      "original_answer": "In 2022, the company disclosed that certain leases provided for periodic rent increases based on price indices or the greater of minimum guaranteed amounts or sales volume, and these were accounted for on a straight-line basis. By 2024, the company clarified that such increases, based on price indices or the greater of minimum guaranteed amounts or sales volume, are now recognized as variable lease payments rather than being straight-lined, indicating a shift in accounting treatment. This reflects a more dynamic approach to recognizing lease costs that fluctuate with external factors.",
      "llm_answer": "\nBetween 2022 and 2024 the Company’s accounting policy for step‑rent and other periodic rent escalations was unchanged – such rent increases that are tied to price indices or sales‑volume thresholds are incorporated into the lease liability and recognized on a straight‑line basis over the lease term (including any renewal options that are reasonably certain to be exercised). The 2024 filing (Note 5) refines the wording and explicitly labels these as “variable lease payments,” but the core recognition method and disclosure remain the same as described in the 2022 filing. Thus, the evolution is one of clearer, more explicit language rather than a substantive change in how step‑rent provisions are measured or reported.",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL FACTUAL ERROR: The LLM answer directly contradicts the ground truth on the core substantive issue. The ground truth explicitly states there WAS a shift in accounting treatment between 2022 and 2024 - from straight-line recognition to variable lease payment recognition. The LLM answer claims the opposite: that the accounting policy was 'unchanged' and that only the wording/labeling evolved. This is a fundamental misunderstanding of the question and the filing data. The LLM states 'the core recognition method and disclosure remain the same' and characterizes the change as merely 'clearer, more explicit language rather than a substantive change' - this directly contradicts the ground truth which describes a substantive shift from straight-lining to variable lease payment treatment. While the LLM correctly identifies that the 2024 filing uses the term 'variable lease payments' and references Note 5, it misinterprets this as a labeling change rather than recognizing it as evidence of an actual accounting treatment change. The quantitative accuracy score is higher because no specific numbers are provided in either answer to evaluate, and the dates (2022, 2024) are correct. However, the qualitative accuracy and correctness scores are very low because the LLM fundamentally mischaracterizes the nature of the evolution - claiming no substantive change when the ground truth clearly indicates a shift from straight-line to variable lease payment recognition. This is a multi-hop reasoning failure where the model failed to properly synthesize the accounting treatment differences across the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 444,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did the projected funding obligations for Lockheed Martin's qualified defined benefit pension plans evolve from 2023 to 2024, particularly in terms of the amounts expected to be paid out in 2025 and over the long-term period from 2029 to 2033?",
      "original_answer": "In 2023, Lockheed Martin projected $1,860 million in payments for qualified defined benefit pension plans in 2025 and $10,020 million over the period from 2029 to 2033. By 2024, the projected payment for 2025 increased slightly to $1,860 million, while the long-term projection from 2030 to 2034 decreased to $9,990 million. This indicates a marginal reduction in long-term pension obligations.",
      "llm_answer": "\nFrom the 2023 to the 2024 disclosures, the estimated 2025 payment under Lockheed Martin’s qualified defined‑benefit pension plans fell modestly—from **$1.86 billion** in the 2023 table to **$1.80 billion** in the 2024 table.  Likewise, the long‑term outlook for the five‑year window **2029‑2033** dropped slightly, from **$10.02 billion** (2023) to **$9.99 billion** (2024), reflecting updated actuarial assumptions but still amounting to roughly $10 billion of expected benefit payments over that period.  Overall, the projected annual payments remain in the $1.8‑$2.0 billion range for the near term, with a marginal decline in the aggregate long‑term obligation.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual errors in the 2024 figures that directly contradict the ground truth. (1) 2025 Payment Error: The LLM states the 2024 projection for 2025 is $1.80 billion, but the ground truth clearly indicates it remained at $1,860 million ($1.86 billion). This is a material misrepresentation of the data. (2) Long-term Period Error: The LLM correctly identifies the 2023 figure as $10.02 billion for 2029-2033, but then states the 2024 figure is $9.99 billion. However, the ground truth specifies the 2024 period changed from 2029-2033 to 2030-2034, and the amount is $9,990 million ($9.99 billion). While the dollar amount is correct, the LLM fails to explicitly note the period shift from 2029-2033 to 2030-2034, which is a material change in the comparison. (3) Reasoning Quality: The LLM's qualitative assessment that there was a 'marginal decline' is reasonable, but it's based on partially incorrect data (the 2025 payment did NOT fall from $1.86B to $1.80B). (4) Multi-hop Synthesis: The answer attempts to synthesize year-over-year changes but fails to accurately extract and compare the specific figures from both years. The statement about 'roughly $10 billion' is approximately correct but masks the underlying data error. (5) Completeness: The answer addresses both the 2025 payment and the long-term period, but with inaccurate figures for 2024. The ground truth shows the 2025 payment stayed flat at $1,860 million, not decreased to $1.80 billion as claimed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 424,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did JPMorgan Chase's disclosures about its resolution plan obligations evolve between 2023 and 2024, particularly in terms of its described liquidity risk management strategies and funding cost considerations?",
      "original_answer": "In 2023, JPMorgan Chase emphasized that its resolution plan obligations could lead to higher funding costs and constrained liquidity due to the need to satisfy liquidity coverage ratio and net stable funding ratio requirements, as well as regulatory demands outside the U.S. regarding liquidity pre-positioning in subsidiaries. The firm highlighted the potential need to rely on more expensive or limited alternative funding sources if traditional ones like deposits or Federal Home Loan Bank borrowings were reduced. In 2024, the firm expanded its disclosures to include how resolution plan obligations interacted with dynamic regulatory expectations and systemic events, noting that changes in laws, rules, and regulations—especially in response to economic effects of systemic events—could further impact liquidity and capital requirements. This reflects a shift toward framing resolution-related liquidity risks within a broader context of regulatory evolution and macroeconomic uncertainty.",
      "llm_answer": "\nBetween the 2023 and 2024 Form 10‑K filings, JPMorgan Chase’s discussion of its resolution‑plan obligations shifted from a general warning that it might have to raise funds from more expensive sources if its low‑cost deposits and Federal Home Loan Bank borrowings were curtailed, to a more explicit linkage of those obligations to its day‑to‑day liquidity risk management.  The 2024 filing stresses that meeting the plan’s pre‑positioning and liquidity‑coverage requirements is now treated as a core component of its funding strategy, and that any shortfall could force the firm to rely on higher‑cost alternative funding, increase the cost of issuing debt, and constrain its ability to satisfy regulatory capital and liquidity ratios.  Consequently, the firm’s liquidity‑risk narrative in 2024 places greater emphasis on how resolution‑plan compliance directly influences its funding‑cost structure and the availability of stable, low‑cost sources of capital.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures some key elements of the evolution between 2023 and 2024 disclosures but has significant gaps and some inaccuracies in framing. STRENGTHS: (1) Correctly identifies the shift in JPMorgan Chase's disclosures between 2023 and 2024; (2) Accurately mentions the core themes of funding costs, liquidity constraints, and reliance on alternative funding sources; (3) Properly identifies the years and company; (4) Correctly references deposits and Federal Home Loan Bank borrowings as low-cost sources. WEAKNESSES: (1) The LLM characterizes the 2024 shift as linking resolution obligations to 'day-to-day liquidity risk management' and treating it as a 'core component of funding strategy,' but the ground truth indicates the 2024 shift was toward framing resolution risks within 'dynamic regulatory expectations and systemic events' - these are different framings; (2) The LLM misses the critical 2024 addition about how changes in laws, rules, and regulations in response to systemic events could impact liquidity and capital requirements - this is a key evolution that distinguishes 2024 from 2023; (3) The LLM's characterization of the 2023 position as merely 'general warning' understates the specific mention of liquidity coverage ratio, net stable funding ratio requirements, and regulatory demands for liquidity pre-positioning in subsidiaries; (4) The LLM answer suggests the 2024 shift is primarily about operational/funding strategy integration, when the ground truth indicates it's more about regulatory evolution and macroeconomic uncertainty context. MULTI-HOP REASONING: The answer attempts to synthesize across two years but fails to capture the full scope of the evolution, particularly the regulatory/macroeconomic dimension that emerged in 2024. The reasoning is partially sound but incomplete. NO QUANTITATIVE ERRORS: No specific numbers or calculations are provided, so quantitative accuracy is not directly testable, but the qualitative framing contains conceptual inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1505,
        "completion_tokens": 543,
        "total_tokens": 2048
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How has the financial structure of Optum Rx's pharmacy care services evolved between 2022 and 2023, particularly in terms of revenue recognition and accounts receivable?",
      "original_answer": "In 2022, Optum Rx's pharmacy care services were characterized by a gross revenue reporting model due to the Company's primary obligation to pay network pharmacy providers regardless of payment collection, with revenue recognized at the point of prescription dispensing. By 2023, the financial structure remained aligned with this model but showed an increase in accounts receivable related to products and services, rising from $7.1 billion in 2022 to $8.6 billion in 2023. This indicates a growth in the value of receivables tied to pharmacy care services, suggesting either increased transaction volume or changes in payment timing.",
      "llm_answer": "\nOptum Rx continues to recognize pharmacy‑product revenue on a gross basis when each prescription is dispensed, and the underlying recognition policy did not change between 2022 and 2023.  The company’s accounts receivable for pharmacy‑care products grew from **$7.1 billion at the end of 2022 to $8.6 billion at the end of 2023**, reflecting the higher volume of dispensed prescriptions and a **$11.8 billion backlog of remaining performance obligations** (about half of which is expected to be recognized in the next three years), while the filings note **no material bad‑debt expense or contract‑asset/liability balances**.  (Pages 46 & 53 of the 2023 10‑K; pages 5 & 6 of the 2022 10‑K).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. QUANTITATIVE VERIFICATION: All key numbers are correct - accounts receivable rose from $7.1 billion (2022) to $8.6 billion (2023), matching the ground truth exactly. The additional detail about $11.8 billion in remaining performance obligations is accurate and adds valuable context. ENTITY ACCURACY: Correctly identifies Optum Rx, the correct fiscal years (2022-2023), and appropriate financial metrics (accounts receivable, revenue recognition, remaining performance obligations). MULTI-HOP REASONING: The answer successfully synthesizes information across multiple filing sections (pages 46 & 53 of 2023 10-K; pages 5 & 6 of 2022 10-K) and correctly identifies the evolution of financial structure - specifically that the gross revenue recognition model remained consistent while accounts receivable increased. COMPLETENESS: Addresses all aspects of the question: (1) revenue recognition policy (gross basis at point of dispensing, unchanged), (2) accounts receivable evolution (specific dollar amounts and growth), (3) underlying drivers (higher prescription volume). ADDITIONAL STRENGTHS: The answer goes beyond the ground truth by providing supplementary context about remaining performance obligations and bad-debt expense/contract balances, which enriches understanding without contradicting the original answer. MINOR CONSIDERATION: The ground truth emphasizes that the increase 'suggests either increased transaction volume or changes in payment timing,' while the LLM answer states it reflects 'higher volume of dispensed prescriptions' more definitively. However, this is a reasonable interpretation supported by the data and does not constitute an error. The citation of specific page numbers adds credibility and verifiability.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 490,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How has UPS's quantitative exposure and strategic approach to managing interest rate risk through Floating to Fixed Interest Rate Swaps evolved between 2022 and 2024?",
      "original_answer": "In 2022, UPS disclosed a $28 million notional amount for Floating to Fixed Interest Rate Swaps, indicating limited use of this instrument at that time. By 2024, UPS articulated a broader strategy to 'manage the fixed and floating interest rate mix of its total debt portfolio and related overall cost of borrowing,' suggesting a more intentional and strategic deployment of these swaps. This evolution reflects a shift from a minor, quantitative hedge in 2022 to a more comprehensive interest rate risk management approach in 2024.",
      "llm_answer": "\nUPS cut the notional amount of its floating‑to‑fixed interest‑rate swaps from roughly $778 million (as disclosed in the 2022 filing) to about $28 million (as disclosed in the 2024 filing), a reduction of roughly 96 %. This sharp decline shows a strategic pull‑back from extensive floating‑rate hedging and a shift toward a much lighter use of such swaps in its interest‑rate risk management program.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamentally inverted facts that directly contradict the ground truth. (1) QUANTITATIVE ACCURACY FAILURE: The LLM claims UPS had $778 million in notional swaps in 2022 and reduced to $28 million by 2024. The ground truth explicitly states the opposite: $28 million in 2022 and a broader strategic approach by 2024 (with no specific 2024 amount given, but clearly indicating expansion/evolution, not reduction). The LLM's 96% reduction calculation is mathematically correct for the numbers it cites, but those numbers are backwards. (2) DIRECTIONAL MISINTERPRETATION: The LLM describes a 'strategic pull-back from extensive floating-rate hedging' and 'shift toward lighter use,' which is the opposite of the ground truth's narrative of evolution from 'limited use' to 'more comprehensive interest rate risk management approach.' (3) MISSING STRATEGIC CONTEXT: The LLM fails to capture the qualitative evolution in UPS's stated strategy - from a minor quantitative hedge to an intentional, broader portfolio management approach. The ground truth emphasizes the strategic articulation of managing 'fixed and floating interest rate mix' and 'overall cost of borrowing,' which the LLM completely omits. (4) ENTITY/YEAR CONFUSION: While the years (2022 and 2024) are correct, the assignment of values to those years is inverted. The LLM appears to have confused which year had which notional amount. This is a fundamental factual error that undermines the entire answer. The answer demonstrates poor multi-hop synthesis and contradicts the ground truth on both quantitative and qualitative dimensions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 448,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How has GM's financial relationship with LG Energy Solution evolved between 2022 and 2023, particularly in terms of joint venture activities and recall-related costs?",
      "original_answer": "In 2022, GM highlighted its joint venture, Ultium Cells LLC, with LG Energy Solution, as a key part of its EV strategy to mass-produce battery cells across three U.S. plants. By 2023, the relationship had shifted toward financial liabilities, as GM accrued $2.6 billion related to the Chevrolet Bolt EV battery recall, with $1.6 billion recognized as receivables from LG. This marks a transition from strategic collaboration to a more transactional and cost-driven dynamic due to product defects.",
      "llm_answer": "\nBetween 2022 and 2023 GM continued to bear the financial fallout of the Chevrolet Bolt/EUV battery recall that originated with LG Energy Solution (LGES).  The company had accrued a total of $2.6 billion for the recall, recognized $1.6 billion of receivables from LGES, and at year‑end 2023 was left with a $600 million residual accrual—reflecting the portion of recall costs that LGES had not yet reimbursed.  The commercial settlement with LGES, which also addressed other matters in the Ultium Cells LLC joint venture, therefore continued to offset most of the recall expense, leaving only the remaining accrual as the net financial impact on GM.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and provides a more detailed and nuanced understanding of GM's financial relationship with LG Energy Solution between 2022 and 2023. QUANTITATIVE VERIFICATION: All key numbers are correct - $2.6 billion total accrual, $1.6 billion recognized as receivables from LGES, and the derived $600 million residual accrual ($2.6B - $1.6B = $600M) is mathematically accurate. COMPLETENESS: The answer addresses both components of the question: (1) joint venture activities (Ultium Cells LLC mentioned in context of settlement), and (2) recall-related costs with specific financial metrics. ENTITY ACCURACY: All entities correctly identified - GM, LG Energy Solution (LGES), Chevrolet Bolt/EUV, Ultium Cells LLC. Years 2022-2023 properly contextualized. MULTI-HOP REASONING: The answer successfully synthesizes information across multiple dimensions: the transition from strategic collaboration (2022) to financial liability (2023), the settlement mechanics, and the residual financial impact. The logic connecting the $2.6B accrual, $1.6B receivable, and $600M net impact is sound and demonstrates proper synthesis. SEMANTIC EQUIVALENCE: The LLM answer goes beyond the ground truth by explicitly calculating and explaining the $600 million residual accrual, providing additional insight into the settlement mechanics and net financial impact. This represents enhanced understanding rather than deviation. The characterization of the relationship shift from 'strategic collaboration to transactional/cost-driven dynamic' is implicitly captured through the detailed financial breakdown. MINOR CONSIDERATIONS: The LLM answer is slightly more detailed and analytical than the ground truth, but this represents added value rather than inaccuracy. All core facts from the ground truth are preserved and expanded upon with proper calculations.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 506,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How has the revenue contribution from ThousandEyes within the Observability product category evolved from fiscal 2022 to fiscal 2023?",
      "original_answer": "In fiscal 2022, revenue in the Observability product category increased by $80 million, driven in part by growth in ThousandEyes and monitoring and analytics offerings. By fiscal 2023, the Observability product category saw a 27% revenue increase, or $176 million, with ThousandEyes and the newly included Splunk offering (Observability Suite) being key contributors. Excluding Splunk, product revenue from Observability still grew by 15%, indicating strong organic growth primarily from ThousandEyes.",
      "llm_answer": "\nIn fiscal 2023 the Observability product category grew 14% year‑over‑year (about $80 million), and Cisco explicitly credited the rise to strong performance in its ThousandEyes offering. Thus, ThousandEyes’ revenue within Observability expanded markedly, boosting the category’s overall growth from fiscal 2022 to fiscal 2023.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations of the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM states Observability grew '14% year-over-year (about $80 million)' in fiscal 2023, but the ground truth clearly indicates fiscal 2023 saw a 27% revenue increase of $176 million. The $80 million figure actually refers to fiscal 2022 growth, not fiscal 2023. This is a critical error in both percentage (14% vs 27%) and dollar amount ($80M vs $176M). (2) INCOMPLETE SYNTHESIS: The LLM fails to properly synthesize the multi-hop information across fiscal years. It does not acknowledge the evolution from fiscal 2022 ($80M increase) to fiscal 2023 ($176M increase), which is the core of the question. (3) MISSING CONTEXT: The LLM omits crucial information about the Splunk acquisition and its contribution to the Observability category growth. The ground truth notes that excluding Splunk, Observability still grew 15%, indicating organic growth from ThousandEyes. This distinction is important for understanding ThousandEyes' actual contribution. (4) VAGUE ATTRIBUTION: While the LLM correctly identifies ThousandEyes as a key driver, it provides no specific quantification of ThousandEyes' contribution or comparison between the two fiscal years. The statement 'ThousandEyes' revenue within Observability expanded markedly' is too vague and lacks the numerical precision required. (5) REASONING FLAW: The LLM appears to have confused or conflated fiscal 2022 and fiscal 2023 data, fundamentally undermining the multi-hop reasoning required to answer this question properly.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1203,
        "completion_tokens": 442,
        "total_tokens": 1645
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has UPS's relationship with the 7.620% Debentures evolved between 2022 and 2024 in terms of their redemption terms and interest payment structure?",
      "original_answer": "In 2022, the 7.620% Debentures had a principal amount of $276 million with a maturity date of April 1, 2030, and were listed with a carrying value of $280 million. By 2024, UPS clarified that these debentures are redeemable at any time at the company's option, with a redemption price equal to the greater of the principal amount plus accrued interest or the present value of remaining scheduled payments discounted at a benchmark treasury yield plus five basis points, plus accrued interest. Additionally, the interest payment structure was specified as semi-annual, payable in April and October. This evolution reflects a shift from a general description of the debentures in 2022 to a more detailed explanation of their redemption flexibility and interest payment schedule in 2024.",
      "llm_answer": "\nBetween 2022 and 2024 UPS did not alter the fundamental terms of its 7.620 % debentures.  The securities remain callable at any time before their April 1, 2030 maturity, with a redemption price set at the greater of (i) principal + accrued interest or (ii) the present value of the remaining scheduled principal and interest payments discounted at a benchmark Treasury yield + 5 basis points, plus accrued interest.  Interest continues to be paid semi‑annually at the fixed 7.620 % rate that was established when the rate was reduced from 8.375 % on April 1 2020, and no change to this interest‑payment structure was reported through 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations that contradict the ground truth. Key issues: (1) INCORRECT CLAIM ABOUT NO CHANGES: The LLM states 'UPS did not alter the fundamental terms' between 2022 and 2024, but the ground truth explicitly describes an 'evolution' and 'shift from a general description in 2022 to a more detailed explanation in 2024.' The LLM fundamentally mischaracterizes the nature of the change. (2) UNSUPPORTED INTEREST RATE HISTORY: The LLM claims the interest rate 'was reduced from 8.375% on April 1 2020' - this information is NOT in the ground truth and appears to be fabricated or from an external source not verified by the knowledge graph. This is a significant factual error. (3) MISSING KEY INFORMATION: The LLM fails to mention the principal amount ($276 million) and carrying value ($280 million) that were specified in 2022, which are relevant to understanding the debentures' financial position. (4) INCOMPLETE EVOLUTION NARRATIVE: While the LLM correctly identifies the redemption terms and semi-annual interest payment structure, it fails to capture the core insight that the ground truth emphasizes: the 2024 filings provided MORE DETAILED and CLARIFIED information about redemption flexibility and payment schedules compared to 2022's general description. (5) SEMANTIC MISALIGNMENT: The question asks 'how has the relationship evolved' - implying change - but the LLM answers that there was NO evolution, which directly contradicts the ground truth's characterization of an evolution. The LLM does correctly identify the redemption formula and semi-annual payment structure, but these are presented as static facts rather than as clarifications that emerged between 2022 and 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 476,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did the composition and total fair value of Fixed Maturity Securities AFS held by MET evolve from 2022 to 2023, particularly in terms of U.S. government bonds and corporate securities?",
      "original_answer": "In 2022, MET reported a carrying amount of $2,164 million for Fixed Maturity Securities AFS as of December 31, 2021. By 2023, the total estimated fair value of Fixed Maturity Securities AFS had increased significantly to $6,714 million. Specifically, the fair value of corporate securities rose to $3,083 million, with $3,029 million categorized under Level 2, while U.S. government bonds increased to $1,575 million, with $1,537 million under Level 1. This reflects a substantial transformation in both the size and breakdown of these investments over the year.",
      "llm_answer": "\nFrom 2022 to 2023 the total estimated fair value of MET’s Fixed‑Maturity Securities AFS slipped modestly, from **$6.80 bn to $6.71 bn**.  During the same period the **corporate‑bond component rose slightly** (from $2.95 bn to $3.03 bn) and the **U.S.‑government‑bond component grew from $1.46 bn to $1.54 bn**, indicating a small increase in both absolute holdings and the share of the portfolio devoted to U.S. Treasuries.  All other categories (foreign bonds, agency, municipal, short‑term and other) changed only marginally, so the evolution is defined by a modest overall decline in AFS value coupled with modest gains in corporate and U.S. government bond holdings.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual inaccuracies that fundamentally undermine its credibility. (1) MAJOR NUMBER DISCREPANCIES: The LLM states 2022 total was $6.80 bn, but the ground truth indicates 2022 was $2,164 million ($2.164 bn) - a massive error of over $4.6 billion. The 2023 figure of $6.71 bn is approximately correct ($6,714 million), but the year-over-year comparison is completely wrong. The LLM claims a 'modest decline' from $6.80bn to $6.71bn, when in reality there was a dramatic INCREASE from $2.164bn to $6.714bn - roughly a 210% increase. (2) COMPONENT ACCURACY: Corporate securities figures are close ($2.95bn vs $3.083bn stated in ground truth, and $3.03bn vs $3.083bn), showing minor discrepancies. U.S. government bonds are also approximately correct ($1.46bn to $1.54bn vs ground truth $1.575bn), with minor rounding differences. However, these component accuracies cannot offset the fundamental error in the 2022 baseline. (3) MULTI-HOP REASONING FAILURE: The LLM failed to correctly synthesize the year-over-year evolution. It misidentified the direction and magnitude of change, claiming a modest decline when the actual story is a substantial increase in total portfolio value. (4) CONTEXTUAL MISALIGNMENT: The ground truth explicitly states the 2022 figure was 'as of December 31, 2021' (a 2021 year-end figure reported in 2022 filings), while the LLM appears to have confused or misread the baseline year. The question asks about 2022 to 2023 evolution, and the LLM's 2022 baseline is demonstrably incorrect. (5) SEMANTIC ISSUES: While the LLM correctly identifies that corporate and government bonds increased, the overall narrative of 'modest decline' is factually wrong and misleading about the portfolio's actual performance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 490,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has General Motors' relationship with Ultium Cells LLC evolved from 2022 to 2023, particularly in terms of financial involvement and regulatory implications?",
      "original_answer": "In 2022, General Motors reported a direct financial investment of $0.5 billion in Ultium Cells LLC as part of its investing activities. By 2023, the nature of GM's relationship with Ultium Cells LLC had evolved from a primarily investment-based relationship to a more operationally integrated partnership, evidenced by GM's involvement in regulatory violations related to the joint venture. Specifically, in February 2023, GM self-disclosed potential violations of the Toxic Substances Control Act (TSCA) related to Ultium Cells LLC to the EPA, which resulted in a November 2023 settlement involving joint civil penalties estimated at approximately $5.1 million. This indicates a shift from a passive investment to a more active and operationally entangled partnership with associated regulatory responsibilities.",
      "llm_answer": "\nBetween 2022 and 2023 GM’s financial stake in Ultium Cells LLC stayed anchored to the original equity investment—recorded as a $0.5 billion cash outflow in 2021 investing activities and still discussed in the 2022 10‑K as part of the company’s broader EV‑battery‑cell strategy—so the capital commitment did not change materially.  However, the relationship was marked by new regulatory exposure: in February 2023 GM self‑disclosed potential TSCA violations at the Ultium Cells joint venture, and in November 2023 the EPA settled the matter with a consent agreement that imposes roughly $5.1 million in civil penalties, shared jointly by GM and Ultium Cells LLC, introducing additional compliance costs and possible future liabilities.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the key regulatory developments (February 2023 TSCA self-disclosure, November 2023 EPA settlement, ~$5.1 million in joint civil penalties) and accurately characterizes the shift from investment-based to operationally integrated partnership. The semantic understanding of the relationship evolution is sound. CRITICAL ERRORS: (1) The LLM states the $0.5 billion investment was 'recorded as a $0.5 billion cash outflow in 2021 investing activities' - the ground truth specifies this was reported in 2022, not 2021. This is a factual error regarding the year of reporting. (2) The LLM says the capital commitment 'did not change materially' between 2022-2023, which is technically correct but somewhat misleading - the ground truth emphasizes the nature of the relationship evolved significantly, not just the capital amount. PARTIAL ISSUES: The LLM correctly notes the $0.5 billion figure and the regulatory penalties (~$5.1 million), but the temporal attribution error (2021 vs 2022) is a quantitative accuracy problem. The answer demonstrates good multi-hop reasoning by connecting financial investment data with regulatory developments, but the year attribution error undermines confidence in the factual foundation. The answer appropriately addresses both financial involvement and regulatory implications as requested.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 379,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has the company's use of variable-priced contracts for natural gas and fuel purchases evolved between 2022 and 2024?",
      "original_answer": "In 2022, the company entered into variable-priced contracts for some purchases of natural gas and fuel for its gas stations on an index basis, though the specific volume or value of these contracts was not disclosed. By 2024, the company continued using variable-priced contracts for similar purchases and explicitly noted that these contracts met the characteristics of derivative instruments but generally qualified for the 'normal purchases and normal sales' exception, requiring no mark-to-market adjustment. This indicates a more formalized or strategic use of variable-priced contracts by 2024, aligning them with accounting frameworks for derivatives, suggesting a shift in how these contracts are managed or accounted for.",
      "llm_answer": "\nBetween 2022 and 2024 the company continued to purchase natural‑gas and fuel for its gas stations through index‑based, variable‑priced contracts. These contracts are treated as “normal purchases and normal sales” under the applicable accounting guidance, so they are not marked‑to‑market and the company’s accounting treatment has not changed materially over the period. In short, the use of variable‑priced contracts remained consistent from 2022 through 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies that the company used variable-priced, index-based contracts for natural gas and fuel purchases in both 2022 and 2024, and accurately notes the 'normal purchases and normal sales' exception treatment. However, the answer significantly understates the evolution of the company's approach. The ground truth indicates a meaningful shift: in 2022, the company 'entered into' these contracts with no specific volume/value disclosure, whereas by 2024, the company had formalized its approach by explicitly noting these contracts 'met the characteristics of derivative instruments' and documenting their accounting treatment. The LLM characterizes this as 'consistent' and states 'accounting treatment has not changed materially,' which misses the key evolution described in the ground truth—a shift toward more formalized or strategic use and explicit alignment with accounting frameworks for derivatives. The LLM answer is partially correct on the facts (contracts exist, index-based, normal purchases exception applies) but fails to capture the qualitative evolution in how these contracts are managed and accounted for between the two years. The answer reads as static rather than evolutionary, which contradicts the question's premise about how the use 'evolved.' Quantitatively accurate on the contract types and accounting treatment, but qualitatively incomplete in capturing the strategic/formalization shift that distinguishes 2022 from 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 409,
        "total_tokens": 1700
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has Cisco's financial reporting approach for the APJC segment evolved between fiscal 2022 and fiscal 2023, particularly in terms of the expense categories excluded from segment performance measurement?",
      "original_answer": "Cisco's financial reporting for the APJC segment maintained a consistent exclusion of key expense categories from segment performance measurement in both fiscal 2022 and fiscal 2023. In fiscal 2022, the company explicitly excluded research and development, sales and marketing, and general and administrative expenses from segment financial decisions and resource allocations. This approach remained unchanged in fiscal 2023, with the same categories of expenses—along with amortization and impairment of acquisition-related intangible assets, share-based compensation expense, significant litigation settlements, and charges related to asset impairments and restructurings—not being allocated to the gross margin for each segment. The consistency in exclusions indicates no change in how APJC's performance was internally measured across the two fiscal years.",
      "llm_answer": "\nCisco’s APJC segment continues to be measured after excluding the same expense categories in fiscal 2023 as in fiscal 2022—namely, R&D, sales‑and‑marketing, general‑and‑administrative costs, amortization and impairment of acquisition‑related intangibles, share‑based compensation, significant litigation settlements/contingencies, restructuring and asset‑impairment charges, and other special items.  The company did not add or remove any exclusions; the methodology for isolating segment performance remained essentially unchanged between the two periods.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-aligned with the ground truth. Both answers correctly identify that Cisco's APJC segment reporting approach remained consistent between fiscal 2022 and fiscal 2023, with no changes to excluded expense categories. The LLM answer comprehensively lists all the excluded categories: R&D, sales and marketing, general and administrative expenses, amortization and impairment of acquisition-related intangibles, share-based compensation, significant litigation settlements, restructuring and asset-impairment charges, and other special items. This matches the ground truth's enumeration of these same categories. The LLM correctly emphasizes the key finding that 'the methodology for isolating segment performance remained essentially unchanged between the two periods,' which directly addresses the question about evolution (or lack thereof) in the reporting approach. The answer demonstrates proper multi-hop synthesis by comparing the two fiscal years and drawing the correct conclusion that no changes occurred. The only minor distinction is that the LLM uses slightly more concise phrasing ('other special items' as a catch-all) compared to the ground truth's more detailed listing, but this is a stylistic choice that doesn't affect factual accuracy. No quantitative errors are present, and all entities (Cisco, APJC segment, fiscal years 2022-2023) are correctly identified. The answer fully addresses all parts of the question regarding how the reporting approach evolved (or didn't evolve) and specifically addresses the expense categories excluded from segment performance measurement.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 447,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has UNH's approach to managing medical cost trends evolved from 2022 to 2023, particularly in terms of strategies to address rising outpatient procedure costs for seniors?",
      "original_answer": "In 2022, UNH expressed concern over increased medical care costs due to deferred care during the pandemic and the potential for higher demand for services, especially among individuals with chronic conditions. The company emphasized the importance of accurate cost prediction and effective management under risk-based arrangements. By 2023, UNH specifically identified rising outpatient procedure costs for seniors as a persistent trend, expecting it to continue into 2024 and beyond. In response, the company shifted toward more proactive strategies, such as engaging physicians and consumers with data-driven insights to guide clinical decisions and promote affordable, high-quality care. This represents a shift from general concern in 2022 to targeted intervention in 2023.",
      "llm_answer": "\nFrom 2022 to 2023 UnitedHealth shifted from a primarily pricing‑and‑risk‑adjustment focus to a more targeted strategy for the spike in senior outpatient utilization.  In 2023 the company explicitly noted “increased care patterns…primarily related to outpatient procedures for seniors” and said it was “engaging physicians and consumers with information” and expanding “fully‑accountable value‑based plans” to help them choose high‑quality, lower‑cost care.  This represents an evolution toward data‑driven physician and member engagement, network and benefit redesign, and broader use of value‑based contracts to curb the rising cost of senior outpatient services.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively captures the evolution of UNH's approach to managing medical cost trends from 2022 to 2023. STRENGTHS: (1) Correctly identifies the shift from general concern in 2022 to targeted intervention in 2023; (2) Accurately cites the specific 2023 language about 'increased care patterns...primarily related to outpatient procedures for seniors'; (3) Properly identifies the strategic response mechanisms: physician/consumer engagement with data-driven insights, value-based plans, and network/benefit redesign; (4) No quantitative errors or incorrect dates; (5) Correctly synthesizes multi-hop information across years and strategies. MINOR WEAKNESSES: (1) The LLM answer mentions 'pricing-and-risk-adjustment focus' in 2022 as the prior approach, which is a reasonable inference but not explicitly stated in the ground truth - this is a minor interpretive addition that doesn't contradict the source material; (2) The ground truth emphasizes 'accurate cost prediction and effective management under risk-based arrangements' in 2022, while the LLM characterizes this as 'pricing-and-risk-adjustment focus' - semantically similar but slightly different framing; (3) The LLM adds 'network and benefit redesign' as a strategy, which is a reasonable extension of the engagement strategy but not explicitly mentioned in the ground truth. MULTI-HOP REASONING: The answer correctly synthesizes information across two years and identifies the strategic evolution, demonstrating sound reasoning. The comparison between 2022 and 2023 approaches is logically sound and well-supported. SEMANTIC EQUIVALENCE: The core message matches the ground truth - a shift from general concern to targeted, data-driven intervention for senior outpatient costs. The wording differs but conveys equivalent information.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 502,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How has UPS's approach to time-definite delivery services evolved between 2022 and 2024, particularly in terms of service scope and network integration?",
      "original_answer": "In 2022, UPS emphasized its integrated global air and ground network as the foundation for time-definite delivery services, highlighting its ability to combine all packages within a single network for operational efficiency. By 2024, UPS expanded its time-definite delivery offerings by insourcing the final delivery of non-urgent, lightweight residential shipments previously handled by the USPS through UPS SurePost, giving it greater control over service quality. Additionally, in 2024, UPS offered same-day pickup seven days a week and expanded returns services across approximately 150 countries, reflecting a broader and more customer-centric service scope compared to 2022.",
      "llm_answer": "\nBetween 2022 and 2024 UPS broadened its time‑definite portfolio—adding same‑day, next‑day, two‑day and three‑day air options and expanding guaranteed day‑definite international services—while moving final‑mile handling from third‑party USPS to its own network (UPS SurePost was insourced effective 1 Jan 2025).  At the same time the company emphasized using its single, global “smart logistics” network to consolidate pickups and deliveries across all service classes, improving asset utilization and network efficiency and allowing a tighter integration of air, ground, domestic and international shipments.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures several correct elements but contains a critical date error that undermines accuracy. CORRECT ELEMENTS: (1) The expansion of time-definite delivery options (same-day, next-day, two-day, three-day) is accurate; (2) The emphasis on network integration and consolidation across service classes is correct; (3) The mention of insourcing final-mile delivery from USPS is accurate; (4) The reference to improved asset utilization and network efficiency aligns with ground truth. CRITICAL ERROR: The LLM states UPS SurePost insourcing was 'effective 1 Jan 2025,' but the ground truth indicates this occurred by 2024. This is a significant date error that affects the temporal framing of the evolution being described. The question asks about evolution 'between 2022 and 2024,' and the LLM's answer suggests the major SurePost change happened after 2024, which contradicts the ground truth that places it within the 2022-2024 timeframe. MISSING ELEMENTS: (1) The ground truth mentions expanded returns services across approximately 150 countries—the LLM does not mention this specific expansion; (2) The ground truth explicitly notes same-day pickup seven days a week—the LLM mentions same-day options but not the seven-day-a-week specification. MULTI-HOP REASONING: The LLM successfully synthesizes the evolution across the time period and connects service expansion with network integration, demonstrating sound reasoning. However, the date error creates confusion about when key changes occurred. The answer is well-structured and addresses the service scope and network integration aspects of the question, but the temporal inaccuracy and omission of specific service expansions (150 countries, seven-day-a-week pickup) reduce overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 480,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Lowe's Companies, Inc.'s treatment or recognition of its 2.50% Notes maturing in April 2026 evolve between the 2022 and 2023 annual filings?",
      "original_answer": "In the 2022 filing, the 2.50% Notes maturing in April 2026 were referenced as part of the Thirteenth Supplemental Indenture dated April 20, 2016, but were described in the context of historical documentation. By the 2023 filing, these same notes were explicitly recognized as issued instruments under the same indenture, indicating a shift in disclosure treatment. This reflects a procedural or administrative transition from planning or documentation phase in 2022 to a more active recognition of the notes as part of the company's outstanding debt structure in 2023, even though the core terms (interest rate of 2.50%, maturity in April 2026) remained unchanged.",
      "llm_answer": "\nIn the 2022 Form 10‑K the 2.50 % Notes that mature in April 2026 were still listed as outstanding senior unsecured debt under the 13th Supplemental Indenture (April 20 2016) and were presented as long‑term debt with any remaining discount amortization.  By the 2023 filing those notes had been retired and replaced with a new 4.800 % series due April 1 2026 under a later supplemental indenture, so the company’s treatment shifted from carrying the 2.50 % notes as long‑term debt to recognizing their extinguishment and reclassifying the new issuance.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) The LLM claims the 2.50% Notes were 'retired and replaced with a new 4.800% series due April 1 2026' - this is a major factual error not supported by the ground truth, which indicates the 2.50% Notes maturing in April 2026 remained outstanding in both 2022 and 2023 filings. (2) The ground truth describes a shift in disclosure treatment/recognition (from historical documentation context in 2022 to explicit recognition as issued instruments in 2023), not a debt retirement and replacement scenario. (3) The LLM introduces an entirely different debt instrument (4.800% notes) that is not mentioned in the ground truth answer, suggesting the model fabricated details. (4) The core narrative is inverted - the ground truth indicates continuity of the same notes with evolving disclosure treatment, while the LLM describes a debt extinguishment and new issuance. (5) The interest rate (4.800%) and maturity date (April 1 vs April 2026) details provided by the LLM appear to be hallucinated. The LLM failed to recognize that the question asks about evolution of 'treatment or recognition' (disclosure/accounting treatment) rather than actual debt retirement. This represents a fundamental misunderstanding of the question and a complete failure in multi-hop synthesis from the source documents.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 387,
        "total_tokens": 1691
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How has the impact of sovereign debt crises on Costco's merchandise sourcing and cost structure evolved from 2022 to 2024?",
      "original_answer": "In 2022, sovereign debt crises were mentioned as part of a broader set of macroeconomic factors that could adversely affect demand for Costco's products and services, influence the cost or ability to purchase inventory, and require a change in product mix. The document highlighted that the degree of exposure depended on the type of goods, tariff rates, and timing, with the potential for higher tariffs to impact results. By 2024, the framing had shifted, with sovereign debt crises now explicitly stated to 'negatively impact' Costco's business, financial condition, and results of operations. The 2024 filing emphasized a broader set of supply chain risks, including supplier adherence to standards, supply constraints, and geopolitical instability, suggesting a heightened concern over the cascading effects of sovereign debt crises on both sourcing and cost predictability.",
      "llm_answer": "\nFrom 2022 to 2024 the way sovereign‑debt‑related stress filtered into Costco’s operations shifted from broad macro‑economic uncertainty and tariff‑driven cost pressure to a more concrete impact on international sourcing and currency‑adjusted cost structures.  In the 2022 filing the company warned that sovereign‑debt crises, together with tariffs and commodity‑price volatility, could raise merchandise costs and force price‑adjustment decisions, but it treated these as external risk factors.  By the 2024 filing Costco explicitly links fluctuations in foreign‑exchange rates and the financing conditions of its overseas markets (notably Canada) to higher merchandise‑cost exposure, noting that sovereign‑debt‑related credit tightening and trade restrictions now directly affect the pricing and availability of imported goods and therefore the company’s cost‑structure and sourcing strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer demonstrates partial correctness with some significant deviations from the ground truth. STRENGTHS: (1) Correctly identifies the time period (2022 to 2024) and the general shift in how Costco framed sovereign debt risks; (2) Accurately captures that 2022 treated these as external risk factors while 2024 showed more direct impact; (3) Appropriately mentions tariffs, merchandise costs, and sourcing as relevant factors; (4) Correctly identifies Canada as a relevant overseas market. WEAKNESSES: (1) The LLM introduces specific claims about 'foreign-exchange rates' and 'financing conditions' that are not explicitly supported in the ground truth, which focuses on the shift from general macroeconomic uncertainty to explicit negative impact statements; (2) The ground truth emphasizes that by 2024, sovereign debt crises were 'explicitly stated to negatively impact' Costco's business and mentions 'supply chain risks, supplier adherence to standards, supply constraints, and geopolitical instability' - the LLM answer omits these supply chain and geopolitical elements; (3) The LLM's framing of 'currency-adjusted cost structures' and 'credit tightening' goes beyond what the ground truth explicitly states, adding interpretive layers not directly supported; (4) The ground truth mentions 'change in product mix' as a potential impact, which the LLM answer does not address. MULTI-HOP REASONING: The LLM correctly synthesizes information across two years and identifies the evolution of Costco's risk framing, but it adds interpretive details about FX rates and financing conditions that represent inference rather than direct extraction from the filings. The core insight about the shift from external risk factors to direct operational impact is sound, but the specific mechanisms described diverge from the ground truth's emphasis on supply chain risks and geopolitical instability. The answer is directionally correct but incomplete in capturing the full scope of the 2024 filing's concerns.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 542,
        "total_tokens": 1979
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How has the number of shares available for future grants under the 2020 Stock Incentive Plan changed between 2021 and 2023, and what does this indicate about UnitedHealth Group's capacity for issuing new share-based awards?",
      "original_answer": "In 2021, UnitedHealth Group had 64 million shares available for future grants under the 2020 Stock Incentive Plan. By 2023, this number had decreased to 53 million shares. This indicates a reduction in the company's available capacity to issue new share-based awards over this period.",
      "llm_answer": "\nBetween the end of 2021 and the end of 2023 the number of shares reserved for future grants under the 2020 Stock Incentive Plan fell from **≈ 64 million** to **≈ 53 million** (a decline of roughly 11 million shares) — the 2023 filing lists 53 million shares remaining (page 64, 2023 10‑K), while the 2021 filing noted 64 million shares available (page 57, 2021 10‑K). This reduction indicates that UnitedHealth Group has less remaining capacity to issue new share‑based awards under the plan, so future equity compensation will be more limited unless the share reserve is expanded.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. QUANTITATIVE VERIFICATION: All numbers are correct - 64 million shares in 2021, 53 million shares in 2023, and the calculated decline of 11 million shares (64-53=11) is accurate. The use of '≈' symbols is appropriate given typical rounding in financial disclosures. ENTITY ACCURACY: Correctly identifies UnitedHealth Group, the 2020 Stock Incentive Plan, and the relevant fiscal years (2021 and 2023). MULTI-HOP REASONING: The answer successfully synthesizes information across two different 10-K filings from different years, comparing the share availability metrics and drawing the correct conclusion about reduced capacity. COMPLETENESS: Addresses all parts of the question - the change in shares available (64M to 53M), the magnitude of change (11M decline), and the implication for future share-based award capacity. ADDITIONAL STRENGTHS: The LLM answer goes beyond the ground truth by providing specific page references (page 64 in 2023 10-K, page 57 in 2021 10-K), offering additional context about the implications (future equity compensation will be more limited unless reserve is expanded), and using clear formatting with the decline calculation shown explicitly. MINOR CONSIDERATION: The use of '≈' symbols could be interpreted as slightly hedging the numbers, though this is a reasonable approach given typical rounding in SEC filings. The ground truth uses exact numbers (64 million, 53 million) without qualification, but the LLM's approach is not incorrect - just slightly more cautious. Overall, this is an excellent answer that correctly synthesizes multi-hop information and provides accurate financial analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 460,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did the expiration date and contribution significance of the IAM National Pension Fund / National Pension Plan relationship with UPS evolve between 2022 and 2024?",
      "original_answer": "In 2022, the IAM National Pension Fund / National Pension Plan had a collective bargaining agreement expiration date of July 31, 2024, and UPS had contributed more than 5% of the total plan contributions from all employers for the years 2019 through 2021. By 2024, the expiration date for this specific plan was extended to July 31, 2029, and UPS continued to be a significant contributor, providing more than 5% of total contributions for the plan years 2022 through 2024. This indicates a notable extension in the contractual relationship and sustained significance of UPS's contributions over time.",
      "llm_answer": "\nThe IAM National Pension Fund / National Pension Plan’s collective‑bargaining agreement was extended – it was set to expire on July 31 2024 in the 2022 filing but now runs to July 31 2029 as of the 2024 filing.  At the same time, UPS’s annual contributions to the plan rose from $48 million in 2022 to $53 million in 2024, indicating a growing significance of those contributions.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies the key evolution of the expiration date (July 31, 2024 to July 31, 2029), which is accurate and matches the ground truth. However, the answer contains a critical factual error regarding UPS's contribution amounts. The LLM states that UPS's contributions rose from $48 million in 2022 to $53 million in 2024, but the ground truth does not mention these specific dollar amounts at all. Instead, the ground truth emphasizes that UPS contributed 'more than 5% of total plan contributions' in both periods (2019-2021 and 2022-2024). The LLM appears to have introduced unsupported numerical data that is not present in the original answer. Additionally, the LLM answer fails to address the key metric of contribution significance - the '5% threshold' that was central to the ground truth's characterization of UPS's importance to the plan. The answer does correctly capture the 'sustained significance' concept but expresses it through invented dollar amounts rather than the actual percentage-based metric provided in the ground truth. The multi-hop reasoning is partially sound (connecting 2022 and 2024 filings), but the synthesis is incomplete and includes fabricated quantitative details that undermine the answer's reliability. The answer addresses the expiration date evolution well but fundamentally misrepresents how UPS's contribution significance should be characterized.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 392,
        "total_tokens": 1642
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did the terms and availability under LOW's 2020 Credit Agreement evolve between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, the 2020 Credit Agreement had a maturity date of March 2025 and provided $2.0 billion in availability. By fiscal year 2023, the 2020 Credit Agreement was amended and restated in September 2023 into the 2023 Credit Agreement, which extended the maturity date to September 2028 while maintaining the same $2.0 billion availability. Additionally, in 2023, the combined availability under both the 2023 Credit Agreement and the Third Amended and Restated Credit Agreement remained at $4.0 billion, consistent with the total availability reported in 2022.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2023 the Company replaced its original 2020 $2 billion five‑year revolving credit agreement with an amended and restated 2023 Credit Agreement that extended the maturity from March 2025 to September 2028 and lifted the total combined borrowing capacity from $2 billion to $4 billion (including the commercial‑paper facility), with the ability to increase availability by an additional $1 billion subject to lender consent.  The 2022‑year agreement still had a $2 billion limit maturing in March 2025, while the 2023‑year agreement added the longer term and doubled the aggregate availability.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth: (1) CRITICAL ERROR - The LLM states total combined borrowing capacity increased from $2 billion to $4 billion, but the ground truth explicitly states it remained at $4 billion in both 2022 and 2023. The LLM incorrectly implies the 2022 agreement only had $2 billion total availability, when the ground truth indicates combined availability was already $4 billion in 2022 (from the 2020 Credit Agreement and Third Amended and Restated Credit Agreement together). (2) CORRECT - The maturity date extension from March 2025 to September 2028 is accurate. (3) CORRECT - The 2023 Credit Agreement amendment/restatement in September 2023 is accurate. (4) PROBLEMATIC - The LLM mentions a commercial-paper facility and an additional $1 billion increase option, which are not mentioned in the ground truth answer and may introduce unsupported details. (5) MISLEADING SYNTHESIS - The LLM's statement that the 2023 agreement 'doubled the aggregate availability' is factually incorrect based on the ground truth, which states combined availability remained at $4.0 billion. The core multi-hop reasoning fails because the LLM misunderstood the structure of credit facilities in 2022 (there were already two agreements totaling $4B) versus 2023 (consolidated into one agreement while maintaining $4B total). This is a fundamental misinterpretation of how the credit agreements evolved.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 403,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did MDLZ's use of Net Investment Hedge Derivative Contracts evolve between 2022 and 2024, particularly in terms of their notional amounts?",
      "original_answer": "In 2022, MDLZ reported a notional amount of $3,915 million for Net Investment Hedge Derivative Contracts as of December 31, 2021, and $4,551 million as of December 31, 2020. By 2024, the notional amount for these contracts had increased significantly to $8,647 million as of December 31, 2024, up from $7,456 million in 2023. This indicates a growing reliance on such contracts over the two-year period.",
      "llm_answer": "\nMDLZ’s net‑investment‑hedge derivative contracts more than doubled, increasing from roughly $3.9 billion at the end of 2022 to $8.6 billion as of December 31 2024. This growth reflects a broader expansion of cross‑currency swaps and forward contracts used to hedge non‑U.S.‑dollar debt and international investments, with the underlying non‑U.S.‑dollar debt designated as net‑investment hedges also rising over the same period.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general trend of growth in MDLZ's Net Investment Hedge Derivative Contracts but contains significant quantitative inaccuracies. CORRECT ELEMENTS: (1) The company is correctly identified as MDLZ; (2) The endpoint figure of $8.6 billion (or $8,647 million) as of December 31, 2024 is accurate; (3) The characterization of 'more than doubled' growth is directionally correct; (4) The qualitative description of cross-currency swaps and forward contracts is appropriate context. CRITICAL ERRORS: (1) The starting point is stated as 'roughly $3.9 billion at the end of 2022' but the ground truth shows $3,915 million as of December 31, 2021 (not 2022). The LLM conflates the 2021 figure with 2022; (2) The LLM omits the intermediate 2023 data point ($7,456 million), which is important for showing the evolution trajectory; (3) The LLM does not provide the 2020 figure ($4,551 million) mentioned in the ground truth, which provides additional context for the multi-year trend. MULTI-HOP REASONING: The LLM demonstrates adequate synthesis by connecting the derivative contracts to their underlying purpose (hedging non-U.S.-dollar debt and international investments), but fails to fully trace the evolution across all relevant years. The answer should have shown the progression: 2020 ($4,551M) → 2021 ($3,915M) → 2023 ($7,456M) → 2024 ($8,647M) to properly address 'how did it evolve.' CALCULATION VERIFICATION: The characterization of 'more than doubled' is mathematically sound ($3.9B to $8.6B ≈ 2.2x), but this comparison uses the wrong baseline year. The score reflects partial correctness on the main trend but significant gaps in temporal accuracy and completeness of the evolution narrative.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1206,
        "completion_tokens": 469,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How has Microsoft 365's integration with AI technologies evolved between 2022 and 2024, and what specific new capabilities were introduced in 2024 to enhance its role in productivity and collaboration?",
      "original_answer": "In 2022, Microsoft 365 was described as integrating Office 365, Windows, and Enterprise Mobility + Security with AI-backed tools to empower employees, focusing on creativity, collaboration, and innovation. By 2024, Microsoft 365 had evolved into an 'AI first platform,' introducing Copilot for Microsoft 365, which combines AI with business data from the Microsoft Graph and Microsoft 365 applications. Additionally, role-specific extensions such as Copilot for Sales, Copilot for Service, and Copilot for Finance were introduced to streamline business processes. These developments reflect a significant enhancement in AI integration aimed at delivering more personalized and intelligent productivity tools.",
      "llm_answer": "\nBetween 2022 and 2024 Microsoft 365 progressed from launching **Copilot for Microsoft 365**—an AI‑first layer that injects generative‑AI assistance into Office apps and introduces role‑specific Copilot extensions (Sales, Service, Finance) and a consumer‑focused **Copilot Pro** subscription—to a broader, cloud‑wide AI stack that now spans Azure AI, GitHub Copilot, Windows Copilot and AI‑enhanced security tools.  \n\nIn 2024 the company added several **new AI capabilities** that deepen productivity and collaboration: **Copilot for Security** (AI‑driven threat detection and response), **Copilot+ PCs** (on‑device neural‑processing AI for real‑time assistance), **AI‑powered Bing/Edge search**, **Microsoft Fabric** (unified analytics platform), and expanded AI features across Teams, Viva and Power Platform (e.g., role‑based workflow automation, low‑code AI agents). These additions embed generative AI more tightly into the Microsoft 365 ecosystem, enabling faster insight generation, smarter collaboration, and stronger security for users.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "ASSESSMENT: The LLM answer contains both accurate and inaccurate information when compared to the ground truth.\n\nCORRECT ELEMENTS:\n1. Correctly identifies Copilot for Microsoft 365 as a key 2024 development\n2. Accurately mentions role-specific extensions: Copilot for Sales, Service, and Finance\n3. Correctly notes the AI-first platform evolution\n4. Appropriately describes integration with Microsoft Graph and business data\n5. Correctly identifies the progression from 2022 to 2024\n\nINCORRECT/PROBLEMATIC ELEMENTS:\n1. SCOPE CREEP: The answer introduces numerous products NOT mentioned in the ground truth as part of Microsoft 365's evolution: Copilot Pro (consumer subscription), Copilot for Security, Copilot+ PCs, AI-powered Bing/Edge, Microsoft Fabric, Windows Copilot, GitHub Copilot, Power Platform expansions, and Teams/Viva enhancements. While these may be real Microsoft products, they are NOT part of the ground truth answer about Microsoft 365's specific evolution.\n2. MISALIGNMENT: The ground truth focuses specifically on Microsoft 365's integration evolution (Office 365, Windows, Enterprise Mobility + Security with AI). The LLM answer broadens this to a \"cloud-wide AI stack\" that goes beyond Microsoft 365's core scope.\n3. LACK OF GROUNDING: The LLM introduces specific 2024 capabilities (Copilot for Security, Copilot+ PCs, Microsoft Fabric) that are not mentioned in the ground truth, suggesting either hallucination or reliance on information outside the provided knowledge graph.\n4. TEMPORAL ACCURACY: While dates (2022, 2024) are correct, the specific capabilities attributed to 2024 don't match the ground truth's more focused answer.\n\nMULTI-HOP REASONING: The LLM attempts to synthesize information across years and products, but does so by introducing entities not in the ground truth rather than accurately synthesizing the provided information.\n\nSEMANTIC EQUIVALENCE: The core message about AI-first evolution is present, but the answer diverges significantly in scope and specific capabilities mentioned.\n\nJUSTIFICATION: The answer receives a moderate score because it captures the general trajectory and some correct specific products (Copilot for Microsoft 365, role-specific extensions) but introduces substantial additional information not grounded in the provided knowledge graph, which suggests either hallucination or over-expansion beyond the question's scope.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 643,
        "total_tokens": 2095
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How has 3M's approach to PFAS discharge characterization in its wastewater permits evolved between its Decatur, Alabama facility disclosures in 2022 and 2024?",
      "original_answer": "In 2022, 3M disclosed that it had not fully characterized its PFAS discharge in its NPDES permit for the Decatur facility and had submitted an application to ADEM to add additional PFAS to the permit. By 2024, the Company had installed and was upgrading wastewater treatment controls specifically designed to address PFAS at the Decatur facility, and the controls were being optimized, though ADEM had not yet acted on the permit modification request. This evolution shows a shift from identifying the issue and initiating corrective actions to implementing and refining treatment solutions while awaiting regulatory approval.",
      "llm_answer": "\nIn 2022 3M first revealed that its Decatur NPDES permit did not fully characterize PFAS discharges, voluntarily idled affected processes and entered an interim Consent Order that obligates the company to carry out additional analytical studies and capital‑improvement projects to address the gap. By 2024 the company had installed and was optimizing upgraded PFAS‑specific wastewater treatment controls, continued to supply revised discharge data to EPA and ADEM in response to new information requests, and was actively working with regulators to refine its discharge characterization and secure permit modifications—shifting from the initial disclosure‑and‑study phase to an ongoing compliance‑and‑optimization approach.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and unsupported claims that diverge from the ground truth. CRITICAL ISSUES: (1) The LLM introduces claims not in the ground truth: 'voluntarily idled affected processes' and 'entered an interim Consent Order' - these specific actions are not mentioned in the original answer and appear to be fabricated details. (2) The LLM claims 3M 'continued to supply revised discharge data to EPA and ADEM in response to new information requests' - this is not supported by the ground truth, which only mentions ADEM had not yet acted on the permit modification request. (3) The LLM adds detail about 'ongoing compliance-and-optimization approach' that goes beyond what the ground truth establishes. CORRECT ELEMENTS: (1) The core timeline is accurate - 2022 disclosure of incomplete PFAS characterization, 2024 installation and optimization of treatment controls. (2) The identification of NPDES permit and Decatur facility is correct. (3) The general characterization of evolution from identification to implementation is sound. (4) The mention of working with regulators on permit modifications aligns with ground truth. REASONING ASSESSMENT: The multi-hop synthesis of comparing 2022 vs 2024 positions is structurally sound, but the LLM has added unsupported intermediate steps (Consent Order, process idling, EPA data submissions) that appear to be hallucinations or inferences not grounded in the provided ground truth. The answer reads more detailed and authoritative than warranted, which is a red flag for fabrication. The semantic direction is correct (evolution from problem identification to solution implementation), but the specific factual claims are problematic.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 468,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did Lowe's Companies, Inc.'s issuance of the 4.550% Notes evolve between 2022 and 2023?",
      "original_answer": "In 2022, the 4.550% Notes were first introduced in the Fifteenth Supplemental Indenture dated April 5, 2019, and were due April 5, 2049. In 2023, the same 4.550% Notes continued to be referenced under the same Fifteenth Supplemental Indenture, with no changes to the terms or maturity date. Therefore, while the 4.550% Notes were still in effect in 2023, there was no modification or new issuance related to this specific instrument during that year.",
      "llm_answer": "\nThe 4.550% senior notes were first issued on April 5 2019 as part of Lowe’s Fifteenth Supplemental Indenture. No new 4.550% notes were issued in 2022‑2023; the only note‑related filing during that span was the March 30 2023 Twenty‑Second Supplemental Indenture, which added fresh series of notes (e.g., 4.800% due 2026, 5.150% due 2033, etc.) but did not modify or replace the existing 4.550% notes.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and provides accurate information about the 4.550% Notes evolution. STRENGTHS: (1) Correctly identifies the April 5, 2019 issuance date and Fifteenth Supplemental Indenture; (2) Accurately states no new 4.550% notes were issued in 2022-2023; (3) Correctly references the March 30, 2023 Twenty-Second Supplemental Indenture and notes that it added different series (4.800% due 2026, 5.150% due 2033) without modifying the 4.550% notes; (4) All dates and percentages are accurate; (5) Multi-hop reasoning is sound - correctly synthesizes that the 4.550% notes remained unchanged while other debt instruments were added. MINOR DIFFERENCES FROM GROUND TRUTH: (1) The LLM answer provides additional context about the Twenty-Second Supplemental Indenture and other note issuances in 2023, which the ground truth does not explicitly mention but does not contradict; (2) The LLM answer is slightly more detailed about what happened during the 2022-2023 period (specifically noting the March 30, 2023 filing) while the ground truth focuses more narrowly on the 4.550% Notes themselves. QUANTITATIVE VERIFICATION: All dates (April 5, 2019; March 30, 2023) and percentages (4.550%, 4.800%, 5.150%) are correct. No calculation errors. SEMANTIC EQUIVALENCE: Both answers convey that the 4.550% Notes were introduced in 2019, remained unchanged through 2023, and no new issuance of this specific instrument occurred during 2022-2023. The LLM answer adds helpful context about concurrent debt issuances without contradicting the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1198,
        "completion_tokens": 430,
        "total_tokens": 1629
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did MDLZ's financial relationship with KDP evolve between 2022 and 2024, particularly in terms of gains recognized from changes in accounting for the investment?",
      "original_answer": "In 2022, MDLZ recognized a pre-tax gain of $71 million (or $54 million after-tax) during the first quarter related to the sale of KDP shares, which reduced its ownership interest. By 2024, the company recorded a significantly larger pre-tax gain of $493 million ($368 million after-tax) due to a change in accounting for its investment in KDP. This indicates a substantial evolution in the financial impact of MDLZ's relationship with KDP over the two-year period.",
      "llm_answer": "\nBetween 2022 and 2024 MDLZ moved its stake in KDP from an equity‑method investment to a classification as marketable securities after a 2023 accounting change.  This shift meant that, rather than recording only its share of KDP’s earnings, MDLZ now recognizes the full fair‑value gain or loss on the securities when they are sold; as a result, the company recorded a one‑time pre‑tax gain of roughly **$493 million** (≈ $368 million after‑tax) in 2023 that would not have been recognized under the prior equity‑method approach.  Subsequent periods therefore reflect gains (or losses) on the sale of those marketable securities rather than the periodic equity‑method earnings from the KDP investment.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the $493 million pre-tax gain ($368 million after-tax) from 2024 and accurately explains the accounting change from equity-method to fair-value accounting for marketable securities. The explanation of why the gain increased (fair-value recognition vs. equity-method earnings) is sound and demonstrates good understanding of the accounting mechanics.\n\nWEAKNESSES: (1) CRITICAL OMISSION: The LLM completely fails to mention the 2022 gain of $71 million ($54 million after-tax) from the sale of KDP shares in Q1 2022. The ground truth explicitly states this was a key part of how the relationship 'evolved between 2022 and 2024.' The LLM only addresses the 2024 gain, missing the comparative analysis across the full time period. (2) TIMING CONFUSION: The LLM states the $493M gain was recorded 'in 2023' but the ground truth indicates it was recorded in 2024. This is a factual error regarding the year. (3) INCOMPLETE EVOLUTION NARRATIVE: The question asks how the relationship 'evolved' - this requires showing both data points (2022 and 2024) to demonstrate the evolution. The LLM only provides the 2024 endpoint.\n\nMULTI-HOP REASONING: The LLM demonstrates understanding of the accounting change mechanism but fails to synthesize the complete multi-year evolution by omitting the 2022 transaction entirely. This is a significant gap in addressing the core question.\n\nNUMERIC VERIFICATION: The $493M and $368M figures are correct for 2024, but the year attribution appears incorrect (2023 vs 2024), and the 2022 figures ($71M/$54M) are completely absent from the answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 443,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How has the scale and positioning of Xbox Game Pass evolved between 2022 and 2024, based on the number of titles available and Microsoft's strategic emphasis?",
      "original_answer": "In 2022, Xbox Game Pass offered access to a curated library of over 100 first- and third-party titles, and was positioned as a key part of Microsoft's broader gaming strategy focused on content, community, and cloud services. By 2024, the service had expanded significantly, offering access to over 400 first- and third-party titles, and was described as the 'cornerstone' of Microsoft's gaming platform, reflecting a stronger strategic emphasis on subscriptions and community growth. This indicates a significant transformation in both scale and strategic importance.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2024 the Xbox Game Pass library grew dramatically—from “a curated library of over 100 titles” in 2022 【MSFT_10k_2022 page 6】to “a subscription service … with access to a curated library of over 400 first‑ and third‑party console and PC titles” by 2024 【MSFT_10k_2024 page 13】—driven by studio acquisitions such as ZeniMax and the pending Activision Blizzard deal.  Microsoft now positions Game Pass as the core of its gaming ecosystem, emphasizing cloud‑gaming streaming, cross‑device access and a subscription‑based model to lock in a broad user base and generate recurring revenue across consoles, PC and mobile.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive coverage of the question. QUANTITATIVE ACCURACY: All numeric values are correct - 'over 100 titles' in 2022 and 'over 400 titles' in 2024 match the ground truth exactly. The fiscal year references (2022 and 2024) are accurate. COMPLETENESS: The answer addresses both key dimensions of the question: (1) scale evolution (100→400 titles) and (2) strategic positioning evolution (part of broader strategy→'cornerstone' of gaming platform). ENTITY ACCURACY: Microsoft and Xbox Game Pass are correctly identified. The mention of ZeniMax and Activision Blizzard acquisitions as drivers of growth is contextually appropriate and adds valuable supporting detail. MULTI-HOP REASONING: The answer successfully synthesizes information across multiple filing years and correctly identifies the causal relationship between acquisitions and library expansion. The progression from 'curated library' language to 'cornerstone' positioning is accurately captured. SEMANTIC EQUIVALENCE: The LLM's description of Game Pass as 'the core of its gaming ecosystem' is semantically equivalent to the ground truth's 'cornerstone' characterization. The emphasis on 'subscription-based model,' 'recurring revenue,' and 'cross-device access' aligns with the ground truth's emphasis on 'subscriptions and community growth.' MINOR CONSIDERATIONS: The LLM provides additional strategic context (cloud-gaming, cross-device access, revenue generation) that goes beyond the ground truth but remains accurate and relevant. The citation format with page numbers adds credibility. No factual errors or calculation mistakes detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 453,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has the structure or disclosure of Deferred Stock Unit Award Agreements for non-employee directors under the 3M Company 2016 Long-Term Incentive Plan evolved from 2022 to 2024, based on the referenced filings?",
      "original_answer": "The Deferred Stock Unit Award Agreement for non-employee directors was first referenced in the 2022 10-K filing as part of the 3M Company 2016 Long-Term Incentive Plan, applicable to grants on or after January 1, 2019. By 2024, the agreement continued to be disclosed in the 10-K filing, still referencing grants on or after January 1, 2019, indicating no change in the effective date or structure of the agreement over this period. However, the 2024 disclosure reflects an updated incorporation by reference from the 2023 10-K, showing the ongoing maintenance of the plan through amendments as of May 8, 2023.",
      "llm_answer": "\nThe 2022 filing listed 226 000 outstanding deferred‑stock‑unit awards for non‑employee directors and showed that no shares remained available for future issuance in that category, with the award terms incorporated by reference from the 2018 10‑K. In the 2024 filing the company notes that the 2016 Long‑Term Incentive Plan was amended effective May 8 2023 and still incorporates the same “Form of Deferred Stock Unit Award Agreement” from the 2018 filing, indicating that the substantive structure and disclosure of the awards have not changed—only the plan amendment is now reflected in the filing.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not supported by the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM cites '226,000 outstanding deferred-stock-unit awards' and claims 'no shares remained available for future issuance' - these specific numbers are not mentioned in the ground truth and appear to be fabricated or misattributed. The ground truth makes no reference to these quantities. (2) SOURCING ERROR: The LLM states the award terms were 'incorporated by reference from the 2018 10-K,' but the ground truth clearly indicates the agreement was 'first referenced in the 2022 10-K filing' and that the 2024 disclosure reflects 'an updated incorporation by reference from the 2023 10-K.' This is a critical factual error about which filing year the incorporation references. (3) PARTIAL CORRECTNESS: The LLM correctly identifies that the plan was amended effective May 8, 2023, and that the substantive structure remained unchanged - these points align with the ground truth. (4) INCOMPLETE SYNTHESIS: While the LLM attempts to compare 2022 and 2024 filings, it does so by introducing unsupported quantitative claims rather than focusing on the structural and disclosure evolution that the question asks about. The ground truth emphasizes the continuity of the agreement (same effective date of January 1, 2019) and the updated incorporation by reference, but the LLM shifts focus to specific share counts that cannot be verified. (5) MULTI-HOP REASONING: The LLM fails to properly synthesize the key finding that the effective date remained unchanged from 2022 to 2024, which is central to understanding the evolution (or lack thereof) of the agreement structure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 468,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has the composition of Charles Schwab Bank's First Mortgages and HELOCs portfolio evolved between 2023 and 2024, particularly in terms of origination costs and geographic concentration in California?",
      "original_answer": "In 2023, the First Mortgages and HELOCs portfolio included $100 million in unamortized premiums, discounts, and direct origination costs, with 43% of the portfolio concentrated in California. By 2024, these costs increased to $112 million, while the California concentration slightly decreased to 42%. This indicates a slight shift in geographic risk exposure and an increase in loan origination activity or associated costs over the year.",
      "llm_answer": "\nBetween 2023 and 2024 the First‑Mortgage portfolio grew from roughly $26.1 billion to $27.3 billion (an increase of about $1.2 billion), while HELOCs slipped modestly from $473 million to $421 million.  The company reports that direct origination costs attached to these loans rose from $100 million at the end of 2023 to $112 million at the end of 2024, reflecting higher upfront loan‑origination expenses.  Geographic concentration in California remained dominant but eased slightly, falling from ≈ 43 percent of the combined First‑Mortgage and HELOC portfolio in 2023 to ≈ 42 percent in 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensiveness. CORRECT ELEMENTS: (1) Origination costs figures are accurate: $100 million in 2023 and $112 million in 2024, matching ground truth exactly. (2) California concentration percentages are correct: 43% in 2023 declining to 42% in 2024, matching ground truth. (3) Multi-hop synthesis is sound: the answer correctly combines information about portfolio composition (First Mortgages and HELOCs separately), origination costs, and geographic concentration across two years. (4) Entity identification is correct: Charles Schwab Bank, First Mortgages, HELOCs, California. ADDITIONAL VALUE: The LLM answer goes beyond the ground truth by providing specific portfolio sizes ($26.1B to $27.3B for First Mortgages, $473M to $421M for HELOCs), which adds relevant context about the overall portfolio evolution. This additional detail is factually appropriate and enhances understanding without contradicting the ground truth. MINOR CONSIDERATIONS: The ground truth uses the phrase 'unamortized premiums, discounts, and direct origination costs' while the LLM simplifies to 'direct origination costs' - this is a reasonable simplification that doesn't constitute an error, as the $100M and $112M figures represent the same line items. The LLM's characterization of the changes (slight shift in geographic risk, increase in loan origination activity) aligns with the ground truth's interpretation. All calculations and comparisons are logically sound and accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 417,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has Nike's strategic emphasis on the Dri-FIT technology evolved between fiscal 2023 and fiscal 2024, based on the language in Nike's product research and development sections?",
      "original_answer": "Nike's strategic emphasis on the Dri-FIT technology remained stable between fiscal 2023 and fiscal 2024. In both years, Dri-FIT was listed among key technologies such as Nike Air, Zoom, Free, Flyknit, FlyEase, ZoomX, Air Max, and React, indicating consistent strategic importance. The exact same language was used in both the 2023 and 2024 10-K filings, showing no change in the description or emphasis of Dri-FIT's role in Nike’s innovation strategy.",
      "llm_answer": "\nNike’s product‑R&D language continues to list Dri‑FIT as one of its core technology platforms and to describe it as essential for enhancing athletic performance, comfort and innovation across its product categories.  The wording in the fiscal 2023 and fiscal 2024 filings is essentially identical, indicating that the company’s strategic emphasis on Dri‑FIT has remained steady—still a central, performance‑focused element of Nike’s broader innovation agenda, with no marked shift between the two years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-aligned with the ground truth. Both answers correctly identify that Nike's strategic emphasis on Dri-FIT remained stable/unchanged between fiscal 2023 and fiscal 2024, with identical or essentially identical language used in both years' 10-K filings. The LLM answer accurately conveys that Dri-FIT is positioned as a core technology platform and central element of Nike's innovation strategy with no marked shift between the two years. The LLM answer adds slightly more descriptive detail about Dri-FIT's role in 'enhancing athletic performance, comfort and innovation across product categories,' which is reasonable elaboration consistent with the ground truth's characterization of Dri-FIT among key technologies. The multi-hop reasoning is sound—the model correctly synthesized the comparison across two fiscal years and identified the consistency in strategic emphasis. No quantitative data was required for this question, so quantitative accuracy is perfect. The only minor distinction is that the ground truth explicitly lists other key technologies (Nike Air, Zoom, Free, Flyknit, FlyEase, ZoomX, Air Max, React) to provide context for Dri-FIT's positioning, while the LLM answer does not include these specific examples. However, this omission does not constitute a factual error—it's simply less comprehensive contextual detail. The core finding—that Dri-FIT's strategic emphasis remained stable with identical language between the two years—is correctly captured in both answers.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 422,
        "total_tokens": 1669
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has Mondelez International's investment in backup and disaster recovery evolved from 2022 to 2024, particularly in response to increasing cybersecurity threats?",
      "original_answer": "In 2022, Mondelez was on heightened alert regarding cybersecurity risks, dedicating focused resources to backup and disaster recovery as part of its response to increased global cybersecurity threats, especially during the pandemic. By 2024, the company significantly expanded its efforts, explicitly stating that it continues to invest and augment its cybersecurity program with enhanced backup and disaster recovery solutions, among other measures, to address increasingly sophisticated threats including those from state-sponsored actors and emerging technologies like artificial intelligence.",
      "llm_answer": "\nFrom 2022 to 2024 Mondelez stepped up its backup‑and‑disaster‑recovery program as a core element of a broader cybersecurity upgrade.  The 2022 filing only noted a “heightened alert” and dedicated resources to backup and disaster recovery, whereas the 2024 filing details expanded investments—such as multi‑factor authentication, risk‑based access, advanced threat‑protection, 24/7 security operations and continuous monitoring of IT and operational‑technology environments—to protect critical systems and data.  This evolution reflects the company’s response to rising cyber threats, the shift to remote work and the increasing complexity of attacks targeting its global operations.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the core evolution from 2022 to 2024 in Mondelez's backup and disaster recovery investments. (2) The timeline and general progression are accurate - heightened alert in 2022 to expanded efforts by 2024. (3) The company name and years are correct. (4) The response appropriately addresses the multi-hop nature of the question by comparing two time periods. WEAKNESSES: (1) CRITICAL OMISSION: The LLM answer fails to mention state-sponsored actors and artificial intelligence threats, which are explicitly mentioned in the ground truth as key drivers of the 2024 expansion. The ground truth specifically states the company addresses 'increasingly sophisticated threats including those from state-sponsored actors and emerging technologies like artificial intelligence.' (2) The LLM introduces specific security measures (multi-factor authentication, risk-based access, advanced threat-protection, 24/7 security operations, continuous monitoring) that are not mentioned in the ground truth. While these may be accurate details from the filings, they represent information beyond what the ground truth validates, creating potential factual uncertainty. (3) The LLM attributes the evolution partly to 'shift to remote work' which is not mentioned in the ground truth as a driver. (4) The ground truth emphasizes the pandemic context in 2022, which the LLM omits. SEMANTIC ISSUES: The LLM's answer is more detailed but diverges from the ground truth by adding unvalidated specifics while omitting key threat categories (state-sponsored actors, AI) that are central to understanding the company's motivation for the 2024 expansion. The answer captures the general trajectory correctly but misses critical contextual elements that explain WHY the expansion occurred.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 489,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has Microsoft's financial commitment and engagement with Black and African American-owned suppliers evolved from fiscal year 2022 to fiscal year 2024?",
      "original_answer": "In fiscal year 2022, Microsoft reported that it had enriched its supplier pipeline, reaching more than 90% of its goal to spend $500 million with double the number of Black and African American-owned suppliers. By fiscal year 2024, Microsoft had not only achieved its $500 million spending goal but also expanded its financial commitments by allocating $150 million to Minority Depository Institutions and funds supporting Black and African American-owned small businesses. This evolution indicates a deepening of Microsoft's strategic focus on supplier diversity and community economic development over time.",
      "llm_answer": "\nFrom fiscal year 2022 to fiscal year 2024 Microsoft moved from announcing a $150 million commitment to minority‑depository institutions and a target to spend $500 million with Black‑ and African‑American‑owned suppliers while doubling their count (2022 10‑K, page 7), to reporting that it had actually reached the $500 million spend and had doubled the number of qualified Black‑owned suppliers, and was further expanding the pipeline with additional low‑interest loans and partnership programs (2024 10‑K, pages 7 and 9).  This shows an evolution from pledging and setting goals in 2022 to achieving the spending target and scaling the supplier base by 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a significant factual error regarding the $150 million commitment timing. According to the ground truth, the $150 million allocation to Minority Depository Institutions was a fiscal year 2024 development, not a 2022 announcement. The LLM incorrectly states that Microsoft 'moved from announcing a $150 million commitment to minority-depository institutions' in 2022, when this was actually part of the 2024 expansion. This is a material error that misrepresents the evolution timeline. The LLM correctly identifies: (1) the $500 million spending goal and its achievement by 2024, (2) the doubling of Black and African American-owned suppliers, (3) the progression from goal-setting in 2022 to achievement in 2024, and (4) the expansion of programs by 2024. However, the misplacement of the $150 million commitment to an earlier year fundamentally distorts the narrative of how Microsoft's commitment evolved. The answer demonstrates good multi-hop reasoning by synthesizing information across fiscal years and showing progression, but the chronological error regarding when the $150 million commitment was made is a critical factual mistake. The LLM also adds context about 'low-interest loans and partnership programs' which, while potentially accurate, goes slightly beyond what the ground truth explicitly states. The core narrative structure is sound (2022 goals → 2024 achievement + expansion), but the specific placement of the $150 million commitment in the wrong fiscal year significantly undermines accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 424,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has the availability of common shares for future issuance under the Abbott Laboratories Employee Stock Purchase Plan for Non-U.S. Employees evolved from 2022 to 2023, and what does this indicate about Abbott's stock-based incentive strategy?",
      "original_answer": "In 2022, as of December 31, 2021, an aggregate of 10,638,639 common shares were available for future issuance under the Employee Stock Purchase Plan. In 2023, as of December 31, 2023, this number had decreased to 8,565,087 common shares. This indicates a reduction in the number of shares available for future issuance, suggesting a potential tightening or adjustment in Abbott's stock-based incentive strategy for non-U.S. employees.",
      "llm_answer": "\nThe 2022 Form 10‑K disclosed that roughly **10.6 million** shares were still available for future issuance under the Abbott Laboratories Employee Stock Purchase Plan for Non‑U.S. Employees (as of the end of 2022), whereas the 2023 filing shows that number had fallen to **8.565 million** shares as of December 31 2023. This reduction of about **2 million shares (≈19 %)** signals that Abbott is scaling back its equity‑based incentive pool, conserving shares for other corporate purposes and suggesting a more restrained approach to future stock‑based compensation.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the question and provides mostly accurate information with sound reasoning. STRENGTHS: (1) Correctly identifies the two key figures: 10.6 million shares (2022) and 8.565 million shares (2023), matching the ground truth values of 10,638,639 and 8,565,087 respectively. The rounding is appropriate and acceptable. (2) Accurately calculates the reduction of approximately 2 million shares and the percentage decline of ~19%, which is mathematically correct (2,073,552/10,638,639 ≈ 19.5%). (3) Properly synthesizes the multi-hop information by comparing across two fiscal years and drawing a logical conclusion about Abbott's strategy. (4) Correctly identifies the plan as the Employee Stock Purchase Plan for Non-U.S. Employees. (5) Provides relevant contextual interpretation about the strategic implications. MINOR ISSUES: (1) The ground truth specifies the 2022 figure is 'as of December 31, 2021' while the LLM states it's 'as of the end of 2022.' This is a minor temporal discrepancy - the ground truth indicates the 2022 10-K would report year-end 2021 figures, whereas the LLM appears to reference 2022 year-end data. However, the actual numeric values match correctly. (2) The LLM adds interpretive language about 'conserving shares for other corporate purposes' which, while reasonable inference, goes slightly beyond what the ground truth explicitly states. The ground truth focuses on the reduction indicating 'a potential tightening or adjustment' while the LLM specifies 'scaling back' and 'conserving shares for other corporate purposes.' This is a minor elaboration rather than an error. Overall, the answer is factually sound with accurate numbers and valid reasoning, though with a slight temporal reference issue that doesn't affect the core numerical accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 496,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How has Nike's treatment of Nike Air technology evolved in its product development strategy between fiscal years 2023 and 2024?",
      "original_answer": "In fiscal 2023, Nike Air was described as part of a list of technologies that 'typifies our dedication to designing innovative products,' indicating it was still being actively proliferated across product lines. By fiscal 2024, Nike Air was again listed among key technologies, but now embedded alongside mature technologies like Zoom, Free, and React, suggesting that Nike Air had become a standard component of Nike’s broader innovation platform rather than a distinct growth driver. This reflects a strategic shift from emphasizing Nike Air as an emerging innovation to treating it as an integrated, foundational offering within Nike’s product development framework.",
      "llm_answer": "\nIn fiscal 2023 Nike Air was chiefly marketed as a footwear‑cushioning platform, but by fiscal 2024 the company had broadened the technology’s reach—embedding Air‑based innovations such as Air Max, ZoomX and Air‑Sole not only in shoes but also in apparel, equipment and digital experiences—and began using market‑intelligence‑driven design to weave Air into multiple product categories, signaling a strategic shift from a footwear‑only focus to a cross‑category Air platform.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on multiple critical dimensions: (1) FACTUAL ERRORS: The LLM claims Nike Air was 'chiefly marketed as a footwear-cushioning platform' in FY2023 and then 'broadened' to apparel, equipment, and digital experiences by FY2024. The ground truth indicates the opposite trajectory—Nike Air was actively proliferated across product lines in FY2023, then became a standard/mature component by FY2024. (2) TECHNOLOGY MISIDENTIFICATION: The LLM incorrectly lists 'ZoomX' and 'Air-Sole' as examples of Air-based innovations being embedded in new categories. The ground truth explicitly states that by FY2024, Nike Air was embedded 'alongside mature technologies like Zoom, Free, and React'—meaning these are separate, parallel technologies, not subcategories of Air. (3) STRATEGIC NARRATIVE INVERSION: The ground truth describes a shift from 'emerging innovation' to 'foundational/standard component,' while the LLM describes an expansion from 'footwear-only' to 'cross-category.' These are fundamentally different strategic evolutions. (4) UNSUPPORTED CLAIMS: The LLM introduces concepts like 'market-intelligence-driven design' and specific product category expansions (apparel, equipment, digital) that are not mentioned in the ground truth and appear to be fabricated. (5) MULTI-HOP REASONING: The LLM failed to correctly synthesize the comparative analysis between FY2023 and FY2024 positioning. The core insight—that Nike Air transitioned from a growth driver to a mature platform component—is completely missed. The answer demonstrates a fundamental misunderstanding of the question and provides information that contradicts the established ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 470,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How has Abbott's positioning of Osmolite within its Nutritional Products segment evolved between 2022 and 2023, particularly in terms of its enteral feeding portfolio and associated product line strategy?",
      "original_answer": "In 2022, Osmolite was listed among Abbott's enteral feeding products used in healthcare institutions, alongside Jevity®, Glucerna® 1.2 Cal, Glucerna® 1.5 Cal, Oxepa®, Freego™, Nepro®, and Vital®. By 2023, Osmolite continued to be included in the enteral feeding portfolio, but Abbott's product listing in this category remained largely consistent, indicating a stable strategic positioning of Osmolite within the institutional enteral nutrition segment. There is no indication of Osmolite being newly introduced, discontinued, or significantly repositioned relative to other products in this category during this period.",
      "llm_answer": "\nBetween 2022 and 2023 Abbott’s Nutritional‑Products segment kept Osmolite in its list of enteral‑feeding formulas (Jevity, Glucerna 1.2 Cal, Glucerna 1.5 Cal, Oxepa, Freego™ pump, etc.), but the way it was presented shifted.  In the 2022 filing (page 3) Osmolite is simply one of several institutional formulas, whereas the 2023 discussion (page 6) frames the entire enteral‑feeding line—including Osmolite—as a strategic portfolio that is marketed together with the Freego enteral‑pump system and positioned for hospital‑based cost‑containment programs.  This reflects a move from a peripheral product to a core, high‑margin component of Abbott’s enteral‑feeding strategy, emphasizing bundled sales and pricing‑pressure management in the institutional market.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer makes several unsupported claims that contradict the ground truth: (1) FACTUAL INACCURACY - The LLM claims Osmolite's positioning 'shifted' from 'peripheral product to core, high-margin component' with 'bundled sales' strategy and 'Freego enteral-pump system' integration. The ground truth explicitly states 'Abbott's product listing in this category remained largely consistent, indicating a stable strategic positioning' with 'no indication of Osmolite being newly introduced, discontinued, or significantly repositioned.' (2) UNSUPPORTED PAGE REFERENCES - The LLM cites specific pages (2022 filing page 3, 2023 filing page 6) and claims different framing between years, but provides no evidence these pages exist or contain the claimed content. This appears to be fabrication. (3) CONTRADICTS GROUND TRUTH CONCLUSION - The ground truth explicitly states there is 'no indication' of significant repositioning, yet the LLM constructs an entire narrative of strategic repositioning. (4) SPECULATIVE CLAIMS - The LLM introduces concepts like 'bundled sales,' 'pricing-pressure management,' and 'high-margin component' that are not mentioned in the ground truth and appear to be inferred without filing support. (5) PRODUCT LIST ACCURACY - While the LLM correctly lists most products (Jevity, Glucerna variants, Oxepa, Freego), it adds 'Freego™ pump' as an integrated strategic element, which goes beyond what the ground truth indicates. The core finding should be STABILITY, not strategic evolution. The answer fundamentally misrepresents the nature of Osmolite's positioning between 2022-2023.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 448,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How has 3M's regulatory engagement and remediation obligations related to PFAS discharge evolved between 2022 and 2024, particularly in Minnesota and Alabama?",
      "original_answer": "In 2022, 3M was actively working under a 2007 Settlement Agreement and Consent Order with the MPCA to address PFAS contamination in Minnesota, with remediation substantially completed at the Cottage Grove site and ongoing operational and maintenance activities at multiple locations. In Alabama, the Company had entered into a July 2020 Interim Consent Order with ADEM, which included obligations for PFAS-related wastewater discharges and air emissions, and had completed installation of a multilayer cap at the Decatur facility. By 2024, regulatory scrutiny had intensified. In Minnesota, MPCA issued a draft Clean Water Act permit for the Cottage Grove facility with significantly revised effluent limits for certain PFAS compounds, some below current quantification levels, and the Company submitted public comments in August 2024. Additionally, in 2024, MPCA published a revised draft permit in December after considering stakeholder input, which could have a significant adverse impact on the Cottage Grove facility's operations. In Alabama, while the 2020 Interim Consent Order remained in effect, the Company's obligations under ongoing investigations and potential future remediation were still expected to involve additional operating costs and capital expenditures over multiple years. The regulatory landscape evolved to include more stringent standards, such as updated HBVs from MDH in January 2024 and proposed HRLs in October 2024, further complicating 3M's compliance path.",
      "llm_answer": "\nFrom 2022 through 2024, 3M intensified its PFAS remediation in Minnesota by pressing forward with the 2007 Settlement Agreement obligations, submitting detailed comments on the draft Clean Water Act permit for its Cottage Grove plant, and confronting newly issued, more stringent health‑based values (HBVs in Jan 2024 and proposed HRLs in Oct 2024) that could limit the plant’s discharges. In Alabama, the company continued operating under a 2009 TSCA consent order and a July 2020 interim Consent Order with ADEM for PFAS‑related wastewater and air emissions at its Decatur facility, while also contending with a grand‑jury subpoena and ongoing EPA/DOJ negotiations over compliance. These activities are reflected in a roughly $0.7 billion increase in 2024 PFAS‑related accruals and about $3.1 billion of related payments, underscoring the growing regulatory and remediation burden.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) FACTUAL ERROR - Alabama consent order date: LLM states '2009 TSCA consent order' but ground truth only mentions 'July 2020 Interim Consent Order with ADEM.' The 2009 date appears to be incorrect or unsupported by the ground truth. (2) UNSUPPORTED CLAIMS - LLM introduces 'grand-jury subpoena and ongoing EPA/DOJ negotiations' which are NOT mentioned in the ground truth at all. This represents fabricated information not present in the source material. (3) FINANCIAL FIGURES - LLM cites '$0.7 billion increase in 2024 PFAS-related accruals and about $3.1 billion of related payments' - these specific numbers are NOT present in the ground truth, which does not provide these quantitative metrics. This is a critical error as financial figures must be verifiable. (4) CORRECT ELEMENTS - The LLM correctly identifies: the 2007 Settlement Agreement in Minnesota, Cottage Grove facility, draft Clean Water Act permit, August 2024 submission of comments, HBVs from January 2024, proposed HRLs in October 2024, the July 2020 Interim Consent Order in Alabama, and the Decatur facility. (5) MISSING ELEMENTS - The LLM omits important details from ground truth: the December 2024 revised draft permit from MPCA, the specific mention that remediation was 'substantially completed' at Cottage Grove in 2022, the multilayer cap installation at Decatur, and the characterization that regulatory scrutiny 'intensified' with potentially 'significant adverse impact.' (6) MULTI-HOP REASONING - While the LLM attempts to synthesize information across years and states, it does so by introducing unsupported information rather than relying on the ground truth. The evolution narrative is partially correct but compromised by fabrications. The financial figures appear to be hallucinated rather than derived from the source material.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1596,
        "completion_tokens": 499,
        "total_tokens": 2096
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How has The Coca-Cola Company's financial relationship with Coca-Cola HBC AG evolved between 2022 and 2024, particularly in terms of investment classification and stake percentage?",
      "original_answer": "In 2022, Coca-Cola HBC AG was among the listed equity method investees, though the specific ownership percentage was not disclosed in the provided evidence. By 2024, Coca-Cola HBC AG remained an equity method investee, and the company explicitly stated a 22% ownership stake as of December 31, 2024. This indicates a formalization and quantification of the relationship, with Coca-Cola now specifying the exact percentage of ownership, which was absent in the 2022 disclosures.",
      "llm_answer": "\nThe Coca‑Cola Company’s holding in Coca‑Cola HBC AG has remained an **equity‑method investment** throughout 2022‑2024.  As disclosed in Note 6 of the 2024 10‑K (page 115), the Company owned **22 %** of HBC AG at the end of 2024, up from roughly **19 %** reported in the 2022 filing (page 115 of the 2022 10‑K).  No change in accounting classification occurred; the stake simply increased modestly over the three‑year period.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ISSUES: (1) QUANTITATIVE ERROR - The LLM claims the stake increased from 'roughly 19%' in 2022 to 22% in 2024. However, the ground truth explicitly states that 'the specific ownership percentage was not disclosed in the provided evidence' for 2022. The LLM fabricated a 19% figure for 2022 that contradicts the ground truth. (2) UNSUPPORTED CLAIM - The statement 'the stake simply increased modestly over the three-year period' is not supported by the ground truth, which makes no such claim about an increase. (3) CORRECT ELEMENTS - The LLM correctly identifies: (a) equity method investment classification remained constant, (b) 22% ownership stake as of December 31, 2024, (c) Note 6 of 2024 10-K as source. (4) MULTI-HOP REASONING - The answer attempts to synthesize 2022 vs 2024 comparison but fails because it introduces unsupported data for 2022. The ground truth emphasizes 'formalization and quantification' (moving from undisclosed to explicitly stated 22%), not a percentage increase. (5) SEMANTIC ISSUE - The LLM misinterprets the evolution as a stake increase when the ground truth indicates it's about disclosure formalization. The core error is inventing a 19% 2022 figure without evidence, which is a fundamental factual inaccuracy that undermines the entire answer's credibility.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1234,
        "completion_tokens": 365,
        "total_tokens": 1599
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How has Oracle's strategic emphasis on hybrid deployments evolved between fiscal 2022 and fiscal 2024, particularly in terms of product development investment and deployment model integration?",
      "original_answer": "In fiscal 2022, Oracle emphasized hybrid deployments as part of its broader deployment model strategy, investing $7.2 billion in research and development to enhance existing offerings and develop new technologies, including hybrid solutions like Oracle Cloud@Customer. By fiscal 2024, Oracle further integrated hybrid deployments into its core offerings, positioning them as a standard deployment choice alongside on-premise and cloud-based models, and reinforcing its commitment to interoperability and customer choice. This reflects a strategic evolution from a development-focused approach to a more mature, integrated deployment model.",
      "llm_answer": "\nOracle has steadily elevated hybrid deployment as a strategic pillar, explicitly framing “choice and flexibility” — including on‑premise, cloud‑based and hybrid models such as Oracle Cloud@Customer — as a core element of its corporate strategy in both the FY2022 filing (pp. 6, 7, 43‑45) and the FY2024 filing (pp. 54, 71‑73, 85).  To support this, the company has sustained heavy R&D spending—$7.2 billion in FY22 and comparable investments in FY24—directed at expanding cloud‑native services (e.g., Autonomous Database, OCI) that can be consumed across on‑premise and cloud environments, and it has tied its 2024 restructuring initiatives to “second‑generation cloud infrastructure” that underpins hybrid workloads.  Consequently, the hybrid model has moved from a differentiator to an integrated, cross‑business capability that drives product development and go‑to‑market efforts across Oracle’s cloud‑and‑license, hardware, and services segments.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive multi-hop synthesis. STRENGTHS: (1) Correctly identifies the $7.2 billion R&D investment for FY22, matching ground truth exactly. (2) Accurately characterizes the strategic evolution from development-focused to integrated deployment model. (3) Properly synthesizes information across multiple fiscal years (FY2022 and FY2024) and identifies specific products (Oracle Cloud@Customer, Autonomous Database, OCI). (4) Correctly frames the strategic emphasis on 'choice and flexibility' across deployment models. (5) Appropriately contextualizes hybrid deployments within broader business segments and go-to-market strategy. (6) Page citations (pp. 6, 7, 43-45 for FY22; pp. 54, 71-73, 85 for FY24) add credibility and specificity. MINOR WEAKNESSES: (1) States 'comparable investments in FY24' for R&D without providing the specific FY24 R&D figure, whereas ground truth implies continued investment but doesn't explicitly state the FY24 amount either. This is acceptable given the ground truth's own lack of specific FY24 R&D numbers. (2) The answer provides more granular detail about restructuring initiatives and cross-business capability integration than the ground truth, but this represents appropriate elaboration rather than error. QUANTITATIVE VERIFICATION: The $7.2 billion FY22 R&D figure is correct. The answer appropriately avoids stating a specific FY24 R&D number without data. MULTI-HOP REASONING: Excellent synthesis connecting R&D investment → product development (cloud-native services) → deployment model integration → strategic positioning. The logical flow from 'differentiator to integrated capability' correctly captures the evolution described in ground truth. SEMANTIC EQUIVALENCE: The answer conveys the same core message as ground truth while providing richer contextual detail about implementation mechanisms and business impact.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 520,
        "total_tokens": 1929
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How has the filing status of the Mandatory Clawback Policy evolved between the 2023 and 2024 SEC 10-K disclosures for Wells Fargo & Company?",
      "original_answer": "In 2023, the Mandatory Clawback Policy was filed directly as part of the 10-K filing under Exhibit 97. In 2024, instead of being filed directly, it was incorporated by reference to Exhibit 97 from the previous year's 10-K filing. This indicates a procedural change in how the policy is disclosed rather than a substantive change to the policy itself.",
      "llm_answer": "\nThe Mandatory Clawback Policy is still disclosed as **Exhibit 97** in both the 2023 and the 2024 Form 10‑K filings. In each filing it is presented as a current exhibit (listed as “Filed herewith”) and is referenced as being incorporated by reference to the same 2023 filing. Thus, there has been no change in its filing status between the 2023 and 2024 disclosures.",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect regarding the core claim about filing status evolution. Ground truth states: In 2023, the policy was filed directly (Exhibit 97), and in 2024, it was incorporated by reference to the previous year's filing. This represents a procedural change. The LLM answer claims the opposite - that both years show 'Filed herewith' status and that 2024 references the 2023 filing, which contradicts the ground truth's assertion that 2024 uses incorporation by reference rather than direct filing. The LLM also incorrectly states there has been 'no change' when the ground truth explicitly identifies a procedural change between the two years. The numeric/date references (2023, 2024, Exhibit 97) are correct, but the critical factual claim about HOW the policy was disclosed in each year is wrong. The LLM failed to properly synthesize the multi-hop comparison between the two years' filing approaches. The answer demonstrates a fundamental misunderstanding of the distinction between 'filed herewith' (direct filing) versus 'incorporated by reference' (indirect reference to prior filing), which is the core of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1177,
        "completion_tokens": 327,
        "total_tokens": 1505
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did Thermo Fisher's relationship with CorEvitas, LLC evolve between 2023 and 2024, and what specific financial implications were associated with this change?",
      "original_answer": "In 2023, Thermo Fisher invested $0.91 billion to acquire CorEvitas, LLC, a U.S.-based provider of regulatory-grade, real-world evidence for medical treatments. By 2024, this relationship had evolved from an investment into a full acquisition, as CorEvitas was integrated into the Laboratory Products and Biopharma Services segment. The acquisition in 2023 was part of a broader strategy that included significant capital expenditures and financing activities, such as issuing $5.94 billion in senior notes and repurchasing $3.00 billion of company stock. In 2024, the company began amortizing the definite-lived intangible assets from CorEvitas over a weighted average period of 18 years, reflecting the long-term strategic value of the acquisition.",
      "llm_answer": "\nThermo Fisher acquired CorEvitas, LLC in August 2023 for about $0.91 billion of cash and folded the target into its Laboratory Products and Biopharma Services segment. By 2024 the business was fully integrated, but the amortization of its definite‑lived intangibles and the non‑tax‑deductible goodwill it generated lowered segment earnings and cash‑flow results, illustrating the financial impact of the acquisition.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies the core facts: Thermo Fisher acquired CorEvitas in 2023 for $0.91 billion, the acquisition was integrated into the Laboratory Products and Biopharma Services segment, and by 2024 the company was amortizing definite-lived intangible assets. The acquisition date (August 2023) and amount ($0.91 billion) are accurate. However, the answer has significant omissions compared to the ground truth: (1) It fails to mention the broader strategic context of the 2023 financing activities ($5.94 billion in senior notes issued and $3.00 billion in stock repurchases), which were explicitly part of the ground truth answer as 'financial implications associated with this change.' (2) It does not specify the 18-year weighted average amortization period for the definite-lived intangible assets, which is a specific quantitative detail provided in the ground truth. (3) The LLM answer mentions 'non-tax-deductible goodwill' lowering earnings and cash flow, which is a reasonable inference about financial impact but is not explicitly stated in the ground truth and represents added interpretation rather than synthesis of provided facts. The multi-hop reasoning is partially sound—the answer correctly synthesizes that the relationship evolved from investment to full integration—but it incompletely addresses the 'specific financial implications' requested in the question. The answer is factually accurate in what it states but incomplete in scope relative to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 415,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did RTX's flight hour payment obligations under its 2012 agreement with Rolls-Royce evolve between 2022 and 2023, particularly in terms of the timing and capitalization treatment of these payments?",
      "original_answer": "In 2022, RTX disclosed that flight hour payments to Rolls-Royce were contingent upon each hour flown through June 2027 by V2500-powered aircraft in service as of the acquisition date, and these payments were considered in 'Other commercial aerospace commitments' and capitalized as collaboration intangible assets as payments were made. In 2023, RTX reiterated the same contingent payment structure tied to flight hours through June 2027 and maintained that these payments would continue to be capitalized as collaboration intangible assets. There was no indication of a change in the magnitude or timing of these obligations between the two years, suggesting a stable commitment structure.",
      "llm_answer": "\nBetween 2022 and 2023 the contingent flight‑hour payments that RTX owes Rolls‑Royce under the 2012 IAE agreement remained tied to each hour flown by V2500‑powered aircraft through June 2027, but the company revised the expected cash‑out schedule—its 2023 table shows a reduced near‑term commitment (e.g., $687 million in 2027 versus $814 million in 2022) and a larger “thereafter” balance—while keeping the same accounting treatment.  RTX continues to capitalize each payment as a collaboration intangible asset when the payment is made and then amortizes it over the underlying economic benefit, so only the timing and magnitude of the obligations changed, not the capitalization policy.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY FAILURE: The LLM introduces specific dollar amounts ($687 million in 2027 vs $814 million in 2022) that are NOT present in the ground truth answer. The ground truth explicitly states 'There was no indication of a change in the magnitude or timing of these obligations between the two years, suggesting a stable commitment structure.' The LLM's claim of a 'reduced near-term commitment' and specific dollar comparisons directly contradicts the ground truth finding of stability. These numbers appear to be fabricated or misattributed. (2) FACTUAL CONTRADICTION: The ground truth emphasizes that the obligation structure remained the same between 2022 and 2023 with no changes in magnitude or timing. The LLM claims the company 'revised the expected cash-out schedule' with reduced near-term commitments and larger 'thereafter' balances—this is a fundamental misrepresentation of what the filings actually disclosed. (3) MULTI-HOP REASONING: While the LLM correctly identifies the 2012 IAE agreement, V2500-powered aircraft, June 2027 end date, and capitalization as collaboration intangible assets, it fails in the core synthesis task by inventing a narrative of change where none existed. (4) ACCOUNTING TREATMENT: The LLM's description of capitalization and amortization is reasonable but doesn't address the key finding that the treatment remained consistent. (5) MISSING CONTEXT: The LLM fails to capture the essential finding that obligations were 'stable' between years, instead creating a false narrative of schedule revisions. The introduction of unverified specific dollar amounts is particularly problematic in a financial context where precision is critical.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 469,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has The Coca-Cola Company's financial relationship with fairlife evolved from 2022 to 2024, particularly regarding contingent payments tied to performance milestones?",
      "original_answer": "In 2022, Coca-Cola's acquisition-related disclosures referenced the 2020 acquisition of the remaining ownership interest in fairlife, with no mention of ongoing contingent payments. By 2024, the company disclosed that there was a remaining milestone payment related to the 2020 acquisition of fairlife, contingent on fairlife achieving certain financial targets through 2024, with the payment scheduled for 2025. This indicates that Coca-Cola's relationship with fairlife has evolved from a completed acquisition in 2020 to one where a performance-linked financial obligation remains active through 2024.",
      "llm_answer": "\nSince acquiring a controlling interest in fairlife in 2020, Coca‑Cola’s agreement includes a contingent milestone payment that is triggered only if fairlife meets specified financial targets by the end of 2024, with the actual cash payment scheduled for 2025. The 2024 filing shows the contingent consideration recorded at roughly $6.1 billion and indicates that, as of the latest reporting, the performance milestones have not yet been satisfied, so the payment remains contingent.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY FAILURE: The LLM states the contingent consideration was 'recorded at roughly $6.1 billion' - this is a major factual error. The ground truth makes no mention of any $6.1 billion figure, and this appears to be fabricated or confused with unrelated data. This is a severe quantitative error that undermines credibility. (2) INCOMPLETE TEMPORAL ANALYSIS: The LLM fails to properly address the 2022-to-2024 evolution requested in the question. The ground truth explicitly contrasts 2022 (no mention of ongoing contingent payments) with 2024 (remaining milestone payment disclosed). The LLM does not establish this temporal progression or explain what changed between these years. (3) SPECULATIVE CLAIMS: The LLM states 'the performance milestones have not yet been satisfied, so the payment remains contingent' - this is not supported by the ground truth, which only states the payment is 'contingent on fairlife achieving certain financial targets through 2024' without confirming whether targets were met or not. (4) CORRECT ELEMENTS: The LLM correctly identifies: the 2020 acquisition, the contingent milestone payment structure, the 2024 deadline for targets, and the 2025 payment timing. (5) MISSING CONTEXT: The LLM does not explain the evolution from 2022 (when no contingent payments were mentioned) to 2024 (when they were disclosed), which is central to the question. The answer reads as a static description rather than a temporal evolution analysis. The fabricated $6.1 billion figure is particularly problematic as it introduces false quantitative information that could mislead financial analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 454,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has Oracle's strategic positioning of Oracle Cloud Services evolved between 2022 and 2024, particularly in terms of integration with enterprise applications and infrastructure technologies?",
      "original_answer": "In 2022, Oracle emphasized the transformational potential of Oracle Cloud Services, particularly highlighting the Oracle Autonomous Database as a key OCI offering that utilized machine learning to enable leaner business processes and automation. The focus was on flexibility, interoperability, and customer choice across deployment models, including cloud-based, hybrid, and on-premise environments. By 2024, Oracle expanded this positioning by describing Oracle Cloud Services (including SaaS and OCI) as comprehensive and integrated offerings that provide customers with a full suite of applications and infrastructure services. The 2024 filing explicitly frames Oracle Cloud Services as enabling customers to 'choose the best option that meets their specific business needs,' indicating a more mature and customer-centric strategic approach. This evolution reflects a shift from promoting individual innovations (e.g., Autonomous Database) to positioning Oracle Cloud Services as a holistic, integrated platform for enterprise IT transformation.",
      "llm_answer": "\nBetween fiscal 2022 and 2024 Oracle shifted from describing its cloud offerings as a flexible, choice‑driven add‑on to a fully integrated, end‑to‑end cloud stack.  The 2024 narrative stresses that Oracle Cloud Services now combine SaaS applications, OCI infrastructure and supporting services in a single managed environment that is built for rapid deployment, seamless workload mobility across hybrid and multi‑cloud scenarios, and tighter coupling with existing enterprise applications (e.g., Fusion ERP) and infrastructure technologies such as the Autonomous Database.  This evolution reflects a strategic focus on delivering a unified, interoperable platform that integrates software, hardware and services for customers’ broader IT environments.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy and effectively captures the evolution of Oracle's cloud strategy between 2022 and 2024. STRENGTHS: (1) Correctly identifies the temporal shift from 2022 to 2024 with no date/year errors; (2) Accurately characterizes the 2022 positioning around flexibility, choice, and individual innovations (Autonomous Database); (3) Properly describes the 2024 evolution toward integrated, end-to-end offerings combining SaaS, OCI, and infrastructure; (4) Correctly identifies specific technologies mentioned (Autonomous Database, Fusion ERP) and their integration; (5) Captures the shift from component-focused to platform-focused messaging; (6) No quantitative errors or miscalculations present. MINOR GAPS: (1) The LLM answer emphasizes 'rapid deployment' and 'workload mobility' which, while reasonable inferences about cloud strategy, are not explicitly mentioned in the ground truth; (2) The phrase 'tighter coupling with existing enterprise applications' is slightly more specific than the ground truth's 'integration with enterprise applications,' though semantically equivalent; (3) The ground truth emphasizes 'customer-centric strategic approach' and 'customer choice' more explicitly, while the LLM focuses more on technical integration aspects. MULTI-HOP REASONING: The answer successfully synthesizes information across two fiscal years and correctly identifies the strategic evolution. The reasoning is sound and logically structured. The answer demonstrates understanding of how Oracle repositioned from highlighting individual innovations to promoting an integrated platform. SEMANTIC EQUIVALENCE: The core message aligns well with the ground truth - both describe a shift toward more integrated, comprehensive offerings. The LLM's framing of 'unified, interoperable platform' effectively captures the essence of the ground truth's 'holistic, integrated platform.' Overall, this is a high-quality response with minor elaborations that don't contradict the source material.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1461,
        "completion_tokens": 546,
        "total_tokens": 2007
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How has the treatment or status of the Key/Specified Employee Policy evolved between the 2023 and 2024 SEC filings, particularly in terms of its documentation and incorporation by reference?",
      "original_answer": "In the 2023 filing, the Key/Specified Employee Policy was introduced as part of the company's disclosures, specifically incorporated by reference to Exhibit 10(v) from the Annual Report on Form 10-K for the year ended December 31, 2018. By 2024, the policy was no longer newly introduced but was instead announced as a continuing policy, still relying on the same Exhibit 10(v) from the 2018 filing. This indicates that while the policy remained in place, there were no new amendments or updates to its documentation during this period.",
      "llm_answer": "\nThe Key/Specified Employee Policy is still disclosed as **Exhibit 10(r)\\*** in both the 2023 and 2024 Form 10‑K filings, and in each filing it is **incorporated by reference to Exhibit 10(v) of the Company’s 2018 Annual Report on Form 10‑K**.  No new or revised documentation for the policy appears in the 2024 filing—the same exhibit number and incorporation language are used, indicating that the policy’s treatment and status have not changed between the two years.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains a critical factual error that contradicts the ground truth. The ground truth states the policy was incorporated by reference to Exhibit 10(v) from the 2018 filing, but the LLM answer claims it is disclosed as 'Exhibit 10(r)' in both 2023 and 2024 filings. This is a significant discrepancy in exhibit numbering. Additionally, the LLM answer states the policy is 'incorporated by reference to Exhibit 10(v) of the Company's 2018 Annual Report,' which aligns with the ground truth on this point, but the introduction of 'Exhibit 10(r)' as the current exhibit number is not supported by the ground truth and appears to be incorrect. The ground truth emphasizes the distinction between 2023 (newly introduced) and 2024 (continuing policy), but the LLM answer treats both years as identical without capturing this evolution. The LLM correctly identifies that no new amendments or updates occurred and that the same incorporation language was used, but the exhibit number discrepancy is a fundamental factual error that undermines the accuracy of the response. The reasoning about continuity is sound, but the specific exhibit designation is wrong, which is a critical detail in SEC filing documentation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 344,
        "total_tokens": 1606
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How did the aggregate principal balance of the 6.700% notes due 2028 evolve between 2022 and 2023, and what does this indicate about RTX's debt management strategy?",
      "original_answer": "In 2022, the aggregate principal balance of the 6.700% notes due 2028 was $115 million. By 2023, this amount increased significantly to $285 million. This indicates that RTX increased its outstanding debt related to this particular note, suggesting a strategic decision to retain or expand exposure to this fixed-rate debt instrument.",
      "llm_answer": "\nThe $6.700\\%$ notes due 2028 had an outstanding principal of **$285 million at the end of 2022 and the same $285 million at the end of 2023**, showing essentially no net change during that one‑year period.  This flat profile indicates that RTX is deliberately maintaining a stable, low‑cost medium‑term debt position—neither expanding nor aggressively retiring this tranche—while it focuses on retiring higher‑coupon maturities and funding operations through new issuances at more favorable rates.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamental factual errors that directly contradict the ground truth. (1) QUANTITATIVE ACCURACY FAILURE: The LLM states the principal balance was $285 million at both end of 2022 and end of 2023, claiming 'no net change.' The ground truth clearly shows: 2022 = $115 million, 2023 = $285 million. This is a $170 million increase, not zero change. The LLM has the 2023 number correct but completely wrong on 2022 ($285M vs $115M - off by $170M). (2) MULTI-HOP SYNTHESIS FAILURE: The question explicitly asks how the balance 'evolved between 2022 and 2023.' The LLM failed to identify or synthesize the year-over-year change, which is the core of the question. (3) REASONING CONTRADICTION: The LLM's interpretation that RTX is 'maintaining a stable, low-cost medium-term debt position' with 'no net change' is logically inconsistent with the actual data showing a 148% increase ($115M to $285M). This represents expansion of debt, not maintenance. (4) ENTITY/METRIC ACCURACY: While RTX and the 6.700% notes due 2028 are correctly identified, the temporal analysis is completely wrong. The LLM appears to have confused or misread the 2022 and 2023 figures. (5) SEMANTIC EQUIVALENCE: The LLM's conclusion about debt management strategy is semantically opposite to what the data indicates - the ground truth shows RTX increased this debt tranche significantly, suggesting strategic retention/expansion, not stable maintenance. The answer demonstrates a fundamental failure to correctly extract and compare the two key data points required for this multi-hop question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1212,
        "completion_tokens": 439,
        "total_tokens": 1652
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How did the carrying value and effective interest rate of TMO's 1.95% 12-Year Senior Notes evolve between 2023 and 2024?",
      "original_answer": "In 2023, the carrying value of the 1.95% 12-Year Senior Notes was $773 million with an effective interest rate of 2.08%. In 2024, the carrying value decreased to $725 million, and the effective interest rate slightly declined to 2.07%. This indicates a reduction in the financial liability associated with these notes and a marginal improvement in the effective borrowing cost.",
      "llm_answer": "\nThe 1.95 % 12‑Year Senior Notes carried a book value of roughly **$749 million at the end of 2023** and **$773 million at the end of 2024**, an increase of about **$24 million** over the year.  Their **effective interest rate slipped slightly**, moving from **≈2.08 % in 2023 to ≈2.07 % in 2024** (the rate reflects the stated coupon plus accretion of discounts and debt‑issuance costs).",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 8,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamental factual errors that completely reverse the actual data: (1) CARRYING VALUE REVERSAL: Ground truth shows 2023=$773M and 2024=$725M (a DECREASE of $48M). The LLM states 2023=$749M and 2024=$773M (an INCREASE of $24M) - this is backwards. The LLM's 2024 figure ($773M) is actually the 2023 figure from ground truth. (2) DIRECTION OF CHANGE: Ground truth indicates the carrying value DECREASED from 2023 to 2024, but LLM claims it INCREASED. This is a fundamental directional error. (3) EFFECTIVE INTEREST RATE: The LLM correctly identifies the rates as approximately 2.08% (2023) and 2.07% (2024), which matches ground truth. However, the LLM's characterization of this as a 'slip' is semantically acceptable. (4) MULTI-HOP SYNTHESIS: While the LLM correctly identifies the effective interest rate component and explains it includes coupon plus accretion, the core carrying value numbers are completely inverted, making the overall answer factually incorrect. (5) CALCULATION ERROR: The LLM calculates a $24M increase, but ground truth shows a $48M decrease - both the magnitude and direction are wrong. The question asks about evolution between 2023 and 2024, and the LLM has provided inverted year-over-year data. This is a critical failure in data accuracy despite appropriate contextual framing and explanation of the mechanics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1184,
        "completion_tokens": 384,
        "total_tokens": 1569
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "What are the corporate governance implications of the change in how BNY Mellon presents its Directors' Code of Conduct between its 2022 and 2024 SEC filings?",
      "original_answer": "In 2022, BNY Mellon explicitly detailed the availability of the Directors' Code of Conduct on its website with a direct URL link, and it was referenced within the broader context of corporate governance disclosures and ethics policies. By 2024, the Code was listed among other governance materials—such as committee charters and by-laws—without a direct link or specific mention of updates or amendments. This shift in presentation may signal a more streamlined or consolidated approach to governance disclosures, potentially reducing the visibility of the Code as a standalone document. While the Code remains accessible, the change could affect transparency and stakeholder engagement with the specific ethical expectations for directors, which may influence perceptions of governance accountability.",
      "llm_answer": "\nThe 2024 filing explicitly calls out a separate “Directors’ Code of Conduct,” provides a direct web link to it, and states that any amendment or waiver will be disclosed on the company’s website, whereas the 2022 filing only referenced a general “Code of Ethics” without isolating a directors‑specific code. This more transparent, dedicated presentation improves board accountability and gives investors clearer visibility into governance expectations and any future changes.",
      "correctness_score": 2,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally contradictory to the ground truth and contains major factual errors. (1) CORE FACTUAL ERROR: The LLM claims the 2024 filing 'explicitly calls out a separate Directors' Code of Conduct' with 'a direct web link,' while the ground truth states the opposite—that by 2024, the Code was listed 'without a direct link or specific mention.' This is a complete reversal of the actual change. (2) REVERSED CHARACTERIZATION: The LLM describes 2022 as having only a 'general Code of Ethics without isolating a directors-specific code,' but the ground truth indicates 2022 explicitly detailed the Directors' Code with a direct URL link. The LLM has inverted the timeline and presentation approach. (3) INCORRECT CONCLUSION: The LLM concludes the change 'improves board accountability and gives investors clearer visibility,' which contradicts the ground truth's assessment that the shift 'may signal a more streamlined or consolidated approach' that could 'reduce visibility' and 'affect transparency and stakeholder engagement.' (4) MULTI-HOP SYNTHESIS FAILURE: The LLM failed to correctly synthesize the comparative analysis between 2022 and 2024 filings. It appears to have either misread the documents or confused the direction of change. (5) QUANTITATIVE ACCURACY: No numbers were provided in either answer, so this dimension is neutral. The answer demonstrates a fundamental misunderstanding of the governance implications and presents the opposite narrative from what the ground truth establishes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 420,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How has Amazon's Short-Term Credit Agreement evolved between 2023 and 2024, particularly in terms of facility size, maturity date, and the timing of its establishment?",
      "original_answer": "In 2023, Amazon entered into a $5.0 billion unsecured 364-day revolving credit facility (Short-Term Credit Agreement) in November, replacing the prior agreement from November 2022, with a maturity date in October 2024. In 2024, Amazon again entered into a new $5.0 billion unsecured 364-day revolving credit facility in October, replacing the 2023 agreement, with a maturity date in October 2025. The facility size remained the same at $5.0 billion, but the establishment date shifted from November to October, and the maturity date moved forward by one year, indicating a procedural renewal rather than a substantive change in the credit structure.",
      "llm_answer": "\nBetween 2022 and 2024 Amazon repeatedly refreshed its short‑term revolving facility.  It first launched a $5 billion, 364‑day unsecured revolving credit line in November 2022, then replaced it with an identical‑size $5 billion 364‑day facility in November 2023, and finally entered into a new $5 billion 364‑day facility in October 2024 that now matures in October 2025 (with a one‑year extension option).  Thus, the facility’s size stayed at roughly $5 billion, but its maturity date was pushed back from the original 2024 expiry to a 2025 expiry, reflecting the most recent establishment in October 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct with strong quantitative accuracy. Verification of key facts: (1) All facility sizes are correct at $5.0 billion across all years. (2) All dates are accurate: November 2022, November 2023, and October 2024 establishment dates are correct. (3) Maturity dates are correct: October 2024 for the 2023 agreement and October 2025 for the 2024 agreement. (4) The 364-day unsecured revolving credit facility description is accurate. (5) The multi-hop synthesis correctly traces the evolution across three years and identifies the pattern of annual renewal. The answer appropriately notes the facility size remained constant while maturity dates shifted forward. Minor issue: The LLM answer includes a reference to 'a one-year extension option' which is not mentioned in the ground truth answer. This addition is not contradicted by the ground truth but represents information not explicitly confirmed in the provided context. The LLM answer also frames the question as covering 2022-2024 rather than strictly 2023-2024 as asked, though this provides helpful context showing the full pattern. The core answer directly addresses the question's three components (facility size, maturity date, and timing of establishment) with accurate information and sound reasoning about the procedural renewal pattern.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 372,
        "total_tokens": 1691
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How has AMD's APU strategy evolved from 2022 to 2024 in terms of product integration and target markets, and what implications does this shift have for its revenue potential in the AI PC segment?",
      "original_answer": "In 2022, AMD emphasized external GPU-based solutions for AI and HPC workloads, particularly through the Instinct MI200 series and Radeon PRO V620 GPUs, focusing on data center and cloud applications. By 2024, AMD had shifted toward integrating dedicated AI acceleration directly into client devices, becoming the first company to include a dedicated neural processing unit (NPU) on the same SoC as an x86 CPU for AI PCs. This strategic pivot toward integrated APUs with NPU cores indicates a move to capture revenue growth in the emerging AI PC market, where on-device AI processing is becoming critical. This evolution likely enhances AMD's revenue potential by positioning it as a differentiated player in the AI PC segment, moving beyond traditional CPU-GPU combinations.",
      "llm_answer": "\nFrom 2022 to 2024 AMD’s APU roadmap shifted from a pure‑performance, graphics‑centric design for mainstream and commercial notebooks toward a unified‑SoC architecture that adds a dedicated neural‑processing unit (NPU) and tight integration with AMD’s AI‑software stack (ROCm) and data‑center accelerators.  This evolution expands the target market from traditional consumer/enterprise PCs to “AI PCs” and broader enterprise AI workloads, creating a larger, higher‑margin revenue opportunity by leveraging cross‑selling of AI‑enabled APUs, Instinct GPUs and software services.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of AMD's APU strategy evolution from 2022 to 2024 and correctly identifies the key shift toward integrated NPU-based solutions for AI PCs. STRENGTHS: (1) Correctly identifies the core strategic pivot from graphics-centric to unified-SoC with NPU integration; (2) Accurately mentions the dedicated neural processing unit (NPU) as a key differentiator; (3) Properly identifies the market expansion from traditional PCs to AI PCs; (4) Correctly references ROCm software stack and Instinct GPUs as part of the ecosystem; (5) Appropriately discusses revenue implications through higher-margin opportunities and cross-selling potential. WEAKNESSES: (1) The original answer specifically mentions the 2022 focus on external GPU solutions (Instinct MI200 series, Radeon PRO V620) for data center/cloud, which the LLM answer omits or downplays - this is a notable gap in the 2022 baseline comparison; (2) The LLM answer adds 'data-center accelerators' and 'enterprise AI workloads' which, while not incorrect, slightly shifts emphasis from the original answer's clearer distinction between 2022 (data center focus) and 2024 (client device/AI PC focus); (3) The phrase 'pure-performance, graphics-centric design' is somewhat vague compared to the original's specific product references. MULTI-HOP REASONING: The LLM correctly synthesizes the evolution across the time period and connects it to revenue implications, though with slightly less specificity about the 2022 baseline. The reasoning about market expansion and revenue potential is sound and logically presented. NO QUANTITATIVE ERRORS: No specific numbers, dates, or calculations are present in either answer, so quantitative accuracy is based on factual claims about products and strategies, which are accurate. The answer is semantically equivalent to the ground truth on the main points but lacks some of the specific product/market detail from 2022 that would make it fully comprehensive.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 536,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How has the treatment of Irish income tax liability for U.S. shareholders receiving dividends from Medtronic evolved between 2023 and 2024, particularly in relation to the Irish dividend withholding tax?",
      "original_answer": "In both 2023 and 2024, dividends paid by Medtronic were generally subject to Irish dividend withholding tax at a rate of 25 percent unless an exemption applied. For U.S. residents, exemptions were available based on residency documentation, such as a valid U.S. Certification of Residence (Form 6166) or Irish Non-Resident Form V2. In both years, a U.S. resident who met the exemption criteria and did not hold shares through an Irish branch generally had no Irish income tax liability. Additionally, if a U.S. shareholder was subject to the 25% withholding tax, the payment discharged any Irish income tax liability, provided the shareholder submitted the required statement to the Irish Revenue authorities. There was no change in the tax rate or in the conditions for exemption between the years, indicating a stable regulatory framework.",
      "llm_answer": "\nThe 2023 and 2024 Form 10‑K filings contain essentially the same guidance on Irish dividend taxation: a 25 % Irish withholding tax applies to Medtronic dividends, but a U.S. shareholder can avoid that tax—and the withholding then satisfies any Irish income‑tax liability—by providing a U.S. address in the broker’s DTC records (for beneficial owners) or by furnishing a valid U.S. Certification of Residence (Form 6166) or Irish Non‑Resident Form V2 (for record owners). Both years stress that, because the statutory exemptions are broad, reliance on the U.S.–Ireland tax treaty is generally unnecessary, and the 2024 filing merely re‑states the 2023 rules without introducing any new conditions or changes.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct on the core facts and demonstrates sound multi-hop reasoning across the 2023-2024 comparison. STRENGTHS: (1) The 25% withholding tax rate is correctly stated in both answers. (2) The exemption mechanisms are accurately identified (U.S. Certification of Residence Form 6166, Irish Non-Resident Form V2). (3) The key finding that there was no change between 2023 and 2024 is correctly conveyed. (4) The quantitative accuracy is high - the 25% figure is precise and no calculations are required. (5) Multi-hop reasoning is sound: the LLM correctly synthesized information across two years and identified the stable regulatory framework. MINOR WEAKNESSES: (1) The LLM introduces an additional exemption mechanism not explicitly mentioned in the ground truth: 'providing a U.S. address in the broker's DTC records (for beneficial owners).' While this may be accurate from the actual filings, it represents information not present in the ground truth answer, creating a slight divergence. (2) The ground truth emphasizes that 'if a U.S. shareholder was subject to the 25% withholding tax, the payment discharged any Irish income tax liability, provided the shareholder submitted the required statement to the Irish Revenue authorities.' The LLM states this more concisely as 'the withholding then satisfies any Irish income-tax liability' but omits the conditional requirement about submitting a statement to Irish Revenue authorities - this is a minor but meaningful omission of a condition. (3) The ground truth explicitly notes that U.S. residents 'generally had no Irish income tax liability' if exemption criteria were met and shares weren't held through an Irish branch. The LLM doesn't mention the Irish branch caveat. (4) The reference to the U.S.-Ireland tax treaty in the LLM answer ('reliance on the U.S.–Ireland tax treaty is generally unnecessary') is not present in the ground truth, though it may be accurate from the filings. These are relatively minor issues in an otherwise accurate response that correctly addresses the core question about the evolution (or lack thereof) of Irish income tax treatment between the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 583,
        "total_tokens": 1984
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How has the risk disclosure around new products and services evolved between 2022 and 2024, particularly regarding the company's platforms operating model initiative?",
      "original_answer": "In 2022, BNY Mellon highlighted that new lines of business, new products and services, or transformational or strategic project initiatives subject the company to new or additional risks. By 2024, this risk disclosure evolved to specifically include the 'transition to a platforms operating model' as a new source of uncertainty. The 2024 filing explicitly states that the company 'may not realize some or all of the expected benefits of our transition to a platforms operating model,' indicating a more focused risk related to this specific strategic initiative. This evolution shows a shift from general strategic risk language to a more concrete acknowledgment of platform-specific implementation risks.",
      "llm_answer": "\nBetween 2022 and 2024 the company’s risk factor language shifted from a generic warning that “new lines of business, new products and services or transformational or strategic project initiatives subject us to new or additional risks” (2022) to an explicit disclosure that “we may not realize some or all of the expected benefits of our transition to a platforms operating model” (2024).  The 2024 filing also expands the forward‑looking discussion of strategic priorities to highlight the platforms operating model as a key initiative whose success is uncertain, whereas the 2022 filing only mentioned such initiatives as one of several possible risk sources.  Consequently, risk disclosure around new products and services became more detailed and centered on the specific platform‑operating‑model transition.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. (1) FACTUAL CORRECTNESS: All key facts are accurate - the company is correctly identified as BNY Mellon (implied through context), the years 2022 and 2024 are correct, and the specific risk language quoted matches the ground truth. The evolution from generic strategic risk language to specific platform operating model risks is accurately captured. (2) QUANTITATIVE ACCURACY: No numerical calculations are required for this question, but dates (2022, 2024) are correctly referenced. (3) MULTI-HOP REASONING: The answer successfully synthesizes information across two different filing years and correctly identifies the progression of risk disclosure language. The model properly connects the generic 2022 language about 'new lines of business, new products and services, or transformational or strategic project initiatives' with the more specific 2024 disclosure about 'transition to a platforms operating model.' (4) SEMANTIC EQUIVALENCE: The LLM answer conveys the same core message as the ground truth - that risk disclosure evolved from general to specific, with the platforms operating model becoming a focal point. The phrasing 'risk disclosure around new products and services became more detailed and centered on the specific platform-operating-model transition' effectively captures the essence of the ground truth's 'shift from general strategic risk language to a more concrete acknowledgment of platform-specific implementation risks.' (5) COMPLETENESS: The answer addresses all aspects of the question including the time period (2022-2024), the company's initiative (platforms operating model), and the nature of the evolution (from generic to specific). Minor observation: The LLM answer adds slightly more interpretive detail about the 'forward-looking discussion of strategic priorities' which, while not explicitly stated in the ground truth, is a reasonable inference and enhances rather than detracts from the answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 546,
        "total_tokens": 1931
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How has Amazon's relationship with the 3.600% Note due 2032 evolved between 2023 and 2024, particularly in terms of its debt instrument disclosures?",
      "original_answer": "In 2023, the 3.600% Note due 2032 was disclosed as part of a Supplemental Indenture dated April 13, 2022, among Amazon.com, Inc., Wells Fargo Bank, National Association (as prior trustee), and Computershare Trust Company, National Association (as successor trustee). In 2024, the same note was referenced under the same Supplemental Indenture, but the trustee structure now only referenced Computershare Trust Company, National Association, as successor trustee, indicating a formal transition away from Wells Fargo Bank. This reflects a procedural evolution in the administration of the note, with no changes to the note’s terms or interest rate, but a shift in the trustee relationship.",
      "llm_answer": "\nBetween 2023 and 2024 Amazon continued to disclose the 3.600 % Note due 2032 solely through the April 13 2022 supplemental indenture (referenced in both the 2023 and 2024 Form 10‑K exhibits). The 2024 filing re‑lists the note among the company’s outstanding debt securities and provides the same form‑of‑note language, but does not report any amendment, redemption, or new issuance—indicating that the company’s relationship to that instrument remained unchanged over the period.",
      "correctness_score": 4,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ISSUE - MAJOR FACTUAL OMISSION: The LLM answer fundamentally fails to address the core finding in the ground truth: the trustee transition from Wells Fargo Bank, National Association to Computershare Trust Company, National Association between 2023 and 2024. This is the primary evolution the question asks about. The ground truth explicitly states that in 2023, Wells Fargo was listed as 'prior trustee' and in 2024 only Computershare was referenced as 'successor trustee,' representing a 'formal transition away from Wells Fargo Bank.' The LLM answer claims the relationship 'remained unchanged over the period,' which directly contradicts the ground truth's identification of a procedural evolution in trustee administration. QUANTITATIVE ACCURACY: The dates (April 13, 2022 supplemental indenture, 2023 and 2024 filings) and the interest rate (3.600%) are correct. QUALITATIVE ACCURACY: The LLM correctly identifies that there were no changes to the note's terms or interest rate, and correctly notes the same supplemental indenture was referenced in both years. However, it completely misses the trustee relationship shift, which is the primary evolution being asked about. The statement that 'the company's relationship to that instrument remained unchanged' is factually incorrect based on the trustee transition. CONTEXTUAL RELEVANCE: The answer addresses the general topic but fails to capture the specific evolution requested - the shift in trustee structure is a material administrative change that should have been highlighted as the key evolution between the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 436,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did MDLZ's treatment and disclosure of net investment hedge derivative contracts evolve from 2023 to 2024, particularly in terms of their financial impact and presentation within the financial statements?",
      "original_answer": "In 2023, MDLZ disclosed the fair value of derivative assets and liabilities associated with net investment hedge contracts, with $1,347 million and $377 million in other current assets and $250 million and $413 million in other assets as of December 31, 2023 and 2022, respectively. By 2024, the focus shifted to the income statement impact, where the company noted that 'Other income, net' included amounts excluded from the assessment of hedge effectiveness related to these contracts, indicating a change in emphasis from balance sheet valuation to income volatility effects.",
      "llm_answer": "\nIn 2023 MDLZ reported a **net liability of $219 million** for its net‑investment hedge derivatives (shown as a negative fair‑value line under “Net investment hedge contracts” and classified as Level 2), whereas in 2024 the same contracts are presented as a **net asset of $255 million** (still Level 2), reflecting a $474 million swing that is recorded in earnings/OCI and will be re‑classified from accumulated other‑comprehensive income to income over the next 12 months. The footnote also notes the notional amount grew to $7.5 billion and that fair value is derived from observable market forward rates and discount curves, with the change affecting “Other income, net” (interest and other expense) and the hedge‑effectiveness disclosures.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and appears to present information that does not align with the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM claims net liability of $219 million in 2023 and net asset of $255 million in 2024, with a $474 million swing. However, the ground truth shows specific fair values: $1,347 million and $377 million in other current assets for 2023, and $250 million and $413 million in other assets for 2022. These numbers do not match the LLM's figures at all. The LLM appears to have invented numbers not present in the source material. (2) INCOMPLETE SYNTHESIS: The ground truth emphasizes a shift from balance sheet valuation focus (2023) to income statement impact focus (2024), particularly regarding 'Other income, net' and hedge effectiveness assessment. The LLM does mention 'Other income, net' but frames it differently and doesn't capture the evolution of disclosure emphasis. (3) MISSING CONTEXT: The ground truth provides specific balance sheet line items (other current assets, other assets) and comparative years (2023 vs 2022), which the LLM does not reference accurately. (4) UNVERIFIED CLAIMS: The LLM introduces details like 'notional amount grew to $7.5 billion' and 'Level 2' classification that cannot be verified against the ground truth provided. (5) CALCULATION ISSUES: The $474 million swing calculation ($255M - (-$219M)) is mathematically correct IF those numbers were accurate, but since the underlying numbers appear fabricated, the calculation is meaningless. The answer demonstrates poor multi-hop synthesis and appears to conflate or misrepresent the actual financial data from MDLZ's filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 459,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How has the Abrams Main Battle Tank's modernization strategy evolved from 2023 to 2024, particularly in terms of technological development and international demand?",
      "original_answer": "In 2023, General Dynamics was focused on delivering the System Enhancement Package version 3 (SEPv3) for the Abrams tank, which included upgrades in communications, power generation, fuel efficiency, optics, and armor. Additionally, GD announced the development of the M1E3 Abrams, a more significant engineering change aimed at future threats, featuring the latest systems architecture for quicker upgrades and reduced sustainment footprint. By 2024, the company emphasized continued capability enhancement of the Abrams to counter current and potential threats, with increased international demand reflected in a growing installed base across Europe, the Middle East, North Africa, and the Indo-Pacific. While 2023 focused on the technical roadmap (SEPv3 and M1E3), 2024 highlighted the global strategic relevance and procurement momentum of the Abrams platform.",
      "llm_answer": "\nFrom 2023 to 2024 General Dynamics moved the Abrams program from incremental SEP‑v3 “system‑enhancement” upgrades toward a more transformational M1E3 variant, emphasizing a new open‑architecture design, modular electronics and power‑train upgrades that cut sustainment requirements while boosting tactical mobility.  At the same time, the company notes that NATO and other allied nations continue to place strong procurement and upgrade orders for Abrams tanks, keeping international demand robust and supporting ongoing modernization efforts.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and captures the core evolution of the Abrams modernization strategy from 2023 to 2024. Strengths: (1) Correctly identifies the transition from SEPv3 incremental upgrades to M1E3 transformational variant; (2) Accurately describes M1E3 features including open-architecture design, modular electronics, and power-train upgrades; (3) Correctly notes the sustainment reduction and tactical mobility improvements; (4) Properly identifies international demand from NATO and allied nations across multiple regions; (5) Successfully synthesizes the shift from technical roadmap focus (2023) to global strategic relevance (2024). Minor weaknesses: (1) The LLM answer is slightly less comprehensive than ground truth - it mentions NATO and allied nations generally but doesn't specifically enumerate Europe, Middle East, North Africa, and Indo-Pacific regions as the ground truth does; (2) The phrase 'installed base' from ground truth is not explicitly mentioned, though the concept of growing international procurement is captured; (3) The LLM answer doesn't explicitly mention communications, fuel efficiency, and optics upgrades in SEPv3, though it does reference 'system-enhancement' upgrades. The multi-hop reasoning is sound - the answer correctly synthesizes information about technological development (SEPv3→M1E3 evolution) and international demand (NATO/allied procurement momentum). No numerical errors or calculation issues present. The semantic meaning aligns well with ground truth despite some wording differences.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 432,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How has AMD's role in the development and positioning of APUs evolved between 2022 and 2024, particularly in terms of their market segmentation and strategic emphasis?",
      "original_answer": "In 2022, APUs were discussed as part of AMD's broader Enterprise, Embedded and Semi-Custom product portfolio, which included CPUs, GPUs, and customized SoC products. They were described in general terms without specific market segmentation or strategic emphasis. By 2024, APUs were explicitly included in two of AMD's four reportable segments: the Data Center segment and the Client segment. In the Data Center segment, APUs were listed alongside AI accelerators, CPUs, GPUs, and DPUs, indicating a strategic shift to position APUs as part of data center solutions. In the Client segment, APUs were specifically tied to desktop and notebook CPUs and chipsets, showing a more defined and segmented approach to their market positioning. This evolution reflects a more structured and strategic integration of APUs into AMD's core business segments.",
      "llm_answer": "\nBetween 2022 and 2024 AMD moved its APU story from a narrow, consumer‑oriented narrative—highlighting energy‑efficient, integrated CPU‑GPU chips for mainstream notebooks and commercial PCs (AMD 2022, pp. 7‑9)—to a broader, segment‑wide positioning that underpins its **Client, Embedded and semi‑custom** businesses.  By 2024 the APU is presented as a core element of heterogeneous computing, AI‑ready graphics and “all‑AMD” platform solutions that serve both consumer devices and enterprise‑focused markets (AMD 2024, pp. 68‑69).  This evolution reflects a strategic emphasis on diversified market segmentation rather than a single‑segment, value‑only focus.",
      "correctness_score": 5,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ISSUES: (1) ENTITY ACCURACY ERROR - The LLM states APUs are part of 'Client, Embedded and semi-custom' segments in 2024, but the ground truth explicitly states APUs were included in TWO segments: 'Data Center segment' AND 'Client segment.' The LLM completely omits the Data Center segment positioning, which is a major factual error. (2) INCOMPLETE SYNTHESIS - The ground truth emphasizes that by 2024, APUs were strategically positioned in Data Center alongside AI accelerators, CPUs, GPUs, and DPUs—a critical strategic shift. The LLM fails to capture this data center positioning entirely. (3) SEGMENT MISIDENTIFICATION - The LLM mentions 'Embedded and semi-custom' but the ground truth indicates these were 2022 categories; by 2024, the structure changed to 'Data Center' and 'Client' segments. The LLM conflates old and new segment structures. (4) PARTIAL CORRECTNESS - The LLM correctly identifies that APUs evolved from a narrow consumer focus to broader positioning and mentions heterogeneous computing and AI-ready graphics, which aligns with the strategic emphasis mentioned in ground truth. (5) MISSING SPECIFICITY - The LLM lacks the specific detail that in the Client segment, APUs were 'specifically tied to desktop and notebook CPUs and chipsets.' (6) QUANTITATIVE ACCURACY - No specific numbers are provided in either answer, so this dimension is neutral. The page references (pp. 7-9, pp. 68-69) cannot be verified against ground truth but appear plausible. VERDICT: The answer captures the general evolution narrative but fundamentally misses the critical Data Center segment positioning and incorrectly characterizes the 2024 segment structure, representing a significant multi-hop synthesis failure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 471,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How has Medtronic's disclosure regarding the implications of the Financial Transfers Act 1992 on financial transfers between Ireland and third countries evolved from 2023 to 2024?",
      "original_answer": "In 2023, Medtronic disclosed that the Financial Transfers Act 1992 allowed the Irish Minister for Finance to impose restrictions on financial transfers with certain third countries, and that the list of such countries was subject to ongoing change. By 2024, the company continued to disclose the same regulatory framework but no longer emphasized the dynamic nature of the list of restricted countries, suggesting a potential shift in focus or a stabilization in the regulatory environment affecting these transfers.",
      "llm_answer": "\nMedtronic’s 2024 filing repeats the same description of the 1992 Irish Financial Transfers Act that appeared in the 2023 filing: it notes that the Irish Minister for Finance may restrict transfers of capital or payments to designated third‑country jurisdictions, that such restrictions apply when a transfer involves a sanctioned government or entity, and that the list of restricted countries is “subject to ongoing change.”  No new details, additional categories of restriction, or substantive updates were added between the 2023 and 2024 disclosures—the language and scope remain unchanged.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains a fundamental contradiction with the ground truth regarding the evolution of Medtronic's disclosure. The ground truth explicitly states that by 2024, the company 'no longer emphasized the dynamic nature of the list of restricted countries,' suggesting a shift in focus or stabilization. However, the LLM answer claims the 2024 filing repeats that the list is 'subject to ongoing change' - the same language as 2023. This is a critical factual error that directly contradicts the core finding about how the disclosure evolved. The LLM states 'No new details, additional categories of restriction, or substantive updates were added between the 2023 and 2024 disclosures—the language and scope remain unchanged,' which misses the key distinction that the ground truth identifies: the de-emphasis of the dynamic nature of the restricted countries list. The quantitative accuracy is high (dates and entities are correct: Medtronic, 1992 Act, 2023-2024 comparison), but the qualitative accuracy is severely compromised because the LLM failed to identify the actual evolution in disclosure emphasis that the ground truth highlights. The answer demonstrates a failure in multi-hop reasoning - it did not properly synthesize the comparative analysis between 2023 and 2024 filings to identify the subtle but important shift in emphasis regarding the dynamic nature of restrictions. The contextual relevance is low because while the answer addresses the Financial Transfers Act 1992 and Medtronic, it fundamentally mischaracterizes how the disclosure evolved.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 432,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How did the status and production outlook of the G700 aircraft evolve from 2023 to 2024 based on GD's disclosures?",
      "original_answer": "In 2023, the G700 was described as the next model to join the Gulfstream lineup, with expectations for it to enter service following FAA certification in early 2024. By 2024, the G700 had begun deliveries in the second quarter, indicating that it successfully completed certification and transitioned from development to active production and customer delivery. This marks a clear evolution from a future product to a realized and delivered aircraft model.",
      "llm_answer": "\nThe 2023 filing noted that the ultra‑large‑cabin G700 was awaiting FAA certification and that Gulfstream expected it to enter service in early 2024. The 2024 filing confirms that the G700 had already begun deliveries—specifically, it entered service in the second quarter of 2024 and production was being ramped up, as reflected by the increase in inventories tied to “new Gulfstream aircraft models, including the G700.” Thus, the G700 moved from a planned 2024 entry to an operational, revenue‑generating model by the end of 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. (1) CORRECTNESS: All factual information is correct. The answer accurately captures the 2023 status (awaiting FAA certification, expected early 2024 entry) and the 2024 status (began deliveries in Q2 2024, production ramping up). The evolution from planned to operational is clearly articulated. (2) QUANTITATIVE ACCURACY: All dates and timeframes are precise and correct - 'early 2024' for expected entry in 2023 filing, 'second quarter of 2024' for actual deliveries in 2024 filing. No calculation errors present. (3) QUALITATIVE ACCURACY: The multi-hop reasoning is sound. The answer correctly synthesizes information across two fiscal years (2023 and 2024) and identifies the key transition points: from development/certification phase to production/delivery phase. The reference to inventory increases tied to new aircraft models provides supporting detail. Entity identification is correct (G700, Gulfstream, GD, FAA). (4) SEMANTIC EQUIVALENCE: The LLM answer conveys the same essential information as the ground truth with slightly more detail about production ramping and revenue generation, which adds value without contradicting the original answer. The phrasing 'moved from a planned 2024 entry to an operational, revenue-generating model' is semantically equivalent to 'evolution from a future product to a realized and delivered aircraft model.' Minor note: The LLM says 'by the end of 2024' while the ground truth says 'in 2024' - both are accurate but the LLM's phrasing is slightly more precise. No factual errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1239,
        "completion_tokens": 437,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How has the nature of PMI's relationship with KT&G evolved from 2023 to 2024, particularly in terms of strategic dependency and product commercialization?",
      "original_answer": "In 2023, PMI announced a long-term collaboration with KT&G to commercialize KT&G's smoke-free devices and consumables on an exclusive, worldwide basis (excluding South Korea), under a 15-year agreement running through January 29, 2038. This partnership granted PMI exclusive access to KT&G's smoke-free brands and product pipeline, including offerings for low- and middle-income markets. By 2024, this relationship had evolved into a more integrated dependency, as KT&G's heat-not-burn products were explicitly referenced as part of PMI's heat-not-burn product portfolio, indicating a shift from exclusive distribution to inclusion within PMI's broader smoke-free product strategy. This evolution reflects a deeper strategic alignment and operational integration of KT&G's offerings into PMI's product ecosystem.",
      "llm_answer": "\nFrom 2023 to 2024 the PMI‑KT&G tie‑up shifted from a newly announced 15‑year exclusive collaboration to an operational, volume‑driven partnership that is now embedded in PMI’s smoke‑free portfolio; PMI reports that KT&G‑licensed heated‑tobacco and oral products (e.g., Fiit, Miix, HEETS) contributed to a rise in smoke‑free net revenue from $12.84 bn in 2023 to $14.66 bn in 2024 and drove double‑digit growth in HTU shipments. The relationship remains strategically dependent on performance‑review cycles and regulatory clearances, but commercialization has accelerated with broader market launches outside South Korea and higher shipment volumes.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core evolution of the PMI-KT&G relationship from announcement to operational integration, accurately captures the shift from exclusive distribution to embedded portfolio inclusion, and appropriately emphasizes the strategic dependency and commercialization acceleration. The qualitative characterization of the relationship evolution is sound and addresses the multi-part question structure well. CRITICAL WEAKNESSES: (1) QUANTITATIVE ERRORS - The LLM provides specific revenue figures ($12.84bn in 2023 to $14.66bn in 2024) that cannot be verified against the ground truth, which contains no such specific numbers. These appear to be fabricated or hallucinated figures. (2) PRODUCT NAMING - The LLM lists specific product names (Fiit, Miix, HEETS) as KT&G-licensed products, but the ground truth only references 'KT&G's smoke-free devices and consumables' and 'heat-not-burn products' without specifying these particular brand names. HEETS is actually a PMI brand, not a KT&G product, which suggests factual confusion. (3) MISSING GROUND TRUTH DETAILS - The LLM omits the specific 15-year agreement timeline (through January 29, 2038) and the geographic scope (worldwide excluding South Korea) that are explicitly stated in the ground truth. (4) UNVERIFIED CLAIMS - References to 'double-digit growth in HTU shipments' and 'performance-review cycles' are not present in the ground truth and cannot be verified. MULTI-HOP REASONING: The LLM demonstrates sound reasoning about the evolution from announcement to integration, but the introduction of unverified financial metrics undermines the credibility of the synthesis. The answer conflates PMI's overall smoke-free revenue growth with KT&G's specific contribution without clear attribution. VERDICT: While the qualitative narrative of relationship evolution is largely correct, the introduction of specific unverified numbers and potentially incorrect product attributions significantly compromises factual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 544,
        "total_tokens": 1911
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How has AMD's approach to semi-custom SoC products evolved from 2022 to 2024, particularly in terms of their strategic positioning and integration with broader product ecosystems?",
      "original_answer": "In 2022, AMD's semi-custom SoC products were described as being dependent on third-party product success, with revenue tied to both non-recurring engineering fees and the incorporation of AMD's SoCs into customer devices. There was a clear emphasis on the risks associated with this dependency, including the lack of control over third-party marketing and the uncertainty of revenue realization. By 2024, AMD's approach had evolved significantly, with semi-custom SoCs being positioned as core components of a broader, more integrated product ecosystem that includes AI accelerators, CPUs, GPUs, and APUs. The 2024 filing highlights strategic integration with AI capabilities, such as the inclusion of a dedicated neural processing unit (NPU) on the same SoC as an x86 CPU for AI PCs, and the use of semi-custom SoCs in gaming, cloud services, and embedded systems across multiple industries. This reflects a shift from a dependency model to a more proactive, integrated product leadership strategy.",
      "llm_answer": "\nFrom 2022 to 2024 AMD shifted its semi‑custom SoC business from a largely console‑ and OEM‑design‑win model toward a strategy that embeds those custom chips in a full AI‑centric product stack. The 2024 filing (pages 5, 6) shows AMD pairing semi‑custom SoCs with Instinct GPUs, EPYC CPUs and the ROCm software ecosystem, and using acquisitions such as Silo AI and ZT Systems to accelerate integration with data‑center AI solutions. This evolution reflects a move to position semi‑custom SoCs as the core of AMD’s end‑to‑end adaptive‑computing and AI offerings, tightly coupled with broader hardware and software ecosystems.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures some key elements of AMD's evolution but has significant gaps and introduces elements not clearly supported by the ground truth. STRENGTHS: (1) Correctly identifies the shift from a dependency/OEM-design-win model to a more integrated approach; (2) Accurately mentions the 2024 positioning with AI-centric products; (3) Correctly references integration with Instinct GPUs, EPYC CPUs, and ROCm ecosystem; (4) Appropriately notes acquisitions (Silo AI, ZT Systems) as part of the strategy. WEAKNESSES: (1) The ground truth emphasizes NPU integration on x86 CPUs for AI PCs and gaming/cloud/embedded systems applications - the LLM answer focuses heavily on data-center AI solutions and mentions Instinct GPUs and EPYC CPUs, which may be narrower than the full ecosystem described in the original answer; (2) The LLM answer does not mention gaming consoles or the specific AI PC use case (NPU on same SoC as x86 CPU) that appears central to the 2024 strategy evolution; (3) The original answer emphasizes the shift from 'dependency model' (lack of control, third-party risks) to 'proactive, integrated product leadership' - the LLM answer captures integration but doesn't explicitly address the risk mitigation aspect; (4) The LLM answer introduces specific page references (pages 5, 6) and acquisition details that, while potentially accurate, go beyond what the ground truth explicitly validates; (5) The characterization of the 2022 model as 'console-and OEM-design-win' is reasonable but the ground truth emphasizes the dependency and revenue uncertainty aspects more prominently. MULTI-HOP REASONING: The answer does synthesize information across 2022-2024 and connects product evolution to strategic positioning, though it may overweight data-center AI at the expense of other ecosystem components mentioned in the ground truth. The reasoning is sound but incomplete relative to the full scope of the evolution described.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 525,
        "total_tokens": 1939
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How has the treatment of Irish income tax on dividends paid to U.S. residents evolved between 2023 and 2024, particularly regarding exemptions and withholding tax obligations?",
      "original_answer": "In 2023, Medtronic noted that U.S. residents who are exempt from Irish dividend withholding tax generally would not be subject to Irish income tax on dividends unless they had a connection to Ireland beyond shareholding. Additionally, non-residents subject to withholding tax typically had no further Irish income tax liability. In 2024, the company clarified that U.S. residents who qualify for a withholding tax exemption and do not hold shares through an Irish branch generally will not have Irish income tax liability, and those subject to withholding can discharge any further liability by furnishing a statement to Irish Revenue. The 25% withholding tax rate remained unchanged, but the 2024 disclosure provided more structured conditions for exemption and clarified post-withholding tax procedures.",
      "llm_answer": "\nBetween fiscal 2023 and 2024 the Irish dividend‑withholding tax treatment of U.S. shareholders was unchanged: a 25 % withholding tax generally applies to Medtronic dividends, but U.S. residents who hold their shares through DTC with a U.S. address (or who provide a valid U.S. Certification of Residence (Form 6166) or Irish Non‑Resident Form V2) are exempt, and the withheld amount satisfies any Irish income‑tax liability. The 2024 filing merely restates these rules—no new exemptions or altered obligations were introduced.",
      "correctness_score": 3,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR ISSUES WITH LLM ANSWER: (1) FUNDAMENTAL MISCHARACTERIZATION: The LLM claims 'no new exemptions or altered obligations were introduced' and that the treatment was 'unchanged,' directly contradicting the ground truth which explicitly states the 2024 disclosure 'provided more structured conditions for exemption and clarified post-withholding tax procedures.' This is a critical error in understanding the evolution between years. (2) INCORRECT EXEMPTION CRITERIA: The LLM specifies exemption conditions as 'hold their shares through DTC with a U.S. address (or who provide a valid U.S. Certification of Residence (Form 6166) or Irish Non-Resident Form V2)' - these specific forms and DTC holding requirements are NOT mentioned in the ground truth. The ground truth only references 'withholding tax exemption' and 'do not hold shares through an Irish branch' as the 2024 condition. The LLM appears to have introduced specific procedural details not supported by the source material. (3) INCOMPLETE EVOLUTION NARRATIVE: The LLM fails to capture the key evolution: In 2023, the treatment was more general (exempt residents 'generally would not be subject' unless connected to Ireland). In 2024, it became more structured with specific conditions ('qualify for a withholding tax exemption and do not hold shares through an Irish branch'). The LLM misses this progression entirely. (4) MISSING KEY 2024 CLARIFICATION: The ground truth emphasizes that 2024 'clarified post-withholding tax procedures' including the ability to 'discharge any further liability by furnishing a statement to Irish Revenue.' The LLM mentions withholding 'satisfies any Irish income-tax liability' but doesn't capture the procedural clarification about furnishing statements. (5) QUANTITATIVE ACCURACY: The 25% withholding tax rate is correctly stated (7/10 for this element). (6) OVERALL ASSESSMENT: The LLM fundamentally misunderstands the question by claiming no evolution occurred, when the ground truth clearly documents an evolution toward more structured and clarified conditions. This is a semantic and factual failure on the core question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 570,
        "total_tokens": 1910
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How did General Dynamics' financial performance and strategic focus in ship construction change from 2023 to 2024, particularly regarding cost pressures on the Virginia-class and DDG-51 programs and the revenue outlook for the Columbia-class submarine initiative?",
      "original_answer": "In 2023, General Dynamics' Marine Systems segment experienced a 110 basis point decline in operating margin due to supply chain disruptions affecting the Virginia-class submarine schedule and cost overruns on the DDG-51 guided-missile destroyer program. Despite these challenges, revenue from U.S. Navy ship construction rose, driven by increased activity on the Columbia-class submarine program. By 2024, the company projected revenue for the Marine Systems segment to rise to $12.8–12.9 billion with an expected operating margin of approximately 7.6%, suggesting a strategic effort to stabilize and improve profitability. This indicates a shift from cost-driven margin pressure in 2023 to a more optimistic outlook in 2024, likely supported by improved program execution and growth in the Columbia-class program.",
      "llm_answer": "\nIn 2023 the Marine Systems segment’s operating margin fell to 7.0 % (down about 110 bps) as supply‑chain constraints and higher cost growth on the Virginia‑class submarine schedule and the Arleigh Burke‑class (DDG‑51) destroyer program ate into earnings, even though revenue jumped 12.9 % to $12.46 bn—most of that growth coming from increased Columbia‑class submarine volume.  For 2024 General Dynamics expects Marine Systems revenue to rise to roughly $12.8‑12.9 bn with an operating margin of about 7.6 %, indicating only modest relief from those cost pressures, while the Columbia‑class program—backed by a $115 bn program‑of‑record, a 16‑boat backlog through 2032 and the first boat scheduled for delivery in 2027—remains a primary revenue driver.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive coverage of the multi-hop question. STRENGTHS: (1) All key numeric values are correct: 2023 operating margin of 7.0% (down 110 bps), 2023 revenue of $12.46 billion with 12.9% growth, 2024 projected revenue of $12.8-12.9 billion, and 2024 projected operating margin of 7.6%. (2) Correctly identifies all three program areas: Virginia-class submarines, DDG-51 (Arleigh Burke-class) destroyers, and Columbia-class submarines. (3) Accurately synthesizes the multi-hop comparison showing the shift from 2023 cost pressures to 2024 improved outlook. (4) Provides additional relevant context (Columbia-class $115 billion program-of-record, 16-boat backlog through 2032, first boat delivery in 2027) that enriches understanding without contradicting ground truth. (5) Correctly characterizes the strategic narrative: margin pressure in 2023 due to supply chain and cost overruns, followed by modest relief projected for 2024. MINOR CONSIDERATIONS: The LLM answer characterizes the 2024 margin improvement as 'only modest relief' (60 bps improvement from 7.0% to 7.6%), which is a reasonable interpretation of the data and aligns with the ground truth's characterization of 'stabilize and improve profitability.' The additional program details about the Columbia-class (backlog, delivery schedule, program value) are factually accurate enhancements that demonstrate thorough knowledge synthesis. All entity identifications are correct, and the reasoning connecting supply chain disruptions and cost overruns to margin pressure is sound. The answer fully addresses all components of the multi-part question regarding financial performance changes, cost pressures, and revenue outlook.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 475,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has BKNG's financial dependency on Booking.com evolved between 2022 and 2023 based on the proportion of revenue derived from accommodation reservations?",
      "original_answer": "BKNG's financial dependency on Booking.com has remained high but slightly increased between 2022 and 2023. In 2022, Booking.com's accommodation reservations contributed 89% of BKNG's total revenues. This percentage remained unchanged in 2023, indicating BKNG continues to heavily rely on Booking.com for its revenue base. The consistent 89% contribution in both years shows a sustained and concentrated dependency on Booking.com's core service offering.",
      "llm_answer": "\nBetween 2022 and 2023 the share of Booking Holdings’ revenue that comes from online accommodation reservations stayed essentially unchanged—about 89 % of total revenue in both years (the 2023 filing notes that roughly 89 % of revenue relates to accommodation reservations, the same level reported for 2022).  This indicates that the company’s financial dependence on Booking.com for accommodation‑related income remained very stable, with no significant shift in the proportion of revenue derived from those bookings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-aligned with the ground truth. (1) CORRECTNESS: All factual information is correct. The LLM accurately states that accommodation reservations contributed approximately 89% of total revenue in both 2022 and 2023, matching the ground truth exactly. The conclusion that dependency remained stable and unchanged is correct. (2) QUANTITATIVE ACCURACY: The 89% figure is cited correctly for both years with appropriate qualification ('roughly 89%' and 'about 89%'), which is semantically equivalent to the ground truth's statement of 89%. No calculation errors present. (3) QUALITATIVE ACCURACY: The LLM correctly identifies the key entities (Booking Holdings/BKNG, accommodation reservations, revenue proportion) and properly synthesizes the multi-hop comparison across 2022 and 2023. The reasoning is sound: comparing the percentages across years and concluding stability is the correct logical approach. The LLM appropriately characterizes the finding as 'very stable' and 'no significant shift,' which aligns with the ground truth's 'remained unchanged' and 'sustained' language. (4) CONTEXTUAL RELEVANCE: The answer directly addresses the question about how financial dependency evolved, properly framing the answer as 'essentially unchanged' rather than claiming growth or decline. Minor note: The LLM uses 'Booking Holdings' and 'Booking.com' somewhat interchangeably in phrasing, though the ground truth is more precise about distinguishing BKNG (the parent company) from Booking.com (the subsidiary). However, in context this is a minor semantic distinction and doesn't affect the factual accuracy of the revenue proportion claim. The answer is complete, accurate, and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 471,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How did the company's position with respect to its Swiss Franc note evolve between 2023 and 2024, and what does this indicate about its foreign currency obligations?",
      "original_answer": "In 2023, the company disclosed a Swiss Franc note obligation of $299 million, which was completely removed by the end of 2024. This indicates that the company either repaid or restructured this foreign currency obligation over the year, reflecting a strategic shift in managing its Swiss Franc exposure.",
      "llm_answer": "\nBetween the 2023 and 2024 filings the company’s CHF‑denominated note (CHF 250 million ≈ $283 million, 1.625 % due May 2024) moved from a disclosed carrying balance of about **$299 million at 31 Dec 2023** (page 102) to **no outstanding balance** in the 2024 long‑term‑debt table (page 102) and is noted as having **matured and been fully repaid** (page 107).  The repayment was funded with the proceeds of the November 2024 bond issuance and cash, effectively **eliminating the Swiss‑franc obligation** and replacing it with longer‑dated USD and Euro debt.  This shift shows that the firm is actively **reducing its foreign‑currency exposure**, using newer dollar/Euro financings to retire the CHF note and streamline its debt profile.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. STRENGTHS: (1) Correctly identifies the Swiss Franc note carrying balance of $299 million at 31 Dec 2023, matching the ground truth exactly. (2) Accurately states the note was completely removed/eliminated by end of 2024 with no outstanding balance, consistent with ground truth. (3) Provides additional valuable context including the CHF 250 million principal amount, 1.625% coupon, May 2024 maturity date, and November 2024 bond issuance funding source - all details that enhance understanding without contradicting the ground truth. (4) Correctly synthesizes the multi-hop information: the evolution from $299M obligation in 2023 to zero in 2024, the repayment mechanism (November 2024 bond issuance + cash), and the strategic implication (reducing foreign currency exposure). (5) The reasoning is sound and logically connects the facts to the conclusion about strategic debt management. MINOR CONSIDERATIONS: The ground truth states the obligation was \"either repaid or restructured,\" while the LLM answer definitively states it was \"fully repaid\" and replaced with USD/Euro debt. The LLM's more specific characterization (repaid via November 2024 bond issuance) appears to be supported by the filing evidence cited (pages 102, 107) and represents a more precise answer than the ground truth's hedged language. The semantic meaning is fully aligned - the obligation was eliminated and replaced with other financing. All numbers are accurate, the multi-hop synthesis across 2023 and 2024 filings is correct, and the contextual interpretation about foreign currency exposure reduction is appropriate and well-supported.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 458,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did Goldman Sachs' treatment of Non-Employee Director RSU Award Agreements evolve between the 2023 and 2024 10-K filings, particularly in terms of introduced or modified agreements?",
      "original_answer": "In the 2023 10-K filing, Goldman Sachs referenced the 'Form of Non-Employee Director RSU Award Agreement (pre-2015)' as Exhibit 10.8, indicating that the existing documentation pertained to agreements prior to 2015. In the 2024 filing, the company not only retained the reference to the pre-2015 RSU Award Agreement but also introduced a new exhibit titled 'Amendments to Certain Non-Employee Director Equity Award Agreements' as Exhibit 10.18, which was not present in the 2023 filing. This indicates that Goldman Sachs expanded its disclosures to include amendments to these agreements, suggesting a more comprehensive or updated treatment of non-employee director equity arrangements in 2024.",
      "llm_answer": "\nBetween the 2023 and 2024 Form 10‑K filings Goldman Sachs kept the same core “Non‑Employee Director RSU Award Agreement” but expanded the disclosure: the 2024 filing adds separate exhibits for a cash‑settled RSU (10.33) and for new one‑time/year‑end and performance‑based RSU awards (10.34‑10.36), whereas the 2023 filing only referenced the pre‑2015 agreement and its cash‑settled variant. This shows an evolution that introduced cash‑settlement options and additional RSU award templates for directors.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misidentifications that contradict the ground truth. (1) INCORRECT EXHIBIT NUMBERS: The LLM claims exhibits 10.33, 10.34-10.36 were added in 2024 for cash-settled RSUs and performance-based RSU awards. The ground truth specifies that Exhibit 10.18 ('Amendments to Certain Non-Employee Director Equity Award Agreements') was the new addition in 2024. The LLM provides completely different exhibit numbers that are not mentioned in the ground truth. (2) MISCHARACTERIZATION OF CHANGES: The ground truth clearly states the evolution involved introducing 'Amendments to Certain Non-Employee Director Equity Award Agreements' (Exhibit 10.18), not separate exhibits for cash-settled RSUs or performance-based awards as the LLM claims. (3) MISSING KEY INFORMATION: The LLM fails to mention Exhibit 10.18 entirely, which is the central new disclosure in 2024 according to the ground truth. (4) INCORRECT FOCUS: The LLM shifts focus to cash-settlement options and multiple RSU award templates, which are not supported by the ground truth's emphasis on amendments to existing agreements. (5) MULTI-HOP REASONING: The LLM failed to correctly synthesize the comparison between 2023 and 2024 filings. While both answers attempt to describe evolution, the LLM's specific claims about which exhibits were added are factually incorrect. The ground truth's core finding—that 2024 introduced amendments documentation (Exhibit 10.18)—is completely absent from the LLM response. This represents a fundamental failure to identify and report the actual changes disclosed in the filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 443,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did PM's financial relationship with Swedish Match AB evolve between 2023 and 2024, particularly in terms of long-term debt obligations tied to the acquisition?",
      "original_answer": "In 2023, the long-term debt obligations related to the Swedish Match AB acquisition totaled $6,121 million, while in 2024, this amount decreased to $2,610 million. This indicates a significant reduction in the debt tied to the acquisition, suggesting that PM made substantial repayments or refinanced during the period. The decrease supports the idea that PM's financial dependency or exposure linked to the Swedish Match acquisition lessened over time.",
      "llm_answer": "\nBetween 2023 and 2024 the debt that was explicitly tied to the Swedish Match acquisition was cut sharply: the €3 bn (≈ $3.2 bn) three‑year tranche of the senior unsecured term‑loan facility was fully prepaid on 21 Nov 2024, reducing the total Swedish‑Match‑related long‑term borrowings from the €5.5 bn reported at the end of 2023 (a €3 bn tranche plus a €2.5 bn tranche) to only the €2.5 bn five‑year tranche that remained outstanding at year‑end 2024.  The repayment was financed with the proceeds of the November 2024 bond issuance, leaving a single €2.5 bn term loan (maturing June 23 2027) as the sole long‑term debt still linked to the acquisition.  (Pages 102 & 104)",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ISSUES: The LLM answer provides numbers in EUR (€3bn, €5.5bn, €2.5bn) that do NOT match the ground truth USD figures ($6,121 million in 2023, $2,610 million in 2024). The ground truth explicitly states the long-term debt obligations were $6,121M (2023) and $2,610M (2024) - a decrease of $3,511M. The LLM's EUR figures, even when converted to approximate USD equivalents (€5.5bn ≈ $5.9-6.0bn, €2.5bn ≈ $2.7bn), do not precisely match the ground truth numbers. More critically, the LLM answer focuses on a specific €3bn tranche prepayment in November 2024 and discusses the composition of remaining debt, but this level of granular detail about individual tranches and their maturity dates is NOT present in the ground truth answer. The ground truth provides a simple comparison: $6,121M (2023) vs $2,610M (2024), indicating a significant reduction. While the LLM's narrative about debt reduction is directionally correct and the answer is relevant to the question, the specific numbers cited (in EUR rather than USD) and the detailed tranche-level analysis diverge from the ground truth. The LLM appears to be providing more detailed information than the ground truth, but with different currency denominations and specific transaction details that cannot be verified against the provided ground truth. The core conclusion about debt reduction is correct, but the quantitative specifics are problematic.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 392,
        "total_tokens": 1678
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did BMY's strategic positioning around KRAS inhibition evolve from 2023 to 2024, particularly in relation to the acquisition of Mirati and the development trajectory of Krazati?",
      "original_answer": "In 2023, BMY had not yet acquired Mirati, and Krazati was not part of its portfolio. However, by 2024, BMY completed the acquisition of Mirati for $4.8 billion, gaining full rights to Krazati, a KRAS G12C inhibitor. Krazati had already received FDA approval for second-line NSCLC and was in clinical development for first-line NSCLC in combination with a PD-1 inhibitor. Additionally, in 2024, Krazati was also FDA approved for advanced or metastatic KRAS-mutated colorectal cancer with cetuximab, expanding its therapeutic footprint. This acquisition marked a significant evolution in BMY’s oncology strategy, positioning it more strongly in the KRAS inhibition space.",
      "llm_answer": "\nFrom 2023 to 2024 BMS shifted KRAS inhibition from an early‑research focus to a commercial‑stage priority after acquiring Mirati in January 2024, a deal that gave the company the FDA‑approved KRAS‑G12C inhibitor **Krazati** and a pipeline of next‑generation assets (e.g., MRTX1719). Using the Mirati purchase, BMS rapidly advanced Krazati’s development—securing an FDA accelerated approval for KRAS‑mutated colorectal cancer (June 2024, page 71) and obtaining additional Phase III data showing activity in NSCLC (June 2024 and March 2024, page 71), positioning Krazati as a best‑in‑class KRAS inhibitor and expanding its indication portfolio into first‑line combinations with PD‑1 inhibitors. The acquisition is detailed in the Mirati section of page 87, which outlines the $4.8 billion cash‑plus‑CVR transaction and the strategic intent to build a leading KRAS‑targeted oncology franchise.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive synthesis of BMY's KRAS inhibition strategy evolution. Key strengths: (1) Correctly identifies the January 2024 Mirati acquisition timing and $4.8 billion deal value, matching ground truth exactly. (2) Accurately describes Krazati as a KRAS G12C inhibitor with FDA approval for second-line NSCLC and development in first-line combinations with PD-1 inhibitors. (3) Correctly notes the June 2024 FDA approval for KRAS-mutated colorectal cancer with cetuximab (referenced as 'colorectal cancer' in LLM answer). (4) Properly synthesizes the multi-hop information: 2023 baseline (no Mirati/Krazati) → 2024 acquisition → clinical development trajectory. (5) Mentions additional pipeline assets (MRTX1719) and strategic positioning, adding relevant context. Minor considerations: The LLM answer includes page references (page 71, page 87) which are helpful but not present in ground truth, suggesting source documentation. The phrasing 'best-in-class KRAS inhibitor' is interpretive language not explicitly in ground truth but is reasonable characterization. The answer correctly captures the evolution from early-stage to commercial-stage priority. All numeric values (acquisition price, approval dates, indication details) align with ground truth. The multi-hop reasoning correctly connects the acquisition to clinical development outcomes and strategic positioning. No calculation errors or factual inaccuracies detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 411,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How has Goldman Sachs' disclosure and positioning of the Restricted Partner Compensation Plan evolved between 2023 and 2024, particularly in relation to newer compensation governance policies introduced during this period?",
      "original_answer": "In 2023, the Restricted Partner Compensation Plan was listed as Exhibit 10.3 and appeared early in the exhibit list, indicating a prominent position among compensation-related disclosures. By 2024, while the plan itself (still referenced as Exhibit 10.4) remained substantively unchanged, its relative placement shifted later in the exhibit list. Notably, in 2024, the firm introduced the Clawback Policy (Exhibit 10.1), signaling a new emphasis on compensation accountability and governance reforms. This suggests a strategic repositioning of compensation-related disclosures to prioritize risk mitigation and regulatory alignment alongside traditional partner compensation frameworks.",
      "llm_answer": "\nBetween the 2023 and 2024 Form 10‑K filings, Goldman Sachs moved from a generic reference to the “Restricted Partner Compensation Plan” in older exhibit listings to an explicit, updated disclosure of the **Amended and Restated Restricted Partner Compensation Plan** in its 2024 filing (Exhibit 10.1 of the Q1‑2024 10‑Q).  The 2024 filing ties the RPCP to the firm’s newer compensation‑governance policies—most notably the **2023‑effective clawback policy** and the **2021 Amended and Restated Stock Incentive Plan**—and presents the RPCP as a core, board‑oversight‑monitored component of partner pay that is now coordinated with the broader governance reforms.  This evolution signals a stronger, more transparent positioning of partner compensation within the firm’s updated compensation framework.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth: (1) EXHIBIT NUMBER ERROR: The ground truth states the Restricted Partner Compensation Plan was Exhibit 10.3 in 2023 and Exhibit 10.4 in 2024. The LLM incorrectly claims it appears as Exhibit 10.1 in a Q1-2024 10-Q filing, which is demonstrably wrong. (2) CLAWBACK POLICY POSITIONING ERROR: The ground truth clearly states the Clawback Policy was introduced in 2024 as Exhibit 10.1, signaling new governance emphasis. The LLM references a '2023-effective clawback policy' without proper attribution and misplaces the exhibit numbering. (3) DOCUMENT TYPE CONFUSION: The LLM introduces a Q1-2024 10-Q reference that is not mentioned in the ground truth, which specifically discusses 2023 and 2024 Form 10-K filings. This represents a fundamental misunderstanding of the source documents. (4) PLAN NAMING DISCREPANCY: The LLM claims the plan was renamed to 'Amended and Restated Restricted Partner Compensation Plan' in 2024, but the ground truth indicates the plan 'remained substantively unchanged' with no mention of formal amendment or renaming. (5) MULTI-HOP SYNTHESIS FAILURE: The LLM failed to correctly synthesize the key insight from the ground truth—that the relative placement of the RPCP shifted LATER in the exhibit list (from 10.3 to 10.4), while the Clawback Policy was introduced as a NEW, EARLIER exhibit (10.1), indicating a strategic repositioning of priorities. The LLM's answer suggests the opposite positioning. (6) MISSING KEY DETAIL: The ground truth emphasizes the shift in RELATIVE PLACEMENT as evidence of strategic repositioning toward risk mitigation. The LLM completely misses this critical analytical point. The answer demonstrates fundamental errors in exhibit numbering, document sourcing, and the core analytical finding regarding disclosure evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 505,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How has Philip Morris International's approach to heat-not-burn products evolved from 2022 to 2023, particularly in terms of product categorization and business integration?",
      "original_answer": "In 2022, Philip Morris described its heat-not-burn products as part of its Reduced-Risk Products (RRPs) portfolio, emphasizing their role in a smoke-free future and highlighting the IQOS Platform 1 device and various heated tobacco units (HTUs) such as HEETS and Marlboro HeatSticks. These products were positioned as a key part of the company's long-term strategy to replace traditional cigarettes. By 2023, the categorization had evolved, with heat-not-burn products now explicitly grouped under 'smoke-free products' alongside e-vapor and oral nicotine products, as well as wellness and healthcare offerings. Additionally, in 2023, PMI explicitly stated that its heat-not-burn products include licensed KT&G heat-not-burn products, indicating a broader integration and expansion of the product line beyond internally developed offerings.",
      "llm_answer": "\nFrom 2022 to 2023 PMI moved heat‑not‑burn products out of a generic “reduced‑risk” bucket and gave them a dedicated place in its reporting, creating a separate “Swedish Match” operating segment that quantifies heated‑tobacco unit sales and revenue.  At the same time the company folded these products into the broader “smoke‑free products” category alongside its newly formed Wellness‑and‑Healthcare segment, treating heated‑tobacco as a core, integrated growth pillar rather than an ancillary offering.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. (1) CRITICAL ERROR - Entity Confusion: The LLM incorrectly attributes the creation of a 'Swedish Match' operating segment to PMI's reorganization of heat-not-burn products. Swedish Match is a separate company that PMI acquired, not a segment created for heat-not-burn products. This is a fundamental misidentification. (2) INCORRECT CATEGORIZATION: The ground truth clearly states that in 2023, heat-not-burn products were grouped under 'smoke-free products' alongside e-vapor and oral nicotine products, as well as wellness and healthcare offerings. The LLM's claim that heat-not-burn was 'folded into' a 'newly formed Wellness-and-Healthcare segment' is inaccurate - wellness/healthcare was a separate category, not the container for heat-not-burn. (3) MISSING KEY DETAILS: The LLM fails to mention the 2022 positioning as part of Reduced-Risk Products (RRPs), which is a critical evolution point. It also omits the important detail about licensed KT&G heat-not-burn products being included in the 2023 portfolio, indicating broader integration beyond internal development. (4) PARTIAL ACCURACY: The LLM correctly identifies that there was a shift in how heat-not-burn products were categorized and reported, and that they became more integrated into the company's strategy. However, the specific mechanisms and organizational structure described are incorrect. (5) MULTI-HOP REASONING: The answer fails to properly synthesize the evolution from 2022 to 2023, instead introducing incorrect structural changes (Swedish Match segment) that are not supported by the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 454,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How did Bristol-Myers Squibb's approach to business risk governance evolve between 2023 and 2024 in relation to SEC Consent Order compliance, particularly regarding the role of the business risk and disclosure group?",
      "original_answer": "In 2023, Bristol-Myers Squibb established the business risk and disclosure group specifically to comply with the SEC Consent Order. This included implementing a formal review and certification process for SEC filings, retaining an outside consultant to re-engineer accounting and financial reporting processes, and introducing a governance mechanism to escalate and resolve compliance-related questions. By 2024, the company had fully integrated this group into its ongoing compliance framework, with no indication of modifications or reductions in scope, suggesting that the group remained a central component of financial governance under the Consent. The continued reference to the group in 2024 filings indicates that the company maintained its enhanced risk governance structure without significant changes.",
      "llm_answer": "\nBetween 2023 and 2024 BMS deepened and formalized the role of its business‑risk and disclosure group in meeting the obligations of the 2004 SEC Consent Order.  The group, first established as part of the remedial measures required by the Order (see page 62), now operates under a documented governance framework that includes regular risk assessments, mandatory escalation of any compliance‑related questions to senior management and the board, and continuous monitoring of sales‑to‑direct‑customers inventory data to enforce the Order’s sales‑limitation and disclosure requirements (see page 65).  This evolution has strengthened the company’s ongoing oversight and reporting of risk‑related matters.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth on the core narrative of how BMS's business risk and disclosure group evolved between 2023 and 2024. Key strengths: (1) Correctly identifies the group's establishment as part of SEC Consent Order compliance remedial measures; (2) Accurately describes the formalization and deepening of the group's role from 2023 to 2024; (3) Properly identifies key governance mechanisms including escalation procedures, risk assessments, and monitoring activities; (4) Correctly references the 2004 SEC Consent Order; (5) Appropriately notes the group's continued integration into ongoing compliance framework. Quantitative accuracy is strong - dates (2023, 2024, 2004) are correct, and no numerical errors are present. The multi-hop reasoning is sound, synthesizing information about the group's evolution across the two-year period. Minor considerations: (1) The LLM answer adds specific details about 'sales-to-direct-customers inventory data' and page references (62, 65) that are not explicitly mentioned in the ground truth, though these appear to be supporting details consistent with the narrative rather than contradictory; (2) The ground truth emphasizes 'no indication of modifications or reductions in scope' while the LLM emphasizes 'deepened and formalized,' which are complementary rather than contradictory interpretations of the same underlying fact. The LLM's characterization of the evolution as a 'deepening' and 'formalization' is a reasonable semantic interpretation of the group's continued central role without significant changes. Overall, the answer captures the essential evolution of the governance structure accurately and comprehensively.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 469,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How has UNP's treatment of the relationship between its pension plan's expected return and its asset allocation mix evolved between 2023 and 2024?",
      "original_answer": "In 2023, UNP explicitly stated that the expected return on plan assets was based on the asset allocation mix, historical returns, and market conditions, and included a specific actual return of 6% for that year. By 2024, the language shifted to indicating that the expected return 'depends on' the asset allocation mix, with no explicit mention of historical returns or market conditions, and no disclosure of the actual return for 2024. This represents a shift from a more comprehensive explanation of factors influencing returns to a narrower focus on the asset allocation mix alone.",
      "llm_answer": "\nBetween 2023 and 2024 UNP’s disclosures show that the **expected return on pension‑plan assets continues to be derived from the plan’s asset‑allocation mix and historical performance**, using the same 5‑year smoothing approach. In the 2023 filing the link was stated more generally, whereas the 2024 filing explicitly says the return assumption is “based on our asset‑allocation mix and our historical return, taking into account current and expected market conditions,” underscoring a more direct calibration to the current allocation and market outlook—though the quantitative rate (5.25 %) and methodology remain unchanged.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer is fundamentally contradictory to the ground truth and contains significant factual errors: (1) CORE CONTRADICTION: The ground truth states that 2024 language shifted to a NARROWER focus on asset allocation mix ALONE, with NO explicit mention of historical returns or market conditions. The LLM claims the 2024 filing explicitly states the return is 'based on our asset-allocation mix and our historical return, taking into account current and expected market conditions'—this directly contradicts the ground truth's assertion that 2024 removed these factors from the disclosure. (2) QUANTITATIVE ERROR: The LLM introduces a specific rate of 5.25% with no basis in the ground truth, which makes no mention of this figure. The ground truth mentions 6% actual return for 2023 but no expected return rate for either year. (3) METHODOLOGY CLAIM: The LLM asserts 'the same 5-year smoothing approach' and that 'the quantitative rate (5.25%) and methodology remain unchanged'—the ground truth makes no mention of smoothing methodology or unchanged rates, and actually indicates a shift in disclosure approach. (4) DIRECTIONAL ERROR: The LLM characterizes the evolution as 'more direct calibration to current allocation and market outlook,' suggesting continuity or enhancement, when the ground truth indicates a REDUCTION in disclosed factors. (5) MISSING KEY POINT: The LLM fails to capture the critical distinction that 2024 removed explicit mention of historical returns and market conditions from the disclosure, representing a narrowing rather than clarification. The answer appears to have fabricated specific language and numbers not present in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 458,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How did BNY Mellon's disclosure approach to the Directors' Code of Conduct evolve between 2022 and 2023, particularly in terms of its accessibility and integration within corporate governance reporting?",
      "original_answer": "In 2022, BNY Mellon explicitly stated that the Directors' Code of Conduct was posted on its website and outlined its applicability to all directors. The document was referenced in the context of broader corporate governance disclosures, including Board Meetings and Committee Information. By 2023, the Directors' Code of Conduct was no longer just referenced but was specifically listed among the governance materials 'available on our website,' alongside key governance documents like the Corporate Governance Guidelines and committee charters. This evolution indicates a more structured and centralized approach to governance disclosures, with the Code being more directly tied to the company's overall governance framework in the 2023 filing.",
      "llm_answer": "\nBetween 2022 and 2023 BNY Mellon shifted from a vague “code of ethics” mention for directors to an explicit, stand‑alone reference to the **Directors’ Code of Conduct** in the 10‑K’s “Available Information” section, noting that the code is posted on the company’s website and that any amendments or waivers will be disclosed there. This makes the code more readily accessible and integrates it directly into the firm’s corporate‑governance reporting, whereas the 2022 filing only alluded to a directors’ code without detailing its placement or transparency commitments.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures some correct elements but introduces problematic characterizations that diverge from the ground truth. CORRECT ELEMENTS: (1) The answer correctly identifies that there was an evolution in disclosure approach between 2022 and 2023; (2) It correctly notes that the Directors' Code of Conduct became more explicitly referenced and accessible; (3) It correctly identifies the 'Available Information' section as relevant to the 2023 disclosure. PROBLEMATIC ELEMENTS: (1) The LLM characterizes the 2022 approach as 'vague' and mentions a 'code of ethics' when the ground truth specifically states BNY Mellon 'explicitly stated' the Directors' Code of Conduct was posted on its website in 2022 - this misrepresents the 2022 disclosure as less clear than it actually was; (2) The LLM claims the 2022 filing 'only alluded to a directors' code without detailing its placement' but the ground truth indicates it was explicitly referenced with clear applicability to all directors; (3) The LLM adds details about 'amendments or waivers will be disclosed there' which are not mentioned in the ground truth and may be inaccurate extrapolation; (4) The characterization of the shift as moving from 'vague' to 'explicit' misses the actual evolution described in the ground truth, which was from a referenced document to a more 'structured and centralized approach' with direct integration into the governance framework. MULTI-HOP REASONING: The answer attempts to synthesize the 2022 and 2023 positions but does so with inaccurate characterization of the 2022 baseline. The core insight about increased accessibility and integration is present but the framing is misleading. SEMANTIC ACCURACY: While the general direction of change is captured, the specific nature of the evolution is mischaracterized, making the answer partially correct but fundamentally flawed in its comparative analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 514,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How has Oracle's strategic positioning of Oracle Database evolved between 2023 and 2024 in terms of deployment flexibility and integration with engineered systems, and what does this indicate about the company's approach to cloud migration and hybrid IT environments?",
      "original_answer": "In 2023, Oracle emphasized the flexibility of running Oracle Database across multiple deployment models, including on-premise, Oracle Cloud, and multicloud environments, with specific offerings like Oracle Exadata Cloud@Customer and Oracle Roving Edge Infrastructure. These options were framed around enabling customers to securely run Oracle Database behind their firewalls while being managed by Oracle. By 2024, Oracle shifted toward deeper integration of Oracle Database within Oracle Engineered Systems, such as the Oracle Exadata Database Machine, which combines database, storage, operating system, and networking hardware into a single optimized platform. This system was highlighted as being available across on-premise, OCI cloud, and hybrid deployments. The evolution from flexible deployment of standalone database services to tightly integrated engineered systems suggests a strategic shift toward offering more holistic, performance-optimized solutions that align with enterprise needs for scalability, security, and simplified maintenance. This indicates a maturation of Oracle's cloud migration strategy, focusing not only on deployment flexibility but also on delivering comprehensive, high-performance infrastructure packages.",
      "llm_answer": "\nBetween 2023 and 2024 Oracle broadened the deployment flexibility of Oracle Database by adding new hybrid‑cloud options—including OCI Dedicated Region, Sovereign Cloud, Roving Edge Infrastructure and expanded use of Exadata Cloud@Customer—while deepening its integration with engineered systems such as Exadata and the broader Oracle Engineered Systems portfolio.  This evolution shows Oracle’s intent to treat the database as a portable, cloud‑native service that can be run in public OCI, on‑premise, or at the edge, facilitating smoother cloud migration and supporting a hybrid‑IT model that balances flexibility with high‑performance, engineered‑system‑backed operations.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of Oracle's strategic evolution between 2023 and 2024, with accurate identification of key deployment options and engineered systems. STRENGTHS: (1) Correctly identifies specific offerings: Exadata Cloud@Customer, Roving Edge Infrastructure, OCI Dedicated Region, Sovereign Cloud, and Exadata Database Machine; (2) Accurately captures the shift toward hybrid-cloud and multi-deployment flexibility; (3) Properly synthesizes the strategic intent around cloud migration and hybrid IT environments; (4) No quantitative errors or incorrect dates/metrics. WEAKNESSES: (1) The LLM answer adds specific offerings (OCI Dedicated Region, Sovereign Cloud) not explicitly mentioned in the ground truth, which could represent either additional accurate information or potential over-specification beyond what was verified in the knowledge graph; (2) The ground truth emphasizes a shift FROM flexible deployment TO tightly integrated engineered systems as the primary evolution, whereas the LLM frames it more as a broadening/expansion of both flexibility AND integration simultaneously, which is a subtle but meaningful difference in characterizing the strategic pivot; (3) The ground truth emphasizes the 'holistic, performance-optimized solutions' and 'maturation' of strategy more explicitly, while the LLM focuses more on portability and flexibility; (4) Missing the explicit framing that the evolution represents a shift in emphasis from standalone database services to comprehensive infrastructure packages. MULTI-HOP REASONING: The LLM correctly synthesizes information across 2023-2024 timeframes and identifies the relationship between deployment options and engineered systems. The reasoning is sound but slightly less nuanced than the ground truth's characterization of the strategic shift. The answer is semantically equivalent in most respects but represents a different emphasis in interpreting the strategic evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1510,
        "completion_tokens": 531,
        "total_tokens": 2041
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How has the implementation of the formal review and certification process of annual and quarterly SEC reports evolved between 2023 and 2024, particularly in terms of compliance monitoring and governance procedures?",
      "original_answer": "In 2023, the company established a formal review and certification process of SEC filings as part of the Consent agreement, which included governance procedures to escalate potential compliance concerns to appropriate management levels and regular monitoring of compliance. By 2024, the company continued to emphasize the implementation of these governance procedures, noting that compliance with the policy was consistently monitored and that the process was integrated into company-wide sales policies to ensure adherence to inventory and sales limitations. The evolution reflects a shift from initial implementation in 2023 to sustained enforcement and integration into broader operational frameworks in 2024.",
      "llm_answer": "\nBetween 2023 and 2024 the company kept the formal review‑and‑certification framework required by the 2004 SEC Consent Order, but it strengthened its governance structure.  In 2024 it created a dedicated business‑risk and disclosure group, formalized an escalation pathway for compliance questions, and required bottom‑up input and documentation in the budgeting process, while expanding regular monitoring of sales‑incentive disclosures and direct‑customer sales limits to ensure tighter oversight of the certification of its annual and quarterly SEC reports.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) INCORRECT DATE REFERENCE: The LLM cites a '2004 SEC Consent Order' when the ground truth clearly indicates the formal review and certification process was established in 2023 as part of a Consent agreement. This is a major factual error that fundamentally misrepresents the timeline. (2) UNSUPPORTED CLAIMS: The LLM introduces specific details not present in the ground truth, including 'dedicated business-risk and disclosure group,' 'formalized escalation pathway,' and 'bottom-up input and documentation in the budgeting process.' While these may sound plausible, they are not corroborated by the ground truth and appear to be fabricated details. (3) INCOMPLETE SYNTHESIS: The ground truth emphasizes the evolution from 'initial implementation in 2023 to sustained enforcement and integration into broader operational frameworks in 2024,' but the LLM fails to capture this progression clearly. Instead, it focuses on 2024 enhancements without properly establishing the 2023 baseline. (4) PARTIAL ACCURACY: The LLM correctly identifies that monitoring of compliance and governance procedures continued/expanded between 2023-2024, and correctly mentions sales-related oversight, which aligns with the ground truth's reference to 'inventory and sales limitations.' However, this partial correctness is overshadowed by the major errors. (5) MULTI-HOP REASONING: The LLM failed to properly synthesize the temporal evolution described in the ground truth - the shift from establishment to sustained enforcement. Instead, it created a narrative around a 2004 consent order that doesn't match the source material.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 466,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How has Philip Morris International's approach to heat-not-burn products evolved from 2022 to 2023, particularly in terms of their market positioning and product categorization?",
      "original_answer": "In 2022, Philip Morris International (PMI) positioned heat-not-burn products as part of its broader Reduced-Risk Products (RRPs) portfolio, emphasizing their potential to present less harm to smokers who switch from traditional cigarettes. These products, including the Platform 1 device and its consumables, were described as being in various stages of development, scientific assessment, and commercialization. By 2023, PMI had refined its categorization, explicitly including heat-not-burn products within the smoke-free product segment, alongside e-vapor and oral nicotine products. Additionally, PMI began including licensed KT&amp;G heat-not-burn products in its portfolio, indicating a broader market approach and potential expansion of partnerships or offerings. This evolution shows a strategic shift from internal development focus to a more integrated and commercialized product positioning.",
      "llm_answer": "\nBetween 2022 and 2023 PMI shifted its heat‑not‑burn (HNB) offering from a generic “Reduced‑Risk Products”/Platform 1 description to a distinct “Smoke‑Free Products” line‑item, reporting a 15 % increase in heated‑tobacco unit shipments (125,263 million units in 2023 vs. 109,169 million in 2022) and a rise in related revenue from $10.19 bn to $12.84 bn.  The company also began to treat HNB as a core component of its broader smoke‑free portfolio—alongside oral nicotine and wellness products—highlighting market‑share growth and positioning HNB as a key growth driver rather than an isolated category.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its credibility. While it correctly identifies the general strategic shift from 'Reduced-Risk Products' to 'Smoke-Free Products' categorization and mentions the inclusion of KT&G products (implied by broader portfolio approach), it introduces unverified and likely incorrect quantitative claims. Specifically: (1) The unit shipment figures (125,263 million units in 2023 vs. 109,169 million in 2022) cannot be verified against the ground truth and appear implausibly high (125+ billion units annually). (2) The revenue figures ($10.19 bn to $12.84 bn) are not mentioned in the ground truth and cannot be confirmed. (3) The 15% increase calculation is mathematically correct IF the numbers were accurate, but the underlying data appears fabricated or misattributed. (4) The reference to 'wellness products' alongside oral nicotine is not supported by the ground truth, which specifically mentions 'oral nicotine products' without wellness categorization. The qualitative aspects are partially correct—the shift from RRPs to smoke-free product positioning is accurately captured, and the emphasis on HNB as a growth driver aligns with the ground truth's characterization of 'strategic shift from internal development focus to more integrated and commercialized positioning.' However, the introduction of unverified financial metrics and unit shipment data represents a critical failure in quantitative accuracy. The answer demonstrates reasonable understanding of the strategic evolution but fails the fundamental requirement of factual correctness by presenting specific numbers without proper verification.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 457,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How has Oracle's strategic positioning of Oracle Database evolved between 2023 and 2024 in terms of deployment flexibility and integration with other Oracle technologies?",
      "original_answer": "In 2023, Oracle emphasized the deployment flexibility of Oracle Database across cloud-based, on-premise, or other IT environments, highlighting its perpetual licensing model and the company's strategy to provide customer choice. By 2024, Oracle Database's role had evolved to become a foundational component within broader engineered systems, such as Oracle Exadata Database Machine, which integrates the database with storage, operating system software, and hardware components for optimized performance. This shift indicates a move toward deeper integration with Oracle's infrastructure technologies, positioning Oracle Database not just as a standalone product but as a core element of Oracle Engineered Systems, available in on-premise, cloud (OCI), and hybrid cloud deployments.",
      "llm_answer": "\nBetween fiscal 2023 and fiscal 2024 Oracle broadened the deployment options for its flagship database to include native on‑premise, OCI‑only, and hybrid on‑premise + OCI configurations, and it tied those options more tightly to the rest of the Oracle stack.  The 2024 filing explicitly highlights integration with Engineered Systems (e.g., Exadata), Java and Middleware, and introduces programs that let customers pivot existing database licenses to the Oracle Cloud, giving far greater flexibility and a unified migration path than the 2023 emphasis on cloud‑license growth alone.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth on the core strategic evolution of Oracle Database between 2023 and 2024. STRENGTHS: (1) Correctly identifies the shift from 2023's emphasis on deployment flexibility and perpetual licensing to 2024's focus on deeper integration with Oracle's broader technology stack; (2) Accurately names specific technologies (Exadata, Java, Middleware, OCI) that represent this integration; (3) Properly captures the multi-deployment model (on-premise, OCI, hybrid) mentioned in ground truth; (4) Correctly synthesizes the evolution toward engineered systems positioning; (5) No quantitative errors or date inaccuracies. MINOR GAPS: (1) The LLM answer mentions 'programs that let customers pivot existing database licenses to the Oracle Cloud' which is a specific detail not explicitly mentioned in the ground truth, though it aligns with the broader migration/flexibility narrative; (2) The phrase 'unified migration path' is LLM's interpretation rather than directly stated in ground truth, though semantically consistent with the evolution described; (3) Ground truth emphasizes Oracle Database as 'foundational component within broader engineered systems' while LLM frames it as 'tied more tightly to the rest of the Oracle stack' - slightly different framing but semantically equivalent. The multi-hop reasoning is sound: the answer correctly synthesizes information about the 2023 positioning, the 2024 positioning, and the evolution between them. The answer appropriately addresses both deployment flexibility and integration aspects of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 442,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How has BMY's strategic relationship with Krazati evolved from 2023 to 2024, and what specific financial commitments were made in 2024 that reflect this evolution?",
      "original_answer": "In 2023, Krazati was mentioned as part of BMY's oncology portfolio, demonstrating a strategic fit into their offerings. By 2024, BMY had acquired Mirati for $4.8 billion, obtaining the rights to Krazati, which had received FDA and EMA approvals for second-line NSCLC and was in clinical development for first-line NSCLC. Additionally, BMY committed $1.0 billion in contingent value rights tied to the development of PRMT5 Inhibitor, further signaling long-term investment in the acquired assets.",
      "llm_answer": "\nFrom 2023 to 2024 BMS moved Krazati from a licensed‑partner arrangement with Mirati to full ownership after acquiring the company, using that deal to accelerate Krazati’s oncology pipeline and multiple new FDA approvals.  In 2024 BMS committed $4.8 billion of cash (plus a $1 billion contingent value right) for the acquisition—recorded as $4.596 bn cash for shares, $248 m fair‑value of CVRs, and a $114 m expense for unvested equity awards—thereby embedding Krazati into its portfolio and financing the transaction with cash on hand and new debt.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the BMY-Mirati-Krazati relationship evolution and provides accurate core financial information. STRENGTHS: (1) Correctly identifies the strategic shift from licensed partnership to full acquisition ownership; (2) Accurately states the $4.8 billion acquisition price; (3) Correctly identifies the $1.0 billion contingent value right (CVR) commitment; (4) Properly synthesizes multi-hop information showing evolution from 2023 to 2024; (5) Appropriately notes Krazati's FDA/EMA approvals and clinical development status. WEAKNESSES: (1) The breakdown of the $4.8 billion into specific components ($4.596B cash, $248M CVR fair value, $114M equity awards) appears to be additional detail not explicitly confirmed in the ground truth, though the total is correct; (2) The statement about 'multiple new FDA approvals' is vague and not substantiated in the ground truth which only mentions second-line NSCLC approval and first-line development; (3) The mention of financing 'with cash on hand and new debt' adds interpretive detail not present in the ground truth. QUANTITATIVE VERIFICATION: The $4.8 billion acquisition price is correct. The $1.0 billion CVR is correct. The component breakdown ($4.596B + $248M + $114M = $4.958B) doesn't precisely equal $4.8B, suggesting these may be accounting allocations rather than the headline deal value. MULTI-HOP REASONING: Successfully synthesizes information across 2023-2024 timeline and connects acquisition to strategic portfolio positioning. The answer goes slightly beyond the ground truth with financing details but maintains factual accuracy on core numbers.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 453,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How has the treatment or status of the 6.244% Fixed-to-Floating Rate Normal Preferred Capital Securities of Mellon Capital IV evolved between 2022 and 2023 based on BK's SEC filings?",
      "original_answer": "In 2022, the 6.244% Fixed-to-Floating Rate Normal Preferred Capital Securities of Mellon Capital IV were introduced as securities registered under Section 12(b) of the Act and were listed on the New York Stock Exchange under the trading symbol BK/P, fully and unconditionally guaranteed by The Bank of New York Mellon Corporation. In 2023, the same securities remained registered under Section 12(b) of the Act, retained the same trading symbol BK/P, and continued to be listed on the New York Stock Exchange with the same guarantee structure. Therefore, there was no change in the treatment or status of these securities between the two years.",
      "llm_answer": "\nBoth the 2022 and 2023 Form 10‑K filings present the 6.244% Fixed‑to‑Floating Rate Normal Preferred Capital Securities of Mellon Capital IV in exactly the same way—trading on the NYSE under the symbol BK/P and being fully and unconditionally guaranteed by The Bank of New York Mellon Corporation.  No amendment, redemption, conversion or other change in their terms or status is disclosed for 2023, indicating that their treatment remained unchanged between the two years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and effectively addresses the multi-hop question about the evolution of the 6.244% Fixed-to-Floating Rate Normal Preferred Capital Securities between 2022 and 2023. STRENGTHS: (1) All key facts are correct - the security name, percentage rate (6.244%), issuer (Mellon Capital IV), trading symbol (BK/P), exchange (NYSE), and guarantor (The Bank of New York Mellon Corporation) are all accurately stated. (2) The core conclusion matches the ground truth: no change in treatment or status between 2022 and 2023. (3) The answer correctly synthesizes information across two years of filings, demonstrating proper multi-hop reasoning. (4) The answer appropriately notes the absence of amendments, redemptions, conversions, or other changes, which is the key finding. (5) Numeric accuracy is perfect - the 6.244% rate is correctly cited. MINOR CONSIDERATIONS: (1) The LLM answer is slightly more concise than the ground truth, which explicitly mentions 'Section 12(b) of the Act' registration status. However, this omission is minor and does not affect the core correctness of the answer. (2) The ground truth explicitly states the securities were 'introduced' in 2022 and 'remained' in 2023, while the LLM answer simply states they are 'presented in exactly the same way' in both years - this is semantically equivalent and captures the same meaning. The LLM's phrasing is actually more direct in conveying the lack of change. MULTI-HOP SYNTHESIS: The answer correctly synthesizes information from both 2022 and 2023 filings to reach the conclusion that status remained unchanged. The reasoning is sound and logically presented.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 453,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How has the capacity and utilization of PMI's short-term credit arrangements changed from 2022 to 2023, and what does this shift suggest about their near-term liquidity posture?",
      "original_answer": "The capacity of PMI's short-term credit arrangements increased from $1.9 billion at the end of 2022 to $2.7 billion at the end of 2023, while the actual utilization decreased slightly from $295 million to $283 million. This indicates that PMI has expanded its available liquidity buffer without increasing its drawdown, suggesting a more conservative approach to short-term financing and working capital management.",
      "llm_answer": "\nFrom 2022 to 2023 PMI’s **uncommitted short‑term credit capacity grew from about $1.9 bn to roughly $2.7 bn** (page 111), while the **total committed revolving facilities remained at $6.3 bn but were extended to 2025‑2028** (pages 88, 108). In both years the company reported **little or no outstanding borrowings under these lines – essentially zero utilization** (page 88: “no borrowings … the entire committed amounts were available”; page 111: “there were no borrowings … the entire committed amounts were available”).  \n\nThis expansion of capacity with near‑zero utilization signals that PMI’s **near‑term liquidity posture is strong and highly cushioned**, giving it ample flexibility to meet working‑capital needs and fund strategic acquisitions without having to rely on expensive or constrained financing.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "CRITICAL DISCREPANCY ON KEY METRIC: The LLM answer states 'essentially zero utilization' and 'little or no outstanding borrowings' for short-term credit arrangements in both years. However, the ground truth clearly indicates utilization of $295 million in 2022 and $283 million in 2023. This is a significant factual error on a core metric of the question. The LLM appears to have conflated short-term credit arrangements (which had $295M and $283M utilization) with committed revolving facilities (which may have had zero borrowings). CORRECT ELEMENTS: (1) Capacity increase from $1.9B to $2.7B is accurate; (2) The characterization of expanded capacity with stable/declining utilization is correct; (3) The conclusion about strong liquidity posture is appropriate. INCORRECT ELEMENTS: (1) Utilization figures are fundamentally wrong - the answer claims zero utilization when actual utilization was $295M (2022) and $283M (2023); (2) The distinction between short-term credit arrangements and committed revolving facilities appears muddled, with the LLM conflating the two; (3) The statement 'essentially zero utilization' directly contradicts the ground truth data. MULTI-HOP REASONING: The LLM correctly synthesized the capacity increase across years and appropriately interpreted what this means for liquidity posture. However, the failure to accurately report utilization figures undermines the entire analysis. The reasoning about liquidity strength is sound, but it's based on incomplete/incorrect data about actual utilization. QUANTITATIVE ACCURACY: While the $1.9B to $2.7B capacity figures are correct, the complete omission or misstatement of the $295M/$283M utilization figures is a critical error that significantly impacts the answer's accuracy on a primary metric requested in the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 490,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How has Oracle's positioning of the Autonomous Database evolved between 2023 and 2024, particularly in terms of integration with other cloud services and automation capabilities?",
      "original_answer": "In 2023, Oracle positioned the Autonomous Database as part of its broader Oracle Cloud Infrastructure (OCI) offerings, emphasizing its automated database operations and the ability to run in cloud, on-premise, or hybrid environments. It was described as a service that Oracle runs, manages, upgrades, and supports on behalf of the customer, with a focus on reducing IT process time and resources. By 2024, Oracle expanded its positioning to highlight deeper integration with other Oracle Cloud services, such as Java Cloud and Oracle APEX low-code service, and emphasized open interfaces and native machine learning capabilities. The 2024 filing also introduced a stronger focus on automation powered by machine learning, including diagnostics, fault prediction, error handling, and automatic threat detection. Additionally, 2024 emphasized the Autonomous Database's role in enabling modern cloud-native application development and analytics, including data lake houses and real-time analysis of transactional data.",
      "llm_answer": "\nBetween fiscal 2023 and fiscal 2024 Oracle has moved the Autonomous Database from a “self‑driving, fully‑managed OCI service” to the central automation engine of its entire cloud stack.  The 2024 positioning emphasizes far‑deeper integration with other OCI services—such as Java Cloud, Oracle APEX low‑code, Analytics Cloud and the new AI‑Infrastructure offerings—while expanding automated capabilities to include automatic scaling, real‑time threat detection/remediation, and consumption‑based pricing across shared, dedicated and Exadata Cloud@Customer deployments.  This evolution reflects Oracle’s strategy of offering the database as an out‑of‑the‑box, low‑labor, cloud‑native foundation that can be consumed on demand and tightly woven into the broader Oracle Cloud ecosystem.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy with excellent alignment to the ground truth. STRENGTHS: (1) Correctly identifies the evolution from 2023 to 2024 positioning; (2) Accurately lists specific integrated services (Java Cloud, Oracle APEX, Analytics Cloud); (3) Properly identifies automation capabilities including machine learning-powered features (threat detection, diagnostics); (4) Correctly characterizes the shift toward deeper integration and cloud-native positioning; (5) No quantitative errors or incorrect dates/numbers; (6) Multi-hop synthesis is sound, connecting 2023 and 2024 positioning across multiple service integrations. MINOR GAPS: (1) The LLM adds some details not explicitly in the ground truth (e.g., 'consumption-based pricing,' 'automatic scaling,' 'Exadata Cloud@Customer deployments,' 'Analytics Cloud') - while these appear reasonable and consistent with Oracle's positioning, they go slightly beyond what was stated in the original answer; (2) The ground truth mentions 'fault prediction' and 'error handling' as specific ML capabilities, while the LLM generalizes to 'threat detection/remediation' and 'automatic scaling' - these are related but not identical; (3) The ground truth emphasizes 'data lake houses and real-time analysis of transactional data' as use cases, which the LLM doesn't explicitly mention. SEMANTIC EQUIVALENCE: The LLM's characterization of the evolution as moving to 'central automation engine' and 'out-of-the-box, low-labor, cloud-native foundation' effectively captures the essence of the ground truth's description of expanded automation and integration. The reasoning is sound and the multi-hop synthesis across years and services is correct. The answer is more detailed and strategic in framing than the ground truth, which is appropriate for the question asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 499,
        "total_tokens": 1956
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did GM's financial relationship with Ultium Cells Holdings LLC evolve between 2023 and 2024, particularly in terms of its capital involvement and strategic positioning?",
      "original_answer": "In 2023, GM's relationship with Ultium Cells Holdings LLC was characterized by contingent capital commitments, with a committed contribution of $0.8 billion, and the entity was classified as a variable interest entity (VIE) where GM lacked voting control. By 2024, GM's involvement evolved into a more direct investment of $0.7 billion, indicating a shift from a potential future obligation to a realized investment stake. This transformation suggests a strategic realignment, providing GM with potentially greater influence over Ultium Cells' operations while stabilizing its financial exposure.",
      "llm_answer": "\nBetween 2023 and 2024 GM’s involvement with Ultium Cells Holdings LLC shifted from a modest equity stake and a small capital commitment to a much larger, strategically‑critical partnership.  In 2023 the company had recorded roughly **$0.5 billion of equity investments** and **about $0.8 billion of committed capital contributions** (giving a total exposure of roughly $3.5 billion).  By the end of 2024 those figures had risen to **approximately $4.3 billion in asset carrying amount** and **$2.3 billion of committed capital contributions**, pushing GM’s maximum exposure to loss to **$7.0 billion**—a more than two‑fold increase that reflects a deeper financial commitment and a strategic positioning of Ultium as a core pillar of GM’s EV battery‑cell supply chain.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that fundamentally contradict the ground truth. (1) QUANTITATIVE ERRORS - CRITICAL: The LLM claims 2023 figures of '$0.5 billion of equity investments' and '$0.8 billion of committed capital contributions' totaling '$3.5 billion exposure,' but the ground truth states only a '$0.8 billion committed contribution' in 2023 with no mention of $0.5B equity or $3.5B total. The LLM's 2024 figures of '$4.3 billion in asset carrying amount' and '$2.3 billion of committed capital contributions' with '$7.0 billion maximum exposure' are entirely fabricated and not supported by the ground truth. The ground truth indicates 2024 involved a '$0.7 billion direct investment,' not $4.3B. (2) MULTI-HOP REASONING FAILURE: The LLM failed to correctly synthesize the evolution described in the ground truth. The ground truth shows a shift FROM contingent commitments ($0.8B) TO realized investment ($0.7B), representing a transition from potential obligation to actual stake. The LLM inverted this logic, claiming an increase from $0.5B to $4.3B, which is directionally and numerically wrong. (3) ENTITY/CLASSIFICATION ACCURACY: The ground truth emphasizes the VIE classification and lack of voting control in 2023, with a strategic realignment by 2024. The LLM completely omits the VIE classification and voting control aspects, missing key structural elements of the relationship. (4) SEMANTIC MISALIGNMENT: While the LLM correctly identifies this as a strategic partnership evolution, it fundamentally misrepresents the financial metrics and direction of change. The claim of a 'two-fold increase' contradicts the ground truth's narrative of shifting from contingent to realized investment. The answer appears to contain fabricated financial data not present in the source documents.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 494,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How has the financial impact of the Litigation Management Deed evolved between 2022 and 2024, particularly in terms of the amount of as-converted value released and the number of series A preferred shares issued during the anniversary releases?",
      "original_answer": "In 2022, as part of the sixth anniversary release assessment required by the Litigation Management Deed, Visa released $3.5 billion of as-converted value and issued 176,655 shares of series A preferred stock. In 2024, during the eighth anniversary release, the company released $2.7 billion of as-converted value and issued 99,264 shares of series A preferred stock. This indicates a decrease in both the value released and the number of shares issued, suggesting a reduction in the financial burden associated with the VE territory covered litigation over time.",
      "llm_answer": "\nBetween the sixth‑anniversary release on June 21 2022 (document V_10k_2022, page 77) and the eighth‑anniversary release on June 21 2024 (document V_10k_2024, page 81), the Company released $3.5 billion of as‑converted value in 2022 and $2.7 billion in 2024, and it issued 176,655 series A preferred shares in 2022 versus 99,264 series A preferred shares in 2024.  Thus, the amount of as‑converted value freed and the number of series A shares granted both declined in the later anniversary release.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All quantitative data is correct: (1) 2022 sixth-anniversary release: $3.5 billion as-converted value and 176,655 series A preferred shares; (2) 2024 eighth-anniversary release: $2.7 billion as-converted value and 99,264 series A preferred shares. The dates are accurate (June 21, 2022 and June 21, 2024), and the document references are properly cited. The multi-hop reasoning is sound - the answer correctly synthesizes information across two different 10-K filings (2022 and 2024) to compare the financial impact evolution. The conclusion that both metrics declined is logically correct and properly supported by the data. The answer uses slightly different wording than the ground truth ('freed' vs 'released', 'granted' vs 'issued') but these are semantically equivalent and acceptable. The answer directly addresses all parts of the multi-part question: the evolution of as-converted value released, the number of shares issued, and the trend over time. Minor deduction (1 point) only for minor stylistic variations in terminology, but the factual content is entirely accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 323,
        "total_tokens": 1613
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How did the financial and strategic relationship between 3M and the Aearo Entities evolve between 2023 and 2024, particularly in terms of litigation impact and business segment adjustments?",
      "original_answer": "In 2023, 3M reconsolidated the Aearo Entities following the dismissal of their bankruptcy filings, lifting the stay on litigation related to Combat Arms Earplugs and entering into the CAE Settlement to resolve existing and future claims. This reconsolidation had an immaterial income statement impact. By 2024, the Aearo Entities were referenced in the context of divestiture and acquisition impacts in the Transportation and Electronics segment, where their deconsolidation in 2022 and reconsolidation in 2023 were each reflected separately as divestiture and acquisition effects. This indicates a shift from litigation-focused involvement in 2023 to a more strategic financial treatment in 2024.",
      "llm_answer": "\nBetween 2023 and 2024 the Aearo Entities—previously de‑consolidated after their 2022 Chapter 11 filing—were re‑consolidated in Q2 2023, bringing their massive Combat‑Arms Earplugs litigation back onto 3M’s balance sheet and prompting a $4.2 billion pre‑tax charge (later accrued as a $5 billion liability) that was recorded as a special‑item cost in the Safety & Industrial segment; the parties then implemented the $6 billion CAE Settlement (cash‑and‑stock payments through 2029), which resolved the bulk of those claims and shifted the related expenses into the segment’s adjusted operating‑income calculations, lifting that segment’s margin to 22.7 % (GAAP) and 23.1 % (adjusted) in 2024.  At the same time, the Aearo divestiture/acquisition effects were reflected in Transportation & Electronics as a modest sales drag, but the segment’s adjusted operating margin rose to 23.2 % as productivity gains offset the lingering PFAS‑related dis‑synergies.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and unsupported claims that diverge substantially from the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM cites a '$4.2 billion pre-tax charge' and '$5 billion liability' for the Combat Arms Earplugs litigation, and a '$6 billion CAE Settlement' - none of these specific figures appear in the ground truth, which states the reconsolidation had 'immaterial income statement impact.' The LLM also provides specific margin percentages (22.7% GAAP, 23.1% adjusted for Safety & Industrial; 23.2% adjusted for Transportation & Electronics) that are not mentioned in the ground truth. These invented numbers are a critical failure. (2) SEGMENT ATTRIBUTION ERROR: The LLM incorrectly attributes the CAE Settlement charge to the 'Safety & Industrial segment,' but the ground truth makes no such segment-specific attribution. (3) INCOMPLETE MULTI-HOP SYNTHESIS: While the LLM correctly identifies the 2023 reconsolidation and 2024 divestiture/acquisition effects in Transportation & Electronics, it fails to properly synthesize the core finding: the shift from litigation-focused involvement in 2023 to strategic financial treatment in 2024. Instead, it invents a narrative about settlement implementation and margin improvements. (4) MISSING KEY CONTEXT: The ground truth emphasizes that the reconsolidation had 'immaterial income statement impact,' which directly contradicts the LLM's assertion of massive charges and settlements. (5) UNSUPPORTED CLAIMS: References to 'cash-and-stock payments through 2029' and specific productivity gains are not in the ground truth. The LLM appears to have hallucinated financial details rather than synthesizing from actual filing data. The answer demonstrates poor multi-hop reasoning by inventing a coherent-sounding but factually incorrect narrative.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 500,
        "total_tokens": 1924
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How has the financial treatment or structure of Class C Common Stock evolved between 2022 and 2024, particularly in terms of its relationship to other stock classes and its earnings per share performance?",
      "original_answer": "In 2022, Class C Common Stock was described in the context of its voting rights and potential influence on corporate actions, particularly in mergers or strategic decisions, with an emphasis on how its holders—typically financial institution clients—might have divergent interests from Class A Common Stockholders. By 2024, Class C Common Stock had a significantly higher earnings per share ($33.17 basic EPS and $33.13 diluted EPS) compared to Class A ($8.29 basic EPS and $8.28 diluted EPS), indicating a shift in its financial performance relative to other stock classes, even though its governance role appeared unchanged.",
      "llm_answer": "\nBetween fiscal 2022 and 2024 Visa’s Class C common stock kept its original structure – it is non‑voting, has no transfer restrictions, and does not convert into another class on its own.  The only structural change was the 2024 exchange offer in which tendered Class B‑1 shares were retired and replaced with newly issued Class B‑2 shares and additional Class C shares, so Class C’s equity position grew only through that issuance.  As a result, the earnings‑per‑share attributable to Class C common stock rose from a basic $33.17 in 2023 to a basic $38.97 in 2024 (diluted $38.92), even though the weighted‑average share count modestly increased, reflecting the higher income allocation and the class’s lack of voting rights that distinguishes it from Class A and the restricted Class B shares.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) CRITICAL QUANTITATIVE ERROR: The LLM states Class C EPS rose from $33.17 in 2023 to $38.97 in 2024. However, the ground truth explicitly states that in 2024, Class C had $33.17 basic EPS and $33.13 diluted EPS. The LLM appears to have confused or fabricated the 2024 figure of $38.97, which contradicts the ground truth. (2) TEMPORAL MISMATCH: The ground truth compares 2022 to 2024, noting the 2024 EPS figures. The LLM compares 2023 to 2024, introducing a year not in the original question scope and providing incorrect 2024 numbers. (3) INCOMPLETE STRUCTURAL ANALYSIS: While the LLM correctly identifies Class C as non-voting and describes the 2024 exchange offer involving Class B-1/B-2 shares, it fails to address the 2022 context that the ground truth emphasizes—the governance role and voting rights comparison in 2022. (4) MISSING KEY COMPARISON: The ground truth explicitly compares Class C EPS ($33.17/$33.13) to Class A EPS ($8.29/$8.28) in 2024, showing Class C significantly outperforms. The LLM mentions this distinction exists but does not provide the actual comparative figures. (5) CALCULATION VERIFICATION: The LLM's claim that EPS rose despite increased share count is presented without supporting data, making it impossible to verify the logic. The ground truth provides specific EPS figures that can be verified. The LLM answer demonstrates structural understanding of Class C characteristics but fails on the core quantitative requirements and introduces factually incorrect EPS figures for 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 425,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How has Qualcomm's involvement in the development and commercialization of ADAS/AD technology evolved from fiscal 2022 to fiscal 2024, based on the specific changes in their strategic activities and revenue categorization?",
      "original_answer": "In fiscal 2022, Qualcomm was actively investing in and developing ADAS/AD technologies as part of its broader innovation and strategic investment initiatives, particularly through its QSI segment and Qualcomm Ventures, with an emphasis on expanding opportunities for its technologies beyond mobile handsets. By fiscal 2024, Qualcomm's engagement had evolved from development to commercialization, as evidenced by the explicit inclusion of ADAS/AD under revenue streams categorized under 'automotive' products. This indicates that ADAS/AD transitioned from a technology under development and investment in 2022 to a revenue-generating product line by 2024.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Qualcomm shifted ADAS/AD from an emerging automotive footnote to a dedicated revenue stream: the company now reports “Automotive (2)” – which explicitly includes connectivity, digital‑cockpit and ADAS/AD – and that line grew from $1.5 billion in 2022 to $2.9 billion in 2024, underscoring a strategic expansion of Snapdragon automotive platforms, RFFE and AI‑focused silicon for driver‑assistance functions.  This growth is reflected in the increasing share of QCT revenue attributed to automotive applications and in the firm’s continued investment in ADAS‑related patents, standards participation and strategic investments aimed at commercializing automated‑driving solutions.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core evolution of Qualcomm's ADAS/AD involvement from development/investment phase in 2022 to commercialization with explicit revenue categorization by 2024, which aligns with the ground truth. The qualitative reasoning about the transition from emerging technology to revenue-generating product line is sound and well-articulated.\n\nHowever, there are significant quantitative accuracy issues:\n\n1. REVENUE FIGURES - CRITICAL ERROR: The LLM states Automotive revenue grew from $1.5 billion in 2022 to $2.9 billion in 2024. These specific numbers cannot be verified against the ground truth provided, which does not include explicit automotive revenue figures for these years. The ground truth emphasizes the CATEGORIZATION change (ADAS/AD being explicitly included in automotive revenue reporting) rather than providing specific dollar amounts. The LLM appears to have introduced specific numbers that may or may not be accurate from the actual 10-K filings.\n\n2. SPECIFICITY CONCERN: The ground truth focuses on the strategic shift in how ADAS/AD is categorized and reported (from development/investment to revenue-generating), while the LLM adds specific revenue growth metrics ($1.5B to $2.9B) that go beyond what the ground truth confirms. This represents either unsupported detail or potential factual error.\n\n3. MULTI-HOP SYNTHESIS: The LLM correctly synthesizes information about the evolution across fiscal years and connects it to strategic initiatives (Snapdragon platforms, RFFE, AI-focused silicon, patents, standards participation). This multi-hop reasoning is sound and comprehensive.\n\n4. ENTITY ACCURACY: All company names, years, and product categories (Automotive, ADAS/AD, QCT, Snapdragon) are correctly identified.\n\n5. SEMANTIC ALIGNMENT: The core message matches the ground truth - transition from development to commercialization with explicit revenue categorization. However, the introduction of unverified specific revenue numbers undermines confidence in the answer's accuracy.\n\nThe answer would score higher if the specific revenue figures were either verified or removed in favor of the qualitative evolution narrative that the ground truth emphasizes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 596,
        "total_tokens": 1956
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How has Visa's U.S. Retrospective Responsibility Plan evolved between 2022 and 2024, particularly in terms of its mechanisms for addressing liability in covered litigation, and what does this evolution suggest about the company's approach to managing litigation risk?",
      "original_answer": "In 2022, Visa's U.S. Retrospective Responsibility Plan was described as a mechanism to address monetary liabilities from settlements or final judgments in U.S. covered litigation, utilizing a U.S. litigation escrow account, though the accrual for liabilities could differ from the escrow balance. By 2024, the plan had become significantly more structured and detailed, introducing a suite of interrelated mechanisms including a U.S. litigation escrow agreement, a conversion feature for Class B common stock, makewhole agreements related to the Class B-1 exchange offer, indemnification obligations from Visa U.S.A. members, an interchange judgment sharing agreement, a loss sharing agreement, and an omnibus agreement. These additions indicate a more comprehensive and layered strategy to manage litigation risk, suggesting Visa has moved toward a more proactive and diversified approach to mitigate potential financial exposure from ongoing or future litigation outcomes.",
      "llm_answer": "\nBetween 2022 and 2024 Visa’s U.S. Retrospective Responsibility Plan has been markedly reinforced: the U.S. litigation escrow account grew from a $1.4 bn balance (beginning‑of‑2023) to $3.1 bn by the end of 2024, with deposits rising to $1.5 bn while cash‑out payments fell to $0.175 bn, and the plan now leans more heavily on the conversion‑feature dilution of class B shares, makewhole reimbursement obligations and the enforcement of member indemnifications to absorb any shortfall.  This shift shows Visa is treating potential litigation liabilities as a balance‑sheet financing issue—pre‑funding them in escrow and shifting the economic burden to equity holders—reflecting a more proactive, risk‑averse approach to managing covered litigation.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM provides specific dollar amounts ($1.4bn, $3.1bn, $1.5bn, $0.175bn) that are NOT present in the ground truth answer. The ground truth makes NO mention of escrow account balances, deposits, or cash-out payments with these specific figures. This represents fabrication of financial data. (2) COMPLETENESS - While the LLM does mention several mechanisms (escrow account, conversion feature, makewhole agreements, member indemnifications), it OMITS several key mechanisms explicitly listed in the ground truth: interchange judgment sharing agreement, loss sharing agreement, and omnibus agreement. The ground truth emphasizes the plan became 'significantly more structured and detailed' with 'a suite of interrelated mechanisms' - the LLM only partially captures this. (3) ENTITY/METRIC ACCURACY - The LLM correctly identifies Visa and the U.S. Retrospective Responsibility Plan, and correctly references the 2022-2024 timeframe. However, the specific financial metrics cited appear to be unsupported by the ground truth. (4) REASONING QUALITY - The LLM's interpretation that Visa is 'treating potential litigation liabilities as a balance-sheet financing issue' and 'shifting the economic burden to equity holders' is a reasonable inference, but this goes beyond what the ground truth explicitly states. The ground truth focuses on structural evolution toward 'more comprehensive and layered strategy' without making these specific characterizations about balance-sheet financing. (5) CRITICAL FLAW - The introduction of specific dollar amounts without ground truth support is a serious factual error that undermines credibility. The answer reads plausibly but contains invented financial data. The qualitative assessment of evolution is partially correct but incomplete in mechanism coverage.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 501,
        "total_tokens": 1962
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did Merck's financial stake in Lynparza evolve between 2023 and 2024, and what indicators suggest changes in the product's performance or strategic importance during this period?",
      "original_answer": "In 2023, Merck reported a $1.5 billion net intangible asset related to Lynparza as part of its collaboration with AstraZeneca. By 2024, although the financial stake amount was not explicitly stated, there was a 9% growth in alliance revenue linked to Lynparza, driven by increased demand in most international markets. Additionally, in January 2025, Lynparza received approval in China for an adjuvant treatment in early breast cancer, indicating expanded market potential. This suggests that while the initial asset value was substantial in 2023, 2024 marked a period of performance-driven growth and regulatory expansion, enhancing its strategic importance.",
      "llm_answer": "\nMerck’s alliance revenue from Lynparza accelerated—rising 9 % in 2024 after an 8 % increase the prior year—and the product’s recorded intangible value remained steady at about $1.5 billion, underscoring a deepening financial stake.  New regulatory wins, notably China’s 2025 approval of Lynparza as an adjuvant therapy for BRCA‑mutated breast cancer and continued strong demand in international markets, point to both improving performance and a growing strategic importance for the drug within Merck’s portfolio.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the 9% growth in alliance revenue for Lynparza in 2024, the $1.5 billion intangible asset value, the China approval in January 2025 for adjuvant breast cancer treatment, and the strategic importance indicators. The reasoning about performance-driven growth and regulatory expansion is sound and well-synthesized. The answer appropriately addresses both financial stake evolution and performance indicators.\n\nWEAKNESSES: (1) QUANTITATIVE ERROR - The LLM introduces an unsupported claim that Lynparza had an '8% increase the prior year' (2023). The ground truth does not mention an 8% growth rate for 2023; it only states the 9% growth occurred in 2024. This is a factual error that adds information not present in the source material. (2) ENTITY SPECIFICATION - The LLM states the China approval is for 'BRCA-mutated breast cancer' while the ground truth simply says 'early breast cancer.' While BRCA-mutation context may be accurate from filings, the ground truth does not specify this detail, representing a minor addition beyond what was confirmed. (3) INTANGIBLE ASSET CHARACTERIZATION - The LLM states the value 'remained steady at about $1.5 billion,' but the ground truth explicitly notes that 'the financial stake amount was not explicitly stated' in 2024. The LLM's assertion of steadiness is an inference not supported by the ground truth.\n\nMULTI-HOP REASONING: The synthesis across 2023-2024 financial data and 2025 regulatory developments is logically sound. The connection between revenue growth, asset value, and strategic importance is well-reasoned.\n\nCALCULATION/VERIFICATION: The 9% figure is correct. The 8% prior-year figure is unsupported and represents a quantitative accuracy issue. The $1.5 billion figure is correct for 2023 but the claim it 'remained steady' in 2024 overstates what the ground truth confirms.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 508,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did Skoal's market position and competitive performance within Altria's oral tobacco products segment evolve between 2022 and 2024, particularly in relation to its key competitor brands?",
      "original_answer": "In 2022, Skoal was one of the premium oral tobacco brands under Altria, alongside Copenhagen and on!, with a retail share of 9.3%. By 2024, Skoal's retail share had declined to 7.6%, indicating a weakening market position. This decline occurred alongside a broader contraction in Altria's oral tobacco segment, which saw total retail share fall from 42.5% in 2023 to 37.5% in 2024. Notably, Copenhagen, Altria's leading brand, also experienced a drop from 23.5% to 19.1% over the same period, while on! oral nicotine pouches gained traction, rising from 6.8% to 8.3%. These shifts suggest that Skoal not only lost market share overall but also underperformed relative to both its primary brand (Copenhagen) and the newer product category (on!).",
      "llm_answer": "\nBetween 2022 and 2024 Skoal’s retail share fell from about 9‑10 % to 7.6 % and its shipment volume dropped from roughly 163 million to 147 million units, while its main MST rival Copenhagen also slipped from 23.5 % to 19.1 % share.  At the same time the on! oral‑nicotine‑pouch brand gained ground, rising from 6.8 % to 8.3 % of retail share, accelerating the shift away from traditional MST products.  The combined share loss, lower volumes and a $354 million impairment of the Skoal trademark signal a clear weakening of Skoal’s competitive position against both established MST peers and the growing pouch segment.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the core narrative of Skoal's market decline from ~9-10% to 7.6% retail share, accurately reports Copenhagen's decline from 23.5% to 19.1%, and correctly notes on!'s rise from 6.8% to 8.3%. The reasoning about the shift from traditional MST to oral nicotine pouches is sound and well-synthesized. The answer appropriately addresses the multi-hop question by comparing Skoal's performance against both Copenhagen and on!.\n\nWEAKNESSES: (1) QUANTITATIVE ERROR - The LLM states Skoal's 2022 retail share as \"about 9-10%\" when the ground truth specifies 9.3% precisely. While this is a minor range approximation, it lacks the precision expected for financial metrics. (2) UNSOURCED CLAIM - The LLM introduces shipment volume data (163 million to 147 million units) and a $354 million Skoal trademark impairment that are NOT mentioned in the ground truth answer. These appear to be additional facts not verified against the original knowledge graph, which is problematic for evaluation purposes. (3) INCOMPLETE CONTEXT - The ground truth mentions Altria's total oral tobacco segment share declining from 42.5% (2023) to 37.5% (2024), which provides important context about the broader market contraction. The LLM omits this contextual data point. (4) TEMPORAL PRECISION - The ground truth specifies the 42.5% figure is from 2023, while the LLM doesn't reference this intermediate year data.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across three entities (Skoal, Copenhagen, on!) and correctly identifies the comparative performance dynamics. The logic connecting market share losses to competitive positioning is sound.\n\nCALCULATION VERIFICATION: No explicit calculations are required, but the percentage comparisons are accurate where stated.\n\nOVERALL ASSESSMENT: The answer captures the essential narrative correctly but introduces unverified data points and omits some ground truth context. The core market share figures for the three brands are accurate, but the additional claims about shipment volumes and trademark impairment cannot be validated against the provided ground truth, reducing confidence in overall accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 588,
        "total_tokens": 1940
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How has the revenue contribution from Dynamics 365 within Microsoft Cloud evolved between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, Dynamics 365 contributed to the $91.2 billion Microsoft Cloud revenue, with Dynamics products and cloud services revenue growing 25%, driven by a 39% increase in Dynamics 365. By fiscal year 2023, the Microsoft Cloud revenue had increased to $111.6 billion, which includes Dynamics 365 as a component. Although the exact growth percentage for Dynamics 365 in 2023 is not explicitly stated, its continued inclusion in the Microsoft Cloud breakdown indicates sustained growth and integration within the broader cloud portfolio.",
      "llm_answer": "\nIn fiscal 2022 Dynamics 365 generated $4.687 billion of Microsoft Cloud revenue, and in fiscal 2023 that amount rose to $5.437 billion—a $0.75 billion (≈16 %) increase. This growth occurred as total Microsoft Cloud revenue expanded from $91.4 billion in 2022 to $111.6 billion in 2023, thereby raising Dynamics 365’s share of the cloud portfolio.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that fundamentally undermine its credibility. (1) CRITICAL ERRORS: The LLM provides specific dollar amounts ($4.687B in FY2022 and $5.437B in FY2023) that are NOT found in the ground truth. The ground truth explicitly states these exact figures are not provided in the filings—it only mentions that Dynamics 365 contributed to the $91.2B Microsoft Cloud revenue in 2022 and was included in the $111.6B in 2023, without breaking out specific Dynamics 365 revenue amounts. The LLM appears to have fabricated these numbers. (2) PARTIAL ACCURACY: The LLM correctly identifies the total Microsoft Cloud revenue figures ($91.4B for 2022 and $111.6B for 2023), though the ground truth states $91.2B for 2022, not $91.4B—a minor discrepancy but still an error. (3) CALCULATION VERIFICATION: The LLM calculates a $0.75B increase and ~16% growth based on its fabricated numbers. Even if those numbers were correct, the calculation is accurate ($5.437B - $4.687B = $0.75B; $0.75B/$4.687B ≈ 16%), but this is irrelevant since the underlying data is false. (4) MULTI-HOP REASONING: The LLM attempts to synthesize information about Dynamics 365's contribution to Microsoft Cloud, but does so by inventing specific revenue figures rather than acknowledging the limitation stated in the ground truth. The ground truth explicitly notes that 'the exact growth percentage for Dynamics 365 in 2023 is not explicitly stated,' yet the LLM provides precise figures and percentages. (5) SEMANTIC ISSUE: The LLM fundamentally misrepresents what information is available in the filings by presenting invented data as fact. This is a critical failure in financial analysis where precision and accuracy are paramount.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1216,
        "completion_tokens": 474,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How has Merck's approach to managing foreign exchange exposure through its Balance Sheet Risk Management Program evolved from 2023 to 2024, particularly in terms of the instruments used and the scope of hedging activities?",
      "original_answer": "In 2023, Merck primarily used forward exchange contracts to offset the effects of exchange on exposures when economically beneficial, focusing on the euro, Swiss franc, Japanese yen, and Chinese renminbi. These contracts were not designated as hedges and were marked to market through Other (income) expense, net. By 2024, the company expanded its approach under a more structured balance sheet risk management program, continuing to use forward contracts but also introducing a broader framework that included purchased local currency put options and collar options. Additionally, the 2024 disclosure highlights a more strategic layering of hedges over time, increasing the portion of forecasted sales hedged as the expected dates approach, based on cost-benefit assessments.",
      "llm_answer": "\nMerck kept using short‑term forward contracts, purchased put options/collars and euro‑denominated debt to hedge foreign‑exchange risk, but in 2024 it broadened the program to embed revenue‑hedging of forecasted sales into earnings (recording $195 million of hedge‑related sales) and to increase the scale of net‑investment hedges, as evidenced by a $(30) million OCI loss on foreign‑exchange contracts and $(192) million loss on euro‑denominated notes. Thus, while the instrument mix remained largely the same, the 2024 approach added a direct earnings component and larger net‑investment hedge positions.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and misinterpretations that substantially diverge from the ground truth. MAJOR ISSUES: (1) QUANTITATIVE ERRORS: The LLM cites specific dollar amounts ($195 million hedge-related sales, $(30) million OCI loss, $(192) million loss on euro-denominated notes) that are not mentioned in the ground truth answer and appear to be fabricated or misattributed. These numbers cannot be verified against the original answer and represent a critical accuracy failure. (2) CONCEPTUAL MISALIGNMENT: The ground truth emphasizes that 2023 used forward contracts NOT designated as hedges (marked to market through Other income expense), while 2024 expanded to include purchased local currency put options and collar options with a more strategic layering approach. The LLM incorrectly suggests the 2024 program added 'direct earnings component' through revenue-hedging of forecasted sales, which is not supported by the ground truth. (3) INSTRUMENT SCOPE: The LLM mentions euro-denominated debt as a hedging instrument, which is not explicitly mentioned in the ground truth. While debt can be used for net-investment hedges, the ground truth focuses on forward contracts, put options, and collar options. (4) MISSING KEY EVOLUTION: The LLM fails to adequately capture the critical evolution described in the ground truth: the shift from non-designated hedges (2023) to a more structured program with strategic layering of hedges over time based on cost-benefit assessments (2024). (5) MULTI-HOP REASONING: While the LLM attempts to synthesize 2023-2024 changes, it does so with unverified numbers and incorrect characterizations of the program's evolution. The answer conflates different types of hedges (net-investment hedges vs. operational hedges) without clear distinction. WHAT WAS CORRECT: The LLM correctly identifies that forward contracts continued to be used and that the program expanded to include additional instruments like put options and collars. The general direction of evolution (expansion/broadening) is correct. OVERALL ASSESSMENT: The answer demonstrates partial understanding of the question's structure but fails on factual accuracy due to invented numbers and mischaracterized program features. The quantitative errors are particularly damaging as they suggest specific financial impacts that cannot be substantiated.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 633,
        "total_tokens": 1997
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How has PayPal's involvement with merchant receivables evolved between 2022 and 2024, particularly in terms of its credit loss provisions and direct investment in merchant financing products?",
      "original_answer": "In 2022, PayPal disclosed its methodology for estimating credit losses on merchant receivables, applying macroeconomic forecasts and historical loss data to calculate allowances, with a principal and interest coverage ratio of approximately 9% as of December 31, 2021, down from 23% in 2020. By 2024, PayPal had significantly expanded its direct involvement by purchasing approximately $1.8 billion in merchant receivables during the year, with an outstanding balance of $1.5 billion as of December 31, 2024, up from $1.2 billion in 2023. This represents a shift from primarily disclosing credit risk exposure to actively investing in and managing merchant receivables through products like PPWC and PPBL, indicating a more strategic and operational role in merchant finance.",
      "llm_answer": "\nBetween 2022 and 2024 PayPal deepened its direct merchant‑financing role – it purchased roughly $1.8 billion of merchant receivables in 2024 (up from $1.7 billion in 2023) and grew the outstanding portfolio to about $1.5 billion, funding the advances through its PPWC/PPBL products and the Paidy revolving credit facility (see PYPL 10‑K 2024 pp. 101‑102).  At the same time, the company’s credit‑loss provisioning improved: the allowance for credit losses on the merchant portfolio fell from $380 million in 2023 to $348 million in 2024 and gross charge‑offs declined as a share of the portfolio, reflecting tighter underwriting and more active monitoring of repayment periods (PYPL 10‑K 2024 pp. 101‑102).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer addresses the core question about PayPal's merchant receivables evolution and provides relevant context about credit loss provisions and direct investment. However, there are significant quantitative discrepancies that lower the overall score.\n\nCORRECT ELEMENTS:\n- Correctly identifies the shift toward direct merchant financing involvement\n- Accurately states the outstanding balance of $1.5 billion as of December 31, 2024\n- Correctly mentions PPWC/PPBL products as funding mechanisms\n- Appropriately notes the improvement in credit loss provisioning (allowance declining from $380M to $348M)\n- Correctly identifies the Paidy revolving credit facility\n- Properly synthesizes the multi-hop concept of evolution from 2022-2024\n\nINCORRECT/PROBLEMATIC ELEMENTS:\n- States $1.7 billion in merchant receivables purchased in 2023, but ground truth does not provide this figure for comparison\n- Claims $1.8 billion purchased in 2024, which matches ground truth, but the 2023 comparison figure ($1.7B) cannot be verified against the original answer\n- Omits the 2022 baseline information about credit loss methodology and the principal/interest coverage ratio (9% in 2021, down from 23% in 2020) that was explicitly mentioned in the ground truth\n- Does not mention the $1.2 billion outstanding balance in 2023 that would provide better context for the growth trajectory\n\nMULTI-HOP REASONING:\nThe LLM successfully synthesizes information across the 2022-2024 period and connects merchant receivables purchases to credit loss provisions. However, it fails to fully capture the complete evolution by omitting the 2022 baseline metrics and methodology discussion that were part of the ground truth answer.\n\nQUANTITATIVE ACCURACY ISSUES:\nThe primary concern is the introduction of the $1.7 billion figure for 2023 purchases, which is not present in the ground truth. This creates a potential factual error. The ground truth only mentions $1.2 billion outstanding in 2023, not purchases. The credit loss allowance figures ($380M and $348M) are correctly stated and represent a meaningful improvement metric.\n\nOVERALL ASSESSMENT:\nThe answer demonstrates good understanding of the merchant receivables evolution and correctly identifies key metrics and products. However, the quantitative discrepancies (particularly the unverified $1.7B figure) and omission of 2022 baseline information prevent a higher score. The answer is directionally correct but incomplete in capturing the full scope of the ground truth answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 673,
        "total_tokens": 2055
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How has the financial significance of smokeable products to MO evolved from 2022 to 2024, considering both goodwill allocation and operating income performance?",
      "original_answer": "In 2022, the goodwill allocated to smokeable products was $99 million, indicating a relatively small portion of MO's overall asset valuation, with total goodwill at $5,177 million. By 2024, although no updated goodwill figure is disclosed specifically for smokeable products, their operating income contribution rose to $10,821 million in 2024 from $10,670 million in 2023, showing sustained profitability. This suggests that while the strategic asset valuation (via goodwill) remained stable or undisclosed, the operational significance of smokeable products remained high and slightly increased in terms of earnings. The lack of updated goodwill allocation in 2024 filings for this segment implies a potential shift in reporting focus toward performance metrics rather than asset valuations.",
      "llm_answer": "\nFrom 2022 through 2024 the operating income contributed by Altria’s smokeable‑product segment rose modestly—from roughly **$10.6 bn in 2022 to $10.8 bn in 2024**—and its share of total segment operating income increased from about **92 % to 96 %** (see MO_10K 2024 p. 31).  At the same time the goodwill assigned to the smokeable segment stayed essentially flat at **≈ $99 million**, a tiny fraction of the company’s overall goodwill (which remains concentrated in oral‑tobacco; see MO_10K 2022 p. 65).  Thus, while the balance‑sheet goodwill allocation has not changed, the financial significance of smokeable products has grown markedly on the income‑statement side, becoming the dominant source of earnings and cash flow for Altria.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the key narrative about smokeable products' growing operational significance despite stable goodwill allocation. The qualitative reasoning is sound—comparing balance sheet (goodwill) vs. income statement (operating income) performance is appropriate and well-articulated. The answer correctly notes goodwill remained at ~$99 million and that smokeable products are the dominant earnings source.\n\nCRITICAL ERRORS: (1) Operating income figures are INCORRECT. LLM states \"$10.6 bn in 2022 to $10.8 bn in 2024\" but ground truth shows $10,670 million (2023) to $10,821 million (2024)—no 2022 figure is provided in ground truth. The LLM appears to have fabricated a 2022 comparison point. (2) Percentage claims (\"92% to 96%\") are not verified in ground truth and appear unsupported. (3) The LLM conflates the time period—it claims \"2022 through 2024\" but then provides 2023-2024 data, creating temporal inconsistency.\n\nPARTIAL ACCURACY: The goodwill figure of $99 million is correct. The observation that goodwill remained stable/undisclosed is accurate. The conclusion about shift toward performance metrics is reasonable inference.\n\nMULTI-HOP REASONING: The synthesis across goodwill allocation and operating income is conceptually sound, but undermined by incorrect numbers. The model correctly identifies this requires combining balance sheet and income statement data.\n\nJUSTIFICATION: While the narrative framework and qualitative analysis are strong (7-8 range), the quantitative errors are significant. Providing 2022 operating income figures not in ground truth, unsupported percentage calculations, and temporal inconsistencies drop the correctness score substantially. The answer demonstrates understanding of the question's multi-hop nature but fails on factual precision—a critical requirement for financial analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 508,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How has the revenue contribution from the commercial portion of LinkedIn within Microsoft Cloud evolved between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, the Microsoft Cloud revenue, which includes the commercial portion of LinkedIn, was reported at $91.2 billion. By fiscal year 2023, this figure had increased to $111.6 billion, indicating a significant growth in the commercial cloud segment that includes LinkedIn. This increase suggests a stronger revenue contribution from LinkedIn's commercial services within the broader Microsoft Cloud portfolio.",
      "llm_answer": "\nThe commercial portion of LinkedIn added roughly **$13.6 billion** to Microsoft Cloud revenue in fiscal 2022 and grew to about **$15.0 billion** in fiscal 2023—an increase of roughly **$1.4 billion (≈10 %)** over the two‑year period.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and appears to contain fabricated data. Critical issues: (1) WRONG NUMBERS: The LLM claims LinkedIn's commercial portion contributed $13.6B in FY2022 and $15.0B in FY2023. These figures are not supported by the ground truth data and appear to be invented. The ground truth clearly states Microsoft Cloud revenue (which includes LinkedIn) was $91.2B in FY2022 and $111.6B in FY2023. (2) MISINTERPRETATION: The LLM fundamentally misunderstood the question. The ground truth answer discusses the total Microsoft Cloud revenue figure that includes LinkedIn's commercial portion, not a separate isolated LinkedIn contribution amount. The LLM invented specific LinkedIn-only revenue numbers that don't exist in the source data. (3) CALCULATION ERROR: Even accepting the LLM's invented numbers, the calculation is slightly off: $15.0B - $13.6B = $1.4B is correct, but $1.4B / $13.6B ≈ 10.3%, not exactly 10%. However, this is a minor issue compared to the fundamental data fabrication. (4) MISSING CONTEXT: The LLM failed to recognize that the question asks about revenue evolution within Microsoft Cloud that includes LinkedIn, not a separate LinkedIn revenue stream. The correct answer should reference the $91.2B to $111.6B growth in total Microsoft Cloud revenue. (5) MULTI-HOP REASONING: The LLM failed to properly synthesize the information - it should have identified that the ground truth provides Microsoft Cloud totals (which include LinkedIn's commercial portion), not isolated LinkedIn figures. The answer demonstrates a complete failure to accurately extract and present the relevant financial data from the source materials.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1162,
        "completion_tokens": 457,
        "total_tokens": 1619
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did the commercialization and market expansion of Lynparza evolve between 2023 and 2024, particularly in terms of geographic approvals and revenue growth?",
      "original_answer": "In 2023, Lynparza received FDA and Japan's MHLW approvals for treating BRCA-mutated metastatic castration-resistant prostate cancer (mCRPC) in combination with abiraterone and prednisone or prednisolone, based on the PROpel trial. By 2024, alliance revenue related to Lynparza grew by 9%, largely due to higher demand in most international markets. Additionally, in January 2025, Lynparza received China's NMPA approval for adjuvant treatment of germline BRCA-mutated, HER2-negative high-risk early breast cancer, based on the OlympiA trial, indicating a significant geographic and therapeutic area expansion.",
      "llm_answer": "\nLynparza’s commercial rollout began with FDA approval (May 2023) for BRCAm mCRPC and a subsequent Japan MHLW approval (August 2023), establishing the first geographic markets for the drug.  During 2024 the product’s label was broadened with additional international approvals—including a China NMPA approval for adjuvant BRCA‑mutated breast cancer (announced in January 2025 but reflecting 2024‑year expansion)—and alliance revenue from Lynparza rose 9 % year‑over‑year, driven by growing demand across these new regions (see pages 7, 55, 58).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key approvals and the 9% revenue growth figure. Strengths: (1) Correctly identifies FDA approval in May 2023 for BRCAm mCRPC, Japan MHLW approval in August 2023, and China NMPA approval in January 2025 for adjuvant breast cancer treatment; (2) Accurately reports the 9% year-over-year alliance revenue growth; (3) Properly synthesizes multi-hop information across geographic approvals and revenue metrics; (4) Correctly notes the therapeutic area expansion from mCRPC to early breast cancer. Minor weaknesses: (1) The phrasing 'announced in January 2025 but reflecting 2024-year expansion' is slightly awkward and could be clearer—the ground truth more explicitly states this approval occurred in January 2025, which is technically outside the 2023-2024 timeframe asked about, though the LLM does acknowledge this temporal distinction; (2) The answer could have been slightly more explicit about the PROpel trial basis for the 2023 approvals and OlympiA trial basis for the 2025 approval, though these details are secondary to the main question; (3) The parenthetical reference to pages (7, 55, 58) adds credibility but is not verifiable in this context. The quantitative accuracy is high—all dates and percentages are correct. The qualitative reasoning correctly identifies the multi-hop synthesis needed (approvals → revenue impact → geographic expansion). The answer appropriately addresses both the 2023-2024 evolution and the forward-looking 2025 approval as context for market expansion trajectory.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 435,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How did RTX's financial treatment of the Powder Metal Matter evolve between 2023 and 2024, particularly in terms of its impact on future income tax benefits?",
      "original_answer": "In 2023, the Powder Metal Matter was noted as a reduction in sales, indicating a negative financial impact. By 2024, the Powder Metal Matter was specifically listed under future income tax benefits at $455 million, down from $644 million in 2023, showing a shift in its financial treatment from a sales reduction to a recognized tax benefit. This represents a decrease of $189 million, or about 29.3%, in its value contribution to future tax benefits.",
      "llm_answer": "\nThe deferred‑tax benefit that RTX had recorded for the Powder Metal Matter fell sharply from **$644 million in 2023 to $455 million in 2024** (see Note 13 – Future income‑tax benefits, page 98 of the 2024 10‑K).  The reduction stems from the company’s reassessment of the realizability of the related tax credits after the 2023 IRS interim guidance on R&D capitalization and subsequent adjustments to valuation allowances (pages 93‑94, 98).  As a result, RTX’s future income‑tax benefit from the Powder Metal Matter is now lower, meaning it will generate fewer tax savings in upcoming periods.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the key financial figures ($644 million in 2023 and $455 million in 2024) and accurately calculates the reduction ($189 million). The numbers are factually correct and properly formatted. The answer correctly identifies this as a deferred tax benefit and notes the shift in financial treatment. WEAKNESSES: (1) The LLM provides additional context about IRS interim guidance and valuation allowances that is NOT present in the ground truth answer. While this may be accurate information from the filing, it goes beyond what the ground truth establishes and introduces unverified claims about causation. (2) The ground truth explicitly states the Powder Metal Matter was 'noted as a reduction in sales' in 2023 before becoming a tax benefit in 2024 - this represents a shift in CLASSIFICATION/TREATMENT. The LLM answer does not clearly articulate this shift from sales reduction to tax benefit classification; instead it focuses on the deferred tax benefit in both years. (3) The ground truth emphasizes the 29.3% decrease calculation, which the LLM does not mention. (4) The LLM's explanation about 'reassessment of realizability' and 'subsequent adjustments to valuation allowances' appears to be inferential reasoning not explicitly confirmed in the ground truth. The core numbers are correct, but the framing of how the financial treatment 'evolved' is incomplete - the LLM misses the critical point that in 2023 it was treated as a sales reduction, not a tax benefit. This is a significant omission in addressing the evolution of financial treatment between the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 442,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How did the borrowing capacity and terms of the Paidy Credit Agreement evolve from 2022 to 2024?",
      "original_answer": "In 2022, the Paidy Credit Agreement provided a secured revolving credit facility of approximately $198 million, with $98 million outstanding as of December 31, 2021. By 2024, the Paidy Credit Agreement had been modified to increase the borrowing capacity to ¥90.0 billion (approximately $574 million as of December 31, 2024), and it was restructured as an unsecured facility. The interest rate also changed from unspecified terms in 2022 to a rate based on the Tokyo Interbank Offered Rate plus a margin ranging from 0.40% to 0.60% in 2024. The maturity date was set for February 2027, and the agreement now includes a financial covenant requiring a maximum consolidated leverage ratio.",
      "llm_answer": "\nFrom February 2022 through 2024 the Paidy Credit Agreement grew from an original ¥60 billion unsecured revolving line to a ¥90 billion limit (≈ $574 million) after a September 2022 amendment, and that ceiling remained unchanged through 2024. The facility continues to bear interest at the Tokyo Interbank Offered Rate plus a margin of 0.40 %–0.60 %, matures in February 2027, and as of 31 December 2024 no borrowings were outstanding, leaving the full ¥90 billion capacity available for working‑capital, capital‑expenditure and other permitted uses.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) CRITICAL FACTUAL ERROR - LLM states the facility was originally ¥60 billion unsecured, but ground truth indicates it was approximately $198 million SECURED in 2022. This is a fundamental mischaracterization of the facility's initial structure and size. (2) FACILITY TYPE CONTRADICTION - LLM claims the facility was unsecured from the beginning, but ground truth explicitly states it was SECURED in 2022 and was RESTRUCTURED to unsecured by 2024. This is a major error in describing the evolution. (3) AMENDMENT TIMING - LLM mentions a September 2022 amendment increasing capacity to ¥90 billion, but ground truth does not specify this timing detail and the original 2022 capacity was stated in dollars ($198M), not yen. (4) MISSING KEY EVOLUTION DETAIL - Ground truth emphasizes the shift from secured to unsecured as a major structural change; LLM completely misses this critical evolution. (5) INTEREST RATE TERMS - LLM correctly states TIBOR + 0.40%-0.60% and February 2027 maturity, which matches ground truth. (6) OUTSTANDING BORROWINGS - LLM correctly notes no borrowings outstanding as of December 31, 2024, which is consistent with ground truth. (7) FINANCIAL COVENANT - Ground truth mentions a maximum consolidated leverage ratio covenant requirement; LLM omits this entirely. The LLM answer fundamentally misrepresents the 2022 starting point and the secured-to-unsecured transition, which are core elements of how the agreement evolved.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 408,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How has Altria's reliance on long-term senior unsecured notes as part of its capital resources evolved between 2022 and 2024?",
      "original_answer": "In 2022, Altria's capital resources included access to credit markets through the issuance of long-term senior unsecured notes, along with $4.5 billion in cash and cash equivalents. By 2024, Altria continued to rely on long-term senior unsecured notes as a key source of capital, but its cash and cash equivalents decreased to $3.1 billion. While the company maintained its $3.0 billion Credit Agreement and continued to use similar capital instruments, the reduction in cash reserves suggests a potentially increased reliance on external financing mechanisms, including long-term senior unsecured notes, to support its operations and strategic initiatives such as dividend payments, share repurchases, and debt repayment.",
      "llm_answer": "\nBetween 2022 and 2024 Altria trimmed the balance of its long‑term senior unsecured notes—paying off $1.1 bn of 4.0% and 3.8% notes that matured in early 2024 and retiring the remaining $1.5 bn of 4.75% notes from 2021—while replacing them with a smaller, later‑dated issuance (a $1 bn tranche of 4.875% notes due 2028 and 5.625% notes due 2035 issued in February 2025).  As a result, total long‑term debt fell from roughly $26.2 bn at the end of 2023 to $24.9 bn by the end of 2024, and the weighted‑average coupon on remaining debt dropped to about 4.3% (from ~4.1% in 2021).  This shows a deliberate shift away from reliance on older, higher‑coupon senior notes toward a more staggered maturity profile and lower‑cost financing, even as the company continues to tap the long‑term note market for liquidity.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer is largely incorrect and addresses a different aspect of the question than what was asked. CRITICAL ISSUES: (1) The question asks about evolution of reliance on long-term senior unsecured notes as part of capital resources between 2022-2024, focusing on how this funding source changed in importance. The ground truth answer correctly identifies that cash decreased from $4.5B (2022) to $3.1B (2024), suggesting increased reliance on external financing including long-term notes. (2) The LLM answer instead provides detailed information about specific debt issuances and retirements (paying off $1.1B of notes, retiring $1.5B, issuing new $1B tranches in Feb 2025), which is NOT mentioned in the ground truth and appears to be fabricated or from different source material. (3) The LLM cites specific coupon rates (4.0%, 3.8%, 4.75%, 4.875%, 5.625%) and maturity dates that cannot be verified against the ground truth. (4) The LLM mentions total long-term debt falling from $26.2B (end 2023) to $24.9B (end 2024) - these specific numbers are not in the ground truth. (5) The LLM references a weighted-average coupon of 4.3% and 4.1% in 2021 - not mentioned in ground truth. (6) The LLM discusses February 2025 issuances, which is beyond the 2022-2024 timeframe asked about. (7) The ground truth focuses on cash reserves declining and continued reliance on long-term notes as a capital source, while the LLM focuses on debt reduction and refinancing strategy - fundamentally different narratives. The LLM answer may contain accurate information about Altria's debt management, but it does not match the ground truth answer and appears to address a different question about debt composition rather than evolution of reliance on this funding source relative to other capital resources.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 488,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How did RTX's financial treatment of the Powder Metal Matter evolve between 2023 and 2024, and what does this indicate about its impact on future income tax benefits?",
      "original_answer": "In 2023, the Powder Metal Matter contributed $644 million to RTX's future income tax benefits. By 2024, this amount decreased to $455 million, indicating a reduced financial benefit from the Powder Metal Matter over time. This decline suggests a diminishing positive impact on RTX's tax position related to this factor.",
      "llm_answer": "\nIn 2023 RTX booked a $5.3 billion net‑sales charge and a $2.5 billion partner‑share reduction in cost of sales tied to the Powder Metal Matter, and it recorded a $644 million deferred‑tax benefit associated with the issue (see page 37‑38). By 2024 that tax benefit had fallen to $455 million (page 104), showing that the tax shelter linked to the Powder Metal Matter is being used up and that future income‑tax gains from it will be limited.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive understanding of the Powder Metal Matter's financial treatment. QUANTITATIVE VERIFICATION: All key numbers are correct - $644 million in 2023 deferred-tax benefit and $455 million in 2024, matching the ground truth exactly. The decline of $189 million ($644M - $455M) is accurately reflected in the narrative. The additional context provided ($5.3 billion net-sales charge and $2.5 billion partner-share reduction) adds relevant detail without contradicting the ground truth. MULTI-HOP REASONING: The answer successfully synthesizes information across years (2023 to 2024) and correctly identifies the relationship between the declining tax benefit and its implications for future tax benefits. The conclusion that 'the tax shelter linked to the Powder Metal Matter is being used up' logically follows from the declining benefit amounts. ENTITY ACCURACY: RTX is correctly identified, fiscal years 2023 and 2024 are accurate, and the financial metrics (deferred-tax benefit) are properly labeled. COMPLETENESS: The answer addresses both the evolution of the financial treatment and what it indicates about future income tax benefits, fully answering the multi-part question. MINOR CONSIDERATIONS: The LLM provides additional context (the $5.3B and $2.5B figures) beyond what was in the ground truth answer, but this is supplementary and accurate rather than contradictory. The page references (37-38, 104) add credibility. The semantic meaning is equivalent to the ground truth - both convey that the tax benefit declined and this indicates diminishing future benefits.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1195,
        "completion_tokens": 446,
        "total_tokens": 1642
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How has PayPal's utilization of the Paidy Credit Agreement evolved between 2022 and 2024, particularly in terms of borrowing capacity and actual drawdown?",
      "original_answer": "In 2022, PayPal had approximately $198 million in borrowing capacity under the Paidy Credit Agreement, with $98 million outstanding as of December 31, 2021, leaving about $100 million available. By 2024, the borrowing capacity had increased to approximately $574 million (¥90.0 billion), and the full amount was drawn down, leaving no borrowing capacity available. This reflects a significant increase in both the scale of the facility and PayPal's reliance on it over the period.",
      "llm_answer": "\nBetween 2022 and 2024 PayPal expanded the Paidy Credit Agreement’s capacity and then fully utilized it.  The facility, originally a ≈ $198 million secured revolving line (with about $100 million of availability as of 31 Dec 2021), was amended in September 2022 to raise the ceiling to ¥90 billion (≈ $574 million).  In the fiscal year ended 31 Dec 2024 the company drew down the entire ¥90 billion, leaving **no borrowing capacity** under the Paidy agreement as of year‑end 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. Verification of key facts: (1) 2022 capacity of ~$198 million - CORRECT; (2) $98 million outstanding as of Dec 31, 2021 with ~$100 million available - CORRECT (implied through the original facility description); (3) September 2022 amendment to ¥90 billion (~$574 million) - CORRECT; (4) Full drawdown by end of 2024 leaving no borrowing capacity - CORRECT. The LLM successfully synthesized multi-hop information across years (2021-2024) and correctly identified the evolution of both borrowing capacity and actual utilization. The answer properly addresses all components of the question: borrowing capacity changes, actual drawdown amounts, and the timeline of evolution. Minor formatting variations (≈ vs approximately) are acceptable and don't affect accuracy. The reasoning is sound - the model correctly identified the amendment date, the capacity increase, and the progression from partial utilization ($100M available in 2021) to full utilization (zero available in 2024). The answer demonstrates clear understanding that this represents increased reliance on the facility, matching the ground truth's characterization. No calculation errors detected. The only minor observation is that the LLM could have explicitly stated the 2021 outstanding amount ($98 million), but this is a very minor omission that doesn't materially affect the answer's quality.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1242,
        "completion_tokens": 392,
        "total_tokens": 1634
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How has the ownership structure and equity relationship between Accenture plc and Accenture Canada Holdings Inc. evolved from 2023 to 2024, particularly regarding noncontrolling interests and exchangeable shares?",
      "original_answer": "In 2023, the noncontrolling ownership interests in Accenture Canada Holdings Inc. held by certain current and former members of Accenture Leadership were less than 1% as of August 31, 2024. By 2024, the structure had evolved to include detailed provisions around Accenture Canada Holdings Inc. exchangeable shares, which can be exchanged for Accenture plc Class A ordinary shares on a one-for-one basis or redeemed for cash. Additionally, Accenture plc Class X ordinary shares were tied directly to these exchangeable shares, with a restriction ensuring the number of Class X shares does not fall below the number of exchangeable shares held. This indicates a more formalized and structured equity relationship in 2024 compared to the simpler noncontrolling interest disclosure in 2023.",
      "llm_answer": "\nBetween fiscal 2023 and 2024 the ownership structure of Accenture Canada Holdings Inc. was unchanged.  Holders of the Canadian holding‑company’s exchangeable shares can still exchange them for Accenture plc Class A ordinary shares on a one‑for‑one basis, and Accenture plc issues Class X ordinary shares to those partners; the Class X shares are redeemable at par but may not be redeemed below the number of exchangeable shares held and the total Class X shares outstanding are capped at the total exchangeable shares outstanding (see ACN_10k_2024.pdf p. 100).  The consolidated financial statements continue to report a noncontrolling interest in Accenture Canada Holdings Inc. that is **less than 1 %** of the equity, the same threshold disclosed at the end of 2023 (see ACN_10k_2024.pdf p. 20), indicating no material evolution in the equity relationship over the year.",
      "correctness_score": 3,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IN CORE CLAIM: The LLM answer fundamentally contradicts the ground truth by stating 'the ownership structure of Accenture Canada Holdings Inc. was unchanged' between 2023 and 2024. The ground truth explicitly states the structure 'had evolved' with 'a more formalized and structured equity relationship in 2024 compared to the simpler noncontrolling interest disclosure in 2023.' This is a major factual error that misrepresents the evolution of the equity relationship.\n\nQUANTITATIVE ACCURACY: The LLM correctly identifies the noncontrolling interest as 'less than 1%' in both years, matching the ground truth. The one-for-one exchange ratio and the relationship between Class X shares and exchangeable shares are accurately described.\n\nQUALITATIVE ACCURACY - MAJOR ISSUE: The LLM's conclusion that there was 'no material evolution in the equity relationship over the year' directly contradicts the ground truth's assertion of evolution. The ground truth emphasizes that 2024 included 'detailed provisions' and 'more formalized and structured' arrangements, while 2023 had 'simpler noncontrolling interest disclosure.' The LLM mischaracterizes this as unchanged when the ground truth clearly indicates structural evolution.\n\nMULTI-HOP REASONING: The LLM failed to properly synthesize the comparison between 2023 and 2024. While it correctly identifies specific mechanisms (exchangeable shares, Class X shares, redemption restrictions), it fails to recognize that the introduction of these detailed provisions and formalized structures represents an evolution from the prior year's simpler disclosure.\n\nCONTEXTUAL RELEVANCE: The question specifically asks 'how has...evolved' - a comparative question requiring identification of changes. The LLM's answer that nothing changed is fundamentally non-responsive to the question's core intent, even though some technical details are accurate.\n\nThe answer demonstrates selective accuracy on isolated facts while missing the overarching narrative of structural evolution that is central to answering the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 559,
        "total_tokens": 1990
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How has Merck's approach to managing balance sheet risk through forward exchange contracts evolved between 2022 and 2024, particularly in terms of the currencies and cost-benefit considerations?",
      "original_answer": "In 2022, Merck explicitly outlined a balance sheet risk management program that involved the use of forward exchange contracts to offset exposures in both developed and developing country currencies, with a specific mention of the Chinese renminbi. The decision to hedge developing country currencies was based on a cost-benefit analysis considering exposure magnitude, exchange rate volatility, and hedging instrument cost. By 2024, while the balance sheet risk management program was still referenced, the detailed discussion around cost-benefit analysis and the specific mention of the Chinese renminbi in the context of developing countries was omitted. This suggests a shift in emphasis or a potential simplification of the decision-making framework for hedging non-developed market exposures.",
      "llm_answer": "\nFrom 2022 to 2024 Merck expanded its forward‑exchange program from a simple, short‑term hedge of monetary‑asset exposures in developed currencies (euro, yen, pound, Swiss franc) to a layered, cost‑benefit‑driven framework.  The company now (i) hedges a portion of forecasted foreign‑currency sales—primarily the euro, Japanese yen and Chinese renminbi—using purchased puts, forwards and collars, (ii) employs designated forward contracts to protect net‑investment in foreign subsidiaries and euro‑denominated debt, and (iii) determines hedge size and maturity by weighing the magnitude of each exposure, its volatility and the cost of the instrument, typically keeping average contract lives under six months.  This evolution reflects a more strategic selection of currencies—including emerging‑market currencies when economical—and a tighter integration of cost‑benefit analysis into the hedge‑design process.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations of the ground truth. Key issues: (1) DIRECTIONAL ERROR: The LLM claims Merck 'expanded' its program from 2022 to 2024, but the ground truth indicates the opposite—a simplification or de-emphasis of detailed cost-benefit analysis and specific currency mentions. (2) INVENTED DETAILS: The LLM introduces specific hedging instruments (purchased puts, collars, designated forward contracts for net-investment in foreign subsidiaries, euro-denominated debt) and operational details (average contract lives under six months) that are NOT mentioned in the ground truth. These appear to be fabricated or from different source material. (3) MISCHARACTERIZATION OF EVOLUTION: The ground truth states that by 2024, the detailed discussion of cost-benefit analysis and specific mention of Chinese renminbi in developing countries context was OMITTED, suggesting simplification. The LLM claims the opposite—that cost-benefit analysis became MORE integrated into the process. (4) CURRENCY HANDLING: While both mention Chinese renminbi, the ground truth specifically contextualizes it as a developing country currency in 2022 with cost-benefit considerations, whereas the LLM presents it as part of a broader 2024 expansion without acknowledging the shift away from detailed developing-market discussion. (5) MULTI-HOP REASONING FAILURE: The LLM failed to correctly synthesize the temporal evolution between 2022 and 2024, instead inverting the direction of change. The answer reads as plausible but contradicts the ground truth's core finding about simplification rather than expansion of the analytical framework.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 457,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "What does the change in RTX's disclosure about the Powder Metal Matter between 2023 and 2024 suggest about its ongoing financial impact on future income tax benefits?",
      "original_answer": "In 2023, the Powder Metal Matter was disclosed as having a net sales charge of $5.3 billion, which negatively impacted net products sales at Pratt & Whitney and contributed to a decline in overall revenue. By 2024, the Powder Metal Matter was listed under future income tax benefits with a value of $455 million, down from $644 million in 2023. This shift indicates that while the matter continues to carry financial significance, its treatment has evolved from a direct operational loss to a deferred tax asset, suggesting a reduction in its immediate negative impact and a potential long-term recovery or resolution.",
      "llm_answer": "\nThe 2024 filing shows the future‑income‑tax benefit that had been recorded for the Powder Metal Matter falling from **$644 million in 2023 to $455 million in 2024** – a reduction of roughly **$190 million**.  This decline signals that the tax credits or deductions tied to the Powder Metal Matter are being exhausted or impaired, so RTX expects **significantly smaller future tax savings** from that item and therefore a reduced impact on its overall deferred‑tax asset position.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) All numeric values are correct: $644 million (2023), $455 million (2024), and the calculated difference of $190 million are all accurate. (2) The LLM correctly identifies the shift in how the Powder Metal Matter is being treated in the financial statements. (3) The calculation of the decline ($644M - $455M = $190M) is accurate. (4) The timeframe (2023 to 2024) is correctly identified.\n\nWEAKNESSES: (1) The LLM's interpretation of what the decline means is incomplete and somewhat speculative. The ground truth indicates the shift represents an evolution from 'a direct operational loss to a deferred tax asset,' suggesting potential recovery or resolution. The LLM's interpretation focuses narrowly on 'tax credits or deductions being exhausted or impaired,' which is a narrower and more negative interpretation than the ground truth suggests. (2) The LLM omits the important context that in 2023, the Powder Metal Matter was disclosed as having a net sales charge of $5.3 billion with direct operational impact. This context is crucial for understanding the significance of the shift to future income tax benefits. (3) The LLM doesn't fully capture the nuance that the shift from operational loss to deferred tax asset suggests 'a reduction in its immediate negative impact and a potential long-term recovery or resolution' - instead focusing only on exhaustion of benefits. (4) The phrase 'significantly smaller future tax savings' is somewhat speculative without explicit confirmation in the ground truth about whether this represents exhaustion vs. other factors.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes the year-over-year comparison but fails to fully integrate the broader context of how the matter's treatment has evolved from operational impact to tax treatment. The reasoning is partially sound but incomplete.\n\nOVERALL: The answer is factually accurate on numbers and calculations but provides an incomplete and somewhat narrow interpretation of what the change suggests about future financial impact.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 550,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How has PayPal's involvement in the merchant receivables space evolved between 2022 and 2024, particularly in terms of its relationship with partner institutions and the scale of its merchant finance offerings?",
      "original_answer": "In 2022, PayPal described its U.S. merchant finance products (PPWC and PPBL) as being provided under a program agreement with WebBank, where PayPal could purchase the related receivables and also sell back a participation interest in the pool of receivables to WebBank. PayPal accounted for this arrangement as a sale and derecognized the portion of participation interests for which control was surrendered. By 2024, PayPal's relationship with partner institutions had evolved, with PayPal now purchasing approximately $1.8 billion in merchant receivables in 2024 (up from $1.7 billion in 2023), and the total outstanding balance in the pool of merchant loans, advances, and interest and fees receivable reached $1.5 billion as of December 31, 2024 (up from $1.2 billion as of December 31, 2023). Additionally, the participation interest sold to the partner institution increased to $53 million in 2024 from $44 million in 2023, indicating a growing level of investment in and collaboration around merchant receivables.",
      "llm_answer": "\nBetween 2022 and 2024 PayPal’s merchant‑finance business expanded markedly: the company purchased roughly $1.8 billion of merchant receivables in 2024 (up from about $1.7 billion in 2023) and the outstanding portfolio grew to $1.5 billion net of the partner’s participation interest (versus $1.2 billion in 2023).  This growth is underpinned by a deeper, risk‑sharing partnership with the issuing banks—most notably WebBank in the U.S. and the firm’s European and Australian subsidiaries—where the partner holds a participation stake in the receivable pool while PayPal retains servicing rights and earns a fee.  Consequently, the scale of PayPal’s merchant‑finance offering has roughly doubled since 2022, and its credit‑risk framework (allowance for credit losses, delinquency monitoring, and macro‑economic underwriting) has been tightened to support the larger, more diversified portfolio.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several correct quantitative elements but introduces significant inaccuracies and unsupported claims that reduce overall correctness. CORRECT ELEMENTS: (1) Merchant receivables purchased in 2024 ($1.8B) and 2023 ($1.7B) are accurate; (2) Outstanding balance figures of $1.5B (2024) and $1.2B (2023) are correct; (3) WebBank partnership identification is accurate; (4) General characterization of risk-sharing partnership structure is appropriate. CRITICAL ERRORS: (1) The LLM states 'outstanding portfolio grew to $1.5 billion net of the partner's participation interest' - this is INCORRECT. The ground truth shows the total outstanding balance in the pool reached $1.5B, while the participation interest sold to partner was $53M (2024) and $44M (2023). The LLM conflates these figures and misrepresents the accounting; (2) The LLM claims 'the scale of PayPal's merchant-finance offering has roughly doubled since 2022' - this is UNSUPPORTED and likely inaccurate. No 2022 comparable figures are provided in the ground truth to support a 'doubling' claim; (3) The LLM introduces details about 'European and Australian subsidiaries' and 'credit-risk framework (allowance for credit losses, delinquency monitoring, and macro-economic underwriting)' that are NOT mentioned in the ground truth and appear to be hallucinated; (4) The LLM omits the important detail about PayPal's 2022 accounting treatment (sale accounting and derecognition of participation interests), which is a key part of how the relationship evolved. QUANTITATIVE ACCURACY ISSUES: The mischaracterization of what the $1.5B represents (net vs. gross) is a material accounting error. The participation interest figures ($53M and $44M) are completely absent from the LLM answer, which is a significant omission of key quantitative data showing the evolution of the partnership. MULTI-HOP REASONING: The LLM attempts to synthesize information about partnership evolution and scale, but does so with inaccurate characterizations and unsupported claims. The reasoning about risk-sharing is directionally correct but lacks precision about the actual accounting mechanics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1494,
        "completion_tokens": 578,
        "total_tokens": 2072
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How did Merck's alliance revenue from Lynparza evolve between 2022 and 2024, and what factors contributed to the change?",
      "original_answer": "In 2022, Merck's alliance revenue from Lynparza was $989 million. By 2024, this revenue grew by 9%, driven by increased demand in most international markets. The growth reflects Lynparza's expanding adoption and new approvals, such as in China in January 2025 for adjuvant treatment in early breast cancer based on the OlympiA trial.",
      "llm_answer": "\nAlliance revenue from Lynparza increased each year from 2022 through 2024, posting a 9 % rise in 2024 (up from lower levels in 2023 and 2022). The growth was driven by stronger demand in international markets, new regulatory approvals—including China’s 2025 NMPA approval—and the continued profitability of the AstraZeneca collaboration, while pricing pressures and competitive dynamics moderated the pace of increase.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ISSUES: (1) QUANTITATIVE ACCURACY - The LLM answer fails to provide the specific 2022 baseline figure ($989 million) that is central to understanding the evolution. The ground truth explicitly states '2022: $989 million' and '2024: grew by 9%' (implying ~$1,078 million in 2024). The LLM vaguely references 'lower levels in 2023 and 2022' without concrete numbers, making it impossible to verify the actual revenue trajectory. (2) INCOMPLETE SYNTHESIS - The ground truth provides a clear quantitative anchor (2022: $989M, 2024: +9% growth), but the LLM omits the baseline year figure entirely. This is a significant gap for a question specifically asking 'how did...evolve between 2022 and 2024.' (3) REASONING QUALITY - The LLM correctly identifies contributing factors (international demand, regulatory approvals including China 2025 NMPA approval, AstraZeneca collaboration) and adds context about 'pricing pressures and competitive dynamics,' which shows reasonable inference but goes beyond the ground truth without explicit support. (4) FACTUAL VERIFICATION - The China 2025 NMPA approval and OlympiA trial reference are correct per ground truth. The mention of 'adjuvant treatment in early breast cancer' is accurate. However, the LLM's statement about 'lower levels in 2023 and 2022' is unsupported by the ground truth, which only provides 2022 and 2024 data. (5) MULTI-HOP SYNTHESIS - The answer attempts to synthesize multiple factors but fails to anchor the quantitative evolution with specific numbers, which is essential for answering 'how did...evolve.' The 9% growth figure is mentioned but not clearly tied to the baseline. STRENGTHS: Correctly identifies key drivers (international markets, regulatory approvals, China approval), mentions the AstraZeneca partnership context, and acknowledges competitive dynamics. WEAKNESSES: Missing the critical $989M baseline figure, vague about year-over-year progression, adds unsupported claims about 2023 levels.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1181,
        "completion_tokens": 533,
        "total_tokens": 1715
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How has PayPal's involvement in merchant receivables evolved between 2022 and 2024, particularly in terms of its financial exposure and operational role?",
      "original_answer": "In 2022, PayPal's involvement in merchant receivables was primarily framed in terms of credit losses and net charge-offs, indicating a focus on risk management and accounting treatment under CECL standards. By 2024, PayPal had significantly expanded its direct involvement through active purchases of merchant receivables—$1.8 billion in 2024 compared to $1.7 billion in 2023—and reported a growing outstanding balance of $1.5 billion, up from $1.2 billion. Additionally, PayPal took on full servicing responsibilities for these receivables, signaling a deeper operational engagement in merchant finance through products like PPWC and PPBL.",
      "llm_answer": "\nBetween 2022 and the end of 2024 PayPal shifted from simply purchasing merchant receivables from a partner bank to **originating and servicing its own merchant‑finance products (PPWC and PPBL)**, growing the outstanding portfolio to roughly **$1.5 billion of merchant loans, advances and interest receivable** as of 31 Dec 2024 (see Note 101 & the delinquency tables in Note 102).  The company now records a **$348 million allowance for credit losses** on these receivables and reports modestly higher gross charge‑offs, reflecting an expanding financial exposure, while operationally it monitors delinquency by days‑past‑due, recalculates repayment rates each month, and must comply with regulator‑mandated reporting and remediation processes.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive understanding of PayPal's merchant receivables evolution. STRENGTHS: (1) Correctly identifies the $1.5 billion outstanding balance as of Dec 31, 2024, matching ground truth exactly. (2) Accurately cites the $1.8 billion in 2024 purchases (implied through context of growing portfolio) and $1.7 billion in 2023, consistent with ground truth. (3) Properly identifies the shift from partner-bank purchasing to direct origination and servicing of PPWC and PPBL products. (4) Correctly references the $348 million allowance for credit losses, demonstrating detailed knowledge of the financial statements. (5) Appropriately notes operational responsibilities including delinquency monitoring, repayment rate calculations, and regulatory compliance. (6) Multi-hop reasoning is sound—synthesizes evolution from 2022 (risk management focus) through 2024 (active origination and servicing). MINOR CONSIDERATIONS: (1) The answer introduces the $348 million allowance figure, which is accurate but not explicitly mentioned in the ground truth summary (though consistent with expanded financial exposure). (2) The answer emphasizes operational details (delinquency monitoring, monthly recalculations, regulatory compliance) that go slightly beyond the ground truth but are contextually appropriate and accurate. (3) The phrasing 'merchant loans, advances and interest receivable' is the precise accounting terminology and correctly reflects the nature of the assets. QUANTITATIVE VERIFICATION: All dollar amounts ($1.5B outstanding, $348M allowance) are accurate; the timeline (2022 to 2024) is correct; the product names (PPWC, PPBL) are accurate. The answer successfully synthesizes multi-hop information across years and demonstrates understanding of both financial exposure metrics and operational engagement changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 508,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How has Merck's involvement in the development and commercialization of Lynparza evolved from 2022 to 2024, particularly in terms of regulatory progress and revenue growth?",
      "original_answer": "In 2022, Merck was awaiting FDA decision on a supplemental NDA for Lynparza for the adjuvant treatment of BRCA-mutated, HER2-negative high-risk early-stage breast cancer, based on the OlympiA trial, with a PDUFA date in Q1 2022. By 2024, Lynparza had not only maintained its approvals but also expanded its regulatory footprint, with a new approval in China in January 2025 for the same indication, indicating continued global regulatory momentum. Additionally, alliance revenue related to Lynparza grew by 9% in 2024 due to increased demand in international markets, showing a measurable increase in commercial success.",
      "llm_answer": "\nFrom 2022 through 2024 Merck pushed Lynparza through a series of regulatory milestones: the FDA gave the drug a priority‑review designation in early 2022 for an adjuvant treatment of BRCA‑mutated, HER2‑negative high‑risk early‑stage breast cancer (page 22), the EU was reviewing a similar indication for metastatic castration‑resistant prostate cancer (page 23), and in January 2025 (announced in the 2024 filing) China’s NMPA approved Lynparza for that adjuvant breast‑cancer setting (page 55).  Consequently, alliance revenue from Lynparza rose about 9 % in 2024, driven by stronger demand in international markets and the impact of these new approvals.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identified the 9% revenue growth figure for 2024 alliance revenue from Lynparza. (2) Correctly noted the January 2025 China NMPA approval for adjuvant breast cancer indication. (3) Properly synthesized the multi-hop information about regulatory progress and commercial success. (4) Correctly identified the BRCA-mutated, HER2-negative high-risk early-stage breast cancer indication. (5) Appropriately noted international market demand as a driver of growth.\n\nWEAKNESSES AND ERRORS: (1) SIGNIFICANT ERROR: The LLM states the EU was reviewing 'a similar indication for metastatic castration-resistant prostate cancer' - this is INCORRECT. The ground truth specifies the indication was for adjuvant breast cancer treatment, not prostate cancer. This represents a material factual error in entity/indication identification. (2) The LLM mentions 'priority-review designation in early 2022' but the ground truth states Merck was 'awaiting FDA decision' with a PDUFA date in Q1 2022 - the LLM's characterization of priority review is not explicitly confirmed in the ground truth and may be an inference. (3) The LLM does not clearly distinguish between what was the status in 2022 versus 2024, making the evolution less clear than the ground truth's explicit before/after comparison. (4) Missing explicit mention that Lynparza 'maintained its approvals' through this period, which is part of the evolution narrative.\n\nMULTI-HOP REASONING: The LLM attempted to synthesize regulatory milestones across years and geographies, but the prostate cancer error undermines the quality of this synthesis. The connection between regulatory approvals and revenue growth is properly made.\n\nNUMERIC VERIFICATION: The 9% figure is correct. The January 2025 date is correct. No calculation errors detected.\n\nOVERALL: The answer captures the main narrative of regulatory progress and revenue growth, but the significant error regarding the EU indication (prostate cancer vs. breast cancer) is a material factual mistake that prevents a higher score. The answer is partially correct but contains a notable inaccuracy that affects credibility.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 578,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How has Boeing's strategy with commodity purchase contracts evolved between 2022 and 2024, particularly in terms of risk management horizon and financial exposure?",
      "original_answer": "In 2022, Boeing disclosed that a 10% change in commodity prices would impact unrealized losses by $46 million, and the company used commodity swaps and purchase contracts to hedge against price volatility, neutralizing material market risk. By 2024, Boeing extended the scope of its hedging strategy, indicating the use of commodity purchase contracts and derivatives to manage exposure through 2031. This represents a shift toward longer-term risk management aligned with extended production planning cycles. The expansion from a general hedging approach in 2022 to a multi-decade horizon in 2024 suggests Boeing is proactively securing cost predictability for strategic business stability.",
      "llm_answer": "\nBoeing has lengthened the horizon of its commodity‑price hedges, moving from short‑term fixes to multi‑year contracts that now run out to 2031 and expanding the use of commodity swaps and purchase contracts to lock in input prices.  This broader, longer‑dated coverage has increased the company’s financial exposure to commodity‑price volatility, which is reflected in a growing unrealized‑loss position in accumulated other comprehensive income – the derivative‑related balance rose from about ($24) million in 2022 to roughly ($211) million by the end of 2024, and a 10 % price move would still generate roughly $46 million of unrealized loss.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM introduces a significant factual error regarding unrealized losses. The ground truth states Boeing's derivative-related balance in accumulated other comprehensive income was approximately ($24) million in 2022, but the LLM claims it 'rose from about ($24) million in 2022 to roughly ($211) million by the end of 2024.' This $211 million figure is NOT supported by the ground truth and appears to be fabricated. The ground truth makes no mention of a $211 million figure for 2024. (2) The LLM correctly identifies the 10% commodity price impact as $46 million, matching the ground truth. (3) The LLM correctly identifies the extension to 2031 and the shift toward longer-term hedging strategies, which aligns with the ground truth. (4) REASONING QUALITY - The LLM's interpretation that 'broader, longer-dated coverage has increased the company's financial exposure' is problematic. The ground truth frames the strategy as 'proactively securing cost predictability for strategic business stability,' suggesting risk REDUCTION, not increased exposure. The LLM's framing contradicts the ground truth's interpretation. (5) MULTI-HOP SYNTHESIS - The LLM does attempt to synthesize information across years (2022 to 2024) and connect hedging strategy to financial metrics, but the synthesis is undermined by the introduction of unsupported numbers. (6) COMPLETENESS - The answer addresses the evolution of strategy and mentions both 2022 and 2024, but the fabricated $211 million figure and mischaracterization of risk direction are material errors that significantly undermine the response's reliability.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 454,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How did Schwab's exposure to PALs and the associated credit risk evolve between 2021 and 2024, particularly in terms of collateralization and allowance for credit losses?",
      "original_answer": "In 2021, all PALs were fully collateralized by securities with fair values exceeding borrowings, and therefore no allowance for credit losses was required. In contrast, by 2024, although PALs experienced slight growth overall, Schwab observed a decrease in the allowance for credit losses due to lower projected loss rates and improved credit quality metrics. This reflects a shift from a focus on full collateralization as the primary risk mitigant to a broader assessment of credit quality and loss projections.",
      "llm_answer": "\nBetween 2021 and 2024 Schwab’s pledged‑asset line (PAL) portfolio grew from roughly $12.7 bn to about $17 bn, yet the lines have remained fully collateralized by securities whose fair value exceeds the outstanding balances, so no allowance for credit losses is recorded for PALs in either year.  The overall allowance for credit losses on the bank‑loan portfolio fell from 0.09 % of total loans in 2023 to 0.05 % in 2024 (and the allowance‑to‑nonaccrual ratio dropped from 253 % to 60 %), reflecting a lower projected loss rate and improved credit quality even as the absolute size of the PAL exposure increased.  Consequently, while exposure to PALs has risen, the credit risk associated with them stays minimal because they are continuously over‑collateralized and are excluded from the allowance calculation.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a fundamental factual error that directly contradicts the ground truth. The ground truth explicitly states that by 2024, PALs experienced 'a decrease in the allowance for credit losses' and that the situation changed from 2021 when 'no allowance for credit losses was required.' However, the LLM answer claims 'no allowance for credit losses is recorded for PALs in either year' (both 2021 and 2024), which is factually incorrect. This is a major error that misrepresents the evolution of credit risk exposure that the question specifically asks about. The LLM also provides specific dollar amounts ($12.7bn to $17bn) and allowance ratios (0.09% to 0.05%, 253% to 60%) that are not mentioned in the ground truth and cannot be verified. While the LLM correctly identifies that PALs remained fully collateralized and that credit quality improved, it fundamentally misses the key evolution: the shift from full collateralization as the primary risk mitigant to a broader assessment including allowance for credit losses. The answer does address the multi-hop nature of the question (comparing 2021 to 2024, discussing collateralization and allowance), but the core factual claim about allowances is inverted from reality. The reasoning about over-collateralization is sound, but it contradicts the ground truth's assertion that allowances did change between these years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 393,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did Boeing's financial treatment and strategic positioning of the 777X program evolve between 2022 and 2024, given the changes in cost impacts and research & development investments?",
      "original_answer": "In 2022, the 777X program negatively impacted Boeing's financials, contributing to higher charges and a cost of sales increase, partly due to a 'reach-forward loss' on the program. By 2024, the program had transitioned to being a strategic investment priority, as evidenced by a $435 million increase in R&D spending in 2024 compared to 2023, following a $525 million increase in 2023 over 2022, indicating a shift from a cost burden to a focal point for future product development.",
      "llm_answer": "\nBoeing’s exposure to the 777X deepened sharply through 2022‑2024: the forward‑loss recognition recorded for the program rose to **$7.6 bn in 2024** (up from $4.7 bn in 2023 and from earlier years), which pushed cost‑of‑sales as a share of revenue higher and added to overall cost‑of‑sales reductions (‑$1.56 bn in 2024).  At the same time, the company’s **R&D spend jumped to $3.812 bn in 2024**, with a **$435 m increase attributed specifically to the 777X program** and other enterprise product‑development investments, underscoring a continued strategic commitment to the aircraft despite delivery delays.  These cost impacts and heightened R&D spending reflect Boeing’s effort to manage the program’s financial risk while preserving its long‑term market position.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) QUANTITATIVE ERRORS - The LLM introduces specific forward-loss figures ($7.6bn in 2024, $4.7bn in 2023) that are NOT present in the ground truth answer. The ground truth makes NO mention of forward-loss amounts at all, only that a 'reach-forward loss' occurred in 2022. These appear to be fabricated numbers. (2) R&D SPENDING CLAIM - The LLM states '$435m increase attributed specifically to the 777X program' but the ground truth indicates the $435m increase in 2024 R&D was the TOTAL increase compared to 2023, not specifically attributed to 777X alone. This is a misrepresentation of the data. (3) COST-OF-SALES CLAIM - The LLM mentions '-$1.56 bn in 2024' cost-of-sales reductions, which is not mentioned in the ground truth and appears unsupported. (4) MISSING KEY INSIGHT - The LLM fails to clearly articulate the core evolution described in ground truth: the shift FROM a cost burden/negative impact (2022) TO a strategic investment priority (2024). Instead, it emphasizes deepening exposure and forward losses, which contradicts the ground truth's narrative of transition. (5) PARTIAL CORRECTNESS - The LLM correctly identifies the $435m R&D increase in 2024 and the general theme of strategic commitment despite challenges, but these correct elements are embedded within largely inaccurate framing. The answer demonstrates hallucination of specific financial figures not supported by the source material, which is a critical failure for financial analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 412,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How has Schwab's exposure to and risk management of Portfolio Against Loans (PALs) evolved between 2022 and 2024, particularly in terms of credit loss allowance methodology and portfolio growth?",
      "original_answer": "In 2022, Schwab applied the practical expedient for PALs due to their collateralized nature and over-collateralization requirements, which limited inherent credit loss. The company monitored collateral daily and maintained strict maintenance levels based on the type of security pledged. By 2024, PALs had contributed to the growth of the average loan portfolio, although there was a slight decrease in 2023. The overall decrease in the allowance for credit losses as a ratio to year-end loans in 2024 was attributed to improved credit quality metrics and lower projected loss rates, indicating a reduced risk profile for PALs despite portfolio growth.",
      "llm_answer": "\nSchwab’s Portfolio‑Against‑Loans (PALs) portfolio expanded modestly—average PAL balances rose from roughly $13.7 bn in 2022 to $14.9 bn in 2024—yet the credit‑loss allowance for this segment remained essentially $0, because the loans are over‑collateralized and Schwab applies a practical‑expedient that waives a formal allowance. Consequently, the overall bank‑loan allowance‑to‑loan ratio fell from 0.09 % in 2023 to 0.05 % in 2024, reflecting improved credit quality, while the PAL risk‑management methodology has stayed unchanged: losses are only recognized if collateral falls below prescribed thresholds, which is rare.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides specific quantitative details about PALs portfolio growth and allowance ratios that are not explicitly contradicted by the ground truth, and correctly identifies the practical expedient methodology and over-collateralization approach. However, there are several evaluation concerns: (1) QUANTITATIVE VERIFICATION: The LLM provides specific numbers ($13.7bn in 2022, $14.9bn in 2024, allowance ratios of 0.09% in 2023 and 0.05% in 2024) that cannot be verified against the ground truth, which provides only qualitative descriptions. The ground truth mentions 'slight decrease in 2023' and 'growth' by 2024, which is consistent with the LLM's figures showing a dip then recovery. The allowance ratio decrease (0.09% to 0.05%) aligns with the ground truth's statement about 'overall decrease in the allowance for credit losses as a ratio to year-end loans in 2024.' (2) METHODOLOGY ACCURACY: Both answers correctly identify the practical expedient application and over-collateralization as key risk management features. The LLM adds useful detail about daily collateral monitoring being replaced by threshold-based recognition, though the ground truth mentions 'daily monitoring' and 'maintenance levels.' (3) MULTI-HOP SYNTHESIS: The LLM successfully synthesizes the evolution between 2022-2024, connecting portfolio growth to allowance methodology changes and credit quality improvements. (4) COMPLETENESS: The LLM addresses all parts of the question (exposure evolution, risk management, credit loss allowance methodology, portfolio growth). However, the LLM states 'risk-management methodology has stayed unchanged' while the ground truth emphasizes evolution and changes in approach. This is a minor semantic discrepancy. (5) MISSING ELEMENTS: The ground truth mentions 'improved credit quality metrics and lower projected loss rates' which the LLM captures as 'improved credit quality' but doesn't explicitly mention projected loss rates. Overall, the answer is substantially correct with good quantitative detail, though some specific numbers cannot be independently verified from the provided ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 572,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did MDLZ's value of British pound sterling notes change from 2022 to 2023, and what does this shift indicate about the company's foreign exchange risk management strategy?",
      "original_answer": "In 2022, MDLZ reported a value of $3 million for British pound sterling notes. By 2023, this value had increased significantly to $45 million. This shift indicates a substantial change in MDLZ's foreign exchange risk management strategy, suggesting an increased exposure to the British pound sterling, which could reflect either a strategic decision to hedge more in this currency or an increase in operational activities tied to the UK market.",
      "llm_answer": "\nThe after‑tax gain on British‑pound‑denominated net‑investment hedges fell sharply from **$45 million in 2022 to essentially $0 (a $45 million decline) in 2023** (MDLZ 10‑K 2023, p. 98).  This drop shows that the company either reduced its GBP‑hedge position or allowed the hedge to become less effective, signaling a more conservative or re‑calibrated foreign‑exchange risk‑management approach.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that directly contradict the ground truth. (1) QUANTITATIVE ERRORS: The LLM states the after-tax gain on GBP net-investment hedges was $45 million in 2022 and $0 in 2023. However, the ground truth clearly indicates the value of British pound sterling NOTES was $3 million in 2022 and $45 million in 2023 - the exact opposite direction of change. The LLM has inverted the numbers and the direction of the trend. (2) ENTITY CONFUSION: The LLM appears to be discussing 'after-tax gains on GBP net-investment hedges' while the ground truth refers to 'British pound sterling notes' - these are different financial instruments/metrics. The LLM may have confused different line items from the 10-K. (3) DIRECTIONAL ERROR: The ground truth shows an INCREASE from $3M to $45M (a $42 million increase), indicating expanded GBP exposure. The LLM describes a DECREASE from $45M to $0 (a $45 million decline), which is the opposite direction and suggests a reduction in hedging. (4) INTERPRETATION MISMATCH: The ground truth interprets the increase as suggesting 'increased exposure to the British pound sterling' and 'a strategic decision to hedge more.' The LLM interprets a decrease as 'reduced GBP-hedge position' and 'more conservative approach.' These are contradictory interpretations based on inverted data. (5) MULTI-HOP REASONING: The LLM failed to correctly synthesize the year-over-year comparison, getting both the magnitude and direction of change wrong. This is a critical failure in multi-hop financial analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 430,
        "total_tokens": 1647
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "Compare the interest rate disclosures for Amgen's 3.125% 2025 Notes in the 2022 and 2024 filings, and explain what this reveals about the company's approach to debt financing for this instrument.",
      "original_answer": "In the 2022 filing, Amgen disclosed a fixed interest rate of 3.125% for the 2025 Notes with no mention of variable rate terms. However, by the 2024 filing, Amgen disclosed that the interest rate for the same 3.125% 2025 Notes was tied to SOFR (Secured Overnight Financing Rate) plus 2.1%. This indicates a shift from a purely fixed-rate structure to a floating-rate mechanism, suggesting Amgen may have refinanced or repriced the notes to adapt to changing market conditions and interest rate environments.",
      "llm_answer": "\nThe 2022 filing lists the 3.125% 2025 Notes as a straight‑fixed‑rate tranche (3.125% coupon, $1 billion outstanding) with no reference to any hedging or floating‑rate structure. In the 2024 filing the same series appears in a table of notes that are covered by interest‑rate swaps, showing a current “interest rate = SOFR + 2.1%” and a $1 billion swap notional, indicating that the notes are now effectively a synthetic floating‑rate debt. This shift shows that Amgen has moved from a pure fixed‑rate financing for the 2025 notes to a hedged, floating‑rate profile, using swaps to align the cost of the 2025 debt with its broader interest‑rate risk‑management strategy.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and provides a more detailed explanation than the ground truth. Key strengths: (1) All numeric values are correct - 3.125% coupon, $1 billion outstanding/notional, SOFR + 2.1% spread are all accurate; (2) The multi-hop synthesis is sound - correctly identifies the shift from fixed-rate (2022) to floating-rate with swaps (2024); (3) The explanation of the mechanism is more sophisticated than ground truth, correctly identifying that swaps create a 'synthetic floating-rate' structure rather than an outright refinancing; (4) All entities and years are correctly identified (Amgen, 2025 Notes, 2022 vs 2024 filings). Minor considerations: (1) The LLM provides additional context about interest-rate risk management strategy that, while reasonable and supported by the data, goes slightly beyond what the ground truth explicitly states; (2) The ground truth uses the word 'refinanced or repriced' while the LLM specifies 'swaps' - the LLM's answer is more precise and technically accurate about the actual mechanism; (3) Both answers correctly convey that there was a shift from fixed to floating-rate structure, but the LLM's explanation of how this was accomplished (via swaps rather than refinancing) is more accurate to typical corporate finance practice. The answer fully addresses the comparison question and explains what this reveals about Amgen's debt financing approach.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 397,
        "total_tokens": 1703
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How has Schwab's reliance on its Commercial Paper Issuance Program evolved between 2022 and 2024 in response to market disruptions and rising interest rates?",
      "original_answer": "In 2022, Schwab introduced its Commercial Paper Issuance Program as one of several potential sources of external financing, alongside unsecured bank credit lines and a universal shelf registration, to address liquidity needs during market disruptions. The company emphasized that while these tools were available, access to financing could still be constrained due to credit market volatility and potential credit rating downgrades. By 2024, Schwab's reliance on the program had increased as a complement to other funding mechanisms like FHLB advances and repurchase agreements, particularly in response to rising short-term interest rates in 2022 and 2023, which led to higher client cash outflows. The company noted that these outflows, outpacing cash generated from maturities and paydowns, required supplemental funding sources, including the commercial paper program, to manage liquidity under more costly and constrained conditions.",
      "llm_answer": "\nBetween 2022 and 2024 Schwab’s dependence on its Commercial Paper Issuance Program receded as a primary source of liquidity.  In the 2022 filing the CP program was listed alongside bank lines and a shelf‑registration, but the company warned that market disruptions and the rapid rise in short‑term rates could limit CP access and forced it to supplement funding with higher‑cost sources such as FHLB advances, repurchase‑agreement borrowings and brokered CDs.  By the 2024 filing the CP program is still noted as one of several backup financing options, but the narrative stresses a broader, more diversified funding mix—indicating that CP issuance now serves mainly as a contingency rather than a core reliance.",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERROR - DIRECTIONAL CONTRADICTION: The LLM answer fundamentally contradicts the ground truth on the core question. Ground truth states that Schwab's reliance on the CP program INCREASED between 2022 and 2024 as a complement to other funding mechanisms in response to rising interest rates and client cash outflows. The LLM answer claims reliance RECEDED and that CP 'now serves mainly as a contingency rather than a core reliance.' This is the opposite of what the ground truth establishes. CORRECT ELEMENTS: (1) The LLM correctly identifies that in 2022 the CP program was listed alongside bank lines and shelf registration; (2) Correctly mentions market disruptions and rising short-term rates; (3) Correctly identifies FHLB advances, repurchase agreements, and brokered CDs as supplemental funding sources; (4) Correctly notes the 2024 filing mentions CP as a backup option. INCORRECT ELEMENTS: (1) The directional trend is inverted - the answer claims CP reliance decreased when it actually increased; (2) The characterization of CP as 'mainly a contingency' contradicts the ground truth that it became increasingly relied upon to manage liquidity under constrained conditions; (3) The narrative misrepresents the evolution - the ground truth shows CP became MORE important as a complement to other mechanisms, not less important. MULTI-HOP REASONING: The LLM failed to correctly synthesize the temporal evolution across 2022-2024 filings. While individual facts about funding sources are mentioned, the overall conclusion about the trend is backwards. This is a fundamental failure in understanding the question's core inquiry about how reliance 'evolved' - the answer provides the opposite evolution. QUANTITATIVE ACCURACY is rated 8 because no specific numbers are provided in either answer, but dates (2022, 2024) are correct. However, the qualitative accuracy is severely compromised by the directional error.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 520,
        "total_tokens": 1936
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How has the status and interest rate structure of the 3.625% Notes evolved from 2022 to 2024, and what does this indicate about the company's debt management strategy?",
      "original_answer": "In 2022, the 3.625% 2024 Notes had a carrying value of $1,400 million with a fixed interest rate of 3.625%. By 2024, these notes were fully paid off, as indicated by the $0 notional amount, and were replaced with floating interest rates tied to SOFR (Secured Overnight Financing Rate). This shift from fixed to floating rate debt indicates a strategic change in Amgen's debt management, aligning with broader market conditions and potentially reducing interest costs in a declining rate environment.",
      "llm_answer": "\nThe 3.625 % fixed‑rate notes were largely eliminated between 2022 and 2024.  In 2022 the company still had 3.625 % 2022 notes on its balance sheet, but those were redeemed in 2021‑2022 (see the 2021 redemption discussion in the 10‑K).  By the end of 2023 the only remaining 3.625 % issue was the 3.625 % 2024 notes, which had a $1.4 bn notional amount and, as shown in the 2023 interest‑rate‑swap table, were effectively converted to a floating‑rate of **SOFR + 3.4 %** through interest‑rate swaps.  In 2024 those notes were fully retired (their notional balance fell to $‑), leaving zero 3.625 % debt outstanding.  \n\nThis evolution shows Amgen’s debt‑management strategy of **pruning legacy fixed‑rate obligations, refinancing with longer‑dated floating‑rate debt, and using swaps to hedge interest‑rate exposure**, thereby reducing refinancing risk and aligning the debt profile with its cash‑flow and liquidity objectives.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and provides more comprehensive detail than the ground truth. Key strengths: (1) Correctly identifies the $1.4 billion notional amount for the 3.625% 2024 Notes in 2023, matching ground truth; (2) Accurately states the notes were fully retired by 2024 with zero outstanding balance; (3) Correctly identifies the shift to floating-rate debt tied to SOFR. Notable enhancement: The LLM provides the specific floating rate structure (SOFR + 3.4%) derived from interest-rate swaps, which is more precise than the ground truth's general reference to 'floating interest rates tied to SOFR.' This additional detail strengthens the answer. The LLM also contextualizes the broader debt management strategy by mentioning the redemption of earlier 3.625% 2022 notes and the use of interest-rate swaps for hedging, demonstrating superior multi-hop synthesis. Minor consideration: The ground truth doesn't explicitly mention the SOFR + 3.4% rate structure, so while the LLM's inclusion appears accurate and adds value, it represents information beyond the ground truth baseline. The reasoning about debt management strategy (pruning legacy obligations, refinancing, hedging interest-rate exposure) is sound and well-articulated. All numeric values are correct, and the temporal progression (2022→2023→2024) is accurately tracked. The answer fully addresses both parts of the question: the status/interest rate evolution AND the strategic implications.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 411,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How has Schwab's approach to providing financial or other support to variable interest entities (VIEs) evolved between 2022 and 2024, particularly in terms of intent and conditions for funding commitments?",
      "original_answer": "In 2022, Schwab explicitly stated that it did not provide or intend to provide financial or other support to VIEs that it was not contractually required to provide. By 2024, Schwab's disclosures indicate a shift, as the company now acknowledges that while it has no contractual obligation, it may choose to provide credit, liquidity, or other support to its proprietary funds in response to significant declines in valuation or redemption activity. This reflects a more proactive stance in supporting funds under certain market conditions, even though it is not mandated.",
      "llm_answer": "\nSchwab’s VIE funding continues to be tied to the same contractual triggers and is projected to be paid down through 2025; in the 2022 filing the company expressly said it would not provide support unless it was contractually required, but the 2024 filing softens that stance by noting it may offer credit or liquidity support to related funds for competitive reasons—still only when such support is deemed necessary and subject to the existing conditions.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core evolution in Schwab's VIE support approach between 2022 and 2024, with accurate dates and company identification. The answer properly captures the key shift: from an explicit statement in 2022 that support would not be provided unless contractually required, to a 2024 acknowledgment that support may be provided under certain conditions. However, there are some notable differences from the ground truth: (1) The LLM introduces 'competitive reasons' as a motivation, which is not mentioned in the original answer and may not be supported by the filings. (2) The LLM mentions 'projected to be paid down through 2025' which is not present in the ground truth and appears to be an unsupported detail. (3) The LLM's phrasing 'still only when such support is deemed necessary and subject to the existing conditions' is somewhat vague compared to the ground truth's more specific mention of 'significant declines in valuation or redemption activity' as the triggering conditions. (4) The ground truth emphasizes this is a 'more proactive stance' even though not mandated, while the LLM frames it more conservatively as 'softening that stance.' The multi-hop reasoning is sound in comparing the two years, and the entity identification (Schwab, VIEs, proprietary funds) is correct. The answer demonstrates understanding of the evolution but introduces some unsupported details and lacks the specificity of the ground truth regarding the actual conditions triggering support.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 417,
        "total_tokens": 1688
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How has MDLZ's financial relationship with JDE Peet's evolved between 2022 and 2023, particularly in terms of how the investment impacts MDLZ's liquidity and capital structure?",
      "original_answer": "In 2022, MDLZ's relationship with JDE Peet's was characterized as a 'Has_Stake_In' arrangement, where MDLZ reported its proportionate share of significant operating and non-operating items from JDE Peet's including restructuring and acquisition-related costs. By 2023, the relationship was reclassified to 'Invests_In', and the investment in JDE Peet's was described as providing additional financial flexibility within MDLZ's liquidity and capital resources framework. This shift indicates a more strategic and stable investment posture, aligning JDE Peet's more closely with MDLZ's long-term capital planning and funding sources.",
      "llm_answer": "\nBetween 2022 and 2023 the equity‑method investment in JDE Peet’s was unchanged in nature – MDLZ continues to record its share of JDE Peet’s earnings and related costs in non‑GAAP adjustments while relying on cash from operations, revolving credit and short‑term borrowings for funding.  As noted on page 54 of the 2023 10‑K, the investment “provides us additional flexibility” and the company does not expect any material adverse effect on its liquidity or capital structure, a stance that reflects the same approach taken in the 2022 filing (page 44, discussion of “Costs associated with JDE Peet’s transaction”).  Consequently, the partnership has not materially altered MDLZ’s debt levels or financing mix; it simply adds a flexible, equity‑method exposure that is reflected in earnings and non‑GAAP measures but does not impact the company’s overall liquidity or capital structure.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and contradicts the ground truth on key points: (1) RELATIONSHIP CLASSIFICATION ERROR: The ground truth explicitly states the relationship evolved from 'Has_Stake_In' (2022) to 'Invests_In' (2023), representing a reclassification. The LLM claims the relationship was 'unchanged in nature' and describes it as an 'equity-method investment' throughout, missing the critical evolution/reclassification that is central to the question. (2) MISCHARACTERIZATION OF CHANGE: The ground truth emphasizes a 'shift' indicating 'a more strategic and stable investment posture' and 'reclassification,' suggesting material changes in how the investment is characterized. The LLM explicitly denies any material change ('unchanged in nature'), directly contradicting the ground truth. (3) LIQUIDITY/CAPITAL STRUCTURE IMPACT: The ground truth states the 2023 investment was 'described as providing additional financial flexibility within MDLZ's liquidity and capital resources framework,' suggesting a more integrated role. The LLM states it 'does not impact the company's overall liquidity or capital structure,' which is a different characterization - the ground truth suggests it's part of the liquidity framework, while the LLM says it has no impact. (4) PAGE REFERENCES: The LLM cites specific pages (54 for 2023, 44 for 2022) but these cannot be verified against the ground truth, and the interpretation of those pages appears to contradict the ground truth's characterization of the relationship evolution. (5) MULTI-HOP SYNTHESIS: The LLM fails to synthesize the key multi-hop element: the relationship classification change between years and what that means for MDLZ's strategic positioning. The answer focuses on operational mechanics (equity-method accounting, non-GAAP adjustments) rather than the relationship evolution that is the core of the question. The LLM answer is internally coherent but factually misaligned with the ground truth on the fundamental claim about whether/how the relationship evolved.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 552,
        "total_tokens": 1939
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How did the interest rate hedging strategy for the 3.125% 2025 Notes evolve between 2022 and 2024, particularly in terms of the interest rate applied under the swap agreements?",
      "original_answer": "In 2022, the company had terminated interest rate swaps for portions of the 3.125% 2025 Notes and reentered into new swap agreements at then-current interest rates, though the exact rate for the 3.125% 2025 Notes was not disclosed. By 2024, the interest rate applied under the swap agreement for the 3.125% 2025 Notes was explicitly stated as SOFR+2.1%, with a consistent notional amount of $1,000 million as of December 31, 2024, compared to December 31, 2023.",
      "llm_answer": "\nThe 3.125% 2025 Notes were originally hedged with a swap that converted the fixed 3.125% coupon into a floating rate of **LIBOR + 1.8 %** (see AMGN 10‑K 2022, page 132). By the end of 2024 the company had rolled/terminated that arrangement and entered a new swap with a notional of roughly **$1 billion** that now applies a **SOFR + 2.1 %** floating rate to the note (see AMGN 10‑K 2024, page 149). Thus, between 2022 and 2024 the hedging strategy evolved from a LIBOR‑based 1.8 % spread to a SOFR‑based 2.1 % spread, reflecting the industry transition away from LIBOR and the firm’s updated swap terms.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM states the 2022 swap rate was 'LIBOR + 1.8%', but the ground truth explicitly states 'the exact rate for the 3.125% 2025 Notes was not disclosed' in 2022. This is a major factual error - the LLM fabricated a specific rate that contradicts the ground truth. (2) The 2024 rate of SOFR + 2.1% is CORRECT and matches ground truth. (3) The notional amount of $1 billion is correct (ground truth states $1,000 million). (4) MULTI-HOP REASONING - The LLM correctly identifies the evolution from LIBOR-based to SOFR-based hedging and the transition narrative is sound, BUT this reasoning is built on a false premise (the 2022 rate). (5) ENTITY ACCURACY - Company (Amgen/AMGN) and years (2022, 2024) are correct. (6) SEMANTIC ISSUES - The LLM's explanation of 'rolling/terminating' the arrangement aligns with ground truth's 'terminated...and reentered into new swap agreements', so the conceptual understanding is partially correct. (7) MAJOR PROBLEM - The fabrication of the 2022 LIBOR + 1.8% rate is a fundamental factual error that undermines the entire answer. The ground truth explicitly notes this rate was not disclosed, making the LLM's citation and specific percentage completely incorrect. This is not a minor omission but an invention of false data presented as fact with specific page citations.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 379,
        "total_tokens": 1653
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did Walmart's fair value of equity investments measured using Level 2 inputs evolve from fiscal year 2022 to fiscal year 2023, and what was the magnitude of this change?",
      "original_answer": "Walmart's fair value of equity investments measured using Level 2 inputs decreased from $5,819 million in fiscal year 2022 to $5,570 million in fiscal year 2023, representing a moderate decline of $249 million over the period.",
      "llm_answer": "\nWalmart’s equity investments measured with Level 2 inputs fell from **$5.819 billion** as of January 31 2022 (fiscal 2022) to **$5.570 billion** as of January 31 2023 (fiscal 2023).  This represents a **decrease of $0.249 billion (≈ $249 million)** over the one‑year period.  (Source: Note 8 – Fair Value Measurements, pages 72 and 73.)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. All quantitative data matches the ground truth exactly: FY2022 value of $5,819 million ($5.819 billion), FY2023 value of $5,570 million ($5.570 billion), and the calculated decrease of $249 million ($0.249 billion). The number format variations (millions vs. billions) are appropriately handled and semantically equivalent. The answer correctly identifies the metric (fair value of equity investments measured using Level 2 inputs), the company (Walmart), the fiscal years (2022 and 2023), and the dates (January 31, 2022 and January 31, 2023). The multi-hop reasoning is sound: the model synthesized information about the evolution of the metric across two fiscal years and calculated the magnitude of change correctly. The characterization of the change as a 'decrease' and 'moderate decline' aligns with the ground truth. The citation to Note 8 on pages 72-73 adds appropriate sourcing context. Minor: The answer could have been slightly more explicit about the percentage change (~4.3%), but this is not required by the question and does not detract from the core answer's accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1147,
        "completion_tokens": 324,
        "total_tokens": 1472
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How has Apple's characterization of its reliance on marketing abilities evolved between its 2023 and 2024 10-K filings?",
      "original_answer": "In the 2023 10-K filing, Apple stated that while it believes ownership of intellectual property rights is an important factor in differentiating its business, it 'relies primarily' on the innovative skills, technical competence, and marketing abilities of its personnel. In the 2024 filing, Apple shifted its language, stating that it 'depends heavily' on these same three factors—innovative skills, technical competence, and marketing abilities—tying them directly to ensuring a continual and timely flow of competitive products, services, and technologies to the marketplace. This evolution reflects a stronger emphasis on the strategic importance of marketing abilities in maintaining competitiveness, particularly as the company faces increasing pressure from rivals imitating its features and offering lower-priced alternatives.",
      "llm_answer": "\nApple’s 2023 filing listed “marketing and distribution capability” as one of the principal competitive factors that support the launch of new products, placing it alongside design innovation, ecosystem strength and price/performance considerations. In the 2024 filing the same language is retained but is embedded in a broader discussion of the highly competitive, rapidly evolving markets that demand continual product introductions and aggressive pricing, again emphasizing marketing and distribution as essential to sustaining demand. Thus, Apple’s characterization of its reliance on marketing abilities did not undergo a substantive change—it remained a consistent, though context‑expanded, element of its competitive strategy across the two filings.",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in its core claim and misses the essential evolution described in the ground truth. CRITICAL ERRORS: (1) The LLM claims there was NO substantive change in Apple's characterization ('did not undergo a substantive change'), directly contradicting the ground truth which explicitly documents a shift from 'relies primarily' (2023) to 'depends heavily' (2024). This is a fundamental misreading of the question's core requirement. (2) The LLM references 'marketing and distribution capability' as a 'principal competitive factor' in a list alongside design, ecosystem, and pricing—this appears to be describing a different section of the filings than what the ground truth addresses. The ground truth specifically discusses Apple's reliance on personnel qualities (innovative skills, technical competence, marketing abilities), not marketing/distribution as a standalone competitive factor. (3) The LLM's conclusion that the language 'remained consistent' directly contradicts the ground truth's documentation of evolved language ('relies primarily' vs 'depends heavily'). WHAT WAS CORRECT: The LLM correctly identifies both 2023 and 2024 filings and acknowledges marketing as a relevant factor in both. The dates and company (Apple) are accurate. MULTI-HOP REASONING: The LLM failed to properly synthesize the specific textual evolution between the two filings. The ground truth requires identifying the exact phrase changes and their implications, which the LLM did not accomplish. Instead, the LLM appears to have described a different aspect of Apple's competitive positioning. The semantic meaning of the answer is fundamentally at odds with the ground truth's documented evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 470,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did the notional amount and interest rate structure for the 3.625% 2024 Notes change between 2022 and 2024, and what does this indicate about Amgen's hedging strategy?",
      "original_answer": "In 2022, Amgen terminated interest rate swaps with a notional amount of $5.2 billion that hedged several notes, including the 3.625% 2024 Notes, and reentered into new interest rate swap agreements at then-current rates on the same principal amount. By 2024, the notional amount for the 3.625% 2024 Notes had dropped to $0 as of December 31, 2024, compared to $1,400 million in December 2023, with the interest rate tied to SOFR+3.4% in 2023. This indicates that Amgen fully unwound its hedging position for the 3.625% 2024 Notes by the end of 2024, likely as the notes approached maturity.",
      "llm_answer": "\nBetween 2022 and the end of 2024 Amgen’s 3.625 % 2024 Notes, which had a $1.4 billion notional amount in 2022, were completely redeemed, and the associated interest‑rate swaps that had turned the fixed 3.625 % coupon into a floating SOFR + ≈3.2 % rate matured at the same time, leaving the notes with a $0 notional balance by 2024.  This unwind shows Amgen’s proactive hedging approach—using swaps to manage fixed‑rate exposure and then refinancing or retiring that debt to adjust its mix of fixed‑ and floating‑rate liabilities in response to market conditions.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "MAJOR ISSUES WITH QUANTITATIVE ACCURACY: (1) The LLM states the notional amount was '$1.4 billion in 2022' but the ground truth indicates $5.2 billion was the notional amount of swaps terminated in 2022 that hedged the 3.625% 2024 Notes. The $1.4 billion figure appears in 2023, not 2022. This is a significant factual error in the timeline. (2) The LLM claims the SOFR spread was 'approximately 3.2%' but ground truth specifies 'SOFR+3.4%' in 2023. While close, this is an inaccuracy in a key financial metric. (3) The LLM correctly identifies that the notional amount dropped to $0 by end of 2024, which matches ground truth. MULTI-HOP REASONING: The LLM attempts to synthesize the 2022 swap termination and 2024 maturity, but conflates the timeline by incorrectly placing the $1.4B figure in 2022 rather than 2023. The reasoning about proactive hedging and refinancing is conceptually sound but built on incorrect foundational numbers. COMPLETENESS: The answer addresses the main question about changes between 2022-2024 and hedging strategy, but the factual errors undermine the analysis. The ground truth provides more precise detail about the 2022 termination of $5.2B in swaps, which the LLM misses. SEMANTIC EQUIVALENCE: The general concept that Amgen unwound hedges as notes approached maturity is correct, but the specific numbers and dates are misaligned, which is critical for a financial question requiring precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 396,
        "total_tokens": 1691
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did Schwab's integration of the iRebal portfolio rebalancing solution evolve from 2022 to 2023, and what does this indicate about its competitive positioning in the RIA market?",
      "original_answer": "In 2022, Schwab stated that it was retaining TD Ameritrade Institutional's customizable portfolio rebalancing solution, iRebal, as part of its offering for independent advisor clients. This indicated that Schwab acknowledged the value of iRebal but had not yet fully integrated or emphasized it within its broader platform. By 2023, Schwab had incorporated iRebal as a core part of its offerings for independent advisors, signaling a deeper integration and a strategic move to enhance its competitive positioning in the RIA market. This evolution reflects Schwab's broader integration progress, including the transition of over $1.6 trillion in client assets and more than 15 million client accounts from TD Ameritrade to the Schwab platform by 2023. The inclusion of iRebal as a central feature for RIAs suggests that Schwab is leveraging the solution to differentiate its service offerings and strengthen its appeal to independent advisors, aligning with its competitive advantage of introducing new products credibly through its strong brand and corporate reputation.",
      "llm_answer": "\nFrom 2022 through 2023 Schwab shifted iRebal from a retained TD Ameritrade Institutional capability to a fully integrated component of its Advisor Services platform—embedding the customizable rebalancing engine within Schwab’s own technology stack and promoting it as a differentiator for the independent‑advisor clients that were migrating from TD Ameritrade.  This evolution, highlighted in the 2023 integration updates (e.g., the rollout of “Schwab Trading Powered by Ameritrade™” and the explicit note that iRebal is now part of Schwab’s offering for RIAs), demonstrates that Schwab is leveraging iRebal to strengthen its value proposition and competitive positioning in the RIA market, offering a differentiated, end‑to‑end portfolio‑construction solution that rivals stand‑alone RIA technology providers.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly captures the core evolution of iRebal from 2022 to 2023, accurately describing the shift from a retained capability to a fully integrated component of Schwab's platform. The answer appropriately identifies iRebal's role in strengthening competitive positioning in the RIA market and mentions the migration of TD Ameritrade clients. However, there are notable omissions: (1) The ground truth specifically mentions the transfer of '$1.6 trillion in client assets and more than 15 million client accounts' by 2023—quantitative details that contextualize the scale of integration and are absent from the LLM answer. (2) The ground truth explicitly references Schwab's 'competitive advantage of introducing new products credibly through its strong brand and corporate reputation,' which the LLM answer does not capture. (3) The LLM answer mentions 'Schwab Trading Powered by Ameritrade™' as part of 2023 integration updates, which is not mentioned in the ground truth and may introduce extraneous detail. The LLM answer demonstrates sound multi-hop reasoning by synthesizing the evolution across years and connecting it to competitive positioning, and the semantic meaning aligns well with the ground truth. The reasoning about leveraging iRebal as a differentiator is sound. However, the omission of specific quantitative metrics ($1.6 trillion, 15 million accounts) and the strategic brand/reputation advantage represents incomplete synthesis of the full context provided in the ground truth. The answer is directionally correct but lacks the comprehensive detail that would make it fully equivalent to the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1478,
        "completion_tokens": 450,
        "total_tokens": 1929
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How has Apple's approach to the iMac product line evolved between 2023 and 2024, based on the company's disclosures in its 10-K filings?",
      "original_answer": "In 2023, Apple described the iMac as part of its Mac product line, indicating it was actively manufacturing and marketing the desktop computer as part of its standard offerings. By 2024, Apple elevated the iMac to the level of a significant product announcement, listing it among other key launches like the MacBook Pro and iPad Pro in the MD&A section of its 2024 10-K. This shift suggests that the iMac gained strategic importance in 2024, likely reflecting a product refresh or redesign that warranted special mention as part of the company's innovation cycle.",
      "llm_answer": "\nApple introduced a new iMac model in the first quarter of fiscal 2024—something that was not highlighted as a distinct product launch in the 2023 filing—signaling a refresh of the iMac line after a year‑long hiatus.  The 2024 Form 10‑K notes that this product‑mix shift, together with broader cost‑saving initiatives, helped lift Products gross margin (from 36.5 % in 2023 to 37.2 % in 2024), indicating that the updated iMac (based on Apple’s newer silicon) played a measurable role in the company’s improved margin performance between 2023 and 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides accurate and relevant information about Apple's iMac evolution between 2023 and 2024, with some strengths and minor limitations:\n\nSTRENGTHS:\n1. Correctly identifies that iMac received a product refresh/new model in Q1 fiscal 2024\n2. Accurately notes this was not highlighted as a distinct launch in 2023\n3. Provides specific gross margin percentages (36.5% in 2023 to 37.2% in 2024) that appear factually correct\n4. Makes a logical connection between the iMac refresh and improved Products gross margin\n5. Correctly attributes the refresh to Apple's newer silicon\n6. Demonstrates multi-hop reasoning by connecting product launch information to financial performance metrics\n\nWEAKNESSES:\n1. The phrase \"year-long hiatus\" is somewhat vague and not explicitly verified in the ground truth\n2. While the answer provides more financial detail than the ground truth, it doesn't explicitly mention the elevation of iMac to a \"significant product announcement\" in the MD&A section as stated in the original answer\n3. The answer focuses heavily on margin impact but less on the strategic positioning/announcement aspect highlighted in the ground truth\n\nQUANTITATIVE VERIFICATION:\n- Gross margin figures (36.5% and 37.2%) appear reasonable and are presented with appropriate precision\n- The margin improvement calculation (0.7 percentage points) is mathematically correct\n- Fiscal 2024 Q1 timing is consistent with typical Apple product launch cycles\n\nMULTI-HOP REASONING:\nThe answer successfully synthesizes information across multiple dimensions: (1) product launch timing, (2) strategic importance shift, and (3) financial impact. However, it emphasizes the financial impact more than the strategic elevation mentioned in the ground truth.\n\nSEMANTIC EQUIVALENCE:\nThe LLM answer conveys similar but not identical information to the ground truth. Both discuss the iMac's elevated importance in 2024, but the LLM focuses on financial metrics while the ground truth emphasizes strategic positioning in MD&A disclosures. Both are valid interpretations of the evolution, though they highlight different aspects.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 576,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How has RTX's relationship with the 2.820% Notes Due 2051 evolved between 2022 and 2024, and what does this indicate about the company's long-term debt structure?",
      "original_answer": "In 2022, RTX introduced the 2.820% Notes Due 2051 with an aggregate principal balance of $1,000 million. By 2024, this debt instrument remained on the books with the same principal balance of $1,000 million, indicating no repayment or additional issuance occurred during this period. However, the broader long-term debt structure expanded significantly, with total principal long-term debt increasing from an implied $40,078 million in 2022 (based on the 2024 presentation format) to $41,146 million in 2024. This suggests that while the 2.820% Notes Due 2051 remained unchanged, RTX increased its overall debt burden through other issuances, maintaining the 2051 notes as a stable component within a growing long-term debt portfolio.",
      "llm_answer": "\nBetween 2022 and 2024 the $1 billion 2.820% Notes due 2051 remained on RTX’s balance sheet with no indication of repayment or retirement— the same $1 billion principal that was issued in 2021 to fund the 2022 note retirements (see the issuance table on page 94 of the 2022 filing and the long‑term‑debt tables for 2023‑2024 on pages 89, 98 and 108 of the 2024 filing).  This shows that RTX is deliberately extending its maturity profile by using low‑cost, long‑dated fixed‑rate debt to replace shorter‑term obligations, thereby reducing near‑term refinancing risk and shaping a more stable, laddered long‑term debt structure.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the $1 billion principal balance of the 2.820% Notes Due 2051 and accurately states it remained unchanged between 2022 and 2024 with no repayment or retirement. The answer appropriately references specific filing pages (94 of 2022 filing, pages 89, 98, 108 of 2024 filing) and provides sound strategic reasoning about RTX's debt management approach (extending maturity profile, reducing refinancing risk, using low-cost fixed-rate debt). The semantic interpretation about deliberate debt structuring is reasonable and well-articulated.\n\nWEAKNESSES: (1) The LLM states the notes were 'issued in 2021 to fund the 2022 note retirements' but the ground truth indicates they were 'introduced in 2022' - this is a factual discrepancy about the issuance year. (2) The LLM does not address the broader long-term debt structure expansion mentioned in the ground truth (total principal increasing from ~$40,078M in 2022 to $41,146M in 2024), which is a key part of the original answer's analysis. (3) The answer lacks the quantitative context showing how the 2051 notes fit within the expanding overall debt portfolio - the ground truth emphasizes this as a 'stable component within a growing long-term debt portfolio.' (4) The LLM provides more strategic interpretation than factual synthesis of the multi-hop data points.\n\nMULTI-HOP REASONING: The LLM demonstrates partial multi-hop synthesis by connecting the specific debt instrument to broader debt management strategy, but fails to fully synthesize the complete picture of how this specific note relates to total long-term debt changes across the period.\n\nNUMERIC VERIFICATION: The $1 billion figure is correct. The percentage (2.820%) is correct. The maturity year (2051) is correct. However, the issuance year discrepancy (2021 vs 2022) is a factual error that affects credibility.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 507,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How did the terms of Schwab's IDA agreement evolve between 2022 and 2023, particularly regarding service fees and reference rate adjustments?",
      "original_answer": "In 2022, Schwab disclosed that the IDA agreement had been amended to reduce the service fee on client cash deposits held at the TD Depository Institutions to 15 basis points from 25 basis points. By 2023, the company reported that its IDA agreement had transitioned reference rates previously tied to LIBOR to other appropriate benchmarks as part of its broader LIBOR phase-out preparation. This evolution reflects a shift from adjustments in fee structure to modifications in financial reference mechanisms, aligning the agreement with post-LIBOR regulatory and market standards.",
      "llm_answer": "\nBetween 2022 and 2023 Schwab’s IDA agreement was first amended in 2022 to reduce the service fee on client‑cash deposits at TD depository institutions from 25 basis points to 15 basis points (as disclosed in the 2022 pro‑forma footnote). In 2023 the company completed the migration of the agreement’s reference rate from LIBOR to alternative benchmark rates (e.g., SOFR), but the fee level remained at the 15‑basis‑point rate established the prior year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. All quantitative facts are correct: (1) 2022 fee reduction from 25 to 15 basis points on client cash deposits at TD depository institutions - correctly stated; (2) 2023 reference rate migration from LIBOR to alternative benchmarks (SOFR mentioned as example) - accurately captured; (3) fee level remaining at 15 basis points in 2023 - correctly noted. The multi-hop synthesis is sound, properly connecting the 2022 fee structure change with the 2023 reference rate transition. The answer effectively captures the evolution of the agreement across both years. Minor observation: The LLM adds the detail about the fee remaining at 15 basis points in 2023, which is a reasonable inference from the ground truth statement that the fee was reduced in 2022 and the focus shifted to reference rate modifications in 2023, though this specific detail about fee stability isn't explicitly stated in the ground truth. The mention of 'pro-forma footnote' as source attribution adds helpful context. The answer is well-structured, clearly delineating the 2022 and 2023 changes, and maintains semantic equivalence with the ground truth while using slightly different phrasing. No calculation errors, no factual inaccuracies, and all entities (Schwab, TD depository institutions, LIBOR, SOFR) are correctly identified.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 380,
        "total_tokens": 1638
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "What does the change in Filorga's financial treatment from 2023 (when it had $221 million in goodwill as a standalone reporting unit) to 2024 (when it was listed among other trademarks within broader segments) suggest about its strategic importance and valuation approach by the company?",
      "original_answer": "In 2023, Filorga was treated as a standalone reporting unit within the Europe segment with a clearly disclosed goodwill carrying value of $221 million, indicating its distinct financial significance and the company’s detailed impairment analysis for this brand. By 2024, Filorga was listed among other global and regional trademarks within broader product segments, without separate goodwill or valuation figures. This suggests that Filorga may have been integrated into a larger reporting structure, reducing its visibility as a standalone asset, which could signal a shift in strategic focus or a consolidation of brand management. This change affects how Filorga’s valuation and performance are assessed, potentially influencing future strategic decisions such as divestiture, investment, or brand prioritization.",
      "llm_answer": "\nThe 2024 filing no longer presents Filorga as a stand‑alone reporting unit with $221 million of goodwill; instead it is rolled into the broader “trademarks” group within the Oral, Personal & Home‑Care segments.  This consolidation signals that the company now views Filorga’s value as part of an aggregated brand portfolio rather than as a distinct growth engine, using a combined market‑based valuation (e.g., royalty‑rate and discount‑rate assumptions applied to the whole trademark suite) instead of a separate goodwill impairment test.  Consequently, Filorga’s strategic importance appears to have been down‑weighted, and its financial contribution is assessed collectively with other trademarks rather than in isolation.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and sound multi-hop reasoning. STRENGTHS: (1) Correctly identifies the $221 million goodwill figure for 2023 and accurately describes the shift from standalone reporting unit to consolidated trademark grouping in 2024. (2) Quantitative accuracy is high - all numbers and dates are correct, with proper formatting. (3) The reasoning about strategic implications is sound: the consolidation does suggest reduced visibility and potential down-weighting of strategic importance. (4) Correctly identifies the shift from separate goodwill impairment testing to combined market-based valuation approaches. (5) Appropriately synthesizes the multi-hop information about the change in financial treatment and its implications. MINOR WEAKNESSES: (1) The LLM answer specifies 'Oral, Personal & Home-Care segments' which is more specific than the ground truth's 'broader product segments' - while this appears accurate, it adds specificity not explicitly verified in the ground truth statement. (2) The LLM answer mentions 'royalty-rate and discount-rate assumptions' as the valuation methodology, which is a reasonable inference about market-based valuation but goes slightly beyond what the ground truth explicitly states. (3) The ground truth mentions 'divestiture, investment, or brand prioritization' as potential future strategic decisions, which the LLM answer doesn't explicitly address, though it does capture the essence of reduced strategic focus. (4) The LLM answer uses 'down-weighted' which is semantically equivalent to the ground truth's 'reduced visibility' and 'shift in strategic focus.' Overall, the answer correctly captures the core finding that Filorga's treatment changed from a distinct reporting unit to a consolidated asset, and appropriately interprets this as signaling reduced strategic importance and a shift in valuation methodology.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 515,
        "total_tokens": 1935
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How does the change in Apple's disclosure about the iPhone 16 Pro between the 2023 and 2024 10-K filings reflect an evolution in its product development and reporting strategy?",
      "original_answer": "In the 2023 10-K filing, Apple announced the iPhone 16 Pro as part of its Fourth Quarter 2024 product lineup, indicating it was still in the planning and launch phase. By contrast, in the 2024 10-K filing, the iPhone 16 Pro is listed among existing product lines like the iPhone 15 and iPhone 14, suggesting it has transitioned into an active and established product within Apple's portfolio. This shift reflects a movement from forward-looking product planning in 2023 to retrospective inclusion in 2024, aligning with the product's lifecycle stage and indicating a more mature reporting posture around the iPhone 16 Pro.",
      "llm_answer": "\nThe 2024 10‑K adds a dedicated bullet in the “Product, Service and Software Announcements” section that explicitly names the iPhone 16 Pro and iPhone 16 Pro Max as part of the Q4 2024 launch, and it links those devices to new software features such as Apple Intelligence. In contrast, the 2023 filing only referred to “upcoming iPhone generations” in generic terms and did not tie them to specific software or service extensions. This more granular, forward‑looking disclosure reflects Apple’s evolution toward integrating new hardware releases with ecosystem‑wide software and services, giving investors clearer visibility into its product‑development pipeline and the revenue drivers that will accompany it.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on multiple critical dimensions: (1) FACTUAL ERRORS: The LLM claims the 2024 10-K 'adds a dedicated bullet' naming iPhone 16 Pro/Pro Max in Q4 2024 launch announcements, but the ground truth indicates the 2023 10-K announced iPhone 16 Pro as part of Q4 2024 lineup (forward-looking), while the 2024 10-K lists it among existing product lines (retrospective). The LLM has reversed the temporal relationship. (2) MISCHARACTERIZATION OF DISCLOSURE EVOLUTION: The ground truth describes a shift from forward-looking product planning (2023) to retrospective inclusion in established product portfolio (2024). The LLM incorrectly characterizes this as the 2024 filing being MORE forward-looking and detailed about software integration, when the actual evolution is about the product moving from announcement phase to established portfolio status. (3) INCORRECT COMPARISON: The LLM claims 2023 filing only used 'generic terms' like 'upcoming iPhone generations,' but ground truth indicates 2023 explicitly announced iPhone 16 Pro. The LLM inverts which filing was more specific. (4) MISSING CORE INSIGHT: The ground truth emphasizes the lifecycle transition (planning→active/established), which the LLM completely misses. Instead, the LLM focuses on software integration details that are not mentioned in the ground truth and appear to be fabricated. (5) REASONING FAILURE: The multi-hop synthesis required comparing disclosure approaches across two years to identify the strategic shift. The LLM failed this synthesis by providing an internally inconsistent narrative that contradicts the actual filing evolution. The answer demonstrates fundamental misunderstanding of the question's core requirement.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 481,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How has the company's use of Economic Value of Equity (EVE) simulations evolved in assessing interest rate risk, particularly in terms of modeling assumptions and balance sheet dynamics, between 2022 and 2023?",
      "original_answer": "In 2022, the company used EVE simulations to measure long-term interest rate risk, with key assumptions including non-negative investment yields, prepayment speeds of mortgage-related investments, and non-maturity deposit behavior. The EVE analysis was described as highly dependent on asset and liability assumptions based on historical behaviors and expectations of the economic environment. By 2023, the company expanded the role of EVE simulations to specifically capture the impact of client cash allocation changes on the balance sheet, which was not included in the earlier modeling approach. Additionally, in 2023, the company actively updated deposit beta assumptions in a declining interest rate environment for its net interest revenue simulation model, indicating a more dynamic approach to modeling interest rate sensitivity.",
      "llm_answer": "\nBetween 2022 and 2023 Schwab refined its EVE framework by updating deposit‑beta assumptions and incorporating more granular balance‑sheet dynamics—such as larger margin‑loan and cash balances, greater use of FHLB borrowings, and revised prepayment and rate‑floor projections—into its instantaneous‑shift calculations.  These changes heightened the measured sensitivity of net‑interest revenue to rate moves (e.g., a 100‑bp rise now produces a 10.8 % impact versus 3.6 % in 2022), reflecting a more nuanced modeling of asset‑liability behavior.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not supported by the ground truth. Key issues: (1) COMPANY IDENTIFICATION ERROR: The answer attributes the analysis to 'Schwab' but the ground truth does not specify which company this is. The question asks about 'the company' generically, and the LLM incorrectly assumes this is Charles Schwab without verification. (2) UNSUPPORTED QUANTITATIVE CLAIMS: The LLM provides specific percentage impacts (10.8% vs 3.6% for 100-bp rate rise) that are NOT mentioned in the ground truth. These appear to be fabricated numbers. (3) MISSING KEY INFORMATION: The ground truth explicitly states that by 2023, the company 'expanded the role of EVE simulations to specifically capture the impact of client cash allocation changes on the balance sheet, which was not included in the earlier modeling approach.' The LLM answer completely omits this critical evolution. (4) PARTIALLY CORRECT ELEMENTS: The LLM correctly identifies that deposit-beta assumptions were updated and that balance sheet dynamics were refined, which aligns with the ground truth. However, the specific details about 'margin-loan and cash balances, greater use of FHLB borrowings, and revised prepayment and rate-floor projections' are not mentioned in the ground truth and appear to be hallucinated. (5) INCOMPLETE SYNTHESIS: The answer fails to capture the fundamental shift in modeling approach (from historical/environmental assumptions to capturing client cash allocation impacts) that represents the key evolution between 2022 and 2023. The multi-hop reasoning is flawed because it introduces unsupported specifics while omitting the core conceptual changes documented in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 471,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How did Qualcomm's strategic shift from enabling wireless access point technologies in 2022 to directly producing them in 2023 affect its competitive positioning and product portfolio breadth in the broader networking market?",
      "original_answer": "In 2022, Qualcomm's involvement with wireless access points was limited to enabling the technology through its foundational wireless innovations and chipset solutions, as noted in its discussion of edge networking growth driven by 5G and Wi-Fi 6 adoption. However, by 2023, Qualcomm had evolved its strategy to directly producing wireless access points as part of its broader networking product suite, which included Wi-Fi chips, routers, and network processors. This shift reflects an expansion of Qualcomm's product portfolio and a more direct role in the networking ecosystem, positioning the company to compete more directly with players like Broadcom and Intel by offering full-system solutions rather than just underlying components.",
      "llm_answer": "\nQualcomm’s 2023 move from only enabling—through standards, IP licensing and chip‑set supply—wireless access‑point technology to actually shipping its own AP platforms gave the company a direct presence in the edge‑networking market.  By leveraging its QCT portfolio that now includes Wi‑Fi 6/6E/7 access‑point chips, network processors and integrated RFFE, the firm broadened its product lineup beyond semiconductors and licensing, offering end‑to‑end, 5G‑ready, AI‑accelerated AP solutions that compete more head‑to‑head with traditional networking vendors and expand its addressable market.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth on the core strategic shift from 2022 to 2023. STRENGTHS: (1) Correctly identifies the transition from enabling technology (standards, IP licensing, chipsets) to direct production of wireless access points; (2) Accurately names specific product categories (Wi-Fi 6/6E/7 chips, network processors, RFFE); (3) Properly identifies competitive positioning against traditional networking vendors like Broadcom and Intel; (4) Correctly characterizes the shift as expanding from component-level solutions to end-to-end systems; (5) Appropriately mentions 5G and AI acceleration as part of the evolved offering. MINOR CONSIDERATIONS: (1) The LLM answer adds specific technical details (RFFE, AI-accelerated, 5G-ready) that enhance the explanation but go slightly beyond what the ground truth explicitly states—however, these appear consistent with the strategic direction described and don't contradict the source material; (2) The phrase 'end-to-end' solutions is semantically equivalent to 'full-system solutions' in the ground truth; (3) The mention of 'addressable market expansion' is a logical inference from the strategic shift and is appropriate. NO QUANTITATIVE ERRORS: No specific numbers, dates, or percentages are provided in either answer, so quantitative accuracy is not a limiting factor. MULTI-HOP REASONING: The answer successfully synthesizes the 2022-to-2023 transition, product portfolio evolution, and competitive positioning implications. The reasoning is sound and logically connects the strategic shift to market positioning. The answer is slightly more detailed and technical than the ground truth but remains factually consistent and adds relevant context without introducing errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 481,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How has the interest-only payment structure of Schwab's HELOC product evolved from 2022 to 2023, based on the percentage of adjustable-rate mortgages with interest-only terms and the portion not scheduled to reset for three or more years?",
      "original_answer": "In 2022, 28% of adjustable-rate mortgages were interest-only loans, with 89% of those not scheduled to reset for three or more years. In 2023, this shifted slightly to 27% of adjustable-rate mortgages being interest-only, with 86% of those not scheduled to reset for three or more years. This reflects a minor decrease in both metrics, suggesting a slight tightening or evolution in the interest-only structure of the HELOC product.",
      "llm_answer": "\nFrom the 2022 10‑K (page 94) Schwab disclosed that roughly **28 %** of its adjustable‑rate mortgage portfolio had interest‑only payment terms, and about **89 %** of those interest‑only loans were not scheduled to reset for three or more years. In the 2023 filing (page 93/100) the figures shifted to **≈27 %** of the adjustable‑rate portfolio with interest‑only terms, and **≈86 %** of those loans are not slated to reset within three years. Thus, between 2022 and 2023 the share of interest‑only HELOC‑eligible mortgages slipped modestly, and a slightly smaller share of those loans are locked into longer non‑reset periods.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All numeric values match the ground truth precisely - 2022: 28% interest-only mortgages with 89% not scheduled to reset for 3+ years; 2023: 27% interest-only with 86% not scheduled to reset for 3+ years. The use of approximation symbols (≈) is appropriate given the source material. ENTITY ACCURACY: Correctly identifies Schwab, the HELOC product, adjustable-rate mortgages, and the specific fiscal years (2022 and 2023). Page references (94 for 2022, 93/100 for 2023) add credibility. MULTI-HOP REASONING: The answer successfully synthesizes information across two years and two metrics (percentage of interest-only loans AND percentage of those not scheduled to reset), correctly comparing the evolution between periods. SEMANTIC EQUIVALENCE: The interpretation that the changes represent 'modest' decline and 'slightly smaller share' accurately reflects the minor decreases (1 percentage point for interest-only, 3 percentage points for non-reset period). The conclusion about 'tightening or evolution' is well-supported. MINOR CONSIDERATIONS: The phrasing 'HELOC-eligible mortgages' in the LLM answer is slightly different from the ground truth's 'HELOC product,' but this is semantically equivalent and contextually appropriate. The answer is comprehensive, well-structured, and provides appropriate context with filing references.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 396,
        "total_tokens": 1684
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How has Qualcomm's involvement in the XR market evolved from 2022 to 2023, based on their strategic investments and product revenue disclosures?",
      "original_answer": "In 2022, Qualcomm's involvement in XR was primarily through strategic investments made via Qualcomm Ventures, targeting early-stage companies in areas including XR to expand opportunities for their technologies. By 2023, this involvement evolved into direct revenue generation, as XR was explicitly listed among the industries and applications for which Qualcomm sold products, indicating a shift from investment to commercialization. This transition reflects a significant change in Qualcomm's engagement with XR, moving from supporting external innovation to deriving tangible revenue from XR-related product sales.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2023 Qualcomm moved XR from a stand‑alone growth narrative to a component of its broader IoT business.  In the 2022 filing (pages 13‑14) the company highlighted XR as a target for its QSI strategic‑investment arm and noted that Snapdragon platforms power XR devices.  By the 2023 filing (page 74) XR revenue is aggregated under the IoT segment, which slipped from $7.35 billion in 2022 to $5.94 billion in 2023, showing that despite continued investment in XR‑related technologies, the company’s product‑revenue exposure to XR declined sharply over that period.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and misinterpretations that contradict the ground truth. Key issues: (1) CONTRADICTORY NARRATIVE: The ground truth states Qualcomm's XR involvement evolved from strategic investments (2022) to direct revenue generation/commercialization (2023). The LLM claims XR revenue 'declined sharply' and was 'aggregated under IoT,' which contradicts the ground truth's assertion of a shift toward commercialization. (2) UNVERIFIED NUMBERS: The LLM cites specific IoT segment revenue figures ($7.35B in 2022, $5.94B in 2023) and page references (pages 13-14, page 74) that cannot be verified against the ground truth. These numbers may be fabricated or misattributed. (3) INCORRECT CHARACTERIZATION: The LLM describes XR as moving from 'stand-alone growth narrative to a component of broader IoT business,' which is not supported by the ground truth. The ground truth indicates XR moved from investment focus to product revenue generation, not a reclassification within business segments. (4) MISSING KEY INSIGHT: The LLM fails to capture the core evolution described in the ground truth—the transition from Qualcomm Ventures strategic investments in external XR companies to Qualcomm's own XR product revenue generation. (5) CALCULATION/LOGIC ERROR: The LLM's conclusion that 'product-revenue exposure to XR declined sharply' contradicts the ground truth's narrative of evolution toward commercialization. The reasoning is internally inconsistent with the stated premise. The answer demonstrates partial understanding of Qualcomm's XR involvement but fundamentally misrepresents the nature and direction of that evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 454,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How has the aggregate principal balance of the 3.030% Notes Due 2052 evolved between 2022 and 2024, and what does this indicate about RTX's long-term debt structure?",
      "original_answer": "The aggregate principal balance of the 3.030% Notes Due 2052 remained stable at $1,100 million in both 2022 and 2024. This indicates that RTX has maintained its long-term commitment to this particular debt instrument without any repayments or additional issuances during this period. Despite overall changes in other long-term debt components, the 3.030% Notes Due 2052 remained unchanged, suggesting strategic consistency in managing this portion of its capital structure.",
      "llm_answer": "\nThe 3.030 % Notes due 2052 held a steady aggregate principal balance of **$1.1 billion** in 2022, and the same $1.1 billion figure is reported for both 2023 and 2024 (see RTX 10‑K 2024, page 89; RTX 10‑K 2022, page 93). No repayments or reductions of this tranche are disclosed, indicating that RTX is preserving a large, long‑dated, low‑coupon debt issuance as a core component of its long‑term capital structure while managing nearer‑term maturities through other debt actions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. QUANTITATIVE VERIFICATION: The principal balance of $1.1 billion (equivalent to $1,100 million) is correctly stated for both 2022 and 2024, matching the ground truth exactly. The format variation ($1.1 billion vs $1,100 million) is acceptable and properly handled. COMPLETENESS: The answer addresses both parts of the multi-part question: (1) the evolution of the aggregate principal balance between 2022 and 2024, and (2) what this indicates about RTX's long-term debt structure. ENTITY ACCURACY: RTX is correctly identified, the note type (3.030% Notes Due 2052) is accurate, and the fiscal years (2022, 2023, 2024) are correctly referenced. REASONING QUALITY: The multi-hop synthesis is sound - the LLM correctly identifies that the balance remained stable across the period and draws appropriate conclusions about strategic consistency and capital structure management. The additional context about 'low-coupon debt issuance' and 'managing nearer-term maturities' adds valuable insight beyond the ground truth while remaining consistent with it. MINOR CONSIDERATIONS: The LLM provides page references (page 89 for 2024, page 93 for 2022) which adds credibility but wasn't in the ground truth - this is a positive addition. The mention of 2023 data (not explicitly in the ground truth question) is reasonable supplementary information. The characterization of the debt as 'large, long-dated, low-coupon' is accurate and contextually appropriate. No factual errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 421,
        "total_tokens": 1664
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How has AXP's focus on Corporate Card solutions evolved between 2023 and 2024, and what does this shift suggest about its broader commercial payments strategy?",
      "original_answer": "In 2023, AXP emphasized evolving its card value propositions and differentiating its corporate card and accounts payable expense management solutions as part of a broader push to strengthen its position in commercial payments. By 2024, while the focus on commercial payments remained, AXP shifted toward designing 'innovative products and features, including financing, banking and payment solutions for our business customers,' indicating a more integrated and solution-oriented approach. This evolution suggests that AXP is expanding beyond just product differentiation to embedding the Corporate Card into a wider suite of business financial services, aligning it more closely with holistic commercial needs.",
      "llm_answer": "\nBetween 2023 and 2024 AXP’s language on corporate‑card initiatives shifted from a general intent to “evolve our card‑value propositions and further differentiate our corporate‑card and expense‑management solutions” (2023 10‑K, p. 8) to a more explicit articulation that these efforts are part of building “a full suite of financing, banking and payment solutions for our business customers” and thereby strengthening its overall commercial‑payments platform (2024 10‑K, p. 8).  This progression shows that AXP is moving beyond simply expanding its corporate‑card portfolio and is now positioning corporate‑card products as the cornerstone of a broader, integrated commercial‑payments strategy that bundles financing, banking and other value‑added services for enterprise clients.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. STRENGTHS: (1) Correctly identifies the temporal shift from 2023 to 2024 with accurate characterization of language changes in both years' 10-K filings. (2) Accurately captures the 2023 positioning focused on 'evolving card value propositions and differentiating corporate card and expense management solutions.' (3) Correctly identifies the 2024 shift toward 'full suite of financing, banking and payment solutions for business customers.' (4) Multi-hop reasoning is sound - properly synthesizes the evolution across two years and correctly interprets what this shift suggests about AXP's broader strategy. (5) Provides specific page references (p. 8 for both years) which adds credibility. (6) The interpretation that AXP is moving from product differentiation to integrated solutions is semantically equivalent to the ground truth's statement about 'embedding the Corporate Card into a wider suite of business financial services.' (7) Correctly identifies the strategic implication: positioning corporate card as cornerstone of broader commercial payments strategy. MINOR CONSIDERATIONS: The LLM answer uses slightly more detailed language ('cornerstone,' 'bundles financing, banking and other value-added services') compared to the ground truth's 'embedding' and 'holistic commercial needs,' but these are semantically equivalent and represent appropriate elaboration rather than deviation. No quantitative errors, no entity misidentification, and the reasoning chain is logically sound. The answer fully addresses both parts of the question (how focus evolved AND what it suggests about strategy).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 462,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How has the strategic positioning of PCA SKIN within Colgate-Palmolive's Oral, Personal and Home Care segment evolved between 2023 and 2024, particularly in terms of its distribution channels?",
      "original_answer": "In 2023, PCA SKIN was listed among Colgate-Palmolive’s principal global and regional trademarks and was included in the broader category of products sold primarily to traditional and eCommerce retailers, wholesalers, distributors, and dentists. By 2024, PCA SKIN remained a listed principal trademark, but the filing specifically expanded the distribution channels to include sales to skin health professionals in some geographies. This indicates a refinement in positioning PCA SKIN within more specialized skincare distribution channels, though no change in production or brand status is indicated.",
      "llm_answer": "\nBetween 2023 and 2024 PCA SKIN remained positioned as a premium skin‑health brand inside Colgate‑Palmolive’s Oral, Personal and Home Care segment, with its products sold chiefly through skin‑health professionals and direct‑to‑consumer channels. The filings do not indicate any shift in these distribution channels, suggesting the brand’s strategic placement and sales approach stayed consistent over the two years.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. (1) CRITICAL ERROR - Distribution Channels: The ground truth states that in 2023, PCA SKIN was sold 'primarily to traditional and eCommerce retailers, wholesalers, distributors, and dentists,' and by 2024 the filing 'expanded the distribution channels to include sales to skin health professionals in some geographies.' The LLM answer incorrectly claims the brand was 'sold chiefly through skin-health professionals and direct-to-consumer channels' with 'no shift in these distribution channels.' This is backwards - the ground truth explicitly indicates an EXPANSION/REFINEMENT to include skin health professionals by 2024, not that this was the primary channel in both years. (2) The LLM answer invents 'direct-to-consumer channels' which are not mentioned in the ground truth. (3) The LLM answer claims 'no shift' when the ground truth explicitly describes a refinement/expansion of distribution channels between the two years. (4) The LLM correctly identifies PCA SKIN as a principal trademark and maintains it within the Oral, Personal and Home Care segment, which is accurate. (5) The characterization as 'premium skin-health brand' is reasonable but not explicitly stated in the ground truth. The multi-hop reasoning fails because the LLM did not properly synthesize the evolution of distribution channels across the two years - it missed the key finding that distribution channels were expanded/refined to include skin health professionals by 2024. The answer fundamentally misrepresents the strategic positioning evolution that the question asks about.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 450,
        "total_tokens": 1715
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How has the strategic focus and commercial positioning of Opdivo evolved between 2022 and 2023, particularly in terms of new tumor indications and combination therapies, and what implications does this have for its revenue growth trajectory?",
      "original_answer": "In 2022, Opdivo was approved for several anti-cancer indications including bladder, blood, CRC, head and neck, RCC, HCC, lung, melanoma, MPM, and stomach cancers, with the Opdivo + Yervoy regimen approved in multiple markets for NSCLC, melanoma, MPM, RCC, CRC, and gastric/esophageal cancers. It reported U.S. revenue growth driven by combinations in NSCLC, kidney cancer, and gastric/esophageal cancers. By 2023, Opdivo's strategic focus expanded into new tumor types and earlier lines of therapy, with an emphasis on broadening its use both as a monotherapy and in combination with Yervoy and other agents. The company also highlighted the potential of a subcutaneous formulation to enhance patient benefits and drive long-term adoption. This evolution indicates a strategic push to sustain revenue growth by diversifying indications and optimizing delivery mechanisms, despite increasing market competition.",
      "llm_answer": "\nBetween 2022 and 2023 the company’s strategy shifted Opdivo from a “stand‑alone” immunotherapy to a broader, earlier‑line engine: the 2023 10‑K explicitly calls for “expanding the use of Opdivo … into additional indications and tumor types both as a monotherapy and in combination with Yervoy and other anti‑cancer agents” and notes progress on a subcutaneous formulation (p. 43).  This commercial repositioning—adding new tumor indications such as earlier‑stage NSCLC, gastric/esophageal cancers and expanded melanoma use, and pairing Opdivo with Yervoy, Cabometyx and other agents—creates multiple growth levers that the firm expects to translate into double‑digit contribution to total sales, helping to offset declines in legacy LOE products and sustain an upward revenue trajectory for Opdivo (pp. 70‑71, 43).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across multiple dimensions. STRENGTHS: (1) Correctly identifies the strategic shift from 'stand-alone' to broader, earlier-line therapy positioning between 2022-2023; (2) Accurately cites specific combination therapies (Opdivo + Yervoy, Cabometyx) and new indications (NSCLC, gastric/esophageal, melanoma); (3) Properly synthesizes the subcutaneous formulation development as a key strategic initiative; (4) Correctly characterizes the revenue growth implications and the goal of offsetting legacy product declines; (5) Appropriately references specific page numbers from the 10-K (pp. 43, 70-71) showing document grounding; (6) Uses accurate terminology ('double-digit contribution to total sales'). MINOR GAPS: (1) The LLM answer mentions 'earlier-stage NSCLC' but the ground truth references 'earlier lines of therapy' more broadly without specifying NSCLC as early-stage; (2) The ground truth explicitly lists 2022 approvals across multiple indications (bladder, blood, CRC, head and neck, RCC, HCC, lung, melanoma, MPM, stomach) which the LLM answer does not detail, though this is not strictly necessary for answering the evolution question; (3) The LLM answer could have been more explicit about the 2022 baseline (approved indications and revenue drivers) before discussing 2023 evolution, though it does reference the shift adequately. QUANTITATIVE ACCURACY: No specific numbers are provided in either answer (no revenue figures, percentages, or dates beyond years), so this dimension is not heavily tested. The reference to 'double-digit contribution' is appropriately vague and matches the ground truth's characterization of growth trajectory. MULTI-HOP REASONING: The answer successfully synthesizes information across multiple strategic dimensions (indications, combinations, formulations) and connects them to revenue implications, demonstrating sound multi-hop reasoning. The logic linking strategic expansion to revenue growth is sound and well-articulated.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1455,
        "completion_tokens": 549,
        "total_tokens": 2004
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did American Express's investment in foreign government bonds and obligations evolve between 2023 and 2024 in terms of fair value and maturity distribution?",
      "original_answer": "In 2023, American Express held $549 million in foreign government bonds and obligations with all of it maturing in 12 months or more and a gross unrealized loss of $1 million. By 2024, the fair value of these investments increased significantly to $765 million, with $764 million maturing within one year and only $1 million maturing after one year but within five years. This indicates a substantial increase in exposure to foreign government bonds, primarily in short-term maturities.",
      "llm_answer": "\nBetween the end of 2023 and the end of 2024 the fair‑value of American Express’s holdings of foreign‑government bonds fell only modestly—from roughly **$770 million** (cost $770 million, no unrealized gain or loss) to **$765 million** (cost $765 million, also no unrealized gain or loss).  The maturity profile remained overwhelmingly short‑term: about **99 %** of the position matures within one year (≈$764 million in 2024 versus $768 million in 2023), with only a trivial amount (≈$1 million) maturing after one year but within five years and nothing maturing beyond five years.  Thus, the exposure stayed essentially unchanged in size and remained almost entirely a near‑term, low‑duration holding.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains fundamental factual errors that directly contradict the ground truth. (1) 2023 Fair Value: LLM states $770 million, but ground truth shows $549 million - a $221 million discrepancy (40% error). (2) 2024 Fair Value: LLM states $765 million, which matches ground truth ($765 million) - this is correct. (3) 2023 Maturity Distribution: LLM claims $768 million matures within one year in 2023, but ground truth explicitly states ALL $549 million matured in 12 months or more (meaning 0% in short-term, 100% in longer-term). This is a complete reversal of the maturity profile. (4) 2024 Maturity Distribution: LLM correctly states $764 million within one year and $1 million after one year but within five years, matching ground truth. (5) Unrealized Gains/Losses: LLM states 'no unrealized gain or loss' for both years, but ground truth shows a $1 million gross unrealized loss in 2023. (6) Trend Analysis: LLM characterizes the change as 'fell only modestly' and 'exposure stayed essentially unchanged,' but ground truth shows a significant 39% increase from $549M to $765M. The LLM's conclusion that 'exposure stayed essentially unchanged' is factually incorrect. The LLM did correctly identify the 2024 maturity profile (99% short-term) and the trivial amount maturing beyond one year, but the 2023 baseline data is severely misrepresented, making the year-over-year comparison fundamentally flawed. The multi-hop reasoning fails because the foundational 2023 numbers are wrong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 423,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How has Walmart's use of intercompany financing arrangements evolved between 2022 and 2024, particularly regarding the amount of cash not freely transferable to the U.S. and the conditions under which such transfers occur?",
      "original_answer": "In 2022, Walmart reported $4.3 billion in cash and cash equivalents that may not be freely transferable to the U.S., with $2.2 billion of that amount subject to approval by Flipkart minority shareholders. By 2024, the amount of cash not freely transferable decreased slightly to $3.3 billion, and the language indicates that these transfers are now generally subject to approval from noncontrolling interest shareholders, rather than specifically tied to Flipkart. This reflects a slight reduction in the magnitude of restricted cash and a broader framing of the conditions under which such transfers occur, suggesting a shift in the structure or focus of intercompany financing arrangements.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2024 the portion of cash that cannot be moved freely to the United States fell modestly—from roughly **$4.3 billion** of cash‑equivalents that were subject to local legal or regulatory restrictions (and, for about $2.2 billion of that amount, could only be accessed through dividends or intercompany financing that required approval of Flipkart’s minority shareholders) to **about $3.5 billion** as of the end of fiscal 2024.  The underlying mechanics have remained the same: Walmart uses intercompany financing to shift cash to the jurisdictions where it is needed at the lowest cost, and earnings can be repatriated to the U.S. generally free of U.S. federal tax but may still incur withholding or state taxes; however, any such repatriations are still contingent on local laws, potential contractual or shareholder approvals, and the Company does not expect these restrictions to have a material impact on its overall liquidity.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer addresses the core question about evolution of Walmart's intercompany financing arrangements between 2022 and 2024, but contains a significant quantitative discrepancy. QUANTITATIVE ISSUES: (1) The 2022 figure of $4.3 billion is correct and matches ground truth. (2) The 2024 figure is stated as 'about $3.5 billion' in the LLM answer, but the ground truth specifies $3.3 billion. This is a material difference of $200 million (6% variance), which is significant for financial analysis and cannot be dismissed as rounding. (3) The $2.2 billion Flipkart-specific amount for 2022 is correctly cited. QUALITATIVE STRENGTHS: (1) The LLM correctly identifies the shift from Flipkart-specific language to broader 'noncontrolling interest shareholders' framing, though it phrases this as 'still contingent on local laws, potential contractual or shareholder approvals' rather than explicitly noting the shift in language scope. (2) The answer appropriately explains the mechanics of intercompany financing and tax implications. (3) Multi-hop synthesis is sound - the answer connects the cash restriction amounts across years and explains the underlying conditions. COMPLETENESS: The answer addresses both the quantitative evolution (amounts) and qualitative evolution (conditions/language shift), though the qualitative shift could be more explicitly highlighted as a key change in how restrictions are framed. The mention of 'does not expect these restrictions to have a material impact on overall liquidity' adds relevant context not explicitly in the ground truth but consistent with typical 10-K disclosures. CRITICAL ERROR: The $3.5 billion vs. $3.3 billion discrepancy for 2024 is the primary issue preventing a higher score, as it represents a factual error in a key metric that the question specifically asks about.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 496,
        "total_tokens": 1929
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did the composition of Texas Instruments' U.S. Retiree Health Care Plan assets evolve between the 2023 and 2024 filings, particularly in terms of fixed income securities and equity securities allocation?",
      "original_answer": "The composition of Texas Instruments' U.S. Retiree Health Care Plan assets remained completely unchanged between the 2023 and 2024 filings. In both years, the plan held $210 million in fixed income securities and cash equivalents, and $54 million in equity securities, resulting in a total of $264 million in plan assets. The fixed income allocation represented approximately 79.5% of the total plan assets, while equity securities represented approximately 20.5% in both years. The identical figures across both filings indicate no evolution in the asset allocation strategy for this plan during the reported period.",
      "llm_answer": "\nBetween the 2023 and 2024 filings the U.S. Retiree Health Care Plan’s asset base shrank modestly—from $264 million to $248 million—with fixed‑income securities (cash and cash‑equivalents) falling from $210 million to $198 million and equity securities from $54 million to $50 million. As a result, the fixed‑income portion stayed roughly 80 % of the portfolio (about 79.5 % in 2023 and 79.8 % in 2024), while the equity portion slipped slightly from ~20.5 % to ~20.2 % of total assets.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on the core factual claims. The ground truth explicitly states that the composition remained 'completely unchanged' between 2023 and 2024 filings, with identical figures in both years: $210 million in fixed income securities and $54 million in equity securities (total $264 million), with allocations of 79.5% and 20.5% respectively. The LLM answer contradicts this by claiming: (1) Total assets decreased from $264M to $248M - INCORRECT, (2) Fixed income fell from $210M to $198M - INCORRECT, (3) Equity fell from $54M to $50M - INCORRECT, (4) Percentages changed from 79.5%/20.5% to 79.8%/20.2% - INCORRECT. All numeric values provided by the LLM are factually wrong. The LLM's calculations are internally consistent (198+50=248, 198/248≈79.8%, 50/248≈20.2%), but these calculations are based on entirely fabricated numbers that do not match the actual filing data. The question is appropriately addressed in terms of scope and relevance, but the answer provides false information about asset evolution when the correct answer is that there was no evolution at all. This represents a complete failure to accurately report the ground truth data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 336,
        "total_tokens": 1627
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did Honeywell's 2006 Stock Plan for Non-Employee Directors evolve between 2022 and 2024 in terms of the specific forms of award agreements offered, and what might this suggest about changes in the company's non-employee director compensation structure?",
      "original_answer": "In 2022, Honeywell's 10-K filing listed both the 'Form of Option Agreement' (Exhibit 10.30) and the 'Form of Restricted Unit Agreement' (Exhibit 10.32) as part of the 2006 Stock Plan for Non-Employee Directors. By 2024, while the 'Form of Option Agreement' was still referenced (Exhibit 10.29), the 'Form of Restricted Unit Agreement' was no longer explicitly mentioned in the exhibit list. This suggests a shift in the types of equity awards offered to non-employee directors, potentially signaling a strategic move toward emphasizing stock options over restricted units in director compensation.",
      "llm_answer": "\nBetween 2022 and 2024 the 2006 Stock Plan for Non‑Employee Directors remained governed by the 2021 omnibus amendment, with awards issued under the “Form of Option Agreement” and “Form of Restricted Unit Agreement.” By the 2024 filing the company had shifted to the 2016 Stock Plan for Directors, referencing “Form of Stock Option Award Agreement” and “Form of Restricted Stock Unit Agreement (Form 1/2)”, indicating a move toward a broader, more structured equity‑based compensation program that includes RSUs and performance‑linked awards for its non‑employee directors.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) WRONG PLAN REFERENCE: The LLM claims the company shifted to the '2016 Stock Plan for Directors' by 2024, but the ground truth explicitly states the 2006 Stock Plan for Non-Employee Directors was still being referenced in 2024 (with Exhibit 10.29). (2) INCORRECT EXHIBIT NUMBERS: The ground truth identifies specific exhibits (10.30 and 10.32 in 2022; 10.29 in 2024), while the LLM provides different exhibit references without proper documentation. (3) WRONG AWARD FORMS: The LLM mentions 'Form of Stock Option Award Agreement' and 'Form of Restricted Stock Unit Agreement (Form 1/2)' which are not mentioned in the ground truth. The ground truth specifically references 'Form of Option Agreement' and 'Form of Restricted Unit Agreement.' (4) MISCHARACTERIZATION OF EVOLUTION: The ground truth indicates the Restricted Unit Agreement was NO LONGER EXPLICITLY MENTIONED by 2024, suggesting a shift away from restricted units. The LLM incorrectly suggests the company moved toward a 'broader' program that INCLUDES RSUs, which contradicts the ground truth's finding. (5) MULTI-HOP SYNTHESIS FAILURE: The LLM failed to correctly synthesize the exhibit list changes between the two years. The core finding—that restricted units were dropped from the explicit exhibit list—is completely missed. The answer demonstrates fundamental misunderstanding of the question and provides incorrect plan names and award structures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 417,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did Walmart's strategic position regarding its ownership stake in Flipkart evolve between 2022 and 2024, particularly in terms of financial implications and potential exposure to regulatory risks?",
      "original_answer": "In 2022, Walmart received $3.2 billion in equity funding related to Flipkart, which reduced its ownership stake from 83% to 75%. This signaled a partial financial exit while maintaining majority control. By 2024, however, Walmart disclosed ongoing regulatory scrutiny in India, including a show cause notice issued in July 2021 and subsequent information requests related to alleged violations of India's Foreign Direct Investment rules during the period 2009–2015—prior to Walmart's acquisition of Flipkart in 2018. Despite the reduced ownership stake, Walmart remained exposed to potential regulatory consequences, including share ownership restrictions, and noted its inability to reasonably estimate potential losses or indemnification proceeds from prior shareholders. The evolution reflects a shift from active financial participation to managing legacy risks tied to Flipkart's pre-acquisition history.",
      "llm_answer": "\nBetween fiscal 2022 and 2024 Walmart’s Flipkart stake fell from ~83 % to ~75 % after a 2022 equity raise that brought in $3.2 bn of cash, then rose to about 85 % in 2024 when it paid $3.5 bn to acquire the remaining non‑controlling shares and settle a $0.9 bn liability to former PhonePe holders, thereby gaining full control and eliminating that accrued liability.  The cash‑intensive transactions reshaped the consolidation of Flipkart’s results, but they also expose Walmart to ongoing Indian foreign‑direct‑investment scrutiny and potential antitrust or enforcement actions that could affect its ownership structure and future cash flows.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant inaccuracies that contradict the ground truth. (1) OWNERSHIP TRAJECTORY ERROR: The LLM claims ownership rose to ~85% in 2024 after a $3.5bn acquisition, but the ground truth states ownership fell from 83% to 75% in 2022 and remained at that reduced level through 2024. The LLM's narrative of a subsequent buyback to 85% is not supported by the ground truth. (2) TRANSACTION DETAILS: The LLM introduces a $3.5bn acquisition and $0.9bn PhonePe liability settlement that are not mentioned in the ground truth. These appear to be fabricated or confused with other transactions. (3) CONTROL CLAIM: The LLM states Walmart gained 'full control' in 2024, but the ground truth indicates Walmart maintained 75% ownership (majority but not full control) and the question specifically asks about 'potential exposure to regulatory risks' and 'inability to reasonably estimate potential losses,' suggesting incomplete control. (4) REGULATORY RISK TREATMENT: While the LLM mentions 'ongoing Indian foreign-direct-investment scrutiny,' it fails to capture the specific regulatory details from the ground truth: the July 2021 show cause notice, the alleged FDI violations during 2009-2015 (pre-acquisition period), and Walmart's inability to estimate potential losses or indemnification from prior shareholders. The ground truth emphasizes these are LEGACY RISKS from pre-acquisition history, not current operational risks. (5) STRATEGIC EVOLUTION MISCHARACTERIZATION: The ground truth describes a shift from 'active financial participation to managing legacy risks,' but the LLM portrays an aggressive consolidation strategy with full control acquisition. These are fundamentally different narratives. The LLM answer demonstrates poor multi-hop synthesis and introduces unsupported financial figures that significantly alter the factual record.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 510,
        "total_tokens": 1912
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How did the composition and strategic emphasis of HON's U.S. cash balances evolve between 2022 and 2024, particularly in terms of total cash holdings and geographic distribution of funds?",
      "original_answer": "In 2022, HON reported holding $11.5 billion of cash and cash equivalents as of December 31, 2021, with an emphasis on safety of principal and diversification among counterparties. By 2024, the company held $11.0 billion in total cash and equivalents as of December 31, 2024, but specifically noted that $8.0 billion of that amount was held in non-U.S. subsidiaries. This represents a shift in geographic distribution, with a larger portion of liquidity positioned outside the U.S., while maintaining the same strategic emphasis on safety and diversification.",
      "llm_answer": "\nBetween the end of 2022 and the end of 2024 Honeywell’s cash pool expanded sharply—from roughly **$9.6 billion** of cash and cash equivalents at the close of 2022 to **$8.1 billion** in 2023 and then to **$11.0 billion** in 2024 (cash‑flow tables, HON_10K‑2022 p. 43; HON_10K‑2024 p. 41).  The company continued to keep the bulk of that cash abroad, reporting that **about $8 billion (≈73 %) of the 2024 balance was held in non‑U.S. subsidiaries**, leaving only roughly **$3 billion of U.S.–based cash** (the remainder of the $11 billion total).  This evolution underscores a strategic emphasis on maintaining a sizable offshore cash base to fund global operations and acquisitions while relying on a more modest U.S. cash buffer for domestic liquidity needs and dividend commitments.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "MAJOR ISSUES WITH QUANTITATIVE ACCURACY: The LLM answer contains significant factual errors in the core numbers that undermine the response. (1) INCORRECT 2022 FIGURE: The LLM states HON held '$9.6 billion' at the close of 2022, but the ground truth indicates $11.5 billion as of December 31, 2021 (which would be reported in the 2022 10-K). This is a $1.9 billion discrepancy. (2) INCORRECT 2023 FIGURE: The LLM introduces an intermediate 2023 figure of $8.1 billion, which is not mentioned in the ground truth and appears to be fabricated or misattributed. (3) 2024 FIGURE CORRECT: The $11.0 billion for 2024 matches the ground truth. (4) GEOGRAPHIC DISTRIBUTION CORRECT: The $8.0 billion held in non-U.S. subsidiaries is accurate, and the calculation that this represents approximately 73% of the total is mathematically correct (8.0/11.0 = 72.7%). The U.S. cash estimate of roughly $3 billion is also correct. MULTI-HOP REASONING: The LLM correctly synthesized the geographic distribution aspect and identified the strategic emphasis on offshore cash positioning. However, the foundational numbers for the 2022 baseline are wrong, which undermines the entire 'evolution' narrative. The answer does address both composition and geographic distribution as requested. SEMANTIC ISSUES: While the LLM's interpretation of strategic emphasis (offshore cash for global operations) is reasonable and aligns with the ground truth's mention of safety and diversification, the incorrect starting point (2022) makes the comparison invalid. The answer would have scored 8-9 if the 2022 figure had been correct, as the 2024 analysis and geographic breakdown are sound.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 453,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How did the financial treatment and liability estimation methodology for the Membership Rewards program evolve from 2023 to 2024, particularly in terms of deferred fees and liability modeling assumptions?",
      "original_answer": "In 2023, the company recognized deferred fees related to Membership Rewards program participants, indicating a focus on the deferral aspect of fee revenue associated with the program. By 2024, the disclosures provided a much more detailed explanation of the liability estimation methodology, including the use of the Ultimate Redemption Rate (URR) and the weighted average cost (WAC) per point. The 2024 filing also quantified the sensitivity of the liability to changes in assumptions, noting that a 25 basis point increase in URR would raise the liability by $197 million, and a 1 basis point increase in WAC per point would increase it by $220 million. This reflects a shift from a simpler mention of deferred fees to a comprehensive, model-driven approach to estimating future redemption liabilities.",
      "llm_answer": "\nFrom 2023 to 2024 the company kept the same core premise – the Membership Rewards liability is estimated by applying an “ultimate redemption rate” (URR) and a weighted‑average cost per point (WAC) to the points of current enrollees, using statistical/actuarial models that factor in enrollment, spend, attrition and redemption‑trend data – but it sharpened the disclosure and quantification of those assumptions.  The 2024 filing (page 86) adds explicit sensitivity results (a 25‑bp rise in URR would add ≈ $197 million to the liability and a 1‑bp rise in WAC would add ≈ $220 million) and notes that the liability grew from $12.8 bn at the end of 2023 to $13.7 bn at the end of 2024, while the deferred‑card‑and‑other‑fees balance increased from $3.0 bn to $3.44 bn, reflecting a larger estimated future redemption cost that is now more explicitly modeled and measured.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensiveness. STRENGTHS: (1) All key numeric values are correct - the sensitivity metrics (25 bp URR increase = $197M, 1 bp WAC increase = $220M) match the ground truth exactly; (2) The liability figures are accurate ($12.8B end of 2023 to $13.7B end of 2024) and the deferred fees balance ($3.0B to $3.44B) are correctly stated; (3) The multi-hop synthesis is sound - the answer correctly identifies the evolution from simpler 2023 disclosures to more detailed 2024 methodology with explicit sensitivity analysis; (4) The core methodology (URR and WAC modeling with statistical/actuarial factors) is accurately described; (5) The answer goes beyond the ground truth by providing additional context (page reference, specific balance sheet items) that enhances understanding without introducing errors. MINOR CONSIDERATIONS: (1) The ground truth emphasizes a 'shift from simpler mention to comprehensive model-driven approach' while the LLM frames it as 'kept the same core premise but sharpened disclosure' - this is a subtle framing difference but semantically equivalent, as both convey that the underlying methodology remained consistent while disclosures became more detailed; (2) The LLM provides slightly more granular detail about the deferred fees balance increase, which adds value without contradicting the ground truth. VERIFICATION: All dollar amounts, basis point changes, and year-over-year comparisons are factually accurate. The reasoning correctly synthesizes information about how the company's treatment evolved from 2023 to 2024, addressing both the deferred fees aspect and the liability modeling assumptions as requested.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 463,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How has Adobe's strategic positioning and integration of Frame.io evolved between 2022 and 2024, particularly in terms of its alignment with Adobe's broader product ecosystem?",
      "original_answer": "In 2022, Adobe described the integration of Frame.io as part of its Digital Media reportable segment, emphasizing its role as a cloud-based video collaboration platform acquired for $1.18 billion, with integration efforts just beginning. By 2024, Frame.io had transitioned from being a newly acquired integration to being positioned as a core component of Adobe's creative collaboration suite, directly integrated with key applications such as Adobe Premiere Pro, After Effects, Photoshop, and Workfront. Additionally, in 2024, Frame.io was included as part of Adobe GenStudio, indicating a deeper strategic alignment with Adobe's broader content production and collaboration ecosystem. This evolution reflects a shift from initial integration to full ecosystem incorporation.",
      "llm_answer": "\nBetween 2022 and 2024 Adobe moved Frame.io from a freshly‑acquired asset into the core collaboration layer of its subscription‑based ecosystem, embedding the platform directly inside the Creative Cloud suite (Premiere Pro, After Effects, Photoshop, Illustrator, Express) and linking it to Document Cloud, Adobe Stock and the Firefly generative‑AI services.  This tight integration ties creative‑production workflows to the broader Digital Experience and Experience Cloud portfolio—enabling seamless hand‑off to analytics, content‑management and marketing tools—while fueling the company’s recurring‑revenue and ARR growth strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core evolution of Frame.io from a newly-acquired asset (2022) to an integrated component of Adobe's ecosystem (2024). It accurately mentions integration with key Creative Cloud applications (Premiere Pro, After Effects, Photoshop) and correctly identifies the strategic alignment with Adobe's broader product ecosystem. The mention of Document Cloud, Adobe Stock, and Firefly integration is contextually appropriate and demonstrates understanding of the ecosystem positioning.\n\nWEAKNESSES: (1) The LLM answer mentions Illustrator and Express as integrated applications, but the ground truth specifically lists Premiere Pro, After Effects, Photoshop, and Workfront—Illustrator and Express are not mentioned in the original answer. (2) Most significantly, the LLM answer completely omits the critical detail that Frame.io was included as part of Adobe GenStudio in 2024, which the ground truth identifies as a key indicator of 'deeper strategic alignment.' This is a material omission for a question specifically about strategic positioning evolution. (3) The LLM answer does not mention the $1.18 billion acquisition price, though this is contextual detail rather than essential to answering the evolution question. (4) The LLM introduces concepts like 'recurring-revenue and ARR growth strategy' and connections to 'analytics, content-management and marketing tools' that, while strategically logical, are not explicitly stated in the ground truth and represent inference beyond the provided knowledge graph.\n\nMULTI-HOP REASONING: The answer demonstrates sound multi-hop reasoning by connecting Frame.io integration across multiple Adobe products and business units. However, it fails to complete the full synthesis by omitting the GenStudio positioning, which is a key waypoint in the 2024 strategic evolution narrative.\n\nNUMERIC/FACTUAL VERIFICATION: No quantitative errors detected. The answer avoids specific numbers, which prevents calculation errors but also means limited quantitative content to verify.\n\nSEMANTIC EQUIVALENCE: The core message about evolution from standalone acquisition to ecosystem integration is conveyed, but the omission of GenStudio and the addition of unverified applications (Illustrator, Express) create factual discrepancies rather than mere wording differences.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 627,
        "total_tokens": 1987
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did the composition of private alternative investments, specifically equity-like funds, evolve between 2022 and 2023 in terms of fair value measurements using significant unobservable inputs (Level 3)?",
      "original_answer": "In 2022, equity-like funds under private alternative investments had a fair value of $5.5 million measured using significant unobservable inputs (Level 3). In 2023, this value increased significantly to $25.4 million. This indicates a fivefold increase in the portion of equity-like funds valued using Level 3 inputs, suggesting a shift toward more opaque or complex valuation methodologies for these investments.",
      "llm_answer": "\nBetween the end of 2022 and the end of 2023 the Level 3 fair‑value attributable to equity‑like funds in the private‑alternative‑investment portfolio slipped modestly—from about **$25.4 million** to **$25.1 million**.  This small decline reflects a slight reduction in the valuation of those investments that rely on significant unobservable inputs, although the overall exposure to private equity‑like assets remains sizable.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains fundamentally incorrect numbers that directly contradict the ground truth. According to the original answer, equity-like funds under Level 3 fair value measurements were $5.5 million in 2022 and $25.4 million in 2023—representing a significant fivefold increase. However, the LLM answer reverses these values entirely, claiming the 2022 value was $25.4 million and the 2023 value was $25.1 million, describing this as a 'modest slip' rather than the actual substantial increase. This is a critical factual error that completely misrepresents the evolution of the portfolio composition. The LLM also mischaracterizes the trend as a decline when the ground truth shows a dramatic increase. While the LLM correctly identifies the relevant metrics (Level 3 fair value, equity-like funds, private alternative investments) and addresses the time period (2022-2023), the core numerical data is inverted and the analytical conclusion is opposite to reality. The reasoning about 'slight reduction' and 'overall exposure remains sizable' contradicts the actual fivefold increase documented in the ground truth. This represents a fundamental failure in quantitative accuracy and multi-hop synthesis of the financial data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 347,
        "total_tokens": 1572
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How has Adobe's integration and positioning of Frame.io within its Digital Media offerings evolved between 2022 and 2024?",
      "original_answer": "In 2022, Adobe had just acquired Frame.io in October 2021 and was beginning to integrate it into the Digital Media segment as a cloud-based video collaboration platform. By 2024, Frame.io had become a core part of Adobe’s creative collaboration tools, being directly integrated with Adobe Premiere Pro, After Effects, Photoshop, Lightroom, and Workfront, and was also included in Adobe GenStudio for scalable content production. This reflects a strategic evolution from initial integration to deeper ecosystem embedding.",
      "llm_answer": "\nAdobe acquired Frame.io in late 2021 and, by the 2022 10‑K, had begun positioning it as a core collaboration layer within the Digital Media segment, integrating the platform with Premiere Pro, After Effects, Photoshop, Lightroom and Workfront to enable frame‑accurate review and approval workflows. In the 2023‑2024 period Adobe deepened that integration, embedding Frame.io throughout the Creative Cloud ecosystem—linking it with Adobe Express, Firefly Services and the GenStudio content‑production suite—and promoting it as a unified, AI‑enhanced hub that spans capture, review, and publishing at scale.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy with minor deviations from the ground truth. STRENGTHS: (1) Correctly identifies Frame.io acquisition timing (late 2021/October 2021), (2) Accurately lists the core integrated applications (Premiere Pro, After Effects, Photoshop, Lightroom, Workfront) in both periods, (3) Properly synthesizes the evolution from initial integration (2022) to deeper ecosystem embedding (2023-2024), (4) Correctly identifies GenStudio as part of the 2024 positioning, (5) Appropriately characterizes the strategic progression from 'core collaboration layer' to 'unified, AI-enhanced hub'. MINOR ISSUES: (1) The LLM introduces 'Adobe Express' and 'Firefly Services' as part of the 2023-2024 integration, which are not explicitly mentioned in the ground truth answer. While these may be accurate additions from the actual filings, they represent information beyond what the ground truth specifies, creating a slight divergence. (2) The characterization of Frame.io as 'AI-enhanced hub' and the emphasis on 'capture, review, and publishing at scale' adds interpretive framing not present in the ground truth, though semantically consistent with the evolution described. MULTI-HOP REASONING: The answer correctly synthesizes information across the 2022-2024 timeframe, comparing and contrasting the positioning in each period. The logical flow from initial integration to deeper embedding is sound. QUANTITATIVE ACCURACY: All dates and timeframes are correct. No calculations required. SEMANTIC EQUIVALENCE: The core message matches the ground truth—Frame.io evolved from initial integration to deeper ecosystem embedding—though the LLM provides additional specific product integrations not mentioned in the ground truth baseline.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 477,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How has CVS's approach to Medication Management evolved between 2022 and 2024, particularly in terms of clinical programs and digital tools aimed at improving medication adherence and cost efficiency?",
      "original_answer": "In 2022, CVS emphasized formulary management through its National Pharmacy and Therapeutics Committee, promoting the use of generic drugs and offering real-time benefit information to guide members toward lower-cost alternatives. The company also operated mail order and specialty pharmacies, and provided clinical programs focused on medication adherence and utilization management, including an industry-leading approach to limit opioid prescriptions to seven-day supplies for acute cases. By 2024, CVS had expanded its Medication Management offerings with the introduction of digital tools like the NovoLogix preauthorization platform and enhanced analytics for identifying lower-cost drug alternatives. The company also launched the CVS Weight Management program, integrating GLP-1 medication optimization with lifestyle coaching, and expanded its value-based care initiatives through Oak Street Health, operating 239 primary care centers across 27 states to better manage chronic conditions and medication use. These developments reflect a shift from primarily cost-containment strategies to a more integrated, digitally enabled, and clinically proactive model of medication support.",
      "llm_answer": "\nBetween 2022 and 2024 CVS broadened its medication‑management portfolio and added a suite of digital capabilities to drive adherence and cost‑efficiency.  The company expanded real‑time formulary and benefit‑information tools, introduced AI‑enabled analytics and the Pharmacy Advisor pharmacist‑counseling platform, and deepened disease‑management, utilization‑management (including opioid‑limit and GLP‑1 weight‑management programs), all integrated with its growing network of retail, mail‑order and specialty pharmacies and linked to value‑based contracts through Oak Street Health and Signify Health.  These enhancements reflect a shift from static formulary design toward data‑driven, digitally delivered clinical programs that simultaneously improve patient outcomes and lower net pharmacy spend.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures the general evolution of CVS's medication management approach between 2022 and 2024, correctly identifying the shift toward digital tools and integrated clinical programs. However, there are significant issues with factual accuracy and completeness:\n\nCORRECT ELEMENTS:\n- Correctly identifies the shift from static formulary design to data-driven, digitally enabled approaches\n- Accurately mentions opioid-limiting programs and GLP-1 weight management\n- Correctly references Oak Street Health as part of value-based care initiatives\n- Appropriately notes the integration of retail, mail-order, and specialty pharmacies\n- Correctly identifies the timeframe (2022-2024)\n\nINCORRECT/PROBLEMATIC ELEMENTS:\n1. QUANTITATIVE ERRORS: The LLM mentions \"239 primary care centers across 27 states\" from the ground truth but fails to include this specific metric, which is a concrete, verifiable number that should have been included.\n2. MISSING KEY PLATFORM: The ground truth specifically mentions \"NovoLogix preauthorization platform\" as a 2024 digital tool introduction. The LLM instead mentions \"Pharmacy Advisor pharmacist-counseling platform,\" which is not mentioned in the ground truth. This is a factual error - introducing a tool not supported by the source material.\n3. INCOMPLETE SYNTHESIS: The ground truth mentions \"Signify Health\" in the LLM answer but this appears to be an addition not clearly supported in the original ground truth statement provided.\n4. MISSING SPECIFICITY: The ground truth emphasizes the National Pharmacy and Therapeutics Committee's role in 2022, which the LLM answer omits entirely.\n5. VAGUE LANGUAGE: The LLM uses \"expanded real-time formulary and benefit-information tools\" rather than the more specific ground truth language about \"real-time benefit information to guide members toward lower-cost alternatives.\"\n\nMULTI-HOP REASONING: The LLM demonstrates sound multi-hop reasoning by connecting 2022 baseline practices with 2024 enhancements and linking them to broader value-based care strategies. However, the introduction of unsupported tools (Pharmacy Advisor) undermines the reliability of this synthesis.\n\nQUANTITATIVE ACCURACY: Moderate concern - while no calculations are performed, the failure to include the specific \"239 primary care centers across 27 states\" metric represents a loss of concrete data points. The introduction of \"Pharmacy Advisor\" without ground truth support is a factual error.\n\nQUALITATIVE ACCURACY: The reasoning structure is sound, but the inclusion of unsupported information (Pharmacy Advisor, Signify Health) and omission of supported specifics (NovoLogix, Oak Street Health center count) indicates incomplete or inaccurate source synthesis.\n\nCONTEXTUAL RELEVANCE: The answer appropriately addresses the question's focus on clinical programs and digital tools, though with some inaccuracies in the specific tools mentioned.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1511,
        "completion_tokens": 776,
        "total_tokens": 2287
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "How has Adobe's integration and positioning of Frame.io within its Creative Cloud ecosystem evolved from 2022 to 2024, and what specific enhancements were made to its collaboration features during this period?",
      "original_answer": "In 2022, Adobe acquired Frame.io and began integrating its cloud-based video collaboration platform into Adobe Creative Cloud, with initial enhancements focused on deeper integration into Premiere Pro and After Effects to deliver native collaborative workflows for video editing. By 2024, Frame.io had evolved into a more comprehensive cloud-native creative collaboration platform, offering real-time upload, review, and approval features not only for video but also for still images, design files, and PDFs. It expanded its integration across Adobe Photoshop, Lightroom, and Workfront, and introduced Camera to Cloud functionality, enabling automatic upload of footage directly into Frame.io from cameras on set. These enhancements reflect a strategic shift from a video-specific collaboration tool to a broader creative asset production and review platform within Adobe’s ecosystem.",
      "llm_answer": "\nAdobe has turned Frame.io from a standalone review service into the core collaborative layer of Creative Cloud, expanding its native integration beyond the 2022 rollout of review‑and‑approval workflows in Premiere Pro and After Effects to encompass Photoshop, Lightroom, Express and Firefly‑powered AI tools by 2024. The result is a real‑time, frame‑accurate environment with features such as Camera‑to‑Cloud auto‑upload, AI‑enhanced commenting and seamless asset sharing across desktop, web and mobile, positioning Frame.io as the backbone for task‑based, cross‑functional collaboration within Creative Cloud.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy with correct identification of key facts and timeline. Strengths: (1) Correctly identifies 2022 as acquisition year and 2024 as endpoint; (2) Accurately lists initial 2022 integrations (Premiere Pro, After Effects); (3) Correctly identifies 2024 expansions including Photoshop, Lightroom, and Camera to Cloud functionality; (4) Properly characterizes the strategic shift from video-specific to broader creative asset platform; (5) Accurately describes real-time, frame-accurate collaboration features. Minor discrepancies: (1) LLM mentions 'Express and Firefly-powered AI tools' which are not explicitly mentioned in ground truth as Frame.io integrations - this represents a slight overreach beyond the verified information; (2) Ground truth mentions 'PDFs' as supported file types, which LLM omits; (3) LLM mentions 'AI-enhanced commenting' which is not explicitly stated in ground truth; (4) Ground truth mentions 'Workfront' integration, which LLM does not include. The LLM answer successfully synthesizes the multi-hop information across the 2022-2024 period and correctly identifies the evolution trajectory. The semantic meaning aligns well with ground truth regarding the transformation from video-specific to comprehensive creative collaboration platform. The additional details about Express, Firefly, and AI-enhanced commenting, while not contradicted by ground truth, go beyond what was verified in the knowledge graph, representing minor factual extensions rather than errors. No numerical calculations or dates are incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 436,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How has the use of recently executed transactions in the valuation of loans and other assets evolved from 2023 to 2024, particularly in terms of their role in fair value determination?",
      "original_answer": "In 2023, recently executed transactions were a key input for determining the fair value of corporate loans and contingent lending commitments, often used alongside market price quotations, implied yields, and proprietary valuation models. By 2024, the role of recently executed transactions remained significant but was more specifically tied to the held-for-sale category of loans and lending commitments, and also extended to the valuation of other assets such as other investments, where they were used in conjunction with discounted cash flow models and comparable company multiples. This reflects a more targeted application of transaction data in valuation practices.",
      "llm_answer": "\nFrom 2023 to 2024 the Firm moved from treating recently‑executed transactions as just one of several observable inputs for Level 2 corporate‑loan and lending‑commitment valuations to making those transaction prices the primary benchmark when direct market quotes are not available.  In 2024 the Company explicitly cites “recently executed transactions” (and the implied yields or spreads they generate) as the key input for estimating fair value of corporate loans, mortgage‑ and asset‑backed securities, and private‑equity investments, and it uses those transaction‑derived levels to classify assets in Level 2 or Level 3 of the fair‑value hierarchy.  Consequently, the roll‑forward tables for 2024 show a larger share of valuations driven by recent transaction data, reflecting a greater reliance on such data for fair‑value determination.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and misrepresentations compared to the ground truth. Key issues: (1) INCORRECT CHARACTERIZATION OF EVOLUTION: The LLM claims the firm 'moved from treating recently-executed transactions as just one of several observable inputs...to making those transaction prices the primary benchmark,' but the ground truth indicates recently executed transactions were already 'a key input' in 2023 and remained 'significant' in 2024 - this is not a shift from secondary to primary status. (2) OVERSTATED SCOPE: The LLM incorrectly expands the asset classes to include 'mortgage- and asset-backed securities, and private-equity investments,' but the ground truth specifies the 2024 application was 'more specifically tied to the held-for-sale category of loans and lending commitments' and 'other investments' - not the broader categories claimed. (3) UNSUPPORTED CLAIMS: The LLM asserts 'roll-forward tables for 2024 show a larger share of valuations driven by recent transaction data' with no quantitative support in the ground truth, which makes no such comparative claim. (4) MISSING KEY DETAIL: The ground truth notes the 2024 application extended to 'other investments' with 'discounted cash flow models and comparable company multiples,' but the LLM omits this important contextual detail about the valuation methodology evolution. (5) MISCHARACTERIZATION OF HIERARCHY: The LLM's claim about Level 2/Level 3 classification being driven by transaction data is not explicitly supported in the ground truth. The answer demonstrates a fundamental misunderstanding of the actual evolution, which was more about targeted application to specific asset categories rather than a shift in the hierarchy of inputs or a dramatic increase in reliance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 486,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How has Adobe's approach to the Substance 3D Stager product evolved between 2022 and 2024, particularly in terms of its positioning within the broader Substance 3D ecosystem?",
      "original_answer": "In 2022, Substance 3D Stager was listed among Adobe's trademarks, indicating it was an established product within the company's portfolio but without detailed information about its functionality or strategic positioning. By 2024, Adobe introduced a more comprehensive view of Substance 3D as an ecosystem, where Stager is specifically described as a tool for building and assembling 3D scenes. This evolution reflects a strategic shift from simply offering the product to integrating it into a broader suite of 3D tools, including Painter, Sampler, Designer, and Modeler, emphasizing its role in enabling end-to-end 3D content creation workflows.",
      "llm_answer": "\nBetween 2022 and 2024 Adobe has expanded Substance 3D Stager from a niche “staging” utility into a central, AI‑enhanced component of the broader Substance 3D suite.  The 2024 filing shows Stager now works tightly with the other Substance 3D desktop apps (Painter, Sampler, Designer, Modeler) and is paired with Adobe Firefly Services and Custom Models, giving enterprises APIs and generative‑AI capabilities for end‑to‑end 3D content creation.  This evolution positions Stager as a core hub of Adobe’s 3D ecosystem rather than an isolated tool.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ISSUES: The LLM answer introduces significant factual claims not supported by the ground truth. Specifically: (1) The claim that Stager was a 'niche staging utility' in 2022 is not supported - the ground truth only states it was 'listed among Adobe's trademarks' with 'no detailed information about functionality.' (2) The assertion about 'AI-enhanced' capabilities and 'Adobe Firefly Services and Custom Models' integration is entirely absent from the ground truth, which makes no mention of AI/Firefly integration. (3) The claim about 'APIs and generative-AI capabilities' is not in the original answer. (4) The characterization of Stager as a 'core hub' is an overstatement compared to the ground truth's more measured description of it being 'specifically described as a tool for building and assembling 3D scenes' within an ecosystem. WHAT WAS CORRECT: The LLM correctly identifies the 2022-2024 timeframe, correctly names all the companion products (Painter, Sampler, Designer, Modeler), and correctly captures the general evolution from isolated product to ecosystem integration. The semantic direction of the answer (evolution toward broader integration) aligns with ground truth. MULTI-HOP REASONING: The LLM failed to synthesize only what was actually stated in the filings, instead inferring or hallucinating details about AI capabilities and Firefly integration that are not present in the ground truth. This represents a fundamental failure in multi-hop reasoning - adding unsupported claims rather than synthesizing available information. The answer reads as plausible but contains material fabrications.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 445,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How did GE's strategic positioning regarding grid-scale batteries evolve from 2022 to 2023, particularly in terms of their role in the company's energy transition strategy and level of strategic reliance?",
      "original_answer": "In 2022, GE mentioned grid-scale batteries as part of a broader set of emerging technologies that 'may become more important over time' in achieving deep decarbonization goals, indicating GE was considering them as a potential future investment. By 2023, GE explicitly listed grid-scale batteries as one of the key technologies 'that may become more important over time' and integrated them into the company’s strategic narrative as a dependency, noting that achieving decarbonization goals would 'depend in part' on such technologies. This reflects a shift from viewing grid-scale batteries as a speculative investment to a more central component of GE's energy transition strategy.",
      "llm_answer": "\nFrom 2022 to 2023 GE’s language shifted from a tentative, risk‑focused acknowledgment of grid‑scale batteries as a possible future storage option (2022 10‑K pages 49, 62, 64) to an explicit strategic emphasis that treats batteries as a key enabler of its decarbonization and power‑generation growth (2023 10‑K pages 29, 30, 42).  In the newer filing the company ties battery investments to the achievement of deep‑decarbonization goals and to the competitiveness of its renewable‑energy businesses, indicating a higher level of strategic reliance on grid‑scale storage than it expressed a year earlier.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the temporal evolution from 2022 to 2023 with accurate characterization of the shift in GE's positioning - from 'tentative, risk-focused acknowledgment' to 'explicit strategic emphasis.' (2) Accurately captures the semantic shift from viewing batteries as 'possible future storage option' to treating them as 'key enabler' of decarbonization goals. (3) Properly synthesizes the multi-hop reasoning: connects the language change across two 10-K filings to demonstrate increased strategic reliance. (4) Correctly identifies that 2023 filing shows batteries are now tied to 'achievement of deep-decarbonization goals' and 'competitiveness of renewable-energy businesses,' matching the ground truth's characterization of 'depend in part' language. (5) Appropriately cites specific page numbers from both 2022 and 2023 10-K filings, demonstrating document-level precision. MINOR CONSIDERATIONS: (1) The LLM answer includes specific page citations (pages 49, 62, 64 for 2022; pages 29, 30, 42 for 2023) which cannot be verified against the ground truth but appear reasonable and add credibility. (2) The phrasing 'higher level of strategic reliance' is semantically equivalent to the ground truth's characterization of the shift from 'speculative investment' to 'more central component.' (3) The answer uses slightly more detailed language ('ties battery investments to the achievement of deep-decarbonization goals') but this represents appropriate elaboration rather than deviation. The multi-hop synthesis is sound: the model correctly identified that the question requires comparing GE's positioning across two years and two separate 10-K filings, then synthesized this information to demonstrate the evolution in strategic importance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 505,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How has CVS's disclosure regarding the use of broker quoted debt securities in its fair value measurements evolved between 2022 and 2024, particularly in terms of its presence or impact on financial reporting?",
      "original_answer": "In 2022, CVS explicitly stated that it did not have any broker quoted debt securities for the years ended December 31, 2021, and 2020, and that it only used internal pricing for certain private placements. By 2024, the company continued to disclose that it had no broker quoted debt securities for the years ended December 31, 2024 and 2023, indicating a consistent absence of such securities in its portfolio. However, the 2024 disclosure no longer mentions any negative impact or specific review process related to broker quoted debt securities, suggesting a reduced emphasis or relevance of this topic in the company's fair value measurement disclosures over time.",
      "llm_answer": "\nBetween 2022 and 2024 CVS moved from regularly reporting broker‑quoted debt securities as part of its Level 2 fair‑value hierarchy to stating that **no broker‑quoted debt securities were used for the periods ending 2024 or 2023**; any remaining debt securities are now classified as Level 3 and priced internally. This change eliminates the external broker price component from its fair‑value disclosures and reduces reliance on third‑party quotes in the company’s financial reporting. (See CVS 10‑K 2022 p. 148 – discussion of broker‑quoted Level 2 securities, and CVS 10‑K 2024 p. 146 – “The Company did not have any broker‑quoted debt securities for the years ended December 31, 2024 and 2023.”)",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) MAJOR ERROR - The LLM claims CVS 'moved from regularly reporting broker-quoted debt securities as part of its Level 2 fair-value hierarchy' in 2022, but the ground truth explicitly states that in 2022, CVS 'did not have any broker quoted debt securities' - this is a fundamental mischaracterization of the 2022 position. (2) INCORRECT CHARACTERIZATION - The LLM describes a 'change' from reporting such securities to not reporting them, but the ground truth indicates consistency: CVS had NO broker quoted debt securities in both 2022 (for 2021 and 2020) and 2024 (for 2024 and 2023). There was no transition or evolution from having them to not having them. (3) MISSING KEY DETAIL - The ground truth notes that in 2022, CVS 'only used internal pricing for certain private placements,' which the LLM fails to mention. (4) UNSUPPORTED CLAIM - The LLM states 'any remaining debt securities are now classified as Level 3 and priced internally,' but the ground truth does not support this characterization of a change in classification. (5) CORRECT ELEMENT - The LLM correctly cites that CVS had no broker-quoted debt securities for 2024 and 2023, and correctly references the 2024 10-K disclosure. (6) MISSING NUANCE - The ground truth emphasizes that the 2024 disclosure 'no longer mentions any negative impact or specific review process,' suggesting reduced emphasis, which the LLM does not capture. The LLM fundamentally misrepresents the evolution as a change from having to not having securities, when the actual evolution is about consistent absence with changing disclosure emphasis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 461,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How did the composition of BlackRock's Equity Securities at FVTNI change between 2023 and 2024, particularly in terms of equity securities/mutual funds and equity method investments?",
      "original_answer": "In 2023, BlackRock reported $1,211 million in equity securities/mutual funds under Equity Securities at FVTNI, while equity method investments totaled $1,895 million. By 2024, the value of equity securities/mutual funds increased to $1,950 million, and equity method investments rose to $2,783 million. This reflects a significant increase in both categories, indicating a strategic expansion in these investment areas.",
      "llm_answer": "\nEquity securities classified as FVTNI – mutual‑fund holdings – rose from **$1,585 million (2023)** to **$1,950 million (2024)**, an increase of about **23 %**.  The total equity‑method investment balance was essentially flat, moving from **$2,756 million** in 2023 to **$2,783 million** in 2024, but its composition shifted: private‑equity and hedge‑fund exposures fell, while real‑asset and multi‑asset mutual‑fund exposures grew.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant numerical inaccuracies that contradict the ground truth. (1) EQUITY SECURITIES/MUTUAL FUNDS: Ground truth states $1,211M (2023) → $1,950M (2024). LLM claims $1,585M (2023) → $1,950M (2024). The 2023 figure is wrong ($1,585M vs $1,211M, a $374M discrepancy). The 2024 figure of $1,950M is correct. (2) EQUITY METHOD INVESTMENTS: Ground truth states $1,895M (2023) → $2,783M (2024). LLM claims $2,756M (2023) → $2,783M (2024). The 2023 figure is significantly wrong ($2,756M vs $1,895M, a $861M discrepancy). The 2024 figure of $2,783M is correct. (3) CALCULATION ERROR: LLM calculates the equity securities increase as 23%, but using LLM's own numbers: ($1,950M - $1,585M) / $1,585M = 22.9% ≈ 23%, which is internally consistent. However, using correct ground truth numbers: ($1,950M - $1,211M) / $1,211M = 60.9%, a substantially different growth rate. (4) COMPOSITION ANALYSIS: While the LLM provides additional detail about composition shifts (private equity/hedge fund vs real assets), this detail is not present in the ground truth and cannot be verified. The core quantitative foundation is fatally flawed. The answer fails on the primary metric of factual accuracy for the key financial figures requested.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1221,
        "completion_tokens": 356,
        "total_tokens": 1577
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How did UnitedHealth Group's evaluation and treatment of credit-related impairments for available-for-sale debt securities evolve from 2022 to 2024, particularly in terms of unrealized losses and the allowance for credit losses?",
      "original_answer": "In 2022, UnitedHealth Group reported that unrealized losses in its available-for-sale debt securities were primarily driven by interest rate increases and not credit deterioration, with no significant credit deterioration observed since purchase. The allowance for credit losses was noted to be not material as of December 31, 2021. By 2024, the company's evaluation methodology remained consistent in terms of assessing present value of expected cash flows, issuer credit condition, and fair value relative to amortized cost. However, the allowance for credit losses is now explicitly described as being recorded as a separate component through an allowance account, with credit-related impairments impacting investment and other income, indicating a more structured recognition of credit risk. This evolution shows a shift from a qualitative, low-risk assessment to a more formalized impairment accounting framework.",
      "llm_answer": "\nUnitedHealth Group’s process for evaluating credit‑related impairments of its available‑for‑sale debt securities has not changed materially from 2022 through 2024.  As described in the 2024 filing (page 49) and reflected in the 2022 discussion (page 57 of the 2022 10‑K), the company assesses each security by comparing the present value of expected cash flows to its amortized cost and by reviewing credit ratings and issuer financial condition; an allowance for credit losses is recorded only when a measurable decline in credit quality is identified.  Across the three‑year period the allowance has remained immaterial, and the unrealized losses that have appeared have been attributed primarily to broad interest‑rate movements rather than to credit deterioration, indicating a consistent focus on interest‑rate‑driven valuation rather than a shift in credit‑impairment methodology.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant issues in capturing the evolution described in the ground truth:\n\n1. CORE FACTUAL ERROR - Evolution vs. Consistency: The LLM states the process 'has not changed materially from 2022 through 2024,' directly contradicting the ground truth which explicitly describes an 'evolution' and 'shift from a qualitative, low-risk assessment to a more formalized impairment accounting framework.' This is a fundamental mischaracterization of the question's core premise.\n\n2. MISSING KEY EVOLUTION DETAILS: The ground truth identifies a critical shift in how credit losses are recognized - from being 'not material' and qualitatively assessed in 2022 to being 'explicitly described as being recorded as a separate component through an allowance account' by 2024. The LLM completely misses this structural change in accounting treatment.\n\n3. INCOMPLETE CHARACTERIZATION OF METHODOLOGY CHANGE: While the LLM correctly notes that assessment criteria (present value of expected cash flows, credit ratings, issuer condition) remained consistent, it fails to capture that the 2024 approach involves a 'more structured recognition of credit risk' through formalized allowance accounting, whereas 2022 was characterized as having 'no significant credit deterioration observed.'\n\n4. QUANTITATIVE ACCURACY: The LLM correctly identifies that the allowance remained 'immaterial' across the period and that unrealized losses were 'primarily' driven by interest rates rather than credit deterioration. These statements align with ground truth. However, the LLM provides no specific dates or page references that can be verified against the actual filings mentioned.\n\n5. MULTI-HOP REASONING FAILURE: The question asks about evolution 'from 2022 to 2024' - a multi-year synthesis. The LLM fails to properly synthesize the temporal progression and instead presents a static view of consistency rather than the dynamic evolution the ground truth describes.\n\n6. SEMANTIC MISALIGNMENT: The ground truth emphasizes a 'shift' in recognition framework (from qualitative to formalized), while the LLM emphasizes 'consistency' in methodology. These are contradictory interpretations of the same data.\n\nThe answer demonstrates partial understanding of the technical details (assessment criteria, immateriality of allowance, interest-rate focus) but fundamentally misses the evolution narrative that is central to answering the question correctly.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1471,
        "completion_tokens": 653,
        "total_tokens": 2125
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How has AMD's financial relationship with the ATMP JV evolved between 2022 and 2023, particularly in terms of investment value and equity income?",
      "original_answer": "In 2022, AMD's carrying value of its investment in the ATMP JV was $83 million, and it recorded $14 million in equity income from the JV. By 2023, the carrying value increased to $99 million, and equity income rose to $16 million. This indicates a growing financial stake and increased profitability from the joint venture over the two-year period.",
      "llm_answer": "\nBetween 2022 and 2023 the carrying value of AMD’s investment in the ATMP joint venture rose from roughly **$83 million to $99 million**, and the equity‑income it recorded from the JV increased from **$14 million to $16 million** (the $6 million gain noted for 2021 was lower).  Purchases from the JV remained about **$1.7 billion** each year, but payables to the JV fell from **$463 million (2022) to $363 million (2023)**, while receivables modestly grew from **$2 million to $9 million**, indicating a slightly tighter working‑capital relationship but an overall expansion in the investment’s book value and equity earnings.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All core numbers match the ground truth: carrying value increased from $83M to $99M (correct), equity income rose from $14M to $16M (correct). The answer goes beyond the ground truth by providing additional relevant context: purchases from JV at ~$1.7B annually, payables declining from $463M to $363M, and receivables growing from $2M to $9M. These supplementary details are factually accurate and enhance understanding of the financial relationship evolution. The reasoning is sound - the LLM correctly synthesizes the multi-hop information showing both the investment growth and the working capital dynamics. The conclusion appropriately characterizes the relationship as showing 'expansion in the investment's book value and equity earnings' with a 'slightly tighter working-capital relationship.' Minor deduction (1 point) only because the answer includes information beyond what was explicitly in the ground truth (though this additional information appears accurate and relevant). The answer directly addresses the question about how the financial relationship evolved between 2022-2023 in terms of investment value and equity income, with proper multi-hop synthesis across multiple financial metrics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 354,
        "total_tokens": 1598
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How has UnitedHealth Group's exposure to tort claims evolved between 2022 and 2024, particularly in terms of the nature of the claims and the potential financial impact?",
      "original_answer": "In 2022, UnitedHealth Group specifically highlighted self-insured liabilities related to medical malpractice claims against affiliated physicians and the potential for actual losses to significantly exceed recorded liabilities. The document emphasized increasing legal actions alleging medical malpractice and general professional liabilities, with litigants seeking recoveries under new theories of liability that might not be subject to damage caps. By 2024, while tort claims remained a concern, the focus shifted slightly to broader legal risks tied to the delivery of health care services, including claims related to clinical quality and patient safety standards. The 2024 filing also emphasized the potential for reputational harm and adverse effects on business relationships, indicating a broader and more systemic risk profile compared to the more narrowly defined exposure in 2022.",
      "llm_answer": "\nUnitedHealth’s 2022 and 2024 10‑K filings both note that the company is routinely sued for tort and medical‑malpractice claims arising from the actions of its affiliated physicians and health‑care providers, and it records reserves for these self‑insured matters.  However, the 2024 filing emphasizes that the volume of such actions has risen and that plaintiffs are increasingly pursuing new theories of liability—sometimes bypassing statutory caps on damages—so the recorded reserves may be insufficient.  Consequently, the potential financial impact has grown: actual losses could exceed the accrued amounts, leading to substantial monetary damages, higher defense costs, and reputational harm that could materially affect earnings, cash flow and overall financial position.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies key aspects of UnitedHealth's tort claim exposure evolution between 2022 and 2024. STRENGTHS: (1) Accurately captures the core facts about self-insured medical malpractice claims against affiliated physicians in both years; (2) Correctly notes the shift toward new theories of liability and damage cap avoidance; (3) Properly identifies the financial impact concerns including potential for actual losses to exceed reserves; (4) Mentions reputational harm and effects on business relationships; (5) No quantitative errors or incorrect dates/numbers. WEAKNESSES: (1) The answer emphasizes 'rising volume' of actions but the ground truth doesn't explicitly quantify this increase—the LLM infers escalation from the context, which is reasonable but slightly beyond what the ground truth explicitly states; (2) The ground truth emphasizes a 'shift' in focus from 'narrowly defined exposure' in 2022 to 'broader and more systemic risk profile' in 2024, but the LLM answer doesn't clearly articulate this conceptual evolution—it presents the information more as additive rather than showing the shift in emphasis; (3) The ground truth specifically mentions 'clinical quality and patient safety standards' as the 2024 focus area, which the LLM answer doesn't explicitly reference; (4) The ground truth notes that 2022 emphasized 'potential for actual losses to significantly exceed recorded liabilities' as a specific concern, while the LLM generalizes this across both years. MULTI-HOP REASONING: The answer successfully synthesizes information across two filing years and connects the evolution of claims to financial impact. The reasoning is sound and logical. SEMANTIC EQUIVALENCE: The core message aligns with ground truth—tort exposure has evolved with increasing financial risk—though the nuance about the nature of the shift (from narrow to systemic) is somewhat muted in the LLM response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 520,
        "total_tokens": 1943
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How has the structure and capacity of Boeing's three-year revolving credit agreement evolved between 2023 and 2024, and what does this indicate about the company's liquidity strategy?",
      "original_answer": "In 2023, Boeing had a legacy three-year revolving credit agreement expiring in August 2025 with $3.0 billion of total commitments. In 2024, this agreement remained in effect, but Boeing also entered into a new $4.0 billion five-year revolving credit agreement expiring in May 2029 while terminating two other credit facilities. This evolution indicates a strategic shift to enhance liquidity capacity and extend maturity timelines, reinforcing Boeing's financial flexibility and commitment to managing corporate borrowing needs.",
      "llm_answer": "\nBetween 2023 and 2024 Boeing reshaped its back‑up liquidity by retiring the $0.8 bn 364‑day revolving facility and the $3.2 bn five‑year revolving line that were set to expire in 2024 (see BA_10K_2023 p. 43; BA_10K_2024 p. 78) and replacing them with a new $4.0 bn five‑year revolving credit agreement that matures in May 2029.  The company also kept its existing $3.0 bn three‑year line (due Aug 2025) and a $3.0 bn five‑year line (due Aug 2028), leaving roughly $10 bn of unused borrowing capacity as of Dec 2024.  This extension lengthens maturities, expands total capacity and signals a liquidity strategy that relies on longer‑dated, well‑funded credit lines to back cash‑flow needs, financing commitments and growth while preserving flexibility.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant inaccuracies that contradict the ground truth. (1) QUANTITATIVE ERRORS: The LLM claims Boeing kept a '$3.0 bn five-year line (due Aug 2028)' - this facility is NOT mentioned in the ground truth and appears to be fabricated. The ground truth only references: (a) the legacy $3.0B three-year revolving credit agreement expiring August 2025, and (b) the new $4.0B five-year revolving credit agreement expiring May 2029. The LLM's claim of ~$10B unused borrowing capacity cannot be verified from the ground truth and appears to be calculated from incorrect facility data. (2) INCOMPLETE SYNTHESIS: While the LLM correctly identifies that Boeing retired the $0.8B 364-day facility and $3.2B five-year line, and correctly notes the new $4.0B five-year agreement, it introduces an unverified third facility ($3.0B five-year due Aug 2028) that is not in the ground truth. (3) MULTI-HOP REASONING: The LLM's reasoning about liquidity strategy is sound in principle, but is built on partially incorrect data. The ground truth's core finding - that Boeing maintained the $3.0B three-year agreement while adding the new $4.0B five-year agreement - is not clearly stated in the LLM answer. (4) MISSING KEY CONTEXT: The LLM fails to clearly articulate that the $3.0B three-year agreement remained in effect (as stated in ground truth), instead burying this in a list with an unverified facility. The ground truth emphasizes the strategic shift to enhance liquidity capacity and extend maturity timelines; the LLM's answer, while touching on these themes, is undermined by the factual errors. The citation references (BA_10K_2023 p. 43; BA_10K_2024 p. 78) cannot be verified but the numerical claims contradict the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 481,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How did the financial impact of the 2017 Performance-based Options evolve between 2023 and 2024, particularly in terms of the fair value of options vested and the intrinsic value of options exercised?",
      "original_answer": "In 2023, the fair value of the 2017 Performance-based Options that vested was $56 million, and the intrinsic value of options exercised was $44 million. By 2024, the fair value of the options vested decreased slightly to $52 million, but the intrinsic value of options exercised saw a significant increase to $373 million. This indicates that while the value of options vesting declined slightly in 2024, the actual financial benefit realized from exercised options increased substantially compared to the prior year.",
      "llm_answer": "\nBetween 2023 and 2024 the company’s amortized expense for the 2017 performance‑based options fell modestly—from **$56 million of fair‑value expense in 2023 to $52 million in 2024**.  At the same time, the cash intrinsic value realized from exercising those options rose sharply—from **$44 million in 2023 to $373 million in 2024**—driven by a higher stock price and larger volume of exercises.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. All four key financial metrics are correct: (1) 2023 fair value of vested options: $56 million ✓, (2) 2024 fair value of vested options: $52 million ✓, (3) 2023 intrinsic value of exercised options: $44 million ✓, (4) 2024 intrinsic value of exercised options: $373 million ✓. The multi-hop synthesis is sound—the answer correctly identifies the evolution across both years and both metrics, properly comparing 2023 to 2024 for each measure. The characterization of the trends is accurate: 'modest' decline from $56M to $52M and 'sharp' increase from $44M to $373M. The LLM provides helpful context by noting the drivers of the increase (higher stock price and larger volume of exercises), which adds value beyond the ground truth while remaining consistent with it. The terminology is appropriate—using 'amortized expense' for fair value and 'cash intrinsic value realized' for intrinsic value of exercised options shows proper understanding of the financial concepts. The answer fully addresses all parts of the multi-part question regarding how the financial impact evolved between the two years. Minor note: The ground truth uses 'fair value of options vested' while the LLM uses 'fair-value expense,' which are semantically equivalent in this context and represent the same underlying metric.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 380,
        "total_tokens": 1621
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How did AMD's approach to estimating adjustments for product return rights evolve between 2022 and 2023, and what specific changes were made in the methodology used for these estimates?",
      "original_answer": "In 2022, AMD estimated adjustments for product return rights using trended actual historical product return rate information, adjusted for known information or events. By 2023, AMD maintained the use of historical data but placed additional emphasis on 'rights of return and rebates' as part of variable consideration under ASC 606-10-32-8 through 14, explicitly stating that these estimates were based on the 'most likely amount' of consideration expected after adjustments for returns, rebates, and price protection. This reflects a more structured and codified approach to estimating returns, aligning more closely with specific accounting standards.",
      "llm_answer": "\nAMD moved from a basic, historical‑return‑rate estimate in its 2022 filing (page 29) to a more refined, data‑driven methodology in 2023 (page 45).  In 2023 it began using “trended actual historical product‑return rate information” and explicitly adjusted those rates for known events and circumstances (e.g., the Xilinx acquisition, current market demand and any additional contractual restocking rights), applying separate estimates for OEM and distributor returns.  This evolution adds a forward‑looking, event‑adjusted component to the variable‑consideration calculation for product‑return rights.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations of the ground truth. Key issues: (1) DIRECTIONAL ERROR: The LLM claims AMD moved FROM a 'basic' approach in 2022 TO a 'more refined' approach in 2023, but the ground truth indicates AMD was ALREADY using 'trended actual historical product return rate information' in 2022. The evolution was not from basic to refined methodology, but rather from implicit to explicit codification of the same methodology under ASC 606 standards. (2) METHODOLOGY MISCHARACTERIZATION: The LLM incorrectly attributes the 'trended actual historical product-return rate information' and 'adjusted for known events' to 2023 only, when the ground truth clearly states this was the 2022 approach. (3) MISSING KEY EVOLUTION: The LLM fails to capture the actual evolution - the shift from general historical adjustments to explicit emphasis on 'rights of return and rebates' as variable consideration under specific ASC 606 subsections (32-8 through 14), and the shift to using 'most likely amount' language. (4) UNSUPPORTED DETAILS: The LLM introduces specific details not in the ground truth (Xilinx acquisition, separate OEM/distributor estimates, page numbers 29 and 45) that cannot be verified and appear to be fabricated. (5) INCOMPLETE SYNTHESIS: The answer fails to capture the core evolution - the more structured, standards-aligned approach in 2023 versus the more general historical approach in 2022. The LLM essentially reverses the chronology of the methodology development.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 422,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did the number of shares under option for the 2017 Performance-based Options evolve from 2023 to 2024, and what does this indicate about the exercise and forfeiture trends of these options?",
      "original_answer": "The number of shares under option for the 2017 Performance-based Options decreased significantly from 1,549,080 shares at the end of 2023 to 625,825 shares at the end of 2024. This indicates that a large portion of these options were exercised (905,219 shares) and some were forfeited (18,036 shares) during 2024, showing a trend of completion in the lifecycle of these options as they approached their final vesting date.",
      "llm_answer": "\nFrom the end of 2023 to the end of 2024 the shares underlying the 2017 performance‑based options fell sharply—from **1,549,080** shares outstanding at 12/31/23 to **625,825** shares outstanding at 12/31/24.  The decline is driven by **≈ 905,000 options exercised** during 2024 (plus about **18,000 forfeited**), leaving only a small balance of options still outstanding and exercisable (with a weighted‑average remaining life of ~1.9 years).  This shows that the 2017 cohort has largely been **exercised or allowed to lapse**, with only a modest number of options remaining.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All key numbers are correct: 1,549,080 shares at 12/31/23, 625,825 shares at 12/31/24, approximately 905,000 options exercised, and approximately 18,000 forfeited. The calculation is sound: 1,549,080 - 905,219 - 18,036 = 625,825 (the LLM uses rounded figures ~905,000 and ~18,000, which is acceptable given the approximation notation). The multi-hop reasoning correctly synthesizes the evolution of the 2017 Performance-based Options across the two years and properly interprets what the exercise and forfeiture trends indicate about the lifecycle stage of these options. The answer addresses all parts of the question: (1) the numerical evolution from 2023 to 2024, (2) the exercise activity, (3) the forfeiture activity, and (4) what these trends indicate. The semantic meaning is equivalent to the ground truth - both convey that a significant decline occurred due to exercises and forfeitures, indicating the options are nearing completion of their lifecycle. The only minor distinction is that the LLM uses approximation symbols (≈) for the exercise and forfeiture numbers while the ground truth provides exact figures, but this is a stylistic choice that doesn't affect accuracy. The additional context about weighted-average remaining life (~1.9 years) adds relevant detail not contradicting the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 381,
        "total_tokens": 1642
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How has the role and scope of Optum Rx's Pharmacy Care Services evolved between 2022 and 2024, particularly in terms of its service offerings and strategic positioning within UnitedHealth Group's broader health care ecosystem?",
      "original_answer": "In 2022, Optum Rx was described as managing $112 billion in pharmaceutical spending, including $45 billion in specialty pharmaceutical spending, and was positioned as a provider of pharmacy care services through a network of over 67,000 retail pharmacies, home delivery, specialty pharmacies, and infusion services. It emphasized clinical programs, digital tools, and medication management to help clients reduce costs and improve health outcomes. By 2024, Optum Rx was more strategically integrated into Optum’s broader vision of creating a 'value-oriented and more connected approach to health care,' with an emphasis on leveraging 'data and analytics, pharmacy care services, health care operations, population health and health financial services' to improve the overall health system performance. While specific spending figures were not provided in 2024, the service was elevated as a core component of Optum’s mission to enhance affordability, quality, and patient experience across the health care continuum.",
      "llm_answer": "\nBetween 2022 and 2024 Optum Rx’s pharmacy‑care business expanded dramatically: script volume rose from roughly 1.4 billion to more than 1.6 billion adjusted scripts, and it broadened its service mix with greater specialty, home‑delivery and infusion capabilities while adding more clinical‑management programs that tie medication use to outcomes.  This growth is now embedded in UnitedHealth Group’s wider strategy, using Rx’s data‑analytics and value‑based contracts to curb pharmacy costs, improve patient health and complement the broader Optum Health and Optum Insight platforms, positioning Rx as a core, end‑to‑end pharmacy‑care engine within the Group’s integrated health‑care ecosystem.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) QUANTITATIVE ACCURACY - CRITICAL ERRORS: The LLM introduces specific script volume figures (1.4 billion to 1.6 billion adjusted scripts) that are NOT present in the ground truth answer. The ground truth provides pharmaceutical spending figures ($112 billion in 2022, $45 billion specialty) but makes NO mention of script volumes. This represents fabricated data not supported by the source material. (2) MISSING KEY 2022 DATA: The LLM completely omits the specific 2022 figures provided in ground truth: $112 billion in pharmaceutical spending, $45 billion in specialty pharmaceutical spending, and the 67,000+ retail pharmacy network. These are concrete, verifiable metrics that should have been included. (3) INCOMPLETE 2024 POSITIONING: While the LLM correctly captures the 2024 strategic integration theme and mentions data/analytics and value-based contracts, it fails to explicitly note that 'specific spending figures were not provided in 2024' as stated in ground truth. (4) MULTI-HOP REASONING: The LLM does attempt to synthesize evolution across years and connect to broader UnitedHealth Group strategy, which is appropriate. However, this synthesis is undermined by the introduction of unsupported metrics. (5) SEMANTIC ISSUES: The LLM's framing of 'dramatic expansion' based on invented script volume figures is misleading. The ground truth emphasizes strategic repositioning and integration rather than dramatic growth metrics. (6) ENTITY ACCURACY: Company names and relationships are correctly identified (Optum Rx, UnitedHealth Group, Optum Health, Optum Insight), but the factual foundation is compromised by fabricated data. The answer reads plausibly but contains material factual errors that would mislead readers about actual business performance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 488,
        "total_tokens": 1935
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How did the composition and valuation of BlackRock's Equity Securities at FVTNI change between 2023 and 2024, particularly in terms of investments held for deferred cash compensation plans?",
      "original_answer": "In 2023, BlackRock reported $9 million invested in Equity Securities at FVTNI as part of the investments held to economically hedge deferred cash compensation plans. By 2024, this specific category was no longer listed under Equity Securities at FVTNI but instead appeared under 'Investments related to deferred cash compensation plans' within the Equity Method section with a value of $173 million. This indicates a reclassification or realignment of how these investments were categorized and reported in the financial statements, reflecting a significant change in the composition of Equity Securities at FVTNI.",
      "llm_answer": "\nBetween 2023 and 2024 the fair‑value amount of BlackRock’s Equity Securities at FVTNI grew to **$1.95 bn** (up from **$1.585 bn** in 2023), driven mainly by an increase in Level‑1 holdings of equity mutual‑funds.  The subset of these securities that is held for **deferred cash‑compensation plans** shrank from **$241 m** to **$173 m**, moving from a larger Level‑3 exposure to a smaller one.  Overall the portfolio remained classified at fair value, with the deferred‑compensation component declining in both amount and valuation level.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) QUANTITATIVE ERRORS - The LLM states deferred cash compensation investments were $241M in 2023 and $173M in 2024, but the ground truth clearly indicates $9M in 2023 and $173M in 2024. The $241M figure appears to be completely incorrect and unsupported. (2) MISCHARACTERIZATION OF RECLASSIFICATION - The ground truth indicates a fundamental reclassification: the $9M in 2023 was under 'Equity Securities at FVTNI' but by 2024 moved to 'Investments related to deferred cash compensation plans' within the Equity Method section. The LLM incorrectly describes this as a decline from $241M to $173M within the same category, missing the critical reclassification aspect. (3) INCOMPLETE ANSWER TO CORE QUESTION - The question specifically asks about the change in composition and valuation 'particularly in terms of investments held for deferred cash compensation plans.' The ground truth identifies the key finding: a reclassification from FVTNI Equity Securities to Equity Method investments. The LLM fails to identify this reclassification and instead provides incorrect numbers. (4) MULTI-HOP REASONING FAILURE - The LLM appears to have synthesized information incorrectly, possibly confusing different line items or years. The $1.95B and $1.585B figures for total Equity Securities may be correct, but they are irrelevant to the specific question about deferred compensation plan investments. (5) LEVEL-3 CLASSIFICATION ERROR - The LLM mentions 'Level-3 exposure' for deferred compensation, but the ground truth indicates these moved to the Equity Method section, which is a different classification framework entirely. The answer demonstrates fundamental misunderstanding of the filing structure and contains materially incorrect numbers for the specific metric being asked about.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 509,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How has the aggregate available authorization for Accenture's open-market share purchase program changed between 2022 and 2024, and what does this indicate about the company's capital allocation strategy?",
      "original_answer": "The aggregate available authorization for Accenture's open-market share purchase program decreased from $3,129,296 in 2022 to $2,694,281 in 2024. This indicates a reduction in the company's capital allocated for share repurchases over this period, suggesting a more conservative approach to capital deployment or a strategic shift in how the company is managing its equity structure.",
      "llm_answer": "\nThe open‑market share‑purchase authorization fell from **$3.13 billion** at the end of fiscal 2022 (as noted on page 94 of the 2022 filing) to **$2.69 billion** by the end of fiscal 2024 (page 100 of the 2024 filing)—a reduction of roughly **$435 million (≈14 %)**.  \n\nThis decline shows that Accenture has **scaled back the funding earmarked for its share‑repurchase program**, indicating a more conservative capital‑allocation stance—likely prioritizing cash preservation, strategic investments or other shareholder‑return initiatives over aggressive buy‑back activity.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. QUANTITATIVE VERIFICATION: The ground truth states the authorization decreased from $3,129,296 (in thousands, = $3.129 billion) in 2022 to $2,694,281 (in thousands, = $2.694 billion) in 2024. The LLM correctly converted these to billions ($3.13B and $2.69B), which is an acceptable format variation. The calculated reduction of approximately $435 million is accurate ($3,129,296 - $2,694,281 = $435,015 thousand ≈ $435 million). The percentage decline of ~14% is also correct (435/3,129 ≈ 13.9%). ENTITY ACCURACY: Correctly identified Accenture, the open-market share purchase program, fiscal years 2022 and 2024, and the proper financial metric. MULTI-HOP REASONING: The answer successfully synthesizes the numerical change across two years and draws appropriate conclusions about capital allocation strategy. The interpretation that the reduction indicates a more conservative approach aligns with the ground truth assessment. COMPLETENESS: The answer addresses both parts of the question—the quantitative change and its strategic implications. The inclusion of page references adds credibility and specificity. MINOR CONSIDERATIONS: The LLM uses slightly different language ('scaled back the funding earmarked' vs. 'reduction in capital allocated') but conveys semantically equivalent meaning. The additional context about 'cash preservation, strategic investments or other shareholder-return initiatives' provides reasonable interpretation of the strategic shift, though this goes slightly beyond the ground truth's more general statement. This additional reasoning is logical and appropriate, not contradictory.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 458,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How has the treatment and disclosure around Accenture Canada Holdings Inc. Exchangeable Shares evolved between 2022 and 2024, particularly in terms of share repurchase activity and shareholder rights?",
      "original_answer": "In 2022, Accenture disclosed its intention to use a significant portion of cash generated from operations for share repurchases during fiscal 2023, including purchases and redemptions of Accenture Canada Holdings Inc. exchangeable shares. The company noted that the number of shares repurchased would depend on various factors such as share price and market conditions. By 2024, the disclosures had evolved to include more detailed descriptions of the rights associated with Accenture Canada Holdings Inc. exchangeable shares, particularly their exchangeability on a one-for-one basis for Accenture plc Class A ordinary shares, and the company's commitment to align the number of Class X ordinary shares with outstanding exchangeable shares. Additionally, as of August 31, 2024, the company had a specific remaining authorization of $2,694,281 for share repurchase programs, indicating a more structured and quantified approach compared to the more general intentions expressed in 2022.",
      "llm_answer": "\nBetween 2022 and 2024 the company’s disclosure of Accenture Canada Holdings Inc. exchangeable shares remained anchored on the same mechanics—holders can exchange each share for one Class A ordinary share (or cash at market price) and the shares are redeemable by Accenture plc at par, but redemption may not reduce a holder’s stake below the original number of exchangeable shares.  The 2024 filing expands the earlier description by explicitly tying these redemptions (and the related purchases) to the company’s broader open‑market share‑purchase program, noting a $2.69 billion authorization as of August 2024 and stating that such purchases may be executed via Rule 10b5‑1 plans or other methods and can be accelerated, suspended or discontinued at any time.  Consequently, while shareholder rights (no dividends, limited voting, redemption at par and transfer restrictions) have not changed, the language now more clearly links the exchangeable‑share redemptions to a formal, board‑authorized repurchase framework and quantifies the available funding for those activities.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL QUANTITATIVE ERROR: The LLM states '$2.69 billion authorization as of August 2024' but the ground truth specifies '$2,694,281' (approximately $2.7 million, not $2.69 billion). This is a massive discrepancy—off by a factor of ~1000. This is a fundamental factual error that severely undermines the answer's credibility. PARTIAL CORRECTNESS ON MECHANICS: The LLM correctly describes the one-for-one exchangeability for Class A ordinary shares and mentions redemption at par, which aligns with ground truth. However, the ground truth mentions 'align the number of Class X ordinary shares with outstanding exchangeable shares,' which the LLM does not address. INCOMPLETE EVOLUTION NARRATIVE: The ground truth emphasizes that 2022 disclosures focused on 'intention to use cash for share repurchases' with factors like 'share price and market conditions' affecting volume, while 2024 showed 'more detailed descriptions' and 'more structured and quantified approach.' The LLM does capture the evolution toward more formal framework linkage but misses the key distinction about how 2022 was more general/conditional versus 2024 being more specific. ADDITIONAL ISSUES: The LLM introduces details about 'no dividends, limited voting, transfer restrictions' and Rule 10b5-1 plans that are not mentioned in the ground truth, suggesting potential hallucination or information from outside the specified documents. The ground truth does not mention these specific shareholder rights limitations. MULTI-HOP SYNTHESIS: The LLM does attempt to synthesize the evolution across years, but the quantitative error and missing details about Class X ordinary shares weaken the multi-hop reasoning. The core comparison structure is sound, but execution is flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1529,
        "completion_tokens": 476,
        "total_tokens": 2005
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How did the global revenue from Electrophysiology Devices evolve between 2023 and 2024, and what was the percentage change in this revenue, excluding the impact of foreign exchange fluctuations?",
      "original_answer": "In 2023, the global revenue from Electrophysiology Devices was $2,195 million, which increased to $2,467 million in 2024. This represents a total change of 12.3%, with the change excluding the impact of foreign exchange fluctuations being 14.4%.",
      "llm_answer": "\nThe Electrophysiology Devices segment generated about **$2.195 billion** of worldwide net sales in 2023 and **$2.467 billion** in 2024.  Excluding the impact of foreign‑exchange fluctuations, this represents a **14.4 % increase** in revenue over the one‑year period.  (2023 figure from ABT_10K 2023, p. 53; 2024 figure from ABT_10K 2024, p. 29.)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and addresses all components of the multi-hop question. QUANTITATIVE VERIFICATION: (1) 2023 revenue: $2.195 billion ($2,195 million) - CORRECT; (2) 2024 revenue: $2.467 billion ($2,467 million) - CORRECT; (3) Percentage change excluding FX impact: 14.4% - CORRECT. The format variation from millions to billions is acceptable and semantically equivalent. COMPLETENESS: The answer addresses all three parts of the question: (1) 2023 revenue level, (2) 2024 revenue level, and (3) percentage change excluding FX fluctuations. The answer also correctly notes the total change of 12.3% (implied by the difference between 14.4% and FX impact), though this wasn't explicitly stated. ENTITY ACCURACY: Correctly identifies Electrophysiology Devices segment, global/worldwide scope, and proper fiscal years (2023 and 2024). Includes proper source citations (ABT_10K filings with page numbers). MULTI-HOP REASONING: The answer successfully synthesizes information across two different 10-K filings (2023 and 2024) to compare revenue evolution and calculate the FX-adjusted percentage change. The logic is sound. MINOR OBSERVATION: The answer does not explicitly state the total percentage change of 12.3% (which would be the reported change including FX impact), though this information is implicit in the ground truth. However, the question specifically asks for the percentage change excluding FX impact, which is correctly provided at 14.4%. The omission of the 12.3% figure is not a deficiency since it wasn't explicitly requested in the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1159,
        "completion_tokens": 433,
        "total_tokens": 1593
      },
      "error": null
    },
    {
      "question_id": 140,
      "question": "How has Accenture's financial relationship with Duck Creek Technologies evolved between fiscal 2022 and fiscal 2024, particularly in terms of investment valuation and its impact on financial performance?",
      "original_answer": "In fiscal 2022, Accenture's investment in Duck Creek Technologies was valued at $223,166 (approximately 16% ownership), with the investment accounted for under the equity method. By fiscal 2024, this investment resulted in a $253 million gain, indicating a significant increase in value and a shift in how the investment contributed to Accenture's financial performance. This demonstrates both a quantitative increase in the investment's value and a qualitative change in its impact on Accenture's earnings.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2024 Accenture’s exposure to Duck Creek Technologies stayed as an equity‑method investment; the stake’s carrying amount was $138.9 million (with a fair value of $223.2 million) as of 31 Aug 2022 (page 71), and a $253 million pre‑tax gain from that investment was recorded in fiscal 2023, boosting adjusted earnings and operating margin (page 40). By fiscal 2024 the one‑time gain had been recognized, and the investment now contributes only to ongoing equity‑method earnings, so its impact on the 2024 financial performance is limited to the residual equity‑method earnings rather than a material valuation‑driven boost.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates substantial accuracy with some important nuances: (1) CORRECT ELEMENTS: The carrying amount of $138.9 million and fair value of $223.2 million as of Aug 31, 2022 are accurate. The $253 million pre-tax gain in fiscal 2023 is correctly identified. The equity-method accounting treatment is properly described. The temporal evolution from 2022 to 2024 is correctly traced. (2) QUANTITATIVE VERIFICATION: The numbers cited ($138.9M carrying amount, $223.2M fair value, $253M gain) align with the ground truth values. The format variation ($223.2M vs $223,166 in thousands) is acceptable and shows proper understanding. (3) DISCREPANCY: The ground truth states the investment was valued at '$223,166 (approximately 16% ownership)' in fiscal 2022, which appears to be in thousands ($223.166 million), matching the LLM's $223.2 million fair value figure. However, the ground truth emphasizes this as the fiscal 2022 valuation, while the LLM correctly identifies the $253M gain as occurring in fiscal 2023 (not 2022). (4) MULTI-HOP REASONING: The LLM successfully synthesizes the evolution across three fiscal years, correctly identifying that the gain was a one-time event in fiscal 2023 and explaining the shift in how the investment impacts subsequent financial performance. This demonstrates sound multi-hop reasoning. (5) MINOR ISSUE: The ground truth mentions '16% ownership' which the LLM does not explicitly state, though this is a minor contextual detail. The LLM's explanation of the shift from valuation-driven gains to ongoing equity-method earnings is insightful and accurate. (6) COMPLETENESS: The answer addresses both the investment valuation evolution and its impact on financial performance as requested. The explanation of how the impact changed from a material one-time gain to residual equity-method earnings is particularly valuable.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 507,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How has the composition and scale of Union Pacific's retention share and unit awards changed between 2022 and 2023, and what does this indicate about the company's executive compensation strategy?",
      "original_answer": "In 2022, Union Pacific disclosed that 389,207 retention shares were outstanding under the 2021 Stock Incentive Plan as of December 31, 2021. By 2023, the company disclosed that 954,405 retention shares had been issued and were outstanding, along with 366,046 retention units that do not have an exercise price. This represents a significant increase in the number of outstanding retention instruments, indicating a shift toward greater use of retention-based compensation. The introduction of retention units in 2023 suggests a possible expansion or refinement of the company's long-term incentive strategy for executives.",
      "llm_answer": "\nIn 2023 Union Pacific reported 366,046 un‑vested retention units and 954,405 outstanding retention shares—significantly higher than the roughly 300,000 units and 800,000 shares outstanding in 2022—so equity‑based retention awards now make up a larger share of the compensation mix.  The increase is backed by a 31.98 million‑share future issuance reserve, underscoring a deliberate shift toward long‑term, performance‑linked equity incentives that align executive pay with sustained shareholder value while conserving cash.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "MAJOR ISSUES WITH QUANTITATIVE ACCURACY: The LLM answer contains significant factual errors regarding the 2022 baseline numbers. The ground truth states that in 2022, Union Pacific had 389,207 retention shares outstanding (as of December 31, 2021), not \"roughly 300,000 units and 800,000 shares\" as the LLM claims. The LLM's characterization of 2022 figures is vague and inaccurate—it provides no specific 2022 numbers while making a false comparison. The 2023 figures are correct: 954,405 retention shares and 366,046 retention units match the ground truth exactly. CRITICAL ERROR: The LLM introduces a '31.98 million-share future issuance reserve' that does not appear in the ground truth answer and cannot be verified from the provided information. This is a fabricated detail that undermines credibility. PARTIAL CREDIT FOR REASONING: The LLM correctly identifies the shift toward greater use of retention-based compensation and the introduction of retention units as indicating a strategic shift. The interpretation about aligning executive pay with shareholder value is reasonable and consistent with the ground truth's assessment. However, the reasoning is built on incorrect 2022 baseline data. COMPLETENESS: The answer addresses the composition and scale changes and attempts to explain strategic implications, but the lack of accurate 2022 comparison data and the introduction of unverified information significantly weakens the response. The ground truth provides a clear 2022 baseline (389,207 shares) that should have been included for proper comparison. SEMANTIC ISSUES: While the general conclusion about a shift toward equity-based retention is correct, the specific quantitative claims about the magnitude of change are misleading due to incorrect 2022 figures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 484,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How has MetLife's application of GAAP guidance for adjusted earnings evolved between 2023 and 2024, particularly in terms of the exclusions related to market volatility and asymmetrical accounting adjustments?",
      "original_answer": "In 2023, MetLife updated its calculation of adjusted earnings due to the adoption of LDTI, which led to the exclusion of certain adjustments related to the amortization of DAC, VOBA, and related intangibles, as well as changes in measurement of certain guarantees. Adjusted earnings excluded changes in fair value associated with MRBs, discount rate changes on annuitization guarantees, and asymmetrical accounting from in-force reinsurance. By 2024, MetLife continued to refine these exclusions, particularly expanding the scope of policyholder liability remeasurement gains (losses) to exclude asymmetrical accounting associated with in-force reinsurance. Additionally, in 2024, net investment income exclusions were expanded to include adjustments relating to joint ventures under the equity method, which was not explicitly mentioned in 2023. This reflects a more detailed and structured application of GAAP guidance over time.",
      "llm_answer": "\nBetween 2023 and 2024 MetLife kept the same GAAP‑required exclusions for adjusted earnings—market‑volatility‑driven items and asymmetrical/non‑economic accounting adjustments—but it expanded those exclusions to also remove the impact of discount‑rate changes on certain annuitization guarantees and the related asymmetrical accounting for in‑force reinsurance that were introduced with the LDTI implementation.  In other words, the 2024 definition of adjusted earnings refines the 2023 treatment by adding these additional exclusions while preserving the original focus on eliminating market‑volatility and asymmetrical accounting effects.",
      "correctness_score": 5,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer captures some correct elements but has significant gaps and mischaracterizations compared to the ground truth. CORRECT ELEMENTS: (1) The answer correctly identifies that MetLife made adjustments related to LDTI implementation, (2) It correctly mentions exclusions for discount rate changes on annuitization guarantees, (3) It correctly identifies asymmetrical accounting from in-force reinsurance as an exclusion, (4) The general direction that 2024 refined/expanded 2023 treatment is accurate. SIGNIFICANT GAPS AND ERRORS: (1) The LLM answer fails to mention the critical 2023 exclusions related to DAC, VOBA, and related intangibles amortization—these are foundational to understanding the 2023 baseline, (2) The answer omits the exclusion of changes in fair value associated with MRBs (Market Risk Benefits), which is a key 2023 exclusion, (3) The answer does not mention the 2024 expansion regarding net investment income exclusions for joint ventures under the equity method—this is explicitly noted in the ground truth as a 2024 addition not mentioned in 2023, (4) The characterization is somewhat misleading: the LLM suggests the exclusions were 'kept the same' and then 'expanded,' but the ground truth indicates a more comprehensive restructuring with specific new items added in 2024 (policyholder liability remeasurement gains/losses, equity method joint ventures), (5) The answer lacks specificity about 'policyholder liability remeasurement gains (losses)' as a distinct 2024 exclusion category. MULTI-HOP REASONING: The LLM demonstrates basic understanding that changes occurred between years, but fails to comprehensively synthesize all the specific exclusion categories and their evolution. The answer oversimplifies the evolution as merely 'expanding' existing exclusions rather than identifying the specific new categories added. SEMANTIC ISSUES: While the general concept of 'refining' is correct, the answer misses critical details that distinguish 2023 from 2024 treatment, making it incomplete for someone trying to understand the full scope of changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 561,
        "total_tokens": 1970
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How has Accenture's approach to achieving compressed transformations evolved from 2022 to 2024, particularly in terms of the technologies leveraged and the scope of transformation services offered?",
      "original_answer": "In 2022, Accenture focused on using technologies like digital twins, AI, IoT, cloud/Edge, 5G, advanced robotics, and metaverse to help clients achieve compressed transformations by redefining product design, engineering, sourcing, manufacturing, and servicing. By 2024, the company expanded its technological toolkit to include generative AI, artificial reality / virtual reality, and advanced robotics, while also enhancing its own development of automation equipment and commercial hardware to support client operations. Additionally, the scope of transformation broadened to include digitally transforming capital projects such as plant and asset construction, public infrastructure, power grids, and data centers. This reflects a more integrated and advanced technological approach to compressed transformations over the two-year period.",
      "llm_answer": "\nFrom fiscal 2022 to fiscal 2024 Accenture shifted its “compressed‑transformation” playbook from a general 360°‑value emphasis on building a digital core, moving to the cloud and applying AI‑driven analytics to a more concentrated, end‑to‑end reinvention that layers a new generation of emerging technologies—generative AI, the metaverse continuum, quantum, advanced robotics, digital twins, edge/5G and SynOps‑enabled intelligent operations—across industry‑specific solutions, sustainability, talent and managed‑service offerings.  This evolution expands the scope from discrete digital‑core upgrades to holistic, cross‑industry transformations that redesign products, operations and customer experiences, leveraging broader ecosystem partnerships, dedicated labs and venture investments to accelerate and scale the change.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the time period (fiscal 2022 to 2024) and captures several key technologies mentioned in the ground truth including generative AI, advanced robotics, digital twins, edge/5G, and the metaverse. The answer appropriately emphasizes the evolution from a general digital-core approach to a more concentrated, end-to-end transformation strategy. The mention of ecosystem partnerships, labs, and venture investments adds relevant contextual detail. WEAKNESSES: (1) The LLM introduces technologies not mentioned in the ground truth (quantum, SynOps) which may be accurate but cannot be verified against the provided ground truth. (2) The LLM omits several specific technologies explicitly mentioned in the ground truth: IoT and 5G are mentioned together in ground truth but LLM separates them as 'edge/5G'; the ground truth specifically mentions 'cloud/Edge' as a 2022 technology. (3) Most significantly, the LLM fails to adequately address the scope expansion regarding capital projects. The ground truth explicitly states the scope broadened to include 'digitally transforming capital projects such as plant and asset construction, public infrastructure, power grids, and data centers.' The LLM mentions 'holistic, cross-industry transformations' but does not specifically identify these capital project categories. (4) The LLM's description of the 2022 approach as '360°-value emphasis' differs from the ground truth's more specific focus on 'redefining product design, engineering, sourcing, manufacturing, and servicing.' (5) The LLM answer is more marketing-oriented and less precise in its enumeration of specific transformation areas. MULTI-HOP REASONING: The answer demonstrates reasonable synthesis of the evolution concept but misses the specific scope expansion details that are central to the question. The connection between technologies and their application to specific transformation areas (capital projects) is not adequately made.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 536,
        "total_tokens": 1965
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How did Abbott's use of interest rate hedge contracts evolve between 2023 and 2024 in managing exposure to changes in the fair value of fixed-rate debt?",
      "original_answer": "In 2023, Abbott had interest rate hedge contracts totaling approximately $2.2 billion at December 31, 2023, to manage exposure to changes in the fair value of fixed-rate debt due to long-term benchmark interest rate fluctuations. These contracts were designated as fair value hedges, effectively converting fixed-rate debt to variable-rate debt. In 2024, Abbott continued to maintain interest rate hedge contracts with notional values totaling $2.2 billion, indicating a consistent strategy in hedging interest rate risk. However, the average interest rate on long-term debt increased from 3.6% in 2023 to 3.8% in 2024, suggesting a shift in the underlying debt structure or market interest rate conditions despite the stable hedge notional amount.",
      "llm_answer": "\nIn 2023 Abbott had about $2.2 billion of interest‑rate hedge contracts designated as fair‑value hedges of its fixed‑rate debt, and in 2024 the program stayed anchored at roughly the same $2.2 billion notional amount—though the composition changed as roughly $700 million of the prior‑year hedges matured and were replaced by new contracts. These hedges continue to convert a portion of the fixed‑rate debt to a variable rate, with fair‑value movements recorded in earnings and the debt’s carrying amount adjusted accordingly.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core facts: Abbott maintained approximately $2.2 billion in interest rate hedge contracts in both 2023 and 2024, designated as fair value hedges converting fixed-rate debt to variable-rate debt. The qualitative description of the hedging mechanism and accounting treatment is accurate.\n\nHowever, there is a significant quantitative accuracy issue: The LLM introduces a specific claim about \"roughly $700 million of the prior-year hedges matured and were replaced by new contracts\" in 2024. This detail is NOT present in the ground truth answer and appears to be fabricated or hallucinated. The ground truth explicitly states the notional values were consistent at $2.2 billion but does NOT mention any $700 million maturity/replacement activity. This is a material factual error that undermines confidence in the response.\n\nAdditionally, the LLM answer omits a key piece of information from the ground truth: the increase in average interest rate on long-term debt from 3.6% in 2023 to 3.8% in 2024. This metric is important context for understanding how the underlying debt structure or market conditions evolved despite stable hedge amounts.\n\nThe LLM correctly addresses the multi-hop synthesis requirement (comparing 2023 to 2024 and explaining the evolution), and the semantic framing of the hedging strategy is appropriate. However, the introduction of unsupported detail about $700 million in maturing hedges is a critical error that suggests the model may have confused or interpolated information not present in the source material. The omission of the interest rate increase also represents incomplete coverage of the ground truth answer.\n\nThe answer demonstrates good understanding of hedging mechanics but fails on factual completeness and introduces potentially false information.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 499,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How has MetLife's treatment and definition of Adjusted Earnings evolved between 2023 and 2024, particularly in relation to GAAP guidance and segment performance measurement?",
      "original_answer": "In 2023, MetLife updated its calculation of Adjusted Earnings due to the adoption of LDTI, removing certain adjustments related to the amortization of DAC, VOBA, and related intangibles, and instead adjusted for changes in measurement of certain guarantees. Adjusted Earnings in 2023 excluded changes in fair value associated with MRBs, discount rate changes on annuitization guarantees, and asymmetrical accounting from in-force reinsurance. By 2024, Adjusted Earnings remained the GAAP measure of segment performance, but the exclusions were more clearly delineated to include market volatility impacts, asymmetrical and non-economic accounting adjustments, revenues and costs from divested businesses, and results from discontinued operations. Specifically, 2024 Adjusted Earnings excluded net investment gains/losses, derivative gains/losses, MRB remeasurement gains/losses, and goodwill impairments, with more structured exclusions such as inflation-indexed benefit adjustments and non-economic losses from single premium annuity contracts. This represents a refinement and expansion of the exclusions introduced in 2023.",
      "llm_answer": "\nBetween 2023 and 2024 MetLife shifted from presenting adjusted earnings mainly as an internal, non‑GAAP performance metric to explicitly designating it as the **GAAP measure of segment performance** in its 2024 filing. The 2024 definition broadens the exclusion list (e.g., market‑volatility effects, asymmetrical accounting, divested‑business results, discontinued operations, MRB remeasurements, net‑investment and derivative gains/losses, goodwill impairments, and LDTI‑related DAC/VOBA amortization changes) and ties the measure to SEC segment‑reporting guidance, whereas the 2023 description covered similar exclusions but did not label adjusted earnings as a formal GAAP segment metric. This evolution reflects a more rigorous alignment with GAAP guidance and a refined methodology following the LDTI implementation.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the evolution of MetLife's Adjusted Earnings definition between 2023 and 2024, with accurate identification of key exclusions and the shift in how the metric is presented. STRENGTHS: (1) Correctly identifies the major shift from non-GAAP internal metric to GAAP segment performance measure in 2024; (2) Accurately lists most exclusions including MRB remeasurements, net investment gains/losses, derivative gains/losses, goodwill impairments, and LDTI-related adjustments; (3) Properly notes the connection to SEC segment-reporting guidance; (4) Correctly references LDTI implementation as context; (5) No quantitative errors or incorrect numbers/dates. WEAKNESSES: (1) The claim that 2023 'did not label adjusted earnings as a formal GAAP segment metric' is somewhat imprecise - the ground truth indicates it remained the GAAP measure of segment performance in both years, though the presentation and clarity of exclusions evolved; (2) Missing some specific 2023 exclusions mentioned in ground truth (discount rate changes on annuitization guarantees, asymmetrical accounting from in-force reinsurance) though the answer does reference 'similar exclusions'; (3) Could have been more explicit about the refinement and expansion nature of the changes rather than suggesting a fundamental shift from non-GAAP to GAAP status; (4) The phrasing 'shifted from presenting adjusted earnings mainly as an internal, non-GAAP performance metric' is slightly misleading since it was already a GAAP segment measure in 2023. The answer captures the essence of the evolution and the key differences, but overstates the degree of change in fundamental status while understating continuity of the GAAP segment performance role across both years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1494,
        "completion_tokens": 483,
        "total_tokens": 1977
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How has the funding and utilization of Accenture's share purchase program evolved from 2022 to 2024, particularly in terms of available authorization and share acquisition methods?",
      "original_answer": "In 2022, Accenture reported an aggregate available authorization of $3,129,296 for its publicly announced open-market share purchase program and other related share purchase programs. This included acquisitions of Accenture plc Class A ordinary shares and Accenture Canada Holdings Inc. exchangeable shares held by current and former members of Accenture Leadership. By 2024, the company clarified that its open-market share purchase program applied specifically to Accenture plc Class A ordinary shares, which were held as treasury shares for employee benefits, such as equity awards. Additionally, in fiscal 2024, Accenture acquired Class A ordinary shares primarily through share withholding for payroll tax obligations tied to employee equity plans. These purchases did not impact the aggregate available authorization for the public share purchase programs, indicating a shift in acquisition methods while maintaining a focus on funding levels.",
      "llm_answer": "\nFrom fiscal 2022 to fiscal 2024 Accenture more than doubled the authority for its share‑purchase program—its publicly announced open‑market authority rose from about **$3.1 billion (as of Aug 2022)** to **$6.7 billion after a $4 billion expansion approved in September 2024**.  The company continued to fund repurchases through the same three channels—open‑market purchases, other authorized purchase programs, and employee‑share withholding—but used the larger pool of authorized funds to buy roughly **13.9 million shares in FY 2024 (up from 12.2 million in FY 2022)** for a total outlay of **≈ $4.5 billion**, with open‑market spend increasing from **$3.15 billion to $3.78 billion** over the same period.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations that fundamentally contradict the ground truth:\n\n1. QUANTITATIVE ACCURACY FAILURES:\n   - The LLM claims the authorization was '$3.1 billion (as of Aug 2022)' but the ground truth states it was '$3,129,296' (approximately $3.1 million, not billion). This is a massive error of three orders of magnitude.\n   - The LLM claims a '$6.7 billion' authorization after a '$4 billion expansion in September 2024,' but the ground truth makes no mention of any such expansion or these figures.\n   - The LLM cites '13.9 million shares in FY 2024' and '12.2 million in FY 2022' with '$4.5 billion' total outlay and '$3.78 billion' open-market spend—none of these figures appear in the ground truth.\n   - The LLM claims open-market spend increased from '$3.15 billion to $3.78 billion,' but the ground truth provides no such spending data.\n\n2. ENTITY AND CONTEXT ACCURACY FAILURES:\n   - The ground truth explicitly states that in 2024, share acquisitions were 'primarily through share withholding for payroll tax obligations tied to employee equity plans' and that 'these purchases did not impact the aggregate available authorization for the public share purchase programs.'\n   - The LLM mischaracterizes the acquisition methods and funding mechanisms, suggesting continued open-market purchases at scale when the ground truth indicates a shift away from this method.\n   - The ground truth clarifies that the program applied to 'Accenture plc Class A ordinary shares' held as treasury shares for employee benefits, not general market repurchases.\n\n3. MULTI-HOP REASONING FAILURES:\n   - The LLM failed to synthesize the key distinction between the 2022 and 2024 periods: the shift from open-market purchases to share withholding for tax obligations.\n   - The LLM invented a narrative about program expansion and increased spending that has no basis in the ground truth.\n   - The LLM did not capture the critical insight that 2024 acquisitions 'did not impact the aggregate available authorization,' indicating a fundamentally different acquisition method.\n\n4. COMPLETENESS:\n   - While the LLM attempted to address the evolution from 2022 to 2024, it did so with fabricated data rather than accurate information.\n   - The LLM failed to mention the specific share types (Class A ordinary shares vs. exchangeable shares) or the employee benefit context that is central to the ground truth.\n\nThe LLM answer appears to have confused Accenture's share repurchase program with a different company's program or generated plausible-sounding but entirely inaccurate financial figures. The core claim about authorization amounts being in the billions rather than millions is a critical factual error that undermines the entire response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 740,
        "total_tokens": 2163
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How did MetLife's treatment and valuation methodology for Unit-linked Securities evolve from 2023 to 2024, particularly in terms of cost basis and fair value sensitivity?",
      "original_answer": "In 2023, MetLife described the cost basis for Unit-linked and FVO securities as primarily equity and fixed maturity securities, with cost representing original cost for equities and amortized cost for fixed maturities. By 2024, Unit-linked securities were included in Level 3 fair value measurements and subjected to valuation techniques involving significant unobservable inputs such as mortality rates, lapse rates, and equity volatility. Additionally, the 2024 disclosures emphasized sensitivity of fair value to changes in these inputs, indicating a more dynamic and assumption-driven valuation approach compared to the more static cost-based method described in 2023.",
      "llm_answer": "\nMetLife classifies its Unit‑linked and FVO securities as Level 3 fair‑value measurements and carries them on the books at amortized cost but reports them at estimated fair value using present‑value and option‑pricing models that depend on unobservable inputs such as interest‑rate curves, credit spreads, equity volatilities and non‑performance risk spreads. In the 2024 filing the Company explicitly notes that several of those Level 3 inputs (e.g., swap and basis curves, repurchase rates) may require extrapolation beyond observable ranges, which makes the fair‑value estimates more sensitive to model assumptions than in 2023, even though the overall valuation framework remains the same.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains both accurate and problematic elements. CORRECT ELEMENTS: (1) Correctly identifies Unit-linked securities as Level 3 fair value measurements in 2024; (2) Accurately mentions valuation techniques using unobservable inputs like equity volatilities; (3) Correctly notes increased sensitivity to model assumptions in 2024 vs 2023; (4) Appropriately references present-value and option-pricing models. PROBLEMATIC ELEMENTS: (1) The answer states securities are 'carried on the books at amortized cost but reports them at estimated fair value' - this is somewhat confusing and doesn't clearly distinguish between the 2023 cost basis approach (original cost for equities, amortized cost for fixed maturities) and the 2024 Level 3 valuation approach; (2) The LLM mentions 'swap and basis curves, repurchase rates' as Level 3 inputs requiring extrapolation, but the ground truth specifically emphasizes 'mortality rates, lapse rates, and equity volatility' as the key unobservable inputs - this is a significant omission of insurance-specific assumptions that are central to the evolution; (3) The answer suggests 'the overall valuation framework remains the same' which contradicts the ground truth's characterization of an evolution from 'static cost-based method' to 'more dynamic and assumption-driven valuation approach'; (4) The answer doesn't clearly articulate the shift in methodology from 2023 to 2024 - it presents the 2024 framework but doesn't adequately contrast it with the 2023 approach. MULTI-HOP REASONING: The answer attempts to synthesize information across years but fails to properly distinguish the methodological evolution. The comparison is implicit rather than explicit. MISSING CONTEXT: The answer lacks emphasis on insurance-specific valuation drivers (mortality, lapse rates) that are critical to understanding MetLife's Unit-linked securities valuation, particularly for a company whose business model depends heavily on these assumptions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 535,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How has the structure and vesting timeline of market-based RSUs evolved between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, market-based RSUs generally vested over four years and grantees could receive between 0% and 300% of the original grant based on total stockholder return (TSR) relative to an index group. By fiscal year 2023, while four-year vesting remained common, the company also introduced market-based RSUs that vested over five years, with vesting contingent on achieving stock price performance milestones. This indicates an expansion in the types of market-based RSUs offered, adding a new vesting structure based on specific stock price targets.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2023 the company shifted the vesting design of its market‑based RSUs. In 2022 all market‑based RSUs were granted with a four‑year vesting period (subject to market‑performance conditions and a 0‑300 % payout range). In 2023 the firm began awarding a new tranche of market‑based RSUs that vest over **five years** and are tied to specific stock‑price performance milestones, while still granting the traditional four‑year awards. This evolution is reflected in the weighted‑average expected term expanding from 3.4 years (2022) to 4.8 years (2023) and the inclusion of five‑year milestone‑based vesting in the 2023 grant descriptions.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the core evolution: four-year vesting in 2022 with 0-300% payout range based on TSR, and introduction of five-year vesting in 2023 with stock price milestones. (2) Accurately captures that both structures coexisted in 2023 (traditional four-year awards continued alongside new five-year awards). (3) Provides additional supporting detail with weighted-average expected term metrics (3.4 years in 2022 vs 4.8 years in 2023), which validates the structural shift and adds quantitative precision. (4) Correctly identifies the performance metrics: TSR-based for the four-year awards and stock price milestones for the five-year awards. (5) Multi-hop synthesis is sound - properly connects vesting timeline changes with performance condition changes across the two fiscal years. MINOR CONSIDERATIONS: The LLM answer goes slightly beyond the ground truth by including the weighted-average expected term expansion (3.4 to 4.8 years), which is additional supporting evidence rather than contradictory information. This enhancement actually strengthens the answer's credibility. The phrasing 'tranche' and 'traditional four-year awards' effectively conveys the coexistence of both structures. All numeric values (4-year, 5-year, 0-300%, 3.4 years, 4.8 years) are either directly stated in ground truth or logically derived from the structural changes described. No calculation errors detected. The answer fully addresses the question about how structure and vesting timeline evolved between the two fiscal years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 447,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "How did the phase-in treatment of the CECL standard's ongoing impact on regulatory capital evolve between 2023 and 2024, and what specific regulatory capital treatment applied during the phase-in period?",
      "original_answer": "In 2023, the CECL Transition Election allowed for the cumulative 'day 2' ongoing impact to be phased into regulatory capital at 25% per year from January 1, 2022, through December 31, 2024. By 2024, this phase-in treatment remained consistent, with the ongoing impact continuing to be phased in at 25% annually, indicating that the regulatory capital treatment under the CECL Transition Rule was applied uniformly across both years as part of the multi-year transition framework.",
      "llm_answer": "\nBetween 2023 and 2024 the Company moved from having phased‑in 75 % of the $2.4 bn “day‑1” CECL‑delayed amount (≈ $1.8 bn) by the end of 2023 to adding the remaining 25 % ($600 m) in 2024, completing the five‑year, 25 %‑per‑year phase‑in of the cumulative “day‑2” CECL impact.  Under the CECL Transition Rule, the delayed adoption impact and the ongoing allowance increase could be added back to regulatory capital and then phased in at 25 % annually; this treatment raised the Company’s CET1 ratio to 13.5 % (reported) versus 12.9 % (excluding the phased‑in amount) by December 31 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misinterpretations of the CECL phase-in treatment. Key issues: (1) CONFLICTING PHASE-IN FRAMEWORK: The ground truth states a 25% per year phase-in from January 1, 2022 through December 31, 2024 (4-year period), but the LLM describes a 'five-year, 25%-per-year phase-in' which is internally inconsistent and contradicts the ground truth timeline. (2) INCORRECT CHARACTERIZATION OF 'DAY 1' VS 'DAY 2': The LLM conflates 'day 1' delayed adoption impact with 'day 2' ongoing impact, treating them as the same thing. The ground truth specifically addresses the 'day 2' ongoing impact phased at 25% annually. The LLM's discussion of the $2.4bn 'day 1' amount and its 75% phase-in by end of 2023 is not mentioned in the ground truth and appears to be a different component. (3) EVOLUTION CLAIM NOT SUPPORTED: The question asks how treatment 'evolved' between 2023 and 2024. The ground truth correctly states the treatment 'remained consistent' with 25% annual phase-in in both years. The LLM suggests a progression from 75% phased-in to 100% completion, which mischaracterizes the consistency of the regulatory treatment framework. (4) MISSING CORE ANSWER: The LLM fails to directly address that the regulatory capital treatment applied uniformly across both years as part of the multi-year transition framework - the key insight from the ground truth. (5) NUMERICAL SPECIFICITY: While the LLM provides specific dollar amounts ($2.4bn, $1.8bn, $600m) and CET1 ratios (13.5% vs 12.9%), these cannot be verified against the ground truth and appear to be company-specific implementation details rather than the regulatory framework itself. The question asks about the regulatory treatment framework evolution, not company-specific capital impacts. The LLM answer demonstrates confusion between the delayed adoption impact and ongoing impact components of CECL, and misrepresents the phase-in timeline and consistency of treatment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 532,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How has Broadcom's relationship with Wilmington Trust, National Association evolved between 2022 and 2023 in terms of the types and terms of senior notes issued under their indentures?",
      "original_answer": "In 2022, Broadcom had an ongoing relationship with Wilmington Trust, National Association as trustee under indentures governing senior notes issued in January 2021, which included notes with interest rates as low as 1.950% (due 2028) and as high as 3.750% (due 2051). By 2023, the relationship had evolved to include new indentures dated April 18, 2022, and July 12, 2024, under which Broadcom issued higher-yielding senior notes, including a 4.926% note due 2037 and later, in October 2024, notes ranging from 4.150% (due 2028) to 4.800% (due 2034). This reflects a shift toward issuing longer-term debt with higher interest rates over time.",
      "llm_answer": "\nBetween 2022 and 2023 Broadcom continued to use Wilmington Trust, National Association as trustee, but the senior‑note program shifted. In 2022 it issued 4.00 % notes maturing 2029 and 4.15 % notes maturing 2032 (plus a 4.926 % 2037 note) under the April 2022 indenture, whereas in 2023 a new series of notes—$5.05 % due 2027, $5.05 % due 2029 and $5.15 % due 2031—was launched under a later indenture, reflecting higher coupon rates and longer maturities.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations compared to the ground truth. Key issues: (1) INCORRECT INTEREST RATES: The LLM claims 4.00% notes due 2029 and 4.15% notes due 2032 were issued in 2022, but the ground truth shows the 2022 indenture (April 18, 2022) included a 4.926% note due 2037. The 4.00% and 4.15% rates don't match ground truth data. (2) FABRICATED 2023 NOTES: The LLM invents 5.05% and 5.15% notes supposedly issued in 2023, which don't appear in the ground truth. The ground truth mentions October 2024 notes (4.150% due 2028 to 4.800% due 2034), not 2023 issuances. (3) TIMELINE CONFUSION: The LLM conflates 2022 and 2023 issuances incorrectly. Ground truth shows 2021 notes (1.950%-3.750%), then April 2022 indenture notes, then July 2024 and October 2024 notes. (4) MISSING CONTEXT: The LLM fails to mention the original January 2021 notes with rates as low as 1.950%, which is important for showing the evolution. (5) INDENTURE DATES: The LLM doesn't clearly distinguish between the April 18, 2022 and July 12, 2024 indentures mentioned in ground truth. The answer demonstrates poor multi-hop synthesis, inventing specific numbers rather than accurately reporting the documented relationship evolution. The core claim about 'higher coupon rates and longer maturities' is directionally correct but undermined by the fabricated specific rates and dates.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 390,
        "total_tokens": 1674
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "How did Capital One's regulatory capital add-back under the CECL Transition Rule evolve from 2023 to 2024, and what was the specific phase-in progression during this period?",
      "original_answer": "In 2023, Capital One had already added back $2.4 billion to its regulatory capital under the CECL Transition Rule, with a phase-in of 50% as of January 1, 2023. By January 1, 2024, the phase-in had progressed to 75%, indicating a 25 percentage point increase over the year. This reflects the structured five-year phase-in process under the CECL Transition Rule, where 25% of the cumulative impact was phased in annually after 2021.",
      "llm_answer": "\nUnder the CECL Transition Rule Capital One was permitted to defer the full CECL‑related capital impact and phase it in at 25 % per year. After a 25 % phase‑in in 2022, the company added back 50 % of the cumulative “day‑2” impact in 2023 and 75 % by the end of 2024 (the remaining 25 % will be phased in during 2025). As a result, the Company’s CET1 ratio was 13.5 % on 31 Dec 2024—including the CECL transition‑rule add‑back—versus 13.3 % on a fully‑phased‑in basis.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is substantially correct and provides comprehensive information about Capital One's CECL Transition Rule regulatory capital add-back evolution. Verification of key facts: (1) Phase-in percentages are accurate - 25% in 2022, 50% in 2023, 75% by end of 2024, with remaining 25% in 2025, matching the ground truth's description of a structured five-year phase-in with 25 percentage point annual increases after 2021. (2) The $2.4 billion add-back mentioned in ground truth for 2023 is not explicitly stated in LLM answer, but this is a minor omission since the question asks about evolution and progression, which the LLM addresses thoroughly. (3) The CET1 ratio figures (13.5% with add-back vs 13.3% fully phased-in as of Dec 31, 2024) are specific quantitative details that demonstrate the impact. (4) Multi-hop reasoning is sound - the answer correctly synthesizes the phase-in progression across years and explains the cumulative impact mechanism. (5) The answer goes beyond the ground truth by providing additional context about the 2022 starting point and 2025 completion, which adds value. The only minor weakness is the lack of the specific $2.4 billion figure from 2023, but this doesn't materially affect the correctness of the phase-in progression narrative. The semantic meaning and factual content align well with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 378,
        "total_tokens": 1609
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "How did the treatment of VMware stock options for non-employee directors evolve between 2022 and 2023 following the Broadcom acquisition?",
      "original_answer": "In 2022, the 10-K filing stated that all outstanding in-the-money VMware stock options and RSU awards held by non-employee directors would be accelerated and converted into the right to receive cash and shares of Broadcom common stock, in equal parts, upon the completion of the acquisition. By 2023, this provision had been realized, with the statement confirming that these awards were indeed accelerated and converted into the right to receive cash and Broadcom shares. This reflects a transition from a planned conversion to an actualized event following the completion of the acquisition.",
      "llm_answer": "\nBefore the Broadcom‑VMware merger, the VMware stock options held by non‑employee directors were ordinary, unvested awards that would remain outstanding until the transaction closed; the merger agreement stipulated that, upon completion of the deal, all in‑the‑money VMware options (and RSUs) for those directors would be **accelerated** and settled in a **split of cash and Broadcom common stock on a 50/50 basis**. After the November 2023 closing, those accelerated awards were paid out as cash and Broadcom shares, ending the directors’ VMware‑stock‑option holdings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and effectively addresses the question about the evolution of VMware stock option treatment for non-employee directors between 2022 and 2023. Strengths: (1) Correctly identifies the key mechanism: acceleration of in-the-money options and RSUs upon acquisition completion; (2) Accurately specifies the 50/50 split between cash and Broadcom common stock; (3) Properly distinguishes the pre-acquisition planned state (2022) from the post-acquisition realized state (November 2023 closing); (4) Correctly names both companies (VMware, Broadcom) and the transaction type (merger); (5) Accurately captures the temporal evolution from stipulated conversion to actualized payout. Quantitative elements are precise: the 50/50 split is correctly stated, and the November 2023 closing date is accurate. The multi-hop reasoning is sound—the answer synthesizes information about the merger agreement terms, the acceleration mechanism, and the actual settlement following deal completion. Minor consideration: The LLM answer provides slightly more operational detail (e.g., 'ending the directors' VMware-stock-option holdings') than the ground truth, but this is additive context that enhances rather than contradicts the core answer. The semantic equivalence is strong—both answers convey the same fundamental evolution from planned conversion to realized event. No factual errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 392,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "How has the therapeutic positioning of Vraylar evolved from 2022 to 2024 based on AbbVie's disclosures?",
      "original_answer": "In 2022, Vraylar was described as being evaluated in Phase 3 clinical trials as an adjunctive treatment for major depressive disorder (MDD), with one trial meeting its primary endpoint and the other showing numerical but not statistically significant improvement. By 2024, Vraylar was disclosed as being indicated for a broader range of psychiatric conditions, including acute and maintenance treatment of schizophrenia, acute treatment of manic or mixed episodes associated with bipolar disorder, acute treatment of depressive episodes associated with bipolar I disorder, and as an adjunctive treatment in major depressive disorder. This reflects a clear expansion and solidification of its therapeutic positioning over time.",
      "llm_answer": "\nFrom the 2022 10‑K (page 60) AbbVie highlighted top‑line Phase 3 data showing that cariprazine (Vraylar) achieved a statistically significant improvement as an **adjunctive treatment for major depressive disorder (MDD)**, marking the first formal push to use Vraylar beyond its original schizophrenia and bipolar‑disorder indications. By the 2024 filing (pages 6‑7), the product’s listed indication now reads “adjunctive treatment of major depressive disorder in adults,” demonstrating that AbbVie has **expanded Vraylar’s therapeutic positioning to include MDD** as a core component of its neuroscience portfolio.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and incomplete synthesis. CRITICAL ERRORS: (1) The LLM states that in 2022, cariprazine 'achieved a statistically significant improvement as an adjunctive treatment for MDD,' but the ground truth explicitly states that one trial met its primary endpoint while 'the other showing numerical but not statistically significant improvement.' This is a material mischaracterization of the 2022 data - the results were mixed, not uniformly statistically significant. (2) The LLM answer is incomplete in addressing the full scope of Vraylar's therapeutic positioning evolution. The ground truth identifies FOUR distinct indications by 2024: (a) acute and maintenance treatment of schizophrenia, (b) acute treatment of manic/mixed episodes in bipolar disorder, (c) acute treatment of depressive episodes in bipolar I disorder, and (d) adjunctive treatment in MDD. The LLM answer only mentions MDD expansion and fails to acknowledge the pre-existing schizophrenia and bipolar disorder indications that were already established. (3) The LLM's framing of MDD as 'beyond its original schizophrenia and bipolar-disorder indications' is correct directionally but the answer fails to comprehensively describe the full 2024 therapeutic positioning. WHAT WAS CORRECT: The LLM correctly identifies that Vraylar expanded to include MDD as an indication, correctly cites the 2022 Phase 3 data discussion, and correctly notes the 2024 filing mentions MDD. However, the answer oversimplifies the evolution by focusing narrowly on MDD expansion while omitting the complete therapeutic profile. The multi-hop synthesis is incomplete - the answer should have synthesized information about all four indications by 2024, not just MDD. The quantitative accuracy is moderate because while page citations appear reasonable, the characterization of the 2022 Phase 3 results as uniformly 'statistically significant' contradicts the ground truth's more nuanced description of mixed results.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 540,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How has GE's accounting policy for long-term services agreements evolved from 2022 to 2024, particularly in terms of revenue recognition method and contract billing estimates?",
      "original_answer": "In 2022, GE recognized revenue for long-term services agreements on a straight-line basis, primarily in the Healthcare and Renewable Energy segments, with periodic invoicing as services were provided. By 2024, GE shifted to using the percentage of completion method for revenue recognition, predominantly within the CES segment, based on costs incurred relative to total expected costs. Additionally, in 2024, GE reported a long-term services agreements net liability balance of $6.6 billion, representing approximately 4.1% of total estimated life of contract billings of $162 billion, indicating a more detailed and forward-looking estimation process involving asset utilization and cost improvements, which was not explicitly mentioned in 2022.",
      "llm_answer": "\nGE has continued to apply the **percentage‑of‑completion method** for its long‑term services agreements, recognizing revenue as costs are incurred relative to the total estimated cost of each contract.  Beginning in 2022 the company refined this approach by **tying revenue to customer‑utilization forecasts and by quantifying the effect of estimate revisions**—e.g., it now states that a 1 percentage‑point change in the estimated profitability of a contract would shift the reported long‑term‑service liability by roughly $0.4 billion—providing greater transparency around how billing‑and‑utilization assumptions are incorporated into revenue recognition.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that contradict the ground truth. (1) MAJOR ERROR - Method Direction: The ground truth explicitly states GE SHIFTED FROM straight-line basis (2022) TO percentage-of-completion method (2024). The LLM claims GE 'continued to apply the percentage-of-completion method' and that this approach was refined 'beginning in 2022,' which is backwards and contradicts the documented evolution. (2) MAJOR ERROR - Segment Attribution: Ground truth identifies Healthcare and Renewable Energy segments using straight-line in 2022, shifting to CES segment using percentage-of-completion in 2024. The LLM provides no segment information and misrepresents the timeline. (3) MISSING KEY METRICS: The ground truth provides specific 2024 figures: $6.6 billion net liability balance and $162 billion total estimated life of contract billings (4.1% ratio). The LLM mentions a '$0.4 billion' sensitivity metric for 1 percentage-point profitability changes, which is not in the ground truth and appears to be fabricated or confused with different data. (4) INCOMPLETE ANSWER: The LLM fails to address the core evolution question - it does not explain what changed from 2022 to 2024, instead presenting a static description of current practice. (5) REASONING FAILURE: The multi-hop synthesis required comparing 2022 vs 2024 accounting policies across segments. The LLM failed this synthesis entirely by not establishing the temporal comparison or segment shifts. The answer reads as if describing only 2024 practices without the required historical comparison. The mention of 'beginning in 2022' refinements appears to conflate timeline elements incorrectly.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 459,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How has IBM's disclosure of the 1.250% Notes due 2027 evolved between the 2022 and 2023 10-K filings?",
      "original_answer": "In the 2022 10-K filing, IBM disclosed the 1.250% Notes due 2027 as part of a list of instruments defining the rights of holders, with Exhibit 4.3 to Form 8-K filed on January 30, 2019, referenced for the notes. In the 2023 10-K filing, the 1.250% Notes due 2027 are listed under registered securities with the trading symbol IBM 27B on the New York Stock Exchange. This evolution reflects a shift from referencing the instrument defining the rights to identifying the notes as a registered class of securities.",
      "llm_answer": "\nIn the 2022 Form 10‑K the 1.250% Notes due 2027 are not listed among the company’s registered securities; the filing only references older 1.250% notes (due 2023) and other debt series, with no explicit disclosure of a 2027 tranche. By contrast, the 2023 Form 10‑K explicitly includes the 1.250% Notes due 2027 (identified as “IBM 27B”) in the table of securities registered under Section 12(b), making the series a distinct, disclosed component of IBM’s debt profile.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. (1) MAJOR ERROR - The LLM claims the 1.250% Notes due 2027 are NOT listed in the 2022 10-K filing, stating only 'older 1.250% notes (due 2023)' are referenced. However, the ground truth explicitly states that in the 2022 10-K, IBM disclosed the 1.250% Notes due 2027 as part of a list of instruments defining the rights of holders, with Exhibit 4.3 referenced. This is a fundamental factual error. (2) PARTIAL CORRECTNESS - The LLM correctly identifies that the 2023 10-K includes the 1.250% Notes due 2027 with the trading symbol 'IBM 27B' on the NYSE, which aligns with the ground truth. (3) MISCHARACTERIZATION OF EVOLUTION - The LLM incorrectly frames the evolution as the notes appearing for the first time in 2023, when the ground truth indicates the notes were disclosed in both years but with different presentation contexts (from instrument definition reference in 2022 to registered securities listing in 2023). (4) MISSING KEY CONTEXT - The LLM fails to mention the Exhibit 4.3 Form 8-K reference from January 30, 2019, which is part of the ground truth's explanation of the 2022 disclosure. (5) REASONING FLAW - The multi-hop synthesis is incomplete and inaccurate; the LLM did not properly synthesize the evolution across both filings, instead presenting a false narrative of absence in 2022 followed by appearance in 2023. The core claim that the notes were absent from 2022 disclosure is demonstrably incorrect per the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 422,
        "total_tokens": 1655
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How has the structure and performance criteria of AbbVie's performance-vested RSUs evolved between 2022 and 2024, particularly in terms of vesting increments and performance metrics?",
      "original_answer": "In 2022, performance-vested RSUs had the potential to vest in one-third increments over a three-year performance period, with performance measured based on AbbVie's return on invested capital (ROIC) relative to a defined peer group of pharmaceutical, biotech, and life science companies for awards granted in 2021 and 2020. By 2024, the vesting structure remained similar—allowing for one-third increments over a three-year period—but the description of performance metrics was streamlined, focusing primarily on ROIC performance against the same peer group, without mention of specific years tied to tranches as seen in 2022. This indicates a simplification or standardization of the performance criteria over time.",
      "llm_answer": "\nBetween 2022 and 2024 AbbVie’s performance‑vested RSUs have continued to be eligible for vesting in three equal one‑third increments over a three‑year performance period.  The original metric—return on invested capital (ROIC) relative to a defined peer group—remained in place, but the criteria were broadened: the 2024 disclosures note that the awards may now be earned not only on ROIC performance but also on achievement of EPS targets and total‑stock‑holder‑return (TSR) relative to the same peer group.  Thus, while the vesting structure (one‑third tranches over three years) has stayed the same, the performance metrics have expanded from a sole ROIC focus to a combined ROIC‑EPS‑TSR framework.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERROR: The LLM answer introduces factually incorrect information not supported by the ground truth. The original answer clearly states that in 2022, performance metrics were based SOLELY on ROIC relative to a peer group, and by 2024, the description remained focused on ROIC without mention of specific years. However, the LLM claims that by 2024, the criteria were 'broadened' to include EPS targets and TSR (total shareholder return) in addition to ROIC. This is a fundamental factual error - the ground truth makes no mention of EPS or TSR being added to the performance metrics framework. The LLM appears to have fabricated or hallucinated this expansion of metrics. The quantitative accuracy score is relatively high (8/10) because the vesting structure details (one-third increments over three years) are correct. However, the qualitative accuracy is very low (2/10) because the core claim about metric expansion is entirely unsupported by the ground truth and represents a major mischaracterization of how AbbVie's performance criteria evolved. The LLM correctly identified that the vesting structure remained consistent, but fundamentally misrepresented the evolution of performance metrics. The ground truth indicates simplification/standardization, while the LLM claims expansion - these are contradictory conclusions. This is a multi-hop synthesis failure where the model introduced information not present in the source material.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 401,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 149,
      "question": "How did GE's financial relationship with AerCap evolve from 2022 to 2024, based on the realized and unrealized gains or losses associated with its investment?",
      "original_answer": "In 2022, GE reported an unrealized loss of $865 million related to its investment in and note with AerCap, indicating a negative valuation impact during that year. By 2024, this position had shifted to a realized and unrealized gain of $38 million, suggesting that GE had either exited part of its position or the value of the remaining investment had improved. This represents a significant turnaround in the financial performance of the AerCap investment over the two-year period.",
      "llm_answer": "\nFrom 2022 through 2024 the “Investment in and note with AerCap – realized and unrealized gain (loss)” line swung from a **$865 million loss in 2022** to **gains of $129 million in 2023 and $38 million in 2024**. These gains (and the earlier loss) are recorded in “Other income (loss)” and reflect the change in fair‑value of GE’s AerCap note/equity position, showing a clear shift from a substantial unrealized loss to modest positive returns over the three‑year period.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the 2022 unrealized loss of $865 million and the 2024 gain of $38 million, matching the ground truth. However, there is a critical quantitative discrepancy: the LLM reports a 2023 gain of $129 million, which is NOT mentioned in the original answer. The ground truth only references 2022 ($865M loss) and 2024 ($38M gain), with no 2023 figure provided. This represents a significant factual error - either the LLM introduced unsupported data or the ground truth is incomplete. The LLM's characterization of the overall trend (from substantial loss to modest gains) is qualitatively accurate and the reasoning about fair-value changes is sound. The answer appropriately identifies the financial metrics (realized and unrealized gains/losses) and correctly notes these are recorded in 'Other income (loss)'. The multi-hop synthesis across the 2022-2024 period is logically structured. However, the introduction of the unexplained 2023 figure ($129 million) without corroboration from the ground truth is a material error that undermines confidence in the answer's accuracy. The answer is more detailed than the ground truth but this additional detail cannot be verified and may be incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 345,
        "total_tokens": 1586
      },
      "error": null
    },
    {
      "question_id": 149,
      "question": "How has IBM's treatment of the 0.300% Notes due 2026 evolved between the 2022 and 2023 SEC filings, particularly in terms of its disclosure status and visibility in financial instruments?",
      "original_answer": "In 2022, the 0.300% Notes due 2026 were disclosed as part of IBM's exhibits under Exhibit 4 to Form 8-K filed November 1, 2016, indicating it was referenced in the context of legal instruments defining holder rights. By 2023, the 0.300% Notes due 2026 were no longer just referenced in exhibits but were explicitly listed as a titled class of notes registered on the New York Stock Exchange under the trading symbol IBM 26B, showing increased visibility and formal recognition in the company's capital structure.",
      "llm_answer": "\nIn the 2022 Form 10‑K the 0.300 % Notes due 2026 were mentioned only in the Exhibit 4 reference to the 2016 8‑K filing and were not otherwise highlighted in the main disclosure sections; in the 2023 filing they remain in the same Exhibit 4 reference but are now also listed prominently in the cover‑page table of registered securities (shown as “0.300 % Notes due 2026 – IBM 26B”), giving the instrument greater visibility to investors. No new substantive discussion or risk‑factor disclosure about those notes was added between the two years.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy in addressing the evolution of IBM's treatment of the 0.300% Notes due 2026 between 2022 and 2023 filings. STRENGTHS: (1) Correctly identifies the 2022 disclosure as being limited to Exhibit 4 reference to the 2016 8-K filing; (2) Accurately notes the 2023 addition of the notes to the cover-page table of registered securities with the trading symbol IBM 26B; (3) Properly characterizes the shift from limited to increased visibility; (4) Correctly identifies the percentage rate (0.300%) and maturity year (2026); (5) Appropriately notes the absence of new substantive risk-factor disclosures. MINOR CONSIDERATIONS: (1) The LLM answer adds the observation that 'no new substantive discussion or risk-factor disclosure about those notes was added between the two years,' which is a reasonable inference but goes slightly beyond what the ground truth explicitly states - the ground truth focuses on the evolution in disclosure status and visibility rather than the absence of new substantive discussion; (2) The ground truth emphasizes 'formal recognition in the company's capital structure' while the LLM answer frames it as 'greater visibility to investors' - these are semantically equivalent but slightly different framings. The multi-hop reasoning is sound: the answer correctly synthesizes information about how the same instrument was treated differently across two filing years, identifying both the continuity (Exhibit 4 reference) and the change (cover-page listing). All numeric values and dates are accurate. The answer directly addresses the question's focus on evolution in disclosure status and visibility.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 455,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 150,
      "question": "How has GE's approach to the RISE Program evolved between 2022 and 2024, particularly in terms of its strategic emphasis and investment focus?",
      "original_answer": "In 2022, GE announced the RISE Program as a collaborative technology development initiative with Safran, targeting a reduction of more than 20% in fuel consumption and CO2 emissions compared to current engines. This marked the initial phase of the program as a forward-looking announcement aimed at shaping the future of sustainable aviation. By 2024, GE's engagement with the RISE Program had evolved into a more concrete investment strategy, with the company making 'significant investments' in the RISE program suite of technologies. This shift indicates a transition from conceptual development to active, funded R&D aimed at enabling a sustainable future of flight. The change reflects a deepening strategic commitment to sustainability and technological leadership in aviation.",
      "llm_answer": "\nBetween 2022 and 2024 GE moved the RISE program from a newly announced partnership focused on sustainable‑engine concepts (e.g., the adaptive‑cycle and Catalyst engines) toward a fully‑integrated, heavily funded growth pillar. 2024 filings show a 28 % rise in total R&D outlays—from $2.1 bn in 2022 to $2.7 bn in 2024—and a larger share of that spending is now customer‑ and partner‑funded, underscoring a strategic shift to scale hybrid‑electric and advanced propulsion technologies that can deliver >20 % fuel‑burn reductions and support the company’s broader sustainability agenda.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer attempts to address the evolution of GE's RISE Program between 2022 and 2024, capturing the general narrative of progression from announcement to active investment. However, there are significant quantitative accuracy issues that undermine the response. (1) QUANTITATIVE PROBLEMS: The LLM introduces specific R&D spending figures ($2.1B in 2022 to $2.7B in 2024, representing a 28% increase) that are NOT present in the ground truth answer. These numbers cannot be verified against the original answer and appear to be fabricated or hallucinated data points. The ground truth makes no mention of specific R&D budget figures or percentage increases. This is a critical error as the question asks about 'investment focus' but the LLM provides unverified financial metrics. (2) QUALITATIVE ALIGNMENT: The LLM correctly identifies the shift from 'newly announced partnership' (2022) to 'fully-integrated, heavily funded growth pillar' (2024), which aligns with the ground truth's transition from 'conceptual development to active, funded R&D.' The mention of >20% fuel-burn reductions is accurate and matches the ground truth. References to 'hybrid-electric and advanced propulsion technologies' and 'sustainability agenda' are contextually appropriate. (3) MULTI-HOP REASONING: The answer demonstrates reasonable synthesis of the evolution narrative, but the introduction of unverified financial data breaks the chain of reasoning. The connection between R&D spending increases and strategic shift is logical, but unsupported by the ground truth. (4) MISSING ELEMENTS: The LLM does not mention Safran partnership explicitly (though implied in 'partner-funded'), and adds details about 'Catalyst engines' and 'adaptive-cycle engines' that, while potentially accurate, are not in the ground truth. The core issue is the fabrication of specific financial metrics without source verification, which is a serious accuracy violation in financial analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 529,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 150,
      "question": "How has the role and emphasis on asset securitizations within American Express's funding strategy evolved from 2022 to 2023, based on the specific disclosures in the respective 10-K filings?",
      "original_answer": "In 2022, American Express defined asset securitizations in a glossary entry, describing the mechanics of transferring loans to trusts that issue asset-backed securities, and noted that securitized loans and receivables were reported as assets while the securities were reported as liabilities. This definition was part of a broader explanation of financial terminology rather than a strategic focus. By 2023, asset securitizations were explicitly positioned as a core component of the company's funding strategy, listed alongside deposits and unsecured debt as key funding sources. The 2023 filing emphasized the importance of diversity in funding sources, with securitizations playing a role in mitigating disruptions in any single funding channel. This represents a shift from a definitional disclosure in 2022 to a strategic emphasis in 2023.",
      "llm_answer": "\nFrom 2022 to 2023 the company moved from a passive, purely definitional reference to asset‑securitizations (limited to a glossary description and a risk‑factor mention) to a strategic, quantified role for securitizations within its funding plan.  The 2023 filing explicitly places securitizations at the center of its diversification strategy—projecting $2 billion‑$6 billion of secured‑term‑debt issuance tied to securitizations and highlighting the ability to “securitize and sell loans and receivables” as a key funding consideration—whereas the 2022 filing only described the mechanics of securitizations without any sizing or strategic emphasis.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ISSUES: (1) UNVERIFIED QUANTITATIVE CLAIM: The LLM introduces a specific dollar range of '$2 billion-$6 billion of secured-term-debt issuance tied to securitizations' that does NOT appear in the ground truth answer. This is a major factual error - the ground truth makes no mention of any specific dollar amounts or projections. This represents either fabrication or hallucination of a specific financial metric. (2) PARTIAL ALIGNMENT ON QUALITATIVE SHIFT: The LLM correctly identifies the core evolution from 'definitional/passive' in 2022 to 'strategic/active' in 2023, which aligns with the ground truth's characterization of moving from 'glossary entry' to 'core component of funding strategy.' (3) MISSING KEY GROUND TRUTH ELEMENTS: The LLM omits the ground truth's specific mention of securitizations being listed 'alongside deposits and unsecured debt as key funding sources' and the emphasis on 'diversity in funding sources' and 'mitigating disruptions in any single funding channel.' (4) REASONING QUALITY: The multi-hop synthesis is sound in structure (comparing 2022 vs 2023 positioning), but the introduction of unverified numbers severely undermines credibility. The characterization of 2022 as having only 'glossary description and risk-factor mention' is reasonable but not explicitly confirmed in ground truth. VERDICT: While the directional analysis is correct, the introduction of specific dollar amounts without ground truth support is a critical factual error that cannot be overlooked in financial analysis. This violates the strict standard required for numerical accuracy in SEC filing analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 446,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How did Emerson's financial and strategic relationship with AspenTech evolve from 2022 to 2023, particularly in terms of investment returns and operational integration?",
      "original_answer": "In 2022, Emerson's relationship with AspenTech was characterized by a minority investment, with AspenTech contributing $656 in sales and a $12 earnings gain, while holding total assets of $14,484. By 2023, Emerson significantly deepened its involvement by acquiring Heritage AspenTech, gaining a 55% ownership stake in the newly formed AspenTech. This acquisition positively impacted gross margins by 0.6 percentage points in 2023 and marked a strategic shift from a passive investment to an active controlling interest, indicating a transformation in the nature of the relationship.",
      "llm_answer": "\nFrom fiscal 2022 to 2023 Emerson’s equity stake in AspenTech moved from a modest, loss‑making investment (the segment posted a $12 million earnings contribution in 2022) to a source of measurable upside—Emerson recorded a $24 million mark‑to‑market gain on its AspenTech equity in 2023 (versus a $50 million loss in 2022) and eliminated the foreign‑currency forwards that had previously eroded results.  At the same time, AspenTech’s process‑automation and software technologies were fully integrated into Emerson’s Software & Control business, helping lift that segment’s sales by 48 % and contributing to overall margin expansion and the growth generated by the Test & Measurement acquisition.  This evolution deepened the strategic partnership, turning AspenTech from a passive equity holding into a core component of Emerson’s global automation portfolio.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations that fundamentally contradict the ground truth:\n\n1. QUANTITATIVE ACCURACY - CRITICAL ERRORS:\n   - Ground truth: 2022 AspenTech contributed $656 in sales and $12 earnings gain\n   - LLM claims: \"$12 million earnings contribution in 2022\" - this appears to confuse the $12 (likely in millions) with a different metric\n   - Ground truth: 2023 involved acquiring Heritage AspenTech with 55% ownership stake\n   - LLM claims: \"$24 million mark-to-market gain on AspenTech equity in 2023 (versus a $50 million loss in 2022)\" - these specific numbers do not appear in the ground truth and represent fabricated financial data\n   - The $656 sales figure from ground truth is completely absent from LLM answer\n   - The $14,484 total assets figure is not mentioned\n\n2. ENTITY/STRUCTURAL ACCURACY - MAJOR ERRORS:\n   - Ground truth: Relationship evolved from \"minority investment\" to \"55% ownership stake in newly formed AspenTech\" through Heritage AspenTech acquisition\n   - LLM describes: \"equity stake moved from loss-making investment to mark-to-market gains\" and \"fully integrated into Software & Control business\"\n   - The LLM fundamentally mischaracterizes the nature of the 2023 transaction - it was an acquisition creating a controlling interest, not merely an equity revaluation\n   - LLM mentions \"Test & Measurement acquisition\" which is not part of the ground truth answer about AspenTech relationship evolution\n\n3. MULTI-HOP REASONING - INCOMPLETE:\n   - Ground truth clearly shows: 2022 (minority investment with specific metrics) → 2023 (acquisition with 55% stake and margin impact of 0.6 percentage points)\n   - LLM answer focuses on mark-to-market gains and currency forwards, which are not mentioned in ground truth\n   - LLM fails to capture the strategic shift from passive to controlling interest\n   - The 0.6 percentage point gross margin improvement from the acquisition is completely missing\n\n4. SEMANTIC ISSUES:\n   - LLM describes \"passive equity holding\" which aligns with 2022, but then conflates this with mark-to-market accounting rather than the actual acquisition event\n   - The answer appears to describe a different financial scenario than what the ground truth documents\n\n5. MISSING KEY INFORMATION:\n   - No mention of Heritage AspenTech acquisition\n   - No mention of 55% ownership stake\n   - No mention of 0.6 percentage point margin impact\n   - No mention of $656 sales or $14,484 assets from 2022\n\nThe LLM answer appears to have fabricated specific financial metrics (mark-to-market gains/losses, currency forward impacts) that do not appear in the ground truth, while simultaneously omitting the core factual elements of the relationship evolution (the acquisition, ownership stake, and margin impact).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 750,
        "total_tokens": 2117
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "How did Emerson's financial relationship with AspenTech evolve between 2022 and 2023, particularly in terms of noncontrolling interest accounting and acquisition-related impacts on equity and expenses?",
      "original_answer": "In 2022, Emerson completed the creation of New AspenTech by contributing its industrial software business and $6.0 billion in cash, resulting in a 55% ownership stake. A noncontrolling interest of $5.9 billion was recorded, with a decrease to additional paid-in capital of $550 million. By 2023, the AspenTech acquisition positively impacted gross margins by 0.6 percentage points and contributed to increased SG&A expenses, which rose by $572 million compared to 2022, partly due to the AspenTech transaction and higher stock compensation expenses. This shows that while the initial accounting impact was significant in 2022, by 2023, the focus had shifted to operational integration and financial performance effects.",
      "llm_answer": "\nBetween 2022 and 2023 Emerson moved from a 55 % equity stake in AspenTech to still owning roughly 57 % while announcing a plan to acquire the remaining shares at $240 per share.  In 2022 the transaction created a $5.9 bn non‑controlling interest for the 45 % it did not own, which reduced additional paid‑in‑capital by about $550 m and generated goodwill and identifiable intangibles that are being amortized (including a $231 m inventory‑step‑up charge that lowered gross margin).  The 2023 financials continue to reflect those acquisition‑related amortization expenses and the ongoing non‑controlling interest, but the proposed full acquisition would eliminate the NCI balance from equity and replace it with 100 % ownership.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides relevant context about Emerson's evolving relationship with AspenTech but contains significant quantitative inaccuracies and introduces information not supported by the ground truth. CORRECT ELEMENTS: (1) The 2022 noncontrolling interest of $5.9 billion is accurate; (2) The $550 million reduction in additional paid-in capital is correct; (3) The general narrative about 2022 transaction creating NCI and 2023 reflecting ongoing impacts is directionally sound; (4) The mention of acquisition-related amortization and intangibles is appropriate. PROBLEMATIC ELEMENTS: (1) The LLM introduces a 57% ownership stake and $240 per share acquisition plan that are NOT mentioned in the ground truth, which only discusses the 55% stake and 2023 operational impacts; (2) The $231 million inventory step-up charge is mentioned but the ground truth states the AspenTech acquisition positively impacted gross margins by 0.6 percentage points, not negatively; (3) The LLM claims the inventory step-up 'lowered gross margin' which contradicts the ground truth's statement of positive margin impact; (4) The LLM does not mention the $572 million increase in SG&A expenses that the ground truth specifically highlights as a key 2023 impact. MULTI-HOP REASONING: The LLM attempts to synthesize the evolution between 2022-2023 but introduces forward-looking information (acquisition plan at $240/share) that appears to be from a different time period or source not in the ground truth. The reasoning about NCI elimination upon full acquisition is logical but speculative. CALCULATION VERIFICATION: No explicit calculations are performed, but the quantitative claims about ownership percentages and the inventory charge lack support in the provided ground truth. The answer reads as if it may be drawing from additional filing information not reflected in the ground truth provided.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 510,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "How has IBM's treatment and disclosure of the 6.22% Debentures due 2027 evolved between the 2022 and 2023 SEC filings?",
      "original_answer": "In 2022, IBM disclosed the 6.22% Debentures due 2027 by referencing the instrument defining the rights of its holders, which was filed as Exhibit 3 to Form 8-K on August 1, 1997. In contrast, the 2023 filing introduces a more structured and visible disclosure by listing the 6.22% Debentures due 2027 with its respective trading symbol (IBM 27) and explicitly identifying it among other registered securities on the New York Stock Exchange. This evolution reflects a shift from a purely historical reference to a more transparent and current market-oriented presentation.",
      "llm_answer": "\nIn the 2022 Form 10‑K (page 31) IBM disclosed the 6.22 % Debentures due 2027 by stating that the governing instrument is “Exhibit 3 to Form 8‑K, filed August 1 1997, and is hereby incorporated by reference.” In the 2023 Form 10‑K (page 1) the same security appears only in the registration table as “6.22 % Debentures due 2027 (IBM 27)” with no accompanying exhibit citation or incorporation language. Consequently, the 2023 filing provides a far more limited disclosure of the debenture, omitting the detailed exhibit‑reference that was present in the 2022 filing.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IN INTERPRETATION: The LLM answer fundamentally mischaracterizes the evolution of disclosure between 2022 and 2023. The ground truth states that 2023 shows a MORE TRANSPARENT and MORE VISIBLE disclosure with explicit trading symbol (IBM 27) and market-oriented presentation. However, the LLM claims the opposite—that 2023 provides 'far more limited disclosure' and 'omits the detailed exhibit-reference.' This is a direct contradiction of the ground truth's core finding. QUANTITATIVE ACCURACY: The numbers are correct (6.22%, 2027, August 1 1997, page references). The trading symbol IBM 27 is correctly identified. QUALITATIVE ACCURACY: The LLM correctly identifies that 2022 included exhibit references and 2023 lists it in a registration table, but fundamentally misinterprets what this means. The ground truth characterizes this shift as an EVOLUTION TOWARD GREATER TRANSPARENCY and CURRENT MARKET-ORIENTED PRESENTATION. The LLM characterizes it as a REDUCTION in disclosure quality. This is a semantic inversion of the actual finding. The LLM's conclusion that 2023 is 'far more limited' directly contradicts the ground truth's assertion that it represents 'more structured and visible disclosure' and 'more transparent...presentation.' MULTI-HOP REASONING: The LLM correctly synthesizes information from both 2022 and 2023 filings but draws the wrong conclusion about what the evolution represents. The factual observations are partially correct, but the interpretation is inverted. This represents a failure in understanding the qualitative significance of the disclosure changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 440,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "How has UnitedHealth Group's exposure to financial risk through risk-based arrangements with healthcare providers evolved from 2023 to 2024, and what implications does this have on its cost estimation and service delivery responsibilities?",
      "original_answer": "In 2023, UnitedHealth Group assumed economic risk under risk-based arrangements where it was responsible for funding healthcare costs, and it recognized premium revenues based on estimated premiums earned, net of projected rebates. The company also highlighted its involvement in value-based arrangements where it received per-patient-per-month premiums and recognized revenue as services were made available. By 2024, the company's exposure expanded as it noted increased responsibility for unpaid healthcare claims if risk-based providers faced financial difficulties or failed to meet their obligations. Additionally, the 2024 disclosures emphasized greater operational risk tied to providers' ability to manage costs, maintain solvency, and provide necessary data for cost estimation, indicating a broader and more complex financial exposure compared to 2023.",
      "llm_answer": "\nFrom 2023 to 2024 UnitedHealth Group broadened its risk‑based and value‑based contracts—especially in Optum Rx and Medicare Advantage—so that premium revenue is now recognized from fixed per‑member or per‑patient‑per‑month rates and the Company assumes the economic risk of funding enrollees’ health‑care costs and of meeting CMS risk‑adjustment calculations.  This deepened exposure forces the Company to more precisely estimate rebates, risk‑adjusted premiums and any liabilities for under‑funded provider arrangements, while also expanding its service‑delivery responsibility to monitor and support the financial viability of contracted physicians, hospitals and other health‑care providers.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the time period (2023 to 2024), correctly names UnitedHealth Group, and accurately captures several key elements: (1) expansion of risk-based and value-based contracts, (2) per-member/per-patient-per-month premium recognition, (3) economic risk assumption for funding healthcare costs, (4) need for more precise cost estimation including rebates and risk-adjusted premiums, and (5) expanded service delivery responsibility to monitor provider financial viability. The semantic meaning aligns well with the ground truth regarding the evolution of financial exposure.\n\nWEAKNESSES: (1) The LLM answer introduces specific business segments (Optum Rx, Medicare Advantage) and mentions CMS risk-adjustment calculations that are not present in the ground truth answer. While these may be factually accurate from the filings, they represent added specificity not in the original answer, which could indicate either hallucination or over-specification. (2) The LLM answer does not explicitly mention the key ground truth element about 'increased responsibility for unpaid healthcare claims if risk-based providers faced financial difficulties or failed to meet their obligations'—this is a material omission regarding counterparty risk exposure. (3) The ground truth emphasizes 'providers' ability to manage costs, maintain solvency, and provide necessary data for cost estimation' as operational risks, while the LLM focuses more on monitoring and support responsibilities without explicitly addressing the solvency and data provision aspects. (4) The ground truth notes the exposure was 'broader and more complex' in 2024, which the LLM captures as 'deepened exposure' but with less emphasis on the complexity dimension.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information about how risk exposure evolved and connects it to implications for cost estimation and service delivery. However, it misses the critical multi-hop connection regarding counterparty credit risk (provider insolvency) that the ground truth explicitly identifies.\n\nNUMERIC/QUANTITATIVE: No specific numbers, percentages, or dollar amounts are provided in either answer, so quantitative accuracy is not directly testable. Both answers appropriately avoid false precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 614,
        "total_tokens": 2027
      },
      "error": null
    },
    {
      "question_id": 153,
      "question": "How did Emerson's financial relationship with AspenTech evolve between 2022 and 2023, particularly in terms of investment magnitude and strategic involvement?",
      "original_answer": "In 2022, Emerson's relationship with AspenTech was primarily financial, as shown by its investment reflected in the Automation Solutions segment, where Emerson reported $362 million invested in AspenTech in 2022. By 2023, the relationship evolved into a strategic partnership following the introduction of a major transaction where Emerson contributed its Industrial Software Business along with approximately $6.0 billion in cash to Heritage AspenTech stockholders, creating 'New AspenTech.' Emerson gained 55% ownership of AspenTech's outstanding shares, marking a significant shift from a minority investment to a controlling stake.",
      "llm_answer": "\nBetween 2022 and 2023 Emerson deepened its stake in AspenTech, contributing two of its own industrial‑software businesses and paying cash to raise its ownership to roughly 55 % (and later about 57 %), turning AspenTech into a core strategic partner.  In 2023 the partnership produced a $24 million mark‑to‑market gain on AspenTech’s foreign‑currency forwards (after a $50 million loss in 2022) and the related hedges were terminated in June 2023, while Emerson also recorded a $56 million gain on its equity investment linked to the transaction.  This heightened equity and currency‑hedge involvement set the stage for Emerson’s November 2024 proposal to acquire the remaining AspenTech shares.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the evolution from minority investment to controlling stake (55%), mentions the Industrial Software Business contribution, and notes the strategic partnership shift. The answer appropriately addresses the 2022-2023 timeframe and captures the magnitude of change. CRITICAL ERRORS: (1) The LLM fails to mention the $362 million investment in 2022, which is a key quantitative anchor for understanding the relationship's evolution. (2) The $6.0 billion cash contribution is completely omitted, which is central to understanding the 'investment magnitude' aspect of the question. (3) The answer introduces information about 2024 (November proposal) and specific derivative gains/losses ($24M mark-to-market gain, $50M loss, $56M equity gain) that, while potentially accurate, are not part of the ground truth answer and go beyond the 2022-2023 timeframe specified in the question. (4) The mention of ownership increasing to 'about 57%' is not supported by the ground truth which states 55%. MULTI-HOP REASONING: The LLM demonstrates understanding that the relationship evolved from financial investment to strategic partnership, but fails to synthesize the complete financial picture by omitting the $362M (2022) and $6.0B (2023) figures that are essential to answering 'investment magnitude.' The reasoning about strategic involvement is sound but incomplete. SEMANTIC ISSUES: While 'contributed two of its own industrial-software businesses' is close to 'contributed its Industrial Software Business,' the plural 'businesses' may be inaccurate. The answer conflates multiple years of information and introduces out-of-scope details that dilute focus from the core 2022-2023 comparison requested.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 472,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 153,
      "question": "How has Adobe Target's role within Adobe's customer journey solutions evolved from fiscal 2022 to fiscal 2023, and what does this evolution indicate about Adobe's strategic direction in AI-driven personalization?",
      "original_answer": "In fiscal 2022, Adobe Target was described as part of a broader set of customer journey solutions, specifically noted alongside Marketo Engage, Adobe Campaign, and Journey Optimizer. It was characterized as a tool for testing, targeting, and personalizing content across channels. By fiscal 2023, Adobe Target was elevated in prominence and described specifically as an 'AI- and machine learning-driven personalization engine' with capabilities for omnichannel personalization and large-scale A/B and multivariate testing through AI-powered automation. This evolution indicates Adobe is placing greater strategic emphasis on AI-driven personalization as a core capability within its customer journey offerings, aligning with its broader push toward AI-powered solutions.",
      "llm_answer": "\nFrom fiscal 2022 to fiscal 2023 Adobe re‑positioned **Adobe Target** from a standalone AI‑enabled testing and targeting component of Experience Cloud into the central AI‑driven personalization engine of the unified Adobe Experience Platform, tightly coupled with Journey Optimizer and real‑time data from the platform.  This evolution reflects Adobe’s strategic push to embed generative‑AI and machine‑learning‑powered personalization across the entire customer journey, moving from a discrete testing tool to an end‑to‑end orchestration layer that delivers scalable, one‑to‑one experiences.  (Pages 15 & 26 of the 2023 10‑K; see also the Digital Experience discussion on page 43.)",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the fiscal 2022 to fiscal 2023 timeframe and accurately captures that Adobe Target evolved toward AI-driven personalization. The answer correctly notes the shift in emphasis and strategic direction toward AI/ML-powered solutions. The citation of specific 10-K pages (15, 26, 43) demonstrates document engagement. The core semantic message aligns with ground truth: Adobe elevated Target's prominence and emphasized AI-driven personalization capabilities.\n\nWEAKNESSES: (1) The LLM introduces claims not supported by the ground truth, specifically: 'central AI-driven personalization engine of the unified Adobe Experience Platform' and 'tightly coupled with Journey Optimizer' - while Journey Optimizer is mentioned in ground truth as a related solution, the ground truth does not describe Target as the 'central' engine or emphasize tight coupling. (2) The phrase 'moving from a discrete testing tool to an end-to-end orchestration layer' overstates the evolution - ground truth describes it as elevated from 'tool for testing, targeting, and personalizing' to 'AI- and machine learning-driven personalization engine,' but does not characterize it as an 'orchestration layer.' (3) The mention of 'generative-AI' is not explicitly supported by ground truth, which focuses on 'AI and machine learning' without specific reference to generative AI. (4) The claim about 'real-time data from the platform' is not mentioned in the ground truth.\n\nMULTI-HOP REASONING: The LLM attempts to synthesize information across fiscal years and connect it to strategic direction, which is appropriate. However, the synthesis introduces interpretations beyond what the ground truth supports.\n\nFACTUAL ACCURACY: No specific numbers, percentages, or dollar amounts are provided in either answer, so quantitative verification is limited. The fiscal years (2022, 2023) are correct. The core evolution narrative is directionally correct but embellished with unsupported details.\n\nSEMANTIC EQUIVALENCE: While the general thrust is similar (Target became more prominent, AI-driven), the LLM's specific characterizations (central engine, orchestration layer, generative AI) diverge from ground truth's more measured description of elevation and emphasis on AI/ML capabilities.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 613,
        "total_tokens": 1992
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How did Emerson's relationship with AspenTech evolve from 2022 to 2023, particularly in terms of its financial stake and post-acquisition integration activities?",
      "original_answer": "In 2022, Emerson reported a balance of $8,326 million related to AspenTech as part of its acquisitions, indicating a significant financial stake following the acquisition of Heritage AspenTech. By 2023, the relationship had evolved into a more integrated structure, with AspenTech operating as a separate publicly traded company under Emerson's acquisition framework. This included the continuation of AspenTech's stock-based compensation plans, such as stock options and restricted stock units, which were now aligned with AspenTech's own equity structure. Additionally, Emerson was actively managing performance stock units tied to predefined goals like annual contract value and free cash flows, showing a shift from a purely financial stake to a more operationally integrated and incentive-driven relationship.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2023 Emerson’s stake in AspenTech shifted from a newly‑acquired subsidiary to an integrated, publicly‑traded unit whose balances are still reflected in Emerson’s goodwill and intangible‑asset schedules (see EMR 10‑K 2022 p. 61 – $8.3 bn goodwill and $2.3 bn/ $1.35 bn identified intangibles for AspenTech).  The 2022 acquisition converted all outstanding Heritage AspenTech options and restricted‑stock units into AspenTech shares and required Emerson to record post‑combination stock‑based‑compensation expense for those awards (EMR 10‑K 2022 pp. 62, 67; EMR 10‑K 2023 pp. 69‑70).  By 2023 the integration focused on aligning AspenTech’s performance‑based equity awards and reporting its results within Emerson’s consolidated financial statements, while the goodwill and intangible‑asset carrying amounts from the 2022 purchase remained on Emerson’s balance sheet.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive synthesis of Emerson's AspenTech relationship evolution from 2022 to 2023. STRENGTHS: (1) Quantitative accuracy is excellent - the $8.3 billion goodwill figure matches the ground truth's $8,326 million (minor formatting difference acceptable), and the intangible asset amounts ($2.3 bn and $1.35 bn) are correctly cited. (2) Multi-hop reasoning is sound - the answer correctly synthesizes information across multiple 10-K filings (2022 and 2023) and identifies the key transition from newly-acquired subsidiary to integrated publicly-traded unit. (3) Entity accuracy is correct - properly identifies Emerson (EMR), AspenTech, and Heritage AspenTech, with accurate fiscal year references. (4) The answer addresses all key aspects of the question: financial stake evolution, post-acquisition integration activities, stock-based compensation alignment, and performance-based equity awards. (5) Semantic equivalence is maintained - the LLM's description of 'integrated, publicly-traded unit' aligns with ground truth's 'more integrated structure' and 'separate publicly traded company.' MINOR CONSIDERATIONS: The LLM answer provides slightly more granular detail about goodwill and intangible asset carrying amounts remaining on the balance sheet, which adds helpful context beyond the ground truth but doesn't contradict it. The citation of specific page numbers (p. 61, pp. 62, 67, pp. 69-70) demonstrates document-level accuracy. The answer correctly captures the shift from purely financial stake to operationally integrated and incentive-driven relationship through discussion of performance-based equity awards and consolidated reporting. No calculation errors detected, and all financial metrics are accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 484,
        "total_tokens": 1916
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How has Adobe Experience Platform's role within Adobe's customer journey solutions evolved from 2022 to 2023, particularly in terms of its integration with AI-powered tools and cross-channel campaign orchestration?",
      "original_answer": "In 2022, Adobe Experience Platform was described as the foundational infrastructure for Adobe Experience Cloud, enabling data standardization and integration with Adobe Sensei to provide AI-powered services such as automated insights, sentiment analysis, and enhanced anomaly detection. It was central to Adobe's differentiation, supporting applications like Adobe Analytics and Adobe Audience Manager. By 2023, Adobe Experience Platform's role had evolved to become the underlying engine for cross-channel campaign orchestration, particularly through its integration with Adobe Journey Optimizer. This app allowed brands to deliver personalized, connected customer journeys across any channel, using real-time data profiles and cloud-native scalability. Additionally, Adobe Mix Modeler, introduced in 2023 and powered by Adobe Sensei, leveraged cross-channel datasets in Adobe Experience Platform to provide machine learning-driven insights for optimizing marketing investments. This indicates a shift from a general AI-enhanced infrastructure role to a more specialized and actionable function in campaign planning and customer journey orchestration.",
      "llm_answer": "\nFrom 2022 to 2023 Adobe Experience Platform shifted from a primarily data‑unification and analytics layer to the core AI‑driven engine that powers Adobe’s end‑to‑end customer‑journey orchestration.  In the 2023 filing the platform is highlighted as the “AI‑and‑machine‑learning‑driven” hub that feeds real‑time, predictive insights into Journey Optimizer and the broader Experience Cloud stack, enabling brands to activate unified profiles across every channel and to automate personalized, cross‑channel campaign execution at scale—capabilities that go well beyond the 2022 emphasis on data stitching, audience activation, and basic AI‑powered analytics.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy with correct identification of the evolution of Adobe Experience Platform from 2022 to 2023. STRENGTHS: (1) Correctly identifies the shift from data-unification/analytics layer to AI-driven orchestration engine; (2) Accurately names key products (Journey Optimizer, Experience Cloud) and their roles; (3) Properly characterizes the 2023 emphasis on real-time profiles, cross-channel activation, and personalized campaign execution; (4) Correctly references Adobe Sensei as the AI/ML foundation; (5) No quantitative errors or incorrect dates; (6) Multi-hop reasoning is sound - successfully synthesizes the evolution across both years and connects platform capabilities to business outcomes. MINOR GAPS: (1) Does not explicitly mention Adobe Mix Modeler, which was introduced in 2023 and is specifically highlighted in the ground truth as a key evolution demonstrating the shift to marketing investment optimization; (2) Does not mention Adobe Analytics or Adobe Audience Manager as specific applications supported by the platform in 2022, though this is contextual detail rather than core to the answer; (3) The phrase 'basic AI-powered analytics' in the LLM answer is somewhat reductive compared to the ground truth's more specific mention of 'automated insights, sentiment analysis, and enhanced anomaly detection.' The omission of Adobe Mix Modeler is the most significant gap, as it represents a concrete 2023 innovation that exemplifies the platform's evolution. However, the core narrative and characterization of the shift is accurate and well-articulated. The answer successfully addresses the multi-part question regarding integration with AI tools and cross-channel orchestration.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1469,
        "completion_tokens": 474,
        "total_tokens": 1943
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How did UnitedHealth Group's approach to care delivery models evolve from 2023 to 2024 in response to Medicare Advantage funding pressures?",
      "original_answer": "In 2023, UnitedHealth Group emphasized accelerating the transition to value-based care delivery models, investing in clinical engagement, integrated care coordination technology, and new delivery channels like in-home and virtual care. The company viewed these innovations as key to future growth despite initial costs. However, by 2024, the company faced significant funding pressures in the Medicare Advantage program, including reduced benchmarks and risk adjustment changes, which led to operational adjustments. These included selective changes to provider networks, benefit structures, and county-level decisions about plan offerings, indicating a shift from expansion-focused investment to cost containment and strategic retrenchment in response to external financial constraints.",
      "llm_answer": "\nUnitedHealth Group’s 2024 strategy sharpened the cost‑control tactics it had begun testing in 2023: it will intensify medical‑and‑operating‑cost management, reshape the size and makeup of its provider networks, and raise member premiums to partly offset the Medicare Advantage rate cuts and risk‑adjustment reductions highlighted in the 2024 rate notices (page 26 & 27).  At the same time, it is accelerating its shift to value‑based, fully‑accountable care models—expanding home‑based, virtual and coordinated‑care services and using data‑analytics to guide physicians toward high‑quality, affordable treatment—so that the same number of seniors can be served while mitigating the funding pressure described in the 2023‑2024 Medicare Advantage outlook (pages 25 & 27).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth on the core evolution of UnitedHealth Group's approach from 2023 to 2024. STRENGTHS: (1) Correctly identifies the dual-track strategy: cost containment measures (medical/operating cost management, provider network reshaping, premium increases) AND continued acceleration of value-based care models (home-based, virtual, coordinated care). (2) Accurately captures the shift from expansion-focused investment (2023) to cost containment and strategic retrenchment (2024). (3) Properly synthesizes the multi-hop reasoning: Medicare Advantage funding pressures (reduced benchmarks, risk adjustment changes) → operational adjustments. (4) Correctly identifies specific response mechanisms: selective provider network changes, benefit structure adjustments, county-level plan decisions. (5) No quantitative errors detected; page references (25, 26, 27) appear reasonable for SEC filing context. MINOR WEAKNESSES: (1) The LLM answer adds some interpretive language ('will intensify,' 'sharpened') that goes slightly beyond the ground truth's more neutral descriptive tone, though this doesn't constitute factual error. (2) The phrase 'raise member premiums' is a specific tactical detail not explicitly mentioned in the ground truth, though it's a reasonable inference from 'benefit structures' adjustments. (3) The ground truth emphasizes 'clinical engagement' and 'integrated care coordination technology' as 2023 investments, which the LLM answer doesn't explicitly mention, though it does reference 'data-analytics' and 'coordinated-care services.' Overall, the answer successfully addresses the multi-hop synthesis required: comparing 2023 vs 2024 strategies, identifying the causal link to Medicare Advantage pressures, and explaining the evolution from investment to retrenchment while maintaining value-based care acceleration.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 512,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 157,
      "question": "How has the composition of TMO's debt instruments evolved between 2022 and 2023, particularly regarding the 1.950% Notes due 2029?",
      "original_answer": "In 2022, the 1.950% Notes due 2029 were listed among TMO's outstanding debt instruments with the trading symbol TMO 29. In 2023, the 1.950% Notes due 2029 remained present with the same trading symbol TMO 29, indicating continuity in this debt instrument. However, TMO introduced new debt instruments in 2023, such as the 3.200% Notes due 2026 and the 3.650% Notes due 2034, suggesting a broader shift in financing strategy. The continued presence of the 1.950% Notes due 2029 indicates no change in this specific liability, even as TMO expanded its debt portfolio.",
      "llm_answer": "\nBetween the 2022 and 2023 Form 10‑K filings the only change in the company’s registered debt is the addition of newer long‑dated series (e.g., the 2.875 % Notes due 2037 and 1.500 % Notes due 2039) while the 1.950 % Notes due 2029 remained listed as an outstanding issue in both years.  Consequently, the absolute amount of the 1.950 % 2029 notes did not change, but as older maturing notes were retired or repurchased the 2029 series comprised a larger share of TMO’s overall long‑term debt composition.  (See the “Securities registered pursuant to Section 12(b)” tables on page 1 of both the 2022 and 2023 10‑K filings.)",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains both correct and incorrect information. CORRECT ELEMENTS: (1) The 1.950% Notes due 2029 remained outstanding in both 2022 and 2023 - this matches the ground truth. (2) The answer correctly identifies that new debt instruments were added in 2023. (3) The reference to the 'Securities registered pursuant to Section 12(b)' tables is appropriate sourcing. (4) The reasoning about composition changes is sound. INCORRECT/PROBLEMATIC ELEMENTS: (1) The LLM cites '2.875% Notes due 2037 and 1.500% Notes due 2039' as new instruments in 2023, but the ground truth specifically mentions '3.200% Notes due 2026 and 3.650% Notes due 2034' as the new instruments introduced. This is a factual error in identifying which specific debt instruments were added. (2) The LLM makes a claim about 'older maturing notes were retired or repurchased' and that 'the 2029 series comprised a larger share of TMO's overall long-term debt composition' - while this reasoning is logical, the ground truth does not provide evidence of this specific compositional shift or confirm that older notes were retired. The ground truth only states the 1.950% Notes 'remained present' with 'no change in this specific liability.' (3) The LLM's statement that 'the absolute amount of the 1.950% 2029 notes did not change' is presented as fact but is not explicitly confirmed in the ground truth. MULTI-HOP SYNTHESIS: The LLM attempts to synthesize information about debt composition changes across years, which is appropriate for the question. However, the specific debt instruments cited are incorrect, which undermines the accuracy of the synthesis. The core finding about continuity of the 1.950% Notes is correct, but the details about which new instruments were added are wrong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 481,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 159,
      "question": "How has the composition of TMO's debt instruments evolved between 2022 and 2023, particularly regarding the 0.500% Notes due 2028 and the introduction of new note categories?",
      "original_answer": "In 2022, TMO listed the 0.500% Notes due 2028 alongside other debt instruments, including the 1.375% Notes due 2028. By 2023, TMO continued to list the 0.500% Notes due 2028, but introduced new debt categories such as the 3.200% Notes due 2026 and the 3.650% Notes due 2034, while maintaining similar categories like the 1.375% Notes due 2028. This indicates a strategic shift toward diversifying TMO's debt portfolio with new interest rate structures and maturity timelines.",
      "llm_answer": "\nBetween 2022 and 2023 Thermo Fisher added a dedicated 0.500 % senior unsecured tranche that matures in 2028 (listed as “0.500 % Notes due 2028 – TMO 28A”) and, alongside it, introduced a new 1.375 % 2028 tranche (TMO 28), expanding the company’s low‑coupon ladder; the 2023 filing also brought in fresh series with maturities in 2031 (0.875 %), 2032 (2.375 %), 2034 (3.650 %), 2037 (2.875 %), 2039 (1.500 %) and 2049 (1.875 %), which were not part of the 2022 debt profile.  Thus, the composition shifted from a narrower set of short‑ to medium‑term notes to a broader, more staggered maturity schedule that now includes these newly‑issued longer‑dated and lower‑rate tranches.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) FACTUAL ERRORS ON KEY DEBT INSTRUMENTS: The LLM claims the 0.500% Notes due 2028 was 'added' or 'introduced' in 2023, but the ground truth explicitly states it was 'listed in 2022' and 'continued to list' in 2023. This is a fundamental mischaracterization of the evolution. (2) INCORRECT NEW INSTRUMENTS LISTED: The LLM lists several debt instruments (2031 0.875%, 2032 2.375%, 2037 2.875%, 2039 1.500%, 2049 1.875%) that are NOT mentioned in the ground truth answer. The ground truth only identifies 3.200% Notes due 2026 and 3.650% Notes due 2034 as new categories introduced in 2023. The LLM appears to have fabricated or misidentified debt instruments. (3) MISSING KEY INFORMATION: The LLM fails to mention the 3.200% Notes due 2026, which is explicitly identified in the ground truth as a new debt category introduced in 2023. (4) INCOMPLETE SYNTHESIS: While the LLM correctly identifies that the 1.375% Notes due 2028 was maintained, it misrepresents the timeline of the 0.500% Notes due 2028. The ground truth shows continuity of this instrument from 2022 to 2023, not a new introduction. (5) SEMANTIC MISALIGNMENT: The LLM's characterization of 'adding a dedicated 0.500% senior unsecured tranche' contradicts the ground truth's indication that this instrument existed in 2022 and was simply continued in 2023. The core narrative of the answer is therefore incorrect regarding the evolution of TMO's debt composition.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 402,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How has the range of excess fair value over carrying value for DHR's reporting units changed between the 2023 and 2024 annual goodwill impairment analyses?",
      "original_answer": "In 2023, the excess of the estimated fair value over carrying value for DHR's reporting units ranged from approximately 140% to 495%. In 2024, this range decreased to between approximately 70% and 450%. This indicates a reduction in the lowest excess fair value percentage, suggesting a decline in the overall cushion before potential impairment.",
      "llm_answer": "\nThe 2023 goodwill‑impairment test showed an excess of fair value over carrying value of roughly **140 %–495 %** (and, after the Company’s 10 % sensitivity test, about **115 %–435 %**). In the 2024 analysis the same excess fell to about **55 %–395 %** (after the same 10 % hypothetical decline). Thus the range has shifted downward and narrowed, with the low‑end dropping by roughly 85–100 percentage points and the high‑end falling by about 100 percentage points.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual inaccuracies in the 2024 figures. Ground truth states 2024 range is 70%-450%, but LLM reports 55%-395%. This is a material discrepancy - the low end is off by 15 percentage points and the high end is off by 55 percentage points. These are not minor rounding differences but substantial errors that fundamentally misrepresent the data. ADDITIONAL ISSUES: (1) The LLM introduces sensitivity test data (115%-435% for 2023 and 55%-395% for 2024 after 10% decline) that is not part of the ground truth answer. While this additional context may be from the filing, it conflates the primary ranges with adjusted ranges, making the answer confusing and potentially misleading about what the actual 2024 range is. (2) The LLM's calculation of the change ('low-end dropping by roughly 85-100 percentage points') is based on incorrect 2024 figures (55% vs actual 70%), so this analysis is mathematically wrong. (3) The ground truth clearly states the 2024 range as 70%-450%, which the LLM completely misrepresents. WHAT WAS CORRECT: The LLM correctly identifies the 2023 range (140%-495%), correctly identifies DHR as the company, correctly identifies this as a goodwill impairment analysis question, and correctly notes the directional trend (downward shift). The reasoning about narrowing range and declining cushion is sound in principle, but is based on incorrect numbers. MULTI-HOP SYNTHESIS: The question requires comparing two years of data from DHR's filings - the LLM attempted this but failed on the 2024 data accuracy, which is the critical comparison point.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1204,
        "completion_tokens": 449,
        "total_tokens": 1653
      },
      "error": null
    },
    {
      "question_id": 161,
      "question": "How did the treatment of canceled RSUs and tax-withheld shares under the 2022 Employee Stock Plan evolve from 2022 to 2023 in terms of their impact on the available share pool?",
      "original_answer": "In 2022, the 2022 Employee Stock Plan specified that canceled RSUs and shares withheld to satisfy tax withholding obligations would increase the number of shares available for grant under the plan by a factor of two times the number of RSUs canceled or shares withheld. However, in 2023, this specific language regarding the factor of two times for RSUs canceled or shares withheld was omitted, indicating a change in how these events were accounted for in the share pool calculation.",
      "llm_answer": "\nIn the 2022 filing the 2022 Employee Stock Plan stated that canceled RSUs and the shares withheld to cover tax withholding would **increase** the shares reserved for future issuance by a **factor of two** (i.e., each canceled RSU or withheld share was counted as two shares toward the pool). By the 2023 filing that language was removed, so the plan now accounts for such cancellations and withholdings only by the **actual number of shares** involved, eliminating the double‑counting rule and therefore reducing the boost to the available share pool.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is substantially correct and demonstrates strong understanding of the multi-hop question. STRENGTHS: (1) Correctly identifies the 2022 plan language specifying a 'factor of two' multiplier for canceled RSUs and tax-withheld shares, (2) Accurately states this language was removed in 2023, (3) Properly explains the impact: the 2022 rule increased available shares by counting each canceled/withheld share as two shares, while 2023 counts only the actual number, (4) Correctly characterizes this as a reduction in the boost to the available share pool, (5) All numeric references (factor of two) are accurate, (6) Multi-hop synthesis is sound - correctly connects the plan language changes across years to their impact on share pool calculations. MINOR CONSIDERATIONS: The LLM uses slightly different phrasing than the ground truth ('double-counting rule' vs. 'factor of two times') but these are semantically equivalent and both accurately describe the mechanism. The explanation of the practical impact (reducing the boost to available shares) adds helpful context that aligns with the ground truth's implication. No factual errors detected. The answer fully addresses all aspects of the question regarding the evolution from 2022 to 2023 and the impact on the available share pool.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 364,
        "total_tokens": 1630
      },
      "error": null
    },
    {
      "question_id": 162,
      "question": "How has Danaher's strategic relationship with Aldevron evolved between 2023 and 2024, particularly in terms of its financial stake and integration into Danaher's business segments?",
      "original_answer": "In 2023, Danaher had a significant financial stake in Aldevron, as evidenced by the $9,561 million in net cash consideration allocated to Aldevron in the acquisition table, indicating a direct ownership interest. By 2024, Aldevron was no longer listed as a separately accounted stake but had been integrated into the Life Sciences segment as part of Danaher's broader portfolio of acquisitions, including Beckman Coulter, Pall, and IDT. This reflects a strategic shift from holding a standalone stake to full operational integration, aligning Aldevron's capabilities in biopharma research and manufacturing with Danaher’s broader life sciences offerings.",
      "llm_answer": "\nSince the 2021 acquisition, Danaher has moved Aldevron’s bioprocessing consumables and services from the Life Sciences portfolio into its core Biotechnology segment, positioning the business as a key growth engine for the company’s life‑science strategy.  The integration is reflected in the $6.1 billion of goodwill and $3.5 billion of other intangibles recorded at purchase, and Aldevron now contributes several billion dollars of revenue and roughly $1.2 billion of operating profit to the Biotechnology segment’s $7.2 billion 2023 sales.  As a result, Aldevron’s financial stake is tightly woven into Danaher’s overall segment performance and risk profile.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains multiple significant factual errors that contradict the ground truth: (1) ACQUISITION DATE ERROR: The LLM states 'Since the 2021 acquisition' but Aldevron was acquired in 2023, not 2021. This is a fundamental factual error. (2) SEGMENT PLACEMENT ERROR: The LLM claims Aldevron was moved into the 'Biotechnology segment,' but the ground truth clearly states it was integrated into the 'Life Sciences segment.' This is a critical entity misidentification. (3) FINANCIAL STAKE CHARACTERIZATION: The ground truth indicates Aldevron had a $9,561 million net cash consideration in 2023 and was no longer listed separately by 2024, showing full integration. The LLM provides different goodwill ($6.1B) and intangibles ($3.5B) figures that don't align with the ground truth's $9,561M figure and don't address the 2023-2024 evolution properly. (4) REVENUE/PROFIT CLAIMS: The LLM claims Aldevron contributes 'several billion dollars of revenue' and '$1.2 billion of operating profit' to a '$7.2 billion 2023 sales' segment, but these specific figures are not verified in the ground truth and appear inconsistent (if Aldevron alone contributes several billion to a $7.2B total, the math doesn't work). (5) MULTI-HOP REASONING: The question specifically asks about evolution 'between 2023 and 2024,' but the LLM focuses on post-2021 integration without clearly addressing the 2023-2024 transition. The ground truth shows a clear evolution from 'significant financial stake' in 2023 to 'full operational integration' by 2024. The LLM fails to capture this temporal evolution. (6) MISSING KEY INFORMATION: The ground truth mentions integration with other acquisitions (Beckman Coulter, Pall, IDT), which the LLM completely omits. Overall, the answer contains fundamental errors in dates, segment names, and financial figures that make it substantially incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 507,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 163,
      "question": "How has Microsoft's strategic positioning of Microsoft 365 evolved between 2023 and 2024, particularly in terms of its integration with AI technologies and its role in the company's commercial business metrics?",
      "original_answer": "In 2023, Microsoft 365 was described as an 'AI first' platform integrating Office, Windows, Copilot, and Enterprise Mobility + Security, with Copilot for Microsoft 365 combining AI with business data to enhance productivity. By 2024, Microsoft had expanded the Microsoft 365 Consumer subscribers metric to include Microsoft 365 Basic subscribers, aligning with internal business management practices and signaling a broader consumer focus. This evolution reflects a strategic shift toward enhancing AI integration and expanding the product's market reach, particularly within the commercial segment.",
      "llm_answer": "\nBetween fiscal 2023 and 2024 Microsoft deepened the AI integration of Microsoft 365 by embedding Copilot and generative‑AI capabilities across Office, Teams, Viva and Dynamics, and by introducing role‑specific Copilot extensions and the Copilot Studio customization platform—transforming the suite into an AI‑first productivity engine.  This evolution is now reflected in the company’s commercial metrics, with Microsoft 365‑related revenue (Office Commercial and the broader Microsoft Cloud) and subscriber measures (including the expanded Microsoft 365 Basic count) highlighted as key growth indicators in the segment reporting and MD&A.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth on the core strategic evolution of Microsoft 365 between 2023 and 2024. STRENGTHS: (1) Correctly identifies the 'AI-first' positioning and Copilot integration as central to the evolution; (2) Accurately mentions the expansion of Microsoft 365 Basic subscribers metric; (3) Properly synthesizes the multi-hop connection between AI integration and commercial business metrics; (4) Correctly identifies the timeframe (fiscal 2023 to 2024); (5) Appropriately references segment reporting and MD&A as sources for metric changes. MINOR GAPS: (1) The LLM answer provides additional details about Copilot extensions, Copilot Studio, and integration across Teams, Viva, and Dynamics that go beyond the ground truth but are not contradictory—these represent reasonable elaborations; (2) The ground truth emphasizes the 'broader consumer focus' aspect more explicitly, while the LLM answer focuses more on commercial metrics and segment reporting; (3) The LLM mentions 'Office Commercial and the broader Microsoft Cloud' revenue metrics, which adds context but wasn't explicitly in the ground truth. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts were provided in either answer, so this dimension is not directly testable. The references to metrics (Microsoft 365 Basic subscribers, revenue measures) are correctly identified. MULTI-HOP REASONING: The answer successfully synthesizes information across multiple dimensions—AI technology integration, product positioning, and commercial business metrics—demonstrating sound multi-hop reasoning. The connection between AI integration and metric expansion is logically sound. SEMANTIC EQUIVALENCE: The LLM answer conveys the same fundamental information as the ground truth while providing additional context and specificity about implementation details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 510,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How has Microsoft's positioning and emphasis on Copilot Pro evolved between 2023 and 2024, particularly in terms of its role within Microsoft 365 apps and web-based AI assistance?",
      "original_answer": "In 2023, Copilot Pro was introduced as a consumer subscription service that offered 'faster and more powerful AI assistance in Microsoft 365 apps and on the web.' By 2024, while the core definition remained consistent, the emphasis on Copilot Pro's differentiation and innovation appeared more pronounced, with language such as 'faster and more powerful AI assistance' retained but now embedded within a broader narrative of AI-driven transformation across Microsoft's ecosystem. This suggests a strategic evolution where Copilot Pro is not only a standalone offering but increasingly integrated into the broader AI-first positioning of Microsoft's productivity suite.",
      "llm_answer": "\nBetween 2023 and 2024 Microsoft moved Copilot Pro from a newly announced consumer‑subscription that simply “offers faster and more powerful AI assistance in Microsoft 365 apps and on the web” to a core, tightly‑integrated pillar of the Microsoft 365 ecosystem.  The 2024 narrative stresses deeper app‑level integration, role‑specific extensions (e.g., Copilot for Sales, Service, Finance), the ability for users to customize Copilot via Copilot Studio, and linkage to Windows 11 and the new Copilot+ PC class, positioning Copilot Pro as the primary consumer‑facing AI interface for both productivity and web‑based assistance.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual issues that diverge from the ground truth. CORRECT ELEMENTS: (1) The LLM correctly identifies the 2023 baseline description of Copilot Pro as 'faster and more powerful AI assistance in Microsoft 365 apps and on the web' - this matches the ground truth. (2) The LLM correctly identifies the timeframe (2023-2024) and the general concept of evolution/positioning change. (3) No quantitative errors in dates or numbers (both answers avoid specific metrics). CRITICAL ERRORS: (1) The ground truth states the 2024 emphasis remained 'consistent' with 2023 language, with the evolution being more about 'pronounced emphasis' and 'broader narrative of AI-driven transformation.' The LLM instead claims a dramatic shift to 'core, tightly-integrated pillar' and 'primary consumer-facing AI interface' - this overstates the evolution and mischaracterizes the ground truth's more measured assessment. (2) The LLM introduces specific product details (Copilot for Sales, Service, Finance; Copilot Studio; Windows 11; Copilot+ PC) that are NOT mentioned in the ground truth. While these may be factually accurate about Microsoft's 2024 offerings, they represent information beyond what the knowledge graph provided and suggest the LLM is extrapolating beyond the source material. (3) The ground truth emphasizes that Copilot Pro is 'not only a standalone offering but increasingly integrated' - a nuanced positioning. The LLM's framing of it as 'the primary consumer-facing AI interface' is more absolutist and doesn't capture this nuance. MULTI-HOP REASONING: The LLM attempts to synthesize evolution across years but does so by introducing unsupported details rather than carefully analyzing the actual positioning statements from the filings. The reasoning quality is compromised by factual overreach. SEMANTIC EQUIVALENCE: While both answers discuss evolution and integration, they differ fundamentally in the magnitude and nature of that evolution - the ground truth suggests continuity with enhanced emphasis, while the LLM suggests a major strategic repositioning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 564,
        "total_tokens": 1895
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How has the structure and availability of the 2007 Omnibus Incentive Plan evolved between 2023 and 2024, particularly in terms of remaining shares available for issuance?",
      "original_answer": "In 2023, the 2007 Omnibus Incentive Plan was described in the context of PSU and RSU awards, vesting conditions, and valuation methods, but no specific figure was provided regarding the remaining shares available for issuance. In contrast, by 2024, the plan explicitly stated that approximately 47 million shares of Danaher common stock remained available for issuance under the plan as of December 31, 2024 (excluding shares underlying outstanding awards). This indicates a more transparent disclosure and potential depletion or tracking of the share pool since the plan's inception, showing a shift in how the company communicates the availability of shares under the plan.",
      "llm_answer": "\nBetween 2023 and 2024 the 2007 Omnibus Incentive Plan kept the same governing language and the original 135 million‑share authorization, but the unused portion of that pool slipped modestly – from roughly **48 million shares available at the end of 2023 to about 47 million shares available at the end of 2024** (as disclosed in the 2024 filing, which notes “approximately 47 million shares … remain available for issuance … (excluding shares underlying outstanding awards)”).  This reduction reflects the shares used for option exercises, RSU/PSU vestings and the company’s recent repurchase activity, while the plan’s structure and the total authorized share reserve remained unchanged.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY FAILURE: The LLM claims 48 million shares were available at the end of 2023, but the ground truth explicitly states 'no specific figure was provided regarding the remaining shares available for issuance' in 2023. This is a major factual error - the LLM invented a 2023 figure that does not exist in the source documents. (2) The LLM correctly identifies ~47 million shares available at end of 2024, which matches the ground truth. (3) MULTI-HOP REASONING FAILURE: The LLM attempts to calculate a year-over-year change (48M to 47M = 1M reduction) but this calculation is based on a non-existent 2023 figure. The ground truth explicitly notes that 2023 had no disclosed figure, making any comparison invalid. (4) STRUCTURAL CLAIMS: The LLM claims the plan kept 'the same governing language and the original 135 million-share authorization' - this information is not present in the ground truth and appears to be unsupported inference. (5) ATTRIBUTION OF CHANGES: The LLM attributes the reduction to 'option exercises, RSU/PSU vestings and repurchase activity' but the ground truth does not provide this level of detail about causes. (6) DISCLOSURE EVOLUTION: The ground truth emphasizes a shift toward 'more transparent disclosure' in 2024, which the LLM mentions but downplays by focusing on the modest numerical change rather than the disclosure improvement. The fundamental problem is that the LLM fabricated a 2023 baseline figure (48M shares) that contradicts the ground truth's explicit statement that no such figure was disclosed in 2023.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 438,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did Microsoft's accounting policy regarding the estimated useful lives of server and network equipment evolve between fiscal years 2023 and 2024, and what factors influenced this change?",
      "original_answer": "In fiscal year 2023, Microsoft increased the estimated useful lives of server and network equipment from four years to six years, effective beginning fiscal year 2023. This change was driven by investments in software that improved operational efficiencies and advances in technology. In fiscal year 2024, the policy remained consistent with the updated six-year estimate, indicating that the initial change was sustained and likely integrated into ongoing asset management practices. The continued focus on cloud and AI infrastructure investments further supported the rationale behind extending the useful lives of these assets.",
      "llm_answer": "\nMicrosoft extended the estimated useful life of its server and network equipment from **four years to six years**, a change that took effect at the start of fiscal 2023 and remained in place through fiscal 2024. The extension was driven by greater software‑driven efficiencies and advances in technology that lengthened the operational lifespan of the hardware, prompting the company to revise its accounting estimate accordingly. No further alteration to the useful‑life assumption was reported for fiscal 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct and well-structured. STRENGTHS: (1) All numeric values are accurate - correctly identifies the change from four years to six years, the fiscal 2023 effective date, and the continuation through fiscal 2024. (2) Quantitative accuracy is perfect - no calculation errors or date misstatements. (3) The core facts are correct: the policy change, its timing, and the factors driving it (software-driven efficiencies and technology advances). (4) The answer correctly synthesizes the multi-hop information showing the evolution across two fiscal years. (5) Semantic equivalence is maintained - 'took effect at the start of fiscal 2023' matches 'effective beginning fiscal year 2023'. MINOR WEAKNESSES: (1) The LLM answer omits one contextual detail from the ground truth: the specific mention of 'cloud and AI infrastructure investments' as a supporting factor for the extended useful lives in fiscal 2024. While the answer mentions 'advances in technology,' it doesn't explicitly connect this to the company's strategic cloud and AI focus that the ground truth emphasizes. (2) The phrase 'greater software‑driven efficiencies' is slightly less precise than the ground truth's 'investments in software that improved operational efficiencies,' though the meaning is semantically equivalent. The answer demonstrates solid multi-hop reasoning by correctly tracking the policy across two fiscal years and explaining the rationale, but misses the opportunity to provide the fuller strategic context around cloud/AI investments that would have elevated it to a 9-10 score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 439,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did MDT's exposure to auction rate securities evolve from 2022 to 2023 in terms of fair value and classification within the balance sheet?",
      "original_answer": "In 2022, MDT reported auction rate securities with a fair value of $33 million and classified them under 'Total' in the investment portfolio without specifying a separate balance sheet classification. By 2023, the fair value of auction rate securities remained at $33 million, but they were explicitly classified under 'Other Assets' instead of being included in the broader investment category. This indicates a shift in how MDT categorized these securities on its balance sheet, moving from a general investment classification to a more distinct reporting under other assets.",
      "llm_answer": "\nMedtronic’s auction‑rate securities were carried at a fair value of **$33 million** in both fiscal 2022 and fiscal 2023.  Throughout this period they remained classified as **Level 3** measurements within **other assets** (i.e., available‑for‑sale debt securities) on the consolidated balance sheet.",
      "correctness_score": 4,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "QUANTITATIVE ACCURACY: The fair value of $33 million for both 2022 and 2023 is correct. However, the LLM introduces additional details (Level 3 measurements, available-for-sale debt securities classification) that are not mentioned in the ground truth and cannot be verified against it.\n\nQUALITATIVE ACCURACY - MAJOR ISSUES: The LLM answer fundamentally misrepresents the evolution described in the ground truth. The original answer explicitly states a SHIFT in classification: from 2022 (classified under 'Total' in investment portfolio without separate balance sheet classification) to 2023 (explicitly classified under 'Other Assets'). The LLM answer claims they \"remained classified as Level 3 measurements within other assets\" throughout both periods, which contradicts the ground truth's core finding of a change in classification. The LLM suggests no evolution occurred (\"Throughout this period\"), directly contradicting the question's premise about how exposure \"evolved.\"\n\nMULTI-HOP REASONING: The question asks specifically about the evolution FROM 2022 TO 2023. The ground truth identifies a clear transition: 2022 had general investment classification → 2023 had explicit 'Other Assets' classification. The LLM fails to capture this temporal evolution and instead presents a static picture claiming consistency across both years.\n\nCONTEXTUAL RELEVANCE: While the LLM addresses the fair value component correctly, it misses the primary point of the question - the CHANGE in balance sheet classification. The introduction of Level 3 and available-for-sale terminology, while potentially accurate, is not part of the ground truth answer and represents speculation beyond the provided data.\n\nCORE PROBLEM: The LLM answer contradicts the ground truth's central finding that there was a shift in classification from 2022 to 2023. This is a fundamental error in understanding the multi-hop synthesis required by the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1218,
        "completion_tokens": 525,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "How did the net gains or losses from Cisco's available-for-sale debt investments change between fiscal years 2023 and 2024, and what does this indicate about the company's investment performance in this category?",
      "original_answer": "In fiscal year 2023, Cisco reported a net loss of $21 million from its available-for-sale debt investments, while in fiscal year 2024, this loss increased to $67 million. This indicates a significant worsening in investment performance related to this category year-over-year.",
      "llm_answer": "\nThe net loss on Cisco’s available‑for‑sale debt investments widened from $21 million in fiscal 2023 to $67 million in fiscal 2024 – an increase of roughly $46 million. This deterioration signals that the company’s debt‑investment portfolio underperformed in 2024, likely reflecting the adverse impact of rising interest rates and market‑value declines on the fair‑value of those securities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. Quantitative verification: (1) FY2023 loss of $21 million - CORRECT, (2) FY2024 loss of $67 million - CORRECT, (3) Year-over-year change calculation of $46 million ($67M - $21M) - CORRECT. All numeric values match the ground truth exactly. Entity accuracy is sound: Cisco correctly identified, available-for-sale debt investments correctly specified, fiscal years 2023 and 2024 correctly referenced. The multi-hop reasoning is sound - the model correctly synthesized the comparison across two fiscal years and calculated the deterioration. The LLM answer goes beyond the ground truth by providing contextual interpretation (rising interest rates, market-value declines) which adds value without contradicting the factual basis. The characterization of the change as a 'widening' of losses and 'deterioration' in performance aligns semantically with the ground truth's description of 'significant worsening.' The only minor distinction is that the LLM provides speculative explanation for the cause (interest rates, fair-value declines) which, while reasonable and not contradicted by the ground truth, represents inference beyond what was explicitly stated in the original answer. This is a minor enhancement rather than an error. The answer fully addresses both parts of the question: the numerical change and what it indicates about investment performance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1183,
        "completion_tokens": 394,
        "total_tokens": 1577
      },
      "error": null
    },
    {
      "question_id": 170,
      "question": "How did Cisco's approach to the APJC region evolve between 2023 and 2024 in terms of operational structure versus financial investment, and what implications does this have for its revenue model in that region?",
      "original_answer": "In 2023, Cisco directly operated in the APJC region as one of its three geographic segments, indicating a strong operational presence focused on delivering products and services. By 2024, Cisco's relationship with APJC evolved to include financial investments, specifically through equity instruments categorized as marketable equity securities, non-marketable equity securities, and equity method investments. While the 2023 filing emphasized operational delivery and customer engagement in APJC, the 2024 financial statements suggest a parallel strategy of capital participation, potentially signaling a shift toward leveraging local market growth through investment rather than solely through direct sales. This dual approach could indicate a broader revenue model incorporating both operational income and investment returns, though the filings do not quantify the specific financial impact of these investments on Cisco's APJC revenue.",
      "llm_answer": "\nBetween fiscal 2023 and 2024 Cisco’s APJC segment contracted both in absolute terms (‑8 % revenue) and as a share of total sales (down from 15.6 % to 14.3 %), signalling that the company is pulling back on the resources it devotes to that geography and re‑allocating investment toward higher‑margin subscription and AI‑driven services (including the Splunk integration) and toward other regions.  This strategic shift means the APJC revenue model is moving away from large, one‑time product sales toward a greater reliance on recurring, subscription‑based revenue, even though overall growth in the region is now modest.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer is fundamentally misaligned with the ground truth and the question being asked. Critical issues: (1) QUANTITATIVE ERRORS: The LLM provides specific revenue decline figures (-8% revenue, share declining from 15.6% to 14.3%) that are not mentioned in the ground truth answer. These numbers cannot be verified against the provided context and appear to be fabricated or from unverified sources. (2) MISINTERPRETATION OF QUESTION: The original question asks about evolution in 'operational structure versus financial investment' and implications for revenue model. The ground truth correctly identifies a shift from direct operations (2023) to financial investments through equity instruments (2024). The LLM completely misses this core distinction and instead focuses on revenue contraction and subscription model shifts, which are not addressed in the ground truth. (3) MISSING KEY INFORMATION: The LLM fails to mention the critical finding that Cisco moved from operating APJC as a geographic segment (2023) to making financial investments in the region (2024) through marketable equity securities, non-marketable equity securities, and equity method investments. This is the central evolution the question asks about. (4) UNSUPPORTED CLAIMS: The LLM makes assertions about 'pulling back on resources,' 'reallocation toward subscription and AI-driven services,' and 'Splunk integration' that are not substantiated in the ground truth answer and appear to be speculative. (5) MULTI-HOP REASONING: The LLM fails to synthesize the operational-to-investment transition that represents the actual multi-hop insight. Instead, it provides a different narrative about revenue model shifts that doesn't align with the ground truth's emphasis on the structural change in how Cisco engages with APJC. The answer demonstrates a fundamental misunderstanding of what the question is asking and provides information that contradicts or diverges significantly from the established ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 537,
        "total_tokens": 1943
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How has Apple's approach to App Store commissions and regulatory compliance evolved between 2022 and 2024, particularly in response to legal and market pressures?",
      "original_answer": "In 2022, Apple acknowledged that changes to the App Store, including those in response to legal and market conditions, could reduce the volume of sales and the commission it earns on those sales, potentially affecting its financial condition. By 2024, Apple had implemented specific changes, particularly in the U.S. and the European Union, to address legal pressures such as the Digital Markets Act (DMA). These changes included new business terms, alternative fee structures, alternative app distribution methods, and additional developer tools and APIs. These adjustments reflect a shift from a more general acknowledgment of potential changes to concrete actions taken in response to regulatory demands, which could significantly affect App Store revenue and commission structures.",
      "llm_answer": "\nApple’s App Store policy has shifted from a static 30 % commission model in 2022—where the company warned that legal actions and the EU Digital Markets Act could force “further changes” to how it charges developers—to an actively revised approach by 2024 that incorporates the DMA‑mandated alternative fee structures, new distribution channels and external payment options, while also responding to U.S. antitrust litigation that compelled it to allow alternative purchasing mechanisms. This evolution reflects a move from merely acknowledging regulatory pressure to implementing concrete commission‑reduction and payment‑process changes to stay compliant and preserve revenue.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth on the core narrative of Apple's App Store evolution from 2022 to 2024. STRENGTHS: (1) Correctly identifies the 30% commission model as the baseline in 2022; (2) Accurately references the Digital Markets Act (DMA) as a key regulatory driver; (3) Properly synthesizes the multi-hop evolution: from 2022 acknowledgment of potential changes to 2024 concrete implementation; (4) Correctly identifies specific 2024 changes including alternative fee structures, new distribution channels, and external payment options; (5) Appropriately mentions U.S. antitrust litigation as a parallel pressure; (6) Captures the semantic shift from passive acknowledgment to active compliance. MINOR WEAKNESSES: (1) The phrase 'commission-reduction' is somewhat interpretive—the ground truth states changes 'could significantly affect' commission structures but doesn't explicitly confirm reductions occurred; (2) The claim about 'preserve revenue' adds interpretive reasoning not explicitly stated in ground truth; (3) Could have been more explicit about the EU-specific nature of some changes (DMA is EU-focused). QUANTITATIVE ACCURACY: The 30% figure is correct and appropriately contextualized. No calculations required. MULTI-HOP REASONING: The answer successfully synthesizes information across 2022-2024 timeline and connects regulatory pressures (DMA, U.S. litigation) to concrete policy changes. SEMANTIC EQUIVALENCE: The answer conveys the same essential information as ground truth with appropriate elaboration. The characterization of the evolution from 'general acknowledgment' to 'concrete actions' matches the ground truth's framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 462,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How did the allocation strategy for Texas Instruments' U.S. Retiree Health Care Plan evolve between fixed income securities and equity securities from 2022 to 2024?",
      "original_answer": "In 2022, the U.S. Retiree Health Care Plan had a diversified mix of fixed income securities and equity securities, with fixed income and cash equivalents totaling $248 million and equity securities at $137 million. By 2024, the allocation strategy showed a significant shift toward a more conservative posture, with fixed income securities and cash equivalents comprising 80% of the portfolio, while equity securities made up only 20%. This reflects a notable increase in emphasis on fixed income securities compared to equities, even though the relative proportions remained the same between 2023 and 2024, suggesting a strategic decision to prioritize capital preservation.",
      "llm_answer": "\nBetween 2022 and 2024 the U.S. Retiree Health Care Plan shifted its asset mix from roughly 64 % fixed‑income / 36 % equity (as shown in the 2022 filing’s plan‑asset table) to about 80 % fixed‑income / 20 % equity by year‑end 2024.  This move brings the allocation closer to the plan’s target range of 75‑85 % fixed income and 15‑25 % equity, reflecting a deliberate rebalancing toward a higher fixed‑income weighting over the two‑year period.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy with correct identification of the allocation shift from approximately 64% fixed-income/36% equity in 2022 to 80% fixed-income/20% equity by 2024. The percentages are mathematically sound: $248M fixed income / ($248M + $137M) = 64.4% and the 2024 80/20 split are accurate. The answer correctly identifies this as a shift toward a more conservative posture and capital preservation strategy. The LLM adds valuable context by referencing the plan's target range of 75-85% fixed income and 15-25% equity, which provides helpful framing for understanding the strategic intent. However, the LLM answer omits the specific dollar amounts ($248M and $137M for 2022) that were included in the ground truth, which would have provided more complete quantitative detail. The multi-hop reasoning is sound—the answer synthesizes the 2022 baseline, 2024 endpoint, and strategic implications correctly. The statement about proportions remaining the same between 2023 and 2024 from the ground truth is not explicitly addressed, though this is a minor omission. The answer's focus on the two-year evolution and the deliberate rebalancing strategy aligns well with the question's intent. The semantic meaning matches the ground truth regarding the shift toward fixed income emphasis and capital preservation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 372,
        "total_tokens": 1656
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How has Texas Instruments' strategic emphasis on Embedded Processing Products evolved from 2022 to 2024, particularly in terms of its contribution to the company's competitive advantages and segment reporting structure?",
      "original_answer": "In 2022, Texas Instruments described Embedded Processing as one of its core product lines within a broader business model that emphasized four competitive advantages: manufacturing and technology strength, a broad product portfolio, strong market channels, and product diversity and longevity. Embedded Processing was positioned as part of this integrated strategy but was not highlighted as a standalone reportable segment. By 2024, Embedded Processing was elevated to a reportable segment alongside Analog, indicating a strategic shift where the company explicitly called out Embedded Processing as a key driver of value. This change suggests that Embedded Processing has become more central to TI's competitive positioning, particularly in terms of enabling optimized performance, power, and cost across a range of customer applications. The elevation to a reportable segment also implies greater operational and financial focus, aligning with the company’s long-term objective of strengthening its competitive advantages and driving free cash flow growth.",
      "llm_answer": "\nFrom the 2022 filing (pp. 18‑23) Embedded Processing was presented as a growth engine—revenue rose 19 % in 2021 and the segment posted $1.174 bn of operating profit, reinforcing TI’s four sustainable competitive advantages and its focus on industrial and automotive markets. In the 2024 filing (pp. 20, 30, 32) the segment’s revenue slipped 25 % YoY to $2.53 bn and operating profit fell 65 % to $352 m, yet it remains a distinct reportable segment that the CODM uses to gauge performance; the downturn indicates a shift from an aggressive growth emphasis to a more defensive, still‑critical role within TI’s overall analog‑and‑embedded strategy.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) FACTUAL ERRORS ON SEGMENT STATUS: The LLM claims Embedded Processing was a reportable segment in 2022 with $1.174bn operating profit, but the ground truth explicitly states it was NOT a reportable segment in 2022—it was only elevated to reportable status by 2024. This is a fundamental misunderstanding of the core question. (2) UNVERIFIABLE NUMBERS: The LLM provides specific 2022 figures ($1.174bn operating profit, 19% revenue growth) and 2024 figures ($2.53bn revenue, $352m operating profit, 65% decline) that cannot be verified against the ground truth and appear inconsistent with the narrative. The ground truth does not provide these specific numbers, suggesting the LLM may have fabricated or misattributed data. (3) INCOMPLETE MULTI-HOP SYNTHESIS: The question asks about evolution from 2022-2024 in terms of (a) contribution to competitive advantages and (b) segment reporting structure. The ground truth clearly addresses both: in 2022, Embedded Processing was part of an integrated strategy with four competitive advantages but NOT a standalone segment; by 2024, it became a reportable segment, indicating strategic elevation. The LLM partially addresses segment reporting but incorrectly backdates the reportable segment status to 2022. (4) REASONING QUALITY: The LLM's interpretation of the downturn (shift from 'aggressive growth' to 'defensive role') is speculative and not supported by the ground truth, which focuses on the elevation to reportable status as indicating greater strategic importance. (5) SEMANTIC MISALIGNMENT: The ground truth emphasizes strategic elevation and increased focus; the LLM emphasizes financial decline and defensive positioning—these are contradictory interpretations of the same evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 481,
        "total_tokens": 1926
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did TMO's issuance and valuation of its 2.00% 10-Year Senior Notes evolve between 2022 and 2024?",
      "original_answer": "In 2022, TMO reported $1,200 million in 2.00% 10-Year Senior Notes due on October 15, 2031, with an effective interest rate of 2.23%. By 2024, the same category of 2.00% 10-Year Senior Notes showed no change in the principal amount at $1,200 million, and the effective interest rate remained at 2.23%. This indicates that TMO maintained a consistent position on this specific debt instrument over the two-year period, with no new issuances or repayments affecting this line item.",
      "llm_answer": "\nThermo Fisher issued the 2.00 % 10‑Year Senior Notes (due 2031) through its finance subsidiary in 2022, initially recording a carrying amount of roughly $1.2 billion at an effective interest rate of 2.23 %. By the end of 2024 the notes remained outstanding with essentially the same carrying value (≈ $1.2 billion), reflecting the ongoing amortization of the original discount and issuance costs and a stable effective rate of about 2.23 % over the 2022‑2024 period.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of all key financial metrics. Quantitative verification: (1) Principal amount of $1.2 billion is correct for both 2022 and 2024; (2) Effective interest rate of 2.23% is accurate; (3) Due date of 2031 (October 15, 2031) is correct; (4) Coupon rate of 2.00% is accurate. The multi-hop synthesis is sound - the answer correctly traces the debt instrument across the 2022-2024 period and identifies that no changes occurred in principal or effective rate. The reasoning about amortization of discount and issuance costs is appropriate and adds helpful context. Minor deviations from ground truth: (1) The LLM mentions 'finance subsidiary' issuance, which is not explicitly stated in the ground truth (though not contradicted); (2) The phrasing 'carrying amount of roughly $1.2 billion' uses 'roughly' while ground truth states exact $1,200 million - this is a minor semantic difference that doesn't affect accuracy; (3) The LLM provides additional context about amortization mechanics that, while reasonable and not incorrect, goes slightly beyond what the ground truth explicitly states. The answer correctly conveys that the position remained stable with no new issuances or repayments, matching the ground truth conclusion. All numeric values are formatted correctly and calculations are accurate. The answer appropriately addresses the 'evolution' aspect of the question by confirming consistency rather than change.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1225,
        "completion_tokens": 413,
        "total_tokens": 1638
      },
      "error": null
    },
    {
      "question_id": 178,
      "question": "How has the financial performance of REMICADE evolved between 2022 and 2024, and what does this indicate about its role in Johnson & Johnson's Pharmaceutical segment?",
      "original_answer": "In 2022, REMICADE was listed as a key product in Johnson & Johnson's Pharmaceutical segment, specifically within the Immunology therapeutic area, indicating its importance in treating immune-mediated inflammatory diseases. By 2024, REMICADE's sales had declined significantly, from $1,839 million in 2023 to $1,605 million in 2024, representing a 12.8% decrease. This decline suggests a diminishing contribution of REMICADE to the company's Immunology revenue, potentially due to market saturation, increased competition, or the emergence of newer biologics within the segment.",
      "llm_answer": "\nREMICADE’s sales have continued to fall: the 2024 10‑K shows $1.6 billion in 2024, a 12.8 % drop from $1.84 billion in 2023, and the 2022 filing reported roughly $2.0 billion in the prior year. This double‑digit decline reflects mounting competitive and biosimilar pressure, causing REMICADE’s contribution to the Pharmaceutical (Innovative Medicine) segment to erode and highlighting the segment’s shift toward newer immunology and oncology products.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct financial figures and calculations. Verified numbers: 2024 sales of $1.6 billion (matches $1,605 million), 2023 sales of $1.84 billion (matches $1,839 million), and the 12.8% decline calculation is accurate. The mention of 2022 sales at 'roughly $2.0 billion' is reasonable approximation language and consistent with the trajectory described. The LLM correctly identifies the multi-hop synthesis: tracking REMICADE's performance across years, understanding its role in the Pharmaceutical segment, and explaining the decline through competitive/biosimilar pressures. The answer appropriately contextualizes the decline within J&J's broader segment strategy (shift toward newer products). Minor strengths: the LLM adds valuable context about biosimilar pressure and segment repositioning that enhances understanding. Minor weaknesses: (1) The original answer specifically mentions 'Immunology therapeutic area' which the LLM generalizes to 'immunology and oncology products' - this is a slight broadening but not incorrect; (2) The original answer notes 'market saturation' as a potential cause while the LLM emphasizes 'competitive and biosimilar pressure' - both are valid interpretations but slightly different emphasis; (3) The LLM uses 'Innovative Medicine' in parentheses which is appropriate segment terminology. The reasoning is sound and multi-hop synthesis is correct: connecting 2022-2024 performance data, understanding therapeutic area positioning, and drawing conclusions about segment evolution. All core facts align with ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 442,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 179,
      "question": "How did the sales performance of REMICADE evolve from 2022 to 2024, and what does this indicate about its market position within JNJ's Immunology portfolio?",
      "original_answer": "In 2022, REMICADE had sales of $3,190 million, showing a decline of 14.9% compared to 2020. By 2024, its sales had further decreased to $1,605 million, representing a 12.8% drop from 2023. This consistent decline indicates a weakening market position of REMICADE within JNJ's Immunology portfolio over time.",
      "llm_answer": "\nREMICADE’s worldwide sales fell 12.8 % year‑over‑year, dropping from $1.84 billion in 2023 to $1.61 billion in 2024 (J&J 2024 10‑K, page 31).  While the overall Immunology portfolio grew modestly (0.4 % operational growth in 2024), REMICADE’s decline contrasts sharply with the double‑digit gains posted by newer Immunology products such as STELARA and TREMFYA, indicating that REMICADE is losing market share and its competitive position within J&J’s Immunology franchise is eroding.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual inaccuracies that undermine its credibility. (1) MAJOR DISCREPANCY - 2024 Sales Figure: Ground truth states REMICADE sales were $1,605 million in 2024, but LLM claims $1.61 billion ($1,610 million). While this is close, the LLM also states 2023 sales were $1.84 billion ($1,840 million), which contradicts the ground truth's 2024 figure of $1,605 million and the stated 12.8% decline calculation. If 2024 was $1,605M and declined 12.8% from 2023, then 2023 should have been approximately $1,840M, which the LLM correctly identifies. However, the ground truth does not provide 2023 sales data, only 2022 ($3,190M) and 2024 ($1,605M). (2) MISSING 2022 DATA: The LLM completely omits the 2022 sales figure of $3,190 million mentioned in the ground truth, which is critical for showing the evolution from 2022 to 2024. The question specifically asks about the evolution from 2022 to 2024, requiring both data points. (3) INCOMPLETE MULTI-HOP SYNTHESIS: The LLM fails to synthesize the full timeline. Ground truth shows: 2022 = $3,190M (down 14.9% from 2020), 2024 = $1,605M (down 12.8% from 2023). This represents a dramatic 50% decline over two years, which the LLM does not capture. (4) QUALITATIVE REASONING: The LLM's reasoning about market position erosion and comparison to STELARA/TREMFYA is sound and relevant, but it's based on incomplete data presentation. (5) CALCULATION VERIFICATION: The 12.8% decline from $1.84B to $1.61B is mathematically correct ($1.84B × 0.872 ≈ $1.60B), but this represents only the 2023-2024 period, not the full 2022-2024 evolution requested. The answer provides good contextual analysis but fails on the fundamental requirement of presenting the complete 2022-2024 sales evolution with accurate figures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1200,
        "completion_tokens": 494,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 180,
      "question": "How has the sales performance of REMICADE evolved between 2021 and 2024, and what factors contributed to this change?",
      "original_answer": "REMICADE's sales declined significantly from $16.8 billion in 2021 (as part of total Immunology sales) to $1,605 million in 2024, reflecting a 12.8% decrease from 2023 to 2024 alone. This decline was primarily driven by biosimilar competition in the U.S. and other global markets, which intensified over time and led to a continued reduction in REMICADE sales.",
      "llm_answer": "\nBetween 2021 and 2024 REMICADE’s sales fell sharply – from about **$3.19 billion in 2021** to **$1.84 billion in 2023** (a ~42 % drop) and then to **$1.61 billion in 2024** (an additional ~13 % decline).  The downturn reflects growing biosimilar competition after the U.S. patent expired, continued price‑pressure and market‑share losses, plus a negative operational trend (‑11.4 % in 2024) and modest currency headwinds (‑1.4 %).  These factors outweighed any gains from the broader Innovative Medicine segment, which grew 4 % overall in 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains fundamentally incorrect numbers that contradict the ground truth. (1) 2021 REMICADE sales: LLM states $3.19 billion, but ground truth indicates $16.8 billion (as part of Immunology sales). This is a massive discrepancy - the LLM understated 2021 sales by approximately 81%. (2) 2023 sales: LLM states $1.84 billion, but ground truth indicates the 2024 figure is $1.605 billion with a 12.8% decline from 2023, which would place 2023 at approximately $1.84 billion - this number happens to be close but appears coincidental given other errors. (3) 2024 sales: LLM states $1.61 billion, which matches ground truth ($1.605 billion) - this is correct. (4) Percentage calculations: LLM claims ~42% drop from 2021 to 2023, but with incorrect 2021 baseline ($3.19B vs actual $16.8B), this calculation is invalid. The actual decline from 2021 to 2024 would be approximately 90%, not the implied trajectory shown. (5) The LLM provides additional operational metrics (-11.4% in 2024, -1.4% currency headwinds) that are not mentioned in the ground truth and cannot be verified. QUALITATIVE ASSESSMENT: The LLM correctly identifies biosimilar competition as a key factor, which aligns with ground truth. However, the mention of U.S. patent expiration and specific operational/currency metrics adds detail not in the ground truth, making it difficult to assess accuracy. The reasoning about market pressures is sound but built on incorrect foundational numbers. MULTI-HOP SYNTHESIS: The answer attempts to synthesize sales trends across years and connect them to causal factors, but the fundamental numerical errors undermine the entire analysis. The comparison to Innovative Medicine segment growth (4% in 2024) is not addressed in ground truth and cannot be verified. CONCLUSION: While the LLM demonstrates understanding of the general trend (declining sales due to biosimilar competition), the quantitative foundation is severely flawed, particularly the 2021 baseline figure which is off by over $13 billion.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1219,
        "completion_tokens": 554,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 181,
      "question": "How did the status and commercial performance of STELARA (ustekinumab) evolve between 2022 and 2024?",
      "original_answer": "In 2022, STELARA was in the filing stage for the treatment of pediatric patients with juvenile psoriatic arthritis in the U.S., indicating it was under regulatory review but not yet approved. By 2024, STELARA had achieved significant commercial success, generating $10,361 million in sales, a decrease from $10,858 million in 2023, representing a 4.6% decline in total sales. This reflects that STELARA had transitioned from a product in active regulatory development to a mature, high-revenue-generating drug facing slight sales decline, suggesting market saturation or increased competition.",
      "llm_answer": "\nSTELARA (ustekinumab) remained a core Immunology product, generating about $10.9 billion in sales in 2023 and $10.4 billion in 2024—a 4.6 % year‑over‑year decline driven by a ‑3.4 % operational drop and a ‑1.2 % currency impact.  The downturn began after the U.S. patent expired in September 2023, when biosimilar competition entered the market, causing the franchise’s growth that had persisted through 2022 (when it was already a ~$5.9 billion business in 2021) to stall and reverse.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the 2023-2024 sales figures ($10.9B in 2023, $10.4B in 2024) and accurately calculates the 4.6% year-over-year decline. The breakdown of the decline into operational (-3.4%) and currency (-1.2%) components is precise. The identification of the September 2023 patent expiration and subsequent biosimilar competition as the cause of the downturn is accurate and provides valuable context. WEAKNESSES: The LLM answer fails to address the 2022 status mentioned in the original question. The ground truth explicitly states that in 2022, STELARA was 'in the filing stage for the treatment of pediatric patients with juvenile psoriatic arthritis in the U.S.' The LLM does not mention this regulatory development milestone at all. Instead, it references 2021 sales (~$5.9B) which, while contextually useful, does not fulfill the requirement to discuss 2022 status. The LLM answer also does not clearly establish the transition from regulatory development to commercial maturity that occurred between 2022 and 2024. CALCULATION VERIFICATION: 2023 to 2024 decline: ($10.9B - $10.4B) / $10.9B = 4.6% ✓ (correct). The operational and currency impact breakdown appears reasonable but cannot be independently verified from the ground truth. MULTI-HOP REASONING: The answer successfully synthesizes information about patent expiration, biosimilar entry, and sales impact, but incompletely addresses the full 2022-2024 evolution requested. The answer is approximately 60% complete relative to the ground truth's scope.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 424,
        "total_tokens": 1682
      },
      "error": null
    },
    {
      "question_id": 182,
      "question": "How did the total net revenue from Restasis in the United States change between 2023 and 2024, and what was the percentage decrease in each year?",
      "original_answer": "In 2023, the United States net revenue from Restasis was $382 million, which decreased to $172 million in 2024. This represents a 38.5% decrease in 2023 compared to 2022, and a further 55.2% decrease in 2024 compared to 2023.",
      "llm_answer": "\nU.S. Restasis net revenue fell from **$621 million in 2022 to $382 million in 2023**, a **38.5 % decline**, and then dropped further to **$172 million in 2024**, which is a **55.2 % decrease from the 2023 level**.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All numeric values are correct: $621M (2022), $382M (2023), and $172M (2024). Both percentage calculations are accurate: 38.5% decrease from 2022 to 2023, and 55.2% decrease from 2023 to 2024. The answer successfully synthesizes multi-hop information by connecting three years of data and calculating year-over-year changes. The LLM goes beyond the ground truth by providing the 2022 baseline figure ($621M), which adds valuable context and allows readers to understand the full trajectory of the decline. The reasoning is sound and logically presented. The only minor distinction is that the ground truth phrasing states 'decreased to $172 million in 2024' while the LLM says 'dropped further to $172 million in 2024' - both convey the same information with slightly different wording. The LLM's inclusion of the 2022 figure actually enhances the answer's completeness without introducing any inaccuracies. All calculations are mathematically correct: ($621M - $382M)/$621M = 38.5%, and ($382M - $172M)/$382M = 55.2%.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1109,
        "completion_tokens": 307,
        "total_tokens": 1416
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has the role and strategic importance of Master Lease Agreements evolved between 2022 and 2023 in supporting AMT's international growth and tenant relationships?",
      "original_answer": "In 2022, AMT emphasized that master lease agreements were comprehensive in nature and instrumental in building strong strategic partnerships with tenants, significantly reducing colocation cycle times and enabling rapid deployment of equipment across its international portfolio of approximately 177,000 communications sites. By 2023, AMT reiterated the importance of these agreements in providing consistent, long-term revenue and reducing non-contractual churn, while operating an expanded international portfolio of approximately 182,000 communications sites. The evolution reflects a continued strategic focus on leveraging master lease agreements to support international growth and tenant retention, with an emphasis on mitigating risks such as customer consolidation and regulatory changes.",
      "llm_answer": "\nBetween 2022 and 2023 the Master Lease Agreements shifted from being primarily a tool to lock in long‑term, non‑cancellable rent and curb churn with U.S. carriers, to a strategic platform that underpins AMT’s international expansion.  The 2023 disclosures emphasize that these comprehensive MLAs are used to diversify exposure across emerging markets, accelerate colocation cycle times, and deepen partnerships with large multinational carriers—thereby driving organic revenue growth and supporting the densification of wireless networks worldwide.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) QUANTITATIVE ACCURACY FAILURE: The LLM answer completely omits the specific portfolio size metrics that are central to the ground truth. Ground truth explicitly states ~177,000 communications sites in 2022 and ~182,000 in 2023—these concrete numbers are absent from LLM response. This is a critical factual omission for a question about evolution between two years. (2) FACTUAL INACCURACY: The LLM claims MLAs shifted 'from being primarily a tool to lock in long-term, non-cancellable rent and curb churn with U.S. carriers' in 2022. The ground truth makes no such distinction about U.S. vs. international focus in 2022, nor does it characterize 2022 MLAs as primarily U.S.-focused. This represents a mischaracterization not supported by the source material. (3) INCOMPLETE SYNTHESIS: While the LLM mentions 'accelerate colocation cycle times,' the ground truth specifically states MLAs 'significantly reducing colocation cycle times' in 2022—the LLM reverses the temporal attribution. (4) MISSING KEY ELEMENTS: Ground truth emphasizes 'reducing non-contractual churn' and 'mitigating risks such as customer consolidation and regulatory changes' in 2023—these specific risk mitigation aspects are absent from LLM answer. (5) UNSUPPORTED CLAIMS: The LLM introduces concepts like 'diversify exposure across emerging markets' and 'deepen partnerships with large multinational carriers' that are not explicitly stated in the ground truth, representing speculation beyond the source material. (6) SEMANTIC ISSUES: The characterization of evolution is fundamentally different—ground truth shows continuity in strategic focus with emphasis on both 2022 and 2023, while LLM presents a false dichotomy of 'shift from U.S. to international.' The answer demonstrates weak multi-hop synthesis and introduces unsupported narrative elements.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 503,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has the role of Google Marketing Platform in the company's advertising revenue generation evolved between 2023 and 2024, particularly in relation to how advertising revenues are recognized and managed across Google Network properties?",
      "original_answer": "In 2023, Google Marketing Platform was directly involved in the recognition of advertising revenues on a gross basis for Google Network properties, meaning the full amount billed to customers was recorded as revenue. By 2024, the platform's role evolved to include a more nuanced evaluation of its principal versus agent status, with an emphasis on its control over advertising inventory before transfer to customers, further supporting the gross revenue reporting. Additionally, 2024 introduced a more detailed explanation of the platform's role in managing advertising across Google Network properties, highlighting its central function in both performance and brand advertising delivery.",
      "llm_answer": "\nBetween 2023 and 2024 the **Google Marketing Platform became a larger share of the company’s ad‑inventory sales**, but the way those revenues are accounted for stayed the same.  Google continues to act as the **principal** for ads placed on its own and Google Network properties – it records the full amount billed to advertisers as advertising revenue and records the payments to network partners (including those delivered through the Marketing Platform) as cost‑of‑revenues.  This gross‑basis recognition lets the company manage and report advertising revenue from the Platform consistently with the rest of its Google Network portfolio, even as the Platform’s contribution to total ad revenue grew.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies that Google Marketing Platform operates on a gross-basis revenue recognition model where Google acts as the principal, recording full amounts billed to advertisers as revenue. This aligns with the ground truth. However, there are significant issues with the response: (1) The LLM claims the Platform 'became a larger share of the company's ad-inventory sales' between 2023-2024, but the ground truth makes no such quantitative claim about growth or increased share - this is an unsupported assertion. (2) The LLM states 'the way those revenues are accounted for stayed the same,' which contradicts the ground truth's explicit statement that there was an evolution in the platform's role, including 'a more nuanced evaluation of its principal versus agent status' and 'more detailed explanation' in 2024. (3) The ground truth emphasizes that 2024 introduced enhanced explanations and more detailed discussion of the platform's role, which the LLM largely omits. (4) The LLM correctly captures the principal/agent framework and gross-basis recognition mechanics, but misses the key point that the accounting treatment itself evolved between years, not remained static. (5) The LLM's statement about 'consistency with the rest of its Google Network portfolio' is reasonable inference but not explicitly stated in the ground truth. The response demonstrates partial understanding of the revenue recognition mechanics but fails to accurately characterize the evolution between 2023-2024, instead suggesting stasis where the ground truth indicates meaningful evolution in how the platform's role is evaluated and explained.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 452,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did the volume and fair value of Federal Funds Purchased & Sec Loaned change between 2023 and 2024, and what does this indicate about BAC's short-term funding strategies?",
      "original_answer": "In 2023, the volume of Federal Funds Purchased & Sec Loaned showed a net change of $16,466 million, indicating a significant increase in short-term funding liabilities. By 2024, the fair value of this category was reported at $192,859 million, a substantial increase from the prior year. This suggests that BAC significantly expanded its reliance on short-term secured funding mechanisms in 2024, likely to support its trading and liquidity management activities.",
      "llm_answer": "\nThe gross “Federal funds purchased and securities loaned or sold under agreements to repurchase” line grew from **$481.9 bn (Level 2 fair‑value) in 2023** to **$570.2 bn in 2024** – an increase of roughly **$88 bn (≈18 %)**.  After netting the offsetting positions, the carrying amount rose from **$178.6 bn to $192.9 bn**, a **$14.3 bn (≈8 %)** increase (2023 → 2024).  \n\nThis jump shows that Bank of America expanded its short‑term wholesale funding by issuing more federal‑fund purchases and securities‑loan transactions, indicating a more aggressive reliance on short‑term market financing to meet liquidity needs and support its short‑term funding strategy in 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "ANALYSIS: The LLM answer provides detailed quantitative information about Federal Funds Purchased & Securities Loaned, but there are significant discrepancies with the ground truth that warrant careful evaluation.\n\nQUANTITATIVE ACCURACY ISSUES:\n1. The LLM cites gross fair values of $481.9bn (2023) and $570.2bn (2024), which are NOT mentioned in the ground truth. The ground truth only references a 2024 fair value of $192,859 million ($192.9bn).\n2. The LLM correctly identifies the carrying amount change from $178.6bn to $192.9bn (≈$14.3bn increase), which aligns with the ground truth's mention of $192,859 million in 2024.\n3. However, the ground truth mentions a 2023 net change of $16,466 million, which the LLM does not directly address. The LLM's $14.3bn figure is close but not identical to the $16.466bn implied by ground truth.\n4. The LLM's percentage calculations (18% for gross, 8% for carrying amount) appear mathematically consistent with the numbers cited, but the source data for the gross figures cannot be verified against ground truth.\n\nMULTI-HOP REASONING:\nThe LLM successfully synthesizes information about the change between years and draws appropriate conclusions about BAC's funding strategy. The reasoning that expanded federal funds purchases indicate increased reliance on short-term wholesale funding is sound and matches the ground truth's interpretation.\n\nCOMPLETENESS:\nThe LLM provides more granular detail than the ground truth (distinguishing between gross and carrying amounts), which could be viewed as either more comprehensive or potentially introducing unverified data. The ground truth is less specific about the exact figures but confirms the directional trend and strategic implications.\n\nKEY DISCREPANCY:\nThe ground truth mentions a 2023 net change of $16,466 million, while the LLM calculates an 8% increase from $178.6bn to $192.9bn (≈$14.3bn). These figures are close but not identical, suggesting either different measurement methodologies or potential data sourcing issues.\n\nSTRENGTHS:\n- Correct identification of the carrying amount figures ($192.9bn for 2024)\n- Sound interpretation of strategic implications\n- Clear presentation of year-over-year changes\n- Appropriate conclusion about short-term funding strategy\n\nWEAKNESSES:\n- Introduces gross fair value figures ($481.9bn, $570.2bn) not present in ground truth\n- Minor discrepancy in the magnitude of change ($14.3bn vs. implied $16.466bn)\n- Does not explicitly reference the 2023 net change figure from ground truth",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 675,
        "total_tokens": 1966
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has PepsiCo's disclosure regarding the sensitivity of pension and retiree medical plan liabilities to market fluctuations evolved between 2022 and 2024?",
      "original_answer": "In 2022, PepsiCo mentioned that the exposure of pension and retiree medical plan assets and liabilities to risks related to market fluctuations was discussed in 'Our Critical Accounting Policies and Estimates.' By 2024, the company expanded this disclosure, explicitly linking the sensitivity of these liabilities not only to market fluctuations but also to inflationary, deflationary, and recessionary conditions. This broader context indicates a more detailed characterization of the macroeconomic risks affecting these obligations, beyond just market volatility.",
      "llm_answer": "\nBetween 2022 and 2024 the company’s wording shifted from a brief, qualitative note that pension and retiree‑medical plan assets and liabilities are “subject to market fluctuations” (2022 PDF p. 34) to a more explicit discussion that ties the exposure of those plans to broader market‑risk factors—interest‑rate and inflation changes—and states that market movements affect the plans’ fair‑value measurement (2024 PDF pp. 40, 42).  In other words, the 2022 filing merely flagged the risk, whereas the 2024 filing integrates the pension and retiree‑medical exposure into the market‑risk narrative and emphasizes its sensitivity to market‑driven changes, though it still does not provide a quantitative sensitivity scenario.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core evolution in PepsiCo's disclosure between 2022 and 2024, capturing that the company moved from a brief mention of market fluctuations to a more detailed discussion. The answer appropriately notes the shift from qualitative flagging to more integrated market-risk narrative. Page references (2022 p. 34, 2024 pp. 40, 42) are provided, showing document-specific grounding. The observation that 2024 lacks quantitative sensitivity scenarios is accurate and adds useful context.\n\nWEAKNESSES: (1) The LLM answer mentions 'interest-rate and inflation changes' as explicit factors in 2024, but the ground truth specifically states the 2024 disclosure expanded to include 'inflationary, deflationary, and recessionary conditions.' The LLM omits 'deflationary' and 'recessionary' conditions, which are material additions to the disclosure scope. (2) The LLM characterizes the 2024 disclosure as focusing on 'interest-rate and inflation changes' but does not fully capture the breadth of macroeconomic risk factors mentioned in the ground truth. (3) The ground truth emphasizes that the 2024 disclosure provides 'broader context' and 'more detailed characterization of macroeconomic risks,' while the LLM frames it primarily as 'market-risk factors' and 'market-driven changes,' which is narrower than the ground truth's characterization.\n\nMULTI-HOP REASONING: The answer successfully synthesizes information across two years (2022 vs 2024) and identifies the evolution in disclosure approach. However, it incompletely captures the full scope of the expanded disclosure in 2024.\n\nNUMERIC/FACTUAL VERIFICATION: No specific numbers or calculations are involved in this question. Page references appear reasonable but cannot be independently verified. The characterization of what changed is partially correct but incomplete regarding the specific risk factors mentioned.\n\nSEMANTIC EQUIVALENCE: While the LLM captures the general evolution, it fails to fully convey the specific expansion to deflationary and recessionary conditions, which represents a material difference from the ground truth's more comprehensive characterization.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 585,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has Adobe's approach to Adobe Scan evolved between 2023 and 2024, particularly in terms of its positioning within Adobe's broader document management ecosystem?",
      "original_answer": "In 2023, Adobe Scan was positioned as a free mobile scanning tool that converts paper documents into editable, searchable PDFs via Adobe Document Cloud services, emphasizing its utility for individual users. By 2024, Adobe Scan remained part of Adobe Document Cloud, but the broader ecosystem placed increased emphasis on integration with cloud-based productivity tools and AI-driven features like Content Credentials and Firefly-powered generative AI workflows, indicating a shift toward deeper integration within enterprise document workflows and enhanced digital trust mechanisms.",
      "llm_answer": "\nAdobe has shifted Adobe Scan from a stand‑alone free mobile scanner to a core entry point of the Adobe Document Cloud suite.  The 2024 filing stresses that Scan now delivers OCR‑enabled, AI‑enhanced PDF creation and seamless sharing that is tightly integrated with Acrobat, Acrobat Sign and the broader Adobe Experience Cloud, positioning the app as the mobile front‑door to Adobe’s end‑to‑end document‑management ecosystem.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer captures some correct elements but introduces unsupported claims and misses key aspects of the ground truth. CORRECT ELEMENTS: (1) Adobe Scan remains part of Adobe Document Cloud in both years; (2) The general direction of increased integration is accurate; (3) No quantitative errors (no numbers provided to verify). PROBLEMATIC ELEMENTS: (1) The LLM claims 2024 filing 'stresses' OCR-enabled, AI-enhanced PDF creation and seamless sharing - the ground truth does not mention OCR specifically or emphasize these technical features; (2) The LLM mentions 'Acrobat, Acrobat Sign and broader Adobe Experience Cloud' integration - the ground truth does not reference Experience Cloud or Acrobat Sign specifically; (3) The LLM describes Scan as 'mobile front-door' which is interpretive language not in the ground truth; (4) CRITICAL OMISSION: The ground truth specifically mentions 'Content Credentials and Firefly-powered generative AI workflows' and 'enhanced digital trust mechanisms' - these are key differentiators between 2023 and 2024 positioning that the LLM completely omits; (5) The ground truth emphasizes a shift toward 'enterprise document workflows' which the LLM does not explicitly address. MULTI-HOP REASONING: The LLM attempts to synthesize evolution across years but does so by introducing details not supported by the ground truth while omitting the specific AI/trust mechanisms that are central to the actual evolution. The answer is partially correct in direction but fails to capture the nuanced positioning shift around Content Credentials, Firefly integration, and digital trust that distinguishes 2024 from 2023.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 451,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has Gemini's role and integration across Google's products evolved from its initial launch in 2023 to 2024, and what specific advancements were made in its multimodal capabilities?",
      "original_answer": "In 2023, Gemini was introduced as a multimodal AI model capable of understanding and operating across different types of information, including text, code, audio, images, and video. It was intended to be leveraged across Alphabet to enhance product experiences. By 2024, Gemini had evolved significantly, with the launch of Gemini 2.0, which became the most capable model yet. It was integrated into all seven of Google's two billion-user products—Android, Chrome, Gmail, Maps, Play Store, Search, and YouTube—powering AI features across these platforms. Additionally, in 2024, Gemini was used in experimental research prototypes such as Project Astra and Project Mariner, showcasing broader and more advanced applications than in 2023.",
      "llm_answer": "\nSince its December 2023 launch, Gemini has progressed from a single multimodal model to Gemini 2.0—a far more capable system that can jointly understand and generate text, code, audio, images and video and is now embedded across Google’s core consumer services (Search, YouTube, Android, Chrome, Gmail, Maps, Play) and into Google Cloud (Vertex AI, Workspace, Duet AI). The 2024 upgrade adds broader modality support, stronger reasoning and multimodal “generalist” capabilities, enabling new experimental agents such as Project Astra (a universal AI assistant) and Project Mariner (a Chrome‑extension prototype), making Gemini the central AI engine powering Google’s products and developer platforms.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive coverage of Gemini's evolution. STRENGTHS: (1) Correctly identifies December 2023 launch date and progression to Gemini 2.0 in 2024; (2) Accurately lists multimodal capabilities (text, code, audio, images, video); (3) Correctly names all seven Google products with 2 billion users (Search, YouTube, Android, Chrome, Gmail, Maps, Play Store); (4) Properly identifies experimental projects (Project Astra and Project Mariner) with accurate descriptions; (5) Mentions additional integration points (Google Cloud, Vertex AI, Workspace, Duet AI) showing broader context; (6) Captures the evolution narrative from single model to more capable system with broader integration. MINOR ISSUES: (1) The original answer specifies 'two billion-user products' as a specific count/characteristic, while the LLM answer lists them but doesn't explicitly emphasize this as a defining metric of the 2024 integration scope; (2) The LLM answer adds information about Google Cloud integration (Vertex AI, Workspace, Duet AI) that wasn't in the ground truth, which is additional context but not contradictory. MULTI-HOP REASONING: The answer successfully synthesizes information across the 2023-2024 timeline, correctly connecting initial launch characteristics to 2024 advancements, and properly links product integration with experimental applications. All numeric references (7 products, 2 billion users) are accurate. The semantic meaning aligns well with the ground truth despite slightly different organizational structure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 433,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has Linde's relationship with helium evolved between 2022 and 2024, particularly in terms of its impact on sales and operating profit?",
      "original_answer": "In 2022, helium was listed as a supply for Linde, indicating a positive or neutral relationship. However, by 2024, the relationship had evolved, and helium was reported to negatively impact the company. Specifically, in 2024, lower volumes in global helium contributed to a 2% decrease in sales for the 'Other' segment, which includes global helium wholesale. Additionally, higher costs due to helium partially offset an insurance recovery for Linde Advanced Materials Technology (LAMT), limiting the operating profit growth in that segment despite a 44% overall increase in operating profit for 'Other'.",
      "llm_answer": "\nLinde’s helium activities are bundled in the “Other” segment, and between 2023 and 2024 their sales fell about 2 % as volumes dropped, while operating profit rose roughly 44 %—the gain coming mainly from an insurance recovery that offset higher helium‑related costs. This shows that helium’s contribution to overall sales is modest and declining, but its profit impact has been cushioned by non‑operational insurance proceeds, reflecting a shift from volume‑driven earnings to a more cost‑ and risk‑managed relationship.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUE - TIME PERIOD MISMATCH: The LLM answer discusses 2023-2024 changes, but the question explicitly asks about 2022-2024 evolution. The ground truth clearly states that in 2022 helium was listed as a supply (positive/neutral), but by 2024 it negatively impacted the company. The LLM completely omits the 2022 baseline and the critical evolution from positive to negative relationship, which is the core of the question.\n\nQUANTITATIVE ACCURACY: The numbers cited (2% sales decrease, 44% operating profit increase) are correct and match the ground truth. However, the LLM fails to provide the full context of how these metrics changed relative to 2022.\n\nQUALITATIVE ACCURACY: The LLM correctly identifies that helium is in the 'Other' segment and accurately describes the 2023-2024 dynamics (insurance recovery offsetting higher costs). However, it misses the fundamental evolution narrative: the shift from helium being a positive supply relationship in 2022 to a negative impact by 2024. The LLM's characterization of 'modest and declining' contribution is partially correct but doesn't capture the qualitative shift from positive to negative impact.\n\nMULTI-HOP REASONING: The LLM demonstrates sound reasoning about the 2023-2024 period but fails the multi-hop synthesis required to answer the 2022-2024 evolution question. It should have synthesized information from three time periods (2022, 2023, 2024) to show the trajectory of change.\n\nCOMPLETENESS: The answer addresses only part of the question. It covers the 2023-2024 period adequately but completely omits the 2022 baseline and the critical evolution from positive to negative relationship that is central to the question.\n\nSEMANTIC EQUIVALENCE: While the wording differs from ground truth, the LLM's interpretation of the 2023-2024 dynamics is semantically equivalent. However, the omission of the 2022-2024 evolution narrative represents a fundamental gap in answering the actual question asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 532,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did the net value of acquired franchise rights evolve from 2022 to 2024, and what was the magnitude of this change?",
      "original_answer": "In 2022, the net value of acquired franchise rights was $789 million, while in 2024 it decreased to $598 million. This represents a significant decline in value over the two-year period.",
      "llm_answer": "\nThe net value of acquired franchise rights fell from $626 million in 2022 to $598 million in 2024, a reduction of $28 million (about a 4.5 % decline).",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains a major factual error in the 2022 baseline figure. Ground truth states the 2022 net value of acquired franchise rights was $789 million, but the LLM claims it was $626 million. This is a $163 million discrepancy (20.7% error). The 2024 figure of $598 million is correct. Because the starting value is wrong, the calculated change magnitude is also incorrect: the LLM reports a $28 million decline (4.5%), when the actual decline from $789M to $598M is $191 million (24.2%). The LLM correctly identified the direction of change (decline) and the 2024 endpoint, but the foundational 2022 number is fundamentally incorrect. The question asks about evolution from 2022 to 2024 and the magnitude of change - both of these require accurate starting and ending values. The LLM's calculation methodology is sound (difference and percentage), but it was applied to incorrect input data. The answer is contextually relevant to the question asked, but the quantitative accuracy is severely compromised by the wrong 2022 baseline figure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1077,
        "completion_tokens": 305,
        "total_tokens": 1383
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Chevron's natural gas delivery commitments and production volumes related to Tengizchevroil evolve from 2023 to 2024?",
      "original_answer": "In 2023, Chevron reported that its natural gas volumes included 596 million cubic feet per day consumed in operations and 7,148 million cubic feet per day as sold, which included its share from Tengizchevroil in Kazakhstan. By 2024, these figures increased to 609 million cubic feet per day consumed and 7,569 million cubic feet per day as sold, indicating a growth in both operational consumption and market delivery. This reflects an increase in Chevron’s involvement and dependency on Tengizchevroil for natural gas production and delivery commitments.",
      "llm_answer": "\nChevron’s contractual natural‑gas delivery obligations tied to the Tengizchevroil joint‑venture remained the same from 2023 to 2024 – the company continued to honor the existing supply commitments without any new volume targets.  At the same time, production from the Tengizchevroil affiliate (reported within Chevron’s “Affiliates” figures) showed a modest rise, with oil‑equivalent output increasing from roughly 406 k to 413 k bbl/d, while natural‑gas output held steady at about 25 million cubic feet per day.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is substantially incorrect and contradicts the ground truth on multiple critical dimensions: (1) QUANTITATIVE ERRORS: The ground truth provides specific natural gas volumes for 2023 (596 MMcf/d consumed, 7,148 MMcf/d sold) and 2024 (609 MMcf/d consumed, 7,569 MMcf/d sold), showing clear increases. The LLM answer claims delivery obligations 'remained the same' and provides completely different metrics (406k-413k bbl/d oil equivalent, 25 MMcf/d natural gas) that don't match the ground truth figures at all. The LLM's numbers appear to be from a different context or misidentified data. (2) DIRECTIONAL CONTRADICTION: The ground truth explicitly states volumes 'increased' from 2023 to 2024. The LLM claims commitments 'remained the same' and that natural gas 'held steady' - directly contradicting the documented growth. (3) INCOMPLETE SYNTHESIS: The question asks about evolution/change from 2023 to 2024. The ground truth provides year-over-year comparison showing increases in both consumed (596→609 MMcf/d) and sold volumes (7,148→7,569 MMcf/d). The LLM fails to provide this comparative analysis and instead claims stasis. (4) METRIC CONFUSION: The LLM conflates different metrics (oil-equivalent barrels per day vs. natural gas volumes in MMcf/d) and provides numbers that don't align with the ground truth's specific natural gas delivery figures. (5) CONTEXTUAL MISALIGNMENT: While the LLM mentions Tengizchevroil correctly, it fundamentally mischaracterizes the nature of the change, claiming no evolution when the ground truth documents clear growth in both operational consumption and market delivery volumes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 448,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has the role of Google Network partners in Google's advertising revenue model evolved between 2023 and 2024, based on changes in the way payments to these partners are described?",
      "original_answer": "In 2023, Google Network partners were described as part of the primary uses of cash from operating activities, specifically noting payments made to these partners as a standard operating expense. By 2024, the description evolved to categorize payments to Google Network partners under Traffic Acquisition Costs (TAC), explicitly linking them to ads displayed on partner properties and tying them directly to revenue generation. This shift indicates a more strategic and performance-based dependency on these partners within the advertising ecosystem.",
      "llm_answer": "\nBetween 2023 and 2024 the filing shifted from a generic reference to “advertising revenue from Google Network properties” (2023 10‑K p. 18) to an explicit accounting‑line item that treats those payments as a cost of revenue. In the 2024 filing (p. 59) the company states that “TAC includes … amounts paid to Google Network partners primarily for ads displayed on their properties,” classifying the payments as a separate expense rather than merely an offset to gross advertising revenue. Thus, the role of Network partners is now recorded as a distinct cost‑center in the revenue model, highlighting a more granular treatment of the payments made to them.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth on the core evolution of Google Network partner payments between 2023 and 2024. Key strengths: (1) Correctly identifies the shift from generic treatment to explicit TAC (Traffic Acquisition Costs) categorization; (2) Accurately captures the semantic shift from operating expense to cost-of-revenue treatment; (3) Properly synthesizes the multi-hop information showing how payments are now linked to revenue generation through partner properties; (4) Correctly cites the 2024 filing language about 'amounts paid to Google Network partners primarily for ads displayed on their properties.' Minor areas for improvement: (1) The LLM references specific page numbers (p. 18 for 2023, p. 59 for 2024) which cannot be verified against the ground truth provided, though this doesn't contradict the core facts; (2) The phrase 'generic reference to advertising revenue from Google Network properties' in the LLM answer is slightly less precise than the ground truth's description of 'payments made to these partners as a standard operating expense,' though both convey similar meaning; (3) The LLM uses 'offset to gross advertising revenue' which is a reasonable interpretation but not explicitly stated in the ground truth. The multi-hop reasoning is sound—the answer correctly synthesizes the evolution across two years and explains the strategic implications. No numerical errors or calculation issues present. The answer fully addresses the question about how the role evolved and how the accounting treatment changed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 433,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has the impact of public policies on Bank of America's climate-related regulatory requirements evolved from 2023 to 2024, particularly in terms of jurisdictional divergence and compliance risks?",
      "original_answer": "In 2023, Bank of America highlighted increasing global regulatory focus on climate change, noting that new or heightened regulatory requirements across state, federal, and non-U.S. jurisdictions were expected to increase legal, compliance, and public disclosure risks and costs. The company specifically mentioned jurisdictional divergence as a challenge. By 2024, this concern intensified, with the company noting that existing and pending disclosure requirements in various jurisdictions, along with jurisdictional divergence, were now actively impacting legal, compliance, and public disclosure risks and costs. This indicates a shift from anticipation of increased risk to experiencing tangible impacts due to evolving public policies.",
      "llm_answer": "\nThe 2023 filing only warned in general terms that climate‑related regulations could affect the firm, without emphasizing the effect of differing rules across jurisdictions. In contrast, the 2024 MD&A (page 24 of the 2024 10‑K) explicitly points out that “an increasing global regulatory focus… with potential jurisdictional divergence” will raise legal, compliance and disclosure costs, making divergent public‑policy requirements a concrete source of heightened compliance risk. Consequently, the impact of public policies on Bank of America’s climate‑related regulatory obligations has shifted from a broad acknowledgment of risk to a specific concern that varying, evolving standards across U.S. and non‑U.S. jurisdictions are amplifying compliance complexity.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures the general evolution of Bank of America's climate-related regulatory concerns from 2023 to 2024, correctly identifying the shift from anticipatory warnings to more concrete impacts. However, there are significant issues with accuracy and completeness: (1) FACTUAL ERRORS: The LLM states the 2024 MD&A is on 'page 24 of the 2024 10-K' - this specific page citation cannot be verified and may be inaccurate. The LLM also reverses the characterization of the 2023 filing, claiming it only gave 'general terms' warnings without emphasizing jurisdictional divergence, when the ground truth explicitly states that 2023 already mentioned 'jurisdictional divergence as a challenge.' (2) INCOMPLETE SYNTHESIS: The LLM fails to accurately capture that the ground truth shows jurisdictional divergence was already a concern in 2023, not newly emphasized in 2024. The evolution is more nuanced - from 'expected to increase' risks in 2023 to 'actively impacting' risks in 2024, not from general to specific mention of divergence. (3) MISCHARACTERIZATION: The LLM suggests the 2023 filing lacked emphasis on jurisdictional divergence, which contradicts the ground truth that explicitly mentions this in 2023. (4) CORRECT ELEMENTS: The LLM correctly identifies the shift from anticipatory to tangible impacts and correctly notes the multi-jurisdictional compliance complexity as a key theme. The semantic understanding of the evolution is partially correct but the specific factual basis is flawed. The answer demonstrates reasonable comprehension of the overall trend but fails on precise factual accuracy regarding what was stated in each year.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 453,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has General Motors' strategic emphasis on full-size pickup trucks evolved from 2022 to 2024, and what quantitative indicators in 2024 suggest a shift toward stronger performance and market positioning for this product line?",
      "original_answer": "In 2022, General Motors identified the success of its full-size SUVs and full-size pickup trucks as a key risk factor, indicating that their performance was critical to the company's competitive position and financial health. By 2024, this strategic emphasis had evolved into a demonstrated strength, as evidenced by a significant increase in net wholesale volumes driven by higher sales of full-size pickup trucks. Additionally, the 2024 report highlights that full-size pickup trucks contributed favorably to the company's EBIT-adjusted results, with a variable profit of approximately 160% for trucks on a weighted-average basis, reflecting improved profitability and market demand for this product line.",
      "llm_answer": "\nGM has moved from a balanced product mix in 2022 to a clearer priority on full‑size pickups by 2024, as shown by a 10.1 % rise in wholesale truck sales to 3,464 units and a contribution to an 11.4 % increase in GM North America’s total net sales to $157.5 bn.  The segment’s EBIT‑adjusted climbed 18.1 % to $14.5 bn and its margin improved to 9.2 % from 8.7 %, signaling stronger performance and market positioning for the full‑size pickup line.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misalignments with the ground truth. (1) CRITICAL ERRORS: The LLM provides specific numbers (10.1% rise in wholesale truck sales to 3,464 units, $157.5 bn in net sales, 18.1% EBIT-adjusted increase to $14.5 bn, margin improvement from 8.7% to 9.2%) that cannot be verified against the ground truth and appear to be fabricated or incorrectly sourced. The ground truth does not provide these specific wholesale volume figures or these exact percentage increases. (2) QUANTITATIVE ACCURACY ISSUES: The ground truth mentions 'significant increase in net wholesale volumes' and 'variable profit of approximately 160% for trucks on a weighted-average basis' - the LLM provides completely different metrics (10.1% truck sales rise, margin percentages) that don't match the ground truth's 160% variable profit figure. The LLM's specific dollar amounts ($157.5 bn, $14.5 bn) and percentages (18.1%, 9.2%, 8.7%) are not corroborated by the ground truth. (3) MULTI-HOP REASONING: While the LLM attempts to synthesize evolution from 2022 to 2024, it does so with unverified numbers. The ground truth clearly states the shift from 'risk factor' (2022) to 'demonstrated strength' (2024), but the LLM's supporting metrics don't align with the ground truth's emphasis on variable profit contribution (160%) and EBIT-adjusted results favorability. (4) MISSING KEY INFORMATION: The LLM fails to mention the critical 160% variable profit metric that the ground truth emphasizes as a key quantitative indicator of improved profitability. Instead, it substitutes margin percentages that aren't in the ground truth. (5) SEMANTIC ISSUES: The LLM's framing of 'balanced product mix in 2022' doesn't match the ground truth's characterization of pickup trucks as a 'key risk factor' in 2022, suggesting a different interpretation of the strategic evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 510,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did the allocation to U.S. Treasury and government agency securities within the nuclear decommissioning trusts evolve from 2022 to 2024, and what does this shift indicate about the company's investment strategy?",
      "original_answer": "In 2022, the allocation to U.S. Treasury and government agency securities was $21 million for Alabama Power and $293 million for Georgia Power. By 2024, this allocation decreased slightly to $20 million for Alabama Power but increased significantly to $349 million for Georgia Power. The overall trend shows a shift in focus toward Georgia Power’s portfolio, indicating a possible reallocation of safer, fixed-income assets to that subsidiary.",
      "llm_answer": "\nBetween 2022 and the end of 2024 the nuclear decommissioning trusts moved from about $21 million (Alabama Power) and $293 million (Georgia Power) invested in U.S. Treasury and government‑agency securities to roughly $20 million and $349 million, respectively. The slight dip in Alabama’s position was more than offset by a sizable rise in Georgia’s exposure, showing that the company is deliberately increasing the share of ultra‑safe Treasury and agency holdings in the trusts to preserve capital and reduce market risk for future decommissioning obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. (1) QUANTITATIVE VERIFICATION: All numbers are correct - Alabama Power 2022: $21M → 2024: $20M; Georgia Power 2022: $293M → 2024: $349M. The characterization of Alabama's change as a 'slight dip' and Georgia's as a 'sizable rise' is accurate ($1M decrease vs $56M increase). (2) COMPLETENESS: The answer addresses both the evolution of allocations and the strategic implications, fully answering the multi-part question. (3) ENTITY ACCURACY: Both subsidiaries (Alabama Power and Georgia Power) are correctly identified, years (2022 and 2024) are correct, and the financial metric (U.S. Treasury and government agency securities) is properly specified. (4) MULTI-HOP REASONING: The answer correctly synthesizes information across two companies and two time periods, then draws a logical conclusion about investment strategy. The interpretation that the company is 'deliberately increasing the share of ultra-safe Treasury and agency holdings' to 'preserve capital and reduce market risk' is a reasonable inference from the data showing net growth in Georgia Power's allocation despite a slight decrease in Alabama Power. (5) SEMANTIC EQUIVALENCE: The LLM's phrasing 'roughly $20 million and $349 million' is semantically equivalent to the ground truth's exact figures, and the strategic interpretation aligns with the ground truth's observation about 'reallocation of safer, fixed-income assets.' Minor difference: The LLM provides slightly more detailed strategic reasoning ('preserve capital and reduce market risk for future decommissioning obligations') compared to the ground truth's more general observation about 'shift in focus toward Georgia Power's portfolio,' but this represents added value rather than inaccuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 487,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has PepsiCo's relationship with independent bottlers evolved from 2022 to 2024 in terms of financial incentives and strategic dependency?",
      "original_answer": "In 2022, PepsiCo provided sales incentives and discounts to independent bottlers primarily through funding of advertising and other marketing activities, with accruals based on annual targets and historical experience. By 2024, the company's relationship had evolved into a more structured dependency, with bottler funding negotiated annually and specifically allocated across trade and consumer programs such as advertising support, new product launches, and vending equipment placement. Additionally, in 2024, sales through independent bottlers contributed to a significant portion of revenue, with Walmart alone accounting for approximately 14% of consolidated net revenue, highlighting increased strategic dependency on these bottlers.",
      "llm_answer": "\nBetween 2022 and 2024 PepsiCo’s financial incentives to independent bottlers remained centered on “bottler funding” that is negotiated annually and tied to performance targets, covering advertising, consumer promotions, new‑product support and vending/cooler‑equipment placement; the company records these amounts as a reduction of revenue based on contract terms and historical experience (PEP 10‑K 2024 pp. 11‑12; PEP 10‑K 2022 pp. 60, 61, 96).  Although the incentive structure is largely consistent, the 2024 disclosures highlight a shift toward more performance‑based, market‑driven funding while underscoring that exclusive territorial rights keep bottlers strategically essential for direct‑store‑delivery distribution—even as the company moves some alcoholic‑beverage distribution to trademark‑licensing models, preserving overall strategic dependency on the bottler network.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core evolution of PepsiCo's bottler incentive structure from 2022-2024, accurately noting that bottler funding is negotiated annually and covers advertising, consumer promotions, new product support, and vending/cooler equipment placement. The answer appropriately references the 10-K filings and correctly identifies that these amounts are recorded as revenue reductions. The discussion of strategic dependency through exclusive territorial rights and direct-store-delivery distribution is relevant and well-reasoned. CRITICAL WEAKNESSES: (1) MISSING KEY QUANTITATIVE DATA: The ground truth specifically mentions that Walmart alone accounted for approximately 14% of consolidated net revenue in 2024, representing a significant metric of strategic dependency. The LLM answer completely omits this crucial quantitative evidence, which is a major factual gap. (2) INCOMPLETE EVOLUTION NARRATIVE: The ground truth emphasizes that the relationship evolved into 'more structured dependency' with specific allocation across programs. While the LLM mentions 'shift toward more performance-based, market-driven funding,' it doesn't clearly articulate the evolution from 2022's simpler incentive structure to 2024's more formalized, strategically dependent relationship. (3) VAGUE ON COMPARISON: The LLM states the incentive structure is 'largely consistent' between years, which somewhat contradicts the ground truth's emphasis on evolution and increased strategic dependency. The ground truth suggests more substantive change than the LLM conveys. (4) TANGENTIAL INFORMATION: The discussion of alcoholic-beverage distribution and trademark-licensing models, while potentially accurate, is not mentioned in the ground truth and may be introducing information not directly relevant to the core question about financial incentives and strategic dependency evolution. QUANTITATIVE ACCURACY ISSUE: The absence of the 14% Walmart revenue figure is a significant quantitative omission that directly impacts the answer's completeness and accuracy regarding strategic dependency metrics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 569,
        "total_tokens": 1974
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has Adobe Firefly's role within Adobe's product innovation strategy evolved from 2023 to 2024, based on its positioning in the company's trademark listings and risk disclosures?",
      "original_answer": "In 2023, Adobe Firefly was listed among Adobe's trademarks, indicating it was an established product within the company's portfolio. By 2024, Adobe Firefly was specifically highlighted in the risk factors section as a newly released generative AI product, reflecting its strategic importance in Adobe's innovation efforts. This evolution shows a shift from being a registered brand to becoming a central part of Adobe's forward-looking product development and AI strategy, with explicit mention of its role in addressing market demands for generative AI capabilities.",
      "llm_answer": "\nAdobe Firefly went from being a newly‑trademarked AI capability in 2023—mentioned only in the trademark index and general AI‑risk language—to a broadly integrated, product‑level feature in 2024, appearing in the Acrobat AI Assistant, Creative Cloud and Document Cloud descriptions and receiving dedicated risk‑factor coverage on generative‑AI regulation, IP liability and monetisation. This shift shows that Firefly moved from an experimental side‑project to a core pillar of Adobe’s product‑innovation strategy, with the company now explicitly tying its growth to AI‑driven differentiation and acknowledging heightened regulatory and competitive risks.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core evolution of Adobe Firefly from 2023 to 2024, capturing the shift from trademark listing to risk factor prominence. The answer accurately notes the product's integration across multiple Adobe products (Acrobat AI Assistant, Creative Cloud, Document Cloud) and correctly identifies the types of risks mentioned (regulatory, IP liability, monetization). The temporal progression and strategic importance are properly conveyed.\n\nWEAKNESSES: (1) The LLM answer introduces specific product integrations (Acrobat AI Assistant, Creative Cloud, Document Cloud) that are not explicitly mentioned in the ground truth. While these may be factually accurate from the filings, they represent details beyond what the ground truth confirms, creating potential overreach. (2) The characterization of Firefly as 'newly-trademarked' in 2023 contradicts the ground truth which states it was 'an established product' in 2023. This is a factual error in the LLM's framing of the 2023 baseline. (3) The ground truth emphasizes the shift from 'registered brand' to 'central part of forward-looking product development,' while the LLM frames it as 'experimental side-project to core pillar'—the latter characterization is not supported by the ground truth.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes information across trademark listings and risk disclosures as required by the question. However, the synthesis introduces details not present in the ground truth, suggesting the model may be inferring beyond what the filings explicitly state.\n\nNUMERIC/FACTUAL VERIFICATION: No specific numbers or dates are provided in either answer, so quantitative accuracy is not directly testable. The years (2023, 2024) are correct.\n\nSEMANTIC ISSUES: The core narrative is similar, but the LLM's specific claims about 'newly-trademarked' status in 2023 and 'experimental side-project' characterization diverge from the ground truth's description of an 'established product' that became more strategically prominent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 552,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the role of contractual rent escalations in driving tenant billing growth changed between 2022 and 2023, particularly in light of the increased churn and lease cancellations in 2023?",
      "original_answer": "In 2022, contractual rent escalations were highlighted as a key factor contributing to tenant billing growth, listed alongside new colocation activity and lease amendments. By 2023, while contractual rent escalations remained a stated driver of growth, the context shifted due to an elevated churn rate of approximately 3%, primarily in the U.S. & Canada segment. This churn, expected to remain elevated through 2025 due to T-Mobile's lease cancellations, introduced a countervailing force against the positive impact of rent escalations, suggesting a more challenging environment for maintaining organic revenue growth solely through escalations.",
      "llm_answer": "\nContractual rent escalations continued to provide a modest, predictable lift—about **$12.5 million net** to U.S. & Canada property revenue in 2023 (page 37)—but this gain was **tiny relative to the $209.9 million segment growth** and was explicitly “net of churn.”  In 2022, escalations were a larger share of growth because churn was lower; the 2023 surge in lease cancellations (notably T‑Mobile’s terminations under the 2020 MLA) and a **3 % churn rate** (page 35) erased much of the escalation benefit.  Consequently, the role of contractual rent escalations in driving tenant‑billing growth **diminished sharply in 2023**, with growth now being powered almost entirely by colocation/lease amendments and new tenant activity rather than escalations.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core narrative shift - that contractual rent escalations played a larger role in 2022 growth but were diminished in 2023 due to elevated churn. It accurately cites the 3% churn rate and T-Mobile lease cancellations as key countervailing forces. The qualitative reasoning about the shift from escalations to colocation/lease amendments/new tenant activity is sound and well-articulated. The answer appropriately addresses the multi-hop synthesis required (comparing 2022 vs 2023, incorporating churn context).\n\nWEAKNESSES - CRITICAL QUANTITATIVE ISSUES: (1) The LLM cites '$12.5 million net' as the escalation contribution to U.S. & Canada property revenue in 2023, but this specific figure cannot be verified against the ground truth and appears to be either fabricated or misinterpreted from source material. The ground truth does not provide this specific dollar amount for escalations. (2) The LLM states this $12.5M was 'net of churn' and represents a 'tiny' portion of $209.9M segment growth - while the logic is sound, the $12.5M figure itself is unverified and potentially incorrect. (3) The LLM claims escalations were 'a larger share of growth' in 2022 but provides no quantitative support for this comparative claim, making it difficult to verify the year-over-year comparison.\n\nMULTI-HOP REASONING: The synthesis is logically sound - the model correctly connects (a) escalations as a 2022 growth driver, (b) elevated 2023 churn rate of ~3%, (c) T-Mobile cancellations, and (d) the resulting diminished role of escalations. However, the introduction of unverified specific dollar amounts undermines confidence in the analysis.\n\nVERIFICATION GAPS: The ground truth states escalations 'remained a stated driver of growth' in 2023 but does not quantify the $12.5M figure or explicitly state that escalations 'diminished sharply.' The LLM's characterization of the shift as 'sharp' and 'diminished' is interpretive rather than directly supported by cited ground truth language.\n\nOVERALL: The answer demonstrates strong qualitative understanding and correct identification of key entities/trends, but the introduction of specific unverified financial figures ($12.5M) and page citations that cannot be confirmed significantly reduces confidence in quantitative accuracy. The core narrative is correct, but the supporting numbers are problematic.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 641,
        "total_tokens": 2002
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has Chevron's (CVX) relationship with Tengizchevroil evolved between 2023 and 2024 in terms of capital expenditure commitments and production involvement?",
      "original_answer": "In 2023, Chevron indicated that nearly half of its Affiliate Capex, which was expected to be $3 billion in 2024, was allocated to Tengizchevroil's FGP/WPMP Project in Kazakhstan. By 2024, Chevron continued to highlight its production involvement with Tengizchevroil, noting that production volumes included Chevron's share from affiliates such as Tengizchevroil in Kazakhstan. While 2023 focused on capital commitments for project development, 2024 emphasized ongoing production contributions from the same entity, indicating a shift from investment to operational phase.",
      "llm_answer": "\nBetween 2023 and 2024 Chevron deepened its financial commitment to Tengizchevroil (TCO).  In 2023 the company’s equity‑affiliated capital outlays were about $3 billion, with roughly ½ directed to TCO’s FGP/WPMP project in Kazakhstan, and 2024‑year affiliate‑capex is projected at a similar $3 billion level, again allocating a major share to TCO’s downstream development.  At the same time, TCO’s proved‑undeveloped reserves (≈ 197 million BOE that had been idle for five + years) remained under active development, and its production contributed to Chevron’s reported affiliate output (≈ 413 million BOE of affiliate production in 2024), signalling an expanded role for TCO in both Chevron’s capital programme and its overall production portfolio.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general evolution of Chevron's relationship with Tengizchevroil between 2023 and 2024, correctly identifying the shift from capital commitment focus to operational/production emphasis. However, there are significant quantitative accuracy issues:\n\nCORRECT ELEMENTS:\n- Correctly identifies ~$3 billion affiliate capex level for both years\n- Correctly notes roughly half directed to TCO's FGP/WPMP project in Kazakhstan\n- Correctly identifies the shift from investment phase (2023) to operational phase (2024)\n- Properly synthesizes multi-hop information about capital commitments and production involvement\n- Correctly names Tengizchevroil and the FGP/WPMP project\n\nINCORRECT/PROBLEMATIC ELEMENTS:\n1. QUANTITATIVE ERRORS: The LLM introduces specific numbers (197 million BOE proved-undeveloped reserves, 413 million BOE affiliate production in 2024) that are NOT present in the ground truth answer. These appear to be fabricated or sourced from outside the provided context. The ground truth does not provide these specific reserve or production figures.\n2. UNSUPPORTED CLAIMS: The statement about reserves being \"idle for five+ years\" is not mentioned in the ground truth.\n3. TERMINOLOGY SHIFT: The LLM describes TCO's involvement as \"downstream development\" when the ground truth specifically refers to the \"FGP/WPMP Project\" without characterizing it as downstream.\n4. OVERREACH: The LLM adds interpretive language about \"expanded role\" that goes beyond what the ground truth explicitly states.\n\nMULTI-HOP REASONING: The reasoning is sound in connecting 2023 capital commitments to 2024 production contributions, correctly synthesizing the evolution. However, the introduction of unsupported numerical data undermines the reliability of the synthesis.\n\nSEMANTIC EQUIVALENCE: The core message aligns with ground truth (shift from capex focus to production focus), but the addition of unverified numbers creates factual inaccuracy rather than mere wording variation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 543,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the specificity of UPS's bond matching approach evolved in determining the discount rate for U.S. pension and postretirement benefit plans between 2023 and 2024?",
      "original_answer": "In 2023, UPS described using a bond matching approach to select specific bonds that would satisfy projected benefit payments, emphasizing its belief that this method reflects the process they would employ to settle pension and postretirement obligations. By 2024, the language evolved to place stronger emphasis on the bond matching approach as a guide for selecting bonds that align with projected benefit cash flows, without any material change in the mechanics of the method. However, the 2024 disclosure included a more precise statement indicating that the approach 'guides' the selection process, suggesting a subtle shift in how the policy is framed operationally, even though the underlying practice remained consistent.",
      "llm_answer": "\nIn 2023 UPS merely stated that it applied a “bond‑matching approach” to select bonds that would satisfy its projected U.S. pension and post‑retirement cash‑flow obligations, without describing how those bonds were chosen. By 2024 the company sharpened the methodology, explaining that the discount rate is derived by matching the plan’s expected benefit payments to a yield curve built from long‑term, high‑quality fixed‑income securities, reflecting a more granular, instrument‑level bond‑selection process.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. (1) MAJOR ERROR - DIRECTION OF EVOLUTION: The ground truth states that in 2023 UPS described using a bond matching approach to select specific bonds, and by 2024 the language evolved to emphasize the approach as a 'guide' for selection. The LLM answer reverses this, claiming that in 2023 the company 'merely stated' without describing how bonds were chosen, and by 2024 it 'sharpened the methodology' with more granular details. This is backwards from the actual evolution described in the ground truth. (2) INCORRECT CHARACTERIZATION OF 2023: The ground truth indicates 2023 already included emphasis on the bond matching approach reflecting the settlement process. The LLM incorrectly portrays 2023 as vague or lacking description. (3) INCORRECT CHARACTERIZATION OF 2024: The ground truth states 2024 placed 'stronger emphasis' on the approach as a 'guide' without material change in mechanics. The LLM claims 2024 introduced a 'sharpened methodology' with 'more granular, instrument-level bond-selection process,' which misrepresents the actual evolution as more substantive than it was. The ground truth explicitly states 'without any material change in the mechanics of the method.' (4) QUANTITATIVE ACCURACY: No specific numbers were required in this question, so this scores well. (5) MULTI-HOP REASONING: The LLM failed to correctly synthesize the comparative evolution between 2023 and 2024 across the two filings. The core reasoning is inverted. (6) SEMANTIC EQUIVALENCE: The answer conveys fundamentally different information than the ground truth regarding how the methodology evolved.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 459,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has Linde's relationship with helium evolved from 2022 to 2024, and what financial impact did this change have on the company's sales and operating profit during this period?",
      "original_answer": "In 2022, helium was a supply input for Linde, indicating a supportive role in operations. By 2024, helium had a negative impact on operations, with a $32 million, or 2%, decrease in sales for the Other segment primarily due to lower volumes in global helium and LAMT. Additionally, helium-related costs contributed to downward pressure on operating profit, partially offset by an insurance recovery for LAMT. This reflects a shift from a neutral or positive relationship to one that posed operational challenges.",
      "llm_answer": "\nFrom 2022 through 2024 Linde’s helium‑wholesale business moved from a growth contributor to a head‑wind: the 2024 filing shows a 2 % underlying decline in the “Other” segment, driven by lower helium volumes that trimmed about $32 million of sales.  Yet the same segment’s operating profit rose 44 % to $43 million, because an insurance recovery on LAMT more than offset the higher helium‑related costs, turning a sales dip into a net profit gain.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key financial metrics and the evolution of Linde's helium relationship from 2022-2024. STRENGTHS: (1) Correctly identifies the $32 million sales decline in the Other segment due to lower helium volumes - matches ground truth exactly. (2) Accurately captures the 2% underlying decline percentage. (3) Correctly notes the 44% operating profit increase to $43 million in the Other segment. (4) Properly synthesizes the multi-hop relationship: helium moved from supportive input to operational headwind, with insurance recovery offsetting helium-related costs. (5) Demonstrates sound reasoning about the paradox of declining sales but rising operating profit. MINOR WEAKNESSES: (1) The LLM characterizes helium as a 'wholesale business' which is not explicitly stated in the ground truth - the ground truth describes helium as a 'supply input' in 2022 and notes 'lower volumes in global helium and LAMT' in 2024. This is a slight interpretive difference but not factually incorrect. (2) The phrase 'helium-wholesale business' could be seen as adding specificity not present in the source material, though it's a reasonable characterization. (3) The ground truth mentions helium had 'negative impact on operations' while the LLM says it became a 'head-wind' - semantically equivalent but slightly different framing. QUANTITATIVE VERIFICATION: All numbers check out - $32 million decline, 2% decrease, 44% operating profit increase, $43 million profit level. The calculations and synthesis across multiple data points are accurate. The multi-hop reasoning correctly connects the sales decline to the profit increase through the insurance recovery mechanism. Overall, this is a high-quality answer with accurate numbers and sound reasoning, with only minor semantic/interpretive variations from the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 511,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did Bank of America's unfunded capital contributions for renewable energy investments evolve between 2023 and 2024, and what was the corresponding change in recognized tax credits related to these investments?",
      "original_answer": "In 2023, Bank of America had unfunded capital contributions for renewable energy investments of $6.2 billion, and it recognized tax credits and other tax benefits of $4.0 billion. By 2024, the unfunded capital contributions decreased to $4.6 billion, and the recognized tax credits slightly declined to $3.9 billion. This indicates a reduction in the Corporation's near-term funding commitments to renewable energy projects, even as the tax benefits remained relatively stable.",
      "llm_answer": "\nBank of America’s unfunded capital commitments for renewable‑energy projects fell sharply—from **$6.2 billion at the end of 2023 to $4.6 billion at the end of 2024**, a reduction of roughly **$1.6 billion**.  At the same time, the tax credits and other tax benefits recognized from those renewable‑energy equity investments declined from **$4.0 billion in 2023 to $3.9 billion in 2024**, a decrease of about **$0.1 billion (≈$100 million)**.  (Pages 131 – 2023 and 132 – 2024).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. QUANTITATIVE VERIFICATION: All numbers are correct - unfunded capital contributions decreased from $6.2B (2023) to $4.6B (2024), a reduction of $1.6B (calculation verified: $6.2B - $4.6B = $1.6B). Tax credits declined from $4.0B (2023) to $3.9B (2024), a decrease of $0.1B/$100M (calculation verified: $4.0B - $3.9B = $0.1B). All figures match the ground truth exactly. ENTITY ACCURACY: Bank of America correctly identified, years 2023 and 2024 correctly specified, metrics properly labeled (unfunded capital contributions and recognized tax credits). MULTI-HOP REASONING: The answer successfully synthesizes information across two years and two distinct metrics, showing the evolution of both unfunded commitments and tax benefits. The comparison and calculations are logically sound. COMPLETENESS: The answer addresses all parts of the multi-part question - the evolution of unfunded capital contributions AND the corresponding change in recognized tax credits. PRESENTATION: The answer includes helpful page references (131-132) and clearly presents both absolute values and calculated differences. The characterization of the decline as 'sharp' for capital contributions and 'slight' for tax credits appropriately reflects the relative magnitudes of change. Minor note: The ground truth uses slightly more cautious language ('slightly declined' vs LLM's 'declined'), but both convey the same meaning. The LLM's additional calculation of the percentage/magnitude of change adds value without introducing error.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 431,
        "total_tokens": 1687
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has General Motors' approach to fleet sales involving commercial fleet customers evolved from 2022 to 2024, particularly in terms of sales channels and profitability considerations?",
      "original_answer": "In 2022, General Motors highlighted that fleet transactions, especially sales to daily rental car companies, were generally less profitable compared to retail sales, and these vehicles were sold either directly or through the dealer network. By 2024, the company emphasized that fleet sales, including those to commercial fleet customers, were completed through the dealer network and in some cases directly with fleet customers, suggesting a more structured and possibly optimized approach to fleet sales. This evolution indicates a strategic shift toward balancing fleet sales with profitability by leveraging both direct and dealer-based channels.",
      "llm_answer": "\nFrom 2022 through 2024 GM has deliberately scaled back the low‑margin, volume‑driven fleet channel—especially sales to daily‑rental companies—and now pursues commercial‑fleet business through tighter, more profitable dealer‑network agreements and, where it makes sense, direct contracts.  The 2022 filing notes that “certain fleet transactions, particularly sales to daily rental car companies, are generally less profitable than retail sales,” and the 2024 documents continue to describe fleet sales as being “completed through the dealer network and in some cases directly with fleet customers,” while emphasizing a focus on “driving an efficient, consolidated fixed‑cost structure” and managing profitability.  Consequently, the company’s fleet‑sale share has continued to shrink (from roughly 16 % of total sales in 2019 to about 11 % in 2021) and its 2024 disclosures reflect a strategic shift toward higher‑margin commercial fleets rather than broad rental‑fleet volume.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "MAJOR ISSUES WITH QUANTITATIVE ACCURACY: The LLM answer introduces specific fleet sales percentages (16% in 2019, 11% in 2021) that are NOT present in the ground truth answer and cannot be verified from the provided context. This is a critical error—the evaluator cannot confirm these numbers are accurate from SEC filings, and they appear to be unsupported claims. The ground truth makes no mention of these specific percentages. QUALITATIVE ASSESSMENT: The LLM correctly identifies the core evolution: (1) 2022 recognition that fleet sales (especially daily rental) are less profitable, (2) 2024 shift toward dealer network and direct fleet customer channels, (3) strategic emphasis on profitability. The semantic understanding of the shift from volume-driven to margin-focused fleet strategy is sound. MULTI-HOP REASONING: The LLM appropriately synthesizes information across 2022 and 2024 filings and correctly identifies the strategic shift. However, the introduction of unsupported percentage data undermines the credibility of the analysis. COMPLETENESS: The answer addresses the question's core elements (sales channels evolution, profitability considerations, time period 2022-2024), but adds unverified quantitative claims. The phrase 'driving an efficient, consolidated fixed-cost structure' appears to be paraphrased language that may or may not be directly from the filings. CRITICAL FLAW: The LLM presents specific historical percentages (2019, 2021) that fall outside the 2022-2024 timeframe of the question and are not mentioned in the ground truth. This represents either hallucination or unsupported extrapolation. The core narrative about the strategic shift is correct, but the quantitative embellishment significantly damages the answer's reliability.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 482,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did PepsiCo's relationship with Sabra evolve between 2022 and 2024, and what financial implications were associated with this change?",
      "original_answer": "In 2022, PepsiCo owned the Sabra brand as part of its joint venture portfolio. However, by 2024, PepsiCo no longer had full ownership but instead held a 50% equity stake, which was remeasured at fair value, resulting in a pre-tax gain of $122 million. This indicates that PepsiCo divested a portion of its ownership in Sabra during the intervening period, marking a strategic shift in its relationship with the brand.",
      "llm_answer": "\nBetween 2022 and 2024 PepsiCo’s stake in the Sabra joint‑venture shifted from a 50 % equity interest that was carried at cost to an equity investment that was re‑measured at fair value.  In 2024 the company recorded a **pre‑tax gain of $122 million (≈ $92 million after‑tax)** on that re‑measurement, which was booked in selling, general and administrative expenses (see page 73).  The one‑time gain lifted net income and earnings per share, reflecting the increased fair‑value of PepsiCo’s previously held 50 % ownership in Sabra.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a fundamental factual contradiction that undermines the entire response. The ground truth states that PepsiCo's relationship evolved FROM full ownership in 2022 TO a 50% equity stake by 2024 (a divestment). However, the LLM answer claims the stake 'shifted from a 50% equity interest...to an equity investment that was re-measured at fair value,' implying PepsiCo held 50% in both periods. This is a major mischaracterization of the evolution described in the question. The LLM correctly identifies: (1) the $122 million pre-tax gain figure, (2) the 50% ownership stake in 2024, and (3) the fair value remeasurement. However, it fails to capture the critical change: that PepsiCo divested from full ownership to 50% ownership between 2022-2024. The LLM's statement about the stake being 'carried at cost' to 're-measured at fair value' appears to describe an accounting treatment change rather than the ownership structure evolution. The after-tax gain calculation ($92 million) is reasonable but not verified against ground truth. The mention of SG&A expenses and impact on EPS adds contextual detail but doesn't compensate for the fundamental misunderstanding of how the relationship evolved. The answer reads as if PepsiCo maintained 50% throughout, when the key story is the transition from majority/full ownership to 50% ownership.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 386,
        "total_tokens": 1621
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has Adobe's treatment of Adobe Scan evolved between 2023 and 2024, particularly in terms of its positioning within Adobe's product ecosystem?",
      "original_answer": "In 2023, Adobe Scan was listed among Adobe's trademarks, indicating it was an established product within the company's portfolio. By 2024, Adobe Scan was explicitly positioned as part of Adobe Document Cloud, which includes Acrobat, Acrobat Sign, and other apps and API services that support digital document and signature workflows. This evolution shows a shift from mere trademark recognition to a more integrated and strategically emphasized role within Adobe’s broader document management and productivity offerings.",
      "llm_answer": "\nBetween 2023 and 2024 Adobe Scan moved from being listed simply as a standalone app inside the Document Cloud suite to being presented as a core, AI‑enhanced component of Adobe’s cloud‑based content workflow. The 2024 filing emphasizes that Scan now works tightly with Adobe Express and Firefly‑powered services—offering generative‑AI scanning features, commercial‑safe “Content Credentials,” and seamless integration across Adobe’s Creative Cloud, Stock and Frame.io ecosystems—whereas the 2023 filing treated it merely as one of several Document Cloud apps. This reflects a shift toward positioning Adobe Scan as part of an integrated, AI‑driven content creation and collaboration platform rather than an isolated scanning tool.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR ISSUES WITH FACTUAL ACCURACY: The LLM answer introduces significant claims not supported by the ground truth. Specifically: (1) The ground truth states Adobe Scan was positioned as part of Adobe Document Cloud in 2024, but makes NO mention of AI-enhancement, Firefly integration, Content Credentials, Creative Cloud ecosystem integration, Stock, or Frame.io connections. (2) The LLM claims Scan works with 'Adobe Express and Firefly-powered services' and offers 'generative-AI scanning features'—these details are completely absent from the ground truth. (3) The LLM references integration across 'Creative Cloud, Stock and Frame.io ecosystems'—the ground truth only mentions Document Cloud positioning alongside Acrobat, Acrobat Sign, and other apps/API services. (4) The LLM's characterization of 2023 treatment as 'standalone app inside the Document Cloud suite' contradicts the ground truth, which states it was merely 'listed among Adobe's trademarks' in 2023, not positioned within Document Cloud. WHAT WAS CORRECT: The LLM correctly identifies that there was an evolution between 2023 and 2024, and that the positioning became more integrated/strategic. The years (2023, 2024) are correct. MULTI-HOP REASONING: The LLM failed to synthesize information accurately from the source documents. It appears to have fabricated or hallucinated details about AI features, Firefly integration, and cross-ecosystem positioning that are not present in the ground truth. This is a critical failure for a financial/regulatory document analysis task where accuracy is paramount. The answer reads more like speculation about what Adobe might have done rather than what the filings actually state.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 462,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has General Motors' financial exposure and nature of obligations to Stellantis evolved from 2022 to 2024, particularly regarding indemnifications and historical liabilities?",
      "original_answer": "In 2022, General Motors continued to have supply-related transactions with Stellantis following the sale of the Opel/Vauxhall business, indicating an ongoing operational relationship. By 2024, the nature of GM's exposure to Stellantis had shifted from operational supplies to financial guarantees and indemnifications tied to legacy liabilities. Specifically, GM had agreed to indemnify Stellantis for certain emissions-related lawsuits, Takata-related recalls, and potential penalties from European regulatory investigations into end-of-life vehicle practices. Additionally, as of December 31, 2024, GM had accrued an immaterial amount related to these matters, showing a continued but reduced financial exposure compared to earlier liabilities. This reflects a transformation from active supply chain involvement to a more passive, indemnification-based financial relationship.",
      "llm_answer": "\nFrom 2022 through 2024 GM’s indemnification exposure to Stellantis has remained modest and largely unchanged: the 2017 sale agreement obligates GM to cover certain historical losses—such as emissions violations, product‑liability claims and recall matters—subject to caps, thresholds and expiration dates extending to 2029, and GM has recorded only insignificant accruals because it cannot reasonably estimate any additional loss.  In both the 2022 and 2024 filings the company reiterates that it is “unable to estimate any reasonably possible material loss” from these indemnity claims, noting that any future indemnification (e.g., for further Takata‑related recalls) is considered remote, and the existing obligations are already covered by the minimal reserves it has set aside.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains several correct elements but has significant gaps and mischaracterizations compared to the ground truth. CORRECT ELEMENTS: (1) The 2017 sale agreement reference is accurate; (2) The mention of emissions violations, product liability, and recall matters as covered indemnifications is correct; (3) The reference to caps, thresholds, and expiration dates extending to 2029 is accurate; (4) The statement about immaterial/insignificant accruals is correct; (5) The inability to reasonably estimate material losses is accurately stated. SIGNIFICANT GAPS AND ERRORS: (1) The LLM answer fails to capture the key evolution described in the ground truth—the shift FROM operational supply-related transactions in 2022 TO financial guarantees and indemnifications by 2024. The LLM characterizes the exposure as 'remained modest and largely unchanged,' which contradicts the ground truth's emphasis on transformation; (2) The LLM answer omits specific indemnification categories mentioned in the ground truth: Takata-related recalls (mentioned only as 'remote' future risk) and European regulatory investigations into end-of-life vehicle practices are completely absent; (3) The LLM answer does not adequately address the 2022-to-2024 evolution—it treats the obligations as static rather than showing how the relationship transformed from supply chain involvement to passive indemnification; (4) The characterization of future Takata claims as 'remote' is mentioned but not integrated into the broader narrative of how obligations evolved. MULTI-HOP REASONING: The LLM answer demonstrates partial synthesis but fails to connect the temporal evolution across years. It focuses on the indemnification structure rather than the transformation of the relationship. The ground truth emphasizes a shift in nature of exposure (operational to financial), while the LLM answer treats indemnifications as the primary focus throughout. QUANTITATIVE ACCURACY: The dates (2017, 2029) and the characterization of accruals as immaterial are correct, but no specific dollar amounts are provided in either answer, so this dimension is limited. CONTEXTUAL RELEVANCE: The answer addresses indemnifications but misses the broader context of relationship evolution that the question specifically asks about ('how has...evolved').",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 619,
        "total_tokens": 2042
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has PepsiCo's relationship with co-packers evolved between 2022 and 2024, particularly in terms of operational dependency and strategic involvement?",
      "original_answer": "In 2022, PepsiCo described its relationship with co-packers as part of a 'highly distributed network of plants, warehouses and distribution centers' that are owned or leased by these third parties, indicating an operational dependency. By 2024, the company's language shifted to emphasize co-packers as part of 'strategic alliances or joint ventures in which we have an equity interest,' suggesting a more active and ownership-based strategic involvement. This evolution reflects a shift from a primarily operational partnership to a more integrated and strategic stake in co-packers.",
      "llm_answer": "\nBetween 2022 and 2024 PepsiCo’s co‑packing relationship moved from a largely outsourced model toward a more strategic partnership.  The company still depends on a globally dispersed network of co‑packer‑owned plants and distribution centers (as disclosed in both the 2022 and 2024 filings), but the 2024 disclosures highlight deeper equity‑based alliances and joint ventures—such as the Juice Transaction and investments in Celsius—showing increased operational reliance and a more strategic role for co‑packers in PepsiCo’s growth and productivity initiatives.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures the general directional shift in PepsiCo's co-packer relationship from 2022 to 2024, correctly identifying the evolution toward more strategic involvement. However, there are significant issues with accuracy and specificity:\n\n(1) CORRECT ELEMENTS:\n- Correctly identifies the shift from outsourced model to strategic partnership\n- Accurately notes the presence of 'highly distributed network' language in both years\n- Correctly identifies equity-based alliances and joint ventures as part of 2024 positioning\n- Appropriately mentions specific examples (Juice Transaction, Celsius investments)\n- Correctly captures the semantic shift from operational dependency to strategic stake\n\n(2) PROBLEMATIC ELEMENTS:\n- The LLM introduces specific examples (Juice Transaction, Celsius investments) that are not mentioned in the ground truth answer. While these may be factually accurate from the filings, they represent information synthesis beyond what the ground truth validates\n- The phrase 'increased operational reliance' is somewhat contradictory to the ground truth's characterization of the shift as moving FROM operational dependency TO strategic involvement. The ground truth emphasizes ownership-based strategic involvement, not increased operational reliance\n- The LLM states co-packers are 'part of PepsiCo's growth and productivity initiatives' which adds interpretation not explicitly in the ground truth\n\n(3) MULTI-HOP REASONING:\n- The multi-hop synthesis is sound in connecting 2022 and 2024 filings\n- However, the introduction of specific transaction examples (Juice Transaction, Celsius) suggests the LLM may be drawing from actual filing data rather than strictly validating against the ground truth provided\n- The core reasoning about the evolution is correct but the supporting details diverge\n\n(4) SEMANTIC EQUIVALENCE:\n- The core message aligns with ground truth: relationship evolved from operational partnership to more strategic, equity-based involvement\n- However, the framing of 'increased operational reliance' contradicts the ground truth's emphasis on moving away from pure operational dependency\n- The ground truth emphasizes 'ownership-based strategic involvement' while LLM emphasizes 'operational reliance,' which are subtly different concepts\n\nThe answer demonstrates understanding of the directional change but introduces specific examples and slightly mischaracterizes the nature of the shift (operational reliance vs. strategic ownership stake).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 669,
        "total_tokens": 1957
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did SPG's financial relationship with ABG evolve between 2023 and 2024, particularly in terms of gains recognized and strategic investments?",
      "original_answer": "In 2023, SPG recognized multiple non-cash pre-tax gains related to its relationship with ABG, including $59.1 million from deemed disposals due to ABG's capital transactions and $157.1 million from the sale of a portion of its ABG interests. Additionally, SPG recorded a $145.8 million gain from the dilution of its ownership in SPARC Group. In 2024, SPG disclosed a pre-tax gain of $18.8 million from the sale of a portion of its ABG interest in December 2021, along with a strategic partnership with ABG to become the core licensee and operating partner for Reebok in the U.S., indicating a shift toward deeper operational collaboration rather than just financial transactions.",
      "llm_answer": "\nBetween 2023 and 2024 SPG’s stake in ABG was gradually divested: in Q4 2023 it sold a portion of its interest, recognizing a $157.1 million pretax gain (plus a $10.3 million non‑cash gain from a deemed disposal) and reducing its ownership to roughly 9.6 %; in Q1 2024 it sold the remaining interest for $1.2 billion, generating a $414.8 million pretax gain (with $103.7 million of related tax expense).  While these transactions wound down the ABG relationship, SPG made strategic investments in the TRG joint venture—acquiring an additional 4 % interest for about $199.6 million in Q3 2023 and a further 4 % for roughly $266.7 million in Q4 2024—bringing its non‑controlling ownership in TRG to 88 % without altering governance rights.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not present in the ground truth, making it substantially incorrect:\n\n1. MAJOR FACTUAL ERRORS:\n   - The LLM claims SPG sold its \"remaining interest\" in Q1 2024 for $1.2 billion with a $414.8 million gain. The ground truth makes no mention of a complete exit or these figures in 2024.\n   - The ground truth states SPG disclosed a $18.8 million gain from a sale of ABG interest in December 2021 (a historical reference), not a 2024 transaction.\n   - The LLM's narrative of complete divestment contradicts the ground truth's emphasis on \"deeper operational collaboration\" through the Reebok partnership.\n\n2. QUANTITATIVE ACCURACY ISSUES:\n   - Ground truth 2023 gains: $59.1M (deemed disposal) + $157.1M (sale) + $145.8M (SPARC dilution) = documented figures\n   - LLM claims $157.1M + $10.3M in 2023 (the $10.3M figure doesn't appear in ground truth)\n   - LLM introduces $414.8M and $103.7M tax expense for 2024 with no ground truth support\n   - LLM's TRG investment figures ($199.6M, $266.7M, 88% ownership) are entirely absent from ground truth\n\n3. MULTI-HOP REASONING FAILURE:\n   - The LLM fundamentally mischaracterizes the relationship evolution. Ground truth emphasizes a shift toward operational partnership (Reebok licensee role), while LLM frames it as complete divestment.\n   - Ground truth mentions SPARC Group dilution gain ($145.8M) which LLM completely omits.\n   - LLM introduces TRG joint venture details that are not in the ground truth at all.\n\n4. ENTITY AND CONTEXT ERRORS:\n   - The ground truth's key 2024 development is the strategic Reebok partnership with ABG, indicating operational deepening. LLM misses this entirely.\n   - LLM conflates different transactions and time periods, creating a false narrative of complete exit.\n\n5. MISSING GROUND TRUTH ELEMENTS:\n   - No mention of the $145.8M SPARC Group dilution gain\n   - No mention of the strategic Reebok partnership as the key 2024 development\n   - No mention of the shift from financial transactions to operational collaboration\n\nThe LLM answer appears to contain fabricated or confused data points that do not align with the ground truth knowledge graph, particularly regarding 2024 transactions and TRG investments.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 613,
        "total_tokens": 1967
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How has Lockheed Martin's involvement in Sikorsky helicopter programs evolved from 2022 to 2024, particularly in terms of production volume and program scope?",
      "original_answer": "In 2022, Lockheed Martin's RMS segment experienced a $560 million increase in product costs, partly due to higher production volume on various Sikorsky helicopter programs. By 2024, RMS explicitly listed Sikorsky helicopter programs—such as those related to the Black Hawk, Seahawk, and CH-53K King Stallion—as key components of its portfolio, indicating a continued and potentially expanded focus. This evolution reflects a shift from being a cost driver to being a clearly defined strategic product line within the RMS segment.",
      "llm_answer": "\nFrom 2022 through 2024 Lockheed Martin accelerated production on its Sikorsky helicopter portfolio—particularly the CH‑53K King Stallion, UH‑60 Black Hawk and Seahawk families—while also expanding the program scope to include new variants and the completion of the VH‑92A Presidential‑helicopter delivery in 2024.  The company’s own cost disclosures cite billions of dollars of higher product costs tied to the increased volume on these Sikorsky programs, underscoring both the rise in output and the broader program envelope over the period.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ISSUES: (1) QUANTITATIVE ACCURACY - The LLM claims 'billions of dollars of higher product costs' but the ground truth specifies a $560 million increase in 2022. This is a major factual error - $560M is not 'billions.' The LLM appears to have fabricated or significantly overstated the cost figures without basis in the ground truth. (2) UNSUPPORTED CLAIMS - The LLM introduces several details not present in the ground truth: (a) 'accelerated production' - ground truth only mentions 'higher production volume' in 2022; (b) 'new variants' - not mentioned in ground truth; (c) 'VH-92A Presidential helicopter delivery in 2024' - completely absent from ground truth; (d) 'UH-60 Black Hawk' - ground truth mentions 'Black Hawk' but not the specific UH-60 designation in this context. (3) MULTI-HOP REASONING - While the LLM correctly identifies the evolution from cost driver to strategic product line concept, it fails to accurately synthesize the actual financial data. The ground truth shows a specific $560M cost increase in 2022, not vague 'billions.' (4) WHAT WAS CORRECT - The LLM correctly identifies: CH-53K King Stallion, Black Hawk, and Seahawk as key programs; the general concept of expanded focus; the RMS segment context; the 2022-2024 timeframe. (5) WHAT WAS WRONG - Fabricated or vastly overstated cost figures ('billions' vs. $560M); introduced unsupported program details (VH-92A, new variants); failed to cite the specific $560M figure from ground truth. The answer reads plausibly but contains material factual errors that undermine credibility.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 432,
        "total_tokens": 1703
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Walmart's ownership stake and financial investment in Alert Innovation evolve between fiscal 2023 and fiscal 2024?",
      "original_answer": "In fiscal 2023, Walmart completed a $0.4 billion acquisition of Alert Innovation, increasing its ownership to approximately 100%. By fiscal 2024, there was no mention of Walmart retaining ownership of Alert Innovation, indicating that the company had fully exited its stake, likely through a sale or divestiture.",
      "llm_answer": "\nBetween fiscal 2023 and fiscal 2024 Walmart’s stake in Alert Innovation moved from 0 % to 100 % after it invested roughly $0.4 billion to acquire the remaining shares in fiscal 2023; the company then held a full‑ownership position throughout fiscal 2024 with no additional capital outlay or change in its ownership percentage.  The investment remained at the $0.4 billion acquisition cost (plus any subsequent adjustments) and was later sold and de‑consolidated in fiscal 2025.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) INCORRECT OWNERSHIP PROGRESSION: The LLM states Walmart's stake moved from 0% to 100% in fiscal 2023, but the ground truth indicates Walmart already had some ownership stake before fiscal 2023 and completed the acquisition to reach 100% in fiscal 2023. The LLM's characterization of starting from 0% is misleading about the initial position. (2) CONTRADICTS GROUND TRUTH ON FISCAL 2024: The ground truth explicitly states 'there was no mention of Walmart retaining ownership of Alert Innovation' in fiscal 2024, indicating a full exit/divestiture. The LLM incorrectly claims Walmart 'held a full-ownership position throughout fiscal 2024 with no additional capital outlay or change in its ownership percentage.' This directly contradicts the ground truth. (3) INTRODUCES UNSUPPORTED INFORMATION: The LLM mentions the investment 'was later sold and de‑consolidated in fiscal 2025,' which goes beyond the scope of the question (which asks about fiscal 2023-2024 evolution) and introduces information not in the ground truth. (4) CORRECT ELEMENTS: The $0.4 billion acquisition amount is correct, and the fiscal 2023 timing is correct. However, the core narrative about fiscal 2024 is fundamentally wrong. The LLM failed to recognize that the ground truth indicates Walmart exited its stake between fiscal 2023 and fiscal 2024, not that it maintained full ownership through fiscal 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1191,
        "completion_tokens": 409,
        "total_tokens": 1601
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did SPG's utilization and management of the Supplemental Facility evolve between 2023 and 2024, particularly in terms of borrowing activity and repayment strategy?",
      "original_answer": "In 2023, SPG utilized the Supplemental Facility as part of its broader capital strategy, borrowing €750.0 million under this facility, which was later repaid on November 17, 2023, following the issuance of senior unsecured bonds. By 2024, there was no outstanding balance under the Supplemental Facility, indicating a full repayment and a shift away from its use. This evolution shows a strategic reduction in reliance on the Supplemental Facility, with SPG opting instead to refinance through long-term unsecured notes, such as the $1.0 billion issuance in September 2024.",
      "llm_answer": "\nIn 2023 the Supplemental Facility was a $3.5 billion unsecured revolving line with an earlier maturity, while in 2024 it was expanded to a $3.5‑$4.5 billion facility extended to a Jan 31 2029 maturity (extendable to 2030) and priced at SOFR + 72.5 bp. The company has been actively borrowing under the enlarged line—using proceeds for acquisitions and refinancing—while following a structured repayment schedule, as reflected by $1.9 billion of net debt repayments in 2024 and principal maturities of $2.68 billion in 2025, $7.35 billion in 2026‑27 and $2.97 billion in 2028‑29, with the remainder due after 2029.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and addresses a completely different aspect of SPG's capital structure than what the ground truth describes. Critical issues: (1) WRONG FACILITY DISCUSSED: The LLM discusses changes to a general revolving credit facility ($3.5B to $3.5-4.5B with Jan 31 2029 maturity), while the ground truth specifically addresses the 'Supplemental Facility' with €750 million borrowing in 2023. These are different facilities. (2) FACTUAL INACCURACY ON 2023-2024 EVOLUTION: Ground truth states SPG borrowed €750M in 2023 and repaid it on November 17, 2023, with NO outstanding balance in 2024. The LLM claims active borrowing under an 'enlarged line' in 2024, which contradicts the ground truth's statement of full repayment and shift away from the Supplemental Facility. (3) MISSING KEY FACTS: The LLM completely omits the €750M borrowing, the November 17, 2023 repayment date, and the refinancing through senior unsecured bonds that triggered the repayment. (4) IRRELEVANT DETAILS: The LLM provides extensive information about debt maturity schedules ($2.68B in 2025, $7.35B in 2026-27, etc.) and SOFR pricing that, while potentially accurate for general debt, are not responsive to the specific question about the Supplemental Facility's evolution. (5) MULTI-HOP REASONING FAILURE: The question asks specifically about the Supplemental Facility's evolution between 2023-2024 in terms of borrowing and repayment strategy. The LLM fails to synthesize the correct information: 2023 had €750M borrowed then repaid; 2024 had zero balance. The LLM appears to have confused or conflated different credit facilities. The answer demonstrates a fundamental misunderstanding of which facility was being discussed and provides contradictory information about borrowing activity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 488,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How has Linde's treatment of helium in its industrial gases business evolved between 2023 and 2024, particularly in terms of its positioning as a primary product and associated supply strategies?",
      "original_answer": "In 2023, helium was explicitly listed as one of Linde's primary products within its industrial gases business, specifically called out alongside gases like oxygen, nitrogen, and hydrogen. The 2023 filing also described helium's distribution through merchant delivery, with contracts typically lasting three to seven years and without minimum purchase requirements. By 2024, helium was no longer specifically named as a distinct product in the industrial gases segment. Instead, it was subsumed under more general descriptions of gas supply methods and contracts, suggesting a reduced emphasis on helium as a standalone offering. This shift indicates a strategic repositioning of helium within Linde's broader gas portfolio, aligning it more closely with other merchant gases rather than maintaining its prior distinct status.",
      "llm_answer": "\nBetween 2023 and 2024 Linde did not reposition helium as a newly‑created product line; it remained classified under “process gases” (alongside oxygen, nitrogen, argon, hydrogen, etc.) and continued to be sold through the same three distribution channels.  The 2024 sales tables show helium (as part of the packaged‑gas portfolio) contributing to the 35 % of total sales generated by packaged‑gas shipments, and the company’s supply strategy still relies on merchant‑truck deliveries and cylinder‑filling facilities rather than dedicated on‑site plants.  Consequently, helium’s role as a high‑value, primary product stayed stable, with emphasis on expanding its reach within packaged‑gas contracts and leveraging long‑term merchant supply agreements rather than a fundamental shift in positioning.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer fundamentally contradicts the ground truth on the core claim of the question. Ground truth states that helium was explicitly listed as a primary product in 2023 but was NO LONGER specifically named in 2024, representing a strategic repositioning. The LLM answer claims the opposite: that helium's role 'stayed stable' and there was 'no fundamental shift in positioning.' This is a critical factual error that directly contradicts the knowledge graph. The LLM introduces specific claims (35% of sales from packaged-gas shipments, classification under 'process gases') that are not verified against the ground truth and appear to be fabricated details. The LLM also mischaracterizes the ground truth's finding of reduced emphasis as 'stability.' The answer does correctly identify that helium is distributed through merchant delivery and cylinder-filling facilities, which aligns with ground truth, but this minor accuracy is overwhelmed by the fundamental misrepresentation of the 2023-2024 evolution. The LLM failed to recognize the key distinction: helium went from being explicitly called out as a primary product (2023) to being subsumed under general descriptions (2024), which is the central finding of the ground truth. The reasoning is flawed because it assumes continuity where the ground truth explicitly documents a shift in positioning and emphasis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 382,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did the allocation of assets in the U.S. Retiree Health Care Plan evolve between 2022 and 2023, particularly in terms of fixed income securities and equity securities?",
      "original_answer": "In 2022, the U.S. Retiree Health Care Plan had $248 in fixed income securities and cash equivalents and $137 in equity securities, totaling $385. In 2023, the plan's allocation changed to $210 in fixed income securities and cash equivalents and $54 in equity securities, totaling $264. This indicates a decrease in both categories, with a more significant reduction in equity securities.",
      "llm_answer": "\nBetween the end of 2022 and the end of 2023 the U.S. Retiree Health Care Plan shifted its asset mix markedly toward fixed‑income.  In 2022 the plan held roughly **$248 million of fixed‑income securities and $137 million of equity securities** (≈64 % fixed‑income, 36 % equity) — as disclosed in the 2022 filing (page 48 of TXN_10k_2022.pdf).  By the end of 2023 those amounts had fallen to **$210 million in fixed‑income and $54 million in equity**, moving the allocation to about **80 % fixed‑income and 20 % equity** — see the 2023 data on page 48 of TXN_10k_2023.pdf.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All quantitative data matches the ground truth exactly: 2022 figures ($248M fixed income, $137M equity) and 2023 figures ($210M fixed income, $54M equity) are correct. The calculated percentages are also accurate: 2022 allocation (64% fixed income, 36% equity) and 2023 allocation (80% fixed income, 20% equity) are mathematically correct. The answer properly synthesizes multi-hop information by comparing the two years and identifying the key trend: a shift toward fixed-income securities with absolute decreases in both categories. The LLM correctly identifies the more significant reduction in equity securities (from $137M to $54M, a 60.6% decline) versus fixed income (from $248M to $210M, a 15.3% decline). The answer includes appropriate source citations (TXN 10-K filings for 2022 and 2023, page 48), demonstrating proper document referencing. The reasoning is sound and the characterization of the shift as 'marked' is justified by the percentage point changes (from 36% to 20% equity). Minor: The phrasing 'shifted its asset mix markedly toward fixed-income' is slightly interpretive but semantically accurate given the percentage increase from 64% to 80%. All entities are correctly identified (U.S. Retiree Health Care Plan, years 2022-2023, asset categories). The answer fully addresses all parts of the question regarding how the allocation evolved.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 393,
        "total_tokens": 1639
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did the financial performance and strategic positioning of Trodelvy evolve between 2022 and 2023, particularly in terms of revenue generation and regulatory milestones?",
      "original_answer": "In 2022, Trodelvy generated $380 million in total product sales, primarily in the U.S., indicating its early commercial presence. By 2023, there was a strategic shift in Trodelvy's positioning as it received significant regulatory approvals: FDA approval for treating HR+/HER2- metastatic breast cancer and EC approval for a similar indication. These developments suggest a strong enhancement in its market potential and therapeutic footprint, although specific revenue figures for 2023 are not provided.",
      "llm_answer": "\nBetween 2022 and 2023 Trodelvy’s worldwide sales jumped from **$680 million to $1.06 billion**, a **≈56 % increase**, driven by stronger demand across its existing indications and expanding use in new patient populations.  In 2023 the company also achieved two key regulatory milestones – **FDA (and EU) approval of Trodelvy as a monotherapy for metastatic HR⁺/HER2‑ breast cancer after prior endocrine therapy and chemotherapy**, and **EU approval for the same breast‑cancer indication** – reinforcing its strategic importance as a flagship oncology asset and a primary growth engine for Gilead.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamentally incorrect financial data. Ground truth states Trodelvy generated $380 million in 2022 product sales, but the LLM claims $680 million - a 79% overstatement. The LLM also claims 2023 sales of $1.06 billion, but the ground truth explicitly states 'specific revenue figures for 2023 are not provided.' This is a major factual error - the LLM fabricated 2023 revenue data that does not exist in the source material. The 56% growth calculation is based on these false numbers and is therefore meaningless. REGULATORY MILESTONES: The LLM correctly identifies FDA and EU approvals for HR+/HER2- metastatic breast cancer, which aligns with ground truth. However, the LLM adds unnecessary detail about 'monotherapy for metastatic HR⁺/HER2‑ breast cancer after prior endocrine therapy and chemotherapy' that goes beyond what the ground truth specifies. MULTI-HOP REASONING: The LLM failed to properly synthesize information from the source documents. It appears to have either: (1) confused Trodelvy's financials with another product, (2) misread the 2022 figure, or (3) hallucinated the 2023 figures entirely. The ground truth is clear that 2023 revenue was not disclosed, yet the LLM confidently states a specific number. CONTEXTUAL ISSUES: While the LLM correctly identifies Trodelvy as a Gilead asset and discusses regulatory approvals appropriately, the foundational financial claims are so inaccurate that the entire answer is unreliable. The question specifically asks about 'revenue generation' between 2022-2023, and the LLM provides completely incorrect data for both years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 446,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did Chevron's downstream-related earnings and investment relationship with GS Caltex evolve from 2022 to 2024, and what does this indicate about the strategic importance of the joint venture?",
      "original_answer": "In 2022, Chevron reported higher downstream-related earnings from GS Caltex in Korea, contributing to improved income from equity affiliates. By 2024, Chevron maintained a 50% ownership stake in GS Caltex Corporation, which operates as a joint venture with GS Energy, importing, producing, and marketing petroleum products, petrochemicals, and lubricants. Additionally, in 2024, Chevron reported $13,850 million in sales and other operating revenues with affiliated companies, including GS Caltex, compared to $16,286 million in 2022. This indicates that while the joint venture remained strategically important, the level of downstream-related revenue with affiliated companies slightly decreased over the period.",
      "llm_answer": "\nBetween 2022 and 2024 Chevron’s 50 % equity in GS Caltex stayed roughly constant at about $3.6 billion (see Note 15 of the 2024 10‑K), while the JV’s downstream earnings shifted from a $185 million loss in 2020 to modest positive contributions in 2022‑2024, a turnaround highlighted in the 2024 filing’s discussion of “higher downstream‑related earnings from … GS Caltex in Korea.”  This improvement shows that the joint venture has become a strategically vital downstream asset, delivering reliable profit and market access in the Korean market for Chevron.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies Chevron's 50% ownership stake in GS Caltex and appropriately notes the improvement in downstream earnings from losses in 2020 to positive contributions in 2022-2024. The reasoning about strategic importance is sound and well-articulated. The reference to Note 15 of the 2024 10-K shows proper sourcing.\n\nCRITICAL ERRORS: (1) The LLM provides an equity value of ~$3.6 billion for Chevron's 50% stake in GS Caltex, but this specific number is not verified in the ground truth and appears to be unsupported. (2) The LLM mentions a $185 million loss in 2020, which is not part of the question's 2022-2024 timeframe and is not mentioned in the ground truth answer. This introduces information outside the scope of the question.\n\nSIGNIFICANT OMISSIONS: The LLM completely fails to address the key quantitative metric from the ground truth: the decline in sales and other operating revenues with affiliated companies from $16,286 million in 2022 to $13,850 million in 2024. This is a material 15% decrease that directly answers the 'evolution' aspect of the question and is central to understanding the relationship's trajectory. The ground truth explicitly states this decrease 'indicates that while the joint venture remained strategically important, the level of downstream-related revenue with affiliated companies slightly decreased over the period.' The LLM's answer focuses only on earnings improvement and misses this crucial revenue decline.\n\nMULTI-HOP REASONING: The LLM demonstrates partial multi-hop synthesis by connecting ownership stake, earnings trends, and strategic importance, but fails to synthesize the complete picture by omitting the revenue comparison across years. The answer is incomplete in addressing the full evolution of the relationship.\n\nSEMANTIC ISSUES: While the LLM's characterization of GS Caltex as 'strategically vital' aligns with the ground truth's 'strategically important,' the LLM's emphasis on 'reliable profit' is somewhat contradicted by the actual revenue decline that the ground truth highlights.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 560,
        "total_tokens": 1890
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did the financial performance and production status of the CH-53K program evolve from 2022 to 2024, particularly in terms of risk retirements and production volume?",
      "original_answer": "In 2022, the CH-53K program contributed to higher operating profit for Sikorsky helicopter programs, with approximately $140 million in increased profit driven by higher risk retirements and production volume. By 2024, while the CH-53K remained a key product within RMS, the overall operating profit for RMS declined significantly—by 73%—partially due to lower profit booking rate adjustments across the portfolio. Although specific profit figures for CH-53K were not disclosed in 2024, the broader profit decline suggests that the gains from risk retirements observed in 2022 may have diminished as the program matured and entered higher-volume production.",
      "llm_answer": "\nFrom 2022 through 2024 the CH‑53K moved from low‑rate initial production to a sustained ramp‑up, with production volume growing enough to generate about **$120 million of additional operating profit in 2024** (the “higher volume and program‑ramp‑up” cited in Aeronautics’ 2024 profit discussion) and backlog expanding as new orders were booked.  At the same time, the program realized several **risk‑retirement adjustments—positive profit‑booking rate changes that added several hundred million dollars of margin over the period—reflecting improved cost estimates and the resolution of earlier overruns**.  Consequently, both the quantity of CH‑53K aircraft produced and the profitability of the program have trended upward, driven by higher risk retirements and increasing order flow.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and contradicts the ground truth on multiple critical points: (1) QUANTITATIVE ERRORS: The LLM claims '$120 million of additional operating profit in 2024' but the ground truth explicitly states that 'specific profit figures for CH-53K were not disclosed in 2024' and that 'overall operating profit for RMS declined significantly—by 73%' in 2024. The LLM's attribution of $120M profit to 2024 appears to be fabricated or misattributed. (2) RISK RETIREMENT CLAIMS: The LLM claims risk-retirement adjustments added 'several hundred million dollars of margin over the period,' but the ground truth indicates that in 2022 there was approximately $140 million in increased profit from risk retirements and production volume combined, and that by 2024 these gains 'may have diminished as the program matured.' The LLM's claim of 'several hundred million dollars' is unsupported and contradicts the ground truth's more modest figures. (3) DIRECTIONAL CONTRADICTION: The ground truth indicates that profit gains from 2022 diminished by 2024 due to lower profit booking rate adjustments, while the LLM claims 'profitability of the program have trended upward' through 2024—a direct contradiction. (4) MISSING CONTEXT: The LLM fails to acknowledge the 73% decline in RMS operating profit in 2024, which is a critical contextual fact. (5) UNSUPPORTED CLAIMS: References to 'Aeronautics' 2024 profit discussion' and specific profit figures cannot be verified against the ground truth and appear to be hallucinated. The LLM answer presents a narrative of consistent upward progress that contradicts the ground truth's more nuanced picture of initial gains followed by significant decline.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 470,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has PayPal's approach to seller protection programs evolved between 2022 and 2023, particularly in terms of risk exposure and strategic emphasis?",
      "original_answer": "In 2022, PayPal highlighted that its seller protection programs carried risk exposure tied to regional variations and regulatory changes, with historical transaction loss rates ranging between 0.09% and 0.15% of TPV. By 2023, the company placed a stronger strategic emphasis on these programs as a competitive differentiator, explicitly linking them to merchant trust and platform growth. While 2022 focused on risk management and potential loss implications, 2023 framed seller protection as part of a broader value proposition to attract and retain merchants, integrating it with analytics, risk management, and other merchant services.",
      "llm_answer": "\nBetween 2022 and 2023 PayPal shifted from merely reporting the modest loss‑rate of its seller‑protection programs (0.09‑0.15 % of TPV) and warning that macro‑economic stress could raise exposure, to positioning those programs as a strategic growth driver.  The 2023 filing emphasizes that protecting merchants is integral to its value proposition, leverages the company’s two‑sided data platform, and involves continual investment in risk‑management systems, while still noting that loss exposure may increase if economic or regulatory conditions deteriorate.  In short, the approach evolved from risk awareness to a proactive, competitive‑differentiation focus on seller protection.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. QUANTITATIVE ACCURACY: The loss-rate figures (0.09%-0.15% of TPV) are correctly cited and properly formatted. No calculation errors present. QUALITATIVE ACCURACY: The answer accurately captures the evolution of PayPal's approach from 2022 to 2023, correctly identifying the shift from risk-focused messaging to strategic positioning. The LLM properly synthesizes the multi-hop information: (1) 2022 emphasis on risk exposure and regulatory changes, (2) 2023 emphasis on competitive differentiation and merchant trust, (3) integration with broader value proposition. ENTITY ACCURACY: PayPal correctly identified, years (2022/2023) correct, metrics (TPV, loss rates) correctly referenced. SEMANTIC EQUIVALENCE: The LLM's phrasing 'shifted from merely reporting...to positioning those programs as a strategic growth driver' effectively conveys the same meaning as the ground truth's 'evolved from risk management...to competitive differentiator.' The mention of 'two-sided data platform' and 'continual investment in risk-management systems' adds appropriate contextual detail consistent with the ground truth's reference to 'analytics, risk management, and other merchant services.' MINOR OBSERVATION: The LLM includes a caveat about economic/regulatory deterioration that appears consistent with the ground truth's acknowledgment of ongoing risk considerations, showing nuanced understanding. The answer is well-structured, comprehensive, and accurately addresses all aspects of the multi-part question regarding evolution, risk exposure, and strategic emphasis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 452,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has Starbucks' approach to its ready-to-drink beverages evolved between 2023 and 2024, particularly in terms of revenue recognition and supplier dependency?",
      "original_answer": "In 2023, Starbucks recognized revenue from ready-to-drink beverages under the 'Other Revenues' category, where sales were generally recognized upon shipment to customers depending on contract terms. By 2024, the company's focus shifted to supplier dependency and supply chain resilience, emphasizing that ready-to-drink beverages are sourced from specialty suppliers under long-term contracts, indicating a strategic move toward securing stable supply rather than just reporting revenue. While 2023 included ready-to-drink beverages in broader revenue disclosures without specific figures, 2024 highlighted the importance of supplier relationships to mitigate delivery risks, signaling a shift from revenue-centric reporting to a supply-chain risk management focus.",
      "llm_answer": "\nBetween fiscal 2023 and 2024 Starbucks eliminated the bulk of its ready‑to‑drink revenue that had previously flowed through the Nestlé‑controlled Global Coffee Alliance—​the $125 million contribution that was reported in 2023 vanished after the Seattle’s Best Coffee sale in Q2 2023 (Financial Highlights, 2023, p. 39).  In 2024 the RTD products are now captured in “Other revenues” and are recognized when control of the product passes to the customer, i.e., upon shipment, and the company continues to rely on several specialty suppliers under long‑term contracts, a dependency it describes as carrying a remote risk of non‑delivery (Risk Related to Supply Chain, p. 15; Revenue‑recognition discussion, p. 65).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not supported by the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM cites a '$125 million contribution' from the Nestlé Global Coffee Alliance in 2023 that is not mentioned in the ground truth. This specific number appears to be fabricated or misattributed. The ground truth explicitly states 'While 2023 included ready-to-drink beverages in broader revenue disclosures without specific figures,' contradicting the LLM's claim of a specific $125M figure. (2) FACTUAL INACCURACY: The LLM references a 'Seattle's Best Coffee sale in Q2 2023' as the reason for revenue elimination, which is not mentioned in the ground truth and appears to be an unsupported claim. (3) INCOMPLETE SYNTHESIS: While the LLM correctly identifies that 2024 shows RTD products in 'Other revenues' with recognition upon shipment and mentions supplier dependency, it fails to capture the core insight from the ground truth: the strategic shift from 'revenue-centric reporting to a supply-chain risk management focus.' (4) PARTIAL CORRECTNESS: The LLM does correctly note that RTD beverages are sourced from specialty suppliers under long-term contracts and recognized upon shipment, which aligns with the ground truth. However, the introduction of unsupported specific numbers ($125M) and the Seattle's Best Coffee sale narrative significantly undermines credibility. (5) MISSING CONTEXT: The ground truth emphasizes a shift in strategic focus toward supply chain resilience and risk mitigation, while the LLM focuses primarily on revenue elimination without adequately explaining the strategic repositioning. The answer demonstrates some understanding of the 2024 position but fundamentally misrepresents the 2023 baseline and introduces fabricated details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 494,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did the geographic reach and regulatory approvals of Trodelvy evolve between 2022 and 2023?",
      "original_answer": "In 2022, Trodelvy generated $370 million in U.S. sales and $10 million in Europe, with no sales reported in other international markets, indicating limited geographic reach. By 2023, Trodelvy received significant regulatory approvals: it was approved by the FDA for treating adult patients with HR+/HER2- metastatic breast cancer, and it obtained EC approval for monotherapy treatment of unresectable or metastatic HR+/HER2- breast cancer. These approvals suggest an expansion of Trodelvy's market access and therapeutic application, likely contributing to broader geographic distribution beyond what was reported in 2022.",
      "llm_answer": "\nBetween 2022 and 2023 Trodelvy’s regulatory footprint grew – the European Commission granted a new monotherapy approval for advanced HR⁺/HER2⁻ breast cancer (a 2022/2023 expansion beyond the 2021 EU approval for metastatic triple‑negative breast cancer), and the U.S. FDA subsequently approved the same HR⁺/HER2⁻ breast‑cancer indication (previously approved only for urothelial cancer and TNBC). These actions extended the drug’s geographic reach to the EU for a new cancer type and reinforced its U.S. presence, while earlier approvals in Canada and other regions remained unchanged.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer addresses the regulatory approvals aspect of the question but has significant gaps and some inaccuracies: (1) QUANTITATIVE ISSUES: The ground truth provides specific 2022 sales figures ($370M U.S., $10M Europe) that are completely absent from the LLM answer. This is a major omission for a question about 'geographic reach' which inherently involves market presence/sales data. The LLM mentions a '2021 EU approval for metastatic triple-negative breast cancer' but the ground truth does not reference this prior approval, making it unclear if this is accurate or an unsupported claim. (2) REGULATORY ACCURACY: The LLM correctly identifies the 2023 FDA approval for HR+/HER2- breast cancer and the EC approval for the same indication. However, it incorrectly states the FDA 'previously approved only for urothelial cancer and TNBC' - the ground truth does not provide this level of detail about prior FDA indications, so this appears to be added information not verified against the source. (3) GEOGRAPHIC REACH: The ground truth explicitly states 'no sales reported in other international markets' in 2022, but the LLM vaguely references 'Canada and other regions' without quantification or clarity on whether these had actual sales. (4) MULTI-HOP SYNTHESIS: The LLM fails to synthesize the complete picture - it addresses regulatory approvals but omits the sales data that demonstrates actual geographic reach. The question asks about both 'geographic reach AND regulatory approvals,' requiring both dimensions. The LLM provides only the regulatory dimension. (5) MISSING CONTEXT: The ground truth notes that approvals 'likely contributing to broader geographic distribution' - the LLM should have attempted to connect regulatory approvals to potential market expansion, but instead provides disconnected regulatory facts without the sales context that would demonstrate actual reach evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 516,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did Simon Property Group's ownership stake and financial gains from transactions involving ABG evolve between 2023 and 2024?",
      "original_answer": "In 2023, Simon Property Group (SPG) experienced multiple dilutions of its ownership stake in ABG through capital transactions, including a reduction from approximately 12.3% to 11.8%, then to 11.7%, and finally to approximately 9.6%. These transactions resulted in non-cash pre-tax gains of $36.4 million, $12.4 million, and $10.3 million, respectively. By contrast, in 2024, SPG no longer disclosed active changes in its ownership stake in ABG. Instead, it referenced a prior transaction from December 20, 2021, where it sold a portion of its interest in ABG for a pre-tax gain of $18.8 million and later acquired additional interests for $100.0 million. This indicates a shift from active stake reduction and financial recognition in 2023 to a more passive disclosure stance in 2024, with no new transactions reported.",
      "llm_answer": "\nIn 2023 Simon Property Group’s ownership in ABG was gradually diluted – from roughly a 12 % stake at the beginning of the year to about a 9–10 % stake by year‑end – as ABG completed a series of capital transactions that produced non‑cash pretax gains of $36.4 million (Q2), $12.4 million (Q3) and $157.1 million (Q4 sale of a portion) plus a $10.3 million gain from a deemed disposal.  In early 2024 SPG sold its remaining ABG interest for $1.2 billion, recognizing a $414.8 million pretax gain and reducing its ownership to zero.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains multiple critical factual errors that fundamentally contradict the ground truth:\n\n1. MAJOR QUANTITATIVE ERRORS:\n   - LLM claims a $157.1 million gain from Q4 sale - this figure does NOT appear in the ground truth\n   - LLM claims a $414.8 million pretax gain in early 2024 - this is NOT mentioned in ground truth\n   - LLM claims SPG sold remaining ABG interest for $1.2 billion in early 2024 - ground truth explicitly states \"SPG no longer disclosed active changes in its ownership stake in ABG\" in 2024\n   - LLM claims ownership reduced to zero in 2024 - ground truth indicates no new transactions reported in 2024\n\n2. CONTRADICTIONS WITH GROUND TRUTH:\n   - Ground truth: 2023 had three specific gains ($36.4M, $12.4M, $10.3M) with stake reductions to 9.6%\n   - LLM: Conflates these with a $157.1M gain that doesn't exist in ground truth\n   - Ground truth: 2024 showed \"passive disclosure stance\" with no new transactions\n   - LLM: Invents a major $1.2B sale transaction in 2024 that contradicts ground truth\n\n3. MULTI-HOP REASONING FAILURE:\n   - The LLM failed to properly synthesize the evolution between 2023 and 2024\n   - Ground truth shows a clear shift from active transactions in 2023 to no new activity in 2024\n   - LLM incorrectly projects continued activity into 2024 with fabricated numbers\n\n4. ENTITY AND TIMELINE ERRORS:\n   - Misidentifies which gains occurred in which quarters\n   - Invents a 2024 transaction that contradicts the ground truth's explicit statement about lack of 2024 activity\n   - The $18.8M and $100.0M referenced in ground truth (from 2021) are completely absent from LLM answer\n\n5. SEMANTIC MISALIGNMENT:\n   - Ground truth emphasizes the SHIFT from active to passive stance\n   - LLM presents a false narrative of continued major transactions\n   - The core insight about the evolution (active in 2023, passive in 2024) is completely lost\n\nThe LLM answer appears to have hallucinated significant financial transactions that do not exist in the source material, making it fundamentally unreliable for financial analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 566,
        "total_tokens": 1899
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How has the 2012 Equity Incentive Plan evolved between the 2023 and 2024 filings, particularly in terms of amendments and forms of award agreements disclosed?",
      "original_answer": "In 2023, the 2012 Equity Incentive Plan was disclosed as amended, including the Third Amendment to the plan, and referenced forms of award agreements from 2012 and 2017. In 2024, the filing included a Fourth Amendment dated August 1, 2024, and introduced additional forms of award agreements from April 2024, showing continued evolution and expansion of the plan over time.",
      "llm_answer": "\nBetween the 2023 and 2024 filings the 2012 Equity Incentive Plan was updated with a **fourth amendment** (effective August 1 2024) that builds on the **third amendment** disclosed in the 2023 Form 10‑K (filed February 2 2023).  The 2024 filing also adds a new set of award‑agreement templates—“Additional Forms” (Exhibit 10.2(K)+) filed in a 10‑Q on April 25 2024—indicating that the plan’s governing documents and the forms of equity awards were revised for the current year.  Thus, the plan has been amended twice in the last two years and the 2024 filing introduces updated award‑agreement language to reflect those changes.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy with correct identification of key amendments and dates. Strengths: (1) Correctly identifies the Fourth Amendment dated August 1, 2024 in the 2024 filing; (2) Correctly references the Third Amendment from the 2023 filing; (3) Accurately notes the introduction of new award agreement forms in April 2024 (10-Q filing on April 25, 2024); (4) Properly synthesizes the multi-hop information showing evolution between 2023 and 2024 filings. Quantitative accuracy is high - all dates are correct (August 1, 2024; February 2, 2023; April 25, 2024). The answer correctly conveys that the plan has been amended twice in the relevant period and that new award agreement templates were introduced. Minor considerations: (1) The LLM provides slightly more specific detail about the 10-Q filing date (April 25, 2024) and exhibit designation (10.2(K)+) than the ground truth explicitly states, though this appears to be accurate supplementary information rather than an error; (2) The phrasing 'amended twice in the last two years' is slightly imprecise since the amendments span from 2023 to 2024, but this is a minor semantic issue that doesn't affect core accuracy. The answer fully addresses the question's focus on how the plan evolved between the two filing years, covering both amendments and forms of award agreements. The multi-hop reasoning correctly synthesizes information across the 2023 and 2024 filings to show progression.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 406,
        "total_tokens": 1659
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did the treatment and valuation of capitalized software licenses evolve between 2022 and 2023, and what does this indicate about the company's investment in software licensing?",
      "original_answer": "In 2022, capitalized software licenses were described as being generally amortized on a straight-line basis over the term of the license, indicating a clear policy for their depreciation over time. By 2023, the company disclosed the actual carrying value of these licenses on the balance sheet at $223 million, up from $152 million in 2022. This increase suggests a growing investment in software licensing, despite the unchanged amortization policy. The evolution from a disclosed accounting method in 2022 to a quantified asset in 2023 reflects a more tangible and increasing role of capitalized software licenses in the company's asset structure.",
      "llm_answer": "\nThe company’s capitalized software‑license balance rose from **$152 million at the end of 2022 to $223 million at the end of 2023** (see TXN_10K_2023.pdf page 27), and the corresponding amortization expense increased from **$54 million in 2022 to $63 million in 2023** (see TXN_10K_2023.pdf page 28).  This upward movement indicates that Texas Instruments is investing more heavily in acquiring or internally developing software licenses, signaling a strategic emphasis on expanding its software‑related assets and the associated revenue‑generating potential.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. All quantitative data is correct: capitalized software licenses increased from $152 million (2022) to $223 million (2023), and amortization expense rose from $54 million to $63 million. The numerical synthesis is accurate and properly sourced. The answer goes beyond the ground truth by including amortization expense data, which provides additional context about the company's software licensing investment trajectory. The multi-hop reasoning is sound—the LLM correctly identifies the company as Texas Instruments and synthesizes balance sheet and expense data to support the conclusion about increased software licensing investment. The interpretation that this reflects strategic emphasis on software-related assets is logical and well-supported. Minor differences from ground truth: (1) The LLM provides more specific evidence (amortization expense) than the original answer, which is a strength; (2) The original answer emphasizes the evolution from disclosed accounting method to quantified asset, while the LLM focuses on the investment implications—both perspectives are valid and complementary. The LLM answer is more analytically complete while maintaining factual accuracy. No calculation errors detected. Entity identification (Texas Instruments, 2022-2023 comparison) is correct. The answer directly addresses how treatment and valuation evolved and what it indicates about investment strategy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 406,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did PayPal's utilization of European customer balances for credit activities evolve between 2022 and 2023, and what does this indicate about its strategic approach to funding credit products?",
      "original_answer": "In 2022, PayPal had approved $3.8 billion of European customer balances for credit activities, representing approximately 37% of European customer balances available for corporate use. In 2023, this approved amount decreased to $3.0 billion, representing 39% of European customer balances. This indicates a slight reduction in the total approved funding base but a higher percentage utilization of available balances, suggesting a more efficient use of existing customer balances for credit activities. Additionally, PayPal entered into a new €40 billion agreement in 2023 to sell consumer installment receivables, with $5.5 billion sold during the year, signaling a strategic shift toward external funding mechanisms to support credit product expansion.",
      "llm_answer": "\nBetween 2022 and 2023 the amount of European customer balances that PayPal may earmark for credit‑product funding fell modestly—from **$3.8 billion (≈ 37 % of eligible European balances) in 2022 to $3.0 billion (≈ 39 % of eligible balances) in 2023**.  The decline in absolute dollars is offset by a slightly higher share of the remaining balances being designated for credit use, indicating that PayPal is leaning more heavily on the **efficient deployment of its existing European deposit pool** to meet liquidity needs for its growing credit portfolio, while still supplementing that source with external partnerships and third‑party funding.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies all key quantitative data points: $3.8 billion (37%) in 2022 declining to $3.0 billion (39%) in 2023. The numerical accuracy is sound and the format variations are acceptable. The LLM also correctly interprets the directional trend (absolute decline offset by higher percentage utilization) and characterizes this as more efficient deployment of existing balances.\n\nWEAKNESSES: The LLM answer is INCOMPLETE on a critical component of the ground truth. The original answer explicitly mentions PayPal's strategic shift toward external funding mechanisms, specifically: (1) a new €40 billion agreement in 2023 to sell consumer installment receivables, and (2) $5.5 billion sold during 2023. The LLM vaguely references 'external partnerships and third-party funding' but fails to provide the specific, material details about the €40 billion agreement and the $5.5 billion in receivables sold. This is a significant omission because these details are central to understanding PayPal's strategic approach to funding credit products—they represent a quantifiable shift toward securitization and external funding mechanisms.\n\nMULTI-HOP REASONING: The LLM demonstrates partial multi-hop synthesis by connecting the European balance data to strategic implications, but it fails to complete the full synthesis by incorporating the external funding mechanisms data. The answer addresses only half of the strategic picture presented in the ground truth.\n\nCALCULATIONS: No calculation errors detected. The percentage comparisons and trend analysis are logically sound.\n\nSEMANTIC EQUIVALENCE: The characterization of 'efficient deployment' and 'existing European deposit pool' is semantically equivalent to the ground truth's 'more efficient use of existing customer balances,' but the omission of specific external funding details represents a material gap in answering the question about strategic approach.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 524,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How has Starbucks' investment relationship with Valor Siren Ventures I L.P. evolved between fiscal years 2023 and 2024, particularly in terms of the carrying value of the investment and its financial impact on Starbucks' consolidated statements?",
      "original_answer": "In fiscal 2023, Starbucks held a limited partnership interest in Valor Siren Ventures I L.P., with the total carrying value of such investments not specifically disclosed for that year. The financial impact of these investments, including Valor Siren Ventures I L.P., was included in 'interest income and other, net' and was not considered material. By fiscal 2024, the total carrying value of Starbucks' investments in Valor Siren Ventures I L.P. and II L.P. combined was $211.9 million as of September 29, 2024. The investment relationship evolved from a general equity stake to a more defined and quantified investment with ongoing monitoring, though the financial impact remained non-material and continued to be reported in 'interest income and other, net.'",
      "llm_answer": "\nBetween fiscal 2023 and 2024 the carrying amount of Starbucks’ limited‑partner interest in Valor Siren Ventures I L.P. (and its sister fund II) grew sharply – the balance‑sheet “Other investments” line rose from about **$24 million as of Oct 1 2023** to **$211.9 million as of Sep 29 2024** (page 75 / 76).  This increase is recorded in shareholders’ equity as part of “Other investments” and any resulting gains or losses are reported in “interest income and other, net” on the consolidated statement of earnings, but the amounts have been immaterial to Starbucks’ overall financial results.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the fiscal 2024 carrying value of $211.9 million as of September 29, 2024, matching the ground truth. It correctly notes that both Valor Siren Ventures I L.P. and II L.P. are involved. The answer appropriately identifies that gains/losses are reported in 'interest income and other, net' and that the amounts are immaterial. The answer demonstrates good understanding of the multi-hop synthesis required (tracking investment evolution across years and financial statement impact). CRITICAL ERRORS: (1) The LLM provides a specific fiscal 2023 carrying value of '$24 million as of Oct 1 2023,' but the ground truth explicitly states 'the total carrying value of such investments not specifically disclosed for that year.' This is a significant factual error - the LLM is providing a number that was not disclosed in the original filings. (2) The LLM claims the balance rose 'from about $24 million' to $211.9 million, implying a specific starting point that contradicts the ground truth's statement that 2023 values were not specifically disclosed. PARTIAL ISSUES: The LLM correctly identifies the general evolution and financial reporting treatment but undermines credibility by citing an undisclosed 2023 figure. The reference to 'page 75/76' suggests source documentation, but if the 2023 figure was not actually disclosed, this is problematic. The answer is otherwise well-structured and addresses the question's components regarding investment evolution and financial impact. The quantitative accuracy is compromised by the unsupported $24 million figure for 2023, even though the 2024 figure is correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 450,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How has the strategic positioning of Analog Products evolved between 2022 and 2023 in terms of TI's competitive advantages and financial contribution?",
      "original_answer": "In 2022, Analog Products were central to TI's strategic focus, contributing to a gross margin of 67.5% driven by the efficiency of their manufacturing strategy, including 300-millimeter production. By 2023, Analog Products remained a core pillar but were framed more explicitly within the context of TI's four sustainable competitive advantages, particularly emphasizing lower costs and greater control of the supply chain. Additionally, the 2023 report reinforced the role of Analog Products in enabling TI to generate and return significant cash, with a renewed emphasis on long-term free cash flow per share growth as the ultimate performance metric.",
      "llm_answer": "\nBetween 2022 and 2023 TI refined the strategic positioning of its Analog business by re‑emphasizing the same four sustainable competitive advantages—strong manufacturing foundation, a broad portfolio, extensive market reach and long‑life product diversity—while sharpening its focus on the industrial and automotive end‑markets that offer the highest growth.  In 2023 Analog generated roughly $13 billion of revenue, about 74 % of total sales, and delivered operating margins above 50 %, supplying the majority of operating profit and free‑cash‑flow that drive TI’s capital‑allocation and shareholder‑return strategy.  (Based on the 2022 MD&A discussion of the four advantages [page 22], the 2023 market‑share table showing Analog’s ~74 % revenue share [page 5], and the 2023 MD&A highlighting Analog’s high‑margin, cash‑generating role [pages 3, 4]).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides substantial correct information but diverges from the ground truth in key ways. STRENGTHS: (1) Correctly identifies the four sustainable competitive advantages framework and their emphasis in both years; (2) Accurately cites Analog's ~74% revenue share and $13 billion revenue figure for 2023; (3) Correctly notes operating margins above 50% and Analog's role in generating free cash flow; (4) Properly synthesizes multi-hop information across MD&A sections and market-share tables; (5) Appropriately emphasizes the shift toward industrial and automotive end-markets. WEAKNESSES: (1) The ground truth specifically mentions 67.5% gross margin in 2022 and 300-millimeter production efficiency—the LLM answer omits these concrete 2022 metrics entirely; (2) The ground truth emphasizes a shift in framing between years (2022: efficiency/manufacturing focus vs. 2023: competitive advantages + cash generation emphasis), but the LLM presents the four advantages as consistent across both years rather than highlighting the evolution in how they were positioned; (3) The ground truth stresses 'long-term free cash flow per share growth as the ultimate performance metric' in 2023, which the LLM mentions only implicitly through 'capital-allocation and shareholder-return strategy'; (4) The LLM's answer is more detailed on 2023 specifics but provides minimal 2022 comparison, making the 'evolution' less clear. QUANTITATIVE VERIFICATION: The $13 billion revenue and ~74% figures appear accurate for 2023; operating margins above 50% is reasonable; however, the 67.5% gross margin from 2022 is missing. MULTI-HOP REASONING: The LLM correctly synthesizes information from multiple sections (MD&A, market-share tables) but fails to fully capture the year-over-year strategic evolution that the ground truth emphasizes. The answer is more of a 2023 snapshot than a true evolution narrative.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 514,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has Chevron's capital allocation strategy in the Lower 48 region evolved from 2022 to 2023, based on the changes in depreciation, depletion, amortization, and impairments?",
      "original_answer": "Chevron's capital allocation in the Lower 48 region increased significantly from 2022 to 2023, as evidenced by the rise in depreciation, depletion, amortization, and impairments from $4,854 million in 2022 to $5,729 million in 2023. This indicates a growing focus on asset development and operational expansion in the Lower 48, contrasting with relatively stable or declining figures in other geographic segments like Europe, Middle East and North Africa.",
      "llm_answer": "\nFrom 2022 to 2023 the Lower 48 segment’s depreciation, depletion and amortization rose sharply from **$4.85 billion to $5.73 billion** (page 92 of the 2023 filing), indicating that Chevron directed more capital toward developing and maintaining its Lower 48 assets.  No separate impairment charge for the Lower 48 is disclosed for 2023, so the higher DD&A reflects a strategic shift toward greater investment rather than a wave of asset write‑downs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and understanding of Chevron's capital allocation strategy in the Lower 48 region. QUANTITATIVE VERIFICATION: The numbers are correct - $4.85 billion (formatted as $4,854 million) for 2022 and $5.73 billion (formatted as $5,729 million) for 2023 match the ground truth exactly. The format variation ($4.85B vs $4,854M) is acceptable and demonstrates flexibility in presentation. COMPLETENESS: The answer addresses the core question about how capital allocation evolved from 2022 to 2023, identifying the significant increase in DD&A as evidence of strategic shift. ENTITY ACCURACY: Correctly identifies Chevron, the Lower 48 region, and the relevant metric (depreciation, depletion, amortization). REASONING QUALITY: The multi-hop synthesis is sound - the LLM correctly interprets rising DD&A as indicating increased capital investment and asset development. The additional insight about the absence of separate impairment charges strengthens the analysis by clarifying that the increase reflects operational expansion rather than asset write-downs. This demonstrates sophisticated understanding of financial statement interpretation. MINOR CONSIDERATIONS: The ground truth mentions comparison with other geographic segments (Europe, Middle East and North Africa), which the LLM answer does not explicitly address. However, the question specifically asks about evolution in the Lower 48 region, so this omission is not critical to answering the core question. The LLM's focus on the Lower 48 segment is appropriate and directly responsive. The citation to page 92 of the 2023 filing adds credibility and specificity. Overall, the answer is factually accurate, well-reasoned, and appropriately addresses the multi-hop nature of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 485,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has Verizon's approach to FWA Broadband evolved between 2023 and 2024, particularly in terms of its positioning within the company's product portfolio and its target customer segments?",
      "original_answer": "In 2023, Verizon provided FWA broadband through both 5G and LTE networks, targeting both Consumer and Business customers, and reported 3.1 million FWA broadband connections. By 2024, the company continued to offer FWA broadband primarily under the Verizon Consumer and Business Group segments, but with a more integrated positioning as an alternative to traditional landline internet access and as part of a broader portfolio that includes IoT and advanced communication services. The shift from 'provides' in 2023 to 'produces' in 2024 indicates a more strategic and product-centric approach to FWA broadband.",
      "llm_answer": "\nBetween 2023 and 2024 Verizon moved FWA broadband from a niche, residential‑only offering to a core, cross‑segment product that underpins its 5G strategy and complements its fiber (Fios) network.  In the 2024 filing the company reports ≈ 3 million FWA connections and highlights FWA as a key growth driver for both the **Consumer** segment (targeting homeowners and renters in underserved markets) and the **Business** segment (serving small‑to‑medium and enterprise customers, including Enterprise‑Public‑Sector and Wholesale channels).  This positioning reflects a shift toward monetising its wireless spectrum and network assets by offering fixed‑wireless access as a stand‑alone broadband solution alongside traditional wireline services.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of Verizon's FWA evolution between 2023-2024 with mostly accurate information. STRENGTHS: (1) Correctly identifies the shift from niche to core product positioning; (2) Accurately reports ~3 million FWA connections (ground truth states 3.1 million, LLM says ≈3 million - acceptable approximation); (3) Correctly identifies both Consumer and Business segments as target markets; (4) Properly synthesizes the multi-hop information about portfolio positioning and strategic approach; (5) Appropriately notes the shift toward monetizing wireless spectrum and network assets. WEAKNESSES: (1) The ground truth specifically mentions the linguistic shift from 'provides' (2023) to 'produces' (2024) as indicating a more strategic approach - the LLM answer captures the strategic shift conceptually but doesn't explicitly reference this linguistic indicator; (2) The LLM adds detail about 'Fios network' complementarity and specific business segments (Enterprise-Public-Sector, Wholesale) that, while plausible, are not explicitly confirmed in the ground truth provided; (3) The characterization of 2023 as 'residential-only' is slightly stronger than the ground truth which simply states it targeted 'Consumer and Business customers' - this is a minor overstatement. QUANTITATIVE VERIFICATION: The ~3 million figure is appropriately approximated from the 3.1 million stated in ground truth (acceptable rounding). MULTI-HOP REASONING: The answer successfully synthesizes information about positioning evolution, customer segments, and strategic intent across the two-year period. The logic connecting spectrum monetization to FWA strategy is sound. SEMANTIC EQUIVALENCE: The core message aligns well with ground truth - evolution from niche to integrated portfolio offering across consumer and business segments.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 501,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has Emerson's relationship with AspenTech evolved from 2022 to 2024, and what financial impact did this evolution have on Emerson's gross margin and equity structure?",
      "original_answer": "In 2022, Emerson partnered with AspenTech, leveraging its asset optimization software to enhance industrial operational efficiency. By 2024, Emerson had significantly deepened this relationship by acquiring a 55% ownership stake in AspenTech as part of a strategic transaction that created 'New AspenTech.' This acquisition contributed positively to Emerson’s gross margin, benefiting it by 0.6 percentage points in 2023 and further influencing financial structure in 2024 with increased SG&A expenses tied to the integration. Additionally, the equity structure was impacted through the recognition of gains and losses associated with the AspenTech stock plans and the broader restructuring of industrial software assets.",
      "llm_answer": "\nBetween fiscal 2022 and 2024 Emerson’s equity relationship with AspenTech moved from a 55 % stake (after the May 2022 Heritage AspenTech transaction) to about 57 % and, by November 2024, Emerson proposed to acquire the remaining shares—effectively moving toward 100 % ownership.  This deeper integration added AspenTech’s software revenue to Emerson’s top line, which helped lift consolidated gross margin from 45.7 % in 2022 to 50.8 % in 2024, while the equity structure shifted as Emerson’s ownership percentage rose and the company prepared to consolidate the remainder of AspenTech’s shares.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant inaccuracies that contradict the ground truth. (1) OWNERSHIP STAKE TIMELINE ERROR: The LLM states Emerson had a 55% stake 'after the May 2022 Heritage AspenTech transaction' and then moved to 57% by 2024. However, the ground truth indicates that in 2022 Emerson partnered with AspenTech (not acquiring 55% then), and only by 2024 did Emerson acquire the 55% ownership stake as part of a strategic transaction creating 'New AspenTech.' The LLM has the timeline completely reversed. (2) GROSS MARGIN CALCULATION ERROR: The LLM claims gross margin improved from 45.7% in 2022 to 50.8% in 2024, a 5.1 percentage point increase. The ground truth states the acquisition contributed 0.6 percentage points to gross margin in 2023 and further influenced 2024 financial structure. The LLM's claimed 5.1 percentage point improvement is not supported and appears to conflate total margin improvement with AspenTech's specific contribution. (3) INCOMPLETE EQUITY STRUCTURE ANALYSIS: The LLM mentions ownership percentage rising and consolidation plans but fails to address the ground truth's specific point about 'gains and losses associated with the AspenTech stock plans and the broader restructuring of industrial software assets' impacting equity structure. (4) MISSING KEY DETAILS: The LLM omits the mention of increased SG&A expenses tied to integration, which was explicitly noted in the ground truth as part of the 2024 financial impact. (5) MULTI-HOP REASONING FAILURE: The LLM failed to correctly synthesize the evolution of the relationship across the 2022-2024 period, getting the sequence of events fundamentally wrong. The answer demonstrates a misunderstanding of when the acquisition occurred and overstates the gross margin impact without proper attribution to AspenTech specifically.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 500,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did the financial relationship between NEE and FPL Group Capital Inc evolve from 2022 to 2023, particularly in terms of the nature of their obligations and capital structure involvement?",
      "original_answer": "In 2022, the relationship was characterized by a guarantee agreement between FPL Group, Inc. and FPL Group Capital Inc. dated October 14, 1998, indicating a direct obligation from FPL Group, Inc. to FPL Group Capital Inc. By 2023, this relationship had evolved into a more complex capital structure involvement, with NEE issuing multiple series of junior subordinated debentures to FPL Group Capital Inc., including Series B, C, L, M, N, O, and P, with maturity dates ranging from 2057 to 2082. This transition reflects a strategic shift from a simple guarantee to a long-term capital financing arrangement.",
      "llm_answer": "\nFrom 2022 to 2023 FPL Group Capital Inc continued to tap the same 1999 master indenture (Exhibit *4(l)–*4(n)) but shifted the mix of its obligations: in 2022 it issued floating‑rate notes due 2072 (Exhibit *4(i)), while in 2023 it added a fixed‑rate 4.45 % note due 2026 (Exhibit *4(j)) and a new floating‑rate series due 2073 (Exhibit *4(k)), all still guaranteed by FPL Group, Inc. and administered by The Bank of New York Mellon, reflecting a deepening of NEE’s capital‑structure involvement through additional tranches of subordinated debt with varied rate structures.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misalignment with the ground truth. Key issues: (1) ENTITY CONFUSION: The LLM discusses FPL Group Capital Inc issuing notes and debt instruments, but the ground truth indicates NEE (NextEra Energy) issued junior subordinated debentures to FPL Group Capital Inc. The LLM reverses the direction of the capital flow. (2) STRUCTURAL MISUNDERSTANDING: The ground truth describes a transition FROM a guarantee agreement (2022) TO NEE issuing debentures TO FPL Group Capital Inc (2023). The LLM describes FPL Group Capital Inc issuing notes that are guaranteed by FPL Group, Inc., which is a different structure entirely. (3) SPECIFIC SERIES ERRORS: The ground truth identifies Series B, C, L, M, N, O, and P debentures with maturity dates 2057-2082. The LLM mentions floating-rate notes due 2072, fixed-rate 4.45% notes due 2026, and floating-rate series due 2073 - these don't match the ground truth series or maturity dates. (4) MISSING KEY INFORMATION: The LLM fails to identify the specific series of junior subordinated debentures (B, C, L, M, N, O, P) that are central to the 2023 relationship evolution. (5) INDENTURE REFERENCE: The LLM references a 1999 master indenture, but the ground truth references a 1998 guarantee agreement, suggesting different underlying documents. The LLM's answer describes a debt issuance structure by FPL Group Capital Inc rather than NEE's capital structure involvement through debenture issuance to FPL Group Capital Inc. This represents a fundamental misunderstanding of the multi-hop relationship between the entities.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 441,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has the positioning and market acceptance of InterStim II evolved between 2022 and 2024, particularly in relation to other InterStim neurostimulators and broader Pelvic Health therapies?",
      "original_answer": "In 2022, InterStim II was described as part of a suite of InterStim neurostimulators including InterStim Micro and InterStim X, with an emphasis on continued acceptance and growth in treating overactive bladder, urinary retention, and bowel incontinence. By 2024, InterStim II was specifically highlighted as a recharge-free neurostimulator, grouped alongside InterStim X and InterStim Micro (now differentiated by recharge status), and positioned within a broader context of continued acceptance and growth of Pelvic Health therapies. This evolution indicates a shift toward emphasizing device-specific attributes (e.g., recharge-free) and integration into a more mature and diversified product portfolio.",
      "llm_answer": "\nFrom 2022 to 2024, InterStim II moved from a newly launched neurostimulator to a core, recharge‑free offering within Medtronic’s Pelvic Health portfolio, as reflected by its inclusion in the growing Specialty‑Therapies sales and the 2024 Neuroscience net‑sales increase. Its positioning alongside the rechargeable InterStim Micro and the newer InterStim X—and the expanding clinical adoption for overactive bladder, urinary retention and fecal incontinence—has driven stronger market acceptance relative to other InterStim devices and to broader Pelvic Health therapies.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies InterStim II as a recharge-free neurostimulator and accurately positions it alongside InterStim X and InterStim Micro. The answer correctly mentions the three indications (overactive bladder, urinary retention, fecal incontinence) and appropriately references Medtronic's Pelvic Health portfolio and Specialty-Therapies sales context. The temporal framing (2022 to 2024) is correct.\n\nWEAKNESSES: (1) The LLM introduces unsupported claims about 'newly launched' status in 2022 and '2024 Neuroscience net-sales increase' without providing specific numbers or verification from the ground truth. The ground truth does not characterize InterStim II as 'newly launched' in 2022. (2) The LLM claims InterStim Micro is 'rechargeable' while the ground truth indicates devices are 'differentiated by recharge status' without explicitly stating Micro's recharge capability. This is a potential factual error. (3) The LLM states InterStim X is 'newer' but the ground truth does not establish a clear temporal hierarchy between InterStim X and InterStim II. (4) The phrase 'stronger market acceptance relative to other InterStim devices' is not explicitly supported by the ground truth, which discusses 'continued acceptance and growth' but does not make comparative claims about relative market acceptance between devices. (5) The LLM answer lacks the key insight from the ground truth about the 'shift toward emphasizing device-specific attributes' as a strategic evolution.\n\nMULTI-HOP REASONING: The answer attempts to synthesize information across product portfolio, time periods, and market positioning, but introduces unsupported inferences (sales increases, relative market acceptance rankings) that go beyond what the ground truth establishes. The reasoning is partially sound but overreaches in several claims.\n\nNUMERIC/QUANTITATIVE: No specific numbers are provided in either answer, so quantitative accuracy is not directly testable. However, the LLM's reference to 'net-sales increase' without data is problematic.\n\nSEMANTIC EQUIVALENCE: The core positioning narrative is similar, but the LLM's framing diverges from the ground truth's emphasis on attribute differentiation and portfolio maturation toward claims about relative market acceptance that aren't grounded in the source material.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 625,
        "total_tokens": 1955
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has Simon Property Group's utilization and management of the Supplemental Facility evolved between 2022 and 2024, particularly in terms of borrowing capacity, interest rate strategies, and repayment actions?",
      "original_answer": "In 2022, the Supplemental Facility had an initial borrowing capacity of $3.5 billion, which could be increased to $4.5 billion, with a maturity date of January 31, 2026. Borrowings under the facility bore interest based on SOFR or similar rates, with a margin determined by the company's credit rating. By 2024, SPG had borrowed €750.0 million under the Supplemental Facility, which was repaid on November 17, 2023, following the issuance of exchangeable bonds. Additionally, interest rate swaps were used in 2023 to fix the rate on these borrowings at 3.81%. This indicates a shift from passive availability in 2022 to active utilization and strategic interest rate management in 2024.",
      "llm_answer": "\nBetween 2022 and 2024 Simon Property Group kept the Supplemental Facility’s size at $3.5‑$4.5 bn and its pricing unchanged – borrowings carried a SOFR + 72.5 bp spread (plus a 0.100‑0.300 % facility fee) – but it extended the maturity from January 2026 to January 2029 (with a one‑year extension to 2030).  The company then sharply reduced its use of the line, repaying the entire €750 m draw that had been outstanding under the facility with proceeds from a €750 m bond issuance on 14 Nov 2023, and by year‑end 2024 the only outstanding balance was a modest average of about $31 m.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides substantial information about the Supplemental Facility's evolution but contains several critical discrepancies with the ground truth:\n\nCORRECT ELEMENTS:\n- Initial borrowing capacity of $3.5-$4.5 billion is correct\n- €750 million borrowing and repayment in November 2023 is correct\n- The bond issuance date of November 14, 2023 is correct (ground truth says November 17, 2023 - minor date discrepancy)\n- Recognition that the facility was actively utilized and then repaid\n- Identification of SOFR-based pricing structure\n\nINCORRECT/MISSING ELEMENTS:\n1. MATURITY DATE ERROR: LLM states maturity extended from January 2026 to January 2029 (with extension to 2030). Ground truth clearly states January 31, 2026 maturity in 2022. The LLM appears to have confused or added information about maturity extensions not mentioned in the ground truth.\n\n2. INTEREST RATE STRATEGY INCOMPLETE: LLM mentions SOFR + 72.5 bp spread and facility fee but OMITS the critical detail from ground truth about interest rate swaps used in 2023 to fix the rate at 3.81%. This is a significant omission regarding interest rate management strategy.\n\n3. REPAYMENT DATE DISCREPANCY: LLM states November 14, 2023 for bond issuance/repayment; ground truth states November 17, 2023. Minor but factually incorrect.\n\n4. OUTSTANDING BALANCE: LLM mentions \"modest average of about $31 m\" by year-end 2024, which is not mentioned in the ground truth and appears to be additional information not verified.\n\n5. FACILITY FEE DETAIL: LLM adds specific facility fee percentages (0.100-0.300%) not explicitly mentioned in ground truth.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes the evolution from 2022 to 2024, showing understanding of the facility's lifecycle. However, it introduces information about maturity extensions that contradict or go beyond the ground truth.\n\nSEMANTIC ISSUES: While the LLM captures the general narrative of utilization and repayment, it fails to adequately address the interest rate swap strategy (3.81% fixed rate), which is a key component of the ground truth answer regarding interest rate strategies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 575,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has Verizon's approach to device payment plans evolved from 2023 to 2024, particularly in terms of customer financing structure and promotional incentives?",
      "original_answer": "In 2023, Verizon permitted customers to acquire equipment using device payment plans that allowed installment payments over time, with no mention of structured promotional incentives or trade-in rights. By 2024, Verizon formalized the device payment plan structure, describing it as a non-interest-bearing installment note typically repaid over a 36-month term, and introduced a defined promotional feature that allows customers to upgrade to a new device after paying a specified portion of their plan and trading in their current device in good working order. This represents a shift from a general financing mechanism to a more structured and incentive-driven model.",
      "llm_answer": "\nFrom 2023 to 2024 Verizon shifted from explicitly accounting for a financing component in its device‑payment arrangements to treating most direct‑channel 36‑month installment plans as having an immaterial financing cost and thus not separating interest, while still using non‑interest‑bearing notes; the 2024 filing adds detailed disclosure of promotional billing‑credits and trade‑in guarantees that are recorded as liabilities and reduce revenue, indicating a more nuanced financing structure and incentive‑driven pricing compared with the earlier period’s simpler subsidized‑plan and fixed‑term approach.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies key structural elements: (1) non-interest-bearing installment notes in both periods, (2) 36-month term structure, (3) shift toward more formalized/structured approach from 2023 to 2024, (4) introduction of promotional features and trade-in mechanisms in 2024. The answer demonstrates understanding of the evolution toward incentive-driven pricing. WEAKNESSES: (1) The LLM introduces accounting-specific language ('immaterial financing cost,' 'recorded as liabilities,' 'reduce revenue') that is not present in the ground truth answer and appears to add interpretive layers not directly supported by the original question or ground truth. (2) The answer conflates accounting treatment with customer-facing financing structure - the ground truth focuses on customer financing options and promotional incentives, while the LLM emphasizes accounting classification. (3) The phrase 'simpler subsidized-plan and fixed-term approach' in the LLM answer is somewhat misleading - the ground truth indicates 2023 had device payment plans without structured promotional incentives, not necessarily 'subsidized plans.' (4) The LLM answer lacks explicit mention of the 'upgrade after paying specified portion' feature that is highlighted in the ground truth as a key 2024 promotional innovation. (5) The answer is more technical/accounting-focused than the ground truth, which is more customer-benefit focused. MULTI-HOP REASONING: The LLM correctly synthesizes information across 2023-2024 periods and identifies the evolution, but the synthesis leans heavily on accounting mechanics rather than customer-facing changes. SEMANTIC EQUIVALENCE: While the core insight about formalization and incentive introduction is present, the framing diverges significantly from the ground truth's emphasis on customer financing structure and promotional rights.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 509,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has The Coca-Cola Company's legal relationship with Aqua-Chem evolved between 2023 and 2024, particularly in terms of its stance on liability for Aqua-Chem's asbestos-related claims?",
      "original_answer": "In 2023, Coca-Cola maintained that it had no obligation to Aqua-Chem for any liabilities or expenses related to claims or lawsuits against Aqua-Chem, as outlined in the Georgia Case. By 2024, while the litigation status remained largely unchanged, Coca-Cola's disclosure now includes a more detailed description of the insurance policies issued during its ownership of Aqua-Chem, particularly highlighting the involvement of multiple insurers and the ongoing coverage litigation. This indicates a shift in emphasis from outright denial of liability to a more nuanced stance centered on insurance coverage and shared responsibility among insurers.",
      "llm_answer": "\nThe Coca‑Cola Company has maintained its 2023‑2024 position that it is **not legally liable** for Aqua‑Chem’s asbestos‑related claims, limiting its exposure to the insurance policies it purchased during its ownership of Aqua‑Chem.  In the 2024 filing the company notes that the Wisconsin appeal was affirmed and the Supreme Court of Wisconsin denied review, leaving only the 2002 Georgia lawsuit—still stayed under the 2004 agreement—as the unresolved matter, while all other coverage disputes have been settled or ruled in the company’s favor.  Consequently, the company’s stance on liability remains a denial of responsibility, with efforts now focused on enforcing the settled insurance coverage rather than confronting new legal exposure.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains both accurate and problematic elements. CORRECT ELEMENTS: (1) The identification that Coca-Cola maintains it is not legally liable for Aqua-Chem's asbestos claims is accurate; (2) The reference to Wisconsin appeal being affirmed and Supreme Court denial of review appears factually sound; (3) The mention of the 2002 Georgia lawsuit remaining stayed under a 2004 agreement is correct; (4) The general characterization of insurance coverage disputes being settled or ruled in the company's favor aligns with the ground truth. PROBLEMATIC ELEMENTS: (1) The LLM answer characterizes Coca-Cola's stance as remaining unchanged between 2023-2024 ('maintained its 2023-2024 position'), which contradicts the ground truth that indicates a SHIFT in emphasis from 'outright denial of liability to a more nuanced stance centered on insurance coverage'; (2) The answer fails to capture the key evolution described in the ground truth—that 2024 filings include 'more detailed description of insurance policies' and represent a shift toward 'shared responsibility among insurers' rather than pure liability denial; (3) The answer emphasizes 'denial of responsibility' and 'efforts focused on enforcing settled insurance coverage' but misses the nuance that the 2024 disclosure represents a more detailed, insurance-focused approach rather than a continuation of the 2023 stance. MULTI-HOP REASONING: The answer does attempt to synthesize information across years and connect litigation outcomes to liability positions, but it fails to identify the critical evolution in Coca-Cola's disclosure strategy and emphasis. The answer treats the relationship as static when the ground truth indicates meaningful evolution in how the company frames its position. MISSING CONTEXT: The answer does not adequately address the shift from 'outright denial' to 'nuanced stance centered on insurance coverage and shared responsibility among insurers,' which is the core of the ground truth answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 536,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Intel's utilization of non-US tax credits impact its long-term income tax liabilities in 2024 compared to 2022, and what does this indicate about the company's international tax strategy?",
      "original_answer": "In 2022, Intel reported long-term income taxes payable of $4.3 billion, which included the transition tax from Tax Reform and uncertain tax positions, reduced by non-US tax credits. By 2024, this figure had decreased to $1.6 billion, indicating that the company's utilization of non-US tax credits had a stronger offsetting effect over time. This suggests a strategic shift or increased effectiveness in leveraging international tax credits to reduce overall tax liabilities.",
      "llm_answer": "\nIn 2024 Intel’s long‑term income‑tax payable dropped to **$1.6 billion** (down from **$2.6 billion** at the end of 2023 and higher still in 2022), a reduction that stems largely from the company’s use of **non‑U.S. tax credits** that offset the transition tax and uncertain‑tax‑position balances (see INTC_10K_2024.pdf p. 83).  The lower liability helped push the **effective tax rate down to 8.5 %**—well below the 21 % statutory rate—reflecting a deliberate international tax strategy that concentrates earnings in low‑tax jurisdictions (e.g., Ireland, Israel, Malaysia) and aggressively claims foreign‑derived tax credits and R&D incentives (see INTC_10K_2024.pdf p. 90).  This shift indicates Intel is actively restructuring its global tax profile to minimize its overall tax burden.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the 2024 long-term income tax payable figure of $1.6 billion, matching the ground truth. (2) The answer appropriately addresses the multi-hop question by comparing years and discussing non-US tax credits' impact. (3) The reasoning about international tax strategy and use of foreign tax credits is sound and relevant. (4) The contextual discussion of low-tax jurisdictions and effective tax rates adds useful context.\n\nWEAKNESSES: (1) CRITICAL QUANTITATIVE ERROR: The LLM states the 2022 figure was 'higher still' but provides no specific number. The ground truth clearly states 2022 was $4.3 billion. The LLM mentions $2.6 billion for 2023 (not in ground truth) but omits the crucial 2022 comparison of $4.3 billion. (2) The LLM introduces a 2023 figure ($2.6 billion) that is not in the ground truth, creating a three-year comparison not supported by the original answer. (3) The effective tax rate of 8.5% and statutory rate of 21% are not mentioned in the ground truth, and while potentially accurate from the filing, they represent information beyond what was provided in the original answer. (4) The specific jurisdictions mentioned (Ireland, Israel, Malaysia) and the characterization of the strategy as 'aggressive' go beyond the ground truth's more measured assessment of 'strategic shift or increased effectiveness.'\n\nMULTI-HOP REASONING: The LLM successfully synthesizes the relationship between non-US tax credits and long-term tax liabilities, and correctly identifies this as indicating an international tax strategy. However, the failure to cite the specific 2022 baseline ($4.3 billion) weakens the comparative analysis that is central to the question.\n\nNUMERIC VERIFICATION: 2024 figure ($1.6B) ✓ CORRECT. 2022 figure (should be $4.3B) ✗ MISSING/INCORRECT. The LLM's statement that 2022 was 'higher still' is vague and fails to provide the critical baseline number needed for proper comparison.\n\nOVERALL: The answer demonstrates good understanding of the strategic implications but contains a significant quantitative gap by not providing the 2022 figure of $4.3 billion, which is essential for answering the comparative question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 588,
        "total_tokens": 1916
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How has the treatment and risk exposure of pension risk transfers evolved between 2022 and 2024, particularly in terms of interest rate sensitivity and regulatory influence?",
      "original_answer": "In 2022, pension risk transfers were part of the Retirement and Income Solutions business, which was described as containing both short- and long-duration products, and was subject to interest rate scenarios that could impact asset-liability management (ALM) strategies. By 2024, regulatory changes, particularly around defined benefit pension plan funding, were found to potentially reduce the likelihood or delay corporate plan sponsors from terminating their plans or transferring pension obligations. This regulatory evolution increased the potential for a shift in the mix of pension risk transfers toward non-guaranteed funding products, indicating a strategic and regulatory-driven change in exposure.",
      "llm_answer": "\nBetween 2022 and 2024 the company’s pension‑risk‑transfer activity (reported in the Retirement & Income Solutions segment) became far more sensitive to interest‑rate shifts—its 2022‑2024 “Rising‑Interest‑Rate” scenario showed a swing from a $‑445 million derivative loss to modest gains and added $15‑$30 million of adjusted earnings, while the firm increasingly relied on interest‑rate derivatives to hedge margin compression on retained assets (see page 34, 61).  At the same time, regulatory risk grew: disclosures note that changes in defined‑benefit plan‑funding rules or stricter solvency/surplus standards could delay or reshape sponsors’ decisions to terminate plans or transfer pension obligations, directly affecting the volume and timing of MetLife’s pension‑risk‑transfer business (see page 32).  Consequently, the treatment of these transfers evolved from a largely capital‑management function to one that is explicitly managed for interest‑rate exposure and subject to evolving regulatory influence.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) UNVERIFIABLE SPECIFIC NUMBERS: The LLM answer cites very specific financial figures ($445 million derivative loss swing, $15-$30 million adjusted earnings gains) and page references (pages 34, 61, 32) that cannot be verified against the ground truth. The ground truth makes NO mention of these specific dollar amounts or page numbers. This is a critical red flag for potential hallucination. (2) COMPANY IDENTIFICATION ERROR: The LLM answer explicitly identifies the company as 'MetLife' multiple times, but the ground truth does not specify which company this analysis pertains to. The question asks about 'the company' generically, and the LLM has made an unverified assumption about company identity. (3) QUANTITATIVE ACCURACY FAILURE: The specific numbers cited ($445M loss, $15-$30M gains) appear to be fabricated or incorrectly sourced, as they do not appear in the ground truth answer. This is a fundamental failure on quantitative accuracy. (4) PARTIAL ALIGNMENT ON QUALITATIVE POINTS: The LLM correctly identifies the key themes from the ground truth: (a) interest rate sensitivity evolution, (b) regulatory influence on pension risk transfers, (c) shift in business strategy. However, these correct points are undermined by the false specific numbers. (5) MULTI-HOP REASONING: The LLM does attempt to synthesize information about how pension risk transfers evolved between 2022-2024 in terms of interest rate sensitivity and regulatory influence, which matches the question's multi-hop requirements. However, the synthesis is contaminated by unverifiable specifics. (6) SEMANTIC EQUIVALENCE: Where the LLM answer aligns with ground truth concepts (regulatory changes affecting plan termination decisions, interest rate exposure management), the semantic meaning is correct. But the addition of specific financial figures that don't appear in ground truth is a major problem. VERDICT: The answer demonstrates understanding of the conceptual framework but fails on factual accuracy due to unverifiable/likely hallucinated specific numbers and company identification without confirmation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 570,
        "total_tokens": 2007
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How has Medtronic's positioning and product strategy around the InterStim Micro neurostimulator evolved between 2022 and 2024?",
      "original_answer": "In 2022, Medtronic positioned the InterStim Micro as part of its broader InterStim therapy offering for treating overactive bladder, urinary retention, and bowel incontinence, alongside InterStim II and InterStim X neurostimulators. It was described as part of a growing and accepted product line within the Pelvic Health therapies under the Specialty Therapies division. By 2024, Medtronic specifically highlighted the InterStim Micro as a 'rechargeable neurostimulator' while emphasizing the continued acceptance and growth of InterStim therapy, particularly in the U.S., and distinguishing it from the recharge-free InterStim X and InterStim II models. This indicates a more targeted marketing and differentiation strategy for the InterStim Micro within the evolving Pelvic Health product portfolio.",
      "llm_answer": "\nMedtronic continued to showcase the InterStim Micro as the rechargeable core of its InterStim neurostimulation portfolio for pelvic‑health indications, emphasizing its role in treating overactive bladder, urinary retention and fecal incontinence.  In the 2022 10‑K (pp. 40‑42) the device was grouped with InterStim II and InterStim X as part of the company’s growth strategy in Neuromodulation, and by the 2024 filing (pp. 39, 74) the narrative had expanded to position InterStim Micro alongside the newer InterStim II/X platforms within the broader AiBLE integrated‑solution ecosystem, underscoring its clinical benefits and rising sales momentum.  Thus, while the product’s fundamental positioning as a rechargeable, minimally invasive therapy remained unchanged, Medtronic broadened its strategic framing to highlight integration with other technologies and to stress its growing market adoption between 2022 and 2024.",
      "correctness_score": 5,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "ASSESSMENT: The LLM answer contains both accurate and problematic elements. CORRECT ELEMENTS: (1) The identification of InterStim Micro as a rechargeable neurostimulator is accurate and matches the ground truth's emphasis on this distinction in 2024. (2) The mention of treating overactive bladder, urinary retention, and fecal/bowel incontinence is correct. (3) The reference to InterStim II and InterStim X as companion products is accurate. (4) The general timeframe (2022-2024) and filing references are appropriate. PROBLEMATIC ELEMENTS: (1) The LLM introduces 'AiBLE integrated-solution ecosystem' which is NOT mentioned in the ground truth and appears to be either fabricated or incorrectly attributed to the InterStim Micro positioning. This is a significant factual error that misrepresents Medtronic's actual strategy. (2) The ground truth emphasizes a KEY DISTINCTION: InterStim X and InterStim II are described as 'recharge-free' models, while InterStim Micro is the rechargeable option. The LLM's framing of 'InterStim II/X platforms' alongside Micro without clearly articulating this critical differentiation misses the core strategic evolution. (3) The ground truth indicates the 2024 positioning specifically DISTINGUISHED InterStim Micro from the recharge-free models, but the LLM suggests integration into a broader ecosystem without emphasizing this differentiation strategy. (4) The LLM's claim about 'rising sales momentum' and 'growing market adoption' lacks specific support from the ground truth, which focuses on positioning and product strategy rather than sales metrics. MULTI-HOP REASONING: The LLM attempts to synthesize 2022 and 2024 positioning but fails to capture the nuanced strategic shift toward differentiation based on the rechargeable vs. recharge-free distinction. The introduction of 'AiBLE' is a critical error that undermines credibility. QUANTITATIVE ACCURACY: Page references (40-42 for 2022, 39 and 74 for 2024) cannot be verified against ground truth but appear plausible. No specific numbers or metrics are provided, so quantitative accuracy is neutral. SEMANTIC EQUIVALENCE: While the LLM uses different wording, it fails to convey the ground truth's core insight about the strategic differentiation between rechargeable (Micro) and recharge-free (X, II) models.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 616,
        "total_tokens": 2042
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How has Simon Property Group's use of the Supplemental Facility evolved between 2022 and 2024, particularly in terms of outstanding borrowings and repayment actions?",
      "original_answer": "In 2022, Simon Property Group had a weighted average outstanding balance under the Credit Facilities (including the Supplemental Facility) of $519.9 million, with a maximum aggregate outstanding balance of $2.1 billion during the year. By 2024, the weighted average outstanding balance under the Facilities had decreased to $311.1 million, and the company had repaid a significant portion of its borrowings, including €750.0 million ($815.4 million U.S. dollar equivalent) under the Supplemental Facility on November 17, 2023. This indicates a strategic reduction and refinancing of debt drawn from the Supplemental Facility over the two-year period.",
      "llm_answer": "\nBetween 2022 and 2024 Simon Property Group’s reliance on the Supplemental Facility shifted from active borrowing to full repayment.  The 2022 filing (page 124) notes that the Facility’s €750 million Euro‑denominated borrowings were outstanding, and in late 2023 the company swapped that debt to a fixed 3.81 % rate and retired it entirely by issuing €750 million of senior unsecured bonds, using the proceeds to repay the Supplemental Facility borrowings on Nov 17 2023 (2024 10‑K page 70).  As a result, by the end of 2024 there were **no outstanding borrowings** under the Supplemental Facility—its $3.5‑$4.5 billion capacity remained available but was no longer being used (2024 10‑K pages 68‑69).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer provides a coherent narrative of Simon Property Group's Supplemental Facility evolution from 2022-2024 with mostly accurate information, but contains some discrepancies with the ground truth:\n\nSTRENGTHS:\n1. Correctly identifies the €750 million repayment on November 17, 2023\n2. Accurately notes the facility had no outstanding borrowings by end of 2024\n3. Correctly describes the strategic shift from active borrowing to full repayment\n4. Properly identifies the refinancing mechanism (senior unsecured bonds)\n5. Appropriately cites specific 10-K page references\n6. Correctly states the facility capacity remained available but unused\n\nWEAKNESSES:\n1. MISSING KEY METRICS: The ground truth provides specific weighted average outstanding balances ($519.9M in 2022 declining to $311.1M in 2024) which the LLM answer does not include. These are important quantitative measures of the facility's evolution.\n2. INCOMPLETE CONTEXT: The ground truth mentions a maximum aggregate outstanding balance of $2.1 billion in 2022, which provides important context about peak usage that the LLM omits.\n3. VAGUE CAPACITY STATEMENT: The LLM states \"$3.5-$4.5 billion capacity\" without clear sourcing, whereas the ground truth focuses on actual usage metrics.\n4. PARTIAL INFORMATION: While the LLM correctly identifies the November 2023 repayment, it doesn't contextualize this within the broader trend of declining weighted average balances throughout the period.\n\nQUANTITATIVE VERIFICATION:\n- €750 million repayment amount: CORRECT\n- November 17, 2023 date: CORRECT\n- 3.81% fixed rate: Mentioned but not in ground truth (cannot verify as error)\n- No outstanding borrowings by 2024: CORRECT\n- Capacity figures ($3.5-$4.5B): Not contradicted but not in ground truth\n\nMULTI-HOP REASONING:\nThe LLM successfully synthesizes information across multiple 10-K filings (2022, 2023, 2024) and correctly traces the causal chain: borrowing → swap to fixed rate → bond issuance → repayment. However, it misses the intermediate step of showing the gradual decline in weighted average balances, which would have provided a more complete picture of the evolution.\n\nThe answer is directionally correct and addresses the core question about how the facility evolved, but lacks the quantitative depth provided in the ground truth regarding weighted average balances and maximum outstanding amounts.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 640,
        "total_tokens": 1983
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did COP's investment activity in the Lower 48 region evolve from 2022 to 2023, based on the changes in depreciation, depletion, amortization, and impairments expenses?",
      "original_answer": "In 2022, COP reported $4,854 million in depreciation, depletion, amortization, and impairments expenses for the Lower 48 region, which increased to $5,729 million in 2023. This indicates a significant increase in investment activity or asset utilization in the Lower 48 region over that period.",
      "llm_answer": "\nBetween 2022 and 2023 the depreciation, depletion, amortization and impairment charge for COP’s Lower 48 segment rose sharply—from **$4.85 billion in 2022 to $5.73 billion in 2023** (see page 133, “Depreciation, Depletion, Amortization and Impairments”).  This increase reflects a larger capital base in the Lower 48, driven by additional proved‑property acquisitions and development drilling (e.g., the Concho and Shell Permian purchases), indicating that the company’s investment activity in that region expanded markedly over the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. QUANTITATIVE VERIFICATION: The core numbers are correct - $4.85 billion (2022) and $5.73 billion (2023) match the ground truth values of $4,854 million and $5,729 million respectively (format variation is acceptable: $4.85B = $4,854M, $5.73B = $5,729M). The increase of approximately $875 million (or 18%) is mathematically accurate. COMPLETENESS: The answer fully addresses the question about how investment activity evolved from 2022 to 2023 based on DD&A changes. ENTITY ACCURACY: COP (ConocoPhillips), Lower 48 region, and the specific metric (Depreciation, Depletion, Amortization and Impairments) are all correctly identified. REASONING QUALITY: The LLM provides sound multi-hop reasoning by: (1) identifying the numerical change, (2) correctly interpreting what DD&A increases signify (larger capital base and asset utilization), and (3) providing specific context about acquisitions (Concho and Shell Permian purchases) and development drilling that drove the increase. This demonstrates proper synthesis of financial data with operational context. MINOR CONSIDERATION: The LLM adds contextual details about specific acquisitions (Concho and Shell Permian) and development drilling that are not explicitly in the ground truth answer, but these are reasonable inferences from the DD&A increase and enhance the answer without contradicting the ground truth. The citation to page 133 adds credibility. Overall, the answer is factually correct, well-reasoned, and appropriately contextual.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1215,
        "completion_tokens": 426,
        "total_tokens": 1641
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How has Verizon's approach to corporate networking solutions evolved from 2023 to 2024, particularly in terms of service description and business segment emphasis?",
      "original_answer": "In 2023, Verizon's Business segment explicitly described offering a broad portfolio of network connectivity products, including private networking services, private cloud connectivity services, and software-defined networking services, with Enterprise and Public Sector revenues reaching $15.1 billion, or approximately 50% of Business's total revenues. By 2024, the Business segment's description became more streamlined, focusing on wireless and wireline communications services and products, including corporate networking solutions, without specifying the same level of detail in offerings or segment revenue. This indicates a shift toward a more generalized presentation of services, potentially signaling a strategic consolidation or simplification of messaging around corporate networking solutions.",
      "llm_answer": "\nFrom 2023 to 2024 Verizon reframed its corporate‑networking story around the **Intelligent Edge Network** – a next‑generation, multi‑use platform that blends 5G, C‑Band spectrum, fiber and edge‑hosted applications to deliver low‑latency, high‑capacity connectivity for enterprises.  In the 2024 filing the **Business segment** is highlighted as the primary vehicle for these “corporate networking solutions, security, managed‑network and IoT services,” with revenue‑mix details (e.g., $14.2 B from Enterprise & Public Sector and $13.1 B from Business Markets & Other) underscoring a shift from the 2023 focus on legacy wireless equipment and goodwill impairments to a stronger emphasis on monetizing network infrastructure and expanding fiber‑based FWA offerings.  This evolution reflects a deliberate move to position Verizon’s network as a unified, cloud‑ready platform for enterprise customers rather than a collection of separate wireless‑only services.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not supported by the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM cites '$14.2B from Enterprise & Public Sector and $13.1B from Business Markets & Other' for 2024, but the ground truth explicitly states that 2024 data 'without specifying the same level of detail in offerings or segment revenue' - meaning these specific revenue figures are not provided in the 2024 filing. The ground truth only confirms 2023 Enterprise and Public Sector revenues of $15.1B (approximately 50% of Business segment). The LLM's 2024 numbers appear fabricated. (2) UNSUPPORTED CLAIMS: The LLM introduces concepts like 'Intelligent Edge Network,' 'C-Band spectrum,' 'edge-hosted applications,' and 'FWA offerings' that are not mentioned in the ground truth. While these may be real Verizon initiatives, they are not part of the documented evolution described in the knowledge graph. (3) INCOMPLETE SYNTHESIS: The ground truth emphasizes a shift from detailed service descriptions (private networking, private cloud connectivity, software-defined networking) to more streamlined messaging. The LLM misses this key point about the change in disclosure detail and instead focuses on strategic positioning narratives not supported by the filings. (4) CONTRADICTORY FRAMING: The ground truth indicates 2024 became 'more streamlined' with less detail, while the LLM suggests 2024 shows 'stronger emphasis' with specific revenue breakdowns - this is backwards. (5) CORRECT ELEMENTS: The LLM correctly identifies that the Business segment is the primary vehicle and that there was a shift in how services are presented, but the specific details and numbers are largely inaccurate or unsupported.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 478,
        "total_tokens": 1923
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did MetLife's valuation approach and sensitivity to fair value changes for FVO securities evolve from 2022 to 2024, particularly in terms of the impact of U.S. dollar appreciation?",
      "original_answer": "In 2022, MetLife reported that FVO securities had an estimated fair value of $1.6 billion and were sensitive to changes in the U.S. dollar, with a 10% appreciation leading to a $54 million decrease in value. By 2024, while no direct fair value figure for FVO securities is provided, the company emphasized a broader sensitivity framework where nonperformance risk spreads and unobservable inputs varied by duration and currency, indicating a more nuanced and dynamic valuation methodology. This evolution shows a shift from a static sensitivity model to a more complex, duration- and currency-dependent approach.",
      "llm_answer": "\nMetLife continued to value its Fair‑Value‑Option securities with discounted‑cash‑flow models that rely on Level 3 unobservable inputs, and the overall valuation framework was unchanged from 2022 through 2024.  The company’s sensitivity analysis still shows that a 10 % appreciation of the U.S. dollar would depress the fair value of its foreign‑currency‑denominated FVO assets by roughly $12 bn, while lifting the fair value of the corresponding dollar‑denominated liabilities by about $3.7 bn, producing a net negative impact of roughly $7–8 bn; this exposure is partially offset by the $217.5 bn of insurance‑contract liabilities that are excluded from the sensitivity calculation.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains major factual errors and contradicts the ground truth on multiple critical dimensions: (1) QUANTITATIVE ERRORS: The LLM cites a $12 billion sensitivity figure for FVO securities to 10% USD appreciation, which is dramatically different from the ground truth's $54 million figure (off by ~220x). The LLM also introduces $3.7 billion and $7-8 billion figures and references $217.5 billion in insurance-contract liabilities that are not mentioned in the ground truth. These numbers appear to be either fabricated or conflated from different contexts. (2) FACTUAL CONTRADICTION: The ground truth explicitly states that MetLife's valuation approach EVOLVED from 2022 to 2024, shifting from a 'static sensitivity model to a more complex, duration- and currency-dependent approach.' The LLM claims the 'valuation framework was unchanged from 2022 through 2024,' which directly contradicts the core finding. (3) MISSING KEY INFORMATION: The LLM fails to address the evolution of the valuation methodology, the shift toward more nuanced sensitivity frameworks, or the role of nonperformance risk spreads and duration-dependent inputs that characterize the 2024 approach. (4) INCOMPLETE ANSWER: The ground truth notes that by 2024 'no direct fair value figure for FVO securities is provided,' but the LLM provides specific dollar amounts without acknowledging this limitation. (5) MULTI-HOP REASONING FAILURE: The question asks about evolution from 2022 to 2024, requiring synthesis across years. The LLM fails to demonstrate this temporal comparison and instead presents a static view. The answer appears to contain data from a different context or company entirely, as the magnitude of the figures (billions vs. millions) and the specific liability amounts do not align with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 490,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How has NextEra Energy's engagement in power marketing activities evolved between 2022 and 2023, particularly in terms of its energy trading services and associated financial performance?",
      "original_answer": "In 2022, NextEra Energy (NEE) was actively engaged in power and fuel marketing and trading activities, primarily providing full energy and capacity requirements services to distribution utilities, including load-following and ancillary services, while also optimizing the value of electricity and fuel contracts and generation assets. By 2023, NEE's subsidiary NEER had expanded its role in power marketing and trading, contributing to a significant increase in net income, which rose from $285 million in 2022 to $3,558 million in 2023. This indicates a substantial evolution and growth in the scale or profitability of NEE’s power marketing and trading activities over the period.",
      "llm_answer": "\nBetween 2022 and 2023 the company’s power‑marketing and trading business moved from a loss to a strong gain.  The “non‑qualifying hedge” component of adjusted earnings swung from a **$696 million after‑tax loss in 2022 to a **$1.5 billion after‑tax gain in 2023** (see the adjusted‑earnings tables in the 2023 10‑K notes), and NEER’s operating revenue rose by roughly **$5.9 billion** in 2023, driven largely by those hedge gains and related commodity‑price movements.  The improved trading results helped lift NEER’s net income and contributed to a **$3.2 billion increase in Net income attributable to NEE** for the year (see NEER’s Results of Operations in the 2023 10‑K).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer provides some relevant information about NextEra Energy's power marketing evolution but contains significant factual discrepancies and introduces numbers not present in the ground truth. CRITICAL ISSUES: (1) The LLM cites a '$696 million after-tax loss in 2022 to $1.5 billion after-tax gain in 2023' for 'non-qualifying hedge' components - these specific figures are NOT in the ground truth and cannot be verified. (2) The LLM claims 'NEER's operating revenue rose by roughly $5.9 billion in 2023' - this figure is not mentioned in the ground truth. (3) The LLM states a '$3.2 billion increase in Net income attributable to NEE' - the ground truth specifies NEER's net income rose from $285 million to $3,558 million (a $3,273 million increase, approximately $3.3 billion), which is close but the LLM rounds to $3.2 billion. (4) The ground truth clearly states NEER's net income rose from $285 million in 2022 to $3,558 million in 2023, but the LLM does not cite these specific figures, instead focusing on hedge components and operating revenue changes. STRENGTHS: The LLM correctly identifies the evolution from loss to gain in power marketing activities, correctly names NEER as the subsidiary, correctly identifies the 2022-2023 timeframe, and appropriately references the 2023 10-K filing. The qualitative narrative about the business moving 'from a loss to a strong gain' aligns with the ground truth's characterization of 'substantial evolution and growth.' WEAKNESSES: The introduction of unverified specific numbers ($696M loss, $1.5B gain, $5.9B revenue increase) without ground truth support is problematic. The answer focuses on hedge accounting mechanics rather than the core operational evolution described in the ground truth. The multi-hop synthesis is incomplete - the answer doesn't clearly connect the hedge gains to the overall net income increase in the way the ground truth does.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 518,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How has The Coca-Cola Company's financial relationship with Coca-Cola FEMSA evolved between 2023 and 2024, particularly in terms of its stake ownership and implications for equity income?",
      "original_answer": "In 2023, Coca-Cola FEMSA was referenced as one of the key bottlers whose financial performance could influence The Coca-Cola Company's credit ratings, indicating an indirect financial dependency. By 2024, The Coca-Cola Company held a 28% ownership stake in Coca-Cola FEMSA, which was accounted for under the equity method. This shift from a dependency-based relationship to a direct ownership stake suggests a strategic evolution, where Coca-Cola now has a more direct financial interest in FEMSA's performance, which will directly impact its equity income (loss) - net line item.",
      "llm_answer": "\nBetween 2023 and 2024 Coca‑Cola Co. kept its 28 % equity stake in Coca‑Cola FEMSA – the ownership percentage was unchanged.  However, the company’s share of FEMSA’s earnings grew, with equity‑income from the investment rising from $1.69 bn (2023) to $1.77 bn (2024) [KO_10k_2024 p. 119; KO_10k_2023 p. 87], reflecting higher net income and larger dividends received from FEMSA [KO_10k_2023 p. 87].  Thus, while the stake itself is stable, the financial relationship is becoming more earnings‑ and cash‑flow‑positive for Coca‑Cola Co.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer provides specific financial figures and correctly identifies the 28% ownership stake in Coca-Cola FEMSA, which aligns with the ground truth. However, there are significant issues with the response:\n\n1. QUANTITATIVE ACCURACY ISSUES:\n   - The LLM cites equity income figures of $1.69 billion (2023) and $1.77 billion (2024) with specific page references, but these cannot be verified against the ground truth provided. The original answer does not provide these specific equity income numbers, making it impossible to confirm accuracy.\n   - The claim that equity income \"rose from $1.69 bn (2023) to $1.77 bn (2024)\" represents a $80 million increase, but without verification from the actual filings, this cannot be confirmed as accurate.\n   - Page references are provided (KO_10k_2024 p. 119; KO_10k_2023 p. 87) but cannot be independently verified.\n\n2. COMPLETENESS AND MULTI-HOP REASONING:\n   - The LLM answer focuses heavily on the stable 28% stake and earnings growth, which is factually relevant but MISSES a critical element from the ground truth: the evolution from an \"indirect financial dependency\" relationship in 2023 to a \"direct ownership stake\" relationship in 2024.\n   - The ground truth emphasizes a strategic shift in the nature of the relationship (dependency-based → direct ownership), but the LLM treats the 28% stake as if it existed in both years without acknowledging this evolution.\n   - The LLM does not address the 2023 context where FEMSA was referenced as a key bottler influencing credit ratings (indirect relationship), which is central to understanding the \"evolution\" asked about in the question.\n\n3. ENTITY AND CONTEXT ACCURACY:\n   - Company names and ticker are correct (Coca-Cola Co., FEMSA).\n   - Years are correctly identified (2023 and 2024).\n   - The equity method accounting is mentioned in the ground truth but not explicitly in the LLM answer.\n\n4. REASONING QUALITY:\n   - The LLM's conclusion that \"the financial relationship is becoming more earnings- and cash-flow-positive\" is reasonable but somewhat misses the point of the question, which asks about the evolution of the relationship itself, not just its profitability.\n   - The LLM correctly notes the stake is \"stable\" but fails to reconcile this with the ground truth's claim of an evolution from indirect to direct relationship.\n\n5. CRITICAL GAP:\n   - The ground truth explicitly states a shift occurred between 2023 and 2024 from \"dependency-based relationship\" to \"direct ownership stake.\" The LLM answer suggests the 28% stake was consistent across both years, which contradicts the evolutionary narrative in the ground truth.\n   - This represents a fundamental misunderstanding of the multi-hop synthesis required: the question asks how the relationship \"evolved,\" implying change, but the LLM presents it as static (\"unchanged\").\n\nThe LLM answer is partially correct on the 28% stake and provides specific equity income figures, but it fails to capture the strategic evolution described in the ground truth and may contain unverified financial data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 817,
        "total_tokens": 2106
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has the financial investment and operational focus on the Lower 48 region evolved between 2022 and 2023 based on production volumes and depreciation expenses?",
      "original_answer": "In 2022, the Lower 48 region showed strong production volumes, particularly in crude oil (447 thousand barrels daily) and natural gas (1,340 million cubic feet daily), indicating a significant operational focus. In 2023, the financial emphasis on the Lower 48 increased further, as evidenced by a rise in depreciation, depletion, amortization, and impairments expenses from $4,854 million in 2022 to $5,729 million in 2023. This reflects a growing financial investment in the region despite stable or moderate production levels in the prior year.",
      "llm_answer": "\nBetween 2022 and 2023 ConocoPhillips markedly increased its financial commitment to the Lower 48, as reflected by a ≈ $0.88 billion (about 18 %) rise in depreciation, depletion and amortization expense for the segment (from $4.86 bn to $5.73 bn).  At the same time, segment sales fell sharply and the available production data show only modest or flat barrel volumes, indicating that the company is shifting from volume‑driven growth to a more capital‑intensive, return‑focused strategy that emphasizes sustaining and expanding the profitability of existing Lower 48 assets.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct financial figures and calculations. Quantitative verification: (1) Depreciation, depletion, amortization expenses correctly stated as $4.86 billion (2022) and $5.73 billion (2023), matching ground truth of $4,854M and $5,729M respectively. (2) The calculated increase of approximately $0.88 billion is accurate ($5,729M - $4,854M = $875M ≈ $0.88B). (3) The percentage increase of ~18% is correctly calculated (875/4854 ≈ 18%). The LLM correctly identifies ConocoPhillips as the company and properly synthesizes the multi-hop information comparing 2022 and 2023 data. The answer appropriately addresses both production volumes and depreciation expenses as requested. Minor strengths: The LLM provides additional strategic interpretation (shift from volume-driven to capital-intensive, return-focused strategy) that goes beyond the ground truth but is reasonable inference. Minor weakness: The ground truth explicitly mentions specific 2022 production volumes (crude oil 447 kbd, natural gas 1,340 mmcf/d) which the LLM does not include, instead referring more generally to 'modest or flat barrel volumes.' The LLM states 'segment sales fell sharply' which is not mentioned in the ground truth provided, suggesting the LLM may have accessed additional data not in the ground truth. This is neither incorrect nor problematic, but represents a slight divergence. Overall, the answer correctly synthesizes the key financial metrics across years and provides sound reasoning about the operational shift, with accurate calculations and proper entity identification.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 444,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has Verizon's strategic relationship with its 4G LTE network evolved between 2023 and 2024 in terms of its role within the company's network infrastructure and growth initiatives?",
      "original_answer": "In 2023, Verizon's 4G LTE network was positioned primarily as a foundational component of its wireless services, specifically highlighted as a means to provide FWA broadband as an alternative to traditional landline internet access. By 2024, the strategic role of the 4G LTE network had evolved into being part of a broader integrated network vision that includes C-Band spectrum, millimeter wave spectrum, and fiber infrastructure, aimed at driving innovative products and services and fueling growth. This shift indicates a move from viewing 4G LTE in a service delivery context to a more strategic asset within a multi-technology ecosystem.",
      "llm_answer": "\nBetween 2023 and 2024 Verizon shifted its 4G LTE network from a stand‑alone service to a strategic platform that underpins its broader growth initiatives.  The company continued to densify and expand LTE capacity — using it to add network density, improve quality of service and support its growing fixed‑wireless access (FWA) broadband business — while simultaneously accelerating 5G rollout and investing $17.1 billion in capital expenditures for wireless, fiber and other advanced technologies.  This evolution positioned LTE as a complementary foundation that enables monetization of the network and fuels the company’s fiber‑expansion strategy (e.g., the planned Frontier acquisition) and overall revenue growth.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general evolution of Verizon's 4G LTE strategy from 2023 to 2024, correctly identifying the shift from a standalone service to a complementary platform within a broader ecosystem. The qualitative reasoning about LTE's role in FWA, network densification, and integration with 5G is sound and aligns with the ground truth.\n\nHowever, there are significant issues with quantitative accuracy:\n\n1. QUANTITATIVE PROBLEMS: The LLM introduces a specific figure of \"$17.1 billion in capital expenditures for wireless, fiber and other advanced technologies.\" This number is NOT present in the ground truth answer and cannot be verified against the provided context. Introducing unverified financial figures is a critical error in financial document analysis.\n\n2. UNSUPPORTED CLAIMS: The mention of \"the planned Frontier acquisition\" is presented as fact but is not mentioned in the ground truth. This represents an addition of information not grounded in the source material.\n\n3. MISSING KEY ELEMENTS: While the LLM answer discusses LTE's role in FWA and network integration, it doesn't explicitly mention the evolution from \"service delivery context\" to \"strategic asset within a multi-technology ecosystem\" as clearly as the ground truth does. The ground truth specifically highlights the shift in how 4G LTE is positioned strategically.\n\n4. PARTIAL ALIGNMENT: The LLM correctly identifies C-Band and millimeter wave as part of the broader network vision (implied through \"5G rollout\"), but doesn't explicitly mention these spectrum types or fiber infrastructure as integrated components of the strategic vision as the ground truth does.\n\nThe answer demonstrates good understanding of the strategic direction but fails on factual precision by introducing unverified numbers and claims. For financial analysis, this is a material weakness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 508,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did Emerson's financial and strategic relationship with AspenTech evolve from 2022 to 2024, particularly in terms of stake value, ownership structure, and the impact on financial metrics such as backlog and gross margin?",
      "original_answer": "In 2022, Emerson held a stake in AspenTech with a backlog value of $1,042 million, indicating a strategic business relationship. By 2024, this relationship evolved significantly as Emerson completed a transaction that resulted in the creation of 'New AspenTech,' where Emerson owned 55% of the outstanding shares. This acquisition had a measurable impact on financial metrics: gross margin in 2023 increased by 3.3 percentage points, partly due to the AspenTech acquisition, and backlog in 2024 reached $8,053 million, up from $6,533 million in 2021, showing the influence of the AspenTech integration.",
      "llm_answer": "\nFrom 2022 through 2024 Emerson’s stake in AspenTech grew from the 55 % it acquired in fiscal 2022 to roughly 57 % held in 2024, and in October 2024 it announced a proposal to buy the remaining shares at $240 per share—effectively taking AspenTech fully private.  This deepening ownership coincided with a sharp rise in AspenTech’s backlog (up from $328 M in 2021 to $1.042 B in 2022) and helped lift Emerson’s gross margin from 45.7 % in 2022 to 50.8 % in 2024, with the Test & Measurement (AspenTech) acquisition adding about 9½ percentage points to sales growth and boosting adjusted EPS, even though inventory step‑up amortization slightly offset the margin gain.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations that fundamentally contradict the ground truth:\n\n1. OWNERSHIP STRUCTURE ERROR: The LLM claims Emerson acquired 55% in fiscal 2022 and held roughly 57% in 2024. The ground truth states Emerson completed a transaction resulting in 55% ownership of 'New AspenTech' by 2024, not that it started at 55% in 2022. The LLM's narrative of gradual increase from 55% to 57% is not supported.\n\n2. BACKLOG NUMBERS - CRITICAL ERROR: The LLM states AspenTech's backlog was $328M in 2021 and $1.042B in 2022. The ground truth indicates Emerson held a stake in AspenTech with a backlog value of $1,042 million in 2022 (which equals $1.042B - this part is correct). However, the LLM then claims Emerson's total backlog reached $8,053M in 2024 and $6,533M in 2021. The ground truth clearly states the $8,053M backlog in 2024 and $6,533M in 2021 are Emerson's overall backlog figures, not AspenTech-specific. The LLM conflates AspenTech backlog with Emerson's total backlog.\n\n3. GROSS MARGIN ERRORS: The LLM claims gross margin increased from 45.7% in 2022 to 50.8% in 2024, with the acquisition adding 9.5 percentage points. The ground truth states gross margin increased by 3.3 percentage points in 2023 partly due to the AspenTech acquisition. The LLM's numbers (45.7% to 50.8% = 5.1 percentage point increase, not 9.5 points) are inconsistent with the ground truth's 3.3 percentage point increase.\n\n4. TRANSACTION TIMING: The LLM mentions an October 2024 announcement to buy remaining shares at $240/share. While this may be factually accurate from filings, the ground truth focuses on the 2024 completion of the transaction creating 'New AspenTech' with 55% ownership, not a future proposal.\n\n5. MULTI-HOP SYNTHESIS FAILURE: The LLM failed to correctly synthesize the relationship between AspenTech's standalone backlog ($1.042B in 2022) and Emerson's consolidated backlog figures ($6.533B in 2021, $8.053B in 2024). These are different metrics at different organizational levels.\n\n6. MISSING KEY INFORMATION: The LLM does not clearly explain the evolution from 2022 (when Emerson held a stake) to 2024 (when the transaction was completed creating New AspenTech with 55% ownership).\n\nThe answer demonstrates fundamental misunderstanding of the financial metrics and ownership structure evolution, with multiple quantitative errors that undermine credibility.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 646,
        "total_tokens": 1983
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has NEE's financial commitment to the Mountain Valley Pipeline evolved between 2022 and 2023, and what does this indicate about its investment strategy?",
      "original_answer": "In 2022, NEE's involvement in the Mountain Valley Pipeline was described as part of its equity method investments, with an ownership stake ranging between 32% and 55%. By 2023, NEE, through its subsidiary NEER, had a more defined 32.8% equity investment in the Mountain Valley Pipeline, which was accompanied by a 20-year natural gas transportation agreement valued at approximately $70 million per year. This indicates a strategic deepening of NEE's commitment to the pipeline, moving from a general equity investment toward a more structured, long-term contractual relationship tied to infrastructure development.",
      "llm_answer": "\nBetween 2022 and 2023 NEE’s exposure to the Mountain Valley Pipeline shifted dramatically: the 2022 10‑K notes that in the first quarter of 2022 the company recorded an additional impairment that **completely wrote off its equity investment** in the pipeline (page 97 of the 2022 filing). Consequently, the 2023 10‑K no longer shows a carrying investment—only a modest **planned equity contribution for 2024** is listed under NEER’s capital‑expenditure commitments (page 108 of the 2023 filing). This reduction reflects a strategic pull‑back from the project, with NEE now limiting its involvement to a small, future‑funding role rather than maintaining a substantial direct investment.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally contradicted by the ground truth and contains critical factual errors: (1) QUANTITATIVE ERRORS: The LLM claims NEE 'completely wrote off its equity investment' in 2022 and that 'the 2023 10-K no longer shows a carrying investment.' However, the ground truth explicitly states that by 2023, NEE through NEER had a 'more defined 32.8% equity investment in the Mountain Valley Pipeline.' This is a direct contradiction—the ground truth shows an active equity investment in 2023, not a write-off. (2) MISSING KEY INFORMATION: The LLM completely omits the 20-year natural gas transportation agreement valued at approximately $70 million per year, which is a critical component of NEE's financial commitment and strategic positioning. (3) MISCHARACTERIZATION OF STRATEGY: The LLM describes this as a 'strategic pull-back' and 'reduction,' when the ground truth indicates a 'strategic deepening of NEE's commitment' with a 'more structured, long-term contractual relationship.' These are opposite conclusions. (4) INCOMPLETE SYNTHESIS: The LLM fails to synthesize the full picture of NEE's evolving commitment, which includes both the equity stake AND the long-term transportation agreement. The answer presents a narrative of divestment when the actual evolution shows deepening commitment through more defined structures. (5) CITATION ISSUES: While the LLM cites specific pages, the interpretation of those pages appears to be incorrect based on the ground truth data. The answer demonstrates a fundamental misunderstanding of NEE's actual financial position and strategic direction regarding the Mountain Valley Pipeline between 2022 and 2023.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 456,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has Coca-Cola's relationship with Costa Limited evolved from 2023 to 2024 in terms of its operational integration and strategic positioning within the Global Ventures segment?",
      "original_answer": "In 2023, Costa Limited was referenced as part of Coca-Cola's direct retail operations, specifically through retail stores operated by Costa, and was included within the Global Ventures operating segment. By 2024, Costa Limited was more strategically embedded within the Global Ventures segment, which now also included the results of innocent and doğadan businesses, as well as fees earned under distribution coordination agreements. This indicates a deeper integration and broader strategic role for Costa within Coca-Cola’s diversified beverage portfolio.",
      "llm_answer": "\nFrom 2023 to 2024 Coca‑Cola deepened the integration of Costa Limited inside its **Global Ventures** segment, shifting the brand from a stand‑alone investment to a core growth platform.  The 2023 filing lists Costa, innocent and doğadan together under Global Ventures, and the 2024 discussion notes that sales through Costa’s retail stores are now reported as part of that segment, underscoring a strategic focus on expanding the chain’s outlet network and leveraging its consumer‑facing model to drive volume and margin.  At the same time, the company refranchised several bottling operations (e.g., in India, Bangladesh and the Philippines), freeing capital and managerial attention to concentrate on the integrated Global Ventures model in which Costa plays a pivotal role.  (Pages 6, 73, 66)",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies Costa Limited's inclusion in the Global Ventures segment in both 2023 and 2024, accurately mentions innocent and doğadan as fellow businesses within that segment, and correctly notes the shift toward deeper integration. The core factual claim about Costa's strategic positioning is sound. WEAKNESSES: (1) The LLM introduces information about refranchising bottling operations in India, Bangladesh, and the Philippines that is NOT present in the ground truth answer. While this may be factually accurate from the filings, it represents scope creep beyond what the original answer addresses and wasn't part of the multi-hop synthesis required. (2) The characterization of Costa shifting from 'stand-alone investment to core growth platform' is interpretive language not explicitly stated in the ground truth. (3) The claim about 'sales through Costa's retail stores are now reported as part of that segment' in 2024 is somewhat misleading—the ground truth states Costa's retail stores were already referenced in 2023 as part of direct retail operations, and by 2024 the segment expanded to include innocent, doğadan, and distribution coordination fees, but doesn't specifically highlight retail store sales as a 2024 change. (4) Page citations (Pages 6, 73, 66) cannot be verified against the ground truth provided. MULTI-HOP REASONING: The answer attempts to synthesize evolution from 2023 to 2024 but adds extraneous information about refranchising that dilutes focus on the specific question about Costa's operational integration and strategic positioning. The core multi-hop synthesis (comparing Costa's role across two years within Global Ventures) is partially correct but embellished with unsupported details. QUANTITATIVE ACCURACY: No specific numbers are provided in either answer, so this dimension is neutral. ENTITY ACCURACY: All entities (Coca-Cola, Costa Limited, Global Ventures, innocent, doğadan) are correctly identified. The answer maintains semantic equivalence on the core claim but introduces interpretive framing and additional context not grounded in the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 572,
        "total_tokens": 1918
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has Intel's investment in financial institution instruments evolved between 2022 and 2024, particularly in terms of the fair value of economically hedged marketable debt investments?",
      "original_answer": "In 2022, Intel recorded net losses of $748 million on economically hedged marketable debt investments. By 2024, the fair value of these hedged investments had decreased to $13.5 billion from $17.1 billion in 2023, with Intel recording net losses of $464 million in 2024. This indicates a reduction in both the size of the hedged investment portfolio and the magnitude of losses compared to two years prior.",
      "llm_answer": "\nIntel’s economically‑hedged marketable‑debt portfolio swung markedly from 2022 through 2024: it posted an unrealized loss of $748 million in 2022, then a $534 million unrealized gain in 2023 that lifted the hedged‑investment fair value to $17.1 billion, and finally a $464 million unrealized loss in 2024 that cut the fair value to $13.5 billion. This trajectory shows a sharp rise in 2023 followed by a decline in 2024, reflecting the volatility of interest‑rate and currency hedging on the portfolio’s market value.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with all key numbers correct: $748 million loss in 2022, $17.1 billion fair value in 2023, $464 million loss in 2024, and $13.5 billion fair value in 2024. The quantitative data is precise and properly formatted. The multi-hop synthesis across three years is sound, correctly tracking the evolution of Intel's hedged investment portfolio. The LLM goes beyond the ground truth by adding interpretive context about the 2023 gain ($534 million unrealized gain) and explaining the volatility drivers (interest-rate and currency hedging), which provides valuable additional insight. The reasoning about the portfolio's trajectory (rise in 2023, decline in 2024) is logically sound and well-articulated. Minor deduction: The ground truth emphasizes 'net losses' while the LLM uses 'unrealized loss/gain' terminology, which is technically more precise but represents a slight semantic shift. The ground truth doesn't explicitly mention the 2023 gain figure, though it does reference the $17.1 billion fair value that year. The LLM's inference of the $534 million gain appears reasonable given the context but isn't directly stated in the ground truth. Overall, the answer is comprehensive, accurate, and provides sound multi-hop reasoning across the 2022-2024 period.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 367,
        "total_tokens": 1608
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did AMT's financial focus regarding communications sites evolve from 2023 to 2024, particularly in terms of recurring revenue generation and asset retirement liabilities?",
      "original_answer": "In 2023, AMT emphasized recurring revenue generation from communications sites, noting that 99% of total revenues came from property operations, which included leasing space on communications sites. By 2024, the focus expanded to include significant liabilities tied to these assets, with an estimated $4.5 billion in undiscounted future cash outlay for asset retirement obligations as of December 31, 2024. This reflects a shift from primarily highlighting revenue streams to also addressing the long-term financial responsibilities associated with site decommissioning.",
      "llm_answer": "\nBetween 2023 and 2024 AMT began describing the vast majority of its site‑lease income as **recurring, multi‑year revenue** that drives its cash‑flow and liquidity outlook (see the “Internally Generated Funds” discussion in the 2024 filing).  At the same time the company **extended the estimated useful life of its tower assets from 20 years to 30 years**, which lowered depreciation expense, increased right‑of‑use assets and lease liabilities, and resulted in a **higher recorded asset‑retirement obligation of about $4.5 bn (undiscounted) as of 31 Dec 2024** (up from $2.08 bn in 2023).  This shift reflects a strategic focus on the long‑term, stable cash flows from communications sites while more explicitly accounting for the future retirement costs of those assets.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the $4.5 billion undiscounted asset retirement obligation as of December 31, 2024, matching the ground truth. The answer appropriately captures the shift from emphasizing revenue streams to addressing long-term financial responsibilities. The semantic understanding of the evolution is sound - moving from revenue focus to including liability considerations. The mention of recurring, multi-year revenue aligns with the ground truth's 99% property operations revenue point.\n\nWEAKNESSES: (1) QUANTITATIVE ERROR - The LLM introduces unsupported information about extending useful life from 20 to 30 years. This specific claim is not present in the ground truth and appears to be fabricated or misattributed. (2) QUANTITATIVE ERROR - The LLM states the prior year (2023) asset retirement obligation was $2.08 billion, which is NOT mentioned in the ground truth. This is an unverified claim that introduces a specific number not in the original answer. (3) INCOMPLETE - The ground truth explicitly mentions '99% of total revenues came from property operations' which the LLM does not cite with this specific percentage. (4) SCOPE CREEP - The LLM adds details about 'right-of-use assets and lease liabilities' that go beyond what the ground truth addresses.\n\nMULTI-HOP REASONING: The LLM demonstrates sound reasoning in connecting the evolution of financial focus across years and linking revenue emphasis to liability accounting. However, the introduction of unverified specific claims (20-to-30 year useful life change, $2.08B prior year figure) undermines the reliability of the synthesis.\n\nCRITICAL ISSUE: The answer contains factual claims that cannot be verified against the ground truth and may be incorrect. While the core insight about the $4.5B obligation and the shift in focus is correct, the additional quantitative details (especially the $2.08B comparison and useful life extension) are problematic and reduce confidence in the overall response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 539,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has XOM's strategic positioning in Guyana evolved between 2023 and 2024, particularly in terms of its legal operating framework and business growth emphasis?",
      "original_answer": "In 2023, XOM's operations in Guyana were governed by the Petroleum Activities Act 2023, which allowed for an exploration period typically up to 10 years and a production period of 20 years for oil fields with a renewal period of up to 10 years. By 2024, Guyana was specifically highlighted as one of XOM's 'Advantaged Assets' under the 'Advantaged Volume Growth' earnings driver, indicating a strategic shift to emphasize Guyana as a key contributor to earnings through volume growth and integration. This evolution shows that Guyana transitioned from being a jurisdiction with defined exploration and production terms to being a core growth asset within XOM's portfolio.",
      "llm_answer": "\nBetween 2023 and 2024 ExxonMobil moved from the nascent licensing regime created by Guyana’s **Petroleum Activities Act 2023**—which first set out a typical 10‑year exploration term and 20‑year (up to 30‑year for gas) production period with renewal options—to a fully operational legal framework that now governs its offshore contracts.  This regulatory certainty allows the company to treat Guyana’s Stabroek block as an **“advantaged asset”** and to shift its growth emphasis from early‑stage exploration to large‑scale development and production, integrating the offshore oil‑equivalent volumes into its broader upstream, energy‑products and low‑carbon portfolio.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core narrative of XOM's strategic evolution in Guyana between 2023-2024, correctly identifying the Petroleum Activities Act 2023 and the shift to 'advantaged asset' status. However, there are significant quantitative accuracy issues: (1) The LLM introduces information about gas production periods ('up to 30-year for gas') that is NOT present in the ground truth and appears to be hallucinated. The ground truth specifies only oil field terms: 10-year exploration, 20-year production with up to 10-year renewal. (2) The LLM adds details about 'Stabroek block' and 'offshore contracts' that, while contextually relevant to Guyana operations, are not explicitly mentioned in the ground truth provided. (3) The LLM expands the answer to include portfolio integration language ('upstream, energy-products and low-carbon portfolio') that goes beyond the ground truth's focus on 'volume growth and integration.' On the positive side: The LLM correctly identifies the legal framework transition, accurately names the Petroleum Activities Act 2023, and properly characterizes the shift from exploration-focused to production/development-focused operations. The multi-hop reasoning is sound—connecting regulatory framework to strategic positioning. The semantic equivalence is generally maintained regarding the core evolution narrative. The main penalty is for introducing unverified quantitative details (the 30-year gas term) and expanding beyond the ground truth scope, which violates the principle of strict accuracy on factual claims.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 429,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has Caterpillar's involvement in the diesel-electric locomotives business evolved between 2023 and 2024, particularly in terms of its strategic positioning and operational responsibilities?",
      "original_answer": "In 2023, Caterpillar's involvement in diesel-electric locomotives was described as part of its broader Machinery, Energy & Transportation (ME&T) segment, which included responsibilities such as remanufacturing Caterpillar reciprocating engines and components, as well as product support for on-highway vocational trucks in North America. By 2024, Caterpillar's positioning had evolved, with diesel-electric locomotives and related components being explicitly tied to integrated systems and solutions for industries like electric power generation, marine, oil and gas, and industrial sectors. Additionally, 2024 emphasized the development of electrified powertrains and zero-emission power sources, signaling a strategic shift toward more advanced and environmentally focused technologies in the locomotive space.",
      "llm_answer": "\nBetween 2023 and 2024 Caterpillar intensified its strategic focus on diesel‑electric locomotives by placing them squarely in the Energy & Transportation segment, where transportation sales rose 4 % and segment profit jumped 16 % thanks to favorable price realization. Operationally, the company expanded its responsibilities to include remanufacturing of locomotives and related components, leasing activities, and the rollout of digital analytics and data‑driven services to support rail customers, while continuing to treat inter‑segment sales as a key revenue source.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misalignments with the ground truth. (1) CRITICAL ERRORS: The LLM introduces specific financial metrics (4% transportation sales rise, 16% segment profit jump) that are NOT present in the ground truth answer. These appear to be fabricated numbers without verification from the source documents. The ground truth makes no mention of these specific percentages. (2) SEGMENT NAMING: The LLM refers to 'Energy & Transportation segment' while the ground truth specifically identifies it as 'Machinery, Energy & Transportation (ME&T) segment' - a material difference in nomenclature. (3) OPERATIONAL RESPONSIBILITIES: The LLM mentions 'leasing activities' and 'digital analytics and data-driven services' which are NOT mentioned in the ground truth. While the ground truth does mention remanufacturing, it does not reference leasing or digital services as part of the 2023-2024 evolution. (4) STRATEGIC POSITIONING: The LLM fails to capture the key strategic shift highlighted in the ground truth - the 2024 emphasis on 'electrified powertrains and zero-emission power sources' and the shift toward 'environmentally focused technologies.' This is a critical omission as it represents the core strategic evolution between the two years. (5) MULTI-HOP REASONING: The LLM does not properly synthesize the evolution narrative. The ground truth clearly shows a progression from traditional diesel-electric locomotives (2023) to a more advanced, sustainability-focused approach (2024). The LLM's answer focuses on financial performance metrics that are unverified and misses this fundamental strategic narrative. (6) INTER-SEGMENT SALES: While the LLM mentions inter-segment sales, this detail is not substantiated in the ground truth. The quantitative accuracy is severely compromised by the introduction of unverified financial figures. The qualitative accuracy suffers from missing the environmental/sustainability angle that defines the 2024 positioning shift.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 540,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has the company's reliance on securitized debt obligations as a funding source evolved from 2022 to 2024, and what does this indicate about its funding strategy?",
      "original_answer": "In 2022, the company disclosed that it raised funding through the issuance of securitized debt obligations, among other instruments, though the exact amount was not provided. By 2024, the company reported a carrying value of $14,264 million for securitized debt obligations, indicating a concrete quantification of this funding source. This evolution suggests a more defined and potentially increased reliance on securitized debt obligations, aligning with a broader strategic emphasis on structured financing.",
      "llm_answer": "\nCapital One’s securitized‑debt balance rose from roughly **$13–14 billion in 2022** (as reported in the 2022 filing) to **about $18 billion by the end of 2024** (carrying amount shown in the 2024 filing).  This increase reflects a deliberate expansion of the firm’s use of loan‑securitization to fund growing credit‑card and auto portfolios, but the securities still account for only **≈4–5 % of total funding**, underscoring that the company’s primary funding remains anchored in core deposits and other stable sources and that securitization is being used selectively as a supplemental, opportunistic tool rather than a core reliance.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains significant factual inaccuracies that fundamentally contradict the ground truth. (1) QUANTITATIVE ACCURACY FAILURE: The LLM claims securitized debt rose from '$13-14 billion in 2022' to 'about $18 billion by end of 2024.' However, the ground truth explicitly states that in 2022 'the exact amount was not provided' and by 2024 the carrying value was '$14,264 million' ($14.264 billion). The LLM's 2024 figure of ~$18 billion is INCORRECT and contradicts the ground truth's $14.264 billion. The 2022 estimate of $13-14 billion is also unsupported by the ground truth which explicitly notes no exact amount was disclosed. (2) CALCULATION/COMPARISON ERROR: The LLM claims an 'increase' from 2022 to 2024, but the ground truth indicates 2022 had no quantified amount while 2024 showed $14.264 billion. The LLM's narrative of growth from ~$13-14B to ~$18B is fabricated. (3) PERCENTAGE CLAIM: The LLM states securitization represents '≈4-5% of total funding,' but this metric is not mentioned in the ground truth and appears to be unsupported speculation. (4) STRATEGIC INTERPRETATION: While the LLM's characterization of securitization as 'supplemental, opportunistic' may be reasonable inference, it contradicts the ground truth's conclusion that the evolution 'suggests a more defined and potentially increased reliance on securitized debt obligations, aligning with a broader strategic emphasis on structured financing.' The LLM's interpretation directly opposes the ground truth's assessment. (5) MULTI-HOP SYNTHESIS: The LLM failed to correctly synthesize the 2022-to-2024 evolution. The ground truth indicates a progression from unquantified disclosure to concrete quantification ($14.264B), suggesting increased strategic importance. The LLM invented numbers and mischaracterized the trend. The answer is fundamentally unreliable due to incorrect financial figures and contradictory strategic conclusions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 526,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has McDonald's treatment of developmental licensees evolved between 2023 and 2024, particularly in terms of financial reporting and relationship management?",
      "original_answer": "In 2023, McDonald's disclosed that developmental licensees paid royalties based on a percentage of sales and generally paid initial fees, and the company allocated consideration among lease and non-lease components using historical methods. By 2024, the company emphasized its ongoing evaluation of business relationships, including those with developmental licensees, to identify potential variable interest entities, although it concluded that consolidation of such entities was not appropriate. Additionally, in 2024, McDonald's updated its rounding presentation to the nearest whole number for reported amounts, which affected how financial figures were presented, though the company clarified that these changes were not significant.",
      "llm_answer": "\nBetween 2023 and 2024 McDonald’s continued to recognize revenue from developmental licensees in the same way—as royalties based on a percent of sales plus initial fees that are allocated between lease and non‑lease components—but it added substantially more transparency around that business.  The 2024 Form 10‑K (pages 45‑46) adopts ASU 2023‑07, which expands segment‑reporting disclosures and now presents a dedicated “International Developmental Licensed Markets & Corporate” segment, giving investors a clearer view of the financial contribution and operating results of developmental licensees.  The filing also provides enhanced footnote detail on how consideration is allocated among lease income, royalty income and initial fees, reflecting a more structured relationship‑management approach for these licensees.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not supported by the ground truth. CRITICAL ISSUES: (1) The LLM claims ASU 2023-07 was adopted in 2024 and created a new 'International Developmental Licensed Markets & Corporate' segment - this is NOT mentioned in the ground truth and appears to be fabricated or confused with other accounting standards. (2) The LLM references specific page numbers (45-46) without verification against the actual filing. (3) The LLM's core claim about enhanced segment reporting and a dedicated segment for developmental licensees contradicts the ground truth, which makes no mention of new segment creation or ASU 2023-07 adoption. WHAT WAS CORRECT: (1) The LLM correctly identifies that royalties are based on percentage of sales plus initial fees (matches ground truth). (2) The LLM correctly notes allocation between lease and non-lease components (matches ground truth). (3) The general direction about increased transparency is somewhat aligned with ground truth's mention of 'ongoing evaluation.' WHAT WAS MISSING/INCORRECT: (1) The ground truth emphasizes McDonald's evaluation of developmental licensees as potential variable interest entities and the conclusion that consolidation was not appropriate - the LLM completely omits this critical aspect. (2) The ground truth mentions rounding presentation changes to nearest whole number in 2024 - the LLM does not address this. (3) The LLM introduces unverified claims about ASU 2023-07 and segment reporting that are not in the ground truth. The answer demonstrates partial understanding of the revenue recognition mechanics but fails on the multi-hop synthesis of how the relationship management and financial reporting actually evolved, particularly regarding VIE evaluation and consolidation considerations.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 497,
        "total_tokens": 1890
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has Southern Company's approach to its Equity and Incentive Compensation Plan evolved between 2023 and 2024, particularly in terms of share availability and executive award disclosures?",
      "original_answer": "In 2023, Southern Company had 26.9 million shares available for awards under the Equity and Incentive Compensation Plan, indicating a reserve for future compensation initiatives. By 2024, the company increased transparency around executive compensation by disclosing specific terms for Named Executive Officer equity awards granted under the 2021 Equity and Incentive Compensation Plan, which was effective May 26, 2021. This evolution shows a shift from internal planning and reserve allocation in 2023 to more detailed public disclosure of executive-level compensation mechanisms in 2024, suggesting a more formalized and transparent governance approach for top-level incentives.",
      "llm_answer": "\nBetween 2023 and 2024 Southern Company’s Equity and Incentive Compensation Plan moved from a 2023‑year‑end availability of **26.9 million shares** (as disclosed in the 2023 “Outstanding Classes of Capital Stock” note on page 311) to a refreshed reserve after the **December 16 2024 ninth amendment to the Employee Savings Plan** (referenced on page 316), which added to the pool of shares that can be issued for future awards.  The 2024 filing also provides a **more detailed executive‑award disclosure**—a specific table of the terms for named‑executive officer equity awards under the 2021 Equity and Incentive Compensation Plan—thereby increasing transparency around how those awards are structured and granted.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains both correct and problematic elements. CORRECT: (1) The 26.9 million shares figure for 2023 is accurate and properly sourced. (2) The identification of the 2021 Equity and Incentive Compensation Plan (effective May 26, 2021) is correct. (3) The observation about increased transparency and more detailed executive award disclosure in 2024 aligns with the ground truth. (4) The general characterization of evolution toward more formalized governance is sound. PROBLEMATIC: (1) The LLM introduces a December 16, 2024 ninth amendment to the Employee Savings Plan as a key element of the evolution, but the ground truth makes no mention of this amendment or any specific share pool refresh. This appears to be either fabricated or misattributed information not supported by the ground truth. (2) The LLM cites specific page numbers (311, 316) which cannot be verified against the ground truth provided. (3) The ground truth emphasizes a shift from 'internal planning and reserve allocation in 2023 to more detailed public disclosure...in 2024,' but the LLM's framing around the Employee Savings Plan amendment introduces a different narrative about share pool refreshing that isn't substantiated. MULTI-HOP REASONING: The LLM correctly synthesizes the two main elements (share availability and disclosure transparency) but introduces unsupported details about the Employee Savings Plan amendment that muddy the analysis. The core insight about transparency evolution is present but partially obscured by potentially inaccurate information about the mechanism of share pool changes. QUANTITATIVE ACCURACY: The 26.9 million shares figure is correct, but the introduction of the December 16, 2024 amendment without corresponding numbers or verification is a significant weakness. The answer lacks the specific quantitative details about 2024 share availability that would complete the comparison.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 517,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did the revenue performance of Inlyta evolve between 2022 and 2023, and what factors contributed to the change in its growth trajectory?",
      "original_answer": "In 2022, Inlyta contributed to Pfizer's operational growth, specifically mentioned among products like Comirnaty, Eliquis, and Vyndaqel that drove growth in the U.S. and international markets. By 2023, Inlyta's global revenue reached $1,036 million, reflecting a 3% total increase and a 5% operational growth. The growth was primarily attributed to the adoption of immune checkpoint inhibitor combinations with Inlyta for first-line treatment of advanced RCC in the U.S., despite lower volumes and net price in certain European markets. This indicates a continuation of growth, albeit at a more moderate pace compared to the broader portfolio dynamics in 2022.",
      "llm_answer": "\nInlyta’s worldwide sales rose only modestly – from **$1.003 billion in 2022 to $1.036 billion in 2023** (a ~3 % increase), with U.S. revenue up 4 % to $642 million and international sales up 3 % to $394 million.  The slowdown from the prior‑year ~5 % growth was attributed to **lower volumes and price cuts in several European markets, heightened competitive pressure, and the lingering impact of the COVID‑19 vaccine revenue decline**, even though the drug continued to gain traction in the United States through combination regimens with immune‑checkpoint inhibitors for first‑line renal‑cell carcinoma and continued expansion in emerging markets.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM correctly identified the key financial metrics - 2022 revenue of $1.003 billion, 2023 revenue of $1.036 billion, and the ~3% overall growth rate. The U.S. revenue figure of $642 million and international sales of $394 million appear reasonable and sum correctly to the total. The identification of immune checkpoint inhibitor combinations for first-line RCC treatment as a growth driver is accurate and matches the ground truth. The mention of European market challenges is also correct.\n\nWEAKNESSES: (1) The LLM introduced information about \"COVID-19 vaccine revenue decline\" as a contributing factor, which is NOT mentioned in the ground truth answer and appears to be an unsupported inference or hallucination. This is a significant accuracy issue as it adds context not present in the source material. (2) The LLM mentions \"heightened competitive pressure\" which is also not explicitly stated in the ground truth. (3) The LLM states a \"slowdown from the prior-year ~5% growth\" - while the ground truth mentions 5% operational growth in 2023, it doesn't explicitly state prior-year growth rates for comparison, making this comparison potentially inaccurate. (4) The breakdown of U.S. ($642M) vs international ($394M) totals to $1.036B, which is correct, but these specific figures are not verified in the ground truth.\n\nMULTI-HOP REASONING: The answer correctly synthesizes information about revenue performance across years and identifies contributing factors. However, the introduction of unsupported factors (COVID vaccine impact) undermines the quality of the synthesis.\n\nCALCULATIONS: The math is correct ($1.003B to $1.036B = 3.3% increase, rounded to 3%). The U.S. and international breakdown sums correctly.\n\nOVERALL: The core financial data and primary growth drivers are accurate, but the inclusion of unsupported factors and potential overstatement of competitive pressures reduces confidence in the answer's reliability.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 531,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How has McDonald's relationship with its franchisees evolved from 2023 to 2024 in terms of financial structure and dependency, particularly regarding revenue recognition and cost-sharing for technology platforms?",
      "original_answer": "In 2023, McDonald's described its relationship with franchisees as a collaborative partnership focused on consistency, quality, and revenue generation through rent, royalties based on a percent of sales, and initial fees. The business model was designed to generate stable and predictable revenue largely tied to franchisee sales. By 2024, the relationship evolved to reflect a stronger dependency on franchisees, particularly in the context of technology platforms. McDonald's began recognizing revenue from franchisees for technology services on a gross basis, with related expenses recorded in 'Other restaurant expenses,' indicating a more integrated and cost-sharing approach. This shift reflects a transformation in the nature of the relationship, with franchisees becoming more operationally interdependent with the company through shared technology infrastructure.",
      "llm_answer": "\nFrom 2023 to 2024 McDonald’s continued to operate a heavily franchised model, but the financial structure shifted toward greater reliance on franchise‑generated revenue and explicit cost‑sharing for technology.  “Other revenues” – which consist of fees franchisees pay to recover the Company’s technology‑platform costs – rose from **$316 million in 2023 to $423 million in 2024** (page 40), and the Company now records those fees gross and recognizes them as revenue when the services are delivered (pages 4‑5).  At the same time, total revenue from franchised restaurants increased to **$15.7 billion** (up from $15.4 billion), while Company‑owned sales stayed flat, indicating a modest but measurable move from pure rent/royalty income to a model that blends royalty income with ongoing technology‑fee income and co‑investment in franchisee‑level upgrades.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively addresses the multi-hop question about McDonald's franchisee relationship evolution from 2023 to 2024. STRENGTHS: (1) Specific financial numbers are accurate and properly cited: $316M to $423M increase in 'Other revenues' for technology platform costs is correct; $15.7B and $15.4B franchise revenue figures are accurate. (2) The multi-hop synthesis is sound - the answer correctly connects revenue recognition changes (gross basis recording), cost-sharing mechanisms, and the shift toward technology-fee dependency. (3) The answer properly identifies the key evolution: from pure rent/royalty model to integrated technology cost-sharing model. (4) Citation of specific pages (40, 4-5) demonstrates source verification. (5) The reasoning about operational interdependence through shared technology infrastructure aligns with the ground truth. MINOR WEAKNESSES: (1) The LLM answer focuses heavily on quantitative metrics and revenue recognition mechanics but could have elaborated slightly more on the qualitative nature of the 'stronger dependency' and 'operational interdependence' aspects mentioned in the ground truth. (2) The phrase 'co-investment in franchisee-level upgrades' is mentioned but not deeply explored in relation to the cost-sharing structure. (3) The answer could have more explicitly stated that this represents a transformation in the relationship nature itself, though this is implied. QUANTITATIVE VERIFICATION: The $316M→$423M increase ($107M or 33.9% growth) and the $15.4B→$15.7B franchise revenue increase ($300M or 1.9% growth) are mathematically sound and factually correct. The answer correctly interprets these as indicators of the structural shift. Overall, the LLM answer successfully synthesizes multi-hop information across years and financial metrics while maintaining factual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 511,
        "total_tokens": 1961
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did the fair value of energy-related derivatives held by Southern Company's subsidiaries evolve from 2022 to 2023, and what does this indicate about the company's exposure to energy market fluctuations?",
      "original_answer": "In 2022, Southern Company's subsidiaries reported a net fair value of $101 million for energy-related derivatives (Mississippi Power: $59 assets, $32 liabilities; Southern Power: $8 assets, $12 liabilities; Southern Company Gas: $28 assets, $65 liabilities). In 2023, the subsidiaries showed a shift with Alabama Power reporting $15 in assets and $110 in liabilities, and Georgia Power reporting $13 in assets and $124 in liabilities for energy-related derivatives. This indicates a significant increase in net liability exposure, rising from a net liability of $54 million in 2022 to a net liability of $219 million in 2023, suggesting a greater exposure to energy market fluctuations.",
      "llm_answer": "\nThe net fair‑value of energy‑related derivatives recorded in the balance sheets of Southern Company’s subsidiaries jumped from about **$45 million in 2022 to roughly $554 million in 2023**—a more than ten‑fold increase. This sharp rise reflects a substantial expansion of the company’s hedging positions and therefore a markedly greater exposure to energy‑price volatility over that period.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamentally incorrect financial figures and fails to accurately synthesize the multi-hop information from the ground truth. Specific issues: (1) QUANTITATIVE ERRORS - The LLM claims net fair value jumped from '$45 million in 2022 to roughly $554 million in 2023,' but the ground truth shows: 2022 had a net LIABILITY of $54 million (not $45M asset), and 2023 had a net LIABILITY of $219 million (not $554M asset). The LLM appears to have confused asset and liability positions, and the 2023 figure is off by more than $335 million. (2) DIRECTIONAL ERROR - The LLM describes this as a 'jump' in positive fair value, when the ground truth indicates an INCREASE in net liability exposure (from -$54M to -$219M), which is a worsening position, not an expansion of hedging positions. (3) INCOMPLETE SYNTHESIS - The ground truth provides detailed subsidiary-level breakdowns (Mississippi Power, Southern Power, Southern Company Gas in 2022; Alabama Power and Georgia Power in 2023), which the LLM completely omits. (4) MISINTERPRETATION - The LLM's conclusion that this reflects 'expansion of hedging positions' contradicts the ground truth's interpretation that it indicates 'greater exposure to energy market fluctuations' due to increased net liabilities. The LLM failed to correctly identify that the company moved from a net asset position to a significantly larger net liability position, which is the opposite of what the LLM claims. This is a critical failure in both quantitative accuracy and multi-hop reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 424,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How has the treatment and significance of the Procter & Gamble 2019 Stock and Incentive Compensation Plan evolved from 2022 to 2024, based on its disclosure context in the 10-K filings?",
      "original_answer": "In 2022, the 2019 Stock and Incentive Compensation Plan was introduced with detailed references to its adoption by shareholders on October 8, 2019, and its additional terms and conditions, indicating its formal establishment and integration into the company's compensation framework. By 2024, the plan was listed among other equity compensation plans as part of the company's broader disclosure on stock ownership and equity compensation, showing that it had become a standard and active component of the company's long-term incentive structure. This evolution reflects the plan's transition from a newly introduced policy to an established part of PG's equity compensation offerings.",
      "llm_answer": "\nFrom 2022 through 2024 the 2019 Stock and Incentive Compensation Plan remained the **only** P&G equity plan that still permits new grants, with the same reserve of **77 million shares** (out of the 187 million shares authorized).  The accounting treatment—options and SARs counted on a one‑for‑one basis and full‑value awards (RSUs, PSUs) counted as five shares each—has not changed, but the plan’s **significance has grown** because all other legacy plans (1992, 2001, 2003, 2009, 2014) are closed to future issuances, making the 2019 Plan the sole source of future equity‑based compensation for the company.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations that contradict the ground truth. (1) CRITICAL ERRORS: The LLM claims the 2019 Plan is the 'only' P&G equity plan permitting new grants and provides specific share reserve numbers (77 million out of 187 million authorized), but the ground truth makes no such claims about exclusivity or these specific figures. The ground truth describes the plan's evolution from 'newly introduced' in 2022 to 'established and active' by 2024, not a transition to sole-source status. (2) QUANTITATIVE ACCURACY ISSUES: The specific numbers cited (77 million shares, 187 million authorized, five-to-one counting for RSUs/PSUs) are presented as fact but cannot be verified against the ground truth provided. These appear to be fabricated or from sources not in the knowledge graph. (3) MULTI-HOP REASONING FAILURE: The LLM fundamentally misunderstood the question's focus. The ground truth emphasizes the plan's evolution in disclosure context and its integration into the compensation framework over time. The LLM instead focuses on comparative plan status and accounting mechanics that are not addressed in the ground truth. (4) SEMANTIC DIVERGENCE: The ground truth describes a transition from 'newly introduced policy' to 'standard component,' while the LLM describes a transition to 'sole source' status—these are entirely different narratives. The LLM's answer appears to conflate or invent information about legacy plans being 'closed to future issuances,' which is not mentioned in the ground truth. (5) CONTEXTUAL MISALIGNMENT: The question asks about 'treatment and significance' in disclosure context; the ground truth addresses this through disclosure prominence and integration. The LLM instead addresses operational/structural significance and accounting treatment, which may be factually accurate but doesn't match the ground truth's framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 517,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has Southern Company's approach to managing the risk of large losses in its pension plan assets evolved from 2023 to 2024, and what specific changes in risk management emphasis can be observed?",
      "original_answer": "In 2023, Southern Company emphasized a formal rebalancing program and external investment manager oversight as key components of managing the risk of large losses, with a strong focus on long-term investment expectations for return and risk. In 2024, while maintaining a diversified asset strategy and rebalancing program, the emphasis on external manager oversight was reduced, and the risk of large losses was more directly linked to the broader market volatility and interest rate fluctuations. This indicates a subtle shift in risk management emphasis from active oversight to market-driven risk exposure.",
      "llm_answer": "\nSouthern Company’s 2024 filing adds a concrete risk‑management framework that was only implied in 2023.  The 2024 discussion (see page 255 and 258) explicitly describes a formal rebalancing program, written guidelines for external managers, and a target‑allocation mix (e.g., 41 % equity, 30 % fixed‑income, 12 % real‑estate, 9 % private‑equity, etc.) that is tracked against actual holdings, and it notes the use of derivatives as hedging tools.  Compared with the 2023 language (page 263), the 2024 approach places greater emphasis on systematic monitoring of asset‑class exposures, a more diversified tilt toward alternative assets such as private‑equity and real‑estate, and a tighter alignment of actual allocations with predefined targets to curb the risk of large losses.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations when compared to the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM provides specific asset allocation percentages (41% equity, 30% fixed-income, 12% real-estate, 9% private-equity) that are presented as facts from the 2024 filing, but these cannot be verified against the ground truth and appear to be fabricated or incorrectly sourced. The ground truth does not mention these specific percentages. (2) DIRECTIONAL CONTRADICTION: The ground truth states that in 2024 'the emphasis on external manager oversight was reduced,' but the LLM claims the 2024 approach 'places greater emphasis on systematic monitoring' and 'written guidelines for external managers.' This is a direct contradiction of the ground truth's key finding about the shift away from external manager oversight. (3) INCOMPLETE SYNTHESIS: The ground truth emphasizes a 'subtle shift in risk management emphasis from active oversight to market-driven risk exposure,' but the LLM focuses on increased formalization and systematic monitoring, missing the critical insight about reduced external manager oversight. (4) PAGE REFERENCES: The LLM cites specific pages (255, 258, 263) without verification against the ground truth, which raises concerns about accuracy of sourcing. (5) MISSING KEY INSIGHT: The ground truth's central finding—that risk management shifted from active oversight to market-driven exposure—is absent from the LLM answer. The LLM instead emphasizes increased systematization and diversification, which may be partially true but misses the primary evolution described in the ground truth. The answer demonstrates some understanding of pension asset management concepts but fails to accurately capture the actual evolution of Southern Company's risk management approach from 2023 to 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 504,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has NVIDIA's role in the development and supply of the CUDA platform evolved between 2022 and 2023, and what does this shift indicate about the company's strategic focus?",
      "original_answer": "In 2022, NVIDIA's relationship with the CUDA platform was primarily as a supplier, providing the platform as part of its accelerated computing offerings. By 2023, NVIDIA's role had evolved into that of a developer, emphasizing a more active and strategic engagement in the platform's expansion and integration within its broader software ecosystem, including CUDA-X libraries, APIs, and domain-specific frameworks. This shift indicates a strategic move toward strengthening its full-stack computing platform to deliver more comprehensive data center-scale solutions.",
      "llm_answer": "\nBetween 2022 and 2023 NVIDIA’s 10‑K filings show CUDA moving from a broad‑based parallel‑programming layer that underpinned its GPU business across gaming, professional visualization and data‑center markets (as noted in the 2022 filing pages 86‑103) to the core software stack of a dedicated AI‑first computing platform.  In the 2023 filing pages 6 and 36 the company explicitly describes CUDA‑enabled AI inference platforms, new hardware such as Ada, Hopper and Grace, and services like DGX Cloud and AI Foundations, signaling a strategic shift toward AI and high‑margin data‑center growth.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer attempts to address the evolution of NVIDIA's CUDA platform role between 2022 and 2023, but contains significant issues: (1) FACTUAL PROBLEMS: The LLM cites specific page numbers (pages 86-103 for 2022, pages 6 and 36 for 2023) without verification that these pages actually contain the claimed information about CUDA's evolution. This is a critical error in multi-hop reasoning - the answer appears to fabricate specific citations. (2) SEMANTIC ALIGNMENT: The ground truth emphasizes a shift from 'supplier' to 'developer' role, focusing on CUDA-X libraries, APIs, and domain-specific frameworks. The LLM answer instead describes a shift from 'broad-based parallel-programming layer' to 'core software stack of AI-first computing platform,' which is a different characterization. While both discuss strategic evolution, they frame it differently. (3) MISSING KEY ELEMENTS: The ground truth specifically mentions 'CUDA-X libraries, APIs, and domain-specific frameworks' as evidence of the developer role. The LLM mentions 'CUDA-enabled AI inference platforms' and hardware (Ada, Hopper, Grace) but doesn't explicitly address the software ecosystem expansion that defines the developer role. (4) ADDED ELEMENTS: The LLM introduces 'DGX Cloud and AI Foundations' services and emphasizes 'high-margin data-center growth,' which are not in the ground truth and may be extrapolations beyond what the filings directly state about CUDA's role evolution. (5) QUANTITATIVE ACCURACY: No specific numbers, percentages, or financial metrics are provided in either answer, so this dimension is neutral. However, the unverified page citations represent a quantitative accuracy failure. (6) MULTI-HOP REASONING: The LLM attempts to synthesize across 2022 and 2023 filings but the reasoning is weakened by potentially fabricated citations and a slightly different framing of the strategic shift. The core insight about strategic focus is present but not precisely aligned with the ground truth's emphasis on full-stack platform development.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 548,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Pfizer's financial relationship with Viatris evolve between 2022 and 2023, particularly in terms of supply agreements and outstanding balances?",
      "original_answer": "In 2022, Pfizer reported $780 million in revenue growth from PC1, primarily reflecting manufacturing of legacy Upjohn products for Viatris under supply agreements. By 2023, the financial relationship had evolved, as indicated by the net amounts due to Viatris under various agreements, which decreased from $94 million as of December 31, 2022, to $33 million as of December 31, 2023. Additionally, most transitional services under the TSAs were completed by the end of 2023, signaling a reduction in operational interdependence.",
      "llm_answer": "\nBetween 2022 and 2023 the post‑spin‑off financial ties with Viatris were wound down.  The amount Pfizer owed Viatris under the interim rebate‑ and MSA‑related arrangements fell from **$94 million at the end of 2022 to about $33 million at the end of 2023**, reflecting the completion of the transitional TSAs and the settlement of those balances.  The longer‑term supply agreements (four‑to‑seven‑year MSAs that govern manufacturing, labeling and packaging for each other) remain in force, but their financial impact has largely run off, leaving only a modest outstanding balance.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong quantitative accuracy with correct dollar amounts ($94 million in 2022, $33 million in 2023) and proper date references (end of 2022 and 2023). The multi-hop synthesis is sound, correctly connecting the decrease in outstanding balances to the completion of transitional services agreements (TSAs). However, there is a notable omission: the ground truth specifically mentions $780 million in revenue growth from PC1 in 2022, reflecting manufacturing of legacy Upjohn products for Viatris under supply agreements. The LLM answer does not address this revenue component at all, which was explicitly part of the original answer's characterization of the financial relationship evolution. The LLM does correctly identify that longer-term MSAs remain in force but with reduced financial impact. The answer appropriately distinguishes between interim rebate/MSA-related arrangements (which decreased) and longer-term supply agreements (which remain). The reasoning about 'winding down' post-spin-off ties is logically sound and well-supported by the data presented. The semantic equivalence is generally good, though the omission of the PC1 revenue figure represents incomplete coverage of the original answer's scope. The answer would have been 9-10 if it had included the $780 million revenue reference from 2022.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 374,
        "total_tokens": 1653
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has the treatment and disclosure of communications sites in relation to debt obligations evolved between 2023 and 2024?",
      "original_answer": "In 2023, communications sites were explicitly referenced as collateral securing debt obligations, such as the 3,343 communications sites securing the Series 2015-2 Notes and the repayment of $1.3 billion in Series 2013-2A Notes funded by the 2023 Securitization. In 2024, while there was no explicit mention of specific communications sites securing debt, the company disclosed broader financial commitments, such as $4.5 billion in estimated undiscounted future cash outlay for asset retirement obligations as of December 31, 2024. This shift indicates a move from site-specific debt disclosures to more general obligations, suggesting a change in how communications sites are framed in relation to financial liabilities.",
      "llm_answer": "\nIn the 2023 filing the company depreciated tower assets over a maximum 20‑year useful life and disclosed that cash flows from communications sites secure its securitized debt, but it did not highlight any change in that depreciation basis. By 2024 the company revised the estimated useful life of towers to 30 years, which increased right‑of‑use assets and lease liabilities, reduced depreciation expense, and explicitly identified the change as a critical audit matter; the 2024 disclosures also more directly tie site‑related lease renewals and cash‑flow risks to debt covenants and present detailed tables of debt maturities and operating‑lease obligations.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer addresses a different aspect of the question than the ground truth and contains significant factual errors. CRITICAL ISSUES: (1) The LLM discusses depreciation/useful life changes (20 years to 30 years) which is NOT mentioned in the ground truth answer at all. This appears to be fabricated or from a different company/context. (2) The ground truth specifically mentions 3,343 communications sites securing Series 2015-2 Notes and $1.3 billion in Series 2013-2A Notes - the LLM provides no such specific numbers. (3) The ground truth mentions $4.5 billion in asset retirement obligations as of December 31, 2024 - the LLM does not reference this figure. (4) The LLM's core claim about a shift from 20-year to 30-year useful lives cannot be verified against the ground truth and appears to be incorrect information. (5) While the LLM correctly identifies that there was a shift in disclosure approach between 2023 and 2024, it attributes this to depreciation policy changes rather than the actual shift from site-specific debt collateral disclosures to broader financial obligation disclosures. QUANTITATIVE ACCURACY: The specific numbers provided in the ground truth (3,343 sites, $1.3 billion, $4.5 billion) are completely absent from the LLM answer, and the numbers the LLM does provide (20 years, 30 years) cannot be verified as correct. QUALITATIVE ACCURACY: The LLM misidentifies the nature of the evolution - it focuses on depreciation/useful life changes rather than collateral disclosure changes. CONTEXTUAL RELEVANCE: While the answer discusses communications sites and debt obligations, it addresses the wrong evolution and introduces unverified claims about accounting policy changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 466,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Comcast's approach to retransmission consent agreements evolved between 2022 and 2023, particularly in terms of revenue recognition and distribution models?",
      "original_answer": "In 2022, Comcast recognized revenue from retransmission consent agreements on a monthly basis as programming was provided, with fees tied to the number of subscribers and generally collected within 60 days. By 2023, the company's Media segment emphasized a combined linear and streaming distribution model, with retransmission fees now explicitly including both traditional and virtual multichannel video providers. The 2023 filing also highlighted a broader integration of Peacock into the distribution ecosystem, suggesting a strategic shift toward hybrid distribution models that blend traditional and streaming services.",
      "llm_answer": "\nComcast’s 2023 10‑K (pp. 18 & 10) makes clear that it still pays local broadcast stations for retransmission‑consent but now stresses that renewal will be subject to “increased payments and other concessions” and that the fees are recorded as part of distribution revenue recognized monthly over multiyear agreements.  In contrast, the 2022 filing (p. 93) mentioned the same fees only in passing and did not highlight the renewal risk or the monthly‑recognition treatment.  Thus, between 2022 and 2023 the company shifted from a generic reference to a more explicit accounting and risk‑focused approach to retransmission‑consent revenue.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misinterpretations that diverge substantially from the ground truth. Key issues: (1) FUNDAMENTAL MISUNDERSTANDING: The LLM discusses Comcast PAYING broadcast stations for retransmission consent, when the ground truth clearly indicates Comcast RECEIVES revenue FROM retransmission consent agreements. This is a critical reversal of the business relationship. (2) MISSING CORE EVOLUTION: The ground truth emphasizes a strategic shift toward hybrid distribution models integrating Peacock and combining linear and streaming services. The LLM completely omits this crucial evolution and instead focuses on payment risk and accounting treatment. (3) INCOMPLETE SYNTHESIS: The ground truth identifies specific changes in distribution models (traditional vs. virtual multichannel video providers, Peacock integration). The LLM provides generic accounting observations without addressing the distribution model evolution that is central to the question. (4) QUESTIONABLE SPECIFICITY: The LLM cites specific page numbers (pp. 18 & 10 for 2023; p. 93 for 2022) but these citations cannot be verified against the ground truth, and the content described doesn't align with the actual filing information. (5) REVENUE DIRECTION ERROR: The ground truth discusses revenue recognition FROM retransmission consent agreements (Comcast's revenue source), while the LLM discusses payments TO broadcast stations (Comcast's expense), suggesting a fundamental misreading of the filings. The answer does correctly identify that revenue is recognized monthly, but this minor accuracy is overshadowed by the major directional error and omission of the strategic distribution model shift that is the heart of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 476,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Caterpillar's involvement in the production and strategic positioning of diesel-electric locomotives evolved from 2023 to 2024?",
      "original_answer": "In 2023, Caterpillar's involvement in diesel-electric locomotives was described as part of its broader ME&T segment, which included responsibilities such as remanufacturing Caterpillar reciprocating engines and components, as well as providing product support for on-highway vocational trucks in North America. By 2024, Caterpillar's engagement had evolved into a more defined production role under the Energy & Transportation segment, which explicitly stated that Caterpillar 'produces' diesel-electric locomotives and components, signaling a more direct and strategic emphasis on this product line. Additionally, in 2024, Caterpillar highlighted competitive pressures in rail-related businesses, naming companies like Wabtec Corp and Siemens Mobility A/S, which was not present in 2023. This indicates a shift from a general operational inclusion to a more prominent and competitive product focus.",
      "llm_answer": "\nCaterpillar still includes diesel‑electric locomotives and related components in its Energy & Transportation segment, but the 2024 discussion shows a clear shift from selling new units toward a service‑focused strategy—highlighting remanufacturing, leasing and aftermarket support of locomotives and related rail products (see page 6 and page 39).  This repositioning is reflected in the modest 4 % rise in Transportation‑segment sales, which the company attributes to stronger rail‑service revenue and favorable price realization rather than growth in new locomotive shipments, indicating that Caterpillar’s involvement has evolved from pure production to a strategic emphasis on value‑added services and fleet support.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations compared to the ground truth. Key issues: (1) INCORRECT STRATEGIC SHIFT: The LLM claims Caterpillar shifted from 'pure production to a strategic emphasis on value-added services and fleet support,' but the ground truth explicitly states the opposite—that Caterpillar's involvement evolved INTO 'a more defined production role' with explicit language that Caterpillar 'produces' diesel-electric locomotives. This is a fundamental mischaracterization of the evolution. (2) MISSING CRITICAL INFORMATION: The LLM completely omits the key finding that Caterpillar identified specific competitors (Wabtec Corp and Siemens Mobility A/S) in 2024 that were not mentioned in 2023, which is central to understanding the strategic shift. (3) UNVERIFIED CLAIMS: The LLM cites a '4% rise in Transportation-segment sales' and attributes it to 'rail-service revenue' rather than new locomotive shipments, but this specific percentage and attribution are not present in the ground truth and appear to be fabricated or misinterpreted. (4) SEGMENT NAMING: While the LLM correctly identifies the 'Energy & Transportation segment,' it fails to note the segment name change from 'ME&T' in 2023 to 'Energy & Transportation' in 2024, which is part of the evolution. (5) SEMANTIC INVERSION: The core narrative is inverted—the ground truth shows increased emphasis on production and competitive positioning, while the LLM describes a shift away from production toward services. This represents a fundamental misunderstanding of the multi-hop synthesis required. The answer demonstrates poor multi-hop reasoning and introduces unsupported quantitative claims.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 465,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has McDonald's relationship with its franchisees evolved in terms of revenue recognition and cost-sharing arrangements between 2023 and 2024?",
      "original_answer": "In 2023, McDonald's revenue from franchisees primarily included rent and royalties based on a percentage of sales with minimum rent payments, and initial fees. The company also mentioned that all restaurants were either operated by McDonald's or by franchisees under franchised arrangements. By 2024, the revenue recognition model remained consistent, but the company provided more detailed disclosures on how it recognizes revenue from franchisees, including the treatment of technology platform fees, which are now presented on a gross basis on the Consolidated Statement of Income. Additionally, in 2024, McDonald's clarified its cost-sharing arrangements for restaurant improvements, where it may fund certain projects and allocate costs between Property and Equipment and Accounts Receivable during the project, finalizing the allocation upon completion. This level of detail on cost-sharing was not present in the 2023 filing, indicating a more nuanced and transparent approach to franchisee financial interactions in 2024.",
      "llm_answer": "\nBetween 2023 and 2024 McDonald’s kept the traditional rent‑and‑royalty model for franchisees but added new, explicitly‑identified revenue streams – gross‑recognized fees for technology‑platform services and brand‑licensing royalties – and clarified that initial franchise fees are amortized over the contract term.  At the same time, the company formalized cost‑sharing for restaurant improvements by allocating those costs between property‑and‑equipment and accounts‑receivable (and adjusting depreciation), and reiterated that advertising‑cooperative contributions remain expense‑based and are not consolidated.  In short, the franchise‑revenue mix broadened and the cost‑sharing arrangements were made more structured and transparent in 2024 versus 2023.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core evolution between 2023 and 2024: (1) the traditional rent-and-royalty model remained consistent, (2) technology platform fees are now presented on a gross basis, (3) cost-sharing arrangements for restaurant improvements were clarified with allocation between Property and Equipment and Accounts Receivable. The answer appropriately captures the increased transparency and detail in 2024 disclosures. The semantic framing of 'broadened franchise-revenue mix' and 'more structured and transparent' aligns with the ground truth's characterization.\n\nWEAKNESSES: (1) The LLM introduces claims not explicitly supported by the ground truth: 'brand-licensing royalties' as a new revenue stream is not mentioned in the original answer; 'initial franchise fees are amortized over the contract term' is stated as a 2024 clarification but the ground truth only mentions 'initial fees' in 2023 without specifying amortization treatment; 'advertising-cooperative contributions remain expense-based and are not consolidated' is entirely absent from the ground truth. (2) The answer adds specificity about 'adjusting depreciation' which, while plausible, is not explicitly stated in the ground truth. (3) The claim about 'brand-licensing royalties' as a new explicit revenue stream in 2024 appears to be an inference not supported by the provided ground truth.\n\nMULTI-HOP REASONING: The answer correctly synthesizes the comparison between 2023 and 2024 across revenue recognition and cost-sharing dimensions. However, it introduces elements (brand-licensing royalties, advertising-cooperative treatment, amortization specifics) that either go beyond or contradict what can be verified from the ground truth.\n\nNUMERIC/FACTUAL VERIFICATION: No specific dollar amounts or percentages are provided in either answer, so quantitative accuracy cannot be directly verified. The factual claims about revenue streams and cost-sharing arrangements are partially correct but include unsupported additions.\n\nJUSTIFICATION: The answer demonstrates good understanding of the overall evolution but overstates its knowledge by introducing details not in the ground truth. This represents a moderate accuracy issue - the core narrative is sound, but the addition of unverified claims (particularly brand-licensing royalties and advertising-cooperative treatment) reduces confidence in the response's reliability.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 649,
        "total_tokens": 2096
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Southern Company's approach to executive equity compensation evolved between 2023 and 2024, particularly regarding plan documentation and award terms?",
      "original_answer": "In 2023, Southern Company disclosed that stock-based compensation, primarily in the form of performance share units (PSUs) and restricted stock units (RSUs), was granted under the Equity and Incentive Compensation Plan to employees ranging from line management to executives. By 2024, the company formalized the terms for Named Executive Officer equity awards under the same plan, indicating a more structured approach to executive compensation. Additionally, the 2024 filing included detailed documentation practices, such as the designation of specific exhibits for equity award terms, which was not present in the 2023 filing. This reflects a shift toward greater specificity and transparency in executive equity compensation documentation.",
      "llm_answer": "\nBetween 2023 and 2024 Southern Company updated the documentation governing its executive equity awards by adopting a ninth amendment to the Employee‑Savings Plan (dated December 16 2024) and revising the Equity and Incentive Compensation Plan to reflect new award terms for named officers. The revised terms now provide for immediate vesting of performance‑share units and restricted‑stock units upon retirement eligibility and require forfeitures to be recognized as they occur, marking a clear evolution in both plan documentation and award conditions from the 2023 framework.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that diverge substantially from the ground truth. (1) CRITICAL ERRORS: The LLM introduces information about a 'ninth amendment to the Employee-Savings Plan (dated December 16 2024)' which is not mentioned in the ground truth answer. The ground truth focuses on the Equity and Incentive Compensation Plan, not the Employee-Savings Plan. This represents a fundamental misidentification of the relevant plan. (2) QUANTITATIVE ACCURACY: The date 'December 16 2024' is introduced without verification against the ground truth, and the reference to a 'ninth amendment' is unsubstantiated. These specific claims cannot be verified and appear to be hallucinated details. (3) QUALITATIVE ACCURACY: While the LLM correctly identifies that Southern Company updated equity compensation documentation between 2023 and 2024, it mischaracterizes the nature of the changes. The ground truth emphasizes formalization of terms for Named Executive Officers and improved documentation practices/transparency. The LLM instead focuses on specific vesting provisions (immediate vesting upon retirement eligibility) and forfeiture recognition, which are not mentioned in the ground truth. (4) MULTI-HOP REASONING: The LLM fails to properly synthesize the evolution described in the ground truth. The ground truth indicates a shift toward 'greater specificity and transparency in executive equity compensation documentation' with 'detailed documentation practices, such as the designation of specific exhibits.' The LLM's answer about vesting and forfeiture terms, while potentially relevant to equity compensation, does not align with the documented evolution described in the ground truth. (5) MISSING ELEMENTS: The LLM answer omits the key point about PSUs and RSUs being the primary forms of compensation, and fails to capture the emphasis on formalization and transparency that characterizes the 2023-2024 evolution. The answer appears to conflate or confuse different plan amendments and introduces unverified specific terms.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 553,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Procter & Gamble's strategic reliance on membership club stores evolved from 2022 to 2024, and what does this shift indicate about the company's broader retail channel strategy?",
      "original_answer": "In 2022, Procter & Gamble identified membership club stores as one of its key retail channels, listing them among a broad set of distribution partners such as mass merchandisers, grocery stores, and e-commerce platforms. However, by 2024, the company's language shifted to emphasize dependency on these membership club stores, indicating a deeper strategic alignment or increased reliance on this channel. This evolution suggests that membership club stores have become more central to P&G's distribution and retail execution strategy, likely reflecting growth in this channel's importance to consumer purchasing behavior and overall market dynamics.",
      "llm_answer": "\nFrom 2022 to 2024 P&G moved away from treating membership‑club stores as a core growth pillar.  The 2022 filing lists “membership club stores” among its key retail customers, but the 2024 disclosures stress that evolving sales channels—especially e‑commerce and hard‑discounter formats—are now the primary levers for growth and that the company must manage trade terms with a more diversified retail base.  This shift reflects a broader strategy to reduce dependence on any single wholesale format and to leverage higher‑margin, higher‑control channels such as online and direct‑to‑consumer sales.",
      "correctness_score": 2,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is fundamentally contradictory to the ground truth and represents a major factual error. Ground truth states that P&G's reliance on membership club stores INCREASED from 2022 to 2024, with language shifting to emphasize 'dependency' and indicating these stores became 'more central' to distribution strategy. The LLM answer claims the opposite: that P&G 'moved away from treating membership-club stores as a core growth pillar' and reduced dependence on this channel. This is a direct contradiction of the established fact pattern. The LLM correctly identifies that 2022 and 2024 are the relevant years and that e-commerce and other channels are mentioned, but it inverts the core finding about membership club stores. The reasoning about diversification and higher-margin channels may be plausible business logic, but it contradicts what the actual filings show about P&G's evolving strategic reliance on membership clubs. The answer demonstrates a failure in multi-hop synthesis - it appears to have misread or misinterpreted the directional shift in P&G's strategic emphasis. No quantitative errors exist (no specific numbers were provided to verify), but the qualitative interpretation is entirely incorrect, making this answer fundamentally unreliable for decision-making.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 362,
        "total_tokens": 1684
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did AMT's involvement with Nigeria Letters of Credit evolve between 2023 and 2024, and what does this indicate about its financial obligations related to this instrument?",
      "original_answer": "In 2023, AMT had a $3.4 million obligation under the Nigeria Letters of Credit as part of its variable rate debt portfolio. However, by 2024, this obligation was no longer present, as indicated by the $0 carrying value in both denominated currency and USD. This indicates that AMT fully settled or otherwise exited its financial obligations tied to Nigeria Letters of Credit within this period.",
      "llm_answer": "\nBetween the end of 2023 and the end of 2024 the company’s reported Nigeria Letters of Credit dropped from a $3.4 million carrying value (as of Dec 31 2023) to $0 million (no carrying value disclosed in the 2024 filings). The 2024 documents note that any draws on these letters of credit bear interest at SOFR + a spread and are due 270 days after drawing, indicating that the prior off‑balance‑sheet commitment was fully drawn, expired or otherwise settled, leaving no remaining financial obligation tied to the Nigeria Letters of Credit at year‑end 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and well-reasoned. STRENGTHS: (1) All key numbers are accurate - correctly identifies the $3.4 million obligation in 2023 and $0 in 2024. (2) The temporal comparison is precise and clearly stated. (3) The answer correctly synthesizes the multi-hop information showing the evolution between years. (4) The conclusion that AMT 'fully settled or otherwise exited' its obligations is sound and matches the ground truth. (5) The additional context about SOFR + spread and 270-day terms adds relevant detail about the instrument's mechanics. MINOR CONSIDERATIONS: (1) The LLM answer includes additional interpretive language ('prior off-balance-sheet commitment was fully drawn, expired or otherwise settled') that goes slightly beyond the ground truth statement, though this is reasonable inference from the data and not contradictory. (2) The phrasing 'no carrying value disclosed in the 2024 filings' is semantically equivalent to the ground truth's '$0 carrying value' - both convey the same information. (3) The answer demonstrates solid multi-hop reasoning by connecting the 2023 obligation, the 2024 absence, and the instrument's terms to reach a logical conclusion about settlement. The quantitative accuracy is high with all dollar amounts and years correct. The qualitative reasoning is sound, properly identifying this as a settlement/exit event rather than a mere accounting change.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 396,
        "total_tokens": 1640
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the valuation methodology and composition of GD's Retirement Annuity Contracts change between 2022 and 2024, and what does this indicate about the company's approach to reporting these assets?",
      "original_answer": "In 2022, GD reported Retirement Annuity Contracts as part of Level 3 assets with a fair value of $35 million as of December 31, 2021, and this value remained relatively stable through December 31, 2020 at $38 million. The contracts were disclosed within a detailed table showing actual returns, unrealized gains and losses, and net purchases or sales. By 2024, Retirement Annuity Contracts were still categorized under Level 3 assets but were now described as being valued using NAV (net asset value) as a practical expedient, excluded from the formal fair value hierarchy. This indicates a shift in GD's reporting methodology from detailed fair value disclosures to a more simplified NAV-based approach, aligning with broader changes in how these contracts are categorized and disclosed.",
      "llm_answer": "\nBetween 2022 and 2024 the Retirement Annuity Contracts stayed in the Level 3 category—i.e., they were valued using significant unobservable inputs and were not priced in an active market.  In the 2022 filing the contracts appeared only as part of a generic “Other investments” line with a reported balance of about $35 million, whereas the 2024 filing presents them as a separate “Retirement annuity contracts” line item with a lower fair‑value of roughly $22 million.  This change shows that General Dynamics continues to rely on internal, non‑market‑observable valuation methods and adjusts the reported amount as its assumptions evolve, reflecting a conservative and relatively opaque approach to reporting these retirement‑related assets.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its credibility:\n\n1. QUANTITATIVE ACCURACY FAILURES:\n   - The LLM claims 2024 fair value is \"roughly $22 million\" but provides no source verification. The ground truth does not mention a $22 million figure for 2024.\n   - The LLM states 2022 balance was \"about $35 million\" which aligns with ground truth ($35 million as of Dec 31, 2021), but this is presented as 2022 data when it's actually 2021 data.\n   - The LLM provides no specific 2024 valuation figure, making the comparison incomplete and potentially inaccurate.\n\n2. METHODOLOGY MISCHARACTERIZATION:\n   - The ground truth explicitly states that by 2024, the contracts were \"valued using NAV (net asset value) as a practical expedient, excluded from the formal fair value hierarchy.\"\n   - The LLM incorrectly claims they \"stayed in the Level 3 category\" in 2024, which contradicts the ground truth's statement that they were \"excluded from the formal fair value hierarchy\" by 2024.\n   - This is a fundamental error in understanding the key change between 2022 and 2024.\n\n3. DISCLOSURE STRUCTURE ERROR:\n   - The LLM claims in 2022 the contracts appeared \"only as part of a generic 'Other investments' line\" but the ground truth indicates they were disclosed \"within a detailed table showing actual returns, unrealized gains and losses, and net purchases or sales.\"\n   - The LLM's characterization of the 2022 disclosure as generic and undifferentiated contradicts the ground truth's description of detailed disclosures.\n\n4. MISSING KEY INSIGHT:\n   - The ground truth emphasizes the shift from \"detailed fair value disclosures to a more simplified NAV-based approach\" and exclusion from the hierarchy.\n   - The LLM misses this critical methodological shift and instead focuses on Level 3 categorization remaining constant, which is incorrect.\n\n5. REASONING QUALITY:\n   - The LLM's conclusion about \"conservative and relatively opaque approach\" may be reasonable inference, but it's built on incorrect factual premises about the 2024 methodology.\n   - The multi-hop synthesis fails because the core change (NAV-based approach and exclusion from hierarchy) is not captured.\n\nThe answer demonstrates partial understanding of the general topic but fails on the specific, verifiable facts that are central to answering the question correctly.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 639,
        "total_tokens": 2035
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How has the composition and value of restricted cash for securitization investors changed between 2022 and 2024, particularly in terms of its fair value hierarchy classification?",
      "original_answer": "In 2022, the company reported restricted cash for securitization investors as part of consolidated VIEs, with the assets and liabilities presented on the consolidated balance sheets. By 2024, the restricted cash for securitization investors was valued at $441 million, with the entire amount classified under Level 1 of the estimated fair value hierarchy, indicating a shift toward more transparent or market-based valuation methods. This reflects a more defined and standardized valuation approach in 2024 compared to 2022, where the fair value hierarchy was not explicitly detailed for this category.",
      "llm_answer": "\nBetween the end of 2022 and the end of 2024 the balance of restricted cash held for securitization investors slipped modestly—from roughly **$460 million** (carrying/fair‑value amount disclosed in the 2022 filing) to **$441 million** in 2024.  In both years the cash is valued at quoted market price with no adjustments, so it remains classified as a **Level 1** item in the fair‑value hierarchy (quoted price in an active market, no Level 2 or Level 3 inputs).  The decline reflects the normal runoff of the securitized loan portfolios rather than a change in how the cash is measured.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy with minor discrepancies. STRENGTHS: (1) Correctly identifies the 2024 value of $441 million for restricted cash for securitization investors, matching the ground truth exactly. (2) Accurately characterizes both years' classification as Level 1 in the fair value hierarchy, indicating quoted market prices with no adjustments. (3) Provides sound multi-hop reasoning by synthesizing information about valuation methodology consistency across both years. (4) Appropriately explains the decline as portfolio runoff rather than a measurement change, showing good contextual understanding. (5) Addresses all parts of the question regarding composition, value, and fair value hierarchy classification. MINOR ISSUES: (1) The 2022 figure is stated as 'roughly $460 million' in the LLM answer versus the ground truth which does not explicitly state a 2022 amount but implies the company reported restricted cash for securitization investors. The LLM's $460 million figure appears reasonable as an approximation but cannot be verified against the ground truth provided. (2) The ground truth notes that 'fair value hierarchy was not explicitly detailed for this category' in 2022, while the LLM states both years were classified as Level 1. This represents a potential inconsistency—the LLM may be inferring 2022 Level 1 classification when the ground truth suggests it wasn't explicitly detailed. This is a meaningful distinction regarding the shift in disclosure practices. QUANTITATIVE VERIFICATION: The 2024 figure of $441 million is correct. The 2022 approximate figure of $460 million cannot be directly verified but is presented as an approximation ('roughly'). The decline calculation ($460M to $441M = ~$19M or ~4% decline) is mathematically sound. QUALITATIVE ASSESSMENT: The reasoning about Level 1 classification and portfolio runoff is logical and well-explained, though the assertion that both years used Level 1 classification may overstate the comparability given the ground truth's note about 2022 lacking explicit hierarchy detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 561,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How has McDonald's relationship with its franchisees evolved in terms of financial recognition and asset management between 2023 and 2024?",
      "original_answer": "In 2023, McDonald's relationship with franchisees was primarily characterized by the acquisition of restaurants from franchisees, resulting in goodwill that was either fully or partially written off depending on the time of sale relative to acquisition. The Company used a discounted cash flow methodology to determine the fair value of acquired restaurants. By 2024, the relationship had transformed into a more dependency-based model, particularly in the area of technology platform services. McDonald's now provides distinct technology-related goods and services to franchisees, recognizing revenue on a gross basis and corresponding expenses within 'Other restaurant expenses.' This marks a shift from asset acquisition and goodwill management toward ongoing service-based financial interactions with franchisees.",
      "llm_answer": "\nBetween 2023 and 2024 McDonald’s accelerated the disposal of under‑performing locations, recording higher gains on sales of restaurant businesses (up from $‑103 million in 2023 to $‑94 million in 2024) and a rise in net asset‑disposition expense (from $‑7 million to $100 million).  The company also applied its goodwill‑write‑off policy more aggressively—goodwill from restaurants purchased from franchisees is now written off entirely if the outlet is sold within 24 months and only proportionally thereafter—resulting in a drop in accumulated goodwill impairment to $1 million (2024) from $15 million (2023).  This shift reflects a move from retaining Company‑owned assets to a franchise‑centric model where financial recognition increasingly comes from sales to franchisees and the associated goodwill/impairment accounting.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations that fundamentally diverge from the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM cites specific financial figures (gains on sales of $-103M in 2023 to $-94M in 2024, net asset-disposition expense from $-7M to $100M, accumulated goodwill impairment dropping from $15M to $1M) that are not supported by the ground truth and appear to be fabricated or misattributed. The negative signs on gains are also logically inconsistent. (2) CONCEPTUAL MISALIGNMENT: The ground truth describes a shift FROM asset acquisition/goodwill management TO service-based financial interactions (technology platform services recognized on a gross basis). The LLM instead describes a shift toward 'franchise-centric model' focused on 'sales to franchisees' and goodwill accounting, which contradicts the ground truth's emphasis on technology services and revenue recognition changes. (3) MISSING KEY INFORMATION: The LLM completely omits the critical evolution described in the ground truth—the introduction of distinct technology-related goods and services to franchisees with gross revenue recognition and corresponding expense treatment. This is the core transformation between 2023-2024. (4) REASONING FAILURE: The LLM's multi-hop synthesis is flawed. It focuses on asset disposition and goodwill impairment mechanics rather than the fundamental shift in the nature of McDonald's financial relationship with franchisees (from transactional asset purchases to ongoing service provision). (5) ACCURACY OF CHARACTERIZATION: The ground truth emphasizes 'dependency-based model' and 'technology platform services' as the 2024 evolution, while the LLM emphasizes disposal acceleration and goodwill write-off policy changes—these are different narratives. The LLM answer appears to describe a different aspect of McDonald's operations or potentially conflates different time periods or metrics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 527,
        "total_tokens": 1937
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How has the treatment of the 2019 Stock and Incentive Compensation Plan evolved between 2022 and 2024 in Procter & Gamble's disclosures, particularly regarding its relationship with other compensation plans and its role in equity compensation?",
      "original_answer": "In 2022, the 2019 Stock and Incentive Compensation Plan was disclosed as part of a broader set of compensation plans, with specific reference to its adoption by shareholders in 2019 and its regulation in conjunction with other plans like the 2014 Stock and Incentive Compensation Plan. By 2024, the 2019 Plan was still included in the list of active equity compensation plans, but it was now referenced in the context of security ownership and the total shares available for issuance, indicating a shift from adoption and governance details to its role in the company's overall equity compensation structure. This reflects a transformation in how the plan is positioned within the company's disclosures, moving from procedural governance to a more strategic ownership framework.",
      "llm_answer": "\nBetween fiscal 2022 and 2024 the 2019 Stock and Incentive Compensation Plan moved from being one of several active equity plans disclosed in the 2022 Exhibit (10‑27) list to the **sole plan that can issue future equity awards**.  The 2024 filing (Item 11 and the “Plan Category” table on page 68) notes that only the 2019 Plan permits new grants, caps the total shares available at 187 million (with full‑value awards counted as five shares each), and integrates stock‑option, SAR, RSU and performance‑stock units under a unified share‑counting rule.  Consequently, earlier plans such as the 2001, 1992 and 2014 Stock and Incentive Compensation Plans are now frozen, and the 2019 Plan’s terms—referenced in the 2021‑2024 proxy statements—are the primary vehicle for Procter & Gamble’s ongoing equity‑compensation program.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and unsupported claims that diverge substantially from the ground truth. Key issues: (1) MAJOR FACTUAL ERROR - The LLM claims the 2019 Plan is now the 'sole plan that can issue future equity awards' and that earlier plans (2001, 1992, 2014) are 'frozen.' The ground truth makes no such claim; it only states the 2019 Plan was 'still included in the list of active equity compensation plans' in 2024. The LLM has fabricated a narrative about plan consolidation not supported by the original answer. (2) UNSUPPORTED SPECIFICS - The LLM provides very specific details (187 million shares cap, five-share counting rule for full-value awards, Item 11 and page 68 references) that cannot be verified against the ground truth provided. While these may be accurate P&G facts, they go far beyond what the original answer states and appear to be hallucinated specifics. (3) MISCHARACTERIZATION OF EVOLUTION - The ground truth describes a shift from 'adoption and governance details to its role in the company's overall equity compensation structure' - a subtle repositioning in disclosure emphasis. The LLM instead claims a dramatic structural change (plan consolidation/freezing) that is not supported. (4) INCOMPLETE ALIGNMENT - The LLM does correctly identify that the 2019 Plan's role changed between 2022 and 2024, but the nature of that change is fundamentally misrepresented. The ground truth emphasizes disclosure framing changes; the LLM emphasizes operational/structural changes. (5) QUANTITATIVE ISSUES - The 187 million share figure and five-share counting rule are presented as fact but cannot be verified against the ground truth, making them potentially fabricated details. The answer demonstrates poor multi-hop reasoning by inventing a narrative structure (plan consolidation) rather than accurately synthesizing the actual evolution described in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 519,
        "total_tokens": 1943
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has Salvatore Ferragamo's presence in Simon Property Group's international outlet locations evolved between 2022 and 2023?",
      "original_answer": "In 2022, Salvatore Ferragamo was listed as a tenant in three of Simon Property Group's international outlet locations in Japan: Gotemba Premium Outlets, Kobe-Sanda Premium Outlets, and Sano Premium Outlets. By 2023, Salvatore Ferragamo appeared in only one of SPG's outlet locations, specifically Las Vegas Outlets North in Nevada, USA. This indicates a significant reduction in Salvatore Ferragamo's presence across SPG's outlet portfolio, shifting from multiple locations in Japan to a single location in the U.S.",
      "llm_answer": "\nSalvatore Ferragamo’s footprint in Simon Property Group’s overseas outlet portfolio was essentially unchanged from 2022 to 2023. The luxury brand remained listed among the tenants of the same international premium‑outlet centers—Japan’s Gotemba, Kobe‑Sanda, Rinku and Sano; Mexico’s Punta Norte; South Korea’s Yeoju; and Canada’s Montreal—with no new locations added or removed, indicating a stable presence across the two years.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on all key factual points. (1) FACTUAL ERRORS: The LLM claims Salvatore Ferragamo's presence was 'essentially unchanged' from 2022 to 2023, but the ground truth shows a significant reduction from 3 locations in 2022 to 1 location in 2023. (2) LOCATION ERRORS: The LLM lists six locations (Gotemba, Kobe-Sanda, Rinku, Sano in Japan; Punta Norte in Mexico; Yeoju in South Korea; Montreal in Canada), but the ground truth specifies only three Japanese locations in 2022 (Gotemba, Kobe-Sanda, Sano) and one U.S. location in 2023 (Las Vegas Outlets North in Nevada). The LLM incorrectly includes Rinku, Punta Norte, Yeoju, and Montreal—none of which appear in the ground truth. (3) GEOGRAPHIC MISCHARACTERIZATION: The ground truth shows a shift FROM Japan TO the U.S., but the LLM describes a stable international presence across multiple countries. (4) QUANTITATIVE ACCURACY: The LLM fails to capture the critical metric: a reduction from 3 to 1 location, representing a 67% decrease in presence. (5) MULTI-HOP REASONING: The LLM failed to correctly synthesize the year-over-year comparison required by the question. The answer is contextually relevant to the question asked but is entirely incorrect in its factual content and conclusions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 366,
        "total_tokens": 1598
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has COP's natural gas position in the Asia Pacific/Middle East region evolved from 2023 to 2024, and what does this indicate about its operational focus in the region?",
      "original_answer": "In 2023, COP reported 312 billion cubic feet of natural gas in the Asia Pacific/Middle East region, while in 2024, this figure slightly decreased to 296 billion cubic feet. This indicates a minor reduction in natural gas reserves in the region, suggesting a potential shift or stabilization in operational focus rather than aggressive growth.",
      "llm_answer": "\nFrom the end‑2023 to the end‑2024 reporting periods the company’s reported natural‑gas volume in the Asia Pacific/Middle East fell from about **312 billion cubic feet (BCF)** to **≈296 BCF**—a decline of roughly **5 %**.  The modest reduction, coupled with stable gas production and a continued emphasis on oil‑focused projects elsewhere, indicates that ConocoPhillips is scaling back its natural‑gas focus in that region and reallocating capital toward higher‑margin oil assets and other geographies.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct numerical data and calculations. Quantitative verification: 2023 figure of 312 BCF is correct, 2024 figure of 296 BCF is correct, and the calculated decline of approximately 5% is accurate (16 BCF / 312 BCF ≈ 5.1%). The time period (end-2023 to end-2024) is correctly identified. Entity accuracy is solid - COP/ConocoPhillips is correctly identified, the Asia Pacific/Middle East region is properly specified, and natural gas volumes are the appropriate metric. The LLM answer goes beyond the ground truth by providing additional interpretation about capital reallocation toward oil assets and higher-margin projects. While this interpretation is reasonable and contextually relevant, it introduces some inference not explicitly stated in the ground truth. The ground truth uses more cautious language ('potential shift or stabilization') while the LLM uses more definitive language ('scaling back,' 'reallocating capital'). Both convey similar meaning but with different levels of certainty. The multi-hop reasoning is sound - the answer correctly synthesizes the year-over-year comparison and draws logical conclusions about operational focus. Minor deduction due to the LLM's slightly more assertive interpretation compared to the more measured ground truth language, though the core factual content and calculations are accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 388,
        "total_tokens": 1605
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has Comcast's approach to wireless gateways evolved from 2022 to 2024, particularly in terms of strategic emphasis and investment?",
      "original_answer": "In 2022, Comcast offered wireless gateways as part of its broadband services, combining modem and Wi-Fi router capabilities to enhance in-and-out-of-home coverage. The focus was on customer-facing features like the xFi whole-home application and advanced security. By 2024, the company elevated its strategic emphasis by shifting from merely offering wireless gateways to actively investing in their deployment as part of its broader network infrastructure upgrades. This included plans to increase capacity and deliver multigigabit symmetrical speeds, signaling a deeper integration of wireless gateways into its long-term network strategy.",
      "llm_answer": "\nFrom 2022 to 2024 Comcast moved away from cutting back on customer‑premise equipment spend and toward a deliberate strategic focus on next‑generation wireless gateways.  In the 2022 filing the company noted only a modest decline in CPE capital outlays, but by the 2024 filing it explicitly earmarks ongoing investment in “the continued deployment of wireless gateways” as part of its scalable‑infrastructure and multigigabit network upgrade, signaling that these gateways are now a core component of its connectivity platform and a priority for future capital spending.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures the general directional shift in Comcast's wireless gateway strategy from 2022 to 2024, correctly identifying a move toward greater strategic emphasis and investment. However, there are several issues with accuracy and specificity:\n\n1. QUANTITATIVE ACCURACY ISSUES:\n   - The LLM mentions \"modest decline in CPE capital outlays\" in 2022 but provides no specific numbers or percentages. The ground truth does not reference this metric, and the LLM appears to have introduced unsupported quantitative claims.\n   - No specific dollar amounts, percentages, or measurable investment figures are provided to substantiate the claimed shift in investment levels.\n   - The claim about \"moving away from cutting back on customer-premise equipment spend\" is vague and lacks supporting data.\n\n2. FACTUAL ALIGNMENT:\n   - The LLM correctly identifies the 2022-2024 timeframe and the shift toward greater strategic emphasis.\n   - The mention of \"multigigabit symmetrical speeds\" and \"scalable infrastructure\" aligns with the ground truth.\n   - The characterization of wireless gateways as \"core component of its connectivity platform\" is consistent with the ground truth's description of \"deeper integration.\"\n\n3. MISSING ELEMENTS FROM GROUND TRUTH:\n   - The LLM does not mention the xFi whole-home application or advanced security features that were emphasized in 2022.\n   - The ground truth's specific reference to \"in-and-out-of-home coverage\" enhancement is absent from the LLM answer.\n   - The ground truth emphasizes the evolution from \"offering\" to \"actively investing in deployment,\" which the LLM captures but less clearly.\n\n4. MULTI-HOP REASONING:\n   - The LLM successfully synthesizes information across the 2022 and 2024 filings to show evolution.\n   - However, the reasoning relies on vague language (\"modest decline,\" \"explicitly earmarks\") without concrete evidence.\n   - The connection between CPE spending and wireless gateway investment strategy is implied but not clearly established.\n\n5. SEMANTIC ISSUES:\n   - The phrase \"moved away from cutting back\" is double-negative phrasing that could confuse rather than clarify.\n   - The LLM introduces the concept of CPE (customer-premise equipment) which, while potentially relevant, is not mentioned in the ground truth and may represent an inference rather than explicit filing content.\n\nOVERALL ASSESSMENT: The LLM answer demonstrates understanding of the directional shift but lacks the specificity, supporting details, and clarity of the ground truth. The introduction of unsupported quantitative claims (CPE capital outlays) and vague language reduces confidence in the answer's accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 717,
        "total_tokens": 2017
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has the G600's market presence and production evolution changed between 2022 and 2024, particularly in terms of cumulative deliveries and its role within Gulfstream's product lineup?",
      "original_answer": "In 2022, the G500 and G600 had cumulative deliveries totaling almost 150 by year-end 2021, and were described as replacements for the G450 and G550 models with improvements in speed, fuel efficiency, cabin volume, and flight controls. By 2024, cumulative deliveries of the G500 and G600 had more than doubled to over 300 by year-end 2024. Additionally, the G600 was no longer described in the context of being a new product introduction, indicating it had become a more established part of Gulfstream's lineup, while the focus shifted to newer models like the G800 and G400.",
      "llm_answer": "\nBetween the 2022 and 2024 filings the G600’s cumulative deliveries more than doubled – the 2022 filing notes “almost 150” aircraft delivered by the end of 2021, while the 2024 filing reports “more than 300” G500/G600 deliveries by the end of 2024, indicating a rapid production ramp‑up.  In Gulfstream’s product hierarchy the G600 continues to serve as the flagship ultra‑long‑range, large‑cabin model that bridges the G500 and the newer ultra‑long‑range G800 (and the upcoming G400), cementing its role as the cornerstone of Gulfstream’s high‑performance, high‑capacity jet lineup.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the key quantitative facts - cumulative deliveries of G500/G600 went from 'almost 150' by end of 2021 to 'more than 300' by end of 2024, representing a doubling. The numeric values and comparison are accurate. The LLM also correctly notes the shift in product positioning away from 'new product introduction' language.\n\nWEAKNESSES: (1) PRODUCT HIERARCHY MISCHARACTERIZATION: The LLM describes the G600 as 'the flagship ultra-long-range, large-cabin model that bridges the G500 and the newer ultra-long-range G800.' This is problematic because the ground truth indicates the G600 is a REPLACEMENT for the G550 (not a bridge between G500 and G800). The G500 and G600 are presented as paired replacements for the G450 and G550 respectively. The LLM's characterization of the G600's role in the lineup appears speculative and doesn't match the ground truth's description of it as a replacement model. (2) INCOMPLETE EVOLUTION NARRATIVE: The ground truth emphasizes that the G600 transitioned from being described as a 'new product introduction' with specific improvements (speed, fuel efficiency, cabin volume, flight controls) to becoming an 'established part of Gulfstream's lineup.' The LLM mentions the shift away from new product language but doesn't capture the specific improvements that defined the G600 in 2022. (3) FOCUS SHIFT NOT FULLY CAPTURED: While the LLM mentions the G800 and G400, it doesn't clearly articulate that the focus shifted TO these newer models, implying the G600 became less prominent in marketing/positioning. The LLM's framing suggests the G600 remains central ('cornerstone'), which contradicts the ground truth's implication that it became less prominent as newer models took focus.\n\nCALCULATION VERIFICATION: The doubling claim is accurate (150 to 300+ is indeed more than double). No calculation errors detected.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across 2022 and 2024 filings but makes an unsupported inference about the G600's role as a 'bridge' between models, which appears to be an extrapolation rather than grounded in the source material.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 577,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has AIG's financial relationship with Corebridge evolved between 2023 and 2024, particularly in terms of equity ownership and income recognition?",
      "original_answer": "In 2023, AIG held 52.2% of Corebridge common stock and was in the process of selling down its stake, with the intention to fully divest over time. By 2024, AIG had transitioned to accounting for its remaining interest in Corebridge using the equity method, recognizing pre-tax income based on dividends received and changes in Corebridge's stock price from June 9, 2024. This represents a shift from direct ownership control to a more passive investment approach, indicating a significant change in the nature of AIG's financial relationship with Corebridge.",
      "llm_answer": "\nBetween the end of 2023 and 2024 AIG’s stake in Corebridge fell from roughly 52 % of the common stock (as reported at 31 Dec 2023) to a smaller, post‑separation holding after it completed the de‑consolidation of Corebridge as a discontinued operation.  As a result, AIG now records the remaining interest under the equity method, recognizing income from dividends and the fair‑value changes of its Corebridge shares—$601 million of equity‑method income (dividends + stock‑price gains) for the June‑10‑to‑Dec‑31 2024 period and a $715 million net gain on the retained investment in 2024—whereas in 2023 the exposure was limited to consolidation and no equity‑method income was recorded.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core narrative of AIG's transition from consolidated ownership to equity method accounting for Corebridge, and correctly identifies the shift from 52% ownership in 2023 to a smaller stake post-separation. However, there are significant quantitative accuracy issues: (1) The LLM introduces specific dollar amounts ($601 million equity-method income for June 10-Dec 31 2024 period and $715 million net gain) that are NOT present in the ground truth answer. These numbers cannot be verified against the original answer and appear to be fabricated or from unverified sources. (2) The LLM states the date as 'June-10' when the ground truth specifies 'June 9, 2024' - a minor but notable discrepancy. (3) The LLM provides more granular detail about the accounting treatment (dividends + stock-price gains, discontinued operation classification) which is accurate and helpful, but goes beyond what the ground truth explicitly states. The qualitative reasoning is sound - the model correctly identifies the shift from consolidation to equity method accounting and understands the implications. The multi-hop synthesis is appropriate, connecting ownership percentage changes to accounting method changes. However, the introduction of unverified financial figures significantly undermines credibility. The answer is contextually relevant and addresses the question's core components about equity ownership evolution and income recognition changes, but the quantitative additions create factual uncertainty that cannot be validated against the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 432,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has Tesla's production strategy for the Solar Roof evolved between 2022 and 2024, particularly in terms of manufacturing dependencies and operational challenges?",
      "original_answer": "In 2022, Tesla was actively producing the Solar Roof at Gigafactory New York, which was specifically highlighted as a dedicated facility for the development and production of Solar Roof and other solar products. The company offered financing options tied to the Solar Roof, indicating a strategic push to integrate the product into its broader energy ecosystem. By 2024, Tesla's disclosures shifted to emphasize increased complexity and risk in ramping production of the Solar Roof, with explicit mention of 'delays in launching and/or ramping production of our energy storage products and Solar Roof.' The 2024 filing also highlighted broader operational dependencies, including the need to achieve 'design tolerances, high quality and output rates' across its manufacturing facilities, and noted potential disruptions due to supply chain coordination, localized procurement challenges, and the need for cost-effective scaling. This indicates a transition from a focused production setup in 2022 to a more complex and risk-laden ramp-up phase in 2024.",
      "llm_answer": "\nBetween 2022 and 2024 Tesla shifted Solar‑Roof production from a pilot‑scale, highly customized line at its Buffalo Gigafactory toward a more modular, volume‑oriented process that now shares equipment and supply‑chain infrastructure with its battery‑and‑energy‑storage factories.  This evolution deepened the company’s reliance on a narrow set of specialty suppliers for solar‑glass, high‑purity silicon cells and integrated roof‑tile components, while also increasing dependence on the Buffalo site’s specialized automation and on local hiring/training programs to meet the plant’s investment and workforce targets.  The tighter integration has created new operational challenges—most notably scaling the multi‑step, roof‑specific assembly line, managing limited‑source material constraints, and keeping production costs aligned with aggressive cost‑reduction goals while maintaining the high quality and regulatory compliance required for the product.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and unsupported claims that diverge substantially from the ground truth. Key issues: (1) LOCATION ERROR: The LLM states Solar Roof production shifted 'from a pilot-scale, highly customized line at its Buffalo Gigafactory' but the ground truth explicitly identifies 'Gigafactory New York' as the dedicated facility in 2022. Buffalo and New York are different locations. (2) UNSUPPORTED CLAIMS: The LLM introduces specific details not present in the ground truth, including: 'modular, volume-oriented process,' 'shares equipment and supply-chain infrastructure with battery-and-energy-storage factories,' 'specialty suppliers for solar-glass, high-purity silicon cells,' 'local hiring/training programs,' and 'aggressive cost-reduction goals.' These details appear fabricated rather than derived from the actual filings. (3) MISSING KEY INFORMATION: The LLM fails to capture the critical 2024 shift that the ground truth emphasizes—the explicit mention of 'delays in launching and/or ramping production' and the transition from a focused 2022 setup to a 'complex and risk-laden ramp-up phase' in 2024. (4) REASONING QUALITY: While the LLM attempts to construct a logical narrative about manufacturing evolution, it does so by inventing specific technical details rather than synthesizing actual filing disclosures. The multi-hop reasoning is fundamentally compromised because the underlying facts are incorrect or unsupported. (5) SEMANTIC DIVERGENCE: The ground truth emphasizes increased complexity and risk in 2024, while the LLM frames the evolution as a strategic shift toward 'volume-oriented' production with 'tighter integration'—a fundamentally different characterization. The ground truth indicates challenges and delays; the LLM suggests deliberate strategic evolution. This represents a material misrepresentation of Tesla's actual disclosures about Solar Roof production challenges.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1506,
        "completion_tokens": 525,
        "total_tokens": 2031
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has the presence of Dolce & Gabbana in SPG-operated properties evolved between 2022 and 2023, and what does this indicate about SPG's brand positioning strategy in its premium outlet locations?",
      "original_answer": "In 2022, Dolce & Gabbana was listed as a tenant in multiple SPG-operated premium outlets in Japan, including Gotemba Premium Outlets, Kobe-Sanda Premium Outlets, and Rinku Premium Outlets. By 2023, Dolce & Gabbana was only listed at Las Vegas Outlets North Premium NV in the U.S. This indicates a strategic shift from a multi-location presence in Japan to a more exclusive, flagship-style positioning in a key U.S. market, suggesting a reevaluation of brand placement and target demographics.",
      "llm_answer": "\nBetween 2022 and 2023 Dolce & Gabbana remained a consistent luxury tenant across SPG’s premium‑outlet portfolio, appearing in dozens of international sites (e.g., Mexico, South Korea, Japan, Canada and the United States) and being listed among the key brand selections in the 2023 International Properties table.  The continued—and slightly expanded—presence of this high‑end designer underscores SPG’s strategy of anchoring its premium outlets with upscale fashion labels to position the centers as premium shopping destinations that attract affluent consumers.",
      "correctness_score": 1,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on multiple critical dimensions: (1) FACTUAL ACCURACY: The ground truth clearly states that Dolce & Gabbana presence DECREASED from 2022 to 2023 (from multiple Japanese locations to only Las Vegas), but the LLM claims it 'remained consistent' and was 'slightly expanded.' This is a direct contradiction of the core finding. (2) SPECIFIC LOCATIONS: The ground truth identifies specific 2022 locations (Gotemba Premium Outlets, Kobe-Sanda Premium Outlets, Rinku Premium Outlets in Japan) and a single 2023 location (Las Vegas Outlets North Premium NV). The LLM vaguely references 'dozens of international sites' without specificity and fails to identify the actual locations mentioned in the ground truth. (3) STRATEGIC INTERPRETATION: The ground truth indicates a strategic SHIFT from multi-location Japan presence to exclusive U.S. flagship positioning, suggesting a reevaluation. The LLM incorrectly interprets this as evidence of 'continued and slightly expanded presence' and 'anchoring strategy,' which misses the actual strategic contraction and repositioning. (4) QUANTITATIVE CLAIMS: The LLM's claim of 'dozens of international sites' and 'slightly expanded presence' cannot be verified against the ground truth data and appears to be fabricated or hallucinated. The actual data shows a reduction from 3+ locations to 1 location. (5) MULTI-HOP REASONING: The LLM failed to properly synthesize the year-over-year comparison and draw the correct conclusion about brand positioning strategy. The answer demonstrates a fundamental misunderstanding of the question's requirement to track evolution/change between two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 464,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did COP's investment in exploration activities in the Asia Pacific/Middle East region evolve between 2023 and 2024, and what does this indicate about the company's strategic focus in that region?",
      "original_answer": "In 2023, COP reported $49 million in exploration expenditures in the Asia Pacific/Middle East region, while in 2024, the company disclosed a total of $0 in new exploration activities in that region. This indicates a complete withdrawal or pause in exploration efforts in the Asia Pacific/Middle East, suggesting a strategic shift away from that region in favor of other geographic areas.",
      "llm_answer": "\nBetween 2023 and 2024 ConocoPhillips kept its exploration outlay in the Asia Pacific/Middle East essentially unchanged (about $49 million each year), but it raised development spending in that region from $383 million to $416 million – roughly an 8 % increase.  This modest shift from pure exploration to higher development investment indicates the company is focusing on advancing and producing from its existing discoveries in the region rather than expanding new exploration acreage, underscoring a strategic emphasis on leveraging its Asia Pacific/Middle East assets for growth.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on the core factual claim. According to the ground truth, COP's exploration expenditures in Asia Pacific/Middle East were $49 million in 2023 and $0 in 2024 - representing a complete withdrawal. The LLM claims exploration spending remained 'essentially unchanged (about $49 million each year),' which directly contradicts the ground truth showing $0 in 2024. This is a critical factual error on the primary metric being asked about. Additionally, the LLM introduces development spending figures ($383M to $416M) that are not mentioned in the ground truth answer and appear to be either fabricated or from a different context. The LLM's interpretation that the company is 'focusing on advancing and producing from existing discoveries' contradicts the ground truth's conclusion of 'complete withdrawal or pause in exploration efforts.' The reasoning about a shift from exploration to development is logically coherent but is based on incorrect premises. The LLM failed to identify the key strategic indicator: the complete cessation of exploration activities ($0 in 2024) represents a significant strategic shift away from the region, not a continuation with modest reallocation. The answer demonstrates a fundamental misunderstanding or misreading of the data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 364,
        "total_tokens": 1620
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has Comcast's financial stake and debt involvement in Universal Beijing Resort evolved from 2022 to 2024?",
      "original_answer": "In 2022, Universal Beijing Resort was introduced as a new entity in Comcast's disclosures, noting its opening in September 2021 and highlighting the increased depreciation and amortization expenses across the company, though no specific financial stake or debt figures were provided at that time. By 2024, Comcast explicitly stated its 30% ownership interest in Universal Beijing Resort and detailed the debt financing structure, including $3.4 billion of debt outstanding as of December 31, 2024, down from $3.5 billion in 2023. Additionally, the assets and liabilities of Universal Beijing Resort were reported as $7.3 billion and $7.0 billion respectively in 2024, compared to $7.8 billion and $7.2 billion in 2023.",
      "llm_answer": "\nComcast continues to hold a 30 % ownership interest in Universal Beijing Resort and, because it controls the venture, consolidates the resort in its Theme Parks segment; this stake has not changed from 2022 through 2024.  The resort’s debt load has been modestly reduced—total borrowings fell from about $3.5 billion (including a $3.1 billion term loan) at the end of 2023 to $3.4 billion (with a $3.0 billion term loan) by the end of 2024—reflecting scheduled repayments of the original ¥29.7 billion (≈$4.2 billion) financing, with no new borrowings or additional guarantees introduced in that period.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides mostly accurate information with correct key figures and demonstrates sound multi-hop reasoning. STRENGTHS: (1) Correctly identifies Comcast's 30% ownership interest in Universal Beijing Resort; (2) Accurately reports debt figures: $3.5 billion in 2023 and $3.4 billion in 2024, matching ground truth exactly; (3) Provides additional context about term loan components ($3.1 billion in 2023, $3.0 billion in 2024) and original ¥29.7 billion financing; (4) Correctly notes the consolidation in Theme Parks segment; (5) Accurately characterizes the debt reduction as 'modest' and reflects scheduled repayments. WEAKNESSES: (1) The LLM states the 30% ownership 'has not changed from 2022 through 2024,' but the ground truth indicates that in 2022, 'no specific financial stake or debt figures were provided at that time,' suggesting the explicit disclosure of the 30% stake may have been new in 2024 rather than consistent throughout the period; (2) Missing the asset and liability figures for 2024 ($7.3 billion assets, $7.0 billion liabilities) and 2023 ($7.8 billion assets, $7.2 billion liabilities) that were explicitly mentioned in the ground truth; (3) Does not address the evolution of disclosure practices from 2022 (when the resort was newly introduced with limited financial detail) to 2024 (when comprehensive financial metrics were provided). The answer demonstrates strong quantitative accuracy on debt figures but incompleteness in addressing the full scope of financial evolution, particularly regarding asset/liability changes and the evolution of disclosure detail across the three-year period.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 447,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did Duke Energy's net derivatives balance and associated settlement activity evolve from 2022 to 2023, and what does this indicate about the company's exposure or management of derivative instruments?",
      "original_answer": "In 2022, Duke Energy's net derivatives balance at the end of the year was $29 million, with settlements totaling $32 million. In 2023, the net derivatives balance decreased to $13 million, while settlements increased significantly to $68 million. This indicates a shift in the company's management of derivative instruments, with a larger reduction in the net balance despite higher settlement activity in 2023.",
      "llm_answer": "\nFrom the end of 2022 to the end of 2023 Duke Energy’s net‑derivative balance fell sharply—from **$22 million (2022)** to **$13 million (2023)**, a decline of roughly 40 %.  The change was driven by a **large increase in settlements** ($68 million in 2023 versus $32 million in 2022) and a **drop in new purchases** ($42 million versus $74 million), while the portfolio posted a modest **$10 million gain** in 2023 compared with a **$35 million loss** in 2022.  This pattern indicates that Duke Energy deliberately **scaled back its derivative positions**, using settlements to unwind contracts and limiting new exposure, which points to a more conservative stance on market‑risk management and a focus on stabilizing cash‑flow outcomes.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains a fundamental factual error on the primary metric. The ground truth states Duke Energy's net derivatives balance was $29 million in 2022, but the LLM claims it was $22 million—a $7 million discrepancy (24% error on the base figure). The 2023 figure of $13 million is correct. This error undermines the entire quantitative foundation of the answer. SETTLEMENT ACTIVITY: The LLM correctly identifies settlements of $32 million (2022) and $68 million (2023), matching the ground truth exactly. ADDITIONAL UNSUPPORTED CLAIMS: The LLM introduces several data points not present in the ground truth: (1) new purchases of $74 million (2022) and $42 million (2023), (2) a $35 million loss in 2022 and $10 million gain in 2023. These figures cannot be verified against the provided ground truth and represent either hallucinated data or information from sources not included in the knowledge graph. The LLM's calculation of a 40% decline is mathematically incorrect for the stated figures ($22M to $13M = 41% decline, but the correct figures $29M to $13M = 55% decline). QUALITATIVE REASONING: While the LLM's interpretation about conservative stance and deliberate scaling back is reasonable and well-articulated, it is built on incorrect foundational numbers. The answer does address the evolution question and attempts multi-hop synthesis, but the factual errors are too significant to overlook. The semantic framing about derivative management is appropriate but cannot compensate for the quantitative inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 432,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did SPG's treatment and disclosure of LTIP Units evolve from 2022 to 2023, particularly in terms of their dilutive effect and valuation modeling?",
      "original_answer": "In 2022, SPG disclosed that LTIP units were part of potentially dilutive securities but had no material dilutive effect for the years 2021, 2020, and 2019. By 2023, SPG provided more detailed disclosures, including the use of a Monte Carlo model to estimate the grant-date fair values of market-based LTIP units and confirmed that these units are treated as participating securities under the two-class method of computing earnings per share. This reflects a shift from a general statement about dilution to a more granular and valuation-focused disclosure in 2023.",
      "llm_answer": "\nFrom 2022 to 2023 SPG’s treatment of LTIP Units was unchanged – they remain “potentially dilutive securities” that are exchangeable for common stock, are granted under the 2019 Stock‑Incentive Plan, and are accounted for as participating securities under the two‑class method, with grant‑date fair values estimated by a Monte‑Carlo model and expense recognized regardless of performance.  The only evolution is that the 2023 filing explicitly extends the “no material dilutive effect” statement to the 2023 fiscal year and updates the weighted‑average share/unit counts, but it still makes no adjustment to net income or to diluted earnings per share because the LTIP Units are not dilutive.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains both accurate and problematic elements. CORRECT ELEMENTS: (1) Accurate identification that LTIP units are treated as participating securities under the two-class method; (2) Correct statement that Monte Carlo model is used for valuation; (3) Correct that units are exchangeable for common stock and granted under 2019 Stock-Incentive Plan; (4) Accurate that no material dilutive effect was disclosed. PROBLEMATIC ELEMENTS: (1) The core claim that treatment was 'unchanged' from 2022 to 2023 contradicts the ground truth, which explicitly states there was 'a shift from a general statement about dilution to a more granular and valuation-focused disclosure in 2023'; (2) The LLM characterizes the evolution as merely extending the 'no material dilutive effect' statement to 2023 and updating share counts, but the ground truth indicates a substantive shift toward 'more detailed disclosures' and 'more granular and valuation-focused disclosure'; (3) The LLM misses the key evolution: 2022 had general statements about dilution, while 2023 provided detailed Monte Carlo valuation methodology disclosure - this is a meaningful change in disclosure approach, not just an extension of prior statements. MULTI-HOP REASONING: The LLM failed to properly synthesize the year-over-year evolution. The question specifically asks how treatment 'evolved,' and the ground truth clearly indicates evolution occurred (from general to granular/detailed), but the LLM asserts no meaningful evolution. This represents a fundamental misunderstanding of the comparative analysis required. QUANTITATIVE ACCURACY: No specific numbers were provided in either answer, so this dimension scores well on what was stated, but the absence of specific metrics (if they existed in source documents) may represent an omission. The characterization of 'no material dilutive effect' is consistent across both answers.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 515,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How has Comcast's financial commitment and involvement in Atairos Group, Inc. evolved between 2022 and 2024, particularly in terms of capital funding and management fee commitments?",
      "original_answer": "Comcast's involvement in Atairos Group, Inc. evolved significantly between 2022 and 2024. In 2022, Comcast was the sole third-party investor with a commitment to fund up to $5 billion in aggregate capital to Atairos. By 2024, this commitment had decreased to up to $4.5 billion, with an additional specific commitment of $40 million annually for a management fee. The reduction in capital commitment and the introduction of a dedicated management fee structure indicate a recalibration of Comcast's financial involvement and strategic oversight of Atairos.",
      "llm_answer": "\nComcast’s original funding commitment to Atairos, set when the vehicle was created in 2016, was a $5 billion aggregate cap (as reflected in the 2022 filing).  In November 2020 the partnership agreement was amended – the 2024 filing shows the cap was cut to $4.5 billion, annual capital‑call limits were reduced to $400 million, and a separate $40 million‑per‑year management‑fee obligation (to be funded in part by the former CFO) was formalized.  Despite the lower cap, Comcast’s equity‑method investment in Atairos grew to roughly $7.3 billion by the end of 2024, indicating that it continued to make additional capital contributions while honoring the $40 million annual management‑fee commitment.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains both correct and problematic elements. CORRECT ELEMENTS: (1) The capital commitment reduction from $5 billion to $4.5 billion is accurate; (2) The $40 million annual management fee commitment is correct; (3) The general narrative about recalibration of Comcast's involvement is sound; (4) The mention of the November 2020 amendment date provides helpful context. PROBLEMATIC ELEMENTS: (1) The LLM introduces the $7.3 billion equity-method investment figure, which is NOT mentioned in the ground truth answer and cannot be verified against it. This is additional information that goes beyond what was asked and what the ground truth establishes; (2) The mention of 'the former CFO' funding part of the management fee is not in the ground truth and introduces unverified details; (3) The $400 million annual capital-call limit is mentioned but not in the ground truth answer, suggesting the LLM may be adding details from the actual filing that weren't part of the synthesized ground truth. MULTI-HOP REASONING: The LLM correctly synthesizes the evolution between 2022 and 2024, identifying the key changes in capital commitment and the introduction of management fees. However, the addition of the $7.3 billion figure and other details suggests the LLM may be conflating information or adding unrequested details. QUANTITATIVE ACCURACY: The core numbers ($5B to $4.5B reduction, $40M annual fee) are correct, but the introduction of unverified figures ($7.3B, $400M) reduces confidence. The ground truth is more conservative and focused, while the LLM provides additional context that may or may not be accurate. SEMANTIC EQUIVALENCE: The core message about evolution and recalibration matches, but the LLM's answer is broader and includes information not in the ground truth, which creates uncertainty about whether all statements are equally well-supported.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 509,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How has COP's natural gas reserves in the Asia Pacific/Middle East region evolved from 2023 to 2024, and what does this indicate about the company's operational focus in that geographic area?",
      "original_answer": "In 2023, COP reported 312 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region, while in 2024, this figure slightly decreased to 296 billion cubic feet. This indicates a modest reduction in reserves over the year, suggesting a potential shift in operational focus or resource allocation in the region.",
      "llm_answer": "\nFrom 2023 to 2024 the company’s proved natural‑gas reserves in the Asia Pacific/Middle East segment slipped from roughly **312 billion cubic feet (BCF) to 296 BCF**, a decline of about **5 %**. This modest reduction—while reserves grew markedly in the Lower 48 and elsewhere—indicates that ConocoPhillips is not expanding its focus in that region and is instead concentrating operational resources on higher‑growth areas such as the U.S. Lower 48.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and provides enhanced context beyond the ground truth. Quantitative verification: (1) 2023 reserves of 312 BCF - CORRECT, (2) 2024 reserves of 296 BCF - CORRECT, (3) Decline calculation of approximately 5% - CORRECT (16 BCF decline / 312 BCF = 5.1%, properly rounded). Entity accuracy: COP/ConocoPhillips correctly identified, Asia Pacific/Middle East region correctly specified, proved natural gas reserves metric correctly identified, years 2023-2024 correctly referenced. Multi-hop reasoning: The answer successfully synthesizes the reserve data across two years and correctly interprets the trend as a modest reduction. The LLM goes beyond the ground truth by providing additional context about operational focus shifts toward the Lower 48, which is a reasonable inference from the data pattern but represents added interpretation. The semantic meaning aligns perfectly with the ground truth statement about 'modest reduction' and 'shift in operational focus.' Minor strengths: The answer includes the specific metric term 'proved natural-gas reserves' and provides the percentage decline calculation, which adds analytical value. No factual errors detected. The only minor consideration is that the additional context about Lower 48 growth, while reasonable and likely accurate, extends beyond what was explicitly stated in the ground truth, though this represents enhancement rather than error.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1205,
        "completion_tokens": 400,
        "total_tokens": 1606
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "Compare Comcast's wireless gateway procurement strategy in 2022 with its network deployment investment focus in 2024.",
      "original_answer": "In 2022, Comcast's relationship with wireless gateways was primarily centered on procurement, as the company purchased a significant amount of customer premise equipment, including wireless gateways, from a limited number of suppliers to provide services to residential and business customers. By 2024, the company's approach had evolved into a more strategic investment focus, with wireless gateways being a key component of its planned capital expenditures. Specifically, in 2024, Comcast emphasized deploying wireless gateways as part of its broader network upgrades aimed at delivering multigigabit symmetrical speeds. This shift indicates a move from passive procurement to active integration of wireless gateways into its infrastructure strategy, aligning with its goals for network scalability and capacity expansion.",
      "llm_answer": "\nIn 2022 Comcast’s wireless‑gateway outlays were a modest part of capital spending that mainly replaced and expanded customer‑premise equipment while overall capex was constrained and focused on maintaining existing service levels. By 2024 the company’s network‑deployment investment has shifted to large‑scale upgrades—scalable infrastructure, line extensions and DOCSIS‑4.0 upgrades for multigigabit speeds—with wireless‑gateway deployment now embedded in a broader capacity‑and‑speed expansion strategy rather than just replenishing CPE.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of the strategic shift in Comcast's wireless gateway approach between 2022 and 2024, with generally accurate characterization of the evolution. STRENGTHS: (1) Correctly identifies the 2022 focus on procurement and CPE replacement/expansion with constrained capex; (2) Accurately captures the 2024 shift toward strategic infrastructure investment with wireless gateways embedded in broader network upgrades; (3) Properly mentions DOCSIS-4.0 and multigigabit symmetrical speeds as key 2024 objectives; (4) Correctly synthesizes the multi-hop comparison showing progression from passive procurement to active integration; (5) Uses appropriate technical terminology (CPE, DOCSIS-4.0, line extensions, capacity expansion). MINOR WEAKNESSES: (1) The phrase 'wireless-gateway outlays were a modest part of capital spending' in 2022 is somewhat vague—the ground truth emphasizes 'significant amount' of CPE procurement, which could suggest more substantial investment than 'modest' implies, though this is interpretive; (2) The LLM answer adds specific technical details (DOCSIS-4.0, line extensions) not explicitly mentioned in the ground truth, which while contextually relevant and likely accurate, goes slightly beyond what was provided in the original answer; (3) No quantitative metrics provided in either answer, so numerical verification is not possible, but this appears to be a limitation of the source data rather than the LLM's performance. MULTI-HOP REASONING: The answer successfully synthesizes information across two time periods (2022 vs 2024) and correctly identifies the strategic evolution. The comparison is logically sound and addresses the core question effectively. SEMANTIC EQUIVALENCE: The LLM's characterization of the shift from 'passive procurement' to 'active integration' aligns well with the ground truth's description of moving from procurement-focused to strategic investment-focused approach.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 530,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How has Tesla's approach to the Solar Roof product evolved between 2022 and 2024, particularly in terms of its strategic importance and production challenges?",
      "original_answer": "In 2022, Tesla highlighted the Solar Roof as a key contributor to the growth in Energy generation and storage revenue, indicating it was being actively deployed alongside products like Megapack and Powerwall. By 2024, Tesla's framing had shifted, with the Solar Roof now positioned as a product facing potential production ramp delays similar to past vehicle and energy storage product launches. This evolution reflects a shift from emphasizing deployment success to cautioning about the operational and manufacturing risks associated with scaling the product.",
      "llm_answer": "\nTesla now treats the Solar Roof as a niche, integrated‑energy offering rather than a core growth engine, positioning it alongside its broader Energy Generation & Storage segment that is increasingly dominated by utility‑scale products such as Megapack and residential battery packs (2022 10‑K p. 38).  Between 2022 and 2024 the company repeatedly warned that scaling Solar Roof is hampered by supply‑chain limits on specialty solar tiles, the need to bring new manufacturing lines online at its expanding factories (e.g., Texas, Berlin) and technical complexities that have caused repeated launch‑and‑ramp delays (2024 10‑K pp. 15, 17).  Consequently, while the product remains part of Tesla’s sustainability narrative, its strategic importance has receded and production challenges have slowed its rollout.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth on the core narrative of Tesla's Solar Roof evolution from 2022 to 2024. STRENGTHS: (1) Correctly identifies the shift from positioning Solar Roof as a key growth contributor (2022) to cautioning about production challenges and ramp delays (2024); (2) Accurately captures the strategic repositioning from core growth engine to niche offering; (3) Properly synthesizes multi-hop information across years and documents; (4) Correctly identifies specific production challenges (supply chain, manufacturing capacity, technical complexity); (5) Appropriately references specific 10-K pages (2022 p. 38, 2024 pp. 15, 17) showing document-level accuracy; (6) Maintains semantic equivalence with ground truth while using slightly different phrasing. MINOR WEAKNESSES: (1) The LLM answer provides more specific operational details (supply-chain limits on specialty tiles, factory expansion references) than the ground truth, which could be viewed as either enhanced context or minor extrapolation beyond what was explicitly stated in the original answer; (2) The characterization of Solar Roof as 'niche' is slightly more definitive than the ground truth's more measured 'shift in framing,' though this is a reasonable inference from the stated facts. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are provided in either answer, so this dimension is not directly testable. The dates (2022, 2024) are correct. MULTI-HOP REASONING: The answer successfully synthesizes information across multiple years and documents, correctly identifying the temporal evolution and connecting it to broader strategic shifts in the Energy segment. The logic linking production challenges to reduced strategic importance is sound and well-supported.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 493,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did Duke Energy's investment in Net Pending Transactions and Other Investments change from 2022 to 2023, and what does this indicate about the company's strategic positioning in this category?",
      "original_answer": "Duke Energy's investment in Net Pending Transactions and Other Investments decreased from $53 million in 2022 to $14 million in 2023. This indicates a significant reduction in exposure or involvement in pending transactions and other investments, suggesting a strategic shift or completion of certain initiatives during this period.",
      "llm_answer": "\nFrom 2022 to 2023 the “Net pending transactions and other investments” line in Duke Energy’s Master Retirement Trust rose sharply—from **$14 million in 2022** to **$54 million in 2023** (an increase of roughly **$40 million, or about 285 %**).  The 2023 figure is split into $40 million classified as Level 1 and $14 million as Level 2, whereas in 2022 it was $5 million Level 1 and $9 million Level 2.  This expansion indicates that Duke Energy is deliberately increasing its exposure to these assets, moving a larger portion into higher‑level (more liquid) valuations, which suggests a strategic shift toward allocating more capital to potentially higher‑return, albeit less certain, investments and reinforcing the trust’s liquidity profile.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that directly contradict the ground truth. (1) CRITICAL NUMERIC ERRORS: The LLM states the investment INCREASED from $14 million in 2022 to $54 million in 2023, when the ground truth clearly shows it DECREASED from $53 million in 2022 to $14 million in 2023. The LLM has essentially inverted the direction and magnitude of change. The LLM claims a $40 million increase (285%), when the actual change was a $39 million DECREASE (approximately 74% reduction). (2) CALCULATION ERRORS: The percentage calculation of 285% is mathematically incorrect for the numbers the LLM cited (($54M-$14M)/$14M = 186%, not 285%), and more importantly, the entire calculation is based on reversed figures. (3) ENTITY/CONTEXT CONFUSION: The LLM introduces 'Master Retirement Trust' and discusses Level 1/Level 2 classifications with specific breakdowns ($40M Level 1, $14M Level 2 in 2023; $5M Level 1, $9M Level 2 in 2022) that are not mentioned in the ground truth answer. This suggests the LLM may be referencing different data or a different section of the filing. (4) STRATEGIC INTERPRETATION REVERSAL: The LLM concludes Duke Energy is 'deliberately increasing exposure' and 'moving a larger portion into higher-level valuations,' which is the opposite of what the ground truth indicates—a significant reduction suggesting completion of initiatives or strategic shift away from these investments. (5) MULTI-HOP REASONING: The LLM failed to correctly synthesize the year-over-year comparison, which is the core requirement of the question. The answer is fundamentally incorrect on the primary metric being evaluated.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 451,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How has the company's implementation of its liability-driven investment framework evolved between 2023 and 2024, particularly in terms of defined contribution plan expenses and the disclosure of plan asset composition?",
      "original_answer": "In 2023, the company disclosed that amounts charged to expense for defined contribution plans totaled $109 million, and the liability-driven investment framework included a 20%/80% equity/fixed income target allocation for pension assets. By 2024, defined contribution plan expenses increased to $112 million, and while the same 20%/80% allocation was maintained, the 2024 filing added a new disclosure indicating that the actual composition of plan assets at year-end would be characterized, suggesting a more detailed transparency in reporting the implementation of the investment framework.",
      "llm_answer": "\nBetween 2023 and 2024 the company’s liability‑driven investment strategy was tweaked rather than overhauled: the target equity allocation was nudged up to roughly 21 % (from about 18 % in 2023) while the corporate‑bond share was expanded to roughly 63 % (from 57 %), and the portion of U.S. Treasury and other government securities was trimmed to about 16 % (from 25 %).  At the same time, the expense recognized for its defined‑contribution plans rose to **$112 million in 2024**, compared with **$109 million in 2023**, reflecting the higher cost of the modestly larger, more liability‑focused asset mix.  The plan‑asset composition is disclosed in the 2024 “actual composition” tables (≈21 % equity, 63 % corporate bonds, 16 % government securities) and was previously disclosed for 2023 (≈18 % equity, 57 % corporate bonds, 25 % government securities).",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. CRITICAL ERRORS: (1) The LLM claims the target equity allocation changed from 18% in 2023 to 21% in 2024, but the ground truth explicitly states the company maintained a consistent 20%/80% equity/fixed income target allocation in both years. (2) The LLM provides specific percentages for corporate bonds (57% to 63%) and government securities (25% to 16%), which are NOT mentioned in the ground truth at all. The ground truth only references the 20%/80% equity/fixed income allocation. (3) The LLM appears to have fabricated detailed asset composition breakdowns that do not appear in the original answer. CORRECT ELEMENTS: The LLM correctly identified that defined contribution plan expenses were $109 million in 2023 and $112 million in 2024 (accurate). The LLM correctly noted that the 2024 filing added disclosure of actual plan asset composition. However, the specific percentages provided for the actual composition (21% equity, 63% corporate bonds, 16% government securities) cannot be verified against the ground truth and appear to be fabricated. The core issue is that the LLM fundamentally misrepresented the evolution of the investment framework by claiming a shift in target allocation when the ground truth indicates the target allocation remained constant at 20%/80%. The LLM's answer suggests a more dramatic strategic shift than actually occurred, which is a major factual error in a financial context where precision is critical.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 422,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How has Qualcomm's strategic focus on On-Device AI evolved between fiscal 2023 and fiscal 2024, and what specific investments or changes in direction were highlighted in the company's disclosures?",
      "original_answer": "In fiscal 2023, Qualcomm emphasized that On-Device AI, combined with 5G and high-performance, low-power computing, would drive adoption of smartphone technologies into industries beyond mobile, such as automotive and IoT. The company positioned itself as a leader in 5G and integrated circuit products to sustain long-term growth. By fiscal 2024, Qualcomm's focus on On-Device AI had evolved into a more investment-driven strategy, with the company explicitly stating it is investing in new product areas and industries beyond mobile handsets, including automotive and IoT, by leveraging its technical expertise and pursuing acquisitions or strategic transactions. This represents a shift from strategic vision to active investment and expansion.",
      "llm_answer": "\nBetween fiscal 2023 and fiscal 2024 Qualcomm shifted its on‑device AI agenda from a mobile‑handset‑centric effort to a cross‑industry strategy that treats AI as a foundational technology for automotive, IoT and other new product areas.  The 2024 filing explicitly states that the company will “continue to make substantial investments in these new and expanded product areas… including on‑device artificial intelligence (AI)” and that AI, together with 5G and high‑performance computing, will drive adoption of its technologies beyond smartphones.  This expansion is underscored by a focus on AI‑related R&D, patent development and ecosystem partnerships to support growth in automotive, IoT and similar domains.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy with correct identification of the evolution in Qualcomm's On-Device AI strategy between fiscal 2023 and 2024. STRENGTHS: (1) Correctly identifies the shift from mobile-handset-centric to cross-industry strategy; (2) Accurately captures the fiscal years (2023 vs 2024); (3) Properly synthesizes multi-hop information showing the progression from strategic vision to active investment; (4) Correctly identifies key industries (automotive, IoT) and technologies (5G, high-performance computing); (5) Includes relevant supporting details about R&D, patents, and ecosystem partnerships that align with the ground truth's mention of 'acquisitions or strategic transactions'; (6) No quantitative errors or date inaccuracies. MINOR GAPS: (1) The LLM answer emphasizes R&D, patents, and ecosystem partnerships but doesn't explicitly mention 'acquisitions or strategic transactions' that were highlighted in the original answer as part of the investment strategy shift; (2) The original answer frames the evolution as 'shift from strategic vision to active investment and expansion' which is captured semantically but not as explicitly stated. The LLM answer provides a more detailed characterization of the strategic shift with specific supporting mechanisms (R&D, patents, partnerships) that enhance understanding, though these weren't explicitly mentioned in the ground truth. The answer correctly addresses all parts of the multi-part question regarding how the focus evolved and what specific investments/changes were highlighted.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 433,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has the classification and presentation of the Voting Trust Agreement between Melvin Simon & Associates, Inc. and the Simon family members evolved between the 2022 and 2023 10-K filings, and what does this indicate about the governance structure's stability?",
      "original_answer": "In the 2022 10-K filing, the Voting Trust Agreement was described as 'Second Amended and Restated' as of March 1, 2004, indicating a formal update to the governance arrangement. In contrast, the 2023 10-K filing refers to the same agreement without the 'Second Amended and Restated' modifier, simply listing it as the Voting Trust Agreement dated March 1, 2004. This shift in presentation suggests that no further amendments were made in the intervening period, signaling stability in the governance structure and a continuation of the same voting trust framework without modification.",
      "llm_answer": "\nThe Voting Trust Agreement is still filed as **Exhibit 9.1** (the “Second Amended and Restated Voting Trust Agreement…”) and **Exhibit 9.2** (the “Voting Trust Agreement…”) in both the 2022 and 2023 Form 10‑K filings, with identical language and the same incorporation by reference to the 2004 Quarterly Report.  This unchanged classification and presentation shows that the family‑controlled voting‑trust structure has not been revised or re‑categorized between the two years, indicating a stable governance arrangement.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Ground truth states that the 2022 10-K describes the agreement as 'Second Amended and Restated' while the 2023 10-K refers to it without this modifier, indicating an evolution in presentation. However, the LLM claims both years filed identical exhibits (Exhibit 9.1 as 'Second Amended and Restated' and Exhibit 9.2 as 'Voting Trust Agreement') with 'identical language' in both 2022 and 2023. This directly contradicts the ground truth's core finding of a shift in presentation between the two years. The LLM also introduces specific exhibit numbers (9.1 and 9.2) and claims about incorporation by reference that are not mentioned in the ground truth and appear to be fabricated details. While the LLM correctly identifies the March 1, 2004 date and the governance stability conclusion, it fundamentally misrepresents the key evolution in classification that the question asks about. The answer fails to capture the actual change in how the agreement was presented between the two filing years, which is the central point of the question. The reasoning about stability is correct in conclusion but based on incorrect premises about the filing presentation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 349,
        "total_tokens": 1655
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did COP's natural gas reserves in the Asia Pacific/Middle East region evolve between 2023 and 2024, and what does this indicate about the region's changing strategic importance to COP's global reserves portfolio?",
      "original_answer": "In 2023, COP reported 312 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region, while in 2024, this figure decreased slightly to 296 billion cubic feet. This represents a reduction of 16 billion cubic feet, or about 5.1%. Despite this decline, the Asia Pacific/Middle East remained a notable contributor to COP's global reserves, especially when considering equity affiliates, which held an additional 5,870 billion cubic feet in 2024. The slight decrease may suggest a shift in emphasis or extraction focus in favor of other regions, indicating a potential reevaluation of the region's role in COP's long-term production strategy.",
      "llm_answer": "\nCOP’s proved natural‑gas reserves in the Asia‑Pacific/Middle‑East region slipped from about **310 billion cubic feet (BCF) at the end of 2023 to roughly 295 BCF at the end of 2024**, a decline of roughly **5 % (≈15‑16 BCF)** (see COP 10‑K 2024, p. 145).  Although the region still contributes a modest share of the company’s total reserves, its **relative weight in the global reserve portfolio fell**, reflecting a strategic shift toward other areas—particularly North‑American assets—where reserve growth is stronger.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct but contains minor quantitative discrepancies. CORRECT ELEMENTS: (1) The directional trend is accurate—reserves declined from 2023 to 2024 in the Asia Pacific/Middle East region. (2) The percentage decline of ~5% is correctly calculated and matches the ground truth. (3) The strategic interpretation about a shift toward other regions (particularly North America) is sound and aligns with the ground truth's assessment. (4) The entity identification (COP, region, time period) is accurate. (5) The citation to COP 10-K 2024, p. 145 adds credibility. QUANTITATIVE DISCREPANCIES: (1) 2023 figure: LLM states '310 BCF' vs. ground truth '312 BCF' (2 BCF difference, ~0.6% variance). (2) 2024 figure: LLM states '295 BCF' vs. ground truth '296 BCF' (1 BCF difference, ~0.3% variance). (3) Decline magnitude: LLM states '15-16 BCF' vs. ground truth '16 BCF' (acceptable range given rounding). MISSING ELEMENTS: The LLM answer does not mention the equity affiliates' 5,870 BCF in 2024, which the ground truth includes as important context for understanding the region's strategic importance. This is a notable omission since the ground truth specifically highlights this as relevant to assessing the region's contribution to global reserves. REASONING QUALITY: The multi-hop synthesis is sound—the LLM correctly connects the reserve decline to strategic portfolio implications and identifies North America as a competing priority. The logic is coherent and well-reasoned. OVERALL ASSESSMENT: The answer is largely accurate with minor numerical variations (likely due to rounding or data source differences) and one significant omission (equity affiliates data). The core narrative and strategic interpretation are correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 477,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did AIG's financial relationship with Corebridge evolve between 2023 and 2024, particularly in terms of debt structure and equity method income?",
      "original_answer": "In 2023, AIG had a direct financial stake in Corebridge, which was reflected in the $9,368 million total Corebridge debt on AIG's balance sheet, including $6,452 million in senior unsecured notes and $989 million in junior subordinated debt, both not guaranteed by AIG. By 2024, AIG no longer consolidated Corebridge as a subsidiary; instead, it reported Corebridge under the equity method as part of discontinued operations. During the second half of 2024, AIG reported equity method income from Corebridge, which included dividends received and changes in its stock price since June 9, 2024. This marks a significant transformation from a consolidated debt relationship to a minority equity investment with associated income reporting.",
      "llm_answer": "\nBetween 2023 and 2024 AIG moved from full consolidation of Corebridge to a partial‑equity relationship: it retained roughly 294 million shares (≈ $8.5 bn at June 9 2024) and now records the investment under the equity method, generating $601 million of equity‑method income for the June‑10 – Dec 31 2024 period (dividends plus the rise in Corebridge’s stock price).  At the same time, Corebridge issued a sizable debt stack – $6.45 bn of senior unsecured notes, $989 m of junior subordinated debt and a $1.5 bn DDTL facility – and AIG provided a guarantee and collateral‑reimbursement arrangement that obligates it to cover any shortfall if Corebridge’s debt is downgraded or defaults.  Consequently, AIG’s own debt balance grew to about $10.3 bn (including Corebridge‑related borrowings), while its exposure to Corebridge shifted from direct consolidation to a contingent guarantor/ equity‑method investor.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not supported by the ground truth:\n\n1. QUANTITATIVE ERRORS (Critical):\n   - LLM claims AIG reported $601 million of equity-method income for June 10-Dec 31 2024 period. Ground truth does NOT specify this number; this appears to be fabricated or misattributed.\n   - LLM states AIG's debt balance grew to $10.3 billion. Ground truth shows $9,368 million (~$9.4 billion) in 2023 Corebridge debt on AIG's balance sheet. The $10.3 billion figure is not verified in ground truth.\n   - LLM mentions $1.5 billion DDTL facility. Ground truth does not mention this facility at all.\n   - LLM claims AIG retained \"roughly 294 million shares (≈ $8.5 bn at June 9 2024)\". Ground truth does not provide share count or this valuation.\n\n2. STRUCTURAL ACCURACY:\n   - LLM correctly identifies the shift from consolidation to equity method accounting (matches ground truth).\n   - LLM correctly identifies the debt components: $6.45 billion senior unsecured notes and $989 million junior subordinated debt (matches ground truth).\n   - However, LLM introduces a guarantee and collateral-reimbursement arrangement that is NOT mentioned in the ground truth. This is a significant addition not supported by the source material.\n\n3. MULTI-HOP REASONING:\n   - The core transformation (consolidation → equity method) is correctly identified.\n   - However, the LLM adds substantial detail about guarantees, contingent obligations, and specific income figures that cannot be verified against the ground truth.\n   - The synthesis appears to conflate or extrapolate beyond what the ground truth states.\n\n4. MISSING/INCORRECT ELEMENTS:\n   - Ground truth emphasizes that Corebridge debt was \"not guaranteed by AIG\" in 2023. LLM contradicts this by claiming AIG \"provided a guarantee\" in the new structure.\n   - Ground truth mentions equity method income \"included dividends received and changes in its stock price since June 9, 2024\" but does NOT quantify this as $601 million.\n   - Ground truth does not mention a DDTL facility.\n\n5. SEMANTIC ISSUES:\n   - The characterization of AIG as a \"contingent guarantor\" directly contradicts the ground truth statement that the debt was \"not guaranteed by AIG.\"\n   - This is a material misrepresentation of AIG's actual obligations.\n\nThe LLM answer demonstrates partial understanding of the consolidation-to-equity-method transition but introduces multiple unsupported claims about financial figures, guarantees, and facilities that are not in the ground truth. The most critical error is the claim about AIG providing guarantees, which directly contradicts the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 713,
        "total_tokens": 2125
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has NextEra Energy's investment strategy in Special Use Funds evolved from 2022 to 2024, particularly in terms of its allocation between fixed income and equity securities, and what does this suggest about its risk appetite or liquidity strategy?",
      "original_answer": "In 2022, NEE's Special Use Funds were entirely composed of fixed income securities, with a carrying amount of $2,505 million. By 2024, the composition had significantly transformed: NEE's Special Use Funds included $6,164 million in equity securities, $722 million in U.S. Government and municipal bonds, $685 million in corporate debt, and $873 million in asset-backed securities. This indicates a strategic shift from a purely fixed income allocation to a more diversified and equity-heavy portfolio, suggesting an increased risk appetite and a potential long-term growth orientation in its investment strategy.",
      "llm_answer": "\nBetween 2021 (shown in the 2022 10‑K, page 63/89) and 2024 (shown in the 2024 10‑K, page 89), the composition of NEE’s Special Use Funds moved from roughly **70 % equity / 30 % fixed‑income** to about **80 % equity / 20 % fixed‑income**.  This tilt toward a larger equity share signals a higher risk appetite and a liquidity strategy that leans on publicly‑traded, relatively liquid equities rather than longer‑duration bonds.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains fundamental inaccuracies that contradict the ground truth. (1) WRONG BASELINE DATA: The LLM claims 2021/2022 Special Use Funds were '70% equity / 30% fixed-income,' but the ground truth explicitly states that in 2022, NEE's Special Use Funds were 'entirely composed of fixed income securities' ($2,505 million). This is a complete contradiction - 0% equity vs. claimed 70% equity. (2) WRONG ENDPOINT DATA: The LLM claims 2024 composition was '80% equity / 20% fixed-income,' but ground truth shows: $6,164M equity + $722M U.S. Gov/municipal + $685M corporate debt + $873M asset-backed = $8,344M total. This yields approximately 73.9% equity and 26.1% fixed income, not 80/20. (3) MISSING SPECIFIC DOLLAR AMOUNTS: The LLM provides only percentages without the actual dollar values ($6,164M equity, $722M bonds, $685M corporate debt, $873M ABS) that are critical to understanding the magnitude of the shift. (4) INCORRECT CHARACTERIZATION OF CHANGE: The LLM describes a shift from 70% to 80% equity (a 10 percentage point increase), but the actual shift is from 0% to ~74% equity - a fundamentally different and much more dramatic transformation. (5) MULTI-HOP REASONING FAILURE: The LLM failed to correctly synthesize the 2022 and 2024 data from the filings. The ground truth shows a complete strategic pivot from pure fixed income to diversified equity-heavy portfolio; the LLM incorrectly suggests a modest rebalancing within an already equity-heavy portfolio. The conclusion about 'higher risk appetite' is directionally correct but based on false premises. The answer demonstrates poor data extraction and calculation accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 458,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has the nature and magnitude of the risk associated with site infrastructure sharing evolved between 2022 and 2024, particularly in relation to 5G technology adoption and its impact on new lease activity?",
      "original_answer": "In 2022, AMT identified site infrastructure sharing as a risk factor that could slow new lease activity or lead to decommissioning of equipment on existing sites, particularly due to the rise of 5G technology. By 2024, this risk evolved into a more specific concern around RAN (Radio Access Network) sharing, roaming, or resale arrangements, which were explicitly tied to the lack of compensation to AMT when carriers opted for shared infrastructure instead of deploying new equipment. The 2024 filing indicates a stronger emphasis on the financial impact of this trend, suggesting a more mature and impactful shift in carrier behavior driven by 5G deployment. This represents a significant evolution in the risk's specificity and perceived threat level.",
      "llm_answer": "\nBetween 2022 and 2024 the risk shifted from a generic warning about future 5G‑driven sharing to a concrete pressure on lease growth; the 2024 filing explicitly ties 5G‑induced roaming/RAN‑sharing and carrier consolidation to slower new‑site deployment and higher churn—especially in the U.S. & Canada and APAC segments—because carriers are increasingly using shared equipment rather than adding new sites, which can curb future lease revenues.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the evolution of site infrastructure sharing risks between 2022 and 2024. STRENGTHS: (1) Correctly identifies the shift from generic 5G warnings in 2022 to specific RAN/roaming/resale concerns in 2024; (2) Accurately captures the financial impact emphasis in 2024 filings; (3) Properly synthesizes the multi-hop connection between 5G adoption, carrier behavior changes, and reduced new lease activity; (4) Correctly identifies geographic segments (U.S. & Canada, APAC) affected; (5) Accurately characterizes the mechanism (carriers using shared equipment rather than deploying new sites); (6) Appropriately emphasizes the evolution from theoretical risk to concrete pressure on lease growth. MINOR WEAKNESSES: (1) The answer mentions 'carrier consolidation' as a driver, which is not explicitly mentioned in the ground truth—while related to the broader context, this adds an inference not directly supported by the original answer; (2) The phrase 'higher churn' is mentioned but the ground truth focuses more on 'decommissioning' and lack of new lease activity rather than explicitly discussing churn rates; (3) The answer could have been more explicit about the 'lack of compensation to AMT' aspect mentioned in the ground truth. MULTI-HOP REASONING: The answer successfully synthesizes information across years (2022 vs 2024) and connects 5G technology adoption to its specific impacts on lease activity and revenue. The reasoning is sound and logically structured. SEMANTIC EQUIVALENCE: The core message aligns well with the ground truth—both convey that the risk evolved from a general concern to a specific, quantifiable threat tied to RAN sharing and reduced new site deployment. No quantitative data (numbers, percentages, dollar amounts) are provided in either answer, so quantitative accuracy is not compromised. Overall, this is a strong answer with minor conceptual additions that don't contradict the ground truth but add slight interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 541,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has Chevron's financial relationship with Angola LNG Limited evolved between 2022 and 2023, particularly in terms of its investment structure and equity method accounting?",
      "original_answer": "Chevron's relationship with Angola LNG Limited evolved from a dependency-based structure in 2022 to a more direct investment model in 2023. In 2022, Chevron reported a 36.4% interest in Angola LNG Limited, but the relationship was categorized under 'Depends_On', indicating a more passive or structurally dependent investment. By 2023, the relationship was reclassified as 'Invests_In', suggesting a more active or strategic financial posture. Additionally, while both years maintained the same ownership percentage (36.4%), the reclassification indicates a shift in how Chevron views or manages its investment, possibly reflecting changes in operational involvement or strategic alignment.",
      "llm_answer": "\nChevron maintained its 36.4 % equity stake in Angola LNG Limited and continued to use the equity‑method for that investment in both 2022 and 2023.  The carrying amount of the investment slipped modestly from $1.96 bn at year‑end 2022 to $1.76 bn at year‑end 2023, and the portion of earnings recognized under the equity method dropped sharply from $1.86 bn in 2022 to only $0.51 bn in 2023—reflecting weaker results from the LNG project but without any change in the accounting method itself.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer addresses a different aspect of Chevron's Angola LNG relationship than what the ground truth describes, resulting in a significant mismatch. CRITICAL ISSUES: (1) The LLM provides specific financial figures ($1.96bn, $1.76bn, $1.86bn, $0.51bn) that cannot be verified against the ground truth, which does not contain these numbers. Without access to the actual SEC filings, these figures are unverifiable and potentially fabricated. (2) The LLM focuses entirely on equity method accounting and carrying amounts, while the ground truth emphasizes the relationship classification shift from 'Depends_On' (2022) to 'Invests_In' (2023)—a fundamental structural change in how the investment is categorized. (3) The LLM correctly identifies the 36.4% equity stake (matching ground truth), but this is the only verifiable alignment. (4) The LLM states 'without any change in the accounting method itself,' which contradicts the ground truth's emphasis on a meaningful reclassification of the relationship type. (5) Multi-hop reasoning is incomplete: the question asks about 'investment structure and equity method accounting,' and while the LLM addresses equity method accounting, it entirely misses the investment structure evolution (the relationship type reclassification). The ground truth indicates a strategic shift in how Chevron manages the investment, while the LLM suggests continuity with only operational performance changes. STRENGTHS: The 36.4% ownership percentage is correct, and the general framing of equity method accounting is appropriate. WEAKNESSES: Unverifiable financial figures, failure to address the relationship classification change, incomplete synthesis of the multi-hop question components, and potential contradiction of the ground truth's core finding about structural evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 493,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has the G600 aircraft's role in Gulfstream's product lineup evolved from 2022 to 2023, particularly in terms of its performance metrics and production status?",
      "original_answer": "In 2022, the G600 was described as a recent addition to the Gulfstream fleet, having entered service in 2019, and was positioned as a clean-sheet aircraft replacing the G550. By 2023, the G600 was no longer characterized as 'new' but rather as a mature product within the lineup, with over 250 cumulative deliveries by year-end 2023. Additionally, in 2023, the G600's advanced technologies, such as the Symmetry Flight Deck, were highlighted as foundational features being extended to newer models like the G700, G800, and G400. This indicates a shift from product introduction to integration within the broader Gulfstream platform.",
      "llm_answer": "\nFrom the 2022 filing the G600 was already positioned as the newest large‑cabin, ultra‑long‑range business jet—offering a faster cruise, better fuel‑efficiency, a larger, more ergonomic cabin, reduced emissions and greater range than the G450/G550 it replaced, with roughly 150 cumulative deliveries by the end of 2021.  The 2023 filing shows that cumulative deliveries had risen to “over 250” by year‑end 2023, confirming that the G600 remained in active production and that its proven performance metrics now support an even larger installed base and a growing service‑revenue stream, while the company prepares to introduce the next‑generation G700.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains both correct and problematic elements. CORRECT ELEMENTS: (1) The cumulative deliveries figures are accurate - roughly 150 by end of 2021 and over 250 by end of 2023, matching the ground truth. (2) The characterization of G600 as replacing G450/G550 is correct. (3) The mention of performance metrics (faster cruise, fuel efficiency, larger cabin, reduced emissions, greater range) aligns with ground truth. (4) The reference to G700 introduction is appropriate. PROBLEMATIC ELEMENTS: (1) The LLM answer focuses heavily on 2022 filing details about performance metrics but FAILS to address the key evolution described in the ground truth - the shift from G600 being characterized as 'new/recent' in 2022 to 'mature' in 2023. This is a critical aspect of the question about how the role 'evolved.' (2) The answer mentions G700 but OMITS the important detail that in 2023, the G600's technologies (Symmetry Flight Deck) were being extended to newer models like G700, G800, and G400, which demonstrates platform integration and the shift from product introduction to broader platform strategy. (3) The answer doesn't explicitly capture the maturation narrative - that by 2023 the G600 was no longer 'new' but rather an established, mature product. MULTI-HOP REASONING: The answer successfully synthesizes data across 2022 and 2023 filings to show production continuity and delivery growth, but fails to synthesize the qualitative evolution in how the product was positioned/characterized. The answer is more of a product description than an analysis of how the role evolved. QUANTITATIVE ACCURACY is solid (numbers are correct), but QUALITATIVE ACCURACY suffers from incomplete synthesis of the positioning shift and missing key contextual details about technology platform integration.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 490,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has McDonald's relationship with its franchisees evolved in terms of financial involvement and strategic collaboration between 2022 and 2024?",
      "original_answer": "In 2022, McDonald's relationship with franchisees was primarily framed around franchised arrangements and license agreements, with franchisees contributing revenue through rent, royalties, and initial fees, while the company did not typically invest in restaurant capital under developmental licenses. By 2024, the company had introduced a more active investment role, co-investing with franchisees to fund restaurant improvements and operating system upgrades. These co-investments were aimed at catering to consumer preferences, improving local performance, and enhancing the brand through modernization. This marks a strategic shift from a largely passive franchising model to a more collaborative and financially engaged partnership.",
      "llm_answer": "\nBetween 2022 and 2024 McDonald’s moved from a purely franchised model—where franchisees alone funded capital upgrades—to an active partnership that includes co‑investment with franchisees for restaurant modernization, technology and delivery upgrades.  The Company deepened its financial involvement by jointly funding improvements while still relying on franchisee‑generated sales for stable cash flow, and it continues to require rigorous standards and alignment on strategic initiatives.  (Pages 30 (2022) and 27 (2024) detail this evolution of co‑investment and collaborative reinvestment.)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. (1) CORRECTNESS: The answer accurately captures the core evolution from a passive franchising model (2022) to active co-investment partnerships (2024). All major factual claims are correct: the shift from franchisees alone funding capital upgrades to joint co-investment, the focus on restaurant modernization and technology upgrades, and the maintenance of franchisee revenue streams through sales. (2) QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts were required by the question, and the LLM appropriately avoided introducing unsupported figures. The page references (Pages 30 for 2022 and 27 for 2024) are cited but cannot be verified from the ground truth provided; however, this citation format is reasonable and doesn't contradict the ground truth. (3) ENTITY ACCURACY: McDonald's is correctly identified, the time period (2022-2024) is accurate, and the financial metrics (co-investment, royalties, rent) are properly identified. (4) MULTI-HOP REASONING: The answer successfully synthesizes the evolution across two years, correctly identifying the strategic shift and its implications. The reasoning is sound: moving from passive to active involvement, maintaining revenue streams while adding capital participation. (5) SEMANTIC EQUIVALENCE: The LLM's phrasing ('purely franchised model,' 'active partnership,' 'co-investment,' 'collaborative reinvestment') conveys the same meaning as the ground truth ('primarily framed around franchised arrangements' to 'more collaborative and financially engaged partnership'). Minor differences in wording ('consumer preferences' and 'local performance' mentioned in ground truth but not LLM) represent acceptable omissions that don't undermine the core answer. The answer is comprehensive, accurate, and directly addresses the question's multi-part nature regarding both financial involvement and strategic collaboration.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 537,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did the financial performance of smokeable products evolve from 2022 to 2023, particularly in terms of net revenues and operating income?",
      "original_answer": "In 2022, smokeable products generated $22,476 million in net revenues and contributed $10,688 million to operating income. In 2023, net revenues from smokeable products decreased slightly to $21,756 million, and operating income from this segment also declined marginally to $10,670 million. This reflects a small decrease in both revenue and profitability year-over-year.",
      "llm_answer": "\nFrom 2022 to 2023 the “smokeable products” segment saw a modest pull‑back in both top‑line sales and profitability.  Net revenues fell from **$22,476 million in 2022 to $21,756 million in 2023** (a decline of roughly $0.72 billion, or about 3 %).  Operating income slipped only slightly, moving from **$10,688 million in 2022 to $10,670 million in 2023** (a drop of about $0.018 billion, or roughly 0.2 %).  In other words, revenue contracted modestly while operating income remained essentially flat, reflecting a small erosion in profitability despite the lower sales.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. All key financial figures are correct: 2022 net revenues of $22,476 million, 2023 net revenues of $21,756 million, 2022 operating income of $10,688 million, and 2023 operating income of $10,670 million. The calculations are accurate: the revenue decline is $720 million (not $0.72 billion as stated, though this is a minor notation issue - $0.72 billion = $720 million, so semantically correct), representing approximately 3% decrease. The operating income decline of $18 million (stated as $0.018 billion) is correct, representing approximately 0.2% decrease. The LLM correctly synthesized the multi-hop comparison across two fiscal years and two financial metrics. The reasoning is sound - the answer appropriately characterizes the performance as a 'modest pull-back' with revenue contracting while operating income remained 'essentially flat,' which accurately reflects the data (3% revenue decline vs 0.2% operating income decline). The answer directly addresses all parts of the question regarding how financial performance evolved from 2022 to 2023 in terms of both net revenues and operating income. Minor deduction only for the notation style ($0.72 billion instead of $720 million, though mathematically equivalent), which is a presentation choice rather than a factual error. The answer is well-structured, provides appropriate context, and demonstrates clear understanding of the multi-hop synthesis required.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1234,
        "completion_tokens": 410,
        "total_tokens": 1645
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has the role of Opdivo within BMY's product development and commercialization strategy evolved from 2022 to 2024, particularly in terms of its collaborative framework and new therapeutic approvals?",
      "original_answer": "In 2022, Opdivo was primarily positioned within a joint development and commercialization framework with Ono, where profits, losses, and development costs were shared—either equally for combination therapies or under an 80-20 split for single-party compounds. Additionally, Opdivo was part of a broader alliance that included other products like Yervoy and Orencia, with structured co-promotion and supply responsibilities. By 2024, Opdivo's role had evolved significantly, marked by a new FDA approval in March 2024 for use in combination with cisplatin and gemcitabine for the first-line treatment of unresectable or metastatic urothelial carcinoma. This reflects a shift from a co-development focus to a more independent product introduction strategy, with BMY taking the lead in expanding Opdivo’s therapeutic applications in key oncology markets.",
      "llm_answer": "\nFrom 2022 through 2024 Opdivo moved from a single‑agent immuno‑oncology product to the center of a multi‑partner development and commercialisation model—most prominently the co‑development/profit‑sharing alliance with Ono in Japan that governs Opdivo (and Yervoy) in that market and the associated joint promotion of combination regimens.  At the same time the drug gained four new global approvals—subcutaneous Opdivo Qvantig (Dec 2024), neoadjuvant NSCLC (Oct 2024), first‑line urothelial carcinoma (May 2024, with cisplatin/gemcitabine) and colorectal‑cancer (Dec 2024, with Yervoy)—demonstrating an expanded indication portfolio and a strategy that relies on collaborative frameworks to drive its broader commercialisation.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core evolution of Opdivo's role from 2022-2024, accurately describes the Ono partnership framework with profit/loss sharing, and correctly identifies the shift toward expanded therapeutic applications. The answer appropriately mentions the collaborative framework and new approvals as requested. The semantic understanding of the strategic shift is sound.\n\nCRITICAL ERRORS - DATES: The LLM provides four approval dates that conflict with the ground truth:\n1. Ground truth states March 2024 for urothelial carcinoma approval; LLM states May 2024 (2-month discrepancy)\n2. LLM mentions October 2024 neoadjuvant NSCLC approval (not mentioned in ground truth)\n3. LLM mentions December 2024 subcutaneous Opdivo Qvantig approval (not in ground truth)\n4. LLM mentions December 2024 colorectal cancer approval (not in ground truth)\n\nThese date discrepancies are significant because the question specifically asks about evolution from 2022-2024, and precise approval dates are factual claims that must be accurate. The ground truth only confirms the March 2024 urothelial carcinoma approval.\n\nPARTIAL ACCURACY: The LLM correctly identifies:\n- The Ono partnership structure and profit-sharing framework\n- The shift from single-agent to multi-partner development model\n- The urothelial carcinoma approval (though with wrong date)\n- The collaborative framework emphasis\n\nMISSING/INCORRECT ELEMENTS:\n- The 80-20 split mentioned in ground truth for single-party compounds is not addressed\n- The broader alliance context (Yervoy, Orencia) is partially mentioned but not fully contextualized\n- Multiple approval dates appear to be fabricated or from sources outside the ground truth knowledge graph\n\nQUALITATIVE ASSESSMENT: The reasoning about strategic evolution is sound and well-articulated, but the factual foundation is compromised by date errors. The multi-hop synthesis (combining partnership info with approval trajectory) is conceptually correct but factually flawed in execution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 550,
        "total_tokens": 1958
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has AMT's disclosure regarding interest rate benchmarks for debt instruments evolved between 2022 and 2024, particularly in terms of referenced rates and associated covenants?",
      "original_answer": "In 2022, AMT's debt instruments referenced LIBOR, EURIBOR, and a defined base rate for USD and EUR denominated borrowings, with the 2021 credit facilities tied to debt ratings and commitment fees ranging from 0.080% to 0.300%. By 2024, AMT disclosed that new drawings under letters of credit in Nigeria bore interest at SOFR (Secured Overnight Financing Rate) plus a spread, indicating a shift away from LIBOR-based instruments. Additionally, while 2022 disclosures detailed specific covenants and optional renewal periods for various credit facilities, the 2024 disclosure focused on the consequences of covenant non-compliance without specifying interest rate structures or renewal terms, suggesting a simplification or evolution in the presentation of covenant-related disclosures.",
      "llm_answer": "\nBetween 2022 and 2024 AMT kept LIBOR and EURIBOR as the benchmark rates for its floating‑rate credit facilities, but the 2024 filing adds a dedicated section on the newly‑issued fixed‑rate 2024 senior notes that spells out the interest‑accrual method (360‑day year for USD, actual‑day count for EUR) and removes the make‑whole premium for redemptions on or after the par‑call date.  The newer disclosure also tightens the covenants: a change‑of‑control repurchase price of 101 % of principal plus accrued interest and a lien‑incurrence cap of 3.5× Adjusted EBITDA (with the same 3.5× EBITDA exception for permitted liens), whereas the 2022 filing only described the general 101 % repurchase and 3.5× EBITDA lien limits in broader terms.  Thus, the evolution is from a generic reference to LIBOR/EURIBOR‑based margins to a detailed, fixed‑rate note schedule coupled with updated, more explicit repurchase and lien‑incurrence covenants.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains significant factual errors and contradicts the ground truth on multiple critical points: (1) BENCHMARK RATE EVOLUTION - Ground truth states AMT shifted FROM LIBOR-based instruments TO SOFR by 2024, indicating a major transition away from LIBOR/EURIBOR. The LLM incorrectly claims AMT 'kept LIBOR and EURIBOR as the benchmark rates' between 2022-2024, which directly contradicts the documented shift to SOFR. (2) SOFR OMISSION - The ground truth explicitly mentions 'new drawings under letters of credit in Nigeria bore interest at SOFR (Secured Overnight Financing Rate) plus a spread' as a key 2024 development. The LLM completely omits SOFR, which is a central element of the evolution being asked about. (3) FIXED-RATE NOTES - The LLM introduces detailed discussion of '2024 senior notes' with specific interest-accrual methods (360-day year for USD, actual-day count for EUR) and make-whole premium details. The ground truth makes no mention of these fixed-rate note specifics, suggesting the LLM may be fabricating or confusing details. (4) COVENANT PRESENTATION - Ground truth states 2024 disclosure 'focused on the consequences of covenant non-compliance without specifying interest rate structures or renewal terms, suggesting a simplification.' The LLM claims the 2024 disclosure 'tightens the covenants' with more explicit terms, which contradicts the ground truth's characterization of simplification. (5) QUANTITATIVE SPECIFICS - The LLM provides specific percentages (101%, 3.5× Adjusted EBITDA) that are not verified in the ground truth and appear to be unsupported details. The multi-hop reasoning fails because the LLM did not correctly synthesize the actual evolution from LIBOR/EURIBOR to SOFR, which is the core finding. The answer demonstrates fundamental misunderstanding of the key disclosure evolution between 2022 and 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 506,
        "total_tokens": 1944
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has McDonald's relationship with franchisees evolved in terms of real estate ownership and co-investment strategy between 2022 and 2024?",
      "original_answer": "In 2022, McDonald's emphasized Systemwide coordination and alignment to manage ESG initiatives, including environmental sustainability and responsible sourcing, which required franchisee cooperation. However, the specific role of franchisees in real estate ownership was not detailed. By 2024, the company explicitly outlined its conventional franchise model, where it typically owns or secures long-term leases on land and buildings, while franchisees invest in equipment, signs, seating, and décor. This co-investment model was described as enabling McDonald's to achieve high restaurant performance levels. The shift from a general emphasis on franchisee collaboration in 2022 to a clearly defined real estate and co-investment strategy in 2024 reflects a more structured and strategic approach to franchise relationships.",
      "llm_answer": "\nBetween 2022 and 2024 McDonald’s moved from a largely “hands‑off” real‑estate stance—owning or long‑term leasing sites and expecting franchisees to bear the equipment and build‑out costs—to an active co‑investment model in which the company partners with franchisees to fund restaurant upgrades, modernizations and new‑build projects.  The 2024 filing explicitly notes that such collaborations are designed to accelerate the rollout of more attractive, higher‑revenue venues while still leveraging the company’s ownership of land and long‑term occupancy rights to control costs and drive stronger performance across the system.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ISSUES: The LLM answer fundamentally misrepresents McDonald's real estate strategy and the evolution between 2022-2024. The ground truth clearly states that McDonald's has CONSISTENTLY owned or secured long-term leases on land and buildings across both 2022 and 2024, with franchisees investing in equipment, signs, seating, and décor. The LLM incorrectly characterizes 2022 as a 'hands-off' real estate stance and falsely claims McDonald's moved TO an 'active co-investment model' by 2024. This is backwards - the company's real estate ownership model was already in place in 2022 and remained consistent through 2024. The LLM invents a narrative of change that doesn't exist in the ground truth. The actual evolution described in the ground truth is more subtle: from general emphasis on franchisee collaboration for ESG initiatives in 2022 to a more explicitly detailed and structured real estate/co-investment strategy articulation in 2024. The LLM's claim about 'hands-off' stance in 2022 contradicts the ground truth entirely. The mention of 'equipment and build-out costs' for franchisees is partially correct but the framing of this as a shift rather than a consistent model is factually wrong. The LLM does correctly identify that McDonald's owns/leases real estate and franchisees invest in equipment/décor, but the temporal narrative and characterization of change is fundamentally incorrect. No specific numbers or dates are provided by either answer, so quantitative accuracy is neutral. The multi-hop reasoning failed because the LLM created a false narrative of evolution rather than accurately synthesizing the actual strategic positioning across the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 460,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did the status and documentation of the 2015 Stock Compensation Plan for Non-Employee Directors change between 2022 and 2023, and what does this evolution indicate about Altria's governance approach to director compensation?",
      "original_answer": "In 2022, the 2015 Stock Compensation Plan for Non-Employee Directors was disclosed with 703,256 shares available for issuance under the plan. By 2023, the plan was formally amended and restated effective October 26, 2022, and was incorporated by reference from Altria's September 30, 2022, Form 10-Q filing. This indicates a formal update to the plan’s structure and governance, suggesting Altria refined its director compensation framework mid-cycle, potentially to align with evolving governance standards or internal compensation strategies.",
      "llm_answer": "\nBetween 2022 and 2023 the 2015 Stock Compensation Plan for Non‑Employee Directors kept its status as the sole, shareholder‑approved vehicle for director compensation; the only evolution was that the October 26 2022 amendment and restatement—first filed in the 2022 Form 10‑K—continued to be cited in the 2023 filing, confirming that no further amendment was made in 2023.  This continuity shows Altria’s governance approach of formally adopting a written, periodically restated compensation plan for directors, ensuring transparent and consistent oversight of director pay.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies the October 26, 2022 amendment and restatement date, which matches the ground truth. However, there are significant issues with completeness and accuracy: (1) The LLM answer omits the critical quantitative detail from the ground truth—the 703,256 shares available for issuance under the plan in 2022—which is a specific factual element that should have been included. (2) The LLM answer claims the amendment was 'first filed in the 2022 Form 10-K' but the ground truth indicates it was 'incorporated by reference from Altria's September 30, 2022, Form 10-Q filing,' suggesting the LLM may have the filing source wrong. (3) The LLM answer focuses heavily on continuity and lack of further amendment in 2023, which is a reasonable inference but goes beyond what the ground truth explicitly states about the evolution between years. (4) The ground truth emphasizes that the plan was 'formally amended and restated' and 'incorporated by reference,' indicating a formal update to structure and governance, while the LLM answer downplays this as mere continuity. (5) The LLM's interpretation that 'no further amendment was made in 2023' is an inference not explicitly stated in the ground truth. The answer demonstrates partial understanding but misses key quantitative data and potentially mischaracterizes the nature of the governance evolution described in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 390,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has the impact of roaming and resale arrangements among wireless service providers on AMT's leasing activity evolved from 2022 to 2024, and what does this indicate about the competitive pressures affecting new lease growth?",
      "original_answer": "In 2022, AMT noted that roaming or resale arrangements among wireless service providers, particularly with the rise of 5G technology, could slow new lease activity if carriers opted to share infrastructure rather than deploy new equipment. By 2024, this concern evolved into a broader risk involving RAN sharing and resale arrangements, which not only threatened new lease activity but also led to potential decommissioning of existing equipment due to redundancy. This indicates a growing competitive pressure where infrastructure sharing is becoming a more viable and widespread alternative to leasing, directly impacting AMT’s revenue growth prospects.",
      "llm_answer": "\nThe company’s disclosures show that the threat from roaming and resale‑type arrangements, which was first flagged as a risk in 2022, became a concrete drag on lease growth by 2024 – carriers are increasingly sharing sites or reselling capacity, which accelerates churn (e.g., the T‑Mobile MLA churn noted in 2023‑24) and reduces the need for new tower leases.  This intensifying competition is evident in the declining pace of new lease sign‑ups across the U.S., Canada, and APAC segments, signaling that roaming/resale pressures are now a primary head‑wind to AMT’s new‑lease growth.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures the general evolution of the roaming/resale threat from 2022 to 2024 and correctly identifies it as an increasing competitive pressure on AMT's lease growth. However, there are several issues: (1) QUANTITATIVE PROBLEMS: The LLM introduces specific claims about 'T-Mobile MLA churn noted in 2023-24' and 'declining pace of new lease sign-ups across the U.S., Canada, and APAC segments' without providing actual numbers or citations from the ground truth. The original answer does not mention T-Mobile MLA churn specifically, and the LLM appears to be adding details not present in the ground truth. (2) COMPLETENESS: The LLM answer addresses the evolution from 2022 to 2024 and the competitive pressure aspect, which matches the question requirements. However, it adds unsupported specifics about T-Mobile and segment-specific declines. (3) ENTITY ACCURACY: The company (AMT) and timeframe (2022-2024) are correct. The mention of T-Mobile is potentially accurate but not verified against the ground truth provided. (4) REASONING: The multi-hop synthesis is sound - the LLM correctly connects the 2022 risk to 2024 impact and links this to competitive pressures. However, the reasoning includes inferences (T-Mobile churn, segment-specific declines) not explicitly stated in the ground truth. (5) KEY DIFFERENCE: The original answer emphasizes the evolution from 'could slow' (2022) to actual decommissioning risk (2024), while the LLM focuses on 'concrete drag' and churn. The LLM's framing is reasonable but introduces specific examples not in the ground truth. The core insight about infrastructure sharing becoming a more viable alternative is present in both answers, but the LLM adds unverified details that reduce confidence in the response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 481,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has McDonald's relationship with its franchisees evolved between 2022 and 2024, particularly in terms of strategic investment and operational expectations?",
      "original_answer": "In 2022, McDonald's highlighted the impact of the COVID-19 pandemic on franchise operations, emphasizing risks related to labor availability, supply chain disruptions, and the importance of executing its 'Accelerating the Arches' strategy to maintain growth. The focus was on franchisees' ability to adapt to changing consumer behavior and operational restrictions. By 2024, McDonald's had shifted toward a more active investment role, co-investing with franchisees to modernize restaurants and improve local performance. The company emphasized franchisee reinvestment in their businesses and introduced structured co-investment initiatives designed to increase the value of the McDonald's brand through restaurant modernization and enhanced consumer appeal. This marks a shift from pandemic-driven operational challenges to a more strategic, investment-backed growth approach.",
      "llm_answer": "\nFrom 2022 to 2024 McDonald’s shifted from a primarily rent‑and‑royalty model to an active partnership that co‑invests with franchisees in restaurant modernization, technology and other capital upgrades while imposing tighter operational standards and requiring continual franchisee reinvestment; this evolution is detailed in the 2024 10‑K (pages 4, 27, 29) and was foreshadowed in the 2022 filing (pages 25‑26, 28‑30).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of McDonald's franchisee relationship evolution between 2022 and 2024. STRENGTHS: (1) Correctly identifies the core shift from pandemic-focused operational challenges (2022) to active co-investment partnerships (2024); (2) Accurately captures the key strategic elements: co-investment in modernization, technology upgrades, and tighter operational standards; (3) Properly synthesizes multi-hop information across two fiscal years; (4) Appropriately references specific 10-K page numbers (2024: pages 4, 27, 29 and 2022: pages 25-26, 28-30) showing document-level precision; (5) Uses semantically equivalent language to ground truth (e.g., 'active partnership' vs 'more active investment role', 'structured co-investment initiatives' vs 'co-investment initiatives'). MINOR CONSIDERATIONS: (1) The LLM answer adds the detail about 'tighter operational standards' which, while reasonable and likely supported by the filings, is not explicitly mentioned in the ground truth answer - this is a minor enhancement rather than an error; (2) The characterization of the prior model as 'primarily rent-and-royalty' is accurate but slightly more specific than the ground truth's framing; (3) The answer is more concise than the ground truth but captures all essential information. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are provided in either answer, so this dimension is not directly testable. The dates (2022, 2024) are correct. MULTI-HOP REASONING: The answer successfully synthesizes information across two fiscal years and identifies the directional shift in strategy, demonstrating sound multi-hop reasoning. The connection between pandemic challenges and subsequent investment strategy is logically sound.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 485,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did NextEra Energy's investment strategy in equity securities within its Special Use Funds evolve from 2022 to 2024?",
      "original_answer": "In 2022, NextEra Energy held $8,922 million in Special Use Funds, with no explicit breakdown of equity securities provided in the filing. By 2024, the company disclosed a more detailed composition, with $6,164 million specifically allocated to equity securities under Special Use Funds. This evolution suggests a strategic shift toward transparency and a potentially greater emphasis on equity investments within these funds. While the total amount in Special Use Funds decreased, the explicit allocation to equities in 2024 indicates a more defined and possibly more aggressive investment posture compared to 2022.",
      "llm_answer": "\nFrom 2022 through 2024 the Special Use Funds moved from a comparatively modest, fixed‑income‑heavy stance to a substantially larger and more diversified equity allocation.  NEE increasingly placed market‑able equities—often through broadly diversified, commingled vehicles—into these funds, emphasizing liquidity, tax efficiency and compliance with FERC/NRC limits on investing in NEE‑affiliated securities while still adhering to the prudent‑investor objectives of risk, diversification and return.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and lacks the specific quantitative data from the ground truth. Key issues: (1) QUANTITATIVE ACCURACY FAILURE: The LLM provides no specific dollar amounts or numbers from the filings. The ground truth clearly states $8,922 million in 2022 and $6,164 million in 2024 for equity securities in Special Use Funds. The LLM's characterization of the evolution as moving to 'substantially larger' equity allocation directly contradicts the ground truth showing a DECREASE from $8,922M to $6,164M. (2) DIRECTIONAL ERROR: The LLM claims an increase in equity allocation ('substantially larger'), but the actual data shows a decrease of $2,758 million. This is a fundamental misrepresentation of the investment strategy evolution. (3) MISSING CRITICAL FACTS: The LLM fails to cite the actual dollar amounts that are central to answering this question. The ground truth emphasizes the specific figures and notes the decrease while highlighting improved transparency. (4) UNSUPPORTED CLAIMS: The LLM makes assertions about 'broadly diversified, commingled vehicles,' FERC/NRC limits, and tax efficiency that are not substantiated in the ground truth and appear to be fabricated details. (5) INCOMPLETE SYNTHESIS: While the LLM attempts to address the 2022-2024 evolution, it does so without the factual foundation provided in the filings. The ground truth's key insight—that while total Special Use Funds decreased, the explicit disclosure of equity allocation increased (suggesting transparency improvement)—is completely missed. The LLM's answer reads as plausible-sounding but is fundamentally disconnected from the actual filing data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 458,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did the financial performance of smokeable products evolve from 2022 to 2023, particularly in terms of net revenues and operating income?",
      "original_answer": "In 2022, smokeable products generated $22,476 million in net revenues and contributed $10,688 million to operating income. In 2023, net revenues from smokeable products decreased slightly to $21,756 million, and operating income from this segment also declined to $10,670 million. This indicates a marginal decrease in both revenue and profitability year-over-year.",
      "llm_answer": "\nFrom 2022 to 2023 Altria’s smokeable‑product net revenues fell from **$22,476 million to $21,756 million** – a drop of roughly **$0.72 billion (≈3 %)**.  Operating income also slipped only modestly, moving from **$10,688 million to $10,670 million**, a decrease of about **$0.02 billion (≈0.2 %)**.  Thus, while revenue declined slightly, operating income remained essentially flat over the same period.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All four key numbers are correct - 2022 net revenues ($22,476M), 2023 net revenues ($21,756M), 2022 operating income ($10,688M), and 2023 operating income ($10,670M) match the ground truth exactly. CALCULATION VERIFICATION: Revenue decline calculation: $22,476M - $21,756M = $720M (LLM states ~$0.72B, which is correct). Percentage: $720M / $22,476M = 3.2% (LLM states ≈3%, acceptable rounding). Operating income decline: $10,688M - $10,670M = $18M (LLM states ~$0.02B, which is correct). Percentage: $18M / $10,688M = 0.17% (LLM states ≈0.2%, acceptable rounding). All calculations are accurate. ENTITY ACCURACY: Correctly identifies Altria as the company, smokeable products as the segment, and 2022-2023 as the time period. MULTI-HOP SYNTHESIS: Successfully synthesizes data across two years and two metrics (revenues and operating income) to provide a comprehensive comparison. SEMANTIC EQUIVALENCE: The LLM's characterization of the changes as 'marginal' and 'modest' aligns with the ground truth's description of 'marginal decrease' and 'declined.' The conclusion that 'operating income remained essentially flat' is semantically equivalent to the ground truth's observation of minimal decline. MINOR CONSIDERATION: The LLM provides slightly more analytical detail (percentage calculations) than the ground truth, but this adds value without introducing errors. The answer fully addresses the question about how financial performance evolved from 2022 to 2023.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1191,
        "completion_tokens": 429,
        "total_tokens": 1620
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has the utilization of Accenture plc Class A Ordinary Shares evolved between 2022 and 2023, particularly in terms of share purchase programs and their intended usage?",
      "original_answer": "In 2022, Accenture disclosed an aggregate available authorization of $3,129,296 for publicly announced open-market share purchase programs and other share purchase programs involving Accenture plc Class A Ordinary Shares and Accenture Canada Holdings Inc. exchangeable shares. By 2023, the company clarified that Class A Ordinary Shares acquired through these programs were being held as treasury shares and intended for employee benefits, such as equity awards. Additionally, in fiscal 2024, shares were acquired via share withholding for payroll tax obligations under employee equity share plans, which were separate from the publicly announced share purchase authorization. This indicates a shift in focus toward internal employee compensation mechanisms while maintaining a formal buyback program.",
      "llm_answer": "\nBetween fiscal 2022 and 2023 the company expanded its Class A repurchase activity: it bought roughly 12.2 million shares in 2022 (about 9.6 million in the publicly‑announced open‑market program and the remainder through employee‑plan withholding), and then increased open‑market purchases to ≈11.8 million shares in 2024 while still using the same treasury‑stock purpose.  The shares acquired are held as treasury stock to fund employee‑benefit programs such as equity awards and the 2010 Employee Share Purchase Plan, and the ESPP issuance rose from 4.4 million shares in 2022 to 5.7 million shares in 2023, reflecting a higher utilization of the share‑purchase programs for employee‑related purposes.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not supported by the ground truth:\n\n1. QUANTITATIVE ACCURACY ISSUES:\n   - The LLM provides specific share repurchase numbers (12.2 million in 2022, 11.8 million in 2024, 4.4 million ESPP in 2022, 5.7 million in 2023) that are NOT present in the ground truth answer\n   - The ground truth only mentions an aggregate authorization of $3,129,296 (a dollar amount, not share count)\n   - The LLM's specific share counts cannot be verified against the provided ground truth and appear to be fabricated or from different sources\n   - ESPP share numbers (4.4M to 5.7M) are presented as fact but not corroborated by ground truth\n\n2. TEMPORAL ACCURACY ISSUES:\n   - The question asks about 2022-2023 evolution, but the LLM introduces 2024 data (11.8 million shares in 2024) which shifts focus away from the requested timeframe\n   - The ground truth mentions fiscal 2024 only as additional context about share withholding, not as a primary comparison point\n\n3. MISSING KEY INFORMATION:\n   - The LLM fails to mention the $3,129,296 authorization figure that is central to the ground truth answer\n   - The ground truth emphasizes a \"shift in focus toward internal employee compensation mechanisms\" which the LLM touches on but doesn't clearly articulate as an evolution\n   - The distinction between publicly announced programs and employee-plan withholding is mentioned but not clearly differentiated in terms of the 2022-2023 evolution\n\n4. REASONING QUALITY:\n   - The LLM attempts multi-hop synthesis but introduces unsupported numerical claims\n   - The connection between share acquisition purposes and employee benefits is correctly identified but the specific metrics are unreliable\n   - The answer conflates different time periods (2022, 2023, 2024) without clear justification for why 2024 data is relevant to a 2022-2023 comparison\n\n5. SEMANTIC ISSUES:\n   - While the general concept of treasury stock for employee benefits is correct, the specific implementation details provided are not verifiable against the ground truth\n   - The answer presents specific share counts as if they are established facts when they should be treated as potentially inaccurate\n\nThe LLM answer demonstrates partial understanding of the topic but fails on factual accuracy by introducing unverified numerical claims and shifting the temporal focus away from the requested 2022-2023 period.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 655,
        "total_tokens": 2037
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How has the nature and structure of AMT's operating covenants evolved between 2022 and 2024, particularly in terms of the types of debt instruments involved and associated interest rate benchmarks?",
      "original_answer": "In 2022, AMT's operating covenants were tied to a variety of credit facilities and loans that referenced LIBOR and EURIBOR as the interest rate benchmarks. These included the 2021 Multicurrency Credit Facility, the 2021 Credit Facility, and several term loans. By 2024, AMT's disclosures indicate a shift in the interest rate benchmark to SOFR, specifically for letters of credit drawn in Nigeria, which were subject to a rate equal to SOFR at the time of drawing plus a spread. This reflects a transition away from LIBOR-based covenants toward SOFR-based structures, signaling a strategic and regulatory evolution in how AMT manages its debt obligations and associated covenants.",
      "llm_answer": "\nBetween 2022 and 2024 the covenants governing AMT’s operating cash‑flows shifted from a primarily floating‑rate structure tied to LIBOR/EURIBOR under the 2021 Multicurrency Credit Facility, 2021 Credit Facility and 2021 Term Loan toward a mixed‑instrument regime that adds fixed‑rate senior notes (e.g., 5.200 %–5.450 % USD notes and 3.900 %–4.100 % EUR notes) and amends the multicurrency facilities with extended maturities and updated applicable margins.  The newer covenants still retain the DSCR‑based cash‑trap and amortization thresholds, but they now also contain rating‑triggered change‑of‑control repurchase rights, a 3.5× Adjusted EBITDA limit on secured liens, and explicit references to the fixed‑coupon interest terms of the 2024 Notes, marking a clear evolution in both the types of debt covered and the benchmark rates used to price them.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not supported by the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM cites specific coupon rates (5.200%-5.450% USD notes, 3.900%-4.100% EUR notes) and a 3.5× Adjusted EBITDA limit on secured liens that are not mentioned in the ground truth. These appear to be fabricated numbers. (2) BENCHMARK TRANSITION MISCHARACTERIZATION: The ground truth clearly states the evolution was from LIBOR/EURIBOR to SOFR, with specific mention of letters of credit in Nigeria using SOFR plus spread. The LLM answer completely omits SOFR and instead focuses on fixed-rate senior notes, which is a different aspect entirely and not the primary benchmark evolution described in the ground truth. (3) INCOMPLETE SYNTHESIS: The LLM discusses DSCR-based cash-trap, amortization thresholds, and rating-triggered change-of-control repurchase rights, none of which appear in the ground truth answer. While these might be real covenant features, they are not part of the documented evolution between 2022-2024 regarding benchmark transitions. (4) MISSING CORE INFORMATION: The LLM fails to mention the critical shift to SOFR-based structures that is central to the ground truth answer. (5) STRUCTURAL ACCURACY: The LLM correctly identifies the 2021 Multicurrency Credit Facility and 2021 Credit Facility as 2022 instruments, but then diverges significantly in describing the 2024 evolution. The answer appears to conflate different aspects of debt structure (fixed vs. floating rates, covenant types) without properly addressing the specific benchmark evolution question. The ground truth is focused and precise about LIBOR/EURIBOR→SOFR transition; the LLM answer introduces unverified details about fixed-rate notes and specific covenant ratios that cannot be confirmed against the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 503,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did Disney+ Hotstar's subscriber base evolve between the 2023 and 2024 SEC filings, and what impact did the consolidation of Star+ into Disney+ in Latin America have on Disney's international streaming strategy?",
      "original_answer": "In the 2023 SEC filing, Disney+ Hotstar reported approximately 36 million paid subscribers as of September 28, 2024. The 2024 filing noted that in certain Latin American countries prior to July 2024, Disney offered both Disney+ and Star+ as separate services, but these were merged into a single Disney+ product offering by the end of June 2024. This consolidation suggests a strategic shift toward streamlining international service offerings, potentially aligning with the model used for Disney+ Hotstar by integrating diverse content into a unified brand to enhance user experience and operational efficiency.",
      "llm_answer": "\nDisney+ Hotstar’s paid subscriber base grew from roughly **30 million** reported in the 2023 filing to **≈36 million** as of September 28 2024 – an increase of about 20 percent.  The June 2024 consolidation of the separate **Star+** service into a single **Disney+** offering in Latin America eliminated a second brand, unified the region’s entertainment and sports content under the Disney+ umbrella, and gave Disney a more scalable, higher‑margin platform that improves monetisation and supports its longer‑term international streaming growth strategy.   (Pages 57 – subscriber definitions and merger; 123 – 2024 financial tables).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identified the key consolidation event (Star+ merged into Disney+ in Latin America by end of June 2024), accurately cited the September 28, 2024 date, and provided sound strategic reasoning about streamlining and operational efficiency. The qualitative analysis of the consolidation's impact on Disney's international strategy is well-articulated and logically sound. CRITICAL ISSUES: (1) QUANTITATIVE ERROR - The LLM claims Disney+ Hotstar grew from '~30 million' in 2023 to '~36 million' in 2024, calculating a 20% increase. However, the ground truth states the 2023 filing reported 'approximately 36 million paid subscribers as of September 28, 2024' - meaning 36 million was the 2024 figure, not a growth target. The LLM appears to have fabricated the '30 million' 2023 baseline without evidence from the ground truth. (2) MISSING CONTEXT - The ground truth does not provide a 2023 subscriber count for comparison, yet the LLM presents a specific growth narrative (30M→36M, +20%) that cannot be verified against the source material. (3) PAGE CITATIONS - The LLM cites 'Pages 57' and '123' without these being mentioned in the ground truth, suggesting potential hallucination of source references. MULTI-HOP REASONING: The consolidation analysis is sound and addresses both parts of the question (subscriber evolution and strategic impact), but the subscriber evolution claim is unsupported by the ground truth. The reasoning about unified branding and operational efficiency is appropriate but somewhat speculative beyond what the ground truth explicitly states. VERDICT: Core strategic insights are correct, but the quantitative foundation is flawed due to an unsupported growth narrative.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 469,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How has the number of employees covered under collective labor agreements changed from 2022 to 2023, and what does this indicate about the company's labor agreement strategy?",
      "original_answer": "In 2022, the company expected to negotiate agreements covering approximately 3,000 employees in the following year. In 2023, the company projected negotiations covering 2,100 employees for the upcoming year. This indicates a reduction in the number of employees involved in labor renegotiations, suggesting a shift in the company's labor agreement strategy, possibly due to fewer expiring agreements or proactive resolution of collective bargaining terms.",
      "llm_answer": "\nFrom the disclosures, the company expected to negotiate 21 collective‑ bargaining agreements covering roughly 3,000 employees in 2022, but in 2023 it plans to negotiate only 20 agreements covering about 2,100 employees. This decline in both the number of agreements and the employee base indicates that the firm is scaling back its labor‑agreement workload—consolidating negotiations and focusing on a smaller group of workers—rather than expanding or maintaining the prior level of coverage.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains both correct and problematic elements. CORRECT ELEMENTS: (1) The core numbers are accurate - 3,000 employees in 2022 and 2,100 employees in 2023 are correct; (2) The directional analysis is sound - the answer correctly identifies a reduction in employee coverage; (3) The reasoning about labor agreement strategy shift is appropriate and matches the ground truth interpretation. PROBLEMATIC ELEMENTS: (1) The LLM introduces additional information about 'number of agreements' (21 vs 20) that is NOT present in the ground truth answer. While this detail may be factually correct from the filing, it goes beyond what was established in the original answer and cannot be verified against the provided ground truth; (2) The characterization of this as 'consolidating negotiations' is an inference not explicitly stated in the ground truth, which more conservatively describes it as 'fewer expiring agreements or proactive resolution'; (3) The phrase 'scaling back its labor-agreement workload' is interpretive language not directly supported by the ground truth statement. MULTI-HOP REASONING: The answer correctly synthesizes the year-over-year comparison and draws logical conclusions about strategy shifts. The reasoning is sound even if some interpretations exceed the ground truth. QUANTITATIVE ACCURACY: The two key numbers (3,000 and 2,100) are correct, but the introduction of agreement counts (21 vs 20) cannot be verified and represents added information. OVERALL ASSESSMENT: The answer is substantially correct on the main question but adds unverified details and uses more interpretive language than the ground truth. The core insight about the reduction and strategy shift is accurate, but the execution includes elements that go beyond the established facts.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 487,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did NextEra Energy's investment in U.S. Government and municipal bonds evolve from 2022 to 2024, and what was the change in total value across these years?",
      "original_answer": "In 2022, NextEra Energy's investment in U.S. Government and municipal bonds totaled $137 million. By 2024, this investment had increased significantly to $161 million under 'Other investments' for NEE. This represents a growth of $24 million, or approximately 17.5%, indicating a strategic increase in this asset class over the two-year period.",
      "llm_answer": "\nNextEra Energy’s holdings of U.S. Government and municipal bonds increased from $177 million in 2022 (as reported in the 2022 filing) to $722 million in 2024 (the total fair‑value shown in the 2024 filing).  This represents a net rise of $545 million over the two‑year period.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on all key metrics. (1) QUANTITATIVE ERRORS - The LLM reports 2022 value as $177 million when ground truth is $137 million (40 million dollar discrepancy). The LLM reports 2024 value as $722 million when ground truth is $161 million (561 million dollar discrepancy). The calculated change of $545 million is completely wrong; the correct change is $24 million. The percentage growth calculation is also wrong (LLM implies ~307% growth vs. actual 17.5%). (2) ENTITY/METRIC CONFUSION - The LLM appears to have pulled numbers from an entirely different investment category or company entity. The $722 million figure does not match NextEra Energy's U.S. Government and municipal bonds holdings in 2024. The LLM may have confused this with total fair-value of all investments or a different asset class. (3) MULTI-HOP REASONING - The LLM failed to correctly synthesize the 2022 and 2024 data from NextEra Energy's filings. The numbers suggest the model either hallucinated values or pulled from incorrect line items in the financial statements. (4) COMPLETENESS - While the LLM attempted to address the evolution and calculate the change, the underlying data is so inaccurate that the answer is misleading. The ground truth shows a modest 17.5% increase in a specific bond category, while the LLM's answer suggests a dramatic 307% increase in what appears to be a different metric entirely. This represents a critical failure in financial data accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1158,
        "completion_tokens": 411,
        "total_tokens": 1570
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How has the role of Opdivo in Bristol-Myers Squibb's product portfolio evolved between 2022 and 2024, particularly in terms of its manufacturing strategy and therapeutic approvals?",
      "original_answer": "In 2022, Opdivo was referenced as a product with both internal manufacturing capability and reliance on third-party manufacturers to meet demand, highlighting its strategic importance in BMY's supply chain. By 2024, Opdivo received a new FDA approval in March for combination therapy with cisplatin and gemcitabine for first-line treatment of unresectable or metastatic urothelial carcinoma, indicating an expansion of its therapeutic applications. This evolution reflects both continued manufacturing investment and increased clinical positioning of Opdivo within BMY's oncology portfolio.",
      "llm_answer": "\nBetween 2022 and 2024 Opdivo’s therapeutic footprint broadened dramatically—gaining EC approval for the Opdivo + Yervoy first‑line colorectal‑cancer regimen, FDA approval for neoadjuvant NSCLC, EC and Japan approvals for urothelial‑cancer, and the launch of the subcutaneous formulation Opdivo Qvantig (Dec 2024).  To meet the expanding list of indications, BMS reinforced its flexible manufacturing model, investing in its own cGMP‑certified sites (e.g., Devens, Cruiserath) while deepening third‑party and backup‑source agreements and upgrading processes (including the new subcutaneous platform) to secure reliable, scalable supply for the growing portfolio.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR DISCREPANCIES IDENTIFIED: The LLM answer contains significant factual errors that contradict the ground truth. (1) INCORRECT APPROVALS: The ground truth specifically states Opdivo received FDA approval in March 2024 for combination therapy with cisplatin and gemcitabine for urothelial carcinoma. The LLM answer mentions EC approval for colorectal cancer, neoadjuvant NSCLC, and urothelial cancer approvals, but NONE of these match the ground truth's specific March 2024 urothelial carcinoma + cisplatin/gemcitabine approval. The LLM appears to have fabricated or confused multiple approvals not mentioned in the ground truth. (2) INCORRECT PRODUCT LAUNCH: The LLM mentions 'Opdivo Qvantig' subcutaneous formulation launch in December 2024, which is NOT mentioned in the ground truth at all. This appears to be hallucinated information. (3) MANUFACTURING DETAILS: While the LLM correctly identifies the dual manufacturing strategy (internal + third-party), it provides specific facility names (Devens, Cruiserath) and details not present in the ground truth, making verification impossible and suggesting potential fabrication. (4) INCOMPLETE ALIGNMENT: The ground truth emphasizes a single, specific 2024 approval (urothelial carcinoma with cisplatin/gemcitabine in March), while the LLM lists multiple unverified approvals across different regions and indications. (5) MULTI-HOP REASONING: The LLM failed to correctly synthesize the specific 2022-2024 evolution described in the ground truth, instead providing a different narrative with unsubstantiated claims. The answer demonstrates poor factual accuracy on the core question elements.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 450,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has Disney's relationship with National Geographic magazine evolved between 2023 and 2024 in terms of its business structure and strategic positioning within the company's portfolio?",
      "original_answer": "In 2023, National Geographic magazine was explicitly described as part of the Entertainment segment under Content Sales/Licensing, and was noted as being 73% owned by Disney. By 2024, the magazine was still reported under Content Sales/Licensing, but the emphasis on its ownership percentage was removed, and it was described more as a publication 'published' by the company rather than a business in which Disney has a direct equity stake. This shift indicates a more operational rather than ownership-focused relationship in 2024 compared to 2023.",
      "llm_answer": "\nBetween fiscal 2023 and 2024 Disney kept National Geographic magazine (and its online business) inside the Entertainment segment’s **Content Sales/Licensing** line and still records it as a **73 %‑owned** subsidiary.  The brand continues to be reported alongside the linear‑network and DTC businesses, supplying magazine‑and‑digital advertising and licensing revenue, but there was no re‑classification or creation of a separate segment—its strategic role remained that of a niche, non‑sports content property that bolsters Disney’s overall content‑sales portfolio.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains a critical factual error that directly contradicts the ground truth. The original answer explicitly states that by 2024, 'the emphasis on its ownership percentage was removed' and the relationship shifted from ownership-focused to operational. However, the LLM answer claims that Disney 'still records it as a 73%-owned subsidiary' in 2024, which is the opposite of what the ground truth indicates. This is a fundamental misunderstanding of the key evolution being described. The LLM correctly identifies that National Geographic remained in the Entertainment segment's Content Sales/Licensing line in both years, and correctly notes the 73% ownership figure for 2023. However, the failure to recognize the shift away from emphasizing ownership in 2024 represents a major error in capturing the core insight of the question about how the relationship 'evolved.' The LLM also misses the semantic shift from describing it as 'a business in which Disney has a direct equity stake' (2023) to 'a publication published by the company' (2024), which is central to understanding the strategic repositioning. The answer provides some relevant context about the segment placement and revenue streams, but this contextual information does not compensate for the incorrect assertion about 2024 ownership emphasis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 370,
        "total_tokens": 1659
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has PayPal's description of its transaction management databases' capabilities evolved between 2023 and 2024, particularly in relation to global payment processing in different currencies?",
      "original_answer": "In 2023, PayPal described its transaction management databases as part of a platform that allowed consumers to withdraw funds in 56 currencies. By 2024, the company updated this figure to 57 currencies, indicating a slight expansion in the global reach of its transaction processing capabilities. Additionally, while both years emphasize the role of these databases in enabling customers to utilize PayPal's suite of products, the 2024 filing introduced a more consumer-centric framing, placing 'consumers' ahead of 'merchants' in describing the ecosystem served by the platform. These changes suggest a refinement in how PayPal positions its transaction management systems within its broader global payments infrastructure.",
      "llm_answer": "\nIn the 2023 filing PayPal described its payments platform as supporting transactions in “approximately 140 currencies,” while the 2024 filing updated that figure to “approximately 150 currencies,” explicitly noting the broader multi‑currency coverage of its transaction‑management databases. Both years still reference the ability to hold balances in 24 currencies and withdraw funds in 57 currencies, but the increase in the number of supported payment currencies shows the evolution of PayPal’s global‑payment processing capability between 2023 and 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. (1) CRITICAL ERRORS: The LLM claims PayPal supported 'approximately 140 currencies' in 2023 and 'approximately 150 currencies' in 2024 for transaction processing. The ground truth states the relevant metric is withdrawal capabilities: 56 currencies in 2023 and 57 currencies in 2024. These are completely different figures and metrics. (2) QUANTITATIVE ACCURACY ISSUES: The LLM introduces numbers (140, 150, 24 currencies for holding balances) that do not appear in the ground truth answer. While the LLM correctly identifies 57 currencies for 2024 withdrawals, it incorrectly states this figure applies to both years, when the ground truth clearly indicates 56 in 2023 and 57 in 2024. (3) MISSING KEY INSIGHT: The ground truth emphasizes an important qualitative evolution - the shift in framing from 'merchants' to 'consumers' in the 2024 filing, which the LLM completely omits. This represents a significant strategic repositioning that the question specifically asks about. (4) MULTI-HOP REASONING: The LLM failed to correctly synthesize the evolution between years. It conflates different metrics (transaction support currencies vs. withdrawal currencies) and misses the consumer-centric framing change that is central to the ground truth answer. (5) CONTEXTUAL MISALIGNMENT: The question asks about evolution in 'transaction management databases' capabilities, and the ground truth correctly identifies the withdrawal currency metric (56→57) as the relevant evolution. The LLM's introduction of 140/150 currency figures appears to be either fabricated or from a different context entirely, making the answer fundamentally unreliable.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 470,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the interest rate terms associated with the Series K Debentures evolve between 2023 and 2024, and what does this indicate about NEE's financing strategy?",
      "original_answer": "In 2023, the Series K Debentures had their interest rate reset to 6.051% per year as part of a remarketing completed in March 2023. By 2024, the terms of the Series K Debentures were further updated through a letter dated March 1, 2023, which set forth certain terms effective March 1, 2023, indicating a continuation of the updated rate and terms from the 2023 remarketing. This suggests that NEE adjusted its financing strategy in response to market conditions, locking in a higher interest rate to secure funding.",
      "llm_answer": "\nBetween 2023 and 2024 the Series K Debentures kept the rate that was reset in March 2023 – 6.051 % per annum, payable semi‑annually on March 1 and September 1 – and no subsequent amendment or new reset was disclosed in the 2024 filings.  This shows that NEE is deliberately locking in long‑dated, fully‑guaranteed fixed‑rate debt at a known cost, using the Series K notes as a stable financing pillar to fund its clean‑energy expansion while preserving flexibility for future refinancing in a rising‑rate environment.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of the 6.051% interest rate and the March 2023 reset date. The quantitative details are accurate: the rate, payment schedule (semi-annually on March 1 and September 1), and the fact that no subsequent amendment was disclosed in 2024 filings are all correct. The LLM correctly synthesizes the multi-hop information by comparing 2023 and 2024 terms and concluding they remained stable. The reasoning about NEE's financing strategy is sound and more detailed than the ground truth, explaining the strategic rationale (locking in fixed-rate debt, funding clean-energy expansion, preserving refinancing flexibility). The LLM answer is more comprehensive in explaining the strategic implications. Minor difference: The ground truth mentions a letter dated March 1, 2023 setting forth terms, while the LLM focuses on the March 2023 remarketing and the absence of subsequent amendments. Both convey the same essential fact that the rate remained stable from 2023 to 2024. The LLM's interpretation that NEE is 'deliberately locking in' fixed-rate debt is a reasonable inference from the facts, though slightly more interpretive than the ground truth's more neutral statement. Overall, the answer correctly addresses both parts of the question (how terms evolved and what it indicates about strategy) with accurate numbers and sound reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 392,
        "total_tokens": 1654
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has ExxonMobil's application of the Unit-of-Production Depreciation method evolved between 2022 and 2023, particularly in response to changes in proved reserves and asset life assumptions?",
      "original_answer": "In 2022, ExxonMobil applied the Unit-of-Production Depreciation method based on proved reserves or proved developed reserves, switching to straight-line depreciation when asset life did not correlate with reserves, and using SEC price-based reserves only when proved reserves were substantially de-booked. By 2023, the company maintained the same core methodology but placed greater emphasis on using the most recent SEC price to determine reserves for depreciation in cases where reserves had been significantly reduced, ensuring a more meaningful allocation of asset costs over the expected life of the asset. This reflects a refinement in the company's approach to align depreciation with updated economic conditions and production realities.",
      "llm_answer": "\nExxonMobil continued to depreciate most upstream assets with the unit‑of‑production method in both 2022 and 2023, but the 2023 disclosure tightens how that method is applied.  It now bases the depreciation factor on proved‑reserve estimates derived from the most recent SEC‑price‑adjusted reserves—especially when reserves are substantially de‑booked—so the depreciation charge reflects the latest reserve volumes and any technical changes.  The company also reiterates that if the unit‑of‑production approach would not produce an equitable allocation of cost over an asset’s economic life, it will switch to straight‑line depreciation, a fallback that is invoked when the asset’s useful life no longer correlates with the underlying reserve life.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of ExxonMobil's Unit-of-Production Depreciation methodology and its evolution between 2022 and 2023. STRENGTHS: (1) Correctly identifies the core methodology in both years - unit-of-production for upstream assets with fallback to straight-line depreciation when asset life doesn't correlate with reserves; (2) Accurately captures the 2023 refinement emphasizing use of most recent SEC price-adjusted reserves, particularly when reserves are substantially de-booked; (3) Properly synthesizes the multi-hop concept that depreciation allocation should reflect updated economic conditions and production realities; (4) No quantitative errors - no specific numbers, percentages, or dollar amounts are provided in either answer, so quantitative accuracy is not compromised; (5) Correctly identifies both years (2022 and 2023) and the company (ExxonMobil). MINOR WEAKNESSES: (1) The LLM answer uses slightly different phrasing ('tightens how that method is applied' vs. 'placed greater emphasis') but conveys the same semantic meaning; (2) The LLM answer emphasizes 'technical changes' alongside reserve volumes, which is a reasonable inference but not explicitly stated in the ground truth; (3) The ground truth mentions 'proved developed reserves' as an alternative basis, which the LLM answer doesn't explicitly mention, though this is a minor omission. MULTI-HOP REASONING: The answer correctly synthesizes information about how the methodology evolved - showing continuity in core approach while highlighting the specific refinement regarding SEC price-based reserves and de-booking scenarios. The logical flow connecting depreciation methodology to economic conditions and production realities is sound. Overall, the answer captures the essential evolution and maintains factual accuracy while using slightly different but semantically equivalent language.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 515,
        "total_tokens": 1899
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has Netflix's strategic emphasis on original programming evolved between 2023 and 2024, particularly in terms of its reliance on third-party production partners versus internal studio scaling?",
      "original_answer": "In 2023, Netflix emphasized its investments in original programming and highlighted the risks associated with third-party production partners, including potential liability and loss due to legal violations, insolvency, or fraud. It also noted its acquisitions like Scanline and Animal Logic as part of scaling internal studio operations. By 2024, the company shifted its language to focus on the growing complexity of managing original content production and placed greater emphasis on the need to improve internal systems, corporate culture, and operational practices related to content creation. The explicit mention of third-party risks present in 2023 was omitted in 2024, suggesting a reduced dependency on external partners and a stronger strategic move toward internal control and scaling.",
      "llm_answer": "\nBetween 2023 and 2024 Netflix shifted from a model that depended heavily on external production partners and licensing deals for its originals—emphasizing the risk that partner relationships could lapse or that partner‑produced content might not meet expectations (see 2023 10‑K pages 6 & 7)—to a strategy that increasingly builds internal studio capacity.  The 2024 filing notes the scaling of its own studios, acquisitions of production outfits such as Scanline and Animal Logic, and a broader push to produce more original programming in‑house, thereby reducing reliance on third‑party producers while still collaborating with outside creators (see 2024 10‑K pages 7 & 30).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth on the core strategic shift Netflix made between 2023 and 2024. STRENGTHS: (1) Correctly identifies the key evolution from external partner reliance to internal studio scaling; (2) Accurately names specific acquisitions (Scanline and Animal Logic) that exemplify the internal scaling strategy; (3) Properly synthesizes the multi-hop reasoning across both years' filings; (4) Correctly captures the shift in emphasis from third-party risks to internal operational improvements; (5) Appropriately notes the continued collaboration with external creators while emphasizing reduced reliance. MINOR WEAKNESSES: (1) The LLM answer references specific page numbers (pages 6, 7, 30) which cannot be verified against the ground truth and may or may not be accurate—this is a minor issue since the core facts are correct; (2) The phrasing about 'partner relationships could lapse' is slightly different from the ground truth's mention of 'liability and loss due to legal violations, insolvency, or fraud,' though both convey similar risk concepts; (3) The answer could have been more explicit about the omission of third-party risk language in 2024 as evidence of the strategic shift, though this is implied. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are provided in either answer, so this dimension is not directly testable. The years (2023, 2024) are correct. MULTI-HOP REASONING: The answer successfully synthesizes information across two years of filings and correctly identifies the causal relationship between acquisitions and the strategic shift. The logic connecting internal scaling to reduced third-party dependency is sound. SEMANTIC EQUIVALENCE: The LLM answer conveys the same essential information as the ground truth, with acceptable variations in wording that maintain factual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 512,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has the strategic positioning of Mastercard's Cyber and Intelligence Solutions evolved between 2022 and 2023?",
      "original_answer": "In 2022, Cyber and Intelligence Solutions were positioned as part of 'Other revenues' and primarily described as products and services offered to prevent, detect, and respond to fraud, ensuring the safety of transactions made on Mastercard products. By 2023, the Cyber and Intelligence Solutions were elevated in strategic importance, being explicitly described as a value-added service that enables secure, easy, and confident transactions across the entire payments ecosystem, indicating a broader role in supporting Mastercard’s core operations and new network investments.",
      "llm_answer": "\nBetween 2022 and 2023 Mastercard kept Cyber and Intelligence Solutions at the core of its “value‑added services and solutions” portfolio, emphasizing that these offerings – which protect and secure transactions on its payments network – are a strategic growth driver.  The 2023 10‑K highlights that revenue from these services contributed to the 13 % rise in net revenue, underscoring a continued (and slightly expanded) strategic focus on cyber‑security and intelligence compared with the prior year.  (See MA_10k_2023.pdf pp. 49, 80; MA_10k_2022.pdf pp. 72‑81.)",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations compared to the ground truth. Key issues: (1) INCORRECT POSITIONING CLAIM: The LLM states Cyber and Intelligence Solutions were 'at the core of its value-added services and solutions portfolio' in both years, but the ground truth explicitly states they were positioned as part of 'Other revenues' in 2022, not as core value-added services. This is a fundamental mischaracterization of the 2022 positioning. (2) MISSING KEY EVOLUTION: The LLM fails to capture the critical strategic shift - that these solutions were ELEVATED in importance from 2022 to 2023, moving from 'Other revenues' classification to explicit positioning as value-added services. This is the core answer to the question about how positioning 'evolved.' (3) UNSUBSTANTIATED QUANTITATIVE CLAIM: The LLM cites a '13% rise in net revenue' attributed to Cyber and Intelligence Solutions, but provides no verification this figure is accurate or that it specifically relates to these solutions. This appears to be an unsupported quantitative assertion. (4) INCOMPLETE DESCRIPTION: The ground truth notes the 2023 positioning emphasizes 'secure, easy, and confident transactions across the entire payments ecosystem' and a 'broader role in supporting Mastercard's core operations and new network investments' - nuances the LLM answer misses. (5) CITATION ACCURACY: While the LLM provides page references, the actual content described doesn't match the ground truth's characterization of the 2022 vs 2023 positioning shift. The answer demonstrates partial understanding of the topic but fundamentally misrepresents the strategic evolution by suggesting continuity rather than elevation/evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 472,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has Tesla's approach to energy storage products evolved from 2023 to 2024, particularly in terms of production challenges and strategic dependencies?",
      "original_answer": "In 2023, Tesla emphasized its modular design and in-house expertise in power electronics and software to optimize the manufacturing and performance of its energy storage products like Megapack. By 2024, Tesla's focus shifted to addressing production ramps and supply chain dependencies, citing potential bottlenecks and the need for efficient, cost-effective manufacturing capabilities. The company also highlighted risks related to supplier reliability and the challenges of scaling production to meet planned output rates and quality standards for energy storage products.",
      "llm_answer": "\nFrom 2023 to 2024 Tesla moved its energy‑storage business from a largely “vehicle‑derived, supplier‑dependent” model toward one that couples in‑house battery‑cell production with an expanded global factory footprint (e.g., the planned Monterrey site and existing Gigafactories in China and Germany).  This shift is intended to cut costs, reduce tariff exposure and secure the lithium‑ion cell supply needed for Megapack and Powerwall, but it also introduces new production‑ramp challenges—namely securing reliable cell supply, managing a more complex, geographically dispersed supply chain, and meeting aggressive cost‑competitiveness targets—making local manufacturing and battery‑cell sourcing critical strategic dependencies.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and introduces unsupported claims not present in the ground truth. Key issues: (1) FACTUAL ERRORS: The LLM claims Tesla shifted from a 'vehicle-derived, supplier-dependent' model to in-house battery-cell production for energy storage, but the ground truth makes no mention of Tesla producing battery cells for Megapack/Powerwall or any shift toward in-house cell production. The ground truth specifically emphasizes 'in-house expertise in power electronics and software' - not battery cell manufacturing. (2) UNSUPPORTED CLAIMS: The LLM introduces specific references to 'Monterrey site,' 'Gigafactories in China and Germany' for energy storage, and 'lithium-ion cell supply' that are not mentioned in the ground truth and appear to conflate Tesla's vehicle battery strategy with energy storage strategy. (3) MISSING CORE ELEMENTS: The LLM fails to capture the ground truth's emphasis on 'modular design' (2023) and the specific evolution toward addressing 'production ramps and supply chain dependencies' (2024). (4) PARTIAL ALIGNMENT: The LLM correctly identifies that both years involve supply chain challenges and production scaling issues, and correctly names Megapack and Powerwall products. However, the framing of the evolution is fundamentally different and introduces incorrect details about vertical integration in battery cell production. (5) MULTI-HOP REASONING: While the LLM attempts to synthesize a narrative about evolution, it does so by introducing information not supported by the ground truth, which undermines the validity of the synthesis. The answer reads as plausible but factually diverges significantly from the actual filing information.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 469,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did NextEra Energy Capital Holdings' issuance strategy for floating rate debentures evolve from 2023 to 2024, particularly in terms of the principal amount and maturity structure?",
      "original_answer": "In 2023, NextEra Energy Capital Holdings disclosed the sale of $600 million in floating rate debentures due in 2026. By 2024, the company formalized this issuance through an Officer's Certificate dated January 31, 2024, specifying the Floating Rate Debentures, Series due January 29, 2026. While the principal amount was not explicitly updated in 2024, the maturity structure remained consistent with the 2026 horizon, indicating a focused strategy on short-to-medium-term floating rate debt. This reflects a continuation of the prior year's approach without significant expansion or restructuring of the floating rate debenture program.",
      "llm_answer": "\nFrom the 2023 filing (page 105) NEECH had only a modest floating‑rate tranche – roughly $600 million of floating‑rate debentures that matured in 2026.  In early 2024 the company broadened its floating‑rate program into a larger, multi‑year issuance (the $3.8 billion debenture offering referenced on page 105), keeping the floating‑rate series at the 2026 maturity but adding later‑dated fixed‑rate pieces up to 2054 and resetting rates to 4.90 %–5.55 %.  Consequently, the strategy moved from a single, short‑term floating‑rate issue to a more diversified floating‑rate component within a staggered maturity ladder.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM claims a '$3.8 billion debenture offering' occurred in early 2024, but the ground truth explicitly states 'the principal amount was not explicitly updated in 2024.' The LLM fabricates a major issuance that does not appear in the ground truth. The $600 million figure from 2023 is correctly cited, but the 2024 expansion to $3.8 billion is unsupported. (2) MATURITY STRUCTURE MISREPRESENTATION: The LLM claims the company 'added later-dated fixed-rate pieces up to 2054' and mentions 'rates to 4.90%-5.55%.' These specific details are not mentioned in the ground truth, which states the maturity structure 'remained consistent with the 2026 horizon' with 'no significant expansion or restructuring.' (3) STRATEGIC CHARACTERIZATION ERROR: The ground truth describes the strategy as 'a continuation of the prior year's approach without significant expansion,' but the LLM characterizes it as moving 'from a single, short-term floating-rate issue to a more diversified floating-rate component within a staggered maturity ladder.' This directly contradicts the ground truth's assertion of consistency and lack of expansion. (4) MULTI-HOP REASONING FAILURE: The LLM failed to correctly synthesize the 2023 and 2024 information. Rather than identifying continuity, it invented a major expansion that doesn't exist in the source material. (5) CITATION ISSUES: References to 'page 105' appear to be fabricated or misinterpreted, as they don't correspond to verifiable ground truth data. The answer demonstrates hallucination of material facts rather than accurate synthesis of filing information.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 468,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has Intel's approach to industry initiatives related to supply chain responsibility evolved from 2023 to 2024, particularly in terms of collaboration focus and supplier engagement scope?",
      "original_answer": "In 2023, Intel announced a significant expansion of its supplier engagement activities under its RISE strategy, aiming to increase the number of suppliers covered in sustainability and compliance programs, and set a goal to achieve net-zero upstream Scope 3 greenhouse gas emissions by 2050. By 2024, Intel's approach evolved to emphasize broader collaboration on responsible minerals sourcing and transparency around climate and water impacts, with a continued focus on capability-building programs for suppliers but without explicit mention of expanding the number of suppliers engaged. The shift indicates a move from announcing strategic expansions to reinforcing and deepening existing industry partnerships.",
      "llm_answer": "\nFrom 2023 to 2024 Intel deepened its industry‑level collaborations under the RISE strategy—expanding beyond the earlier focus on climate‑water transparency and responsible‑minerals sourcing to include joint standards for GHG emissions, renewable‑energy use and circular‑economy initiatives—while at the same time broadening the scope of its supplier engagement. The 2024 disclosures show a markedly larger, more granular supplier base (including indirect tiers), new performance‑linked incentives for emissions reductions, and heightened targets such as 100 % renewable electricity and net‑zero Scope 3 by 2050, indicating a more comprehensive and integrated approach to supply‑chain responsibility.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and contradicts the ground truth on key points: (1) DIRECTIONAL ERROR: The ground truth states Intel's approach shifted FROM announcing strategic expansions TO reinforcing existing partnerships, emphasizing a consolidation rather than expansion. The LLM claims the opposite—that Intel 'expanded beyond' and 'broadened the scope' of supplier engagement, which directly contradicts the ground truth's core finding. (2) UNSUPPORTED CLAIMS: The LLM introduces specific claims not present in the ground truth: 'joint standards for GHG emissions,' 'renewable-energy use and circular-economy initiatives,' 'performance-linked incentives for emissions reductions,' and '100% renewable electricity' targets. These appear to be fabricated or hallucinated details not supported by the provided ground truth. (3) SCOPE MISCHARACTERIZATION: The ground truth explicitly notes that 2024 disclosures did NOT include 'explicit mention of expanding the number of suppliers engaged,' yet the LLM claims a 'markedly larger, more granular supplier base (including indirect tiers).' This is a direct factual error. (4) PARTIAL ACCURACY: The LLM correctly identifies the RISE strategy, the net-zero Scope 3 by 2050 goal, and the general focus on responsible minerals sourcing and transparency—these elements align with ground truth. However, the overall narrative arc is inverted. (5) MULTI-HOP REASONING: The synthesis fails because it misinterprets the evolution trajectory. The ground truth describes a shift from expansion announcements to deepening existing work; the LLM describes continued expansion, which is fundamentally incorrect. The answer demonstrates poor reading comprehension of the ground truth's key distinction about the nature of the strategic shift.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 490,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has the characterization of the assumptions underlying the standardized measure of discounted future cash flows evolved between XOM's 2022 and 2023 disclosures, particularly regarding the company's framing of its dependency on first-day-of-the-month average prices?",
      "original_answer": "In XOM's 2022 filing, the standardized measure of discounted future cash flows was described as being 'prepared on the basis of certain prescribed assumptions,' which included first-day-of-the-month average prices. This framing emphasized that the assumptions were foundational to the calculation but did not explicitly highlight the degree of dependency on them. In contrast, the 2023 filing reflects a shift in tone by emphasizing that the standardized measure 'depends on' these prescribed assumptions, particularly first-day-of-the-month average prices, which are described as discrete points in time that 'may cause significant variability in cash flows from year to year as prices change.' This indicates a more explicit acknowledgment of the sensitivity and dependency of the measure on these assumptions, even though the actual calculation methodology remained unchanged, using the same 10 percent discount factor, year-end costs, and legislated tax rates.",
      "llm_answer": "\nBetween 2022 and 2023 ExxonMobil kept the same description of the standardized discounted‑cash‑flow measure: it is calculated using first‑day‑of‑the‑month average prices (along with year‑end costs and statutory tax rates) and a 10 % discount rate.  The company repeatedly stresses that this “prescribed” use of discrete average prices can create substantial year‑to‑year variability in the resulting cash‑flow estimates and that the measure is not meant to reflect the firm’s actual expected cash flows.  In other words, the 2023 filing reiterates the 2022 framing—highlighting the company’s reliance on first‑day‑of‑the‑month averages and the resulting sensitivity of the standardized measure to those price points.",
      "correctness_score": 3,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains a fundamental factual error that directly contradicts the ground truth and the core premise of the question. The question asks how the characterization has 'evolved' between 2022 and 2023, and the ground truth clearly establishes that there WAS a shift in framing: from 2022's 'prepared on the basis of certain prescribed assumptions' to 2023's emphasis on the measure 'depends on' these assumptions with explicit acknowledgment of sensitivity. However, the LLM answer explicitly states 'Between 2022 and 2023 ExxonMobil kept the same description' and 'the 2023 filing reiterates the 2022 framing.' This is directly contradictory to the ground truth's central finding of an evolution in tone and framing. The LLM correctly identifies the technical details (10% discount rate, first-day-of-the-month average prices, year-end costs, statutory tax rates) and accurately notes the emphasis on variability and that the measure doesn't reflect actual expected cash flows. However, by claiming the descriptions remained the same rather than evolved, the LLM fundamentally misses the key distinction the question is asking about. The quantitative accuracy is high (all technical parameters correct), but the qualitative accuracy is severely compromised because the LLM failed to recognize and articulate the shift from 'prescribed assumptions' framing to 'depends on' framing with explicit sensitivity acknowledgment. This is a critical multi-hop reasoning failure where the model needed to synthesize the evolution of language and emphasis across two years of filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 435,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has MA's digital identity solutions evolved between 2022 and 2023, particularly in terms of their integration with open banking capabilities and reach across financial institutions?",
      "original_answer": "In 2022, MA introduced its digital identity solutions as part of an open banking platform that enabled data providers and third parties to access consumer data on a permissioned basis, aiming to improve customer experience and financial inclusion. The platform leveraged data principles such as consumer protection and consent management, and it focused on identity verification across people, devices, and transactions. In 2023, MA expanded its open banking capabilities, achieving connectivity to over 95% of deposit accounts in the U.S. and approximately 3,000 banks across Europe, which significantly enhanced the reach and application of its digital identity solutions. Additionally, in 2023, MA partnered with leading financial institutions to launch an ACH payment solution using its open banking infrastructure, indicating a deeper integration of digital identity within broader financial services.",
      "llm_answer": "\nBetween 2022 and 2023 Mastercard moved its digital‑identity capabilities from a stand‑alone verification suite (e.g., device‑intelligence, behavioral biometrics, Ekata‑based verification) into the core of its open‑banking platform.  In 2023 the company leveraged that platform to launch an ACH‑bill‑payment solution that uses its consent‑centric identity framework, and it expanded connectivity to > 95 % of U.S. deposit accounts and roughly 3,000 European banks, giving a far broader set of financial institutions a single, privacy‑by‑design identity layer to enable secure, seamless payments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY: All numeric values are correct - >95% of U.S. deposit accounts, approximately 3,000 European banks, and the 2022-2023 timeframe are all accurately stated. The format variations (>95% vs 'over 95%') are acceptable and equivalent. COMPLETENESS: The answer addresses all major components of the question: (1) evolution of digital identity solutions between 2022-2023, (2) integration with open banking capabilities, and (3) reach across financial institutions. The LLM effectively synthesizes the multi-hop information by connecting the evolution of digital identity capabilities with the expansion of open banking infrastructure and its application to ACH payments. ENTITY ACCURACY: Mastercard (MA) is correctly identified, years 2022-2023 are correct, and all financial metrics/capabilities mentioned are accurate. REASONING QUALITY: The multi-hop synthesis is sound - the answer correctly traces how digital identity evolved from standalone verification tools into an integrated component of the open banking platform, then demonstrates the practical application through the ACH payment solution launch. The logic connecting identity verification, consent management, and broader financial services integration is clear and accurate. SEMANTIC EQUIVALENCE: The LLM answer uses slightly different but semantically equivalent language (e.g., 'stand-alone verification suite' vs 'identity verification solutions,' 'consent-centric identity framework' vs 'consent management'). These variations actually add helpful specificity without contradicting the ground truth. Minor note: The LLM answer provides additional context about specific verification technologies (device-intelligence, behavioral biometrics, Ekata) that weren't explicitly in the ground truth but are consistent with typical Mastercard offerings and enhance understanding without introducing inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 535,
        "total_tokens": 1920
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has Tesla's approach to the Solar Roof product evolved between 2023 and 2024, particularly in terms of production challenges and strategic dependencies?",
      "original_answer": "In 2023, Tesla emphasized the engineering and design maturity of the Solar Roof, highlighting its aesthetic appeal, durability, and integration with Powerwall. The company positioned Solar Roof as a customized solution within its broader energy product suite. However, by 2024, Tesla acknowledged that the production ramp of Solar Roof faced delays similar to those experienced with other products. The 2024 filing also noted that the company's future success 'depends in large part' on scaling mass-market vehicle production, which indirectly signals a potential strategic prioritization shift that could affect Solar Roof's development and deployment timelines.",
      "llm_answer": "\nBetween 2023 and 2024 Tesla moved Solar Roof from a largely installer‑driven, externally supplied product toward a more vertically integrated, capacity‑building approach.  In 2023 the filings emphasized limited installation efficiency and dependence on multiple third‑party component sources, whereas the 2024 disclosures show new engineering‑talent programs, expanded Gigafactory footprints (including the planned Mexico site) and a strategic push to produce its own battery cells and related hardware to support Solar Roof’s energy‑storage integration—yet both years stress that specialized glass, inverter and battery‑cell supply remain key bottlenecks and strategic dependencies for scaling production.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and misrepresentations compared to the ground truth. Key issues: (1) MAJOR FACTUAL ERROR: The LLM claims Tesla moved toward 'vertically integrated, capacity-building approach' with 'new engineering-talent programs, expanded Gigafactory footprints (including the planned Mexico site)' and 'strategic push to produce its own battery cells' for Solar Roof. The ground truth makes no mention of these strategic initiatives related to Solar Roof specifically. The Mexico Gigafactory and battery cell production are separate Tesla initiatives not directly tied to Solar Roof evolution in the filings. (2) MISCHARACTERIZATION: The LLM describes 2023 as emphasizing 'limited installation efficiency and dependence on multiple third-party component sources,' which contradicts the ground truth stating 2023 emphasized 'engineering and design maturity...aesthetic appeal, durability, and integration with Powerwall.' (3) MISSING KEY INFORMATION: The LLM fails to capture the critical 2024 acknowledgment that Solar Roof production faced delays and that Tesla's strategic prioritization may have shifted toward mass-market vehicle production, potentially affecting Solar Roof timelines. (4) UNSUPPORTED CLAIMS: The assertion about 'installer-driven, externally supplied product' in 2023 and the shift toward vertical integration is not supported by the ground truth. (5) PARTIAL ACCURACY: The LLM correctly identifies that supply chain dependencies (glass, inverters, battery cells) remain bottlenecks, which aligns with ground truth, but this is overshadowed by the numerous inaccuracies. The answer demonstrates a fundamental misunderstanding of Tesla's actual Solar Roof strategy evolution between 2023-2024, conflating separate corporate initiatives with Solar Roof-specific developments.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 498,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has NextEra Energy, Inc.'s use of Pledge Agreements evolved between 2023 and 2024, particularly in terms of the dates and counterparties involved?",
      "original_answer": "In 2023, NextEra Energy, Inc. disclosed a Pledge Agreement dated September 1, 2022, involving Deutsche Bank Trust Company Americas and The Bank of New York Mellon. By 2024, the company introduced two new Pledge Agreements dated June 1, 2024, and October 1, 2024, with the same counterparties. This indicates an evolution in the structure and timing of these agreements, expanding their use over time.",
      "llm_answer": "\nBetween 2023 and 2024 the company added two new pledge agreements—dated June 1 2024 and October 1 2024—that follow the same structure as the earlier 2022 pledge. Both 2024 agreements involve **NextEra Energy, Inc.** as the pledgor, **Deutsche Bank Trust Company Americas** as collateral/custodial agent, and **The Bank of New York Mellon** as purchase‑contract agent, but they secure more recent series of junior‑subordinated debentures (Series Q, R and the exchangeable senior notes). Consequently, NEE’s use of pledge agreements has expanded with newer 2024 dates while retaining the same core counterparties.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and addresses the core question about NextEra Energy's pledge agreement evolution between 2023 and 2024. STRENGTHS: (1) All dates are accurate - correctly identifies the September 1, 2022 agreement from 2023 disclosures and the two new agreements dated June 1, 2024 and October 1, 2024. (2) Counterparties are correctly identified - Deutsche Bank Trust Company Americas and The Bank of New York Mellon are both named accurately. (3) The multi-hop synthesis is sound - the answer correctly traces the evolution from 2023 to 2024 and identifies the expansion pattern. (4) Additional context provided about the pledgor (NextEra Energy, Inc.), roles of counterparties (collateral/custodial agent and purchase-contract agent), and the securities involved (junior-subordinated debentures Series Q, R, and exchangeable senior notes) adds helpful detail. MINOR WEAKNESSES: (1) The ground truth answer is more concise and focused on the core evolution, while the LLM answer adds supplementary details about the specific debenture series and agent roles that, while accurate and relevant, go slightly beyond what was explicitly stated in the ground truth. (2) The phrasing 'collateral/custodial agent' for Deutsche Bank is slightly more specific than the ground truth's simpler reference to 'Deutsche Bank Trust Company Americas,' though this is not incorrect. (3) The answer could have been slightly more explicit about the 2022 agreement being disclosed in 2023 filings versus the 2024 agreements being disclosed in 2024 filings, though this is implied. QUANTITATIVE VERIFICATION: All dates (September 1, 2022; June 1, 2024; October 1, 2024) match the ground truth exactly. Entity names match precisely. The logical flow of the evolution is correct. No calculation errors present. The answer demonstrates accurate multi-hop reasoning by connecting information across years and identifying the pattern of expansion while maintaining consistent counterparties.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 536,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has Intel's strategic positioning in Edge AI evolved from 2023 to 2024, particularly in terms of its software platform offerings and ecosystem partnerships?",
      "original_answer": "In 2023, Intel emphasized its edge-native software platform with modular building blocks, premium services, and support offerings, aiming to enable developers to build, deploy, run, manage, connect, and secure distributed edge infrastructure and Edge AI across multiple verticals. The platform was described as a horizontal approach to scaling infrastructure for intelligent edge and hybrid AI, supporting diverse architectures and avoiding vendor lock-in. By 2024, Intel's strategy had evolved under its NEX initiative, which aimed to transform networks and edge compute systems from fixed-function hardware to general-purpose compute, acceleration, and networking devices running cloud-native software on programmable hardware. Intel highlighted broader ecosystem partnerships and a focus on rapid digital transformation from cloud to edge, leveraging core strengths in compute, connectivity, software, and large-scale manufacturing. This shift indicates a more integrated and scalable approach to Edge AI, with a stronger emphasis on cloud-native programmability and collaboration with partners to drive automation and secure data integrity at the edge.",
      "llm_answer": "\nFrom 2023 to 2024 Intel shifted its Edge‑AI strategy from a hardware‑centric rollout toward a fully‑integrated software platform.  In 2023 it introduced AI‑enabled silicon (e.g., Core Ultra with an integrated neural‑processing unit and 4th‑Gen Xeon Scalable processors with vRAN Boost) and began building an ecosystem of partners, while 2024 expanded that effort by delivering a modular, edge‑native software stack—most notably the OpenVINO 2023.1 toolkit with GenAI enhancements—and deepening collaborations with a broad set of telecom, cloud and OEM partners (Ericsson, Nokia, Cisco, Dell, HPE, Amazon, Google, Microsoft) to position Intel’s hardware as the programmable foundation for intelligent‑edge AI workloads.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer demonstrates partial understanding of Intel's Edge AI evolution but contains significant factual inaccuracies and omissions when compared to the ground truth. STRENGTHS: (1) Correctly identifies the shift from hardware-centric to software-platform approach; (2) Appropriately mentions ecosystem partnerships with major vendors (Ericsson, Nokia, Cisco, Dell, HPE, Amazon, Google, Microsoft); (3) References OpenVINO toolkit and GenAI enhancements; (4) Captures the 2023-2024 timeframe evolution. CRITICAL ERRORS: (1) The LLM references 'OpenVINO 2023.1' which appears to be a version number error or anachronism - this specific version designation is not substantiated in the ground truth; (2) Fails to mention Intel's NEX initiative, which is explicitly highlighted in the ground truth as a key strategic evolution for 2024; (3) Misses the core 2024 strategic shift toward 'general-purpose compute, acceleration, and networking devices running cloud-native software on programmable hardware' - instead focusing narrowly on software stack delivery; (4) Does not adequately capture the 2023 positioning around 'modular building blocks, premium services, and support offerings' or the 'horizontal approach to scaling infrastructure'; (5) Omits the important distinction about avoiding vendor lock-in mentioned in 2023 strategy; (6) Lacks emphasis on 'cloud-native programmability' as a key 2024 evolution. MULTI-HOP REASONING: The answer attempts to synthesize information across years but fails to properly integrate the NEX initiative context and the shift toward cloud-native programmability, which are central to understanding the strategic evolution. The answer reads more as a product/partnership announcement rather than a strategic positioning analysis. QUANTITATIVE ISSUES: While no specific numbers are provided in either answer, the LLM's reference to specific product versions (Core Ultra, 4th-Gen Xeon, OpenVINO 2023.1) lacks verification against ground truth sources.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1472,
        "completion_tokens": 537,
        "total_tokens": 2009
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did the composition and value of CVS's long-term debt related to senior notes due in 2030 evolve between 2023 and 2024, particularly regarding the 1.75% senior notes due August 2030?",
      "original_answer": "In 2023, the 1.75% senior notes due August 2030 had a value of $1,250 million. In 2024, this value remained unchanged at $1,250 million. However, other senior notes due in 2030, such as the 3.75% senior notes due April 2030, decreased from $1,500 million in 2023 to $1,500 million in 2024, indicating stability in some areas of long-term debt but no change in the 1.75% notes specifically.",
      "llm_answer": "\nBetween the 2023 and 2024 filings the Company’s long‑term debt schedule lists the same $1.25 billion of 1.75 % senior notes maturing in August 2030 in both years—no new issuance, redemption, or re‑measurement is shown. Consequently, while the overall mix of senior notes (including a range of maturities from 2024 through 2050) remained substantial, the composition and outstanding balance of the 1.75 % notes due August 2030 stayed unchanged at $1.25 billion.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key fact that the 1.75% senior notes due August 2030 remained at $1.25 billion (or $1,250 million) in both 2023 and 2024, with no changes. The number format variation ($1.25 billion vs $1,250 million) is acceptable and semantically equivalent. The LLM appropriately notes there was no new issuance, redemption, or re-measurement. However, there is a notable incompleteness: the original answer mentions the 3.75% senior notes due April 2030 as another component of the 2030 debt composition, which the LLM answer does not specifically address. The original answer states these notes were $1,500 million in both years (unchanged), providing a more complete picture of the 2030 debt composition. The LLM answer acknowledges 'a range of maturities from 2024 through 2050' but doesn't specifically detail other 2030 notes. The LLM's statement about 'overall mix of senior notes' is somewhat vague compared to the ground truth's specific mention of the 3.75% notes. The reasoning is sound regarding the 1.75% notes specifically, but the answer is incomplete in addressing the full composition of 2030 debt as requested in the question. The quantitative accuracy for the 1.75% notes is perfect, but the omission of other 2030 notes details represents a gap in completeness for a multi-hop question about debt composition.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1222,
        "completion_tokens": 377,
        "total_tokens": 1600
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did Netflix's ad-supported subscription plan evolve between 2023 and 2024 in terms of its role within the company's pricing strategy and membership growth objectives?",
      "original_answer": "In 2023, Netflix introduced the ad-supported subscription plan as a new, lower-priced option aimed at expanding its membership base and addressing competitive pressures by offering a more accessible entry point. This was part of broader efforts to adjust pricing models and membership plans to improve value perception. By 2024, the ad-supported plan had become a core component of Netflix's pricing strategy, explicitly included in a range of plans designed to meet varied consumer needs, indicating its integration into the company's long-term growth framework. This evolution reflects a shift from experimental pricing to a strategic offering intended to support sustained membership growth across different market segments.",
      "llm_answer": "\nBetween 2023 and 2024 Netflix deepened the strategic role of its ad‑supported tier.  In 2023 the company first rolled out the lower‑priced, advertising‑supported plan as a way to broaden its price‑sensitive audience, and by 2024 it had become a core lever in the firm’s pricing strategy—used to fuel membership growth, offset price increases on higher‑tier plans, and attract new subscribers while preserving overall margin targets.  The tier was also integrated into the company’s scaling roadmap (e.g., new technology and content‑production investments) to sustain growth amid intensified competition.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth on the core narrative of Netflix's ad-supported plan evolution. STRENGTHS: (1) Correctly identifies 2023 as the introduction year and 2024 as the integration/maturation phase; (2) Accurately captures the plan's dual purpose: broadening price-sensitive audience and serving as a strategic growth lever; (3) Properly synthesizes the multi-hop concept that the plan evolved from experimental/new offering to core strategic component; (4) Correctly notes the plan's role in offsetting price increases and attracting new subscribers; (5) No quantitative errors or incorrect numbers/dates. MINOR WEAKNESSES: (1) The LLM answer adds some details not explicitly in the ground truth (e.g., 'offset price increases on higher-tier plans,' 'new technology and content-production investments,' 'scaling roadmap') - while these are reasonable inferences about Netflix's strategy, they go slightly beyond what the ground truth explicitly states; (2) The phrase 'preserving overall margin targets' is an inference not directly supported by the ground truth; (3) The ground truth emphasizes 'addressing competitive pressures' more explicitly, while the LLM focuses more on internal strategic integration. MULTI-HOP REASONING: The answer correctly synthesizes the temporal evolution (2023→2024) and the strategic shift (experimental→core component), which is the essence of the multi-hop question. The reasoning connecting membership growth objectives to the plan's evolution is sound. SEMANTIC EQUIVALENCE: The LLM's characterization of the plan's role is semantically equivalent to the ground truth - both describe a shift from new/lower-priced option to integrated strategic offering. The wording differs but conveys the same fundamental insights.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 489,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How has Tesla's approach to the Tesla Semi evolved between 2023 and 2024, based on its production status and strategic positioning?",
      "original_answer": "In 2023, Tesla stated that it had begun early production and deliveries of the Tesla Semi, indicating initial market introduction and limited availability. By 2024, Tesla's production status for the Tesla Semi had advanced to 'pilot production' at its Nevada facility, suggesting a more structured and expanded phase of manufacturing, though not yet full-scale commercial production. This evolution reflects Tesla's strategic progression from initial rollout to a more mature testing and scaling phase for the commercial electric vehicle.",
      "llm_answer": "\nBetween 2023 and 2024 Tesla progressed the Semi from the “early production and deliveries” phase disclosed in 2023 to an explicit “pilot‑production” stage at its Nevada gigafactory (2024 table of vehicle‑model production status).  This shift reflects a strategic positioning of the Semi as a cornerstone of Tesla’s commercial‑vehicle roadmap—leveraging its next‑generation platform, vertical‑integrated battery‑cell production and AI‑driven cost‑reduction goals to move the truck toward scalable, lower‑cost volume manufacturing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive understanding of Tesla's Semi evolution. STRENGTHS: (1) Correctly identifies the progression from 'early production and deliveries' in 2023 to 'pilot production' in 2024, matching the ground truth exactly. (2) Accurately cites the Nevada gigafactory as the location for pilot production. (3) Properly synthesizes the multi-hop information across two fiscal years. (4) All dates and entities are correct (Tesla, Semi, Nevada facility). (5) The answer goes beyond the ground truth by adding strategic context about next-generation platforms, vertical-integrated battery production, and AI-driven cost reduction, which are reasonable inferences about Tesla's commercial vehicle strategy but not explicitly required by the question. MINOR CONSIDERATIONS: (1) The LLM answer adds interpretive details about 'cornerstone of Tesla's commercial-vehicle roadmap' and specific strategic initiatives that, while contextually relevant and likely accurate, extend slightly beyond what the ground truth explicitly states. However, this represents value-added analysis rather than factual error. (2) The reference to '2024 table of vehicle-model production status' suggests sourcing from a specific filing document, which adds credibility. VERIFICATION: The core factual claims (2023 status, 2024 status, Nevada location, progression from early to pilot production) all align perfectly with the ground truth. No numerical errors, date errors, or entity misidentifications present. The multi-hop reasoning correctly synthesizes information across the two-year period.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 444,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "What does the expansion of NextEra Energy's Executive Retention Employment Agreements from 2023 to 2024 suggest about the company's approach to leadership continuity and its strategic emphasis on executive talent retention?",
      "original_answer": "In 2023, NextEra Energy had active Executive Retention Employment Agreements with executives including Mark Lemasney (signed January 1, 2023) and Armando Pimentel, Jr. (signed February 15, 2023), indicating a focus on retaining key leadership at that time. By 2024, the company not only maintained those agreements but also introduced a new agreement with Brian Bolster, dated May 6, 2024, showing an expansion in the number of covered executives. This evolution suggests that NextEra Energy has placed increasing strategic importance on securing leadership continuity and minimizing executive turnover risk, particularly during periods of potential transition or uncertainty. The addition of new executives under retention agreements implies a proactive approach to talent management, which could signal confidence in leadership or a response to external pressures affecting executive mobility.",
      "llm_answer": "\nThe 2024 filings show a clear expansion of NextEra’s executive‑retention program—new 2024 agreements for executives such as Nicole Daggs and Brian Bolster were added to the roster that already included several 2023‑dated contracts.  By extending retention terms for both existing and newly‑appointed senior leaders, the company signals that maintaining a stable, experienced leadership team is a strategic priority as it pursues its large‑scale clean‑energy and infrastructure initiatives.  This focus on continuity underscores NextEra’s intent to safeguard the talent that drives its long‑term growth and regulatory‑intensive operations.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core concept that NextEra expanded its Executive Retention Employment Agreements from 2023 to 2024, and accurately conveys the strategic implications about leadership continuity and talent retention. The reasoning about safeguarding talent for long-term growth and regulatory operations is sound and relevant. The answer appropriately addresses the multi-part question about what the expansion suggests.\n\nWEAKNESSES - ENTITY ACCURACY: The LLM introduces Nicole Daggs as a 2024 executive with a retention agreement, but the ground truth only mentions Mark Lemasney (2023), Armando Pimentel, Jr. (2023), and Brian Bolster (2024). Nicole Daggs is not mentioned in the original answer, representing a potential factual error or hallucination. This is a significant issue as it adds an entity not supported by the ground truth.\n\nWEAKNESSES - COMPLETENESS: The LLM answer omits specific names from 2023 (Mark Lemasney and Armando Pimentel, Jr.) that were explicitly mentioned in the ground truth. While the answer references \"several 2023-dated contracts,\" it fails to name the specific executives, reducing specificity and completeness.\n\nWEAKNESSES - DATES: The LLM correctly identifies 2023 and 2024 as the relevant periods and mentions May 6, 2024 for Brian Bolster (matching ground truth), but doesn't provide the specific 2023 dates (January 1, 2023 and February 15, 2023) that were in the original answer.\n\nQUALITATIVE REASONING: The LLM's interpretation of what the expansion suggests is sound and aligns with the ground truth's conclusions about strategic importance, leadership continuity, and proactive talent management. The connection to clean-energy initiatives and regulatory operations adds relevant context.\n\nOVERALL ASSESSMENT: The answer captures the main thrust of the question and provides reasonable strategic analysis, but contains a factual error (Nicole Daggs) and lacks the specific executive names and dates that were in the ground truth. The qualitative reasoning is good, but the quantitative/entity accuracy issues prevent a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 570,
        "total_tokens": 1972
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How has Intel's approach to xPU products evolved from 2023 to 2024, particularly in terms of strategic focus and product development priorities?",
      "original_answer": "In 2023, Intel's focus on xPU products was part of a broader R&D strategy that included process and packaging technology, AI, and software, with $16.0 billion spent on R&D. The company faced challenges in timely product development and manufacturing process introductions, which had previously caused delays and cost overruns. By 2024, Intel had evolved its approach by embedding xPU products more deeply into its strategic priorities, specifically under the theme of 'product competitiveness.' The company announced the creation of an advisory group to expand the x86 ecosystem and emphasized the xPU family of products—including client and data center GPUs, IPUs, FPGAs, and other accelerators—as a way to meet diverse computing needs. This represents a shift from a general R&D focus to a more structured and strategic product development initiative.",
      "llm_answer": "\nFrom 2023 to 2024 Intel shifted xPU from a peripheral accelerator offering to a central strategic pillar.  In the 2023 filing the company described xPU merely as “a family of client‑ and data‑center GPUs, IPUs, FPGAs and other accelerators” that it used to address AI and other workloads, while still relying on its own fabs and selective third‑party foundry capacity [INTC 10‑K 2023, p. 49‑50].  By 2024 the narrative had expanded: the 2024 filing calls xPU “the family of accelerators that, together with the x86 core, will democratize compute and power every phase of the AI continuum,” creates an advisory group to grow the x86 ecosystem, and pledges to develop leading products across all xPU categories while leveraging advanced packaging, new process nodes (Intel 4/3) and a nascent foundry business to deliver them at scale [INTC 10‑K 2024, pp. 5‑6, 93‑94].  Thus, the evolution is marked by a stronger strategic focus on xPU as a growth engine, a broader product roadmap, and deeper integration with Intel’s open‑platform and foundry initiatives.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of Intel's xPU evolution from 2023 to 2024. STRENGTHS: (1) Correctly identifies the shift from peripheral to central strategic focus; (2) Accurately characterizes 2023 positioning as part of broader R&D strategy addressing AI workloads; (3) Properly describes 2024 evolution including advisory group creation, expanded narrative around 'democratizing compute,' and integration with foundry/packaging initiatives; (4) Appropriately cites specific page references (10-K 2023 pp. 49-50, 10-K 2024 pp. 5-6, 93-94); (5) Captures key product categories (client/data center GPUs, IPUs, FPGAs, accelerators); (6) Mentions advanced packaging and process nodes (Intel 4/3) as enablers. MINOR GAPS: (1) The ground truth mentions the specific $16.0 billion R&D spend in 2023, which the LLM answer does not include—this is a factual omission but not critical to answering the strategic evolution question; (2) The ground truth explicitly mentions 'product competitiveness' as the 2024 theme, which the LLM answer doesn't directly reference, though it captures the substance through 'growth engine' language; (3) The ground truth notes 2023 challenges with 'timely product development and manufacturing process introductions,' which the LLM answer omits. QUANTITATIVE ACCURACY: No numerical errors detected; page citations appear reasonable for 10-K filings. QUALITATIVE ACCURACY: Multi-hop reasoning is sound—correctly synthesizes information about strategic positioning across two years and identifies the evolution pattern. The characterization of the shift from 'peripheral' to 'central' effectively captures the ground truth's distinction between general R&D focus and structured strategic initiative. CONTEXTUAL RELEVANCE: Directly addresses the question about evolution in strategic focus and product development priorities with appropriate detail and specificity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1476,
        "completion_tokens": 515,
        "total_tokens": 1992
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has Netflix's approach to advertising technology evolved between 2023 and 2024, particularly in terms of organizational development and infrastructure investment?",
      "original_answer": "In 2023, Netflix emphasized its limited experience with advertising and outlined several dependencies, particularly on third-party service providers for ad management and the need to attract and retain advertisers. The company also highlighted risks related to developing the necessary advertising technology infrastructure. By 2024, Netflix shifted toward a more proactive stance, emphasizing its ability to 'develop and expand an advertising sales and advertising technology organization team' and 'develop the technology and related infrastructure to support advertising and drive value to advertisers.' This indicates a strategic evolution from reliance on external providers to internal development and investment in ad tech capabilities.",
      "llm_answer": "\nBetween 2023 and 2024 Netflix moved from merely acknowledging the risk of “limited experience offering advertising” and the need to “develop the technology and related infrastructure to support advertising” (2023 10‑K p. 10) to actually building a dedicated ad‑sales and ad‑tech organization and investing heavily in the underlying platform.  The 2024 filing lists “our ability to develop and expand an advertising‑sales and advertising‑technology organization team” as a priority and shows a sharp rise in capitalized research expenses—from $593 million in 2023 to $1.08 billion in 2024 (2024 10‑K p. 64)—signaling that the company has created a formal advertising‑technology team, expanded its infrastructure, and is now driving advertiser‑value through proprietary measurement and delivery tools.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of Netflix's advertising technology evolution between 2023 and 2024, with accurate qualitative characterization of the strategic shift from external reliance to internal development. The answer correctly identifies the key organizational and infrastructure investment themes that match the ground truth.\n\nSTRENGTHS:\n1. Correctly captures the strategic evolution narrative: from acknowledging limited experience and external dependencies (2023) to building dedicated internal teams and infrastructure (2024)\n2. Accurately references the shift in company positioning and priorities\n3. Provides specific supporting evidence with R&D capitalization figures\n4. Multi-hop reasoning is sound - synthesizes organizational development AND infrastructure investment aspects\n5. Proper citation format with page references enhances credibility\n6. Semantic equivalence is strong - conveys the same strategic narrative as ground truth\n\nQUANTITATIVE CONCERNS:\n1. The R&D capitalization figures ($593M in 2023 to $1.08B in 2024) cannot be verified against the provided ground truth, which does not include specific financial metrics\n2. While these numbers appear plausible and are presented with specific page references, they represent additional data not in the original answer\n3. The calculation showing an 82% increase is mathematically correct IF the base numbers are accurate, but this cannot be confirmed from the ground truth provided\n4. No calculation errors detected in the presented figures\n\nMINOR ISSUES:\n1. The LLM introduces specific financial data (R&D capitalization) that, while potentially accurate and relevant, goes beyond what the ground truth explicitly confirms\n2. The answer is slightly more detailed than the ground truth, which could indicate either enhanced research or potential extrapolation\n\nOVERALL ASSESSMENT:\nThe answer demonstrates excellent qualitative understanding and multi-hop synthesis of the organizational and infrastructure investment evolution. The core narrative matches the ground truth precisely. The quantitative additions (R&D figures) are presented confidently with citations but cannot be independently verified against the provided ground truth. The answer would score higher if the R&D figures were confirmed, but the strong qualitative accuracy and sound reasoning justify a score of 8.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 637,
        "total_tokens": 2028
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has Tesla's approach to free Supercharging programs evolved between 2023 and 2024, particularly in terms of revenue recognition and program structure?",
      "original_answer": "In 2023, Tesla's free Supercharging programs were included under Automotive Sales Revenue as part of the revenue associated with new vehicle deliveries, indicating they were bundled with vehicle sales and recognized over time. By 2024, Tesla began deferring revenue related to features such as FSD (Supervised), internet connectivity, and free Supercharging, recognizing these as liabilities to be amortized over time rather than immediately upon vehicle delivery. This structural shift reflects a more formalized and segmented approach to monetizing these features, including free Supercharging, which allows Tesla to better align revenue recognition with service delivery.",
      "llm_answer": "\nTesla continued to treat free Supercharging as a distinct performance obligation that is delivered at vehicle hand‑off and recognized over the expected ownership life on a straight‑line basis (as disclosed in the 2023 10‑K, page 41).  In the 2024 filing the company reports a much larger deferred‑revenue balance for these services—$3.6 bn at the end of 2024 versus $2.9 bn at the end of 2023 (page 59)—and recognizes $1.19 bn of revenue from them in 2024 compared with $0.60 bn in 2023, reflecting an expanded fleet and a more granular allocation of the transaction price to the Supercharging obligation.  The underlying recognition method (straight‑line over the vehicle’s life) has not changed, but the scale and accounting detail of the program have grown substantially between 2023 and 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) CONTRADICTS GROUND TRUTH ON CORE FINDING: The LLM claims free Supercharging was treated as 'a distinct performance obligation...recognized over the expected ownership life on a straight-line basis' in 2023, but the ground truth explicitly states that in 2023, free Supercharging was 'included under Automotive Sales Revenue as part of the revenue associated with new vehicle deliveries' and 'recognized over time' as bundled with vehicle sales. The LLM's characterization of the 2023 treatment is fundamentally incorrect. (2) MISSES THE KEY STRUCTURAL SHIFT: The ground truth emphasizes that by 2024, Tesla 'began deferring revenue' and recognizing these as 'liabilities to be amortized over time rather than immediately upon vehicle delivery.' The LLM claims the 'underlying recognition method (straight-line over the vehicle's life) has not changed,' which directly contradicts the ground truth's assertion of a structural shift from immediate recognition to deferred recognition. (3) UNVERIFIABLE NUMBERS: The LLM provides specific dollar amounts ($3.6bn deferred revenue at end of 2024, $2.9bn at end of 2023, $1.19bn revenue in 2024, $0.60bn in 2023) and page references (page 59, page 41) that cannot be verified against the provided ground truth and appear to be fabricated or from different sources. These numbers are presented with false confidence. (4) INCOMPLETE ANSWER: The LLM fails to address the fundamental evolution described in the ground truth—the shift from bundled/immediate recognition to deferred/segmented recognition. Instead, it claims continuity where the ground truth identifies a significant structural change. (5) REASONING FLAW: The LLM's conclusion that 'the scale and accounting detail of the program have grown substantially' misses the point that the accounting METHOD itself changed, not just the scale. The ground truth indicates a qualitative shift in how these revenues are recognized, not merely a quantitative expansion.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 554,
        "total_tokens": 1924
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has NextEra Energy's approach to issuing Series O Junior Subordinated Debentures evolved between 2023 and 2024, particularly in terms of coupon structure and maturity dates, and what might this shift indicate about their financing strategy?",
      "original_answer": "In 2023, NextEra Energy issued the Series O Junior Subordinated Debentures due on May 1, 2079, with no explicit coupon rate disclosed in the filing. This indicates a potentially fixed or deferred interest structure typical for long-dated junior subordinated instruments. By 2024, the Series O Debentures were issued with a defined coupon rate of 5.55% and a significantly shorter maturity date of November 1, 2029. This represents a strategic shift toward issuing more conventional debt instruments with shorter durations and clearly defined interest costs. This evolution suggests a possible recalibration of NextEra’s capital structure strategy, favoring shorter-term, more predictable financing over long-dated, potentially lower-yielding instruments.",
      "llm_answer": "\nBetween 2023 and 2024 NextEra retired the long‑dated Series O junior subordinated debentures that were originally issued in 2019 (a fixed‑coupon tranche maturing in 2079) and replaced them with a new Series O issuance (dated Oct 31 2024) that matures on Nov 1 2029 and carries a different coupon—reported as a fixed‑rate near 5 % (or a floating‑rate linked to a benchmark).  This shift shortens the average maturity of the company’s junior‑subordinated debt and reflects a strategic move toward more flexible, shorter‑term financing at potentially lower cost.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains several significant factual errors that undermine its credibility: (1) COUPON RATE ERROR: The ground truth specifies the 2024 Series O coupon as 5.55%, but the LLM states it as 'near 5%' or 'floating-rate linked to a benchmark.' This is a material misstatement of a key financial metric. (2) MATURITY DATE ACCURACY: The LLM correctly identifies the 2029 maturity date (Nov 1, 2029), which matches the ground truth. (3) RETIREMENT CLAIM: The LLM claims NextEra 'retired' the original 2023 Series O debentures, but the ground truth indicates these were simply issued in 2023 with a 2079 maturity—there is no evidence of retirement. This represents a fundamental misunderstanding of the transaction. (4) ISSUANCE DATE CONFUSION: The LLM references an Oct 31, 2024 issuance date, which is not mentioned in the ground truth and appears to be fabricated or confused. (5) COUPON STRUCTURE: The ground truth notes the 2023 issuance had 'no explicit coupon rate disclosed,' suggesting a potentially fixed or deferred structure. The LLM's characterization of the 2024 coupon as potentially 'floating-rate' contradicts the ground truth's clear statement of a 5.55% fixed rate. (6) STRATEGIC ANALYSIS: While the LLM's general conclusion about shorter-term financing is directionally similar to the ground truth, the reasoning is undermined by the factual errors above. The ground truth emphasizes 'more conventional debt instruments with shorter durations and clearly defined interest costs,' while the LLM introduces uncertainty about whether the coupon is fixed or floating. MULTI-HOP SYNTHESIS: The LLM fails to properly synthesize the 2023-to-2024 comparison. It conflates the original 2019 issuance with the 2023 issuance, creating confusion about the timeline. The ground truth clearly distinguishes between the 2023 and 2024 issuances as separate events with different characteristics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 515,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has ExxonMobil's consideration of OPEC investment activities evolved in its impairment assessment framework from 2022 to 2023, particularly in relation to long-term oil supply dynamics?",
      "original_answer": "In 2022, ExxonMobil explicitly stated that OPEC investment activities and production policies had an impact on world oil supplies and were considered in the context of impairment assessments. By 2023, while the company still acknowledged OPEC's influence on global oil supply, the discussion of OPEC was embedded more broadly within a comprehensive cash flow assessment framework that included forward-looking variables such as greenhouse gas emission costs and net-zero targets. This indicates a shift from a direct focus on OPEC's role to a more integrated view of macroeconomic and environmental factors affecting long-term asset valuation.",
      "llm_answer": "\nFrom 2022 to 2023 ExxonMobil shifted from merely referencing OPEC’s investment and production policies as a peripheral factor shaping overall supply, to explicitly incorporating those policies into the long‑term supply assumptions that drive its discounted‑cash‑flow impairment tests. This evolution makes OPEC’s supply decisions a direct input for estimating future production and price paths, thereby influencing the recoverability assessment of its upstream assets.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains a fundamental factual error that contradicts the ground truth. The ground truth explicitly states that ExxonMobil shifted FROM a direct focus on OPEC TO a more integrated view that embeds OPEC discussion within a broader framework including environmental factors. The LLM answer claims the opposite - that ExxonMobil shifted FROM merely referencing OPEC as peripheral TO explicitly incorporating OPEC policies as direct inputs. This is a critical reversal of the actual evolution described in the original answer. The LLM correctly identifies the years (2022-2023) and the company (ExxonMobil), and the general topic of impairment assessments and supply dynamics. However, the directional change is inverted. The ground truth indicates a de-emphasis of OPEC's direct role in favor of broader macroeconomic and environmental considerations, while the LLM suggests an increased emphasis on OPEC's direct role. This represents a major semantic and factual error in understanding the evolution of ExxonMobil's framework. The LLM's reasoning about DCF tests and asset recoverability is logically sound in isolation, but it describes the wrong direction of change, making the core answer incorrect despite some accurate contextual elements.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 353,
        "total_tokens": 1642
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has Netflix's approach to its ad-supported subscription plan evolved from 2023 to 2024, based on the level of detail and strategic emphasis provided in the filings?",
      "original_answer": "In 2023, Netflix's ad-supported subscription plan was mentioned in the context of uncertainty and risk, particularly around consumer adoption and the lack of operating history with such offerings, which could lead to discrepancies between forecasts and actual results. By 2024, the ad-supported plan was presented as part of the company's broader pricing strategy, explicitly included in the description of plans offered to meet a variety of consumer needs. This shift indicates a move from a risk-focused perspective to a more confident, strategic positioning of the ad-supported plan as a core part of Netflix's business model.",
      "llm_answer": "\nFrom 2023 to 2024 Netflix moved from a barely‑mentioned, peripheral reference to a clearly articulated strategic pillar for its ad‑supported tier. The 2023 filing only discusses the plan in generic risk language (e.g., “pricing strategies” and “new revenue streams” are listed among uncertain forecasts), whereas the 2024 filing devotes explicit text in the Business overview and forward‑looking statements to the ad‑supported subscription plan, describing it as a key element of its pricing mix, a driver of membership growth and a focus of testing and forecasting. Thus, the company’s approach shifted from an implicit, low‑detail mention to a deliberate, high‑visibility emphasis on the ad‑supported plan as a core growth and revenue‑diversification strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth. Both responses correctly identify the key evolution: Netflix's ad-supported plan shifted from a risk-focused, uncertainty-laden discussion in 2023 to a confident, strategic positioning in 2024. The LLM answer accurately captures the semantic essence of this transition, describing the move from 'barely-mentioned, peripheral reference' to 'clearly articulated strategic pillar,' which directly parallels the ground truth's characterization of moving from 'risk-focused perspective to more confident, strategic positioning.' The LLM provides additional supporting detail (e.g., 'driver of membership growth,' 'focus of testing and forecasting,' 'core growth and revenue-diversification strategy') that enriches the answer without contradicting the ground truth. No quantitative data was required for this qualitative question, so quantitative accuracy is perfect by default. The multi-hop reasoning is sound: the answer correctly synthesizes information across two fiscal years (2023 and 2024) and identifies the strategic shift in how Netflix presented its ad-supported plan. The only minor consideration is that the LLM's language is slightly more emphatic ('barely-mentioned,' 'low-detail mention') compared to the ground truth's more measured tone, but this represents stylistic variation rather than factual error. The answer fully addresses the question's request to explain how the approach 'evolved' based on 'level of detail and strategic emphasis,' demonstrating clear understanding of the multi-hop synthesis required.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 438,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has Amazon's approach to shipping offers evolved between 2022 and 2024, particularly in terms of cost drivers and strategic focus on fulfillment efficiency?",
      "original_answer": "In 2022, Amazon highlighted that shipping costs were expected to increase as customers increasingly adopted its shipping offers, used faster delivery methods, and as the company expanded its fulfillment network. Shipping costs in 2021 were $76.7 billion, and the company anticipated continued growth in these costs. The strategic emphasis was on mitigating these increases through higher sales volumes, network optimization, supplier negotiations, and operational efficiencies. By 2024, the focus had shifted: while the company still invested in expanding its fulfillment network, it emphasized fulfillment network efficiencies as a key cost offset. The 2024 report notes that increased sales and network investments drove up fulfillment costs, but these were partially offset by efficiency gains. This marks a strategic evolution from a customer-driven cost increase in 2022 to a more operations-centric efficiency focus by 2024.",
      "llm_answer": "\nBetween 2022 and 2024 Amazon’s shipping‑offer strategy shifted from a pure expansion play—where higher labor rates, constrained labor markets and supply‑chain constraints drove steep rises in fulfillment and shipping costs—to a model that pairs continued network growth with efficiency‑focused initiatives; it now leans on higher sales volumes, improved productivity, technology upgrades and better supplier terms to keep shipping‑cost growth from outpacing revenue, while treating Prime‑related shipping benefits as marketing tools rather than marketing expense.  The company’s strategic focus is therefore on expanding and optimizing its fulfillment network to meet rising shipment volumes while driving down the cost‑per‑unit through scale, network efficiencies and foreign‑exchange headwinds.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES: (1) QUANTITATIVE ACCURACY - The LLM answer introduces specific claims about 'higher labor rates, constrained labor markets and supply-chain constraints' as 2022 drivers that are NOT mentioned in the ground truth. The ground truth cites the $76.7 billion 2021 shipping cost figure, which the LLM completely omits. The LLM provides NO verifiable numbers, dates, or metrics from the actual filings. (2) FACTUAL ERRORS - The LLM claims the company treats 'Prime-related shipping benefits as marketing tools rather than marketing expense' - this distinction is not supported by the ground truth and appears to be an unsupported inference. (3) INCOMPLETE SYNTHESIS - While the LLM correctly identifies the shift from expansion-focused to efficiency-focused strategy, it fails to cite the specific $76.7 billion 2021 figure that anchors the ground truth's 2022 discussion. (4) SPECULATIVE CONTENT - The LLM introduces concepts like 'foreign-exchange headwinds' that are not mentioned in the ground truth, suggesting hallucination or over-interpretation. (5) PARTIAL CORRECTNESS - The LLM does correctly capture the core strategic evolution: from customer-driven cost increases (2022) to efficiency-focused operations (2024), and correctly identifies cost mitigation strategies (higher volumes, network optimization, supplier negotiations). However, the introduction of unsupported details and complete absence of verifiable numbers significantly undermines credibility. The answer reads more like strategic analysis than evidence-based synthesis from actual filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 432,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did Duke Energy's utilization and reporting of the Master Retirement Trust evolve between 2023 and 2024, particularly in terms of asset allocation and disclosure practices?",
      "original_answer": "In 2023, Duke Energy's Master Retirement Trust was described in terms of its investment objective, focusing on achieving sufficient returns for plan benefits, with specific mention of VEBA trusts and their target and actual asset allocations. By 2024, the reporting evolved to include a more detailed breakdown of how different subsidiaries were allocated portions of the trust, such as Duke Energy Progress at 15% and Duke Energy Florida at 18%. Additionally, 2024 introduced a reconciliation of beginning and ending balances for pension and post-retirement assets, including Level 3 fair value disclosures, which was not present in 2023. This reflects a shift toward more granular and transparent reporting on trust assets and their valuation methodologies.",
      "llm_answer": "\nBetween 2023 and 2024 Duke Energy enhanced its Master Retirement Trust disclosures by adding a full fair‑value hierarchy breakdown (Level 1‑3) and a reconciliation of Level 3 assets, and it revised the target asset mix—shifting the RCBP allocation to 35 % liability‑hedging and 65 % return‑seeking and the DELPP allocation to 80 % liability‑hedging and 20 % return‑seeking. The 2024 year‑end portfolio shows a modest reallocation from corporate‑debt and government securities into cash and short‑term investment funds, and the filings now present separate tables that detail target versus actual allocations and the impact of the 2024 CCR Rule on coal‑ash‑related obligations.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not supported by the ground truth. CRITICAL ISSUES: (1) The LLM provides specific percentage allocations (RCBP 35% liability-hedging/65% return-seeking, DELPP 80% liability-hedging/20% return-seeking) that are NOT mentioned in the ground truth answer. These appear to be fabricated numbers. (2) The LLM mentions 'CCR Rule on coal-ash-related obligations' which is completely absent from the ground truth and appears to be hallucinated content. (3) The LLM discusses 'reallocation from corporate-debt and government securities into cash and short-term investment funds' with no supporting evidence in the ground truth. CORRECT ELEMENTS: (1) The LLM correctly identifies that 2024 reporting included 'fair-value hierarchy breakdown (Level 1-3)' and 'reconciliation of Level 3 assets,' which aligns with the ground truth mention of 'Level 3 fair value disclosures.' (2) The LLM correctly notes enhanced disclosure practices between 2023 and 2024. (3) The mention of 'separate tables that detail target versus actual allocations' aligns with the ground truth's reference to 'target and actual asset allocations.' MISSING ELEMENTS: (1) The ground truth specifically mentions subsidiary allocations (Duke Energy Progress at 15%, Duke Energy Florida at 18%), which the LLM completely omits. (2) The ground truth mentions VEBA trusts, which the LLM does not address. (3) The ground truth emphasizes the shift toward 'more granular and transparent reporting,' which the LLM only partially captures. The LLM appears to have conflated or invented specific allocation percentages and introduced unrelated regulatory information (CCR Rule), suggesting significant hallucination rather than accurate synthesis of the source material.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 488,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How has Google's financial relationship with Google Network Partners evolved between 2022 and 2024, particularly in terms of the cost structure and payment obligations?",
      "original_answer": "In 2022, Google's cost of revenues included significant Traffic Acquisition Costs (TAC) paid to Google Network partners, primarily for ads displayed on their properties, with a noted higher cost percentage compared to Google Search properties due to the substantial share of advertiser revenues paid out as TAC. By 2024, Google Network partners were referenced in the context of operating cash outflows, indicating that payments to these partners had become a primary use of operating cash. This shift suggests a transformation in the nature of the financial relationship, from a cost-of-revenue model to a more direct operational cash flow obligation, reflecting a potential increase in the scale or structure of Google's dependency on these partners.",
      "llm_answer": "\nBetween 2022 and 2024 Google’s “Google Network Partner” payments—made through the Traffic‑Acquisition‑Cost (TAC) program—rose from roughly **$50 billion (2022)** to **$54.9 billion (2024)**, yet the **TAC rate fell from about 21 % of total ad revenue to 20.7 %** (see GOOGL_10k_2024 p. 11, p. 32; GOOGL_10k_2022 p. 5).  This reflects a shift in the ad mix: a larger share of revenue now comes from Google‑owned Search & other properties, where TAC is lower, while the absolute dollar outlays to partners have increased.  Consequently, the **cost‑structure burden of Network‑partner payments has declined as a percentage of cost of revenues**, even though the contractual obligation to pass through a substantial portion of ad revenue earned on partner sites remains unchanged.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ISSUES: The LLM answer provides specific dollar amounts ($50 billion in 2022, $54.9 billion in 2024) and TAC rate percentages (21% to 20.7%) that cannot be verified against the ground truth and appear to be fabricated. The ground truth does NOT provide these specific numerical values—it only describes a qualitative shift in how Google's relationship with Network Partners evolved from a cost-of-revenue model to operating cash flow obligations. The LLM has invented precise figures without evidence from the filings. Additionally, the LLM's interpretation contradicts the ground truth's key insight: the ground truth emphasizes a TRANSFORMATION in the nature of the relationship (from cost-of-revenue to cash flow obligations), suggesting increased scale/dependency, while the LLM claims the cost-structure burden has DECLINED as a percentage. The ground truth indicates payments became 'a primary use of operating cash,' implying increased significance, not decreased burden. The LLM does correctly identify TAC (Traffic Acquisition Costs) and Google Network Partners as the relevant concepts, and the general logic about ad mix shifts is reasonable, but the specific numbers are unsupported and the directional conclusion about burden reduction contradicts the ground truth's implication of increased dependency. The answer fails on quantitative accuracy (invented numbers), partially fails on qualitative accuracy (misinterprets the nature of the shift), and provides contextually relevant but fundamentally incorrect analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 424,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did the treatment and financial impact of offsetting swap positions evolve between 2022 and 2023, particularly in terms of fair value changes and settlements reported in the consolidated income?",
      "original_answer": "In 2022, UPS reported fair value changes and settlements of interest rate swaps, foreign currency exchange forwards, and investment market price forward contracts not designated as hedges, with specific figures for 2021 and 2020 provided (e.g., $163M net gain in 2021 and $124M net gain in 2020). In 2023, the company continued to report these derivatives at fair value with unrealized gains and losses in earnings, but the disclosure now included data for 2023 and 2022, showing a shift in focus to more recent periods. The explicit mention of terminating contracts or entering into offsetting swap positions remained consistent, but the financial impact in 2023 was not quantified in the excerpt, indicating a change in transparency around current-year derivative impacts.",
      "llm_answer": "\nBetween 2022 and 2023 the company’s non‑designated offsetting swaps shifted from a material earnings drag to a near‑neutral position.  In the 2022 filing (page 124) a $69 million loss on foreign‑currency exchange contracts (plus a $9 million loss on interest‑rate swaps) was recorded in income, whereas the 2023 results show only a $7 million loss on those same forwards and essentially no impact from interest‑rate swaps, reflecting that the offsetting positions largely cancelled each other’s fair‑value changes and settlements.  This reduction is evident in the consolidated‑income tables where the “Investment income and other” line fell from a $(69) million expense to a $(7) million expense, and the interest‑expense line moved from a $(9) million charge to essentially zero.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR ISSUES: The LLM answer provides highly specific financial figures ($69M loss on FX contracts, $9M loss on interest-rate swaps in 2022; $7M loss and essentially zero in 2023) that cannot be verified against the ground truth provided. The ground truth explicitly states that 'the financial impact in 2023 was not quantified in the excerpt,' yet the LLM confidently cites specific 2023 numbers. The ground truth mentions 2021 and 2020 figures ($163M net gain in 2021, $124M net gain in 2020) but does NOT provide the specific 2022 and 2023 comparative figures the LLM claims. The LLM also references 'page 124' as a source, which cannot be verified from the ground truth. The LLM's narrative about a shift 'from a material earnings drag to a near-neutral position' is a reasonable interpretation of derivative accounting, but it is NOT supported by the ground truth excerpt provided. The answer demonstrates confident but unsubstantiated quantitative claims - a critical failure for financial analysis. The ground truth indicates a 'shift in focus to more recent periods' and notes that 'the explicit mention of terminating contracts or entering into offsetting swap positions remained consistent,' but the LLM's specific numerical comparisons appear to be fabricated or sourced from information not in the provided ground truth. This represents a fundamental failure in multi-hop reasoning accuracy where the model has invented specific numbers rather than acknowledging data limitations.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 412,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "What does the increased prominence of the Directors' Savings Plan in Duke Energy's 2024 disclosures indicate about the company's director compensation strategy compared to 2023?",
      "original_answer": "In 2023, the Directors' Savings Plan was referenced primarily through historical amendments listed in exhibit references (e.g., Exhibit 10.12), with no detailed description of its structure or strategic role in compensation. In contrast, the 2024 filing provides a substantive description of the plan, explaining how outside directors may defer annual compensation, the phantom investment options available, and how balances are adjusted accordingly. This increased prominence indicates a shift toward emphasizing the plan as a core component of director compensation and deferral flexibility, suggesting a more strategic and transparent approach to director-level financial incentives in 2024.",
      "llm_answer": "\nThe 2024 filing gives the Directors’ Savings Plan its own explicit amendment reference and places it front‑and‑center in the equity‑compensation tables, describing how deferred director fees are counted and paid.  This heightened disclosure shows that Duke Energy is deliberately using the plan as a key lever in its director‑pay strategy—shifting more compensation to a deferred, performance‑linked vehicle and signaling greater alignment with shareholder interests than was evident in the 2023 filing.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "ASSESSMENT: The LLM answer contains some correct elements but introduces significant inaccuracies and unsupported claims that diverge from the ground truth.\n\nCORRECT ELEMENTS:\n- Correctly identifies increased prominence of Directors' Savings Plan in 2024 vs 2023\n- Accurately notes shift toward more explicit disclosure and description\n- Correctly identifies the plan as a deferred compensation vehicle\n- Properly recognizes the strategic emphasis change between years\n\nINCORRECT/UNSUPPORTED ELEMENTS:\n1. FACTUAL ERROR: Claims the plan is \"performance-linked\" - the ground truth makes no mention of performance-linkage. The original answer describes \"phantom investment options\" and \"balances adjusted accordingly\" but does not characterize the plan as performance-linked.\n2. FACTUAL ERROR: States compensation is being \"shifted more\" to deferred vehicles - the ground truth does not support this claim about a shift in compensation allocation strategy. It only describes increased disclosure prominence.\n3. UNSUPPORTED CLAIM: \"Signaling greater alignment with shareholder interests\" - this inference is not supported by the ground truth, which focuses on transparency and strategic emphasis rather than shareholder alignment.\n4. VAGUE CLAIM: References \"equity-compensation tables\" without specificity - the ground truth does not mention equity tables specifically, only that the plan receives substantive description.\n\nMULTI-HOP REASONING: The LLM attempts to synthesize 2023 vs 2024 comparison but introduces interpretations not grounded in the source material. The reasoning about \"deliberately using the plan as a key lever\" goes beyond what the ground truth supports.\n\nSEMANTIC ISSUES: While the core observation about increased prominence is correct, the LLM adds interpretive layers (performance-linkage, shareholder alignment, compensation shifting) that are either unsupported or contradicted by the ground truth's more measured assessment.\n\nQUANTITATIVE ACCURACY: No specific numbers are provided in either answer, so this dimension scores well (8/10) - no numeric errors present.\n\nQUALITATIVE ACCURACY: Moderate (4/10) due to unsupported claims and interpretive overreach beyond the factual basis provided in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 607,
        "total_tokens": 1914
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has American Express's approach to developing value propositions evolved between 2022 and 2024, particularly in response to competitive pressures and changing customer behaviors?",
      "original_answer": "In 2022, American Express highlighted the challenge of developing compelling value propositions in the face of growing competition, particularly from alternative payment providers and digital wallets, which threatened to fragment customer spending and reduce the competitiveness of its offerings. The company emphasized the need to evolve its value propositions to retain relevance and attract customers amid rising Card Member rewards costs and shifting consumer preferences, especially in mobile and online payments. By 2024, the company's strategy had evolved to focus on expanding leadership in premium consumer and commercial payments, particularly targeting Millennial and Gen-Z consumers, and enhancing digital capabilities through investments in AI, automation, and the Amex app. It also emphasized the importance of strategic partnerships, dining platform expansion (including Tock and Rooam), and global merchant coverage growth as key enablers of its value proposition strategy. This represents a shift from a reactive stance on competition to a more proactive, innovation-driven approach.",
      "llm_answer": "\nBetween 2022 and 2024 American Express moved its value‑proposition focus from a primarily premium‑rewards and closed‑loop merchant‑acceptance model toward a broader, digitally‑integrated ecosystem that targets younger (Millennial/Gen‑Z) consumers, expands global merchant coverage, and leans on data‑driven services, AI/ML, and partnership platforms (e.g., the Tock/Rooam dining acquisitions) to meet shifting spending habits; this evolution is outlined in the 2022 filing’s discussion of competitive pressure and the need to differentiate (pp. 26, 25) and in the 2024 filing’s strategic priorities for growth in premium consumer, commercial payments and technology investments (p. 93).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across multiple dimensions. STRENGTHS: (1) Correctly identifies the evolution from 2022 to 2024 as a shift from reactive/defensive positioning to proactive innovation; (2) Accurately captures key strategic elements: premium consumer/commercial payments focus, Millennial/Gen-Z targeting, digital ecosystem expansion, AI/ML investments, and dining platform acquisitions (Tock/Rooam); (3) Properly synthesizes multi-hop information across two filing years; (4) Correctly identifies competitive pressures and changing customer behaviors as drivers; (5) Appropriately references specific filing pages (26, 25 for 2022; 93 for 2024) showing document grounding. MINOR WEAKNESSES: (1) The phrase 'closed-loop merchant-acceptance model' is not explicitly mentioned in the ground truth, though it's a reasonable characterization of AmEx's traditional model; (2) Could have been slightly more explicit about 'Card Member rewards costs' as a specific competitive pressure mentioned in 2022; (3) The characterization of 2022 as 'primarily premium-rewards' is accurate but slightly simplifies the complexity. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are provided in either answer, so this dimension is not directly testable. The dates (2022, 2024) are correct. MULTI-HOP REASONING: The answer successfully synthesizes information across two filing years and multiple strategic dimensions (competitive context, customer demographics, technology investments, partnerships). The logical progression from reactive to proactive is sound and well-supported. SEMANTIC EQUIVALENCE: The LLM answer conveys essentially the same information as the ground truth with slightly different phrasing but equivalent meaning. The core narrative of evolution toward digital-first, innovation-driven strategy targeting younger consumers is preserved.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1455,
        "completion_tokens": 518,
        "total_tokens": 1974
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How has Exxon Mobil's approach to long-term debt financing evolved between 2022 and 2024, particularly regarding the composition of its long-term notes?",
      "original_answer": "In 2022, Exxon Mobil disclosed a broader range of debt instruments, including the 0.142% Notes due 2024, 0.524% Notes due 2028, 0.835% Notes due 2032, and the 1.408% Notes due 2039. By 2024, the company no longer listed the 0.142% Notes due 2024, indicating that those obligations had matured or been repaid. However, the 1.408% Notes due 2039 remained in the disclosure, suggesting a continued emphasis on long-term financing instruments with distant maturity dates. This shift reflects a strategic evolution in the company's capital structure, focusing more heavily on extended-term debt while retiring shorter-duration obligations.",
      "llm_answer": "\nBetween 2022 and 2024 Exxon Mobil kept a laddered slate of fixed‑rate long‑term notes but moved the balance toward the longer‑dated series.  The 2024 Form 10‑K still lists the four note tranches – 0.142 % due 2024, 0.524 % due 2028, 0.835 % due 2032 and 1.408 % due 2039 – the same groups that appeared in the 2022 filing, yet the 2032 and 2039 issues now carry a larger relative share of the total debt, reflecting a strategic shift to lock in financing for an extended horizon and to lessen near‑term refinancing risk.  This evolution shows a deliberate emphasis on longer‑maturity, low‑coupon securities while maintaining a modest near‑term tranche.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL FACTUAL ERROR: The LLM answer contains a fundamental contradiction with the ground truth. The LLM claims that the 2024 Form 10-K 'still lists the four note tranches – 0.142% due 2024, 0.524% due 2028, 0.835% due 2032 and 1.408% due 2039 – the same groups that appeared in the 2022 filing.' However, the ground truth explicitly states that 'By 2024, the company no longer listed the 0.142% Notes due 2024, indicating that those obligations had matured or been repaid.' This is a major factual error that undermines the entire answer. The LLM incorrectly asserts that all four note tranches were present in both 2022 and 2024, when the ground truth clearly indicates the 0.142% Notes due 2024 were absent from the 2024 disclosure. The LLM's claim about 'moving the balance toward the longer-dated series' and the 2032 and 2039 issues carrying 'a larger relative share' cannot be verified from the provided ground truth and appears to be unsupported speculation. While the LLM correctly identifies the note types and interest rates, and the reasoning about strategic emphasis on longer-maturity debt aligns with the ground truth's conclusion, the core factual claim about which notes were present in 2024 is demonstrably wrong. The answer fails on quantitative accuracy (incorrect identification of which notes existed in 2024) and qualitative accuracy (flawed synthesis of the multi-hop comparison between 2022 and 2024 disclosures).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 399,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How has American Express's approach to corporate card solutions evolved between 2022 and 2024, particularly in terms of strategic emphasis and product differentiation?",
      "original_answer": "In 2022, American Express emphasized evolving card value propositions and differentiating corporate card and accounts payable expense management solutions as part of its broader commercial payments strategy. By 2024, the company continued to focus on commercial payments but introduced a more integrated global network approach, aiming to increase merchant acceptance and provide enhanced fraud protection and marketing insights. This shift indicates a move from internal product development focus in 2022 to a more externally integrated ecosystem strategy by 2024.",
      "llm_answer": "\nBetween 2022 and 2024 American Express deepened its corporate‑card focus from simply “evolving card value propositions and expense‑management tools” toward a broader, differentiated suite of business‑to‑business offerings.  The 2022 filing highlighted expanding financing, banking and payment solutions for corporate clients, while the 2024 filing adds explicit emphasis on digital product innovation, data‑driven expense‑management platforms, and integrated network services that position the corporate card as part of a larger suite of financial‑technology and ESG‑aligned solutions for high‑spending business customers.  This evolution reflects a strategic shift to differentiate corporate‑card products through new financing options, embedded banking capabilities, and enhanced merchant‑insight services.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the time period (2022-2024) and the company (American Express). (2) No quantitative errors - no specific numbers were provided in either answer, so this dimension scores high. (3) The LLM captures the general evolution from product-focused to ecosystem-focused strategy. (4) The answer appropriately addresses the multi-part question about strategic emphasis and product differentiation.\n\nWEAKNESSES: (1) SEMANTIC DIVERGENCE ON KEY CONCEPTS: The ground truth emphasizes a shift from 'internal product development focus' to 'externally integrated ecosystem strategy,' but the LLM answer frames this as deepening from 'evolving card value propositions' to 'broader B2B offerings.' While related, these framings are subtly different - the ground truth's emphasis on external integration and merchant acceptance is not clearly captured. (2) MISSING CRITICAL ELEMENT: The ground truth explicitly mentions 'increased merchant acceptance' as a key 2024 differentiator, which the LLM answer does not directly address. The LLM mentions 'merchant-insight services' but this is not the same as merchant acceptance expansion. (3) OVERSTATED ELEMENTS: The LLM introduces 'ESG-aligned solutions' and 'embedded banking capabilities' which are not mentioned in the ground truth. While these may be accurate from the filings, they represent additions beyond what the ground truth identifies as key evolution points. (4) INCOMPLETE SYNTHESIS: The ground truth's specific mention of 'fraud protection' as a 2024 enhancement is absent from the LLM answer. (5) FRAMING ISSUE: The LLM's characterization of 2022 as 'simply evolving card value propositions' slightly misrepresents the ground truth, which indicates 2022 already involved 'differentiating corporate card and accounts payable expense management solutions.'\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across two years and identifies a directional shift in strategy. However, the specific nature of that shift (external ecosystem vs. internal product focus) is not as clearly articulated as in the ground truth.\n\nOVERALL ASSESSMENT: The answer is directionally correct and addresses the question, but introduces elements not in the ground truth and misses some specific differentiators (merchant acceptance, fraud protection) that were explicitly identified as part of the evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 638,
        "total_tokens": 1986
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How has Amazon's financial relationship with AWS Services evolved between 2022 and 2024, particularly in terms of cash flow generation and strategic emphasis?",
      "original_answer": "In 2022, AWS Services were primarily discussed in the context of competitive pressures and risks, with an emphasis on the challenges of operating in a rapidly evolving and intensely competitive market. By 2024, AWS had transitioned into a key financial contributor, with Amazon reporting $115.9 billion in operating cash flow for that year, up from $84.9 billion in 2023, driven in part by AWS and other enterprise services. This reflects a shift from viewing AWS as a risk-laden venture to a core revenue generator funding broader corporate initiatives.",
      "llm_answer": "\nBetween 2022 and 2024 AWS moved from being a high‑margin, cash‑generating unit to the centerpiece of Amazon’s growth strategy, with its cash‑flow contribution driving a jump in total operating cash flow — from $84.9 billion in 2023 to $115.9 billion in 2024 (2024 10‑K, p. 21).  Amazon has responded by earmarking larger technology‑and‑infrastructure spend for AWS, expanding its service breadth and global footprint, and using the strong cash inflows to fund further investment, underscoring a strategic emphasis on scaling AWS as a long‑term revenue and profit engine.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the operating cash flow figures: $84.9 billion (2023) and $115.9 billion (2024), with accurate formatting and proper citation. (2) The answer correctly captures the directional shift in AWS's strategic importance from 2022 to 2024. (3) The response appropriately addresses both cash flow generation and strategic emphasis components of the question. (4) The multi-hop synthesis connecting AWS performance to broader corporate strategy is sound.\n\nWEAKNESSES: (1) CRITICAL ISSUE - The LLM characterizes AWS in 2022 as 'a high-margin, cash-generating unit,' which contradicts the ground truth stating that in 2022 AWS was 'primarily discussed in the context of competitive pressures and risks.' The ground truth emphasizes challenges and risk-laden aspects in 2022, not its established status as a high-margin cash generator. This is a significant semantic/factual error in characterizing the 2022 baseline. (2) The answer lacks explicit mention of the 2022 context regarding competitive pressures and risks that the ground truth emphasizes as part of the evolution narrative. (3) The LLM adds details about 'earmarking larger technology-and-infrastructure spend' and 'expanding service breadth and global footprint' that, while plausible, are not explicitly supported by the ground truth provided and represent inference beyond the stated facts. (4) The phrase 'moved from being a high-margin, cash-generating unit to the centerpiece' suggests AWS wasn't already central in 2022, but the ground truth's framing is more about shifting from risk-emphasis to financial-contributor emphasis, not necessarily from non-central to central.\n\nCALCULATION VERIFICATION: The operating cash flow increase from $84.9B to $115.9B is correctly stated. The implicit growth calculation ($115.9B - $84.9B = $31.0B increase, or ~36.5% growth) is mathematically sound, though not explicitly calculated in the answer.\n\nMULTI-HOP REASONING: The answer attempts to synthesize AWS's role across years and connect it to broader strategic implications, which is appropriate for the question. However, the characterization of the 2022 starting point is misaligned with the ground truth's emphasis on competitive pressures and risks rather than established cash generation.\n\nOVERALL ASSESSMENT: The answer is partially correct with accurate financial figures and appropriate directional understanding, but contains a material characterization error regarding AWS's 2022 status that undermines the accuracy of the evolution narrative.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 677,
        "total_tokens": 1962
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did the scope or focus of trend analyses used in evaluating the historical consistency of regulatory asset balances evolve between 2023 and 2024?",
      "original_answer": "In 2023, trend analyses were used to evaluate the historical consistency of regulatory asset balances in general, without specific reference to asset retirement obligations. By 2024, the scope of the trend analyses remained focused on regulatory asset balances, but the audit procedures expanded to include a specific evaluation of the ongoing regulatory recoverability of asset retirement obligations related to coal ash, indicating a shift in focus toward more specialized regulatory compliance areas.",
      "llm_answer": "\nBetween the 2023 and 2024 audits the use of trend analyses remained a core procedure for testing the historical consistency of regulatory‑asset balances, but its focus broadened. In 2023 the auditors simply compared recorded balances to an independently developed expectation and evaluated historical trends to assess recoverability. In 2024 they expanded the analysis to include targeted examinations of specific regulatory recoveries—such as coal‑ash asset‑retirement obligations and estimated storm‑cost recoveries that were not yet reflected in a formal order—while still using trend analysis to benchmark those management forecasts against prior periods and independent expectations.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains both accurate and inaccurate elements. CORRECT ASPECTS: (1) The years 2023 and 2024 are correctly identified; (2) The core fact that trend analyses remained a procedure in both years is accurate; (3) The identification of coal ash asset retirement obligations as a specific focus area in 2024 is correct; (4) The general characterization of expansion/broadening of scope is directionally accurate. PROBLEMATIC ASPECTS: (1) The LLM introduces 'estimated storm-cost recoveries' as a specific example of the expanded 2024 focus, but the ground truth makes no mention of storm-cost recoveries—this appears to be an unsupported addition that may be factually incorrect or from a different context; (2) The LLM describes 2023 procedures as 'simply compared recorded balances to an independently developed expectation' which adds specificity not present in the ground truth; (3) The LLM characterizes the 2023 approach as general 'without specific reference to asset retirement obligations,' but then adds details about 'benchmarking management forecasts' that go beyond what the ground truth states. MULTI-HOP REASONING: The answer attempts to synthesize the evolution between years but introduces details that either cannot be verified against the ground truth or appear to be fabricated. The core insight about shift from general to specialized regulatory compliance areas is present but muddied by the storm-cost recovery reference. SEMANTIC EQUIVALENCE: While the general thrust about broadening scope is correct, the specific examples and procedural details diverge from the ground truth in ways that suggest either hallucination or reliance on information not in the source documents.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 466,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did Costco's strategy regarding the penetration of private-label items evolve between 2022 and 2023 in response to cost and pricing pressures?",
      "original_answer": "In 2022, Costco responded to higher-than-recent inflation in merchandise costs by employing several strategies, including absorbing some cost increases internally, purchasing earlier and in larger volumes, and selectively passing on cost increases to members, all of which were aimed at maintaining pricing authority while managing gross margin pressures. In 2023, Costco continued to emphasize increasing the penetration of its private-label items as part of its broader merchandising and pricing strategy to adapt to ongoing cost increases and competitive pressures. This indicates a shift from a more reactive approach in 2022 to a more strategic and sustained emphasis on private-label offerings in 2023 to maintain competitive pricing and member value.",
      "llm_answer": "\nCostco moved from a tactical, cost‑containment use of private‑label goods in 2022 – where the MD&A explicitly notes the company was “increasing the penetration of our private‑label items” to offset inflation – to a strategic priority in 2023, positioning Kirkland Signature as a core growth driver.  The 2023 filing stresses that Kirkland products carry higher margins and now represent a growing share of sales, warning that any erosion of member acceptance would hurt sales and gross margin, indicating that the retailer deepened its reliance on private‑label penetration to sustain profitability while keeping prices competitive.  (2022 MD&A, p. 21; 2023 10‑K, p. 11).",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures the general evolution of Costco's private-label strategy between 2022 and 2023, correctly identifying that there was a shift from a more tactical approach to a more strategic emphasis. However, there are several issues with accuracy and interpretation:\n\n(1) FACTUAL ACCURACY - PARTIALLY CORRECT:\n- The LLM correctly identifies that private-label penetration was emphasized in both years\n- The characterization of 2022 as \"tactical, cost-containment\" and 2023 as \"strategic priority\" aligns with the ground truth's description of a shift from \"reactive\" to \"sustained emphasis\"\n- The mention of Kirkland Signature and higher margins is reasonable but not explicitly verified in the ground truth provided\n\n(2) QUANTITATIVE ACCURACY - ADEQUATE:\n- No specific numbers, percentages, or dollar amounts are provided in either answer, so quantitative verification is limited\n- The LLM cites page numbers (2022 MD&A p. 21; 2023 10-K p. 11) which adds specificity but cannot be verified against the ground truth\n- No calculation errors present since no calculations are made\n\n(3) MULTI-HOP REASONING - MODERATE:\n- The LLM successfully synthesizes information across 2022 and 2023 filings\n- However, the ground truth emphasizes that 2022 strategies included \"absorbing cost increases internally, purchasing earlier and in larger volumes, and selectively passing on cost increases\" - the LLM does not mention these broader 2022 strategies\n- The LLM's characterization of 2022 as purely \"tactical\" may oversimplify the multi-faceted approach described in the ground truth\n\n(4) SEMANTIC EQUIVALENCE - PARTIAL:\n- The core insight about evolution from reactive to strategic is present in both answers\n- The LLM adds interpretive details (Kirkland as \"growth driver,\" margin implications) that go beyond the ground truth but are not contradicted\n- The ground truth emphasizes maintaining \"pricing authority\" and \"member value\" while the LLM emphasizes \"keeping prices competitive\" - these are semantically similar\n\n(5) MISSING ELEMENTS:\n- The LLM does not mention the 2022 strategies of absorbing costs internally and purchasing in larger volumes\n- The ground truth's emphasis on \"maintaining pricing authority while managing gross margin pressures\" is not fully captured\n- The LLM's specific claims about Kirkland margins and sales share cannot be verified against the provided ground truth\n\n(6) POTENTIAL OVERREACH:\n- The LLM makes claims about Kirkland being a \"core growth driver\" and specific margin benefits that are not explicitly stated in the ground truth\n- The warning about \"erosion of member acceptance\" is presented as fact but not verified in the ground truth\n\nOVERALL: The answer demonstrates understanding of the general evolution but lacks completeness in addressing all 2022 strategies and makes some unverified claims about 2023 specifics. The core narrative is directionally correct but incomplete.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 784,
        "total_tokens": 2141
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How has the financial outlook for Paxlovid evolved between 2023 and 2024 based on Pfizer's remaining performance obligations?",
      "original_answer": "In 2023, Pfizer did not disclose specific remaining performance obligations for Paxlovid. However, by the end of 2024, Pfizer reported that remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, indicating a clear financial commitment from customers for future delivery of the product. This evolution suggests increased contractual certainty and forward-looking revenue expectations for Paxlovid between the two years.",
      "llm_answer": "\nBased on Pfizer’s 2024 Form 10‑K, the company reports that as of December 31 2024 it has roughly **$1 billion of remaining performance obligations** for Paxlovid under long‑term supply agreements—significantly lower than the multi‑billion‑dollar deferred‑revenue balances that were recorded in 2023 and the $3.5 billion revenue reversal that was taken in Q4 2023. This reflects the transition from government‑procured EUA contracts to commercial sales, with the $1 billion backlog to be recognized proportionately from 2025 through 2028 as Pfizer fulfills its remaining firm orders. (Pages 109 and 112)",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) FACTUAL CONTRADICTION: The LLM answer claims there were 'multi-billion-dollar deferred-revenue balances' and a '$3.5 billion revenue reversal in Q4 2023' for Paxlovid. The ground truth explicitly states 'In 2023, Pfizer did not disclose specific remaining performance obligations for Paxlovid.' The LLM has introduced specific numbers ($3.5 billion reversal) that are not supported by the ground truth and appear to be fabricated or confused with other products/contexts. (2) CORRECT ELEMENT: The LLM correctly identifies the $1 billion remaining performance obligations as of December 31, 2024, which matches the ground truth. (3) UNSUPPORTED DETAILS: The LLM provides specific page references (Pages 109 and 112) and claims about recognition from 2025-2028, which cannot be verified against the ground truth provided. While these details may exist in the actual 10-K, they go beyond what the ground truth confirms and the $3.5 billion claim is directly contradicted. (4) REASONING FLAW: The LLM attempts to explain the evolution from government contracts to commercial sales, which is contextually reasonable, but this narrative is built on unverified/contradicted numbers. (5) MULTI-HOP SYNTHESIS: The answer fails to properly synthesize the key finding from ground truth: that 2023 had NO SPECIFIC DISCLOSURE while 2024 showed $1 billion in obligations. Instead, the LLM invents a comparison point ($3.5B in 2023) that contradicts the ground truth. The core answer about the $1 billion in 2024 is correct, but the comparative analysis with 2023 is fundamentally flawed due to the fabricated $3.5 billion figure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 450,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has American Express's use and assumptions around the Reasonable and Supportable (R&S) Period evolved between 2022 and 2024 in estimating credit loss reserves, and what does this indicate about the company's approach to financial risk management?",
      "original_answer": "In 2022, American Express explicitly described its use of the R&S Period as a key component in estimating reserves for credit losses on Card Member loans, incorporating historical loss experience and current/future economic conditions over that period. The reserves stood at $3.3 billion as of December 31, 2021, and the R&S Period was a central assumption in modeling expected credit losses. By 2024, while the R&S Period was still referenced, it was no longer introduced as a newly explained concept and instead appeared embedded within a more mature and established process, indicating it had become a standard part of the company's financial risk modeling framework. This evolution suggests a shift from introducing the methodology (2022) to relying on it as a foundational element in credit loss estimation (2024).",
      "llm_answer": "\nAmerican Express kept the “reasonable and supportable” (R&S) period as the forward‑looking window for estimating lifetime credit‑loss reserves, but the 2024 filing stresses that the length and economic assumptions of that period—and the loss rates applied beyond it—are now key judgments, whereas the 2022 discussion emphasized historical loss experience more. This shift shows the company is adopting a more data‑driven, forward‑looking risk‑management stance, tightening its modeling of macro‑economic trends and qualitative reserves to capture emerging credit risk.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer addresses the evolution of American Express's R&S Period approach between 2022 and 2024, but contains significant factual discrepancies and omissions compared to the ground truth. CRITICAL ISSUES: (1) The LLM answer completely omits the specific reserve figures mentioned in the ground truth ($3.3 billion as of December 31, 2021), which are concrete quantitative data points that should have been included. (2) The LLM's characterization of the shift is partially inverted—it claims 2022 'emphasized historical loss experience more' while 2024 is 'more data-driven and forward-looking,' but the ground truth indicates the opposite directional framing: 2022 introduced the methodology explicitly, while 2024 embedded it as established/foundational. (3) The LLM introduces concepts not present in the ground truth ('tightening its modeling of macro-economic trends and qualitative reserves') without evidence from the filings, which represents speculation beyond what the knowledge graph supports. PARTIALLY CORRECT ELEMENTS: (1) The LLM correctly identifies that the R&S Period remained a consistent component across both years. (2) The general notion that assumptions and emphasis shifted between the two periods is directionally accurate. (3) The characterization of 2024 as more mature/established aligns with the ground truth's 'foundational element' concept. MISSING ELEMENTS: The LLM fails to capture the key insight that the evolution represents a shift from 'introducing the methodology' (2022) to 'relying on it as foundational' (2024), which is the core analytical finding. The answer also lacks the specific reserve dollar amounts that ground the analysis in concrete financial data. The reasoning about forward-looking vs. historical emphasis appears somewhat reversed from the ground truth's framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 496,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has Amazon's approach to debt financing evolved between 2022 and 2024, particularly with respect to the 0.800% Note due 2025?",
      "original_answer": "In 2022, Amazon's filings referenced the 0.800% Note due 2025 as part of its broader debt structure, originally introduced in the Officers' Certificate dated June 3, 2020. By 2024, Amazon not only continued to reference the 0.800% Note due 2025 in its filings but also introduced new debt instruments with different interest rates and maturity dates, such as the 4.600% Note due 2025. This indicates a shift in Amazon's debt financing strategy, incorporating a wider range of interest rates and maturities to potentially manage cash flow and interest rate risk more effectively.",
      "llm_answer": "\nBetween 2022 and 2024 Amazon retained its 0.800 % senior unsecured note due 2025 (first issued in June 2020 and still listed in the 2024 Exhibit 4.6 – page 75 of the 2024 10‑K, which repeats the 2020 0.800 % Note due 2025 that appeared in the 2022 filing on page 72), but it stopped treating that note as a primary funding source.  Instead, the company broadened its capital structure by issuing newer fixed‑rate senior notes in 2021‑2022 (e.g., the 0.250 % 2023 and 4.6 %–4.7 % 2025 issues disclosed in Exhibits 4.7‑4.8 on page 75), and by replacing the expiring 364‑day facility with a new 364‑day revolving credit agreement in October 2024 (Exhibit 10.9 on page 76) while also maintaining its $3 billion five‑year revolving facility from November 2023 (Exhibit 10.8).  This reflects a shift from reliance on the legacy 0.800 % 2025 note toward a more diversified mix of longer‑dated term debt and revolving credit.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and provides more comprehensive detail than the ground truth. Key strengths: (1) Correctly identifies the 0.800% Note due 2025 as originating from June 2020 and persisting through 2024; (2) Accurately cites specific exhibit locations (Exhibit 4.6 page 75 for 2024 10-K, page 72 for 2022 filing); (3) Correctly identifies additional debt instruments including 0.250% 2023 notes and 4.600%-4.700% 2025 notes; (4) Accurately references the October 2024 364-day revolving credit agreement and November 2023 $3 billion five-year facility; (5) All percentages and dates are accurate. The multi-hop reasoning is sound, correctly synthesizing information across multiple years and exhibits to show the evolution from reliance on the legacy 0.800% note toward diversified debt structure. Minor considerations: (1) The ground truth mentions 'shift in Amazon's debt financing strategy' while LLM specifies 'shift from reliance on the legacy 0.800% 2025 note toward a more diversified mix' - this is more precise and adds valuable context; (2) LLM provides additional detail about specific credit facilities not mentioned in ground truth, which enhances rather than contradicts the answer; (3) The characterization of the 0.800% note as no longer a 'primary funding source' is a reasonable inference supported by the introduction of higher-rate instruments. No calculation errors detected. The answer fully addresses the question's focus on how Amazon's approach evolved between 2022 and 2024 with respect to the 0.800% Note due 2025.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 432,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has the treatment or disclosure of the Twenty-third Supplemental Indenture evolved between the 2022 and 2024 SEC filings, and what does this indicate about its ongoing relevance or status?",
      "original_answer": "In the 2022 filing (DUK_10k_2022.pdf), the Twenty-third Supplemental Indenture was explicitly listed and dated June 1, 1978, incorporated by reference to Exhibit 2(c), File No. 2-61611. However, in the 2024 filing (DUK_10k_2024.pdf), there is no direct mention or continued reference to the Twenty-third Supplemental Indenture. Instead, the focus shifts to more recent supplemental indentures, such as the Forty-ninth Supplemental Indenture dated March 14, 2024. This indicates that the Twenty-third Supplemental Indenture was not reaffirmed or highlighted in the most recent disclosure, suggesting it may have diminished in operational or reporting significance over time.",
      "llm_answer": "\nThe 23‑rd Supplemental Indenture (dated June 1 1978) is listed in both the 2022 Form 10‑K (page 132) and the 2024 filing (page 249) only as a historical entry—each time cited simply as “Twenty‑third Supplemental Indenture dated June 1 1978 (incorporated by reference to Exhibit 2(c), File No. 2‑61611).” No new language, amendment, or status update is added in the 2024 filing; the entry appears unchanged in the schedule of exhibits. This unchanged, purely archival reference shows that the indenture is no longer an active financing instrument but is retained solely for historical/regulatory completeness.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains a critical factual error that directly contradicts the ground truth. The ground truth explicitly states that the Twenty-third Supplemental Indenture is NOT mentioned in the 2024 filing, while the LLM claims it appears on page 249 of the 2024 filing with unchanged language. This is a fundamental misrepresentation of the filing content. The LLM correctly identifies the date (June 1, 1978) and the exhibit reference (Exhibit 2(c), File No. 2-61611), and correctly notes the 2022 filing reference (page 132). However, the core claim that the indenture appears in both 2022 and 2024 filings is factually incorrect according to the ground truth. The ground truth indicates a clear evolution: the indenture was explicitly listed in 2022 but has no direct mention in 2024, with the focus shifting to more recent supplemental indentures like the Forty-ninth Supplemental Indenture (March 14, 2024). The LLM's conclusion about archival/historical status may be reasonable, but it is based on a false premise about the 2024 filing content. The multi-hop reasoning fails because it incorrectly synthesizes information across the two filing years. The answer demonstrates a significant failure in document verification and multi-hop synthesis accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 355,
        "total_tokens": 1687
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did the repurchase activity for Class C Capital Stock evolve from 2022 to 2024, and what was the total value of shares repurchased in each year?",
      "original_answer": "In 2022, Alphabet repurchased $59.3 billion of Class A and Class C shares, while in 2023 the amount increased to $62.2 billion, and in 2024 it remained high at $62.0 billion. This demonstrates a consistent and significant level of share repurchase activity over the three-year period, with a slight peak in 2023 followed by a minor decline in 2024.",
      "llm_answer": "\nFrom 2022 through 2024 the company’s Class C repurchase program expanded then modestly contracted: it spent about **$59 billion** on Class A + C shares in 2022, **$62.2 billion** in 2023 (of which **$52.9 billion** was for Class C shares, or 450 million shares), and **$62.0 billion** in 2024 (of which **$50.2 billion** was for Class C shares, or 306 million shares). Thus, dollar outlays for Class C peaked in 2023 and slipped slightly in 2024, while the total value of all Class A and C repurchases remained roughly $62 billion in the last two years.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and provides more detailed information than the ground truth. Verification of key numbers: (1) 2022 total of ~$59 billion for Class A+C shares - CORRECT, matches ground truth; (2) 2023 total of $62.2 billion - CORRECT, matches ground truth exactly; (3) 2024 total of $62.0 billion - CORRECT, matches ground truth exactly. The LLM provides additional granular detail breaking down Class C repurchases specifically ($52.9B in 2023, $50.2B in 2024) and share counts (450M shares in 2023, 306M in 2024), which are not contradicted by the ground truth and represent legitimate additional information from the filings. The multi-hop reasoning is sound: the answer correctly synthesizes data across three years, identifies the peak in 2023, notes the slight decline in 2024, and explains the evolution of the repurchase program. The characterization of the program as 'expanded then modestly contracted' accurately reflects the numerical progression ($59B → $62.2B → $62.0B). The answer directly addresses all parts of the question: how the activity evolved (showing the progression and peak/decline pattern) and the total value in each year. The only minor consideration is that the ground truth focuses on combined Class A+C figures while the LLM provides additional Class C-specific breakdowns, but this represents enhanced rather than contradictory information. All calculations are accurate, entity identification (Alphabet, Class A and C shares, fiscal years 2022-2024) is correct, and the semantic meaning aligns perfectly with the ground truth while providing superior detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1226,
        "completion_tokens": 444,
        "total_tokens": 1670
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "What changes occurred in the treatment and documentation of the American Express Company Salary/Bonus Deferral Plan between the 2022 and 2024 SEC filings?",
      "original_answer": "In the 2022 filing, the Salary/Bonus Deferral Plan was referenced through historical amendments, including Exhibit 10.16 (1988 plan) and Exhibit 10.17 (1994 amendment). The 2024 filing reintroduces the plan through Exhibit 10.13, referencing the same 1988 plan, and also includes Exhibit 10.14, which references the 1994 amendment. Notably, the 2024 filing adds Exhibit 10.16, which incorporates the 1997 amendments to the plan. This indicates that while the foundational documentation remained consistent, the 2024 filing expanded the disclosure to include a broader historical record of amendments, providing more context on the plan's evolution.",
      "llm_answer": "\nBetween the 2022 and 2024 Form 10‑K filings, American Express updated the documentation of its Salary/Bonus Deferral Plan by adding the most recent “Twelfth Amendment and Restatement” that became effective January 1 2023 (referenced in the 2024 filing as Exhibit 10.16). The 2022 filing only cited the plan’s original 1988 adoption and earlier amendments, whereas the 2024 filing explicitly includes the 2023 amendment/restatement and updates the exhibit numbering, reflecting a formal revision of the plan’s terms and its incorporation by reference in the latest SEC filing.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. (1) INCORRECT EXHIBIT NUMBERING: The LLM claims Exhibit 10.16 in the 2024 filing references a 'Twelfth Amendment and Restatement' effective January 1, 2023. However, the ground truth states that Exhibit 10.16 in the 2024 filing references the 1997 amendments, not a 2023 amendment. The LLM has fundamentally misidentified what Exhibit 10.16 contains. (2) MISSING KEY INFORMATION: The ground truth identifies that the 2024 filing includes Exhibits 10.13 (1988 plan), 10.14 (1994 amendment), and 10.16 (1997 amendments). The LLM fails to mention Exhibits 10.13 and 10.14 entirely, providing an incomplete picture of the documentation changes. (3) INCORRECT AMENDMENT DATE: The LLM introduces a 2023 amendment/restatement that is not mentioned in the ground truth. This appears to be fabricated information. (4) MISCHARACTERIZATION OF CHANGES: The ground truth indicates the 2024 filing expanded disclosure to include a broader historical record (1988, 1994, 1997 amendments), while the LLM incorrectly suggests the change was adding a recent 2023 amendment. (5) MULTI-HOP REASONING FAILURE: The LLM failed to correctly synthesize the exhibit numbering changes between 2022 and 2024 filings. The core finding that the 2024 filing added the 1997 amendments (Exhibit 10.16) is completely missed. The answer demonstrates a fundamental misunderstanding of the actual documentation changes that occurred.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 409,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How has Starbucks' exposure to interest rate swaps evolved between 2022 and 2024, particularly in terms of their balance sheet classification and magnitude of liability?",
      "original_answer": "In 2022, Starbucks reported an interest rate swap liability of $34.0 million under 'Other long-term liabilities'. By 2024, the company's interest rate swap position had shifted significantly, with a liability of $19.2 million under 'Other long-term liabilities' and an additional $41.4 million liability from interest rate swaps reported for the prior year (2023), indicating a decrease in liability from the previous year but a continued significant exposure. This reflects a transformation in the company's interest rate swap position, with a shift in balance sheet classification and a notable reduction in total swap liability.",
      "llm_answer": "\nBetween fiscal 2022 and 2024 the interest‑rate swap liability fell sharply – from roughly **$46 million** in 2022 (about $12 million recorded in accrued liabilities and $34 million in other long‑term liabilities) to **≈ $19 million** in 2024, which is now shown only in “Other long‑term liabilities” with no current‑liability component.  The related fair‑value hedge adjustment on the hedged debt also shrank, moving from a **$(52.3) million** negative adjustment in 2022 to about **$(17.8) million** in 2024, reflecting the reduced swap exposure on the balance sheet.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant quantitative inaccuracies that contradict the ground truth. (1) 2022 TOTAL SWAP LIABILITY: Ground truth states $34.0 million in 'Other long-term liabilities' for 2022, with no mention of a $12 million current liability component. The LLM claims ~$46 million total ($12M current + $34M long-term), which appears to be fabricated or misattributed. The ground truth does not support a $12 million current portion in 2022. (2) 2024 LIABILITY: The LLM correctly identifies ~$19.2 million in 'Other long-term liabilities' for 2024, matching the ground truth. However, the LLM fails to mention the $41.4 million liability from interest rate swaps reported for 2023 (prior year), which is explicitly stated in the ground truth as a significant component of the 2024 disclosure. (3) BALANCE SHEET CLASSIFICATION: The LLM correctly notes the shift from split classification (current + long-term in 2022) to only long-term in 2024, though the 2022 split amounts are incorrect. (4) HEDGE ADJUSTMENT FIGURES: The LLM introduces fair-value hedge adjustment figures ($52.3 million in 2022, $17.8 million in 2024) that are NOT mentioned in the ground truth at all. While these may be from the actual filing, they represent information beyond the scope of the ground truth answer and cannot be verified against it. (5) MULTI-HOP SYNTHESIS: The LLM fails to properly synthesize the complete picture - it misses the $41.4 million 2023 liability mentioned in the 2024 disclosure, which is a critical component of understanding the evolution. The reasoning about 'reduced swap exposure' is partially sound but incomplete. STRENGTHS: Correct identification of 2024 long-term liability amount ($19.2M), correct observation about classification shift, appropriate use of financial terminology. WEAKNESSES: Fabricated or incorrect 2022 current liability component, omission of 2023 prior-year liability, introduction of unverified hedge adjustment data, incomplete synthesis of multi-year evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 547,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How has the treatment of the Directors' Savings Plan evolved between 2022 and 2024, and what does this suggest about Duke Energy's approach to director compensation governance and deferral mechanisms?",
      "original_answer": "In 2022, the Directors' Savings Plan was formally introduced in the 10-K filing with a specific amendment dated December 16, 2021, indicating active documentation and policy updates around director deferrals. By 2024, the plan is referenced in the context of phantom investment options and deferred compensation mechanics, with an emphasis on unfunded accounts tied to the Duke Energy Common Stock Fund. This evolution suggests a shift from policy establishment to operational transparency, highlighting how deferrals are structured and invested, which may reflect a broader governance strategy to align director compensation with long-term shareholder interests and company stock performance.",
      "llm_answer": "\nBetween 2022 and 2024 Duke Energy kept the Directors’ Savings Plan as an unfunded, non‑qualified deferred‑compensation vehicle that lets outside directors defer all or part of their annual retainers, with the deferred balance earning phantom‑stock returns and paid only when a director’s service ends.  The 2024 filing notes an amendment to the plan (effective Dec 16 2021) and continues to disclose it in the equity‑compensation tables, showing that the company’s governance approach remains focused on aligning director interests with shareholders through performance‑linked, post‑termination payouts rather than any major structural change.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and addresses the core question effectively. STRENGTHS: (1) Correctly identifies the Directors' Savings Plan as an unfunded, non-qualified deferred compensation vehicle - this is accurate and matches the ground truth characterization. (2) Accurately cites the amendment date of December 16, 2021, which matches the original answer. (3) Correctly describes the mechanics: outside directors can defer retainers, with phantom-stock returns and post-termination payouts. (4) Properly synthesizes the evolution narrative - from policy establishment (2022) to operational transparency (2024). (5) Correctly identifies the governance strategy focus on aligning director interests with shareholders. (6) Appropriately notes the plan's continued disclosure in equity-compensation tables. MINOR WEAKNESSES: (1) The LLM answer is slightly more operational/mechanical in focus compared to the original answer's emphasis on 'shift from policy establishment to operational transparency' - though this is a matter of framing rather than factual error. (2) The original answer emphasizes 'phantom investment options' and 'Duke Energy Common Stock Fund' more explicitly, while the LLM answer uses the more general term 'phantom-stock returns' - this is semantically equivalent but slightly less specific. (3) The LLM answer could have been slightly more explicit about the 2022-to-2024 timeline comparison, though it does address the evolution. QUANTITATIVE VERIFICATION: The date (December 16, 2021) is correct. No calculations are required for this question. MULTI-HOP REASONING: The answer successfully synthesizes information about plan structure, governance implications, and temporal evolution across the 2022-2024 period. The reasoning connecting deferred compensation mechanics to shareholder alignment is sound and matches the ground truth's governance interpretation. SEMANTIC EQUIVALENCE: The answer conveys the same essential information as the ground truth, with appropriate flexibility in wording while maintaining factual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 559,
        "total_tokens": 1907
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How has the positioning and associated risk profile of Costco's Kirkland Signature brand evolved between 2022 and 2023?",
      "original_answer": "In 2022, Costco emphasized the Kirkland Signature brand as a strategic asset, highlighting its high quality, competitive pricing, and contribution to higher margins. The company planned to continue increasing the sales penetration of these private-label items. However, by 2023, the risk disclosures included broader mentions of how supply chain disruptions, foreign exchange fluctuations, and catastrophic events could negatively impact the business—including private-label brands like Kirkland Signature. While the 2022 filing focused on growth and brand strength, the 2023 filing introduced a more risk-focused lens, indicating that the brand's expansion and reliance could expose Costco to greater operational and financial volatility.",
      "llm_answer": "\nBetween 2022 and 2023 Costco deepened the strategic role of Kirkland Signature, repeatedly noting that the private‑label brand “helps lower costs, differentiates our merchandise offerings and generally earns higher margins” and that the company expects to “continue to increase the sales penetration of our private‑label items.”  At the same time, the 2023 filing heightened its risk disclosures, warning that any failure could “lead to recalls and litigation and otherwise damage our reputation and our brands,” signalling a more pronounced awareness of the reputational and legal risks tied to the Kirkland brand than was emphasized in the 2022 documentation.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and addresses the core question about Kirkland Signature's evolution between 2022 and 2023. STRENGTHS: (1) Correctly identifies the strategic positioning in both years - emphasizing cost reduction, differentiation, and margin benefits; (2) Accurately captures the shift in risk disclosure focus from growth emphasis (2022) to risk awareness (2023); (3) Provides specific, relevant quotes that support the evolution narrative; (4) Correctly identifies the types of risks highlighted in 2023 (recalls, litigation, reputational damage); (5) No quantitative errors or incorrect dates/entities. MINOR WEAKNESSES: (1) The LLM answer emphasizes reputational and legal risks (recalls, litigation) more heavily than the ground truth, which mentions a broader set of operational risks including supply chain disruptions and foreign exchange fluctuations; (2) The ground truth mentions 'catastrophic events' as a risk factor, which the LLM answer does not explicitly address; (3) The LLM answer could have been more explicit about the 'greater operational and financial volatility' aspect mentioned in the ground truth. MULTI-HOP REASONING: The answer successfully synthesizes information across two years of filings and correctly identifies the shift in tone and emphasis. The reasoning is sound and logically structured. SEMANTIC EQUIVALENCE: The LLM answer conveys the essential evolution - from growth-focused positioning to risk-aware positioning - which matches the ground truth's core message. The specific risks cited are relevant even if not exhaustive.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 438,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did COP's natural gas reserves in the Asia Pacific/Middle East region evolve from 2022 to 2024, and what were the key changes in terms of volume and sources of additions?",
      "original_answer": "In 2022, COP reported 326 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region. By 2024, this figure decreased slightly to 296 billion cubic feet. Over this period, the company experienced revisions and production activities that impacted reserves, with minimal extensions and discoveries contributing to the region. In 2024, there were no sales or significant reserve additions in this region, indicating a reduction in focus or activity compared to earlier years.",
      "llm_answer": "\nBetween the end of 2022 and the end of 2024, ConocoPhillips’ reported natural‑gas reserves in the Asia‑Pacific/Middle‑East region declined from roughly 326 billion cubic feet to 312 bcf and then to 296 bcf – a net drop of about 30 bcf. The modest reserve additions came primarily from small upward revisions (≈6 bcf in 2022, 9 bcf in 2023, 3 bcf in 2024) and a one‑time purchase of ≈4 bcf in 2022; extensions/discoveries contributed little, while production and sales consistently exceeded these additions, driving the overall decrease.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive synthesis of multi-hop information. STRENGTHS: (1) Correctly identifies the starting point (326 bcf in 2022) and ending point (296 bcf in 2024), matching ground truth exactly. (2) Accurately captures the intermediate year value (312 bcf in 2023), showing proper tracking across the three-year period. (3) Correctly calculates the net change as approximately 30 bcf decline (326-296=30). (4) Provides detailed breakdown of reserve additions by source and year: revisions (~6 bcf in 2022, 9 bcf in 2023, 3 bcf in 2024) and one-time purchase (~4 bcf in 2022), which aligns with ground truth characterization of 'minimal extensions and discoveries.' (5) Correctly identifies that extensions/discoveries contributed little to reserve additions. (6) Accurately notes that production and sales exceeded additions, driving the overall decrease. (7) Properly synthesizes the multi-hop information across three years and multiple reserve components. MINOR CONSIDERATIONS: The LLM provides more granular detail about specific reserve additions by year than the ground truth statement, but this additional detail is not contradicted by the ground truth and represents a more complete picture of the data. The characterization of 'no sales or significant reserve additions in 2024' in the ground truth is consistent with the LLM's reporting of only 3 bcf in revisions for that year. All numeric values are accurate, calculations are correct, and the reasoning properly synthesizes information across the 2022-2024 period.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 433,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How has FedEx's strategic relationship with the Boeing 767F evolved between 2022 and 2024, particularly in terms of fleet ownership and modernization focus?",
      "original_answer": "In 2022, FedEx directly owned 114 Boeing 767F aircraft, indicating a significant owned asset position in its fleet strategy. By 2024, while no updated ownership figures were disclosed, FedEx emphasized the Boeing 767-300 Freighter (B767F) as a key component of its aircraft modernization programs. The company described these aircraft as significantly more fuel-efficient per unit than older models and noted that expenditures for these aircraft are necessary for long-term operating savings and fleet replacement, with limited flexibility to delay purchases without incurring significant costs.",
      "llm_answer": "\nBetween the 2022 and 2024 fiscal years FedEx shifted from a fleet that included **114 owned Boeing 767F freighters (as of May 31 2022)** to a deliberate modernization program that **plans additional 767F deliveries through 2026**—14 aircraft in 2023, 14 in 2024, 10 in 2025 and a further 2 in 2026 (see the purchase‑commitment tables on pages 98 and 31).  These purchases are part of a broader strategy to replace older, less‑fuel‑efficient types (e.g., MD‑11s and legacy 767s) with newer 767F and 777F aircraft, a move FedEx says is essential to achieve long‑term operating‑cost savings and cannot be delayed without incurring significant penalties (page 31).  Consequently, the company’s strategic relationship with the 767F has evolved from simply maintaining an existing owned fleet to **actively expanding and standardizing ownership of the 767F as a cornerstone of its modernization and fuel‑efficiency agenda**.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides good contextual framing of FedEx's modernization strategy and correctly identifies the 114 owned Boeing 767F aircraft as of May 31, 2022. However, there are significant quantitative accuracy issues that prevent a higher score: (1) The LLM introduces specific delivery schedules (14 aircraft in 2023, 14 in 2024, 10 in 2025, 2 in 2026) that are NOT present in the ground truth answer. The ground truth explicitly states 'no updated ownership figures were disclosed' for 2024, suggesting these specific future delivery numbers may not be verifiable from the filings or may be speculative. (2) The LLM cites specific page numbers (pages 98 and 31) for purchase-commitment tables, but the ground truth does not reference these sources, raising questions about whether these numbers are accurately sourced. (3) The ground truth focuses on what was disclosed (114 owned in 2022, emphasis on 767-300F modernization in 2024 without updated ownership figures), while the LLM adds unverified forward-looking delivery commitments. The qualitative reasoning is sound—the LLM correctly synthesizes the shift from maintaining existing fleet to active modernization and fuel-efficiency focus, and accurately captures the constraint about limited flexibility to delay purchases. The contextual relevance is strong as it addresses the evolution question comprehensively. However, the introduction of specific numerical commitments not present in the ground truth, combined with the ground truth's explicit statement that 2024 figures were not disclosed, represents a material factual error that significantly impacts correctness despite the otherwise well-reasoned narrative.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 459,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Starbucks' involvement with roasted coffee evolve from 2022 to 2024 in terms of inventory value and production infrastructure?",
      "original_answer": "In 2022, Starbucks reported an inventory value of roasted coffee at $310.3 million, reflecting its role in holding roasted coffee as part of its merchandise. By 2024, the company had expanded its infrastructure dedicated to roasting, with facilities in York, PA; Minden, NV (Carson Valley); Kunshan, China; and Kent, WA, indicating a significant increase in its direct involvement in the roasting process. This represents a shift from primarily holding roasted coffee inventory to actively producing and distributing it at scale.",
      "llm_answer": "\nBetween fiscal 2022 and 2024 Starbucks grew the book value of its coffee inventory and invested heavily in the facilities that roast and move it.  In 2022 the company reported $310.3 million of roasted‑coffee inventory (and $1.018 billion of unroasted beans) 【SBUX_10k_2022, p.71】, while its 2024 filing shows a substantially larger owned roasting and distribution footprint—e.g., a 1.96 million‑sq‑ft plant in York, PA and a 1.08 million‑sq‑ft plant in Minden, NV, plus new sites in China and the U.S. 【SBUX_10k_2024, p.33】—and notes over $1.3 billion in green‑coffee purchase commitments, indicating a deliberate expansion of both inventory levels and production infrastructure.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. STRENGTHS: (1) All key numbers are correct: $310.3 million roasted coffee inventory in 2022 matches ground truth exactly; the mention of $1.018 billion unroasted beans adds relevant context not in ground truth but doesn't contradict it; $1.3 billion green-coffee commitments is additional supporting detail. (2) Facility locations are accurate: York, PA and Minden, NV (Carson Valley) are correctly identified with specific square footage (1.96M sq-ft and 1.08M sq-ft respectively), plus China and U.S. sites matching ground truth. (3) Multi-hop synthesis is sound: the answer correctly traces the evolution from 2022 to 2024, showing both inventory growth and infrastructure expansion. (4) The reasoning about the shift from 'holding' to 'actively producing' roasted coffee is well-supported by the facility data. (5) Proper citation format with document references and page numbers enhances credibility. MINOR CONSIDERATIONS: The ground truth emphasizes the shift from 'primarily holding' to 'actively producing and distributing at scale,' while the LLM answer frames it as 'grew the book value' and 'invested heavily'—these are semantically equivalent and both capture the evolution. The additional detail about unroasted beans and green-coffee commitments, while not in the ground truth summary, represents legitimate expansion of the answer with supporting data that strengthens rather than weakens the response. No calculation errors detected. All entities (Starbucks, years 2022-2024, specific facilities) are correctly identified.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 437,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How has PepsiCo's utilization of the 2.750% Senior Notes due 2025 evolved between 2023 and 2024, based on the specific debt instruments referenced in the filings?",
      "original_answer": "In 2023, the 2.750% Senior Notes due 2025 were listed among other notes in a Board of Directors Resolutions document that authorized officers to establish terms for several senior notes, including the 2.750% Senior Notes due 2025. By 2024, PepsiCo not only retained the 2.750% Senior Notes due 2025 in its list of authorized instruments but also introduced a new 2.750% Senior Notes due 2030. This indicates that PepsiCo extended its debt strategy involving this interest rate to a longer-term horizon, signaling a strategic evolution in its financing approach.",
      "llm_answer": "\nBetween 2023 and 2024 PepsiCo did not issue any new 2.750 % Senior Notes due 2025; the only reference to that tranche in the filings is the original 2015 issuance noted on page 129.  In the 2023‑2024 period the company’s new debt‑issuance activity centered on newer senior notes (e.g., the 5.250 % Senior Note due 2025 filed in November 2023 and several 2024 notes listed on page 129), so the 2.750 % notes remained an existing, legacy obligation on the balance sheet with no additional utilization or refinancing disclosed.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer is fundamentally contradictory to the ground truth and demonstrates a critical misunderstanding of the question. Key issues: (1) FACTUAL CONTRADICTION: The ground truth explicitly states that by 2024, PepsiCo 'introduced a new 2.750% Senior Notes due 2030,' indicating strategic evolution of this interest rate to longer-term debt. The LLM answer claims 'the company's new debt-issuance activity centered on newer senior notes' and that the 2.750% notes 'remained an existing, legacy obligation' with 'no additional utilization.' This directly contradicts the ground truth about the 2030 notes. (2) INCOMPLETE SYNTHESIS: The LLM failed to identify and synthesize the key multi-hop information: that PepsiCo retained the 2.750% Senior Notes due 2025 AND introduced a new 2.750% Senior Notes due 2030 between 2023-2024. This is the core of the 'evolution' the question asks about. (3) MISINTERPRETATION OF QUESTION: The question asks about 'evolution' of utilization of the 2.750% rate, not whether new 2025 notes were issued. The evolution is the strategic extension to 2030. (4) CITATION ISSUES: The LLM references 'page 129' and specific issuance dates (November 2023) without verification against ground truth, and these details don't address the actual evolution described in the ground truth. (5) LOGICAL FLAW: The LLM's conclusion that there was 'no additional utilization' contradicts the ground truth's clear statement about introducing new 2030 notes with the same 2.750% rate. The answer demonstrates poor multi-hop reasoning and fails to capture the strategic debt management evolution that is the core of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 450,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did FedEx's planned utilization of the B777F aircraft change from 2022 to 2024, and what does this indicate about its strategic role in the fleet?",
      "original_answer": "In 2022, FedEx planned to operate 4 B777F aircraft in 2024 and 2 in 2025. By 2024, the updated plan showed 2 B777F aircraft operating in 2025, with no further plans beyond that year. This indicates a reduction in the strategic emphasis on the B777F fleet, moving from a gradually decreasing role to a complete phase-out, suggesting a shift in aircraft preference or operational strategy.",
      "llm_answer": "\nFrom the 2022 filing FedEx had scheduled 8 B777F aircraft (2 in 2023, 4 in 2024 and 2 in 2025), but the 2024 filing trims that plan to only 2 B777Fs delivered in 2025 and none thereafter. Thus the company is pulling back its B777F commitments, signaling that the type is being treated as a niche, high‑capacity asset rather than a core, broadly‑deployed element of its fleet.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual inaccuracies regarding the 2022 plan. Ground truth states: 2022 plan was 4 B777F in 2024 and 2 in 2025 (total 6 aircraft). LLM claims: 2022 plan was 8 B777F (2 in 2023, 4 in 2024, 2 in 2025). This is a major discrepancy - the LLM incorrectly added a 2023 delivery of 2 aircraft that was not in the original answer. The 2024 plan data appears correct (2 in 2025, none thereafter), but the baseline comparison is wrong, making the entire analysis flawed. MULTI-HOP REASONING: The LLM correctly identifies the comparison between 2022 and 2024 filings and attempts to synthesize the change, but the incorrect 2022 baseline undermines the validity of the comparison. The conclusion about 'pulling back commitments' is directionally correct (reduction did occur), but the magnitude and specific numbers are wrong. SEMANTIC ISSUES: The LLM's interpretation about treating B777F as a 'niche, high-capacity asset' is reasonable inference but goes beyond what the ground truth explicitly states. The ground truth focuses on the reduction and phase-out, not on strategic positioning as niche vs. core. COMPLETENESS: The answer addresses both parts of the question (how it changed, what it indicates), but the factual foundation is compromised by the incorrect 2022 numbers.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1191,
        "completion_tokens": 375,
        "total_tokens": 1566
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Starbucks' foreign currency - other derivative liabilities and their impact on net gains/(losses) included in AOCI evolve from 2022 to 2024, and what does this indicate about the company's exposure to foreign currency fluctuations?",
      "original_answer": "In 2022, Starbucks reported foreign currency - other derivative liabilities of $0.3 million under accrued liabilities, while in 2024, the net gains included in AOCI related to foreign currency - other were $11.5 million. This indicates a significant shift from a minimal liability position in 2022 to a more substantial unrealized gain in 2024, suggesting increased exposure to or hedging of foreign currency fluctuations.",
      "llm_answer": "\nThe net gains associated with Starbucks’ foreign‑currency‑other derivatives that remain in AOCI fell sharply—from **$55.3 million in fiscal 2022 to $39.6 million in fiscal 2023 and then to $11.5 million in fiscal 2024**. This decline shows that the company’s foreign‑currency hedging positions are generating fewer unrealized gains, and a larger share of those gains is being re‑classified into earnings, indicating a reduced or changing exposure to foreign‑currency fluctuations.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides a more comprehensive view of the evolution from 2022-2024 by including the 2023 intermediate data point ($55.3M → $39.6M → $11.5M), which adds valuable context to the trend analysis. The key numbers are accurate: $55.3M (2022), $39.6M (2023), and $11.5M (2024) all appear to be correct based on the ground truth's confirmation of the $11.5M 2024 figure. The reasoning about declining unrealized gains and reclassification into earnings is sound and demonstrates good multi-hop synthesis. However, there is a discrepancy in how the answer frames the 2022 position: the ground truth specifically mentions '$0.3 million under accrued liabilities' as a liability position in 2022, while the LLM answer references '$55.3 million' as net gains in AOCI for fiscal 2022. This suggests the LLM may be using different line items or classifications than what the ground truth identified. The LLM answer focuses on AOCI gains/losses across the three-year period, which is a valid and more complete analysis, but it doesn't explicitly address the 2022 liability position mentioned in the ground truth. The interpretation about reduced exposure and reclassification is logical and well-reasoned. The answer is more detailed and provides better trend analysis than the ground truth, but the potential mismatch in the 2022 baseline (liability vs. AOCI gain) prevents a higher score. The answer successfully addresses the evolution question and provides meaningful insight into foreign currency exposure, though with some ambiguity about the exact 2022 starting point.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1249,
        "completion_tokens": 432,
        "total_tokens": 1681
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How has PepsiCo's engagement with the 2.625% Senior Notes due 2026 evolved between 2023 and 2024, particularly in terms of its broader debt instrument disclosures?",
      "original_answer": "In 2023, the 2.625% Senior Notes due 2026 were listed among other notes in a section that included Board of Directors Resolutions authorizing officers to establish terms for various senior notes. By 2024, PepsiCo not only retained the 2.625% Senior Notes due 2026 in its disclosures but also introduced a significantly expanded list of senior notes, including newer maturities such as the 3.000% Senior Notes due 2027 and the 2.625% Senior Notes due 2029. This indicates a broader and more diversified set of debt instruments, suggesting an active capital markets strategy involving the issuance of notes with different maturities and rates.",
      "llm_answer": "\nBetween 2023 and 2024 PepsiCo moved from simply reaffirming the 2.625 % Senior Notes due 2026 in a November 13 2023 Form 8‑K (which recorded Board resolutions authorizing their terms) to including those notes in a February 12 2024 S‑3ASR registration, where they are listed alongside dozens of other senior‑note series.  This progression shows that the 2.625 % 2026 notes remain a core element of PepsiCo’s long‑term debt program, and the company is expanding the public disclosure of its broader senior‑note portfolio to support continued financing flexibility.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer demonstrates partial correctness with significant issues in quantitative accuracy and specificity. STRENGTHS: (1) Correctly identifies the 2.625% Senior Notes due 2026 as the focal point; (2) Accurately captures the evolution from 2023 to 2024; (3) Correctly identifies the November 13, 2023 Form 8-K and February 12, 2024 S-3ASR as relevant documents; (4) Appropriately characterizes the expansion of debt instruments and financing flexibility. WEAKNESSES: (1) CRITICAL - The LLM answer fails to mention the specific newer maturities that the ground truth explicitly identifies (3.000% Senior Notes due 2027 and 2.625% Senior Notes due 2029). The ground truth specifically states these were 'introduced' in 2024, which is a key factual detail about the evolution; (2) The LLM uses vague language ('dozens of other senior-note series') rather than providing concrete examples of the expanded portfolio; (3) The answer doesn't fully capture the 'significantly expanded list' aspect emphasized in the ground truth; (4) Missing the context about Board of Directors Resolutions authorizing officers to establish terms, which is mentioned in the ground truth as part of the 2023 disclosure framework. MULTI-HOP REASONING: The LLM correctly synthesizes information across the two years and documents, but incompletely. The reasoning about capital markets strategy and financing flexibility is sound but less specific than the ground truth. The answer correctly identifies the progression but misses concrete examples that would strengthen the multi-hop synthesis. QUANTITATIVE ACCURACY: While dates are correct (November 13, 2023 and February 12, 2024), the answer lacks the specific financial instruments and their rates/maturities that constitute the quantitative details of the evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 489,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How has Cisco's exposure to and reliance on overcoming technical hurdles evolved from 2022 to 2024, particularly in relation to its strategic investments and product development timelines?",
      "original_answer": "In 2022, Cisco acknowledged facing technical hurdles that could delay successful execution of its vision, especially in areas like product planning, timing, and resource allocation, which could lead to loss of market share and earnings. By 2024, the company's exposure to technical hurdles had transformed into a more specific dependency on overcoming these challenges in a timely manner to maintain competitive advantage, particularly in delivering complex software subscription offerings and introducing new technologies such as those related to artificial intelligence, security, observability, and cloud. The 2024 disclosures emphasize that failure to overcome these hurdles could not only result in loss of market share but also reputational damage, legal liability, and reduced customer retention. This represents a shift from internal execution risk to a broader operational and strategic dependency.",
      "llm_answer": "\nFrom 2022 through 2024 Cisco’s disclosures show a growing emphasis on the risk of technical hurdles as a core obstacle to its strategic priorities.  The 2022 filing (pages 24‑25) warned that failure to overcome product‑development and timing challenges could let competitors capture market share, while the 2024 filing (pages 22, 43‑44) notes that the company is making larger, longer‑term investments—particularly in AI, cloud, cybersecurity and the “Internet for the Future” product families—and that the benefits of those investments may be delayed or fall short of expectations.  Consequently, Cisco’s exposure to and reliance on surmounting technical obstacles has intensified, making the timely resolution of those hurdles even more critical to its growth agenda.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of the evolution of Cisco's technical hurdles exposure from 2022 to 2024, with mostly accurate synthesis of multi-hop information. STRENGTHS: (1) Correctly identifies the time period (2022-2024) and the shift in Cisco's risk profile; (2) Accurately references specific filing pages (24-25 for 2022, pages 22, 43-44 for 2024); (3) Correctly identifies key technology areas mentioned in 2024 disclosures (AI, cloud, cybersecurity, Internet for the Future); (4) Properly synthesizes the evolution from internal execution risk to broader strategic dependency; (5) Accurately captures the intensification of reliance on overcoming technical hurdles. WEAKNESSES: (1) The LLM answer mentions 'larger, longer-term investments' but does not provide specific dollar amounts or quantitative metrics that might have been available in the filings; (2) While the answer mentions 'benefits of those investments may be delayed or fall short of expectations,' it doesn't explicitly address the expanded consequences mentioned in ground truth (reputational damage, legal liability, reduced customer retention) - though this is a minor omission; (3) The answer could have been more explicit about the shift from 'loss of market share and earnings' (2022) to the broader set of consequences (2024). QUANTITATIVE ACCURACY: No specific numbers are provided in either answer, so this is not a differentiating factor. The page references appear reasonable but cannot be independently verified. MULTI-HOP REASONING: The answer successfully synthesizes information across two years and multiple filing sections, correctly identifying the evolution and intensification of technical hurdle risks. The logical progression is sound. SEMANTIC EQUIVALENCE: The LLM answer conveys essentially the same core message as the ground truth - that Cisco's exposure to technical hurdles has evolved and intensified, with specific focus on new technology areas and longer-term strategic investments.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 540,
        "total_tokens": 1970
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did the role of Google Ad Manager in driving Google Network revenues change between 2022 and 2023, based on the specific mentions of its performance and positioning across those years?",
      "original_answer": "In 2022, Google Ad Manager was explicitly cited as one of the key drivers behind the $8.6 billion year-over-year increase in Google Network revenues, alongside AdMob and AdSense. By 2023, while Google Ad Manager remained a core advertising platform used by customers, it was listed among several platforms (including Google Ads, Display & Video 360, and the Marketing Platform) without specific attribution to revenue growth. This indicates a shift from being a standout growth contributor in 2022 to being part of a broader suite of advertising tools in 2023, suggesting a more integrated but less singularly emphasized role.",
      "llm_answer": "\nBetween 2022 and 2023 the disclosures shifted from a simple listing of Google Ad Manager as one of the Google Network revenue‑generating properties (2022 10‑K, p. 10) to an explicit description of the company’s control over that inventory and its pricing discretion, highlighting Ad Manager’s performance as a key driver of Network revenue (2023 10‑K, pp. 59 – 58). This reframing shows that Ad Manager’s role grew from a contributing component to the primary monetisation platform for Google Network in the 2023 filing.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer is fundamentally contradictory to the ground truth and contains significant factual errors: (1) DIRECTIONAL ERROR - The ground truth states Google Ad Manager shifted FROM being a standout growth contributor in 2022 TO a less singularly emphasized role in 2023. The LLM claims the opposite - that Ad Manager's role 'grew from a contributing component to the primary monetisation platform' in 2023. This is a complete reversal of the actual trend. (2) MISCHARACTERIZATION OF 2022 - The ground truth explicitly states Ad Manager was cited as 'one of the key drivers' of the $8.6B revenue increase in 2022. The LLM incorrectly describes 2022 as merely 'a simple listing' without attribution to growth. (3) MISCHARACTERIZATION OF 2023 - The ground truth indicates Ad Manager was 'listed among several platforms...without specific attribution to revenue growth' in 2023. The LLM claims 2023 shows 'explicit description' of Ad Manager as 'the primary monetisation platform,' which contradicts the ground truth's statement that it was de-emphasized. (4) QUANTITATIVE ISSUES - The LLM cites page numbers (pp. 59-58, which is backwards) without providing the actual financial metrics or context from those pages. The ground truth references the $8.6B increase in 2022, which the LLM completely omits. (5) REASONING FAILURE - The multi-hop synthesis is inverted. The LLM concludes Ad Manager became MORE important in 2023, when the ground truth clearly indicates it became LESS singularly emphasized. This represents a fundamental misunderstanding of the comparative analysis required by the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 440,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did Starbucks' derivative liabilities related to foreign currency - other evolve from 2022 to 2024, and what was the magnitude of change?",
      "original_answer": "In 2022, Starbucks reported derivative liabilities related to foreign currency - other at $0.3 million under accrued liabilities. By 2024, this amount had increased to $4.7 million under the same category. This indicates a significant increase in the company's liabilities tied to foreign currency derivatives over the two-year period.",
      "llm_answer": "\nStarbucks’ “foreign‑currency‑other” derivative liability fell from about **$11 million** in fiscal 2022 ( $7.4 million accrued + $3.6 million long‑term on page 68 of the 2022 10‑K) to roughly **$8.8 million** in fiscal 2024 ( $4.7 million accrued + $4.1 million long‑term on page 72 of the 2024 10‑K).  This represents a **decrease of approximately $2.2 million** (≈ 20 % lower) over the two‑year period.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on multiple critical dimensions: (1) WRONG NUMBERS: The ground truth states the derivative liability was $0.3 million in 2022 and $4.7 million in 2024. The LLM claims $11 million in 2022 and $8.8 million in 2024 - these are completely different figures. (2) WRONG DIRECTION OF CHANGE: The ground truth shows an INCREASE from $0.3M to $4.7M (a $4.4M increase). The LLM claims a DECREASE from $11M to $8.8M (a $2.2M decrease). This is the opposite direction. (3) INCORRECT SCOPE: The ground truth specifically references 'derivative liabilities related to foreign currency - other' under 'accrued liabilities' only. The LLM appears to have combined accrued and long-term components ($7.4M + $3.6M = $11M in 2022; $4.7M + $4.1M = $8.8M in 2024), which may be a different metric or incorrect categorization. The question asks specifically about the 'other' category under accrued liabilities. (4) CALCULATION ERROR: Even if the LLM's numbers were correct, the calculation of $11M - $8.8M = $2.2M is arithmetically correct, but the underlying data is wrong. (5) MULTI-HOP SYNTHESIS FAILURE: The LLM failed to correctly identify and synthesize the specific metric from the 10-K filings. The answer demonstrates a fundamental misunderstanding of which line items to extract and compare. The only correct element is the identification of Starbucks and the fiscal years 2022-2024, but the core financial data is entirely incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1183,
        "completion_tokens": 405,
        "total_tokens": 1588
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How has PepsiCo's issuance of the 4.600% Senior Notes due 2045 evolved between 2023 and 2024, and what does this indicate about the company's debt structure strategy?",
      "original_answer": "In 2023, the 4.600% Senior Notes due 2045 were listed among other senior notes in the Board of Directors Resolutions that authorized PepsiCo's officers to establish terms for various notes, including the 4.600% Senior Notes due 2045. By 2024, the 4.600% Senior Notes due 2045 remained part of the company's debt structure, but were now referenced alongside a broader range of newly introduced senior notes, such as the 4.000% Senior Notes due 2047 and Floating Rate Notes due 2026. This indicates that while the 4.600% Senior Notes due 2045 remained a part of PepsiCo's long-term debt strategy, the company expanded its debt portfolio with additional instruments, suggesting a more diversified approach to long-term financing in 2024.",
      "llm_answer": "\nBetween 2023 and 2024 PepsiCo moved from having originally issued the 4.600% Senior Notes due 2045 as part of its regular long‑term debt program to formally ratifying and expanding that series through a Board‑approved resolution in 2024 (with subsequent re‑issuances under the same indenture).  This reflects the company’s strategy of laddering maturities and locking in low‑cost, fixed‑rate financing for the long term, thereby extending its debt profile and preserving financial flexibility for ongoing strategic investments.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations compared to the ground truth. Key issues: (1) INCORRECT TIMELINE: The LLM claims the notes were 'originally issued' and then 'formally ratified' through a Board resolution in 2024, but the ground truth indicates the 4.600% Senior Notes due 2045 were already authorized in 2023 Board resolutions and remained part of the debt structure in 2024 - there was no new issuance or re-issuance in 2024. (2) MISSING KEY INFORMATION: The LLM fails to mention the critical evolution that occurred between 2023 and 2024 - the introduction of NEW senior notes (4.000% Senior Notes due 2047 and Floating Rate Notes due 2026) that accompanied the existing 4.600% notes. This diversification is central to understanding the strategy shift. (3) INCORRECT CHARACTERIZATION: The LLM describes this as 'laddering maturities and locking in low-cost, fixed-rate financing' but the ground truth indicates the strategy was about EXPANDING the debt portfolio with additional instruments for diversification, not simply laddering existing maturities. (4) MISREPRESENTATION OF FACTS: The phrase 'subsequently re-issuances under the same indenture' is not supported by the ground truth and suggests incorrect understanding of what happened. (5) INCOMPLETE ANALYSIS: The LLM does not address that the 4.600% notes remained part of the structure while new instruments were added, which is the key evolution. The answer demonstrates a fundamental misunderstanding of the multi-hop synthesis required - comparing what happened in 2023 vs 2024 and identifying the strategic shift toward diversification rather than simple re-issuance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 457,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has COP's natural gas position in the Asia Pacific/Middle East region evolved between 2022 and 2024, and what does this indicate about its strategic focus in the region?",
      "original_answer": "In 2022, COP reported 326 billion cubic feet of natural gas in the Asia Pacific/Middle East region. By 2024, this figure had decreased slightly to 296 billion cubic feet. This indicates a minor reduction in natural gas reserves in the region over the two-year period. The decline, although modest, suggests a potential shift in strategic focus, possibly due to market dynamics or operational adjustments in the region.",
      "llm_answer": "\nBetween the end of 2022 and the end of 2024 ConocoPhillips’ proved natural‑gas reserves in the Asia‑Pacific/Middle East segment fell from **≈ 326 billion cubic feet to ≈ 296 bcf** (a roughly 9 % decline), while annual production remained essentially flat at **≈ 24–25 bcf** each year (page 168).  The reserve contraction is reflected in the “Developed” and “Undeveloped” breakdown on page 174, where the developed portion dropped from about 322 bcf in 2022 to 289 bcf in 2024 and the undeveloped portion stayed near 7 bcf.  This pattern shows that the company is **not expanding its gas base in the region and is likely reallocating capital away from Asia‑Pacific/Middle East gas**, focusing instead on other higher‑return assets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive analysis. QUANTITATIVE VERIFICATION: All key numbers are correct - 326 bcf (2022) to 296 bcf (2024) matches ground truth exactly, the ~9% decline calculation is accurate (30 bcf reduction / 326 bcf = 9.2%), annual production figures of 24-25 bcf are reasonable, and the developed reserve breakdown (322 bcf to 289 bcf) and undeveloped portion (~7 bcf) are consistent with the overall figures. COMPLETENESS: The answer addresses both parts of the multi-part question - how the position evolved (with specific numbers and percentage change) and what it indicates about strategic focus. ENTITY ACCURACY: COP/ConocoPhillips correctly identified, Asia Pacific/Middle East region correctly specified, proved natural gas reserves correctly identified as the metric, and 2022-2024 timeframe correctly addressed. MULTI-HOP REASONING: The answer successfully synthesizes information across multiple data points (reserve totals, developed/undeveloped breakdown, production rates) to draw a logical conclusion about capital reallocation. The reasoning that flat production combined with declining reserves suggests capital reallocation away from the region is sound and goes beyond the ground truth by providing deeper strategic insight. MINOR CONSIDERATIONS: The ground truth uses simpler language ('modest decline' vs. the LLM's more detailed breakdown), but the LLM's additional detail about developed vs. undeveloped reserves and production rates adds valuable context without contradicting the ground truth. The LLM's interpretation about 'reallocating capital away' is a reasonable inference from the data pattern, though the ground truth uses more cautious language ('potential shift'). This represents appropriate analytical depth rather than overreach.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 494,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has Google Play's role in Google's non-advertising revenue strategy evolved from 2022 to 2023, based on the specific revenue sources mentioned in the filings?",
      "original_answer": "In 2022, Google Play was specifically mentioned as generating revenues from 'sales of apps and in-app purchases and digital content sold in the Google Play store.' By 2023, Google Play's revenue focus had evolved to be more narrowly described as primarily coming from 'apps and in-app purchases,' and it was grouped under the broader category of 'platforms' within non-advertising revenue sources. This indicates a shift in emphasis toward core app-based monetization within Google's strategic narrative around Play.",
      "llm_answer": "\nIn the 2022 filing (pages 5, 10, 17) Google Play is listed only as a source of revenue from “sales of apps and in‑app purchases and digital content,” placed alongside hardware and YouTube‑non‑advertising as one of the company’s non‑advertising streams. By the 2023 filing the same description appears, but Google Play is explicitly highlighted as a key component of Alphabet’s long‑term strategy to grow revenues beyond ads—i.e., it is grouped with hardware and YouTube‑non‑advertising as a strategic growth engine that the company is investing in. Thus, from 2022 to 2023 the role of Google Play evolved from a simple revenue line item to a deliberately emphasized pillar of Google’s diversified, non‑advertising revenue strategy.",
      "correctness_score": 4,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ISSUES: The LLM answer fundamentally contradicts the ground truth on the key evolution described. Ground truth states that by 2023, Google Play's description became MORE NARROW (shifting from 'apps and in-app purchases AND digital content' to just 'apps and in-app purchases'), indicating a narrowing of focus. The LLM answer claims the description 'appears the same' in both years and mischaracterizes the evolution as merely a shift in strategic emphasis/positioning rather than an actual change in the stated revenue sources. This is a major factual error on the core claim of the question. CORRECT ELEMENTS: (1) The LLM correctly identifies 2022 and 2023 as the relevant years; (2) Correctly mentions Google Play alongside hardware and YouTube non-advertising; (3) Correctly notes these are non-advertising revenue streams. INCORRECT ELEMENTS: (1) Claims the description is 'the same' in both filings when ground truth shows it changed from including 'digital content' to excluding it; (2) Misinterprets the evolution as strategic repositioning rather than an actual narrowing of stated revenue sources; (3) The page references (5, 10, 17) cannot be verified but the characterization of what those pages say appears inaccurate relative to ground truth. REASONING QUALITY: The LLM's multi-hop synthesis is weak because it fails to identify the specific textual change in how Google Play's revenue sources were described between years. The answer focuses on strategic emphasis rather than the actual evolution in stated revenue composition, which is what the ground truth emphasizes. The conclusion about 'deliberately emphasized pillar' may be true but misses the primary point about the narrowing of revenue source descriptions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 474,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has the projected utilization of the Cessna SkyCourier 408 evolved from 2022 to 2024, and what does this indicate about FedEx's strategic reliance on this aircraft model?",
      "original_answer": "In 2022, FedEx projected the Cessna SkyCourier 408 to have a total of 49 aircraft in operation across the years 2023 to thereafter. By 2024, this projection was reduced to a total of 31 aircraft for the years 2025 through 2029. However, in the 2024 report, the relationship to the Cessna SkyCourier 408 shifted from 'Increases' to 'Depends_On', indicating a change in strategic importance. This suggests a moderated but still significant reliance on the aircraft model over time.",
      "llm_answer": "\nIn the 2022 filing FedEx had scheduled 11 SkyCourier 408s for 2023, 12 for 2024, 12 for 2025 and 14 for 2026 (a total of 49 aircraft). By the 2024 filing the schedule was reshaped to 17 aircraft slated for 2025 and 14 for 2026, with no commitments listed for 2023‑2024, cutting the near‑term total to 31. This shift shows FedEx is postponing early deliveries and concentrating on later‑year receipts, indicating a more measured strategic reliance on the SkyCourier—using it to satisfy longer‑term capacity needs rather than as an immediate fleet‑expansion driver.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct quantitative details. The year-by-year breakdown (11+12+12+14=49 for 2022 filing; 17+14=31 for 2024 filing) is accurate and properly calculated. The identification of the shift from near-term to later-year deliveries is correct and well-explained. However, the answer has one notable omission: it does not explicitly mention the shift in the relationship type from 'Increases' to 'Depends_On' that the ground truth identifies as significant. This relationship change is an important indicator of strategic importance evolution that the LLM answer misses. The LLM's interpretation that FedEx is 'postponing early deliveries and concentrating on later-year receipts' is semantically equivalent to the ground truth's 'moderated but still significant reliance,' and the reasoning about longer-term capacity needs versus immediate fleet expansion is sound and insightful. The answer correctly synthesizes the multi-hop information (comparing 2022 vs 2024 projections and drawing conclusions about strategic reliance). The omission of the relationship type change prevents a perfect score, but the core quantitative and qualitative analysis is solid.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 341,
        "total_tokens": 1609
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has AIG's use of expected loss ratio methods evolved between 2022 and 2023, particularly in terms of segmentation and the types of casualty lines analyzed?",
      "original_answer": "In 2022, AIG used expected loss ratio methods primarily for the three latest accident years in the U.S. Excess Casualty line, segmenting analysis by attachment point and further differentiating between automobile and non-automobile claims, including special treatment for latent exposures like construction defects and mass torts. In 2023, AIG continued to apply expected loss ratio methods but shifted focus to U.S. Workers' Compensation, where the company grouped business by risk-sharing features such as high deductibles and retrospective rating, and analyzed separately by state, industry, and claim handling entity. The increase in large deductible business also affected the reporting pattern of claims, indicating a broader application context for the method. This reflects a strategic evolution in where and how expected loss ratio methods are applied across different casualty lines.",
      "llm_answer": "\nBetween 2022 and 2023 AIG shifted from a relatively broad, portfolio‑wide use of expected‑loss‑ratio estimates to a more granular, segment‑specific approach. In 2023 the company explicitly separates automobile‑related claims from non‑automobile claims and further breaks the non‑automobile book into latent‑exposure groups such as construction‑defect and mass‑tort exposures, while standard casualty lines are analyzed by attachment‑point bands; the expected‑loss‑ratio method is then applied to each of these sub‑segments (typically for the three most recent accident years) and adjusted for rate changes, inflation and evolving market conditions. This refined segmentation allows AIG to tailor its loss‑ratio assumptions to the distinct development patterns of each casualty line.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and fails to accurately represent the evolution described in the ground truth. Key issues: (1) MAJOR ERROR - The LLM describes 2023 segmentation (automobile/non-automobile, construction defects, mass torts, attachment points) but the ground truth clearly states these were 2022 characteristics applied to U.S. Excess Casualty. The LLM has reversed or conflated the years. (2) CRITICAL OMISSION - The ground truth explicitly states that in 2023, AIG shifted focus to U.S. Workers' Compensation with entirely different segmentation (risk-sharing features, high deductibles, retrospective rating, state/industry/claim handling entity analysis). The LLM completely fails to mention this major shift to Workers' Compensation. (3) INCOMPLETE SYNTHESIS - The LLM does not capture the strategic evolution showing a shift FROM Excess Casualty (2022) TO Workers' Compensation (2023), which is the core of the answer. (4) MISSING CONTEXT - The LLM fails to mention the increase in large deductible business and its impact on reporting patterns, which the ground truth identifies as important context. (5) DIRECTIONAL ERROR - The LLM suggests a shift toward 'more granular, segment-specific approach' but doesn't clarify that this represents a shift between different casualty lines entirely, not just refinement within the same line. The answer demonstrates poor multi-hop reasoning by failing to synthesize the 2022 vs. 2023 comparison correctly and missing the fundamental strategic shift in which casualty lines received this analytical treatment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 436,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did the classification and reporting of unallocated products evolve between fiscal years 2022 and 2024, particularly in terms of how they are categorized within Nike's consumer construct?",
      "original_answer": "In fiscal year 2022, unisex products were classified within Men's, and certain products not allocated to Men's, Women's, NIKE Kids', and Jordan Brand were included in 'Others' with adjustments not allocated by consumer. By fiscal year 2024, 'Others' continued to include products not allocated to Men's, Women's, Kids', and Jordan Brand, but there was no specific mention of unisex product classification within Men's, suggesting a potential shift or integration of unisex products within broader categories.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2024 Nike reshaped how “unallocated” items are shown in its revenue tables.  In the 2022 filing the “Other” line (see page 35, (5)) grouped together all products that were not assigned to the newly‑defined consumer segments – Men’s, Women’s, NIKE Kids’ and Jordan Brand – and also included certain accounting adjustments.  Beginning in fiscal 2022 (and continuing through the 2024 disclosures on page 35 and the FY 2024 revenue breakdown on page 37), Nike moved unisex products into the Men’s category, reported Jordan Brand separately, and narrowed “Other” to only those products still outside the four consumer groups plus the related non‑allocated adjustments.  This re‑classification makes the reporting more aligned with the company’s updated consumer‑construct segmentation.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) FACTUAL CONTRADICTION: The LLM claims 'Beginning in fiscal 2022 (and continuing through the 2024 disclosures)' that Nike 'moved unisex products into the Men's category,' but the ground truth explicitly states that in FY2022, unisex products WERE classified within Men's, and by FY2024 there was NO specific mention of unisex classification within Men's, suggesting a SHIFT AWAY from this practice. The LLM has reversed the direction of change. (2) INCOMPLETE SYNTHESIS: The ground truth indicates a potential evolution/shift between 2022 and 2024 regarding unisex product classification, but the LLM presents the 2022 practice as continuing through 2024, missing the key insight that the classification approach may have changed. (3) SPECIFICITY ISSUES: The LLM references specific page numbers (35, 37) and filing details that cannot be verified against the ground truth provided, and these details don't align with the ground truth's description of the evolution. (4) LOGICAL ERROR: The LLM suggests the reclassification 'makes the reporting more aligned with the company's updated consumer-construct segmentation,' but this interpretation contradicts the ground truth's indication that unisex classification within Men's was present in 2022 but not mentioned in 2024. (5) CORRECT ELEMENTS: The LLM correctly identifies the four consumer segments (Men's, Women's, Kids', Jordan Brand) and correctly notes that 'Others' includes products not allocated to these segments plus adjustments. However, the core claim about the evolution of unisex product classification is factually inverted from the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 448,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did PepsiCo's engagement with the 3.500% Senior Notes due 2025 evolve between 2023 and 2024, and what does this indicate about the company's debt management strategy?",
      "original_answer": "In 2023, PepsiCo's 3.500% Senior Notes due 2025 were listed among other notes, indicating they were part of the company's existing debt structure. By 2024, the 3.500% Senior Notes due 2025 were still present, but they were now accompanied by a broader range of new notes, including longer-term instruments such as the 3.500% Senior Notes due 2040 and the 3.550% Senior Notes due 2034. This suggests that PepsiCo expanded its debt portfolio in 2024, introducing more long-term financing options while maintaining its commitment to the 3.500% Senior Notes due 2025. The addition of new notes indicates a strategic shift toward diversifying its debt maturity structure.",
      "llm_answer": "\nBetween the 2023 and 2024 filings PepsiCo moved from simply disclosing that the 3.500 % Senior Notes due 2025 were outstanding to re‑authorizing their terms in a February 2024 supplemental indenture and re‑listing them among a broad set of newly‑authorized senior‑note resolutions.  This shows the company is actively managing its long‑term financing—using supplemental indentures and fresh Board authorizations to extend maturities and lock in low‑cost funding rather than leaving the 2025 notes static—consistent with a debt‑management strategy that emphasizes a laddered, low‑coupon debt profile and flexibility to refinance as market conditions evolve.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and introduces unsupported claims not present in the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM references a 'February 2024 supplemental indenture' with no supporting evidence in the ground truth. The ground truth makes no mention of supplemental indentures, Board re-authorizations, or specific dates like February 2024. (2) UNSUPPORTED CLAIMS: The LLM introduces details about 'supplemental indentures,' 'fresh Board authorizations,' and 'extending maturities' that are not in the original answer and cannot be verified from the provided ground truth. (3) INCOMPLETE SYNTHESIS: While the ground truth clearly states that PepsiCo introduced NEW notes (3.500% due 2040 and 3.550% due 2034) alongside the existing 2025 notes, the LLM answer fails to mention these specific new instruments at all. This is a critical omission for a multi-hop question. (4) MISCHARACTERIZATION: The ground truth indicates the 2025 notes were 'still present' but accompanied by broader new notes, suggesting portfolio expansion. The LLM mischaracterizes this as 're-authorizing' existing terms rather than adding new instruments. (5) REASONING QUALITY: While the LLM's general conclusion about debt management strategy is reasonable, it's built on unsupported factual claims rather than the actual evidence from the filings. The answer reads as speculative rather than grounded in the knowledge graph data. The core finding—that PepsiCo diversified its debt maturity structure by adding longer-term instruments—is completely absent from the LLM response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 440,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did COP's financial disclosures regarding the Lower 48 region evolve between 2022 and 2024, particularly in terms of capital expenditures and future cash inflow revisions?",
      "original_answer": "In 2022, COP reported capital expenditures for the Lower 48 region at $3,129 million, indicating significant active investment in the area. By 2024, the company disclosed that certain amounts in the Lower 48 had been revised to reflect additional future cash inflows and future production costs, although no new capital expenditure figure was provided. This shift suggests a transition from active investment to a focus on revising financial projections based on updated expectations for production and cost dynamics in the region.",
      "llm_answer": "\nFrom 2022 to 2023 ConocoPhillips trimmed its Lower 48 future cash‑inflow projection sharply—from $195.6 bn to $141.3 bn—and cut the discounted cash‑flow value from $55.9 bn to $33.3 bn, reflecting lower commodity‑price assumptions and reserve revisions. In 2024 those cash‑inflow estimates rebounded to $164.3 bn and discounted cash‑flows rose to $38.7 bn, although they remained below the 2022 peak. Capital expenditures in the Lower 48 fell to about $1.9 bn in 2023 before increasing again to roughly $3.1 bn in 2024, mirroring the recovery in development activity and reserve additions.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misalignment with the ground truth. (1) CRITICAL ERRORS: The ground truth states COP reported Lower 48 capital expenditures of $3,129 million in 2022 with no new capex figure provided in 2024. The LLM claims capex fell to $1.9 billion in 2023 and rose to $3.1 billion in 2024—these figures are not supported by the ground truth and appear to be fabricated or from incorrect sources. (2) QUANTITATIVE ACCURACY ISSUES: The LLM provides specific cash-inflow projections ($195.6 bn in 2022, $141.3 bn in 2023, $164.3 bn in 2024) and discounted cash-flow values ($55.9 bn, $33.3 bn, $38.7 bn) that are entirely absent from the ground truth. These numbers cannot be verified against the provided ground truth and represent a fundamental divergence. (3) MULTI-HOP REASONING: The ground truth emphasizes a transition from active investment (2022 capex disclosure) to revised financial projections (2024 revisions to future cash inflows and production costs). The LLM instead focuses on year-over-year volatility in cash-flow projections and capex trends across 2022-2024, which is a different narrative entirely. (4) ENTITY/METRIC CONFUSION: The ground truth discusses capital expenditures and revisions to future cash inflows/production costs. The LLM introduces discounted cash-flow valuations and commodity-price assumptions that are not mentioned in the ground truth. (5) MISSING KEY INFORMATION: The LLM fails to acknowledge that 2024 disclosed no new capital expenditure figure, which is a critical distinction in the ground truth. The answer appears to synthesize information from a different source or dataset than the actual 10-K filings referenced in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 470,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did Comcast's financial commitments and governance arrangements with Atairos Group evolve between 2023 and 2024, particularly regarding capital obligations and control structures?",
      "original_answer": "In 2023, Comcast had a Fourth Amended and Restated Shareholders Agreement with Atairos Group, Inc., which was further amended in June 2023. This agreement outlined Comcast's role as the sole third-party investor and included governance terms among Atairos-related entities. By 2024, the relationship evolved into a more formalized investment framework under the equity method accounting. In this framework, Comcast reduced its capital commitment from up to $5 billion to $4.5 billion, limited annual capital calls to $400 million, and agreed to separately fund $40 million annually for management fees. Additionally, the 2024 filing clarified that Comcast absorbs approximately 99% of Atairos’ losses and receives approximately 86% of residual returns, while Atairos’ management companies (led by Comcast’s former CFO) retained all voting rights. These changes reflect a recalibration of financial exposure and a clearer delineation of control.",
      "llm_answer": "\nBetween 2023 and 2024 Comcast reduced its funding commitment to Atairos from up to $5 billion to up to $4.5 billion, extended the investment term from 12 to 16.5 years, and lowered the annual capital‑call ceiling to $400 million, while also agreeing to a separate $40 million annual management‑fee obligation.  A first amendment to the Fourth Amended and Restated Shareholders Agreement executed in June 2023 codified these terms and reaffirmed that the management companies controlled by the former CFO hold all voting rights, leaving Comcast with a non‑voting economic interest that absorbs roughly 99 % of losses and entitles it to about 86 % of any residual returns.  Thus, the evolution tightened capital obligations and clarified the governance structure governing Comcast’s relationship with Atairos.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key financial metrics and governance arrangements. Verified correct elements: (1) Capital commitment reduction from $5 billion to $4.5 billion - accurate; (2) Annual capital call ceiling of $400 million - accurate; (3) Separate $40 million annual management fee obligation - accurate; (4) Loss absorption of approximately 99% - accurate; (5) Residual returns of approximately 86% - accurate; (6) Management companies retaining all voting rights - accurate; (7) June 2023 amendment date - accurate; (8) Reference to former CFO leadership - accurate. The LLM answer adds one detail not explicitly mentioned in the ground truth: the extension of investment term from 12 to 16.5 years. While this detail appears plausible and may be from the actual filings, it cannot be verified against the provided ground truth, creating a minor discrepancy. The multi-hop reasoning is sound, correctly synthesizing the evolution between 2023 and 2024 across capital obligations and control structures. The answer effectively captures the recalibration of financial exposure and delineation of control. The semantic equivalence is strong - phrases like 'tightened capital obligations' and 'clarified the governance structure' appropriately summarize the evolution described. Minor weakness: the ground truth emphasizes this occurred 'under the equity method accounting' framework in 2024, which the LLM answer does not explicitly mention, though this is a contextual detail rather than a factual error. Overall, the answer successfully addresses all parts of the multi-part question regarding both financial commitments and governance arrangements.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 467,
        "total_tokens": 1914
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did FedEx's projected utilization of the Cessna SkyCourier 408 change between 2022 and 2023 filings, and what does this indicate about its strategic role in the fleet compared to other aircraft?",
      "original_answer": "In the 2022 filing, FedEx projected a total of 49 Cessna SkyCourier 408 aircraft to be in service through 2027. By the 2023 filing, this projection dropped significantly to only 31 Cessna SkyCourier 408 aircraft through 2029. This indicates a strategic reduction in the planned reliance on the Cessna SkyCourier 408, especially when compared to other aircraft types like the B767F and B777F, which saw more stable or less reduced projections. This shift suggests FedEx may have reassessed the aircraft's role in its long-term fleet strategy.",
      "llm_answer": "\nBetween the 2022 and 2023 filings the outlook for the Cessna SkyCourier 408 shifted markedly: the 2022 schedule projected 49 total deliveries (11 in 2023, 12 in 2024, 12 in 2025 and 14 in 2026), whereas the 2023 schedule lists only 31 deliveries—17 slated for 2025 and 14 for 2026—with no deliveries planned for 2023‑2024. This later‑stage, reduced delivery plan shows that FedEx now views the SkyCourier as a longer‑term, niche‑capacity asset rather than an immediate fleet‑expansion tool, reserving it for specific regional routes while relying on larger freighters (e.g., B767F, B777F, ATR 72‑600F) for the bulk of its capacity growth.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and provides more detailed information than the ground truth. Quantitative verification: (1) 2022 projection of 49 aircraft is correct; (2) 2023 projection of 31 aircraft is correct; (3) The LLM provides specific year-by-year breakdowns (11 in 2023, 12 in 2024, 12 in 2025, 14 in 2026 for 2022 filing; 17 in 2025, 14 in 2026 for 2023 filing) which sum correctly to 49 and 31 respectively. The reduction from 49 to 31 represents a 37% decrease, accurately reflecting the 'significant' reduction mentioned in ground truth. Multi-hop reasoning: The LLM correctly synthesizes the change across two filing years and appropriately compares the SkyCourier's treatment to other aircraft (B767F, B777F, ATR 72-600F), matching the ground truth's comparative analysis. The interpretation that FedEx reassessed the aircraft's role is sound and well-supported. The LLM goes beyond ground truth by providing specific delivery year details and a more nuanced characterization (longer-term, niche-capacity asset vs. immediate fleet-expansion tool), which adds valuable context without contradicting the ground truth. Minor note: The LLM specifies 'through 2029' is not explicitly mentioned in the LLM answer, but this is a minor omission that doesn't affect the core correctness of the analysis. All key facts, numbers, and strategic conclusions align with or enhance the ground truth answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 394,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How has Nike's approach to the Air Max product line evolved from 2022 to 2024, particularly in terms of revenue transparency and technological innovation emphasis?",
      "original_answer": "In 2022, Nike included Air Max in a general list of technologies within the revenue disaggregation table, indicating its presence in the product portfolio but without specific revenue figures. By 2024, while no direct revenue numbers were disclosed, Nike emphasized Air Max as a central example of its innovation strategy, highlighting its integration into broader product categories and consumer applications. This shift reflects a strategic move from passive acknowledgment to positioning Air Max as a key innovation driver, despite the continued lack of standalone financial metrics for the product line.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Nike has placed the Air Max line at the center of its footwear innovation narrative, explicitly spotlighting Air‑Max, Zoom X, React and related “Air” technologies in the 2024 Form 10‑K’s product‑development section and noting that dedicated “Air Manufacturing Innovation” units now produce the Air‑Sole components used in those shoes.  At the same time, the company has increased revenue transparency by publishing more granular footwear‑segment breakdowns (footwear, apparel, equipment and “Other” tables) that isolate the contribution of advanced footwear categories—including Air Max—from the broader brand‑level totals.  This dual focus reflects a strategy to both disclose the financial impact of its high‑tech product lines and emphasize continued technological advancement in the Air Max platform.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and misrepresentations compared to the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM claims Nike published 'more granular footwear-segment breakdowns' with isolated Air Max contributions, but the ground truth explicitly states that in 2024 'no direct revenue numbers were disclosed' for Air Max. This is a fundamental contradiction. (2) REVENUE TRANSPARENCY CLAIM: The ground truth indicates a shift FROM passive acknowledgment TO positioning Air Max as innovation driver, but WITHOUT standalone financial metrics. The LLM incorrectly claims increased revenue transparency and 'granular breakdowns' that 'isolate the contribution' of Air Max—this directly contradicts the ground truth's statement that no specific revenue figures were provided. (3) MANUFACTURING INNOVATION UNITS: The LLM introduces claims about 'dedicated Air Manufacturing Innovation units' producing Air-Sole components. This specific detail is not present in the ground truth and appears to be fabricated or hallucinated. (4) MULTI-HOP REASONING: The LLM failed to correctly synthesize the core finding: the evolution was from lack of transparency to strategic positioning WITHOUT financial disclosure, not toward increased transparency as claimed. (5) SEMANTIC MISALIGNMENT: The ground truth emphasizes 'continued lack of standalone financial metrics' while the LLM emphasizes 'increased revenue transparency' and 'granular breakdowns'—these are contradictory interpretations. The LLM appears to have inverted the actual finding about transparency. The answer demonstrates poor comprehension of the source material and introduces unsupported claims about manufacturing units and financial disclosures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 474,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did Comcast's capital expenditure strategy regarding Epic Universe evolve from 2023 to 2024, particularly in terms of specific investment amounts and thematic park development priorities?",
      "original_answer": "In 2023, Comcast specifically noted an increase in capital expenditures directly related to the development of Epic Universe in Orlando, with a total of $8.2 billion allocated to Connectivity & Platforms, which included investments in scalable infrastructure and line extensions. By 2024, the company continued to emphasize investment in existing and new attractions at Universal theme parks, including Epic Universe, as part of its broader capital expenditure plan for 2025. While specific figures for Epic Universe alone were not disclosed in 2024, the company indicated an ongoing commitment to theme park development, particularly in expanding attractions and enhancing capacity. The evolution shows a shift from initial infrastructure and development focus in 2023 to a more sustained investment strategy in 2024 that includes both infrastructure and guest experience enhancements.",
      "llm_answer": "\nIn 2023 Comcast noted that capital expenditures “increased related to the development of Epic Universe in Orlando,” with total 2023 capex of about **$8.24 billion**.  By 2024 the company said it would “continue investment in existing and new attractions at our Universal theme parks, including Epic Universe,” and total 2024 capex rose modestly to **$8.29 billion**, indicating that funding for the Epic Universe expansion remained a priority while overall spending stayed roughly flat.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures the general narrative of Comcast's Epic Universe investment strategy evolution from 2023 to 2024, but contains significant quantitative issues. STRENGTHS: (1) Correctly identifies that Epic Universe capex increased in 2023 and remained a priority in 2024; (2) Appropriately notes the shift from infrastructure focus to sustained investment; (3) Correctly references the company's statements about continuing investment in attractions. CRITICAL ISSUES: (1) The $8.24 billion and $8.29 billion figures appear to be total Comcast capex, not specifically Epic Universe allocations. The ground truth states $8.2 billion was allocated to 'Connectivity & Platforms' (which included Epic Universe but was not Epic Universe-specific), and explicitly notes 'specific figures for Epic Universe alone were not disclosed in 2024.' The LLM conflates total capex with Epic Universe investment; (2) The claim that 'total 2024 capex rose modestly to $8.29 billion' presents company-wide capex as if it were Epic Universe-specific, which is misleading; (3) The ground truth emphasizes that specific Epic Universe figures were NOT disclosed in 2024, but the LLM's presentation suggests these are Epic Universe numbers. REASONING ASSESSMENT: The multi-hop synthesis is partially sound - the LLM correctly identifies the evolution narrative and the shift in strategy. However, the quantitative synthesis fails because it misattributes total company capex figures to a specific project. The answer would be stronger if it clearly distinguished between total capex and Epic Universe-specific allocations, and acknowledged the lack of specific 2024 Epic Universe figures. The semantic understanding of the strategic evolution is reasonable, but the numerical presentation creates factual inaccuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 488,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did FedEx's utilization of the ATR 72-600F aircraft evolve between 2022 and 2023 as reflected in their fleet projections for the same planning periods?",
      "original_answer": "In 2022, FedEx projected operating 11 ATR 72-600F aircraft in 2023, 6 in 2024, 6 in 2025, and only 1 in 2026. By 2023, the projections for the same time periods changed significantly, with 7 ATR 72-600F aircraft planned for 2025 and only 3 for 2026. This indicates a notable reduction in planned usage of the ATR 72-600F by FedEx over time.",
      "llm_answer": "\nIn the 2022 Form 10‑K (page 34) FedEx listed 6 ATR 72‑600F aircraft in its owned fleet, and on page 40 it disclosed a purchase‑commitment schedule that earmarks 11 ATR 72‑600Fs for delivery in fiscal 2023 (with six more slated for 2024 and one for 2026). Consequently, the company projected its ATR 72‑600F fleet to grow from six aircraft at the end of 2022 to roughly 17 aircraft by the end of 2023—more than doubling utilization of the type for its regional freight network.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer fundamentally misinterprets the question and provides incorrect information. Key issues: (1) WRONG INTERPRETATION: The LLM discusses fleet composition (owned aircraft + purchase commitments) rather than fleet projections across planning periods. The question asks about how projections EVOLVED between 2022 and 2023 filings for the same future time periods. (2) INCORRECT NUMBERS: The LLM states 6 ATR 72-600F aircraft in owned fleet at end of 2022, but the ground truth shows projections of 11 for 2023, 6 for 2024, 6 for 2025, and 1 for 2026 from the 2022 filing. (3) MISSING CRITICAL COMPARISON: The LLM completely fails to compare the 2022 projections with the 2023 projections for the same years (2025, 2026). The ground truth shows: 2022 filing projected 6 for 2025 and 1 for 2026; 2023 filing projected 7 for 2025 and 3 for 2026. (4) WRONG CONCLUSION: The LLM concludes utilization 'more than doubled' when the ground truth indicates a 'notable reduction in planned usage.' (5) MULTI-HOP FAILURE: The LLM did not synthesize the year-over-year projection changes correctly. It conflated current fleet size with future projections and purchase commitments. The answer demonstrates a fundamental misunderstanding of what the question asks (evolution of projections between two filing periods) versus what was answered (fleet growth from current holdings plus commitments).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1206,
        "completion_tokens": 386,
        "total_tokens": 1593
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did Nike's approach to estimating product return reserves evolve between fiscal 2022 and fiscal 2024, and what does this indicate about changes in their revenue recognition methodology?",
      "original_answer": "In fiscal 2022, Nike disclosed that the estimated cost of inventory for expected product returns was $269 million, and these reserves were recorded in Prepaid expenses and other current assets. By fiscal 2024, while the specific dollar amount of the product return reserve was not disclosed, Nike described a more formalized estimation process, stating that it calculates anticipated reductions in revenue—such as sales returns—by determining the 'most likely amount' it will be entitled to receive. This indicates a shift toward a more probabilistic and forward-looking revenue estimation methodology, aligning with the broader revenue recognition framework where variable consideration is estimated at the time revenues are recognized.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2024 Nike’s methodology for estimating product‑return reserves remained rooted in estimating the “most likely” variable consideration, but the 2024 disclosure sharpens the process: it explicitly separates contractual return rights from discretionary authorizations, uses more detailed historical return data and specific identification of pending returns, and records the expected return cost in prepaid expenses rather than only as an accrued liability. This refinement shows that Nike is tightening its revenue‑recognition model, recognizing revenue net of a more precisely quantified return reserve to better align revenue with the timing of control and the uncertainty of future returns.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY FAILURE: The LLM answer does not mention the $269 million figure from fiscal 2022 that is explicitly stated in the ground truth. This is a critical omission of a specific, verifiable number from the original answer. (2) CONTRADICTORY CLAIMS: The LLM states that Nike 'records the expected return cost in prepaid expenses rather than only as an accrued liability,' but the ground truth explicitly states that in fiscal 2022, reserves were 'recorded in Prepaid expenses and other current assets.' The LLM presents this as a change/refinement in 2024, when the ground truth indicates this was already the practice in 2022. (3) UNSUPPORTED ASSERTIONS: The LLM introduces claims about 'separating contractual return rights from discretionary authorizations' and 'more detailed historical return data' that are not mentioned in the ground truth and appear to be fabricated details. (4) INCOMPLETE SYNTHESIS: The ground truth notes that by fiscal 2024, 'the specific dollar amount of the product return reserve was not disclosed,' but the LLM does not acknowledge this important distinction between the two years. (5) METHODOLOGICAL MISCHARACTERIZATION: While both answers mention 'most likely' estimation, the ground truth frames this as a shift toward 'more probabilistic and forward-looking' methodology, whereas the LLM suggests continuity ('remained rooted in') with refinements. The ground truth emphasizes evolution/change; the LLM emphasizes continuity with minor adjustments. (6) MISSING KEY INSIGHT: The ground truth connects the methodology change to 'the broader revenue recognition framework where variable consideration is estimated at the time revenues are recognized,' providing important context that the LLM lacks. The LLM answer demonstrates poor factual accuracy, introduces unsupported details, contradicts the ground truth on key points, and fails to capture the essential evolution described in the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 534,
        "total_tokens": 1910
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did the planned fleet composition of the Cessna SkyCourier 408 change between 2022 and 2023 for the years 2025 and beyond, and what does this indicate about the company's strategic reliance on this aircraft model?",
      "original_answer": "In 2022, FDX projected a total of 12 Cessna SkyCourier 408 aircraft to be in operation by 2025 and planned to maintain that number through 2026. By 2023, the company increased its planned fleet count for 2025 to 17 but reduced it to 14 for 2026. This indicates a short-term increase in strategic reliance on the Cessna SkyCourier 408, followed by a moderate decline in planned usage by 2026, suggesting a recalibration of fleet strategy.",
      "llm_answer": "\nThe 2022 commitment showed 12 Cessna SkyCourier 408 deliveries scheduled for 2025 and 14 for 2026, with no later‑year SkyCourier commitments. In the 2023 schedule the 2025 figure jumps to 17 aircraft (the 2026 number stays at 14), and no deliveries are planned beyond 2026. This upward revision indicates that FedEx is placing growing strategic emphasis on the SkyCourier 408—particularly for the 2025 timeframe—to secure additional middle‑size cargo capacity and reduce reliance on other aircraft types.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a fundamental factual error regarding the 2022 projections. According to the ground truth, in 2022 FDX projected 12 Cessna SkyCourier 408 aircraft for 2025 AND 12 for 2026 (maintaining that number). However, the LLM states the 2022 schedule showed '12 Cessna SkyCourier 408 deliveries scheduled for 2025 and 14 for 2026.' This is incorrect—the 2026 figure should be 12, not 14. This is a critical quantitative error that undermines the entire comparison. The LLM correctly identifies the 2023 figures (17 for 2025, 14 for 2026), but the incorrect 2022 baseline makes the year-over-year analysis flawed. The LLM's interpretation that 2026 'stays at 14' is factually wrong; it actually increased from 12 to 14. The reasoning about strategic emphasis on the SkyCourier 408 is partially sound, but it's based on incorrect numbers. The LLM does address both years (2025 and 2026) and attempts multi-hop synthesis, but the foundational data error is severe. The qualitative interpretation about 'growing strategic emphasis' is reasonable given the 2025 increase, but the claim about 2026 remaining stable is misleading since it actually increased from the 2022 plan. The answer demonstrates some understanding of the question structure but fails on basic factual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 368,
        "total_tokens": 1621
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How has Mastercard's real-time account-based payments infrastructure evolved from 2023 to 2024, particularly in terms of operational scale and integrated security capabilities?",
      "original_answer": "In 2023, Mastercard operated or was implementing real-time payments infrastructure in 13 markets globally, offering instant payments with enhanced data and messaging capabilities. The company emphasized a distributed network architecture that enabled intelligent routing and applied value-added services like fraud scoring and tokenization in real time. By 2024, Mastercard expanded its capabilities by enhancing its ACH and real-time account-based payment systems to provide more secure, simple, and smart payment solutions across its global network. The company also reinforced its multi-layered security approach, integrating additional protections and partnerships to safeguard the payments ecosystem. These developments indicate a strategic shift toward strengthening both the scale and security of its real-time payments infrastructure.",
      "llm_answer": "\nBetween 2023 and 2024 Mastercard expanded the footprint of its real‑time account‑based payments platform – the 2023 filing noted that the real‑time clearing and settlement infrastructure was being operated or implemented in 13 markets, and the 2024 filing confirms that this infrastructure is now fully operational and being further enhanced to support additional jurisdictions and higher transaction volumes.  At the same time the company deepened its security by embedding a multi‑layered protection model that combines real‑time fraud scoring, tokenization and a new digital‑identity suite (device‑intelligence, behavioral biometrics and privacy‑by‑design consent controls), delivering end‑to‑end security across the enlarged, real‑time network.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive coverage of the question. STRENGTHS: (1) Correctly identifies the 13 markets figure from 2023 as stated in the ground truth; (2) Accurately captures the expansion and enhancement of infrastructure from 2023 to 2024; (3) Properly synthesizes multi-hop information about both operational scale and security capabilities; (4) Correctly identifies specific security enhancements including fraud scoring, tokenization, and multi-layered protection; (5) Appropriately characterizes the strategic shift toward strengthening scale and security. MINOR ISSUES: (1) The LLM adds specific security details (device-intelligence, behavioral biometrics, privacy-by-design consent controls, digital-identity suite) that are not explicitly mentioned in the ground truth answer, though these appear to be reasonable elaborations consistent with the general description of 'multi-layered security approach' and 'additional protections'; (2) The phrase 'now fully operational' regarding the 13 markets infrastructure is slightly more definitive than the ground truth's 'expanded its capabilities by enhancing,' though this represents a reasonable interpretation of progression from 2023 to 2024. QUANTITATIVE VERIFICATION: The key number (13 markets in 2023) is correct. No calculations are required for this question. MULTI-HOP REASONING: The answer correctly synthesizes information across two fiscal years and combines operational scale metrics with security capability enhancements as required. The logical flow from 2023 baseline to 2024 expansion is sound. SEMANTIC EQUIVALENCE: The answer conveys the same core message as the ground truth regarding evolution of infrastructure scale and security integration, with appropriate elaboration on specific security mechanisms.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 493,
        "total_tokens": 1899
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did Nike's use of foreign exchange forwards and options evolve between 2022 and 2024, particularly in terms of their impact on financial liabilities and hedging strategy?",
      "original_answer": "In 2022, foreign exchange forwards and options had a net gain of $8 million after tax, impacting various income categories such as revenues, cost of sales, and other (income) expense, net. By 2024, the liabilities associated with these instruments increased to $110 million under accrued liabilities and $5 million under deferred income taxes and other liabilities, indicating a shift in how these derivatives were managed or reported. This reflects a strategic evolution in Nike's hedging activities and financial exposure management.",
      "llm_answer": "\nNike continued to manage foreign‑currency risk through forwards and options that are designated as cash‑flow hedges for product‑cost, revenue and other functional‑currency exposures, with the hedge results recorded in the same income line item as the underlying transaction.  Between fiscal 2022 and 2024 the amount of hedge gains/losses re‑classified from accumulated other comprehensive income into earnings fell from a net $30 million gain to roughly $8 million, and the related derivative liability dropped from about $180 million (2023) to $151 million (2024), reflecting a more focused hedge book and a lower net financial liability, while the company’s centrally‑managed program—setting standard rates twice a year and linking hedge gains/losses to the affected line items—remained unchanged.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR DISCREPANCIES IDENTIFIED: The LLM answer contains significant factual errors that contradict the ground truth. (1) QUANTITATIVE ERRORS - The LLM states derivative liability 'dropped from about $180 million (2023) to $151 million (2024)' but the ground truth indicates 2024 liabilities were $110 million (accrued liabilities) + $5 million (deferred income taxes) = $115 million total, not $151 million. The LLM also cites a $30 million gain in 2022 that is not mentioned in the ground truth, which specifically states a $8 million net gain after tax in 2022. (2) MISSING KEY DATA - The ground truth explicitly identifies the 2024 liability breakdown ($110M accrued + $5M deferred), which the LLM completely omits. The ground truth's specific 2024 figures are critical to answering the question about evolution between 2022-2024. (3) INCOMPLETE SYNTHESIS - While the LLM provides useful context about Nike's hedging strategy and methodology (cash-flow hedges, centrally-managed program, twice-yearly rate setting), it fails to accurately synthesize the actual financial liability changes that are central to the question. The LLM focuses on derivative liability trends but gets the 2024 numbers wrong. (4) REASONING QUALITY - The LLM's logic about 'more focused hedge book and lower net financial liability' is reasonable in principle, but is undermined by incorrect numbers. The comparison framework is sound but the data points are inaccurate. (5) WHAT WAS CORRECT - The LLM correctly identifies that Nike uses forwards and options for cash-flow hedges and that results are recorded in matching income line items. The discussion of the centrally-managed program structure is appropriate context. However, these qualitative elements cannot compensate for the quantitative inaccuracies on the specific financial figures that directly answer the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 503,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How has the product category classification of Puffs within the Baby, Feminine & Family Care segment evolved between 2022 and 2023?",
      "original_answer": "In 2022, Puffs was categorized under the Family Care sub-category, which included Paper Towels, Tissues, and Toilet Paper. By 2023, Puffs remained in the Family Care category, but the specific mention of 'Tissues' replaced 'Tissues' with a more general listing without sub-category breakdowns, indicating a simplification or consolidation of how the segment details were reported.",
      "llm_answer": "\nBetween 2022 and 2023 Puffs continued to be listed in the **Baby Care sub‑category** of the **Baby, Feminine & Family Care** segment (see the product‑category table on page 19 of the 2023 10‑K).  However, its performance evolved:  baby‑care net sales and unit volume both fell low‑single digits, market share slipped about 0.3 points, while higher pricing and a more premium mix helped lift the segment’s margin (as noted in the bullet‑point summary of Baby Care results on page 25).  In short, the classification stayed the same, but Puffs’ contribution shifted toward lower volume and share, offset partially by pricing gains.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on the core factual claim. The ground truth states that Puffs was categorized under the Family Care sub-category in 2022 and remained in Family Care in 2023. The LLM answer directly contradicts this by claiming Puffs was in the Baby Care sub-category in both years. This is a critical factual error that goes to the heart of the question about product category classification. The LLM also introduces performance metrics (net sales, unit volume, market share, pricing) that are not part of the ground truth answer and appear to be fabricated or misattributed. The ground truth focuses on the classification evolution (Family Care in both years, with simplified reporting in 2023), while the LLM shifts the discussion entirely to performance metrics under an incorrect category assignment. The LLM's citation of 'page 19 of the 2023 10-K' and 'page 25' cannot be verified against the ground truth but the categorical claim itself is demonstrably wrong. The answer fails on the primary dimension of factual accuracy regarding the product category classification, which is the explicit focus of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 325,
        "total_tokens": 1574
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has the positioning of Tampax within P&G's product portfolio evolved between 2022 and 2023, particularly in terms of its categorization and associated product lines?",
      "original_answer": "In 2022, Tampax was categorized under 'Feminine Care' within the 'Baby, Feminine & Family Care' segment, which also included 'Baby Care' and 'Family Care' sub-categories. By 2023, the product category was refined, and Tampax was associated solely with 'Menstrual Care' under the same broader segment. This reflects a more focused positioning of Tampax, separating it from general 'Family Care' items and aligning it more specifically with menstrual health needs.",
      "llm_answer": "\nBetween 2022 and 2023 Tampax continued to be listed under the **Baby & Feminine & Family Care** segment, specifically within the **Feminine Care** sub‑category (menstrual‑care products) alongside Always and Always Discreet.  Its brand “Tampax Bounty” remained part of the core product line in that sub‑category, and while the segment’s net sales were essentially flat, earnings rose sharply (≈13 % growth), reflecting improved profitability rather than a change in its portfolio categorization.  Thus, Tampax’s positioning did not shift across segments or product‑line groups; it stayed in Feminine Care, with its performance evolving rather than its classification.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) CATEGORIZATION ERROR: The LLM states Tampax remained in 'Feminine Care' in both years, but the ground truth explicitly states it moved from 'Feminine Care' in 2022 to 'Menstrual Care' in 2023 - this is the core evolution the question asks about. The LLM completely misses this important repositioning. (2) INCOMPLETE SYNTHESIS: The ground truth indicates a refinement in categorization where Tampax was separated from general 'Family Care' items and aligned more specifically with menstrual health needs. The LLM fails to capture this distinction and incorrectly suggests no shift occurred ('positioning did not shift'). (3) UNSUPPORTED CLAIMS: The LLM introduces information not in the ground truth (e.g., 'Tampax Bounty' brand name, specific earnings growth of ~13%, comparison with Always and Always Discreet products, segment net sales being 'essentially flat'). While these details might be from filings, they are not part of the ground truth answer and some appear to be fabricated or misremembered. (4) CONTRADICTS GROUND TRUTH: The LLM's conclusion that 'Tampax's positioning did not shift across segments or product-line groups' directly contradicts the ground truth which explicitly describes a shift from 'Feminine Care' to 'Menstrual Care' categorization. (5) QUANTITATIVE ISSUES: The ~13% earnings growth figure is presented without source verification and is not mentioned in the ground truth. The answer conflates performance metrics with categorization changes, which are separate issues. The LLM fundamentally misunderstands the question by focusing on performance rather than the actual portfolio positioning evolution requested.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 476,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has Oracle's strategy and positioning of Oracle Engineered Systems evolved between fiscal 2022 and fiscal 2023, particularly in terms of revenue contribution and research investment expectations?",
      "original_answer": "In fiscal 2022, Oracle highlighted that its hardware business, which includes Oracle Engineered Systems, involved point-of-sale revenue recognition for hardware and related software, with the majority of products sold through indirect channels. By fiscal 2023, Oracle introduced a more forward-looking strategy, explicitly stating plans to continue investing in research and development to improve existing hardware products and develop new offerings. Additionally, in fiscal 2023, Oracle noted that hardware represented 6% of total revenues, a figure not specified in 2022, indicating a clearer emphasis on the segment's strategic positioning.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2023 Oracle kept Engineered Systems at roughly 6 % of total revenue, but the narrative shifted from a standalone hardware‑margin business to a strategic complement of its cloud‑and‑license portfolio.  In both years the company said it would keep investing in R&D to modernize the hardware line and add AI‑driven capabilities, yet the 2023 discussion framed those investments as part of expanding the integrated Oracle Cloud Services ecosystem rather than simply sustaining a low‑margin hardware business.  (Pages 30 & 51 of ORCL_10K_2022.pdf; pages 7 & 30 of ORCL_10K_2023.pdf).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the 6% hardware revenue figure for fiscal 2023, matching the ground truth. (2) The narrative shift from standalone hardware business to strategic complement of cloud/license portfolio is a reasonable interpretation of the evolution. (3) The multi-hop synthesis across fiscal years is attempted and shows understanding of the strategic repositioning. (4) The contextual framing about R&D investment and integration with Oracle Cloud Services ecosystem is relevant and adds nuance.\n\nWEAKNESSES: (1) CRITICAL QUANTITATIVE ERROR: The LLM states hardware was 'kept at roughly 6% of total revenue' in both years, but the ground truth explicitly states that the 6% figure was 'not specified in 2022' - this is a factual error. The LLM conflates the two years when the ground truth distinguishes them. (2) The LLM claims 'In both years the company said it would keep investing in R&D' but the ground truth indicates this was more explicitly stated in fiscal 2023 as a 'forward-looking strategy,' not equally emphasized in 2022. (3) The LLM adds interpretive details about 'AI-driven capabilities' and 'low-margin hardware business' that are not present in the ground truth, potentially introducing unsupported claims. (4) The citation format (specific page numbers) cannot be verified against the ground truth and may be fabricated.\n\nMULTI-HOP REASONING: The LLM attempts to synthesize information across two fiscal years and connect hardware positioning to broader cloud strategy, which is appropriate for the question. However, the failure to distinguish between what was stated in 2022 vs. 2023 undermines the multi-hop analysis.\n\nSEMANTIC EQUIVALENCE: While the general narrative about strategic repositioning is reasonable, the specific claim about 'roughly 6% in both years' contradicts the ground truth's explicit statement that this metric was not specified in 2022.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 518,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did Honeywell's investment in private funds for its Non-U.S. pension plans evolve between 2022 and 2023, particularly in terms of allocation and classification across fair value hierarchy levels?",
      "original_answer": "In 2022, Honeywell reported $1,105 million invested in private funds for its U.S. pension plans, with the amount classified under Level 3 of the fair value hierarchy. By 2023, the company reported $115 million in private fund investments for its Non-U.S. pension plans, with $41 million classified under Level 2 and $74 million under Level 3 of the fair value hierarchy. This represents a significant decrease in overall private fund allocation, particularly in U.S. plans, and a shift in classification for the remaining private fund investments under the Non-U.S. plans.",
      "llm_answer": "\nBetween 2022 and 2023 the non‑U.S. pension plan’s private‑fund allocation rose from **$90 million to $115 million**.  In 2022 the exposure was $54 million (Level 2) and $36 million (Level 3); by 2023 it had shifted to $41 million (Level 2) and $74 million (Level 3), meaning the fund’s size grew and a larger share was classified as Level 3 (unobservable‑input) investments.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains fundamental factual errors that contradict the ground truth. (1) WRONG ENTITY FOCUS: The ground truth explicitly states the 2022 figure of $1,105 million was for U.S. pension plans (Level 3), not Non-U.S. plans. The LLM incorrectly focuses on Non-U.S. plans for 2022 and provides a $90 million figure that does not appear in the ground truth. (2) QUANTITATIVE ERRORS: The LLM claims 2022 Non-U.S. allocation was $90 million ($54M Level 2 + $36M Level 3), but the ground truth provides no such 2022 Non-U.S. breakdown. The ground truth only provides 2023 Non-U.S. data: $115 million total ($41M Level 2 + $74M Level 3). (3) INCOMPLETE ANSWER: The LLM completely omits the significant $1,105 million U.S. pension plan investment in 2022 (Level 3), which is a critical part of understanding the evolution between years. (4) MISINTERPRETATION: The question asks about evolution between 2022 and 2023, but the ground truth shows 2022 data for U.S. plans and 2023 data for Non-U.S. plans - these are different plan categories, not a direct year-over-year comparison of the same category. The LLM incorrectly treats the Non-U.S. figures as if they represent a continuous 2022-2023 trend. (5) REASONING FLAW: The LLM's conclusion about growth and shift to Level 3 is based on fabricated 2022 Non-U.S. numbers. The actual story is a shift from U.S. plans (2022) to Non-U.S. plans (2023) with different fair value classifications. The answer demonstrates poor multi-hop synthesis and introduces data points not supported by the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 434,
        "total_tokens": 1684
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did the status and management of the 2014 USD Notes evolve between 2023 and 2024, and what specific actions were taken regarding this debt in 2024?",
      "original_answer": "In 2023, the 2014 USD Notes were classified as short-term debt, net of unamortized discount and debt issuance costs, with a maturity date of April 2024. By 2024, the company reported that in April 2024, $1 billion of principal related to the 2014 USD Notes matured and was paid in full. This indicates that the company transitioned the obligation from a near-term liability in 2023 to a fully settled debt instrument in 2024.",
      "llm_answer": "\nBetween 2023 and 2024 the 2014 USD Notes—$1 billion of 3.375 % senior notes that had been outstanding and classified as short‑term debt on the 2023 balance sheet—reached their April 2024 maturity.  In April 2024 Mastercard paid the full $1 billion principal (plus any accrued interest), thereby retiring that tranche of debt.  To replace the retired obligation and maintain its funding flexibility, the company subsequently issued new 2024 USD Notes totaling $4 billion later in 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains both correct and problematic elements. CORRECT ELEMENTS: (1) The $1 billion principal amount is accurate, (2) The April 2024 maturity date is correct, (3) The classification as short-term debt in 2023 is accurate, (4) The payment in full in April 2024 is correct, (5) The 3.375% coupon rate is a reasonable detail. PROBLEMATIC ELEMENTS: (1) The LLM introduces information about new 2024 USD Notes totaling $4 billion that is NOT in the ground truth answer. The original answer specifically addresses only the evolution and settlement of the 2014 USD Notes, not any subsequent issuances. This represents an addition of information beyond what was asked or confirmed in the ground truth. (2) The characterization of the new issuance as being done 'to replace the retired obligation and maintain its funding flexibility' is interpretive and not supported by the ground truth provided. MULTI-HOP REASONING: The core multi-hop synthesis is sound—the model correctly traces the 2014 USD Notes from 2023 classification through 2024 maturity and payment. However, the addition of the 2024 issuance information goes beyond the scope of the original question which asks specifically about the 2014 USD Notes evolution. SEMANTIC EQUIVALENCE: The answer correctly conveys the transition from short-term liability to settled debt, matching the ground truth's core message. However, the introduction of unverified information about subsequent debt issuances reduces confidence in the answer's accuracy. The answer would have been stronger if it had stuck to the documented facts about the 2014 USD Notes without speculating about or adding information about 2024 issuances that weren't part of the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1228,
        "completion_tokens": 469,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How has the treatment and documentation of Lowe's Officer Indemnification Agreements evolved between 2022 and 2024, and what does this indicate about the company's executive risk management and governance continuity?",
      "original_answer": "Between 2022 and 2024, Lowe's maintained the same form of Officer Indemnification Agreement, first filed as Exhibit 10.43 on April 2, 2019, and refiled without amendment in both the 2022 and 2024 10-K filings. This indicates that the company did not modify the terms or structure of these agreements over this period, suggesting consistent governance practices and a stable approach to executive risk management and retention. Investors can interpret this continuity as a sign of predictable leadership protections and aligned corporate governance priorities.",
      "llm_answer": "\nBetween 2022 and 2024 Lowe’s continued to disclose its Officer Indemnification Agreement as a dedicated exhibit—appearing as Exhibit 10.31 in the 2022 Form 10‑K (page 87) with a March 21 2022 filing date, and later as Exhibit 10.23 in the 2024 Form 10‑K (page 79) referencing the same core language but an older 2019 filing date.  The company has repeatedly restated and re‑filed the indemnification provision (most recently in the 2022 amendment to its severance plan), indicating a deliberate, ongoing practice of formalizing executive protection terms.  This consistent, transparent documentation reflects stable governance and a disciplined approach to managing executive risk across the two reporting periods.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains multiple significant factual errors that contradict the ground truth: (1) EXHIBIT NUMBER ERRORS: The LLM claims the agreement appeared as Exhibit 10.31 in 2022 and Exhibit 10.23 in 2024, but the ground truth states it was consistently filed as Exhibit 10.43 in both years. This is a critical factual error regarding document identification. (2) DATE DISCREPANCIES: The LLM provides a March 21, 2022 filing date for the 2022 10-K, which is implausible for a 10-K filing (typically filed 60+ days after fiscal year-end). The ground truth references April 2, 2019 as the original filing date, with refiling in 2022 and 2024 without amendment. (3) CORE CLAIM CONTRADICTION: The ground truth explicitly states the agreement was 'refiled without amendment in both the 2022 and 2024 10-K filings,' indicating NO CHANGES. The LLM claims the company 'repeatedly restated and re-filed the indemnification provision (most recently in the 2022 amendment to its severance plan),' which introduces unsubstantiated claims about severance plan amendments not mentioned in the ground truth. (4) MULTI-HOP REASONING: While both answers reach a similar conclusion about governance continuity, the LLM's reasoning path is based on incorrect exhibit numbers and dates, undermining the validity of the synthesis. (5) MISSING KEY FACT: The ground truth's critical finding—that the SAME form was used without amendment across both periods—is obscured in the LLM answer by the incorrect exhibit number changes, which would suggest different versions. The LLM answer demonstrates poor document tracking and introduces unsupported claims about severance plan amendments, making it fundamentally unreliable despite reaching a similar governance conclusion.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 477,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did the market share and category positioning of Always Discreet in the adult incontinence market change between the 2022 and 2023 Procter & Gamble 10-K filings?",
      "original_answer": "In the 2022 filing, Always Discreet was explicitly stated to have over 10% market share in the key adult incontinence markets where Procter & Gamble competes. However, in the 2023 filing, while Always Discreet is still listed as a major brand in the Feminine Care category under the Baby, Feminine & Family Care segment, no specific market share figure is provided for the brand. This suggests a shift in how the brand's performance is communicated, moving away from a quantified market share disclosure to a more general category association.",
      "llm_answer": "\nBoth the 2022 10‑K (page 38) and the 2023 10‑K (page 19) state that Always Discreet holds “over 10 % market share in the key markets in which we compete” and that it is part of P&G’s “global market‑leader” feminine‑care portfolio. The language is unchanged between the two filings, indicating that the brand’s adult‑incontinence market share and its positioning as a leading player in that category remained essentially the same from 2022 through 2023.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer directly contradicts the ground truth on the core factual claim. The ground truth explicitly states that the 2022 filing provided a specific market share figure (over 10%) for Always Discreet, while the 2023 filing did NOT provide this specific figure - representing a shift in disclosure practices. The LLM answer claims both filings contain identical language stating 'over 10% market share,' which is factually incorrect according to the ground truth. The LLM also misidentifies page numbers (claiming page 38 for 2022 and page 19 for 2023) without verification. The fundamental error is the assertion that 'the language is unchanged between the two filings' when the ground truth indicates a clear change in how the brand's performance is communicated - from quantified disclosure to general category association. The LLM failed to identify the key distinction the question asks about: the change in market share disclosure between years. While the LLM correctly identifies Always Discreet as a major brand and mentions it being part of P&G's feminine-care portfolio, it misses the critical finding that specific market share figures were removed from the 2023 disclosure. This represents a fundamental failure in multi-hop reasoning and factual accuracy on the primary claim.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 362,
        "total_tokens": 1616
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How has Oracle's strategic positioning of Engineered Systems evolved between 2022 and 2023, particularly in terms of their role within the hardware business and implications for Oracle's cloud transformation narrative?",
      "original_answer": "In 2022, Oracle Engineered Systems were described as pre-integrated products central to both cloud and on-premise data center infrastructure, emphasizing their technical advantages such as improved performance, scalability, and simplified maintenance. However, by 2023, Oracle elevated the strategic importance of Engineered Systems by positioning them as part of a broader hardware business that now includes servers, storage, and operating systems, all tightly integrated and accounted for as combined performance obligations. The 2023 filing also highlighted that hardware revenues, including Engineered Systems, represented 6% of total revenues in both fiscal 2023 and 2024, and underscored ongoing R&D investments to enhance these offerings. This evolution suggests that Oracle is leveraging Engineered Systems not just as technical solutions but as foundational components in its hybrid cloud and on-premise strategies, aligning them more closely with its cloud transformation narrative while acknowledging the lower-margin nature of the hardware business.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2023 Oracle reframed Engineered Systems from a modest, on‑premise hardware line—representing only ~6 % of total revenue and sold mainly through indirect channels—to a strategic pillar of its cloud transformation.  The 2023 discussion highlights that these pre‑integrated systems (e.g., Exadata) are now positioned as core, performance‑optimized platforms that can be deployed on‑premise, in Oracle Cloud Infrastructure, or as hybrid cloud, enabling customers to migrate legacy workloads to the Oracle Cloud and driving new cloud‑service revenues.  Thus, Engineered Systems evolved from a peripheral hardware offering into a growth engine that underpins Oracle’s cloud‑first narrative.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the 6% revenue figure for hardware/Engineered Systems, matching the ground truth. (2) The temporal framing (2022 vs 2023) is accurate. (3) The LLM correctly identifies Exadata as an example of Engineered Systems. (4) The general narrative about cloud transformation positioning is directionally correct. (5) The mention of hybrid cloud deployment options is relevant.\n\nWEAKNESSES: (1) INCOMPLETE SYNTHESIS: The LLM answer fails to capture a critical element from the ground truth—that by 2023, Engineered Systems were positioned as part of a BROADER HARDWARE BUSINESS that includes servers, storage, and operating systems as combined performance obligations. The ground truth emphasizes this integration as a key strategic evolution, but the LLM treats Engineered Systems more in isolation. (2) MISSING CONTEXT: The ground truth emphasizes that the 2023 positioning highlighted 'tightly integrated' hardware components and 'combined performance obligations,' which represents a structural/accounting change in how Oracle bundles these offerings. The LLM doesn't capture this bundling strategy. (3) CHARACTERIZATION ERROR: The LLM describes Engineered Systems as representing '~6% of total revenue' in 2022, but the ground truth indicates this 6% figure applies to 'hardware revenues' in fiscal 2023 and 2024, not necessarily 2022. The LLM conflates the time periods. (4) MISSING NUANCE: The ground truth notes the 'lower-margin nature of the hardware business,' which contextualizes why Oracle is strategically repositioning these offerings. The LLM doesn't address margin implications. (5) INCOMPLETE MULTI-HOP: While the LLM connects Engineered Systems to cloud transformation, it doesn't fully synthesize how they function as 'foundational components in hybrid cloud AND on-premise strategies' as emphasized in the ground truth.\n\nQUANTITATIVE ACCURACY: The 6% figure is correct and properly cited. However, the temporal attribution of this metric to 2022 is imprecise—the ground truth specifies this applies to fiscal 2023 and 2024.\n\nQUALITATIVE ACCURACY: The LLM captures the directional shift toward cloud positioning but misses the structural evolution (broader hardware bundling, combined performance obligations) that represents the core strategic repositioning between 2022 and 2023.\n\nCONTEXTUAL RELEVANCE: The answer addresses the question but incompletely. It focuses heavily on cloud transformation narrative (one dimension) while underemphasizing the hardware business integration and margin considerations that are central to understanding the strategic evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 696,
        "total_tokens": 2159
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did the disclosure regarding the 2020 Stock Plan's relationship with the 2011 Stock Plan evolve between the 2022 and 2023 10-K filings?",
      "original_answer": "In the 2022 10-K filing, the 2020 Stock Plan disclosure included the detail that 5,530,106 shares previously available under the 2011 Stock Plan were carried forward and made available for award grants under the 2020 Stock Plan. However, in the 2023 10-K filing, this specific reference to the 2011 Stock Plan and the carry-forward of shares was omitted. This indicates a shift in how the company chose to present the lineage and transition between the two stock plans, focusing only on the 2020 Stock Plan without linking it to its predecessor in the disclosed text.",
      "llm_answer": "\nIn the 2022 10‑K the Company merely noted that the 2020 Stock Plan succeeded the 2011 Plan and that shares authorized but unissued under the 2011 Plan would be available for grant under the 2020 Plan, without quantifying the carry‑over. The 2023 filing retained that language but added a specific figure—5,530,106 shares that were available under the 2011 Plan at the time of the 2020 adoption—and included an updated table showing shares available for grant, granted, exercised and expired under the 2020 Plan. Consequently, the 2023 disclosure expanded the prior description by providing an explicit share‑carryover number and detailed activity metrics, whereas the 2022 filing left those details implicit.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and directly contradicts the ground truth. Key errors: (1) DIRECTIONAL ERROR - The LLM states the 2022 filing 'merely noted' without quantifying the carry-over, while the 2023 filing 'added a specific figure—5,530,106 shares.' This is the OPPOSITE of what actually occurred. The ground truth clearly states the 2022 10-K included the specific detail of 5,530,106 shares, while the 2023 10-K OMITTED this reference. (2) QUANTITATIVE ACCURACY - The number 5,530,106 is correct, but it is attributed to the wrong year's disclosure direction. The LLM claims this number was added in 2023, when it was actually present in 2022 and removed in 2023. (3) CHARACTERIZATION ERROR - The LLM describes the evolution as an 'expansion' of disclosure from 2022 to 2023, when the ground truth indicates a contraction or simplification (removal of the specific carry-forward reference). (4) MULTI-HOP REASONING - The LLM failed to correctly synthesize the comparative analysis between the two years. The question asks how the disclosure 'evolved,' and the correct answer is that it became less detailed regarding the 2011 Plan connection, not more detailed. The LLM's reasoning is internally logical but factually inverted relative to the source documents. The contextual relevance score is high because the LLM at least addressed the right topic and years, but the core factual content is reversed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 395,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How has Honeywell's allocation strategy toward private funds evolved between 2022 and 2023, and what might this indicate about the company's capital deployment priorities?",
      "original_answer": "In 2022, Honeywell reported $1,244 million invested in private funds, as disclosed in the 2022 10-K filing. By 2023, this amount increased slightly to $1,265 million, as noted in the 2023 10-K filing. This represents a modest increase of approximately 1.7%, suggesting that Honeywell maintained a relatively stable allocation strategy toward private funds despite broader reductions in total assets under the U.S. plans. This slight upward trend may indicate a strategic decision to preserve or slightly expand exposure to alternative investments, potentially to capitalize on expected higher returns or diversification benefits from private fund investments.",
      "llm_answer": "\nBetween 2022 and 2023 Honeywell kept its private‑fund exposure essentially unchanged – direct private‑investment holdings edged up from **$1.284 bn to $1.293 bn** and private‑fund assets measured at NAV rose from **$1.258 bn to $1.265 bn**, but the share of total pension assets devoted to these alternatives slipped only marginally (from roughly 7.4 % to 7.6 %).  This stability reflects the company’s disciplined, target‑range approach (10‑20 % “other” investments) that prioritises preserving long‑term, diversified returns while limiting illiquidity risk, indicating that capital deployment is being steered toward core businesses and cash‑generating assets rather than aggressive expansion into new growth ventures.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamentally incorrect financial figures that contradict the ground truth. (1) QUANTITATIVE ACCURACY FAILURES: The LLM reports private-fund assets at NAV as rising from $1.258 bn to $1.265 bn, but the ground truth clearly states the 2022 figure was $1,244 million ($1.244 bn) and 2023 was $1,265 million ($1.265 bn). The LLM's 2022 figure of $1.258 bn is incorrect - it appears to have confused or misread the data. Additionally, the LLM introduces entirely new figures ($1.284 bn to $1.293 bn for 'direct private-investment holdings') that do not appear in the ground truth at all, suggesting the model fabricated or hallucinated these numbers. (2) CALCULATION ERRORS: The ground truth calculates a 1.7% increase from $1,244M to $1,265M. The LLM's figures would yield a different percentage increase, and the model does not even attempt to calculate the actual percentage change despite mentioning percentage allocations. (3) MULTI-HOP SYNTHESIS FAILURE: The LLM failed to correctly synthesize the core data points from the 2022 and 2023 10-K filings. It introduced extraneous information about 'direct private-investment holdings' and percentage allocations (7.4% to 7.6%) that are not supported by the ground truth answer. (4) ENTITY/METRIC CONFUSION: While the LLM correctly identifies Honeywell and the 2022-2023 timeframe, it misidentifies or misrepresents the specific financial metrics being tracked. The ground truth focuses on private funds investments ($1,244M → $1,265M), while the LLM conflates this with other metrics not mentioned in the ground truth. (5) REASONING QUALITY: The qualitative interpretation about 'disciplined, target-range approach' and '10-20% other investments' is not supported by the ground truth answer, which makes no mention of these target ranges or strategic frameworks. The conclusion about 'capital deployment steered toward core businesses' is speculative and not grounded in the provided data. The answer demonstrates a fundamental failure to accurately retrieve and report the correct financial figures from the source documents.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 568,
        "total_tokens": 1919
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did the status and disclosure of Class B-2 Common Stock evolve between 2023 and 2024, particularly regarding its outstanding status and relationship to other stock classes?",
      "original_answer": "In 2023, Class B-2 Common Stock was subject to conversion rate adjustments tied to the U.S. litigation escrow account under the U.S. retrospective responsibility plan, which caused dilution in as-converted shares. Additionally, it was noted that no shares of Class B-2 were outstanding prior to the Class B-1 exchange offer. By 2024, the 10-K filing only referenced Class B-2 Common Stock in relation to its lack of outstanding shares prior to the Class B-1 exchange offer, with no further updates or disclosures regarding its conversion mechanics or dilution impacts, suggesting a reduced emphasis or potential discontinuation of its active role in the capital structure.",
      "llm_answer": "\nBetween fiscal 2023 and fiscal 2024 the company went from having **no outstanding shares of Class B‑2 common stock** (the column shows “‑” for 2023 and 2022) to issuing that class as part of the **Class B‑1 exchange offer** completed in May 2024, which retired the tendered ≈ 241 million B‑1 shares and created **≈ 120 million B‑2 shares (and 48 million C shares)**—the 49 million‑share figure appears in the 2024 EPS tables.  The new B‑2 class is convertible to Class A common stock only after the U.S. covered litigation is resolved, and its conversion‑rate adjustments are designed to have **double the impact** of the B‑1 rate changes, while still being subject to transfer restrictions and dividend participation that mirror the other stock classes.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer provides substantial detail about the Class B-2 evolution but contains significant quantitative discrepancies and some conceptual misalignments with the ground truth. STRENGTHS: (1) Correctly identifies that Class B-2 had no outstanding shares in 2023 and were created via the Class B-1 exchange offer in May 2024; (2) Accurately notes the conversion mechanics tied to U.S. litigation resolution; (3) Properly describes transfer restrictions and dividend participation mirroring other classes; (4) Correctly identifies the relationship between B-2 and B-1 conversion rate adjustments. CRITICAL ISSUES: (1) QUANTITATIVE ERRORS - The LLM states '≈120 million B-2 shares' were created, but provides conflicting information by also mentioning '49 million-share figure' from EPS tables without reconciliation. The ground truth does not specify these exact share counts, making verification difficult, but the internal inconsistency (120M vs 49M) is problematic; (2) The LLM claims B-2 conversion rates have 'double the impact' of B-1 rate changes - this specific claim is not present in the ground truth and appears to be an inference or error; (3) The LLM provides much more operational detail about the May 2024 exchange offer mechanics than the ground truth, which focuses on the evolution of disclosure emphasis. CONCEPTUAL MISALIGNMENT: The ground truth emphasizes a 'reduced emphasis or potential discontinuation' of B-2's active role by 2024, noting that the 2024 10-K only referenced B-2 in relation to lack of prior outstanding shares. The LLM answer, conversely, presents B-2 as newly active and prominent post-May 2024. This represents a fundamental difference in interpretation - the ground truth suggests B-2 became less relevant in disclosure, while the LLM suggests it became more operationally significant. MULTI-HOP REASONING: The LLM successfully synthesizes information across 2023-2024 filings and the exchange offer mechanics, but the synthesis appears to add details not explicitly confirmed in the ground truth. The answer reads as more detailed operational analysis rather than a disclosure evolution analysis as requested.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 578,
        "total_tokens": 1942
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did the financial obligations related to the Target Circle program change between 2022 and 2024, and what does this indicate about the program's evolution?",
      "original_answer": "In 2022, the deferred revenue related to the Target Circle program was $89 million as of January 29, 2022, while in 2024, the deferred revenue related to the program was $117 million as of February 3, 2024. This indicates a significant increase in the company's liability tied to unredeemed rewards, suggesting growth in program participation or changes in redemption patterns. However, by February 1, 2025, the deferred revenue had dropped to $19 million, signaling a sharp decline, which may reflect either a surge in reward redemptions or a strategic change in how the program's liabilities are recognized or managed.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2024 the liability that represents unearned Target Circle rewards fell dramatically—from about **$89 million** (as of January 29 2022) to **$19 million** (as of February 1 2025), a decline of roughly **$70 million** (and a further drop from $117 million in 2023).  This reduction shows that Target is recognizing more of the accrued rewards and/or scaling back the program’s future payout obligations, indicating that the Target Circle loyalty scheme has been **re‑structured or narrowed** rather than expanded.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant issues with temporal accuracy and incomplete synthesis of the multi-hop information. CORRECT ELEMENTS: (1) The $89 million figure for January 29, 2022 is accurate; (2) The $19 million figure for February 1, 2025 is accurate; (3) The $117 million intermediate figure is correctly identified; (4) The general interpretation that the decline suggests changes in program management is reasonable. CRITICAL ERRORS: (1) The LLM frames the comparison as '2022 to 2024' in the opening but then jumps to 2025 data, creating confusion about the actual time period being analyzed. The ground truth explicitly addresses 2022, 2024, and 2025 as three distinct data points, but the LLM conflates them by stating 'fell dramatically from about $89 million (as of January 29 2022) to $19 million (as of February 1 2025)' - this skips over the 2024 intermediate value of $117 million in the main comparison, only mentioning it parenthetically. (2) The question specifically asks about changes 'between 2022 and 2024,' but the LLM's primary comparison is 2022 to 2025, which goes beyond the question's scope. (3) The LLM's interpretation that the program was 'restructured or narrowed' is speculative and not fully supported by the ground truth, which presents the 2025 drop as potentially indicating 'a surge in reward redemptions or a strategic change' without definitively concluding restructuring. (4) The LLM fails to properly synthesize the three-year progression: 2022 ($89M) → 2024 ($117M, an increase) → 2025 ($19M, a sharp decline). The ground truth explicitly notes this progression shows initial growth followed by sharp decline, but the LLM presents it as a simple downward trend. CALCULATION VERIFICATION: The $70 million decline calculation ($89M to $19M) is arithmetically correct, but this calculation spans 2022-2025, not 2022-2024 as the question asks. The answer would be more accurate if it focused on the $89M to $117M increase (a $28M increase) for the 2022-2024 period specifically.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 544,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did the fair value of Netflix's 4.375% Senior Notes change between December 31, 2022, and December 31, 2023, and what does this indicate about investor perception or market conditions?",
      "original_answer": "The fair value of Netflix's 4.375% Senior Notes decreased from $980 million on December 31, 2022, to $996 million on December 31, 2023. This indicates a shift in investor perception or market conditions, as the fair value moved closer to the principal amount at par, suggesting a stabilization or improved outlook for the company's debt.",
      "llm_answer": "\nThe Level 2 fair‑value estimate for Netflix’s 4.375% Senior Notes rose from **$980 million on December 31 2022 to $996 million on December 31 2023**—an increase of roughly **$16 million (≈1.6 %)**.  This price appreciation reflects that market yields for comparable debt have fallen (or that investors perceive Netflix’s credit risk as lower), making the existing higher‑coupon notes more attractive and signaling a generally more favorable market environment for the company’s borrowing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-reasoned. QUANTITATIVE VERIFICATION: All numbers are correct - fair value increased from $980 million (Dec 31, 2022) to $996 million (Dec 31, 2023), representing a $16 million increase of approximately 1.6%. The calculation is accurate: $16M/$980M = 1.63%, correctly rounded to 1.6%. ENTITY ACCURACY: Netflix, 4.375% Senior Notes, and the specific dates are all correctly identified. The Level 2 fair-value classification is appropriately noted. REASONING QUALITY: The LLM provides sound multi-hop synthesis by: (1) identifying the numerical change, (2) calculating the percentage increase, and (3) interpreting what this means for investor perception and market conditions. The interpretation that falling market yields or lower perceived credit risk makes higher-coupon notes more attractive is economically sound and demonstrates understanding of bond valuation mechanics. COMPARISON TO GROUND TRUTH: The ground truth states the fair value 'moved closer to the principal amount at par, suggesting a stabilization or improved outlook.' The LLM's interpretation (market yields fell or credit risk perception improved) is semantically equivalent and actually provides more specific economic reasoning. Both answers correctly identify that the change indicates improved market conditions/investor perception. MINOR CONSIDERATION: The ground truth uses slightly different language ('moved closer to par') while the LLM provides more detailed economic explanation. Both are correct interpretations of the same phenomenon. The LLM answer is more comprehensive in explaining the mechanism behind the fair value change.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 453,
        "total_tokens": 1670
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did the equity structure related to Class C Common Stock evolve between 2023 and 2024, particularly in terms of share issuance and equity classification?",
      "original_answer": "In 2023, Visa conducted an exchange offer where 241 million shares of Class B-1 common stock were tendered, and in exchange, approximately 48 million shares of Class C common stock were issued. This indicates active restructuring of stock classes tied to the Visa Europe retrospective responsibility plans. By 2024, the balance of Class C common stock remained at 10 shares issued and outstanding, as stated in the equity section of the balance sheet. This suggests that while there was active movement and restructuring involving Class C shares in 2023, the 2024 disclosures indicate a stabilization or conclusion of that phase of equity restructuring.",
      "llm_answer": "\nBetween fiscal 2023 and fiscal 2024 the company’s class C common stock grew from essentially 10 shares (outstanding on the balance sheet) to ≈ 48 million new shares issued in May 2024 as part of the exchange offer for tendered class B‑1 common stock.  These newly issued class C shares remain classified as a separate class of common stock that is convertible into class A common stock (and, together with class B‑1 and B‑2 stock, can be converted into class A preferred stock) and retain the same limited‑voting rights as before; the only change was a substantial increase in the number of class C shares outstanding.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) TIMELINE REVERSAL: The LLM states the exchange offer occurred in May 2024, but the ground truth clearly indicates it occurred in 2023. This is a critical chronological error. (2) DIRECTIONAL ERROR: The LLM describes Class C shares growing FROM 10 shares TO 48 million shares between 2023-2024, but the ground truth indicates the opposite sequence - the 48 million shares were issued in 2023 via the exchange offer, and by 2024 the balance remained at 10 shares. The LLM has reversed the temporal sequence of events. (3) MISSING KEY DETAIL: The ground truth specifies that 241 million shares of Class B-1 common stock were tendered in the 2023 exchange offer, which the LLM completely omits. (4) MISCHARACTERIZATION OF 2024 STATUS: The ground truth emphasizes that by 2024 the Class C balance was 10 shares (suggesting stabilization after 2023 activity), but the LLM incorrectly portrays 2024 as the year when 48 million shares were newly issued. (5) CONVERSION RIGHTS: While the LLM correctly notes convertibility features, this detail is secondary to the fundamental factual errors about timing and sequence. The answer demonstrates a fundamental misunderstanding of the multi-hop temporal synthesis required - it failed to correctly sequence events across the 2023-2024 period and reversed the direction of equity movement.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 395,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How has Lowe's engagement with Rough Plumbing evolved from 2022 to 2024, particularly in terms of its business classification and service offerings?",
      "original_answer": "In 2022, Rough Plumbing was classified under the 'Building Products' category, indicating it was primarily offered as a product within Lowe's merchandise divisions. By 2024, Lowe's had expanded its engagement with Rough Plumbing by integrating it into both installation services and protection plans, signaling a shift from a pure product offering to a more service-oriented approach. This evolution reflects a strategic move to bundle Rough Plumbing with labor and extended protection, contributing to the approximately 5% of total sales attributed to installed sales in 2024.",
      "llm_answer": "\nFrom 2022 to 2024 Rough Plumbing shifted from being reported simply as a sub‑category of the **Building Products** segment (which accounted for roughly 32 % of net sales in 2022 – see LOW_10k_2022 page 55) to being treated as a core element of Lowe’s **installed‑sales and home‑services** offering.  The 2024 disclosures (LOW_10k_2024 pages 4, 7) place Rough Plumbing among the “major installed‑sales categories” and tie it to the company’s “Expand home services” and “Pro penetration” strategic pillars, emphasizing installation by independent contractors, protection‑plan coverage and integration with the omnichannel/loyalty ecosystem rather than just a product line.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the core evolution of Rough Plumbing from a product classification to a service-oriented offering integrated with installation services and protection plans. The qualitative reasoning is sound and well-supported with specific document references (LOW_10k_2022 page 55, LOW_10k_2024 pages 4, 7). The answer appropriately synthesizes the multi-hop information about the strategic shift and mentions key elements like independent contractors, protection-plan coverage, and omnichannel integration.\n\nHowever, there are quantitative accuracy concerns: (1) The LLM states Building Products accounted for 'roughly 32% of net sales in 2022' but the ground truth does not provide this specific percentage, making this an unsupported claim. (2) The ground truth explicitly mentions 'approximately 5% of total sales attributed to installed sales in 2024,' but the LLM answer does not include this specific metric, which is a notable omission given its relevance to quantifying the service-oriented shift. (3) The LLM provides specific page references that cannot be verified against the ground truth provided.\n\nThe answer demonstrates strong qualitative understanding of the business evolution and strategic positioning, correctly identifying the shift from Building Products classification to integrated services. The mention of 'major installed-sales categories,' 'Expand home services,' and 'Pro penetration' strategic pillars shows good synthesis. However, the missing 5% installed sales figure and the unverified 32% Building Products claim represent gaps in quantitative completeness. The answer is directionally correct but lacks precision on key financial metrics that would strengthen the response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 473,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did the introduction and subsequent status of Class B-2 common stock evolve between 2023 and 2024, and what does this indicate about its role in the company's capital structure?",
      "original_answer": "In 2023, Class B-2 common stock was newly introduced with 77 million shares outstanding, indicating its initial incorporation into the company's equity structure. By 2024, the company disclosed that no shares of Class B-2 common stock were outstanding prior to the Class B-1 common stock exchange offer, suggesting a strategic shift where Class B-2 shares may have been replaced or restructured as part of a broader capital realignment. This indicates a transformation in the role of Class B-2 common stock within the company’s capital structure.",
      "llm_answer": "\nClass B‑2 common stock was created in May 2024 as part of Visa’s exchange offer that retired 241 million Class B‑1 shares and issued roughly 120 million new Class B‑2 shares (plus 48 million Class C shares); there were no B‑2 shares outstanding before that offer. By the end of 2024 the company reported about 49 million weighted‑average B‑2 shares (used in EPS calculations and shown in the equity section), giving the firm a new class of equity that can be issued only in connection with the B‑1 exchange and that carries transfer and conversion restrictions until the U.S. covered litigation is resolved. This addition expands the authorized capital, provides a mechanism to retire restricted B‑1 shares, and reshapes the ownership and voting profile of Visa’s equity, signaling that B‑2 stock is being used to restructure the capital base and manage litigation‑related equity obligations.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) WRONG COMPANY: The LLM discusses Visa's Class B-2 stock creation in May 2024, but the ground truth indicates this is about a different company with Class B-2 stock introduced in 2023 with 77 million shares outstanding. The LLM appears to have confused the company entirely. (2) WRONG TIMELINE: Ground truth shows Class B-2 was introduced in 2023 (not May 2024), with 77 million shares outstanding initially. The LLM claims creation in May 2024. (3) WRONG NUMBERS: The LLM cites 241 million Class B-1 shares retired, 120 million Class B-2 shares issued, and 48 million Class C shares - none of these numbers appear in the ground truth, which mentions 77 million B-2 shares in 2023 and zero outstanding prior to an exchange offer. (4) WRONG CONTEXT: The LLM introduces litigation-related equity obligations and covered litigation context that is not present in the ground truth. The ground truth simply indicates a strategic shift/restructuring between 2023 and 2024. (5) MULTI-HOP REASONING FAILURE: The LLM failed to correctly synthesize the evolution between 2023 and 2024. Ground truth shows: 2023 had 77M B-2 shares outstanding (newly introduced), 2024 showed zero outstanding prior to exchange offer (suggesting replacement/restructuring). The LLM's narrative about Visa's exchange offer is entirely different from what the ground truth describes. The answer demonstrates fundamental misidentification of the company and time period, making it largely irrelevant to the actual question being asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 439,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How has the financial liability associated with the Target Circle program changed between 2022 and 2024, and what does this indicate about the program's growth or evolution?",
      "original_answer": "In 2022, the Target Circle program was described primarily in terms of its benefits to customers, such as earning 1% rewards on non-RedCard purchases, but no specific liability figure was disclosed. By 2024, the deferred revenue related to the Target Circle program had grown to $117 million as of February 3, 2024, indicating a significant increase in the program's financial liability and suggesting substantial growth or expansion of the program. This increase reflects a greater number of participants or increased transactional activity within the program.",
      "llm_answer": "\nThe Target Circle program’s deferred‑revenue liability fell sharply from about **$117 million at the end of fiscal 2023** (the 2022‑reporting period) to roughly **$19 million by the end of fiscal 2024**.  This >80 % decline shows that the program’s financial liability is contracting, reflecting either higher reward‑redemption rates, a change in how the program is structured, or a deliberate scaling back, indicating that Target Circle has moved past its rapid‑growth phase into a more mature, revenue‑recognizing stage.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on multiple critical dimensions: (1) QUANTITATIVE ERRORS: The LLM claims deferred revenue was $117 million at end of fiscal 2023 and fell to $19 million by end of fiscal 2024. The ground truth states that in 2022 no specific liability figure was disclosed, and by 2024 (February 3, 2024) the deferred revenue was $117 million. The LLM has inverted the direction of change and misidentified the years. (2) DIRECTIONAL ERROR: The LLM describes a sharp DECLINE (>80% drop), while the ground truth indicates GROWTH from no disclosed figure in 2022 to $117 million by 2024. This is a fundamental misreading of the data. (3) INTERPRETATION ERROR: The LLM concludes the program is 'contracting' and in a 'mature, revenue-recognizing stage,' which directly contradicts the ground truth's interpretation that the $117 million figure 'indicates a significant increase in the program's financial liability and suggesting substantial growth or expansion.' (4) TEMPORAL CONFUSION: The LLM conflates fiscal 2023 with the 2022-reporting period and misaligns the timeline. The ground truth clearly distinguishes between 2022 (no disclosure) and 2024 (February 3, 2024 with $117 million). (5) MISSING CONTEXT: The LLM fails to acknowledge that 2022 had no disclosed liability figure, which is a critical part of understanding the change. The answer demonstrates a complete reversal of the actual financial trend and provides an analysis that is 180 degrees opposite to what the data shows.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 425,
        "total_tokens": 1703
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How has NVDA's exposure to and concern about pollution limits evolved between 2023 and 2024, particularly in terms of regulatory impact on operations and customer data center expansion?",
      "original_answer": "In 2023, NVDA highlighted that pollution limits and related climate regulations could increase direct and indirect costs, including compliance, energy, and capital expenditures, and could require changes to manufacturing processes and supply chain operations. By 2024, the company expanded its concern to include not only cost increases but also the potential for land and permitting constraints tied to pollution limits, which could impair customers' ability to expand data center capacity—an essential market for NVDA's products. This indicates a growing concern that regulatory tightening around pollution could directly affect demand for NVDA's offerings.",
      "llm_answer": "\nBetween 2023 and 2024 NVIDIA’s focus on pollution‑related risk moved from a generic acknowledgement of climate change to a concrete concern about upcoming regulations.  The 2024 filing explicitly warns that new carbon‑tax, emissions, water‑use and other pollution limits could raise its own operating costs and, more importantly, restrict customers’ ability to expand data‑center capacity by limiting power, water and permitting availability—making pollution‑related rules a direct operational and revenue risk.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of NVDA's evolving pollution-related regulatory concerns between 2023 and 2024. STRENGTHS: (1) Correctly identifies the evolution from 2023 to 2024 as moving from generic acknowledgment to concrete regulatory concerns; (2) Accurately captures the 2024 expansion of concerns to include land/permitting constraints and customer data center expansion impacts; (3) Properly synthesizes the multi-hop connection between pollution regulations → customer constraints → NVDA revenue risk; (4) No quantitative errors or incorrect dates; (5) Correctly identifies the specific regulatory mechanisms (carbon tax, emissions, water-use limits) and their operational impacts (power, water, permitting availability). MINOR WEAKNESSES: (1) The phrase 'generic acknowledgement of climate change' in the LLM answer is slightly broader than the ground truth's more specific framing of 'direct and indirect costs including compliance, energy, and capital expenditures' in 2023; (2) The LLM answer doesn't explicitly mention the 2023 concern about manufacturing process and supply chain changes, though this is a minor omission; (3) The characterization of 2023 concerns as 'generic' could be seen as slightly reductive compared to the ground truth's more detailed enumeration. MULTI-HOP REASONING: The answer correctly synthesizes information across years and connects regulatory impacts to both direct operations and indirect customer impacts on demand. The logic flow is sound and demonstrates proper understanding of how pollution regulations create cascading effects on NVDA's business. Overall, this is a strong answer with accurate core facts and good synthesis, with only minor contextual details omitted.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 474,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did the composition and valuation of the company's Guaranteed Senior Notes evolve between 2023 and 2024, particularly in terms of issuance, repayment, and fair value inputs?",
      "original_answer": "In 2023, the company's Japanese subsidiary issued four Guaranteed Senior Notes totaling approximately $500 at fixed interest rates ranging from 1.400% to 2.120%. These notes were valued using Level 3 inputs. In 2024, the Japanese subsidiary repaid $77 of these Guaranteed Senior Notes. The fair value of long-term debt, including Guaranteed Senior Notes, was approximately $5,412 at the end of 2024, compared to $5,738 at the end of 2023. This indicates a reduction in the overall fair value of long-term debt, partially driven by repayments on the Guaranteed Senior Notes.",
      "llm_answer": "\nBetween September 3 2023 and September 1 2024 the company’s Guaranteed Senior Notes—issued by its Japanese subsidiary—expanded from roughly **$484 million** (recorded as other long‑term debt) to about **$919 million**, reflecting a **$500 million issuance in November 2023** that was later reduced by a **$77 million repayment in July 2024**. These notes carry fixed rates of **1.400 %–2.120 %** and mature between **2033 and 2043**, and their fair value is estimated using **Level 3 inputs** (unobservable Japanese market‑rate assumptions).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR DISCREPANCIES IDENTIFIED: The LLM answer contains significant factual errors that contradict the ground truth. (1) ISSUANCE AMOUNT ERROR: The LLM states a '$500 million issuance in November 2023' which matches the ground truth ($500 total), but then claims the notes 'expanded from roughly $484 million...to about $919 million.' This math is internally inconsistent and contradicts the ground truth. The ground truth indicates the 2023 issuance was approximately $500 total, not that there was a $484M starting balance that grew to $919M. (2) FAIR VALUE OMISSION: The LLM completely fails to address the fair value comparison between years, which is a core part of the original question. The ground truth explicitly states fair value was $5,412 in 2024 vs $5,738 in 2023—a critical metric for understanding the evolution. The LLM provides no fair value figures for comparison. (3) REPAYMENT ACCURACY: The $77 million repayment in July 2024 is correctly stated. (4) INTEREST RATES AND MATURITY: The 1.400%-2.120% rates and 2033-2043 maturity dates are correct and represent good additional detail. (5) LEVEL 3 INPUTS: Correctly identified as the valuation methodology. (6) MULTI-HOP SYNTHESIS FAILURE: The LLM failed to synthesize the key comparison metric (fair value evolution) that directly answers how the composition and valuation 'evolved.' The answer focuses on balance sheet amounts but misses the valuation comparison entirely. The opening and closing balance figures presented ($484M to $919M) appear to be fabricated or misinterpreted, as they don't align with the ground truth narrative of a $500M issuance followed by $77M repayment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 451,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Netflix's investment in streaming service improvements and associated risk exposure evolve from 2022 to 2024, based on the specific personnel and cybersecurity-related changes disclosed in those years?",
      "original_answer": "In 2022, Netflix disclosed a $384 million increase in personnel-related costs driven by headcount growth to support production activity and improve the streaming service. By 2024, the focus had evolved to include significant emphasis on cybersecurity, with detailed descriptions of enterprise-wide security programs, third-party risk management, and the potential financial impact of cyber incidents. The company highlighted the risk of unauthorized data releases and digital content theft, noting that such events could adversely affect business operations and financial results. This represents a shift from purely growth-oriented investment in streaming to a more risk-aware posture as the service matured.",
      "llm_answer": "\nFrom 2022 through 2024 Netflix stepped up its spending on technology and development – the 2022 filing notes a 24 % jump in tech‑dev expenses driven by head‑count growth to improve streaming infrastructure – and simultaneously expanded its cybersecurity organization.  The 2024 filing adds a dedicated Vice President of Security and Privacy Engineering, a formal enterprise‑wide security program, a bug‑bounty initiative and Board‑level oversight of cyber risk, indicating a deliberate investment in personnel and governance to protect the streaming platform.  These additions deepen the company’s focus on streaming‑service enhancements but also raise its exposure to cyber‑related liabilities, regulatory scrutiny and reputational risk.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the evolution from 2022 to 2024, recognizes the shift from growth-oriented investment to risk-aware posture, and accurately describes cybersecurity enhancements (VP of Security and Privacy Engineering, enterprise-wide security program, bug-bounty initiative, Board-level oversight). The qualitative reasoning about the shift in focus and risk exposure is sound and well-articulated. CRITICAL ERRORS: (1) QUANTITATIVE ACCURACY FAILURE: The LLM states '24% jump in tech-dev expenses' but the ground truth specifies '$384 million increase in personnel-related costs.' These are fundamentally different metrics - the LLM provides a percentage without the dollar amount, and conflates 'tech-dev expenses' with 'personnel-related costs.' The ground truth does not mention a 24% figure. (2) INCOMPLETE SYNTHESIS: The LLM mentions 'technology and development' spending but fails to cite the specific $384 million personnel cost increase that is central to the ground truth answer. (3) MISSING KEY DETAIL: The ground truth emphasizes specific risks like 'unauthorized data releases and digital content theft' with potential adverse effects on 'business operations and financial results' - the LLM mentions 'cyber-related liabilities, regulatory scrutiny and reputational risk' which are related but not the same specific risks disclosed. MULTI-HOP REASONING: The LLM successfully synthesizes information across 2022 and 2024 filings and correctly identifies the evolution pattern. However, the failure to accurately cite the $384 million figure undermines the quantitative foundation of the answer. The answer reads plausibly but contains a material factual error in the specific financial metric cited.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 474,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did The Bank of New York Mellon Corporation's approach to restricted stock unit agreements evolve between the 2023 and 2024 filings, particularly in terms of the lifecycle management of these equity instruments and their implications for executive compensation strategy?",
      "original_answer": "In the 2023 filing, the '2024 Form of Restricted Stock Unit Agreement' was newly introduced and explicitly stated as 'Filed herewith,' indicating it was a current and newly adopted form for that year. This suggests the company was actively updating its equity compensation framework to align with strategic goals for executive retention and incentives. By the 2024 filing, this '2024 Form' was no longer newly filed but instead was referenced as 'Previously filed,' signaling it had become an established part of the company's compensation structure. Additionally, in 2024, the company introduced the '2025 Form of Restricted Stock Unit Agreement,' which was marked as 'Filed herewith,' showing a forward-looking update to the equity compensation strategy. This evolution indicates a consistent, proactive approach to managing executive compensation frameworks, with new forms being introduced annually and the prior year’s forms transitioning into reference documents. This reflects a mature, iterative process in shaping executive incentives and aligning them with long-term corporate objectives.",
      "llm_answer": "\nBetween the 2023 and 2024 filings BNY Mellon swapped its prior 2023 Restricted Stock Unit agreement (Exhibit 10.24) for a refreshed 2024 RSU form (Exhibit 10.26) that revises vesting schedules, performance‑metric language and related disclosures, and it also filed a 2025 RSU draft (Exhibit 10.29) in the same filing—showing a deliberate, periodic update cycle.  This iterative lifecycle management tightens performance conditions and extends the award horizon, directly shaping the executive compensation strategy by aligning equity incentives with longer‑term performance goals.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its credibility. CRITICAL ERRORS: (1) The LLM claims a '2023 Restricted Stock Unit agreement (Exhibit 10.24)' was replaced, but the ground truth indicates the 2023 filing introduced the '2024 Form' as newly filed ('Filed herewith'). The LLM incorrectly suggests there was a prior 2023 form being replaced, when the ground truth shows the 2024 Form was the NEW introduction in 2023. (2) The LLM provides specific exhibit numbers (10.24, 10.26, 10.29) that cannot be verified against the ground truth and appear to be fabricated details. The ground truth does not reference these specific exhibit numbers. (3) The LLM claims the 2024 RSU form 'revises vesting schedules, performance-metric language and related disclosures' but the ground truth makes no such specific claims about what changed in the form itself—only that it transitioned from 'Filed herewith' to 'Previously filed' status. PARTIALLY CORRECT ELEMENTS: The LLM correctly identifies that there is an iterative annual update cycle (2024 Form in 2023 filing, 2025 Form in 2024 filing), which aligns with the ground truth's description of 'new forms being introduced annually.' The LLM also correctly captures the general concept of lifecycle management and forward-looking strategy. However, the specific characterization of what changed between forms (vesting schedules, performance metrics) is unsupported speculation rather than factual synthesis. The multi-hop reasoning is partially sound in recognizing the pattern, but the execution contains fabricated details and mischaracterization of the 2023 baseline. The answer demonstrates understanding of the general concept but fails on factual accuracy regarding the specific evolution described in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 487,
        "total_tokens": 1939
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How has the status and structure of the 4.90% Senior Notes evolved from 2023 to 2024, particularly in terms of their carrying amount and maturity timeline?",
      "original_answer": "In 2023, the 4.90% Senior Notes were newly issued in November 2023, with a principal amount of $750 million, a discount of $3.4 million, and a maturity date of April 15, 2029. Interest payments were scheduled semi-annually starting April 15, 2024. By 2024, these notes remained outstanding, with a carrying amount of $743 million as of January 28, 2024. The maturity date remained unchanged at April 2029, and the notes continued to be listed among the company’s long-term debt obligations. The carrying amount slightly decreased, reflecting the initial discount and amortization progress over the year.",
      "llm_answer": "\nThe $750 million, 4.90 % senior notes issued in November 2023 remain outstanding in 2024, maturing on **April 15, 2029** and carrying a **$743 million carrying amount** (net of the $3.4 million discount) on the February 2 2025 balance sheet—essentially the same level as the prior year after amortizing the discount.  Their terms (semi‑annual interest on April 15 and October 15, redemption rights, and change‑of‑control provisions) have not been altered, so the notes continue to be scheduled for repayment only at maturity in 2029.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains both correct and problematic elements. CORRECT ELEMENTS: (1) Principal amount of $750 million is accurate, (2) Interest rate of 4.90% is correct, (3) Issuance date of November 2023 is accurate, (4) Maturity date of April 15, 2029 is correct, (5) Discount amount of $3.4 million is accurate, (6) Carrying amount of $743 million is correct, (7) Semi-annual interest payment schedule is accurate, (8) The notes remain outstanding in 2024 is correct. PROBLEMATIC ELEMENTS: (1) The LLM states the carrying amount is from 'February 2 2025 balance sheet' when the ground truth specifies 'January 28, 2024' - this is a significant date discrepancy that suggests the LLM may be referencing a different fiscal period than intended. The ground truth explicitly states the $743 million carrying amount was 'as of January 28, 2024,' not February 2025. (2) The LLM's statement that the carrying amount is 'essentially the same level as the prior year' is somewhat misleading - the ground truth indicates the carrying amount 'slightly decreased' from the initial $746.6 million ($750M - $3.4M discount) to $743 million, reflecting amortization progress. The LLM doesn't clearly articulate this amortization dynamic. MULTI-HOP REASONING: The LLM successfully synthesizes information about the notes' evolution from 2023 to 2024, correctly identifying that they were newly issued in 2023 and remain outstanding in 2024. However, the date confusion undermines confidence in the synthesis. CALCULATION VERIFICATION: The carrying amount calculation ($750M - $3.4M = $746.6M initial, declining to $743M) is implicitly correct in the LLM answer, though not explicitly shown. The discount amortization logic is sound but not clearly explained. The critical issue is the balance sheet date discrepancy, which raises questions about whether the LLM is accurately tracking the temporal evolution requested in the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 519,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did the issuance and repayment of Guaranteed Senior Notes by Costco's Japanese subsidiary evolve between 2023 and 2024?",
      "original_answer": "In 2023, Costco's Japanese subsidiary issued four Guaranteed Senior Notes totaling approximately $500 at fixed interest rates ranging from 1.400% to 2.120%. In 2024, the subsidiary repaid $77 of these Guaranteed Senior Notes. Additionally, the proceeds from the issuance of these notes were referenced in the 2024 filing as a source of financing activity, indicating continued financial engagement with this instrument.",
      "llm_answer": "\nBetween 2023 and 2024 the Japanese subsidiary added roughly $500 of Guaranteed Senior Notes in November 2023, and then began retiring part of that issuance—repaying $77 of the notes in July 2024.  The net effect was an increase in the subsidiary’s other long‑term debt from about $484 million in 2023 to roughly $919 million in 2024, reflecting the new $500 issuance less the $77 repayment.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core facts: issuance of approximately $500 in Guaranteed Senior Notes in 2023 and repayment of $77 in 2024. The timing details (November 2023 issuance, July 2024 repayment) and the subsidiary relationship are accurate. However, there are significant issues with the quantitative analysis: (1) The LLM introduces specific debt balance figures ($484 million in 2023 and $919 million in 2024) that are NOT present in the ground truth answer and cannot be verified. These appear to be fabricated numbers used to support a calculation. (2) The LLM's calculation logic ($500 issuance - $77 repayment = net increase) is mathematically sound in isolation, but the specific balance figures cited ($484M to $919M) are unsupported and potentially incorrect. The ground truth does not provide these balance figures, suggesting the LLM may have hallucinated them. (3) The ground truth mentions interest rates (1.400% to 2.120%) which the LLM omits entirely. (4) The ground truth references that proceeds were noted as a financing activity source in the 2024 filing, which the LLM does not mention. The LLM's core narrative about issuance and repayment is directionally correct, but the introduction of unverified balance sheet figures and the omission of interest rate details represent material accuracy problems. The multi-hop reasoning about the evolution between years is present but compromised by the unsupported quantitative claims.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1196,
        "completion_tokens": 405,
        "total_tokens": 1602
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How has the risk associated with competitors developing after-market parts for DHR's products evolved from 2022 to 2023, particularly in terms of its impact on the company's business and financial statements?",
      "original_answer": "In 2022, the risk of competitors developing after-market parts was described as a direct threat that could 'detract from our sales,' with an emphasis on how commoditization and private-label offerings could reduce market prices and erode DHR's competitive position. By 2023, the framing of this risk shifted to being 'Impacted By' such competition, with a broader contextualization within cost containment trends in the healthcare industry and pricing pressures from managed care and government reimbursement policies. While the core risk remained, it was presented as one of several external pressures rather than a primary threat, suggesting a relative de-emphasis in severity or a strategic recalibration in how the company perceives this risk.",
      "llm_answer": "\nThe filings show that the risk of competitors offering after‑market parts and services has been repeatedly flagged as a material threat—first in the 2022 10‑K (e.g., page 23 and page 25) and again in the 2023 10‑K (page 20 and page 21).  In both years the language warns that such after‑market offerings can “detract from our sales,” create pricing pressure and erode market share, which can adversely affect revenue, earnings and cash‑flow performance.  Thus, the risk has not changed materially between 2022 and 2023; it remains a recurring concern that can negatively impact Danaher’s business and financial statements.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer fundamentally misses the core evolution described in the ground truth. While the LLM correctly identifies that the risk was flagged in both 2022 and 2023 10-Ks and accurately notes the language about 'detract from our sales' and pricing pressure, it fails to capture the critical shift in how the risk was framed between the two years. The ground truth explicitly states that by 2023, the framing shifted from a 'direct threat' to being 'Impacted By' competition, with broader contextualization within industry cost containment trends and external pressures. The LLM concludes 'the risk has not changed materially between 2022 and 2023,' which directly contradicts the ground truth's finding of a meaningful shift in how the company presented and contextualized this risk. The LLM treats both years as essentially equivalent ('recurring concern'), missing the nuanced evolution in severity perception or strategic recalibration. The quantitative accuracy is reasonable (page references appear plausible, though not verified), but the qualitative analysis is severely deficient. The LLM failed to perform the multi-hop synthesis required to understand how the risk's presentation evolved, instead providing a static comparison that misses the temporal evolution central to the question. The answer demonstrates incomplete reading comprehension of the filing language and fails to identify the strategic shift in risk framing that distinguishes 2023 from 2022.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 407,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How has Netflix's approach to membership plans evolved from 2022 to 2024, particularly in terms of pricing strategy and service features, and what business challenges were these changes intended to address?",
      "original_answer": "In 2022, Netflix experienced a 19% revenue increase driven by an 11% growth in average paying memberships and a 7% rise in average monthly revenue per membership, partly due to price increases and favorable foreign exchange rates. However, paid net membership additions dropped by 50% compared to the prior year, signaling early signs of member acquisition challenges. By 2024, Netflix responded by introducing a lower-priced ad-supported subscription plan and enforcing terms of use to limit multi-household usage. These changes were aimed at addressing fluctuating member acquisition, retention pressures, and increasing competition in the streaming and broader entertainment market. The company acknowledged that macroeconomic conditions, content competition, and consumer sensitivity to pricing adjustments could negatively impact membership growth and profitability.",
      "llm_answer": "\nFrom 2022 through 2024 Netflix shifted from modest, uniform price increases on its core plans to a more flexible pricing architecture that added an ad‑supported tier, widened the monthly‑fee range (U.S. $2‑$27 in 2022 → $1‑$32 in 2024) and introduced extra‑member surcharges, while also expanding the service with games and live‑programming offerings.  These changes were designed to raise average revenue per member, offset the slowing pace of net‑member additions and the heightened competition for viewers, and mitigate the pressure of rising content‑costs and pandemic‑related production delays.  (Pages 23‑24, 2022 10‑K; 4, 6, 7, 22, 2024 10‑K).",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies Netflix's strategic shift from 2022-2024, including the introduction of ad-supported tiers, extra-member surcharges, and expansion into games/live programming. The answer appropriately addresses pricing strategy evolution and business challenges (slowing member additions, competition, content costs). The multi-hop synthesis across years is sound, and the contextual framing is relevant.\n\nWEAKNESSES - QUANTITATIVE ACCURACY: The LLM provides specific price ranges ($2-$27 in 2022 → $1-$32 in 2024) that cannot be verified against the ground truth, which does not provide these specific price points. This is a significant concern as these appear to be invented or unsourced numbers. The ground truth mentions 11% membership growth and 7% ARPU increase in 2022, plus a 50% drop in paid net additions - none of which appear in the LLM answer. The LLM does not cite the specific 2022 metrics that were central to the ground truth.\n\nWEAKNESSES - COMPLETENESS: The LLM answer omits key quantitative data from the ground truth: (1) the 19% revenue increase in 2022, (2) the 11% growth in average paying memberships, (3) the 7% rise in ARPU, and (4) the 50% drop in paid net membership additions. These metrics are critical to understanding the business challenges that prompted the strategic changes.\n\nWEAKNESSES - ENTITY/METRIC ACCURACY: While the LLM correctly identifies Netflix and the 2022-2024 timeframe, it introduces unverified price range data that may be inaccurate or fabricated. The ground truth does not provide these specific price points, making this a factual liability.\n\nREASONING QUALITY: The causal logic is sound - the LLM correctly connects pricing changes to addressing member acquisition slowdown and competition. However, the reasoning lacks the quantitative foundation provided in the ground truth, which would have strengthened the answer.\n\nVERIFICATION ISSUES: The specific price ranges cited ($2-$27 and $1-$32) cannot be confirmed from the ground truth and appear to be either hallucinated or sourced from unstated documents. This is a critical accuracy concern that prevents a higher score despite otherwise reasonable analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 591,
        "total_tokens": 1987
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How has Boeing's approach to in-orbit incentive payments evolved between 2022 and 2023, particularly in terms of risk exposure and financial recognition?",
      "original_answer": "In 2022, Boeing highlighted the financial risks associated with in-orbit incentive payments, particularly in the context of potential program cancellations or failure to meet performance criteria, which could trigger termination provisions or loss of payments. The company noted that these risks were part of ongoing fixed-price development programs like Commercial Crew, KC-46A Tanker, and VC-25B. By 2023, Boeing had recorded $1,585 million in additional losses on its five most significant fixed-price development programs, which included those mentioned in 2022, and explicitly stated that in-orbit incentive payments were at risk if satellites failed to meet performance criteria over up to 15 years post-acceptance. The company also emphasized that the net present value of these fees was recognized as revenue during the construction period, increasing financial exposure if performance issues arose. This represents a shift from general risk acknowledgment in 2022 to a more specific quantification of losses and a detailed explanation of revenue recognition practices tied to in-orbit performance in 2023.",
      "llm_answer": "\nBetween 2022 and 2023 Boeing’s disclosures on in‑orbit incentive payments became more explicit about **when** the revenue is recorded and **what risks** remain.  In the 2023 filing it states that the **net‑present‑value of the in‑orbit incentive fees is recognized as revenue during the construction period**, and that the payment is **contingent on the satellite meeting performance specifications for up to 15 years**—if it does not, the company may have to **refund the customer and record a charge**.  The 2022 filing merely noted that such payments exist; the 2023 discussion adds a clear statement of revenue timing and underscores the heightened exposure to refunds and earnings volatility as Boeing expands its satellite contracts.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key evolution in Boeing's disclosures between 2022 and 2023 regarding in-orbit incentive payments, particularly the shift toward more explicit discussion of revenue recognition timing (net present value recognized during construction period) and performance-contingent risks (15-year post-acceptance period). The qualitative reasoning about the evolution from general risk acknowledgment to specific quantification is sound and well-articulated.\n\nHowever, there is a significant quantitative omission: The ground truth specifically mentions that Boeing recorded $1,585 million in additional losses on its five most significant fixed-price development programs in 2023. This is a concrete, material financial figure that directly addresses the question about 'financial recognition' and the evolution of risk exposure. The LLM answer fails to include this critical quantitative data point, which represents a substantial gap in completeness.\n\nAdditionally, while the LLM correctly identifies the programs mentioned in 2022 context (Commercial Crew, KC-46A Tanker, VC-25B), it does not explicitly reference these programs or acknowledge that the 2023 losses were recorded on these same programs, missing an important element of the multi-hop synthesis.\n\nThe LLM's characterization of the shift as moving from 'merely noted' in 2022 to 'explicit' in 2023 is accurate and well-supported. The discussion of revenue timing, performance contingencies, and refund/charge risks is factually correct based on the ground truth. The semantic equivalence is strong for the qualitative aspects.\n\nThe answer demonstrates good reasoning about the evolution of disclosure practices but falls short on quantitative completeness by omitting the $1,585 million loss figure, which is a material omission for a financial question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 503,
        "total_tokens": 1968
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How has the disclosure and accessibility of the Directors' Code of Conduct evolved between 2023 and 2024?",
      "original_answer": "In 2023, the Directors' Code of Conduct was explicitly described as being posted on the company's website at a specific URL: https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/invrelations/directors-code-of-conduct.pdf, and the company stated its intention to disclose amendments or waivers on the website. In 2024, while the Code remained accessible, it was referenced more generally as part of a broader list of governance materials available on the company’s website, including committee charters and governance guidelines, without repeating the direct URL. The change indicates a shift from detailed disclosure of access to a more consolidated and implicit reference, suggesting a streamlined but less direct approach to public access in 2024.",
      "llm_answer": "\nThe 2024 filing again posts the Directors’ Code of Conduct on the company’s website (the same PDF link used in 2023) and states that any amendments or waivers will be disclosed there, but it now calls the code out explicitly in the “Available Information” section and notes that it can be accessed via the corporate website and its social‑media channels. Thus, while the core disclosure remains the same, the 2024 filing gives the code a more prominent, easily reachable placement and emphasizes additional digital channels for public access.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. CRITICAL ERRORS: (1) The LLM claims the 2024 filing 'again posts' the same PDF link and 'calls the code out explicitly in the Available Information section,' but the ground truth explicitly states that in 2024 the code was 'referenced more generally as part of a broader list of governance materials...without repeating the direct URL.' This is a direct contradiction. (2) The LLM asserts the 2024 filing gives the code 'more prominent, easily reachable placement,' but the ground truth indicates the opposite—a shift to 'a more consolidated and implicit reference, suggesting a streamlined but less direct approach.' (3) The LLM introduces claims about 'social-media channels' for access that are not mentioned in the ground truth at all. WHAT WAS CORRECT: The LLM correctly identifies that amendments/waivers disclosure remained part of the disclosure framework, and correctly notes the 2023 URL reference. REASONING ASSESSMENT: The multi-hop synthesis is fundamentally flawed. The LLM mischaracterizes the evolution as increased prominence and accessibility when the ground truth describes decreased directness and specificity. The LLM appears to have inverted the actual trend. QUANTITATIVE ACCURACY: No specific numbers or dates are involved, so this scores higher, but the factual claims about what appears where are incorrect. The answer fails to capture the core finding that disclosure became less direct and more consolidated between 2023 and 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 424,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How has the role and deployment strategy of Mobileye Drive™ evolved between 2022 and 2023?",
      "original_answer": "In 2022, Mobileye launched the SAE L4 Self-Driving System (SDS), Mobileye Drive™, and secured multiple collaborations for commercial use, including with Udelv for autonomous cargo delivery and with Transdev for self-driving mobility services. Additionally, Mobileye achieved its first consumer L4 design win with Geely. By 2023, Mobileye’s strategy had evolved to focus on supplying the Mobileye Drive™ self-driving system to transportation network companies, public transit operators, and suppliers of AV-ready vehicle platforms, with plans to bundle it with Moovit’s urban mobility and transit intelligence application. This shift indicates a more defined go-to-market strategy targeting fleet deployment and mobility-as-a-Service (MaaS) ecosystems.",
      "llm_answer": "\nBetween 2022 and 2023 Mobileye Drive™ shifted from being a proprietary stack used only in Intel‑Mobileye’s own Robotaxi pilots (e.g., the Germany‑based SIXT service launched in 2022) to a commercial‑grade L4 platform that the company intends to sell to third‑party mobility providers.  In 2023 the deployment strategy was reframed around supplying Mobileye Drive™ to transportation‑network companies, public‑transit operators and AV‑ready vehicle manufacturers as part of a MaaS‑focused go‑to‑market model, rather than limiting it to internal Robotaxi or consumer‑grade “Chauffeur” projects.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures some correct elements but introduces unverified claims and misses key ground truth details. CORRECT ELEMENTS: (1) The shift from internal/proprietary use to commercial third-party deployment is accurate; (2) The 2023 focus on transportation network companies, public transit operators, and AV-ready vehicle platforms matches ground truth; (3) The MaaS-focused go-to-market model is correctly identified; (4) The general evolution narrative is sound. PROBLEMATIC ELEMENTS: (1) The LLM introduces specific claims about 'Germany-based SIXT service launched in 2022' and 'Robotaxi pilots' that are NOT mentioned in the ground truth and cannot be verified from the provided knowledge graph - this is a factual addition not supported by source material; (2) The LLM mentions 'Chauffeur' projects as a contrast point, which is not in the ground truth; (3) The LLM characterizes 2022 as 'proprietary stack used only in Intel-Mobileye's own Robotaxi pilots' but the ground truth explicitly mentions multiple external collaborations in 2022 (Udelv, Transdev, Geely design win) - this misrepresents the 2022 strategy; (4) MISSING KEY DETAILS: The ground truth mentions specific 2022 partnerships (Udelv for autonomous cargo delivery, Transdev for self-driving mobility services, Geely consumer L4 design win) that the LLM completely omits; (5) The ground truth mentions bundling with Moovit's urban mobility application in 2023, which the LLM does not include. MULTI-HOP REASONING: The LLM correctly synthesizes the evolution concept but fails to properly integrate all the partnership and collaboration data points that define the 2022 baseline. The reasoning about the shift to third-party deployment is sound, but the characterization of what 2022 actually entailed is inaccurate. QUANTITATIVE ACCURACY: No specific numbers or dates are provided in either answer, so this dimension is neutral (7/10 for not introducing false specifics, though the SIXT claim is unverified). QUALITATIVE ACCURACY: Moderate - the evolution narrative is partially correct but incomplete and contains unsupported claims about internal robotaxi programs.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 576,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How has the structure and distribution rate of the Tower Preferred Interests evolved from 2022 to 2024?",
      "original_answer": "In 2022, the Tower Preferred Interests were divided into two series: the September series (Class A-1) totaling $1,500 with a 5.0% initial preferred distribution, and the December series (Class A-2) totaling $4,500 with a 4.75% initial preferred distribution. These distributions reset every five years. By 2024, the structure was amended in August 2024 to reclassify all 2019 Tower preferred interests into Fixed Rate Class A Limited Membership Interests (Tower Fixed Rate Interests) paying a 5.90% preferred distribution. Additionally, a portion of these fixed-rate interests will transition annually into Floating Rate Class A Limited Membership Interests (Tower Floating Rate Interests), which will pay a distribution equal to SOFR plus 250 basis points. This represents both a structural and rate evolution in the Tower Preferred Interests.",
      "llm_answer": "\nFrom 2022 through the August 2024 amendment (effective Nov 2024), the Tower Preferred Interests shifted from the original two fixed‑rate series—Class A‑1 ($1.5 bn) paying a 5.0% quarterly distribution and Class A‑2 ($4.5 bn) paying 4.75%—to a unified structure in which all of the former interests are now designated **Fixed‑Rate Class A Limited Membership Interests** with a higher 5.90% preferred distribution, while a portion is re‑classified each year into **Floating‑Rate Class A Interests** that pay SOFR + 250 basis points (reset every five years). This amendment changed both the rate levels and the composition of the preferred interests, moving from two separate fixed‑rate series to a combined fixed‑plus‑floating structure with a new reset schedule.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of all key financial metrics and structural changes. Quantitative verification: (1) 2022 structure correctly identified - Class A-1 at $1,500M (or $1.5bn) with 5.0% rate, Class A-2 at $4,500M (or $4.5bn) with 4.75% rate; (2) 2024 amendment correctly dated to August 2024 with November 2024 effective date; (3) Fixed Rate Class A Interests correctly stated at 5.90%; (4) Floating Rate formula correctly identified as SOFR + 250 basis points. The LLM uses '$1.5 bn' and '$4.5 bn' notation which is semantically equivalent to the ground truth's '$1,500' and '$4,500' (both referring to millions). Multi-hop reasoning is sound: the answer correctly synthesizes the evolution from two separate series to a unified structure with both fixed and floating components. The five-year reset schedule is mentioned in both answers. Minor observation: The LLM answer adds clarifying detail about the 'quarterly distribution' frequency for the original series, which is not explicitly contradicted by ground truth but represents an inference. The LLM also slightly reframes the floating-rate transition as 'a portion is re-classified each year' which accurately captures the annual transition mechanism. The answer comprehensively addresses both the structural evolution and rate changes requested in the question. No calculation errors detected. The semantic equivalence is maintained throughout - the answer conveys the same substantive information as the ground truth with appropriate professional terminology.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 433,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did the investment approach and unrealized gains/(losses) for Level 3 assets related to the Balanced Index Fund evolve from 2022 to 2023?",
      "original_answer": "In 2022, the company disclosed unrealized losses for Level 3 assets still held at year-end, including ($16) million for corporate fixed income securities and ($11) million for mortgage-backed and asset-backed fixed income securities. By 2023, these values shifted to unrealized gains of $2 million for corporate fixed income securities and $6 million for mortgage-backed and asset-backed fixed income securities. This indicates a significant turnaround in the performance of these assets. Additionally, while the Balanced Index Fund's composition remained at approximately 60% equities and 40% debt securities in both years, the valuation methodology in 2023 explicitly referenced a market approach based on quoted market prices (Level 1), suggesting a more transparent and standardized valuation process.",
      "llm_answer": "\nThe Balanced Index Fund still follows its 60 %‑equity / 40 %‑debt allocation and is valued using Level 1 market prices; however, the Level 3 securities it contains shifted from an overall unrealized loss of about **$90 million at the end of 2022** to a modest unrealized **gain of roughly $14 million by the end of 2023**—driven by a $2 million gain in corporate fixed‑income securities and a $6 million gain in mortgage‑backed/asset‑backed securities in 2023, compared with $16 million and $11 million of losses, respectively, in 2022.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a major factual error in its opening statement. It claims Level 3 securities shifted from 'an overall unrealized loss of about $90 million at the end of 2022' to 'a modest unrealized gain of roughly $14 million by the end of 2023.' This $90 million figure is NOT supported by the ground truth. According to the original answer, the 2022 unrealized losses were: ($16) million for corporate fixed income + ($11) million for mortgage-backed/asset-backed = ($27) million total, NOT $90 million. The LLM appears to have fabricated or misremembered this aggregate figure. The 2023 gains calculation is correct: $2 million + $6 million = $8 million (though the LLM states 'roughly $14 million,' which is also incorrect). CORRECT ELEMENTS: (1) The 60%/40% equity/debt allocation is accurate for both years; (2) The specific 2023 gains ($2M corporate, $6M mortgage-backed/asset-backed) are correct; (3) The 2022 losses ($16M and $11M) are correctly cited; (4) The reference to Level 1 market pricing methodology is appropriate. MULTI-HOP REASONING: The LLM correctly synthesized the comparison between 2022 and 2023 performance, but the synthesis is undermined by the incorrect aggregate loss figure. The reasoning about the turnaround from losses to gains is sound, but the magnitude is wrong. CALCULATION ERROR: The LLM's claim of a '$90 million' loss in 2022 is a fundamental error that cannot be reconciled with the ground truth data. This represents either a significant calculation mistake or data hallucination. The answer demonstrates partial understanding of the question's components but fails on quantitative accuracy due to the fabricated aggregate figure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 466,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How has BNY Mellon's emphasis on accounting developments in its forward-looking statements evolved between 2023 and 2024, and what does this reveal about the changing influence of accounting standards on its strategic priorities?",
      "original_answer": "In 2023, BNY Mellon included accounting developments among a broader list of potential influences on forward-looking statements, noting they 'may impact our businesses' without specific elaboration. By 2024, the company expanded this language, explicitly stating that accounting developments 'may impact our businesses, regulatory, technology, market, economic or accounting developments and the impacts of such developments on our businesses.' This shift indicates a more integrated view of accounting changes as part of strategic risk and planning considerations. The inclusion of terms like 'capital plans including dividends and repurchases' and 'efficiency savings' in 2024 further suggests that accounting developments are increasingly tied to concrete business decisions and performance metrics.",
      "llm_answer": "\nBetween the 2023 and 2024 Form 10‑K filings, BNY Mellon moved accounting developments from a generic “risk factor” mention in 2023 to a explicitly highlighted element of its forward‑looking statements in 2024, directly tying changes in accounting standards to strategic priorities such as capital allocation, technology investment and the use of non‑GAAP measures. This evolution reveals that evolving accounting standards have become a core driver of the firm’s strategic planning and investor communications, rather than a peripheral concern.",
      "correctness_score": 5,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the years (2023 and 2024) and the company (BNY Mellon). (2) The general direction of change is captured - that accounting developments received more explicit attention in 2024. (3) The LLM appropriately notes the shift from peripheral to more integrated treatment. CRITICAL WEAKNESSES: (1) The LLM's characterization of 2023 as a 'generic risk factor mention' is not supported by the ground truth, which states accounting developments were 'among a broader list of potential influences on forward-looking statements.' This is a mischaracterization of the baseline. (2) The LLM claims accounting developments were 'explicitly highlighted' in 2024 and 'directly tying changes in accounting standards to strategic priorities such as capital allocation, technology investment and the use of non-GAAP measures.' However, the ground truth does not support this specific linkage. The ground truth states the 2024 language expanded to include 'regulatory, technology, market, economic or accounting developments' - but does not explicitly tie accounting to capital allocation or non-GAAP measures in the way the LLM suggests. (3) The LLM introduces concepts ('non-GAAP measures,' 'technology investment') that are not mentioned in the ground truth answer, suggesting over-interpretation or hallucination. (4) The ground truth specifically mentions 'capital plans including dividends and repurchases' and 'efficiency savings' as concrete business decisions tied to accounting developments in 2024, but the LLM generalizes this to 'capital allocation' without the specificity. (5) The LLM's claim that accounting standards became 'a core driver of the firm's strategic planning' is an overstatement not fully supported by the ground truth, which indicates a more 'integrated view' rather than a 'core driver.' MULTI-HOP REASONING: The LLM attempts to synthesize the evolution across years but makes unsupported leaps in interpretation. The reasoning is partially sound but contains factual inaccuracies in what the ground truth actually states.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 558,
        "total_tokens": 1916
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did the evolution of risks related to store safety and cybersecurity in 2023 potentially impact the associate experience, as compared to the engagement-focused initiatives highlighted in 2022?",
      "original_answer": "In 2022, HD emphasized internal initiatives to improve the associate experience through engagement surveys, a digital engagement platform, and recognition programs, which historically showed that four out of five associates were emotionally committed. However, in 2023, the company highlighted external risks such as increased store shrink, particularly from organized retail crime, and cybersecurity threats that could compromise associate data and store safety. These risks were noted to potentially erode trust, impact associate morale and retention, and damage the company's reputation. This shift indicates that while HD was actively fostering associate engagement in 2022, the emergence or escalation of external risks in 2023 introduced new challenges that could undermine those earlier gains in associate experience.",
      "llm_answer": "\nIn 2023 the filing warned that any failure to keep stores safe or to protect against escalating cyber‑threats could erode associate morale, increase turnover and undermine the day‑to‑day work experience, directly affecting the employee‑focused culture. By contrast, the 2022 narrative highlighted engagement‑driven initiatives—surveys, a digital associate platform, recognition programs and expanded compensation—to deepen emotional commitment. Thus, while 2022 built engagement through supportive programs, the 2023 safety and cybersecurity risks introduced new pressures that could diminish that engagement if not successfully managed.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. QUANTITATIVE ACCURACY: No numeric values, percentages, or dollar amounts were required in this question, and the LLM correctly avoided introducing unsupported numbers. The temporal references (2022 vs 2023) are accurate. ENTITY ACCURACY: The company (HD/Home Depot) is correctly identified, and the fiscal years are properly distinguished. COMPLETENESS: The answer addresses all key components of the multi-part question: (1) 2022 engagement initiatives (surveys, digital platform, recognition programs, compensation), (2) 2023 risks (store safety/shrink, cybersecurity threats), and (3) the comparative impact on associate experience. MULTI-HOP REASONING: The synthesis is sound—the model correctly connects 2022 engagement efforts to 2023 risk emergence and explains the causal relationship (risks could undermine earlier gains). The logic that safety/cybersecurity failures could erode morale, increase turnover, and damage the work experience is properly established. SEMANTIC EQUIVALENCE: The LLM's phrasing ('erode associate morale, increase turnover and undermine the day-to-day work experience') closely mirrors the ground truth's language ('erode trust, impact associate morale and retention, damage the company's reputation'). The characterization of 2022 as 'engagement-driven' and 2023 as introducing 'new pressures' accurately captures the shift described in the ground truth. MINOR CONSIDERATIONS: The LLM adds 'expanded compensation' as a 2022 initiative, which is a reasonable inference but not explicitly mentioned in the ground truth summary provided. This is a minor enhancement rather than an error. The answer is well-structured, directly addresses the question, and maintains appropriate focus on the comparative analysis requested.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 500,
        "total_tokens": 1878
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has the role of the 'learning curve' in influencing cost and production estimates evolved between 2022 and 2023, particularly in relation to program profitability and risk management?",
      "original_answer": "In 2022, the 'learning curve' was identified as a risk factor that could negatively impact program profitability due to production complexities, rework, and delays—especially in programs like the 787—potentially leading to additional losses and abnormal production costs. By 2023, the 'learning curve' was no longer framed solely as a risk but was integrated into the company's cost estimation process, factored into production rate assumptions, supplier performance trends, and internal labor efficiency projections. This shift indicates that Boeing began treating the learning curve as a predictable and manageable component of production planning rather than an unpredictable risk.",
      "llm_answer": "\nBetween 2022 and 2023 the learning‑curve assumption shifted from a relatively routine cost‑reduction factor used to set program accounting quantities and margin forecasts to a central risk driver that directly shapes cost and production estimates.  The 2023 disclosures make clear that variations in the learning‑curve estimate can swing program gross‑margin assumptions by roughly $300 million (or about $330 million on a 1 % margin change) and have already generated cumulative catch‑up adjustments and the prospect of future losses on key development programs, underscoring its heightened importance for profitability and risk management.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally contradictory to the ground truth and contains critical factual errors: (1) DIRECTIONAL REVERSAL: The LLM claims the learning curve shifted FROM 'routine cost-reduction factor' TO 'central risk driver,' which is the exact opposite of the ground truth. The ground truth states it shifted FROM a risk factor TO an integrated, predictable component of cost estimation. This is a fundamental misunderstanding of the evolution described. (2) QUANTITATIVE ERRORS: The LLM introduces specific dollar amounts ($300 million, $330 million) and margin change percentages (1%) that do not appear in the ground truth and cannot be verified. These appear to be fabricated numbers without source support. (3) INCOMPLETE SYNTHESIS: The LLM fails to capture the key distinction in the ground truth—that by 2023, Boeing was treating the learning curve as 'predictable and manageable' rather than 'unpredictable.' Instead, the LLM emphasizes heightened risk and volatility. (4) MISSING CONTEXT: The LLM does not mention specific programs like the 787, which was highlighted in the ground truth as a key example. (5) SEMANTIC CONTRADICTION: While the LLM addresses the question's topic, it provides an inverted narrative—suggesting increased risk and uncertainty in 2023 when the ground truth indicates decreased risk through better integration into planning processes. The answer demonstrates a fundamental failure in multi-hop reasoning and factual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 407,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has the treatment or disclosure of the Dividend Reinvestment Plan evolved between the 2023 and 2024 SEC filings, particularly in relation to officer or director participation and associated trading arrangements?",
      "original_answer": "In the 2023 filing, the Dividend Reinvestment Plan was mentioned in the context of officer or director participation alongside the employee stock purchase plan and 401(k) plan, with specific reference to elections to have shares withheld for tax purposes or to pay the exercise price of stock awards. The disclosure also included a detailed description of how these elections may be structured under Rule 10b5-1 or non-Rule 10b5-1 trading arrangements as defined in Item 408(c) of Regulation S-K. In the 2024 filing, the Dividend Reinvestment Plan was again referenced in the context of officer or director participation, but the detailed explanation of Rule 10b5-1 and non-Rule 10b5-1 trading arrangements was omitted, indicating a simplification or standardization of the disclosure without the earlier level of specificity regarding trading frameworks.",
      "llm_answer": "\nThe 2023 filing first disclosed that certain officers and directors participate in the company’s dividend‑reinvestment (and other) plans and that their share‑withholding elections can be structured to satisfy the affirmative‑defense safe harbor of Rule 10b5‑1 or, alternatively, to constitute non‑Rule 10b5‑1 trading arrangements. The 2024 filing repeats essentially the same language verbatim (Item 9(b) of “Other Information”), updating only the reference period (Dec. 31 2024 vs. Dec. 31 2023) and the holder count in Item 5, so no substantive change or new evolution in the treatment or disclosure of the dividend‑reinvestment plan’s officer/director participation and associated trading arrangements is evident.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer directly contradicts the ground truth on the core factual claim. The ground truth explicitly states that there WAS an evolution/change between 2023 and 2024: the 2023 filing included 'detailed explanation of Rule 10b5-1 and non-Rule 10b5-1 trading arrangements' while the 2024 filing 'omitted' this detailed explanation, indicating 'a simplification or standardization of the disclosure without the earlier level of specificity.' The LLM answer claims the opposite - that the 2024 filing 'repeats essentially the same language verbatim' with 'no substantive change or new evolution.' This is a fundamental factual error that goes to the heart of the question. The LLM appears to have either misread the filings or failed to identify the actual differences in disclosure treatment between the two years. The question specifically asks 'How has the treatment or disclosure...evolved' (implying change), and the ground truth confirms this evolution occurred, while the LLM denies it occurred. Additionally, the LLM's claim that only 'the reference period' and 'holder count' changed is contradicted by the ground truth's explicit statement about omitted detailed explanations of trading arrangements. The LLM's reasoning is internally inconsistent with the documented evidence of disclosure evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 367,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has The Home Depot's investment in creating an interconnected shopping experience evolved from fiscal 2021 to fiscal 2023, and what specific changes were made in the way this experience is tailored to customers?",
      "original_answer": "In fiscal 2021, The Home Depot invested $2.6 billion in capital expenditures focused on supporting an interconnected customer experience. By fiscal 2023, the company had advanced this strategy by leveraging enhanced merchandising information technology tools to build an interconnected shopping experience tailored to customers' shopping intent and location. This represents a shift from general investment in interconnectedness to a more refined, data-driven personalization strategy.",
      "llm_answer": "\nFrom fiscal 2021 through fiscal 2023 the retailer shifted from a broad, infrastructure‑focused rollout of omnichannel services (BOPIS, curb‑side pickup, mobile‑app enhancements) to a more data‑driven, personalized experience.  In 2023 the company explicitly said it is using “enhanced merchandising information‑technology tools … to build an interconnected shopping experience that is **tailored to our customers’ shopping intent and location**,” and it invested in store‑level tech such as electronic shelf‑labels, curb‑side lockers, expanded self‑checkout and mobile‑app navigation to make that tailored journey seamless across stores, online and on‑the‑job‑site — changes that go well beyond the foundational investments described in the 2021 filing.  (Pages 5, 7 & 8 of HD_10‑K 2023; page 5 of HD_10‑K 2022).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy with minor considerations. STRENGTHS: (1) Correctly identifies the $2.6 billion capital expenditure figure from fiscal 2021 (implied through context of foundational investments). (2) Accurately captures the shift from broad omnichannel infrastructure (BOPIS, curbside pickup, mobile-app enhancements) to data-driven personalization. (3) Correctly quotes the key phrase about 'enhanced merchandising information-technology tools' and 'tailored to our customers' shopping intent and location' from the 2023 filing. (4) Properly identifies specific 2023 investments (electronic shelf-labels, curbside lockers, expanded self-checkout, mobile-app navigation). (5) Multi-hop reasoning is sound - synthesizes evolution across fiscal years and connects specific tactical changes to strategic shift. (6) Provides proper source citations (HD_10-K 2023, 2022). MINOR CONSIDERATIONS: (1) The LLM answer does not explicitly state the $2.6 billion figure from fiscal 2021, though it references 'foundational investments described in the 2021 filing.' The ground truth explicitly mentions this number. However, the answer does convey the concept of fiscal 2021 investments. (2) The answer goes beyond the ground truth by providing additional specific examples of store-level technology investments, which adds helpful context but wasn't in the original answer. This is supplementary rather than contradictory. QUANTITATIVE ACCURACY: The answer avoids specific dollar amounts but correctly contextualizes the investment evolution. No calculation errors present. QUALITATIVE ACCURACY: The semantic meaning aligns well with ground truth - both convey a shift from general interconnectedness investment to refined, data-driven personalization. The reasoning about how the experience became 'tailored' is accurate. CONTEXTUAL RELEVANCE: Highly relevant, directly addresses both parts of the question (evolution from 2021-2023 and specific changes in tailoring).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 537,
        "total_tokens": 1879
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has the financial relationship between DHR and Aldevron evolved between 2022 and 2023, particularly in terms of capital investment and acquisition-related expenditures?",
      "original_answer": "In 2022, DHR anticipated capital expenditures of approximately $1.5 billion, with a portion of this spending attributed to increased manufacturing capacity for products related to the Aldevron Acquisition, among others. This reflects a growing capital commitment tied to Aldevron. By 2023, the financial relationship had evolved significantly, as evidenced by the net cash consideration paid to Aldevron amounting to $9,561 million, indicating that Aldevron had transitioned from being primarily a capital investment target to a core component of DHR's consolidated assets. This represents a substantial shift in the nature of their relationship from a dependency to a stakeholding and integration model.",
      "llm_answer": "\nBetween 2022 and 2023 Danaher’s financial relationship with Aldevron shifted from the one‑time $9.6 bn cash purchase in August 2021 to a program of ongoing capital investment that grew to roughly **$1.5 bn in 2022** to expand Aldevron’s manufacturing capacity for COVID‑19‑related and broader biopharma demand; the company has since recorded only modest acquisition‑related outlays (e.g., $27 m of transaction costs in 2023 for the Abcam deal), indicating that subsequent spending has been focused on integrating and scaling the acquired business rather than on new purchase‑price expenditures.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and misinterpretations that substantially undermine its accuracy:\n\n1. CRITICAL ERROR - Timeline Confusion: The LLM states the $9.6 billion acquisition occurred in August 2021, then claims the financial relationship 'shifted from' this one-time purchase to ongoing capital investment in 2022-2023. This is backwards. The ground truth shows that in 2022, DHR was making capital expenditures (~$1.5 billion) for manufacturing capacity related to Aldevron, and by 2023, the net cash consideration of $9,561 million was paid. The LLM has the chronology inverted.\n\n2. QUANTITATIVE ACCURACY ISSUES: While the LLM correctly cites $1.5 billion for 2022 capital expenditures and approximately $9.6 billion for the acquisition amount, it misplaces these figures temporally and contextually. The ground truth indicates the $9,561 million was paid in 2023 (or represents the final settlement), not that it was a 2021 transaction being referenced retrospectively.\n\n3. INCOMPLETE SYNTHESIS: The LLM fails to properly synthesize the multi-hop relationship evolution. The ground truth clearly states: 2022 showed capital investment for manufacturing capacity → 2023 showed the net cash consideration payment of $9,561 million, representing a transition from capital investment target to consolidated asset. The LLM conflates these into a confusing narrative about a 2021 purchase followed by 2022 investments.\n\n4. IRRELEVANT INFORMATION: The mention of the Abcam deal and $27 million in transaction costs for 2023 is not part of the ground truth answer about DHR-Aldevron relationship evolution and introduces extraneous information that dilutes focus on the actual question.\n\n5. SEMANTIC MISALIGNMENT: The ground truth emphasizes a 'substantial shift' from dependency to 'stakeholding and integration model,' while the LLM frames it as shifting from a one-time purchase to ongoing integration. The conceptual framing differs significantly.\n\n6. MISSING KEY INSIGHT: The LLM does not capture the ground truth's key finding that by 2023, Aldevron had 'transitioned from being primarily a capital investment target to a core component of DHR's consolidated assets.'\n\nThe answer demonstrates partial understanding of the financial figures but fails in temporal accuracy, proper synthesis of the evolution narrative, and complete capture of the relationship transformation described in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 650,
        "total_tokens": 1981
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How has the structure and total value of Telco LLC's preferred interests evolved from 2022 to 2024, and what changes were made to the distribution rates and reset schedules during this period?",
      "original_answer": "In 2022, Telco LLC had $2,000 in nonconvertible cumulative preferred interests (Telco Class A-1) with an initial preferred distribution rate of 4.25% annually, subject to reset every seven years. By 2024, Telco LLC expanded its preferred interests with the issuance of an additional $5,250 in preferred interests (Telco Class A-2 and A-3) in April 2023, bringing the total cumulative preferred interests to $7,250. The new preferred interests (Class A-2 and A-3) carried a significantly higher initial preferred distribution rate of 6.85% annually, with the first reset scheduled for November 1, 2027, and every seven years thereafter. This represents both a structural expansion in the capital stack and a strategic shift toward higher-yielding preferred instruments.",
      "llm_answer": "\nFrom the 2022 filing (page 105) AT&T had $2 billion of Telco LLC cumulative preferred interests (the original Telco Class A‑1).  After the April 2023 expansion (page 87), an additional $5.25 billion of Class A‑2 and A‑3 interests were issued, so that by the end of 2024 the total preferred‑interest balance had grown to $7.25 billion.  The original Class A‑1 continues to pay a 4.25 % cumulative distribution with a seven‑year reset, while the newly added Class A‑2/A‑3 carry a higher 6.85 % initial distribution and a reset that begins on Nov 1 2027 and thereafter every seven years; no other distribution‑rate or reset‑schedule changes were made during the 2022‑2024 period.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains a fundamental unit error that invalidates all quantitative claims. The ground truth specifies values in THOUSANDS ($2,000 and $5,250 in thousands = $2.0 billion and $5.25 billion total), but the LLM incorrectly states these as BILLIONS ($2 billion and $5.25 billion), which would make the total $7.25 billion instead of the correct $7.25 million. This is a 1,000x magnitude error. Additionally, the LLM introduces AT&T as the entity when the question specifically asks about Telco LLC - while AT&T may be the parent company, the answer conflates the two entities. The LLM also adds unsupported claims ('no other distribution-rate or reset-schedule changes were made during the 2022-2024 period') that go beyond what can be verified from the stated ground truth. The distribution rates (4.25% and 6.85%), reset schedules (7-year cycles, November 1, 2027 first reset for Class A-2/A-3), and the April 2023 issuance date are all correct. However, the massive unit conversion error and entity confusion are fatal flaws that make the answer fundamentally incorrect despite getting some structural details right. The multi-hop reasoning about the expansion and comparison between old and new preferred interests is sound in logic, but the numerical foundation is completely wrong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 367,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How has AIG's use of Expected Loss Ratio Methods evolved between 2022 and 2024, particularly in terms of the types of insurance lines and the rationale for their application?",
      "original_answer": "In 2022, AIG used Expected Loss Ratio Methods primarily for the latest accident year and in combination with other methods like loss development for aviation exposures, due to their high-severity nature. By 2024, AIG expanded the use of Expected Loss Ratio Methods to include U.S. Workers' Compensation, a long-tail line of business, where it was used in combination with loss development and frequency/severity methods. This reflects a broader application of the method across different insurance lines with varying claim characteristics.",
      "llm_answer": "\nBetween 2022 and 2024 AIG moved the expected‑loss‑ratio technique from a narrow focus on short‑tail lines (e.g., U.S. Property and certain program business) to a much broader set of long‑tail and specialty lines—including U.S. Workers’ Compensation, U.S. Excess Casualty, U.S. Financial Lines, and UK/Europe Casualty—driven by the 2017 adverse‑development‑reinsurance (ADC) arrangement and the need to model slower‑emerging, high‑severity risks (see 2024 Form 10‑K pages 151, 146, 152).  The 2022 filing (2022 Form 10‑K page 273) had described the method only for aviation and program‑business reserves, but by 2024 it was applied across those additional lines to capture inflation, deductible‑program complexity, and the longer emergence patterns that the ADC created.  Consequently, the rationale shifted from a simple premium‑to‑loss extrapolation to a more nuanced, experience‑based approach that incorporates risk‑sharing features, emerging severity trends, and the impact of large‑deductible business on reserve development.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and contradictions with the ground truth. Key issues: (1) ENTITY ACCURACY FAILURE: The LLM claims Expected Loss Ratio Methods were used for 'short-tail lines (e.g., U.S. Property and certain program business)' in 2022, but the ground truth explicitly states they were used 'primarily for the latest accident year and in combination with other methods like loss development for aviation exposures' - aviation is a high-severity line, not a short-tail line. The LLM incorrectly characterizes the 2022 baseline. (2) INCOMPLETE/INCORRECT LINE EXPANSION: The LLM lists U.S. Excess Casualty, U.S. Financial Lines, and UK/Europe Casualty as 2024 applications, but the ground truth only mentions U.S. Workers' Compensation as the new line added by 2024. The LLM appears to have fabricated or misattributed additional lines. (3) UNSUPPORTED CLAIMS: The LLM references a '2017 adverse-development-reinsurance (ADC) arrangement' as a driver, but this is not mentioned in the ground truth and appears to be an unsupported inference or hallucination. (4) REASONING DISCONNECT: While the LLM correctly identifies an evolution from narrow to broader application, the specific lines cited and the rationale (ADC arrangement, deductible-program complexity) are not supported by the ground truth. The ground truth's rationale focuses on 'high-severity nature' and 'long-tail' characteristics, not ADC arrangements. (5) PAGE CITATIONS: The LLM provides specific page numbers (151, 146, 152, 273) which cannot be verified against the ground truth and may be fabricated. The ground truth does not provide these citations. The answer demonstrates multi-hop reasoning attempt but fails on factual accuracy regarding which lines were added and why.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 482,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How has Target's approach to its owned brands evolved from 2023 to 2024, particularly in terms of strategic emphasis and product portfolio development?",
      "original_answer": "In 2023, Target emphasized expanding its owned brands portfolio as a core strategic element to drive relevancy and market share growth. By 2024, the company shifted focus to producing a broad range of owned and exclusive brands, listing over 40 distinct brands across various categories, indicating a more concrete execution phase of brand development and diversification.",
      "llm_answer": "\nFrom 2023 to 2024 Target moved beyond simply “strengthening” its owned‑brand portfolio (the 2023 strategy noted this as a core goal) to an aggressive expansion and diversification of that portfolio.  In 2024 the company launched or expanded several new exclusive lines—including the low‑price “dealworthy” essentials, Auden, Cat & Jack, Gigglescape and up&up—and grew 11 of its owned brands to more than $1 billion in annual sales (page 6, 2024 10‑K).  It also leaned heavily on high‑visibility designer and celebrity collaborations (e.g., Diane von Furstenberg, Taylor Swift | Eras Tour Book, Wicked × Stanley) and on exclusive design partnerships to differentiate the assortment across stores and digital channels (pages 3 and 26, 2024 10‑K).  Thus, the strategic emphasis shifted from building a solid owned‑brand base to using a broader, higher‑profile portfolio of exclusive brands as the primary driver of newness, style, value and guest loyalty.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides good qualitative analysis of Target's strategic shift from 2023 to 2024, correctly identifying the evolution from emphasis on expanding the portfolio to aggressive diversification and execution. The answer appropriately captures the shift in strategic focus and mentions concrete examples of brand initiatives. However, there are significant quantitative accuracy issues: (1) The claim that '11 of its owned brands' grew to more than $1 billion in annual sales cannot be verified against the ground truth and appears to be an unsupported specific claim. (2) The specific brand names listed (Auden, Cat & Jack, Gigglescape, up&up) and designer collaborations (Diane von Furstenberg, Taylor Swift Eras Tour Book, Wicked × Stanley) are presented as facts but are not mentioned in the ground truth answer and cannot be verified. (3) The ground truth states 'over 40 distinct brands' in 2024, but the LLM answer does not mention this specific quantifiable metric, which is a key piece of evidence for the portfolio expansion claim. The LLM answer does correctly capture the core strategic evolution (from emphasis to execution/diversification) and the multi-hop reasoning is sound in comparing 2023 vs 2024 approaches. The answer is contextually relevant and well-structured, but the introduction of unverified specific numbers and brand names without corroboration from the ground truth significantly undermines its reliability. The answer would have been stronger by focusing on the verified 'over 40 brands' metric rather than introducing unverified claims about specific brands and the $1 billion threshold.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 446,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "What does IBM's continued listing of the 0.875% Notes due 2030 in 2024 alongside the new 2.900% Notes due 2030 suggest about its debt financing strategy and the market conditions for long-term borrowing?",
      "original_answer": "In 2023, IBM listed the 0.875% Notes due 2030 (trading symbol IBM30A) among its registered securities, indicating its initial issuance of this long-term debt instrument. By 2024, IBM not only maintained the 0.875% Notes due 2030 in its capital structure but also introduced a new 2.900% Notes due 2030 (trading symbol IBM30C). The significant increase in the interest rate—from 0.875% to 2.900%—for the same maturity year suggests that IBM may have pursued additional financing in 2024 under less favorable interest rate conditions, or it may be targeting different investor segments with varied risk-return profiles. This dual listing could also indicate a strategic effort to diversify its debt portfolio and manage refinancing risks by having multiple instruments maturing in the same year but with different coupon rates.",
      "llm_answer": "\nIBM kept its original 0.875 % Notes due 2030 on the 2024 filing but added a brand‑new 2.900 % Notes due 2030 issue.  The dual listing shows that the company is still comfortable carrying its low‑cost legacy tranche, yet it must supplement it with a higher‑coupon, longer‑dated bond—indicating that today’s capital‑market environment makes long‑term borrowing more expensive and selective, so IBM is issuing fresh debt at a higher yield to meet funding needs while preserving the cheaper legacy issue.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with all key numbers correct: 0.875% Notes due 2030 and 2.900% Notes due 2030 are accurately cited with proper percentage formatting. The quantitative comparison (0.875% vs 2.900% increase) is precise and correctly calculated. The multi-hop reasoning is sound—the model correctly synthesizes that IBM maintained the legacy lower-rate debt while issuing new higher-rate debt in 2024, and appropriately interprets this as reflecting changed market conditions for long-term borrowing. The answer captures the core insight about market conditions making long-term borrowing more expensive. However, compared to the ground truth, the LLM answer omits some nuance: (1) it doesn't mention the trading symbols (IBM30A, IBM30C) which provide additional specificity, (2) it doesn't explicitly reference the 2023 initial issuance context, and (3) it doesn't mention the strategic benefit of diversifying the debt portfolio or managing refinancing risks by having multiple instruments with different coupon rates maturing in the same year. The LLM's interpretation that IBM is 'targeting different investor segments' is implied but not explicitly stated. The phrase 'longer‑dated bond' is slightly imprecise since both notes mature in 2030, so they have the same maturity date, not different dates. Overall, the answer is substantially correct in its core thesis about market conditions and debt strategy, with minor omissions of contextual details and one minor imprecision about maturity dates.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 423,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did the composition of AT&T's long-term debt instruments evolve between 2022 and 2024, particularly regarding the 4.000% Global Notes due June 1, 2049 and the addition of new long-term notes?",
      "original_answer": "In 2022, AT&T listed the 4.000% Global Notes due June 1, 2049 (T 49A) among other long-term debt instruments, but did not include the 4.300% Global Notes due November 18, 2034. By 2024, the 4.000% Global Notes due 2049 remained registered under the same symbol (T 49A), and the company added the 4.300% Global Notes due 2034 (T 34C). This indicates that AT&T expanded its long-term debt portfolio by introducing new maturities while maintaining existing long-dated obligations like the 2049 notes.",
      "llm_answer": "\nBetween 2022 and 2024 the mix of AT&T’s long‑term debt shifted mainly by adding newer, higher‑coupon tranches while retaining the existing 4.000 % Global Notes due June 1 2049 (identified in the 2024 filing as “T 49A” on page 2).  The 2024 Form 10‑K shows that, in addition to the 2049 notes, AT&T issued several fresh senior unsecured series—including 4.25 % notes maturing in 2043 and 2044 and higher‑yielding 5.35 % and 5.625 % notes due in 2066‑67—expanding the overall long‑term debt balance and pushing the maturity profile further out.  The company also disclosed in 2024 the planned $2.25 billion issuance of non‑convertible cumulative preferred interests in Telco LLC, representing a new tier of long‑term financing that did not appear in the 2022 filing.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not supported by the ground truth. CRITICAL ISSUES: (1) The ground truth specifically mentions the 4.300% Global Notes due November 18, 2034 (T 34C) as the key new addition in 2024, but the LLM answer completely omits this instrument and instead discusses 4.25% notes due 2043/2044 and 5.35%/5.625% notes due 2066-67, which are not mentioned in the ground truth. (2) The LLM introduces a $2.25 billion preferred interests issuance in Telco LLC that is not part of the ground truth answer and appears to be extraneous information. (3) The LLM correctly identifies the 4.000% Global Notes due June 1, 2049 (T 49A) as present in both years, which matches the ground truth. (4) The core multi-hop reasoning about debt composition evolution is partially sound in concept, but the specific instruments cited are incorrect. The ground truth provides a clear, focused answer about two specific instruments (the 2049 notes retained, the 2034 notes added), while the LLM provides a broader but inaccurate narrative with wrong coupon rates and maturity dates. The LLM appears to have hallucinated or confused debt instruments from the actual filings. The answer demonstrates some understanding of the question's intent but fails on factual accuracy regarding the specific debt instruments that should be the focus of the answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 387,
        "total_tokens": 1715
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did the financial impact of the Heritage AspenTech acquisition evolve between 2023 and 2024, particularly in terms of intangibles amortization and restructuring costs?",
      "original_answer": "In 2023, the intangibles amortization related to the Heritage AspenTech acquisition was $258, while in 2024, this figure decreased to $97. Additionally, restructuring costs were $72 in 2023 and increased to $228 in 2024. This indicates a reduction in the amortization burden but a significant rise in restructuring expenses over the two years.",
      "llm_answer": "\nIn 2023 the Heritage AspenTech acquisition contributed roughly **$258 million** of intangible amortization (part of the $482 million total reported on page 55), and by 2024 the company’s total intangible amortization jumped to **$1.077 billion**—with $560 million of that amount tied to the newer NI acquisition, so the AspenTech‑related amortization continued but became a smaller share of the overall expense (page 55).  At the same time, restructuring costs linked to the acquisition more than tripled, rising from **$72 million in 2023 to $228 million in 2024** (including $43 million of integration‑related stock compensation disclosed on page 56), reflecting deeper integration and cost‑reduction activities after the deal.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) INTANGIBLES AMORTIZATION - The LLM states AspenTech amortization was $258M in 2023 (CORRECT) but then claims it 'continued but became a smaller share' in 2024 without providing the actual 2024 figure. The ground truth clearly states the 2024 figure DECREASED to $97M, not that it remained substantial. The LLM's statement that 'total intangible amortization jumped to $1.077 billion' with '$560 million tied to the newer NI acquisition' is contextually confusing and obscures the key finding: AspenTech amortization specifically DECLINED from $258M to $97M. (2) RESTRUCTURING COSTS - The LLM correctly identifies restructuring costs rising from $72M in 2023 to $228M in 2024, which matches ground truth exactly. However, the mention of '$43 million of integration-related stock compensation' adds detail not in the ground truth answer, which is acceptable as supplementary context. (3) MULTI-HOP SYNTHESIS - The LLM attempts to synthesize information across multiple acquisitions (AspenTech and NI), but this creates confusion about what specifically happened to AspenTech's financial impact. The question asks specifically about Heritage AspenTech evolution, not comparative analysis with other acquisitions. (4) MISSING KEY INSIGHT - The ground truth emphasizes the REDUCTION in amortization burden (from $258M to $97M, a 62% decrease) paired with INCREASED restructuring costs. The LLM fails to clearly state the $97M 2024 figure for AspenTech amortization, which is a material omission. The answer reads as if AspenTech amortization remained significant in 2024, when it actually declined substantially. (5) QUANTITATIVE VERIFICATION: $258M (2023) ✓, $72M (2023) ✓, $228M (2024) ✓, but $97M (2024 AspenTech amortization) is MISSING/NOT STATED.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 483,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How has AIG's use of expected loss ratio methods for workers' compensation evolved between 2022 and 2024, particularly in relation to the segmentation of business types and the impact of large deductible accounts?",
      "original_answer": "In 2022, AIG applied expected loss ratio methods primarily to guaranteed cost business in the most recent accident year, while for excess of deductible business, these methods were given significant weight in the most recent five accident years. The company also noted that the proportion of large deductible business had increased, slowing the reporting pattern of claims. By 2024, AIG continued to use expected loss ratio methods but placed greater emphasis on segmentation by deductible size and claim handling (AIG vs. third-party administrators), and explicitly highlighted the increasing influence of large deductible accounts on slowing claim emergence. Additionally, 2024 disclosures emphasized limitations in claim count data due to aggregation and reinsurance exclusions, which were not as prominently noted in 2022.",
      "llm_answer": "\nBetween 2022 and 2024 AIG deepened its reliance on **expected‑loss‑ratio (ELR) methods** for workers‑compensation, but only within the **excess‑of‑deductible and large‑deductible segments** that now make up a growing share of the book.  The company began **segmenting the portfolio by deductible size, state and industry** and gave ELR estimates (typically weighted toward the most recent five accident years) greater prominence for those excess‑of‑deductible lines, while still using development‑based methods for the guaranteed‑cost portion.  This segmentation—driven in part by the 80 % adverse‑development‑reinsurance (ADC) cover on large‑deductible accounts—slowed claim‑reporting patterns but allowed AIG to lean more heavily on actuarial ELR inputs to set reserves.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) QUANTITATIVE ERROR - The LLM introduces a specific '80% adverse-development-reinsurance (ADC) cover on large-deductible accounts' figure that does NOT appear in the ground truth. This is a fabricated number that significantly undermines credibility. (2) INCOMPLETE SYNTHESIS - The LLM answer focuses heavily on excess-of-deductible and large-deductible segments but FAILS to adequately address the evolution of guaranteed cost business treatment, which was explicitly mentioned in the ground truth as a key distinction in 2022. The ground truth states ELR methods were 'primarily' applied to guaranteed cost in the most recent accident year in 2022, but the LLM largely omits this. (3) MISSING KEY EVOLUTION - The ground truth emphasizes that 2024 disclosures 'explicitly highlighted the increasing influence of large deductible accounts on slowing claim emergence' and noted 'limitations in claim count data due to aggregation and reinsurance exclusions, which were not as prominently noted in 2022.' The LLM mentions slowed claim patterns but does NOT capture the specific evolution regarding data limitations disclosure. (4) PARTIAL ACCURACY - The LLM correctly identifies: (a) deepened reliance on ELR methods, (b) segmentation by deductible size, (c) greater emphasis on excess-of-deductible segments, (d) use of most recent five accident years for weighting, (e) continued use of development-based methods for guaranteed-cost. However, these correct elements are undermined by the fabricated 80% figure and incomplete coverage of the 2022-2024 evolution. (5) REASONING QUALITY - The multi-hop synthesis is partially sound but incomplete; the LLM connects deductible segmentation to claim patterns but fails to fully synthesize the disclosure evolution and data limitation aspects that distinguish 2024 from 2022.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 500,
        "total_tokens": 1917
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How has Target's approach to cybersecurity threat investigation and response evolved from 2023 to 2024, particularly in terms of its Cyber Fusion Center operations and collaboration with external organizations?",
      "original_answer": "In 2023, Target operated its Cyber Fusion Center as part of its threat investigation and response capabilities, and emphasized collaboration with organizations across industries to share threat intelligence and best practices. By 2024, Target not only maintained its Cyber Fusion Center but also introduced a more structured incident response program with a coordinated escalation model to inform management and the Board of Directors during security incidents. Additionally, in 2024, Target expanded its external engagement by incorporating regular training and compliance activities for team members, and by leveraging third-party vendors to assess and test its cybersecurity program. This represents a more comprehensive and mature approach to cybersecurity threat response and collaboration.",
      "llm_answer": "\nTarget’s 2024 cybersecurity framework adds a formal **Cyber Fusion Center** and a **coordinated escalation model** that feeds incident‑response information to senior management and the Board, embedding the function within the enterprise‑risk‑management program and giving it explicit board‑level oversight. Compared with the 2023 filing—where the focus was on annual training, third‑party testing and general risk‑management integration—2024 expands the Fusion Center’s role, details its escalation process, and stresses **collaboration with external industry groups** to share threat intelligence and best practices, thereby broadening and formalizing its threat‑investigation and response capabilities.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy with correct identification of key elements and sound multi-hop reasoning. STRENGTHS: (1) Correctly identifies both 2023 and 2024 cybersecurity approaches; (2) Accurately captures the introduction of the coordinated escalation model in 2024; (3) Properly synthesizes the evolution from general risk management to more structured incident response; (4) Correctly emphasizes board-level oversight and external collaboration; (5) No quantitative errors or date inaccuracies. MINOR WEAKNESSES: (1) The LLM characterizes 2023 as focusing on 'annual training, third-party testing and general risk-management integration,' which slightly misrepresents the ground truth. The ground truth indicates that in 2023, Target already operated the Cyber Fusion Center and emphasized collaboration—these were not new in 2024, but rather maintained and expanded. The LLM's phrasing could imply these elements were absent in 2023; (2) The answer could be more explicit that the Cyber Fusion Center itself existed in 2023 and was maintained in 2024, rather than suggesting it was 'added' in 2024. The ground truth states Target 'not only maintained its Cyber Fusion Center but also introduced' the escalation model, indicating continuity rather than new creation; (3) Minor semantic issue: the LLM says 2024 'expands the Fusion Center's role' when the ground truth emphasizes it was 'maintained' and enhanced with new structures. MULTI-HOP REASONING: The answer correctly synthesizes information across two years and identifies the evolution in approach, properly connecting the Cyber Fusion Center operations with external collaboration and escalation procedures. The reasoning is sound and logically structured. ENTITY ACCURACY: All entities (Target, Cyber Fusion Center, Board of Directors, external organizations) are correctly identified. No date or company name errors. Overall, this is a strong answer with minor characterization issues that don't significantly impact the core correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 546,
        "total_tokens": 1937
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did Eli Lilly's financial relationship with Baqsimi evolve between 2023 and 2024, particularly in terms of revenue recognition and contractual arrangements?",
      "original_answer": "In 2023, Eli Lilly reported $579.0 million in revenue specifically attributed to the sale of the rights for Baqsimi. By 2024, Baqsimi was included within broader collaboration and other revenue disclosures, reflecting its integration into revenue from collaborations and other arrangements, which included the 2023 sales of rights for both the olanzapine portfolio and Baqsimi. This shift indicates a move from direct product revenue to a more complex revenue recognition model under collaborative arrangements, suggesting a strategic evolution in how the company accounts for and manages its financial relationship with Baqsimi.",
      "llm_answer": "\nBetween June 2023 and the end of 2024 Eli Lilly moved from a one‑time divestiture of Baqsimi to an ongoing supply relationship with Amphastar.  In 2023 the company sold the product’s rights, recorded the full $625 million transaction price (the $500 M cash received in 2023 plus the $125 M cash received in 2024) and recognized a $579 M gain, and it entered a supply agreement that obligates Amphastar to purchase Baqsimi that Lilly manufactures; because the manufactured product has no alternative use and Lilly has a right to payment, it now recognizes net product revenue over time as it ships the product.  In addition, Lilly is eligible for up to $450 M of future sales‑based milestones, which have not been included in the transaction price and therefore will be recognized only when the related milestones are achieved.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer provides substantially correct information with strong quantitative accuracy and good multi-hop synthesis. STRENGTHS: (1) Correctly identifies the $579M gain/revenue recognition in 2023 (matches ground truth exactly). (2) Accurately describes the shift from divestiture to ongoing supply relationship with Amphastar. (3) Correctly identifies the $625M total transaction price ($500M in 2023 + $125M in 2024) and explains the revenue recognition mechanics. (4) Properly identifies the $450M future sales-based milestones and their treatment. (5) Demonstrates sound multi-hop reasoning by synthesizing the contractual arrangement, revenue recognition model, and strategic evolution. (6) Correctly explains the shift from one-time divestiture to ongoing supply arrangement. MINOR ISSUES: (1) The ground truth states $579.0M in revenue 'specifically attributed to the sale of the rights for Baqsimi' in 2023, while the LLM describes this as a 'gain' from a $625M transaction. While these are related, the ground truth emphasizes revenue recognition while the LLM emphasizes the gain calculation. This is a subtle distinction but both are technically correct interpretations of the same transaction. (2) The ground truth mentions that 'by 2024, Baqsimi was included within broader collaboration and other revenue disclosures' but the LLM focuses more on the supply agreement mechanics rather than explicitly addressing how it appears in 2024 financial statements. However, the LLM's explanation of the ongoing revenue recognition model effectively captures this evolution. (3) The LLM provides more detailed contractual and accounting mechanics than the ground truth, which is actually more informative but slightly beyond what was explicitly stated in the original answer. QUANTITATIVE VERIFICATION: All numbers are accurate ($579M, $625M, $500M, $125M, $450M). The calculation logic is sound. MULTI-HOP SYNTHESIS: The answer successfully synthesizes information about the transaction structure, revenue recognition changes, and contractual arrangements across the 2023-2024 period.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 562,
        "total_tokens": 1929
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did AT&T's approach to managing its capital structure through preferred interests evolve from 2023 to 2024, particularly regarding the repurchase of Mobility Preferred Interests and the expansion of Tower Holdings and Telco LLC preferred interests?",
      "original_answer": "In 2023, AT&T repurchased the remaining 213 million Mobility Preferred Interests for $5,414, removing $2,650 from 'Accounts payable and accrued liabilities' and $2,670 from 'Other noncurrent liabilities.' This repurchase was primarily funded by the issuance of $5,250 in new Telco LLC preferred interests, which carried a 6.85% annual distribution rate. By 2024, AT&T had shifted focus toward expanding its Tower Holdings preferred interests, where $6,000 in 2019 Tower preferred interests were restructured into fixed and floating rate classes with a 5.90% base rate and SOFR + 250 bps, respectively. Additionally, the total Telco LLC preferred interests increased to $7,250, including the original $2,000 (Telco Class A-1) and the 2023 additions. This reflects a strategic pivot from repurchasing legacy preferred interests to leveraging new preferred structures with more flexible redemption and distribution terms to manage capital and liquidity.",
      "llm_answer": "\nIn 2023 AT&T retired its Mobility preferred equity by repurchasing the remaining 213 million Mobility Preferred Interests for $5.414 bn, funding the buy‑back with the April 2023 expansion of Telco LLC’s cumulative preferred interests; by the end of 2024 there were no Mobility preferred interests left on the balance sheet.  At the same time the company reshaped its Tower Holdings preferred structure in August 2024—resetting the rate to a 5.90 % fixed distribution and creating a floating‑rate tranche (SOFR + 250 bps) that can be called in 2029—while continuing to hold the $7.25 bn of Telco LLC preferred interests that were originally issued in 2020 and expanded in April 2023.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of AT&T's capital structure evolution but contains some notable issues:\n\nSTRENGTHS:\n1. Correctly identifies the 2023 Mobility Preferred Interests repurchase of 213 million shares for $5.414 billion\n2. Accurately captures the shift from Mobility to Telco LLC preferred interests\n3. Correctly states the Tower Holdings restructuring in 2024 with 5.90% fixed rate and SOFR + 250 bps floating rate\n4. Properly identifies the $7.25 billion Telco LLC preferred interests total\n5. Correctly notes the elimination of Mobility preferred interests from the balance sheet\n6. Appropriately characterizes the strategic pivot from repurchasing legacy to leveraging new structures\n\nWEAKNESSES:\n1. CRITICAL ERROR: States Telco LLC preferred interests were \"originally issued in 2020\" when ground truth indicates the original Telco Class A-1 was $2,000 (issued earlier, not specified as 2020 in ground truth)\n2. INCOMPLETE DETAIL: Fails to mention the specific funding mechanism - that the 2023 Mobility repurchase was \"primarily funded by the issuance of $5,250 in new Telco LLC preferred interests\" with 6.85% distribution rate\n3. MISSING CONTEXT: Does not explain the balance sheet impact (removal from 'Accounts payable and accrued liabilities' and 'Other noncurrent liabilities')\n4. INCOMPLETE SYNTHESIS: While mentions April 2023 expansion, doesn't clearly break down the composition of the $7.25 billion ($2,000 original + $5,250 new)\n5. MINOR IMPRECISION: States \"continuing to hold\" the $7.25 bn but doesn't clarify this includes both original and 2023 additions\n\nQUANTITATIVE VERIFICATION:\n- $5.414 billion repurchase: CORRECT\n- 213 million shares: CORRECT\n- $7.25 billion Telco LLC: CORRECT (though composition not fully explained)\n- 5.90% fixed rate: CORRECT\n- SOFR + 250 bps: CORRECT\n- 2029 call date: CORRECT\n\nMULTI-HOP REASONING:\nThe answer successfully synthesizes information across 2023-2024 and connects the Mobility repurchase to Telco LLC expansion and Tower Holdings restructuring. However, it misses the causal link that the Mobility repurchase was specifically funded by the Telco LLC issuance, and doesn't fully explain the composition of the final $7.25 billion figure.\n\nOVERALL: The answer captures the main narrative and most key facts correctly but omits important details about funding mechanisms, distribution rates, and the specific composition of preferred interests. The error about 2020 issuance date is a factual inaccuracy that slightly undermines credibility, though the core numbers are correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 689,
        "total_tokens": 2123
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did Emerson's relationship with AspenTech evolve from 2023 to 2024, and what financial impacts did this transformation have on Emerson's gross margin and ownership structure?",
      "original_answer": "In 2023, Emerson had a business relationship with AspenTech as part of its Software and Control offerings. By 2024, this relationship transformed into a more significant strategic position, as Emerson acquired a 55% ownership stake in 'New AspenTech' (formerly Heritage AspenTech) following a transaction that included approximately $6.0 billion in cash. This change in relationship had a measurable financial impact: the AspenTech acquisition contributed to a 3.3 percentage point increase in gross margin in 2023 and was part of broader changes that led to a 1.8 percentage point increase in gross margin in 2024. Additionally, the ownership stake marked a structural shift in Emerson’s involvement with AspenTech, moving from a partner to a majority shareholder.",
      "llm_answer": "\nFrom 2023 to 2024 Emerson’s stake in AspenTech moved from roughly 55 % (a minority holding after the 2022 “New AspenTech” transaction) to a publicly announced proposal to buy the remaining shares at $240 per share—valuing the company at about $15 bn and putting Emerson on track to own 100 % of AspenTech.  The acquisition helped lift Emerson’s overall gross margin to 50.8 % in 2024 (up 1.8 percentage points), although the benefit was partially offset by about $231 million of inventory‑step‑up amortization that shaved roughly 1.3 percentage points off the margin.  At the same time, the transaction increased Emerson’s ownership share from ~55 % to about 57 % (and set the stage for full ownership), reshaping its equity structure and giving it complete control of the industrial‑software business.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth:\n\n1. CRITICAL OWNERSHIP STRUCTURE ERROR: The LLM states Emerson's stake moved from \"roughly 55%\" in 2023 to \"about 57%\" in 2024. This is fundamentally incorrect. The ground truth clearly states that in 2023, Emerson had a business relationship with AspenTech (not a 55% stake), and by 2024, Emerson acquired a 55% ownership stake. The LLM has reversed the timeline and misrepresented the ownership percentages.\n\n2. TRANSACTION TIMING ERROR: The LLM references a \"2022 'New AspenTech' transaction\" as the basis for the 55% stake, but the ground truth indicates the 55% acquisition occurred in 2024, not 2022. This is a major chronological error.\n\n3. ACQUISITION AMOUNT DISCREPANCY: The ground truth specifies \"approximately $6.0 billion in cash\" for the acquisition, but the LLM mentions a \"$240 per share\" proposal valuing the company at \"about $15 bn.\" These numbers don't align with the ground truth figure of $6.0 billion.\n\n4. GROSS MARGIN ATTRIBUTION ERROR: The LLM correctly states the 1.8 percentage point increase in 2024 gross margin, but incorrectly attributes this primarily to the AspenTech acquisition. The ground truth indicates the AspenTech acquisition contributed to a 3.3 percentage point increase in 2023 (not 2024), and the 1.8 percentage point increase in 2024 was part of broader changes.\n\n5. INVENTORY STEP-UP DETAIL: The LLM introduces specific details about \"$231 million of inventory-step-up amortization\" and \"1.3 percentage points\" impact that are not mentioned in the ground truth. While this may be accurate supplementary information, it wasn't part of the original answer.\n\n6. RELATIONSHIP EVOLUTION MISCHARACTERIZATION: The ground truth describes a transformation from a business relationship/partner to a majority shareholder. The LLM incorrectly frames this as a progression from 55% to 57% to 100%, which doesn't match the ground truth narrative.\n\nThe answer demonstrates partial understanding of the AspenTech transaction but fundamentally misrepresents the timeline, ownership structure evolution, and financial impacts. The multi-hop reasoning is flawed due to incorrect synthesis of the 2023-2024 timeline.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 603,
        "total_tokens": 2003
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How has AIG's Japan pension plans' contribution to non-U.S. pension obligations evolved between 2022 and 2024, and what change occurred in the weighted average discount rate applied to these plans during this period?",
      "original_answer": "In 2022, AIG's Japan pension plans accounted for 61% of total non-U.S. pension assets, with an expected long-term rate of return of 1.85%. By 2024, the Japan pension plans' share of non-U.S. projected benefit obligations decreased to 50% as of December 31, 2024, from 54% in 2023, and the weighted average discount rate increased to 1.81% in 2024 from 1.48% in 2023. This indicates a relative decline in the size of the Japan pension plans within AIG's non-U.S. pension structure, accompanied by a notable increase in the discount rate applied, likely reflecting changes in market conditions or investment strategy.",
      "llm_answer": "\nBetween 2022 and 2024 the Japan‑specific pension plans have consistently made up about one‑half of AIG’s non‑U.S. pension obligations – roughly 54 % of the total in 2023 and 50 % in 2024, indicating only a modest decline in their relative share.  At the same time, the weighted‑average discount rate applied to these plans rose from about 1.09 % in 2022 to 1.48 % in 2023 and then to 1.81 % in 2024, an increase of roughly 0.72 percentage points over the two‑year period.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer addresses the core question about Japan pension plans' evolution and discount rate changes, but contains a significant quantitative error that undermines accuracy. CORRECT ELEMENTS: (1) The percentages for 2023 (54%) and 2024 (50%) are accurate; (2) The discount rates for 2023 (1.48%) and 2024 (1.81%) are correct; (3) The overall trend analysis is sound - showing relative decline in Japan plans' share and increase in discount rates; (4) The calculation of the 0.72 percentage point increase (1.81% - 1.09% = 0.72%) is mathematically correct. CRITICAL ERROR: The LLM states the discount rate was 1.09% in 2022, but the ground truth indicates the relevant 2022 metric was an 'expected long-term rate of return of 1.85%' - not a discount rate of 1.09%. The ground truth does not explicitly provide a 2022 discount rate figure for comparison. The LLM appears to have either fabricated or misinterpreted the 2022 discount rate figure. MULTI-HOP REASONING: The answer correctly synthesizes information across three years (2022-2024) and properly connects the two main elements of the question (contribution/share evolution and discount rate changes). The reasoning about market conditions is appropriate inference. COMPLETENESS: The answer addresses both parts of the multi-part question - the evolution of Japan plans' contribution to non-U.S. obligations AND the change in weighted average discount rate. However, the 2022 discount rate comparison is problematic since the ground truth doesn't clearly establish this baseline for discount rates (only for expected return rates). The answer would be stronger if it acknowledged this data limitation rather than stating a specific 2022 discount rate figure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 469,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did Amazon's disclosure about the impact of competitive stores on its business evolve between the 2022 and 2023 10-K filings, particularly in terms of the framing of external market conditions?",
      "original_answer": "In the 2022 10-K filing, Amazon described competitive stores as a general factor among many that could impact sales and operating results, listing them alongside internal capabilities such as inventory management and customer satisfaction. The 2022 filing included the phrase: 'the introduction of competitive stores, websites, products, services, price decreases, or improvements' as a potential cause of sales fluctuations. In contrast, the 2023 filing retained the same core language but embedded it within a broader context that emphasized external economic and geopolitical conditions, stating that revenue and operating profit growth 'depends on the continued growth of demand for the products and services offered by us or our sellers, and our business is affected by, among other things, general economic, business, and geopolitical conditions worldwide.' This indicates a shift toward framing competitive pressures as part of a larger set of external risks rather than a standalone concern.",
      "llm_answer": "\nIn the 2022 filing Amazon described competition mainly as a threat from a handful of large, established retailers and technology firms that could out‑spend it on price, selection and fulfillment and that could leverage scale, supplier relationships and brand power to pressure the business. By the 2023 filing the language shifted to stress that the Internet’s comparison‑shopping environment lowers entry barriers, allowing new, smaller or niche players—and well‑funded newcomers—to compete with Amazon, and that rapid changes in business models make the competitive landscape increasingly dynamic and unpredictable. Thus, the framing moved from focusing on the power of incumbent rivals to emphasizing a more fluid, open market where external conditions continuously enable new entrants.",
      "correctness_score": 2,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and does not match the ground truth. CRITICAL ERRORS: (1) The LLM describes a completely different evolution of Amazon's competitive disclosure language than what the ground truth documents. The ground truth states that both 2022 and 2023 filings used similar language about 'competitive stores, websites, products, services, price decreases, or improvements' and that the shift was about embedding this within broader external economic/geopolitical context. The LLM instead claims the 2022 filing focused on 'large, established retailers and technology firms' and the 2023 filing shifted to emphasize 'new, smaller or niche players' and 'entry barriers'—this is entirely fabricated and not supported by the ground truth. (2) The LLM's characterization of the evolution is inverted: it suggests movement from incumbent focus to new entrant focus, whereas the ground truth indicates the core competitive language remained consistent while the contextual framing shifted to emphasize external economic conditions. (3) The LLM introduces specific concepts ('comparison-shopping environment,' 'entry barriers,' 'well-funded newcomers') that do not appear in the ground truth answer and appear to be hallucinated details. (4) The LLM fails to capture the actual key insight: that Amazon's disclosure evolved by placing competitive pressures within a broader framework of 'general economic, business, and geopolitical conditions worldwide' rather than treating competition as a standalone concern. The answer demonstrates poor multi-hop reasoning and factual accuracy regarding the actual content of the SEC filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 452,
        "total_tokens": 1912
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How has Target's exposure to port security risks evolved between 2023 and 2024, particularly in terms of geographic focus and operational impact?",
      "original_answer": "In 2023, Target specifically highlighted California ports as a key area affected by port security issues, mentioning that these ports were where the company received a significant portion of its imported merchandise. By 2024, Target broadened its focus, referring to 'major U.S. ports' without specifically naming California, indicating a more generalized concern across multiple locations. Additionally, in 2023, the company noted it had made alternative arrangements due to past disruptions, while in 2024, the emphasis shifted to potential future impacts, including increased costs and inventory supply issues, due to ongoing global conflicts and labor disputes.",
      "llm_answer": "\nBetween 2023 and 2024 Target’s discussion of port‑security risk moved from a specific focus on “California ports” (2023) to a broader warning about “major U.S. ports” where it receives a large share of imported merchandise (2024).  In both filings the risk is presented as a supply‑chain interruption that can raise costs, cause inventory shortages or out‑of‑stocks, and ultimately damage sales and reputation, but the 2024 filing expands the geographic scope and emphasizes that any recurrence could further increase costs and strain Target’s operations.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key evolution in Target's port security risk disclosure between 2023 and 2024: the shift from specific focus on California ports to broader mention of major U.S. ports. The dates (2023 vs 2024) are accurate, and the company name (Target) is correct. The answer accurately captures the geographic broadening of concern. However, there are some notable omissions and minor inaccuracies: (1) The LLM states the 2024 filing mentions 'major U.S. ports where it receives a large share of imported merchandise' - while the geographic broadening is correct, the original answer specifies that in 2023 Target noted it had 'made alternative arrangements due to past disruptions,' whereas in 2024 the emphasis shifted to 'potential future impacts.' The LLM answer mentions both years present the risk as supply-chain interruption but doesn't clearly distinguish the temporal shift from past/remedial actions (2023) to future/preventive concerns (2024). (2) The LLM adds contextual details about 'global conflicts and labor disputes' that are mentioned in the original answer but not explicitly emphasized in the LLM response. (3) The multi-hop reasoning is sound - the answer correctly synthesizes information about how Target's disclosure evolved across two years and two filings. The core factual claims are accurate, but the answer could have been more precise in distinguishing the shift from past disruptions/alternative arrangements to future impact concerns. The answer is semantically equivalent to the ground truth on the main point (geographic broadening) but slightly underemphasizes the temporal shift in risk framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 453,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did Emerson's financial relationship with Heritage AspenTech evolve between 2023 and 2024, particularly in terms of acquisition-related amortization and restructuring costs?",
      "original_answer": "In 2023, Emerson reported $258 million in intangibles amortization related to the Heritage AspenTech acquisition. By 2024, this specific amortization was no longer reported, indicating that the focus had shifted away from AspenTech as a newly acquired entity. Additionally, restructuring costs increased significantly from $72 million in 2023 to $228 million in 2024, suggesting that Emerson undertook more extensive restructuring activities in 2024, potentially reflecting integration efforts or strategic realignments following the AspenTech acquisition.",
      "llm_answer": "\nBetween 2023 and 2024 the amortization of the intangibles acquired in the Heritage AspenTech deal fell out of the spotlight—2023’s $258 million amortization (page 55) was now embedded in the $1.08 billion of total intangible amortization for 2024, of which $560 million related to the newer NI acquisition (page 55).  At the same time, restructuring outlays linked to the AspenTech integration more than tripled, rising from $72 million in 2023 to $228 million in 2024 (page 55), driven by additional workforce cuts, facility exits and $43 million of integration‑related stock compensation attributed to NI (page 56).  In short, Emerson moved from ongoing amortization of the Heritage AspenTech purchase to a larger, one‑time restructuring expense to consolidate the combined business.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core facts from the ground truth: (1) $258 million in Heritage AspenTech intangibles amortization in 2023, (2) restructuring costs rising from $72 million in 2023 to $228 million in 2024, and (3) the shift in focus from amortization to restructuring. However, there are significant issues with the quantitative accuracy and multi-hop synthesis: (1) The LLM introduces new information about a $1.08 billion total intangible amortization figure for 2024 and $560 million related to NI acquisition that is NOT in the ground truth answer. This represents an attempt to provide additional context but introduces unverified numbers. (2) The claim that the $258 million 'was now embedded in the $1.08 billion' is a calculation/synthesis that cannot be verified against the ground truth, which explicitly states the Heritage AspenTech amortization 'was no longer reported' in 2024. (3) The mention of '$43 million of integration-related stock compensation attributed to NI' is additional detail not in the ground truth. (4) The statement about 'additional workforce cuts, facility exits' adds qualitative detail not in the original answer. The core narrative is sound—the shift from amortization to restructuring is correctly identified—but the LLM has added substantial new quantitative claims (the $1.08B and $560M figures) that go beyond the ground truth and may be inaccurate. The qualitative reasoning about the business integration strategy is reasonable but the quantitative additions create uncertainty about factual accuracy. The answer demonstrates good understanding of the multi-hop relationship between the two years and companies, but the introduction of unverified numbers significantly undermines confidence in the response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 482,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How has AIG's use of Expected Loss Ratio methods evolved between 2022 and 2024, particularly in terms of the weight given to this method across different lines of business and accident years?",
      "original_answer": "In 2022, AIG applied Expected Loss Ratio methods primarily for more recent accident years in lines such as D&O, E&O, EPLI, and professional liability, where losses are low frequency and high severity. The method was also used in conjunction with IBNR factor methods for low frequency/high severity losses, with factors continually reevaluated based on emerging claim experience and market factors. By 2024, AIG continued to use Expected Loss Ratio methods but expanded their application to include U.S. Workers' Compensation, a long-tail line of business, where they were used in combination with loss development and frequency/severity methods. This reflects a broader application of the method across different risk profiles and a more integrated approach to reserving in complex portfolios.",
      "llm_answer": "\nBetween 2022 and 2024 AIG moved from a general “use the Expected‑Loss‑Ratio method in recent accident years” approach to a more‑specific weighting scheme.  In 2024 the company said the method is given **significant weight only in the most recent accident year for guaranteed‑cost workers‑compensation**, while for **excess‑of‑deductible and other long‑tail lines it may be weighted over the five most recent years**, and for **specialty liability lines (D&O, E&O, EPLI, etc.) it is consistently emphasized in the most recent years**.  This reflects a shift toward line‑specific, accident‑year windows for the weight placed on the Expected‑Loss‑Ratio method.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and introduces specific claims not supported by the ground truth. Key issues: (1) The LLM claims specific weighting schemes ('significant weight only in the most recent accident year for guaranteed-cost workers' compensation' and 'weighted over the five most recent years' for excess-of-deductible lines) that are not mentioned in the ground truth. These appear to be fabricated details. (2) The ground truth indicates that in 2022, Expected Loss Ratio methods were used for D&O, E&O, EPLI, and professional liability (low frequency/high severity lines), NOT workers' compensation. By 2024, the method was EXPANDED to include U.S. Workers' Compensation - the LLM reverses this relationship by emphasizing workers' compensation in 2024 with specific accident-year windows. (3) The LLM's characterization of the evolution as moving toward 'line-specific, accident-year windows' is not supported by the ground truth, which describes the evolution as expanding application across different risk profiles and integrating the method into complex portfolios. (4) The ground truth mentions that in 2022, Expected Loss Ratio methods were used 'in conjunction with IBNR factor methods' and that 'factors continually reevaluated based on emerging claim experience and market factors' - the LLM omits this important context. (5) The LLM introduces quantitative specificity ('five most recent years') that does not appear in the ground truth. The answer demonstrates poor multi-hop synthesis and appears to contain hallucinated details rather than accurately reflecting the documented evolution of AIG's reserving methodology.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 456,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How has the monetization strategy for Amazon's film groups evolved between 2022 and 2023, based on changes in capitalized video and music content costs and associated expenses?",
      "original_answer": "Amazon's monetization strategy for film groups evolved between 2022 and 2023, as evidenced by an increase in both the capitalized video and music content costs and the associated expenses. In 2022, the capitalized costs were $16.7 billion with total video and music expenses of $16.6 billion, while in 2023, these figures increased to $17.4 billion and $18.9 billion, respectively. This indicates a more aggressive investment in content and a corresponding rise in monetization efforts.",
      "llm_answer": "\nAmazon boosted the amount of video‑and‑music content it has capitalized — from **$16.7 billion at the end of 2022 to $17.4 billion at the end of 2023** — and the related expense jumped from **$16.6 billion in 2022 to $18.9 billion in 2023**.  This reflects a more aggressive monetization of its film‑group assets: higher content spend, a shorter weighted‑average remaining life for the capitalized library (down to ~2.6 years), and faster amortization to “Cost of sales,” indicating that Amazon is investing more heavily in original and licensed titles and seeking to recover those costs more quickly through Prime streaming and related revenue streams.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and goes beyond the ground truth in several ways. QUANTITATIVE VERIFICATION: All four key financial figures are correct: capitalized costs $16.7B (2022) → $17.4B (2023), and expenses $16.6B (2022) → $18.9B (2023). The year-over-year increases are accurately represented. COMPLETENESS: The answer addresses the core question about monetization strategy evolution and provides the required multi-hop synthesis across 2022-2023 data. ENTITY ACCURACY: Amazon is correctly identified, fiscal years are accurate, and financial metrics (capitalized video and music content costs, associated expenses) are properly labeled. REASONING QUALITY: The LLM demonstrates superior multi-hop reasoning by not only presenting the numbers but also interpreting what they signify about Amazon's strategy. The answer correctly identifies this as evidence of 'more aggressive investment in content' and 'more aggressive monetization.' ADDED VALUE: The LLM answer includes additional relevant context from the filings (weighted-average remaining life of ~2.6 years, faster amortization to 'Cost of sales,' connection to Prime streaming revenue) that enriches understanding without contradicting the ground truth. This additional detail demonstrates deeper synthesis of the underlying data. SEMANTIC EQUIVALENCE: The phrasing 'boosted the amount' and 'jumped' effectively conveys the same meaning as 'increase' in the ground truth. The conclusion about 'more aggressive investment' and 'faster cost recovery' aligns perfectly with the ground truth's characterization. MINOR CONSIDERATION: The LLM provides interpretive analysis beyond what was explicitly in the ground truth answer, but this is additive rather than contradictory and demonstrates sound financial reasoning. No factual errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 495,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How has Philip Morris International's financial relationship with RBH evolved between 2022 and 2024, particularly in terms of its stake and associated impairment?",
      "original_answer": "In 2022, Philip Morris maintained a trademark relationship with RBH, continuing to report volume of brands sold by RBH such as HEETS and other heated tobacco units. By 2024, PMI held an equity investment in RBH, which became subject to a significant impairment charge of $2,316 million due to unresolved allocation of a $32.5 billion Canadian tobacco litigation settlement among RBH, ITL, and JTIM. This reflects a shift from a trademark and brand licensing relationship to a more direct equity investment facing financial impairment.",
      "llm_answer": "\nBetween 2022 and the end of 2024 Philip Morris International’s equity stake in RBH (Rothmans, Benson & Hedges) remained in place, but the investment’s carrying value came under intense pressure from the Canadian CCAA restructuring and the still‑unresolved CAD 32.5 bn settlement allocation among RBH, Imperial Tobacco Canada and JTI Macdonald.  Consequently, PMI performed a valuation in 2024 and recorded a $2.3 bn non‑cash impairment charge (reflected in the 2024 earnings), reducing the book value of its RBH investment.  (Pages 37 [2022] and 30 [2024] of the filings).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key financial metrics and entities. STRENGTHS: (1) Correctly identifies the impairment charge as $2.3 billion (matching the ground truth's $2,316 million when rounded), (2) Accurately states the Canadian settlement amount as CAD 32.5 billion, (3) Correctly names the three parties involved in the settlement allocation dispute (RBH, Imperial Tobacco Canada/ITL, and JTI Macdonald/JTIM), (4) Properly identifies the shift in PMI's relationship with RBH and the 2024 impairment charge, (5) Provides appropriate context about the CCAA restructuring and valuation process. MINOR WEAKNESSES: (1) The answer states PMI's equity stake 'remained in place' between 2022-2024, but the ground truth indicates a shift FROM a trademark/brand licensing relationship TO an equity investment - the LLM doesn't clearly articulate this evolution in the relationship structure, (2) The answer could have been more explicit about the 2022 baseline (trademark relationship with volume reporting) versus the 2024 position (direct equity investment with impairment). QUANTITATIVE VERIFICATION: The $2.3 billion figure is accurate (ground truth states $2,316 million, which rounds to $2.3 billion - acceptable format variation). The CAD 32.5 billion settlement amount is correct. MULTI-HOP REASONING: The answer successfully synthesizes information about PMI's changing relationship with RBH across the 2022-2024 period and connects it to the Canadian litigation settlement impact. The reasoning is sound and logically presented. SEMANTIC EQUIVALENCE: The answer conveys the essential information about the evolution of PMI's financial relationship with RBH, though it could have been slightly more explicit about the nature of the relationship change from trademark licensing to equity investment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 503,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did the sensitivity of LLY's net product revenue to changes in sales return, rebate, and discount liabilities evolve between 2023 and 2024, based on the disclosures in the respective 10-K filings?",
      "original_answer": "In 2023, LLY disclosed that a 5% change in its consolidated sales return, rebate, and discount liability would result in a $615 million change in revenue. In 2024, while the company continued to describe the accounting policy for revenue recognition and accruals for rebates and discounts, it did not provide an updated sensitivity figure. This omission suggests that the company did not disclose a revised estimate for the impact of liability changes on revenue in 2024, indicating a lack of updated quantitative disclosure compared to 2023.",
      "llm_answer": "\nThe 2023 and 2024 10‑Ks both state that a 5 % movement in the consolidated sales‑return, rebate and discount accrual would change net product revenue by roughly **$615 million**.  Although the accrual balance grew from about $8.2 billion (end‑2022) to $10.7 billion (end‑2023), the disclosed dollar impact per percentage‑point change remained the same, indicating that the revenue‑sensitivity to these liability fluctuations did not materially evolve between the two years.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer directly contradicts the ground truth on the core factual claim. Ground truth states: '2024...did not provide an updated sensitivity figure' and 'lack of updated quantitative disclosure compared to 2023.' The LLM claims: 'The 2023 and 2024 10-Ks both state that a 5% movement...would change net product revenue by roughly $615 million' and 'the disclosed dollar impact per percentage-point change remained the same.' This is a fundamental factual error - the LLM asserts that 2024 disclosed the same $615M sensitivity figure, when the ground truth explicitly states no such disclosure was made in 2024. The LLM also introduces unsupported numbers ($8.2B end-2022, $10.7B end-2023 accrual balances) that are not mentioned in the ground truth and cannot be verified. The LLM's conclusion that 'revenue-sensitivity to these liability fluctuations did not materially evolve' is based on the false premise that both years disclosed comparable figures. The question asks how sensitivity 'evolved' between 2023 and 2024, and the correct answer is that it cannot be compared because 2024 lacked the disclosure. The LLM fundamentally misrepresents what was disclosed in the 2024 10-K, making this answer factually incorrect on the primary claim.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 356,
        "total_tokens": 1623
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How has the role and revenue contribution of Bulk shipments evolved from 2022 to 2024, based on Union Pacific's disclosures?",
      "original_answer": "In 2022, Bulk shipments had an average revenue per car of $3,305 in 2021 (referenced in the 2022 filing), showing a 6% increase from 2020. By 2024, Bulk shipments had grown in strategic importance, contributing 32% of total freight revenues, with detailed operations covering grain, fertilizer, and coal markets, including international connections to Mexico and access to Canadian interline routes. This indicates a transformation in the Bulk segment's role from a revenue-per-unit perspective to a more strategically embedded and revenue-significant component of Union Pacific's operations.",
      "llm_answer": "\nIn 2024 Bulk shipments generated about 32 % of Union Pacific’s total freight revenue—up slightly from roughly 30 % in 2022 and 31 % in 2023—while the segment’s dollar revenue rose to approximately $7.3 billion, driven by modest volume gains in grain, fertilizer and food that offset declining coal volumes and kept Bulk as a stable, core contributor to the railroad’s overall freight earnings.  (See 2024 PDF pages 6‑8 for the 32 % share and 2022 PDF page 35 for prior‑year freight‑revenue trends.)",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) QUANTITATIVE ACCURACY PROBLEMS: The LLM provides specific percentages (32% in 2024, 30% in 2022, 31% in 2023) and a dollar amount ($7.3 billion) that are NOT present in the ground truth. The ground truth only confirms 32% in 2024 and does not provide 2022/2023 percentage comparisons or the $7.3B figure. These appear to be fabricated numbers. (2) INCOMPLETE GROUND TRUTH SYNTHESIS: The ground truth mentions 'average revenue per car of $3,305 in 2021' and '6% increase from 2020' from the 2022 filing, which the LLM completely omits. This is a significant omission of historical context. (3) MISSING STRATEGIC CONTEXT: The ground truth emphasizes the transformation from 'revenue-per-unit perspective to a more strategically embedded and revenue-significant component,' including specific operational details (grain, fertilizer, coal, international connections to Mexico, Canadian interline routes). The LLM mentions grain, fertilizer, and food but misses coal's strategic importance and international connections. (4) PARTIAL CREDIT FOR WHAT'S CORRECT: The LLM correctly identifies 32% for 2024 and mentions grain, fertilizer, and coal. The narrative about modest volume gains and declining coal is reasonable but unsupported by the ground truth. (5) CITATION ISSUES: The LLM cites specific PDF pages but the numbers provided (30% in 2022, 31% in 2023, $7.3B) cannot be verified against the ground truth and appear to be hallucinated. The multi-hop reasoning fails because the LLM invents data points rather than synthesizing actual filing information. The answer partially addresses the evolution question but does so with unreliable numbers and incomplete historical context.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 466,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did the interest rate of IBM's Notes due 2028 evolve between 2023 and 2024, and what does this indicate about IBM's debt strategy?",
      "original_answer": "In 2023, IBM had 1.750% Notes due 2028 (IBM 28A) listed, and in 2024, the same 1.750% Notes due 2028 (IBM 28A) were still present in the disclosures. This indicates that the interest rate for this specific issuance remained unchanged over the two years. However, IBM introduced new notes with different interest rates in 2024, such as the 2.900% Notes due 2030 and the 3.150% Notes due 2033, suggesting a broader strategy to issue debt at higher rates for longer maturities.",
      "llm_answer": "\nThe coupon rate on IBM’s 2028 notes was unchanged at 0.300 % (IBM 28B) and 1.750 % (IBM 28A) in both 2023 and 2024. This stability shows IBM is deliberately locking in low, fixed rates on long‑dated debt, underscoring a conservative debt strategy that prioritizes low‑cost financing and a strong balance sheet.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM incorrectly states there was a 0.300% Notes due 2028 (IBM 28B) in both years. The ground truth only mentions IBM 28A at 1.750% for both 2023 and 2024. There is no mention of IBM 28B with 0.300% in the ground truth answer. This is a factual error introducing a non-existent security. (2) INCOMPLETE SYNTHESIS - The LLM failed to address the key strategic insight from the ground truth: IBM introduced NEW notes in 2024 (2.900% Notes due 2030 and 3.150% Notes due 2033) at higher rates for longer maturities. This is crucial context for understanding IBM's debt strategy evolution. The ground truth explicitly states this indicates a 'broader strategy to issue debt at higher rates for longer maturities,' which the LLM completely omitted. (3) REASONING QUALITY - While the LLM correctly identifies that the 1.750% rate remained stable, it mischaracterizes this as evidence of a 'conservative debt strategy' without acknowledging that IBM was simultaneously issuing higher-rate debt for longer terms, which suggests a more nuanced strategy of diversifying maturity profiles and accepting higher rates for extended duration. (4) ENTITY ACCURACY - The introduction of IBM 28B is unexplained and contradicts the ground truth. The LLM should have only referenced IBM 28A. (5) MISSING CONTEXT - The answer fails to complete the multi-hop analysis by not synthesizing the 2024 new issuances as part of IBM's overall debt strategy evolution. The ground truth clearly indicates this is important for understanding the full picture of IBM's debt strategy between 2023-2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1193,
        "completion_tokens": 444,
        "total_tokens": 1638
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did AT&T's capital structure strategy regarding preferred interests evolve from 2023 to 2024, particularly in relation to the Mobility Preferred Interests and the introduction of new preferred instruments?",
      "original_answer": "In 2023, AT&T repurchased all of its Mobility Preferred Interests, which had a redemption value of approximately $5,340 million and paid annual cash distributions of $373 million. This marked a significant shift in strategy, as the company eliminated this class of preferred interests. In 2024, AT&T introduced structural modifications to other preferred instruments, including the restructuring of its Tower Holdings preferred interests to include both fixed and floating rate components, and the expansion of Telco LLC preferred interests to a total of $7,250 million. This evolution indicates a strategic pivot from Mobility-based preferred capital to more diversified and strategically tailored preferred instruments tied to infrastructure and telecommunications assets.",
      "llm_answer": "\nFrom 2023 to 2024 AT&T eliminated its former Mobility Preferred Interests—completing the repurchase of the remaining 213 million shares in April 2023 (see page 55 of the 2023 10‑K).  In 2024 the company introduced a new preferred‑equity structure, amending the 2019 Tower Holdings preferred interests to create Fixed‑Rate and Floating‑Rate Class A membership interests with reset distribution rates and adding $5.25 billion of additional cumulative preferred interests in the Telco LLC vehicle (see page 87 of the 2024 10‑K).  This shift moves AT&T’s capital‑structure strategy from the now‑retired Mobility preferred instrument to a layered, reset‑rate preferred framework that can be managed independently and on more flexible terms.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key strategic shift from Mobility Preferred Interests to diversified preferred instruments and accurately describes the 2024 modifications to Tower Holdings and Telco LLC preferred interests. However, there are significant quantitative discrepancies that lower the overall score. QUANTITATIVE ISSUES: (1) The ground truth states Mobility Preferred Interests had a redemption value of approximately $5,340 million and paid annual cash distributions of $373 million—the LLM answer omits these specific financial metrics entirely. (2) The ground truth indicates Telco LLC preferred interests expanded to a total of $7,250 million, but the LLM states '$5.25 billion of additional cumulative preferred interests' were added. These are different metrics (total vs. additional), and the numbers don't align ($7.25B total ≠ $5.25B additional). This is a critical error in synthesizing the multi-hop financial information. (3) The LLM provides specific details about 213 million shares repurchased in April 2023 and page references, which adds credibility but doesn't compensate for the missing/incorrect financial figures. QUALITATIVE STRENGTHS: The LLM correctly identifies the strategic pivot, accurately describes the structural modifications (fixed/floating rate components), and properly characterizes the evolution as moving from Mobility-based to diversified infrastructure-tied instruments. The reasoning about 'reset-rate preferred framework' and 'flexible terms' is sound. MULTI-HOP SYNTHESIS: The answer successfully synthesizes information across 2023 and 2024 filings and correctly identifies the causal relationship between the elimination of one instrument class and the introduction of others. However, the incomplete financial data and the discrepancy regarding Telco LLC preferred interests amounts represent a failure to fully and accurately synthesize the quantitative multi-hop information. The answer is directionally correct but materially incomplete on key financial metrics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 546,
        "total_tokens": 1940
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How has Amazon's characterization of the competitive threat from websites evolved between 2022 and 2023, and what specific changes in language indicate a shift in the nature of this competition?",
      "original_answer": "In 2022, Amazon described competitive websites as part of a broader list of fluctuating business factors, indicating a general awareness of competitive pressures. By 2023, Amazon's language evolved to reflect a more direct and strategic competitive stance, specifically highlighting the introduction of 'competitive stores, websites, products, services, price decreases, or improvements' as a central concern. This shift indicates a more focused and intensified competitive threat from digital platforms, suggesting an evolution from a general operational risk to a more strategic and dynamic competitive challenge.",
      "llm_answer": "\nBetween 2022 and 2023 Amazon moved from a broad, generic warning that it “faces the introduction of competitive stores, websites, products, services, price decreases, or improvements” (2022 10‑K, page 9) to a detailed articulation of the **principal competitive factors** that now include **selection, price, convenience, speed and reliability of services, and the ability to lock‑in customers** (2023 10‑K, page 4).  The newer language also stresses that many rivals have **greater resources, longer histories, stronger brands, and control over critical inputs**, can pursue **restrictive distribution deals, aggressive pricing, and heavy investment in technology and fulfillment**, and that the internet **lowers entry barriers for new, smaller competitors** (2023 10‑K, page 4).  These changes signal a shift from viewing competition mainly as price‑driven new entrants to seeing it as a multifaceted battle over ecosystem advantages, strategic lock‑in, and the capacity of rivals to out‑invest and out‑maneuver Amazon.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies that Amazon's language evolved between 2022 and 2023, with accurate citations to specific 10-K pages (2022 page 9, 2023 page 4). The answer provides concrete examples of the shift in language, including the specific competitive factors mentioned (selection, price, convenience, speed, reliability, lock-in). The dates and document references are accurate. The answer demonstrates multi-hop synthesis by comparing language across two years and identifying thematic shifts.\n\nWEAKNESSES: The LLM answer diverges significantly from the ground truth in its characterization of the shift. The ground truth emphasizes a move from 'general awareness of competitive pressures' to 'more direct and strategic competitive stance,' focusing on the introduction of competitive elements as a 'central concern.' The LLM answer instead characterizes the shift as moving from 'price-driven new entrants' to 'multifaceted battle over ecosystem advantages,' which is a different analytical framing. The ground truth suggests the 2022 language was more generic/general, while the LLM presents the 2022 language as already specific ('faces the introduction of competitive stores, websites, products, services, price decreases, or improvements'). This suggests the LLM may be conflating or misrepresenting what was actually stated in 2022. The ground truth's core insight about evolution from 'general operational risk to strategic and dynamic competitive challenge' is not clearly captured in the LLM's framing of 'price-driven vs. ecosystem advantages.' The LLM adds substantial detail about rivals' resources, distribution deals, and entry barriers that, while potentially accurate to the 2023 10-K, goes beyond what the ground truth identifies as the key shift in characterization.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes information across two years and identifies language changes, but the interpretation of what those changes represent differs from the ground truth's assessment. The reasoning is logical but appears to emphasize different aspects of the competitive threat evolution than the ground truth identifies.\n\nCITATION ACCURACY: Page references appear plausible but cannot be independently verified. The specific language quoted for 2022 may not accurately represent the actual 2022 10-K language based on the ground truth's description of it as more 'general.'",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 643,
        "total_tokens": 2065
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How has PM's relationship with KT&G evolved from 2022 to 2024, particularly in terms of its strategic reliance on KT&G's heat-not-burn products within PMI's smoke-free product portfolio?",
      "original_answer": "In 2022, PM had a global collaboration agreement with KT&G that allowed PMI to exclusively distribute KT&G's smoke-free products, including heat-not-burn products like LIL Mini and LIL Plus, outside of South Korea. This agreement was initially for three years, indicating a strategic partnership aimed at expanding KT&G's products globally. By 2024, this relationship had evolved such that KT&G's heat-not-burn products were no longer just distributed by PMI but were integrated into PMI's broader smoke-free product portfolio, specifically being listed among PMI's own heat-not-burn offerings. This indicates a deeper strategic reliance on KT&G's product line within PMI's own commercialization efforts, suggesting a shift from a distribution partnership to a more embedded supplier or technology partner role for KT&G.",
      "llm_answer": "\nFrom 2022 through 2024 PMI moved the 2020 global collaboration with KT&G from a pilot‑phase partnership into a core, multi‑regional distribution model, making KT&G’s heat‑not‑burn devices and consumables (e.g., LIL, Fiit, Miix) a central pillar of PMI’s smoke‑free portfolio.  This is reflected in the rapid rise of PMI’s smoke‑free net revenues—from about $10 bn in 2022 to $14.7 bn in 2024—with a growing share of that growth driven by licensed KT&G heat‑not‑burn products sold across Europe, the Americas and other markets, underscoring PMI’s strategic reliance on KT&G’s HNB offerings to replace declining cigarette volumes.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) QUANTITATIVE ERRORS - The LLM introduces specific revenue figures ($10bn in 2022, $14.7bn in 2024) that are NOT present in the ground truth and cannot be verified. These appear to be fabricated numbers. The ground truth makes no mention of specific revenue figures for smoke-free products. (2) PRODUCT NAME ERRORS - The LLM lists 'Fiit' and 'Miix' as KT&G heat-not-burn products, but the ground truth only mentions 'LIL Mini' and 'LIL Plus'. The introduction of unverified product names is problematic. (3) TIMELINE CONFUSION - The LLM references a '2020 global collaboration' but the ground truth indicates the agreement was in place in 2022 (described as 'initially for three years'). This creates confusion about when the partnership began. (4) PARTIAL CORRECTNESS - The LLM correctly identifies: the evolution from distribution to deeper integration, the multi-regional expansion, the strategic reliance on KT&G's HNB products, and the role in offsetting declining cigarette volumes. (5) MISSING KEY DETAIL - The ground truth emphasizes the shift from 'distribution partnership to a more embedded supplier or technology partner role,' which the LLM captures conceptually but doesn't articulate as clearly. (6) SYNTHESIS QUALITY - The multi-hop reasoning about portfolio integration is sound, but the fabricated financial data undermines credibility. The answer reads plausibly but contains unverifiable claims that violate the requirement for factual accuracy in financial statements.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 418,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did IBM's use of the PWCC Plan for funding employee awards evolve between 2022 and 2024, particularly in terms of its administration and scope?",
      "original_answer": "In 2022, the PWCC Plan was described as being used solely to fund awards for employees of PwCC who joined IBM after the acquisition, and it was stated that the plan would continue to be used for this purpose. By 2024, while the plan's administration and terms remained substantively identical to the 2001 Plan, IBM emphasized that the PWCC Plan 'has been and will continue to be used solely' for funding awards for former PwCC employees, indicating a reaffirmation rather than a change in scope. However, the shift in language from 'has been and will continue to be' in 2022 to a more definitive tone in 2024 suggests a stronger commitment to maintaining the plan’s current usage without expansion.",
      "llm_answer": "\nBetween 2022 and 2024 IBM kept the PWCC Acquisition Long‑Term Performance Plan strictly limited to awarding former PricewaterhouseCoopers Consulting employees, but it refreshed the plan’s administration by tying it to the 2022 amendment of the Amended and Restated Deferred Compensation and Equity Award Plan (effective December 13 2022) and by documenting the awards under the same governance structure used for the company’s other long‑term performance plans.  The scope did not broaden – senior executives remain excluded – but the plan’s documentation and oversight were updated to reflect the 2022 amendment and to align with the Executive Compensation and Management Resources Committee’s authority over all compensatory plans.  (Pages 23 and 28 of IBM 2024 10‑K; page 28 of IBM 2022 10‑K).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not supported by the ground truth. Key issues: (1) INCORRECT ENTITY NAME: The LLM refers to 'PWCC Acquisition Long-Term Performance Plan' when the ground truth consistently calls it the 'PWCC Plan' - this is a material error in entity identification. (2) UNSUPPORTED CLAIMS: The LLM claims the plan was 'refreshed' and 'tied to the 2022 amendment of the Amended and Restated Deferred Compensation and Equity Award Plan (effective December 13 2022)' - this specific detail about a 2022 amendment and effective date is NOT mentioned in the ground truth, which states the plan's 'administration and terms remained substantively identical to the 2001 Plan.' This represents a factual error or hallucination. (3) INCORRECT EVOLUTION NARRATIVE: The ground truth describes a subtle shift in language from 2022 to 2024 ('has been and will continue to be' becoming more definitive), suggesting a reaffirmation rather than administrative changes. The LLM instead claims administrative updates and governance alignment, which contradicts the ground truth's assertion of substantive identity to the 2001 Plan. (4) SCOPE ACCURACY: The LLM correctly identifies that the scope remained limited to former PwCC employees and that senior executives remain excluded, which aligns with ground truth. (5) CITATION ISSUES: The LLM provides specific page references (Pages 23 and 28 of IBM 2024 10-K; page 28 of IBM 2022 10-K) but these cannot be verified against the ground truth provided. The core error is mischaracterizing administrative evolution when the ground truth emphasizes substantive continuity with only a linguistic shift in commitment language.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 467,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did AT&T's financial obligations and strategic approach to Mobility Preferred Interests evolve between 2023 and 2024, and what does this shift indicate about its broader capital structure management?",
      "original_answer": "In 2023, AT&T repurchased all remaining Mobility Preferred Interests for a total of $5,414 million, which included accrued and unpaid distributions, effectively eliminating this financial obligation. By 2024, there was no mention of Mobility Preferred Interests in the disclosures, indicating a complete exit from this instrument. This contrasts with AT&T's treatment of other preferred interests, such as the Tower Holdings and Telco LLC preferred interests, which remained outstanding and were even expanded or restructured in 2024. This shift indicates a strategic move to reduce certain long-term liabilities while maintaining or adjusting other capital instruments for flexibility, suggesting a selective approach to managing its capital structure.",
      "llm_answer": "\nBetween 2023 and 2024 AT&T eliminated its Mobility Preferred Interests—repurchasing the remaining ≈ 213 million interests in April 2023 for $5.4 bn and re‑classifying them from equity to a cash‑settlement liability—so that no preferred‑equity obligation remained on the balance sheet.  In 2024 the company reshaped its tower‑related preferred securities (resetting the 2019 Tower preferred interests into fixed‑ and floating‑rate tranches and expanding the Telco LLC preferred stack), effectively refinancing those obligations at newer rates and with greater flexibility.  This transition reflects a broader capital‑structure strategy of actively retiring legacy preferred equity, restructuring remaining preferred‑interest arrangements to match current market conditions, and using cash and staged equity‑linked instruments to improve liquidity and reduce long‑term financing risk.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core narrative—AT&T eliminated Mobility Preferred Interests in 2023 and made no mention of them in 2024, while restructuring other preferred interests (Tower Holdings and Telco LLC). The qualitative reasoning about capital structure management is sound and well-articulated. The answer appropriately addresses the multi-hop synthesis required by the question.\n\nWEAKNESSES AND ERRORS:\n\n1. QUANTITATIVE ACCURACY ISSUES:\n   - The LLM states \"≈ 213 million interests in April 2023 for $5.4 bn\" but the ground truth specifies the total repurchase was $5,414 million (or $5.414 billion). While $5.4 bn is a reasonable approximation, the precision is reduced and the \"213 million interests\" figure is not verified in the ground truth.\n   - The ground truth explicitly states \"$5,414 million\" which includes \"accrued and unpaid distributions.\" The LLM's approximation loses this specificity.\n   - The LLM mentions \"April 2023\" as the timing, but the ground truth does not specify this month—this is an unverified detail.\n\n2. TERMINOLOGY AND CLASSIFICATION ISSUE:\n   - The LLM states AT&T \"re-classified them from equity to a cash-settlement liability,\" but the ground truth simply states they \"repurchased all remaining Mobility Preferred Interests\" and that there was \"no mention of Mobility Preferred Interests in the disclosures\" in 2024. The reclassification detail is not explicitly confirmed in the ground truth and may be an inference.\n\n3. COMPLETENESS:\n   - The LLM answer goes beyond the ground truth by adding details about \"cash and staged equity-linked instruments\" and \"improving liquidity and reducing long-term financing risk\" that are not explicitly stated in the ground truth. While these are reasonable inferences about capital structure strategy, they represent extrapolation beyond what the knowledge graph confirms.\n\n4. MULTI-HOP REASONING:\n   - The synthesis across 2023 and 2024 is correct in concept.\n   - The comparison with Tower Holdings and Telco LLC preferred interests is accurate and well-integrated.\n   - The broader strategic conclusion is sound but somewhat speculative beyond the ground truth.\n\nVERIFICATION OF KEY FACTS:\n   ✓ Mobility Preferred Interests eliminated in 2023: CORRECT\n   ✓ No mention in 2024: CORRECT\n   ✓ $5.4 billion repurchase: APPROXIMATELY CORRECT (ground truth: $5,414 million)\n   ✓ Tower Holdings and Telco LLC preferred interests restructured/expanded: CORRECT\n   ✓ Strategic shift toward selective liability reduction: CORRECT\n   ? April 2023 timing: UNVERIFIED\n   ? Reclassification from equity to liability: INFERRED, NOT EXPLICITLY CONFIRMED\n   ? Details about cash instruments and liquidity improvements: EXTRAPOLATED\n\nThe answer demonstrates strong qualitative understanding and multi-hop reasoning but loses points for approximate quantification, unverified details, and some extrapolation beyond the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 782,
        "total_tokens": 2205
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How has IBM's relationship with stock exchange regulations evolved in terms of regulatory exposure for its debt securities between 2022 and 2024?",
      "original_answer": "In 2022, IBM described stock exchange regulations as one of several factors influencing the value of its debt securities, placing it among other external variables beyond the company's control. By 2024, IBM's language shifted to indicate a more direct regulatory exposure, stating it is 'subject to' stock exchange regulations, which implies a heightened recognition of their binding impact on the company's financing activities. This evolution reflects a stronger acknowledgment of regulatory influence in 2024 compared to the more general mention in 2022.",
      "llm_answer": "\nBetween 2022 and 2024 IBM’s disclosures show that its exposure to stock‑exchange regulations for debt securities has remained anchored in the same core SEC requirements—namely, reporting of debt issuances, compliance with listing and registration rules, and the need to respond to rating‑agency actions—but the language has broadened to reflect newer regulatory themes.  The 2024 10‑K (pages 11 and 20) expands the risk‑factor discussion to include heightened scrutiny of ESG‑related, cybersecurity and data‑privacy regulations that could affect the company’s ability to issue or maintain debt, whereas the 2022 filing (pages 18 and 22) focused more narrowly on interest‑rate, currency and market‑liquidity risks.  Consequently, IBM’s regulatory exposure has evolved from a primarily financial‑market focus to a broader compliance landscape that now integrates emerging securities‑exchange and regulatory requirements.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer fundamentally misses the core finding from the ground truth. The ground truth identifies a specific evolution in IBM's language regarding stock exchange regulations: from describing them as 'one of several factors influencing the value of its debt securities' (2022) to stating the company is 'subject to' stock exchange regulations (2024). This represents a shift from passive/general mention to direct regulatory exposure language. The LLM answer instead discusses a broadening of regulatory themes from financial-market focus to ESG/cybersecurity/data-privacy concerns, which is a different analytical framework entirely. The LLM introduces specific page references (pages 11, 20, 18, 22) that cannot be verified against the ground truth and appear to be fabricated details. The LLM's discussion of 'newer regulatory themes' and 'emerging securities-exchange requirements' does not align with the ground truth's focus on the linguistic shift in how IBM characterizes its regulatory exposure (from 'factors influencing' to 'subject to'). The answer demonstrates a fundamental misunderstanding of what the question asks—the evolution of language/characterization of regulatory exposure—versus what the LLM provides—a discussion of expanding regulatory scope. Additionally, the LLM provides no direct quotes or specific evidence from the 2022 vs 2024 filings that would support its claims. The quantitative accuracy is low because the LLM cites specific page numbers without verification. The qualitative accuracy is low because the multi-hop reasoning fails to identify the key linguistic shift that constitutes the actual evolution. The answer is contextually somewhat relevant to IBM's regulatory exposure but addresses the wrong aspect of the evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 482,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did Disney's financial relationship with A&E evolve from 2022 to 2024, particularly in terms of equity income contribution?",
      "original_answer": "In 2022, Disney's equity investment in A&E was a significant component of its equity income, with A&E being one of the most notable equity method investees alongside CTV Specialty Television. By 2024, Disney's equity in the income of investees had decreased by $207 million, specifically due to lower income generated from A+E. This indicates a material decline in the financial contribution from A&E to Disney over the two-year period.",
      "llm_answer": "\nFrom 2022 through 2024 Disney’s 50 % equity stake in A+E stayed the same, but the earnings that flowed back to Disney fell sharply.  In the 2022 filing (page 25) A+E was presented as an equity‑method investment, and by the 2024 filing (page 26) Disney reported that “equity in the income of investees decreased $207 million to $575 million … due to lower income from A+E,” indicating a sizable drop in the joint‑venture’s contribution to Disney’s equity income.  The decline reflects weaker operating performance and related goodwill impairments at A+E, so that A+E’s equity‑income contribution was far smaller in 2024 than it had been in 2022.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. Strengths: (1) Correctly identifies the $207 million decrease in equity income from A+E, matching the ground truth exactly. (2) Accurately cites the 2024 filing statement about 'equity in the income of investees decreased $207 million to $575 million.' (3) Properly identifies A+E as an equity-method investment and notes Disney's 50% stake. (4) Correctly synthesizes the multi-hop relationship showing the evolution from 2022 to 2024. (5) Provides additional context about goodwill impairments and weaker operating performance, which adds depth beyond the ground truth without contradicting it. (6) Appropriately references specific filing pages (25 and 26) showing document-level verification. Minor considerations: (1) The ground truth mentions 'A+E' vs 'A&E' naming - the LLM uses 'A+E' which appears to be the correct SEC filing terminology based on the quoted text. (2) The LLM provides slightly more detail about the causes (goodwill impairments, weaker operating performance) than the ground truth, but this is supplementary and accurate. (3) The answer fully addresses the question about how the financial relationship evolved, the equity income contribution decline, and the specific dollar amounts. The quantitative accuracy is excellent with the $207 million figure and $575 million ending balance both correct. The qualitative reasoning about the decline in contribution and its causes is sound and well-supported.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 409,
        "total_tokens": 1674
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did the carrying value of securitized debt obligations change from 2022 to 2023, and what does this indicate about the company's long-term funding strategy?",
      "original_answer": "In 2022, the long-term funding, which primarily consists of securitized debt obligations and senior and subordinated notes, stood at $42.3 billion as of December 31, 2021, with a significant portion driven by securitized debt obligations. By December 31, 2023, the carrying value of securitized debt obligations alone decreased to $18.043 billion. This indicates a strategic shift or reduction in reliance on securitized debt obligations as part of the company's long-term funding structure over this period.",
      "llm_answer": "\nThe carrying amount of securitized debt obligations grew from **$16.97 billion at the end of 2022 to $18.04 billion at the end of 2023**—an increase of roughly **$1.07 billion (about 6 %)**.  \n\nThis rise shows that Capital One deliberately **expanded its securitization activity**, using securitized debt as a larger share of its long‑term funding mix to support asset growth and diversify funding sources.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. (1) QUANTITATIVE ERRORS: The LLM states securitized debt obligations were $16.97 billion at end of 2022 and $18.04 billion at end of 2023. However, the ground truth indicates the carrying value was $18.043 billion at December 31, 2023 (which matches the LLM's 2023 figure), but provides no 2022 figure for securitized debt alone—only a 2021 figure of $42.3 billion for total long-term funding. The LLM's 2022 figure of $16.97 billion cannot be verified against the ground truth and appears to be fabricated. (2) DIRECTIONAL INTERPRETATION ERROR: The LLM concludes that the increase from $16.97B to $18.04B indicates 'deliberate expansion' and 'larger share' of securitization activity. However, the ground truth explicitly states this represents 'a strategic shift or reduction in reliance on securitized debt obligations.' This is a fundamental contradiction—the LLM reached the opposite conclusion from the ground truth. (3) CALCULATION: The LLM's math is internally consistent ($18.04B - $16.97B = $1.07B, approximately 6% increase), but this is based on an unverified 2022 baseline figure. (4) MULTI-HOP REASONING: The LLM failed to properly synthesize the information. The ground truth shows a dramatic decrease from $42.3B (2021 total long-term funding) to $18.043B (2023 securitized debt alone), indicating a reduction in securitization reliance. The LLM misinterpreted a modest year-over-year increase as evidence of expansion, missing the larger strategic context of overall reduction. (5) MISSING CONTEXT: The LLM did not acknowledge the comparison to 2021 baseline or the broader strategic shift away from securitized debt that the ground truth emphasizes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 477,
        "total_tokens": 1709
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How has Disney's approach to scripted programming evolved between 2022 and 2024, particularly in terms of its international general entertainment channels and its strategic shift toward DTC platforms?",
      "original_answer": "In 2022, Disney operated approximately 220 General Entertainment channels outside the U.S., primarily under the Fox, National Geographic, and Star brands, featuring a mix of scripted, reality, and documentary programming across multiple languages and regions. By 2024, there was a notable strategic shift, with increased emphasis on DTC platforms and less focus on traditional linear channels. The 2024 report highlights that Disney, along with Fox Corporation and Warner Bros. Discovery, planned a joint venture (Venu Sports) to distribute sports content via a DTC platform, signaling a broader move toward streaming. Additionally, Disney announced plans to launch a new DTC offering in early fall 2025 that would include live linear streams of ESPN channels and ESPN+. This reflects a strategic pivot from scripted linear content toward live and sports-driven DTC offerings, indicating a transformation in Disney’s programming and distribution priorities.",
      "llm_answer": "\nBetween 2022 and 2024 Disney reduced the role of its international general‑entertainment linear channels (Fox, Star, National Geographic, etc.) as the primary outlet for scripted programming and instead began concentrating that content on its direct‑to‑consumer services—most notably Disney+, Disney+ Hotstar and the forthcoming ad‑supported Disney+ tier that will also carry ESPN linear feeds.  The company has reorganized its Media & Entertainment Distribution unit, introduced price increases and an ad‑supported Disney+ offering, and is shifting monetisation from licensing those channels to DTC distribution while still maintaining the channels only where regulatory or market requirements demand.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general strategic shift from linear channels to DTC platforms correctly and demonstrates sound reasoning about Disney's transformation. However, there are significant gaps in quantitative accuracy and completeness when compared to the ground truth.\n\nSTRENGTHS:\n- Correctly identifies the shift from international general entertainment linear channels (Fox, Star, National Geographic) to DTC platforms\n- Accurately names the DTC services (Disney+, Disney+ Hotstar)\n- Correctly mentions the ad-supported tier and ESPN linear feeds integration\n- Properly characterizes the strategic pivot from licensing to DTC distribution\n- Good qualitative reasoning about the transformation in programming priorities\n\nWEAKNESSES:\n1. MISSING QUANTITATIVE DATA: The ground truth specifies \"approximately 220 General Entertainment channels outside the U.S.\" in 2022. The LLM answer provides no specific numbers about the scale of these operations, which is a significant omission for a multi-hop financial question.\n\n2. INCOMPLETE MULTI-HOP SYNTHESIS: The ground truth mentions the Venu Sports joint venture (Disney, Fox Corporation, Warner Bros. Discovery) as a specific strategic indicator of the DTC shift. The LLM answer omits this entirely, missing a key piece of evidence for the strategic transformation.\n\n3. MISSING TEMPORAL SPECIFICITY: The ground truth mentions \"early fall 2025\" for the new DTC offering launch. The LLM answer references \"forthcoming\" but lacks this specific timing detail.\n\n4. INCOMPLETE ENTITY SYNTHESIS: While the LLM mentions Disney's reorganization and price increases, it doesn't synthesize the broader industry context (Fox Corporation, Warner Bros. Discovery partnership) that the ground truth includes.\n\n5. VAGUE LANGUAGE: The LLM uses \"maintaining the channels only where regulatory or market requirements demand\" which is interpretive rather than grounded in specific filing data.\n\nCALCULATIONS/NUMBERS: No calculations are required for this question, but the absence of the \"220 channels\" figure represents a quantitative accuracy gap.\n\nMULTI-HOP REASONING: The LLM demonstrates adequate multi-hop reasoning in connecting the strategic shift across different platforms and business units, but fails to synthesize the complete picture including the Venu Sports venture and specific channel counts.\n\nOVERALL ASSESSMENT: The answer is directionally correct and captures the main strategic narrative, but lacks the specific quantitative details and complete entity synthesis that would make it fully aligned with the ground truth. For a financial/strategic question requiring multi-hop synthesis, the omission of the 220-channel figure and Venu Sports venture represents material gaps.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 730,
        "total_tokens": 2158
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did Tesla's financial and operational challenges related to energy storage products evolve from 2022 to 2023, particularly in terms of accounts receivable and production scaling dependencies?",
      "original_answer": "In 2022, Tesla disclosed significant long-term government rebates receivable related to its energy storage products, with a balance of $627 million as of December 31, 2021, indicating extended collection periods of up to a year or more. By 2023, the focus shifted from financial implications of receivables to operational dependencies, as Tesla highlighted production scaling risks for energy storage products, including bottlenecks, supplier constraints, and facility ramp delays at factories in Nevada, Texas, and other locations. These changes reflect a shift from financial exposure tied to receivables to broader production and supply chain dependencies affecting the company's ability to meet cost and profitability targets.",
      "llm_answer": "\nFrom 2022 to 2023 Tesla’s energy‑storage receivables grew markedly—long‑term government rebate balances jumped (e.g., from $46 million to $627 million) and payments from financing partners took longer, creating greater volatility and a larger portion of accounts receivable that can remain outstanding for up to a year. At the same time, scaling storage‑product production became increasingly dependent on external supply‑chain factors (notably semiconductor availability and the performance of leased manufacturing equipment), so any bottleneck or delay in those areas now directly limits the company’s ability to increase output.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) MAJOR QUANTITATIVE ERROR: The LLM states long-term government rebate balances 'jumped from $46 million to $627 million,' but the ground truth indicates the $627 million balance was as of December 31, 2021 (not 2023), and there is no mention of a $46 million figure in the original answer. This represents a fundamental misreading of the timeline and data. (2) TEMPORAL MISALIGNMENT: The ground truth clearly states the $627 million balance was disclosed in 2022 filings but dated to December 31, 2021. The LLM incorrectly frames this as a 2022-to-2023 progression when it actually represents 2021-to-2022 data. (3) INCOMPLETE SYNTHESIS: The LLM correctly identifies the shift from financial receivables focus to operational/production scaling risks, which aligns with the ground truth's core insight about the evolution from 'financial exposure tied to receivables to broader production and supply chain dependencies.' However, this correct reasoning is undermined by the quantitative errors. (4) MISSING SPECIFICITY: The ground truth mentions specific facility locations (Nevada, Texas) and types of bottlenecks; the LLM mentions semiconductors and leased equipment but lacks the facility-specific detail. (5) SEMANTIC ISSUES: The phrase 'payments from financing partners took longer' is not supported by the ground truth, which discusses government rebates receivable, not financing partner payments. The LLM appears to have conflated or invented details not present in the original answer. The core conceptual understanding of the shift from receivables to production scaling is partially correct, but the execution is severely compromised by factual errors in numbers and timeline.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 468,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How has the role of syrups in Coca-Cola's business model evolved between 2022 and 2023, particularly in relation to its bottling partners and fountain retailers?",
      "original_answer": "In 2022, Coca-Cola's relationship with syrups was primarily defined by its sales to both consolidated and unconsolidated bottling partners, with revenue and volume recognition dependent on the ownership structure of those partners. Specifically, concentrate and syrup sales were not recognized until finished products were sold to third parties in the case of consolidated bottlers, while recognition occurred immediately for unconsolidated bottlers. By 2023, the company's description of syrups shifted to emphasize their role as a dependency within a broader operational framework, particularly in relation to fountain retailers. In 2023, the company clarified that it manufactures fountain syrups and sells them directly to fountain retailers or authorized wholesalers and bottlers, highlighting a more integrated and strategic role for syrups in its finished beverage delivery system. This represents a shift from a primarily volume-driven metric to a more operationally embedded component of the business model.",
      "llm_answer": "\nBetween 2022 and 2023 the company’s syrup (concentrate) business remained anchored in the “sell‑to‑bottler” model—revenue is recognized only when the bottler’s finished beverage is sold to a third‑party consumer—yet the way that revenue is captured has shifted toward the fountain channel.  In North America the Company now sells a growing volume of fountain‑syrup directly to fountain retailers (and to authorized wholesalers who supply those retailers), integrating syrup sales into its North‑America operating segment and tying pricing to variable‑consideration arrangements that reflect bottler‑level volume and mix.  Consequently, while overall concentrate sales volume grew only modestly, the share of revenue derived from syrup sold for fountain‑service has risen, making syrups a more direct source of earnings tied to the Company’s bottling‑partner and fountain‑retail relationships.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures some correct elements but contains significant deviations from the ground truth. CORRECT ELEMENTS: (1) The answer correctly identifies the shift in syrup business focus toward fountain channels between 2022-2023; (2) Correctly notes that Coca-Cola sells fountain syrups directly to fountain retailers and authorized wholesalers; (3) Appropriately emphasizes the North America operating segment focus; (4) Correctly identifies the relationship between syrup sales and bottling partners/fountain retailers. PROBLEMATIC ELEMENTS: (1) The LLM introduces the concept of 'variable-consideration arrangements' and 'bottler-level volume and mix' pricing which are not mentioned in the ground truth and appear to be speculative additions; (2) The statement 'concentrate sales volume grew only modestly' introduces a quantitative claim not present in the ground truth, and no specific numbers are provided to verify this; (3) The phrase 'share of revenue derived from syrup sold for fountain-service has risen' is presented as fact but the ground truth does not provide specific evidence of revenue share increases; (4) The LLM's characterization of the 2022 model as 'sell-to-bottler' with revenue recognition 'only when the bottler's finished beverage is sold' is accurate but oversimplifies the distinction between consolidated and unconsolidated bottlers mentioned in the ground truth. MULTI-HOP REASONING: The LLM attempts to synthesize the evolution across years and relate it to bottling partners and fountain retailers, which is appropriate. However, it adds interpretive details about pricing mechanisms and revenue share that go beyond what the ground truth establishes. The core insight about the shift from volume-driven to operationally embedded syrups is present but expressed differently. MISSING ELEMENTS: The ground truth emphasizes a shift from 'primarily volume-driven metric to more operationally embedded component' which the LLM captures conceptually but doesn't explicitly state. The distinction between consolidated and unconsolidated bottler revenue recognition timing is omitted from the LLM answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1481,
        "completion_tokens": 573,
        "total_tokens": 2054
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did Disney's investment in Other Mortgage- and Asset-Backed Securities (MBS & ABS) evolve from fiscal year 2022 to fiscal year 2024, and what was the trend in its proportion relative to the overall fair value hierarchy?",
      "original_answer": "In fiscal year 2022, Disney's investment in Other MBS & ABS was valued at $96 million, representing 1% of the total plan asset mix. By fiscal year 2024, this investment increased to $120 million, maintaining a 1% share of the total plan asset mix. While the absolute value of the investment grew moderately, its proportional representation within the portfolio remained stable.",
      "llm_answer": "\nDisney’s holding of Other‑mortgage‑ and asset‑backed securities measured under the fair‑value hierarchy rose steadily: $84 million in fiscal 2022 (page 104), $120 million in fiscal 2023 (page 107‑2023 table), and $166 million in fiscal 2024 (page 107‑2024 table). In each year these securities represented roughly 1 % of the total assets recorded at fair value, so while the absolute dollar amount grew, its share of the overall fair‑value hierarchy remained essentially unchanged.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains significant factual inaccuracies that fundamentally contradict the ground truth. (1) QUANTITATIVE ACCURACY FAILURES: The LLM reports FY2022 as $84 million, but ground truth states $96 million (12% error). The LLM reports FY2024 as $166 million, but ground truth states $120 million (38% error). These are substantial discrepancies, not minor rounding differences. The LLM also introduces FY2023 data ($120 million) that was not requested and appears to be fabricated or misread from source documents. (2) MULTI-HOP REASONING: While the LLM correctly identifies the trend direction (increasing absolute values with stable proportions at ~1%), the specific numbers used to support this reasoning are wrong. The conclusion about proportional stability is correct in principle, but is based on incorrect underlying data. (3) ENTITY ACCURACY: The company (Disney) and metric (Other MBS & ABS) are correctly identified, and the fiscal years are correct, but the values assigned to those years are materially incorrect. (4) GROUND TRUTH VERIFICATION: Ground truth clearly states FY2022=$96M and FY2024=$120M with both at 1% of total. The LLM's claim of $84M→$120M→$166M trajectory is factually wrong. The FY2024 figure of $166M is particularly problematic as it contradicts the stated endpoint. (5) CONTEXTUAL RELEVANCE: The answer does address the question's core components (evolution over time, proportion analysis), but the factual errors undermine the entire response. The inclusion of unrequested FY2023 data, while potentially helpful, does not compensate for the fundamental numerical inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1234,
        "completion_tokens": 449,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did the focus areas of Skunk Works' advanced development programs evolve between 2022 and 2023 in relation to next-generation military aircraft capabilities?",
      "original_answer": "In 2022, Skunk Works' Advanced Development Programs focused on future systems including unmanned and manned aerial systems and next-generation capabilities for hypersonics, intelligence, surveillance, reconnaissance, situational awareness, and air mobility. By 2023, the focus had evolved to emphasize air dominance, hypersonics, intelligence, surveillance, reconnaissance, situational awareness, and air mobility. The shift highlights an increased emphasis on air dominance as a core next-generation capability while maintaining focus on hypersonics and ISR. This represents a refinement of priorities rather than a complete overhaul of focus areas.",
      "llm_answer": "\nBetween 2022 and 2023 the Skunk Works’ Advanced Development Programs broadened its thrust from a primary emphasis on rapid‑prototype concepts for next‑generation air‑dominance, intelligence‑surveillance‑reconnaissance and mobility toward a more pronounced focus on hypersonic strike weapons, AI‑enabled autonomy and network‑enabled, multi‑domain system integration, while still advancing unmanned and manned aerial systems for future fighter capabilities. This evolution reflects Lockheed Martin’s effort to accelerate technology insertion that can meet the increasingly complex, contested environments expected for 6th‑generation military aircraft.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer introduces significant information NOT present in the ground truth, including: (1) 'hypersonic strike weapons' - ground truth mentions hypersonics but not specifically 'strike weapons'; (2) 'AI-enabled autonomy' - completely absent from ground truth; (3) 'network-enabled, multi-domain system integration' - not mentioned in ground truth; (4) '6th-generation military aircraft' - not referenced in ground truth. The LLM also MISCHARACTERIZES the evolution: Ground truth states 2022 included 'unmanned and manned aerial systems' which were MAINTAINED in 2023, not 'broadened' as the LLM suggests. The ground truth explicitly states the shift was 'a refinement of priorities rather than a complete overhaul,' but the LLM describes a 'broadened thrust' toward new focus areas. CORRECT ELEMENTS: The LLM correctly identifies that both years included hypersonics, ISR, and air mobility/dominance. The years (2022-2023) are correct. However, the LLM fundamentally misrepresents the nature of the evolution by adding capabilities not documented in the ground truth and by overstating the degree of change. The answer appears to conflate Skunk Works' actual documented focus areas with speculative or inferred capabilities. This is a case where the LLM has fabricated details that sound plausible but contradict the actual ground truth from SEC filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 384,
        "total_tokens": 1713
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How has Tesla's approach to the Powerwall product evolved from 2022 to 2023, particularly in terms of integration strategy and production emphasis?",
      "original_answer": "In 2022, Tesla emphasized cross-selling Powerwall with residential solar energy products due to better availability and growing grid stability concerns. The company was also focused on improving installation capabilities and price efficiencies for Solar Roof, which is closely related to Powerwall integration. By 2023, Tesla had advanced its integration strategy by designing both Solar Roof and solar energy systems to specifically integrate with Powerwall, indicating a more deliberate and engineered approach to product synergy. This evolution reflects a shift from a sales and availability focus to a deeper technical and strategic integration within Tesla's energy ecosystem.",
      "llm_answer": "\nFrom 2022 to 2023 Tesla shifted the Powerwall from a stand‑alone add‑on for residential solar—where the focus was on cross‑selling, improving availability and hiring installers—to a tightly integrated offering that is engineered together with Solar Roof and built on a modular, vehicle‑derived battery architecture.  The 2023 emphasis moved to scaling this modular, software‑controlled storage platform (using shared power‑electronics and in‑house cell components) to meet rising grid‑service demand, rather than primarily expanding installer labor and external battery supply.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ISSUES: The LLM answer introduces significant factual claims NOT present in the ground truth, which is a major problem for evaluation against SEC filing data. Specifically: (1) The claim about 'modular, vehicle-derived battery architecture' is not mentioned in the original answer and appears to be fabricated or unsourced. (2) The reference to 'shared power-electronics and in-house cell components' is not in the ground truth. (3) The emphasis on 'grid-service demand' as a 2023 focus is not supported by the original answer, which emphasizes 'grid stability concerns' in 2022 and technical integration in 2023. WHAT WAS CORRECT: (1) The core evolution from cross-selling/availability focus (2022) to integrated engineering approach (2023) is accurately captured. (2) The mention of Solar Roof integration is correct. (3) The general shift from sales/availability to technical integration is semantically aligned. WHAT WAS MISSING/INCORRECT: (1) The LLM adds technical details about battery architecture and power electronics that cannot be verified against the ground truth and may be hallucinated. (2) The framing around 'installer labor and external battery supply' is partially correct but oversimplifies the actual evolution described. (3) The 'modular, software-controlled storage platform' framing, while plausible, is not explicitly stated in the ground truth. MULTI-HOP REASONING: The LLM demonstrates understanding of the temporal evolution and product integration concepts, but fails to stay grounded in the actual filing data by introducing unverified technical specifications. This is particularly problematic for SEC filing analysis where accuracy is paramount. The answer reads more like an inference or interpretation rather than a direct synthesis of filing information.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 488,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How has Gilead's strategic positioning around Biktarvy evolved between 2022 and 2024, particularly in terms of its role within the company's HIV portfolio and associated commercial risks?",
      "original_answer": "In 2022, Biktarvy was prominently positioned as a key revenue-generating product within Gilead’s HIV portfolio, highlighted as a single-tablet regimen combining bictegravir, emtricitabine, and tenofovir alafenamide (TAF), emphasizing its convenience and efficacy. By 2024, while Biktarvy remained a core product, the company faced heightened commercial risk as it became more dependent on HIV products containing TAF. A shift in treatment paradigms or reduced preference for nucleoside-based therapies could significantly impact Biktarvy’s sales and, by extension, Gilead’s financial stability. This reflects a transition from a focus on product innovation to increased vulnerability due to overreliance on a narrow therapeutic class.",
      "llm_answer": "\nBetween 2022 and 2024 Gilead kept Biktarvy at the centre of its HIV portfolio—as a once‑daily, TAF‑based single‑tablet regimen that still generates a large share of the company’s HIV revenue.  However, the company’s strategy shifted toward protecting that revenue stream in the face of growing commercial risks: it highlighted the threat of generic competition, state‑level affordability reviews and 340B/Medicaid rebate pressures that could erode pricing power, and underscored the need to complement Biktarvy with new HIV innovations to sustain sales growth.  Consequently, while Biktarvy remains a key earnings driver, its strategic positioning now carries heightened risk of market‑share loss and pricing constraints.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "ASSESSMENT: The LLM answer contains significant deviations from the ground truth in its core analytical framing, despite capturing some accurate elements.\n\nCORRECT ELEMENTS:\n- Correctly identifies Biktarvy as a TAF-based single-tablet regimen\n- Accurately notes Biktarvy's continued importance to HIV portfolio revenue\n- Correctly identifies the timeframe (2022-2024)\n- Appropriately mentions commercial risks and pricing pressures\n- Quantitative accuracy is reasonable (no specific numbers to verify, and format/terminology are appropriate)\n\nSIGNIFICANT ERRORS & OMISSIONS:\n1. FUNDAMENTAL MISCHARACTERIZATION: The LLM introduces specific commercial risks (generic competition, 340B/Medicaid rebate pressures, state-level affordability reviews) that are NOT mentioned in the ground truth. While these are plausible industry concerns, they represent factual additions not supported by the source material.\n\n2. STRATEGIC NARRATIVE DIVERGENCE: The ground truth emphasizes a shift from \"product innovation focus\" to \"vulnerability due to overreliance on a narrow therapeutic class\" (TAF-based therapies). The LLM instead frames the strategy as \"protecting revenue stream\" through \"complementing Biktarvy with new HIV innovations.\" These represent opposite strategic interpretations.\n\n3. MISSING KEY INSIGHT: The ground truth's critical point about \"shift in treatment paradigms or reduced preference for nucleoside-based therapies\" as a systemic risk is absent from the LLM answer. Instead, the LLM focuses on pricing/competitive pressures rather than therapeutic class obsolescence risk.\n\n4. TONE MISALIGNMENT: The ground truth conveys increasing vulnerability and dependency risk; the LLM conveys active risk management and strategic complementation, which is a different narrative.\n\nQUANTITATIVE ACCURACY: 8/10 - No specific numbers to verify; terminology and format are appropriate.\n\nQUALITATIVE ACCURACY: 4/10 - While the answer demonstrates understanding of Biktarvy's importance, it fundamentally misinterprets the nature of the strategic shift and introduces unsupported specific risks.\n\nCONTEXTUAL RELEVANCE: 6/10 - Addresses the question's components but with incorrect emphasis and missing the core insight about therapeutic class vulnerability.\n\nCORRECTNESS SCORE JUSTIFICATION: 5/10 - The answer is partially correct on surface-level facts (Biktarvy's role, TAF-based formulation, commercial risks exist) but fails on the fundamental analytical interpretation of how the strategic positioning evolved. The introduction of specific risks not in the ground truth and the mischaracterization of the strategic shift from innovation-focus to dependency-vulnerability represent material errors that undermine the answer's reliability.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 731,
        "total_tokens": 2106
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did the composition of the U.S. Retrospective Responsibility Plan change between 2022 and 2023, particularly regarding the mechanisms referenced in relation to the U.S. Litigation Escrow Agreement?",
      "original_answer": "In 2022, the U.S. Retrospective Responsibility Plan included mechanisms such as the U.S. Litigation Escrow Agreement, the conversion feature of Class B common stock, indemnification obligations of Visa U.S.A. members, an interchange judgment sharing agreement, a loss sharing agreement, and an omnibus agreement. By 2023, the composition evolved to include a new element — 'makewhole agreements relating to the Class B-1 common stock exchange offer' — while retaining the U.S. Litigation Escrow Agreement and other previously listed mechanisms. This indicates an expansion of the plan to incorporate additional financial safeguards or compensatory measures.",
      "llm_answer": "\nThe 2022 and 2023 U.S. Retrospective Responsibility Plans retain the same core mechanisms—U.S. litigation escrow agreement, the conversion feature of class B common stock, indemnification obligations of Visa U.S.A. members, the interchange‑judgment sharing agreement, the loss‑sharing agreement and the omnibus agreement.  What changed between the years was the level of disclosure: the 2023 filing expanded the description of the escrow‑account balances and clarified that the conversion feature dilutes class B shares in a way that economically mirrors a class A repurchase, and it emphasized the indemnification and loss‑sharing obligations that are triggered if escrow funds are insufficient.  No new mechanisms were added or removed; the composition remained stable with only enhanced detail.",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERROR: The LLM answer directly contradicts the ground truth on the fundamental question being asked. The ground truth explicitly states that a NEW ELEMENT was added in 2023: 'makewhole agreements relating to the Class B-1 common stock exchange offer.' The LLM answer claims 'No new mechanisms were added or removed; the composition remained stable with only enhanced detail.' This is factually incorrect and represents a complete misunderstanding of the key change between 2022 and 2023. The LLM correctly identifies the core mechanisms present in both years (litigation escrow agreement, conversion feature, indemnification obligations, interchange judgment sharing agreement, loss sharing agreement, omnibus agreement), but fails to recognize and report the critical addition of the makewhole agreements in 2023. The LLM's assertion that only disclosure levels changed is unsupported by the ground truth, which clearly indicates compositional change through the addition of new mechanisms. While the LLM's description of the existing mechanisms is accurate and the reasoning about escrow balances and dilution effects may be contextually relevant, these details do not address the core question about compositional changes. The answer demonstrates a fundamental failure in multi-hop synthesis—the model needed to identify what was present in 2022, what was present in 2023, and articulate the differences. Instead, it incorrectly concluded there were no compositional changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 410,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How has the strategic importance of Biktarvy evolved for GILD from 2022 to 2024, based on its patent protection timeline and the company's risk disclosures around HIV product dependency?",
      "original_answer": "In 2022, Biktarvy was listed with a U.S. patent expiration in 2033 and no expiration listed in the E.U., indicating strong long-term protection and likely a key revenue driver. By 2024, although patent details were not explicitly mentioned, the company highlighted heightened risk around its HIV products, including Biktarvy, due to market competition and potential shifts in treatment paradigms. This suggests that despite long-term patent protection, Biktarvy's strategic position has become more vulnerable due to external market and regulatory pressures.",
      "llm_answer": "\nFrom 2022 through 2024 Biktarvy remains under strong patent protection—its composition‑of‑matter patents are projected to expire in 2033 (U.S. and EU) with a pending U.S. term‑extension that would keep exclusivity until at least 2028 and regulatory exclusivity through 2032—so it continues to serve as Gilead’s flagship HIV revenue driver. At the same time, the company’s risk disclosures flag growing vulnerability: heavy reliance on HIV products makes sales exposed to generic competition, shifting treatment paradigms, and the need to launch new formulations (e.g., the pediatric low‑dose tablet) in order to sustain or grow that revenue stream.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) PATENT EXPIRATION DATES - The LLM claims U.S. and EU patent expiration in 2033, but the ground truth explicitly states 2033 for U.S. only with 'no expiration listed in the E.U.' This is a significant factual error. The LLM also introduces unsupported claims about 'pending U.S. term-extension that would keep exclusivity until at least 2028' and 'regulatory exclusivity through 2032' - these specific dates and mechanisms are NOT mentioned in the ground truth and appear to be fabricated. (2) TEMPORAL EVOLUTION - The ground truth emphasizes a KEY SHIFT from 2022 to 2024: in 2022, Biktarvy had strong patent protection with no EU expiration listed (suggesting indefinite protection), but by 2024, the company highlighted 'heightened risk' around HIV products. The LLM fails to capture this evolution, instead presenting a static view that Biktarvy 'remains under strong patent protection' without acknowledging the shift in risk disclosure emphasis. (3) MULTI-HOP REASONING - The ground truth correctly synthesizes that despite long-term patent protection, strategic vulnerability increased due to external pressures (competition, treatment paradigm shifts). The LLM mentions these risks but doesn't adequately convey the paradox of strong IP protection coexisting with heightened strategic vulnerability. (4) UNSUPPORTED DETAILS - The LLM introduces specific product details (pediatric low-dose tablet) and term-extension mechanisms not present in the ground truth, suggesting hallucination. (5) MISSING NUANCE - The ground truth's key insight is that patent protection alone doesn't guarantee strategic importance when market dynamics shift; the LLM misses this critical distinction.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 468,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "Have there been any modifications to the financial guarantees provided by AT&T for Illinois Bell Telephone Company between 2022 and 2023, particularly in terms of guarantee structure or referenced documentation?",
      "original_answer": "The financial guarantee relationship between AT&T and Illinois Bell Telephone Company remained structurally unchanged between 2022 and 2023. In 2022, AT&T's guarantee for Illinois Bell Telephone Company was referenced under Exhibit 4-d to Form 10-K for the period ending December 31, 2011. In 2023, the same guarantee was still in place and referenced under the identical exhibit number (Exhibit 4-d) and filing history (Form 10-K for the period ending December 31, 2011). There is no indication of modifications to the guarantee structure, terms, or documentation between the two years.",
      "llm_answer": "\nNo amendment or new exhibit relating to the AT&T guaranty of Illinois Bell’s obligations appears in the 2022 or 2023 filings. Both the 2022 (pages 141‑145) and 2023 (pages 84, 86, 102‑104) filings continue to reference the original 2011 Exhibit 4‑c guaranty and do not disclose any revised guarantee structure, restated terms, or additional documentation for Illinois Bell between 2022 and 2023.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERROR - EXHIBIT NUMBER MISMATCH: The LLM answer states the guarantee is referenced under 'Exhibit 4-c' while the ground truth clearly indicates it is 'Exhibit 4-d'. This is a factual error in a key piece of documentation. The LLM also cites specific page numbers (141-145 for 2022, pages 84, 86, 102-104 for 2023) that cannot be verified against the ground truth and appear to be hallucinated details. CORRECT ELEMENTS: The LLM correctly identifies that (1) no modifications occurred between 2022 and 2023, (2) the guarantee remained unchanged, (3) both years reference the same original 2011 filing, and (4) no revised terms or additional documentation were disclosed. The core conclusion matches the ground truth. REASONING QUALITY: The multi-hop synthesis is sound - the LLM correctly compared the 2022 and 2023 filings and concluded no changes occurred. However, the specific exhibit citation error (4-c vs 4-d) is a significant factual mistake that undermines credibility. The page number citations, while adding apparent specificity, are unverifiable and likely incorrect. QUANTITATIVE ACCURACY: The year 2011 is correct, but the exhibit number is wrong, and page citations are unreliable. This represents a major error in documentary reference accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 356,
        "total_tokens": 1618
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "What does the consistent Class C to Class A common stock conversion rate between 2022 and 2023 suggest about the potential impact on Class A common stockholders' voting power in significant corporate transactions?",
      "original_answer": "In 2022, the Class C common stock had a conversion rate of 4.0000 into Class A common stock, and this rate remained unchanged in 2023. Despite the as-converted Class A common stock value increasing slightly from 38 million in 2022 to 39 million in 2023, the unchanged conversion rate suggests that the relative voting power dilution for Class A common stockholders remained stable. This stability implies that there was no structural change in how Class C stockholders could influence significant corporate decisions through their voting rights tied to Class A equivalents.",
      "llm_answer": "\nThe unchanged 4 to 1 conversion ratio for Class C common stock in 2022 and 2023 means that Visa did not alter the number of Class A shares that Class C holders can obtain, so no additional dilution of Class A voting power arises from that conversion. As a result, any voting‑power impact in significant corporate actions will remain governed by the existing Class B and preferred‑stock provisions rather than by a shift in the Class C‑to‑Class A conversion.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies the 4:1 (or 4.0000) conversion ratio and its consistency between 2022 and 2023, which matches the ground truth. The quantitative accuracy is solid on this core fact. However, there are significant issues with the overall response: (1) The LLM introduces information about Class B and preferred stock provisions that is NOT present in the ground truth answer and appears to be speculative or from external knowledge not grounded in the filing data. (2) The ground truth emphasizes that the unchanged conversion rate suggests 'stable relative voting power dilution' and 'no structural change,' focusing on the implications for Class A stockholders' voting power specifically. The LLM answer shifts focus to Class B and preferred stock, which dilutes the core insight. (3) The LLM correctly notes that the unchanged conversion ratio means 'no additional dilution' arises from that conversion, which aligns with the ground truth's point about stability. (4) However, the LLM fails to mention the as-converted Class A common stock values (38 million in 2022 to 39 million in 2023) that the ground truth cites as supporting evidence. (5) The reasoning about 'voting-power impact in significant corporate actions' being 'governed by existing Class B and preferred-stock provisions' is not substantiated by the ground truth and represents a departure from the filing-based analysis. The answer is partially correct on the core conversion rate fact but introduces unsupported claims and omits key supporting data points from the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 431,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Tesla's relationship with the Solar Roof evolve from 2022 to 2023 in terms of production focus and strategic dependencies?",
      "original_answer": "In 2022, Tesla directly produced the Solar Roof at Gigafactory New York, indicating active involvement in its manufacturing. However, by 2023, Tesla's disclosures shifted to emphasizing dependencies and risks associated with scaling production, including potential delays, supply chain constraints, and challenges in launching and ramping products like the Solar Roof. This reflects a transition from a production-centric view to a more cautionary outlook on strategic execution risks.",
      "llm_answer": "\nFrom 2022 to 2023 Tesla moved the Solar Roof from a pilot‑scale, Buffalo‑centric project toward a higher‑volume, cost‑optimized offering that is now integrated with Powerwall and sold through its global manufacturing and sales network; production focus shifted to improving yield and lowering expenses by using shared lines, software‑driven design, and broader supplier sourcing.  At the same time, the company’s strategic dependence shifted from reliance on a single factory to a distributed supply chain and to government incentives (tax credits, land‑use agreements), and it explicitly warned that any delay in scaling the Solar Roof could jeopardize its broader energy‑generation business.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is substantially incorrect and contradicts the ground truth on multiple critical dimensions: (1) FACTUAL ERRORS: The ground truth explicitly states Tesla directly produced Solar Roof at Gigafactory New York in 2022, but the LLM claims it was 'pilot-scale, Buffalo-centric' (Buffalo is where Gigafactory New York is located, but the characterization as merely pilot-scale contradicts the ground truth's assertion of 'direct production'). (2) DIRECTIONAL CONTRADICTION: The ground truth describes a shift FROM production-centric TO cautionary outlook on risks and dependencies. The LLM describes the opposite trajectory - FROM pilot-scale TO higher-volume, cost-optimized offering with improved yield and lower expenses. This is a fundamental misreading of the evolution. (3) MISSING KEY ELEMENTS: The ground truth emphasizes Tesla's shift to emphasizing 'dependencies and risks' including 'potential delays, supply chain constraints, and challenges in launching and ramping products.' The LLM instead presents an optimistic narrative about integration, distributed supply chains, and government incentives - missing the cautionary tone entirely. (4) UNSUPPORTED CLAIMS: The LLM introduces specific details not in the ground truth (integration with Powerwall, software-driven design, broader supplier sourcing, government tax credits, land-use agreements) that appear fabricated or hallucinated. (5) MULTI-HOP REASONING: The LLM failed to correctly synthesize the 2022-to-2023 evolution. The ground truth shows a clear pivot from active manufacturing to risk acknowledgment; the LLM shows a narrative of operational improvement and scaling. (6) SEMANTIC MISMATCH: The ground truth's 'cautionary outlook on strategic execution risks' is fundamentally different from the LLM's 'cost-optimized offering' narrative. The LLM appears to have generated a plausible-sounding but factually incorrect answer about Solar Roof evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 523,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How has the role of syrups in Coca-Cola's business model evolved between 2022 and 2023, particularly in terms of their relationship to finished beverage production and distribution channels?",
      "original_answer": "In 2022, Coca-Cola described syrups as intermediate products used primarily in fountain beverage production, where bottling partners or fountain retailers mix them with water and sweeteners to create finished beverages for immediate consumption. The company emphasized that syrups were a key part of the concentrate operations, which generally yield lower net operating revenues but higher gross profit margins compared to finished product operations. By 2023, the company expanded its description to emphasize that fountain syrup sales in the U.S. were directly managed by Coca-Cola and sold to both fountain retailers and authorized wholesalers or bottling partners. Additionally, the 2023 filing highlighted that fountain syrup operations were specifically included in the North America operating segment, indicating a more structured and regionally focused approach to syrup distribution. This evolution reflects a strategic shift toward tighter control and segmentation of syrup-related revenue streams within the broader beverage production ecosystem.",
      "llm_answer": "\nBetween 2022 and 2023 the Company’s syrup business remained anchored in its “concentrate operations” but took on a more central, higher‑margin role: syrups are now sold both to bottling partners (who use them to make packaged finished drinks) and directly to fountain‑retailers and wholesalers, with those sales reported in the Global Ventures and Bottling Investments segments – a shift that tightens the link between syrup supply, finished‑beverage production and the Company’s broader distribution network 【page 6; page 32】 (2022 description) and is reflected in the segment‑level disclosures shown in the 2023 filing 【page 122】.  This evolution underscores a strategic move to treat syrup sales as a primary growth channel that feeds both the packaged‑goods bottling system and the expanding fountain‑retail channel.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) SEGMENT ATTRIBUTION ERROR - The LLM claims syrup sales are 'reported in the Global Ventures and Bottling Investments segments' in 2023, but the ground truth explicitly states they are 'included in the North America operating segment.' This is a critical factual error that contradicts the core finding about structural changes. (2) INCOMPLETE CHARACTERIZATION OF 2022 - The LLM fails to adequately capture that in 2022, syrups were described as 'intermediate products' with 'lower net operating revenues but higher gross profit margins' compared to finished products. This margin distinction is important context. (3) DISTRIBUTION CHANNEL ACCURACY - The LLM correctly identifies that 2023 shows direct sales to fountain retailers and wholesalers, but incorrectly attributes this to different segments. The ground truth specifies these are in the 'North America operating segment,' not Global Ventures/Bottling Investments. (4) STRATEGIC FRAMING - While the LLM captures the general idea of 'tighter control' and 'strategic shift,' it misidentifies the mechanism (segment placement) through which this control is exercised. (5) MULTI-HOP SYNTHESIS - The model attempts to synthesize across years but makes a fundamental error in segment classification that undermines the entire analysis. The page citations provided (page 122 for 2023) may reference segment disclosures, but the segment identification itself is incorrect. WHAT WAS CORRECT: The LLM correctly identifies that syrups remain part of concentrate operations, that they serve both bottling partners and fountain retailers, and that there was an evolution toward more direct management. However, these correct elements are overshadowed by the critical segment misidentification.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1480,
        "completion_tokens": 480,
        "total_tokens": 1961
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How has the company's operational focus on Africa/Eurasia evolved between 2022 and 2024, particularly in terms of its geographic reporting structure and financial contribution?",
      "original_answer": "In 2022, Africa/Eurasia was reported as part of the Oral, Personal and Home Care segment with an operating profit of $203 million, indicating a relatively minor financial contribution compared to other regions. By 2024, the company maintained Africa/Eurasia as a distinct reportable operating segment within the Oral, Personal and Home Care geographic structure. Additionally, in 2024, the company realigned its skin health business, shifting it from Europe to North America, signaling a strategic refinement in geographic reporting. This change suggests a more nuanced operational focus in how the company organizes and evaluates its regional performance, including in Africa/Eurasia.",
      "llm_answer": "\nBetween 2022 and 2024 the company kept Africa/Eurasia as a distinct geographic operating segment, and its operating‑profit contribution remained modest—about $200 million (roughly 6 % of total operating profit) in the latest figures disclosed. The only structural change was the July 2024 realignment that moved skin‑health brands from Europe to North America, which left Africa/Eurasia’s reporting and financial contribution unchanged.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates substantial accuracy with mostly correct information but has some notable gaps in completeness. STRENGTHS: (1) Correctly identifies Africa/Eurasia as a distinct reportable operating segment maintained between 2022-2024; (2) Accurately cites the July 2024 skin health realignment from Europe to North America; (3) Provides reasonable financial context with ~$200 million operating profit figure, which aligns with the ground truth's $203 million for 2022; (4) Correctly characterizes the contribution as modest (~6% of total operating profit is a reasonable estimate); (5) Sound multi-hop reasoning connecting geographic structure changes to strategic refinement. WEAKNESSES: (1) The answer states Africa/Eurasia's 'reporting and financial contribution unchanged' which is somewhat misleading—while the segment remained distinct, the ground truth emphasizes this as part of a 'more nuanced operational focus' and 'strategic refinement in geographic reporting,' suggesting the company was actively managing and evaluating regional performance differently; (2) The answer doesn't fully capture the evolution aspect of the question—it presents the situation more as static ('kept...unchanged') rather than highlighting how the company's operational focus evolved; (3) Missing the context that the skin health realignment represents a broader strategic shift in how the company organizes regional performance; (4) The percentage calculation (~6%) is reasonable but not explicitly verified against ground truth figures. QUANTITATIVE VERIFICATION: The $200-203 million figure is accurate (minor rounding acceptable). The percentage estimate of 6% appears reasonable but isn't explicitly confirmed in the ground truth. Dates (2022, 2024, July 2024) are all correct. MULTI-HOP REASONING: The answer correctly synthesizes information about segment structure persistence and the 2024 realignment, but could better connect these to the broader evolution narrative. The reasoning is sound but somewhat incomplete in addressing the 'evolution' aspect of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 559,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How has Johnson & Johnson's strategic presentation of its Orthopaedics business evolved between 2023 and 2024, particularly in terms of global sales performance and emphasis on enabling technologies?",
      "original_answer": "In 2023, JNJ's Orthopaedics segment was presented primarily through quantifiable sales figures, with global revenue reaching $8,942 million, showing a 4.1% increase from the prior year. The 2023 data emphasized steady growth, particularly in the U.S. ($5,525 million, up 3.8%) and modest international growth ($3,417 million, up 4.6%). By 2024, the strategic framing of Orthopaedics shifted from financial metrics to a qualitative emphasis on innovation and enabling technologies. The 2024 filing described Orthopaedics as a portfolio 'supported by products and enabling technologies' across hips, knees, trauma, spine, and sports medicine, without revisiting specific revenue figures. This reflects a strategic pivot from highlighting quantitative performance to underscoring technological leadership and product diversification within the segment.",
      "llm_answer": "\nBetween 2023 and 2024 the Orthopaedics business grew modestly – worldwide sales rose from **$8.94 billion in 2023** (U.S. $5.53 B, International $3.42 B) to roughly **$9.3 billion in 2024**, with international sales out‑pacing U.S. growth (page 90, page 8).  The 2024 presentation increasingly frames orthopaedics around **enabling technologies**—robotic‑assisted surgery, navigation and digital health platforms—highlighting these tools as core growth drivers and allocating greater R&D and partnership resources to them (pages 8, 103).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS: (1) The LLM provides a 2024 revenue figure of '$9.3 billion' which is NOT present in the ground truth. The ground truth explicitly states that the 2024 filing 'without revisiting specific revenue figures' - meaning 2024 numbers were NOT disclosed in the filing. This is a major factual error that contradicts the core finding that 2024 shifted away from quantitative metrics. (2) The LLM claims 'international sales out-pacing U.S. growth' but provides no 2024 breakdown to support this comparison, and the ground truth indicates 2024 did not provide specific revenue figures at all. (3) The LLM correctly identifies the 2023 figures ($8,942M ≈ $8.94B, U.S. $5,525M ≈ $5.53B, International $3,417M ≈ $3.42B) with proper format conversion. (4) The qualitative shift toward 'enabling technologies' is correctly identified and aligns with ground truth emphasis on innovation framing. (5) However, the LLM's citation of specific page numbers and claims about R&D allocation cannot be verified against the ground truth provided. MULTI-HOP REASONING: The LLM failed to synthesize the key insight that 2024 deliberately moved AWAY from quantitative reporting, instead fabricating a 2024 revenue figure. This is a fundamental misunderstanding of the strategic evolution described in the ground truth. The answer conflates the presence of enabling technology discussion (correct) with the presence of 2024 revenue data (incorrect). VERDICT: While the LLM captures some qualitative elements correctly, the invention of a 2024 revenue figure that contradicts the ground truth's explicit statement about the absence of 2024 figures is a critical error that severely undermines the answer's credibility.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 465,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How has Visa's approach to managing litigation liabilities through loss sharing agreements evolved between 2022 and 2023, particularly in terms of the scope of U.S. covered litigation and liability allocation?",
      "original_answer": "In 2022, Visa detailed specific amendments to its loss sharing agreement, including the October 2015 amendment that expanded the scope of U.S. covered litigation to include opt-out actions from the Rule 23(b)(3) Settlement Class in MDL 1720 that arose out of similar facts or circumstances. This amendment was part of a broader framework involving the omnibus agreement, under which Visa assumed 66.6667% of any monetary liability in covered settlements or judgments, with Mastercard assuming 33.3333%. In 2023, Visa consolidated its approach under the U.S. Retrospective Responsibility Plan, which now encompasses the loss sharing agreement as part of a broader set of mechanisms designed to address potential liabilities from U.S. covered litigation. Notably, the 2023 filing emphasizes that U.S. covered litigation now includes matters that have been 'settled or otherwise fully or substantially resolved,' indicating a shift toward resolution and consolidation of past liabilities. The evolution from a focus on specific amendments and liability sharing with Mastercard in 2022 to a more comprehensive and retrospective liability framework in 2023 suggests a strategic pivot toward finalizing and managing legacy litigation exposure.",
      "llm_answer": "\nBetween 2022 and 2023 Visa broadened the definition of “U.S. covered litigation” to expressly include any post‑October 2015 opt‑out actions from the Interchange MDL that are not transferred to the MDL, whereas the 2022 disclosure only referenced the MDL and related matters.  At the same time the allocation of liability was refined: the omnibus agreement now splits any settlement or judgment amount ≈ 66.7 % to Visa and ≈ 33.3 % to Mastercard, and each Visa member’s share is calculated by its membership proportion under the loss‑sharing agreement, with any shortfall funded from the litigation escrow and reflected through conversion‑rate adjustments to the preferred‑stock recovery account.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant issues in addressing the core question about evolution of Visa's litigation liability management between 2022 and 2023. STRENGTHS: (1) Correctly identifies the 66.7%/33.3% liability split between Visa and Mastercard, (2) Mentions the omnibus agreement framework, (3) References the October 2015 amendment and MDL context. CRITICAL WEAKNESSES: (1) The LLM answer focuses on broadening the definition of 'U.S. covered litigation' to include 'post-October 2015 opt-out actions from the Interchange MDL,' but the ground truth indicates the October 2015 amendment already expanded scope to include opt-out actions from Rule 23(b)(3) Settlement Class in MDL 1720 - this is not a 2022-to-2023 evolution but rather a pre-existing framework. (2) The LLM answer fails to address the key 2023 evolution identified in the ground truth: the consolidation under the 'U.S. Retrospective Responsibility Plan' and the shift toward 'settled or otherwise fully or substantially resolved' matters. This represents the actual strategic pivot mentioned in the ground truth. (3) The LLM introduces concepts like 'litigation escrow,' 'conversion-rate adjustments,' and 'preferred-stock recovery account' that are not mentioned in the ground truth and appear to be fabricated details not supported by the source material. (4) The answer mischaracterizes what changed between 2022 and 2023 - it suggests a broadening of scope when the ground truth indicates a consolidation and retrospective approach to managing legacy litigation. (5) The multi-hop reasoning is incomplete: the answer does not synthesize the evolution from 'specific amendments and liability sharing' (2022) to 'comprehensive and retrospective liability framework' (2023) as described in the ground truth. The quantitative accuracy is moderate (liability percentages correct) but the qualitative accuracy is poor due to misidentification of what actually evolved and introduction of unsupported details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1499,
        "completion_tokens": 534,
        "total_tokens": 2033
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did CL's investment in Guaranteed Investment Contracts evolve between 2022 and 2024, and what does this shift indicate about the company's pension plan asset strategy?",
      "original_answer": "In 2022, CL held $1 million in Guaranteed Investment Contracts under its United States Pension Plans and $55 million under its International Pension Plans. By 2024, the company had completely phased out Guaranteed Investment Contracts from its United States Pension Plans, reducing the International allocation to $34 million. This represents a significant shift away from Guaranteed Investment Contracts in the U.S. and a moderate decrease internationally, indicating a strategic reallocation of pension plan assets.",
      "llm_answer": "\nBetween 2022 and 2024 Colgate‑Palmolive’s exposure to Guaranteed Investment Contracts (GICs) in its defined‑benefit plans fell sharply – the International portfolio dropped from about **$34 million in 2023 to $30 million in 2024** (and from roughly **$55 million in 2020**), while the U.S. plans held **no GICs at all**.  This reduction reflects a deliberate move away from low‑yield, illiquid guaranteed contracts toward a larger share of fixed‑income securities, pooled funds and other market‑linked assets, signalling that the company is reshaping its pension‑plan asset strategy to improve liquidity, better match liability cash‑flow needs and seek higher risk‑adjusted returns.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant quantitative inaccuracies that undermine its credibility. (1) INCORRECT NUMBERS: The ground truth states International GICs were $55 million in 2022 and $34 million in 2024. The LLM claims $34 million in 2023 and $30 million in 2024, which contradicts the ground truth values. The LLM also references $55 million in 2020 (not provided in ground truth) rather than 2022. (2) MISSING KEY DATA: The LLM completely omits the U.S. Pension Plans data for 2022 ($1 million), which is a critical part of the evolution story. While the LLM correctly notes U.S. plans held 'no GICs at all' in 2024, it fails to establish the baseline from which this elimination occurred. (3) MULTI-HOP SYNTHESIS FAILURE: The question asks about evolution 'between 2022 and 2024,' but the LLM provides 2023-2024 data for International plans and references 2020 data, creating a confused timeline that doesn't properly address the requested period. (4) QUALITATIVE REASONING: The LLM's interpretation about strategic reallocation toward 'fixed-income securities, pooled funds and other market-linked assets' is reasonable and aligns with the ground truth's characterization of 'strategic reallocation,' but this cannot compensate for the quantitative errors. (5) ENTITY ACCURACY: The company is correctly identified as Colgate-Palmolive (CL), and the distinction between U.S. and International plans is maintained, though the data is wrong. The core answer structure is sound, but the execution is severely flawed due to incorrect numbers and missing critical baseline data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 440,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How has the strategic positioning and functionality of the Mastercard Developer Platform evolved between 2022 and 2024, particularly in terms of its role in enabling integration of digital assets and new technologies?",
      "original_answer": "In 2022, the Mastercard Developer Platform was described as a single access point that enables customers and partners to leverage Mastercard's digital assets and services, with an emphasis on ease of integration into new and existing solutions. By 2024, the platform continued to serve this role but expanded its strategic positioning by explicitly aligning with emerging technologies such as blockchain and digital currencies. In 2024, the platform was referenced in the context of enabling integration with the Mastercard Multi-Token Network™, which supports programmable payments and facilitates secure, scalable, and interoperable blockchain-based transactions. This evolution shows a shift from a general digital integration platform to one that specifically supports next-generation financial technologies and programmable commerce solutions.",
      "llm_answer": "\nBetween 2022 and 2024 the Mastercard Developer Platform shifted from a primarily payments‑API gateway to a broader, single‑access hub that streamlines integration of Mastercard’s digital assets and emerging technologies.  The 2024 disclosures note that the platform “makes it easy for customers and partners to leverage our many digital assets…by providing a single access point with tools and capabilities to find APIs across a broad range of Mastercard services,” and that it now supports blockchain‑based programmable payments, crypto‑related services, tokenization, biometric authentication and other new tech — all of which enable partners to embed digital‑asset functionality (e.g., blockchain wallets, Click‑to‑Pay, tokenized credentials) directly into their solutions [page 14, 13, 15].  This evolution reflects a strategic positioning of the platform as the primary conduit for partners to integrate new payment‑related innovations such as blockchain ecosystems, digital‑first cards and contactless/Click‑to‑Pay experiences.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the core evolution of the platform from 2022 to 2024, capturing the shift toward supporting emerging technologies. (2) The answer accurately references specific technologies mentioned in the ground truth (blockchain, digital currencies, programmable payments, tokenization). (3) The LLM provides additional contextual details about specific features (Click-to-Pay, biometric authentication, digital-first cards) that align with the platform's expanded scope. (4) The answer correctly identifies the platform's role as a 'single access point' in both periods. (5) Page references are provided, suggesting source documentation.\n\nWEAKNESSES: (1) CRITICAL: The LLM answer claims the platform shifted 'from a primarily payments-API gateway' in 2022, but the ground truth states it was already described as 'a single access point' in 2022 - this mischaracterizes the 2022 baseline. The ground truth does not describe it as primarily an API gateway in 2022. (2) The LLM answer does not explicitly mention the Mastercard Multi-Token Network™, which is specifically highlighted in the ground truth as a key 2024 development. This is a notable omission of a named product/initiative. (3) The ground truth emphasizes the shift toward 'next-generation financial technologies and programmable commerce solutions' as the key strategic positioning change, while the LLM frames it more broadly as a 'conduit for partners to integrate new payment-related innovations' - slightly different emphasis. (4) The LLM provides more granular feature details than the ground truth, which could be seen as either helpful elaboration or potential over-specification beyond what was verified in the knowledge graph.\n\nMULTI-HOP REASONING: The answer correctly synthesizes information across 2022 and 2024 periods and identifies the evolution pattern. However, the characterization of the 2022 starting point appears inaccurate based on the ground truth.\n\nNUMERIC/FACTUAL VERIFICATION: No specific numbers, dates, or calculations are provided in either answer, so quantitative accuracy is not directly testable. The years (2022, 2024) are correct.\n\nJUSTIFICATION: The answer captures much of the correct evolution narrative but contains a material mischaracterization of the 2022 baseline and omits the specific Multi-Token Network reference. These are meaningful gaps in accuracy relative to the ground truth, warranting a score in the 6 range rather than 7+.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1488,
        "completion_tokens": 659,
        "total_tokens": 2147
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How has the company's investment in U.S. common stocks within its pension plans evolved between 2022 and 2024, and what does this indicate about its strategic asset allocation?",
      "original_answer": "In 2022, the company reported no investments in U.S. common stocks within its pension plans, while by 2024, there was still no allocation to U.S. common stocks in the U.S. pension plan. However, the international pension plan maintained a $2 million investment in U.S. common stocks in both years. This indicates a continued strategic decision to avoid direct exposure to U.S. common stocks in the domestic pension portfolio while maintaining a minimal presence in the international portfolio.",
      "llm_answer": "\nBetween 2022 and 2024 the company’s direct exposure to U.S. common stocks in its pension funds fell to a near‑negligible level—​the 2024 disclosure shows only a $1 million (Level 1) holding, down from a slightly larger direct position in 2022 that was later absorbed into pooled‑fund allocations, and by 2023 the separate “U.S. common stocks” line was eliminated altogether.  This shift reflects a deliberate move away from concentrated equity exposure toward a more diversified mix of pooled funds, fixed‑income and other assets that aligns with the plan’s target allocation (≈ 26 % U.S. equity, 60 % fixed income), underscoring a strategic re‑balancing to reduce risk and support a broader, more stable asset‑allocation framework.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM claims a '$1 million (Level 1) holding' in 2024, but the ground truth explicitly states there was 'no allocation to U.S. common stocks in the U.S. pension plan' in 2024. The LLM also references a 'slightly larger direct position in 2022' that was 'absorbed into pooled-fund allocations,' but the ground truth states the company 'reported no investments in U.S. common stocks within its pension plans' in 2022. (2) INCOMPLETE SYNTHESIS: The LLM completely misses the critical detail that the international pension plan maintained a $2 million investment in U.S. common stocks in both 2022 and 2024. This is a material omission that changes the narrative. (3) FABRICATED DETAILS: The LLM introduces specific percentages ('≈ 26% U.S. equity, 60% fixed income') and references to 'pooled funds' and 'target allocation' that are not mentioned in the ground truth and appear to be hallucinated. (4) INCORRECT NARRATIVE: The LLM describes a 'shift' and 'deliberate move away' from equity exposure, but the ground truth indicates a consistent strategic decision to maintain zero exposure in the U.S. plan while keeping minimal exposure ($2M) in the international plan across both years. The LLM fundamentally mischaracterizes the evolution (or lack thereof) of the company's U.S. common stock allocation. The answer demonstrates poor multi-hop reasoning and factual accuracy on the core quantitative data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 420,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did Disney's strategic focus on cruise ships evolve between 2022 and 2023, particularly in terms of capital investment plans and operational risk considerations?",
      "original_answer": "In 2022, Disney highlighted cruise ships as a key part of its capital investment strategy within the Parks & Experiences segment, noting that a majority of its capital spending was directed toward theme parks, resorts, and cruise ships. This indicated a growth-oriented approach focused on expanding physical assets. By 2023, the emphasis had shifted toward operational risks associated with cruise ships, particularly in the context of external disruptions like hurricanes and global events (e.g., the impact of Hurricane Milton on Walt Disney World operations). The 2023 filing framed cruise ships more as an operational exposure rather than a growth engine, signaling a shift from investment to risk mitigation. This evolution reflects a recalibration of strategic focus from asset expansion to managing volatility and external threats.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2023 Disney moved from treating cruise‑ship development as just one component of its overall parks‑and‑experiences capital budget (see 2022 10‑K pages 24 and 17, which note that “the majority of the Company's capital spend… is… for theme‑park expansion, new attractions, cruise ships, capital improvements”) to an explicit strategic priority: in 2023 the company announced plans to expand its cruise‑ship fleet and to increase investment in the Experiences segment (2023 10‑K page 21).  This shift signals a stronger, dedicated focus on growing the cruise business, but it also introduces execution and market‑risk considerations—management warns that new investments carry uncertainty, can strain cost structures, and depend on consumer demand and broader economic conditions (2023 10‑K pages 21‑22).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer fundamentally misrepresents the evolution of Disney's strategic focus on cruise ships between 2022 and 2023. CRITICAL ERRORS: (1) DIRECTIONAL REVERSAL: The LLM claims Disney moved FROM treating cruise ships as 'just one component' TO 'an explicit strategic priority' with 'stronger, dedicated focus on growing the cruise business.' This directly contradicts the ground truth, which states the shift was FROM a 'growth-oriented approach' TO 'operational risks' and 'risk mitigation.' The LLM has inverted the narrative entirely. (2) MISSING KEY CONTEXT: The ground truth emphasizes that 2023 shifted focus to 'operational risks associated with cruise ships, particularly in the context of external disruptions like hurricanes and global events.' The LLM completely omits this critical risk-mitigation aspect that defines the 2023 evolution. (3) MISCHARACTERIZATION OF 2023 STRATEGY: The LLM frames 2023 as announcing 'plans to expand its cruise-ship fleet and to increase investment,' presenting this as a growth signal. However, the ground truth indicates 2023 reframed cruise ships as an 'operational exposure rather than a growth engine,' signaling a shift FROM investment TO risk management. (4) INCOMPLETE SYNTHESIS: While the LLM does mention 'execution and market-risk considerations' and warnings about uncertainty, these are presented as secondary concerns accompanying growth plans, not as the primary strategic reorientation that actually occurred. The ground truth indicates risk mitigation became the PRIMARY focus, not a secondary consideration. (5) PAGE REFERENCES: The LLM cites specific page numbers (2022 10-K pages 24 and 17; 2023 10-K pages 21-22) but these cannot be verified against the ground truth, and the interpretation of what those pages convey appears incorrect based on the ground truth narrative. The answer demonstrates a fundamental misunderstanding of the question's core requirement: identifying how Disney's strategic focus EVOLVED, which requires recognizing a shift in emphasis and priority, not merely adding risk considerations to an ongoing growth strategy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 567,
        "total_tokens": 1989
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has Mastercard's use of short duration foreign exchange derivative contracts evolved between 2022 and 2024, particularly in terms of their role in managing foreign exchange risk during daily settlement activities?",
      "original_answer": "In 2022, Mastercard used short duration foreign exchange derivative contracts to manage foreign exchange risk associated with daily settlement activities, aiming to reduce exposure to volatility from currency fluctuations on anticipated receipts and disbursements. By 2024, the company continued this practice, maintaining the same stated objective of minimizing volatility in gains and losses due to foreign exchange fluctuations. However, the context changed as the company actively adjusted its hedging strategies involving euro-denominated debt, de-designating and re-designating portions of it in 2023 and 2024, which indicates a more dynamic approach to managing foreign exchange exposure across the period. The continuity in the use of short duration contracts contrasts with the evolving structure of the company’s broader foreign exchange risk management strategy.",
      "llm_answer": "\nMastercard continued to rely on short‑duration foreign‑exchange derivatives to neutralize the few‑day currency exposure that occurs in its daily settlement of payments, but the program was markedly scaled back between 2022 and 2024.  The notional amount of the non‑designated FX contracts fell from roughly $5.4 bn in 2023 to about $2.7 bn in 2024, indicating a narrower use of these instruments as the company shifted toward longer‑term cash‑flow and net‑investment hedges for broader currency risk.  The derivatives remain classified as non‑designated economic hedges, with any gains or losses recorded directly in general and administrative expense and forward points amortized over the brief hedge period.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not supported by the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM provides specific notional amounts ($5.4bn in 2023, $2.7bn in 2024) that are not mentioned in the ground truth answer. These numbers cannot be verified against the provided ground truth and appear to be fabricated or from unreliable sources. (2) CONTRADICTORY NARRATIVE: The ground truth emphasizes CONTINUITY in the use of short duration contracts with the same stated objective between 2022 and 2024, while the LLM claims the program was 'markedly scaled back.' This is a fundamental contradiction. (3) MISSING KEY INFORMATION: The LLM fails to mention the important context about euro-denominated debt hedging adjustments (de-designating and re-designating in 2023-2024) that the ground truth identifies as indicating a 'more dynamic approach.' (4) PARTIAL ACCURACY: The LLM correctly identifies that these are non-designated economic hedges with gains/losses recorded in general and administrative expense, and correctly notes the short duration nature of the contracts. However, this partial correctness is overshadowed by the major factual errors. (5) MULTI-HOP REASONING: The LLM failed to properly synthesize the evolution described in the ground truth, which emphasizes continuity in daily settlement hedging while noting broader strategic changes in the company's overall FX risk management approach. The LLM instead created a narrative of scaling back that contradicts the ground truth's emphasis on continuity. The answer demonstrates a fundamental misunderstanding of how Mastercard's FX derivative strategy evolved between 2022-2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 465,
        "total_tokens": 1878
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has Salesforce's strategic relationship with enterprise cloud companies evolved from 2023 to 2024, particularly in terms of investment focus and ecosystem integration?",
      "original_answer": "In 2023, Salesforce maintained a portfolio of strategic investments in enterprise cloud companies, technology startups, and system integrators, with a focus on digitally transforming industries and expanding its solution ecosystem. These investments were described as ranging from early to late-stage companies, including those concurrent with initial public offerings. By 2024, Salesforce's relationship with enterprise cloud companies shifted from primarily investing to a broader strategic dependency, leveraging these partners as part of its ecosystem to accelerate reach into new markets and industries. The 2024 filing emphasized the Salesforce Platform's role in enabling third-party developers and ISVs to create and deliver cloud-based applications through the AppExchange, indicating a deepened integration and dependency on enterprise cloud partners beyond mere financial investment.",
      "llm_answer": "\nFrom 2023 to 2024 Salesforce shifted from a broad‑based investment program in enterprise‑cloud startups toward a more AI‑centric, ecosystem‑focused strategy.  In the 2023 filing (page 23) the company described “strategic investments in privately‑held and public enterprise‑cloud companies…to expand our solution ecosystem,” while the 2024 filing (pages 8 and 10) emphasizes that these investments now target AI‑driven platforms and are tightly integrated with Salesforce’s own services—most visibly through the Agentforce AI‑agent layer and deeper AppExchange/partner collaborations.  This evolution reflects a tighter coupling of capital deployment with product‑level ecosystem integration, accelerating the company’s reliance on acquired cloud technologies and partner‑built extensions to deliver AI‑enhanced capabilities.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures some correct elements but introduces significant inaccuracies and unsupported claims. CORRECT ELEMENTS: (1) The answer correctly identifies the shift from 2023 to 2024 in Salesforce's strategic approach; (2) Correctly mentions AppExchange and partner ecosystem integration; (3) Appropriately references the evolution toward ecosystem dependency. SIGNIFICANT ERRORS: (1) The LLM introduces 'AI-centric' and 'Agentforce AI-agent layer' as primary drivers of the 2023-2024 evolution, but the ground truth does not emphasize AI as the key differentiator in this shift. The ground truth focuses on the shift from 'investing' to 'strategic dependency' and ecosystem integration, not AI-centricity; (2) The LLM cites specific page numbers (page 23 for 2023, pages 8 and 10 for 2024) without verification against actual filings—these citations cannot be confirmed and may be hallucinated; (3) The characterization of the shift as 'from broad-based investment program...toward AI-centric' misrepresents the ground truth, which emphasizes the shift from financial investment to strategic ecosystem dependency, not an AI pivot. MULTI-HOP REASONING: The LLM attempts to synthesize across 2023 and 2024 filings but does so by introducing an AI narrative that isn't supported by the ground truth. The ground truth emphasizes 'leveraging these partners as part of its ecosystem' and 'deepened integration and dependency,' while the LLM emphasizes 'AI-driven platforms' and 'Agentforce.' QUANTITATIVE ISSUES: No specific financial metrics are provided in either answer, so quantitative accuracy is difficult to assess, but the LLM's unsupported page citations represent a factual accuracy problem. SEMANTIC EQUIVALENCE: While the LLM's general framing of ecosystem integration is semantically similar to the ground truth, the emphasis on AI as the primary driver of evolution diverges from the ground truth's focus on the shift from investment to strategic dependency. The answer is partially correct but contains material inaccuracies in characterizing the nature of the strategic evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 564,
        "total_tokens": 2000
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did the company's approach to accrual rates for vendor funding programs evolve between fiscal 2023 and fiscal 2024, particularly in terms of sensitivity to projected purchase volumes?",
      "original_answer": "The company's approach to accrual rates for vendor funding programs remained methodologically consistent between fiscal 2023 and fiscal 2024, with no material changes in the recognition methodology over the past three fiscal years. However, in fiscal 2023, the company specifically highlighted sensitivity to 'graduated purchase volumes' that could impact accrued amounts, emphasizing the importance of projected volumes in determining accrual rates. In fiscal 2024, this explicit reference to 'graduated purchase volumes' was omitted, suggesting a potential simplification or stabilization in how accrual rates were adjusted throughout the year, despite continued monitoring of historical purchase trends and vendor confirmations.",
      "llm_answer": "\nThe filing shows that the company’s method for accruing vendor‑fund revenues was unchanged between fiscal 2023 and fiscal 2024 – it continues to base accruals on the terms of each vendor agreement and to revise those accrual rates throughout the year as actual purchase volumes are compared with projections.  Because many of the funding arrangements provide stepped or graduated increases when purchase thresholds are met, the accrual amounts are especially sensitive to whether the company exceeds or falls short of those projected volumes.  The company emphasizes that it performs ongoing analyses of purchase trends, confirms accrued amounts with select vendors, and notes that deviations from projected volumes can materially affect the recorded vendor‑fund balance, but it did not adopt a new methodology – the same sensitivity‑focused approach was retained from 2023 to 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains both accurate and problematic elements. CORRECT ASPECTS: (1) The core fact that methodology remained unchanged between fiscal 2023 and 2024 is accurate. (2) The description of accrual rates being based on vendor agreement terms and revised throughout the year is correct. (3) The mention of stepped/graduated increases and sensitivity to purchase thresholds is accurate. (4) The reference to ongoing analyses of purchase trends and vendor confirmations is correct. PROBLEMATIC ASPECTS: (1) The LLM answer states the company 'did not adopt a new methodology – the same sensitivity-focused approach was retained from 2023 to 2024,' which is misleading. The ground truth indicates that while methodology remained consistent, there was a KEY CHANGE in disclosure: fiscal 2023 explicitly highlighted sensitivity to 'graduated purchase volumes,' but fiscal 2024 OMITTED this explicit reference, suggesting a potential simplification or stabilization in how accrual rates were adjusted. (2) The LLM answer fails to capture this important evolution in disclosure/emphasis between the two years. The ground truth emphasizes that the explicit reference to 'graduated purchase volumes' was omitted in fiscal 2024, which is a material change in how the company communicated about its approach, even if the underlying methodology remained consistent. (3) The LLM answer conflates 'no change in methodology' with 'no change in approach,' missing the nuanced distinction that the ground truth makes about changes in disclosure emphasis and communication. MULTI-HOP REASONING: The LLM correctly synthesizes information about how accrual rates work and their sensitivity to volumes, but fails to properly synthesize the comparative analysis between fiscal 2023 and fiscal 2024 disclosures. The question specifically asks about evolution 'between fiscal 2023 and fiscal 2024,' and the ground truth identifies a specific evolution in disclosure (omission of explicit 'graduated purchase volumes' language), which the LLM answer misses entirely. QUANTITATIVE ACCURACY: No specific numbers are provided in either answer, so this dimension is neutral (8/10 for not introducing errors). QUALITATIVE ACCURACY: The LLM demonstrates understanding of vendor funding mechanics but fails to capture the key insight about the evolution in disclosure emphasis, which is the core of what the question asks about.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 640,
        "total_tokens": 2053
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How has the strategic relationship between LLY and Boehringer Ingelheim evolved from 2022 to 2024, particularly in terms of legal involvement and collaborative dependency on the Jardiance product?",
      "original_answer": "In 2022, LLY was not a direct party to the Jardiance patent litigation initiated by Boehringer Ingelheim (BI) against generic drug manufacturers under the Hatch-Waxman Act, indicating a more arms-length relationship in legal matters. By 2024, LLY's business became significantly dependent on the Jardiance collaboration, as the product was selected under the Inflation Reduction Act (IRA) for government-set pricing with a 66% discount compared to the 2023 list price, directly impacting LLY's revenue projections and business strategy. This shift reflects a deeper strategic entanglement and dependency on BI's partnership for navigating regulatory and pricing pressures.",
      "llm_answer": "\nFrom 2022 through 2024 the LLY‑Boehringer Ingelheim partnership remained a global, cost‑sharing collaboration on the Jardiance franchise, but the structure shifted in 2024 when the two companies amended the agreement to re‑allocate commercialization duties in certain smaller markets and to trigger a one‑time $300 million payment to LLY; the amendment also introduced new performance‑payment obligations for BI that can reduce LLY’s net Jardiance revenue and can cause the royalty LLY receives to rise or fall with sales thresholds.  Throughout the period LLY continues to share development and commercialization costs equally in the most significant markets, records its share of those costs as R&D and SG&A, and earns a royalty on Jardiance sales while paying BI a royalty on Basaglar sales, and the companies remain entangled in ongoing patent‑infringement and product‑liability matters in which BI defends and indemnifies LLY.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is substantially incorrect and fails to address the core question about the evolution of the LLY-BI relationship from 2022 to 2024. Critical issues: (1) FACTUAL ERRORS: The LLM provides detailed information about cost-sharing arrangements, a $300 million payment, royalty structures, and patent indemnification that are NOT mentioned in the ground truth answer. These appear to be fabricated or from different sources not relevant to the specific question asked. (2) MISSING KEY INFORMATION: The LLM completely fails to address the central distinction in the ground truth - that in 2022 LLY was NOT a direct party to Jardiance patent litigation (indicating arms-length relationship), while by 2024 LLY became significantly dependent on Jardiance due to IRA pricing selection with a 66% discount. This is the core evolution the question asks about. (3) QUANTITATIVE ACCURACY: The ground truth specifies a 66% discount under IRA pricing in 2024 - the LLM mentions a $300 million payment but provides no information about the IRA pricing impact or the 66% discount figure. (4) MULTI-HOP REASONING: The question requires synthesizing information about: (a) legal involvement changes (2022 vs 2024), (b) collaborative dependency evolution, and (c) Jardiance product impact. The LLM addresses only general partnership structure and cost-sharing, missing the legal involvement dimension entirely and the specific IRA pricing dependency that defines the 2024 shift. (5) SEMANTIC MISMATCH: The ground truth emphasizes a shift from 'arms-length' to 'deeper strategic entanglement and dependency' driven by regulatory/pricing pressures. The LLM describes ongoing operational arrangements without capturing this fundamental evolution. The answer reads as generic partnership boilerplate rather than addressing the specific evolution question posed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 501,
        "total_tokens": 1915
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did Disney's capital investment strategy toward cruise ships evolve from 2022 to 2023, particularly in relation to its broader Parks & Experiences business?",
      "original_answer": "In 2022, Disney's 10-K filing highlighted cruise ships as part of its broader Experiences segment but did not specifically emphasize capital investment in them, instead noting general risks from macroeconomic conditions such as inflation, supply chain delays, and currency fluctuations that could impact the implementation of business plans, including those for parks and resorts. By 2023, Disney explicitly listed cruise ships as part of its significant capital investments, indicating a strategic elevation in focus. The 2023 filing stated that the majority of the company’s capital spend was directed toward parks and experiences, including 'new attractions, cruise ships, capital improvements and systems infrastructure.' This shift demonstrates a clear prioritization of cruise ships as a key growth area within the broader Experiences segment.",
      "llm_answer": "\nFrom 2022 to 2023 Disney moved from an aggressive capital‑spending stance on new cruise‑ship construction—evidenced in the 2022 filing’s note that “the majority of the Company’s capital spend… is principally for … new attractions, **cruise ships**, capital improvements and systems infrastructure” (DIS 10‑K 2022, p. 24)—to a more restrained approach.  After the 2022 DMED restructuring and a renewed focus on cost discipline, the 2023 disclosures shifted the emphasis toward core park and resort projects, with capital‑expenditure plans for the cruise line limited to incremental upgrades and fleet‑optimization rather than the launch of new vessels (DIS 10‑K 2023, pp. 11‑12, 87).  Thus, the company’s capital‑investment strategy toward cruise ships evolved from expanding the fleet as a growth lever to integrating and preserving existing cruise‑ship assets within the broader Parks & Experiences business.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer fundamentally contradicts the ground truth on the core factual claim. Ground truth states that cruise ships were NOT specifically emphasized in 2022 but WERE explicitly listed as significant capital investments in 2023. The LLM reverses this narrative, claiming Disney moved from 'aggressive capital-spending' on cruise ships in 2022 to a 'more restrained approach' in 2023. This is factually backwards. The LLM cites a 2022 quote mentioning cruise ships as part of capital spend, but the ground truth explicitly states the 2022 filing did NOT specifically emphasize capital investment in cruise ships—it only noted general risks. The LLM's characterization of 2023 as shifting 'emphasis toward core park and resort projects, with capital-expenditure plans for the cruise line limited to incremental upgrades' directly contradicts the ground truth, which states 2023 explicitly listed cruise ships as part of significant capital investments. The LLM invents details about 'DMED restructuring' and 'cost discipline' that are not supported by the ground truth. The LLM also misrepresents the evolution as moving FROM expansion TO preservation, when the ground truth shows the opposite: FROM general mention TO explicit strategic elevation. The only correct element is that both answers discuss the Parks & Experiences segment and capital allocation, but the directional narrative is entirely inverted. This represents a fundamental failure in multi-hop reasoning and factual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 417,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How has Mastercard Foundry's role in fostering innovation evolved between 2022 and 2024, particularly in relation to its engagement with emerging technologies and fintech partnerships?",
      "original_answer": "In 2022, Mastercard Foundry (formerly known as Mastercard Labs) was primarily described as a vehicle for bringing customers and partners access to thought leadership, innovation methodologies, new technologies, and early-stage fintech players. By 2024, its role had evolved into a more active innovation engine, with continued emphasis on identifying and experimenting with future technologies, start-ups, and trends. Specifically, in 2024, Foundry was positioned as a key enabler of blockchain-based business models and programmable payments through the Mastercard Multi-Token Network™, indicating a strategic shift toward deeper integration with next-generation financial technologies.",
      "llm_answer": "\nBetween 2022 and 2024 Mastercard Foundry moved from a primarily “lab‑style” incubator that ran short‑term prototyping workshops toward a full‑scale innovation engine that actively embeds emerging technologies—such as blockchain‑based multi‑token payments, tokenization, AI‑driven fraud and data analytics, and real‑time account‑based payments—into the core of its offering.  At the same time, Foundry deepened its fintech partnerships by co‑creating VCN‑enabled corporate payment flows, launching the Alias‑Based Remittances and Payouts platform, and collaborating with central banks, digital‑wallet providers and other fintechs to enable faster, data‑rich disbursements and cross‑border transactions.  This evolution reflects a shift from experimental pilots to strategic, ecosystem‑wide collaborations that leverage new tech to create new payment products and revenue streams.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ISSUES: (1) FACTUAL ERRORS - The LLM introduces specific initiatives NOT mentioned in the ground truth: 'VCN-enabled corporate payment flows,' 'Alias-Based Remittances and Payouts platform,' and 'collaborating with central banks, digital-wallet providers' are not referenced in the original answer. These appear to be fabricated or confused with other Mastercard initiatives. (2) INCOMPLETE CORE FACTS - The LLM correctly identifies the evolution from 'lab-style' to 'innovation engine' and mentions blockchain/multi-token payments (which aligns with ground truth's 'Mastercard Multi-Token Network™'), but fails to mention the original 2022 description of Foundry's role in providing 'thought leadership, innovation methodologies, new technologies, and early-stage fintech players access.' (3) QUANTITATIVE ACCURACY - No numbers, dates, or percentages are provided in either answer, so this dimension scores well (8/10) as there are no calculation errors, though the lack of specificity is notable. (4) QUALITATIVE ACCURACY - The LLM's reasoning about evolution is partially sound (lab to engine transition is correct), but the introduction of unverified specific products/partnerships significantly undermines credibility. The answer conflates general Mastercard initiatives with Foundry-specific activities. (5) MULTI-HOP SYNTHESIS - The answer attempts to synthesize 2022-2024 evolution but does so by adding information not in the ground truth rather than accurately synthesizing what was provided. The core insight about blockchain/multi-token network integration is present but buried among unverified claims. VERDICT: While the answer demonstrates understanding of the general evolution trajectory, it fails the primary test of factual accuracy by introducing specific partnerships and platforms that cannot be verified against the ground truth, which is a critical failure in financial/corporate analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 519,
        "total_tokens": 1920
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How has the financial and strategic nature of the collaboration with Boehringer Ingelheim evolved between 2022 and 2024, particularly in terms of regulatory designations and pricing pressures?",
      "original_answer": "In 2022, the collaboration with Boehringer Ingelheim included the development of a therapy that had received Breakthrough Therapy and Fast Track designations from the FDA, indicating early-stage regulatory support and potential expedited development. By 2024, the collaboration faced significant pricing pressures under the Inflation Reduction Act, with Jardiance—part of the LLY-Boehringer Ingelheim partnership—selected for government-set pricing effective in 2026, subject to a 66% discount compared to the 2023 U.S. list price. This marks a shift from regulatory facilitation to regulatory-driven financial constraints.",
      "llm_answer": "\nBetween 2022 and 2024 the Boehringer Ingelheim alliance moved from a simple cost‑sharing arrangement for the Jardiance and Basaglar franchises to a more nuanced structure that added a $300 million performance payment, revised commercial‑responsibility splits in smaller markets, and updated royalty‑performance payment mechanics.  Regulatory‑wise, Jardiance kept its FDA Breakthrough‑Therapy and Fast‑Track designations (and related EU approvals) throughout, but the partnership now confronts significant pricing pressure because the IRA‑mandated government‑set price for Jardiance—scheduled to take effect in 2026—includes a roughly 66 % discount, underscoring a shift toward tighter price controls that will erode revenue despite the continued breakthrough‑designation benefits.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the 66% discount on Jardiance pricing under the IRA effective in 2026—this matches the ground truth exactly. (2) The regulatory designations (Breakthrough Therapy and Fast Track) are correctly mentioned as persisting through the period. (3) The core insight about the shift from regulatory facilitation to regulatory-driven financial constraints is captured. (4) The 2022-2024 timeframe is properly addressed. WEAKNESSES: (1) The LLM introduces substantial information NOT in the ground truth—specifically the $300 million performance payment, revised commercial-responsibility splits, and updated royalty-performance mechanics. While these details may be factually accurate from the filings, they were not part of the original answer's focus on regulatory designations and pricing pressures. This represents scope creep beyond what was asked. (2) The ground truth emphasizes the evolution from 'early-stage regulatory support' (2022) to 'regulatory-driven financial constraints' (2024), but the LLM's answer muddies this narrative by stating designations were 'kept...throughout,' which somewhat contradicts the evolutionary arc of the question. (3) The LLM mentions Basaglar alongside Jardiance, which the ground truth does not reference, adding potentially confusing detail. QUANTITATIVE VERIFICATION: The 66% discount figure is correct and properly contextualized. The 2026 effective date is correct. The $300 million figure cannot be verified against the ground truth provided. MULTI-HOP REASONING: The LLM does synthesize information across 2022-2024 and connects regulatory status to pricing impacts, but the additional commercial details dilute focus on the specific question about regulatory designations and pricing pressures. The answer is partially correct but includes extraneous information that wasn't part of the ground truth synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 513,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How has the strategic positioning of the CH-53K King Stallion heavy lift helicopter evolved within Lockheed Martin's Rotary and Mission Systems segment from 2023 to 2024?",
      "original_answer": "In 2023, the CH-53K King Stallion heavy lift helicopter was described as part of Lockheed Martin's near-to-mid-term growth elements, specifically under the Rotary and Mission Systems (RMS) segment, alongside radar surveillance systems. By 2024, the CH-53K remained a highlighted program within RMS, but the emphasis shifted to framing it within a broader context of advancing all-domain mission solutions and digital technologies such as AI/ML and autonomy. While no specific revenue figures are provided, the helicopter's positioning evolved from being a growth driver among several others to being part of a more integrated, technologically advanced portfolio aimed at improving interoperability and supporting multi-domain solutions.",
      "llm_answer": "\nFrom 2023 to 2024 the CH‑53K moved from being highlighted as a standout growth pillar within RMS—underscored by the 2023 award of the full 12‑helicopter Israeli order—to a central component of Lockheed’s 21st‑Century Security strategy, being integrated into multi‑domain, joint‑all‑domain plans and supported by expanded production and sustainment efforts to capture growing international demand.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. (1) MAJOR ERROR - UNSUPPORTED CLAIMS: The LLM introduces specific claims not present in the ground truth, including: (a) '2023 award of the full 12-helicopter Israeli order' - this specific order detail is not mentioned in the original answer and cannot be verified from the provided ground truth; (b) 'expanded production and sustainment efforts' - not mentioned in ground truth; (c) 'capturing growing international demand' - not substantiated in ground truth. (2) QUANTITATIVE ACCURACY: The LLM provides a specific number ('12-helicopter Israeli order') that is not corroborated by the ground truth, which explicitly states 'no specific revenue figures are provided.' This represents a critical factual error. (3) QUALITATIVE ACCURACY: While the LLM correctly identifies the general evolution from growth driver to integrated portfolio component, it fabricates supporting details. The ground truth describes a shift from 'near-to-mid-term growth elements' to 'part of a more integrated, technologically advanced portfolio' - the LLM's framing of '21st-Century Security strategy' and 'multi-domain, joint-all-domain plans' goes beyond what the ground truth supports. (4) MULTI-HOP REASONING: The LLM fails to properly synthesize the available information. It adds external details (Israeli order, production expansion) that are not part of the knowledge graph answer, suggesting either hallucination or reliance on external knowledge rather than the provided ground truth. (5) SEMANTIC EQUIVALENCE: The core concept of evolution from standalone growth element to integrated solution is preserved, but the specific supporting evidence is fabricated, making the answer fundamentally unreliable despite surface-level thematic alignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 494,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "What does the change in LLY's diabetes product portfolio co-commercialized with Boehringer Ingelheim between 2022 and 2024 indicate about the companies' shifting strategic priorities or market focus?",
      "original_answer": "In 2022, LLY and Boehringer Ingelheim were jointly developing and commercializing a broader portfolio of diabetes products, including Trajenta, Jentadueto, Jardiance, Glyxambi, Synjardy, Trijardy XR, and Basaglar. By 2024, the portfolio had narrowed to include only Jardiance, Glyxambi, Synjardy, and Trijardy XR. This indicates a strategic refocusing, potentially driven by lifecycle management, shifting market demand, or prioritization of products with stronger commercial performance or longer patent protection. The removal of Trajenta, Jentadueto, and Basaglar may reflect declining market relevance, generic competition, or a strategic decision to streamline the collaboration around products with greater growth potential or therapeutic differentiation.",
      "llm_answer": "\nThe 2022‑2024 evolution of the Lilly‑Boehringer Ingelheim diabetes alliance shows that the two firms are deliberately concentrating on diabetes as a core growth engine—expanding the co‑commercialized portfolio (e.g., adding Jardiance, Glyxambi, Synjardy, Trijardy XR and Basaglar) and reinforcing a joint development/commercialization framework that shares risk and leverages each company’s sales reach.  This focus, together with Lilly’s new direct‑to‑consumer platforms for obesity and migraine, signals a strategic shift toward prioritising high‑value, chronic‑disease assets (especially metabolic diseases) and using the BI partnership to accelerate market access, payer‑value demonstrations, and sustained revenue growth, while pulling back from broader therapeutic diversification.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer fundamentally contradicts the ground truth on the core factual claim. Ground truth states the portfolio NARROWED from 7 products in 2022 (Trajenta, Jentadueto, Jardiance, Glyxambi, Synjardy, Trijardy XR, Basaglar) to 4 products in 2024 (Jardiance, Glyxambi, Synjardy, Trijardy XR). The LLM claims the portfolio was 'expanding' and lists products as being 'added,' which is factually incorrect. Specifically: (1) The LLM states 'expanding the co-commercialized portfolio (e.g., adding Jardiance, Glyxambi, Synjardy, Trijardy XR and Basaglar)' - this is backwards. These products were NOT added; rather, Trajenta, Jentadueto, and Basaglar were REMOVED. (2) The LLM incorrectly includes Basaglar in the 2024 portfolio when ground truth explicitly states it was removed. (3) The LLM's strategic interpretation ('deliberately concentrating on diabetes as a core growth engine') misses the actual implication: the narrowing suggests lifecycle management, generic competition, or deprioritization of weaker performers. (4) The LLM introduces unsupported claims about 'direct-to-consumer platforms for obesity and migraine' that are not part of the ground truth answer and appear to conflate LLY's broader strategy with the specific BI diabetes collaboration question. The reasoning about 'expanding' and 'adding' products is logically inverted from what the data shows. While the LLM correctly identifies the companies and general timeframe, the fundamental mischaracterization of portfolio direction (expansion vs. contraction) and the inclusion of incorrect products in the 2024 portfolio represent major factual errors that undermine the entire answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 459,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did the financial performance and strategic importance of the JASSM program evolve between 2023 and 2024, particularly in terms of production activity and its contribution to backlog?",
      "original_answer": "In 2023, JASSM was a product under the Missiles and Fire Control (MFC) segment, contributing to the company's portfolio of tactical missiles, but there was no specific mention of significant changes in its production volume or backlog contribution. By 2024, JASSM experienced a production ramp-up, contributing to a $1.2 billion increase in tactical and strike missile programs within MFC. Additionally, JASSM was specifically cited as a key contributor to the increase in backlog alongside PAC-3 and GMLRS. This indicates a notable rise in both production activity and strategic importance for JASSM in 2024.",
      "llm_answer": "\nIn 2024 the JASSM program helped drive a sharp rise in Missiles & Fire Control net‑sales—about $1.4 billion of the segment’s $1.4 billion sales increase came from higher JASSM production—and that surge lifted the segment’s year‑end backlog to $38.8 billion, up from $32.2 billion in 2023.  Consequently, JASSM became a key contributor to the overall backlog growth (the company cites “higher orders on … JASSM” as a primary reason for the backlog increase), even though the segment’s operating profit fell because of reach‑forward losses on other classified contracts.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM claims JASSM contributed $1.4 billion to MFC's sales increase, but the ground truth states $1.2 billion. This is a significant numerical discrepancy ($200M error). The LLM also provides specific backlog figures ($38.8B in 2024, $32.2B in 2023) that are not present in the ground truth, making them unverifiable and potentially incorrect. (2) MULTI-HOP REASONING - While the LLM correctly identifies JASSM as a key contributor to backlog growth in 2024 and mentions the production ramp-up, it introduces unverified financial specifics that contradict the ground truth's more measured statement of a '$1.2 billion increase in tactical and strike missile programs.' (3) COMPLETENESS - The LLM addresses both production activity and backlog contribution, which are the core elements of the question. However, it adds information about operating profit decline due to reach-forward losses that, while potentially accurate, is not mentioned in the ground truth and may be extraneous. (4) ENTITY ACCURACY - Correctly identifies MFC segment and JASSM program, and correctly notes the 2023-2024 timeframe. (5) SEMANTIC ISSUES - The ground truth indicates JASSM was 'a product under' MFC in 2023 with 'no specific mention of significant changes,' whereas the LLM implies more detailed historical comparison. The core factual error of $1.4B vs $1.2B is a material discrepancy that significantly undermines the answer's reliability.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 410,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How has JPM's focus in evaluating credit risk for Business Banking Loans evolved between 2023 and 2024, and what implications does this shift have for identifying early signs of borrower distress?",
      "original_answer": "In 2023, JPM focused on Business Banking Loans as part of its broader prime consumer credit strategy, emphasizing loan performance and scoring models within the 'Consumer, excluding credit card loan portfolio' segment. By 2024, the focus shifted toward delinquency rates as the primary credit quality indicator, particularly noting that loans more than 30 days past due serve as early warnings of financial difficulty. This evolution suggests a more proactive stance in identifying early signs of borrower distress, aligning Business Banking Loans with broader consumer loan risk frameworks where early delinquency tracking enhances risk mitigation. The shift indicates a strategic move toward earlier intervention and more granular performance monitoring.",
      "llm_answer": "\nBetween 2023 and 2024 JPMorgan moved from a delinquency‑focused view of its Business Banking loans to a risk‑rating‑driven framework.  In the 2024 disclosures (Note 261) the Firm classifies wholesale loans by internal risk grade—​investment‑grade, non‑investment‑grade, criticized‑performing and criticized‑nonaccrual—and reports the corresponding gross charge‑offs, a level of granularity that was only hinted at in the 2023 discussion of “scored auto and business banking loans” (page 250).  Consequently, early signs of borrower distress are now identified through downgrades into the criticized‑performing/nonaccrual buckets and the associated rise in charge‑offs, rather than relying primarily on past‑due status or generic delinquency metrics.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that contradict the ground truth. (1) DIRECTIONAL ERROR: The LLM claims JPM moved FROM delinquency-focused TO risk-rating-driven, which is the OPPOSITE of what the ground truth states. The ground truth explicitly says the focus shifted FROM loan performance/scoring models (2023) TO delinquency rates as primary indicator (2024). (2) INCORRECT FRAMEWORK: The LLM incorrectly references wholesale loan classifications (investment-grade, non-investment-grade, criticized-performing, criticized-nonaccrual) and Note 261, which appears to be about wholesale/commercial loans, not Business Banking Loans. The ground truth specifically addresses Business Banking Loans within the consumer credit segment. (3) WRONG METRIC EMPHASIS: The LLM states early distress is now identified through risk downgrades and charge-offs rather than delinquency metrics. This directly contradicts the ground truth which states the 2024 shift was TOWARD delinquency rates (loans 30+ days past due) as the primary early warning indicator. (4) MISSING CONTEXT: The LLM fails to acknowledge that Business Banking Loans are part of the 'Consumer, excluding credit card loan portfolio' segment, not wholesale loans. (5) CITATION ISSUES: The reference to page 250 and Note 261 cannot be verified against the ground truth provided, and the wholesale loan framework described does not align with Business Banking Loans classification. The answer demonstrates a fundamental misunderstanding of the evolution described in the ground truth and appears to conflate Business Banking Loans with wholesale commercial lending frameworks.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 450,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did Target Corporation's SPP II plan terms evolve between the 2022 and 2023 filings, and what does this suggest about the company's executive compensation framework?",
      "original_answer": "In the 2022 filing, the SPP II plan was described under the 2016 Plan Statement, as amended and restated effective April 3, 2016. However, in the 2023 filing, the SPP II plan was updated to the 2022 Plan Statement, as amended and restated effective May 1, 2022. This indicates that Target Corporation revised the SPP II plan within this timeframe, reflecting a shift in the structure or terms of the plan. Such changes could signal adjustments in the company's executive compensation strategy, potentially aligning incentives more closely with updated business objectives or governance standards.",
      "llm_answer": "\nBetween the 2022 and 2023 filings Target swapped the standalone “SPP II (2016 Plan Statement)” for a restated “SPP II (2022 Plan Statement)” that became effective May 1 2022 and is now filed as Exhibit 10.6 in the 2023 Form 10‑K.  The restated version updates the performance‑metric definitions, share‑limit provisions and governance language and places the plan inside the broader 2022 long‑term incentive framework that also includes the newly restated SPP I.  This consolidation shows that Target is streamlining its executive‑compensation architecture around a newer, unified plan structure, signaling a more centralized, performance‑driven compensation approach.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and provides more detailed information than the ground truth. Key strengths: (1) Correctly identifies the shift from 2016 Plan Statement to 2022 Plan Statement, (2) Accurately cites the May 1, 2022 effective date, (3) Correctly references Exhibit 10.6 in the 2023 Form 10-K, (4) Properly identifies the multi-hop synthesis showing how SPP II was updated within the broader 2022 long-term incentive framework. The answer goes beyond the ground truth by providing additional context about performance-metric definitions, share-limit provisions, governance language updates, and the consolidation with SPP I. This additional detail is accurate and relevant. Minor consideration: The ground truth uses more cautious language ('could signal adjustments') while the LLM is more definitive ('signaling a more centralized, performance-driven compensation approach'), but this represents a reasonable interpretation of the evidence rather than a factual error. All dates, plan names, and structural details are correct. The multi-hop reasoning correctly synthesizes information about how the plan evolved and what this suggests about compensation strategy. No calculation errors or factual inaccuracies detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 352,
        "total_tokens": 1674
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did the financial obligations related to Incyte under the Olumiant collaboration evolve from 2022 to 2024, particularly regarding potential future milestone payments?",
      "original_answer": "In 2022, Incyte was eligible to receive up to $100.0 million in additional development-related regulatory milestones and another $100.0 million in sales-based milestones under the Olumiant agreement. By 2024, there is no mention of remaining regulatory milestones, suggesting they were either paid out or no longer applicable, and only ongoing royalty payments based on sales tiers (up to 20%) and a low teens royalty for sales exceeding a threshold in the context of COVID-19 treatment are explicitly referenced. This indicates a shift from a structure with both regulatory and sales milestones to one focused primarily on sales-based compensation.",
      "llm_answer": "\nFrom 2022 through 2024 the company has already satisfied the regulatory‑milestone obligations that were pending under the Incyte collaboration—​the $260 million and $210 million milestone payments tied to U.S., EU and Japanese approvals were capitalized as intangible assets in 2021‑2022, so no additional regulatory milestone payments are outstanding.  The only remaining contingent amounts are up to $100 million of sales‑based milestones (plus tiered royalties up to 20 %) that could be triggered if Olumiant reaches specified worldwide sales thresholds, a potential future payment that has not changed materially since the 2022 filing.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM introduces numbers ($260 million and $210 million milestone payments) that do not appear in the ground truth and are not substantiated. The ground truth clearly states $100 million in development-related regulatory milestones and $100 million in sales-based milestones for 2022. The LLM's claim about $260M and $210M capitalized as intangible assets in 2021-2022 is unsupported and appears to be fabricated. (2) INCOMPLETE SYNTHESIS: While the LLM correctly identifies that regulatory milestones are no longer mentioned in 2024 and that sales-based milestones (up to $100M) remain, it mischaracterizes the evolution by introducing unverified historical payments. (3) PARTIAL ACCURACY: The LLM correctly notes the tiered royalties up to 20% and that sales-based milestones of up to $100 million remain, which aligns with the ground truth. However, this correct information is undermined by the false claims about prior milestone payments. (4) REASONING FLAW: The LLM attempts to explain why regulatory milestones disappeared (they were paid out and capitalized), but the specific dollar amounts cited ($260M, $210M) are not validated by the ground truth and appear to be hallucinated. The ground truth simply states they 'were either paid out or no longer applicable' without specifying these amounts. (5) MISSING CONTEXT: The LLM fails to clearly articulate the shift from a dual-milestone structure (regulatory + sales) to a sales-focused structure, which is the core insight of the ground truth answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 447,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How has Cisco's financial exposure in the APJC region evolved between fiscal 2022 and fiscal 2023, based on its segment reporting and asset balances?",
      "original_answer": "In fiscal 2022, Cisco reported its business performance across geographic segments including APJC, though specific financial figures for APJC were not disclosed in the provided data. By fiscal 2023, Cisco's balance sheet showed that its assets in the APJC region stood at $5,382 million as of July 29, 2023, following additions from acquisitions and foreign currency translation adjustments. This indicates a more detailed financial disclosure regarding APJC in 2023 compared to 2022, where segment-level asset values were not explicitly itemized.",
      "llm_answer": "\nCisco’s APJC segment revenue is reported as $8.0 billion for fiscal 2022, but the excerpt does not provide a fiscal 2023 figure, so a direct year‑over‑year comparison of exposure cannot be derived from the supplied pages. The only quantitative trend available is the overall rise in contract liabilities from $25.6 billion to $28.5 billion, although the region‑specific portion of that increase is not disclosed.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misalignment with the ground truth. (1) CRITICAL ERROR - The LLM cites $8.0 billion in APJC segment revenue for fiscal 2022, which is not mentioned in the ground truth and appears to be fabricated or from an unsupported source. The ground truth explicitly states that 'specific financial figures for APJC were not disclosed in the provided data' for fiscal 2022. (2) MISSING KEY DATA - The LLM completely fails to identify or report the $5,382 million in APJC assets as of July 29, 2023, which is the primary quantitative finding in the ground truth. This is a major omission of the most concrete financial metric provided. (3) IRRELEVANT INFORMATION - The LLM introduces contract liabilities data ($25.6 billion to $28.5 billion) that is not part of the ground truth answer and is not region-specific, making it tangential to the question about APJC financial exposure. (4) INCOMPLETE SYNTHESIS - The question asks about evolution between fiscal 2022 and 2023 based on segment reporting AND asset balances. The ground truth addresses both (noting lack of 2022 disclosure but providing 2023 asset data). The LLM only attempts segment revenue comparison and misses the asset balance component entirely. (5) REASONING FLAW - The LLM's statement that 'a direct year-over-year comparison of exposure cannot be derived' contradicts the ground truth's finding that 2023 asset data ($5,382 million) does provide quantifiable exposure information. The LLM demonstrates poor multi-hop synthesis by failing to connect available data points and introducing unsupported figures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 444,
        "total_tokens": 1685
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How has the strategic collaboration between LLY and Boehringer Ingelheim, specifically regarding Jardiance, evolved from 2022 to 2024 in response to regulatory changes?",
      "original_answer": "In 2022, Jardiance revenue was growing significantly, with a 30% increase in the U.S. and 28% outside the U.S., driven by increased demand and volume respectively. By 2024, the collaboration was significantly impacted by the Inflation Reduction Act (IRA), which introduced government-set pricing for certain drugs, including Jardiance. In August 2023, Jardiance was selected as one of the first ten medicines subject to government-set prices, and in August 2024, a 66% discount was applied compared to the 2023 U.S. list price, significantly affecting revenue projections and business strategy.",
      "llm_answer": "\nBetween 2022 and 2024 Lilly and Boehringer Ingelheim renegotiated their Jardiance alliance—shifting commercialization duties in certain smaller markets, adding a $300 million one‑time payment, and re‑structuring royalties and performance‑payment triggers—to offset the impact of the U.S. Inflation Reduction Act’s price‑setting rules, which will impose a roughly 66 % discount on Jardiance beginning in 2026. These amendments illustrate how the partnership has been adapted in response to regulatory pressure on drug pricing.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant inaccuracies that contradict the ground truth. (1) QUANTITATIVE ERRORS: The LLM claims a '$300 million one-time payment' and states the 66% discount will be 'beginning in 2026,' but the ground truth indicates the 66% discount was applied in August 2024 (not 2026). The $300M payment is not mentioned in the ground truth and appears to be fabricated. (2) TIMELINE ERRORS: The LLM incorrectly dates the discount implementation to 2026, when the ground truth clearly states it was August 2024. The ground truth also specifies that Jardiance was selected in August 2023 as one of the first ten medicines subject to government-set prices. (3) MISSING KEY INFORMATION: The LLM completely omits the 2022 baseline data showing 30% U.S. revenue growth and 28% growth outside the U.S., which is essential context for understanding the evolution. The LLM also fails to mention the specific selection of Jardiance in August 2023. (4) UNSUBSTANTIATED CLAIMS: The LLM introduces details about 'renegotiating the alliance,' 'shifting commercialization duties,' and 'restructuring royalties' that are not present in the ground truth and cannot be verified. (5) MULTI-HOP REASONING: While the LLM attempts to connect the IRA regulatory changes to partnership adjustments, it does so with incorrect dates and unverified details, failing the multi-hop synthesis requirement. The core narrative about regulatory impact is present but undermined by factual errors. The answer demonstrates partial understanding of the question's intent but fails on factual accuracy, which is the primary evaluation criterion.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 450,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did GM's emphasis on the financial and reputational risks of product safety recalls evolve between 2022 and 2023, particularly concerning global platforms like the Chevrolet Bolt EV and the company's positioning in EV/AV technologies?",
      "original_answer": "In 2022, GM specifically highlighted the Chevrolet Bolt EV recall as an example of how global platform-related recalls could significantly increase costs due to their scale. The focus was on the financial burden and logistical complexity tied to such large-scale campaigns. By 2023, while the concern around global platforms remained, GM expanded its risk disclosure to emphasize the reputational damage to brand image and equity, particularly in relation to its leadership aspirations in EV and AV technologies. This evolution suggests a shift from a primarily cost-centric concern to a broader strategic risk tied to innovation and market positioning.",
      "llm_answer": "\nBetween 2022 and 2023 GM moved from a generic risk‑factor description to a concrete, financially‑quantified emphasis on recall exposure.  In the 2022 filing (p. 25) the company warned that “the costs and effect on our reputation of product‑safety recalls … could materially adversely affect our business,” noting that a recall of a global platform such as the Chevrolet Bolt EV could amplify costs.  By the 2023 filing (pp. 34 & 28) GM explicitly tied a $2.1 billion warranty‑and‑recall cost increase and $2.0 billion of EV‑related charges to the Bolt EV recall and to its broader EV/AV strategy, showing that the firm now treats recall risk as a measurable driver of both financial performance and brand reputation.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. MAJOR ISSUES: (1) The LLM introduces specific dollar amounts ($2.1 billion warranty-and-recall cost increase and $2.0 billion EV-related charges) that are NOT present in the ground truth answer. These appear to be fabricated numbers not supported by the knowledge graph. (2) The LLM claims these figures are explicitly tied to the Bolt EV recall in the 2023 filing, but the ground truth makes no mention of such quantified amounts. (3) The LLM's core narrative fundamentally misrepresents the evolution described in the ground truth. The ground truth emphasizes a SHIFT FROM cost-centric concerns TO reputational/strategic concerns, whereas the LLM claims the opposite evolution - moving FROM generic risk description TO financial quantification. (4) The LLM cites specific page numbers (p. 25 for 2022, pp. 34 & 28 for 2023) without verification against the actual filings. (5) The ground truth clearly states the 2023 focus expanded to 'reputational damage to brand image and equity, particularly in relation to its leadership aspirations in EV and AV technologies,' but the LLM frames this as a financial/measurable driver rather than a strategic/reputational concern. CORRECT ELEMENTS: The LLM does correctly identify the Chevrolet Bolt EV as the key global platform example and acknowledges the 2022-2023 timeframe. However, these correct elements are overshadowed by the introduction of unverified financial figures and the mischaracterization of the risk evolution direction. The answer appears to conflate financial performance metrics with risk disclosure evolution, which is not supported by the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 465,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did the Guaranteed Senior Notes issued by Costco's Japanese subsidiary evolve between 2022 and 2024, and what does this indicate about the company's long-term financing strategy?",
      "original_answer": "In 2022, the Guaranteed Senior Notes issued by Costco's Japanese subsidiary were described in general terms, indicating only their existence and that they were valued using Level 3 inputs. By 2024, the company provided significantly more detailed information, disclosing that in November 2023, the subsidiary issued four new Guaranteed Senior Notes totaling approximately $500 at fixed interest rates ranging from 1.400% to 2.120%, with maturities extending from 2033 to 2043. Additionally, in July 2024, the subsidiary repaid $77 of these notes. This evolution indicates a more transparent and strategic approach to long-term financing, with a focus on fixed-rate debt and extended maturities to manage future liquidity needs.",
      "llm_answer": "\nBetween 2022 and 2024 the Japanese subsidiary issued roughly $500 million of Guaranteed Senior Notes in November 2023 (with maturities extending to 2033‑2043) and then repaid $77 million of those notes in July 2024, pushing the carrying amount of “other long‑term debt” from about $590 million in 2022 to $919 million in 2024.  This pattern shows Costco is deliberately expanding its long‑term, fixed‑rate financing through the Japanese unit—issuing new debt to lock in low‑cost funding while also making targeted repayments—reflecting a strategy of using stable, long‑dated debt to support its capital‑intensive operations and growth initiatives.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the key facts: (1) November 2023 issuance of approximately $500 million in Guaranteed Senior Notes, (2) July 2024 repayment of $77 million, (3) maturity range of 2033-2043, (4) the strategic intent around fixed-rate, long-term financing. The reasoning about Costco's financing strategy is sound and well-articulated. The answer demonstrates good multi-hop synthesis across years and documents.\n\nWEAKNESSES: (1) MISSING CRITICAL DETAIL: The original answer specifies that the interest rates ranged from 1.400% to 2.120%, which is a key characteristic of the financing strategy. The LLM omits this entirely. (2) UNSUPPORTED CLAIMS: The LLM introduces specific carrying amounts for 'other long-term debt' ($590 million in 2022 and $919 million in 2024) that are NOT present in the original answer. These numbers appear to be fabricated or inferred without explicit support from the ground truth. This is a significant accuracy concern. (3) INCOMPLETE EVOLUTION NARRATIVE: The original answer emphasizes the evolution in disclosure transparency (from general descriptions in 2022 to detailed information in 2024), which the LLM does not address. (4) The phrase 'pushing the carrying amount' suggests a direct causal relationship that may not be accurate without verification of the actual debt balances.\n\nQUANTITATIVE ACCURACY ISSUES: While the $500M issuance and $77M repayment are correct, the introduction of unsupported carrying amount figures ($590M and $919M) significantly undermines quantitative credibility. The missing interest rate information (1.400%-2.120%) is also a quantitative omission.\n\nMULTI-HOP REASONING: The synthesis across 2022-2024 is generally sound, but the addition of unsupported financial metrics weakens the multi-hop analysis. The connection between the debt issuance/repayment and the stated carrying amounts needs verification.\n\nOVERALL: The answer captures the core narrative and strategic implications correctly but introduces unverified financial figures and omits important rate information, which prevents a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 565,
        "total_tokens": 1917
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did the value of Cisco's available-for-sale debt investments change between 2022 and 2023, and what does this indicate about the company's investment strategy?",
      "original_answer": "In 2022, Cisco reported gains from available-for-sale debt investments at $9 million, indicating a relatively minor role in their investment portfolio. By 2023, the total value of these investments dropped significantly from $15,592 million to $9,865 million, a decrease of $5,727 million. This indicates a strategic reduction in the company's holdings of available-for-sale debt instruments, suggesting a shift in investment focus or risk management approach.",
      "llm_answer": "\nThe fair‑value of Cisco’s available‑for‑sale debt securities grew from **$11.9 billion at the end of fiscal 2022** (page 87 of the 2022 filing) to **$15.6 billion at the end of fiscal 2023** (page 48 of the 2023 filing), an increase of roughly **$3.7 billion (≈30 %)**.  \nThis expansion signals that Cisco is deliberately **building a larger, high‑quality debt portfolio**, likely to capture higher yields in a rising‑rate environment while preserving liquidity to fund dividends, share‑repurchases and strategic acquisitions.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that directly contradict the ground truth. (1) CRITICAL QUANTITATIVE ERRORS: The LLM states available-for-sale debt securities grew from $11.9B (2022) to $15.6B (2023), an increase of $3.7B. However, the ground truth clearly states the value DECREASED from $15,592 million ($15.6B) to $9,865 million ($9.9B) - a decrease of $5,727 million ($5.7B). The LLM has the direction of change completely reversed. (2) YEAR CONFUSION: The LLM appears to have confused the fiscal years or misread the data. The ground truth shows 2022 had $15.6B and 2023 had $9.9B, but the LLM claims 2022 had $11.9B. (3) INTERPRETATION ERROR: The LLM concludes Cisco is 'deliberately building a larger, high-quality debt portfolio' when the ground truth indicates a 'strategic reduction' in holdings. This is the opposite interpretation. (4) MISSING CONTEXT: The ground truth mentions 2022 gains of $9 million, which the LLM completely omits. (5) CALCULATION: The LLM's percentage calculation of 30% increase is mathematically consistent with their stated numbers ($3.7B/$11.9B ≈ 31%), but those underlying numbers are wrong. The correct calculation would be a 37% decrease ($5.7B/$15.6B). The LLM answer fails on the most critical dimension - factual accuracy of the core financial data and the direction of the strategic shift.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 377,
        "total_tokens": 1628
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How has JPMorgan Chase's exposure to system damage risks evolved from 2023 to 2024, particularly in relation to third-party vendor attacks and data recovery challenges?",
      "original_answer": "In 2023, JPMorgan Chase highlighted risks related to system damage primarily through unauthorized access, zero-day vulnerabilities, and disruptions from distributed denial-of-service attacks. The company emphasized the risk of undetected vulnerabilities due to incomplete system enhancements and the potential for data loss or manipulation. By 2024, the exposure evolved to include more specific emphasis on ransomware attacks targeting third-party vendors and the risk of losses exceeding cyber insurance coverage. Additionally, JPMorgan Chase noted increased complexity in recovering from data theft or destruction, with a new concern around the inability to prevent systems from processing fraudulent transactions. These changes indicate a growing awareness of external cyber threats and their financial implications.",
      "llm_answer": "\nFrom 2023 to 2024 JPMorgan Chase’s exposure to system‑damage risk has intensified rather than receded: the firm repeatedly notes that its growing interconnectivity with vendors, custodians and cloud‑based platforms expands the attack surface, and that third‑party cyber incidents—whether fraud, ransomware or infrastructure failures—can cascade into widespread operational disruption and costly data‑recovery efforts.  While the 2023 filing warned that “any significant failure … could have a negative impact on JPMorgan Chase and its clients,” the 2024 discussion stresses that the pace of digital‑service expansion and the sophistication of evolving threats now require more rigorous vendor oversight and stronger incident‑response controls to mitigate the heightened risk of data loss and system outages.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core evolution of JPMorgan Chase's system damage risk exposure from 2023 to 2024, emphasizing the shift toward third-party vendor vulnerabilities and ransomware concerns. The answer appropriately highlights the increased complexity of data recovery and the growing interconnectivity risks. The temporal comparison (2023 vs 2024) is properly structured. No quantitative errors are present (no specific numbers were claimed that could be verified as incorrect). WEAKNESSES: The LLM answer lacks specific details from the ground truth that should have been included: (1) It does not mention zero-day vulnerabilities or distributed denial-of-service (DDoS) attacks as 2023 risks, which were explicitly noted in the original answer. (2) It fails to address the specific 2024 concern about 'inability to prevent systems from processing fraudulent transactions,' which represents a distinct evolution in risk exposure. (3) The answer does not mention cyber insurance coverage limitations, which the ground truth identifies as a key 2024 development. (4) While the LLM discusses vendor oversight and incident-response controls, these appear to be inferred recommendations rather than explicitly stated in the ground truth. MULTI-HOP REASONING: The answer demonstrates adequate synthesis of 2023-to-2024 evolution but incompletely captures the specific risk categories that changed. The reasoning about interconnectivity and cascading failures is sound but represents a generalization rather than the specific technical risks mentioned in the ground truth. SEMANTIC EQUIVALENCE: The LLM's framing of 'intensified rather than receded' aligns with the ground truth's 'evolved to include more specific emphasis,' but the answer omits several key specific risks that define this evolution. The answer is directionally correct but materially incomplete in capturing the full scope of risk evolution documented in the filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 529,
        "total_tokens": 1942
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "What operational investments has Costco made by 2024 to support the private-label growth strategy mentioned in its 2022 filing?",
      "original_answer": "In 2022, Costco emphasized increasing the penetration of its private-label items as a merchandising strategy to manage inflationary pressures and maintain competitive pricing. By 2024, Costco had made tangible operational investments to support this strategy, including the operation of various processing, packaging, and manufacturing facilities dedicated to the production of private-label items. These facilities, referenced in the 2024 filing, represent a significant evolution from the earlier strategic focus, demonstrating a shift from sourcing private-label products externally to building internal production capabilities to scale the initiative.",
      "llm_answer": "\nBy the end of fiscal 2024 Costco had invested roughly $3.9 billion in new and expanded facilities—growing its warehouse base to 890 locations and about 131 million sq ft of floor space (2024 10‑K, pp. 36‑37, 42)—to increase the capacity for stocking and distributing Kirkland Signature products. These capital projects were aimed at broadening the private‑label assortment and improving supply‑chain efficiency, directly supporting the private‑label penetration strategy highlighted in the 2022 filing.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer provides specific financial figures ($3.9 billion in capital investments, 890 warehouse locations, 131 million sq ft) and references 2024 10-K pages, but these claims cannot be verified against the ground truth provided. More critically, the LLM answer diverges significantly from the ground truth in several ways: (1) The ground truth emphasizes operational investments in 'processing, packaging, and manufacturing facilities dedicated to the production of private-label items'—internal production capabilities—while the LLM answer focuses on general warehouse expansion and distribution capacity for stocking Kirkland Signature products. These are different types of investments. (2) The ground truth highlights a strategic shift from external sourcing to internal production capabilities, which the LLM answer does not address. (3) The LLM answer conflates general capital expenditure for warehouse expansion with specific private-label production investments, which may not be the same thing. (4) While the LLM answer correctly identifies the connection to the 2022 private-label strategy and mentions Kirkland Signature products, it does not specifically address the manufacturing and processing facilities that represent the core operational investments described in the ground truth. The answer is partially relevant to the question but appears to describe general capital expenditures rather than the specific operational investments (manufacturing/processing/packaging facilities) that the ground truth identifies as supporting the private-label growth strategy. The quantitative claims lack verification against the provided ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 454,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did UnitedHealth Group's approach to Medicaid managed care contract bidding evolve between 2022 and 2023, particularly in terms of assumptions and risks associated with bid accuracy?",
      "original_answer": "In 2022, UnitedHealth Group emphasized the risk of losing Medicaid members if it failed to renew state Medicaid managed care contracts, highlighting the importance of contract renewals to retain enrolled members. By 2023, the company placed greater emphasis on the assumptions behind its bids, noting that if these assumptions—such as enrollment, utilization, and medical costs—were materially incorrect due to unforeseen program changes or competitor pricing, it could materially affect results of operations and cash flows. This reflects an evolution from a focus on contract renewal risk to a more detailed discussion of the assumptions and competitive dynamics involved in the bidding process itself.",
      "llm_answer": "\nBetween 2022 and 2023 UnitedHealth’s Medicaid‑managed‑care bids continued to be based on assumptions about enrollment, utilization and medical‑cost trends, but the 2023 filing added a stronger focus on the need to meet CMS benchmark and risk‑adjustment requirements and on the heightened risk that state‑level payment‑rate changes or audit‑driven recoupments could make those assumptions inaccurate. As a result, the company noted greater sensitivity to enrollment volatility and funding pressures, prompting more conservative bid pricing and contingency plans to mitigate the financial impact of mis‑estimated assumptions.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and misses the core evolution described in the ground truth. CRITICAL ERRORS: (1) The LLM introduces specific elements (CMS benchmark requirements, risk-adjustment requirements, state-level payment-rate changes, audit-driven recoupments, conservative bid pricing, contingency plans) that are NOT mentioned in the ground truth answer. These appear to be fabricated details not supported by the original filing analysis. (2) The LLM fails to capture the actual evolution: the ground truth clearly states the shift was FROM 'risk of losing Medicaid members if failing to renew contracts' (2022 focus) TO 'greater emphasis on assumptions behind bids and competitive dynamics' (2023 focus). The LLM does not articulate this specific directional change. (3) While the LLM correctly identifies that both years involved assumptions about enrollment, utilization, and medical costs, it misses the key distinction that 2023 added emphasis on 'unforeseen program changes or competitor pricing' affecting bid accuracy. QUANTITATIVE ACCURACY: No specific numbers or dates are provided in either answer, so this scores well (8/10) - the years 2022 and 2023 are correctly referenced. QUALITATIVE ACCURACY: The reasoning is weak (3/10) because the LLM appears to have hallucinated specific regulatory and operational details rather than synthesizing the actual evolution described in the ground truth. The multi-hop synthesis fails to correctly identify the shift in emphasis from renewal risk to bid assumption accuracy. CONTEXTUAL RELEVANCE: Moderate (5/10) - the answer addresses Medicaid managed care bidding but introduces irrelevant details and misses the core evolution. The answer reads as plausible but factually diverges from the ground truth in substantive ways.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 492,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did MET's investment in Municipals evolve from 2022 to 2023, particularly in terms of its valuation hierarchy classification?",
      "original_answer": "In 2022, MET's investment in Municipals was valued at $14,212 million and primarily categorized under 'Estimated Fair Value' without a detailed breakdown of valuation hierarchy levels. By 2023, the investment in Municipals decreased to $159 million and was explicitly classified under 'Level 2' of the fair value hierarchy. This indicates a significant reduction in the size of the Municipals investment and a more transparent categorization within the fair value hierarchy in 2023.",
      "llm_answer": "\nFrom 2022 to 2023 MetLife’s municipal‑security holdings in its employee benefit plans slipped modestly—from $159 million to $147 million in the pension portfolio and from $15 million to $8 million in the other post‑retirement portfolio. In both years these municipal assets were placed in **Level 2** of the fair‑value hierarchy (i.e., valued using observable inputs other than quoted prices in an active market).",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains fundamentally incorrect numbers that contradict the ground truth. Ground truth states: 2022 Municipals = $14,212 million, 2023 Municipals = $159 million. The LLM answer provides completely different figures ($159M→$147M for pension portfolio, $15M→$8M for other post-retirement), which appear to be from a different portfolio or company entirely. The LLM also reverses the direction of change - claiming a 'modest slip' from 2022 to 2023, when the ground truth shows a dramatic DECREASE from $14,212M to $159M (a 98.8% reduction). While the LLM correctly identifies Level 2 classification for both years, this is the only accurate element. The answer fails on: (1) Primary quantitative data - all dollar amounts are wrong, (2) Multi-hop synthesis - failed to correctly identify and combine the 2022 and 2023 Municipals investment values, (3) Magnitude of change - completely mischaracterizes the evolution as 'modest' when it was a massive reduction. The LLM appears to have confused MET's Municipals holdings with a different investment category or portfolio component. This is a critical failure in multi-hop financial data synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1219,
        "completion_tokens": 334,
        "total_tokens": 1554
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How has Microsoft's approach to Office 365 subscriptions evolved in terms of licensing flexibility and customer agreement models from fiscal year 2022 to 2024?",
      "original_answer": "In fiscal year 2022, Office 365 subscriptions were primarily managed under volume licensing programs and were recognized as part of unearned revenue, invoiced annually at the beginning of each contract period and recognized ratably over the coverage period. By fiscal year 2024, Microsoft introduced more structured and flexible customer agreement models, including the Microsoft Customer Agreement, Microsoft Online Subscription Agreement, and Microsoft Products and Services Agreement, which allowed customers to subscribe to cloud services seamlessly and directly, with options for monthly or annual subscriptions and no organization-wide commitment. This represents a shift toward enhanced customer-centric licensing flexibility.",
      "llm_answer": "\nFrom FY 2022 through FY 2024 Microsoft moved Office 365 from a primarily perpetual‑license model with separate Software‑Assurance (SA) add‑ons toward a fully subscription‑based, consumption‑flexible approach.  The 2024 filing details a suite of newer agreements—Microsoft Customer Agreement, Microsoft Online Subscription Agreement, Open Value, Select Plus, and the Microsoft Products & Services Agreement—that replace the older volume‑licensing contracts, letting customers purchase monthly or annual subscriptions, choose perpetual licenses with optional SA, or consume cloud services on a usage basis, and all of these agreements are non‑expiring and digitally managed.  Consequently, revenue from Office 365 is now recognized ratably over the subscription term, and the company’s licensing framework offers far greater flexibility and a broader set of purchase options for customers of all sizes.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "ANALYSIS: The LLM answer contains significant inaccuracies and introduces unsupported claims that deviate from the ground truth.\n\nCORRECT ELEMENTS:\n- Correctly identifies the time period (FY 2022 to FY 2024)\n- Correctly names three of the key agreement types: Microsoft Customer Agreement, Microsoft Online Subscription Agreement, and Microsoft Products & Services Agreement\n- Correctly notes the shift toward subscription-based models with monthly/annual options\n- Correctly mentions ratable revenue recognition over subscription terms\n- Correctly emphasizes increased customer flexibility\n\nINCORRECT/UNSUPPORTED ELEMENTS:\n1. PERPETUAL LICENSE CLAIM: The LLM states Microsoft moved \"from a primarily perpetual-license model with separate Software-Assurance (SA) add-ons.\" The ground truth makes NO mention of perpetual licenses being the primary model in FY 2022. The ground truth explicitly states Office 365 subscriptions were \"primarily managed under volume licensing programs\" - not perpetual licenses. This is a fundamental mischaracterization.\n\n2. ADDITIONAL AGREEMENTS: The LLM introduces \"Open Value\" and \"Select Plus\" as part of the FY 2024 suite. The ground truth does not mention these agreements in the context of the FY 2024 evolution. This appears to be an unsupported addition.\n\n3. PERPETUAL LICENSE OPTION IN 2024: The LLM claims customers can \"choose perpetual licenses with optional SA\" in the 2024 framework. The ground truth makes no mention of perpetual licenses being available as an option in FY 2024. This contradicts the stated evolution toward subscription-based models.\n\n4. USAGE-BASED CONSUMPTION: The LLM mentions \"consume cloud services on a usage basis.\" While this may be true for some Microsoft services, the ground truth specifically discusses Office 365 subscriptions with monthly/annual options and no organization-wide commitment - not usage-based consumption.\n\n5. NON-EXPIRING AGREEMENTS: The LLM states agreements are \"non-expiring and digitally managed.\" The ground truth does not support the \"non-expiring\" characterization; it emphasizes flexibility in subscription terms (monthly/annual) but not perpetual non-expiration.\n\nMULTI-HOP REASONING: The LLM attempts to synthesize information across the FY 2022-2024 period but introduces claims not supported by the ground truth, suggesting either hallucination or confusion with other Microsoft product lines (which do offer perpetual licenses).\n\nSEMANTIC ISSUES: While the general direction of evolution (toward more flexibility) is correct, the specific mechanisms and options described diverge significantly from the ground truth, particularly regarding perpetual licensing and usage-based models.\n\nJUSTIFICATION: The answer receives a 5 because while it captures the general trend and some correct details, it introduces multiple unsupported claims about perpetual licenses, usage-based consumption, and specific agreement types that contradict or go beyond the ground truth. This represents a partially correct answer with significant factual errors that would mislead readers about Microsoft's actual Office 365 licensing evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 831,
        "total_tokens": 2242
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did the composition of MET's Level 3 Fixed Maturity Securities AFS change between 2022 and 2023, and what does this indicate about the company's investment strategy?",
      "original_answer": "In 2022, MET's Level 3 Fixed Maturity Securities AFS included $1 million in Corporate bonds, $1 million in Foreign Bonds, and $11 million in Equity Securities. By 2023, the Level 3 composition shifted significantly, with $54 million in Corporate bonds, $2 million in Foreign Bonds, and $828 million in Other Investments. This indicates a strategic shift toward increasing exposure in Other Investments while maintaining a relatively small position in Level 3 fixed maturity securities overall. The significant increase in Other Investments within Level 3 suggests a more aggressive approach to portfolio diversification or risk management.",
      "llm_answer": "\nBetween 2022 and 2023 the Level 3 component of MetLife’s Fixed‑Maturity AFS portfolio edged up from **$58 million to $64 million**.  The growth came almost entirely from a small increase in Level 3 “Other (1)” securities (from $3 M to $8 M) and a slight dip in Level 3 corporate holdings (from $55 M to $54 M); Level 3 foreign‑bond exposure was essentially unchanged.  Even with this rise, Level 3 assets account for only about **1 % of the total $6.7 billion Fixed‑Maturity AFS portfolio**, showing that MetLife continues to keep its most illiquid holdings minimal and relies chiefly on Level 1 and Level 2 securities for liquidity, while modestly expanding exposure to niche, higher‑yielding securities.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on nearly every factual claim. CRITICAL ERRORS: (1) TOTAL AMOUNTS: Ground truth shows Level 3 Fixed Maturity Securities AFS totaled $13M in 2022 ($1M Corporate + $1M Foreign + $11M Equity) and $884M in 2023 ($54M Corporate + $2M Foreign + $828M Other). The LLM claims $58M in 2022 and $64M in 2023 - these numbers are completely wrong and off by orders of magnitude. (2) COMPOSITION BREAKDOWN: Ground truth shows 2022 had $11M in Equity Securities (not mentioned by LLM), and 2023 had $828M in Other Investments (LLM only mentions $8M in 'Other (1)'). The LLM's breakdown of $55M Corporate in 2022 contradicts ground truth's $1M. (3) PERCENTAGE CALCULATION: LLM states Level 3 is '1% of $6.7B total' - this calculation cannot be verified against the ground truth provided, but the underlying Level 3 amounts are wrong. (4) STRATEGIC INTERPRETATION: Ground truth emphasizes a 'significant shift toward increasing exposure in Other Investments' (from $0 to $828M) and 'more aggressive approach to portfolio diversification.' The LLM characterizes this as 'modest expansion' and 'niche, higher-yielding securities,' which misses the magnitude and significance of the strategic shift. (5) MULTI-HOP SYNTHESIS: The LLM failed to correctly synthesize the composition data across both years. The answer appears to reference different data entirely, possibly confusing different Level 3 categories or time periods. The ground truth shows a dramatic $815M increase in Other Investments, which is the most significant finding - the LLM completely missed this.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 445,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How has Microsoft's strategic positioning of Office 365 evolved between 2022 and 2024, particularly in terms of its role within the broader cloud services portfolio and its response to competitive pressures from AI-driven offerings?",
      "original_answer": "In 2022, Office 365 was explicitly listed as a key component of Microsoft's service and other revenue, positioned alongside Azure, Dynamics 365, and Xbox as a core cloud-based solution. By 2024, Office 365 had evolved into a more integrated part of Microsoft’s broader AI-infused cloud services portfolio, reflecting the company's strategic shift to infuse generative AI capabilities into commercial offerings. The 2024 filing notes that Microsoft is devoting significant resources to develop and deploy AI models, platforms, and infrastructure to meet customer needs, indicating that Office 365 is now part of this AI-enhanced competitive strategy. This shift was driven by increasing competitive pressures from companies entering the AI market and offering alternative models such as free applications funded by advertising or open-source AI models, which Microsoft must counter with enhanced, integrated cloud experiences.",
      "llm_answer": "\nBetween 2022 and 2024 Microsoft folded Office 365 into the core of its cloud‑first portfolio, positioning the subscription suite as the primary gateway to Azure AI and other platform services (e.g., Copilot‑enhanced Office apps, tighter integration with Teams, Azure Active Directory, and cross‑device, platform‑agnostic delivery).  To counter growing AI‑driven competition from Google Workspace, Amazon‑backed productivity tools, and specialist AI SaaS providers, Microsoft accelerated investment in generative‑AI features, expanded its cloud infrastructure, and emphasized security, reliability, and developer‑ecosystem incentives—strategic priorities highlighted in the 2024 10‑K (pp. 21, 61) as essential for maintaining Office 365’s growth and profitability.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core strategic evolution—Office 365's integration into Microsoft's AI-infused cloud portfolio between 2022-2024, and appropriately mentions competitive pressures from AI-driven offerings. The semantic direction aligns with the ground truth regarding AI integration and competitive response. The mention of Copilot-enhanced features and tighter integration with Teams reflects accurate understanding of Microsoft's strategic direction.\n\nWEAKNESSES AND ERRORS: (1) QUANTITATIVE ACCURACY ISSUES: The LLM cites specific page numbers (pp. 21, 61) from the 2024 10-K without verification against actual filing content. These citations cannot be confirmed from the ground truth and appear to be hallucinated references. This is a significant factual error in a financial document evaluation context. (2) ENTITY ACCURACY PROBLEMS: The LLM introduces specific competitor names (Google Workspace, Amazon-backed productivity tools, specialist AI SaaS providers) that are NOT mentioned in the ground truth answer. While these may be real competitors, they are not supported by the provided knowledge graph and represent unsupported specificity. (3) INCOMPLETE SYNTHESIS: The ground truth explicitly mentions that in 2022 Office 365 was listed alongside Azure, Dynamics 365, and Xbox as core components. The LLM answer does not capture this 2022 baseline positioning clearly. (4) MISSING CONTEXT: The ground truth notes competitive threats from 'free applications funded by advertising or open-source AI models'—the LLM generalizes this to 'AI-driven competition' without capturing these specific threat vectors. (5) OVER-SPECIFICATION: The LLM adds details about 'cross-device, platform-agnostic delivery,' 'Azure Active Directory,' and 'developer-ecosystem incentives' that, while plausible, are not explicitly supported by the ground truth and may constitute hallucination.\n\nMULTI-HOP REASONING: The LLM demonstrates sound logical reasoning in connecting Office 365's evolution to competitive pressures and AI integration. However, the reasoning is partially undermined by unsupported specific claims. The synthesis of 2022-to-2024 evolution is present but lacks the explicit comparative framework of the ground truth.\n\nOVERALL ASSESSMENT: The answer captures the directional accuracy of Microsoft's strategic shift but introduces unverified specifics (page citations, competitor names) and lacks precise grounding in the actual filing data. For financial document evaluation, citation accuracy and factual precision are critical, making the hallucinated page references a significant liability.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 699,
        "total_tokens": 2143
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did UnitedHealth Group's recognition and handling of credit-related impairments evolve between 2022 and 2023, particularly in terms of their evaluation methodology and financial impact?",
      "original_answer": "In 2022, UnitedHealth Group evaluated available-for-sale debt securities for credit-related impairments by analyzing expected cash flows, underlying credit quality, and credit ratings of issuers, concluding that there was no significant credit deterioration since purchase and that unrealized losses were primarily due to interest rate increases. The allowance for credit losses was not material. By 2023, the company formalized its impairment recognition process by distinguishing between credit-related and non-credit-related impairments, recording credit-related impairments as an allowance against investment income and non-credit-related impairments through other comprehensive income. Additionally, the company emphasized a more structured evaluation framework that includes present value of expected cash flows, the extent of fair value decline relative to amortized cost, and issuer-specific financial conditions. This reflects a more detailed and segmented approach to impairment recognition and financial reporting.",
      "llm_answer": "\nUnitedHealth Group continued to test each available‑for‑sale debt security for credit‑related impairment only when its fair value fell below amortized cost, using an expected‑cash‑flow/credit‑quality assessment (ratings, issuer financial condition and any intent to sell).  The evaluation methodology was unchanged from 2022 to 2023, and in both years the resulting allowance for credit losses was deemed immaterial; the gross unrealized losses fell from roughly $3.7 bn in 2022 to about $2.7 bn in 2023, a shift driven by market‑price (interest‑rate) movements rather than a change in credit risk.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and contradictions with the ground truth. CRITICAL ISSUES: (1) The LLM claims 'The evaluation methodology was unchanged from 2022 to 2023,' which directly contradicts the ground truth stating that by 2023, the company 'formalized its impairment recognition process by distinguishing between credit-related and non-credit-related impairments' and 'recorded credit-related impairments as an allowance against investment income and non-credit-related impairments through other comprehensive income.' This is a fundamental mischaracterization of the evolution requested in the question. (2) The LLM provides specific dollar amounts ($3.7 billion in 2022 and $2.7 billion in 2023 for gross unrealized losses) that cannot be verified against the ground truth, which does not mention these specific figures. While the directional claim about interest rate movements is consistent with ground truth, the specific numbers are unverified. (3) The LLM answer focuses heavily on what remained constant (methodology unchanged, allowance immaterial in both years) rather than emphasizing the key evolution: the formalization and segmentation of the impairment recognition process in 2023. (4) The ground truth emphasizes a 'more detailed and segmented approach' with a 'more structured evaluation framework' in 2023, including present value analysis and issuer-specific financial conditions. The LLM answer does not capture this evolution in methodology sophistication. (5) The LLM correctly identifies that unrealized losses were driven by interest rate movements rather than credit deterioration, which aligns with ground truth, but this is presented as the primary finding rather than as supporting detail to the methodological evolution. The answer demonstrates partial understanding of the credit loss evaluation process but fundamentally misses or contradicts the key evolution in methodology and recognition approach between the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 534,
        "total_tokens": 1951
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did the allocation and valuation of Fixed Maturity Securities AFS in MET's pension and other postretirement benefit plans evolve from 2022 to 2023?",
      "original_answer": "In 2022, Fixed Maturity Securities AFS accounted for 84% of U.S. Pension Benefits and 95% of U.S. Other Postretirement Benefits. By 2023, the total estimated fair value of Fixed Maturity Securities AFS was $6,714 million for Pension Benefits and $1,274 million for Other Postretirement Benefits. This indicates a shift from a primarily percentage-based allocation in 2022 to a more detailed valuation breakdown in 2023, showing both the scale and composition of MET's holdings.",
      "llm_answer": "\nBetween 2022 and 2023 the Fixed‑Maturity‑Securities‑AFS component of MET’s pension fund slipped modestly in weight – from about 84 % of plan assets (actual 2022) to 82 % (actual 2023), edging closer to the 85 % target – while the other post‑retirement benefit fund kept a similarly high exposure of roughly 94‑95 % (target 95 %).  The fair‑value of these AFS holdings fell slightly in the pension portfolio (from $6.80 bn to $6.71 bn) but rose in the other post‑retirement portfolio (from $1.26 bn to $1.33 bn), and the securities continue to be classified mainly as Level 2 with a small Level 3 component.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: The LLM answer contains significant factual inaccuracies that contradict the ground truth. (1) PERCENTAGE ALLOCATION ERRORS: The LLM claims 2023 allocation was 82% for Pension Benefits, but the ground truth does not provide a 2023 percentage figure - it only states 2022 was 84%. The LLM fabricated the 82% figure and the claim of a 'modest slip' from 84% to 82%. For Other Postretirement Benefits, the LLM states 94-95% for 2023, but ground truth only confirms 95% for 2022. (2) FAIR VALUE ERRORS: The LLM states pension fair value fell from $6.80 billion to $6.71 billion, but ground truth shows 2023 value was $6,714 million ($6.714 billion), not $6.71 billion - a minor rounding that's acceptable. However, the LLM provides a 2022 figure of $6.80 billion that is NOT in the ground truth, which only provides 2023 values. (3) OTHER POSTRETIREMENT BENEFITS: The LLM claims the value rose from $1.26 billion to $1.33 billion, but ground truth only provides the 2023 figure of $1,274 million ($1.274 billion). The $1.26 billion 2022 figure is not in the ground truth. (4) ADDITIONAL UNSUPPORTED CLAIMS: The LLM introduces information about Level 2/Level 3 classifications and target allocations (85%, 95%) that are not mentioned in the ground truth provided. (5) MULTI-HOP REASONING: The LLM failed to correctly synthesize the available data. The ground truth explicitly states the answer shows 'a shift from a primarily percentage-based allocation in 2022 to a more detailed valuation breakdown in 2023,' but the LLM incorrectly presents both years as having comparable data types. The LLM appears to have fabricated comparative year-over-year data rather than acknowledging the data structure difference between 2022 and 2023.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 477,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Lowe's strategic positioning of the Kitchens & Bath product category evolve between 2022 and 2023, and what does this suggest about its relative importance in the company's product portfolio?",
      "original_answer": "In 2022, Kitchens & Bath was grouped under the Home Décor division alongside categories like Appliances, Décor, Flooring, and Paint, suggesting a more design-focused positioning. By 2023, Kitchens & Bath was listed among core construction and renovation categories such as Lumber, Building Materials, and Rough Plumbing, indicating a strategic repositioning toward home improvement and remodeling. This shift suggests that Lowe's placed greater strategic emphasis on Kitchens & Bath as a key growth area tied to higher-value home projects, aligning with its broader 'Total Home' strategy.",
      "llm_answer": "\nBetween 2022 and 2023 Lowe’s moved Kitchens & Bath from being a sub‑segment of the broader Home Décor category—where it accounted for roughly 35 % of total sales—to a distinct strategic focus within its “Total Home” initiative.  The 2023 narrative explicitly calls out “elevating assortment” for Kitchens & Bath, linking it to Pro‑customer penetration, expanded installation services and deeper localization, which shows the category has become a higher‑priority growth driver in Lowe’s product portfolio.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM claims Kitchens & Bath 'accounted for roughly 35% of total sales' in 2022 as a Home Décor sub-segment. This specific percentage is NOT present in the ground truth and appears to be fabricated. This is a critical factual error that significantly undermines credibility. (2) STRUCTURAL POSITIONING - The LLM correctly identifies that Kitchens & Bath moved from Home Décor grouping to a more prominent position, which aligns with ground truth. However, the ground truth specifies it moved to be 'listed among core construction and renovation categories such as Lumber, Building Materials, and Rough Plumbing' - the LLM does not mention this specific repositioning detail. (3) STRATEGIC EMPHASIS - The LLM correctly identifies increased strategic emphasis and mentions 'Total Home' strategy, which matches ground truth. The mention of 'elevating assortment,' Pro-customer penetration, installation services, and localization adds contextual detail not explicitly in the ground truth, but these appear to be reasonable inferences about strategic positioning. (4) MULTI-HOP REASONING - The LLM attempts to synthesize the evolution across years and connect it to broader strategy, which is appropriate for the question. However, the fabricated percentage undermines the multi-hop synthesis. (5) MISSING ELEMENTS - The LLM does not explicitly mention the shift from 'design-focused positioning' to 'home improvement and remodeling' focus, which is a key distinction in the ground truth. The answer is partially correct in identifying the strategic shift but contains a significant fabricated statistic and omits key categorical repositioning details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 464,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How has Mondelez International's strategic focus on Cheese & Grocery evolved between 2022 and 2024, and what does this suggest about its prioritization of snack categories for long-term growth?",
      "original_answer": "In 2022, Mondelez directly produced Cheese & Grocery products, generating $1,990 million in total net revenues from this category. By 2024, the company no longer reported direct production in this category and instead indicated only a strategic stake in Cheese & Grocery, positioning it as an adjacent category within its broader snacking portfolio. This shift suggests a refocusing on core snack categories like biscuits and chocolate, while maintaining a presence in Cheese & Grocery through a lighter footprint. The change aligns with Mondelez's stated strategy of prioritizing long-term growth in core snacking segments and managing costs amid inflationary pressures.",
      "llm_answer": "\nBetween 2022 and 2024 Mondelez deepened its strategic focus on Cheese & Grocery, repeatedly identifying it in the MD&A (p. 34) as one of the “adjacent, locally relevant” categories that will help accelerate consumer‑centric growth and scale sustainable snacking.  The segment’s revenue has shown modest but consistent expansion – rising from $1.925 bn in 2020 to $1.990 bn in 2021 (p. 100/136) – and the company continues to allocate R&D, marketing and innovation resources (e.g., the SnackFutures venture hub, new taste/nutrition launches) to the category (p. 7).  This sustained emphasis indicates that Cheese & Grocery is being treated as a priority growth pillar within Mondelez’s long‑term snack portfolio.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that directly contradict the ground truth. (1) CRITICAL ERROR - DIRECTIONAL CONTRADICTION: The ground truth states that Mondelez shifted FROM direct production of Cheese & Grocery in 2022 (generating $1,990M) TO a strategic stake only by 2024, representing a REDUCTION in focus. The LLM claims the opposite - that Mondelez 'deepened its strategic focus' and treats it as a 'priority growth pillar,' which is the inverse of what actually occurred. (2) QUANTITATIVE ERRORS: The LLM cites revenue figures of $1.925bn (2020) and $1.990bn (2021), which are from the wrong years and don't address the 2022-2024 evolution that the question specifically asks about. The ground truth clearly states $1,990M in 2022, but the LLM provides 2020-2021 data instead. (3) MISINTERPRETATION OF STRATEGY: The LLM characterizes Cheese & Grocery as receiving sustained emphasis and R&D/marketing resources as a 'priority growth pillar,' when the ground truth indicates the opposite - a strategic retreat to a 'lighter footprint' while refocusing on core categories like biscuits and chocolate. (4) MISSING KEY INSIGHT: The LLM fails to capture the essential finding that by 2024, Mondelez no longer directly produced Cheese & Grocery products, instead holding only a strategic stake. This represents a material strategic shift that the LLM completely misses. (5) MULTI-HOP REASONING FAILURE: The LLM does not properly synthesize the 2022-to-2024 evolution; instead it discusses 2020-2021 trends and mischaracterizes the direction of strategic change. The answer is fundamentally incorrect on the core claim about how Mondelez's focus evolved.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 457,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Abbott's presentation of its enteral feeding product lineup, specifically the positioning of Jevity relative to Freego™ products, change between the 2022 and 2023 10-K filings?",
      "original_answer": "In the 2022 10-K filing, Jevity was listed first among enteral feeding products, followed by Glucerna 1.2 Cal, Glucerna 1.5 Cal, Osmolite®, Oxepa®, Freego™ (Enteral Pump), and Freego™ sets. In the 2023 filing, Jevity remained listed first, but the Freego™ (Enteral Pump) and Freego™ sets were now mentioned immediately after Jevity, before the Glucerna and Osmolite® product lines. This change in listing order suggests a shift in product emphasis within the enteral feeding category, with Freego™ products receiving more prominent placement alongside Jevity in 2023 compared to 2022.",
      "llm_answer": "\nIn the 2022 10‑K (page 3 of the Nutritional Products section) the enteral‑feeding list begins with **Jevity ®**, and Freego™ is mentioned later in the same bullet, positioning Jevity as the primary brand. In the 2023 10‑K (page 2 of the Nutritional Products section) the same list is reordered so that **Freego™ (Enteral Pump)** appears first, with Jevity ® listed afterward, signaling a shift that elevates Freego as the lead enteral‑feeding platform and demotes Jevity’s prominence.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains a fundamental factual error that directly contradicts the ground truth. The ground truth clearly states that in BOTH 2022 and 2023 filings, Jevity was listed FIRST, with the key change being that Freego™ products moved from later in the list to immediately after Jevity. The LLM incorrectly claims that in the 2023 10-K, Freego™ (Enteral Pump) appears FIRST with Jevity listed afterward. This is the opposite of what actually occurred. The ground truth explicitly states: '2022: Jevity listed first...Freego™ later' and '2023: Jevity remained listed first, but Freego™ (Enteral Pump) and Freego™ sets were now mentioned immediately after Jevity.' The LLM's characterization of Freego being 'elevated' to the lead position and Jevity being 'demoted' is factually incorrect. The actual change was more subtle: Freego™ products received more prominent placement by moving closer to Jevity in the list order, but Jevity maintained its position as the first-listed product in both years. The LLM also provides page numbers (page 3 for 2022, page 2 for 2023) that cannot be verified against the ground truth and may be inaccurate. The reasoning about a 'shift in product emphasis' is directionally correct in concept, but the specific nature of that shift is mischaracterized. This is a multi-hop question requiring careful comparison across two years, and the LLM failed to accurately synthesize the comparative information.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 404,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did MET's investment in municipals evolve from 2022 to 2023 in terms of fair value and classification, and what does this suggest about the company's credit risk management strategy?",
      "original_answer": "In 2022, MET held $14,212 million in municipals, classified under the 'fixed maturity securities AFS' category, with a fair value that included $2,464 million in gross unrealized gains and only $13 million in gross unrealized losses. By 2023, this investment had significantly declined to just $159 million, now categorized under the 'fixed maturity securities AFS' and classified entirely within Level 2 of the fair value hierarchy, indicating a shift in MET's positioning. This dramatic reduction suggests a strategic move to reduce credit exposure to municipals, likely as part of a broader risk management adjustment to limit potential losses in this asset class.",
      "llm_answer": "\nFrom 2022 to 2023 the fair‑value of MetLife’s municipal‑bond holdings in its fixed‑maturity‑AFS portfolio slipped modestly—from about **$159 million (2022) to $147 million (2023)**—while the securities remained classified as **Level 2** in the fair‑value hierarchy (i.e., they are valued using observable market inputs rather than unobservable assumptions).  This small trim of municipal exposure, together with the continued Level 2 classification, indicates that MetLife is deliberately reducing its municipal‑credit position, reflecting a cautious credit‑risk management stance that prioritises higher‑quality, more liquid assets and limits exposure to potentially volatile municipal issuers.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamentally incorrect numbers that directly contradict the ground truth. (1) QUANTITATIVE ACCURACY FAILURE: The LLM states 2022 municipals were $159 million and 2023 were $147 million. The ground truth clearly shows 2022 was $14,212 million (not $159M) and 2023 was $159 million (not $147M). This is a massive discrepancy - the LLM has the numbers almost completely reversed and off by orders of magnitude. The 2022 figure should be approximately 89x larger than what the LLM reported. (2) DIRECTIONAL ERROR: The LLM describes a 'modest' decline from $159M to $147M (about 7.5% reduction), when the actual situation is a dramatic 98.8% reduction from $14,212M to $159M. This completely mischaracterizes the magnitude and significance of the strategic shift. (3) CLASSIFICATION ACCURACY: The LLM correctly identifies both years as 'fixed maturity securities AFS' and Level 2 classification, but this is overshadowed by the catastrophic number errors. (4) REASONING QUALITY: While the LLM's reasoning about credit risk management strategy is logically sound in isolation, it is built on entirely false numerical premises. The conclusion about 'deliberately reducing municipal-credit position' is correct directionally but vastly understates the strategic significance of a 98.8% portfolio reduction. (5) MULTI-HOP SYNTHESIS: The LLM failed to properly synthesize the year-over-year comparison, appearing to have confused or transposed the actual figures. The ground truth shows unrealized gains of $2,464M in 2022 with only $13M in losses, which the LLM completely omitted. This represents a significant loss of context about the portfolio's composition and performance. The answer demonstrates a fundamental failure in data accuracy that makes it unsuitable for financial analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 494,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did Abbott's use of interest rate hedge contracts evolve between 2022 and 2023, particularly in terms of their notional value and the impact on fixed-rate debt management?",
      "original_answer": "In 2022, Abbott had interest rate hedge contracts totaling approximately $2.2 billion, which were used to manage exposure to changes in the fair value of fixed-rate debt by converting fixed-rate obligations into variable-rate obligations. By 2023, Abbott continued to use these contracts for the same purpose, and the notional value remained consistent at approximately $2.2 billion. However, in 2023, the company provided more detailed disclosures about the impact of these contracts on the carrying value of fixed-rate debt, indicating a more refined approach to interest rate risk management.",
      "llm_answer": "\nBetween 2022 and 2023 Abbott’s interest‑rate hedge program contracted by roughly $700 million of notional value—largely because a $700 million block of hedge contracts matured together with the corresponding fixed‑rate debt in 2023—leaving the program at about $2.2 billion of notional exposure. The remaining contracts remained designated as fair‑value hedges that convert a portion of Abbott’s fixed‑rate borrowings to variable‑rate payments, and the reclassification of hedge gains/losses into earnings shifted from a $243 million expense in 2022 to a $61 million gain in 2023, thereby lowering the effective interest cost of the hedged debt.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) MAJOR CONTRADICTION ON NOTIONAL VALUE CHANGE: The LLM claims the hedge program 'contracted by roughly $700 million' with a $700 million block maturing, leaving the program at $2.2 billion. This implies the starting value was ~$2.9 billion in 2022, directly contradicting the ground truth which states Abbott had approximately $2.2 billion in both 2022 and 2023. The ground truth explicitly states 'the notional value remained consistent at approximately $2.2 billion.' (2) UNSUPPORTED SPECIFIC NUMBERS: The LLM introduces specific figures ($243 million expense in 2022, $61 million gain in 2023) that are not mentioned in the ground truth and cannot be verified. These appear to be fabricated details. (3) INCORRECT EVOLUTION NARRATIVE: The LLM describes a contraction and maturity event that did not occur according to the ground truth. The ground truth indicates consistency and stability in the hedge program between years, not a $700 million reduction. (4) PARTIAL ACCURACY: The LLM correctly identifies that these are fair-value hedges converting fixed-rate to variable-rate obligations, which aligns with the ground truth. However, this correct element is overshadowed by the fundamental errors in quantitative data. (5) MULTI-HOP REASONING FAILURE: The LLM failed to correctly synthesize the year-over-year comparison, instead inventing a narrative of contraction that contradicts the source material. The answer demonstrates hallucination of specific financial metrics and misrepresentation of the hedge program's evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 447,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How did 3M's issuance and management of fixed rate registered notes evolve between 2022 and 2024, particularly in terms of repayment activity and interest rate strategies?",
      "original_answer": "In 2022, 3M had a significant amount of fixed rate registered notes, including $600 million of 10-year notes due 2030 with a coupon rate of 3.05%, and $650 million of 30-year notes due 2050 with a coupon rate of 3.70%. The company also issued $3.25 billion in fixed rate registered notes in August 2019, including $1.0 billion of 10-year notes due 2029 and $1.0 billion of 30-year notes due 2049. In 2024, 3M repaid $1.1 billion in medium-term notes that matured, and in 2023, it repaid $500 million in fixed-rate registered notes. Additionally, interest rate swaps initiated in 2021 converted portions of the fixed-rate notes due 2049 and 2050 into floating-rate debt through mid-2028, indicating a strategic shift toward managing interest rate exposure. This shows a decrease in the amount of fixed-rate debt outstanding and a shift toward floating-rate instruments through swaps.",
      "llm_answer": "\nBetween 2022 and 2024 3M largely wound down its fixed‑rate registered‑note program: the $1.75 bn series issued in 2020 matured and the company retired $500 m of those notes in 2023 and an additional $1.1 bn of medium‑term (largely registered) notes in 2024, rather than issuing new fixed‑rate debt.  At the same time, it managed interest‑rate risk by swapping $800 m of the 2049/2050 fixed‑rate notes into floating‑rate exposure (SOFR‑based) through 2028 and by relying on floating‑rate notes with put provisions, thereby reducing the fixed‑rate balance and aligning debt‑service costs with current market rates.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general narrative of 3M winding down fixed-rate registered notes and managing interest rate risk through swaps, but contains significant quantitative discrepancies and incomplete information compared to the ground truth.\n\nCORRECT ELEMENTS:\n- Correctly identifies that 3M repaid $500 million in fixed-rate registered notes in 2023\n- Correctly identifies that 3M repaid $1.1 billion in medium-term notes in 2024\n- Correctly identifies the strategic shift toward floating-rate instruments through swaps\n- Correctly identifies the use of SOFR-based swaps through 2028\n- Correctly identifies the use of floating-rate notes with put provisions\n- Appropriate characterization of the overall strategy (winding down fixed-rate program)\n\nINCORRECT/PROBLEMATIC ELEMENTS:\n1. QUANTITATIVE ERROR - Swap amount: LLM states \"$800 m of the 2049/2050 fixed-rate notes into floating-rate exposure\" but ground truth does not specify this exact amount. The ground truth mentions \"interest rate swaps initiated in 2021 converted portions of the fixed-rate notes\" without specifying $800m.\n2. MISSING SPECIFIC DEBT DETAILS: LLM does not mention the specific coupon rates (3.05% for 2030 notes, 3.70% for 2050 notes) or the specific maturity dates and amounts from 2022 baseline ($600m due 2030, $650m due 2050).\n3. INCOMPLETE HISTORICAL CONTEXT: LLM mentions \"$1.75 bn series issued in 2020\" but ground truth references $3.25 billion issued in August 2019 with specific breakdowns ($1.0 billion 10-year, $1.0 billion 30-year notes).\n4. VAGUE CHARACTERIZATION: LLM says \"$1.75 bn series issued in 2020 matured\" but ground truth doesn't clearly support this characterization - the ground truth discusses 2019 issuances.\n\nMULTI-HOP REASONING:\nThe LLM successfully synthesizes information across 2022-2024 and connects repayment activity with interest rate strategy. However, it lacks the specific numerical details and precise debt instrument descriptions from the ground truth.\n\nSEMANTIC EQUIVALENCE:\nWhile the overall narrative is semantically similar (winding down fixed-rate debt, managing rates through swaps), the LLM omits important specific financial metrics and coupon rates that characterize the evolution of the debt portfolio.\n\nJUSTIFICATION:\nThe answer demonstrates good qualitative understanding of the strategy but fails on quantitative precision. The $800m swap figure appears unsupported by the ground truth, and the omission of specific coupon rates, maturity dates, and precise issuance amounts represents incomplete synthesis of the multi-hop information required.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 693,
        "total_tokens": 2073
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How has the role of securities issuances in Schwab's capital structure evolved between 2023 and 2024, particularly in relation to its overall funding sources and capital management strategy?",
      "original_answer": "In 2023, securities issuances by CSC were identified as a primary source of capital, directly supporting the company's capital management strategy, which included balance sheet growth and financial support to subsidiaries. By 2024, while still listed as one of several funding sources, securities issuances were positioned among a broader set of liquidity tools, including FHLB borrowings, repurchase agreements, and CDs, indicating a more diversified funding approach. This shift suggests a strategic evolution where securities issuances remain important but are more integrated within a wider capital structure framework.",
      "llm_answer": "\nBetween 2023 and 2024 Schwab’s reliance on capital‑market issuances receded.  In the 2023 MD&A the firm described securities issuances by CSC as a **primary source of capital** to fund balance‑sheet growth, support its subsidiaries and the 2023 IDA arrangement, and sustain regulatory‑capital buffers.  By 2024 the same discussion lists issuances only as **one of several secondary funding options**—alongside client‑generated cash, FHLB borrowings, CD issuances and repo facilities—reflecting a strategic shift toward using internally generated deposits and diversified funding sources while employing securities issuance more selectively to meet liquidity or regulatory needs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. STRENGTHS: (1) Correctly identifies the temporal evolution from 2023 to 2024, with accurate characterization of securities issuances shifting from 'primary source of capital' to 'one of several secondary funding options.' (2) Accurately captures the specific context of 2023 (balance sheet growth, subsidiary support, IDA arrangement, regulatory capital buffers) and 2024 (diversified funding approach). (3) Properly synthesizes multi-hop information by comparing funding strategies across two fiscal years and identifying the strategic shift toward internally generated deposits. (4) Correctly names the company (CSC/Schwab) and relevant funding mechanisms (FHLB borrowings, CDs, repo facilities). (5) The semantic meaning is equivalent to ground truth - both convey that securities issuances remained important but became less central to capital strategy. MINOR CONSIDERATIONS: (1) The LLM uses slightly more detailed language ('client-generated cash' and 'more selectively to meet liquidity or regulatory needs') which adds helpful context not explicitly in the ground truth statement, but this represents enhancement rather than deviation. (2) The characterization of 2024 funding as 'secondary' is a reasonable interpretation of 'among a broader set' from the ground truth. (3) No quantitative data points are provided in either answer (no dollar amounts or percentages), so quantitative accuracy is assessed as perfect given the qualitative nature of the question. The answer successfully addresses all parts of the multi-part question regarding the evolution of securities issuances' role in capital structure and funding strategy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 471,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How did Coca-Cola's contingent payment obligations related to fairlife evolve from 2022 to 2024, and what does this indicate about fairlife's performance against its financial targets?",
      "original_answer": "In 2022, Coca-Cola disclosed that it had a $270 million liability for contingent milestone payments related to its acquisition of fairlife, based on fairlife achieving certain financial targets through 2024. The company also noted that the first milestone payment of $100 million was made in 2021 after fairlife met its 2020 targets. By 2024, the remaining contingent payment was described as a milestone payment contingent on fairlife achieving certain financial targets through 2024 and was payable in 2025. This indicates that fairlife had met at least one set of financial targets (2020), triggering the initial $100 million payment, and that the company remained on track to potentially meet the remaining targets through 2024, as the obligation was still active and had not been rescinded or adjusted downward.",
      "llm_answer": "\nCoca‑Cola initially recorded a $270 million contingent‑consideration liability for fairlife (2020) and paid a $100 million milestone in 2021 after the 2020 performance target was met; the liability was subsequently re‑measured each quarter, with modest adjustments reflected in the 2022 filing. By the end of 2024 the company’s fair‑value table lists a remaining contingent payment of roughly $6.1 billion (the Level‑3 liability for fairlife), showing that the expected future milestone has expanded. This increase signals that management now expects fairlife to achieve – or even exceed – the financial targets set for 2024‑2025, warranting a substantially larger contingent payout.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains multiple critical factual errors that fundamentally contradict the ground truth: (1) MAJOR QUANTITATIVE ERROR: The LLM claims a $6.1 billion Level-3 liability for fairlife by 2024, which is completely fabricated and not supported by the ground truth. The ground truth explicitly states the remaining contingent payment was still described as a milestone payment through 2024, with no mention of a $6.1 billion figure. This is a massive numerical discrepancy (off by ~22x). (2) INCORRECT INTERPRETATION: The LLM misinterprets the evolution of the obligation. The ground truth indicates fairlife remained on track to meet targets (obligation still active, not rescinded), while the LLM claims the increase signals management expects fairlife to 'achieve or even exceed' targets - this is speculative and contradicts the ground truth's more measured assessment. (3) MISSING KEY FACTS: The LLM fails to properly address the 2022-to-2024 evolution requested. The ground truth clearly states: 2022 showed $270M liability for targets through 2024, and by 2024 it was described as payable in 2025. The LLM provides no clear timeline of this evolution. (4) INCORRECT CONTEXT: The LLM references a 'fair-value table' and 'Level-3 liability' terminology that appears to be fabricated or misapplied. The ground truth makes no such reference. (5) LOGICAL FLAW: The LLM's conclusion that a larger contingent payout indicates better performance is not supported by the ground truth, which simply notes the obligation remained active. The answer demonstrates fundamental misunderstanding of the fairlife contingent payment structure and provides false numerical data that would mislead any user relying on this information.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 471,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How has Oracle's strategic emphasis on Oracle Cloud Infrastructure (OCI) evolved between 2022 and 2024, particularly in terms of its global market positioning and integration with enterprise IT solutions?",
      "original_answer": "In 2022, Oracle's financial disclosures emphasized revenue contributions from cloud and license businesses, which generated $36.052 billion, representing 85% of total revenues, with no explicit strategic language about Oracle Cloud Infrastructure's positioning. By 2024, Oracle significantly elevated OCI's role, describing it as a core component of Oracle Cloud Services alongside SaaS, and emphasizing its ability to provide 'comprehensive and integrated applications and infrastructure services' that enable customers to choose deployment models best suited to their needs. This reflects a clear strategic shift toward positioning OCI as a central pillar in Oracle’s enterprise IT offerings, not just a contributor to cloud revenue.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2024 Oracle shifted OCI from a peripheral “cloud‑and‑license” add‑on to a central growth engine, explicitly embedding it in its global go‑to‑market story and linking restructuring, capital spending and sales initiatives to its expansion. The 2024 filing portrays OCI as a comprehensive, integrated cloud‑infrastructure offering that works alongside existing Oracle software and hardware in hybrid and multi‑cloud deployments, and highlights increased investment in data‑center capacity and second‑generation infrastructure to strengthen its worldwide market positioning and deepen integration with enterprise IT solutions.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly captures the core strategic shift from 2022 to 2024, accurately describing OCI's evolution from a peripheral offering to a central pillar of Oracle's enterprise IT strategy. The qualitative characterization of OCI as 'comprehensive and integrated' and the mention of increased data-center investment and second-generation infrastructure align well with the ground truth. The answer appropriately addresses the multi-part question about global market positioning and enterprise IT integration. WEAKNESSES: (1) QUANTITATIVE ACCURACY ISSUE - The LLM answer fails to include the specific financial metrics from the ground truth: the $36.052 billion cloud and license revenue figure for 2022 and the 85% of total revenues percentage. These concrete numbers are critical evidence of the strategic shift and their omission is a significant gap. (2) The LLM answer uses vague language like 'peripheral add-on' and 'central growth engine' without grounding these characterizations in the actual 2022 disclosures that showed 'no explicit strategic language about Oracle Cloud Infrastructure's positioning.' (3) The answer makes claims about 'restructuring, capital spending and sales initiatives' that are not explicitly verified in the ground truth provided. (4) The phrase 'second-generation infrastructure' appears in the LLM answer but is not mentioned in the ground truth, raising questions about whether this is accurate or inferred. MULTI-HOP REASONING: The LLM successfully synthesizes the evolution across two fiscal years and connects strategic positioning to operational changes (data-center investment, deployment models). However, the lack of quantitative grounding weakens the synthesis. The answer demonstrates good understanding of the strategic narrative but lacks the specific financial evidence that would make it fully credible. OVERALL ASSESSMENT: The answer captures the directional shift correctly but loses points for omitting key quantitative evidence and making some unsupported claims about specific initiatives.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 555,
        "total_tokens": 1917
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How has the treatment and risk profile of PALs evolved between 2023 and 2024, particularly in terms of credit loss allowance and collateralization?",
      "original_answer": "In 2023, there was a slight decrease in PALs, and the allowance for credit losses was influenced by improved credit quality metrics and lower projected loss rates. By 2024, all PALs were fully collateralized by securities with fair values exceeding borrowings, and no allowance for credit losses for PALs was required as they were all subject to the collateral maintenance practical expedient under ASC 326. This indicates a strengthening in the risk profile and treatment of PALs over the period.",
      "llm_answer": "\nBetween 2023 and 2024 the Company’s treatment of Pledged‑Asset Lines (PALs) did not change materially: PALs remained fully collateralized by securities whose fair value exceeded the borrowing amount, and under ASC 326 the Company applies the collateral‑maintenance practical expedient, which eliminated the need for any allowance for credit losses – the allowance stayed at $0 in both years. The only operational shift noted is that unsecured PAL balances are now charged off no later than 90 days past due, but because virtually all PALs are secured, the credit‑loss risk profile remains very low and the collateral coverage continues to be the primary risk mitigant.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains both accurate and problematic elements. CORRECT ELEMENTS: (1) The statement that PALs were fully collateralized by securities with fair values exceeding borrowings in 2024 is accurate. (2) The ASC 326 collateral maintenance practical expedient application is correctly identified. (3) The $0 allowance for credit losses in both years is accurate. (4) The semantic understanding that collateral coverage is the primary risk mitigant is sound. PROBLEMATIC ELEMENTS: (1) The LLM claims 'treatment of PALs did not change materially' between 2023 and 2024, which contradicts the ground truth that indicates evolution/strengthening in the risk profile. The ground truth explicitly states 'This indicates a strengthening in the risk profile and treatment of PALs over the period,' suggesting material changes occurred. (2) The LLM introduces information about 'unsecured PAL balances charged off no later than 90 days past due' which is not mentioned in the ground truth and appears to be extraneous detail that may not be directly relevant to the question about evolution between years. (3) The LLM fails to capture the nuance that in 2023 there was 'a slight decrease in PALs' and that allowance was 'influenced by improved credit quality metrics and lower projected loss rates' - these details suggest the evolution was more complex than 'no material change.' MULTI-HOP REASONING: The LLM correctly synthesizes information about collateralization and ASC 326 treatment across both years, but misses the comparative evolution aspect that the ground truth emphasizes. The answer is internally consistent but doesn't fully address how the treatment 'evolved' as the question specifically asks. QUANTITATIVE ACCURACY: Numbers are correct ($0 allowance both years, full collateralization), but the characterization of change/evolution is inaccurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 505,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How has Nike's relationship with the Asia Pacific & Latin America (APLA) region evolved between fiscal years 2023 and 2024, particularly in terms of operational structure and strategic emphasis?",
      "original_answer": "In fiscal year 2023, Nike's relationship with APLA was characterized by direct operational involvement, with the region being one of the geographies where certain employees were represented by trade unions, indicating a more localized and embedded workforce structure. By fiscal year 2024, Nike transitioned parts of its APLA operations to third-party distributors, signaling a strategic shift away from direct control toward a more outsourced model. This evolution reflects a broader restructuring effort to optimize the business model and reduce operational complexity in certain international markets.",
      "llm_answer": "\nBetween fiscal 2023 and 2024 Nike kept APLA as a separate reportable geographic segment (NIKE + Jordan brands) but reshaped its operating model there.  The company completed the divestiture of its Argentina and Uruguay entities to third‑party distributors—an initiative started in FY 2023—so that those markets now run under a distributor‑driven structure rather than direct subsidiaries.  This shift underscores a strategic emphasis on simplifying the APLA supply chain, concentrating on core brand and direct‑to‑consumer growth, and positioning the region as a key driver of global expansion.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core evolution of Nike's APLA relationship between FY2023 and FY2024, correctly identifying the shift from direct operations to third-party distributor models. The specific mention of Argentina and Uruguay divestiture is accurate and provides concrete examples of the transition. The answer correctly identifies APLA as a separate reportable segment and accurately describes the strategic shift toward outsourcing.\n\nStrengths: (1) Correctly identifies the transition from direct operational control to distributor-driven structure, matching the ground truth's core finding; (2) Provides specific geographic examples (Argentina, Uruguay) that substantiate the broader claim; (3) Accurately notes this was an initiative started in FY2023 and completed by FY2024; (4) Correctly maintains APLA as a reportable segment; (5) Appropriately contextualizes the shift as part of operational optimization.\n\nWeaknesses: (1) The ground truth emphasizes the workforce structure aspect (trade union representation indicating embedded workforce), which the LLM answer does not address; (2) The LLM answer adds interpretive elements about \"core brand and direct-to-consumer growth\" and \"key driver of global expansion\" that, while plausible, are not explicitly stated in the ground truth and may represent inference beyond what the filings directly support; (3) The phrase \"simplifying the APLA supply chain\" is somewhat interpretive rather than directly stated.\n\nMulti-hop reasoning: The answer successfully synthesizes information about the operational structure changes across the two fiscal years and correctly identifies the strategic shift. The reasoning is sound and logically connects the divestiture actions to broader business model optimization.\n\nNo quantitative errors detected. All dates and entities are correctly identified. The answer is semantically equivalent to the ground truth on the main point (shift from direct to outsourced operations) but omits the workforce/union representation detail that was part of the original answer's characterization of FY2023 operations.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 567,
        "total_tokens": 1879
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How did Abbott's positioning and strategic emphasis on Pedialyte evolve between 2022 and 2023, particularly in relation to its U.S. Pediatric Nutritional business and product portfolio expansion?",
      "original_answer": "In 2022, Pedialyte was highlighted as a key growth driver within Abbott's U.S. Pediatric Nutritional business, with sales increasing 10.3% for the year, alongside Similac and PediaSure. By 2023, Pedialyte was formally included in Abbott's product portfolio under the Nutritional Products segment, listed among major brands such as Ensure, Glucerna, and PediaSure, signaling a more structured integration into Abbott's broader nutritional offerings. This reflects a strategic evolution from being a contributor to growth in 2022 to being a formally recognized and embedded part of the company's core U.S. Pediatric Nutritional product lineup in 2023.",
      "llm_answer": "\nBetween fiscal 2022 and 2023 Abbott deepened its strategic focus on Pedialyte as a core growth driver within the U.S. pediatric‑nutritional portfolio.  In 2022 the company highlighted double‑digit sales growth for Pedialyte (part of the 10.3 % rise in U.S. pediatric nutritionals) and began expanding the line with new formats and flavors, while the 2023 filing underscores a consumer‑direct marketing approach and a broader product portfolio (e.g., powder, ready‑to‑drink, new flavor extensions) that positions Pedialyte as the flagship oral‑rehydration brand across the pediatric market.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the 10.3% growth figure for U.S. pediatric nutritionals in 2022, matching the ground truth. (2) The temporal evolution narrative is sound - moving from 2022 to 2023 positioning. (3) The mention of product portfolio expansion (new formats, flavors, powder, ready-to-drink) aligns with the ground truth's reference to 'product portfolio expansion.' (4) The characterization of Pedialyte as a 'core growth driver' is appropriate. WEAKNESSES: (1) The LLM claims Pedialyte had 'double-digit sales growth' in 2022, but the ground truth states the 10.3% growth was for the entire U.S. Pediatric Nutritional business (which includes Similac and PediaSure), not specifically Pedialyte alone. This is a subtle but important distinction - the LLM appears to have misattributed the 10.3% figure to Pedialyte specifically rather than the broader category. (2) The LLM introduces details about 'consumer-direct marketing approach' and 'flagship oral-rehydration brand' that are not present in the ground truth, suggesting potential hallucination or extrapolation beyond the source material. (3) The ground truth emphasizes 'formal inclusion in Abbott's product portfolio under the Nutritional Products segment' and listing 'among major brands such as Ensure, Glucerna, and PediaSure' - this structural/organizational aspect is missing from the LLM answer. (4) The LLM's characterization of the evolution is less precise than the ground truth's distinction between being 'a contributor to growth' (2022) versus 'formally recognized and embedded' (2023). MULTI-HOP REASONING: The LLM attempts to synthesize information across two fiscal years but conflates the growth metric attribution and adds unsupported details about marketing approaches. The core evolution narrative is present but incomplete regarding the formal portfolio integration aspect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 508,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did RTX's financial position regarding its 7.100% notes due 2027 evolve from 2022 to 2023, and what does this indicate about its debt management strategy?",
      "original_answer": "In 2022, RTX disclosed an aggregate principal balance of $6 million for its 7.100% notes due 2027. By 2023, RTX had a stake in the same notes with an aggregate principal balance of $135 million. This indicates a significant increase in RTX's exposure to this particular debt instrument, suggesting a shift in its debt management strategy, possibly involving refinancing or restructuring.",
      "llm_answer": "\nFrom the end of 2022 to the end of 2023 the $135 million of 7.100 % notes due 2027 that appeared on RTX’s 2022 balance‑sheet (page 93 of the 2022 10‑K) was no longer listed in the 2023 long‑term‑debt schedule (page 108 of the 2023 10‑K), indicating that the entire tranche was retired during 2023.  RTX used cash on hand and the proceeds of newer, lower‑cost borrowings—including 2023 term‑loan facilities and freshly issued notes with maturities in 2026‑2034—to extinguish the remaining balance, reflecting a deliberate strategy of retiring higher‑coupon debt and reshaping the company’s maturity profile toward more flexible, lower‑interest financing.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains a fundamental factual contradiction with the ground truth. According to the knowledge graph, RTX had $6 million in 7.100% notes due 2027 in 2022 and $135 million in 2023—representing a SIGNIFICANT INCREASE. However, the LLM claims the opposite: that $135 million appeared on the 2022 balance sheet and was retired/eliminated by 2023. This is backwards. The LLM states the notes were 'no longer listed in the 2023 long-term-debt schedule' and were 'retired during 2023,' which directly contradicts the ground truth showing an increase from $6M to $135M. The LLM's narrative about retiring higher-coupon debt and using cash/new borrowings is plausible debt management strategy language, but it is applied to the wrong direction of change. The quantitative error is severe: the LLM inverts the actual trend (decrease vs. increase). The ground truth indicates RTX INCREASED its exposure to these notes from $6M to $135M, suggesting possible acquisition of these notes or refinancing activity that added to this position. The LLM's interpretation that these notes were eliminated is factually incorrect based on the knowledge graph data. This represents a complete misreading of the financial evolution described in the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 355,
        "total_tokens": 1618
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How has Nike's relationship with Converse evolved in terms of revenue performance and strategic positioning between fiscal 2023 and fiscal 2024?",
      "original_answer": "In fiscal 2023, Converse revenues decreased by 15% on a currency-neutral basis, driven by declines in North America and Western Europe, with both wholesale and direct-to-consumer channels experiencing drops in unit sales and average selling price. By fiscal 2024, Converse was described as a wholly-owned subsidiary that operates on a stand-alone basis, indicating a strategic shift toward maintaining it as a distinct brand within Nike’s portfolio. This evolution reflects a move from a financially struggling entity in 2023 to a more strategically positioned brand in 2024, despite the earlier revenue contraction.",
      "llm_answer": "\nBetween fiscal 2023 and fiscal 2024 Converse’s revenue slipped 14 % on a reported basis (≈15 % in constant‑currency terms) to $2.08 bn, with footwear down 16 % and wholesale sales down 15 % as unit volumes fell 12 % and ASP slipped 3 % because of heavier promotions; earnings before interest and taxes fell 30 % to $474 m, reflecting the lower volume, a 130‑basis‑point gross‑margin contraction from foreign‑currency headwinds and higher discounting. Strategically, Converse continues to be reported as a stand‑alone brand within Nike’s portfolio—focused on casual sneakers, apparel and licensing—but its growth is now concentrated in Asian markets and dependent on licensing arrangements, while Nike is shifting emphasis toward higher‑margin digital and direct‑to‑consumer channels.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) TEMPORAL CONFUSION - The LLM answer conflates fiscal 2023 and fiscal 2024 data. The ground truth states that in fiscal 2023, Converse revenues decreased by 15% on a currency-neutral basis. The LLM answer presents detailed metrics (14% reported, 15% constant-currency, $2.08bn revenue, 16% footwear decline, 15% wholesale decline, 30% EBIT decline to $474m) but attributes these to 'between fiscal 2023 and fiscal 2024' without clarifying which year these metrics belong to. The specific numbers ($2.08bn, $474m EBIT, 30% EBIT decline) appear to be fiscal 2024 year-end figures, not the comparison between years. (2) INCOMPLETE MULTI-HOP SYNTHESIS - The ground truth emphasizes the strategic evolution: from a 'financially struggling entity in 2023' to a 'more strategically positioned brand in 2024' operating as a 'wholly-owned subsidiary on a stand-alone basis.' The LLM answer mentions the stand-alone positioning but fails to clearly articulate the strategic shift or the contrast between 2023 struggles and 2024 positioning. (3) FACTUAL ACCURACY CONCERNS - While the LLM provides specific numbers, the ground truth does not provide these detailed metrics ($2.08bn, $474m, specific percentage breakdowns). The LLM appears to be adding information not in the ground truth, which raises questions about source accuracy. The 14-15% revenue decline aligns with ground truth's 15% figure, but the additional granular data cannot be verified against the provided ground truth. (4) MISSING KEY INSIGHT - The ground truth emphasizes the strategic repositioning as a 'distinct brand within Nike's portfolio' with a move from financial struggle to strategic positioning. The LLM mentions stand-alone status and licensing but doesn't clearly convey this evolution narrative. (5) QUESTIONABLE ADDITIONS - The LLM's claims about 'growth concentrated in Asian markets' and 'shifting emphasis toward higher-margin digital and direct-to-consumer channels' are not mentioned in the ground truth and appear to be extrapolations or from different sources. The answer reads more like detailed fiscal 2024 performance data rather than a comparison of how the relationship evolved between the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 592,
        "total_tokens": 1942
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How has Coca-Cola's financial risk assessment regarding digital evolution changed from 2022 to 2024, particularly in terms of its impact on sales growth and margin improvement?",
      "original_answer": "In 2022, Coca-Cola viewed digital evolution as a risk factor that could negatively impact its business if it failed to implement digital transformation initiatives effectively, potentially leading to a loss in sales and brand relevance. By 2024, the company shifted its stance, identifying digital evolution as a strategic dependency, emphasizing that its future success would rely on expanding digital capabilities to increase sales and improve margins. The 2024 filing explicitly states that failure to digitalize operations could adversely impact financial performance, indicating a stronger financial linkage to digital initiatives than in 2022.",
      "llm_answer": "\nIn the 2022 filing (p. 16) the company merely observed that “shopping patterns are being affected by the digital evolution,” treating digital change as a peripheral risk. By contrast, the 2024 filing (p. 137 / p. 19) elevates digitalization to a top priority and explicitly warns that “if we are not successful in our efforts to digitalize the Coca‑Cola system, our ability to increase sales and improve margins may be negatively affected,” while also noting that the associated investments could weigh on financial performance. Thus, the risk assessment shifted from a generic mention of digital trends to a direct linkage of digital success with sales‑growth and margin‑improvement objectives.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. STRENGTHS: (1) Correctly identifies the temporal shift from 2022 to 2024 in Coca-Cola's digital risk assessment; (2) Accurately characterizes the 2022 stance as treating digital evolution as a peripheral/generic risk ('shopping patterns are being affected'); (3) Precisely captures the 2024 shift to viewing digitalization as a strategic priority with direct linkage to sales growth and margin improvement; (4) Includes the specific quote from 2024 filing about failure to digitalize negatively affecting 'ability to increase sales and improve margins'; (5) Notes the additional consideration of investment costs impacting financial performance; (6) Demonstrates sound multi-hop reasoning by synthesizing information across two different filing years and connecting digital strategy to specific financial outcomes. QUANTITATIVE ACCURACY: No numeric values, percentages, or dollar amounts are present in either answer, so this dimension is not applicable but receives full marks as no errors exist. QUALITATIVE ACCURACY: The characterization of the evolution from 'peripheral risk' to 'strategic dependency' is semantically equivalent to the ground truth's framing. The reasoning correctly identifies the causal linkage between digital capabilities and financial performance metrics. MINOR CONSIDERATIONS: The LLM provides specific page references (p. 16, p. 137/p. 19) which add credibility but are not verified against the ground truth. The answer is slightly more detailed and specific than the ground truth while maintaining complete factual accuracy. The semantic meaning is fully preserved and the multi-hop synthesis across years is executed correctly.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 476,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How has Oracle's strategic emphasis on Oracle Cloud Services evolved from fiscal year 2022 to 2024, particularly in terms of research and development investment and the positioning of cloud offerings relative to on-premise solutions?",
      "original_answer": "In fiscal year 2022, Oracle invested $7.2 billion in research and development, highlighting its commitment to enhancing Oracle Cloud Services, including Oracle SaaS and OCI, as part of a broader strategy to offer flexible and interoperable deployment models. Oracle positioned cloud services as a key differentiator against competitors by emphasizing rapid deployment, security, and integration. By fiscal year 2024, Oracle continued to emphasize cloud services but restructured its messaging to position Oracle Cloud Software-as-a-Service and Oracle Cloud Infrastructure as central to enabling customers to 'choose the best option that meets their specific business needs.' While the 2024 report does not specify the R&D investment amount, the increased focus on cloud-first positioning and integration with customer-specific needs indicates a strategic deepening of Oracle's commitment to cloud services over on-premise offerings.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 Oracle has steadily increased the share of its R&D budget devoted to cloud‑focused innovation—building on the $7.2 billion invested in FY 2022 and continuing to fund second‑generation OCI infrastructure and autonomous database capabilities (as highlighted in the 2024 restructuring discussion of “investments in resources and geographies that better address the development, marketing, sale and delivery of our cloud‑based offerings”).  At the same time, the company has repositioned its Oracle Cloud Services (SaaS and OCI) as the preferred, lower‑cost, rapidly deployable alternative to traditional on‑premise licenses, promoting hybrid and full‑cloud deployment models that offer greater flexibility, reduced upfront capital outlay and integrated management relative to on‑premise solutions.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of Oracle's cloud strategy evolution and correctly identifies the $7.2 billion FY2022 R&D investment. The answer appropriately acknowledges that the 2024 report does not specify the R&D investment amount, which aligns with the ground truth. The qualitative positioning of cloud services as a preferred alternative to on-premise solutions is accurately captured, including references to flexibility, rapid deployment, security, and integration benefits. The multi-hop synthesis across fiscal years 2022-2024 is sound, connecting R&D investment to strategic messaging shifts. However, there are minor issues: (1) The phrase 'steadily increased the share of its R&D budget devoted to cloud-focused innovation' makes a claim about increasing share/percentage that is not explicitly supported in the ground truth, which only confirms continued emphasis without quantifying the increase in R&D budget allocation; (2) The characterization of cloud as 'preferred, lower-cost, rapidly deployable alternative' adds interpretive language ('preferred,' 'lower-cost') that goes slightly beyond the ground truth's more measured positioning language about 'choosing the best option that meets specific business needs'; (3) The reference to '2024 restructuring discussion' and specific language about 'investments in resources and geographies' appears to be paraphrased from actual filing language but is presented without direct quotation, making verification difficult. The answer is substantively correct on the core facts and demonstrates good multi-hop reasoning, but makes some minor inferential leaps beyond what the ground truth explicitly states.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 461,
        "total_tokens": 1923
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has the status and availability of shares under the Norwest Corporation Directors' Formula Stock Award Plan evolved between 2023 and 2024?",
      "original_answer": "In 2023, the Norwest Corporation Directors' Formula Stock Award Plan was described as a plan under which shares of common stock were awarded to non-employee directors, with the ability to defer receipt of awards until a future year. However, it was noted that no future stock awards or deferrals could be made under this plan. In 2024, the 10-K filing further clarified that no future awards or deferrals would be made under the plan and that column (a) of the equity compensation table reflected all shares issuable under the plan upon distribution of outstanding awards or deferred compensation benefits. This indicates that by 2024, the plan was fully closed to any new activity and only existing obligations remained. The number of shares issuable in 2024 related to this plan was minimal (only 391 shares), showing that the plan had effectively concluded its active phase.",
      "llm_answer": "\nBetween 2023 and 2024 the Norwest Corporation Directors’ Formula Stock Award Plan moved from having a modest pool of shares that could still be issued (4,264,741 shares were listed as “issuable upon distribution of deferred compensation” in the 2023 tables) to essentially no remaining availability—by 2024 the plan’s description notes that **no future stock awards or deferrals may be made**, and only a handful of shares (≈ 391) remain tied to previously‑granted deferred awards that are being wound down. Consequently, the plan’s share reserve is now effectively exhausted, and any further share issuance under this plan is not possible.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the plan's evolution and correctly identifies the key transition: from a plan with active share issuance capability in 2023 to a fully closed plan in 2024. STRENGTHS: (1) Correctly cites the 4,264,741 shares figure for 2023 deferred compensation, which aligns with ground truth context; (2) Accurately states that no future awards or deferrals could be made under the plan; (3) Correctly identifies the 391 shares remaining in 2024 as tied to previously-granted deferred awards; (4) Properly characterizes the plan as 'effectively exhausted' and 'wound down'; (5) Demonstrates sound multi-hop reasoning by synthesizing the 2023-to-2024 transition. MINOR CONSIDERATIONS: (1) The LLM uses approximate notation ('≈ 391') which is slightly informal but not incorrect—391 is the precise figure; (2) The answer emphasizes the 'share reserve is now effectively exhausted' which is a reasonable interpretation but the ground truth notes 'minimal' shares rather than explicitly stating exhaustion; (3) The LLM provides more specific quantitative detail (4,264,741 shares) than the ground truth summary, which adds value and demonstrates deeper engagement with the data. QUANTITATIVE VERIFICATION: The 4,264,741 figure for 2023 and 391 figure for 2024 appear consistent with typical SEC filing disclosures for such plans. The characterization of the transition is factually sound. MULTI-HOP REASONING: The answer successfully synthesizes information across two fiscal years and correctly identifies the causal relationship between the plan closure and the reduction in available shares. The logic is sound and well-articulated.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 456,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has McDonald's disclosure around food safety concerns evolved between 2022 and 2023, particularly in relation to supply chain risks and cost volatility?",
      "original_answer": "In 2022, McDonald's characterized food safety concerns primarily as reputational risks that could impact brand perception and financial results due to incidents like food-borne illness or contamination. The focus was on the potential damage to consumer trust and the company's image. By 2023, the framing had evolved to emphasize food safety concerns as contributors to supply chain volatility, specifically in relation to commodity cost fluctuations. The 2023 filing noted that food safety issues, along with other macroeconomic and regulatory factors, could exacerbate volatility in the prices of key ingredients like beef, chicken, and pork, thereby affecting profitability. This indicates a shift in emphasis from reputational impact to financial exposure through supply chain disruption and cost pressures.",
      "llm_answer": "\nBetween 2022 and 2023 McDonald’s moved from a generic “food‑safety could harm the brand” statement in the 2022 10‑K to a dedicated, detailed discussion in the 2023 filing that explicitly links food‑safety events to supply‑chain vulnerability and commodity‑price volatility. The 2023 document calls out the “particularly volatile” markets for beef, chicken and pork, cites seasonal shifts, climate conditions, international markets, food‑safety concerns, recalls and regulations as drivers of cost swings, and notes that hedging only partially mitigates the resulting margin pressure—whereas the 2022 filing mentioned food‑safety only as a broad risk without this supply‑chain and cost‑volatility focus.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. STRENGTHS: (1) Correctly identifies the evolution of McDonald's disclosure from 2022 to 2023, capturing the shift from reputational risk framing to supply chain/cost volatility focus. (2) Accurately names the specific commodities (beef, chicken, pork) mentioned in the 2023 filing. (3) Properly synthesizes the multi-hop connection between food safety concerns, supply chain vulnerability, and commodity price volatility. (4) Correctly notes that hedging only partially mitigates margin pressure, adding nuance about financial exposure. (5) Accurately characterizes the 2022 filing as containing only generic food safety risk language without supply chain linkage. (6) No quantitative errors or date inaccuracies present. MINOR CONSIDERATIONS: The LLM answer uses slightly more detailed language (e.g., 'dedicated, detailed discussion,' 'particularly volatile markets,' 'seasonal shifts, climate conditions, international markets') than the ground truth, but this represents elaboration rather than inaccuracy—these details are consistent with typical 10-K disclosures and don't contradict the ground truth. The semantic meaning is fully preserved and the core factual claims are all correct. The answer demonstrates sound multi-hop reasoning by connecting food safety concerns → supply chain disruption → cost volatility → profitability impact, which is exactly what the question asks for.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 409,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has the carrying value and interest rate of TMO's 1.750% 7-Year Senior Notes evolved between 2023 and 2024?",
      "original_answer": "In 2023, TMO's 1.750% 7-Year Senior Notes, due on October 15, 2028, had a carrying value of $700 million and an effective interest rate of 1.89%. In 2024, both the carrying value and effective interest rate remained unchanged at $700 million and 1.89% respectively. This indicates that there was no change in the financial structure or valuation of this particular debt instrument over the period.",
      "llm_answer": "\nThe $1.75 % 7‑Year Senior Notes (euro‑denominated, maturing 4/15/2027) had a carrying amount of **$662 million at the end of 2023** and **$621 million at the end of 2024**.  Correspondingly, the effective interest rate fell slightly from **1.97 % (2023)** to **1.96 % (2024)**.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on multiple critical dimensions: (1) WRONG DEBT INSTRUMENT: The ground truth specifies TMO's 1.750% 7-Year Senior Notes due October 15, 2028 (USD-denominated). The LLM identifies a different instrument - euro-denominated notes maturing 4/15/2027. These are completely different securities. (2) WRONG CARRYING VALUES: Ground truth shows $700M in both 2023 and 2024. LLM reports $662M (2023) and $621M (2024) - all three numbers are incorrect. (3) WRONG INTEREST RATES: Ground truth shows 1.89% in both years (unchanged). LLM reports 1.97% (2023) and 1.96% (2024) - both incorrect and showing a different trend. (4) WRONG MATURITY DATE: Ground truth specifies October 15, 2028; LLM states 4/15/2027 - a different maturity date entirely. (5) CURRENCY MISMATCH: Ground truth implies USD; LLM explicitly states euro-denominated. The LLM appears to have identified an entirely different debt instrument from a different issuance. This is a complete failure to correctly identify and synthesize the required information. The answer demonstrates no correct factual elements and fails on all quantitative metrics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1160,
        "completion_tokens": 325,
        "total_tokens": 1485
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did RTX's exposure to its 7.000% notes due 2038 change between 2022 and 2023, and what does this suggest about its approach to managing long-term debt maturities?",
      "original_answer": "In 2022, RTX disclosed an aggregate principal balance of $11 million for its 7.000% notes due 2038. By 2023, this amount had increased significantly to $148 million. This suggests that RTX either issued additional tranches of this note or restructured its debt to extend maturities, indicating a strategic shift toward increasing exposure to this particular long-term debt instrument.",
      "llm_answer": "\nThe carrying amount of RTX’s 7.000 % notes due 2038 was $148 million at the end of 2022 and remained $148 million at the end of 2023 (see the long‑term‑debt tables on page 85 of the 2023 filing and the comparable table on page 85 of the 2022 filing). Thus the company’s exposure to that specific tranche was unchanged. This flat‑line position indicates that RTX is not actively reshaping that long‑dated debt but is instead maintaining a stable, laddered maturity profile while managing the overall debt portfolio through other issuances and repayments.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains a critical factual error that directly contradicts the ground truth. The ground truth clearly states that RTX's 7.000% notes due 2038 had an aggregate principal balance of $11 million in 2022 and increased to $148 million in 2023. The LLM answer incorrectly claims the carrying amount was $148 million at the end of 2022 and remained $148 million at the end of 2023, which is factually wrong. The LLM has reversed the 2022 figure, stating $148M instead of $11M. This is a fundamental quantitative error that undermines the entire analysis. The LLM's conclusion that 'the company's exposure to that specific tranche was unchanged' is therefore incorrect - there was actually a significant increase from $11M to $148M, representing a 1,245% increase. The LLM's interpretation that this represents a 'stable, laddered maturity profile' is also incorrect given the actual substantial increase in exposure. While the LLM's reasoning about debt management strategies would be sound if the numbers were correct, the factual inaccuracy of the baseline data makes the entire answer unreliable. The question specifically asks about how the exposure 'changed between 2022 and 2023,' and the correct answer is that it increased dramatically, not remained flat. This is a clear case where the LLM has provided incorrect financial data that contradicts the ground truth from the SEC filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1239,
        "completion_tokens": 389,
        "total_tokens": 1628
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did McDonald's financial relationship with its franchisees evolve between 2022 and 2023, particularly regarding the collection of rent and royalties?",
      "original_answer": "In 2022, McDonald's disclosed that it had deferred approximately $1 billion in rent and royalties from franchisees, primarily during the first half of 2020, due to the impact of government restrictions related to COVID-19. By the end of 2021, the company had collected substantially all of these deferred amounts. In contrast, the 2023 filing reflects a return to standard operations, with no mention of ongoing deferrals or pandemic-related financial accommodations. Instead, the 2023 report outlines the normalization of franchise operations, including a detailed breakdown of restaurant ownership types, which indicates that franchisees were operating under regular financial obligations without pandemic-era relief measures.",
      "llm_answer": "\nAfter deferring roughly $1 billion of rent and royalty payments from franchisees in early 2020 because of COVID‑19, McDonald’s had recovered virtually all of those amounts by the end of 2021 and resumed normal cash‑flow collections throughout 2022‑2023.  The 2023 10‑K shows that future minimum rent obligations under conventional franchise agreements remained strong at $33.8 billion, with scheduled payments of $3.06 billion in 2022 and $2.95 billion in 2023, and franchise‑generated rent and royalty revenue rose to $8.38 billion and $4.65 billion in 2023—up from $6.84 billion and $3.83 billion in 2020—indicating a rebound and continued growth in the company’s financial relationship with its franchisees.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly captures the core narrative about McDonald's pandemic-era deferrals (~$1 billion in 2020) and recovery by end of 2021, plus normalization in 2022-2023. The qualitative reasoning about the evolution of the financial relationship is sound and addresses the question well. However, there are significant quantitative accuracy issues that prevent a higher score: (1) The LLM introduces specific revenue figures ($8.38B, $4.65B for 2023; $6.84B, $3.83B for 2020) and future minimum rent obligations ($33.8B total, $3.06B in 2022, $2.95B in 2023) that are NOT present in the ground truth answer. These appear to be fabricated or hallucinated numbers not verified against the actual 10-K filings. (2) The ground truth explicitly states 'no mention of ongoing deferrals' in 2023 and focuses on 'normalization of franchise operations,' while the LLM adds detailed financial metrics that go beyond what the ground truth confirms. (3) The comparison of 2020 vs 2023 revenue figures in the LLM answer cannot be verified against the provided ground truth. While the LLM's narrative structure and reasoning about recovery and normalization align with the ground truth, the introduction of unverified specific dollar amounts is problematic. The answer demonstrates good multi-hop reasoning (connecting 2020 deferrals → 2021 recovery → 2022-2023 normalization) but fails on quantitative precision by presenting numbers without ground truth validation. The contextual relevance is strong as it directly addresses how the relationship evolved, but the unsubstantiated figures significantly undermine credibility.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 443,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How has The Coca-Cola Company's financial stake in Embotelladora Andina S.A. evolved from 2022 to 2024, and what does this indicate about the company's strategic positioning with respect to this equity investment?",
      "original_answer": "In 2022, Coca-Cola recognized a gain of $39 million from the partial sale of its ownership interest in Embotelladora Andina S.A., indicating a strategic refranchising or divestiture move while retaining an equity stake. By 2024, Coca-Cola still held a financial stake in Andina, with a carrying value of $90 million and a fair value of $168 million, showing that the company maintained its involvement but with a relatively modest valuation compared to other equity investments. This indicates a partial exit strategy rather than a complete divestiture, with ongoing but reduced exposure.",
      "llm_answer": "\nBetween 2022 and the end of 2024 Coca‑Cola’s equity stake in Embotelladora Andina S.A. remained roughly the same – about 19 % of the outstanding shares (as disclosed in the 2022 10‑K notes and reiterated in the 2024 10‑K equity‑method table).  The carrying amount of the investment edged up from roughly $80 million in 2022 to $90 million in 2024, while the market‑based fair value jumped to $168 million, leaving a $78 million excess over book value (see the fair‑value vs. carrying‑value table on page 87 of the 2024 filing).  This pattern indicates that Coca‑Cola continues to view Andina as a strategic minority holding that provides a foothold in the Latin‑American market rather than an asset to be divested or reduced.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides a reasonable narrative about Coca-Cola's strategic positioning with Embotelladora Andina, but contains significant quantitative discrepancies when compared to the ground truth. STRENGTHS: (1) Correctly identifies the ~19% ownership stake maintained across the period; (2) Accurately cites the 2024 carrying value of $90 million and fair value of $168 million; (3) Correctly calculates the $78 million excess ($168M - $90M); (4) Provides sound strategic interpretation about minority holding and Latin American market positioning; (5) Appropriately references specific filing locations. CRITICAL ISSUES: (1) The ground truth explicitly mentions a $39 million gain recognized in 2022 from a partial sale, indicating a strategic divestiture event - the LLM answer completely omits this material transaction, stating the stake 'remained roughly the same' without acknowledging the 2022 refranchising activity; (2) The LLM states carrying amount 'edged up from roughly $80 million in 2022 to $90 million in 2024' - while the 2024 figure is correct, the 2022 baseline is not verified against ground truth and the characterization of this change as 'edging up' may misrepresent the significance of the 2022 partial sale event; (3) The answer frames this as continuity ('continues to view Andina as strategic') when the ground truth indicates a 'partial exit strategy' with 'reduced exposure' - these are subtly different strategic narratives. MULTI-HOP REASONING: The LLM successfully synthesizes information across 2022 and 2024 filings and connects ownership percentages to fair value metrics, but fails to integrate the critical 2022 transaction event that fundamentally shapes the evolution narrative. The answer reads as a static comparison rather than capturing the dynamic evolution implied by the question. CALCULATION VERIFICATION: The $78 million excess is correctly calculated; the ownership percentage and 2024 valuations are accurate. However, the omission of the 2022 gain event represents a material gap in quantitative completeness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 555,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How has Oracle's strategic investment in cloud infrastructure evolved from 2022 to 2024, particularly regarding internal development efforts and the positioning of Oracle Cloud Infrastructure in its product portfolio?",
      "original_answer": "In 2022, Oracle emphasized internal development as a core strategy, dedicating significant resources to research and development to maintain and improve its existing product suite, including cloud technologies. The company highlighted its global R&D workforce and the importance of innovation in response to evolving market demands. By 2024, this focus had evolved into a more product-specific strategy with the explicit introduction of Oracle Cloud Infrastructure (OCI) as a central offering within Oracle Cloud Services. OCI was positioned as a comprehensive and integrated infrastructure solution, indicating a shift from general cloud development to a structured, customer-facing product portfolio. This evolution demonstrates a strategic deepening of Oracle's cloud infrastructure commitment, aligning internal R&D with the delivery of a defined, market-ready suite of cloud services.",
      "llm_answer": "\nOracle has turned its cloud‑infrastructure push from a peripheral initiative in 2022 into a core strategic pillar by 2024, pouring ever‑larger capital and R&D resources into building out OCI’s second‑generation data‑center capacity, expanding its service catalog (e.g., Autonomous Database, OCI @ Customer, multi‑cloud networking) and lengthening hardware lifecycles (the server useful‑life was extended from 4 to 5 years in FY 2023, reducing depreciation expense).  The 2024 restructuring plan explicitly earmarks cost‑saving measures to fund these cloud‑focused investments, positioning OCI alongside traditional license, hardware and services as a primary growth engine in Oracle’s product portfolio.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and introduces unsupported claims not present in the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM claims 'server useful-life was extended from 4 to 5 years in FY 2023' - this specific claim is not mentioned in the ground truth and appears to be fabricated. No depreciation expense figures are provided in either answer to verify this claim. (2) UNSUPPORTED DETAILS: The LLM introduces specific product examples (Autonomous Database, OCI @ Customer, multi-cloud networking) and mentions 'second-generation data-center capacity' and '2024 restructuring plan' - none of these details appear in the ground truth. This represents hallucination rather than synthesis from actual filing data. (3) MISSING CORE ELEMENTS: The ground truth emphasizes the shift from 'general cloud development to a structured, customer-facing product portfolio' and highlights the importance of R&D workforce and innovation in response to market demands. The LLM answer focuses on capital allocation and depreciation mechanics rather than the strategic positioning evolution described in the ground truth. (4) MULTI-HOP REASONING: While the LLM attempts to show evolution from 2022 to 2024, it does so by introducing unverified claims rather than synthesizing actual filing information. The ground truth's key insight about positioning OCI as 'a comprehensive and integrated infrastructure solution' is not adequately captured. (5) SEMANTIC MISMATCH: The ground truth emphasizes strategic deepening and alignment of R&D with market-ready services. The LLM answer shifts focus to cost-saving measures and depreciation accounting, which represents a different analytical perspective not supported by the ground truth. The answer reads as plausible but contains fabricated details that would fail verification against actual 10-K filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 508,
        "total_tokens": 1924
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did TMO's involvement with The Binding Site Group evolve between 2023 and 2024, and what does this indicate about the company's integration and strategic focus post-acquisition?",
      "original_answer": "In 2023, TMO acquired The Binding Site Group for $2.70 billion as part of its Specialty Diagnostics segment, expanding its portfolio in diagnostics for blood cancers and immune disorders. By 2024, the company had integrated the acquisition into its asset base, with The Binding Site Group contributing to the 19-year weighted-average amortization period for customer relationships among definite-lived intangible assets. This evolution indicates a strategic focus on long-term value creation through integration of acquired innovation into its core diagnostics offerings.",
      "llm_answer": "\nThermo Fisher completed the acquisition of The Binding Site Group in early 2023 (Note 12, 2023 acquisition) and reported the target within the Specialty Diagnostics segment; by the 2024 filing the business is fully integrated, as shown by its contribution to the segment’s revenue and income (Specialty Diagnostics segment income rose from $1,124 M in 2023 to $1,159 M in 2024, page 62‑63).  This continued contribution demonstrates that TMO is using the acquisition to reinforce its specialty‑diagnostics platform—particularly in blood‑cancer and immune‑system testing—and to generate synergistic growth, underscoring a strategic focus on expanding and leveraging its diagnostics portfolio post‑acquisition.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the 2023 acquisition of The Binding Site Group for the Specialty Diagnostics segment and accurately describes the integration by 2024. The qualitative reasoning about strategic focus on blood-cancer and immune-system testing, and the emphasis on synergistic growth and portfolio expansion, aligns well with the ground truth. However, there are quantitative accuracy issues: (1) The LLM cites Specialty Diagnostics segment income rising from $1,124M in 2023 to $1,159M in 2024, but the ground truth does not provide these specific numbers for verification—this appears to be unsourced data that cannot be confirmed against the knowledge graph. (2) The ground truth mentions the $2.70 billion acquisition price, which the LLM omits entirely. (3) The ground truth specifically references the 19-year weighted-average amortization period for customer relationships among definite-lived intangible assets, which the LLM does not mention. The LLM's multi-hop reasoning is sound—it correctly synthesizes that the acquisition was made in 2023, integrated by 2024, and demonstrates strategic focus. The semantic equivalence is good regarding the strategic intent. However, the missing acquisition price and intangible asset details represent incomplete coverage of the ground truth, and the unverified segment income figures create quantitative uncertainty. The answer is directionally correct but lacks key financial details from the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 408,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How has the disclosure and accessibility of the Directors' Code of Conduct evolved between 2022 and 2024, particularly in terms of website links and scope of application?",
      "original_answer": "In 2022, the Directors' Code of Conduct was posted on BNY Mellon's website at a specific URL: https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-of-conduct.pdf, and it applied to all directors. By 2024, while the scope of application remained the same—applying to all directors—the URL for the Directors' Code of Conduct had changed to https://www.bny.com/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-ofconduct.pdf. This indicates a change in the website structure or domain branding, likely reflecting a broader rebranding from 'BNY Mellon' to 'BNY', while maintaining the same governance policy content and disclosure intent.",
      "llm_answer": "\nBetween 2022 and 2024 the Directors’ Code of Conduct remained limited to “all directors of BNY Mellon,” but its public location and transparency measures were refined. In the 2022 filing the code was posted at a lengthier URL — `https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/in relations/directors-code-of-conduct.pdf` — whereas the 2024 filing moved the document to a cleaner path — `bnymellon/documents/pdf/investor-relations/directors-code-ofconduct.pdf` — making it easier for users to locate. Both years note that any future amendments or waivers of the Directors’ Code will be disclosed on the company’s website, but the 2024 version explicitly highlights this commitment, improving accessibility and transparency.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) URL ACCURACY - The LLM provides INCORRECT URLs for both years. The 2022 URL in the LLM answer shows 'in relations' instead of 'investor-relations' (truncated/corrupted), and the 2024 URL is incomplete/malformed (missing the full domain 'https://www.bny.com/'). The ground truth shows: 2022: https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-of-conduct.pdf and 2024: https://www.bny.com/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-ofconduct.pdf. The LLM's claim about a 'cleaner path' is factually incorrect - the 2024 URL actually changed the domain from bnymellon.com to bny.com, not simplified the path structure. (2) DOMAIN CHANGE MISCHARACTERIZATION - The LLM fails to identify the key domain change from 'bnymellon.com' to 'bny.com', which is the primary structural change. Instead, it incorrectly describes this as a path simplification. (3) SCOPE ACCURACY - The LLM correctly identifies that scope remained 'all directors' in both years, which matches ground truth. (4) MISSING KEY INSIGHT - The ground truth explicitly notes this reflects 'rebranding from BNY Mellon to BNY', which the LLM does not capture. (5) ACCESSIBILITY CLAIMS - The LLM makes unsupported claims about 'cleaner path' and 'easier for users to locate' that contradict the actual URL changes shown in ground truth. The answer demonstrates partial understanding of the question's intent but contains multiple factual errors in the specific URLs and mischaracterizes the nature of the changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 432,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How has McDonald's relationship with franchisees evolved in terms of financial reporting and strategic emphasis between 2022 and 2023?",
      "original_answer": "In 2022, McDonald's noted that the results of operations from restaurant businesses purchased and sold in transactions with franchisees were not material to the consolidated financial statements, indicating a limited financial impact from such transactions. By 2023, the company explicitly included franchisees and licensees as key stakeholders in its business model, emphasizing their role alongside company-operated restaurants in a detailed breakdown of restaurant ownership types. This shift reflects a more strategic and transparent focus on franchisees as integral to McDonald's global business structure.",
      "llm_answer": "\nBetween 2022 and 2023 McDonald’s continued its shift toward a heavier franchised model—franchised restaurants grew to 21,818 (up from 21,720 in 2022) and now represent roughly 93 % of system‑wide locations—while the company’s financial reporting increasingly centers on franchisee sales and margins rather than company‑operated revenue.  The 2023 10‑K highlights that the rise in operating income was driven by stronger franchised revenues and improved franchisee profitability, and it provides more detailed segment and non‑GAAP disclosures that isolate franchisee contributions, underscoring a strategic emphasis on supporting franchisee investment and financial health as a core growth lever.  (See page 42 for the franchised‑restaurant count and operating‑income breakdown; page 30 for the discussion of franchisee‑related risks and financing; page 45 and page 18 for the gains from sales of restaurants to franchisees.)",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer addresses the evolution of McDonald's relationship with franchisees but contains significant issues: (1) QUANTITATIVE PROBLEMS: The LLM provides specific numbers (21,818 franchised restaurants in 2023, up from 21,720 in 2022, representing ~93% of system-wide locations) that cannot be verified against the ground truth, which makes no mention of these specific counts or percentages. These appear to be fabricated or unsourced details. The ground truth focuses on qualitative shifts in reporting and strategic emphasis, not specific restaurant counts. (2) MISALIGNMENT WITH GROUND TRUTH: The original answer emphasizes two key points: (a) in 2022, franchisee transactions were noted as immaterial to consolidated financials, and (b) by 2023, franchisees were explicitly highlighted as key stakeholders with detailed breakdown of ownership types. The LLM answer largely ignores the 2022 baseline about materiality and instead jumps to 2023 metrics without establishing the comparative evolution. (3) MULTI-HOP REASONING: The LLM attempts to synthesize information about financial reporting changes and strategic emphasis, but does so by introducing unverified numbers rather than grounding the answer in the actual reporting shifts described in the ground truth. The references to specific pages (42, 30, 45, 18) suggest detailed filing knowledge but cannot be validated. (4) SEMANTIC ISSUES: While the LLM correctly identifies that McDonald's shifted toward emphasizing franchisees as integral to the business model, it frames this primarily through quantitative metrics (restaurant counts, revenue percentages) rather than the qualitative reporting evolution (materiality assessment, stakeholder emphasis) that the ground truth emphasizes. (5) MISSING CORE INSIGHT: The ground truth's key finding—that 2022 treated franchisee transactions as immaterial while 2023 elevated them to strategic importance—is largely absent from the LLM response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 528,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How did the accounting treatment or status of the contingent consideration liabilities related to the Clif Bar acquisition evolve between 2023 and 2024, particularly in terms of fair value measurement and purchase price allocation adjustments?",
      "original_answer": "In 2023, the contingent consideration liabilities related to the Clif Bar acquisition were actively measured at fair value using a Monte Carlo simulation, with $548 million classified as long-term liabilities at December 31, 2023. These liabilities were tied to performance targets in 2025 and 2026 and were subject to fair value adjustments recorded in selling, general, and administrative expenses. By 2024, there is no direct mention of the contingent consideration liabilities; instead, the 2024 filing references purchase price allocation adjustments for Clif Bar during 2023. This indicates that the contingent consideration may have been finalized or reclassified as part of the purchase price allocation process, though the 2024 disclosure does not provide updated figures or valuation methods for these liabilities.",
      "llm_answer": "\nIn 2023 the Clif Bar earn‑out was recorded at a fair‑value of $548 million (a Level 3 liability) and any subsequent changes in that fair value were charged to SG&A expense as part of the purchase‑price allocation. During 2024 the liability remained classified as long‑term and was re‑measured periodically; updates to the earn‑out estimates, discount‑rate adjustments and the $33 million reduction recorded in the “Other (1)” PPA line altered the carrying amount, with any payments or revised projections also flowing through earnings, but no new acquisition or fundamental change in the accounting treatment occurred.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations of the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM claims the liability 'remained classified as long-term' and was 're-measured periodically' in 2024, but the ground truth explicitly states 'there is no direct mention of the contingent consideration liabilities' in 2024. The LLM introduces a '$33 million reduction recorded in the Other (1) PPA line' which is not mentioned in the ground truth and appears to be fabricated. (2) FACTUAL MISREPRESENTATION: The ground truth indicates the contingent consideration may have been 'finalized or reclassified' by 2024 with no updated figures provided, suggesting the liability was resolved or removed from the balance sheet. The LLM incorrectly suggests ongoing measurement and periodic re-measurement in 2024, which contradicts the ground truth's statement that there is 'no direct mention' in 2024. (3) INCOMPLETE SYNTHESIS: While the LLM correctly identifies the $548 million fair value and Level 3 classification for 2023, it fails to capture the key evolution described in the ground truth - that the 2024 filing shows a shift from contingent consideration liability disclosure to purchase price allocation adjustments, indicating a fundamental change in accounting treatment or status. (4) UNSUPPORTED CLAIMS: The statement 'no new acquisition or fundamental change in the accounting treatment occurred' directly contradicts the ground truth's implication that the contingent consideration was finalized/reclassified. The LLM appears to have invented details about 2024 activity rather than acknowledging the absence of disclosure. The answer demonstrates poor multi-hop reasoning by failing to synthesize the key evolution between years and instead fabricating continuity that the ground truth does not support.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 501,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How has AMD's strategic emphasis on Vulkan API support evolved between 2022 and 2024, and what does this reveal about its approach to maintaining competitiveness in the discrete GPU market?",
      "original_answer": "In 2022, AMD highlighted its support for Vulkan as part of its Radeon™ series discrete GPUs, which were built on the RDNA 2 architecture and aimed at delivering high-performance gaming and creation workloads. By 2024, AMD continued to support Vulkan but shifted its focus toward the newer RDNA 3 architecture, which underpins the Radeon RX 7000 Series GPUs. This evolution suggests AMD is maintaining its commitment to Vulkan while advancing its GPU capabilities to meet the growing demands of immersive gaming and AI/ML computing. This strategic continuity in API support combined with architectural innovation indicates AMD’s effort to stay competitive by offering both backward compatibility and cutting-edge performance enhancements.",
      "llm_answer": "\nBetween 2022 and 2024 AMD shifted from merely “supporting” Vulkan to making it a central pillar of its GPU software strategy—highlighting Vulkan 1.3 compliance, Vulkan‑based ray‑tracing extensions, and tight integration with ROCm and FidelityFX in the Radeon RX 6000/7000 launches and Instinct data‑center accelerators. This emphasis on an open, cross‑platform API shows AMD’s broader competitiveness play: leveraging industry‑standard standards to reduce reliance on proprietary stacks (e.g., Nvidia’s CUDA/DirectX), lower developer friction, and broaden its addressable market while preserving price‑performance advantages against rivals.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and unsupported claims that diverge substantially from the ground truth. Key issues: (1) UNSUPPORTED CLAIMS: The LLM introduces specific technical details (Vulkan 1.3 compliance, Vulkan-based ray-tracing extensions, ROCm/FidelityFX integration) that are not mentioned in the ground truth and cannot be verified from the provided context. These appear to be hallucinated details. (2) MISSING CORE INFORMATION: The ground truth explicitly mentions RDNA 2 architecture (2022) and RDNA 3 architecture (2024) as key architectural evolution markers. The LLM answer completely omits this critical architectural progression, which is central to understanding AMD's strategic evolution. (3) INCORRECT PRODUCT REFERENCES: The LLM mentions 'Radeon RX 6000/7000 launches' as if both occurred during the 2022-2024 period, but the ground truth clearly indicates RX 6000 series (RDNA 2) was the 2022 focus while RX 7000 series (RDNA 3) represents the 2024 evolution. (4) SPECULATIVE REASONING: The LLM's explanation about 'reducing reliance on CUDA/DirectX' and 'lowering developer friction' goes beyond what the ground truth supports. While the reasoning is plausible, it's not grounded in the actual filing data. (5) INCOMPLETE SYNTHESIS: The ground truth emphasizes 'backward compatibility and cutting-edge performance enhancements' as the strategic approach, which the LLM answer fails to capture. The ground truth's focus on maintaining commitment while advancing capabilities is more nuanced than the LLM's competitive positioning narrative. The LLM answer reads more like industry analysis speculation rather than a synthesis of actual SEC filing information.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 466,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did RTX's integration-related charges impact its operating profit trends between 2022 and 2023, particularly with the introduction of the Powder Metal Matter charge in 2023?",
      "original_answer": "In 2022, RTX reported a decrease in Acquisition Accounting Adjustments, which contributed positively to its operating profit. However, in 2023, there was a significant $2.9 billion charge associated with the Powder Metal Matter, which became a major driver of the $1.9 billion decrease in Operating Profit compared to 2022. This reflects a notable shift from a declining trend in integration-related charges in 2022 to a significant new expense in 2023 that directly impacted profitability.",
      "llm_answer": "\nThe 2023 operating‑profit decline (‑$1.9 bn, from $5.5 bn in 2022 to $3.6 bn) was driven largely by integration‑related costs, most notably the $2.9 bn “Powder Metal Matter” charge that RTX recorded in 2023; this one‑time expense more than offset the modest profit gains seen at Collins and Raytheon. Consequently, the operating‑profit margin fell from 8.2 % in 2022 to 5.2 % in 2023, reflecting the heavy impact of the integration charge on the overall profit trend.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the $2.9 billion Powder Metal Matter charge as a major driver of the operating profit decline in 2023, and accurately captures the core narrative that integration-related charges shifted from declining in 2022 to a significant new expense in 2023. The answer appropriately addresses the multi-hop synthesis required by the question. CRITICAL ISSUES: (1) QUANTITATIVE ERRORS - The LLM provides specific operating profit figures ($5.5B in 2022, $3.6B in 2023) and margin percentages (8.2% in 2022, 5.2% in 2023) that cannot be verified against the ground truth. The ground truth only confirms a $1.9 billion decrease but does not provide the absolute values or margin percentages cited by the LLM. These specific numbers appear to be fabricated or from unverified sources. (2) INCOMPLETE GROUND TRUTH SYNTHESIS - The ground truth mentions that 2022 saw a 'decrease in Acquisition Accounting Adjustments, which contributed positively to its operating profit,' but the LLM does not explicitly address this positive contribution from 2022, instead focusing primarily on 2023. (3) MISSING CONTEXT - The LLM mentions 'modest profit gains seen at Collins and Raytheon' but this detail is not present in the ground truth and appears to be unsupported information. CALCULATION VERIFICATION: The $1.9 billion decrease is correctly stated. However, without independent verification of the $5.5B and $3.6B figures, the margin calculations (8.2% and 5.2%) cannot be confirmed as accurate. REASONING QUALITY: The multi-hop reasoning is sound in connecting the Powder Metal Matter charge to the operating profit decline, but the introduction of unverified specific numbers undermines confidence in the answer's reliability.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 475,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How has MDLZ's relationship with Clif Bar evolved between 2023 and 2024, particularly in terms of acquisition-related financial activities?",
      "original_answer": "In 2023, MDLZ acquired Clif Bar, as noted in the 2023 10-K filing, with specific reference to the August 1, 2022 acquisition and related financial impacts such as integration costs and contingent consideration adjustments. By 2024, the relationship had evolved to include purchase price allocation adjustments for Clif Bar during the prior year, as detailed in the 2024 10-K filing. This indicates that the company had moved beyond the initial acquisition phase into a period of financial recalibration and consolidation of the Clif Bar acquisition.",
      "llm_answer": "\nMDLZ’s 2023 financial statements still carried a $548 million contingent‑consideration liability for the 2022 Clif Bar acquisition—up from $452 million in 2022—showing that earn‑out obligations were being accrued but no new acquisition‑related cash outflows were recorded. By 2024 that liability remained at $548 million, and the company recorded $153 million of intangible‑asset impairment charges tied to Clif Bar brands, indicating the relationship had moved from the initial purchase to ongoing integration, performance‑based payments and periodic impairment testing.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides specific financial details about MDLZ's Clif Bar relationship evolution between 2023-2024 that go beyond the ground truth answer. Strengths: (1) The answer correctly identifies the August 1, 2022 acquisition date (consistent with ground truth), (2) Provides specific contingent consideration liability figures ($548M in 2023, remaining at $548M in 2024) showing year-over-year comparison, (3) Correctly identifies the $153M intangible asset impairment charge for Clif Bar in 2024, (4) Accurately characterizes the evolution from initial acquisition phase to integration and performance-based payments, (5) The multi-hop reasoning is sound—synthesizing acquisition history, contingent liabilities, and impairment charges across two fiscal years. Potential concerns: (1) The ground truth answer does not explicitly mention the specific dollar amounts ($548M, $452M, $153M) or the impairment charge, making it difficult to verify these numbers against the original source. However, these appear to be legitimate details from the actual 10-K filings that enhance rather than contradict the ground truth. (2) The ground truth mentions 'purchase price allocation adjustments' in 2024, while the LLM answer focuses on impairment charges—these are related but distinct concepts. The LLM answer's focus on impairment testing is a reasonable interpretation of post-acquisition financial recalibration. (3) Minor discrepancy: Ground truth references 'contingent consideration adjustments' while LLM specifies the liability amounts and their movement. The LLM answer is more specific and detailed. Overall, the LLM answer demonstrates strong multi-hop synthesis across fiscal years and correctly characterizes the relationship evolution. The specific financial figures appear reasonable for a major acquisition of this scale, though they cannot be fully verified against the provided ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 516,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How has Gulfstream's approach to energy efficient engines evolved from 2023 to 2024, and what specific aircraft developments reflect this shift?",
      "original_answer": "In 2023, Gulfstream emphasized its leadership in the use of sustainable aviation fuel (SAF) and energy efficient engines, focusing on continuous R&D investment to develop technologically advanced business jets. However, no new aircraft model powered by energy efficient engines was introduced that year. By 2024, Gulfstream had transitioned from announcement and development phases to actual production of energy efficient engines, as evidenced by the introduction of the G700, which features 'all-new engines' designed for high-speed performance and efficiency. This marks a tangible evolution from strategic positioning in 2023 to operational realization in 2024.",
      "llm_answer": "\nFrom 2023 to 2024 Gulfstream shifted from highlighting the fuel‑saving performance of its existing clean‑sheet jets (the G500 and G600, introduced in 2018‑19) to rolling out a brand‑new, higher‑efficiency powerplant in the ultra‑long‑range G700, which entered service in March 2024 and is marketed together with expanded use of sustainable‑aviation fuel.  This evolution is reflected in the 2024 product lineup, where the G700’s “all‑new engines” are presented as the latest step in Gulfstream’s strategy of pairing advanced, energy‑efficient propulsion with SAF‑compatible operations, while the earlier G500/G600 family continues to serve as the benchmark for fuel‑efficient, low‑emission business jets.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general evolution narrative (2023 positioning to 2024 production) and correctly identifies the G700 as the key aircraft with 'all-new engines' introduced in 2024. However, there are significant factual errors that reduce accuracy: (1) The LLM incorrectly references the G500 and G600 as being 'introduced in 2018-19' and as part of the 2024 comparison baseline - the ground truth makes no mention of these aircraft in the context of the 2023-2024 evolution. (2) The LLM states the G700 'entered service in March 2024' - this specific date is not verified in the ground truth, which only states it was 'introduced' in 2024. (3) The LLM adds details about 'expanded use of sustainable-aviation fuel' and 'SAF-compatible operations' that, while thematically consistent with the ground truth's mention of SAF focus, go beyond what the ground truth explicitly states about the 2024 shift. The core multi-hop reasoning is sound: the answer correctly synthesizes that Gulfstream moved from R&D/announcement phase (2023) to production/introduction phase (2024), with the G700 as the tangible evidence. The semantic equivalence is generally maintained - 'all-new engines' matches the ground truth exactly. However, the introduction of unverified aircraft models (G500/G600) and specific dates (March 2024) introduces factual uncertainty. The answer demonstrates good qualitative reasoning about the strategic shift but lacks strict adherence to ground truth facts.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 409,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How has AMD's relationship with semi-custom SoC products evolved from 2022 to 2024, particularly in terms of revenue structure and strategic positioning?",
      "original_answer": "In 2022, AMD's relationship with semi-custom SoC products was characterized by dependency, with revenue derived from both non-recurring engineering fees and sales of the products themselves, and success was directly tied to third-party product performance. By 2024, AMD's relationship evolved to one of active production and broader strategic integration, as semi-custom SoC products became part of a more diversified product portfolio that includes AI accelerators, GPUs, APUs, and DPUs. This shift indicates a more central and controlled role for AMD in the development and commercialization of these products, aligning them more closely with long-term industry trends and internal innovation strategies.",
      "llm_answer": "\nFrom 2022 through 2024 AMD’s semi‑custom SoC revenue moved from a relatively sizable, high‑growth line (the risk discussion in the 2022 filing stresses that such revenue is earned only when the company’s custom chips are incorporated into a customer’s product and is paid as non‑recurring engineering fees) to a much smaller, more specialized slice of the business.  In the 2024 financial tables the Gaming segment—where most semi‑custom sales sit—fell from **$6.8 billion in 2022** to **$2.6 billion in 2024**, and the only customer that alone accounted for ≥10 % of consolidated revenue contributed just **16‑18 %** of Gaming revenue in 2023‑24, underscoring how the revenue stream is now concentrated on a few OEM wins rather than broad market demand.  Consequently, AMD now positions semi‑custom SoCs as a high‑margin, design‑win‑driven offering that is recognized over the production cycle and depends on a limited set of customers, rather than as a primary growth engine for the company.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer provides specific financial metrics and attempts to trace the evolution of AMD's semi-custom SoC business, but contains significant quantitative inaccuracies and misalignment with the ground truth's core thesis.\n\nCRITICAL ISSUES:\n\n1. QUANTITATIVE ACCURACY PROBLEMS:\n   - The LLM cites Gaming segment revenue of $6.8B (2022) and $2.6B (2024), but these figures cannot be verified against the ground truth and appear to conflate Gaming segment (which includes console gaming) with semi-custom SoC products specifically\n   - The claim about a single customer representing \"16-18% of Gaming revenue in 2023-24\" is presented as fact but lacks verification\n   - The LLM provides specific percentages without clear sourcing from the filings\n\n2. MISALIGNMENT WITH GROUND TRUTH:\n   - Ground truth emphasizes EVOLUTION from \"dependency\" (2022) to \"active production and broader strategic integration\" (2024), suggesting GROWTH in strategic importance\n   - LLM answer frames the evolution as DECLINE (\"much smaller, more specialized slice\"), which contradicts the ground truth's narrative of increased integration and centrality\n   - Ground truth highlights diversification into AI accelerators, GPUs, APUs, and DPUs alongside semi-custom SoCs; LLM answer focuses narrowly on revenue contraction\n\n3. REASONING GAPS:\n   - LLM conflates Gaming segment performance with semi-custom SoC performance without clear distinction\n   - The multi-hop synthesis fails to capture the strategic positioning shift emphasized in ground truth\n   - LLM interprets revenue decline as strategic repositioning, but ground truth suggests the opposite: increased strategic importance despite potential revenue shifts\n\n4. WHAT WAS CORRECT:\n   - Correctly identifies that semi-custom SoCs involve non-recurring engineering fees\n   - Correctly notes dependency on customer product success\n   - Appropriately characterizes the business as design-win-driven\n   - Timeframe (2022-2024) is correct\n\n5. SEMANTIC MISALIGNMENT:\n   - Ground truth: semi-custom SoCs became \"part of a more diversified product portfolio\" with \"more central and controlled role\"\n   - LLM: semi-custom SoCs became \"a high-margin, design-win-driven offering\" that is \"not a primary growth engine\"\n   - These represent fundamentally different interpretations of strategic positioning\n\nThe LLM answer provides plausible-sounding financial analysis but appears to misinterpret the direction and nature of AMD's strategic evolution with semi-custom SoCs, and the specific revenue figures lack clear verification against the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 695,
        "total_tokens": 2122
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How has the company's structure of preferred share authorization evolved between fiscal years 2023 and 2024, and what does this indicate about its capital strategy?",
      "original_answer": "The company's preferred share authorization structure remained unchanged between fiscal years 2023 and 2024, with 127.5 million Preferred Shares at $0.20 par value and 500 thousand A Preferred Shares at $1.00 par value authorized in both years. Additionally, no Preferred Shares or A Preferred Shares were issued or outstanding in either year. This indicates that the company has not utilized or pursued any changes in its preferred share structure as part of its capital strategy during this period.",
      "llm_answer": "\nIn both fiscal 2023 and fiscal 2024 Medtronic’s charter authorizes the same preferred‑share structure—127.5 million Preferred Shares ($0.20 par) and 500 thousand A‑Preferred Shares ($1.00 par)—and, as noted in the 2023 and 2024 10‑K filings, none of these shares were issued or outstanding in either year.  This unchanged authorization and zero issuance indicate that Medtronic is not relying on preferred equity to fund its operations or growth, but is instead pursuing a capital strategy centered on debt financing (e.g., senior note issuances and credit‑facility borrowings) and returning capital to shareholders through ordinary‑share repurchases.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy on the core quantitative elements. All numbers are correct: 127.5 million Preferred Shares at $0.20 par value and 500 thousand A Preferred Shares at $1.00 par value are accurately stated for both fiscal years 2023 and 2024. The statement that no shares were issued or outstanding in either year is also correct. The answer properly identifies that the authorization structure remained unchanged between the two years.\n\nHowever, there is a notable issue with entity identification. The LLM answer attributes this information to Medtronic, but the original answer does not specify which company is being discussed. The question asks about \"the company\" without naming it. While the LLM's inference that this relates to Medtronic may be reasonable if the context of the conversation established Medtronic as the subject, this represents an assumption not explicitly validated against the ground truth provided.\n\nThe LLM answer goes beyond the ground truth by adding interpretive analysis about capital strategy, specifically stating that the company is \"pursuing a capital strategy centered on debt financing (e.g., senior note issuances and credit-facility borrowings) and returning capital to shareholders through ordinary-share repurchases.\" While this reasoning is logical and represents sound financial analysis, it extends beyond what the ground truth explicitly states. The ground truth simply notes that the unchanged structure \"indicates that the company has not utilized or pursued any changes in its preferred share structure as part of its capital strategy during this period.\" The LLM's additional claims about debt financing and share repurchases are not contradicted by the ground truth but are not explicitly confirmed either.\n\nThe multi-hop reasoning is sound: the LLM correctly synthesizes that unchanged authorization + zero issuance = no reliance on preferred equity. The semantic equivalence is strong, with the core message matching the ground truth. The answer is well-structured and contextually relevant to the question about capital strategy evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 574,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How has the framing of reputational risk related to adverse publicity evolved between 2022 and 2024 in BK's risk disclosures, particularly in terms of associated impacts or linked concerns?",
      "original_answer": "In 2022, BK identified adverse publicity as a risk that could negatively affect its business, financial condition, and results of operations, and linked it with government scrutiny and other reputational harm. By 2024, the framing of this risk remained present but was expanded to include broader reputational impacts from sustainability concerns such as climate change and diversity, in addition to being tied to new operational models like the platforms operating model transition. This indicates a broadening of the contexts in which adverse publicity could negatively impact BK's reputation and business outcomes.",
      "llm_answer": "\nIn the 2022 filing (page 4) the company merely listed “adverse events, publicity, government scrutiny or other reputational harm” as a catch‑all risk that could “negatively affect our business,” without tying it to any broader strategic or ESG themes. By the 2024 filing (pages 4 and 5) the same language is retained but is expanded to explicitly connect reputational risk to sustainability and ESG concerns—e.g., “climate‑change and diversity concerns could … damage our reputation”—and to note that geopolitical, climate‑related and pandemic‑related events can also generate adverse publicity. Thus, the framing shifted from a generic warning about bad press to a more nuanced view that links reputational harm to ESG‑related and strategic risks that could affect capital access, regulatory standing and the firm’s long‑term initiatives.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across multiple dimensions. STRENGTHS: (1) Correctly identifies the temporal comparison (2022 vs 2024) with accurate filing references; (2) Accurately captures the core evolution: from generic adverse publicity/government scrutiny framing to expanded ESG-linked reputational risks; (3) Properly synthesizes the multi-hop information showing how sustainability concerns (climate change, diversity) became explicitly connected to reputational risk in 2024; (4) Correctly identifies the operational context shift (platforms operating model transition mentioned in ground truth is implicitly captured through the broader strategic risks discussion); (5) No quantitative errors or date inaccuracies; (6) The reasoning about the shift from 'catch-all risk' to 'nuanced view' with ESG connections is sound and well-articulated. MINOR CONSIDERATIONS: (1) The LLM answer adds interpretive detail about 'capital access, regulatory standing and the firm's long-term initiatives' which, while logically sound and consistent with the evolution described, goes slightly beyond the explicit ground truth statement which focuses on the broadening of contexts (sustainability concerns, operational models); (2) The specific mention of 'geopolitical, climate-related and pandemic-related events' in the 2024 filing is accurate but represents a minor elaboration beyond the ground truth's focus on sustainability and operational model transitions. These are not errors but rather reasonable extensions of the core finding. The answer successfully demonstrates multi-hop reasoning by synthesizing information across two filing years and correctly identifying the semantic shift in how reputational risk is framed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 479,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How did Amazon's financial investment and valuation approach toward Anthropic, PBC evolve from 2023 to 2024, particularly in terms of investment classification and the factors affecting its valuation?",
      "original_answer": "In 2023, Amazon disclosed a $1.25 billion convertible note investment in Anthropic, PBC, classified as available-for-sale and reported at fair value with unrealized gains and losses included in 'Accumulated other comprehensive income (loss).' The note was categorized as a Level 3 asset, and Amazon had an agreement to invest an additional $2.75 billion in a second convertible note by Q1 2024. By 2024, the investment was still classified as available-for-sale but was noted to be part of a broader portfolio of convertible debt investments in private companies, primarily referencing Anthropic, PBC. The 2024 filing emphasized increased complexity in valuing private company investments due to the lack of readily available market data and global economic uncertainty, indicating a shift toward acknowledging heightened valuation risk. While the classification remained consistent, the 2024 disclosure placed more emphasis on the challenges of valuation rather than the mechanics of the investment itself.",
      "llm_answer": "\nIn 2023 Amazon recorded a $1.25 billion convertible note in Anthropic, PBC as an **available‑for‑sale, Level 3** equity‑linked investment, recognizing unrealized gains and losses in accumulated other‑comprehensive income and measuring it at fair value.  In 2024 the company added an additional up‑to $2.75 billion second convertible note (still classified as available‑for‑sale, Level 3) and continued to adjust the carrying amount for observable price changes or impairments, with valuation increasingly driven by the lack of a public market, heightened global economic uncertainty, and the need for qualitative impairment testing rather than reliable market‑price sensitivities.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several significant issues that prevent a higher score: (1) CRITICAL ERROR - The LLM states the $2.75 billion second convertible note was 'added' in 2024, but the ground truth clearly indicates this was an agreement made in 2023 to invest by Q1 2024. The LLM conflates the timing of the commitment with the timing of the investment. (2) CLASSIFICATION ERROR - The LLM incorrectly classifies the investment as 'equity-linked investment' when the ground truth specifies it as a 'convertible note investment.' While semantically related, this is a material mischaracterization of the instrument type. (3) PARTIAL ACCURACY - The LLM correctly identifies: the $1.25 billion initial investment in 2023, available-for-sale classification, Level 3 asset status, fair value measurement, unrealized gains/losses in accumulated other comprehensive income, and the 2024 emphasis on valuation challenges due to lack of market data and economic uncertainty. (4) MISSING CONTEXT - The LLM fails to clearly distinguish the 2023 commitment of the $2.75 billion from its actual deployment timeline, which is a key aspect of how the investment 'evolved' from 2023 to 2024. (5) REASONING QUALITY - The multi-hop synthesis is partially sound but undermined by the temporal misplacement of the second investment. The answer does capture the shift toward acknowledging valuation complexity, but the structural error about when the second note was added weakens the overall narrative of evolution. The quantitative accuracy is reduced due to the timing error regarding the $2.75 billion investment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 438,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How has the nature of the risks related to the protection of MDLZ's intellectual property, including know-how, evolved between 2023 and 2024?",
      "original_answer": "In 2023, MDLZ emphasized the importance of protecting its intellectual property rights, particularly trademarks, patents, copyrights, and know-how, through a combination of legal mechanisms such as patent and trademark laws, licensing agreements, and third-party nondisclosure agreements. The company expressed concern that failure to protect these rights or any legal changes reducing intellectual property protections—especially in response to developments in artificial intelligence technologies—could significantly harm its competitiveness and financial condition. In 2024, while the company maintained its emphasis on the significance of intellectual property rights, it did not specifically mention artificial intelligence as a factor affecting protection. Instead, the 2024 disclosure focused on the broader risks of legal or regulatory non-compliance and the potential for civil or criminal penalties, reputational damage, and financial loss due to litigation or enforcement actions. This shift indicates a broadening of the risk context without the specific emphasis on AI-related threats present in 2023.",
      "llm_answer": "\nBetween 2023 and 2024 the company’s IP‑risk narrative shifted from a focus on ordinary infringement litigation and the need to protect trademarks, patents, trade‑secrets and know‑how, to an explicit warning that emerging **artificial‑intelligence developments and related legal changes could weaken or reshape that protection**.  The 2024 filing therefore broadens the threat landscape—adding AI‑related vulnerabilities and the risk that new regulatory or technological shifts could diminish the effectiveness of existing IP safeguards—whereas the 2023 discussion only mentioned such risks in more general terms.",
      "correctness_score": 2,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth. The ground truth explicitly states that in 2023, MDLZ emphasized concerns about artificial intelligence as a factor affecting IP protection, and that in 2024, the company did NOT specifically mention AI. The LLM answer reverses this chronology entirely, claiming that 2023 only mentioned risks 'in more general terms' while 2024 added 'explicit warning' about AI-related vulnerabilities. This is the opposite of what actually occurred. The ground truth is clear: '2023...expressed concern...especially in response to developments in artificial intelligence technologies' and '2024...did not specifically mention artificial intelligence as a factor affecting protection.' The LLM has inverted the temporal evolution of the risk narrative. While the LLM correctly identifies that there was a shift in emphasis between the two years and correctly names the company (MDLZ), the core factual claim about which year emphasized AI is completely backwards. This is a critical error that makes the answer fundamentally misleading and incorrect, despite the absence of numerical calculations to verify.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 331,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How has Goldman Sachs' treatment of Non-Employee Director Equity Award Agreements evolved between the 2023 and 2024 SEC filings, particularly in terms of referenced agreements and their timelines?",
      "original_answer": "In 2023, Goldman Sachs referenced Non-Employee Director Equity Award Agreements through Exhibit 10.17, which pointed to an amendment dated November 28, 2008. By 2024, the company continued to disclose these agreements under the same exhibit number (10.18), but the referenced source shifted to Exhibit 10.69 from the 2008 Annual Report, indicating a formalization or consolidation of prior amendments. This evolution shows a continuation of the policy with deeper historical documentation being emphasized in the later filing.",
      "llm_answer": "\nThe 2023 Form 10‑K still cites the legacy “pre‑2015” Non‑Employee Director RSU Award Agreement (and its cash‑settled variant) as the governing document, whereas the 2024 Form 10‑K replaces those references with updated exhibits that are labeled as amended and restated agreements—adding separate fully‑vested and base‑/supplemental RSU award forms. This change reflects the formal amendment of the director‑equity awards (effective December 1 2023) and shows the company now discloses the revised agreement structure using newer exhibit numbers.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misalignments with the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM cites 'December 1 2023' as an effective date for formal amendments, but the ground truth references November 28, 2008 as the amendment date in 2023 filings. The LLM provides a different date without supporting evidence from the actual filings. (2) EXHIBIT NUMBER DISCREPANCIES: The ground truth clearly states the 2023 filing referenced Exhibit 10.17 pointing to November 28, 2008 amendment, and 2024 shifted to Exhibit 10.18 referencing Exhibit 10.69 from the 2008 Annual Report. The LLM answer does not mention these specific exhibit numbers (10.17, 10.18, 10.69) at all, which are critical factual details. (3) INCOMPLETE SYNTHESIS: The LLM discusses 'amended and restated agreements' and 'separate fully-vested and base-/supplemental RSU award forms' but these details are not corroborated by the ground truth, which focuses on the exhibit reference evolution and historical documentation emphasis. (4) MISCHARACTERIZATION: The LLM frames this as replacing 'legacy pre-2015' agreements with 'updated exhibits,' but the ground truth indicates continuity of the same policy with consolidation of historical documentation references. (5) MISSING CORE FACTS: The LLM fails to address the specific exhibit number transitions (10.17→10.18) and the shift from direct amendment reference to 2008 Annual Report exhibit reference, which are the central elements of the ground truth answer. The answer demonstrates poor multi-hop synthesis and introduces unsupported claims about December 2023 amendments and RSU form variations.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 453,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How has BKNG's relationship with travel service providers evolved between 2022 and 2023 in terms of revenue recognition and contractual responsibilities?",
      "original_answer": "In 2022, BKNG described its relationship with travel service providers as one where it connects consumers to providers through its platforms, emphasizing its role as an intermediary without taking responsibility for delivering the travel services. The company highlighted that it earns revenues primarily from facilitating reservations and also mentioned the impact of cancellations during the pandemic recovery phase. By 2023, BKNG provided more detailed accounting treatment around its contracts with travel service providers, specifying that it recognizes revenue on a net basis due to its role as an agent, and further clarified its revenue recognition timing as occurring at the point when travelers begin using the arranged services. This reflects a shift from a general description of the relationship to a more structured and accounting-driven dependency on travel service providers, particularly in how it recognizes commissions and transaction revenues.",
      "llm_answer": "\nBetween 2022 and 2023 BKNG shifted from a primarily agency‑style arrangement—where it earned a commission or margin and did not bear responsibility for delivering the travel service—to a merchant‑based model in which it actively processes travelers’ payments, assumes greater fulfillment risk, and recognizes revenue gross of the amounts payable to providers.  This evolution reflects expanded contractual duties (e.g., payment‑processing, chargebacks, ancillary fees, and the “Connected‑Trip” integration) that now accompany its revenue recognition for travel‑service bookings.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that contradict the ground truth. (1) CRITICAL ERROR - Direction of Change: The ground truth explicitly states BKNG moved FROM a general intermediary description TO more detailed accounting treatment with net basis revenue recognition as an agent. The LLM claims the opposite - that BKNG shifted FROM agency-style TO merchant-based model with GROSS revenue recognition. This is a complete reversal of the actual evolution. (2) CRITICAL ERROR - Revenue Recognition Basis: Ground truth indicates BKNG recognizes revenue on a NET basis (as an agent), while LLM claims it shifted to recognizing revenue GROSS of amounts payable to providers. These are opposite accounting treatments. (3) CRITICAL ERROR - Contractual Responsibilities: Ground truth emphasizes BKNG's role as an intermediary WITHOUT responsibility for delivering travel services, and that it earns commissions from facilitating reservations. LLM incorrectly claims BKNG 'assumes greater fulfillment risk' and 'actively processes travelers' payments' - this mischaracterizes the relationship. (4) UNSUPPORTED CLAIMS: The LLM introduces specific details ('Connected-Trip integration,' 'chargebacks,' 'payment-processing') that are not mentioned in the ground truth and appear to be fabricated or misattributed. (5) MULTI-HOP REASONING: The LLM failed to correctly synthesize the 2022-to-2023 evolution. The actual evolution was toward MORE detailed accounting disclosure and clarification of agent status, not a shift toward merchant model. The answer demonstrates a fundamental misunderstanding of BKNG's business model and revenue recognition practices.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 455,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "What specific changes occurred in the structure of Goldman Sachs' executive life insurance policy disclosures between the 2023 and 2024 10-K filings?",
      "original_answer": "In the 2023 10-K filing, Goldman Sachs included the Goldman Sachs & Co. LLC Executive Life Insurance Policy and Certificate with Metropolitan Life Insurance Company (Exhibit 10.11) and a form of the policy with Pacific Life & Annuity Company (Exhibit 10.12). In the 2024 10-K filing, these exhibits were not only retained but renumbered to 10.12 and 10.13 respectively, indicating a reorganization of exhibit numbering. This renumbering and retention of the policies in the 2024 filing demonstrates a structural update in how the policies are presented within the filing, rather than a substantive change in the policies themselves.",
      "llm_answer": "\nBetween the 2023 and 2024 Form 10‑K filings Goldman Sachs re‑numbered its executive‑life‑insurance disclosures: the Metropolitan Life policy moved from Exhibit 10.11 (2023) to Exhibit 10.12 (2024), and the Pacific Life policy shifted from Exhibit 10.12 (2023) to Exhibit 10.13 (2024). In addition, the 2024 filing adds a specific reference to the “form of Executive Life Insurance Policy with Pacific Life & Annuity Company … including policy specifications and a restriction on the policy owner’s rights,” a level of detail that was not present in the 2023 filing, which only cited the earlier 2006 exhibits without that explicit restriction language.",
      "correctness_score": 4,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the exhibit renumbering (10.11→10.12 and 10.12→10.13) and accurately names both insurance companies (Metropolitan Life Insurance Company and Pacific Life & Annuity Company). The numeric/exhibit number accuracy is sound. CRITICAL ERRORS: The LLM introduces unsupported claims about the 2024 filing adding 'specific reference to the form of Executive Life Insurance Policy with Pacific Life & Annuity Company...including policy specifications and a restriction on the policy owner's rights' and claims this level of detail 'was not present in the 2023 filing.' The ground truth makes no mention of these substantive content differences or new restriction language in 2024. The ground truth explicitly states the changes represent 'a structural update in how the policies are presented within the filing, rather than a substantive change in the policies themselves.' The LLM contradicts this by asserting substantive content additions in 2024. MULTI-HOP REASONING: The LLM fails to properly synthesize the core finding—that the changes were structural (renumbering) rather than substantive. Instead, it invents content differences unsupported by the ground truth. This represents a fundamental misunderstanding of what changed between filings. The answer conflates exhibit renumbering with policy content changes, which are distinct issues. COMPLETENESS: While the LLM addresses the renumbering aspect, it fails to capture the key insight that both policies were 'retained' in 2024, emphasizing continuity rather than substantive modification.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 434,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has the strategic importance and manufacturing approach for FBAR filters evolved between 2022 and 2024, particularly in terms of internal fabrication and competitive positioning?",
      "original_answer": "In 2022, FBAR filters were highlighted as a key product utilizing Broadcom’s proprietary processes, fabricated internally to protect IP and accelerate time to market, alongside vertical-cavity surface emitting lasers and side emitting lasers. The internal fabrication was specifically emphasized as a means to maintain competitive advantage by safeguarding innovation. By 2024, FBAR filters remained part of the internal fabrication strategy, but the context expanded to include a more comprehensive list of competitors in the semiconductor space, such as Qorvo, Qualcomm, and Skyworks, indicating a more intense competitive environment. This suggests that while the internal manufacturing strategy for FBAR filters remained consistent, the competitive pressure in wireless communications increased significantly, requiring Broadcom to reinforce its IP protections and innovation cycle.",
      "llm_answer": "\nBetween 2022 and 2024 Broadcom kept FBAR‑filter wafer processing in‑house (primarily in the United States and Singapore) rather than outsourcing it, using internal fabrication to protect its proprietary technology and accelerate time‑to‑market. This continued internal‑fab approach underpins its competitive positioning as the early‑market leader in FBAR‑based RF front‑end modules—technology that still holds a substantial share of the cellular handset market and differentiates Broadcom from other RF‑filter suppliers.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies the core fact that Broadcom maintained internal fabrication of FBAR filters between 2022 and 2024 to protect IP and accelerate time-to-market, which aligns with the ground truth. The mention of specific manufacturing locations (United States and Singapore) adds helpful detail not contradicted by the original answer. However, the LLM answer has significant gaps in addressing the evolution aspect of the question: (1) It fails to mention the 2022 context of FBAR filters being highlighted alongside VCSELs and side-emitting lasers as key proprietary products. (2) Most critically, it completely omits the key evolution point from the ground truth—that by 2024, the competitive landscape expanded to include specific competitors (Qorvo, Qualcomm, Skyworks), indicating intensified competitive pressure in wireless communications. (3) The LLM answer does not adequately capture how the strategic importance evolved or how the competitive environment changed between these two years. The answer focuses on the consistency of the internal fabrication strategy but misses the critical insight about increased competitive intensity and the need to reinforce IP protections. The statement about being 'early-market leader' and holding 'substantial share of the cellular handset market' appears reasonable but is not explicitly verified in the ground truth provided. The multi-hop reasoning is incomplete—while the answer correctly synthesizes that internal fabrication remained consistent, it fails to synthesize the evolution in competitive context, which is central to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 442,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has BMY's strategic positioning of Krazati evolved between 2023 and 2024, particularly in terms of clinical development focus and financial valuation?",
      "original_answer": "In 2023, Krazati was positioned as part of BMY’s oncology portfolio with specific clinical trials listed: KRYSTAL-17 for 1L NSCLC TPS<50%, KRYSTAL-10 for 2L CRC, and KRYSTAL-12* for 2L+ Mutated NSCLC. By 2024, BMY had acquired Mirati for $4.8 billion, securing full rights to Krazati, which had already received FDA and EMA approvals for second-line NSCLC and FDA approval for advanced KRAS-mutated colorectal cancer. Additionally, Krazati was now being developed in combination with a PD-1 inhibitor for first-line NSCLC, indicating a significant expansion in its clinical and commercial strategy.",
      "llm_answer": "\nBetween 2023 and 2024 BMY transformed Krazati from a late‑stage investigational asset in Mirati’s pipeline into an FDA/EMA‑approved oncology drug and then expanded its clinical focus to first‑line KRAS‑mutated NSCLC (KRYSTAL‑17) and additional KRAS‑mutated CRC indications, as shown by the multiple registrational trials listed in the 2024 10‑K.  The acquisition was valued at roughly $4.8 billion in cash plus a $1 billion contingent value right, which is reflected on the balance sheet as $1.7 billion of indefinite‑lived IPRD and $2 billion of R&D technology, underscoring a strategic pivot to use Krazati as a near‑term revenue driver and a catalyst for future milestone‑based valuation.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the core strategic evolution of Krazati from investigational to approved asset, accurately cites the $4.8 billion acquisition price, and properly synthesizes the multi-hop information about clinical development expansion and regulatory approvals. The answer appropriately addresses both clinical development focus and financial valuation components of the question. The mention of combination therapy with PD-1 inhibitor for first-line NSCLC aligns with ground truth.\n\nCRITICAL ERRORS: (1) The LLM states the CVR (contingent value right) as '$1 billion' but then claims balance sheet reflects '$1.7 billion of indefinite-lived IPRD and $2 billion of R&D technology' - these numbers don't reconcile with the stated $4.8B + $1B CVR structure. The ground truth doesn't specify these balance sheet allocations, suggesting the LLM may be fabricating specific accounting line items. (2) The LLM incorrectly characterizes KRYSTAL-17 as 'first-line KRAS-mutated NSCLC' when ground truth specifies it as '1L NSCLC TPS<50%' - these are different patient populations (TPS<50% is broader than just KRAS-mutated). (3) The statement about '$2 billion of R&D technology' lacks verification in ground truth and appears to be an unsupported detail.\n\nMULTI-HOP REASONING: The synthesis across 2023 and 2024 positioning is generally sound, correctly connecting the acquisition event to the expansion of clinical development. However, the specific balance sheet allocations introduce unverified quantitative claims that undermine confidence.\n\nQUANTITATIVE ISSUES: While $4.8B is correct, the additional balance sheet figures ($1.7B IPRD, $2B R&D technology) cannot be verified against ground truth and appear to be hallucinated specificity. The CVR amount ($1B) is stated but then the subsequent accounting treatment doesn't clearly reconcile.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 506,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How has the relationship between BKNG and travel service providers evolved between 2022 and 2023, particularly in terms of how BKNG manages financial obligations and incentives related to these providers?",
      "original_answer": "In 2022, BKNG primarily competed with travel service providers, highlighting the intense and evolving nature of the competitive landscape in the online travel market. By 2023, BKNG's relationship with travel service providers shifted to a more dependent model, as evidenced by the increase in the 'Deferred merchant bookings' liability on its balance sheet, which reflects amounts estimated to be payable to travel service providers. Additionally, BKNG introduced more incentive programs, such as referral bonuses, rebates, and loyalty points, which are recognized as a reduction of revenue, indicating a strategic shift toward enhancing partnerships and incentivizing collaboration with travel service providers rather than solely competing with them.",
      "llm_answer": "\nBetween 2022 and 2023 BKNG moved from a largely traffic‑driving role to a deeper financial integration with travel service providers, handling a larger share of payment processing and using the “Deferred merchant bookings” reserve to hold cash until providers complete reservations.  At the same time, the Company formalized incentive arrangements—rebates, referral bonuses and loyalty points—treating their estimated value as a direct reduction of revenue, and it strengthened licensing and compliance obligations to manage the heightened fiscal and regulatory risks of these relationships.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across most dimensions. STRENGTHS: (1) Correctly identifies the shift from competition to a more dependent/integrated relationship model between 2022-2023; (2) Accurately references 'Deferred merchant bookings' as the key balance sheet liability reflecting amounts payable to providers; (3) Correctly identifies the three specific incentive programs: rebates, referral bonuses, and loyalty points; (4) Accurately states these incentives are treated as revenue reductions; (5) Properly synthesizes the multi-hop relationship evolution across both years. MINOR DIFFERENCES: (1) The LLM answer adds contextual details about 'payment processing,' 'licensing and compliance obligations,' and 'regulatory risks' that are not explicitly mentioned in the ground truth. While these are reasonable inferences about how such relationships typically evolve, they represent additions beyond what the ground truth specifies; (2) The phrasing 'traffic-driving role' and 'deeper financial integration' are interpretive framings not explicitly stated in the original answer, though they capture the essence of the shift accurately. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are provided in either answer, so this dimension is not directly testable. Both answers appropriately avoid making unsupported numerical claims. MULTI-HOP REASONING: The LLM successfully synthesizes information across the 2022-2023 timeframe and correctly identifies the relationship evolution as the primary change. The connection between deferred merchant bookings and incentive programs is properly established. SEMANTIC EQUIVALENCE: The core message—that BKNG shifted from competition to partnership with enhanced financial obligations and incentive programs—is conveyed accurately in both answers, despite different wording.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 510,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How has Broadcom's involvement in the development of Custom Touch Controllers evolved from 2022 to 2024, particularly in terms of their role in the product lifecycle?",
      "original_answer": "In 2022, Broadcom was described as supplying Custom Touch Controllers as part of its semiconductor solutions for the wireless market. By 2024, the company's role had evolved to include producing these controllers as part of its broader custom silicon solutions, reflecting a deeper engagement in their development. This shift indicates a strategic move from being a component supplier to an active producer involved in the design and creation process.",
      "llm_answer": "\nFrom 2022 to 2024 Broadcom moved custom touch controllers from a standalone wireless component to a core, highly integrated element of its mobile‑device semiconductor roadmap.  The company broadened their scope by pairing the controllers with its own inductive‑charging ASICs and embedding them in AI‑ready wireless solutions, positioning the technology as a central driver across the entire product lifecycle—from early design through end‑of‑life support.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ISSUES: The LLM answer introduces significant factual claims not supported by the ground truth. The original answer states Broadcom moved from 'supplying' to 'producing' Custom Touch Controllers with deeper engagement in development. However, the LLM answer makes several unsupported claims: (1) pairing controllers with 'inductive-charging ASICs' - not mentioned in ground truth, (2) 'embedding them in AI-ready wireless solutions' - not mentioned in ground truth, (3) positioning as 'central driver across entire product lifecycle' - overstates the ground truth's more modest claim about 'deeper engagement in development.' The LLM appears to have fabricated technical details and product integration specifics that don't appear in the source material. WHAT WAS CORRECT: The core timeline (2022-2024) is accurate, and the general direction of evolution from component supplier to more active producer is directionally correct. WHAT WAS INCORRECT: The specific technical implementations (inductive-charging ASICs, AI-ready solutions) are not grounded in the provided ground truth. The characterization of the role as a 'central driver across entire product lifecycle' is an overstatement compared to the ground truth's description of 'deeper engagement in development.' The answer demonstrates hallucination of technical details rather than faithful synthesis of available information. MULTI-HOP REASONING: The model failed to properly synthesize the available information and instead added unsupported technical claims. The reasoning quality is poor because it introduces facts not present in the source material.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 445,
        "total_tokens": 1677
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How has Union Pacific's approach to freight cars evolved from 2023 to 2024, particularly in terms of asset acquisition strategy?",
      "original_answer": "In 2023, Union Pacific primarily leased freight cars as part of its operational strategy, reflecting a reliance on leased assets for rail operations. By 2024, the company's strategy shifted toward acquiring freight cars, including lease buyouts of $143 million in 2024 compared to $57 million in 2023, indicating a more aggressive stance on asset ownership to support replacement and growth opportunities.",
      "llm_answer": "\nUnion Pacific’s freight‑car strategy shifted from a heavier reliance on finance‑lease assets in 2022‑23 to a greater emphasis on direct ownership and lease‑buyouts in 2024.  The company increased its cash capital investment in freight cars to **$788 million** (up from $728 million in 2023) and used lease‑buyouts of $143 million, while finance‑lease assets fell to $244 million (from $310 million).  As part of its 2025 capital plan, Union Pacific explicitly states it will continue to “acquire freight cars to support replacement and growth opportunities,” signaling a move toward owning a larger, more modern fleet rather than relying on third‑party lease arrangements.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy with correct identification of the strategic shift from leasing to ownership. STRENGTHS: (1) The core lease-buyout figures are accurate: $143 million in 2024 vs $57 million in 2023 matches the ground truth exactly. (2) The directional shift from leasing to ownership is correctly identified and well-articulated. (3) The answer provides additional context with freight car capital investment figures ($788M in 2024 vs $728M in 2023) and finance-lease asset reductions ($244M vs $310M), which support and enhance the main narrative. (4) The 2025 forward-looking statement about acquiring freight cars for 'replacement and growth opportunities' aligns with the ground truth language. (5) Multi-hop reasoning is sound - the answer synthesizes data across years and connects capital allocation decisions to strategic intent. MINOR CONSIDERATIONS: (1) The LLM introduces additional financial metrics ($788M, $728M, $244M, $310M) that are not explicitly mentioned in the ground truth answer. While these appear reasonable and support the narrative, they cannot be verified against the provided ground truth. (2) The ground truth focuses specifically on the 2023-2024 comparison, while the LLM extends the analysis to 2022-23 and 2025, which adds context but goes slightly beyond the question scope. (3) The phrasing 'finance-lease assets' vs the ground truth's simpler 'leased freight cars' represents a more technical characterization, which is appropriate but slightly different in terminology. QUANTITATIVE VERIFICATION: The critical lease-buyout numbers ($143M 2024, $57M 2023) are correct. The directional comparison (increase from $57M to $143M) is accurate. The additional metrics provided are internally consistent and logically support the narrative of a shift toward ownership. Overall, the answer correctly addresses the core question with accurate key figures and sound reasoning, with only minor additions beyond the ground truth scope.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 537,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "What were the financial and operational impacts of Nike's structural changes in APLA between FY2022 and FY2023, particularly regarding the transition of certain businesses to third-party distributors?",
      "original_answer": "In FY2022, Nike directly operated within APLA as part of its geographic operating segments, which included associated costs and foreign currency impacts such as non-recurring impairment charges due to the anticipated release of non-cash cumulative foreign currency translation losses from transitioning certain businesses to third-party distributors. By FY2023, Nike had shifted its relationship with APLA from direct operations to a strategic stake, where the company now oversees results through third-party distributors. This transition is reflected in the 2023 filing noting that APLA includes results for the NIKE and Jordan brands and referencing Note 18 on divestitures related to the transition. Operationally, this change represents a strategic shift to reduce direct operational overhead in APLA, likely aiming to improve financial efficiency and focus on brand management rather than local execution.",
      "llm_answer": "\nThe structural overhaul of Nike’s APLA business culminated in the second‑quarter FY2023 sale of its Argentina and Uruguay operations to third‑party distributors, generating a $550 million net loss—$389 million of which was the release of previously accumulated foreign‑currency translation losses—recorded in the Corporate segment.  As a result, revenue and associated costs that had been reported under the NIKE Brand APLA segment were removed, shifting those sales and related expenses to the distributors and reducing Nike’s direct control over inventory, receivables and operating overhead in those markets.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides specific quantitative details (the $550 million net loss and $389 million foreign currency translation loss) that are not present in the ground truth answer, which is concerning for verification purposes. The ground truth answer is more general, discussing the transition from direct operations to third-party distributors without citing specific loss figures. The LLM answer correctly identifies: (1) the transition of APLA operations to third-party distributors, (2) the timing as Q2 FY2023, (3) the release of foreign currency translation losses, (4) the shift from direct operational control to distributor-based model, and (5) the reduction in direct overhead. However, critical issues exist: The LLM answer specifies Argentina and Uruguay operations specifically, while the ground truth discusses a broader APLA transition without naming specific countries. The ground truth mentions 'certain businesses' transitioning, not necessarily all APLA operations. The specific dollar amounts ($550M loss, $389M FX loss) cannot be verified against the ground truth provided, which only references 'non-recurring impairment charges' and 'non-cash cumulative foreign currency translation losses' without quantifying them. The LLM answer is more detailed and specific but may be introducing unverified specificity. The reasoning about operational impacts (reduced overhead, improved efficiency, shift from execution to brand management) aligns well between both answers. The multi-hop synthesis is sound in both cases, connecting the structural change to financial and operational consequences. The LLM answer's specificity about Argentina/Uruguay and exact loss amounts represents either superior detail from the source documents or potential hallucination—without access to the actual 10-K filings, this cannot be definitively confirmed. The answer is contextually relevant and addresses the question comprehensively, but the unverified quantitative specificity creates uncertainty.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 539,
        "total_tokens": 1934
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How has Broadcom's involvement with InP lasers evolved from 2022 to 2024, particularly in terms of their internal fabrication strategy and competitive positioning?",
      "original_answer": "In 2022, Broadcom disclosed using internal fabrication facilities for products based on proprietary processes, including vertical-cavity surface emitting lasers and side emitting lasers using GaAs and InP lasers for fiber optic communications. By 2024, Broadcom continued this strategy but began emphasizing the competitive landscape more explicitly, listing companies like Coherent Corp., Lumentum Holdings Inc., and others as competitors in semiconductor solutions. This indicates a strategic shift toward highlighting InP laser capabilities as part of its competitive differentiation in the market.",
      "llm_answer": "\nFrom 2022 to 2024 Broadcom moved from a hybrid approach—outsourcing most III‑V wafer processing while maintaining a modest internal capability for proprietary devices—to a stronger, dedicated internal‑fab strategy for its InP lasers, investing in U.S. and Singapore III‑V facilities to produce vertical‑cavity surface‑emitting and side‑emitting InP lasers for fiber‑optic communications.  This shift is presented as a key competitive differentiator that protects IP, accelerates time‑to‑market and reinforces Broadcom’s position as a premium supplier of high‑performance optical components amid a crowded fiber‑optic market.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and unsupported claims that contradict the ground truth. Key issues: (1) FABRICATION STRATEGY MISCHARACTERIZATION: The LLM claims Broadcom moved from 'outsourcing most III-V wafer processing' to 'a stronger, dedicated internal-fab strategy' with 'investing in U.S. and Singapore III-V facilities.' The ground truth states Broadcom disclosed using 'internal fabrication facilities' in 2022 and 'continued this strategy' in 2024—indicating consistency, not a shift from outsourcing to internal fabrication. The LLM invents a narrative of strategic evolution that is not supported by the source material. (2) UNSUPPORTED CLAIMS: The LLM adds specific details about 'U.S. and Singapore III-V facilities,' 'protects IP,' 'accelerates time-to-market,' and 'premium supplier positioning' that do not appear in the ground truth and cannot be verified from the provided information. (3) COMPETITIVE POSITIONING: While the ground truth mentions Broadcom began 'emphasizing the competitive landscape more explicitly' and listed competitors like Coherent Corp. and Lumentum Holdings, the LLM frames this as part of a broader strategic shift narrative without grounding it in the actual disclosure evolution. (4) MULTI-HOP REASONING: The LLM fails to correctly synthesize the 2022-2024 evolution. The ground truth indicates continuity in internal fabrication strategy with increased emphasis on competitive differentiation, not a fundamental shift in manufacturing approach. The LLM's interpretation represents a misreading of the evidence. (5) QUANTITATIVE ACCURACY: No specific numbers, dates, or metrics are provided in either answer, so this dimension is neutral, but the LLM's invented specificity (facility locations) without factual basis is problematic.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 490,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How has the ownership structure of Swoosh, LLC in relation to NIKE's Class A and Class B Common Stock evolved between 2022 and 2023, and what implications does this have for shareholder influence?",
      "original_answer": "In 2022, Swoosh, LLC beneficially owned approximately 77% of NIKE's Class A Common Stock, which would translate to approximately 16% ownership of Class B Common Stock if all shares were converted. In 2023, the ownership structure remained consistent with Swoosh, LLC still beneficially owning approximately 77% of Class A Common Stock, with a commensurate ownership percentage of approximately 16% in Class B Common Stock if all shares were converted. Despite the consistency in ownership percentages, the continued concentration of ownership in Swoosh, LLC implies sustained influence by Travis Knight, who has a significant role in managing the Class A Common Stock owned by Swoosh, LLC, potentially affecting shareholder decisions and market dynamics.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2023 the ownership stake held by Swoosh, LLC was essentially unchanged: the 2022 filing notes that Swoosh beneficially owned ≈ 77 % of the Class A shares, and if those shares were converted to Class B they would represent about 16 % of the Class B shares (the same figures are reflected in the 2023 filing). Because Class A shareholders elect three‑quarters of NIKE’s board, Swoosh’s large Class A holding gives it outsized influence over governance even though, after conversion, its direct voting interest in the Class B class is only ~16 %. Consequently, any shift in the conversion of those shares would modestly affect Swoosh’s voting power, but the dual‑class structure preserves its overall control over key corporate decisions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. QUANTITATIVE VERIFICATION: All numerical values are correct - Swoosh, LLC's 77% ownership of Class A Common Stock in both 2022 and 2023, and the ~16% conversion equivalent for Class B shares are accurately stated. The answer correctly identifies the consistency of ownership structure between the two years. ENTITY ACCURACY: All entities are correctly identified (Swoosh, LLC, NIKE, Class A/B Common Stock, Travis Knight). Fiscal years 2022 and 2023 are properly referenced. MULTI-HOP REASONING: The answer successfully synthesizes information across multiple dimensions: (1) ownership percentages across two years, (2) conversion mechanics between share classes, (3) governance implications via board election structure (three-quarters board control), and (4) the relationship between ownership concentration and shareholder influence. IMPLICATIONS ANALYSIS: The LLM answer goes beyond the ground truth by explicitly explaining the governance mechanism (Class A shareholders elect three-quarters of the board) and how the dual-class structure preserves control despite the lower Class B conversion percentage. This represents enhanced contextual understanding. MINOR DIFFERENCES: The ground truth mentions Travis Knight's role in managing the Class A shares, while the LLM answer focuses more on the structural implications of the dual-class system. Both perspectives are valid and complementary. The LLM's discussion of how share conversion would affect voting power is a logical extension of the ground truth analysis. COMPLETENESS: The answer addresses all aspects of the question - the evolution (or lack thereof) of ownership structure, the specific percentages, and the implications for shareholder influence. The explanation of why Swoosh maintains outsized influence despite lower Class B conversion percentage demonstrates sophisticated understanding of the dual-class voting structure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 528,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How did PMI's strategic positioning of Reduced-Risk Products evolve from 2022 to 2023, particularly in terms of portfolio integration and market availability?",
      "original_answer": "In 2022, PMI classified Reduced-Risk Products (RRPs) as a distinct category, including heated tobacco units, heat-not-burn devices, e-vapor, and oral nicotine products, with separate net revenue reporting. By 2023, RRPs were integrated into a broader category called Smoke-Free Products (SFPs), which now also included wellness and healthcare offerings. Additionally, PMI reported that its smoke-free products were available in 84 markets by the end of 2023, a notable expansion from the unspecified market availability in 2022. This evolution reflects a strategic shift toward consolidating RRPs under a unified smoke-free vision and expanding their global footprint.",
      "llm_answer": "\nFrom 2022 through 2023 PMI moved from simply acquiring Swedish Match AB to fully integrating its oral‑nicotine (ZYN) franchise with its heat‑not‑burn IQOS platform and embedding the combined offering into the company’s four regional segments; this integration was reflected in the 2023 reporting that smoke‑free products were now sold in 84 markets and in the continued rise of reduced‑risk product net revenues (up from $6.8 bn in 2020 to $9.1 bn in 2021 and still growing in 2023).  The shift also saw PMI ending its U.S. commercial tie‑up with Altria and taking full control of IQOS in the United States, cementing a globally‑distributed RR‑portfolio as a core growth pillar.  (Pages 29, 30, 96‑97).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and misalignments with the ground truth. CRITICAL ISSUES: (1) The answer conflates the Swedish Match acquisition (which occurred in 2022) with the 2022-2023 evolution question, introducing irrelevant historical context. (2) The revenue figures cited ($6.8bn in 2020, $9.1bn in 2021) are from 2020-2021, not the 2022-2023 period asked about, making them temporally incorrect for answering the question. (3) The answer introduces information about ending the Altria tie-up and taking full control of IQOS in the US, which is not mentioned in the ground truth and appears to be extraneous detail not directly addressing the portfolio integration and market availability evolution. (4) The answer fails to address the key ground truth finding: the reclassification from 'Reduced-Risk Products' (RRPs) as a distinct category in 2022 to 'Smoke-Free Products' (SFPs) in 2023, which is the core strategic positioning evolution. (5) While the answer correctly identifies 84 markets in 2023, it doesn't establish the comparison baseline from 2022 ('unspecified market availability') as the ground truth does. CORRECT ELEMENTS: The answer does mention the 84 markets figure for 2023 and acknowledges growth in reduced-risk product revenues, but these are presented without proper temporal context. The multi-hop reasoning is weak because it doesn't synthesize the actual portfolio reclassification (RRPs→SFPs) that represents the strategic positioning evolution. The answer reads more like a narrative of M&A activity and regional integration rather than addressing the specific question about portfolio categorization and market availability evolution from 2022 to 2023.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 466,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How has Caterpillar's strategic role in the reciprocating engines business evolved from 2022 to 2024, and what impact has this had on its revenue composition and gross margin potential?",
      "original_answer": "In 2022, Caterpillar primarily sold reciprocating engines through its global dealer network and through subsidiary Perkins Engines Company Limited, which operated 90 distributors across 171 countries. By 2024, Caterpillar expanded its involvement by including the remanufacturing of Caterpillar reciprocating engines and components, as well as offering remanufacturing services for other companies. This evolution from a seller to a full lifecycle service provider likely improved gross margin potential, as remanufacturing typically involves lower material costs compared to new engine production and leverages existing asset value. The shift also diversified revenue composition by incorporating service-based income streams alongside traditional product sales.",
      "llm_answer": "\nFrom 2022 to 2024 Caterpillar shifted its reciprocating‑engine business from a pure equipment supplier to a strategic, solutions‑focused role in Power Generation—highlighting large engines for data‑center and gas‑compression applications and expanding aftermarket/remanufacturing services.  This repositioning lifted the Power‑Generation share of the Energy & Transportation segment (sales rose 22 % YoY) and raised its profit margin from 17.6 % to 19.9 % of sales, driving overall revenue growth and improving the segment’s gross‑margin potential.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and introduces unsupported claims not present in the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM cites specific margin improvements (17.6% to 19.9%) and 22% YoY sales growth for Power Generation segment, but these figures are not verified in the ground truth and appear to be fabricated or misattributed. The ground truth makes no mention of these specific percentages or growth rates. (2) ENTITY/SCOPE CONFUSION: The LLM shifts focus to 'Power Generation' and 'data-center and gas-compression applications' which are not mentioned in the ground truth. The ground truth specifically discusses Perkins Engines Company Limited with 90 distributors across 171 countries, which the LLM completely omits. (3) INCOMPLETE SYNTHESIS: The LLM fails to mention the critical detail about Perkins Engines subsidiary and its distribution network, which is central to understanding Caterpillar's strategic role. (4) MISSING KEY EVOLUTION: The ground truth emphasizes the shift from 'seller to full lifecycle service provider' including remanufacturing of engines and components for other companies. The LLM mentions remanufacturing but frames it differently and doesn't capture the full scope of the business model evolution. (5) MARGIN ANALYSIS: While both answers discuss margin improvement, the LLM provides specific unverified percentages whereas the ground truth correctly identifies the mechanism (remanufacturing's lower material costs) without claiming specific margin figures. (6) REVENUE COMPOSITION: The ground truth correctly identifies diversification into service-based income streams; the LLM mentions this but with less clarity and more speculation. The answer demonstrates partial understanding of the business evolution but introduces unverified quantitative claims that undermine credibility.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 506,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did BNY Mellon's approach to disclosing amendments to the Directors' Code of Conduct evolve between 2022 and 2023, particularly in terms of the mechanisms and transparency commitments outlined for informing stakeholders of changes?",
      "original_answer": "BNY Mellon's approach to disclosing amendments to the Directors' Code of Conduct remained consistent between 2022 and 2023, with the company reaffirming its commitment to post any amendments or waivers on its website in both years. There was no change in the specific mechanism or transparency commitment described across the two years, indicating a stable governance communication strategy.",
      "llm_answer": "\nBetween 2022 and 2023 BNY Mellon kept the same basic promise—to post any amendments or waivers to the Directors’ Code of Conduct on its website—but the 2023 filing made the commitment more concrete.  The 2022 filing only said the company “intends to disclose” such changes, while the 2023 version specifies the exact web location of the code and states that amendments will be disclosed there promptly, reflecting a modest but clearer transparency pledge.",
      "correctness_score": 2,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer directly contradicts the ground truth on the core factual claim. The ground truth explicitly states that 'BNY Mellon's approach to disclosing amendments to the Directors' Code of Conduct remained consistent between 2022 and 2023' and that 'There was no change in the specific mechanism or transparency commitment described across the two years.' However, the LLM answer claims there WAS a meaningful evolution, stating that '2022 filing only said the company \"intends to disclose\" such changes, while the 2023 version specifies the exact web location of the code and states that amendments will be disclosed there promptly.' This is a fundamental factual error. The LLM has invented specific language differences ('intends to disclose' vs. 'promptly') that are not supported by the ground truth and directly contradict the stated consistency. The LLM appears to have fabricated details about the evolution of disclosure language to make it sound like there was a change when the ground truth explicitly confirms there was none. While the answer is well-written and addresses the question structure, it fails on the most critical dimension: factual accuracy regarding what actually changed (or didn't change) between the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1234,
        "completion_tokens": 351,
        "total_tokens": 1585
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How has Nike's strategic approach to the APLA market evolved between FY22 and FY23, particularly in terms of operational structure and market participation?",
      "original_answer": "In FY22, Nike operated directly in APLA, maintaining a significant presence through its NIKE Direct operations and wholesale distribution, with APLA contributing to the 14% growth in the NIKE Direct business. By FY23, Nike began transitioning certain businesses within APLA to third-party distributors, signaling a strategic shift away from direct market participation in some parts of the region. This change indicates a move toward a more distributed, partner-driven model in APLA, altering the way Nike engages with that market.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2023 Nike shifted the APLA operating segment from a largely direct‑operated, wholesale‑heavy model toward a more asset‑light, partnership‑focused structure.  The 2023 filing notes that several APLA markets were transferred to third‑party distributors (Note 15) while the company continued to shrink its wholesale account base and expand NIKE Direct digital and owned‑store experiences (MD&A FY22‑23).  As a result, market participation moved from broad wholesale coverage to a selective, digitally‑driven presence that relies on fewer, higher‑margin partners and greater control of the consumer journey in the region.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of Nike's APLA strategic evolution between FY22 and FY23. STRENGTHS: (1) Correctly identifies the core strategic shift from direct operations to third-party distributor model; (2) Accurately references the transition of APLA markets to third-party distributors; (3) Properly characterizes the move toward asset-light, partnership-focused structure; (4) Correctly notes the shift toward NIKE Direct digital and owned-store experiences; (5) Appropriately describes the move to selective, higher-margin partners. MINOR ISSUES: (1) The LLM answer adds interpretive details about 'fewer, higher-margin partners' and 'greater control of the consumer journey' that, while logically consistent with the stated strategy, are not explicitly confirmed in the ground truth provided; (2) The reference to 'shrinking wholesale account base' is mentioned but the ground truth emphasizes the transition to third-party distributors more directly than a wholesale reduction narrative. QUANTITATIVE ACCURACY: No specific numbers or percentages are provided in either answer, so this dimension is not directly testable. The ground truth mentions '14% growth in NIKE Direct business' but the LLM answer appropriately does not cite specific percentages, avoiding potential errors. MULTI-HOP REASONING: The LLM successfully synthesizes information across FY22 and FY23 filings, correctly identifying the operational structure changes and market participation shifts. The logic connecting direct operations → third-party distributors → asset-light model is sound. SEMANTIC EQUIVALENCE: The LLM answer conveys the same fundamental information as the ground truth while providing additional contextual detail about the strategic implications (asset-light, partnership-focused, selective presence). The core facts align well with the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 507,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How has the impact of Favorable Price Realization on Caterpillar's sales and profitability evolved from 2022 to 2024?",
      "original_answer": "In 2022, favorable price realization contributed to a $9.223 billion increase in total sales and revenues, driven by higher end-user demand and changes in dealer inventories. By 2024, favorable price realization continued to play a key role, partially offsetting a $2.251 billion decrease in sales volume and contributing to an increase in profit from $10.335 billion in 2023 to $10.792 billion in 2024. This indicates that while Caterpillar faced declining sales volume in 2024, the company leveraged pricing strategies more effectively to maintain profitability.",
      "llm_answer": "\nFrom 2022 through 2024 the role of favorable price realization shifted from a modest boost to segment revenue growth—evidenced by the $732 million gain in Construction Industries and $101 million gain in Energy & Transportation shown in the 2021‑2020 comparison on page 34 of the 2021 10‑K, which helped lift overall sales in 2022—to a critical driver that more than offset lower volumes in 2024, with the 2024 MD&A explicitly stating that “the profit impact of lower sales volume was more than offset by favorable price realization” (CAT_10k_2024.pdf, p. 30). Consequently, while price realization primarily supported sales growth in the early‑2020s, by 2024 it became essential for preserving profitability as unit sales declined.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains multiple critical errors that severely undermine its credibility:\n\n1. QUANTITATIVE ACCURACY - MAJOR FAILURES:\n   - The LLM cites $732 million and $101 million figures from a 2021-2020 comparison on page 34 of the 2021 10-K, which is completely irrelevant to the 2022-2024 timeframe asked about in the question\n   - The ground truth provides specific numbers: $9.223 billion increase in 2022, $2.251 billion decrease in 2024, profit increase from $10.335 billion (2023) to $10.792 billion (2024)\n   - The LLM provides NONE of these key figures from the ground truth\n   - The LLM's cited numbers ($732M, $101M) are from the wrong year period entirely (2021-2020 vs. 2022-2024)\n\n2. ENTITY AND TEMPORAL ACCURACY - CRITICAL ERRORS:\n   - The LLM references 2021-2020 comparison data when the question explicitly asks about 2022-2024\n   - This represents a fundamental misunderstanding of the question's scope\n   - The LLM conflates early-2020s trends with the specific 2022-2024 period requested\n\n3. MULTI-HOP REASONING - INCOMPLETE:\n   - The ground truth synthesizes: (a) 2022 favorable price realization impact ($9.223B), (b) 2024 volume decline ($2.251B), (c) profit evolution ($10.335B to $10.792B)\n   - The LLM only provides a general narrative about price realization's shifting role without the specific quantitative synthesis required\n   - The LLM does correctly note that price realization offset lower volumes in 2024, but lacks the supporting numbers\n\n4. COMPLETENESS:\n   - Ground truth provides: 2022 sales impact, 2024 volume decline, profit figures for 2023-2024\n   - LLM provides: only a qualitative narrative with wrong-year data\n   - Missing all key quantitative metrics from the correct time period\n\n5. SEMANTIC EQUIVALENCE:\n   - While the LLM's general conclusion (price realization became more critical in 2024) aligns directionally with ground truth, the execution is fundamentally flawed\n   - The use of 2021-2020 data instead of 2022-2024 data is a disqualifying error\n   - The LLM does cite the 2024 MD&A correctly regarding price realization offsetting volume decline, but this alone cannot compensate for the missing quantitative analysis\n\nThe answer demonstrates poor document navigation, temporal confusion, and failure to provide the specific financial metrics that form the core of the ground truth answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 634,
        "total_tokens": 1951
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How has General Motors' approach to EV manufacturing capacity evolved between 2023 and 2024, particularly in terms of strategic focus and supply chain development?",
      "original_answer": "In 2023, General Motors emphasized significant investments in EV manufacturing capacity based on expectations for future EV demand, acknowledging the risks and uncertainties associated with such investments, including high fixed costs and limitations on closing facilities. By 2024, GM's strategy had evolved to include a stronger emphasis on developing a resilient, scalable, and sustainable North American-focused EV supply chain. This included advancing strategic sourcing initiatives to secure supply through investments in raw materials suppliers and the execution of multi-year supply agreements. The shift indicates a more structured and regionally focused approach to EV manufacturing, aiming to mitigate supply chain risks and ensure long-term scalability.",
      "llm_answer": "\nBetween 2023 and 2024 GM moved from a broad‑based push to “scale EV manufacturing capabilities” toward a more disciplined, supply‑chain‑centric strategy.  In 2024 the company highlighted a shift to building a **resilient, North‑American‑focused EV supply chain**—investing in strategic raw‑material sourcing (e.g., Lithium Americas), signing multi‑year supplier agreements, and increasing capital spending on EV plants to match long‑term demand expectations—while still funding the expansion through cash generated by its high‑margin ICE trucks and SUVs.  This reflects a strategic focus on **cost‑effective scaling and supply‑chain security** rather than simply adding capacity.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across multiple dimensions. STRENGTHS: (1) Correctly identifies the evolution from 2023 to 2024 - from broad capacity scaling to supply-chain-centric strategy; (2) Accurately captures key 2024 strategic elements: resilient, North American-focused EV supply chain, strategic raw material sourcing, multi-year supplier agreements; (3) Properly synthesizes the multi-hop reasoning connecting 2023 investments with 2024 supply chain focus; (4) Correctly identifies the financing mechanism (cash from high-margin ICE vehicles); (5) Specific example (Lithium Americas) demonstrates concrete knowledge; (6) Semantic equivalence is strong - 'cost-effective scaling and supply-chain security' captures the essence of the ground truth's 'structured and regionally focused approach to mitigate supply chain risks.' MINOR CONSIDERATIONS: (1) The LLM adds contextual detail about funding through ICE profits that, while accurate and relevant, goes slightly beyond the ground truth's explicit scope - this is additive rather than contradictory; (2) The phrase 'disciplined, supply-chain-centric strategy' is a reasonable characterization but uses slightly different terminology than ground truth's 'structured and regionally focused approach' - both convey the same strategic shift; (3) No quantitative metrics (dollar amounts, capacity numbers, percentages) are provided in either answer, so quantitative accuracy cannot be penalized for omissions that don't exist in ground truth. The answer successfully addresses all parts of the multi-part question regarding strategic focus and supply chain development evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 457,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How has Pfizer's financial commitment to Paxlovid evolved from 2022 to 2024, based on remaining performance obligations disclosed in the 10-K filings?",
      "original_answer": "In 2022, Pfizer's 10-K filing did not disclose specific remaining performance obligations related to Paxlovid. However, by 2024, Pfizer reported that remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, indicating a significant ongoing financial commitment tied to future delivery of the product. This shows a clear evolution from an undefined obligation in 2022 to a quantified $1 billion commitment in 2024.",
      "llm_answer": "\nBased on the disclosed remaining performance obligations, Pfizer’s Paxlovid commitment fell sharply after 2022.  At the end of 2023 the company had roughly $5 billion of deferred revenue (and about $4 billion of total remaining contracted revenue) tied to government‑purchase agreements, but by the end of 2024 that figure had been reduced to only ≈ $1 billion of future revenue to be recognized from Paxlovid contracts through 2028.  This reflects the winding‑down of the large U.S. government stock‑purchase program and the shift to commercial sales, so the financial commitment that existed in 2022 has been largely satisfied or reversed, leaving a modest $1 billion of remaining obligations in 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides a more detailed narrative than the ground truth but contains significant quantitative discrepancies that undermine its accuracy. CORRECT ELEMENTS: (1) The $1 billion figure for 2024 remaining performance obligations is accurate and matches ground truth; (2) The characterization of a decline from 2022-2024 is directionally correct; (3) The explanation about winding down government programs and shift to commercial sales is contextually appropriate and adds useful detail; (4) The multi-hop reasoning across years is sound. PROBLEMATIC ELEMENTS: (1) The LLM introduces specific 2023 figures ($5 billion deferred revenue, $4 billion remaining contracted revenue) that are NOT mentioned in the ground truth and cannot be verified against it. These appear to be fabricated or hallucinated numbers; (2) The claim about obligations extending 'through 2028' is not supported by the ground truth; (3) The ground truth explicitly states that 2022 had NO disclosed specific remaining performance obligations, but the LLM's framing suggests there was a clear 2022 baseline to compare against, which is misleading. QUANTITATIVE ACCURACY ISSUE: The introduction of unverified 2023 figures ($5B and $4B) is a critical error. While the 2024 figure ($1B) is correct, the intermediate year data cannot be confirmed and appears to be invented, significantly reducing confidence in the answer's reliability. REASONING: The multi-hop synthesis is logically sound (showing decline over time, explaining business context), but it's built partially on unverified data. The answer goes beyond what can be confirmed from the ground truth by adding specific intermediate-year figures that may or may not be accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 468,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has Caterpillar's approach to monitoring supplier financial viability evolved between 2022 and 2023, particularly in terms of risk mitigation strategies and contractual agreements?",
      "original_answer": "In 2022, Caterpillar indicated that it uses 'a variety of agreements with suppliers to protect our intellectual property and processes to monitor and mitigate risks of the supply base causing a business disruption,' including monitoring supplier financial viability. By 2023, Caterpillar maintained the same monitoring approach but placed a more explicit emphasis on 'supplier financial viability' as a key risk factor, listing it as the first risk under its supply chain disclosures. Additionally, in 2023, Caterpillar reinforced its global strategic sourcing models to build long-term supplier relationships and leverage enterprise spend, suggesting a potentially more structured or prioritized focus on supplier financial health compared to 2022.",
      "llm_answer": "\nBetween 2022 and 2023 Caterpillar moved from a general statement that it “monitors supplier financial viability, the ability to increase or decrease production, business continuity, quality and delivery” (2022 10‑K, p. 11) to a concrete, contract‑driven risk‑mitigation framework.  In the 2023 filing (p. 9) the company notes that it uses a variety of supplier agreements and monitoring processes—tying continued supply to the supplier’s financial health and giving Caterpillar rights to adjust or terminate orders if financial thresholds are breached—thereby tightening the contractual safeguards that underpin its supply‑chain risk management.  This evolution reflects a more explicit focus on financial‑viability clauses and continuity planning to guard against supply‑base disruptions.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies that Caterpillar's approach evolved between 2022 and 2023, with increased emphasis on supplier financial viability and contractual safeguards. However, there are significant issues with the response: (1) FACTUAL CONCERNS: The LLM claims the 2023 filing explicitly ties 'continued supply to the supplier's financial health and giving Caterpillar rights to adjust or terminate orders if financial thresholds are breached.' The ground truth does not mention these specific contractual mechanisms (adjust/terminate orders based on financial thresholds). This appears to be an inference or fabrication not supported by the ground truth. (2) MISSING KEY INFORMATION: The LLM fails to mention that in 2023, Caterpillar 'listed supplier financial viability as the first risk under its supply chain disclosures,' which is a concrete, measurable change highlighted in the ground truth. This is a significant omission. (3) MISSING CONTEXT: The ground truth mentions 'reinforced its global strategic sourcing models to build long-term supplier relationships and leverage enterprise spend,' which the LLM does not address. (4) QUANTITATIVE ACCURACY: Page numbers are cited (2022 p. 11, 2023 p. 9) but cannot be verified against ground truth. The specific quote about monitoring 'ability to increase or decrease production, business continuity, quality and delivery' is not mentioned in the ground truth. (5) MULTI-HOP REASONING: The LLM attempts to synthesize evolution across years but does so by introducing details not in the ground truth rather than accurately synthesizing what was provided. The answer reads as more speculative than factual. The core insight about evolution is correct, but the specific mechanisms described are not validated by the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 487,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has Visa's approach to Risk and Identity Solutions evolved between 2022 and 2024, particularly in terms of its strategic positioning and integration within its value-added services?",
      "original_answer": "In 2022, Visa positioned Risk and Identity Solutions as part of a broader set of value-added services aimed at supporting clients, but without detailed elaboration on specific capabilities or strategic direction. By 2024, Risk and Identity Solutions were embedded within a more structured value-added services framework, with a clear three-pillar strategy: (1) services for Visa transactions, (2) network-agnostic services for non-Visa transactions, and (3) services beyond payments. This evolution reflects a more strategic and comprehensive integration of Risk and Identity Solutions into Visa's broader service portfolio, with an emphasis on scalability and business outcomes.",
      "llm_answer": "\nBetween 2022 and 2024 Visa moved its Risk and Identity Solutions from a basic fraud‑prevention portfolio into an AI‑driven, end‑to‑end suite (the Visa Protect family) that is tightly integrated with its core payment networks.  The 2024 launches of Visa Deep Authorization, Visa Protect for A2A Payments and the scheme‑agnostic Risk Manager with Advanced Authorization embed real‑time risk scoring across both card‑based and non‑card (A2A) flows, linking the solutions to Visa Direct, Visa B2B Connect and the Visa + interoperability platform and positioning risk management as a strategic, value‑added service that underpins both consumer and commercial payments.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and misalignments with the ground truth. Key issues: (1) ENTITY/PRODUCT ERRORS: The LLM introduces specific product names (Visa Protect family, Visa Deep Authorization, Visa Protect for A2A Payments, Risk Manager with Advanced Authorization) that are not mentioned in the ground truth. These appear to be fabricated or hallucinated details not supported by the knowledge graph. (2) STRATEGIC FRAMEWORK MISMATCH: The ground truth clearly states a three-pillar strategy in 2024: (a) services for Visa transactions, (b) network-agnostic services for non-Visa transactions, and (c) services beyond payments. The LLM answer does not articulate this three-pillar framework at all, instead focusing on product launches and AI-driven capabilities. (3) INTEGRATION DESCRIPTION: The ground truth emphasizes 'structured value-added services framework' and 'scalability and business outcomes.' The LLM answer emphasizes 'AI-driven, end-to-end suite' and 'real-time risk scoring' - these are different characterizations not supported by the ground truth. (4) MISSING CORE INSIGHT: The ground truth's key evolution is about positioning within a broader value-added services portfolio with clear strategic pillars. The LLM answer misses this structural evolution entirely. (5) UNSUPPORTED SPECIFICITY: References to Visa Direct, Visa B2B Connect, and the Visa + interoperability platform are not mentioned in the ground truth and appear to be added without factual basis. (6) 2022 BASELINE: The ground truth notes 2022 had 'without detailed elaboration on specific capabilities' - the LLM doesn't adequately capture this baseline comparison. The answer demonstrates hallucination of specific product names and strategic details not present in the source material, while failing to capture the actual three-pillar strategic framework that defines the evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 514,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has the company's exposure to shelf space limitations as a risk factor evolved between 2022 and 2023, particularly in relation to changes in retail customer policies and the expansion of alternative retail channels?",
      "original_answer": "In 2022, the company noted that it had been and could continue to be negatively affected by changes in retail customer policies such as limitations on access to shelf space and delisting of products. By 2023, the company was actively impacted by these limitations and described them as part of a broader set of evolving retail dynamics, including the growth of eCommerce and alternative retail channels such as subscription services and direct-to-consumer businesses. This evolution indicates a shift from potential risk to an actively experienced challenge, with the company planning to invest more in digital and analytics capabilities to adapt.",
      "llm_answer": "\nBetween 2022 and 2023 the company’s exposure to shelf‑space risk stayed pronounced and even deepened.  In 2022 it flagged that “limitations on access to shelf space, de‑stocking, fulfillment requirements and delistings” of its products were already hurting sales, while the rapid growth of e‑commerce and alternative retail channels was creating pricing pressure on retailer relationships.  By 2023 the same themes were reiterated with added emphasis that “the retail landscape … continues to evolve as a result of the rapid growth of e‑commerce, changing consumer preferences and the increased presence of alternative retail channels,” noting that these trends “have created and may continue to create pricing pressures and/or adversely affect our relationships with our key retailers.”  Consequently, the company’s reliance on traditional shelf space has become increasingly vulnerable as alternative channels expand and retail policies grow more restrictive.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy and effectively addresses the multi-hop question about how shelf space risk evolved between 2022 and 2023. STRENGTHS: (1) Correctly identifies the evolution from potential risk to actively experienced challenge, matching the ground truth's core insight. (2) Accurately captures specific risk factors mentioned in filings: shelf space limitations, delisting, destocking, fulfillment requirements in 2022, and eCommerce/alternative retail channels in both years. (3) Properly synthesizes the multi-hop information showing how retail dynamics evolved and how the company's exposure deepened. (4) Correctly notes the shift in emphasis and the addition of pricing pressure concerns in 2023. (5) Uses appropriate direct quotes that align with filing language. (6) No quantitative errors or incorrect dates/entities. MINOR WEAKNESSES: (1) The ground truth explicitly mentions the company's planned investment in digital and analytics capabilities to adapt, which the LLM answer does not include. This is a notable omission of a key forward-looking element. (2) The LLM answer frames the evolution as 'deepened' risk, while the ground truth frames it more as a shift from 'potential' to 'actively experienced' - subtle but meaningful distinction. The LLM's characterization is reasonable but slightly different in emphasis. (3) The ground truth emphasizes the company's active response/adaptation plans, while the LLM focuses more on vulnerability without addressing mitigation strategies. VERIFICATION: No factual errors detected. Years (2022, 2023) correct. Risk factors accurately identified. Multi-hop synthesis is sound - the answer successfully connects retail policy changes with alternative channel growth and their combined impact on the company. The reasoning about increasing vulnerability is logically sound based on the information presented.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 513,
        "total_tokens": 1934
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has Oracle's approach to hybrid deployments evolved between fiscal years 2023 and 2024, particularly in terms of product offerings and strategic emphasis?",
      "original_answer": "In fiscal 2023, Oracle emphasized hybrid deployments as part of its broader deployment models, including on-premise, cloud-based, and hybrid options such as Oracle Exadata Cloud@Customer and Dedicated Region offerings. The company highlighted its commitment to providing customers with choice and flexibility in how they deploy Oracle technologies. By fiscal 2024, Oracle continued to support hybrid deployments but introduced more specific product integrations and services tailored for hybrid environments, indicating a strategic shift toward deeper integration and support for customer-managed cloud and on-premise IT environments. This evolution reflects Oracle's ongoing investment in making hybrid deployments more interoperable and extensible with other IT and cloud environments.",
      "llm_answer": "\nOracle’s hybrid strategy moved from a broad “choice‑and‑flexibility” message in FY 2023—highlighting on‑premise, cloud and hybrid models such as Exadata Cloud@Customer, Dedicated Regions and multicloud options—to a more focused, product‑driven emphasis in FY 2024.  In the 2024 filing the company explicitly ties its restructuring savings and new investments to “the continued emphasis on developing, marketing, selling and delivering our cloud‑based offerings,” noting that the initiatives are aimed at expanding second‑generation cloud infrastructure and accelerating the rollout of hybrid‑ready services.  This signals a strategic shift toward positioning hybrid deployments as a core growth engine, with a richer portfolio of cloud‑integrated hardware and software offerings that are marketed as the preferred path for customers seeking flexible, interoperable IT environments.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of Oracle's hybrid deployment evolution between FY2023 and FY2024, with accurate characterization of the strategic shift. STRENGTHS: (1) Correctly identifies the FY2023 emphasis on 'choice and flexibility' with specific product examples (Exadata Cloud@Customer, Dedicated Regions); (2) Accurately captures the FY2024 shift toward more focused, product-driven emphasis; (3) Properly synthesizes the multi-hop information about Oracle's strategic evolution across fiscal years; (4) No quantitative errors or incorrect numbers/dates; (5) Correctly identifies the shift from broad messaging to deeper integration and hybrid-ready services. WEAKNESSES: (1) The LLM introduces additional context about 'restructuring savings' and 'second-generation cloud infrastructure' that, while potentially accurate, goes beyond what the ground truth explicitly states about the evolution between these two years; (2) The phrase 'core growth engine' and 'preferred path' represent interpretive language not explicitly confirmed in the ground truth; (3) The answer adds specificity about 'cloud-integrated hardware and software offerings' that extends beyond the ground truth's focus on 'deeper integration and support for customer-managed cloud and on-premise IT environments.' MULTI-HOP REASONING: The answer successfully synthesizes information across two fiscal years and correctly identifies the directional change in strategy. The comparison between FY2023 and FY2024 approaches is logically sound. SEMANTIC EQUIVALENCE: The core message aligns well with the ground truth - Oracle moved from emphasizing choice/flexibility to emphasizing deeper integration and hybrid-ready services. The LLM's characterization of this as a shift toward 'positioning hybrid deployments as a core growth engine' is a reasonable interpretation, though slightly more assertive than the ground truth's more measured language about 'ongoing investment.'",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 530,
        "total_tokens": 1951
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has Pfizer's financial commitment to Paxlovid evolved between 2022 and 2024, based on remaining performance obligations and contracted revenue expectations?",
      "original_answer": "In 2022, Pfizer indicated that Paxlovid had the potential to provide ongoing revenue streams, though it acknowledged that post-pandemic revenues might not match the levels seen during the pandemic. By 2024, Pfizer reported that remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, with contracted revenue expected to be recognized from 2025 through 2028. This reflects a continued but reduced financial commitment compared to the pandemic period, as the company anticipates delivery and revenue recognition over a multi-year horizon rather than immediate high-volume sales.",
      "llm_answer": "\nBetween 2022 and 2024 Pfizer’s Paxlovid revenue collapsed from $18.9 bn (2022) to $1.3 bn (2023) and $5.7 bn (2024), as the bulk of government‑procured supply was replaced by commercial pricing and the company recorded a $3.5 bn revenue reversal in Q4 2023 that was later adjusted upward by $771 m in Q1 2024.  As of 31 Dec 2024 the company has only about **$1 bn of remaining performance obligations** for long‑term Paxlovid contracts—covering deliveries through 2025‑2028—reflecting a marked shift from the multi‑billion‑dollar government orders of 2022‑23 to smaller, deferred‑revenue commercial agreements (including a no‑cash $442 m revenue from a 1 m‑course government stockpile).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer provides substantially more detailed and comprehensive information than the ground truth, with strong quantitative accuracy. Key strengths: (1) The $1 billion remaining performance obligations figure matches the ground truth exactly; (2) The 2025-2028 delivery timeline is correct; (3) The characterization of the shift from pandemic-era government orders to smaller commercial agreements aligns with the ground truth's description of 'reduced financial commitment'; (4) The revenue figures ($18.9B in 2022, $1.3B in 2023, $5.7B in 2024) and the Q4 2023 revenue reversal details provide concrete evidence of the evolution described in the ground truth. Minor considerations: (1) The ground truth is more general/summary-level while the LLM provides granular details (Q4 2023 reversal of $3.5B, Q1 2024 adjustment of $771M, $442M no-cash government stockpile), which goes beyond but doesn't contradict the ground truth; (2) The LLM's specific revenue figures for 2022-2024 are not explicitly mentioned in the ground truth but are consistent with the narrative of 'reduced financial commitment' and the shift from pandemic to post-pandemic levels; (3) The LLM correctly synthesizes the multi-hop information: showing how revenues collapsed while RPOs remained at $1B, demonstrating the evolution of financial commitment. The answer directly addresses the question about how Pfizer's financial commitment evolved, providing both the quantitative evidence (revenue collapse, RPO stability) and qualitative context (shift from government to commercial). All verifiable numbers appear accurate, and the multi-hop reasoning connecting revenue trends, RPOs, and contract structure is sound.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 463,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How has Caterpillar's relationship with its independent dealers evolved between 2022 and 2023, particularly in terms of contractual obligations and strategic emphasis?",
      "original_answer": "In 2022, Caterpillar described its relationship with independent dealers in general terms as part of its global sales and marketing strategy. By 2023, the company formalized and detailed these relationships through standardized sales and service agreements, granting dealers the right to purchase, sell, and service Caterpillar products within specified territories. In exchange, dealers were obligated to develop and promote Caterpillar products, maintain adequate sales and support personnel, and keep detailed financial records accessible to Caterpillar. This represents a shift from a general partnership model to a more structured contractual framework, indicating a strategic emphasis on formalizing dealer relationships to enhance control and accountability.",
      "llm_answer": "\nCaterpillar still governs its ties with independent dealers through standard sales‑and‑service agreements that are terminable at will on 90 days’ notice, but in 2023 it reinforced the dealer’s obligations to develop and promote the brand, maintain adequate sales‑and‑support staff, keep detailed financial records and accept a non‑exclusive trademark license.  The strategic emphasis shifted toward a deeper partnership model—requiring dealers to drive market expansion, participate in product‑improvement programs and align with Caterpillar’s talent‑development and sustainability goals to support the company’s long‑term profitable growth.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains both accurate and problematic elements. CORRECT ELEMENTS: (1) The identification of standardized sales-and-service agreements is accurate; (2) The dealer obligations mentioned (develop and promote products, maintain adequate sales/support personnel, keep financial records) align with the ground truth; (3) The 90-day termination notice detail is specific and appears factually grounded; (4) The mention of non-exclusive trademark license is a relevant contractual detail. PROBLEMATIC ELEMENTS: (1) The ground truth emphasizes a shift FROM general partnership language IN 2022 TO formalized contractual framework IN 2023, representing evolution/change. The LLM answer presents the 2023 state but doesn't clearly establish the 2022 baseline or the evolution between years - it says 'still governs' which suggests continuity rather than change; (2) The ground truth focuses on 'shift from general partnership model to more structured contractual framework' as the key evolution. The LLM answer instead emphasizes a shift toward 'deeper partnership model' with new strategic elements (market expansion, product-improvement programs, talent-development, sustainability goals) that are NOT mentioned in the ground truth; (3) These additional strategic elements (product-improvement programs, talent-development, sustainability goals) appear to be inferred or added by the LLM rather than grounded in the provided ground truth; (4) The LLM answer doesn't clearly articulate the 2022-to-2023 evolution as a movement toward 'more structured contractual framework' and 'enhanced control and accountability' as stated in ground truth. MULTI-HOP REASONING: The question requires comparing 2022 and 2023 positions. The LLM answer addresses 2023 details well but fails to establish clear comparison with 2022 baseline, weakening the multi-hop synthesis. The answer conflates formalization with deepening partnership rather than emphasizing the shift toward contractual structure and control. QUANTITATIVE ACCURACY is high (no numeric errors detected). QUALITATIVE ACCURACY is lower due to the mismatch between the evolution narrative in ground truth versus the LLM's framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 585,
        "total_tokens": 1942
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How did the company's financial allocation or operational focus related to Africa/Eurasia evolve from 2022 to 2023, based on capital expenditures and restructuring charges?",
      "original_answer": "In 2022, the company reported capital expenditures for Africa/Eurasia at $33 million, showing a steady increase from $13 million in 2021 and $8 million in 2020. However, in 2023, the company indicated that approximately 10% of the cumulative pretax charges from the 2022 Global Productivity Initiative would relate to initiatives undertaken in Africa/Eurasia, signaling a shift in focus toward restructuring and cost optimization in the region rather than continued capital investment. This reflects a strategic evolution from growth-oriented capital allocation to operational restructuring within Africa/Eurasia.",
      "llm_answer": "\nFrom 2022 to 2023 the company cut its spending and restructuring outlay in Africa/Eurasia sharply.  Capital expenditures fell from **$30 million in 2022 to $10 million in 2023**, and the pre‑tax restructuring charges tied to the 2022 Global Productivity Initiative dropped from roughly **$11 million (10 % of the $110 million total 2022 charges) to about $3 million (10 % of the $32 million total 2023 charges)**.  This decline signals a reduced financial allocation and operational focus on the Africa/Eurasia region over that period.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual inaccuracies that fundamentally undermine its credibility. (1) CAPITAL EXPENDITURES ERROR: The ground truth states Africa/Eurasia capex was $33 million in 2022, but the LLM claims $30 million - a $3 million discrepancy. More problematically, the LLM invents a 2023 capex figure of $10 million that does not appear in the ground truth at all. The ground truth does not provide a 2023 capex number for Africa/Eurasia, only noting a shift toward restructuring charges. (2) RESTRUCTURING CHARGES ERROR: The LLM fabricates specific numbers ($11 million for 2022 and $3 million for 2023) that are not supported by the ground truth. The ground truth only states that approximately 10% of cumulative pretax charges from the 2022 Global Productivity Initiative would relate to Africa/Eurasia initiatives - it does not provide absolute dollar amounts for 2022 or 2023 restructuring charges in the region. The LLM's calculation of '10% of $110 million' and '10% of $32 million' appears to be invented data. (3) MULTI-HOP REASONING FAILURE: While the LLM correctly identifies the shift from capital investment to restructuring focus (which aligns with ground truth), it does so by citing false numbers. The reasoning about 'reduced financial allocation' is directionally correct but built on fabricated data. (4) MISSING CONTEXT: The ground truth emphasizes the historical growth trajectory ($8M in 2020 → $13M in 2021 → $33M in 2022) before the strategic shift, which the LLM completely omits. The ground truth's characterization of the shift as 'from growth-oriented capital allocation to operational restructuring' is more nuanced than the LLM's simple 'sharp cut' narrative. VERDICT: The answer demonstrates a fundamental failure in quantitative accuracy by inventing specific numbers not present in source data. While the directional conclusion about shifting focus is reasonable, the supporting numbers are entirely unreliable.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 539,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How has Qualcomm's strategic focus on 5G technologies evolved from 2022 to 2024, particularly in terms of investment emphasis and commercialization outcomes?",
      "original_answer": "In 2022, Qualcomm was heavily investing in 5G technologies as part of its broader strategy to expand beyond mobile handsets into areas like automotive and IoT, with an emphasis on developing leading and cost-effective 5G-based technologies and products. The company acknowledged significant risks around the success of these investments due to potential regulatory hurdles, competition, and the long design-in cycles typical of new industries like automotive. By 2024, Qualcomm had transitioned from a primarily investment phase to a more mature stage where it had developed a leading patent portfolio in 5G NR and was actively licensing these technologies. The company reported generating the majority of its QTL revenues from OFDMA-based products, including multimode 3G/4G/5G devices such as smartphones, indicating a successful commercialization phase. This shift shows that Qualcomm moved from strategic investment and development in 5G across multiple industries to a position of market leadership and monetization in 5G technologies.",
      "llm_answer": "\nBetween 2022 and 2024 Qualcomm shifted from a handset‑centric, patent‑licensing emphasis on 5G NR to a broader, ecosystem‑wide strategy that couples continued investment in OFDMA‑based 5G patents and modem‑RF technology with targeted expansion into automotive, IoT and other non‑handset markets; the company increased spending on integrated 5G‑AI modem‑RF platforms and on standard‑essential patents for 5G NR while expanding its commercialization efforts beyond smartphones. This evolution reflects a strategic focus on creating new licensing and chip‑sale revenue streams in emerging 5G‑enabled industries, even as it navigates supply‑chain constraints and heightened regulatory risk in China.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains both accurate and problematic elements. CORRECT ASPECTS: (1) The identification of Qualcomm's expansion into automotive and IoT markets is accurate and matches the ground truth. (2) The mention of OFDMA-based 5G products and 5G NR patents aligns with the original answer. (3) The characterization of a shift from investment phase to commercialization is fundamentally sound. PROBLEMATIC ASPECTS: (1) The LLM introduces claims about '5G-AI modem-RF platforms' and 'increased spending on integrated 5G-AI modem-RF platforms' that are NOT supported by the ground truth. The original answer makes no mention of AI integration or AI-focused platform development. (2) The LLM states the company 'increased spending' on these technologies, but the ground truth does not provide specific spending increase data or comparisons between 2022 and 2024 investment levels. This is an unsupported quantitative claim. (3) The mention of 'supply-chain constraints and heightened regulatory risk in China' adds contextual details not present in the ground truth, which only mentions 'regulatory hurdles' generally. (4) The LLM's framing of 'handset-centric, patent-licensing emphasis' being shifted away from is somewhat misleading—the ground truth indicates handsets remained important (smartphones with multimode 3G/4G/5G devices), not that the company moved away from them. MULTI-HOP REASONING: The LLM does attempt to synthesize the evolution from 2022 to 2024, but introduces speculative elements (AI integration, specific spending increases) not grounded in the source material. The core narrative of moving from investment to commercialization is present but muddied by unsupported claims. QUANTITATIVE ACCURACY: No specific numbers are provided in either answer, so this is neutral, but the LLM's claims about 'increased spending' lack supporting data. The answer reads as partially fabricated with plausible-sounding but unverified details about AI platforms and China-specific regulatory risks.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 541,
        "total_tokens": 1978
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How has Pfizer's financial and strategic positioning of Paxlovid evolved between 2022 and 2024, particularly in terms of revenue contribution and contractual commitments?",
      "original_answer": "In 2022, Paxlovid generated $76 million in revenue, marking its initial contribution as a newly launched product targeting high-risk COVID-19 patients. By 2024, while direct revenue figures for Paxlovid are not explicitly stated, Pfizer disclosed approximately $1 billion in remaining performance obligations tied to future Paxlovid deliveries under existing contracts. This indicates a strategic shift from initial market entry to securing longer-term contractual commitments, despite potential market or regulatory challenges reflected in the context of government returns and adjustments in 2024.",
      "llm_answer": "\nBetween 2022 and 2024 Paxlovid’s revenue collapsed from **$18.9 bn (2022)** to **$1.3 bn (2023)** and then edged up to **$5.7 bn (2024)**, reflecting the shift from the massive U.S. government EUA purchases to commercial‑market sales and the associated revenue reversals.  By the end of 2024 the company reported **≈ $1 bn of remaining contracted revenue** from long‑term Paxlovid supply agreements (expected deliveries through 2028), a stark contrast to the billions of dollars of EUA‑related orders and deferred revenue that dominated 2022‑23.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamentally incorrect financial figures that directly contradict the ground truth. (1) QUANTITATIVE ACCURACY FAILURES: The LLM claims Paxlovid generated $18.9 billion in 2022, but the ground truth explicitly states $76 million in 2022 revenue - a massive discrepancy of over 240x the actual figure. The LLM also claims $1.3 billion in 2023 and $5.7 billion in 2024, neither of which are mentioned in the ground truth. The only number that aligns is the ~$1 billion in remaining performance obligations, which the LLM correctly identifies. (2) MULTI-HOP REASONING FAILURE: The LLM attempts to construct a narrative about the shift from government EUA purchases to commercial sales, but this narrative is built entirely on fabricated revenue numbers. The ground truth presents a different story: modest initial revenue ($76M in 2022) followed by contractual commitments (~$1B in remaining obligations) - not a collapse from billions to billions. (3) ENTITY AND METRIC CONFUSION: While the LLM correctly identifies Pfizer and Paxlovid, it appears to have confused or conflated different financial metrics or possibly data from different products/periods. The magnitude of error suggests either hallucination or severe data retrieval failure. (4) CONTEXTUAL MISALIGNMENT: The ground truth emphasizes a 'strategic shift from initial market entry to securing longer-term contractual commitments,' while the LLM emphasizes a 'revenue collapse' narrative - these are fundamentally different interpretations, with the LLM's being unsupported by the actual data. The only accurate element is the ~$1 billion remaining obligations figure and the general timeframe (2022-2024). The answer fails on the primary metric of factual accuracy regarding the core financial figures that are central to answering the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 501,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How has the company's exposure to credit market tightness as a supply chain risk evolved between 2022 and 2023, and what does this indicate about its changing vulnerability to external financial conditions?",
      "original_answer": "In 2022, tighter credit or capital markets were described as a risk that 'negatively impacts' suppliers, with a direct concern that this could disrupt the supply of raw and packaging materials. By 2023, the framing shifted to indicate that the company's operations are 'impacted by' these conditions, suggesting a broader recognition of ongoing vulnerability. This evolution reflects a continuation of concern over credit market conditions but with a more integrated perspective on how such financial constraints affect not just suppliers, but the company's overall supply chain resilience.",
      "llm_answer": "\nBetween 2022 and 2023 the company continued to list “the impact on our suppliers of tighter credit or capital markets” as an operational risk, but it paired that risk with concrete evidence of strong liquidity—cash from operations rose to $3.7 bn, the revolving credit facility was extended to 2028, and $1.5 bn of senior notes were issued in 2023 at higher coupons.  This shows that, while supplier‑level credit pressure remained a concern, the firm’s own exposure to external financial conditions has diminished, reflecting a reduced vulnerability to credit‑market tightness.",
      "correctness_score": 4,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer introduces significant factual and reasoning errors that diverge substantially from the ground truth. CRITICAL ISSUES: (1) The LLM fundamentally misinterprets the question's focus. The ground truth addresses how the company's FRAMING of credit market risk evolved between 2022-2023 (from 'negatively impacts suppliers' to 'impacted by' conditions), indicating a shift in perspective on vulnerability. The LLM instead pivots to discussing the company's own liquidity position and concludes the company's vulnerability has DIMINISHED. This is a semantic inversion of the ground truth's message. (2) The ground truth indicates INCREASED vulnerability recognition ('more integrated perspective on how such financial constraints affect...the company's overall supply chain resilience'), while the LLM claims REDUCED vulnerability. This is contradictory. (3) QUANTITATIVE ISSUES: While the numbers cited ($3.7bn cash from operations, 2028 credit facility extension, $1.5bn senior notes) may be factually accurate from the filings, they are IRRELEVANT to answering the question about how exposure/framing evolved. The LLM uses financial strength metrics to argue reduced vulnerability, but the ground truth is about the company's stated risk perception shifting to acknowledge broader operational impact. (4) MULTI-HOP REASONING FAILURE: The question requires synthesizing how risk language/framing changed across two years. The LLM instead synthesizes liquidity metrics with risk statements, creating a false equivalence (strong liquidity ≠ reduced credit market exposure risk). (5) The LLM's conclusion that 'the firm's own exposure to external financial conditions has diminished' directly contradicts the ground truth's finding of 'continuation of concern' with 'more integrated perspective' on vulnerability. CORRECT ELEMENTS: The LLM does correctly identify that credit/capital market impacts on suppliers remained a concern in both years, and the financial metrics cited appear plausible. However, these correct elements are embedded in fundamentally flawed reasoning that misses the core analytical point.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 569,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How has Pfizer's financial commitment and contractual obligations related to Paxlovid evolved from 2022 to 2024, based on disclosed figures and agreements?",
      "original_answer": "In 2022, Paxlovid was under Emergency Use Authorization (EUA) in the U.S. and had received conditional marketing authorization (CMA) in the EU and full approval in Japan, indicating early-stage regulatory and commercial momentum. By 2024, Pfizer disclosed that remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, reflecting firm orders from long-term contracts with customers. This shows a significant financial commitment to Paxlovid, with delivery expected from 2025 through 2028, subject to renegotiation. Additionally, 2024 included a $771 million favorable final adjustment related to a prior revenue reversal tied to Paxlovid EUA-labeled treatment courses returned by the U.S. government, indicating ongoing financial adjustments and evolving contractual dynamics.",
      "llm_answer": "\nFrom 2022 to 2024 Pfizer’s Paxlovid financial exposure shifted dramatically from a peak of **$18.9 billion of revenue in 2022** (driven by government‑procured supply contracts) to a steep decline in 2023, when the U.S. government began winding down its distribution and Pfizer recorded a **$3.5 billion non‑cash revenue reversal** for expected returns of EUA‑labeled courses. In 2024 the company recognized a **$771 million favorable adjustment** for 5.1 million returned courses and earned **$442 million from a no‑cost 1 million‑course supply to the U.S. Strategic National Stockpile**, while remaining contracted revenue for Paxlovid fell to roughly **$1 billion expected through 2028** and deferred revenue dropped from $5.1 billion (2023) to $2.2 billion (2024). This evolution reflects the transition from large‑scale government purchases to commercial‑market sales and the associated contractual adjustments.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides substantial additional context and detail beyond the ground truth, with mostly accurate numbers but some verification concerns: CORRECT ELEMENTS: (1) $18.9 billion 2022 revenue figure is accurate and relevant context; (2) $3.5 billion non-cash revenue reversal in 2023 is correct; (3) $771 million favorable adjustment in 2024 is correct; (4) ~$1 billion remaining performance obligations through 2028 matches ground truth; (5) The narrative arc from government-procured contracts to commercial market transition is sound. AREAS OF CONCERN: (1) The $442 million figure for 'no-cost 1 million-course supply to the U.S. Strategic National Stockpile' is not mentioned in the ground truth and cannot be verified from provided sources; (2) The deferred revenue figures ($5.1 billion in 2023 declining to $2.2 billion in 2024) are not mentioned in ground truth and lack verification; (3) The '5.1 million returned courses' detail is not in ground truth. MULTI-HOP REASONING: The LLM successfully synthesizes the evolution from 2022-2024, connecting government procurement decline, revenue reversals, and transition to commercial contracts. The logic is sound and well-structured. GROUND TRUTH ALIGNMENT: The LLM answer covers all key points from ground truth (EUA status in 2022, $1 billion obligations through 2028, $771 million adjustment in 2024) but adds substantial unverified details. The core answer is correct but enhanced with information that cannot be confirmed against the provided ground truth. The additional context about deferred revenue and specific course numbers appears to be extrapolation or from sources not reflected in the ground truth knowledge graph. SEMANTIC EQUIVALENCE: The answer conveys the same fundamental evolution and financial commitment trajectory as ground truth, with enhanced detail on the transition mechanics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 506,
        "total_tokens": 1943
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How has the financial liability and risk exposure related to Aearo Technologies' respirator mask/asbestos litigation evolved from 2023 to 2024?",
      "original_answer": "In 2023, MMM had an accrual of $574 million for respirator mask/asbestos liabilities excluding Aearo, and Aearo was in bankruptcy proceedings, which resulted in a stay of litigation. By 2024, MMM, through Aearo, had accruals of $51 million specifically for Aearo-related asbestos, silica-related, and coal mine dust claims. Additionally, Aearo’s liability was limited by its agreement with Cabot, where Cabot assumed responsibility for claims involving exposure prior to January 1, 1997, as long as Aearo continued to pay a quarterly fee of $100,000. This represents a shift from a broader liability exposure under bankruptcy protection in 2023 to a more defined and limited liability framework in 2024, with Aearo actively managing its share of liability through contractual arrangements and cost-sharing with other co-defendants.",
      "llm_answer": "\nBetween the end of 2023 and the end of 2024 the Company’s accrued liability for Aearo‑related respirator‑mask/asbestos claims fell from about **$62 million** (as reported on page 83 for Dec 31 2023) to roughly **$51 million** (page 87 for Dec 31 2024), indicating a modest reduction in the specific Aearo exposure.  At the same time, the broader respirator‑mask/asbestos reserve (excluding Aearo) remained large—​$574 million as of Dec 31 2023 (page 83) and had been increased by **$57 million** during 2023 (page 83)—and the firm continued to settle and pay substantial amounts (e.g., a **$1.5 billion** payment in January 2024 for the Combat‑Arms earplug settlement and related insurance recoveries, pages 105‑108), underscoring that overall financial risk from these matters remains high despite the downward trend in the Aearo accrual.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains a significant factual error regarding the 2023 Aearo accrual. The LLM states the accrual was '$62 million' as of Dec 31, 2023, but the ground truth indicates it was part of the broader $574 million accrual (excluding Aearo). The ground truth does not specify a separate $62 million figure for Aearo in 2023—it only mentions that Aearo was in bankruptcy proceedings with a stay of litigation. The LLM's claim of a decline from $62M to $51M cannot be verified against the ground truth and appears to be fabricated or misread from the source documents. MISSING KEY INFORMATION: The LLM answer fails to mention critical contractual details from the ground truth: (1) Aearo's agreement with Cabot where Cabot assumed responsibility for pre-January 1, 1997 claims, and (2) the $100,000 quarterly fee arrangement. These are essential to understanding the 'more defined and limited liability framework' mentioned in the ground truth. PARTIAL CREDIT FOR CONTEXT: The LLM correctly identifies that the 2024 accrual was $51 million and provides relevant contextual information about the broader respirator-mask/asbestos liability ($574M in 2023) and the Combat-Arms settlement ($1.5B in January 2024). However, these contextual details do not compensate for the core factual error about the 2023 Aearo-specific accrual. MULTI-HOP REASONING: The LLM attempts to synthesize information across multiple years and entities but fails to accurately capture the transition from bankruptcy protection (2023) to a contractual liability-sharing arrangement (2024). The reasoning about 'downward trend' is based on the incorrect $62M figure. CONCLUSION: While the LLM demonstrates understanding of the general topic and provides some accurate supporting details, the fundamental error regarding the 2023 Aearo accrual figure and the omission of the Cabot agreement details represent significant failures in accuracy and completeness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 532,
        "total_tokens": 1949
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did the retail share of Skoal, a product of MO, change between 2023 and 2024, and how does this compare to its shipment volume trend between 2020 and 2021?",
      "original_answer": "The retail share of Skoal decreased from 9.3% in 2023 to 7.6% in 2024, indicating a decline in market presence. In contrast, Skoal's shipment volume was also declining between 2020 and 2021, dropping from 208.5 million packs/cans in 2020 to 197.4 million packs/cans in 2021. Both metrics show a consistent downward trend, suggesting a potential long-term challenge for the product's performance in the market.",
      "llm_answer": "\nSkoal’s retail‑share slipped from **9.3 % in 2023 to 7.6 % in 2024**, a decline of about **1.7 percentage points**.  Over the earlier period, its shipment volume also fell—from **208.5 million units in 2020 to 197.4 million in 2021**, a drop of roughly **5 %**.  Thus, the downward movement in Skoal’s retail share mirrors the same downward trend in its shipment volumes.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. Verification of key facts: (1) Retail share numbers are correct: 9.3% in 2023 and 7.6% in 2024, with the calculated decline of 1.7 percentage points being accurate. (2) Shipment volume numbers are correct: 208.5 million units in 2020 and 197.4 million in 2021. (3) The percentage decline calculation for shipment volume is approximately correct: (208.5-197.4)/208.5 = 11.1/208.5 ≈ 5.3%, which the LLM rounded to 'roughly 5%' - this is a reasonable approximation. (4) Multi-hop synthesis is sound: the answer correctly identifies and compares two distinct time periods (2023-2024 for retail share and 2020-2021 for shipment volume) and draws the appropriate conclusion that both metrics show downward trends. (5) Entity identification is correct: Skoal is properly identified as a product of MO (Altria/Phillip Morris). (6) The reasoning is logical and well-presented, clearly showing the parallel decline patterns. Minor note: The LLM uses 'units' instead of 'packs/cans' for shipment volume, but this is a semantic variation that doesn't affect accuracy. The answer fully addresses all parts of the multi-part question and provides appropriate context about the implications of these trends.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1198,
        "completion_tokens": 351,
        "total_tokens": 1549
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How has Qualcomm's approach to multimedia technologies evolved from 2022 to 2024, particularly in terms of engineering focus areas and integration into product offerings?",
      "original_answer": "In 2022, Qualcomm emphasized engineering expertise in multimedia technologies such as camera, video, display, and computer vision as part of a broader set of capabilities including modem, RF, and sensor perception technologies. The focus was on enhancing existing products and developing new technologies for industries beyond mobile handsets, such as automotive and IoT. By 2024, the company's description of its multimedia technology efforts remained consistent, but there was a notable expansion in the integration of AI, particularly generative AI, into its research and development strategy. Additionally, in 2024, Qualcomm placed greater emphasis on enabling developers to design and deploy applications across multiple device categories and industries, signaling a more deliberate diversification strategy. This evolution reflects a shift from primarily hardware-centric multimedia innovation in 2022 to a more platform-oriented, AI-enhanced approach by 2024.",
      "llm_answer": "\nFrom 2022 to 2024 Qualcomm moved its Snapdragon engineering focus from a communications‑centric SoC to a multimedia‑first architecture, embedding dedicated AI‑accelerated camera, video and display pipelines (including Hexagon NPU and computer‑vision blocks) directly into the chipset.  These capabilities are now tightly coupled with the 5G modem‑RF front‑end and RFFE modules, creating integrated modem‑to‑antenna solutions that deliver higher‑performance, power‑efficient multimedia experiences across handsets, automotive and IoT products.",
      "correctness_score": 4,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "ASSESSMENT: The LLM answer contains significant factual and conceptual errors that diverge substantially from the ground truth.\n\nCORRECT ELEMENTS:\n- Correctly identifies Qualcomm as the company\n- Correctly identifies the 2022-2024 timeframe\n- Correctly mentions multimedia technologies (camera, video, display)\n- Correctly references AI/NPU integration\n- Correctly identifies product categories (handsets, automotive, IoT)\n- Correctly mentions 5G modem and RF technologies\n\nMAJOR ERRORS AND MISREPRESENTATIONS:\n\n1. FUNDAMENTAL CHARACTERIZATION ERROR: The LLM claims Qualcomm moved from \"communications-centric SoC to multimedia-first architecture.\" The ground truth indicates multimedia technologies were ALREADY emphasized in 2022 as core engineering expertise. The evolution was NOT from communications-centric to multimedia-first, but rather from hardware-centric multimedia innovation to AI-enhanced, platform-oriented approach.\n\n2. MISSING KEY EVOLUTION: The ground truth emphasizes the critical shift from 2022 to 2024 was the \"expansion of AI integration, particularly generative AI\" and a shift toward \"platform-oriented, AI-enhanced approach.\" The LLM mentions AI but frames it as embedded hardware acceleration rather than the broader strategic pivot toward generative AI and platform enablement.\n\n3. INCOMPLETE STRATEGIC CONTEXT: The ground truth highlights that by 2024, Qualcomm placed \"greater emphasis on enabling developers to design and deploy applications across multiple device categories and industries.\" The LLM answer focuses on hardware integration but misses this crucial developer-enablement and diversification strategy shift.\n\n4. MISCHARACTERIZATION OF INTEGRATION: The LLM describes \"tightly coupled\" hardware integration as the evolution, but the ground truth indicates the evolution was toward a more platform-oriented approach with AI integration, not primarily about hardware coupling.\n\n5. OVERSTATED TECHNICAL SPECIFICITY: The LLM provides specific technical details (Hexagon NPU, RFFE modules, modem-to-antenna solutions) that are not mentioned in the ground truth and may represent fabrication or over-specification beyond what the filings actually state.\n\nMULTI-HOP REASONING: The LLM failed to properly synthesize the multi-year evolution. It presents a single narrative about hardware architecture rather than capturing the actual evolution from hardware-centric (2022) to AI-enhanced, platform-oriented (2024).\n\nSEMANTIC DIVERGENCE: While both answers mention AI and multimedia, they describe fundamentally different evolutions. The ground truth emphasizes strategic platform shift and developer enablement; the LLM emphasizes hardware architecture changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 721,
        "total_tokens": 2104
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did 3M's financial relationship with the Aearo Entities evolve between 2023 and 2024, particularly in terms of equity investment and intercompany balances?",
      "original_answer": "In 2023, 3M reconsolidated the Aearo Entities, which resulted in the removal of a $0.7 billion asset balance in equity and other investments and a $0.6 billion net liability for former intercompany amounts from its consolidated balance sheet as of December 31, 2023. By 2024, the Aearo Entities were no longer consolidated, and instead, 3M now 'has a stake in' them, indicating a shift from full consolidation to a retained equity interest. This reflects a significant change in the financial structure and relationship between 3M and the Aearo Entities.",
      "llm_answer": "\nBetween 2023 and 2024, 3M eliminated the modest $0.7 bn equity stake it had held in the Aearo Entities and, after re‑consolidating them in Q2 2023, recorded a net inter‑company liability of about $0.6 bn that was reflected in other assets and other liabilities.  The 2023‑24 CAE settlement then replaced that inter‑company exposure with a $5 bn accrued liability (later increased to $6 bn over 2023‑29) and a series of cash payments (e.g., $10 m, $147 m, $250 m and $253 m), so that 3M’s financial relationship shifted from a small equity investment and related inter‑company balances to a large contingent cash‑outlay and liability.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not present in the ground truth, which substantially undermines its accuracy. CRITICAL ERRORS: (1) The LLM states 3M 'eliminated the modest $0.7 bn equity stake' - this is incorrect. The ground truth clearly states the $0.7 billion was an 'asset balance in equity and other investments' that was REMOVED from the balance sheet upon reconsolidation in 2023, not eliminated between 2023-2024. (2) The LLM introduces a CAE settlement with $5-6 billion accrued liability and specific cash payments ($10m, $147m, $250m, $253m) that are NOT mentioned in the ground truth answer. This appears to be extraneous information that conflates the Aearo situation with a separate settlement matter. (3) The LLM mischaracterizes the 2023 event, stating 3M 'recorded a net inter-company liability of about $0.6 bn that was reflected in other assets and other liabilities' - the ground truth indicates this $0.6 billion net liability was REMOVED from the consolidated balance sheet upon reconsolidation, not recorded as a new liability. CORRECT ELEMENTS: (1) The $0.7 billion and $0.6 billion figures are accurate. (2) The general concept that the relationship shifted is correct. (3) The mention of reconsolidation in 2023 is accurate. MULTI-HOP REASONING: The LLM failed to properly synthesize the 2023-2024 evolution. The ground truth shows: 2023 = reconsolidation (removal of equity investment and intercompany balances from balance sheet), 2024 = deconsolidation (shift to retained equity interest). The LLM conflates these events and introduces unrelated settlement information. The answer demonstrates incomplete understanding of the actual financial relationship evolution and introduces material inaccuracies that would mislead readers about 3M's actual financial position and transactions with the Aearo Entities.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 510,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How has Visa's Risk and Identity Solutions evolved between 2022 and 2024, particularly in terms of their strategic positioning within the company's broader value-added services portfolio?",
      "original_answer": "In 2022, Visa's Risk and Identity Solutions were described as tools that 'transform data into insights for near real-time decisions' and included named products like Visa Advanced Authorization and Visa Secure. These solutions were positioned primarily around fraud prevention and payment security, with an emphasis on helping clients protect account holder data and prevent fraud in the context of omnichannel commerce. By 2024, Risk and Identity Solutions had been elevated as one of five core categories within a more expansive value-added services portfolio that now includes Open Banking Solutions and Advisory Services. The 2024 report highlights that Visa offered more than 200 products and services as of September 30, 2024, many designed to work together for 'high impact business outcomes,' indicating a broader strategic integration of Risk and Identity Solutions within a more diversified services ecosystem.",
      "llm_answer": "\nBetween 2022 and 2024 Visa’s Risk and Identity Solutions progressed from a focused set of fraud‑prevention and authentication tools (e.g., Visa Advanced Authorization, Visa Secure) to a broader, AI‑driven suite that now includes products such as Visa Deep Authorization, Visa Protect for A2A payments and scheme‑agnostic Risk Manager.  These newer capabilities are tightly integrated with Visa’s emerging payment flows—Visa Direct, Visa B2B Connect, cross‑border and open‑banking services—positioning risk and identity as a core pillar of Visa’s value‑added services portfolio and a key differentiator that monetises data‑driven insights across both card‑based and non‑card payment ecosystems.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ISSUES: (1) FACTUAL ERRORS - The LLM introduces specific product names (Visa Deep Authorization, Visa Protect for A2A payments, scheme-agnostic Risk Manager) that are NOT mentioned in the ground truth. These appear to be fabricated or hallucinated details not supported by the original filing data. (2) MISSING KEY INFORMATION - The ground truth explicitly states that by 2024, Risk and Identity Solutions were positioned as 'one of five core categories' within the value-added services portfolio and mentions 'more than 200 products and services as of September 30, 2024.' The LLM completely omits these specific quantitative benchmarks and the five-category framework. (3) UNSUPPORTED CLAIMS - The LLM claims integration with 'Visa Direct, Visa B2B Connect, cross-border and open-banking services' but the ground truth only mentions that Open Banking Solutions and Advisory Services are separate categories alongside Risk and Identity Solutions, not integrated products. (4) PARTIAL ACCURACY - The LLM correctly identifies the evolution from fraud-prevention focus to broader positioning and correctly names Visa Advanced Authorization and Visa Secure as 2022 products. The characterization of the shift from focused to broader/AI-driven is directionally correct but lacks grounding in actual filing data. (5) MULTI-HOP SYNTHESIS - While the LLM attempts to synthesize evolution across years, it does so by introducing unverified product details rather than relying on documented information. The ground truth's emphasis on the portfolio structure (five core categories, 200+ products) is completely absent. QUANTITATIVE ACCURACY: The LLM provides no specific numbers, dates, or metrics from the filings, whereas the ground truth references 'September 30, 2024' and 'more than 200 products and services' - these should have been included. QUALITATIVE ACCURACY: The reasoning about evolution is present but undermined by factual inaccuracies and hallucinated product names that cannot be verified against the source documents.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 548,
        "total_tokens": 1961
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did RTX's disclosure and quantification of Acquisition Accounting Adjustments' impact on operating profit evolve between 2023 and 2024?",
      "original_answer": "In 2023, RTX provided specific quantified impacts of Acquisition Accounting Adjustments on operating profit, showing a negative impact of $1,998 million in 2023, compared to $1,893 million in 2022 and $2,203 million in 2021. By 2024, RTX shifted its disclosure approach by providing qualitative policy context about the components of these adjustments, but did not include updated quantitative figures for the current year's impact on operating profit. This represents a move from concrete numerical disclosure to a more conceptual explanation of acquisition accounting practices without continuing the year-over-year quantification.",
      "llm_answer": "\nRTX continues to present acquisition‑accounting adjustments as a separate line‑item below segment operating profit.  The total adjustment grew from a $1.998 billion drag on 2023 operating profit to a $2.058 billion drag in 2024 (≈ $60 million higher), with the increase coming mainly from higher amortization of acquired intangibles and a modest rise in the amortization of customer contractual obligations (Collins fell slightly, while Pratt & Whitney and Raytheon each rose).  Thus, the company’s disclosure and quantification of these adjustments became slightly more material in 2024, reflecting a modest uptick in the post‑acquisition amortization that reduces consolidated operating profit.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally contradicted by the ground truth on the core factual claim. Ground truth explicitly states: 'By 2024, RTX shifted its disclosure approach by providing qualitative policy context about the components of these adjustments, but did not include updated quantitative figures for the current year's impact on operating profit.' The LLM answer claims the opposite - that RTX provided a specific 2024 quantified figure of $2.058 billion. This is a critical factual error that directly contradicts the ground truth's central finding about the evolution of RTX's disclosure approach. The LLM also provides specific segment-level details (Collins, Pratt & Whitney, Raytheon) that are not mentioned in the ground truth and appear to be fabricated. The 2023 figure of $1.998 billion is correctly stated (matching the ground truth's $1,998 million), but this accuracy is overshadowed by the major error regarding 2024 disclosure. The LLM fundamentally misunderstood the question's focus on how disclosure evolved - the key point is that RTX moved FROM quantitative disclosure TO qualitative-only disclosure, not that quantification continued or became more detailed. The answer demonstrates a failure to synthesize the multi-hop information correctly and invents specific numerical data that contradicts the ground truth's explicit statement that 2024 lacked quantitative figures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 388,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How has Microsoft's Office 365 Commercial revenue contribution to the Microsoft Cloud evolved between fiscal years 2022 and 2023, and what does this indicate about its growth trajectory within the broader cloud ecosystem?",
      "original_answer": "In fiscal year 2022, Office 365 Commercial was explicitly cited as a key growth driver within the Productivity and Business Processes segment, contributing to an 18% overall revenue increase for the company. By fiscal year 2023, Office 365 Commercial was included in a newly disclosed consolidated Microsoft Cloud revenue figure, which reached $111.6 billion in FY2023, up from $91.4 billion in FY2022. This indicates that Office 365 Commercial continued to grow as part of a broader, increasingly transparent cloud revenue portfolio that now includes Azure, LinkedIn (commercial portion), Dynamics 365, and other cloud services.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2023 the Office 365 Commercial portion of Microsoft’s “Office products and cloud services” revenue rose from **$44.9 billion to $48.8 billion**—about a **9 % increase**.  During the same period Microsoft Cloud total revenue grew from **$91.4 billion to $111.6 billion**, so the Office 365 Commercial segment’s share of the cloud business expanded, highlighting its accelerating contribution and the strong growth trajectory of Office 365 within Microsoft’s broader cloud ecosystem.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ISSUES IDENTIFIED: (1) UNVERIFIABLE NUMBERS: The LLM provides specific Office 365 Commercial revenue figures ($44.9B in FY2022 and $48.8B in FY2023) that are NOT present in the ground truth answer. The ground truth does not cite these specific numbers for Office 365 Commercial standalone revenue. These appear to be fabricated or sourced from undisclosed data. (2) CALCULATION ERROR: The LLM claims a 9% increase from $44.9B to $48.8B, but the actual calculation is ($48.8B - $44.9B) / $44.9B = 8.7%, not 9%. This is a minor rounding issue but still an error. (3) INCOMPLETE SYNTHESIS: While the LLM correctly cites the Microsoft Cloud totals ($91.4B to $111.6B), it fails to address the ground truth's key insight that Office 365 Commercial was 'explicitly cited as a key growth driver' in FY2022 and was 'included in a newly disclosed consolidated Microsoft Cloud revenue figure' in FY2023—indicating a shift in reporting methodology. (4) MISSING CONTEXT: The ground truth emphasizes the broader cloud ecosystem composition (Azure, LinkedIn commercial, Dynamics 365, etc.), which the LLM mentions only tangentially. (5) UNSUBSTANTIATED CLAIM: The statement that 'Office 365 Commercial segment's share of the cloud business expanded' cannot be verified from the ground truth, which does not provide Office 365 Commercial's specific contribution percentages. The core problem is that the LLM introduces specific revenue numbers for Office 365 Commercial that contradict or extend beyond the ground truth without justification, making the answer unreliable despite correctly citing the Microsoft Cloud aggregate figures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 446,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How did Merck's alliance revenue related to Lynparza evolve between 2023 and 2024, and what factors contributed to the change?",
      "original_answer": "In 2023, alliance revenue for Lynparza was part of Merck's broader alliance revenue reporting, which included profits based on product sales net of cost of sales and commercialization costs. By 2024, alliance revenue related to Lynparza specifically grew by 9%, driven by higher demand in most international markets. This growth indicates a positive shift in Lynparza's market performance during the period.",
      "llm_answer": "\nAlliance revenue from Lynparza rose from **$1.116 billion in 2022 to $1.199 billion in 2023** and then **increased about 9 % in 2024**, taking the total to roughly **$1.30 billion**.  The jump was driven primarily by **stronger international demand**, especially in China where the NMPA approved Lynparza in January 2025 (effective late‑2024) for a new adjuvant breast‑cancer indication, and by continued uptake in existing markets.  Higher sales volumes and the resulting profit‑share arrangement with AstraZeneca (net of cost‑of‑sales and commercialization expenses) accounted for the growth.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) QUANTITATIVE ERRORS: The LLM provides specific dollar amounts ($1.116B in 2022, $1.199B in 2023, $1.30B in 2024) that cannot be verified against the ground truth. The ground truth does not provide these specific figures - it only states that alliance revenue 'grew by 9%' in 2024. The LLM appears to have fabricated precise numbers without source support. (2) TEMPORAL MISMATCH: The ground truth focuses on 2023-2024 evolution, but the LLM introduces 2022 data ($1.116B) that wasn't requested and may be inaccurate. (3) SPECULATIVE CONTENT: The LLM mentions NMPA approval in January 2025 for a new adjuvant breast-cancer indication, which is presented as fact but goes beyond what the ground truth states. This appears to be extrapolation or hallucination. (4) PARTIAL ACCURACY: The LLM correctly identifies the 9% growth in 2024 and correctly mentions stronger international demand as a driver, which aligns with the ground truth. The mention of AstraZeneca profit-share arrangement and cost-of-sales/commercialization expenses is contextually appropriate and matches ground truth language. (5) MULTI-HOP REASONING: While the LLM attempts to synthesize information about drivers of change (international demand, China approval, profit-sharing), the specific claims about China approval timing and new indications lack ground truth support and appear to be unsupported elaborations. The core answer structure is reasonable but undermined by unverified specifics. VERDICT: The answer contains some correct elements (9% growth, international demand driver, AstraZeneca arrangement) but is significantly compromised by fabricated financial figures and unverified claims about regulatory approvals.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 469,
        "total_tokens": 1715
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How has the treatment and disclosure of the Procter & Gamble 2014 Stock and Incentive Compensation Plan evolved between 2023 and 2024, particularly in terms of its regulatory context and inclusion in equity compensation reporting?",
      "original_answer": "In 2023, the 2014 Stock and Incentive Compensation Plan was disclosed in the context of regulatory documentation and was referenced alongside other compensation plans and agreements, such as the 2009 and 2019 plans, indicating its active role in executive compensation. By 2024, the plan was included in a broader list of equity compensation plans for reporting on stock issuances upon exercise of options, suggesting a shift from regulatory disclosure to a focus on ownership structure and equity compensation transparency. This evolution indicates a more integrated view of the 2014 plan within the company’s overall equity compensation framework.",
      "llm_answer": "\nIn the 2023 filing the 2014 Stock and Incentive Compensation Plan appeared only as an exhibit (Item 10‑24) and was mentioned in the Compensation and Leadership Development Committee’s regulations (Item 10‑25), with no explicit note that it no longer permits new grants. By the 2024 filing the plan is explicitly grouped with the 2019 Plan in the Committee’s regulations, is listed in the equity‑compensation table as a closed plan with zero shares available for future issuance, and its terms are again incorporated by reference (Item 10‑26), reflecting a more transparent regulatory framing that makes clear the 2014 plan is no longer used for new awards while still being disclosed as required under the SEC’s equity‑compensation reporting rules.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer provides specific details about item numbers, regulatory framing, and the evolution of disclosure that are not present in the ground truth answer. However, there are significant concerns about factual accuracy and verifiability: (1) The ground truth answer is general and conceptual, describing a shift from 'regulatory disclosure to a focus on ownership structure and equity compensation transparency' without specific item numbers or filing details. (2) The LLM answer introduces very specific item numbers (10-24, 10-25, 10-26) and claims about the plan being listed as 'closed plan with zero shares available for future issuance' that cannot be verified against the ground truth. (3) The LLM answer claims the 2014 plan 'no longer permits new grants' and is 'no longer used for new awards' - while this may be accurate, it is not explicitly stated in the ground truth. (4) The LLM answer's multi-hop reasoning is sound in structure (comparing 2023 vs 2024 treatment), but the specific factual claims about item numbers and equity compensation table entries are not corroborated by the ground truth. (5) Both answers correctly identify the core evolution: the plan's role changed between 2023 and 2024, and it became part of a broader equity compensation framework. (6) The LLM answer is more detailed and specific, but this specificity creates risk if the item numbers or specific claims are inaccurate. Without access to the actual 10-K filings, the specific item numbers and table references cannot be verified. The answer demonstrates good reasoning about the evolution of disclosure practices but introduces unverified specific details that deviate from the ground truth's more general characterization.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 470,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How has the treatment of the 1992 Stock Plan evolved between the 2023 and 2024 10-K filings, particularly in terms of its role within the company's equity compensation structure?",
      "original_answer": "In the 2023 10-K filing, the 1992 Stock Plan was referenced as an adopted plan with specific terms and conditions incorporated by reference to prior filings. However, in the 2024 10-K filing, the 1992 Stock Plan is listed among other equity compensation plans in a consolidated table that outlines shares authorized for issuance upon the exercise of options, warrants, and rights. This indicates a shift from a standalone referenced plan to one being tracked alongside newer plans, suggesting its role has transitioned from active adoption to a more passive stake within the broader equity compensation framework.",
      "llm_answer": "\nBetween the 2023 and 2024 10‑K filings the company’s disclosures show that the 1992 Stock Plan has been effectively retired from new equity awards.  The 2024 filing (Exhibit 10‑3) notes that, unlike the 2019 Stock and Incentive Compensation Plan, the 1992 Plan “allows for future grants” only in the past – all current and future equity awards are now made under the 2019 (and related) plans, and the 1992 Plan’s remaining shares are limited to the outstanding options and RSUs that were granted before it was closed.  Consequently, the 1992 Plan now serves only as a repository for legacy awards, while the 2019 Plan provides the bulk of the company’s ongoing equity‑compensation structure.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations compared to the ground truth. (1) MAJOR ERRORS: The LLM claims the 1992 Stock Plan has been 'effectively retired from new equity awards' and that it 'allows for future grants only in the past' - this is contradictory and unsupported by the ground truth. The ground truth indicates the plan transitioned from being 'referenced as an adopted plan' to being 'listed among other equity compensation plans in a consolidated table,' not that it was retired. (2) UNSUPPORTED CLAIMS: The LLM references 'Exhibit 10-3' and makes specific claims about what the 2024 filing states regarding the 1992 Plan versus the 2019 Plan, but the ground truth does not mention these exhibits or make such comparative statements. (3) MISCHARACTERIZATION: The ground truth describes a shift from 'standalone referenced plan to one being tracked alongside newer plans' - a more nuanced evolution. The LLM oversimplifies this to 'legacy awards repository,' which goes beyond what the ground truth supports. (4) MISSING CORE INSIGHT: The ground truth emphasizes the shift in HOW the plan is disclosed (from referenced to consolidated table), while the LLM focuses on retirement/closure status, which is not supported by the ground truth. (5) QUANTITATIVE ISSUES: No specific numbers are provided in either answer, but the LLM's characterization of the plan's status is factually incorrect based on the ground truth. The answer demonstrates poor multi-hop synthesis and introduces unsupported details that contradict the actual evolution described in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 442,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How has the company's emphasis on large-scale transformations evolved between 2023 and 2024, particularly in terms of client spending patterns and revenue conversion timelines?",
      "original_answer": "In 2023, the filing noted that clients were reducing or deferring spending on smaller contracts with shorter durations and that there was a slowdown in client spending, especially for consulting services. However, clients were still prioritizing large-scale transformations, which convert to revenue over a longer period. In 2024, the filing reiterated that clients continued to prioritize large-scale transformations, emphasizing the ongoing shift toward longer-duration contracts. While there was no explicit quantitative metric provided in either year, the repeated emphasis in both filings on the extended revenue conversion timeline for large-scale transformations indicates a strategic reinforcement of this focus, especially amid ongoing economic volatility.",
      "llm_answer": "\nBetween fiscal 2023 and 2024 the company’s focus on large‑scale transformations deepened: the risk‑factor discussion notes that “clients continue to prioritize large‑scale transformations, which convert to revenue over a longer period,” and that the slowdown in fiscal 2024 was driven primarily by a pull‑back in short‑duration, smaller contracts rather than in these transformational engagements. Consequently, revenue recognition shifted toward a longer‑term, multi‑quarter conversion cycle, with the mix of work moving to higher‑value, longer‑horizon projects that boosted operating margins despite only modest revenue growth. (See Risk Factors Item 1A (page 21) and the operating‑income commentary (page 47).)",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across most dimensions. STRENGTHS: (1) Correctly identifies the core evolution between 2023-2024: clients prioritizing large-scale transformations with longer revenue conversion timelines; (2) Accurately captures the shift away from short-duration, smaller contracts; (3) Properly synthesizes the multi-hop information showing how this strategic focus manifested in both risk factors and operating income commentary; (4) Correctly notes the absence of explicit quantitative metrics while still conveying the strategic emphasis; (5) Appropriately references specific filing sections (Risk Factors Item 1A page 21, operating income commentary page 47) showing document-level accuracy. MINOR WEAKNESSES: (1) The LLM answer adds interpretive detail about 'operating margins' improving 'despite only modest revenue growth' - while this is a reasonable inference from the filing context, the ground truth does not explicitly state this margin improvement connection, making this a slight extrapolation beyond what was directly confirmed; (2) The phrase 'revenue recognition shifted toward a longer-term, multi-quarter conversion cycle' is accurate but slightly more specific/technical than the ground truth's more general statement about 'extended revenue conversion timeline'; (3) Does not explicitly mention the 2023 context of 'slowdown in client spending, especially for consulting services' as clearly as the ground truth, though it does reference the pullback in short-duration contracts. QUANTITATIVE VERIFICATION: No specific numbers, percentages, or dollar amounts are provided in either answer, which is appropriate given the question's focus on qualitative evolution and the ground truth's acknowledgment that 'no explicit quantitative metric provided.' MULTI-HOP REASONING: The answer successfully synthesizes information across multiple filing sections (risk factors and operating income commentary) and correctly traces the evolution across two fiscal years. The logic connecting client spending patterns to revenue conversion timelines is sound and well-articulated.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 574,
        "total_tokens": 1951
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How did Accenture's issuance of Class A Ordinary Shares for employee compensation change from fiscal 2023 to 2024, and what was the impact on the company's equity structure?",
      "original_answer": "In fiscal 2023, Accenture acquired Class A Ordinary Shares primarily through share withholding for payroll tax obligations related to employee equity awards. In fiscal 2024, the company issued 7,970 Class A Ordinary Shares specifically for employee share programs, while also purchasing 12,181 treasury shares. This shift reflects a more active use of Class A Ordinary Shares for compensation purposes in 2024. The equity structure was impacted as Class A Ordinary Shares increased from 15,656,591 in 2023 to 15,664,561 in 2024, while treasury shares decreased in value from $(3,408,491) million to $(6,678,037) million, indicating a significant reallocation of shares for employee programs.",
      "llm_answer": "\nFrom fiscal 2023 to fiscal 2024 the number of Class A ordinary shares issued for employee compensation fell – the 2010 Employee Share Purchase Plan issued about 4.9 million shares in 2024 versus 5.7 million shares in 2023 (≈14 % lower), and total issuances under all employee‑share programs dropped from roughly 8.5 million shares to 7.97 million shares.  This reduction lessened dilution of existing shareholders and left a marginally larger treasury‑share balance, while overall shareholders’ equity grew only through higher additional‑paid‑in‑capital and retained earnings rather than through the addition of new shares.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and contradicts the ground truth on multiple critical points: (1) DIRECTION OF CHANGE: The LLM claims shares issued for employee compensation FELL from 2023 to 2024 (8.5M to 7.97M), but the ground truth explicitly states the company ISSUED 7,970 shares in 2024 for employee programs - a much smaller number than the LLM's millions figure. The ground truth shows an increase in Class A Ordinary Shares from 15,656,591 to 15,664,561, indicating growth, not reduction. (2) QUANTITATIVE ERRORS: The LLM cites 4.9M shares in 2024 vs 5.7M in 2023 under the 2010 Employee Share Purchase Plan, and 8.5M vs 7.97M total - these numbers are orders of magnitude larger than the ground truth's 7,970 shares issued in 2024. The ground truth mentions 12,181 treasury shares purchased, not millions. (3) TREASURY SHARES MISCHARACTERIZATION: The LLM states treasury shares left a 'marginally larger balance,' but ground truth shows treasury shares DECREASED in value from $(3,408,491) million to $(6,678,037) million - a significant increase in absolute value (more negative), not a marginal change. (4) MISSING KEY DETAILS: The LLM fails to mention the specific treasury share purchases (12,181 shares) or the actual equity structure changes with precise numbers. (5) REASONING FLAW: The LLM's conclusion about 'lessened dilution' contradicts the ground truth's description of 'more active use' of shares for compensation in 2024. The answer appears to reference different data or misinterprets the filing information entirely.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 429,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How did MDLZ's exposure to Canadian-denominated debt instruments change between 2022 and 2023, and how does this shift compare to the company's overall trend in managing foreign currency-denominated debt during this period?",
      "original_answer": "In 2022, MDLZ reported a decrease in Canadian notes of $3 million, continuing a trend of declining balances from $17 million in 2019 to $7 million in 2020 and $3 million in 2021. However, in 2023, the company experienced an increase in Canadian notes by $8 million, reversing the previous downward trajectory. This shift contrasts with the broader pattern of fluctuating foreign currency exposure, where Euro notes decreased significantly from $211 million in 2021 to $81 million in 2023, while Swiss franc notes also showed volatility. The reversal in Canadian notes indicates a notable deviation from the prior year's trend of reducing exposure to this currency denomination.",
      "llm_answer": "\nMDLZ’s Canadian‑denominated debt exposure slipped in 2023 – the after‑tax gain on the Canadian‑dollar net‑investment hedge fell from **$25 million in 2022 to a **$8 million loss in 2023**, signalling a reduction in the outstanding Canadian‑currency notional and an unwind of the related hedge.  This move fits the broader pattern of the company actively trimming and reshaping its foreign‑currency‑denominated debt and hedge coverage, as reflected by the declining after‑tax gains on other non‑U.S. currency hedges and the absence of new foreign‑currency debt redemptions in 2023.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and addresses a completely different metric than what the ground truth provides. Critical issues: (1) QUANTITATIVE ERRORS: The LLM cites hedge gains/losses ($25M in 2022, $8M loss in 2023) which are entirely different from the actual Canadian notes balances that should be reported ($3M in 2022, increasing to $11M in 2023 based on the $8M increase mentioned in ground truth). These are not equivalent metrics - one measures derivative hedge accounting results, the other measures actual debt principal amounts. (2) METRIC CONFUSION: The LLM discusses 'after-tax gains on Canadian-dollar net-investment hedge' which is a derivative/hedge accounting metric, not the actual Canadian-denominated debt exposure that the question asks about. The ground truth clearly states Canadian notes decreased by $3M in 2022 and increased by $8M in 2023. (3) DIRECTIONAL ERROR: The LLM suggests a 'reduction in outstanding Canadian-currency notional' when the ground truth explicitly states there was an $8M INCREASE in 2023, reversing the prior downward trend. (4) INCOMPLETE SYNTHESIS: While the LLM does attempt to contextualize within broader foreign currency trends, it does so using incorrect data. The ground truth provides specific comparisons (Euro notes $211M→$81M, Swiss franc volatility) which the LLM does not address. (5) MISSING KEY FACTS: The LLM completely omits the historical context provided in ground truth (2019-2021 declining trend from $17M to $3M) and the significance of the 2023 reversal. The answer appears to conflate derivative hedge results with actual debt principal balances, representing a fundamental misunderstanding of the financial metrics involved.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 467,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How has Accenture's approach to engaging with growth-stage companies evolved from 2023 to 2024, particularly in terms of strategic involvement and investment activity?",
      "original_answer": "In 2023, Accenture Ventures was described as primarily partnering with growth-stage companies that create innovative enterprise technologies. By 2024, the relationship evolved from a partnership model to a more direct investment approach, indicating a deeper financial and strategic commitment. This shift from 'partners with' to 'invests in' growth-stage firms suggests Accenture is taking a more active role in shaping innovation ecosystems through capital allocation, aligning with its broader innovation strategy supported by $1.3 billion in R&D spending in fiscal 2023 and $1.2 billion in fiscal 2024.",
      "llm_answer": "\nFrom fiscal 2023 through fiscal 2024, Accenture’s core tactic— Accenture Ventures partnering with and investing in growth‑stage companies that build innovative enterprise technologies — remained unchanged.  What did shift in 2024 is the emphasis on integrating those external innovations more tightly into Accenture’s own ecosystem: the filing highlights that Accenture Labs and its global network of innovation hubs now incubate, prototype and scale the technologies sourced from growth‑stage firms, allowing Accenture to embed those solutions directly into client engagements and deliver them at scale across its delivery model.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misses the core evolution described in the ground truth. CRITICAL ERRORS: (1) The LLM claims the approach 'remained unchanged' from 2023-2024, directly contradicting the ground truth which explicitly states the relationship 'evolved from a partnership model to a more direct investment approach.' This is a fundamental misunderstanding of the question's core premise. (2) QUANTITATIVE ACCURACY FAILURE: The ground truth provides specific R&D spending figures ($1.3 billion in fiscal 2023 and $1.2 billion in fiscal 2024) that contextualize Accenture's innovation strategy. The LLM answer completely omits these numbers, failing to include key quantitative data that supports the evolution narrative. (3) MULTI-HOP REASONING FAILURE: The ground truth synthesizes the shift from 'partners with' to 'invests in' language as evidence of deeper financial commitment and active role in innovation ecosystems. The LLM misses this critical distinction entirely. (4) SEMANTIC MISMATCH: While the LLM discusses integration of external innovations through Labs and innovation hubs, this represents a different aspect of strategy (operational integration) rather than the strategic shift in investment approach that the question asks about. The LLM conflates operational changes with the fundamental shift in engagement model. (5) INCOMPLETE SYNTHESIS: The ground truth clearly identifies a 2023-to-2024 evolution; the LLM incorrectly states continuity. This is not a minor wording difference but a factual contradiction of the primary finding. The LLM answer demonstrates poor multi-hop synthesis by failing to connect the language shift ('partners with' vs 'invests in') to the underlying strategic evolution in financial commitment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 483,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How has Merck's financial and strategic involvement in the Lynparza collaboration with AstraZeneca evolved from 2022 to 2024, particularly in terms of asset amortization and alliance revenue growth?",
      "original_answer": "In 2022, Merck was amortizing an intangible asset balance of $1.1 billion related to Lynparza, which included capitalized milestone payments, and was expected to be amortized through 2028. By 2024, the focus shifted from asset amortization to revenue growth, with alliance revenue from Lynparza increasing by 9% due to higher demand in international markets. Additionally, in early 2025, Lynparza received a new approval in China for adjuvant treatment in early breast cancer, indicating an expansion in its therapeutic footprint and strategic importance to Merck.",
      "llm_answer": "\nFrom 2022 through 2024 Merck continued to amortize the $1.1 billion Lynparza‑related intangible asset (recorded in “Other Intangibles, Net”) over its remaining useful life to 2028, with amortization expense running at roughly $160‑$170 million per year.  Alliance revenue from Lynparza grew from $444 million in 2019 to $725 million in 2020 and $989 million in 2021, and in 2024 the collaboration posted a 9 % year‑over‑year increase, reflecting expanding sales and the ongoing equal‑profit‑sharing, cost‑sharing arrangement with AstraZeneca while the intangible asset is steadily written down through 2028.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: (1) Correctly identifies the $1.1 billion intangible asset balance related to Lynparza and the 2028 amortization timeline. (2) Accurately states the 9% year-over-year alliance revenue increase in 2024. (3) Properly describes the equal-profit-sharing, cost-sharing arrangement with AstraZeneca. (4) Correctly notes the asset is being written down through 2028. (5) Good contextual understanding of the collaboration structure.\n\nWEAKNESSES: (1) MAJOR ISSUE - Provides historical revenue data (2019-2021: $444M, $725M, $989M) that is NOT in the ground truth and appears to be extraneous information not requested or verified. This introduces unverified numbers into the answer. (2) Provides specific amortization expense estimates ($160-$170M per year) that are NOT in the ground truth - these appear to be calculated estimates but lack verification. (3) CRITICAL OMISSION - Fails to mention the 2025 China approval for adjuvant treatment in early breast cancer, which the ground truth identifies as a key strategic development indicating expansion of therapeutic footprint. This is a significant omission for a question asking about evolution through 2024 and beyond. (4) Does not clearly distinguish between the 2022 focus on asset amortization versus the 2024 shift to revenue growth as emphasized in ground truth.\n\nMULTI-HOP REASONING: The answer attempts to synthesize information about both amortization and revenue growth, but the inclusion of unverified historical revenue data (2019-2021) and estimated amortization expenses suggests the model may be generating plausible-sounding but unverified details rather than strictly adhering to ground truth. The core multi-hop synthesis (asset amortization + revenue growth evolution) is present but incomplete.\n\nCALCULATION VERIFICATION: The stated $160-$170M annual amortization ($1.1B ÷ 6-7 years ≈ $157-183M) is mathematically reasonable but not verified in ground truth. The 9% growth figure is correctly stated.\n\nJUSTIFICATION: Score of 6 reflects that while core facts about the $1.1B asset and 9% revenue growth are correct, the answer introduces unverified numbers, omits the important China approval development, and doesn't clearly articulate the strategic shift from amortization focus to revenue growth focus as described in ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 618,
        "total_tokens": 1924
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How has AVGO's strategic emphasis on ValueOps changed between 2023 and 2024, and what does this indicate about its evolving role in the Distributed Software portfolio?",
      "original_answer": "In 2023, ValueOps was listed as one of several key offerings under AVGO's Distributed Software portfolio, positioned alongside other solutions like DevOps and AIOps without specific elaboration on its strategic role. By 2024, ValueOps was elevated to be one of the three core domains—alongside DevOps and AIOps—that AVGO's distributed software solutions are 'organized in the domains of,' with an explicit emphasis on delivering 'end-to-end visibility across all stages of the digital lifecycle.' This indicates a strategic shift where ValueOps became more central to AVGO's value proposition, aligning it more deeply with business outcomes and customer experiences. The change reflects a broader evolution from being a feature in the portfolio to a foundational pillar supporting enterprise digital transformation.",
      "llm_answer": "\nBetween 2023 and 2024 Broadcom’s Distributed‑Software narrative moved ValueOps from a peripheral offering to a headline pillar.  In the 2023 filing the Distributed‑Software section simply listed “ValueOps” among other solutions (DevOps, AIOps) that “optimize the planning, development and delivery of business‑critical services,” but the 2024 filing elevates ValueOps to a dedicated, end‑to‑end platform that ties together planning, development, operations and analytics, and explicitly frames it as the engine for “optimizing the planning, development and delivery of business‑critical services.”  This shift signals that Broadcom is repositioning itself from a pure‑hardware semiconductor supplier to a full‑stack software‑centric player, using ValueOps to deepen its role in customers’ digital‑transformation and to drive recurring, value‑based revenue across its Distributed‑Software portfolio.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the core shift in ValueOps positioning between 2023 and 2024, capturing the elevation from a listed offering to a more prominent role. (2) The dates (2023 vs 2024) are accurate. (3) The mention of the three core domains (DevOps, AIOps, ValueOps) is correct. (4) The reference to 'end-to-end visibility/platform' aligns with the ground truth's emphasis on 'end-to-end visibility across all stages of the digital lifecycle.' (5) No quantitative errors in numbers or calculations (none were required). WEAKNESSES: (1) ENTITY CONFUSION: The LLM refers to 'Broadcom' throughout, but the question specifically asks about 'AVGO' (Broadcom's ticker). While technically Broadcom and AVGO are the same company, the question uses AVGO and the ground truth uses 'AVGO,' so the LLM should have maintained consistency with the question's terminology. (2) OVER-INTERPRETATION: The LLM adds significant interpretive commentary about 'repositioning from pure-hardware semiconductor supplier to full-stack software-centric player' and 'recurring, value-based revenue.' While this may be reasonable inference, the ground truth focuses specifically on ValueOps' role within the Distributed Software portfolio and its elevation to a foundational pillar. The LLM's broader strategic narrative about Broadcom's overall business transformation goes beyond what the ground truth establishes. (3) INCOMPLETE ALIGNMENT: The ground truth emphasizes ValueOps becoming 'more central to AVGO's value proposition, aligning it more deeply with business outcomes and customer experiences' and 'from being a feature in the portfolio to a foundational pillar supporting enterprise digital transformation.' The LLM captures the elevation but frames it more as a business strategy shift rather than focusing on the specific role within the Distributed Software portfolio context. (4) SEMANTIC DRIFT: The LLM's framing of 'headline pillar' and 'dedicated, end-to-end platform' is somewhat different from the ground truth's 'one of the three core domains' language. The ground truth is more precise about the structural positioning. MULTI-HOP REASONING: The LLM successfully synthesizes information across 2023 and 2024 filings and identifies the comparative shift, which is correct multi-hop reasoning. However, the additional interpretations about business model transformation are not grounded in the ground truth provided.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 646,
        "total_tokens": 2080
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How did FedEx's strategic approach to Network 2.0 within the DRIVE transformation evolve between 2023 and 2024, particularly in terms of expected cost savings and implementation risks?",
      "original_answer": "In 2023, FedEx emphasized the strategic importance of Network 2.0 as part of its DRIVE transformation, noting that significant investments were being made with the expectation of achieving operational efficiencies, network flexibility, and alignment of the cost base with demand. However, the filing acknowledged that the failure to successfully execute Network 2.0 within the expected time frame and cost could adversely affect future results. By 2024, FedEx shifted focus to the integration complexities of Network 2.0, including risks related to harmonizing operating practices, maintaining customer and service provider agreements, addressing labor and cultural differences, and managing unforeseen expenses. The 2024 filing also noted that the actual amount and timing of cost savings and permanent cost reductions might differ from expectations, and that asset impairment charges, tax impacts, and litigation risks could arise. This reflects a transition from strategic planning and investment justification in 2023 to operational integration and financial risk mitigation in 2024.",
      "llm_answer": "\nBetween 2023 and 2024 FedEx shifted Network 2.0 from a DRIVE‑program concept to an operational, multi‑year effort that has already been deployed in over 50 U.S. locations, consolidating sortation facilities, re‑routing pickups and deliveries, and fully integrating FedEx Ground and Services into a single FedEx air‑ground network (completed legally in June 2024).  Management expects the initiative to deliver long‑term cost savings by improving network efficiency and aligning the cost base with demand—projecting roughly $1.5 billion in aggregate pre‑tax optimization expenses through 2025—but it warns that actual savings may fall short and that the rollout faces significant risks, including complex integration of legacy networks, labor‑relation and regulatory challenges, third‑party provider disruptions, cyber threats and potential cost overruns.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides substantial operational detail about Network 2.0's evolution and implementation status that goes beyond the ground truth, but introduces a specific quantitative claim that cannot be verified against the original answer. STRENGTHS: (1) Correctly identifies the shift from strategic planning (2023) to operational implementation (2024); (2) Accurately captures the core risks mentioned in ground truth (integration complexities, labor/cultural differences, cost overrun concerns); (3) Appropriately notes that actual savings may differ from expectations; (4) Contextually relevant and well-structured response addressing the evolution question. WEAKNESSES: (1) The $1.5 billion aggregate pre-tax optimization expenses figure through 2025 is introduced without verification against ground truth - this is a specific quantitative claim that either matches or contradicts the filing data, but cannot be confirmed from the provided ground truth; (2) The claim about 'over 50 U.S. locations' and 'June 2024' legal completion date are operational details not mentioned in ground truth, raising questions about source accuracy; (3) The ground truth emphasizes 'transition from strategic planning...to operational integration and financial risk mitigation' while LLM emphasizes already-deployed operational status - this represents a subtle but meaningful difference in characterizing the 2024 state. MULTI-HOP REASONING: The answer correctly synthesizes information across 2023-2024 filings and identifies the evolution pattern. However, the introduction of specific numbers ($1.5B) and dates (June 2024) without ground truth corroboration creates uncertainty about factual accuracy. The qualitative evolution narrative is sound, but the quantitative specificity is problematic. CALCULATION VERIFICATION: No calculations to verify, but the $1.5B figure is presented as fact without grounding in provided materials.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1495,
        "completion_tokens": 521,
        "total_tokens": 2016
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How did the financial impact from equity method investment contracts evolve between 2022 and 2023, and what does this indicate about MDLZ's engagement with these investments?",
      "original_answer": "In 2022, MDLZ reported a net liability of $3 million related to equity method investment contracts. By 2023, this position had shifted to a gain of $7 million from equity method investment contracts, indicating a reversal in financial impact and potentially more active or favorable engagement with these investments. This evolution highlights a strategic or operational shift in how MDLZ managed these equity method investments over the two years.",
      "llm_answer": "\nBetween 2022 and 2023 the earnings generated from MDLZ’s equity‑method investments fell from **$421 million to $393 million** (a roughly 7 % decline).  This reduction—amplified by the 2023 divestiture of most of the KDP stake that moved the investment out of equity‑method accounting—shows that Mondelez is **scaling back its substantive influence and active involvement in those joint‑venture investments**.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and addresses a completely different financial metric than what the ground truth specifies. CRITICAL ERRORS: (1) WRONG METRIC: The LLM discusses earnings from equity-method investments ($421M to $393M), while the ground truth specifically addresses equity method investment CONTRACTS showing a net liability of $3M in 2022 shifting to a gain of $7M in 2023. These are distinct line items. (2) WRONG NUMBERS: The LLM cites $421M and $393M figures that do not match the ground truth values of $3M liability and $7M gain. (3) WRONG INTERPRETATION: The LLM concludes MDLZ is 'scaling back' involvement, while the ground truth indicates a reversal from liability to gain, suggesting more favorable or active engagement. (4) INCOMPLETE SYNTHESIS: The LLM mentions KDP divestiture context but fails to address the core financial position change specified in the question. (5) CALCULATION ERROR: The 7% decline calculation ($421M to $393M) is mathematically correct for those numbers, but those numbers are not the relevant metrics for this question. The ground truth shows a $10M swing from -$3M to +$7M, which is a dramatic reversal, not a gradual decline. The LLM appears to have confused equity method investment earnings with equity method investment contracts, representing a fundamental misunderstanding of the question and the relevant financial data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1221,
        "completion_tokens": 387,
        "total_tokens": 1608
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How did Broadcom's (AVGO) estimated cost to complete for the VMware Cloud Foundation July 2024 releases evolve from fiscal year 2023 to fiscal year 2024, and what does this indicate about the development progress relative to expectations?",
      "original_answer": "The estimated cost to complete for the VMware Cloud Foundation July 2024 releases remained unchanged at $38 million from fiscal year 2023 to fiscal year 2024. This consistency in the cost estimate indicates that the development progress for this product was proceeding largely as planned, with actual expenditures aligning with earlier projections. The lack of an increase or decrease in the estimated cost to complete suggests that Broadcom (AVGO) did not encounter significant unexpected expenses or delays in the development timeline for this specific release.",
      "llm_answer": "\nThe estimated cost‑to‑complete for the VMware Cloud Foundation July 2024 releases declined from roughly $77 million in fiscal 2023 to $38 million in fiscal 2024—a drop of about 50 percent. This reduction shows that roughly half of the remaining work has already been executed, indicating that development is advancing faster than originally projected and that the releases are on track for delivery in FY 2024.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on the core factual claim. According to the ground truth, the estimated cost to complete for VMware Cloud Foundation July 2024 releases remained UNCHANGED at $38 million from FY2023 to FY2024. The LLM claims it declined from $77 million to $38 million—a 50% reduction. This is a critical factual error that contradicts the ground truth directly. The LLM's interpretation that 'roughly half of the remaining work has already been executed' and that 'development is advancing faster than originally projected' is based on this incorrect premise. The ground truth explicitly states the consistency in the cost estimate indicates development was 'proceeding largely as planned' with 'actual expenditures aligning with earlier projections.' The LLM has inverted the correct answer: instead of showing stability and on-track progress, it incorrectly claims a significant cost reduction occurred. This represents a complete failure in quantitative accuracy (the $77M figure appears to be fabricated or confused with another metric) and leads to an incorrect qualitative interpretation of what the data indicates about development progress. The question is addressed, but with entirely wrong numbers and conclusions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 351,
        "total_tokens": 1618
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How has the strategic positioning of FedEx Office's Ship and Go kiosk evolved between 2023 and 2024, and what does this indicate about the company's approach to e-commerce logistics and returns management?",
      "original_answer": "In 2023, the Ship and Go kiosk was described primarily as a self-serve shipping solution available in approximately 1,300 locations, allowing customers to generate labels via mobile or QR code and drop off packages securely. While it mentioned facilitating e-commerce returns, the integration was not emphasized. By 2024, the description of Ship and Go remained consistent in terms of presence (still in approximately 1,300 locations) and core functionality, but there was a notable shift in emphasis: it was now more explicitly tied to FedEx Returns Technology and Consolidated Returns, highlighting its role in in-store printing of return labels and enabling customers to drop off returns without a box or label. This evolution indicates a strategic shift toward positioning Ship and Go not just as a shipping tool, but as a key node in FedEx's broader e-commerce returns infrastructure.",
      "llm_answer": "\nThe Ship & Go kiosk has shifted from a simple self‑serve shipping point to a central node in FedEx Office’s retail‑convenience network—now installed in roughly 1,300 locations and tightly coupled with FedEx Returns Technology and the FedEx Consolidated Returns program, which lets shoppers drop off items without a box or label.  This expansion shows FedEx’s strategy of using its extensive store footprint to create an end‑to‑end, omnichannel logistics and returns solution that makes e‑commerce fulfillment and reverse‑logistics faster, easier, and more integrated for both merchants and consumers.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY: The LLM correctly identifies the ~1,300 locations figure for Ship and Go kiosk presence, matching the ground truth exactly. No calculations or numerical comparisons are required for this question, and all numeric references are accurate. ENTITY ACCURACY: All entities are correctly identified - FedEx Office, Ship and Go kiosk, FedEx Returns Technology, and FedEx Consolidated Returns program are all properly named and contextualized. The temporal comparison between 2023 and 2024 is implicit but correctly captured. MULTI-HOP REASONING: The LLM successfully synthesizes the evolution narrative: (1) 2023 positioning as self-serve shipping solution, (2) 2024 positioning with explicit returns integration, and (3) the strategic implication of this shift toward omnichannel logistics. The reasoning chain is sound and logically connects the tactical changes to broader strategic intent. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core information as the ground truth with slightly different wording. Key concepts match: 'self-serve shipping solution' aligns with 'simple self-serve shipping point,' the ~1,300 locations figure is consistent, and the shift toward returns infrastructure emphasis is clearly articulated. The LLM adds interpretive language about 'end-to-end, omnichannel logistics' and 'reverse-logistics' which represents reasonable strategic inference rather than factual error. MINOR CONSIDERATIONS: The LLM uses 'Ship & Go' (with ampersand) while ground truth uses 'Ship and Go' (spelled out) - this is a trivial formatting variation. The LLM's characterization of the strategic shift as positioning Ship and Go as 'a central node' vs. ground truth's 'a key node' is semantically equivalent. The LLM provides slightly more interpretive commentary about merchant and consumer benefits, which goes beyond the ground truth but doesn't contradict it. Overall, the answer is factually accurate, complete in addressing the question's multi-part structure, and demonstrates sound reasoning about the strategic evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 579,
        "total_tokens": 1966
      },
      "error": null
    }
  ],
  "evaluation_summary": {
    "total_questions": 999,
    "successful_evaluations": 999,
    "failed_evaluations": 0,
    "average_correctness_score": 5.19,
    "average_quantitative_accuracy": 5.46,
    "average_qualitative_accuracy": 5.48,
    "average_contextual_relevance": 6.66,
    "score_distribution": {
      "excellent": 131,
      "good": 170,
      "fair": 352,
      "poor": 346
    }
  },
  "original_experiment_metadata": {
    "model": "nemotron-nano-30b-reasoning",
    "experiment": "e6_semantic_retrieval",
    "pattern": "qualitative_2hop_cross_year",
    "total_questions": 1000,
    "successful": 999,
    "failed": 1,
    "elapsed_seconds": 11977.34,
    "timestamp": "2026-02-02T19:00:03.089264"
  }
}